{
    "55046d5ff8aee20f27000007": [
        {
            "text": "amphiregulin",
            "probability": 0.4190681157551987,
            "start_logit": 6.00173807144165,
            "end_logit": 5.885627746582031,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG) and epiregulin",
            "probability": 0.3294587011065109,
            "start_logit": 6.00173807144165,
            "end_logit": 5.645045280456543,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epiregulin",
            "probability": 0.2481795597888132,
            "start_logit": 5.71843957901001,
            "end_logit": 5.645045280456543,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG) and epiregulin (EREG)",
            "probability": 0.0010508459131344581,
            "start_logit": 6.00173807144165,
            "end_logit": -0.10281025618314743,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epiregulin (EREG)",
            "probability": 0.0007915968685958896,
            "start_logit": 5.71843957901001,
            "end_logit": -0.10281025618314743,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG)",
            "probability": 0.0005554206882707856,
            "start_logit": 6.00173807144165,
            "end_logit": -0.7404351830482483,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregu",
            "probability": 0.00015406456482478423,
            "start_logit": 6.00173807144165,
            "end_logit": -2.022789239883423,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG) and epiregu",
            "probability": 0.00010947074936553753,
            "start_logit": 6.00173807144165,
            "end_logit": -2.3645036220550537,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG) and epiregulin (EREG",
            "probability": 8.628395332059811e-05,
            "start_logit": 6.00173807144165,
            "end_logit": -2.6025173664093018,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epiregu",
            "probability": 8.246375735727589e-05,
            "start_logit": 5.71843957901001,
            "end_logit": -2.3645036220550537,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "(AREG) and epiregulin",
            "probability": 8.074690591648319e-05,
            "start_logit": -2.3121485710144043,
            "end_logit": 5.645045280456543,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "am",
            "probability": 7.797012633300489e-05,
            "start_logit": 6.00173807144165,
            "end_logit": -2.7038352489471436,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "epiregulin (EREG",
            "probability": 6.499726211517366e-05,
            "start_logit": 5.71843957901001,
            "end_logit": -2.6025173664093018,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "amphiregulin (AREG) and e",
            "probability": 5.7665648153685506e-05,
            "start_logit": 6.00173807144165,
            "end_logit": -3.0054993629455566,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "e",
            "probability": 4.343923874419545e-05,
            "start_logit": 5.71843957901001,
            "end_logit": -3.0054993629455566,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "lin",
            "probability": 3.645055538263554e-05,
            "start_logit": -3.3480939865112305,
            "end_logit": 5.885627746582031,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "regulin",
            "probability": 3.0233272885531263e-05,
            "start_logit": -3.5351076126098633,
            "end_logit": 5.885627746582031,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "lin (AREG) and epiregulin",
            "probability": 2.8656326214016132e-05,
            "start_logit": -3.3480939865112305,
            "end_logit": 5.645045280456543,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "regulin (AREG) and epiregulin",
            "probability": 2.376848641208577e-05,
            "start_logit": -3.5351076126098633,
            "end_logit": 5.645045280456543,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        },
        {
            "text": "gulin",
            "probability": 1.9549032451179255e-05,
            "start_logit": -3.9711248874664307,
            "end_logit": 5.885627746582031,
            "question_text": "List signaling molecules (ligands) that interact with the receptor EGFR?"
        }
    ],
    "553fa78b1d53b76422000007": [
        {
            "text": "MicroRNAs",
            "probability": 0.43855560189385284,
            "start_logit": -2.032909631729126,
            "end_logit": -2.4252426624298096,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MicroRNAs (miRNAs)",
            "probability": 0.18911695735635317,
            "start_logit": -2.032909631729126,
            "end_logit": -3.2663636207580566,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "profiled miRNA expression",
            "probability": 0.05711160156706771,
            "start_logit": -3.449141263961792,
            "end_logit": -3.047490358352661,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "Micro",
            "probability": 0.04849963729625197,
            "start_logit": -2.032909631729126,
            "end_logit": -4.627172946929932,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "expression",
            "probability": 0.03672729464505749,
            "start_logit": -3.8906283378601074,
            "end_logit": -3.047490358352661,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MicroRNA",
            "probability": 0.0340022304477877,
            "start_logit": -2.032909631729126,
            "end_logit": -4.982303142547607,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MicroRNAs (miRNAs) have shown diagnostic and prognostic potential in stage III and IV EOCs,",
            "probability": 0.03344477630507645,
            "start_logit": -2.032909631729126,
            "end_logit": -4.998833656311035,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "MicroRNAs (",
            "probability": 0.02216862321844782,
            "start_logit": -2.032909631729126,
            "end_logit": -5.410051345825195,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "profiled",
            "probability": 0.019627485467714173,
            "start_logit": -3.449141263961792,
            "end_logit": -4.115566730499268,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "profiled miRNA expression in stage I EOC tumours to assess whether there is a miRNA signature",
            "probability": 0.017110118092476007,
            "start_logit": -3.449141263961792,
            "end_logit": -4.2528276443481445,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "d miRNA expression",
            "probability": 0.015181177564470686,
            "start_logit": -4.774092197418213,
            "end_logit": -3.047490358352661,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "(miRNAs)",
            "probability": 0.012800207883947142,
            "start_logit": -4.725813865661621,
            "end_logit": -3.2663636207580566,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "profiled miRNA expression in stage I EOC tumours to assess whether there is a miRNA signature associated",
            "probability": 0.011246989552383443,
            "start_logit": -3.449141263961792,
            "end_logit": -4.672397136688232,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "expression in stage I EOC tumours to assess whether there is a miRNA signature",
            "probability": 0.011003164529647065,
            "start_logit": -3.8906283378601074,
            "end_logit": -4.2528276443481445,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "profiled miRNA expression in stage I EOC tumours to assess whether there is a miRNA signature associated with overall and progression-free survival",
            "probability": 0.010231768468259314,
            "start_logit": -3.449141263961792,
            "end_logit": -4.767000198364258,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "profiled miRNA",
            "probability": 0.009207511569945506,
            "start_logit": -3.449141263961792,
            "end_logit": -4.872478008270264,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "We profiled miRNA expression",
            "probability": 0.009082648823553651,
            "start_logit": -5.287782669067383,
            "end_logit": -3.047490358352661,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "s",
            "probability": 0.009002625436007662,
            "start_logit": -5.918879985809326,
            "end_logit": -2.4252426624298096,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "miRNA expression",
            "probability": 0.008111184277924599,
            "start_logit": -5.400904655456543,
            "end_logit": -3.047490358352661,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        },
        {
            "text": "assess whether there is a miRNA signature",
            "probability": 0.007768395603775984,
            "start_logit": -4.238747596740723,
            "end_logit": -4.2528276443481445,
            "question_text": "Which miRNAs could be used as potential biomarkers for epithelial ovarian cancer?"
        }
    ],
    "5149199dd24251bc05000040": [
        {
            "text": "pyridostigmine",
            "probability": 0.984406542954379,
            "start_logit": 4.771732807159424,
            "end_logit": 4.764069080352783,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridostigmine is the most commonly used, are recommended as first-line therapy for MG. Pyridostigmine",
            "probability": 0.011555745952143367,
            "start_logit": 3.1589043140411377,
            "end_logit": 1.9320414066314697,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridostigmine. Despite a lack of data from well controlled clinical trials to support their use, AChE inhibitors",
            "probability": 0.0016294610657923933,
            "start_logit": 4.771732807159424,
            "end_logit": -1.6397205591201782,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "Pyridostigmine",
            "probability": 0.001334729458536096,
            "start_logit": 1.0004501342773438,
            "end_logit": 1.9320414066314697,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "mine",
            "probability": 0.00029199993159425365,
            "start_logit": -3.3513078689575195,
            "end_logit": 4.764069080352783,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "p",
            "probability": 0.000260780492070094,
            "start_logit": 4.771732807159424,
            "end_logit": -3.472046136856079,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridostigmine.",
            "probability": 0.00021606033731402186,
            "start_logit": 4.771732807159424,
            "end_logit": -3.6601674556732178,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "yridostigmine",
            "probability": 0.00012162974688975665,
            "start_logit": -4.22707986831665,
            "end_logit": 4.764069080352783,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "pyridostigmine. Despite a lack of data from well controlled clinical trials to support their use, AChE inhibitors, of which p",
            "probability": 9.420301288201427e-05,
            "start_logit": 4.771732807159424,
            "end_logit": -4.4902729988098145,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "mine. Despite a lack of data from well controlled clinical trials to support their use, AChE inhibitors, of which pyridostigmine",
            "probability": 5.595536389842361e-05,
            "start_logit": -3.3513078689575195,
            "end_logit": 3.1118698120117188,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "AChE inhibitors, of which pyridostigmine",
            "probability": 1.6005861322815564e-05,
            "start_logit": -4.602907180786133,
            "end_logit": 3.1118698120117188,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "mine is the most commonly used, are recommended as first-line therapy for MG. Pyridostigmine",
            "probability": 5.705431678337289e-06,
            "start_logit": -4.454615116119385,
            "end_logit": 1.9320414066314697,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "yridostigmine is the most commonly used, are recommended as first-line therapy for MG. Pyridostigmine",
            "probability": 3.601196030864122e-06,
            "start_logit": -4.914767742156982,
            "end_logit": 1.9320414066314697,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase",
            "probability": 3.2955454305616437e-06,
            "start_logit": -1.422536849975586,
            "end_logit": -1.6488838195800781,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase (AChE) inhibitors",
            "probability": 1.5017978964779419e-06,
            "start_logit": -1.422536849975586,
            "end_logit": -2.4347925186157227,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "oral acetylcholinesterase",
            "probability": 8.304325149544393e-07,
            "start_logit": -2.800917148590088,
            "end_logit": -1.6488838195800781,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "ace",
            "probability": 5.992834779062768e-07,
            "start_logit": -1.422536849975586,
            "end_logit": -3.353476047515869,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "acetylcholinesterase (AChE) inhibitor",
            "probability": 4.90364102115068e-07,
            "start_logit": -1.422536849975586,
            "end_logit": -3.554062604904175,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "mine. Despite a lack of data from well controlled clinical trials to support their use, AChE inhibitors",
            "probability": 4.833394527416596e-07,
            "start_logit": -3.3513078689575195,
            "end_logit": -1.6397205591201782,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        },
        {
            "text": "oral acetylcholinesterase (AChE) inhibitors",
            "probability": 3.7843259345173693e-07,
            "start_logit": -2.800917148590088,
            "end_logit": -2.4347925186157227,
            "question_text": "Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis?"
        }
    ],
    "5709e4b2cf1c32585100001c": [
        {
            "text": "Dvl-1",
            "probability": 0.5229141963221039,
            "start_logit": 4.1796488761901855,
            "end_logit": 3.4068028926849365,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL-1",
            "probability": 0.43783109963739114,
            "start_logit": 4.208029270172119,
            "end_logit": 3.200838327407837,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dvl-1 gene",
            "probability": 0.0193986138795648,
            "start_logit": 4.1796488761901855,
            "end_logit": 0.11258711665868759,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL-1;",
            "probability": 0.006850556650882696,
            "start_logit": 4.208029270172119,
            "end_logit": -0.9566649794578552,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "The Dvl-1",
            "probability": 0.0030075579414914925,
            "start_logit": -0.978640079498291,
            "end_logit": 3.4068028926849365,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dvl-1 gene on chromosome 1p36",
            "probability": 0.002666576919459396,
            "start_logit": 4.1796488761901855,
            "end_logit": -1.8718189001083374,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL-1; the latter suppresses beta-catenin",
            "probability": 0.0020275017499061126,
            "start_logit": 4.208029270172119,
            "end_logit": -2.1741905212402344,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "DVL",
            "probability": 0.0013899623442625534,
            "start_logit": 4.208029270172119,
            "end_logit": -2.551718235015869,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dvl",
            "probability": 0.0013876594168969719,
            "start_logit": 4.1796488761901855,
            "end_logit": -2.524996042251587,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "1",
            "probability": 0.0006826909182430326,
            "start_logit": -2.4614815711975098,
            "end_logit": 3.4068028926849365,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "D",
            "probability": 0.0006061006602445227,
            "start_logit": 4.1796488761901855,
            "end_logit": -3.3533236980438232,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Dvl-1 gene on chromosome 1",
            "probability": 0.0005289979985077331,
            "start_logit": 4.1796488761901855,
            "end_logit": -3.4893851280212402,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "l-1",
            "probability": 0.0001316616576351719,
            "start_logit": -4.107288360595703,
            "end_logit": 3.4068028926849365,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": ". Wnt signaling activates the gene encoding DVL-1",
            "probability": 0.0001156444579227803,
            "start_logit": -4.031038761138916,
            "end_logit": 3.200838327407837,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Wnt signaling activates the gene encoding DVL-1",
            "probability": 0.00011194426638710782,
            "start_logit": -4.063558101654053,
            "end_logit": 3.200838327407837,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "The Dvl-1 gene",
            "probability": 0.0001115717562035254,
            "start_logit": -0.978640079498291,
            "end_logit": 0.11258711665868759,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "the gene encoding DVL-1",
            "probability": 9.686444429635004e-05,
            "start_logit": -4.20824670791626,
            "end_logit": 3.200838327407837,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "Wnt signaling pathways. Wnt signaling activates the gene encoding DVL-1",
            "probability": 5.903240989049171e-05,
            "start_logit": -4.70347261428833,
            "end_logit": 3.200838327407837,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "L-1",
            "probability": 5.64406976300497e-05,
            "start_logit": -4.748368740081787,
            "end_logit": 3.200838327407837,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        },
        {
            "text": "1 gene",
            "probability": 2.5325871080242323e-05,
            "start_logit": -2.4614815711975098,
            "end_logit": 0.11258711665868759,
            "question_text": "List the human genes encoding for the dishevelled proteins?"
        }
    ],
    "54d4e03a3706e89528000001": [
        {
            "text": "Class I",
            "probability": 0.9118897928369198,
            "start_logit": 3.1899027824401855,
            "end_logit": 3.048126459121704,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class I antiarrhythmic agents",
            "probability": 0.04818298416357542,
            "start_logit": 3.1899027824401855,
            "end_logit": 0.10761325061321259,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "I",
            "probability": 0.01589728367671921,
            "start_logit": -0.8594681024551392,
            "end_logit": 3.048126459121704,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics",
            "probability": 0.01207401682813071,
            "start_logit": 3.1899027824401855,
            "end_logit": -1.276336908340454,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class I antiarrhythmic",
            "probability": 0.005718276285213652,
            "start_logit": 3.1899027824401855,
            "end_logit": -2.0237252712249756,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class",
            "probability": 0.0029239791273905076,
            "start_logit": 3.1899027824401855,
            "end_logit": -2.6944472789764404,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "I antiarrhythmic agents",
            "probability": 0.0008399902857298604,
            "start_logit": -0.8594681024551392,
            "end_logit": 0.10761325061321259,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "antiarrhythmic agents",
            "probability": 0.0005773614663190744,
            "start_logit": -1.2343899011611938,
            "end_logit": 0.10761325061321259,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Antiarrhythmic agents are traditionally classified according to Vaughan Williams into four classes of action. Class I",
            "probability": 0.0005574269958761128,
            "start_logit": -4.210040092468262,
            "end_logit": 3.048126459121704,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class III",
            "probability": 0.0003901660720709095,
            "start_logit": -0.5639092326164246,
            "end_logit": -0.9547634720802307,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "I antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics",
            "probability": 0.00021049042564357575,
            "start_logit": -0.8594681024551392,
            "end_logit": -1.276336908340454,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "antiarrhythmic agents include most of the drugs traditionally thought of as antiarrhythmics",
            "probability": 0.00014467912648549906,
            "start_logit": -1.2343899011611938,
            "end_logit": -1.276336908340454,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "I antiarrhythmic",
            "probability": 9.968864764358074e-05,
            "start_logit": -0.8594681024551392,
            "end_logit": -2.0237252712249756,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "verapamil and diltiazem",
            "probability": 9.506344580373386e-05,
            "start_logit": -1.0609694719314575,
            "end_logit": -1.8697311878204346,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "verapamil",
            "probability": 8.78701214479368e-05,
            "start_logit": -1.0609694719314575,
            "end_logit": -1.9484158754348755,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class II",
            "probability": 6.868409027989888e-05,
            "start_logit": -0.9982722401618958,
            "end_logit": -2.257455348968506,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "antiarrhythmic",
            "probability": 6.852029690897327e-05,
            "start_logit": -1.2343899011611938,
            "end_logit": -2.0237252712249756,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "diltiazem",
            "probability": 6.337798659206079e-05,
            "start_logit": -1.4663974046707153,
            "end_logit": -1.8697311878204346,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class II agents are antisympathetic drugs, particularly the beta-adrenoceptor blockers",
            "probability": 5.661461526837652e-05,
            "start_logit": -0.9982722401618958,
            "end_logit": -2.4507057666778564,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        },
        {
            "text": "Class IV antiarrhythmic drugs are the calcium channel blockers verapamil and diltiazem",
            "probability": 5.3733505980557666e-05,
            "start_logit": -1.6314772367477417,
            "end_logit": -1.8697311878204346,
            "question_text": "Which are the classes of anti-arrhythmic drugs according to Vaughan-Williams classification?"
        }
    ],
    "55072c803b8a5dc045000001": [
        {
            "text": "NOTCH1",
            "probability": 0.33982262082351183,
            "start_logit": -0.9013475179672241,
            "end_logit": -0.5917380452156067,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH1, 3",
            "probability": 0.20406824739378893,
            "start_logit": -0.9013475179672241,
            "end_logit": -1.1017073392868042,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3 complex with NOTCH1",
            "probability": 0.12203505442154691,
            "start_logit": -1.9254629611968994,
            "end_logit": -0.5917380452156067,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3 complex with NOTCH1, 3",
            "probability": 0.07328376085164869,
            "start_logit": -1.9254629611968994,
            "end_logit": -1.1017073392868042,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH",
            "probability": 0.07196525736178362,
            "start_logit": -0.9013475179672241,
            "end_logit": -2.1439783573150635,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH1, 3, and 4",
            "probability": 0.034103457730615266,
            "start_logit": -0.9013475179672241,
            "end_logit": -2.8907630443573,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3",
            "probability": 0.033690023710542354,
            "start_logit": -1.9254629611968994,
            "end_logit": -1.8788446187973022,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3 complex with NOTCH",
            "probability": 0.02584373011226644,
            "start_logit": -1.9254629611968994,
            "end_logit": -2.1439783573150635,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "3",
            "probability": 0.017690999970985118,
            "start_logit": -3.3467459678649902,
            "end_logit": -1.1017073392868042,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "1",
            "probability": 0.014947081938659562,
            "start_logit": -4.02525520324707,
            "end_logit": -0.5917380452156067,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "CADASIL mutants of NOTCH3 complex with NOTCH1",
            "probability": 0.012797829125855675,
            "start_logit": -4.180495738983154,
            "end_logit": -0.5917380452156067,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3 complex with NOTCH1, 3, and 4",
            "probability": 0.012247028493962486,
            "start_logit": -1.9254629611968994,
            "end_logit": -2.8907630443573,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "1, 3",
            "probability": 0.008975932230414289,
            "start_logit": -4.02525520324707,
            "end_logit": -1.1017073392868042,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "CADASIL mutants of NOTCH3 complex with NOTCH1, 3",
            "probability": 0.007685275788379355,
            "start_logit": -4.180495738983154,
            "end_logit": -1.1017073392868042,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH1, 3, and 4,",
            "probability": 0.006400650560470931,
            "start_logit": -0.9013475179672241,
            "end_logit": -4.563762187957764,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "CADASIL mutants of NOTCH3",
            "probability": 0.0035330763667641737,
            "start_logit": -4.180495738983154,
            "end_logit": -1.8788446187973022,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "3, and 4",
            "probability": 0.00295648283075895,
            "start_logit": -3.3467459678649902,
            "end_logit": -2.8907630443573,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH3 mutations that lead to NOTCH3",
            "probability": 0.0029195478421713064,
            "start_logit": -3.441152334213257,
            "end_logit": -2.8089282512664795,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "CADASIL mutants of NOTCH3 complex with NOTCH",
            "probability": 0.0027102347232871777,
            "start_logit": -4.180495738983154,
            "end_logit": -2.1439783573150635,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        },
        {
            "text": "NOTCH1, 3, and 4, slow NOTCH3",
            "probability": 0.002323707722586994,
            "start_logit": -0.9013475179672241,
            "end_logit": -5.576997756958008,
            "question_text": "Which are the different isoforms of the mammalian Notch receptor?"
        }
    ],
    "53061af558348c0f52000002": [
        {
            "text": "atherosclerosis, osteoarthritis, macular degeneration, and Alzheimer dementia",
            "probability": 0.09204003052939914,
            "start_logit": 4.41269063949585,
            "end_logit": 4.380264759063721,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "atherosclerosis, osteoarthritis",
            "probability": 0.0901916237765111,
            "start_logit": 4.41269063949585,
            "end_logit": 4.359977722167969,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "Alzheimer dementia",
            "probability": 0.08569997367032825,
            "start_logit": 4.341319561004639,
            "end_logit": 4.380264759063721,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "osteoarthritis, macular degeneration, and Alzheimer dementia",
            "probability": 0.0839372162675623,
            "start_logit": 4.320536136627197,
            "end_logit": 4.380264759063721,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "osteoarthritis",
            "probability": 0.08225153541244755,
            "start_logit": 4.320536136627197,
            "end_logit": 4.359977722167969,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "macular degeneration, and Alzheimer dementia",
            "probability": 0.08220021168151222,
            "start_logit": 4.299624919891357,
            "end_logit": 4.380264759063721,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "atherosclerosis, osteoarthritis, macular degeneration",
            "probability": 0.08131642119556132,
            "start_logit": 4.41269063949585,
            "end_logit": 4.256389141082764,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "osteoarthritis, macular degeneration",
            "probability": 0.07415766805744209,
            "start_logit": 4.320536136627197,
            "end_logit": 4.256389141082764,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "macular degeneration",
            "probability": 0.07262304235463167,
            "start_logit": 4.299624919891357,
            "end_logit": 4.256389141082764,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "atherosclerosis",
            "probability": 0.07090400458669727,
            "start_logit": 4.41269063949585,
            "end_logit": 4.119368076324463,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cancer, atherosclerosis, osteoarthritis, macular degeneration, and Alzheimer dementia",
            "probability": 0.04341166724622435,
            "start_logit": 3.6611952781677246,
            "end_logit": 4.380264759063721,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cancer, atherosclerosis, osteoarthritis",
            "probability": 0.04253984638273149,
            "start_logit": 3.6611952781677246,
            "end_logit": 4.359977722167969,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cancer, atherosclerosis, osteoarthritis, macular degeneration",
            "probability": 0.0383537619260998,
            "start_logit": 3.6611952781677246,
            "end_logit": 4.256389141082764,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cancer, atherosclerosis",
            "probability": 0.03344263399129666,
            "start_logit": 3.6611952781677246,
            "end_logit": 4.119368076324463,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "dementia",
            "probability": 0.013052253370420465,
            "start_logit": 2.459427833557129,
            "end_logit": 4.380264759063721,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cancer",
            "probability": 0.01070922539855681,
            "start_logit": 3.6611952781677246,
            "end_logit": 2.980642080307007,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "atherosclerosis, osteoarthritis, macular degeneration,",
            "probability": 0.0009670912153962219,
            "start_logit": 4.41269063949585,
            "end_logit": -0.17542129755020142,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "osteoarthritis, macular degeneration,",
            "probability": 0.0008819526029084019,
            "start_logit": 4.320536136627197,
            "end_logit": -0.17542129755020142,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "macular degeneration,",
            "probability": 0.0008637013934443262,
            "start_logit": 4.299624919891357,
            "end_logit": -0.17542129755020142,
            "question_text": "Which are the major characteristics of cellular senescence?"
        },
        {
            "text": "cancer, atherosclerosis, osteoarthritis, macular degeneration,",
            "probability": 0.0004561389408287665,
            "start_logit": 3.6611952781677246,
            "end_logit": -0.17542129755020142,
            "question_text": "Which are the major characteristics of cellular senescence?"
        }
    ],
    "53137541e3eabad021000010": [
        {
            "text": "Sox2, Oct3/4 (Pou5f1), Klf4, and c-Myc",
            "probability": 0.12859403395529406,
            "start_logit": 5.530816555023193,
            "end_logit": 4.711721897125244,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Sox2",
            "probability": 0.1279549113775945,
            "start_logit": 5.530816555023193,
            "end_logit": 4.70673942565918,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Sox2, Oct3/4 (Pou5f1), Klf4",
            "probability": 0.11964040725212724,
            "start_logit": 5.530816555023193,
            "end_logit": 4.639552116394043,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Klf4, and c-Myc",
            "probability": 0.09173861226166113,
            "start_logit": 5.193099498748779,
            "end_logit": 4.711721897125244,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Oct3/4 (Pou5f1), Klf4, and c-Myc",
            "probability": 0.09042682613575007,
            "start_logit": 5.178697109222412,
            "end_logit": 4.711721897125244,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Klf4",
            "probability": 0.0853511208424011,
            "start_logit": 5.193099498748779,
            "end_logit": 4.639552116394043,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc",
            "probability": 0.08456170087363112,
            "start_logit": 5.111637592315674,
            "end_logit": 4.711721897125244,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Oct3/4 (Pou5f1), Klf4",
            "probability": 0.0841306705500784,
            "start_logit": 5.178697109222412,
            "end_logit": 4.639552116394043,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Myc",
            "probability": 0.057825389015478075,
            "start_logit": 4.731584072113037,
            "end_logit": 4.711721897125244,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Sox2, Oct3/4 (Pou5f1)",
            "probability": 0.02506542091377034,
            "start_logit": 5.530816555023193,
            "end_logit": 3.0765507221221924,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Oct3/4 (Pou5f1)",
            "probability": 0.01762590681132911,
            "start_logit": 5.178697109222412,
            "end_logit": 3.0765507221221924,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Sox2, Oct3/4",
            "probability": 0.012940956449742318,
            "start_logit": 5.530816555023193,
            "end_logit": 2.4154586791992188,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Klf4, and c-Myc, and the Thomson factors, namely Sox2, Oct3",
            "probability": 0.012540487701836234,
            "start_logit": 5.193099498748779,
            "end_logit": 2.721740961074829,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc, and the Thomson factors, namely Sox2, Oct3",
            "probability": 0.01155941804338041,
            "start_logit": 5.111637592315674,
            "end_logit": 2.721740961074829,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Sox2, Oct3",
            "probability": 0.01006035192897032,
            "start_logit": 5.530816555023193,
            "end_logit": 2.163663625717163,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Oct3/4",
            "probability": 0.009100030405127406,
            "start_logit": 5.178697109222412,
            "end_logit": 2.4154586791992188,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Klf4, and c-Myc, and the Thomson factors, namely Sox2, Oct3, Lin28",
            "probability": 0.007939718096267064,
            "start_logit": 5.193099498748779,
            "end_logit": 2.2646563053131104,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Myc, and the Thomson factors, namely Sox2, Oct3",
            "probability": 0.00790461684480432,
            "start_logit": 4.731584072113037,
            "end_logit": 2.721740961074829,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "Klf4, and c-Myc, and the Thomson factors, namely Sox2",
            "probability": 0.007720843879029168,
            "start_logit": 5.193099498748779,
            "end_logit": 2.2367022037506104,
            "question_text": "Which are the Yamanaka factors?"
        },
        {
            "text": "c-Myc, and the Thomson factors, namely Sox2, Oct3, Lin28",
            "probability": 0.0073185766617278256,
            "start_logit": 5.111637592315674,
            "end_logit": 2.2646563053131104,
            "question_text": "Which are the Yamanaka factors?"
        }
    ],
    "5718bbb37de986d80d00000b": [
        {
            "text": "Alpers syndrome",
            "probability": 0.24930002076543964,
            "start_logit": 3.967376232147217,
            "end_logit": 3.8654513359069824,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Myocerebrohepatopathy Spectrum disorders (MCHS), 2) Alpers syndrome",
            "probability": 0.07348713992412963,
            "start_logit": 2.7458295822143555,
            "end_logit": 3.8654513359069824,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Myoclonus Epilepsy Myopathy Sensory Ataxia",
            "probability": 0.07329950541543954,
            "start_logit": 3.5495986938476562,
            "end_logit": 3.0591256618499756,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "autosomal dominant Progressive External Ophthalmoplegia",
            "probability": 0.06521661150555443,
            "start_logit": 3.728508710861206,
            "end_logit": 2.763375997543335,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Ataxia Neuropathy Spectrum (ANS) disorders, 4) Myoclonus Epilepsy Myopathy Sensory Ataxia",
            "probability": 0.05381253329509265,
            "start_logit": 3.240551233291626,
            "end_logit": 3.0591256618499756,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "autosomal recessive Progressive External Ophthalmoplegia",
            "probability": 0.053081340634172976,
            "start_logit": 3.4001851081848145,
            "end_logit": 2.8858108520507812,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, 3) Ataxia Neuropathy Spectrum (ANS) disorders, 4) Myoclonus Epilepsy",
            "probability": 0.049815705552769915,
            "start_logit": 3.967376232147217,
            "end_logit": 2.255124568939209,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "childhood Myocerebrohepatopathy Spectrum disorders (MCHS), 2) Alpers syndrome",
            "probability": 0.04678759549763196,
            "start_logit": 2.294337272644043,
            "end_logit": 3.8654513359069824,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, 3) Ataxia Neuropathy Spectrum (ANS) disorders",
            "probability": 0.040220509425931625,
            "start_logit": 3.967376232147217,
            "end_logit": 2.0411713123321533,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "autosomal dominant Progressive External Ophthalmoplegia (adPEO)",
            "probability": 0.03859465164094703,
            "start_logit": 3.728508710861206,
            "end_logit": 2.2387754917144775,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Alpers syndrome, 3) Ataxia Neuropathy Spectrum",
            "probability": 0.03666062866989378,
            "start_logit": 3.967376232147217,
            "end_logit": 1.9484976530075073,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Myoclonus Epilepsy",
            "probability": 0.03280407575708723,
            "start_logit": 3.5495986938476562,
            "end_logit": 2.255124568939209,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "autosomal recessive Progressive External Ophthalmoplegia (arPEO)",
            "probability": 0.02947680484417085,
            "start_logit": 3.4001851081848145,
            "end_logit": 2.297589063644409,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Myoclonus Epilepsy Myopathy",
            "probability": 0.028271863142335523,
            "start_logit": 3.5495986938476562,
            "end_logit": 2.1064388751983643,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Ataxia Neuropathy Spectrum (ANS) disorders, 4) Myoclonus Epilepsy",
            "probability": 0.02408297858065994,
            "start_logit": 3.240551233291626,
            "end_logit": 2.255124568939209,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Myoclonus Epilepsy Myopathy Sensory Ataxia (MEMSA)",
            "probability": 0.0238110620698028,
            "start_logit": 3.5495986938476562,
            "end_logit": 1.9347220659255981,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Myocerebrohepatopathy Spectrum disorders",
            "probability": 0.02335376869260875,
            "start_logit": 2.7458295822143555,
            "end_logit": 2.719099283218384,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Ataxia Neuropathy Spectrum (ANS) disorders, 4) Myoclonus Epilepsy Myopathy",
            "probability": 0.020755673152751924,
            "start_logit": 3.240551233291626,
            "end_logit": 2.1064388751983643,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Ataxia Neuropathy Spectrum (ANS) disorders",
            "probability": 0.019444262733203096,
            "start_logit": 3.240551233291626,
            "end_logit": 2.0411713123321533,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        },
        {
            "text": "Ataxia Neuropathy Spectrum",
            "probability": 0.017723268700376514,
            "start_logit": 3.240551233291626,
            "end_logit": 1.9484976530075073,
            "question_text": "Which currently known mitochondrial diseases have been attributed to POLG mutations?"
        }
    ],
    "54f9d3eedd3fc62544000004": [
        {
            "text": "calsequestrin",
            "probability": 0.20649012067244193,
            "start_logit": 5.2307820320129395,
            "end_logit": 4.845082759857178,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin, and calsequestrin",
            "probability": 0.20361504418584692,
            "start_logit": 5.216760635375977,
            "end_logit": 4.845082759857178,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin",
            "probability": 0.1755269722559853,
            "start_logit": 5.216760635375977,
            "end_logit": 4.696644306182861,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor (Ca(2+) release channel), triadin, and calsequestrin",
            "probability": 0.13126581210807575,
            "start_logit": 4.777753829956055,
            "end_logit": 4.845082759857178,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor (Ca(2+) release channel), triadin",
            "probability": 0.11315809522907111,
            "start_logit": 4.777753829956055,
            "end_logit": 4.696644306182861,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "Junctin",
            "probability": 0.08441355518782655,
            "start_logit": 4.523967266082764,
            "end_logit": 4.657372951507568,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor",
            "probability": 0.07879246704684381,
            "start_logit": 4.777753829956055,
            "end_logit": 4.3346757888793945,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor (Ca(2+) release channel)",
            "probability": 0.001376214241038998,
            "start_logit": 4.777753829956055,
            "end_logit": 0.2871948182582855,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "the ryanodine receptor (Ca(2+) release channel), triadin, and calsequestrin",
            "probability": 0.0011177270291069326,
            "start_logit": 0.011826647445559502,
            "end_logit": 4.845082759857178,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "the ryanodine receptor (Ca(2+) release channel), triadin",
            "probability": 0.0009635400076270712,
            "start_logit": 0.011826647445559502,
            "end_logit": 4.696644306182861,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "the ryanodine receptor",
            "probability": 0.0006709170399659338,
            "start_logit": 0.011826647445559502,
            "end_logit": 4.3346757888793945,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "receptor (Ca(2+) release channel), triadin, and calsequestrin",
            "probability": 0.0005227341222737942,
            "start_logit": -0.7481528520584106,
            "end_logit": 4.845082759857178,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "receptor (Ca(2+) release channel), triadin",
            "probability": 0.0004506245505801718,
            "start_logit": -0.7481528520584106,
            "end_logit": 4.696644306182861,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "Junctin is a major transmembrane protein in cardiac junctional sarcoplasmic reticulum,",
            "probability": 0.0003203373163991367,
            "start_logit": 4.523967266082764,
            "end_logit": -0.9167357683181763,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "calsequestrin.",
            "probability": 0.0003141248051059102,
            "start_logit": 5.2307820320129395,
            "end_logit": -1.6431347131729126,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "receptor",
            "probability": 0.00031377180731268883,
            "start_logit": -0.7481528520584106,
            "end_logit": 4.3346757888793945,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin, and calsequestrin.",
            "probability": 0.0003097510712048637,
            "start_logit": 5.216760635375977,
            "end_logit": -1.6431347131729126,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor (Ca(2+) release channel), triadin, and calsequestrin.",
            "probability": 0.00019968920310201244,
            "start_logit": 4.777753829956055,
            "end_logit": -1.6431347131729126,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "triadin,",
            "probability": 0.00010177358440978698,
            "start_logit": 5.216760635375977,
            "end_logit": -2.756153106689453,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        },
        {
            "text": "ryanodine receptor (Ca(2+) release channel),",
            "probability": 7.672853578133534e-05,
            "start_logit": 4.777753829956055,
            "end_logit": -2.599623203277588,
            "question_text": "Which proteins participate in the formation of the ryanodine receptor quaternary macromolecular complex?"
        }
    ],
    "515deafd298dcd4e51000025": [
        {
            "text": "lymphoid nodular hyperplasia",
            "probability": 0.24849423606331839,
            "start_logit": 4.0595011711120605,
            "end_logit": 4.590381145477295,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "lymphoid nodular hyperplasia (LNH) and mucosal inflammation",
            "probability": 0.18986436036451135,
            "start_logit": 4.0595011711120605,
            "end_logit": 4.3212714195251465,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "ileocolonic lymphoid nodular hyperplasia",
            "probability": 0.16436954708947638,
            "start_logit": 3.6461987495422363,
            "end_logit": 4.590381145477295,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "mucosal inflammation",
            "probability": 0.1547164668442962,
            "start_logit": 3.854785442352295,
            "end_logit": 4.3212714195251465,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "ileocolonic lymphoid nodular hyperplasia (LNH) and mucosal inflammation",
            "probability": 0.1255880998124875,
            "start_logit": 3.6461987495422363,
            "end_logit": 4.3212714195251465,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "lymphoid nodular hyperplasia (LNH)",
            "probability": 0.04931821196689066,
            "start_logit": 4.0595011711120605,
            "end_logit": 2.973254919052124,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "ileocolonic lymphoid nodular hyperplasia (LNH)",
            "probability": 0.03262213358620934,
            "start_logit": 3.6461987495422363,
            "end_logit": 2.973254919052124,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "ileocolonic",
            "probability": 0.009484177619153066,
            "start_logit": 3.6461987495422363,
            "end_logit": 1.7378888130187988,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "Intestinal pathology, i.e., ileocolonic lymphoid nodular hyperplasia",
            "probability": 0.0046528787283412875,
            "start_logit": 0.08156763017177582,
            "end_logit": 4.590381145477295,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "lymphoid nodular hyperplasia (LNH) and mucosal inflammation,",
            "probability": 0.0031612533218076224,
            "start_logit": 4.0595011711120605,
            "end_logit": 0.22593006491661072,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "nodular hyperplasia",
            "probability": 0.003061143559843397,
            "start_logit": -0.3371299207210541,
            "end_logit": 4.590381145477295,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "mucosal inflammation,",
            "probability": 0.002576038724755267,
            "start_logit": 3.854785442352295,
            "end_logit": 0.22593006491661072,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "nodular hyperplasia (LNH) and mucosal inflammation",
            "probability": 0.002338895554203176,
            "start_logit": -0.3371299207210541,
            "end_logit": 4.3212714195251465,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "lymphoid nodular hyperplasia (LNH",
            "probability": 0.002276808008207919,
            "start_logit": 4.0595011711120605,
            "end_logit": -0.10226403921842575,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "ileocolonic lymphoid nodular hyperplasia (LNH) and mucosal inflammation,",
            "probability": 0.0020910496153650005,
            "start_logit": 3.6461987495422363,
            "end_logit": 0.22593006491661072,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "ileocolonic lymphoid nodular hyperplasia (LNH",
            "probability": 0.0015060224617180638,
            "start_logit": 3.6461987495422363,
            "end_logit": -0.10226403921842575,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "LNH) and mucosal inflammation",
            "probability": 0.0010679266478630049,
            "start_logit": -1.1210896968841553,
            "end_logit": 4.3212714195251465,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "lymphoid",
            "probability": 0.001026395529283064,
            "start_logit": 4.0595011711120605,
            "end_logit": -0.8989853262901306,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "Intestinal pathology, i.e., ileocolonic lymphoid nodular hyperplasia (LNH)",
            "probability": 0.0009234486200400278,
            "start_logit": 0.08156763017177582,
            "end_logit": 2.973254919052124,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        },
        {
            "text": "lymphoid nodular h",
            "probability": 0.0008609058822292733,
            "start_logit": 4.0595011711120605,
            "end_logit": -1.0748085975646973,
            "question_text": "List the endoscopic diagnoses that have been reported in children with autism"
        }
    ],
    "52bf202003868f1b06000018": [
        {
            "text": "epilepsy",
            "probability": 0.9961915677753044,
            "start_logit": 6.890684604644775,
            "end_logit": 6.601062774658203,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epile",
            "probability": 0.0011903881764471918,
            "start_logit": 6.890684604644775,
            "end_logit": -0.12859734892845154,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "pilepsy",
            "probability": 0.0010745460227121555,
            "start_logit": 0.05864329636096954,
            "end_logit": 6.601062774658203,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "e",
            "probability": 0.0004830383954518889,
            "start_logit": 6.890684604644775,
            "end_logit": -1.0305359363555908,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "treatment of epilepsy",
            "probability": 0.0003996710235068585,
            "start_logit": -0.9303684830665588,
            "end_logit": 6.601062774658203,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "psy",
            "probability": 0.0003583719475971928,
            "start_logit": -1.0394388437271118,
            "end_logit": 6.601062774658203,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "salivary TDM can be usefully applied so as to optimize the treatment of epilepsy",
            "probability": 0.00013993560740470975,
            "start_logit": -1.979827880859375,
            "end_logit": 6.601062774658203,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy with carbamazepine",
            "probability": 6.713132185204398e-05,
            "start_logit": 6.890684604644775,
            "end_logit": -3.003981351852417,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "antiepileptic",
            "probability": 2.3179778041936873e-05,
            "start_logit": 1.5166507959365845,
            "end_logit": 1.3066819906234741,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy with carbamazepine, clobazam, ethosuximide, gabapentin",
            "probability": 2.0232932067937892e-05,
            "start_logit": 6.890684604644775,
            "end_logit": -4.203320503234863,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy with carbamazepine, clobazam",
            "probability": 1.4506073963531078e-05,
            "start_logit": 6.890684604644775,
            "end_logit": -4.536064624786377,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "antiepileptic drug",
            "probability": 1.2366227458523116e-05,
            "start_logit": 1.5166507959365845,
            "end_logit": 0.6783708930015564,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "epilepsy.",
            "probability": 1.1516319981220598e-05,
            "start_logit": 4.601818561553955,
            "end_logit": -2.4780008792877197,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "optimize the treatment of epilepsy",
            "probability": 1.0971459209559627e-05,
            "start_logit": -4.525712966918945,
            "end_logit": 6.601062774658203,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "pile",
            "probability": 1.2840169720985017e-06,
            "start_logit": 0.05864329636096954,
            "end_logit": -0.12859734892845154,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "treatment of epile",
            "probability": 4.775825014395452e-07,
            "start_logit": -0.9303684830665588,
            "end_logit": -0.12859734892845154,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "antiepileptic drug (AED)",
            "probability": 2.554134013354104e-07,
            "start_logit": 1.5166507959365845,
            "end_logit": -3.201470136642456,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "antiepileptic drug (AED) therapeutic drug monitoring (TDM)",
            "probability": 1.9891710547536017e-07,
            "start_logit": 1.5166507959365845,
            "end_logit": -3.451465368270874,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "treatment of e",
            "probability": 1.9379450313407178e-07,
            "start_logit": -0.9303684830665588,
            "end_logit": -1.0305359363555908,
            "question_text": "What are the main indications of lacosamide?"
        },
        {
            "text": "salivary TDM can be usefully applied so as to optimize the treatment of epile",
            "probability": 1.672145176760771e-07,
            "start_logit": -1.979827880859375,
            "end_logit": -0.12859734892845154,
            "question_text": "What are the main indications of lacosamide?"
        }
    ],
    "56be0da3ef6e394741000007": [
        {
            "text": "thrombocytopenia",
            "probability": 0.3652313079679851,
            "start_logit": 5.149392127990723,
            "end_logit": 5.250874042510986,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia and acute renal injury",
            "probability": 0.23255822107574234,
            "start_logit": 5.149392127990723,
            "end_logit": 4.799483776092529,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "renal injury",
            "probability": 0.1012122688427276,
            "start_logit": 4.317471504211426,
            "end_logit": 4.799483776092529,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "acute renal injury",
            "probability": 0.09608221216702793,
            "start_logit": 4.265455722808838,
            "end_logit": 4.799483776092529,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.09014451626526056,
            "start_logit": 3.7502753734588623,
            "end_logit": 5.250874042510986,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia and acute renal injury",
            "probability": 0.05739882612752337,
            "start_logit": 3.7502753734588623,
            "end_logit": 4.799483776092529,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia",
            "probability": 0.022494311907399443,
            "start_logit": 3.7502753734588623,
            "end_logit": 3.862722396850586,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "thrombocytopenia and acute renal injury.",
            "probability": 0.007151962401288737,
            "start_logit": 5.149392127990723,
            "end_logit": 1.3177299499511719,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia, thrombocytopenia",
            "probability": 0.005010435572678437,
            "start_logit": 0.8603841066360474,
            "end_logit": 5.250874042510986,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia, thrombocytopenia",
            "probability": 0.004049289321279442,
            "start_logit": 0.6474026441574097,
            "end_logit": 5.250874042510986,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia, thrombocytopenia and acute renal injury",
            "probability": 0.0031903562432245122,
            "start_logit": 0.8603841066360474,
            "end_logit": 4.799483776092529,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "renal injury.",
            "probability": 0.0031126241762769505,
            "start_logit": 4.317471504211426,
            "end_logit": 1.3177299499511719,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "acute renal injury.",
            "probability": 0.00295485735001139,
            "start_logit": 4.265455722808838,
            "end_logit": 1.3177299499511719,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia, thrombocytopenia and acute renal injury",
            "probability": 0.0025783537737139794,
            "start_logit": 0.6474026441574097,
            "end_logit": 4.799483776092529,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia, thrombocytopenia and acute renal injury.",
            "probability": 0.0017652106403430714,
            "start_logit": 3.7502753734588623,
            "end_logit": 1.3177299499511719,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic",
            "probability": 0.0017093155971249622,
            "start_logit": 3.7502753734588623,
            "end_logit": 1.285552978515625,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.0012502846011409848,
            "start_logit": 0.8603841066360474,
            "end_logit": 3.862722396850586,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "anemia",
            "probability": 0.0010104439046312104,
            "start_logit": 0.6474026441574097,
            "end_logit": 3.862722396850586,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": "microangiopathic hemolytic anemia,",
            "probability": 0.000787910544344196,
            "start_logit": 3.7502753734588623,
            "end_logit": 0.5110892057418823,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        },
        {
            "text": ": microangiopathic hemolytic anemia, thrombocytopenia",
            "probability": 0.0003072915202757507,
            "start_logit": -1.931097149848938,
            "end_logit": 5.250874042510986,
            "question_text": "List Hemolytic Uremic Syndrome Triad."
        }
    ],
    "515a7ffdd24251bc050000a5": [
        {
            "text": "inhibition of cell growth",
            "probability": 0.32980874101056407,
            "start_logit": 5.383742332458496,
            "end_logit": 5.914973258972168,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "induction of fibronectin expression and inhibition of cell growth",
            "probability": 0.19879070124322146,
            "start_logit": 4.877481937408447,
            "end_logit": 5.914973258972168,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "induction of fibronectin expression",
            "probability": 0.08400999986668295,
            "start_logit": 4.877481937408447,
            "end_logit": 5.053656578063965,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "decreased key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 0.06433208043823654,
            "start_logit": 3.7492878437042236,
            "end_logit": 5.914973258972168,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "significantly decreased key TGFbeta responses, including induction of fibronectin expression and inhibition of cell growth",
            "probability": 0.05937794381193564,
            "start_logit": 3.66915225982666,
            "end_logit": 5.914973258972168,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "fibronectin expression and inhibition of cell growth",
            "probability": 0.051373962421971744,
            "start_logit": 3.5243608951568604,
            "end_logit": 5.914973258972168,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "decreased key TGFbeta responses, including induction of fibronectin expression",
            "probability": 0.0271870768362913,
            "start_logit": 3.7492878437042236,
            "end_logit": 5.053656578063965,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "cell growth",
            "probability": 0.02691552155853013,
            "start_logit": 2.877932548522949,
            "end_logit": 5.914973258972168,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "significantly decreased key TGFbeta responses, including induction of fibronectin expression",
            "probability": 0.025093432542507916,
            "start_logit": 3.66915225982666,
            "end_logit": 5.053656578063965,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "decreased key TGFbeta responses",
            "probability": 0.02355046514748308,
            "start_logit": 3.7492878437042236,
            "end_logit": 4.910060405731201,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "significantly decreased key TGFbeta responses",
            "probability": 0.021736871973458766,
            "start_logit": 3.66915225982666,
            "end_logit": 4.910060405731201,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "fibronectin expression",
            "probability": 0.021710907749856286,
            "start_logit": 3.5243608951568604,
            "end_logit": 5.053656578063965,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "induction of fibronectin",
            "probability": 0.015070349343123669,
            "start_logit": 4.877481937408447,
            "end_logit": 3.3354499340057373,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "inhibition",
            "probability": 0.010238053700229758,
            "start_logit": 5.383742332458496,
            "end_logit": 2.4425718784332275,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "hibition of cell growth",
            "probability": 0.008790916975908376,
            "start_logit": 1.7589484453201294,
            "end_logit": 5.914973258972168,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "growth",
            "probability": 0.008450186489923215,
            "start_logit": 1.719417929649353,
            "end_logit": 5.914973258972168,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "inhibition of cell growth. Thus, our results demonstrate that km23 is required for TGFbeta induction of fibronectin expression",
            "probability": 0.008013375832065829,
            "start_logit": 5.383742332458496,
            "end_logit": 2.1975724697113037,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "induction of fibronectin expression and inhibition",
            "probability": 0.006170939764053256,
            "start_logit": 4.877481937408447,
            "end_logit": 2.4425718784332275,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "decreased key TGFbeta responses, including induction of fibronectin",
            "probability": 0.004877023523288247,
            "start_logit": 3.7492878437042236,
            "end_logit": 3.3354499340057373,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        },
        {
            "text": "significantly decreased key TGFbeta responses, including induction of fibronectin",
            "probability": 0.004501449770668042,
            "start_logit": 3.66915225982666,
            "end_logit": 3.3354499340057373,
            "question_text": "What are the effects of depleting protein  km23-1 (DYNLRB1)  in a cell?"
        }
    ],
    "56a92be0a17756b72f000009": [
        {
            "text": "SoxB1",
            "probability": 0.16550200750191274,
            "start_logit": 4.61664342880249,
            "end_logit": 3.8301737308502197,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1 (also called Oct4) and SoxB1",
            "probability": 0.11931228364110982,
            "start_logit": 4.289404392242432,
            "end_logit": 3.8301737308502197,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 (also called Oct4) and SoxB1",
            "probability": 0.11730976490888981,
            "start_logit": 4.272478103637695,
            "end_logit": 3.8301737308502197,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 and SoxB1",
            "probability": 0.11127195944231703,
            "start_logit": 4.307201385498047,
            "end_logit": 3.742609739303589,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1 and SoxB1",
            "probability": 0.10527851299489463,
            "start_logit": 4.251833438873291,
            "end_logit": 3.742609739303589,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1",
            "probability": 0.09689761799022581,
            "start_logit": 4.307201385498047,
            "end_logit": 3.6042873859405518,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1",
            "probability": 0.09400738967262381,
            "start_logit": 4.289404392242432,
            "end_logit": 3.5918028354644775,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog",
            "probability": 0.059363127540271156,
            "start_logit": 4.307201385498047,
            "end_logit": 3.1143057346343994,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Oct4) and SoxB1",
            "probability": 0.0385517106412624,
            "start_logit": 3.159660577774048,
            "end_logit": 3.8301737308502197,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "SoxB1 are required to initiate the zygotic developmental program and induce clearance of the maternal program by activating miR-430",
            "probability": 0.028962582892546433,
            "start_logit": 4.47369384765625,
            "end_logit": 2.230144739151001,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1 (also called Oct4)",
            "probability": 0.015390495618973038,
            "start_logit": 4.289404392242432,
            "end_logit": 1.782179594039917,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 (also called Oct4)",
            "probability": 0.015132183944478156,
            "start_logit": 4.272478103637695,
            "end_logit": 1.782179594039917,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1 (also called Oct4",
            "probability": 0.006677775892370197,
            "start_logit": 4.289404392242432,
            "end_logit": 0.9472144246101379,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 (also called Oct4",
            "probability": 0.006565697144851941,
            "start_logit": 4.272478103637695,
            "end_logit": 0.9472144246101379,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Oct4)",
            "probability": 0.0049729157436378965,
            "start_logit": 3.159660577774048,
            "end_logit": 1.782179594039917,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "SoxB",
            "probability": 0.003914275758413834,
            "start_logit": 4.61664342880249,
            "end_logit": 0.08582072705030441,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "miR-430",
            "probability": 0.002940406280739007,
            "start_logit": 2.18623685836792,
            "end_logit": 2.230144739151001,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Pou5f1 (also called Oct4) and SoxB",
            "probability": 0.0028218460101276668,
            "start_logit": 4.289404392242432,
            "end_logit": 0.08582072705030441,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 (also called Oct4) and SoxB",
            "probability": 0.002774484587462097,
            "start_logit": 4.272478103637695,
            "end_logit": 0.08582072705030441,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        },
        {
            "text": "Nanog, Pou5f1 and SoxB",
            "probability": 0.002352961792892549,
            "start_logit": 4.307201385498047,
            "end_logit": -0.11369267851114273,
            "question_text": "Which factors activate zygotic gene expression during the maternal-to-zygotic transition in zebrafish?"
        }
    ],
    "56c3327c50c68dd41600000c": [
        {
            "text": "C",
            "probability": 0.552639642801127,
            "start_logit": 3.0453250408172607,
            "end_logit": 2.1276302337646484,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "G-rich RNA strand by an RNA polymerase upon transcription of a C",
            "probability": 0.15661387153414022,
            "start_logit": 1.7844022512435913,
            "end_logit": 2.1276302337646484,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C-rich DNA template strand",
            "probability": 0.06891649068387029,
            "start_logit": 3.0453250408172607,
            "end_logit": 0.04581957682967186,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "G",
            "probability": 0.06419756697965309,
            "start_logit": 1.7844022512435913,
            "end_logit": 1.2358121871948242,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C-rich DNA",
            "probability": 0.03720586258726266,
            "start_logit": 3.0453250408172607,
            "end_logit": -0.5706095695495605,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "RNA strand by an RNA polymerase upon transcription of a C",
            "probability": 0.019582033277692115,
            "start_logit": -0.29476863145828247,
            "end_logit": 2.1276302337646484,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "G-rich RNA strand by an RNA polymerase upon transcription of a C-rich DNA template strand",
            "probability": 0.019530409298616862,
            "start_logit": 1.7844022512435913,
            "end_logit": 0.04581957682967186,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "transcription of a C",
            "probability": 0.013552560427789297,
            "start_logit": -0.6628056168556213,
            "end_logit": 2.1276302337646484,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "RNA polymerase upon transcription of a C",
            "probability": 0.011649571499728721,
            "start_logit": -0.8141117095947266,
            "end_logit": 2.1276302337646484,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C-rich DNA template",
            "probability": 0.01079466193679045,
            "start_logit": 3.0453250408172607,
            "end_logit": -1.8080241680145264,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "G-rich RNA strand by an RNA polymerase upon transcription of a C-rich DNA",
            "probability": 0.010543858478960614,
            "start_logit": 1.7844022512435913,
            "end_logit": -0.5706095695495605,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C-rich DNA template strand.",
            "probability": 0.006391281230704699,
            "start_logit": 3.0453250408172607,
            "end_logit": -2.332141160964966,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "a C",
            "probability": 0.005468391776440307,
            "start_logit": -1.5703965425491333,
            "end_logit": 2.1276302337646484,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "a G-rich RNA strand by an RNA polymerase upon transcription of a C",
            "probability": 0.004641324553876258,
            "start_logit": -1.7343813180923462,
            "end_logit": 2.1276302337646484,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "generation of a G-rich RNA strand by an RNA polymerase upon transcription of a C",
            "probability": 0.003724147158473915,
            "start_logit": -1.9545432329177856,
            "end_logit": 2.1276302337646484,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "C-rich",
            "probability": 0.0034773299989223987,
            "start_logit": 3.0453250408172607,
            "end_logit": -2.9408111572265625,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "G-rich RNA strand",
            "probability": 0.0032485419563547356,
            "start_logit": 1.7844022512435913,
            "end_logit": -1.747946858406067,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "G-rich RNA strand by an RNA polymerase upon transcription of a C-rich DNA template",
            "probability": 0.0030591250914501437,
            "start_logit": 1.7844022512435913,
            "end_logit": -1.8080241680145264,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "RNA strand by an RNA polymerase upon transcription of a C-rich DNA template strand",
            "probability": 0.0024419620118329927,
            "start_logit": -0.29476863145828247,
            "end_logit": 0.04581957682967186,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        },
        {
            "text": "G-rich RNA strand by an RNA polymerase upon transcription",
            "probability": 0.002321366716313443,
            "start_logit": 1.7844022512435913,
            "end_logit": -2.0839970111846924,
            "question_text": "Which DNA sequences are more prone for the formation of R-loops?"
        }
    ],
    "5314a7a4dae131f847000003": [
        {
            "text": "C84Y",
            "probability": 0.169691914361314,
            "start_logit": 5.0778889656066895,
            "end_logit": 4.865331649780273,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V, C84Y",
            "probability": 0.16159010929547743,
            "start_logit": 5.028967380523682,
            "end_logit": 4.865331649780273,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V",
            "probability": 0.14408633807600305,
            "start_logit": 5.028967380523682,
            "end_logit": 4.750681400299072,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "C84Y, E134D",
            "probability": 0.09534325897009104,
            "start_logit": 5.0778889656066895,
            "end_logit": 4.288830757141113,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V, C84Y, E134D",
            "probability": 0.09079117113830124,
            "start_logit": 5.028967380523682,
            "end_logit": 4.288830757141113,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "E134D",
            "probability": 0.08255431155983932,
            "start_logit": 4.93386173248291,
            "end_logit": 4.288830757141113,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "C84Y, E134D, and D145E",
            "probability": 0.0725058699274272,
            "start_logit": 5.0778889656066895,
            "end_logit": 4.0150146484375,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V, C84Y, E134D, and D145E",
            "probability": 0.06904413501511933,
            "start_logit": 5.028967380523682,
            "end_logit": 4.0150146484375,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "E134D, and D145E",
            "probability": 0.06278023470735043,
            "start_logit": 4.93386173248291,
            "end_logit": 4.0150146484375,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "D145E",
            "probability": 0.04410496737803374,
            "start_logit": 4.580793857574463,
            "end_logit": 4.0150146484375,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(A8V, C84Y",
            "probability": 0.0019393171965217087,
            "start_logit": 0.6062403917312622,
            "end_logit": 4.865331649780273,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(A8V",
            "probability": 0.0017292463903448455,
            "start_logit": 0.6062403917312622,
            "end_logit": 4.750681400299072,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(A8V, C84Y, E134D",
            "probability": 0.0010896265882145856,
            "start_logit": 0.6062403917312622,
            "end_logit": 4.288830757141113,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(A8V, C84Y, E134D, and D145E",
            "probability": 0.0008286304089871366,
            "start_logit": 0.6062403917312622,
            "end_logit": 4.0150146484375,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "C84Y,",
            "probability": 0.0006186270667425797,
            "start_logit": 5.0778889656066895,
            "end_logit": -0.7489055395126343,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V, C84Y,",
            "probability": 0.0005890912110003495,
            "start_logit": 5.028967380523682,
            "end_logit": -0.7489055395126343,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V,",
            "probability": 0.00034838769697709623,
            "start_logit": 5.028967380523682,
            "end_logit": -1.2741706371307373,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "C84Y, E134D, and D145E)",
            "probability": 0.0001294348774131902,
            "start_logit": 5.0778889656066895,
            "end_logit": -2.313230276107788,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "A8V, C84Y, E134D, and D145E)",
            "probability": 0.00012325511245815944,
            "start_logit": 5.028967380523682,
            "end_logit": -2.313230276107788,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "E134D, and D145E)",
            "probability": 0.00011207302238357615,
            "start_logit": 4.93386173248291,
            "end_logit": -2.313230276107788,
            "question_text": "which mutations of troponin C gene have been found to cause hypertrophic cardiomyopathy?"
        }
    ],
    "56c6dd275795f9a73e000008": [
        {
            "text": "Methylation of histone H3 at lysine 9",
            "probability": 0.47801123147735447,
            "start_logit": 2.7075843811035156,
            "end_logit": 0.8202762007713318,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "Methylation of histone H3 at lysine 9 (H3-Lys9",
            "probability": 0.19020803168901088,
            "start_logit": 2.7075843811035156,
            "end_logit": -0.1012396514415741,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "Methylation of histone H3 at lysine 9 (H3-Lys9)",
            "probability": 0.13205081666201246,
            "start_logit": 2.7075843811035156,
            "end_logit": -0.4661712050437927,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "Methylation",
            "probability": 0.08225408487130112,
            "start_logit": 2.7075843811035156,
            "end_logit": -0.9395449757575989,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "Met",
            "probability": 0.05132212678420122,
            "start_logit": 2.7075843811035156,
            "end_logit": -1.411236047744751,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3-Lys9",
            "probability": 0.015250251123011649,
            "start_logit": 0.18406197428703308,
            "end_logit": -0.1012396514415741,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "histone H3 at lysine 9",
            "probability": 0.011609722691806141,
            "start_logit": -1.010206937789917,
            "end_logit": 0.8202762007713318,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3-Lys9)",
            "probability": 0.01058739789909096,
            "start_logit": 0.18406197428703308,
            "end_logit": -0.4661712050437927,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "Methylation of histone H3",
            "probability": 0.010508770873057469,
            "start_logit": 2.7075843811035156,
            "end_logit": -2.997147798538208,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "histone H3 at lysine 9 (H3-Lys9",
            "probability": 0.004619687480645121,
            "start_logit": -1.010206937789917,
            "end_logit": -0.1012396514415741,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "histone H3 at lysine 9 (H3-Lys9)",
            "probability": 0.003207191090331372,
            "start_logit": -1.010206937789917,
            "end_logit": -0.4661712050437927,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "9",
            "probability": 0.0021494406689629326,
            "start_logit": -2.6968421936035156,
            "end_logit": 0.8202762007713318,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "Methylation of histone H3 at lysine 9 (H3-Lys9) by site-specific histone met",
            "probability": 0.002013900096662816,
            "start_logit": 2.7075843811035156,
            "end_logit": -4.649284839630127,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3-Lys9) by site-specific histone methyltransferases (Suv39h HMTases)",
            "probability": 0.0014404881436383547,
            "start_logit": 0.18406197428703308,
            "end_logit": -2.4608535766601562,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "(H3-Lys9",
            "probability": 0.0011708048929437971,
            "start_logit": -2.382842540740967,
            "end_logit": -0.1012396514415741,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "9 (H3-Lys9",
            "probability": 0.0008552955494626676,
            "start_logit": -2.6968421936035156,
            "end_logit": -0.1012396514415741,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "(H3-Lys9)",
            "probability": 0.0008128244685160719,
            "start_logit": -2.382842540740967,
            "end_logit": -0.4661712050437927,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "lysine 9",
            "probability": 0.0007285007574292824,
            "start_logit": -3.7788164615631104,
            "end_logit": 0.8202762007713318,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "H3 at lysine 9",
            "probability": 0.0006056488336318764,
            "start_logit": -3.9635047912597656,
            "end_logit": 0.8202762007713318,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        },
        {
            "text": "9 (H3-Lys9)",
            "probability": 0.000593783946929172,
            "start_logit": -2.6968421936035156,
            "end_logit": -0.4661712050437927,
            "question_text": "Which post-translational histone modifications are characteristic of constitutive heterochromatin?"
        }
    ],
    "5322d9339b2d7acc7e000011": [
        {
            "text": "apoptosis",
            "probability": 0.44597325772204116,
            "start_logit": 5.925272464752197,
            "end_logit": 6.190701484680176,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition and apoptosis",
            "probability": 0.259403947242598,
            "start_logit": 5.383399963378906,
            "end_logit": 6.190701484680176,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition",
            "probability": 0.17766976212079288,
            "start_logit": 5.383399963378906,
            "end_logit": 5.812241554260254,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells",
            "probability": 0.028605404198712114,
            "start_logit": 5.925272464752197,
            "end_logit": 3.444038152694702,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "induced growth inhibition and apoptosis",
            "probability": 0.01711710130006778,
            "start_logit": 2.6650915145874023,
            "end_logit": 6.190701484680176,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition and apoptosis of CCA cells",
            "probability": 0.0166385643828015,
            "start_logit": 5.383399963378906,
            "end_logit": 3.444038152694702,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "induced growth inhibition",
            "probability": 0.011723766536738142,
            "start_logit": 2.6650915145874023,
            "end_logit": 5.812241554260254,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells, with an associated decrease",
            "probability": 0.009914347069110974,
            "start_logit": 5.925272464752197,
            "end_logit": 2.384425401687622,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition and apoptosis of CCA cells, with an associated decrease",
            "probability": 0.005766760045651417,
            "start_logit": 5.383399963378906,
            "end_logit": 2.384425401687622,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells, with an associated decrease in mitogen-activated protein kinases, PI3K/Akt",
            "probability": 0.005598327782395415,
            "start_logit": 5.925272464752197,
            "end_logit": 1.8129104375839233,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells,",
            "probability": 0.0052142772614024386,
            "start_logit": 5.925272464752197,
            "end_logit": 1.7418429851531982,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition and apoptosis of CCA cells,",
            "probability": 0.0030329264820361614,
            "start_logit": 5.383399963378906,
            "end_logit": 1.7418429851531982,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis induction",
            "probability": 0.0028428264193218855,
            "start_logit": 4.547706127166748,
            "end_logit": 2.512807607650757,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "apoptosis of CCA cells, with an associated decrease in mitogen-activated protein kinases",
            "probability": 0.0021477498907985474,
            "start_logit": 5.925272464752197,
            "end_logit": 0.8548632264137268,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "decrease",
            "probability": 0.0020080689115835274,
            "start_logit": 4.328463077545166,
            "end_logit": 2.384425401687622,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth",
            "probability": 0.0015399048949190006,
            "start_logit": 5.383399963378906,
            "end_logit": 1.0640356540679932,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "poptosis",
            "probability": 0.0013182165099404383,
            "start_logit": 0.1012931689620018,
            "end_logit": 6.190701484680176,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "growth inhibition and apoptosis of CCA cells, with an associated decrease in mitogen-activated protein kinases",
            "probability": 0.0012492560702154116,
            "start_logit": 5.383399963378906,
            "end_logit": 0.8548632264137268,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "decrease in mitogen-activated protein kinases, PI3K/Akt",
            "probability": 0.0011338949401627763,
            "start_logit": 4.328463077545166,
            "end_logit": 1.8129104375839233,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        },
        {
            "text": "inhibition and apoptosis",
            "probability": 0.0011016402187100992,
            "start_logit": -0.07818634808063507,
            "end_logit": 6.190701484680176,
            "question_text": "What are the main results of PRKAR1A Knockdown?"
        }
    ],
    "56c1f005ef6e39474100003a": [
        {
            "text": "IL-4",
            "probability": 0.6555416616800854,
            "start_logit": 4.7001423835754395,
            "end_logit": 4.394019603729248,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor \u03b1, markedly improved disease activity, but the effect of IL-4/IL-13",
            "probability": 0.2001965481917456,
            "start_logit": 4.7001423835754395,
            "end_logit": 3.207857370376587,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor \u03b1, markedly improved disease activity, but the effect of IL-4",
            "probability": 0.059480544692898554,
            "start_logit": 4.7001423835754395,
            "end_logit": 1.9942070245742798,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4/IL-13",
            "probability": 0.023205610174387308,
            "start_logit": 2.545236825942993,
            "end_logit": 3.207857370376587,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-13",
            "probability": 0.022259859152739238,
            "start_logit": 2.5036277770996094,
            "end_logit": 3.207857370376587,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor \u03b1",
            "probability": 0.022196322413639565,
            "start_logit": 4.7001423835754395,
            "end_logit": 1.0084843635559082,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor \u03b1,",
            "probability": 0.009830866635567608,
            "start_logit": 4.7001423835754395,
            "end_logit": 0.19408483803272247,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4",
            "probability": 0.0014815182212074664,
            "start_logit": -1.3922520875930786,
            "end_logit": 4.394019603729248,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor \u03b1, markedly improved disease activity,",
            "probability": 0.0012314223028537434,
            "start_logit": 4.7001423835754395,
            "end_logit": -1.883272409439087,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor",
            "probability": 0.0011152063477572363,
            "start_logit": 4.7001423835754395,
            "end_logit": -1.9824028015136719,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL",
            "probability": 0.0009482935799185131,
            "start_logit": 4.7001423835754395,
            "end_logit": -2.144533395767212,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "targeting IL-4",
            "probability": 0.0005154753998772356,
            "start_logit": -2.4479851722717285,
            "end_logit": 4.394019603729248,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4 receptor \u03b1, markedly improved disease activity, but the effect of IL-4/IL-13",
            "probability": 0.00045244238666504867,
            "start_logit": -1.3922520875930786,
            "end_logit": 3.207857370376587,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor \u03b1, markedly improved disease activity, but the effect of IL",
            "probability": 0.0004206909756096614,
            "start_logit": 4.7001423835754395,
            "end_logit": -2.957298994064331,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "IL-4 receptor \u03b1, markedly improved disease activity, but the effect of IL-4/IL",
            "probability": 0.0003093965294533191,
            "start_logit": 4.7001423835754395,
            "end_logit": -3.264573812484741,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "13",
            "probability": 0.0002751659120316966,
            "start_logit": -1.889538288116455,
            "end_logit": 3.207857370376587,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "targeting IL-4 receptor \u03b1, markedly improved disease activity, but the effect of IL-4/IL-13",
            "probability": 0.0001574215671795758,
            "start_logit": -2.4479851722717285,
            "end_logit": 3.207857370376587,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": "4 receptor \u03b1, markedly improved disease activity, but the effect of IL-4",
            "probability": 0.0001344254925675173,
            "start_logit": -1.3922520875930786,
            "end_logit": 1.9942070245742798,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": ", a fully human mAb targeting IL-4",
            "probability": 0.00012482011132054335,
            "start_logit": -3.866201162338257,
            "end_logit": 4.394019603729248,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        },
        {
            "text": ", dupilumab, a fully human mAb targeting IL-4",
            "probability": 0.00012230823249513229,
            "start_logit": -3.8865303993225098,
            "end_logit": 4.394019603729248,
            "question_text": "Which interleukins are inhibited by Dupilumab?"
        }
    ],
    "513ce3c8bee46bd34c000008": [
        {
            "text": "MSX2",
            "probability": 0.25428516763535663,
            "start_logit": 4.969391345977783,
            "end_logit": 4.427757740020752,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1-, -2, -3, TWIST, and MSX2",
            "probability": 0.19680259974919542,
            "start_logit": 4.713136196136475,
            "end_logit": 4.427757740020752,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "TWIST, and MSX2",
            "probability": 0.14825350543701893,
            "start_logit": 4.429858684539795,
            "end_logit": 4.427757740020752,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1-, -2, -3, TWIST",
            "probability": 0.13615883090192535,
            "start_logit": 4.713136196136475,
            "end_logit": 4.059378623962402,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1",
            "probability": 0.1277801772372751,
            "start_logit": 4.713136196136475,
            "end_logit": 3.995867967605591,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "TWIST",
            "probability": 0.10256990508835621,
            "start_logit": 4.429858684539795,
            "end_logit": 4.059378623962402,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1-, -2",
            "probability": 0.013028310860796357,
            "start_logit": 4.713136196136475,
            "end_logit": 1.7126812934875488,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1-, -2, -3",
            "probability": 0.012651480310564022,
            "start_logit": 4.713136196136475,
            "end_logit": 1.683330774307251,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "-3, TWIST, and MSX2",
            "probability": 0.001260730174093917,
            "start_logit": -0.3373739421367645,
            "end_logit": 4.427757740020752,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "MSX2)",
            "probability": 0.000874534044868764,
            "start_logit": 4.969391345977783,
            "end_logit": -1.244762659072876,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "-3, TWIST",
            "probability": 0.0008722422712208627,
            "start_logit": -0.3373739421367645,
            "end_logit": 4.059378623962402,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1-, -2,",
            "probability": 0.0007335955804845414,
            "start_logit": 4.713136196136475,
            "end_logit": -1.164240837097168,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1-, -2, -3,",
            "probability": 0.0007196674865941143,
            "start_logit": 4.713136196136475,
            "end_logit": -1.1834094524383545,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1-, -2, -3, TWIST, and MSX2)",
            "probability": 0.000676840789417013,
            "start_logit": 4.713136196136475,
            "end_logit": -1.244762659072876,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "FGFR1-,",
            "probability": 0.0006607933455676375,
            "start_logit": 4.713136196136475,
            "end_logit": -1.2687575817108154,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "(FGFR1-, -2, -3, TWIST, and MSX2",
            "probability": 0.0005958545392555776,
            "start_logit": -1.0868237018585205,
            "end_logit": 4.427757740020752,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "2, -3, TWIST, and MSX2",
            "probability": 0.0005240808467571163,
            "start_logit": -1.2151743173599243,
            "end_logit": 4.427757740020752,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "3, TWIST, and MSX2",
            "probability": 0.0005224770033173941,
            "start_logit": -1.2182393074035645,
            "end_logit": 4.427757740020752,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "-2, -3, TWIST, and MSX2",
            "probability": 0.0005193352847437275,
            "start_logit": -1.2242705821990967,
            "end_logit": 4.427757740020752,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        },
        {
            "text": "TWIST, and MSX2)",
            "probability": 0.0005098714131912353,
            "start_logit": 4.429858684539795,
            "end_logit": -1.244762659072876,
            "question_text": "Which human genes are more commonly related to craniosynostosis?"
        }
    ],
    "56d06e043975bb303a000011": [
        {
            "text": "advanced, oestrogen receptor-positive, HER2-negative",
            "probability": 0.22444539102187586,
            "start_logit": 0.8123041391372681,
            "end_logit": 0.17667219042778015,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced, oestrogen receptor-positive, HER2-negative breast cancer",
            "probability": 0.1672372205440164,
            "start_logit": 0.8123041391372681,
            "end_logit": -0.11754695326089859,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced",
            "probability": 0.15053229682376268,
            "start_logit": 0.8123041391372681,
            "end_logit": -0.22278258204460144,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced, oestrogen receptor-positive",
            "probability": 0.1350825001759668,
            "start_logit": 0.8123041391372681,
            "end_logit": -0.3310745358467102,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast cancer",
            "probability": 0.055985010722859926,
            "start_logit": -0.28202515840530396,
            "end_logit": -0.11754695326089859,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "oestrogen receptor-positive, HER2-negative",
            "probability": 0.042652316972501055,
            "start_logit": -0.848246693611145,
            "end_logit": 0.17667219042778015,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "oestrogen receptor-positive",
            "probability": 0.03420206817963384,
            "start_logit": -0.6026791334152222,
            "end_logit": -0.28969085216522217,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "oestrogen receptor-positive, HER2-negative breast cancer",
            "probability": 0.031780803819438735,
            "start_logit": -0.848246693611145,
            "end_logit": -0.11754695326089859,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "HER2-negative",
            "probability": 0.027919928972495508,
            "start_logit": -1.2719875574111938,
            "end_logit": 0.17667219042778015,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "negative",
            "probability": 0.023167204156197843,
            "start_logit": -1.4585906267166138,
            "end_logit": 0.17667219042778015,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "HER2-negative breast cancer",
            "probability": 0.020803507249081404,
            "start_logit": -1.2719875574111938,
            "end_logit": -0.11754695326089859,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "breast cancer cells",
            "probability": 0.01851511221645888,
            "start_logit": -0.4470266103744507,
            "end_logit": -1.05904221534729,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "negative breast cancer",
            "probability": 0.017262189315710594,
            "start_logit": -1.4585906267166138,
            "end_logit": -0.11754695326089859,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "oestrogen receptor-positive breast cancer cells",
            "probability": 0.015846279678088746,
            "start_logit": -0.6026791334152222,
            "end_logit": -1.05904221534729,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "oestrogen receptor-positive breast cancer",
            "probability": 0.008159430121506068,
            "start_logit": -0.6026791334152222,
            "end_logit": -1.7228026390075684,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "positive, HER2-negative",
            "probability": 0.005825162653858526,
            "start_logit": -2.839141368865967,
            "end_logit": 0.17667219042778015,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced, oestrogen receptor-positive, HER2-negative breast",
            "probability": 0.0056582871576130464,
            "start_logit": 0.8123041391372681,
            "end_logit": -3.5038390159606934,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "patients with advanced, oestrogen receptor-positive, HER2-negative",
            "probability": 0.0053396969982988166,
            "start_logit": -2.926159381866455,
            "end_logit": 0.17667219042778015,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "advanced,",
            "probability": 0.005245187712583845,
            "start_logit": 0.8123041391372681,
            "end_logit": -3.5796492099761963,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        },
        {
            "text": "positive, HER2-negative breast cancer",
            "probability": 0.004340405508051427,
            "start_logit": -2.839141368865967,
            "end_logit": -0.11754695326089859,
            "question_text": "In which breast cancer patients can palbociclib be used?"
        }
    ],
    "571e1e11bb137a4b0c000004": [
        {
            "text": "type 2 diabetes",
            "probability": 0.28039625082358716,
            "start_logit": -2.419095754623413,
            "end_logit": -2.3541579246520996,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "diabetes",
            "probability": 0.18830610135217954,
            "start_logit": -2.817230701446533,
            "end_logit": -2.3541579246520996,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "sensitization, bring about a new therapeutic approach to the management of type 2 diabetes",
            "probability": 0.10169227688627937,
            "start_logit": -3.4333481788635254,
            "end_logit": -2.3541579246520996,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "type 2 diabetes mellitus",
            "probability": 0.0919972617640493,
            "start_logit": -2.419095754623413,
            "end_logit": -3.4686028957366943,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.061782729430156766,
            "start_logit": -2.817230701446533,
            "end_logit": -3.4686028957366943,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "insulin secretion or sensitization, bring about a new therapeutic approach to the management of type 2 diabetes",
            "probability": 0.047347168042741576,
            "start_logit": -4.1977925300598145,
            "end_logit": -2.3541579246520996,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "sensitization, bring about a new therapeutic approach to the management of type 2 diabetes mellitus",
            "probability": 0.03336496471907262,
            "start_logit": -3.4333481788635254,
            "end_logit": -3.4686028957366943,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "with a novel mechanism independent of insulin secretion or sensitization, bring about a new therapeutic approach to the management of type 2 diabetes",
            "probability": 0.023230589481526887,
            "start_logit": -4.909829616546631,
            "end_logit": -2.3541579246520996,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "type 2 diabetes mellitus.",
            "probability": 0.021050988057709902,
            "start_logit": -2.419095754623413,
            "end_logit": -4.943414211273193,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "type 2 diabetes mellitus. The aim of this meta-analysis was to evaluate the safety",
            "probability": 0.02103922693341235,
            "start_logit": -2.419095754623413,
            "end_logit": -4.943973064422607,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "type 2 diabetes mellitus. The aim of this meta-analysis was to evaluate the safety and efficacy",
            "probability": 0.016529161896358384,
            "start_logit": -2.419095754623413,
            "end_logit": -5.185235500335693,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "insulin secretion or sensitization, bring about a new therapeutic approach to the management of type 2 diabetes mellitus",
            "probability": 0.01553447950684265,
            "start_logit": -4.1977925300598145,
            "end_logit": -3.4686028957366943,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "sensitization,",
            "probability": 0.015252117573280793,
            "start_logit": -3.4333481788635254,
            "end_logit": -4.2513909339904785,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "diabetes mellitus.",
            "probability": 0.01413724141858313,
            "start_logit": -2.817230701446533,
            "end_logit": -4.943414211273193,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "diabetes mellitus. The aim of this meta-analysis was to evaluate the safety",
            "probability": 0.014129342983930438,
            "start_logit": -2.817230701446533,
            "end_logit": -4.943973064422607,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "sensitization",
            "probability": 0.012907039926142014,
            "start_logit": -3.4333481788635254,
            "end_logit": -4.418336391448975,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "type 2 diabetes mellitus. The aim of this meta-analysis",
            "probability": 0.012507817570290238,
            "start_logit": -2.419095754623413,
            "end_logit": -5.46400785446167,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "diabetes mellitus. The aim of this meta-analysis was to evaluate the safety and efficacy",
            "probability": 0.011100512314911508,
            "start_logit": -2.817230701446533,
            "end_logit": -5.185235500335693,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "mechanism independent of insulin secretion or sensitization, bring about a new therapeutic approach to the management of type 2 diabetes",
            "probability": 0.00929483682335174,
            "start_logit": -5.825840473175049,
            "end_logit": -2.3541579246520996,
            "question_text": "List side effects of SGLT2 inhibitors?"
        },
        {
            "text": "diabetes mellitus. The aim of this meta-analysis",
            "probability": 0.008399892495593652,
            "start_logit": -2.817230701446533,
            "end_logit": -5.46400785446167,
            "question_text": "List side effects of SGLT2 inhibitors?"
        }
    ],
    "56a3a386496b62f23f000007": [
        {
            "text": "JASPAR phyloFACTS",
            "probability": 0.2095894421594673,
            "start_logit": 1.0783857107162476,
            "end_logit": -0.4675685465335846,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR FAM",
            "probability": 0.18258953597174346,
            "start_logit": 1.0923078060150146,
            "end_logit": -0.6194005608558655,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR",
            "probability": 0.13503093343115125,
            "start_logit": 1.0783857107162476,
            "end_logit": -0.9072152376174927,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR phyloFACTS serves as a non-redundant extension to JASPAR CORE, enhancing the overall breadth of JASPAR",
            "probability": 0.12644699469130405,
            "start_logit": 1.0783857107162476,
            "end_logit": -0.9728959202766418,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR phyloFACTS serves as a non-redundant extension to JASPAR CORE",
            "probability": 0.0637224378916195,
            "start_logit": 1.0783857107162476,
            "end_logit": -1.6581823825836182,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR FAM--a collection of familial TFBS models and JASPAR phyloFACTS",
            "probability": 0.05626071624609999,
            "start_logit": 1.0923078060150146,
            "end_logit": -1.796644687652588,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR phyloFACTS serves as a non-redundant extension to JASPAR",
            "probability": 0.05551445429663925,
            "start_logit": 1.0783857107162476,
            "end_logit": -1.796075701713562,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR CORE",
            "probability": 0.03990790240416299,
            "start_logit": 0.7308677434921265,
            "end_logit": -1.778626799583435,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR CORE, enhancing the overall breadth of JASPAR",
            "probability": 0.035814810751314576,
            "start_logit": -0.18307597935199738,
            "end_logit": -0.9728959202766418,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR CORE, enhancing the overall breadth of JASPAR for promoter sequence analysis. The new release of JASPAR",
            "probability": 0.024049838494118715,
            "start_logit": -0.18307597935199738,
            "end_logit": -1.3711291551589966,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR FAM--a collection of familial TFBS models and JASPAR",
            "probability": 0.01301740953341457,
            "start_logit": 1.0923078060150146,
            "end_logit": -3.2603535652160645,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR phyloFACTS serves as a non-redundant extension to JASPAR CORE,",
            "probability": 0.01120708186195421,
            "start_logit": 1.0783857107162476,
            "end_logit": -3.3961732387542725,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR for promoter sequence analysis. The new release of JASPAR",
            "probability": 0.009273557121422351,
            "start_logit": -1.1360372304916382,
            "end_logit": -1.3711291551589966,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR grows into a meta-database of collections of TFBS models derived by diverse approaches. We present JASPAR CORE",
            "probability": 0.00636099200656789,
            "start_logit": -1.1055222749710083,
            "end_logit": -1.778626799583435,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "phyloFACTS",
            "probability": 0.00625818190665884,
            "start_logit": -2.432875156402588,
            "end_logit": -0.4675685465335846,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "jaspar",
            "probability": 0.006051988498806733,
            "start_logit": -0.32921281456947327,
            "end_logit": -2.60473370552063,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR is available at http://jaspar",
            "probability": 0.0054651495537679125,
            "start_logit": -0.43120822310447693,
            "end_logit": -2.60473370552063,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR grows into a meta-database of collections of TFBS models derived by diverse approaches. We present JASPAR",
            "probability": 0.005296864240513596,
            "start_logit": -1.1055222749710083,
            "end_logit": -1.9616961479187012,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "jaspar.genereg.net",
            "probability": 0.004278278912363759,
            "start_logit": -0.32921281456947327,
            "end_logit": -2.9515697956085205,
            "question_text": "List the releases of JASPAR database"
        },
        {
            "text": "JASPAR is available at http://jaspar.genereg.net",
            "probability": 0.003863430026909266,
            "start_logit": -0.43120822310447693,
            "end_logit": -2.9515697956085205,
            "question_text": "List the releases of JASPAR database"
        }
    ],
    "56c1f038ef6e394741000051": [
        {
            "text": "photophobia",
            "probability": 0.4422402398651093,
            "start_logit": 4.695015907287598,
            "end_logit": 5.0543975830078125,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia and photophobia",
            "probability": 0.27445850893108986,
            "start_logit": 4.217962741851807,
            "end_logit": 5.0543975830078125,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia",
            "probability": 0.1346724460293361,
            "start_logit": 4.217962741851807,
            "end_logit": 4.342442989349365,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis follicularis with atrichia and photophobia",
            "probability": 0.09296440432205377,
            "start_logit": 3.1353793144226074,
            "end_logit": 5.0543975830078125,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis follicularis with atrichia",
            "probability": 0.045616161701346934,
            "start_logit": 3.1353793144226074,
            "end_logit": 4.342442989349365,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis follicularis",
            "probability": 0.00558907141344865,
            "start_logit": 3.1353793144226074,
            "end_logit": 2.2429940700531006,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "follicularis with atrichia and photophobia",
            "probability": 0.0014943335077604362,
            "start_logit": -0.9951570630073547,
            "end_logit": 5.0543975830078125,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "follicularis with atrichia",
            "probability": 0.0007332457990006201,
            "start_logit": -0.9951570630073547,
            "end_logit": 4.342442989349365,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "(ichthyosis follicularis with atrichia and photophobia",
            "probability": 0.0003687724839629939,
            "start_logit": -2.3944127559661865,
            "end_logit": 5.0543975830078125,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "photophobia) syndrome was established in a 1-year-old boy with congenital hairlessness,",
            "probability": 0.00031437762168330907,
            "start_logit": 4.695015907287598,
            "end_logit": -2.1946160793304443,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyosis",
            "probability": 0.00021190736517133564,
            "start_logit": 3.1353793144226074,
            "end_logit": -1.0294251441955566,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "ichthyotic skin changes with follicular hyperkeratoses, and photophobia",
            "probability": 0.0001953837047617673,
            "start_logit": -0.49324437975883484,
            "end_logit": 2.518014669418335,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia and photophobia) syndrome was established in a 1-year-old boy with congenital hairlessness,",
            "probability": 0.00019510574911686288,
            "start_logit": 4.217962741851807,
            "end_logit": -2.1946160793304443,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "(ichthyosis follicularis with atrichia",
            "probability": 0.0001809508207161464,
            "start_logit": -2.3944127559661865,
            "end_logit": 4.342442989349365,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "with atrichia and photophobia",
            "probability": 0.0001600112260691956,
            "start_logit": -3.229348659515381,
            "end_logit": 5.0543975830078125,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "photo",
            "probability": 0.0001520875056076508,
            "start_logit": 4.695015907287598,
            "end_logit": -2.920754909515381,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "photophobia) syndrome was established in a 1-year-old boy with congenital hairlessness, generalized ichthyotic skin changes",
            "probability": 0.00013330508560922588,
            "start_logit": 4.695015907287598,
            "end_logit": -3.0525705814361572,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "photophobia) syndrome was established in a 1-year-old boy with congenital hairlessness",
            "probability": 0.0001275388625688513,
            "start_logit": 4.695015907287598,
            "end_logit": -3.096789836883545,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "obia",
            "probability": 9.776104969012392e-05,
            "start_logit": -3.7220664024353027,
            "end_logit": 5.0543975830078125,
            "question_text": "List symptoms of the IFAP syndrome."
        },
        {
            "text": "atrichia and photo",
            "probability": 9.438695589722123e-05,
            "start_logit": 4.217962741851807,
            "end_logit": -2.920754909515381,
            "question_text": "List symptoms of the IFAP syndrome."
        }
    ],
    "571529efcb4ef8864c000001": [
        {
            "text": "mersacidin",
            "probability": 0.38435929982580785,
            "start_logit": 5.2171430587768555,
            "end_logit": 4.603074550628662,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin",
            "probability": 0.22837900692127724,
            "start_logit": 4.763381481170654,
            "end_logit": 4.536264896392822,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin however, mersacidin",
            "probability": 0.16735859294660632,
            "start_logit": 4.763381481170654,
            "end_logit": 4.225397109985352,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "mersacidin with the peptidoglycan precursor rather than with the enzyme. Unlike vancomycin",
            "probability": 0.09279575371321325,
            "start_logit": 3.8627758026123047,
            "end_logit": 4.536264896392822,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "mersacidin with the peptidoglycan precursor rather than with the enzyme. Unlike vancomycin however, mersacidin",
            "probability": 0.06800172652566298,
            "start_logit": 3.8627758026123047,
            "end_logit": 4.225397109985352,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "mersacidin differs from that of vancomycin",
            "probability": 0.03968971762164966,
            "start_logit": 4.067001819610596,
            "end_logit": 3.4827301502227783,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "moenomycin. The analogy to the glycopeptides may hint at an interaction of mersacidin",
            "probability": 0.007082273697355359,
            "start_logit": 2.574958086013794,
            "end_logit": 3.251276731491089,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "mersacidin in vitro is in the range of that of the glycopeptide antibiotic vancomycin",
            "probability": 0.0049258136265362155,
            "start_logit": 2.9996609687805176,
            "end_logit": 2.463468313217163,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin but 2-3 orders of magnitude higher than that of the competitive enzyme inhibitor moenomycin",
            "probability": 0.002833365343144909,
            "start_logit": 2.587552309036255,
            "end_logit": 2.3225526809692383,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "moenomycin",
            "probability": 0.0027979050740857417,
            "start_logit": 2.574958086013794,
            "end_logit": 2.3225526809692383,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "mersacid",
            "probability": 0.0003988881733658454,
            "start_logit": 5.2171430587768555,
            "end_logit": -2.2675774097442627,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "mersacidin-induced accumulation of UDP-N-acetylmuramoyl-pentapeptide,",
            "probability": 0.00039262965190490747,
            "start_logit": 5.2171430587768555,
            "end_logit": -2.2833917140960693,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "The lantibiotic mersacidin",
            "probability": 0.0003364371589622438,
            "start_logit": -1.913708209991455,
            "end_logit": 4.693004131317139,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "lantibiotic mersacidin",
            "probability": 0.0001993574668760294,
            "start_logit": -2.4370200634002686,
            "end_logit": 4.693004131317139,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "me",
            "probability": 0.00010588557518304513,
            "start_logit": 5.2171430587768555,
            "end_logit": -3.5938994884490967,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin however,",
            "probability": 0.00010465536425411447,
            "start_logit": 4.763381481170654,
            "end_logit": -3.1518242359161377,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "mersacidin inhibits peptidoglycan formation from UDP-N-acetylmuramoyl-tripeptide",
            "probability": 7.656375793437553e-05,
            "start_logit": 4.833470821380615,
            "end_logit": -3.5344624519348145,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin however, mersacid",
            "probability": 6.210546830894988e-05,
            "start_logit": 4.763381481170654,
            "end_logit": -3.6736629009246826,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vancomycin however, me",
            "probability": 5.286556864326086e-05,
            "start_logit": 4.763381481170654,
            "end_logit": -3.834744691848755,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        },
        {
            "text": "vanA resistance gene cluster. This indicates that the molecular target site of mersacidin differs from that of vancomycin",
            "probability": 4.715651922746929e-05,
            "start_logit": -2.6683733463287354,
            "end_logit": 3.4827301502227783,
            "question_text": "Which antibiotics target peptidoglycan biosynthesis?"
        }
    ],
    "53358cd2d6d3ac6a3400004e": [
        {
            "text": "trichothiodystrophy",
            "probability": 0.8009784745858856,
            "start_logit": 3.467301845550537,
            "end_logit": 3.3468425273895264,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "ichthyosis characterized by a peculiar anomaly of hair growth which has been termed trichothiodystrophy",
            "probability": 0.12240729852114404,
            "start_logit": 1.5888217687606812,
            "end_logit": 3.3468425273895264,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "congenital ichthyosis characterized by a peculiar anomaly of hair growth which has been termed trichothiodystrophy",
            "probability": 0.02152898154027231,
            "start_logit": -0.14913222193717957,
            "end_logit": 3.3468425273895264,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "ichthyosis",
            "probability": 0.016457958643448196,
            "start_logit": 1.5888217687606812,
            "end_logit": 1.3402976989746094,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "hypogonadism, cataracts",
            "probability": 0.004700454666845244,
            "start_logit": 0.8016277551651001,
            "end_logit": 0.8743417859077454,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "hypogonadism",
            "probability": 0.004480242902213235,
            "start_logit": 0.8016277551651001,
            "end_logit": 0.8263598084449768,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "trichothiodystrophy.",
            "probability": 0.0033990406898782755,
            "start_logit": 3.467301845550537,
            "end_logit": -2.1154983043670654,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "congenital ichthyosis",
            "probability": 0.0028946238672537756,
            "start_logit": -0.14913222193717957,
            "end_logit": 1.3402976989746094,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "hypogonadism, cataracts, osteosclerosis, dysphonia",
            "probability": 0.0026370951206619677,
            "start_logit": 0.8016277551651001,
            "end_logit": 0.2963605225086212,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "hypogonadism, cataracts, osteosclerosis",
            "probability": 0.002569106287658383,
            "start_logit": 0.8016277551651001,
            "end_logit": 0.2702406346797943,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "hypoplasia of subcutaneous fatty tissue, prematurely aged facial appearance, hypogonadism, cataracts",
            "probability": 0.0024080334036100572,
            "start_logit": 0.13277891278266907,
            "end_logit": 0.8743417859077454,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "hypoplasia of subcutaneous fatty tissue, prematurely aged facial appearance, hypogonadism",
            "probability": 0.0022952193626956507,
            "start_logit": 0.13277891278266907,
            "end_logit": 0.8263598084449768,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "trichothiodystrophy. The hair shafts are extremely brittle, and they show alternating light and dark banding",
            "probability": 0.0022333595886198463,
            "start_logit": 3.467301845550537,
            "end_logit": -2.535484552383423,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "dysplasia of nails, hypoplasia of subcutaneous fatty tissue, prematurely aged facial appearance, hypogonadism",
            "probability": 0.0022228727093427532,
            "start_logit": 0.1007508635520935,
            "end_logit": 0.8263598084449768,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "dysphonia",
            "probability": 0.0020398129939438576,
            "start_logit": 0.5448079109191895,
            "end_logit": 0.2963605225086212,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "ichthyosis characterized by a peculiar anomaly of hair growth",
            "probability": 0.001907497796162767,
            "start_logit": 1.5888217687606812,
            "end_logit": -0.8147191405296326,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "hair growth which has been termed trichothiodystrophy",
            "probability": 0.0017283042765707257,
            "start_logit": -2.671391487121582,
            "end_logit": 3.3468425273895264,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "cataracts",
            "probability": 0.0012739894176035291,
            "start_logit": -0.5038782358169556,
            "end_logit": 0.8743417859077454,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "osteosclerosis, dysphonia",
            "probability": 0.0009308158269565916,
            "start_logit": -0.23974406719207764,
            "end_logit": 0.2963605225086212,
            "question_text": "List two common features of Tay syndrome."
        },
        {
            "text": "osteosclerosis",
            "probability": 0.0009068177992327532,
            "start_logit": -0.23974406719207764,
            "end_logit": 0.2702406346797943,
            "question_text": "List two common features of Tay syndrome."
        }
    ],
    "52b2d405f828ad283c000009": [
        {
            "text": "MSC",
            "probability": 0.24856737136341547,
            "start_logit": 1.5861393213272095,
            "end_logit": 0.24709303677082062,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "MSC interaction with B",
            "probability": 0.2133594146252924,
            "start_logit": 1.5861393213272095,
            "end_logit": 0.09435725212097168,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "MSC interaction with B cells",
            "probability": 0.1608447674066079,
            "start_logit": 1.5861393213272095,
            "end_logit": -0.18818116188049316,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Mesenchymal stromal cells",
            "probability": 0.11251290292321428,
            "start_logit": 0.9689078330993652,
            "end_logit": 0.0716785117983818,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "B",
            "probability": 0.06375988639777276,
            "start_logit": 0.3782854378223419,
            "end_logit": 0.09435725212097168,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "MSC interaction with B cells provides stimuli for B",
            "probability": 0.05164372800387803,
            "start_logit": 1.5861393213272095,
            "end_logit": -1.3242521286010742,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "B cells",
            "probability": 0.04806651778423931,
            "start_logit": 0.3782854378223419,
            "end_logit": -0.18818116188049316,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Mesenchymal stromal cells (MSCs)",
            "probability": 0.035787830505173444,
            "start_logit": 0.9689078330993652,
            "end_logit": -1.0737814903259277,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "B cells provides stimuli for B",
            "probability": 0.015433104915794976,
            "start_logit": 0.3782854378223419,
            "end_logit": -1.3242521286010742,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "MSC interaction with B cells provides stimuli for B-cell survival",
            "probability": 0.012609766926046385,
            "start_logit": 1.5861393213272095,
            "end_logit": -2.734149217605591,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "B cells provides stimuli for B-cell survival and therefore may contribute to the pathogenesis of rheumatoid arthritis",
            "probability": 0.011025204626490563,
            "start_logit": 0.3782854378223419,
            "end_logit": -1.6605830192565918,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "M",
            "probability": 0.005236211906562498,
            "start_logit": 1.5861393213272095,
            "end_logit": -3.613022565841675,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "MSC interaction",
            "probability": 0.00402876433851214,
            "start_logit": 1.5861393213272095,
            "end_logit": -3.8751611709594727,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Mesenchymal stromal",
            "probability": 0.003916142428695942,
            "start_logit": 0.9689078330993652,
            "end_logit": -3.2862823009490967,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "B cells provides stimuli for B-cell survival",
            "probability": 0.003768276680544478,
            "start_logit": 0.3782854378223419,
            "end_logit": -2.734149217605591,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "B-cell survival and therefore may contribute to the pathogenesis of rheumatoid arthritis",
            "probability": 0.0035989137165871312,
            "start_logit": -0.7412664890289307,
            "end_logit": -1.6605830192565918,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "B cells provides stimuli for B-cell survival and therefore may contribute to the pathogenesis of rheumatoid arthritis.",
            "probability": 0.0024684401993670547,
            "start_logit": 0.3782854378223419,
            "end_logit": -3.1571805477142334,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "B-cell survival",
            "probability": 0.0012300635764094453,
            "start_logit": -0.7412664890289307,
            "end_logit": -2.734149217605591,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "Mesenchymal stromal cells (MSCs) represent a unique cell type with anti-proliferative effects on activated T and B",
            "probability": 0.0011218280181782385,
            "start_logit": 0.9689078330993652,
            "end_logit": -4.5364298820495605,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        },
        {
            "text": "MSC-derived factors other than B",
            "probability": 0.001020863657217726,
            "start_logit": -2.1909375190734863,
            "end_logit": -1.4708950519561768,
            "question_text": "Which cell types are known to be driving Rheumatoid Arthritis?"
        }
    ],
    "518cb4b5310faafe08000006": [
        {
            "text": "antiarrhytmic drugs (that didn't show equivalent efficacy as amiodarone",
            "probability": 0.44160313388414374,
            "start_logit": 0.10749086737632751,
            "end_logit": -2.230768918991089,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "antiarrhytmic drugs",
            "probability": 0.3935009641692808,
            "start_logit": 0.10749086737632751,
            "end_logit": -2.346096992492676,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "thyroidectomy",
            "probability": 0.06067554359830098,
            "start_logit": -1.7824054956436157,
            "end_logit": -2.3257434368133545,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "anti",
            "probability": 0.05782379641026526,
            "start_logit": 0.10749086737632751,
            "end_logit": -4.263780117034912,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "amiodarone",
            "probability": 0.024497388360040923,
            "start_logit": -3.239543914794922,
            "end_logit": -1.7755792140960693,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "drugs (that didn't show equivalent efficacy as amiodarone",
            "probability": 0.003509142298231715,
            "start_logit": -4.727549076080322,
            "end_logit": -2.230768918991089,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "drugs",
            "probability": 0.0031269046159524256,
            "start_logit": -4.727549076080322,
            "end_logit": -2.346096992492676,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "thy",
            "probability": 0.0029977441512463697,
            "start_logit": -1.7824054956436157,
            "end_logit": -5.333424091339111,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "total thyroidectomy",
            "probability": 0.002694847639981575,
            "start_logit": -3.8300294876098633,
            "end_logit": -3.3923184871673584,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "thyroidectomy is the treatment of choice",
            "probability": 0.0022114194876233506,
            "start_logit": -1.7824054956436157,
            "end_logit": -5.6376495361328125,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "thyroidectom",
            "probability": 0.0014597749309029112,
            "start_logit": -1.7824054956436157,
            "end_logit": -6.053001880645752,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "several other antiarrhytmic drugs (that didn't show equivalent efficacy as amiodarone",
            "probability": 0.0009237518812971141,
            "start_logit": -6.062232494354248,
            "end_logit": -2.230768918991089,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "other antiarrhytmic drugs (that didn't show equivalent efficacy as amiodarone",
            "probability": 0.000845737144493167,
            "start_logit": -6.150467395782471,
            "end_logit": -2.230768918991089,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "several other antiarrhytmic drugs",
            "probability": 0.0008231310605666272,
            "start_logit": -6.062232494354248,
            "end_logit": -2.346096992492676,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "total thyroidectomy in amiodarone-induced thyrotoxicosis",
            "probability": 0.0007918065469930829,
            "start_logit": -3.8300294876098633,
            "end_logit": -4.617098331451416,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "other antiarrhytmic drugs",
            "probability": 0.0007536141758431147,
            "start_logit": -6.150467395782471,
            "end_logit": -2.346096992492676,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "one",
            "probability": 0.0007002733355310635,
            "start_logit": -6.7943949699401855,
            "end_logit": -1.7755792140960693,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "thyroidectomy in amiodarone-induced thyrotoxicosis",
            "probability": 0.00036914914280346137,
            "start_logit": -4.593145847320557,
            "end_logit": -4.617098331451416,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "ectomy",
            "probability": 0.00035363409527966065,
            "start_logit": -6.927438735961914,
            "end_logit": -2.3257434368133545,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        },
        {
            "text": "tomy",
            "probability": 0.0003382430712226707,
            "start_logit": -6.9719367027282715,
            "end_logit": -2.3257434368133545,
            "question_text": "Which drugs are utilized to treat amiodarone-induced thyroitoxicosis?"
        }
    ],
    "552faa43bc4f83e828000004": [
        {
            "text": "GSTM4",
            "probability": 0.4031679359091299,
            "start_logit": 4.976159572601318,
            "end_logit": 4.872064590454102,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 promoter, and regulates GSTM4",
            "probability": 0.3200066570549239,
            "start_logit": 4.745148181915283,
            "end_logit": 4.872064590454102,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B1",
            "probability": 0.07640026437370515,
            "start_logit": 4.275211811065674,
            "end_logit": 3.9096453189849854,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 expression through a GGAA-microsatellite in its promoter. Reduction of GSTM4",
            "probability": 0.06703037367128964,
            "start_logit": 4.976159572601318,
            "end_logit": 3.077857255935669,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "glutathione S-transferase M4 (GSTM4",
            "probability": 0.04548375253803529,
            "start_logit": 3.904751777648926,
            "end_logit": 3.761474370956421,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "glutathione S-transferase M4",
            "probability": 0.028914017039883742,
            "start_logit": 3.904751777648926,
            "end_logit": 3.308445692062378,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 expression through a GGAA",
            "probability": 0.018621818840746512,
            "start_logit": 4.976159572601318,
            "end_logit": 1.797045350074768,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 promoter, and regulates GSTM4 expression through a GGAA",
            "probability": 0.014780704179939581,
            "start_logit": 4.745148181915283,
            "end_logit": 1.797045350074768,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 expression",
            "probability": 0.004112136094111584,
            "start_logit": 4.976159572601318,
            "end_logit": 0.2866540253162384,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "glutathione S-transferase M4 (GSTM4)",
            "probability": 0.0037679333231800953,
            "start_logit": 3.904751777648926,
            "end_logit": 1.2706458568572998,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GGAA-microsatellite in its promoter. Reduction of GSTM4",
            "probability": 0.0034776772452345763,
            "start_logit": 2.017378330230713,
            "end_logit": 3.077857255935669,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 promoter, and regulates GSTM4 expression",
            "probability": 0.0032639275290189088,
            "start_logit": 4.745148181915283,
            "end_logit": 0.2866540253162384,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B1,",
            "probability": 0.0031720904899266785,
            "start_logit": 4.275211811065674,
            "end_logit": 0.7280499935150146,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4)",
            "probability": 0.0029440630331636296,
            "start_logit": 3.658015727996826,
            "end_logit": 1.2706458568572998,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 levels caused a loss of oncogenic transformation. Furthermore, reduction of GSTM4",
            "probability": 0.0011910679054254513,
            "start_logit": 3.4552292823791504,
            "end_logit": 0.5684919953346252,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "NR0B1, through a GGAA",
            "probability": 0.0010748464847769685,
            "start_logit": 4.275211811065674,
            "end_logit": -0.3541629910469055,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GGAA",
            "probability": 0.0009661392604630948,
            "start_logit": 2.017378330230713,
            "end_logit": 1.797045350074768,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 promoter",
            "probability": 0.0008902468846119012,
            "start_logit": 4.745148181915283,
            "end_logit": -1.0125336647033691,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 promoter,",
            "probability": 0.0003800101138952135,
            "start_logit": 4.745148181915283,
            "end_logit": -1.8638346195220947,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        },
        {
            "text": "GSTM4 expression had worse outcomes than those with lower expression levels. These data show that GSTM4",
            "probability": 0.0003543380285380158,
            "start_logit": -0.5538718700408936,
            "end_logit": 3.365238904953003,
            "question_text": "Which are the genes thought to be regulated by EWS/FLI?"
        }
    ],
    "533c3af6c45e13371400000d": [
        {
            "text": "familial cylindromatosis (FC), and multiple familial trichoepithelioma",
            "probability": 0.1733216347962019,
            "start_logit": 4.255946636199951,
            "end_logit": 3.7261929512023926,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial cylindromatosis",
            "probability": 0.14003096586510863,
            "start_logit": 4.255946636199951,
            "end_logit": 3.5129075050354004,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "multiple familial trichoepithelioma",
            "probability": 0.1377126838914063,
            "start_logit": 4.025967121124268,
            "end_logit": 3.7261929512023926,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial cylindromatosis (FC), and multiple familial trichoepithelioma (MFT)",
            "probability": 0.10845740814322262,
            "start_logit": 4.255946636199951,
            "end_logit": 3.257401466369629,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "multiple familial trichoepithelioma (MFT)",
            "probability": 0.08617482047680382,
            "start_logit": 4.025967121124268,
            "end_logit": 3.257401466369629,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial cylindromatosis (FC)",
            "probability": 0.06856999258680578,
            "start_logit": 4.255946636199951,
            "end_logit": 2.798898935317993,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "Brooke-Spiegler syndrome",
            "probability": 0.06488102799713975,
            "start_logit": 2.972179651260376,
            "end_logit": 4.0273661613464355,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis (FC), and multiple familial trichoepithelioma",
            "probability": 0.03915337844874362,
            "start_logit": 2.768284320831299,
            "end_logit": 3.7261929512023926,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "Brooke-Spiegler syndrome (BSS), familial cylindromatosis",
            "probability": 0.03878744446364212,
            "start_logit": 2.972179651260376,
            "end_logit": 3.5129075050354004,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis",
            "probability": 0.03163301227516372,
            "start_logit": 2.768284320831299,
            "end_logit": 3.5129075050354004,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis (FC), and multiple familial trichoepithelioma (MFT)",
            "probability": 0.024500541733261445,
            "start_logit": 2.768284320831299,
            "end_logit": 3.257401466369629,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "Brooke-Spiegler syndrome (BSS), familial cylindromatosis (FC)",
            "probability": 0.01899333310244477,
            "start_logit": 2.972179651260376,
            "end_logit": 2.798898935317993,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial trichoepithelioma",
            "probability": 0.01579760045032737,
            "start_logit": 1.860655665397644,
            "end_logit": 3.7261929512023926,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "cylindromatosis (FC)",
            "probability": 0.01548996969210207,
            "start_logit": 2.768284320831299,
            "end_logit": 2.798898935317993,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "Brooke-Spiegler syndrome (BSS)",
            "probability": 0.01400040548707182,
            "start_logit": 2.972179651260376,
            "end_logit": 2.4938971996307373,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial trichoepithelioma (MFT)",
            "probability": 0.00988547564612666,
            "start_logit": 1.860655665397644,
            "end_logit": 3.257401466369629,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "MFT)",
            "probability": 0.0045486013373274015,
            "start_logit": 1.0844088792800903,
            "end_logit": 3.257401466369629,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "trichoepithelioma",
            "probability": 0.004261616995913009,
            "start_logit": 0.5504462718963623,
            "end_logit": 3.7261929512023926,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "trichoepithelioma (MFT)",
            "probability": 0.0026667411394965686,
            "start_logit": 0.5504462718963623,
            "end_logit": 3.257401466369629,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        },
        {
            "text": "familial cylindromatosis (FC), and multiple familial trichoepithelioma (MFT",
            "probability": 0.0011333454716904885,
            "start_logit": 4.255946636199951,
            "end_logit": -1.3037822246551514,
            "question_text": "Which pathological conditions are caused by mutations in the CYLD gene?"
        }
    ],
    "571f3b320fd6f91b68000007": [
        {
            "text": "hirsutism, obesity",
            "probability": 0.08429752119410656,
            "start_logit": 5.027576923370361,
            "end_logit": 5.224884033203125,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hirsutism",
            "probability": 0.07521751286253653,
            "start_logit": 5.027576923370361,
            "end_logit": 5.110915660858154,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "obesity",
            "probability": 0.06541136843701628,
            "start_logit": 4.77392053604126,
            "end_logit": 5.224884033203125,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation, hirsutism, obesity",
            "probability": 0.06379321668037846,
            "start_logit": 4.748871326446533,
            "end_logit": 5.224884033203125,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hirsutism, obesity, striae, acne and hypertension",
            "probability": 0.06169717977889752,
            "start_logit": 5.027576923370361,
            "end_logit": 4.912769794464111,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hirsutism, obesity, striae, acne",
            "probability": 0.058503864543495564,
            "start_logit": 5.027576923370361,
            "end_logit": 4.85962438583374,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation, hirsutism",
            "probability": 0.05692180538915315,
            "start_logit": 4.748871326446533,
            "end_logit": 5.110915660858154,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "growth retardation, hirsutism, obesity",
            "probability": 0.05303608866677677,
            "start_logit": 4.564197063446045,
            "end_logit": 5.224884033203125,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "obesity, striae, acne and hypertension",
            "probability": 0.047874444003514094,
            "start_logit": 4.77392053604126,
            "end_logit": 4.912769794464111,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "growth retardation, hirsutism",
            "probability": 0.0473233687653298,
            "start_logit": 4.564197063446045,
            "end_logit": 5.110915660858154,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation, hirsutism, obesity, striae, acne and hypertension",
            "probability": 0.046690122110952886,
            "start_logit": 4.748871326446533,
            "end_logit": 4.912769794464111,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "obesity, striae, acne",
            "probability": 0.04539656426945356,
            "start_logit": 4.77392053604126,
            "end_logit": 4.85962438583374,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "weight gain, growth retardation, hirsutism, obesity, striae, acne",
            "probability": 0.04427354036744377,
            "start_logit": 4.748871326446533,
            "end_logit": 4.85962438583374,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hypertension",
            "probability": 0.04170167481081849,
            "start_logit": 4.635879993438721,
            "end_logit": 4.912769794464111,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "growth retardation, hirsutism, obesity, striae, acne and hypertension",
            "probability": 0.03881700257483302,
            "start_logit": 4.564197063446045,
            "end_logit": 4.912769794464111,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "acne and hypertension",
            "probability": 0.03785551692331267,
            "start_logit": 4.5391154289245605,
            "end_logit": 4.912769794464111,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "growth retardation, hirsutism, obesity, striae, acne",
            "probability": 0.03680791680852952,
            "start_logit": 4.564197063446045,
            "end_logit": 4.85962438583374,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "acne",
            "probability": 0.035896195616108004,
            "start_logit": 4.5391154289245605,
            "end_logit": 4.85962438583374,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "hirsutism, obesity, striae",
            "probability": 0.030709368211474852,
            "start_logit": 5.027576923370361,
            "end_logit": 4.215099334716797,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        },
        {
            "text": "striae, acne and hypertension",
            "probability": 0.027775727985868633,
            "start_logit": 4.229501247406006,
            "end_logit": 4.912769794464111,
            "question_text": "Which are the common symptoms of Cushing's syndrome?"
        }
    ],
    "54d65b6b3706e8952800000c": [
        {
            "text": "myelin protein 22",
            "probability": 0.35645003539440706,
            "start_logit": 3.1495070457458496,
            "end_logit": 3.3360249996185303,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22",
            "probability": 0.25099155969317133,
            "start_logit": 3.1703290939331055,
            "end_logit": 2.964428186416626,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein 22 gene (PMP22",
            "probability": 0.2458194353206115,
            "start_logit": 3.1495070457458496,
            "end_logit": 2.964428186416626,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "peripheral myelin protein 22",
            "probability": 0.04342920704575721,
            "start_logit": 1.0444451570510864,
            "end_logit": 3.3360249996185303,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "peripheral myelin protein 22 gene (PMP22",
            "probability": 0.029950181210102553,
            "start_logit": 1.0444451570510864,
            "end_logit": 2.964428186416626,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22",
            "probability": 0.018700221322687085,
            "start_logit": 0.2018483281135559,
            "end_logit": 3.3360249996185303,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein 22 gene",
            "probability": 0.015410361846607507,
            "start_logit": 3.1495070457458496,
            "end_logit": 0.19487105309963226,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "22 gene (PMP22",
            "probability": 0.012896275464882524,
            "start_logit": 0.2018483281135559,
            "end_logit": 2.964428186416626,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "(PMP22",
            "probability": 0.006659082526241684,
            "start_logit": -0.45910850167274475,
            "end_logit": 2.964428186416626,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22)",
            "probability": 0.002936805192443625,
            "start_logit": 3.1703290939331055,
            "end_logit": -1.4836688041687012,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein 22 gene (PMP22)",
            "probability": 0.0028762871346576725,
            "start_logit": 3.1495070457458496,
            "end_logit": -1.4836688041687012,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "the peripheral myelin protein 22",
            "probability": 0.0021637672110876535,
            "start_logit": -1.9548362493515015,
            "end_logit": 3.3360249996185303,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "peripheral myelin protein 22 gene",
            "probability": 0.0018775697259949154,
            "start_logit": 1.0444451570510864,
            "end_logit": 0.19487105309963226,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein",
            "probability": 0.0016559961218762488,
            "start_logit": 3.1495070457458496,
            "end_logit": -2.035766363143921,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "the peripheral myelin protein 22 gene (PMP22",
            "probability": 0.0014922036223289634,
            "start_logit": -1.9548362493515015,
            "end_logit": 2.964428186416626,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22),",
            "probability": 0.0014830754060078265,
            "start_logit": 3.1703290939331055,
            "end_logit": -2.1668732166290283,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein 22 gene (PMP22),",
            "probability": 0.0014525140179550403,
            "start_logit": 3.1495070457458496,
            "end_logit": -2.1668732166290283,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22), including heterozygous duplications (CMT1A), deletions",
            "probability": 0.001291921972039082,
            "start_logit": 3.1703290939331055,
            "end_logit": -2.3048601150512695,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "myelin protein 22 gene (PMP22), including heterozygous duplications (CMT1A), deletions",
            "probability": 0.0012652996380960707,
            "start_logit": 3.1495070457458496,
            "end_logit": -2.3048601150512695,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        },
        {
            "text": "PMP22), including heterozygous duplications",
            "probability": 0.0011982001330441464,
            "start_logit": 3.1703290939331055,
            "end_logit": -2.3801705837249756,
            "question_text": "List genes that have been found mutated in CMT1A (Charcot-Marie-Tooth disease type 1 A)."
        }
    ],
    "517a8c918ed59a060a000043": [
        {
            "text": "Enteroviruses",
            "probability": 0.9815025321994091,
            "start_logit": 4.931334018707275,
            "end_logit": 5.2338995933532715,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enterovir",
            "probability": 0.01103169538364527,
            "start_logit": 4.931334018707275,
            "end_logit": 0.7455875277519226,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses have been considered to be the most common cause of acute myocarditis",
            "probability": 0.002942013606870574,
            "start_logit": 4.931334018707275,
            "end_logit": -0.5760907530784607,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enter",
            "probability": 0.0011975446199528157,
            "start_logit": 4.931334018707275,
            "end_logit": -1.4749116897583008,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "oviruses",
            "probability": 0.0009015402821771548,
            "start_logit": -2.061401128768921,
            "end_logit": 5.2338995933532715,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "uses",
            "probability": 0.0006925696217774307,
            "start_logit": -2.32509708404541,
            "end_logit": 5.2338995933532715,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses have been considered to be the most common cause of acute myocarditis and possible consequence of dilated cardiomyopathy",
            "probability": 0.0003518585312315407,
            "start_logit": 4.931334018707275,
            "end_logit": -2.6997110843658447,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "iruses",
            "probability": 0.0002574104710604915,
            "start_logit": -3.314833879470825,
            "end_logit": 5.2338995933532715,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enterov",
            "probability": 0.00022291221010885967,
            "start_logit": 4.931334018707275,
            "end_logit": -3.1561622619628906,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses have been considered to be the most common cause",
            "probability": 0.0002137089160408227,
            "start_logit": 4.931334018707275,
            "end_logit": -3.1983253955841064,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses have been considered to be",
            "probability": 0.000178410223957608,
            "start_logit": 4.931334018707275,
            "end_logit": -3.378854751586914,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses have been considered to be the most common cause of acute",
            "probability": 0.00016233614388988082,
            "start_logit": 4.931334018707275,
            "end_logit": -3.473271131515503,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses have been considered to be the most common",
            "probability": 0.0001273889060513915,
            "start_logit": 4.931334018707275,
            "end_logit": -3.71569561958313,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses have been considered",
            "probability": 0.00010440426500466067,
            "start_logit": 4.931334018707275,
            "end_logit": -3.9146697521209717,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "Enteroviruses have",
            "probability": 9.020513199125328e-05,
            "start_logit": 4.931334018707275,
            "end_logit": -4.060853958129883,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "ovir",
            "probability": 1.0132951717177406e-05,
            "start_logit": -2.061401128768921,
            "end_logit": 0.7455875277519226,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adeno- and herpes viruses",
            "probability": 4.6083127101152364e-06,
            "start_logit": -0.39906761050224304,
            "end_logit": -1.704676866531372,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "adeno- and herpes",
            "probability": 3.056797179345525e-06,
            "start_logit": -0.39906761050224304,
            "end_logit": -2.115170955657959,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "ir",
            "probability": 2.8931906053636653e-06,
            "start_logit": -3.314833879470825,
            "end_logit": 0.7455875277519226,
            "question_text": "Which viruses are best known to cause myocarditis?"
        },
        {
            "text": "herpes viruses",
            "probability": 2.7782346193612573e-06,
            "start_logit": -0.905113697052002,
            "end_logit": -1.704676866531372,
            "question_text": "Which viruses are best known to cause myocarditis?"
        }
    ],
    "571f2b5bbb137a4b0c000010": [
        {
            "text": "PDCD10",
            "probability": 0.9906796027410596,
            "start_logit": 4.725276470184326,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 mutations have not been systematically examined,",
            "probability": 0.0021239204296257383,
            "start_logit": 4.725276470184326,
            "end_logit": -1.9306113719940186,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 mutations",
            "probability": 0.0018709412479546313,
            "start_logit": 4.725276470184326,
            "end_logit": -2.0574333667755127,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "D10",
            "probability": 0.0010997880695611836,
            "start_logit": -2.0779972076416016,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "10",
            "probability": 0.0007949375010690345,
            "start_logit": -2.40260648727417,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "P",
            "probability": 0.0005768059313217596,
            "start_logit": 4.725276470184326,
            "end_logit": -3.2341244220733643,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "rare PDCD10",
            "probability": 0.000546901476048598,
            "start_logit": -2.7766013145446777,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "DCD10",
            "probability": 0.00045142464978888456,
            "start_logit": -2.968461513519287,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 mutations have not been systematically examined",
            "probability": 0.0004234734555757731,
            "start_logit": 4.725276470184326,
            "end_logit": -3.5431394577026367,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "caused by rare PDCD10",
            "probability": 0.00023966900999201787,
            "start_logit": -3.6016111373901367,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 mutations have not",
            "probability": 0.00017961176099338046,
            "start_logit": 4.725276470184326,
            "end_logit": -4.400832653045654,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "by rare PDCD10",
            "probability": 0.0001743697740916241,
            "start_logit": -3.919691801071167,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 mutations have not been",
            "probability": 0.0001528838032591874,
            "start_logit": 4.725276470184326,
            "end_logit": -4.561952114105225,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 mutations have not been systematically",
            "probability": 0.00014264450998051448,
            "start_logit": 4.725276470184326,
            "end_logit": -4.631274700164795,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "CD10",
            "probability": 0.000124023329442374,
            "start_logit": -4.260400295257568,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 mutations have",
            "probability": 0.000105210866746563,
            "start_logit": 4.725276470184326,
            "end_logit": -4.93566370010376,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD10 mutations have not been systematically examined, and",
            "probability": 0.0001024976354433147,
            "start_logit": 4.725276470184326,
            "end_logit": -4.961790561676025,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "PDCD",
            "probability": 9.936107498007831e-05,
            "start_logit": 4.725276470184326,
            "end_logit": -4.992869853973389,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "phenotypic manifestations of cerebral cavernous malformation disease caused by rare PDCD10",
            "probability": 6.324782270856779e-05,
            "start_logit": -4.933809280395508,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        },
        {
            "text": "cerebral cavernous malformation disease caused by rare PDCD10",
            "probability": 4.8684910357485816e-05,
            "start_logit": -5.19550085067749,
            "end_logit": 4.2145161628723145,
            "question_text": "Which genes have been associated with Cerebral Cavernous Malformation?"
        }
    ],
    "550320cbe9bde6963400002d": [
        {
            "text": "hypodontia",
            "probability": 0.2587934677983061,
            "start_logit": 4.335811614990234,
            "end_logit": 5.085012912750244,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia, hypogonadotropic hypogonadism",
            "probability": 0.2057640861846126,
            "start_logit": 4.335811614990234,
            "end_logit": 4.855712890625,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypogonadotropic hypogonadism",
            "probability": 0.18435226701327778,
            "start_logit": 4.2259297370910645,
            "end_logit": 4.855712890625,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypodontia",
            "probability": 0.15563270118598793,
            "start_logit": 3.827280044555664,
            "end_logit": 5.085012912750244,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypodontia, hypogonadotropic hypogonadism",
            "probability": 0.12374199709297024,
            "start_logit": 3.827280044555664,
            "end_logit": 4.855712890625,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination",
            "probability": 0.054827553991773643,
            "start_logit": 3.827280044555664,
            "end_logit": 4.0417070388793945,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypogonadism",
            "probability": 0.007319153340395311,
            "start_logit": 0.9995759725570679,
            "end_logit": 4.855712890625,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination,",
            "probability": 0.0019397158583769993,
            "start_logit": 3.827280044555664,
            "end_logit": 0.7000556588172913,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia,",
            "probability": 0.001329939701590135,
            "start_logit": 4.335811614990234,
            "end_logit": -0.1858838051557541,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "(hypomyelination, hypodontia",
            "probability": 0.001079908002220771,
            "start_logit": -1.1433428525924683,
            "end_logit": 5.085012912750244,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "(hypomyelination, hypodontia, hypogonadotropic hypogonadism",
            "probability": 0.000858624002880887,
            "start_logit": -1.1433428525924683,
            "end_logit": 4.855712890625,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia, hypogonadotropic",
            "probability": 0.0008183035223103044,
            "start_logit": 4.335811614990234,
            "end_logit": -0.6715393662452698,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypodontia,",
            "probability": 0.0007997964938368286,
            "start_logit": 3.827280044555664,
            "end_logit": -0.1858838051557541,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypogonadotropic",
            "probability": 0.0007331508245200091,
            "start_logit": 4.2259297370910645,
            "end_logit": -0.6715393662452698,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypoplastic crowns and roots (figure), indicative of 4H syndrome (hypomyelination",
            "probability": 0.0006145738045785302,
            "start_logit": -0.6637390851974487,
            "end_logit": 4.0417070388793945,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypomyelination, hypodontia, hypogonadotropic",
            "probability": 0.0004921097454686011,
            "start_logit": 3.827280044555664,
            "end_logit": -0.6715393662452698,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "(hypomyelination",
            "probability": 0.0003804387756988855,
            "start_logit": -1.1433428525924683,
            "end_logit": 4.0417070388793945,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypodontia, hypogonadotropic hypogonadism)",
            "probability": 0.00018144450690968576,
            "start_logit": 4.335811614990234,
            "end_logit": -2.1778228282928467,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "tia",
            "probability": 0.00017820477013872816,
            "start_logit": -2.945040702819824,
            "end_logit": 5.085012912750244,
            "question_text": "List symptoms of 4H leukodystrophy."
        },
        {
            "text": "hypogonadotropic hypogonadism)",
            "probability": 0.00016256338414613163,
            "start_logit": 4.2259297370910645,
            "end_logit": -2.1778228282928467,
            "question_text": "List symptoms of 4H leukodystrophy."
        }
    ],
    "511a4d391159fa8212000003": [
        {
            "text": "MET",
            "probability": 0.3315894493855933,
            "start_logit": 1.3650667667388916,
            "end_logit": 0.5724446177482605,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1 are required for maintenance of genomic cytosine met",
            "probability": 0.1338320465035328,
            "start_logit": 1.3650667667388916,
            "end_logit": -0.33486735820770264,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase MET",
            "probability": 0.11154148141781192,
            "start_logit": 0.2755657136440277,
            "end_logit": 0.5724446177482605,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DDM1 and a cytosine methyltransferase MET",
            "probability": 0.09565906655873062,
            "start_logit": 0.1219596415758133,
            "end_logit": 0.5724446177482605,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "met",
            "probability": 0.0739084808755335,
            "start_logit": 0.2755657136440277,
            "end_logit": 0.16087564826011658,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DDM1 and a cytosine met",
            "probability": 0.06338463683160592,
            "start_logit": 0.1219596415758133,
            "end_logit": 0.16087564826011658,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1",
            "probability": 0.04862942265655121,
            "start_logit": 1.3650667667388916,
            "end_logit": -1.347224235534668,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase MET1 are required for maintenance of genomic cytosine met",
            "probability": 0.04501899790792957,
            "start_logit": 0.2755657136440277,
            "end_logit": -0.33486735820770264,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DDM1",
            "probability": 0.031456725582907526,
            "start_logit": 0.1219596415758133,
            "end_logit": -0.5397330522537231,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase MET1",
            "probability": 0.016358173800931238,
            "start_logit": 0.2755657136440277,
            "end_logit": -1.347224235534668,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DDM1 and a cytosine methyltransferase MET1",
            "probability": 0.014028930013410084,
            "start_logit": 0.1219596415758133,
            "end_logit": -1.347224235534668,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1 are required for maintenance of genomic cytosine methylation",
            "probability": 0.008469856085406749,
            "start_logit": 1.3650667667388916,
            "end_logit": -3.0949394702911377,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1 are required for maintenance of genomic cytosine methylation.",
            "probability": 0.005307437569771068,
            "start_logit": 1.3650667667388916,
            "end_logit": -3.5623438358306885,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methylation",
            "probability": 0.00411352776299073,
            "start_logit": 0.6428342461585999,
            "end_logit": -3.0949394702911377,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "DDM",
            "probability": 0.003824277765687604,
            "start_logit": 0.1219596415758133,
            "end_logit": -2.6469762325286865,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methyltransferase MET1 are required for maintenance of genomic cytosine methylation",
            "probability": 0.002849126523514124,
            "start_logit": 0.2755657136440277,
            "end_logit": -3.0949394702911377,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "cytosine met",
            "probability": 0.0027056506506719035,
            "start_logit": -2.5361764430999756,
            "end_logit": -0.33486735820770264,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "methylation.",
            "probability": 0.002577646133941942,
            "start_logit": 0.6428342461585999,
            "end_logit": -3.5623438358306885,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1 are required for maintenance of genomic cytosine",
            "probability": 0.002390992230314088,
            "start_logit": 1.3650667667388916,
            "end_logit": -4.359744548797607,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        },
        {
            "text": "MET1 are required for maintenance of genomic c",
            "probability": 0.0023540737431641643,
            "start_logit": 1.3650667667388916,
            "end_logit": -4.375305652618408,
            "question_text": "Which are the plant DNA (cytosine-5) methyltransferase families?"
        }
    ],
    "517137c18ed59a060a000001": [
        {
            "text": "CHD7",
            "probability": 0.9841473674342638,
            "start_logit": 5.644210338592529,
            "end_logit": 4.655823707580566,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is",
            "probability": 0.008451347624226927,
            "start_logit": 5.644210338592529,
            "end_logit": -0.10162603110074997,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodomain",
            "probability": 0.0028954783429558065,
            "start_logit": 5.644210338592529,
            "end_logit": -1.1728016138076782,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD",
            "probability": 0.0012205860186578822,
            "start_logit": 5.644210338592529,
            "end_logit": -2.036620855331421,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodomain-containing, ATP dependent helicase protein",
            "probability": 0.0005996815283599182,
            "start_logit": 5.644210338592529,
            "end_logit": -2.7473084926605225,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CH",
            "probability": 0.0005154003828886156,
            "start_logit": 5.644210338592529,
            "end_logit": -2.8987631797790527,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodomain-containing, ATP dependent helicase",
            "probability": 0.0004599226853431869,
            "start_logit": 5.644210338592529,
            "end_logit": -3.012648820877075,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a",
            "probability": 0.0003828479757870004,
            "start_logit": 5.644210338592529,
            "end_logit": -3.1960692405700684,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a ch",
            "probability": 0.00023118955661916645,
            "start_logit": 5.644210338592529,
            "end_logit": -3.7004692554473877,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodomain-containing",
            "probability": 0.0002186759752440116,
            "start_logit": 5.644210338592529,
            "end_logit": -3.7561161518096924,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodomain-containing, ATP dependent helicase protein that",
            "probability": 0.00021714075852937017,
            "start_logit": 5.644210338592529,
            "end_logit": -3.7631614208221436,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "7",
            "probability": 0.00015418017471329463,
            "start_logit": -3.1171987056732178,
            "end_logit": 4.655823707580566,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodoma",
            "probability": 0.00012003988942285575,
            "start_logit": 5.644210338592529,
            "end_logit": -4.3558831214904785,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodomain-containing, ATP dependent helicase protein that is highly expressed in the developing ear",
            "probability": 0.00011856819996098247,
            "start_logit": 5.644210338592529,
            "end_logit": -4.368218898773193,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodomain-containing,",
            "probability": 0.00010720676290770529,
            "start_logit": 5.644210338592529,
            "end_logit": -4.468947887420654,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "CHD7 is a chromodomain-containing, ATP dependent helicase protein that is highly expressed",
            "probability": 9.390915007564549e-05,
            "start_logit": 5.644210338592529,
            "end_logit": -4.60137939453125,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "D7",
            "probability": 3.800246067163971e-05,
            "start_logit": -4.517669677734375,
            "end_logit": 4.655823707580566,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "Chd7",
            "probability": 2.4987387116044593e-05,
            "start_logit": -0.2672805190086365,
            "end_logit": -0.013845181092619896,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "is",
            "probability": 2.1436728090505194e-06,
            "start_logit": -2.635350227355957,
            "end_logit": -0.10162603110074997,
            "question_text": "In which proteins is the chromodomain present?"
        },
        {
            "text": "7 is",
            "probability": 1.324019447070391e-06,
            "start_logit": -3.1171987056732178,
            "end_logit": -0.10162603110074997,
            "question_text": "In which proteins is the chromodomain present?"
        }
    ],
    "531d7430267d7dd053000008": [
        {
            "text": "treatment",
            "probability": 0.11988339904158175,
            "start_logit": -3.9074225425720215,
            "end_logit": -3.9611899852752686,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment protocol",
            "probability": 0.11504068147299139,
            "start_logit": -3.9074225425720215,
            "end_logit": -4.0024237632751465,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment protocol based on current scientific evidence",
            "probability": 0.07459365258974802,
            "start_logit": -3.9074225425720215,
            "end_logit": -4.435654163360596,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment protocol based",
            "probability": 0.060021540384871556,
            "start_logit": -3.9074225425720215,
            "end_logit": -4.653006076812744,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "suggests a treatment",
            "probability": 0.05887615580058377,
            "start_logit": -4.618505954742432,
            "end_logit": -3.9611899852752686,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "a treatment",
            "probability": 0.0569995404150449,
            "start_logit": -4.6508989334106445,
            "end_logit": -3.9611899852752686,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "suggests a treatment protocol",
            "probability": 0.05649783990075134,
            "start_logit": -4.618505954742432,
            "end_logit": -4.0024237632751465,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "a treatment protocol",
            "probability": 0.054697030826759266,
            "start_logit": -4.6508989334106445,
            "end_logit": -4.0024237632751465,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment outcome usually can be achieved. This article highlights the significance of precipitating factors in burning mouth syndrome and suggests a treatment",
            "probability": 0.04525994132720253,
            "start_logit": -4.881519794464111,
            "end_logit": -3.9611899852752686,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment outcome usually can be achieved. This article highlights the significance of precipitating factors in burning mouth syndrome and suggests a treatment protocol",
            "probability": 0.0434316555531014,
            "start_logit": -4.881519794464111,
            "end_logit": -4.0024237632751465,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "suggests a treatment protocol based on current scientific evidence",
            "probability": 0.03663382542302896,
            "start_logit": -4.618505954742432,
            "end_logit": -4.435654163360596,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "treatment protocol based on current scientific evidence.",
            "probability": 0.03592329314510223,
            "start_logit": -3.9074225425720215,
            "end_logit": -5.166323661804199,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "a treatment protocol based on current scientific evidence",
            "probability": 0.03546616086536232,
            "start_logit": -4.6508989334106445,
            "end_logit": -4.435654163360596,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "This article highlights the significance of precipitating factors in burning mouth syndrome and suggests a treatment",
            "probability": 0.0320241051931506,
            "start_logit": -5.227453231811523,
            "end_logit": -3.9611899852752686,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "based on current scientific evidence",
            "probability": 0.03198359586912811,
            "start_logit": -4.7542548179626465,
            "end_logit": -4.435654163360596,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "This article highlights the significance of precipitating factors in burning mouth syndrome and suggests a treatment protocol",
            "probability": 0.030730484073987423,
            "start_logit": -5.227453231811523,
            "end_logit": -4.0024237632751465,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "suggests a treatment protocol based",
            "probability": 0.02947728869336622,
            "start_logit": -4.618505954742432,
            "end_logit": -4.653006076812744,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "a treatment protocol based",
            "probability": 0.028537731197912454,
            "start_logit": -4.6508989334106445,
            "end_logit": -4.653006076812744,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "protocol",
            "probability": 0.028186581646337604,
            "start_logit": -5.313862323760986,
            "end_logit": -4.0024237632751465,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        },
        {
            "text": "based",
            "probability": 0.02573549657998814,
            "start_logit": -4.7542548179626465,
            "end_logit": -4.653006076812744,
            "question_text": "Which are the drugs utilized for the burning mouth syndrome?"
        }
    ],
    "5523f1a62c8b63434a000002": [
        {
            "text": "PLN",
            "probability": 0.6180826272950667,
            "start_logit": 0.8187271356582642,
            "end_logit": -0.232628732919693,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Mutations in the gene encoding PLN",
            "probability": 0.08446090053588355,
            "start_logit": -1.1716063022613525,
            "end_logit": -0.232628732919693,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN have been associated with idiopathic dilated cardiomyopathy",
            "probability": 0.07075030519874978,
            "start_logit": 0.8187271356582642,
            "end_logit": -2.4000940322875977,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN have been associated with idiopathic dilated cardiomyopathy; however, no systematic search for PLN",
            "probability": 0.04434364673613812,
            "start_logit": 0.8187271356582642,
            "end_logit": -2.867281436920166,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN have been associated with idiopathic dilated cardiomyopathy;",
            "probability": 0.029973889021702248,
            "start_logit": 0.8187271356582642,
            "end_logit": -3.2589242458343506,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Mutations",
            "probability": 0.02744121494076367,
            "start_logit": -1.1716063022613525,
            "end_logit": -1.3568713665008545,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN have been associated",
            "probability": 0.017082545094848432,
            "start_logit": 0.8187271356582642,
            "end_logit": -3.8211936950683594,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN have been associated with idiopathic dilated cardiomyopathy; however, no systematic search for PLN mutations",
            "probability": 0.01638559118367985,
            "start_logit": 0.8187271356582642,
            "end_logit": -3.8628485202789307,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "gene encoding PLN",
            "probability": 0.016072477047459944,
            "start_logit": -2.83078670501709,
            "end_logit": -0.232628732919693,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN have",
            "probability": 0.012472667989830257,
            "start_logit": 0.8187271356582642,
            "end_logit": -4.135711193084717,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN have been associated with idiopathic dilated",
            "probability": 0.010088890743689533,
            "start_logit": 0.8187271356582642,
            "end_logit": -4.347815990447998,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Mutations in the gene encoding PLN have been associated with idiopathic dilated cardiomyopathy",
            "probability": 0.009668018847943289,
            "start_logit": -1.1716063022613525,
            "end_logit": -2.4000940322875977,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Phospholamban (PLN",
            "probability": 0.00911022765677073,
            "start_logit": -2.09629487991333,
            "end_logit": -1.534831166267395,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Phospholamban",
            "probability": 0.008601774388962707,
            "start_logit": -2.09629487991333,
            "end_logit": -1.5922603607177734,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN have been",
            "probability": 0.007176275522007033,
            "start_logit": 0.8187271356582642,
            "end_logit": -4.688470363616943,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Mutations in the gene encoding PLN have been associated with idiopathic dilated cardiomyopathy; however, no systematic search for PLN",
            "probability": 0.006059552834820817,
            "start_logit": -1.1716063022613525,
            "end_logit": -2.867281436920166,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "Mutations in the gene encoding PLN have been associated with idiopathic dilated cardiomyopathy;",
            "probability": 0.004095927546798745,
            "start_logit": -1.1716063022613525,
            "end_logit": -3.2589242458343506,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "PLN)",
            "probability": 0.0027641321053941833,
            "start_logit": -0.7948177456855774,
            "end_logit": -4.028979301452637,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "LN",
            "probability": 0.0026909659777226494,
            "start_logit": -4.617994785308838,
            "end_logit": -0.232628732919693,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        },
        {
            "text": "in the gene encoding PLN",
            "probability": 0.002678369331768007,
            "start_logit": -4.622686862945557,
            "end_logit": -0.232628732919693,
            "question_text": "Which mutations of phopspholamban have been found in patients with cardiomyopathy?"
        }
    ],
    "52df8ce798d023950500000d": [
        {
            "text": "vitamins and minerals",
            "probability": 0.3541679329870217,
            "start_logit": 3.4957878589630127,
            "end_logit": 3.059964656829834,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin",
            "probability": 0.17790735111757536,
            "start_logit": 3.4957878589630127,
            "end_logit": 2.3714563846588135,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "minerals",
            "probability": 0.16200873354443682,
            "start_logit": 2.7136669158935547,
            "end_logit": 3.059964656829834,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin supplementation. Additional studies are warranted in order to design adapted prescriptions in antioxidant vitamins and minerals",
            "probability": 0.1261961751181258,
            "start_logit": 2.7728590965270996,
            "end_logit": 2.750959873199463,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamins",
            "probability": 0.07539146918805584,
            "start_logit": 3.4957878589630127,
            "end_logit": 1.5128875970840454,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin supplementation. Additional studies are warranted in order to design adapted prescriptions in antioxidant vitamin",
            "probability": 0.056761057963271425,
            "start_logit": 2.7728590965270996,
            "end_logit": 1.9519727230072021,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin supplementation. Additional studies are warranted in order to design adapted prescriptions in antioxidant vitamins",
            "probability": 0.03306605037320985,
            "start_logit": 2.7728590965270996,
            "end_logit": 1.411629319190979,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "antioxidant vitamins and minerals",
            "probability": 0.0073179662855080915,
            "start_logit": -0.07464608550071716,
            "end_logit": 2.750959873199463,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "antioxidant vitamin",
            "probability": 0.0032915063243095844,
            "start_logit": -0.07464608550071716,
            "end_logit": 1.9519727230072021,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "antioxidant vitamins",
            "probability": 0.0019174609816784093,
            "start_logit": -0.07464608550071716,
            "end_logit": 1.411629319190979,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "s and minerals",
            "probability": 0.00041318447318645587,
            "start_logit": -3.2578444480895996,
            "end_logit": 3.059964656829834,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin supplementation. Additional studies are warranted in order to design adapted prescriptions in anti",
            "probability": 0.00036837970392102006,
            "start_logit": 2.7728590965270996,
            "end_logit": -3.0855188369750977,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "micronutritional supplementations rich in vitamins and minerals",
            "probability": 0.0003405102197743087,
            "start_logit": -3.451293468475342,
            "end_logit": 3.059964656829834,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "supplementations rich in vitamins and minerals",
            "probability": 0.00021728475887857157,
            "start_logit": -3.9005298614501953,
            "end_logit": 3.059964656829834,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "micronutritional supplementations rich in vitamin",
            "probability": 0.00017104674248058076,
            "start_logit": -3.451293468475342,
            "end_logit": 2.3714563846588135,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin supplementation. Additional studies are warranted in order to design adapted prescriptions in antioxidant",
            "probability": 0.00011587144109702718,
            "start_logit": 2.7728590965270996,
            "end_logit": -4.242151737213135,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "supplementations rich in vitamin",
            "probability": 0.00010914753225759793,
            "start_logit": -3.9005298614501953,
            "end_logit": 2.3714563846588135,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "s",
            "probability": 8.795427699085695e-05,
            "start_logit": -3.2578444480895996,
            "end_logit": 1.5128875970840454,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamins and minerals.",
            "probability": 7.694272367559793e-05,
            "start_logit": 3.5006508827209473,
            "end_logit": -5.379363536834717,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        },
        {
            "text": "vitamin supplementation",
            "probability": 7.397424454493978e-05,
            "start_logit": 2.7728590965270996,
            "end_logit": -4.690916061401367,
            "question_text": "Which are the supplemental antioxidant in athletes?"
        }
    ],
    "5505b9ff8e1671127b000001": [
        {
            "text": "LC3",
            "probability": 0.9793656278645309,
            "start_logit": 5.126009941101074,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3.",
            "probability": 0.011373054369408574,
            "start_logit": 5.126009941101074,
            "end_logit": 0.6261528134346008,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "autophagy marker LC3",
            "probability": 0.003207339510387396,
            "start_logit": -0.5954533219337463,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "marker LC3",
            "probability": 0.001295542877988778,
            "start_logit": -1.5019652843475342,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3. TEM",
            "probability": 0.0008715575545904852,
            "start_logit": 5.126009941101074,
            "end_logit": -1.9425674676895142,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "3",
            "probability": 0.0008453397151144536,
            "start_logit": -1.928911805152893,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "the autophagy marker LC3",
            "probability": 0.0008192918878111613,
            "start_logit": -1.9602099657058716,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC",
            "probability": 0.0005942275561013574,
            "start_logit": 5.126009941101074,
            "end_logit": -2.325587034225464,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "L",
            "probability": 0.0003997801673254043,
            "start_logit": 5.126009941101074,
            "end_logit": -2.7219345569610596,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3. TEM analysis confirmed that a significant portion of C. trachomatis resided within double-membrane-bound compartments,",
            "probability": 0.0003778743459189297,
            "start_logit": 5.126009941101074,
            "end_logit": -2.778287649154663,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "C3",
            "probability": 0.0002429886671938958,
            "start_logit": -3.175635576248169,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3. TEM analysis confirmed that a significant portion of C. trachomatis resided within double-membrane-bound compartments",
            "probability": 0.00019122128409527637,
            "start_logit": 5.126009941101074,
            "end_logit": -3.4594180583953857,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LC3. TEM analysis",
            "probability": 7.661559617486728e-05,
            "start_logit": 5.126009941101074,
            "end_logit": -4.374048709869385,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Rab7 and LAMP1",
            "probability": 7.591120227590253e-05,
            "start_logit": 0.8980939984321594,
            "end_logit": -0.15536916255950928,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "Rab7",
            "probability": 6.649955093843803e-05,
            "start_logit": 0.8980939984321594,
            "end_logit": -0.28773823380470276,
            "question_text": "List markers for autophagy."
        },
        {
            "text": ", C. trachomatis associated with the autophagy marker LC3",
            "probability": 5.478580209310721e-05,
            "start_logit": -4.665219306945801,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "autophagy marker LC3.",
            "probability": 3.724579012674292e-05,
            "start_logit": -0.5954533219337463,
            "end_logit": 0.6261528134346008,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "LAMP1",
            "probability": 3.680310933016647e-05,
            "start_logit": 0.17411206662654877,
            "end_logit": -0.15536916255950928,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "associated with the autophagy marker LC3",
            "probability": 3.6311247954909336e-05,
            "start_logit": -5.0765228271484375,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        },
        {
            "text": "gy marker LC3",
            "probability": 3.1981900639081425e-05,
            "start_logit": -5.203480243682861,
            "end_logit": 5.08181095123291,
            "question_text": "List markers for autophagy."
        }
    ],
    "57090784cf1c325851000011": [
        {
            "text": "myelodisplastic syndrome",
            "probability": 0.3352581479274108,
            "start_logit": 4.799309253692627,
            "end_logit": 4.594580173492432,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "non-Hodgkin lymphoma",
            "probability": 0.3319677833548585,
            "start_logit": 5.069693088531494,
            "end_logit": 4.314333438873291,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "non-Hodgkin lymphoma (NHL)",
            "probability": 0.27357636574405203,
            "start_logit": 5.069693088531494,
            "end_logit": 4.120876312255859,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myelodisplastic syndrome (MDS)",
            "probability": 0.042924039410769804,
            "start_logit": 4.799309253692627,
            "end_logit": 2.539111375808716,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myelodisplastic",
            "probability": 0.002825901671144945,
            "start_logit": 4.799309253692627,
            "end_logit": -0.18149316310882568,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "lymphoma",
            "probability": 0.002758228359930068,
            "start_logit": 0.27924373745918274,
            "end_logit": 4.314333438873291,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "lymphoma (NHL)",
            "probability": 0.002273070244877428,
            "start_logit": 0.27924373745918274,
            "end_logit": 4.120876312255859,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "non-Hodgkin lymphoma (NHL",
            "probability": 0.0017184866924901388,
            "start_logit": 5.069693088531494,
            "end_logit": -0.949260413646698,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "non-Hodgkin lymphoma (NHL).",
            "probability": 0.0010195691770598914,
            "start_logit": 5.069693088531494,
            "end_logit": -1.4713243246078491,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "non-Hodgkin",
            "probability": 0.0008411203454115834,
            "start_logit": 5.069693088531494,
            "end_logit": -1.6637250185012817,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "(NHL)",
            "probability": 0.0007677572475589583,
            "start_logit": -0.8061693906784058,
            "end_logit": 4.120876312255859,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "NHL)",
            "probability": 0.0006995608233221383,
            "start_logit": -0.8991902470588684,
            "end_logit": 4.120876312255859,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Hodgkin lymphoma",
            "probability": 0.0006651974390600868,
            "start_logit": -1.1430162191390991,
            "end_logit": 4.314333438873291,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "Hodgkin lymphoma (NHL)",
            "probability": 0.0005481926470129128,
            "start_logit": -1.1430162191390991,
            "end_logit": 4.120876312255859,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "non",
            "probability": 0.0005252133332128968,
            "start_logit": 5.069693088531494,
            "end_logit": -2.134655237197876,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "subtypes of non-Hodgkin lymphoma",
            "probability": 0.0003989504470093984,
            "start_logit": -1.654262900352478,
            "end_logit": 4.314333438873291,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "subtypes of non-Hodgkin lymphoma (NHL)",
            "probability": 0.0003287771250022984,
            "start_logit": -1.654262900352478,
            "end_logit": 4.120876312255859,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "myelodisplastic syndrome (MDS",
            "probability": 0.00031630050953553225,
            "start_logit": 4.799309253692627,
            "end_logit": -2.3713831901550293,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "certain subtypes of non-Hodgkin lymphoma",
            "probability": 0.0002944754209437025,
            "start_logit": -1.957904577255249,
            "end_logit": 4.314333438873291,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        },
        {
            "text": "oma",
            "probability": 0.00029286207933667814,
            "start_logit": -1.9633983373641968,
            "end_logit": 4.314333438873291,
            "question_text": "Which syndromes are associated with mutations in the EZH2 gene?"
        }
    ],
    "55414a763f2354b713000003": [
        {
            "text": "TMPDB",
            "probability": 0.6996615491428759,
            "start_logit": 5.121891975402832,
            "end_logit": 5.13913631439209,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB",
            "probability": 0.28571586229307794,
            "start_logit": 5.121891975402832,
            "end_logit": 4.243537425994873,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB release 6.2",
            "probability": 0.003982647285957185,
            "start_logit": 4.437717437744141,
            "end_logit": 0.6546608805656433,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is",
            "probability": 0.002347101835143883,
            "start_logit": 5.121891975402832,
            "end_logit": -0.5582790970802307,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database",
            "probability": 0.002308007910645014,
            "start_logit": 5.121891975402832,
            "end_logit": -0.575075626373291,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies.",
            "probability": 0.0018884245416935144,
            "start_logit": 5.121891975402832,
            "end_logit": -0.7757174968719482,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMP",
            "probability": 0.0013130462735564427,
            "start_logit": 5.121891975402832,
            "end_logit": -1.1391105651855469,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies. TMP",
            "probability": 0.000497595863952161,
            "start_logit": 5.121891975402832,
            "end_logit": -2.1094274520874023,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB release",
            "probability": 0.0004895580514755288,
            "start_logit": 5.121891975402832,
            "end_logit": -2.1257126331329346,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "database of experimentally-characterized transmembrane (TM) topologies. TMPDB",
            "probability": 0.000302607390790149,
            "start_logit": -1.7284249067306519,
            "end_logit": 4.243537425994873,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "T",
            "probability": 0.0002616370128381276,
            "start_logit": 5.121891975402832,
            "end_logit": -2.7522575855255127,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB release",
            "probability": 0.000246985223436065,
            "start_logit": 4.437717437744141,
            "end_logit": -2.1257126331329346,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a",
            "probability": 0.00019215133864287134,
            "start_logit": 5.121891975402832,
            "end_logit": -3.0609323978424072,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies",
            "probability": 0.00016768071016770805,
            "start_logit": 5.121891975402832,
            "end_logit": -3.1971540451049805,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies. T",
            "probability": 0.00014361985413135418,
            "start_logit": 5.121891975402832,
            "end_logit": -3.352045774459839,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB is a database of experimentally-characterized transmembrane (TM) topologies. TMPDB release 6",
            "probability": 0.00012822956552802225,
            "start_logit": 5.121891975402832,
            "end_logit": -3.465393543243408,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "a database of experimentally-characterized transmembrane (TM) topologies. TMPDB",
            "probability": 0.0001143262832622915,
            "start_logit": -2.7018046379089355,
            "end_logit": 4.243537425994873,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB release 6.2 contains a total of 302",
            "probability": 0.00010347889985440121,
            "start_logit": 4.437717437744141,
            "end_logit": -2.995673418045044,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "B",
            "probability": 7.079787253379446e-05,
            "start_logit": -4.07663106918335,
            "end_logit": 5.13913631439209,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        },
        {
            "text": "TMPDB release 6",
            "probability": 6.469265043765953e-05,
            "start_logit": 4.437717437744141,
            "end_logit": -3.465393543243408,
            "question_text": "Which databases exist for experimentally determined topologies of \u03b1-helical transmembrane proteins ?"
        }
    ],
    "56ebfa13107309bc2f000004": [
        {
            "text": "Histone posttranslational modifications",
            "probability": 0.20848088567854525,
            "start_logit": 0.7484541535377502,
            "end_logit": 1.496585726737976,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "structural",
            "probability": 0.09154263498624247,
            "start_logit": 1.7519313097000122,
            "end_logit": -0.3299339711666107,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "structurally and functionally distinct",
            "probability": 0.08361413498485472,
            "start_logit": 1.7519313097000122,
            "end_logit": -0.4205262064933777,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "functionally distinct",
            "probability": 0.08304876015579322,
            "start_logit": 1.745146632194519,
            "end_logit": -0.4205262064933777,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "structurally and functional",
            "probability": 0.08031639380566882,
            "start_logit": 1.7519313097000122,
            "end_logit": -0.4607650339603424,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "functional",
            "probability": 0.07977331735780577,
            "start_logit": 1.745146632194519,
            "end_logit": -0.4607650339603424,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "structurally and functionally distinct chromatin compartments of eukaryotic nuclei. The association of different histone modifications with euchromatic",
            "probability": 0.04540342830666933,
            "start_logit": 1.7519313097000122,
            "end_logit": -1.0311511754989624,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "functionally distinct chromatin compartments of eukaryotic nuclei. The association of different histone modifications with euchromatic",
            "probability": 0.04509642333050903,
            "start_logit": 1.745146632194519,
            "end_logit": -1.0311511754989624,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "Histone posttranslational modifications mediate establishment",
            "probability": 0.037607362751257416,
            "start_logit": 0.7484541535377502,
            "end_logit": -0.2160617858171463,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "Histone posttranslational modifications mediate establishment of structural",
            "probability": 0.03355975776916226,
            "start_logit": 0.7484541535377502,
            "end_logit": -0.3299339711666107,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "Histone posttranslational modifications mediate establishment of structurally and functionally distinct",
            "probability": 0.030653149940369,
            "start_logit": 0.7484541535377502,
            "end_logit": -0.4205262064933777,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "Histone posttranslational modifications mediate establishment of structurally and functional",
            "probability": 0.029444189818394112,
            "start_logit": 0.7484541535377502,
            "end_logit": -0.4607650339603424,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "structurally and functionally distinct chromatin compartments of eukaryotic nuclei. The association of different histone modifications",
            "probability": 0.021592194445465944,
            "start_logit": 1.7519313097000122,
            "end_logit": -1.774406909942627,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "functionally distinct chromatin compartments of eukaryotic nuclei. The association of different histone modifications",
            "probability": 0.021446194211822683,
            "start_logit": 1.745146632194519,
            "end_logit": -1.774406909942627,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "establishment",
            "probability": 0.02038871311593151,
            "start_logit": 0.136235773563385,
            "end_logit": -0.2160617858171463,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "structurally and functionally distinct chromatin compartments of eukaryotic nuclei.",
            "probability": 0.0186914728307381,
            "start_logit": 1.7519313097000122,
            "end_logit": -1.9186713695526123,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "functionally distinct chromatin compartments of eukaryotic nuclei.",
            "probability": 0.01856508644572676,
            "start_logit": 1.745146632194519,
            "end_logit": -1.9186713695526123,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "establishment of structural",
            "probability": 0.018194316839532307,
            "start_logit": 0.136235773563385,
            "end_logit": -0.3299339711666107,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "establishment of structurally and functionally distinct",
            "probability": 0.01661850857151424,
            "start_logit": 0.136235773563385,
            "end_logit": -0.4205262064933777,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        },
        {
            "text": "establishment of structurally and functional",
            "probability": 0.015963074653997024,
            "start_logit": 0.136235773563385,
            "end_logit": -0.4607650339603424,
            "question_text": "Which are the roles of chromatin compartments in the eukaryotic nucleus?"
        }
    ],
    "533c2230c45e133714000002": [
        {
            "text": "neural differentiation",
            "probability": 0.27876624471851885,
            "start_logit": 3.350883960723877,
            "end_logit": 3.13322377204895,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "neural differentiation including neuritogenesis",
            "probability": 0.27382248879076326,
            "start_logit": 3.350883960723877,
            "end_logit": 3.115330219268799,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "neuritogenesis",
            "probability": 0.18505400356240223,
            "start_logit": 2.9590516090393066,
            "end_logit": 3.115330219268799,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate immunity",
            "probability": 0.05695447040963835,
            "start_logit": 2.456366539001465,
            "end_logit": 2.439619779586792,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "degradation of 80K-H, leading to neural differentiation",
            "probability": 0.02239658997049452,
            "start_logit": 0.8294190764427185,
            "end_logit": 3.13322377204895,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "degradation of 80K-H, leading to neural differentiation including neuritogenesis",
            "probability": 0.02199939957701648,
            "start_logit": 0.8294190764427185,
            "end_logit": 3.115330219268799,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation",
            "probability": 0.020149220517156008,
            "start_logit": 0.7236759662628174,
            "end_logit": 3.13322377204895,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate immunity, viral infection, carcinogenesis, and development",
            "probability": 0.019846325393912116,
            "start_logit": 2.456366539001465,
            "end_logit": 1.3853864669799805,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "differentiation including neuritogenesis",
            "probability": 0.019791885903447926,
            "start_logit": 0.7236759662628174,
            "end_logit": 3.115330219268799,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate immunity, viral infection",
            "probability": 0.018783382161099905,
            "start_logit": 2.456366539001465,
            "end_logit": 1.3303401470184326,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "innate immunity, viral infection, carcinogenesis",
            "probability": 0.014158858050146703,
            "start_logit": 2.456366539001465,
            "end_logit": 1.0477080345153809,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "regulates Ras signaling via degradation of 80K-H, leading to neural differentiation",
            "probability": 0.011267865023218911,
            "start_logit": 0.1424652338027954,
            "end_logit": 3.13322377204895,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "regulates Ras signaling via degradation of 80K-H, leading to neural differentiation including neuritogenesis",
            "probability": 0.011068036042640807,
            "start_logit": 0.1424652338027954,
            "end_logit": 3.115330219268799,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "Ras signaling via degradation of 80K-H, leading to neural differentiation",
            "probability": 0.009614984955843968,
            "start_logit": -0.016166822984814644,
            "end_logit": 3.13322377204895,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "Ras signaling via degradation of 80K-H, leading to neural differentiation including neuritogenesis",
            "probability": 0.009444468834285808,
            "start_logit": -0.016166822984814644,
            "end_logit": 3.115330219268799,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "development",
            "probability": 0.006119256412960206,
            "start_logit": 1.2797882556915283,
            "end_logit": 1.3853864669799805,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "carcinogenesis, and development",
            "probability": 0.006074759238187587,
            "start_logit": 1.2724900245666504,
            "end_logit": 1.3853864669799805,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "regulates Ras signaling",
            "probability": 0.0055866939954908375,
            "start_logit": 0.1424652338027954,
            "end_logit": 2.4316565990448,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "Ras signaling",
            "probability": 0.004767183366934147,
            "start_logit": -0.016166822984814644,
            "end_logit": 2.4316565990448,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        },
        {
            "text": "carcinogenesis",
            "probability": 0.004333883075841311,
            "start_logit": 1.2724900245666504,
            "end_logit": 1.0477080345153809,
            "question_text": "What are the biological roles proposed for proteins containing the SPRY domain?"
        }
    ],
    "514241fcd24251bc05000006": [
        {
            "text": "PSP1",
            "probability": 0.41222456028229126,
            "start_logit": 2.049842119216919,
            "end_logit": 1.6218175888061523,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSP1 interacts in vivo with a subset of the total cellular pool of p54nrb",
            "probability": 0.1116306747797347,
            "start_logit": 2.049842119216919,
            "end_logit": 0.315445214509964,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "p54nrb and other RNA-binding proteins including PSP1",
            "probability": 0.10994518018616457,
            "start_logit": 0.8572381734848022,
            "end_logit": 1.4928351640701294,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSP1, a protein with sequence similarity to p54nrb",
            "probability": 0.09189502394569295,
            "start_logit": 1.6642705202102661,
            "end_logit": 0.5064678192138672,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "p54nrb",
            "probability": 0.05770361351307132,
            "start_logit": 0.8572381734848022,
            "end_logit": 0.8481730818748474,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "p54nrb and other RNA-binding proteins including PSP1, a protein with sequence similarity to p54nrb",
            "probability": 0.04100174122760933,
            "start_logit": 0.8572381734848022,
            "end_logit": 0.5064678192138672,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "p54nrb that acts as a marker for paraspeckles. We show that PSP1",
            "probability": 0.03437284188272177,
            "start_logit": -0.4344593584537506,
            "end_logit": 1.6218175888061523,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA-binding proteins including PSP1",
            "probability": 0.031235849225448083,
            "start_logit": -0.4011772572994232,
            "end_logit": 1.4928351640701294,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "P54nrb",
            "probability": 0.016629394926939066,
            "start_logit": 0.07606641203165054,
            "end_logit": 0.3851969540119171,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSP1,",
            "probability": 0.016020568054998265,
            "start_logit": 1.6642705202102661,
            "end_logit": -1.2403056621551514,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "p54nrb. We map the domain within PSP1",
            "probability": 0.015204551923107917,
            "start_logit": -0.42319533228874207,
            "end_logit": 0.7948816418647766,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSP1 that is mediating this interaction and show it is required for the correct localization of PSP1",
            "probability": 0.014588632341963585,
            "start_logit": 0.3598131835460663,
            "end_logit": -0.02947910688817501,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSP1 to paraspeckles. This interaction is necessary but not sufficient for paraspeckle targeting by PSP1",
            "probability": 0.01322307043588584,
            "start_logit": -0.015291878953576088,
            "end_logit": 0.2473464012145996,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA-binding proteins including PSP1, a protein with sequence similarity to p54nrb",
            "probability": 0.011648752631064487,
            "start_logit": -0.4011772572994232,
            "end_logit": 0.5064678192138672,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "p54nrb and other RNA-binding proteins including PSP1,",
            "probability": 0.007148060444475573,
            "start_logit": 0.8572381734848022,
            "end_logit": -1.2403056621551514,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "p54nrb and other RNA",
            "probability": 0.006406974334846099,
            "start_logit": 0.8572381734848022,
            "end_logit": -1.349759578704834,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "PSP",
            "probability": 0.004332396746810588,
            "start_logit": 2.049842119216919,
            "end_logit": -2.9336297512054443,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA-binding proteins including PSP1,",
            "probability": 0.002030791508276825,
            "start_logit": -0.4011772572994232,
            "end_logit": -1.2403056621551514,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "RNA",
            "probability": 0.0018202460896939996,
            "start_logit": -0.4011772572994232,
            "end_logit": -1.349759578704834,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        },
        {
            "text": "p54nrb and other RNA-binding proteins including PSP",
            "probability": 0.0009370755192037616,
            "start_logit": 0.8572381734848022,
            "end_logit": -3.2721381187438965,
            "question_text": "The protein NONO forms heterodimers. With which proteins?"
        }
    ],
    "56f802ea09dd18d46b000017": [
        {
            "text": "AMPA",
            "probability": 0.34953300973143464,
            "start_logit": 2.9949116706848145,
            "end_logit": 1.8430869579315186,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPA, kainate",
            "probability": 0.29989643404018174,
            "start_logit": 2.9949116706848145,
            "end_logit": 1.6899261474609375,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPA, kainate, and NMDA",
            "probability": 0.07072792596647011,
            "start_logit": 2.9949116706848145,
            "end_logit": 0.24532943964004517,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "kainate",
            "probability": 0.06851770184185468,
            "start_logit": 1.518566608428955,
            "end_logit": 1.6899261474609375,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "iGluRs (AMPA",
            "probability": 0.049360916183507214,
            "start_logit": 1.0374726057052612,
            "end_logit": 1.8430869579315186,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "iGluRs (AMPA, kainate",
            "probability": 0.04235125819951653,
            "start_logit": 1.0374726057052612,
            "end_logit": 1.6899261474609375,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "NMDA",
            "probability": 0.035404220576649124,
            "start_logit": 2.3029022216796875,
            "end_logit": 0.24532943964004517,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "kainate, and NMDA",
            "probability": 0.016159294987195687,
            "start_logit": 1.518566608428955,
            "end_logit": 0.24532943964004517,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPARs",
            "probability": 0.014336817448422023,
            "start_logit": 0.864657998085022,
            "end_logit": 0.7795735001564026,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPA, kainate, and NMDA receptor",
            "probability": 0.012026139671194792,
            "start_logit": 2.9949116706848145,
            "end_logit": -1.526428461074829,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "iGluRs",
            "probability": 0.011290566186937238,
            "start_logit": 1.0374726057052612,
            "end_logit": 0.36789554357528687,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "iGluRs (AMPA, kainate, and NMDA",
            "probability": 0.009988170296552853,
            "start_logit": 1.0374726057052612,
            "end_logit": 0.24532943964004517,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "NMDA receptor",
            "probability": 0.006019914988125314,
            "start_logit": 2.3029022216796875,
            "end_logit": -1.526428461074829,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AM",
            "probability": 0.003111745791537702,
            "start_logit": 2.9949116706848145,
            "end_logit": -2.8783271312713623,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "kainate, and NMDA receptor",
            "probability": 0.0027476267096561095,
            "start_logit": 1.518566608428955,
            "end_logit": -1.526428461074829,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPAR",
            "probability": 0.002194852917643177,
            "start_logit": 0.40524280071258545,
            "end_logit": -0.6377271413803101,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "iGluRs (AMPA, kainate, and NMDA receptor",
            "probability": 0.0016983267840056334,
            "start_logit": 1.0374726057052612,
            "end_logit": -1.526428461074829,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPA, kainate, and NMDA receptor subtypes",
            "probability": 0.0016091072190310086,
            "start_logit": 2.9949116706848145,
            "end_logit": -3.5378315448760986,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPA receptor",
            "probability": 0.0015553342753656045,
            "start_logit": 0.6199999451637268,
            "end_logit": -1.1969088315963745,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        },
        {
            "text": "AMPA, kainate, and NMDA receptor subtypes) are tetrameric assemblies,",
            "probability": 0.0014706361847189782,
            "start_logit": 2.9949116706848145,
            "end_logit": -3.6278159618377686,
            "question_text": "List human proteins that are subject to a dimer-to-tetramer transition."
        }
    ],
    "531376c8e3eabad021000012": [
        {
            "text": "PLN",
            "probability": 0.43161517102263813,
            "start_logit": 2.5539073944091797,
            "end_logit": 1.1494410037994385,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Lys82Arg, Arg73Gln) and one truncation mutation in the PLN gene (Leu39Ter",
            "probability": 0.09529902007097932,
            "start_logit": 1.6314457654953003,
            "end_logit": 0.5613877773284912,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Leu39Ter",
            "probability": 0.09226590776220892,
            "start_logit": 1.599100947380066,
            "end_logit": 0.5613877773284912,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg73Gln) and one truncation mutation in the PLN gene (Leu39Ter",
            "probability": 0.08040542740882514,
            "start_logit": 1.4615079164505005,
            "end_logit": 0.5613877773284912,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Lys82Arg, Arg73Gln",
            "probability": 0.061904345571238736,
            "start_logit": 1.6314457654953003,
            "end_logit": 0.1299586296081543,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg73Gln",
            "probability": 0.052229764381751545,
            "start_logit": 1.4615079164505005,
            "end_logit": 0.1299586296081543,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Lys82Arg",
            "probability": 0.049700721643842344,
            "start_logit": 1.6314457654953003,
            "end_logit": -0.08961229771375656,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN gene (Leu39Ter",
            "probability": 0.04595807277724275,
            "start_logit": 0.9021557569503784,
            "end_logit": 0.5613877773284912,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(PLN",
            "probability": 0.03088289069697338,
            "start_logit": -0.0834246575832367,
            "end_logit": 1.1494410037994385,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Leu39Ter). A variant was also identified in the CASQ2 gene (Asp63Glu",
            "probability": 0.012699345462962336,
            "start_logit": 1.599100947380066,
            "end_logit": -1.421736478805542,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "P",
            "probability": 0.006726660114275078,
            "start_logit": 2.5539073944091797,
            "end_logit": -3.012014627456665,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN gene (Leu39Ter). A variant was also identified in the CASQ2 gene (Asp63Glu",
            "probability": 0.006325602350484022,
            "start_logit": 0.9021557569503784,
            "end_logit": -1.421736478805542,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "PLN)",
            "probability": 0.0062532045273770015,
            "start_logit": 2.5539073944091797,
            "end_logit": -3.0849993228912354,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Leu39Ter)",
            "probability": 0.005605696487014539,
            "start_logit": 1.599100947380066,
            "end_logit": -2.2395036220550537,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg73Gln) and one truncation mutation in the PLN gene (Leu39Ter)",
            "probability": 0.004885102557319302,
            "start_logit": 1.4615079164505005,
            "end_logit": -2.2395036220550537,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(Lys82Arg, Arg73Gln",
            "probability": 0.003977112459404298,
            "start_logit": -1.113588571548462,
            "end_logit": 0.1299586296081543,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Lys82Arg, Arg73Gln)",
            "probability": 0.0034894744829235555,
            "start_logit": 1.6314457654953003,
            "end_logit": -2.745880603790283,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "Lys82Arg, Arg73Gln) and one truncation mutation in the PLN",
            "probability": 0.003359489233766983,
            "start_logit": 1.6314457654953003,
            "end_logit": -2.7838428020477295,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(Leu39Ter",
            "probability": 0.003223913710156693,
            "start_logit": -1.7549777030944824,
            "end_logit": 0.5613877773284912,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        },
        {
            "text": "(Lys82Arg",
            "probability": 0.0031930772786159167,
            "start_logit": -1.113588571548462,
            "end_logit": -0.08961229771375656,
            "question_text": "which mutations of phospholamban gene have been found to cause hypertrophic cardiomyopathy?"
        }
    ],
    "5312280ce3eabad02100000a": [
        {
            "text": "17",
            "probability": 0.5370022537823268,
            "start_logit": 0.8147789835929871,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q11.2",
            "probability": 0.1492691640126651,
            "start_logit": 0.8147789835929871,
            "end_logit": -0.5569337010383606,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "chromosome 17",
            "probability": 0.09471727102284715,
            "start_logit": -0.9203269481658936,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "the causative gene (NF1) has been assigned to chromosome 17",
            "probability": 0.02645725813392254,
            "start_logit": -2.195692777633667,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "chromosome 17q11.2",
            "probability": 0.02632832127530025,
            "start_logit": -0.9203269481658936,
            "end_logit": -0.5569337010383606,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "(NF1) has been assigned to chromosome 17",
            "probability": 0.025043872048338467,
            "start_logit": -2.250594139099121,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "causative gene (NF1) has been assigned to chromosome 17",
            "probability": 0.020427867368181734,
            "start_logit": -2.4543232917785645,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "neurofibromatosis type 1, of which the causative gene (NF1) has been assigned to chromosome 17",
            "probability": 0.01439443536529155,
            "start_logit": -2.8043816089630127,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "assigned to chromosome 17",
            "probability": 0.014380642304696835,
            "start_logit": -2.80534029006958,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q11",
            "probability": 0.014158989033375844,
            "start_logit": 0.8147789835929871,
            "end_logit": -2.912335157394409,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "2",
            "probability": 0.010437546917786809,
            "start_logit": -1.8455625772476196,
            "end_logit": -0.5569337010383606,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q11.",
            "probability": 0.010316643108470197,
            "start_logit": 0.8147789835929871,
            "end_logit": -3.228926420211792,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "NF1) has been assigned to chromosome 17",
            "probability": 0.008728932616762273,
            "start_logit": -3.3045802116394043,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "gene (NF1) has been assigned to chromosome 17",
            "probability": 0.008053102155263534,
            "start_logit": -3.3851659297943115,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q",
            "probability": 0.007873754770409034,
            "start_logit": 0.8147789835929871,
            "end_logit": -3.499149799346924,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "the causative gene (NF1) has been assigned to chromosome 17q11.2",
            "probability": 0.007354257409352935,
            "start_logit": -2.195692777633667,
            "end_logit": -0.5569337010383606,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "(NF1) has been assigned to chromosome 17q11.2",
            "probability": 0.006961382038837662,
            "start_logit": -2.250594139099121,
            "end_logit": -0.5569337010383606,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "17q11.2.",
            "probability": 0.006439079429460817,
            "start_logit": 0.8147789835929871,
            "end_logit": -3.7002992630004883,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "been assigned to chromosome 17",
            "probability": 0.005976944363141618,
            "start_logit": -3.6833138465881348,
            "end_logit": 0.7233174443244934,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        },
        {
            "text": "causative gene (NF1) has been assigned to chromosome 17q11.2",
            "probability": 0.005678282843569029,
            "start_logit": -2.4543232917785645,
            "end_logit": -0.5569337010383606,
            "question_text": "Abnormalities in which chromosomes were linked to the Moyamoya disease?"
        }
    ],
    "54df69af1388e8454a000005": [
        {
            "text": "epirubicin",
            "probability": 0.9938043954838803,
            "start_logit": 4.112643241882324,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "e",
            "probability": 0.0013686629481630523,
            "start_logit": 4.112643241882324,
            "end_logit": -2.6947617530822754,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin-based regimens",
            "probability": 0.0007523148391132046,
            "start_logit": 4.112643241882324,
            "end_logit": -3.293196439743042,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "bicin",
            "probability": 0.0006671405630950564,
            "start_logit": -3.1936516761779785,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin-based regimens in premenopausal patients with lymph node-positive breast cancer.",
            "probability": 0.0005468616840444067,
            "start_logit": 4.112643241882324,
            "end_logit": -3.6121554374694824,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "in",
            "probability": 0.0004923311418872275,
            "start_logit": -3.4975008964538574,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "dose intensity of epirubicin",
            "probability": 0.0004478246966017789,
            "start_logit": -3.5922505855560303,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubic",
            "probability": 0.00038358862242512595,
            "start_logit": 4.112643241882324,
            "end_logit": -3.966780662536621,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "evaluate the duration and dose intensity of epirubicin",
            "probability": 0.0002961217397820134,
            "start_logit": -4.0058817863464355,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epi",
            "probability": 0.00023967819941628527,
            "start_logit": 4.112643241882324,
            "end_logit": -4.43705415725708,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin-based",
            "probability": 0.00021312612867852246,
            "start_logit": 4.112643241882324,
            "end_logit": -4.55446720123291,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "rubicin",
            "probability": 0.00016438418125455285,
            "start_logit": -4.594446182250977,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "pirubicin",
            "probability": 0.0001292059681709224,
            "start_logit": -4.835244655609131,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "duration and dose intensity of epirubicin",
            "probability": 0.00012085430528585795,
            "start_logit": -4.902066707611084,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "To evaluate the duration and dose intensity of epirubicin",
            "probability": 0.00011704578262033077,
            "start_logit": -4.93408727645874,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "intensity of epirubicin",
            "probability": 8.499262722567761e-05,
            "start_logit": -5.254087924957275,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epiru",
            "probability": 5.163186550881392e-05,
            "start_logit": 4.112643241882324,
            "end_logit": -5.972212314605713,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin-based regimens in premenopausal patients with lymph node-positive breast cancer",
            "probability": 4.590634943321142e-05,
            "start_logit": 4.112643241882324,
            "end_logit": -6.089747905731201,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "the duration and dose intensity of epirubicin",
            "probability": 3.918200893664489e-05,
            "start_logit": -6.028434753417969,
            "end_logit": 3.8929443359375,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        },
        {
            "text": "epirubicin-based regime",
            "probability": 3.475086447732403e-05,
            "start_logit": 4.112643241882324,
            "end_logit": -6.368146896362305,
            "question_text": "Which drugs are included in the FEC-75 regimen?"
        }
    ],
    "5536554abc4f83e828000008": [
        {
            "text": "D22S1 and D22S15",
            "probability": 0.3838087848285693,
            "start_logit": 3.620011329650879,
            "end_logit": 3.8075757026672363,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S15",
            "probability": 0.31587685559437384,
            "start_logit": 3.4252192974090576,
            "end_logit": 3.8075757026672363,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1",
            "probability": 0.23182800771927278,
            "start_logit": 3.620011329650879,
            "end_logit": 3.30342698097229,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22S15,",
            "probability": 0.026538520941350348,
            "start_logit": 3.620011329650879,
            "end_logit": 1.136028528213501,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S15,",
            "probability": 0.02184135662976935,
            "start_logit": 3.4252192974090576,
            "end_logit": 1.136028528213501,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22",
            "probability": 0.0023617206450202008,
            "start_logit": 3.620011329650879,
            "end_logit": -1.2831783294677734,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22",
            "probability": 0.002329753421451681,
            "start_logit": 3.620011329650879,
            "end_logit": -1.2968063354492188,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "two probes, D22S1 and D22S15",
            "probability": 0.00228346690784391,
            "start_logit": -1.5044382810592651,
            "end_logit": 3.8075757026672363,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "between two probes, D22S1 and D22S15",
            "probability": 0.0022275356225134983,
            "start_logit": -1.5292372703552246,
            "end_logit": 3.8075757026672363,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "two probes, D22S1",
            "probability": 0.0013792586435320629,
            "start_logit": -1.5044382810592651,
            "end_logit": 3.30342698097229,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "between two probes, D22S1",
            "probability": 0.0013454750539951038,
            "start_logit": -1.5292372703552246,
            "end_logit": 3.30342698097229,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22S15, by both in situ hybridization and somatic cell hybrids",
            "probability": 0.001326522225151252,
            "start_logit": 3.620011329650879,
            "end_logit": -1.8600081205368042,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S15, by both in situ hybridization and somatic cell hybrids",
            "probability": 0.0010917354837096458,
            "start_logit": 3.4252192974090576,
            "end_logit": -1.8600081205368042,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22S15, by both in situ hybridization",
            "probability": 0.000989674780332814,
            "start_logit": 3.620011329650879,
            "end_logit": -2.1529476642608643,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "localized between two probes, D22S1 and D22S15",
            "probability": 0.000903478942804487,
            "start_logit": -2.431635618209839,
            "end_logit": 3.8075757026672363,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S15, by both in situ hybridization",
            "probability": 0.0008145080832691562,
            "start_logit": 3.4252192974090576,
            "end_logit": -2.1529476642608643,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "15",
            "probability": 0.0007817532575287305,
            "start_logit": -2.5763492584228516,
            "end_logit": 3.8075757026672363,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "been localized between two probes, D22S1 and D22S15",
            "probability": 0.0007740564411135782,
            "start_logit": -2.5862436294555664,
            "end_logit": 3.8075757026672363,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "22S1 and D22S15",
            "probability": 0.0007500591590500129,
            "start_logit": -2.617736339569092,
            "end_logit": 3.8075757026672363,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        },
        {
            "text": "D22S1 and D22S15, by",
            "probability": 0.0007474756193480908,
            "start_logit": 3.620011329650879,
            "end_logit": -2.433622360229492,
            "question_text": "Between which probes does the recurrent translocation breakpoint on chromosome 22 of neuroepithelioma lie?"
        }
    ],
    "56f3f0f02ac5ed1459000017": [
        {
            "text": "CPModule",
            "probability": 0.8768378209279769,
            "start_logit": 2.9945340156555176,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CPModule'",
            "probability": 0.0679232086474658,
            "start_logit": 2.9945340156555176,
            "end_logit": -0.33862993121147156,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "'CPModule",
            "probability": 0.02722088410514668,
            "start_logit": -0.4778035581111908,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CPM",
            "probability": 0.006524592935826989,
            "start_logit": 2.9945340156555176,
            "end_logit": -2.681429147720337,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "ChIP-Seq based data, we developed a novel powerful CRM detection method 'CPModule",
            "probability": 0.004505048429525547,
            "start_logit": -2.2765893936157227,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CRM detection method 'CPModule",
            "probability": 0.0035367376592538844,
            "start_logit": -2.518583297729492,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "C",
            "probability": 0.002404865605754957,
            "start_logit": 2.9945340156555176,
            "end_logit": -3.679513692855835,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "'CPModule'",
            "probability": 0.002108633713684476,
            "start_logit": -0.4778035581111908,
            "end_logit": -0.33862993121147156,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "detection method 'CPModule",
            "probability": 0.0019742697704268385,
            "start_logit": -3.1015894412994385,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CPModule'.",
            "probability": 0.0012304655781967475,
            "start_logit": 2.9945340156555176,
            "end_logit": -4.349615097045898,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "developed a novel powerful CRM detection method 'CPModule",
            "probability": 0.0009947032278382125,
            "start_logit": -3.7870988845825195,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CPModule'. By applying it on a well-studied ChIP-Seq",
            "probability": 0.0008825334465584879,
            "start_logit": 2.9945340156555176,
            "end_logit": -4.681966304779053,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "detection on ChIP-Seq based data, we developed a novel powerful CRM detection method 'CPModule",
            "probability": 0.0006714800847220318,
            "start_logit": -4.18005895614624,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "a novel powerful CRM detection method 'CPModule",
            "probability": 0.0006698446450236374,
            "start_logit": -4.182497501373291,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "novel powerful CRM detection method 'CPModule",
            "probability": 0.0006018282036139283,
            "start_logit": -4.289571285247803,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "PModule",
            "probability": 0.0005568315834305246,
            "start_logit": -4.36728048324585,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "powerful CRM detection method 'CPModule",
            "probability": 0.0005307520270319119,
            "start_logit": -4.415248394012451,
            "end_logit": 2.2193143367767334,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "ChIP-Seq based data, we developed a novel powerful CRM detection method 'CPModule'",
            "probability": 0.0003489782684348151,
            "start_logit": -2.2765893936157227,
            "end_logit": -0.33862993121147156,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "CRM detection method 'CPModule'",
            "probability": 0.00027396921554617053,
            "start_logit": -2.518583297729492,
            "end_logit": -0.33862993121147156,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        },
        {
            "text": "'CPM",
            "probability": 0.00020255192454112175,
            "start_logit": -0.4778035581111908,
            "end_logit": -2.681429147720337,
            "question_text": "Which are the most widely used computational methods for the identification of CRMs (cis-regulatory modules)?"
        }
    ],
    "532ad23ad6d3ac6a34000011": [
        {
            "text": "Standard numbering schemes",
            "probability": 0.5306903503775197,
            "start_logit": -1.3430596590042114,
            "end_logit": -1.176088571548462,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Standard",
            "probability": 0.1962788222289276,
            "start_logit": -1.3430596590042114,
            "end_logit": -2.1707310676574707,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Standard numbering schemes have been successfully implemented for several protein families, including lactamases and antibodies,",
            "probability": 0.055833690214808655,
            "start_logit": -1.3430596590042114,
            "end_logit": -3.427889823913574,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Standard numbering",
            "probability": 0.04571973280230644,
            "start_logit": -1.3430596590042114,
            "end_logit": -3.627737283706665,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "numbering schemes",
            "probability": 0.03078980018656841,
            "start_logit": -4.190054893493652,
            "end_logit": -1.176088571548462,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Standard numbering schemes have been successfully implemented for several protein families, including lactamases and antibodies, whereas a numbering scheme",
            "probability": 0.02539438351746906,
            "start_logit": -1.3430596590042114,
            "end_logit": -4.2157392501831055,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "schemes",
            "probability": 0.02171451301332785,
            "start_logit": -4.539257526397705,
            "end_logit": -1.176088571548462,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Standard numbering schemes have been successfully implemented",
            "probability": 0.015706887847307248,
            "start_logit": -1.3430596590042114,
            "end_logit": -4.696167945861816,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "thiamine-diphosphate (ThDP) -dependent decarboxylases",
            "probability": 0.012905482208809866,
            "start_logit": -1.5188387632369995,
            "end_logit": -4.716835975646973,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Standard numbering schemes have been successfully implemented for several protein families, including lactamases",
            "probability": 0.011619540196699038,
            "start_logit": -1.3430596590042114,
            "end_logit": -4.997579097747803,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "thiamine-diphosphate (ThDP)",
            "probability": 0.011120654463526013,
            "start_logit": -1.5188387632369995,
            "end_logit": -4.8656840324401855,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Standard numbering schemes have been successfully implemented for several protein families,",
            "probability": 0.010857961894677757,
            "start_logit": -1.3430596590042114,
            "end_logit": -5.06536865234375,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "thiamine-diphosphate",
            "probability": 0.008839269071631566,
            "start_logit": -1.5188387632369995,
            "end_logit": -5.0952839851379395,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "Standard numbering schemes have been successfully implemented for several protein families, including lactamases and antibodies, whereas",
            "probability": 0.0063212583035430646,
            "start_logit": -1.3430596590042114,
            "end_logit": -5.606348991394043,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "lactamases and antibodies,",
            "probability": 0.004246036148398011,
            "start_logit": -3.9194512367248535,
            "end_logit": -3.427889823913574,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "numbering schemes have been successfully implemented for several protein families, including lactamases and antibodies,",
            "probability": 0.0032393808633787826,
            "start_logit": -4.190054893493652,
            "end_logit": -3.427889823913574,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "numbering",
            "probability": 0.0026525853288361274,
            "start_logit": -4.190054893493652,
            "end_logit": -3.627737283706665,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "schemes have been successfully implemented for several protein families, including lactamases and antibodies,",
            "probability": 0.002284574030579427,
            "start_logit": -4.539257526397705,
            "end_logit": -3.427889823913574,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "lactamases and antibodies, whereas a numbering scheme",
            "probability": 0.00193119011060562,
            "start_logit": -3.9194512367248535,
            "end_logit": -4.2157392501831055,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        },
        {
            "text": "ThDP) -dependent decarboxylases",
            "probability": 0.0018538871910799713,
            "start_logit": -3.4592063426971436,
            "end_logit": -4.716835975646973,
            "question_text": "What systems have been developed for the numbering of antibody residues?"
        }
    ],
    "5156be75d24251bc05000088": [
        {
            "text": "stromal keratitis",
            "probability": 0.6983504018212312,
            "start_logit": 2.188734531402588,
            "end_logit": 2.0718977451324463,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "keratitis",
            "probability": 0.24316468235913882,
            "start_logit": 1.133752465248108,
            "end_logit": 2.0718977451324463,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "stromal keratitis (SK)",
            "probability": 0.03821654568260424,
            "start_logit": 2.188734531402588,
            "end_logit": -0.8335546851158142,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "keratitis (SK)",
            "probability": 0.013306950447137918,
            "start_logit": 1.133752465248108,
            "end_logit": -0.8335546851158142,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "Herpes simplex virus",
            "probability": 0.002141864344538782,
            "start_logit": -0.42365843057632446,
            "end_logit": -1.1027536392211914,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "titis",
            "probability": 0.0015321969919693335,
            "start_logit": -3.933283805847168,
            "end_logit": 2.0718977451324463,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "stromal keratitis (SK).",
            "probability": 0.0009341304651880982,
            "start_logit": 2.188734531402588,
            "end_logit": -4.544962406158447,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "Herpes simplex virus (HSV)",
            "probability": 0.0008844641301718766,
            "start_logit": -0.42365843057632446,
            "end_logit": -1.987203598022461,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "s",
            "probability": 0.0004596313662554344,
            "start_logit": 2.188734531402588,
            "end_logit": -5.254153728485107,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "keratitis (SK).",
            "probability": 0.00032526298725837254,
            "start_logit": 1.133752465248108,
            "end_logit": -4.544962406158447,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ocular disease",
            "probability": 0.00018155415672291652,
            "start_logit": -2.166830062866211,
            "end_logit": -1.8274599313735962,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "infectious ocular disease",
            "probability": 0.00014818467093193858,
            "start_logit": -2.369924783706665,
            "end_logit": -1.8274599313735962,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "titis (SK)",
            "probability": 8.38479883245406e-05,
            "start_logit": -3.933283805847168,
            "end_logit": -0.8335546851158142,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "Herpes simplex",
            "probability": 6.40411970066454e-05,
            "start_logit": -0.42365843057632446,
            "end_logit": -4.612658977508545,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "ocular disease.",
            "probability": 5.026855187080225e-05,
            "start_logit": -2.166830062866211,
            "end_logit": -3.1116342544555664,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "infectious ocular disease.",
            "probability": 4.102923861208224e-05,
            "start_logit": -2.369924783706665,
            "end_logit": -3.1116342544555664,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "involvement in an infectious ocular disease",
            "probability": 3.6170095599614265e-05,
            "start_logit": -3.7801513671875,
            "end_logit": -1.8274599313735962,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "this is one of the first reports of miRNA involvement in an infectious ocular disease",
            "probability": 2.968433452952265e-05,
            "start_logit": -3.97776460647583,
            "end_logit": -1.8274599313735962,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "angiogenesis. Herpes simplex virus",
            "probability": 2.542587048353893e-05,
            "start_logit": -4.857323169708252,
            "end_logit": -1.1027536392211914,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        },
        {
            "text": "one of the first reports of miRNA involvement in an infectious ocular disease",
            "probability": 2.366330042468853e-05,
            "start_logit": -4.204458713531494,
            "end_logit": -1.8274599313735962,
            "question_text": "Which diseases is microRNA 132 (miR-132) implicated in?"
        }
    ],
    "57169b63cb4ef8864c00000b": [
        {
            "text": "GLAST",
            "probability": 0.6473116195492912,
            "start_logit": 3.942803144454956,
            "end_logit": 2.96797251701355,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ASpartate Transporter (GLAST",
            "probability": 0.24599217129029183,
            "start_logit": 2.9752750396728516,
            "end_logit": 2.96797251701355,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLAST)",
            "probability": 0.03173513463030567,
            "start_logit": 3.942803144454956,
            "end_logit": -0.04743088409304619,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLutamate ASpartate Transporter (GLAST",
            "probability": 0.02097967207365444,
            "start_logit": 0.5135293006896973,
            "end_logit": 2.96797251701355,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "(GLAST",
            "probability": 0.013731925268407998,
            "start_logit": 0.08969876170158386,
            "end_logit": 2.96797251701355,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ASpartate Transporter (GLAST)",
            "probability": 0.012060025555132447,
            "start_logit": 2.9752750396728516,
            "end_logit": -0.04743088409304619,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLAST).",
            "probability": 0.0071629048622967005,
            "start_logit": 3.942803144454956,
            "end_logit": -1.5359396934509277,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ASpartate Transporter",
            "probability": 0.005566145055049219,
            "start_logit": 2.9752750396728516,
            "end_logit": -0.8206244707107544,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "G",
            "probability": 0.003324857738196083,
            "start_logit": 3.942803144454956,
            "end_logit": -2.3034284114837646,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ASpartate Transporter (GLAST).",
            "probability": 0.0027220560648193045,
            "start_logit": 2.9752750396728516,
            "end_logit": -1.5359396934509277,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ASpartate",
            "probability": 0.002018696423852209,
            "start_logit": 2.9752750396728516,
            "end_logit": -1.834875226020813,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "AS",
            "probability": 0.0017221880017873792,
            "start_logit": 2.9752750396728516,
            "end_logit": -1.9937316179275513,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ASpartate Transporter (G",
            "probability": 0.0012635165962564694,
            "start_logit": 2.9752750396728516,
            "end_logit": -2.3034284114837646,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLutamate ASpartate Transporter (GLAST)",
            "probability": 0.0010285505429682609,
            "start_logit": 0.5135293006896973,
            "end_logit": -0.04743088409304619,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ASpartate Transport",
            "probability": 0.0010206036133555058,
            "start_logit": 2.9752750396728516,
            "end_logit": -2.516932964324951,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "Transporter (GLAST",
            "probability": 0.0006958496646926255,
            "start_logit": -2.892646312713623,
            "end_logit": 2.96797251701355,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "(GLAST)",
            "probability": 0.0006732221143035424,
            "start_logit": 0.08969876170158386,
            "end_logit": -0.04743088409304619,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "GLutamate ASpartate Transporter",
            "probability": 0.0004747138795385496,
            "start_logit": 0.5135293006896973,
            "end_logit": -0.8206244707107544,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "the GLutamate ASpartate Transporter (GLAST",
            "probability": 0.00026782237269513297,
            "start_logit": -3.8474559783935547,
            "end_logit": 2.96797251701355,
            "question_text": "Which are the human glutamate transporters?"
        },
        {
            "text": "ASpartate Transporter (",
            "probability": 0.000248324703105338,
            "start_logit": 2.9752750396728516,
            "end_logit": -3.930345296859741,
            "question_text": "Which are the human glutamate transporters?"
        }
    ],
    "55184d46622b194345000001": [
        {
            "text": "colloidal Coomassie Blue",
            "probability": 0.5276500586577663,
            "start_logit": 4.165539264678955,
            "end_logit": 4.30050802230835,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue",
            "probability": 0.4465384491655887,
            "start_logit": 3.998631477355957,
            "end_logit": 4.30050802230835,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "colloidal Coomassie Blue,",
            "probability": 0.007359641558960565,
            "start_logit": 4.165539264678955,
            "end_logit": 0.02808595634996891,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue,",
            "probability": 0.006228300128522114,
            "start_logit": 3.998631477355957,
            "end_logit": 0.02808595634996891,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "colloidal Coomassie",
            "probability": 0.0028603919384808042,
            "start_logit": 4.165539264678955,
            "end_logit": -0.9169666171073914,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie",
            "probability": 0.002420685754236617,
            "start_logit": 3.998631477355957,
            "end_logit": -0.9169666171073914,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Sypro Ruby",
            "probability": 0.001822814862879762,
            "start_logit": 0.8921056985855103,
            "end_logit": 1.9058902263641357,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "colloidal Coomassie Blue, when used as an infrared dye",
            "probability": 0.0007976413733164514,
            "start_logit": 4.165539264678955,
            "end_logit": -2.194021463394165,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "colloidal Coomassie Blue, when used as an infrared",
            "probability": 0.0007522230692759232,
            "start_logit": 4.165539264678955,
            "end_logit": -2.252647638320923,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue, when used as an infrared dye",
            "probability": 0.0006750260631773288,
            "start_logit": 3.998631477355957,
            "end_logit": -2.194021463394165,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue, when used as an infrared",
            "probability": 0.0006365895677819157,
            "start_logit": 3.998631477355957,
            "end_logit": -2.252647638320923,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Blue",
            "probability": 0.0005262075297797548,
            "start_logit": -2.7449536323547363,
            "end_logit": 4.30050802230835,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "colloidal",
            "probability": 0.00047800666378444804,
            "start_logit": 4.165539264678955,
            "end_logit": -2.7060558795928955,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "co",
            "probability": 0.0003139448640017131,
            "start_logit": 4.165539264678955,
            "end_logit": -3.1264631748199463,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "colloidal Co",
            "probability": 0.0002947585006550349,
            "start_logit": 4.165539264678955,
            "end_logit": -3.1895241737365723,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Co",
            "probability": 0.0002494475298566067,
            "start_logit": 3.998631477355957,
            "end_logit": -3.1895241737365723,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "two-dimensional gel electrophoresis in top-down proteomic analyses, a more cost effective alternative such as Coomassie Blue",
            "probability": 0.00014318468153977557,
            "start_logit": -1.3989003896713257,
            "end_logit": 1.652894377708435,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue infrared fluorescence",
            "probability": 0.00013463050084604007,
            "start_logit": 1.0346559286117554,
            "end_logit": -0.8422632217407227,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "infrared dye, may provide sensitive, post-electrophoretic in-gel protein detection that can rival even Sypro Ruby",
            "probability": 7.517221250884241e-05,
            "start_logit": -2.2962498664855957,
            "end_logit": 1.9058902263641357,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        },
        {
            "text": "Coomassie Blue infrared",
            "probability": 4.282537704139395e-05,
            "start_logit": 1.0346559286117554,
            "end_logit": -1.987666368484497,
            "question_text": "List protein gel staining methods visualizing the entire protein set."
        }
    ],
    "54cf43abf693c3b16b000008": [
        {
            "text": "sagittal and both lambdoid sutures",
            "probability": 0.3435483888063351,
            "start_logit": 4.229767322540283,
            "end_logit": 3.398742437362671,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "lambdoid sutures",
            "probability": 0.18287090159585775,
            "start_logit": 3.599219799041748,
            "end_logit": 3.398742437362671,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal and both lambdoid",
            "probability": 0.15852509089650962,
            "start_logit": 4.229767322540283,
            "end_logit": 2.6253273487091064,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal",
            "probability": 0.09115427260470857,
            "start_logit": 4.229767322540283,
            "end_logit": 2.071967840194702,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "lambdoid",
            "probability": 0.08438294936714734,
            "start_logit": 3.599219799041748,
            "end_logit": 2.6253273487091064,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "both lambdoid sutures",
            "probability": 0.0588800355521016,
            "start_logit": 2.4659414291381836,
            "end_logit": 3.398742437362671,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "both lambdoid",
            "probability": 0.02716928180137198,
            "start_logit": 2.4659414291381836,
            "end_logit": 2.6253273487091064,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "the sagittal and both lambdoid sutures",
            "probability": 0.022157278193815414,
            "start_logit": 1.4886053800582886,
            "end_logit": 3.398742437362671,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "the sagittal and both lambdoid",
            "probability": 0.010224133351048536,
            "start_logit": 1.4886053800582886,
            "end_logit": 2.6253273487091064,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "the sagittal",
            "probability": 0.005879027940357993,
            "start_logit": 1.4886053800582886,
            "end_logit": 2.071967840194702,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "involving the sagittal and both lambdoid sutures",
            "probability": 0.005592284964714261,
            "start_logit": 0.1118273138999939,
            "end_logit": 3.398742437362671,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "involving the sagittal and both lambdoid",
            "probability": 0.002580473409963391,
            "start_logit": 0.1118273138999939,
            "end_logit": 2.6253273487091064,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sutures",
            "probability": 0.0022543168969069915,
            "start_logit": -0.796713650226593,
            "end_logit": 3.398742437362671,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "involving the sagittal",
            "probability": 0.0014838103881899991,
            "start_logit": 0.1118273138999939,
            "end_logit": 2.071967840194702,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "trisutural fusion, dubbed the \"Mercedes Benz pattern,\" involving the sagittal and both lambdoid",
            "probability": 0.0008905174057964868,
            "start_logit": -0.9520981907844543,
            "end_logit": 2.6253273487091064,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal and both",
            "probability": 0.0006886061367372591,
            "start_logit": 4.229767322540283,
            "end_logit": -2.813671350479126,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sa",
            "probability": 0.0005393780848018259,
            "start_logit": 4.229767322540283,
            "end_logit": -3.0579240322113037,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "trisutural fusion, dubbed the \"Mercedes Benz pattern,\" involving the sagittal",
            "probability": 0.0005120606833160826,
            "start_logit": -0.9520981907844543,
            "end_logit": 2.071967840194702,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagit",
            "probability": 0.0004302519357017023,
            "start_logit": 4.229767322540283,
            "end_logit": -3.2839698791503906,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        },
        {
            "text": "sagittal and both la",
            "probability": 0.00023693998461831494,
            "start_logit": 4.229767322540283,
            "end_logit": -3.8805339336395264,
            "question_text": "Synostosis of which cranial structures are characteristic to the Mercedes Benz syndrome?"
        }
    ],
    "55391ce8bc4f83e828000018": [
        {
            "text": "Hedgehog",
            "probability": 0.8215226625811678,
            "start_logit": 4.910717487335205,
            "end_logit": 4.009955883026123,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Gli1",
            "probability": 0.08363943828033879,
            "start_logit": 3.7081751823425293,
            "end_logit": 2.92785382270813,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedgehog (Hh)",
            "probability": 0.03921420319703469,
            "start_logit": 4.910717487335205,
            "end_logit": 0.9678353667259216,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Smoothened or Gli1",
            "probability": 0.015204766031559206,
            "start_logit": 2.0032689571380615,
            "end_logit": 2.92785382270813,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedgehog (Hh) signaling is an important factor in growth and patterning during embryonic development. A mutation in Patched",
            "probability": 0.009113223939652181,
            "start_logit": 4.910717487335205,
            "end_logit": -0.4914771020412445,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedgehog (Hh) signaling",
            "probability": 0.00745963303667372,
            "start_logit": 4.910717487335205,
            "end_logit": -0.6916974186897278,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Patched, Smoothened or Gli1",
            "probability": 0.00592244236887824,
            "start_logit": 1.0604089498519897,
            "end_logit": 2.92785382270813,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Gli1,",
            "probability": 0.0036079788813916463,
            "start_logit": 3.7081751823425293,
            "end_logit": -0.21551358699798584,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Smoothened",
            "probability": 0.0031330222345320466,
            "start_logit": 2.0032689571380615,
            "end_logit": 1.348242998123169,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedgehog (Hh",
            "probability": 0.002615101555982433,
            "start_logit": 4.910717487335205,
            "end_logit": -1.7399007081985474,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Gli1, which regulate the Hh",
            "probability": 0.0023424080400517135,
            "start_logit": 3.7081751823425293,
            "end_logit": -0.6474818587303162,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Patched, Smoothened",
            "probability": 0.001220350486545921,
            "start_logit": 1.0604089498519897,
            "end_logit": 1.348242998123169,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedgehog (Hh) signaling is an important factor in growth and patterning during embryonic development. A mutation",
            "probability": 0.0009567709056299362,
            "start_logit": 4.910717487335205,
            "end_logit": -2.7453949451446533,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Gli1, which regulate the Hh signaling",
            "probability": 0.0008480587575199344,
            "start_logit": 3.7081751823425293,
            "end_logit": -1.6634666919708252,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Gli1, which regulate the Hh signaling pathway",
            "probability": 0.0006919437919189085,
            "start_logit": 3.7081751823425293,
            "end_logit": -1.8669118881225586,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Smoothened or Gli1,",
            "probability": 0.0006558924338359923,
            "start_logit": 2.0032689571380615,
            "end_logit": -0.21551358699798584,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hedge",
            "probability": 0.0005478552776855404,
            "start_logit": 4.910717487335205,
            "end_logit": -3.302947759628296,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Hh) signaling is an important factor in growth and patterning during embryonic development. A mutation in Patched, Smoothened",
            "probability": 0.00048771337043064804,
            "start_logit": 0.1432434469461441,
            "end_logit": 1.348242998123169,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "Smoothened or Gli1, which regulate the Hh",
            "probability": 0.0004258250286193242,
            "start_logit": 2.0032689571380615,
            "end_logit": -0.6474818587303162,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        },
        {
            "text": "hog",
            "probability": 0.00039070980055124237,
            "start_logit": -2.740232229232788,
            "end_logit": 4.009955883026123,
            "question_text": "Which signaling pathways have been associated with medulloblastoma formation and growth?"
        }
    ],
    "51542dc3d24251bc0500007e": [
        {
            "text": "enanthema",
            "probability": 0.13532139208364408,
            "start_logit": 5.613256931304932,
            "end_logit": 5.361239433288574,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "enanthema and fever without skin rash",
            "probability": 0.13049616844983986,
            "start_logit": 5.613256931304932,
            "end_logit": 5.324930667877197,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever",
            "probability": 0.10915566970073447,
            "start_logit": 5.410131931304932,
            "end_logit": 5.349486827850342,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "gastrointestinal disorders",
            "probability": 0.10732254330215231,
            "start_logit": 5.569733619689941,
            "end_logit": 5.172948837280273,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash",
            "probability": 0.10525025045538328,
            "start_logit": 5.410131931304932,
            "end_logit": 5.313052654266357,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash and gastrointestinal disorders",
            "probability": 0.09149067323216584,
            "start_logit": 5.410131931304932,
            "end_logit": 5.172948837280273,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "enanthema and fever",
            "probability": 0.08880625832573387,
            "start_logit": 5.613256931304932,
            "end_logit": 4.940043926239014,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash",
            "probability": 0.08180521520524546,
            "start_logit": 5.158132076263428,
            "end_logit": 5.313052654266357,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash and gastrointestinal disorders",
            "probability": 0.07111065466017909,
            "start_logit": 5.158132076263428,
            "end_logit": 5.172948837280273,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever without skin rash",
            "probability": 0.05900204604419991,
            "start_logit": 4.819485187530518,
            "end_logit": 5.324930667877197,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "gastrointestinal disorders. Respiratory symptoms",
            "probability": 0.004221357306441813,
            "start_logit": 5.569733619689941,
            "end_logit": 1.9372668266296387,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash and gastrointestinal disorders. Respiratory symptoms",
            "probability": 0.0035986365029809938,
            "start_logit": 5.410131931304932,
            "end_logit": 1.9372668266296387,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash and gastrointestinal disorders. Respiratory symptoms",
            "probability": 0.0027970216916168395,
            "start_logit": 5.158132076263428,
            "end_logit": 1.9372668266296387,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever,",
            "probability": 0.0022494149318416975,
            "start_logit": 5.410131931304932,
            "end_logit": 1.4673819541931152,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "gastrointestinal",
            "probability": 0.0018849586839076338,
            "start_logit": 5.569733619689941,
            "end_logit": 1.1310160160064697,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash and gastrointestinal",
            "probability": 0.0016068957527404044,
            "start_logit": 5.410131931304932,
            "end_logit": 1.1310160160064697,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash and gastrointestinal",
            "probability": 0.0012489514494889284,
            "start_logit": 5.158132076263428,
            "end_logit": 1.1310160160064697,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "gastrointestinal disorders. Respiratory",
            "probability": 0.00104644826587734,
            "start_logit": 5.569733619689941,
            "end_logit": 0.5425119400024414,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "fever, skin rash and gastrointestinal disorders. Respiratory",
            "probability": 0.0008920796451702265,
            "start_logit": 5.410131931304932,
            "end_logit": 0.5425119400024414,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        },
        {
            "text": "skin rash and gastrointestinal disorders. Respiratory",
            "probability": 0.0006933643106560116,
            "start_logit": 5.158132076263428,
            "end_logit": 0.5425119400024414,
            "question_text": "What are the symptoms of abacavir hypersensitivity?"
        }
    ],
    "51595fb0d24251bc0500009c": [
        {
            "text": "Bcl-xL",
            "probability": 0.21261461061024642,
            "start_logit": 2.6653237342834473,
            "end_logit": 2.1934914588928223,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Hsp90",
            "probability": 0.16203792225805602,
            "start_logit": 2.5047104358673096,
            "end_logit": 2.082453966140747,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "PKC to reduce TNBC invasive potential. The results identify Hsp90",
            "probability": 0.07495643956300486,
            "start_logit": 1.733787178993225,
            "end_logit": 2.082453966140747,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Ras/Raf/MAPK",
            "probability": 0.06148332019867125,
            "start_logit": 1.9152953624725342,
            "end_logit": 1.7028045654296875,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Akt and Bcl-xL",
            "probability": 0.05224759506410106,
            "start_logit": 1.2618364095687866,
            "end_logit": 2.1934914588928223,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Bcl-xL to induce apoptosis, and inhibition of activated NF-kappaB, Akt, ERK2",
            "probability": 0.05109680601909758,
            "start_logit": 2.6653237342834473,
            "end_logit": 0.7677322626113892,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Ras/Raf",
            "probability": 0.04249959405145487,
            "start_logit": 1.9152953624725342,
            "end_logit": 1.3335331678390503,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Tyk2, and PKC to reduce TNBC invasive potential. The results identify Hsp90",
            "probability": 0.037213226976666895,
            "start_logit": 1.0335443019866943,
            "end_logit": 2.082453966140747,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "PKC",
            "probability": 0.0345699584911729,
            "start_logit": 1.733787178993225,
            "end_logit": 1.3085318803787231,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Bcl-xL to induce apoptosis, and inhibition of activated NF-kappaB, Akt",
            "probability": 0.031226910750982075,
            "start_logit": 2.6653237342834473,
            "end_logit": 0.27529051899909973,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Akt",
            "probability": 0.028796240537470326,
            "start_logit": 1.2618364095687866,
            "end_logit": 1.5977424383163452,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Ras",
            "probability": 0.027893557702482176,
            "start_logit": 1.9152953624725342,
            "end_logit": 0.9124343991279602,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Raf/MAPK",
            "probability": 0.027876519743201274,
            "start_logit": 1.1243141889572144,
            "end_logit": 1.7028045654296875,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "ERK2, Tyk2, and PKC to reduce TNBC invasive potential. The results identify Hsp90",
            "probability": 0.025414853126096516,
            "start_logit": 0.6522138118743896,
            "end_logit": 2.082453966140747,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Raf/MAPK pathway and G(2)-M phase to contribute to its anti-proliferative effect, degradation of activated Akt",
            "probability": 0.0250963551166313,
            "start_logit": 1.1243141889572144,
            "end_logit": 1.5977424383163452,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Ras/Raf/MAPK pathway",
            "probability": 0.024224297188615754,
            "start_logit": 1.9152953624725342,
            "end_logit": 0.7713947892189026,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Akt, ERK2, Tyk2, and PKC to reduce TNBC invasive potential. The results identify Hsp90",
            "probability": 0.023507665292787232,
            "start_logit": 0.5742065906524658,
            "end_logit": 2.082453966140747,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Bcl-xL to induce apoptosis, and inhibition of activated NF-kappaB",
            "probability": 0.019921020569192954,
            "start_logit": 2.6653237342834473,
            "end_logit": -0.17421424388885498,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "Raf",
            "probability": 0.019269303753036832,
            "start_logit": 1.1243141889572144,
            "end_logit": 1.3335331678390503,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        },
        {
            "text": "MAPK",
            "probability": 0.01805380298703184,
            "start_logit": 0.6898857951164246,
            "end_logit": 1.7028045654296875,
            "question_text": "Proteomic analyses have revealed proteins associated with the triple-negative breast cancers. List some proposed proteins."
        }
    ],
    "5547d700f35db75526000007": [
        {
            "text": "spastic-flaccid",
            "probability": 0.3030119109943204,
            "start_logit": 4.486978054046631,
            "end_logit": 3.8173208236694336,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid, spastic, or spastic-flaccid",
            "probability": 0.19052253077736855,
            "start_logit": 4.022976398468018,
            "end_logit": 3.8173208236694336,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic, or spastic-flaccid",
            "probability": 0.1716226309948399,
            "start_logit": 3.918503999710083,
            "end_logit": 3.8173208236694336,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic-flaccid dysarthria",
            "probability": 0.0711670523688466,
            "start_logit": 4.486978054046631,
            "end_logit": 2.3685786724090576,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid, spastic",
            "probability": 0.06275453112771184,
            "start_logit": 4.022976398468018,
            "end_logit": 2.7067811489105225,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic",
            "probability": 0.05652926031919382,
            "start_logit": 3.918503999710083,
            "end_logit": 2.7067811489105225,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid, spastic, or spastic-flaccid dysarthria",
            "probability": 0.04474717472585532,
            "start_logit": 4.022976398468018,
            "end_logit": 2.3685786724090576,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic, or spastic-flaccid dysarthria",
            "probability": 0.04030823979034257,
            "start_logit": 3.918503999710083,
            "end_logit": 2.3685786724090576,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid",
            "probability": 0.02183127472932867,
            "start_logit": 4.022976398468018,
            "end_logit": 1.6508939266204834,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid, spastic, or spastic",
            "probability": 0.013781621025637507,
            "start_logit": 4.022976398468018,
            "end_logit": 1.1908862590789795,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic, or spastic",
            "probability": 0.012414479537633093,
            "start_logit": 3.918503999710083,
            "end_logit": 1.1908862590789795,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid dysarthria",
            "probability": 0.004285920361923524,
            "start_logit": 1.6772834062576294,
            "end_logit": 2.3685786724090576,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic-flaccid dysarthria of speech",
            "probability": 0.0021264143244389493,
            "start_logit": 4.486978054046631,
            "end_logit": -1.1420141458511353,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "dysarthria",
            "probability": 0.0014184275980344153,
            "start_logit": 0.5714970231056213,
            "end_logit": 2.3685786724090576,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid, spastic, or spastic-flaccid dysarthria of speech",
            "probability": 0.00133700961537763,
            "start_logit": 4.022976398468018,
            "end_logit": -1.1420141458511353,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic, or spastic-flaccid dysarthria of speech",
            "probability": 0.0012043778072874762,
            "start_logit": 3.918503999710083,
            "end_logit": -1.1420141458511353,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spastic-flaccid dysarthria of speech.",
            "probability": 0.00028107238411887077,
            "start_logit": 4.486978054046631,
            "end_logit": -3.1655943393707275,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "spa",
            "probability": 0.00027544649018065636,
            "start_logit": 4.486978054046631,
            "end_logit": -3.1858131885528564,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "a flaccid, spastic, or spastic-flaccid",
            "probability": 0.00020389724884567391,
            "start_logit": -2.8169331550598145,
            "end_logit": 3.8173208236694336,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        },
        {
            "text": "flaccid, spastic, or spastic-flaccid dysarthria of speech.",
            "probability": 0.0001767277787141498,
            "start_logit": 4.022976398468018,
            "end_logit": -3.1655943393707275,
            "question_text": "Which are the major types of the motor speech disorder dysarthria?"
        }
    ],
    "531b1e3cb166e2b80600003b": [
        {
            "text": "histone modifications",
            "probability": 0.42756490204688363,
            "start_logit": -3.013124942779541,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "modifications",
            "probability": 0.0786133615709585,
            "start_logit": -4.706689357757568,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "histone modifications as well as higher-order chromatin structures",
            "probability": 0.06606530337245331,
            "start_logit": -3.013124942779541,
            "end_logit": -4.761902809143066,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "associated histone modifications",
            "probability": 0.061370759661814905,
            "start_logit": -4.9542975425720215,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "forming chromatin domains of associated histone modifications",
            "probability": 0.05321103099208703,
            "start_logit": -5.096965312957764,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "chromatin domains of associated histone modifications",
            "probability": 0.050395505613180964,
            "start_logit": -5.151329040527344,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "histone modifications as well as higher-order chromatin structures.",
            "probability": 0.04819174709696923,
            "start_logit": -3.013124942779541,
            "end_logit": -5.077358722686768,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "histone",
            "probability": 0.04223822517162829,
            "start_logit": -3.013124942779541,
            "end_logit": -5.209220886230469,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "his",
            "probability": 0.03672302548007761,
            "start_logit": -3.013124942779541,
            "end_logit": -5.349142551422119,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "domains of associated histone modifications",
            "probability": 0.02910872941159897,
            "start_logit": -5.700192928314209,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "They bind the genome at specific sites, forming chromatin domains of associated histone modifications",
            "probability": 0.016144826706098743,
            "start_logit": -6.289631366729736,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "tone modifications",
            "probability": 0.015771140526151462,
            "start_logit": -6.31304931640625,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "modifications as well as higher-order chromatin structures",
            "probability": 0.01214696425373157,
            "start_logit": -4.706689357757568,
            "end_logit": -4.761902809143066,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "repress transcription of numerous target genes. They bind the genome at specific sites, forming chromatin domains of associated histone modifications",
            "probability": 0.01061024340048112,
            "start_logit": -6.709411144256592,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "associated histone modifications as well as higher-order chromatin structures",
            "probability": 0.009482719081584339,
            "start_logit": -4.9542975425720215,
            "end_logit": -4.761902809143066,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "transcription of numerous target genes. They bind the genome at specific sites, forming chromatin domains of associated histone modifications",
            "probability": 0.009133726909375198,
            "start_logit": -6.859257221221924,
            "end_logit": -2.8944404125213623,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "modifications as well as higher-order chromatin structures.",
            "probability": 0.008860678744053717,
            "start_logit": -4.706689357757568,
            "end_logit": -5.077358722686768,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "forming chromatin domains",
            "probability": 0.008291970950601532,
            "start_logit": -5.096965312957764,
            "end_logit": -4.753418445587158,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "forming chromatin domains of associated histone modifications as well as higher-order chromatin structures",
            "probability": 0.008221916458586612,
            "start_logit": -5.096965312957764,
            "end_logit": -4.761902809143066,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        },
        {
            "text": "chromatin domains",
            "probability": 0.007853222551683229,
            "start_logit": -5.151329040527344,
            "end_logit": -4.753418445587158,
            "question_text": "Which histone modifications are associated with Polycomb group (PcG) proteins?"
        }
    ],
    "52d832dd98d0239505000003": [
        {
            "text": "SerP/ThrP-Xaa-Xaa-Ser/Thr",
            "probability": 0.32498396357818854,
            "start_logit": 3.494235038757324,
            "end_logit": 2.8356339931488037,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "SerP/ThrP",
            "probability": 0.15547589462275307,
            "start_logit": 3.494235038757324,
            "end_logit": 2.09834885597229,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "SerP/ThrP-Xaa-Xaa-Ser",
            "probability": 0.13392063472350718,
            "start_logit": 3.494235038757324,
            "end_logit": 1.9491055011749268,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "SerP",
            "probability": 0.09120721762141647,
            "start_logit": 3.494235038757324,
            "end_logit": 1.5649921894073486,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "ThrP-Xaa-Xaa-Ser/Thr",
            "probability": 0.05371275399014685,
            "start_logit": 1.6941096782684326,
            "end_logit": 2.8356339931488037,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "SerP/ThrP-Xaa-Xaa",
            "probability": 0.03833919664454649,
            "start_logit": 3.494235038757324,
            "end_logit": 0.6983309388160706,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "SerP/ThrP-Xaa",
            "probability": 0.03354730298633561,
            "start_logit": 3.494235038757324,
            "end_logit": 0.5648146271705627,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "ThrP",
            "probability": 0.0256967709647025,
            "start_logit": 1.6941096782684326,
            "end_logit": 2.09834885597229,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "ThrP-Xaa-Xaa-Ser",
            "probability": 0.022134157107039594,
            "start_logit": 1.6941096782684326,
            "end_logit": 1.9491055011749268,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "SerP/ThrP-Xaa-Xaa-Ser/Thr,",
            "probability": 0.02210755987934811,
            "start_logit": 3.494235038757324,
            "end_logit": 0.14777778089046478,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "Thr",
            "probability": 0.02129418268838281,
            "start_logit": 0.7688931226730347,
            "end_logit": 2.8356339931488037,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "Xaa-Xaa-Ser/Thr",
            "probability": 0.01667346421634682,
            "start_logit": 0.5242776870727539,
            "end_logit": 2.8356339931488037,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "Xaa-Ser/Thr",
            "probability": 0.01480923349221321,
            "start_logit": 0.4057100713253021,
            "end_logit": 2.8356339931488037,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "prephosphorylated residue(s), SerP/ThrP-Xaa-Xaa-Ser/Thr",
            "probability": 0.010358642264932296,
            "start_logit": 0.048280373215675354,
            "end_logit": 2.8356339931488037,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "Xaa-Xaa-Ser",
            "probability": 0.006870864907632982,
            "start_logit": 0.5242776870727539,
            "end_logit": 1.9491055011749268,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "ThrP-Xaa-Xaa",
            "probability": 0.006336632167552898,
            "start_logit": 1.6941096782684326,
            "end_logit": 0.6983309388160706,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "Xaa-Ser",
            "probability": 0.006102645580444639,
            "start_logit": 0.4057100713253021,
            "end_logit": 1.9491055011749268,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "Ser/Thr",
            "probability": 0.0059285576623726785,
            "start_logit": -0.5097598433494568,
            "end_logit": 2.8356339931488037,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "ThrP-Xaa",
            "probability": 0.005544636764528954,
            "start_logit": 1.6941096782684326,
            "end_logit": 0.5648146271705627,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        },
        {
            "text": "prephosphorylated residue(s), SerP/ThrP",
            "probability": 0.0049556881376084634,
            "start_logit": 0.048280373215675354,
            "end_logit": 2.09834885597229,
            "question_text": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?"
        }
    ],
    "56bb616dac7ad10019000008": [
        {
            "text": "warfarin",
            "probability": 0.4688879223716596,
            "start_logit": 5.304871559143066,
            "end_logit": 4.949552536010742,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban versus warfarin",
            "probability": 0.28925541425838963,
            "start_logit": 4.821817874908447,
            "end_logit": 4.949552536010742,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban",
            "probability": 0.17211111346037516,
            "start_logit": 4.821817874908447,
            "end_logit": 4.43038272857666,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfarin in Japanese patients with atrial fibrillation (J-ROCKET AF) trial revealed that rivaroxaban",
            "probability": 0.059087091265437236,
            "start_logit": 5.304871559143066,
            "end_logit": 2.8782012462615967,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban was not inferior to warfarin",
            "probability": 0.008351559523010338,
            "start_logit": 3.096806764602661,
            "end_logit": 3.129701852798462,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfarin in Japanese patients with atrial fibrillation",
            "probability": 0.0007311928185444918,
            "start_logit": 5.304871559143066,
            "end_logit": -1.5138893127441406,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban versus warfarin in Japanese patients with atrial fibrillation",
            "probability": 0.0004510704403753053,
            "start_logit": 4.821817874908447,
            "end_logit": -1.5138893127441406,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "warfari",
            "probability": 0.00018653912860767185,
            "start_logit": 5.304871559143066,
            "end_logit": -2.879925489425659,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "ban versus warfarin",
            "probability": 0.000136940476663933,
            "start_logit": -2.8337011337280273,
            "end_logit": 4.949552536010742,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban versus warfari",
            "probability": 0.00011507537376499593,
            "start_logit": 4.821817874908447,
            "end_logit": -2.879925489425659,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban versus",
            "probability": 9.483755655903851e-05,
            "start_logit": 4.821817874908447,
            "end_logit": -3.073347330093384,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "ban",
            "probability": 8.148154452649257e-05,
            "start_logit": -2.8337011337280273,
            "end_logit": 4.43038272857666,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "n",
            "probability": 8.122282320682095e-05,
            "start_logit": -3.356051206588745,
            "end_logit": 4.949552536010742,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "atrial fibrillation (J-ROCKET AF) trial revealed that rivaroxaban was not inferior to warfarin",
            "probability": 7.506232086837903e-05,
            "start_logit": -1.615078091621399,
            "end_logit": 3.129701852798462,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "war",
            "probability": 7.482388383907494e-05,
            "start_logit": 5.304871559143066,
            "end_logit": -3.793429374694824,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "analysis of the rivaroxaban versus warfarin",
            "probability": 6.387819833893543e-05,
            "start_logit": -3.596269369125366,
            "end_logit": 4.949552536010742,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "the rivaroxaban versus warfarin",
            "probability": 6.303080525855577e-05,
            "start_logit": -3.609623908996582,
            "end_logit": 4.949552536010742,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "atrial fibrillation (J-ROCKET AF) trial revealed that rivaroxaban",
            "probability": 5.8370936708955686e-05,
            "start_logit": -1.615078091621399,
            "end_logit": 2.8782012462615967,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "versus warfarin",
            "probability": 4.721420648065904e-05,
            "start_logit": -3.898552656173706,
            "end_logit": 4.949552536010742,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        },
        {
            "text": "rivaroxaban versus war",
            "probability": 4.615860738493911e-05,
            "start_logit": 4.821817874908447,
            "end_logit": -3.793429374694824,
            "question_text": "What medication were compared in the ROCKET AF Trial?"
        }
    ],
    "56b3a3ce8525abca1e000005": [
        {
            "text": "perilipin 1 and fat-specific protein 27",
            "probability": 0.3645741192148094,
            "start_logit": 2.2167916297912598,
            "end_logit": 2.3613946437835693,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "fat-specific protein 27",
            "probability": 0.3570638092512587,
            "start_logit": 2.1959762573242188,
            "end_logit": 2.3613946437835693,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 1 and fat-specific protein 27 (FSP27",
            "probability": 0.06828378197959085,
            "start_logit": 2.2167916297912598,
            "end_logit": 0.6863370537757874,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "fat-specific protein 27 (FSP27",
            "probability": 0.06687712050495095,
            "start_logit": 2.1959762573242188,
            "end_logit": 0.6863370537757874,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "FSP27",
            "probability": 0.03893278735632839,
            "start_logit": 1.6549561023712158,
            "end_logit": 0.6863370537757874,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 1 and fat-specific protein 27 (FSP27)",
            "probability": 0.02758169851347201,
            "start_logit": 2.2167916297912598,
            "end_logit": -0.22018277645111084,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "fat-specific protein 27 (FSP27)",
            "probability": 0.02701350923661517,
            "start_logit": 2.1959762573242188,
            "end_logit": -0.22018277645111084,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "FSP27)",
            "probability": 0.015726024130771187,
            "start_logit": 1.6549561023712158,
            "end_logit": -0.22018277645111084,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin",
            "probability": 0.011488741794579977,
            "start_logit": 2.2167916297912598,
            "end_logit": -1.0959676504135132,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 1",
            "probability": 0.008377814333114762,
            "start_logit": 2.2167916297912598,
            "end_logit": -1.4117481708526611,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "27",
            "probability": 0.0024414462698710533,
            "start_logit": -2.7893476486206055,
            "end_logit": 2.3613946437835693,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "protein 27",
            "probability": 0.0018788737521611605,
            "start_logit": -3.0512657165527344,
            "end_logit": 2.3613946437835693,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 1 and fat",
            "probability": 0.001695052326948154,
            "start_logit": 2.2167916297912598,
            "end_logit": -3.0096216201782227,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "fat",
            "probability": 0.0016601338626116393,
            "start_logit": 2.1959762573242188,
            "end_logit": -3.0096216201782227,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "(FSP27",
            "probability": 0.0014612308836791763,
            "start_logit": -1.6276015043258667,
            "end_logit": 0.6863370537757874,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 1 and fat-specific",
            "probability": 0.0013928285015538718,
            "start_logit": 2.2167916297912598,
            "end_logit": -3.205998659133911,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "fat-specific",
            "probability": 0.0013641359169149331,
            "start_logit": 2.1959762573242188,
            "end_logit": -3.205998659133911,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "perilipin 1 and fat-specific protein",
            "probability": 0.0008066388763709854,
            "start_logit": 2.2167916297912598,
            "end_logit": -3.7522144317626953,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "fat-specific protein",
            "probability": 0.0007900219316376515,
            "start_logit": 2.1959762573242188,
            "end_logit": -3.7522144317626953,
            "question_text": "List proteins of lipids droplets"
        },
        {
            "text": "(FSP27)",
            "probability": 0.000590231362759893,
            "start_logit": -1.6276015043258667,
            "end_logit": -0.22018277645111084,
            "question_text": "List proteins of lipids droplets"
        }
    ],
    "535d59349a4572de6f000009": [
        {
            "text": "sepsis",
            "probability": 0.7890883644255874,
            "start_logit": 5.461252689361572,
            "end_logit": 5.239054203033447,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia",
            "probability": 0.14295689465435757,
            "start_logit": 5.168751239776611,
            "end_logit": 3.8232204914093018,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia management in hemodialysis",
            "probability": 0.029725566161669357,
            "start_logit": 5.168751239776611,
            "end_logit": 2.2526848316192627,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia management",
            "probability": 0.026080046639776255,
            "start_logit": 5.168751239776611,
            "end_logit": 2.1218478679656982,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "chronic kidney disease",
            "probability": 0.0022388022310974804,
            "start_logit": 2.6285529136657715,
            "end_logit": 2.2068166732788086,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "psis",
            "probability": 0.00199622562679422,
            "start_logit": -0.5183674097061157,
            "end_logit": 5.239054203033447,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia control, the response to Epo, and possibly survival. Therefore, anti-hepcidin therapies may improve anemia",
            "probability": 0.001223925968010786,
            "start_logit": 0.40827178955078125,
            "end_logit": 3.8232204914093018,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "chronic kidney disease and hemodialysis",
            "probability": 0.0008729102522708975,
            "start_logit": 2.6285529136657715,
            "end_logit": 1.2649531364440918,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "hemodialysis",
            "probability": 0.0008534613726874343,
            "start_logit": 1.6182887554168701,
            "end_logit": 2.2526848316192627,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "inflammatory and anti-microbic action during sepsis",
            "probability": 0.0008467543722553559,
            "start_logit": -1.3759702444076538,
            "end_logit": 5.239054203033447,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia of chronic kidney disease",
            "probability": 0.0007970036435051736,
            "start_logit": 1.595715880393982,
            "end_logit": 2.2068166732788086,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "se",
            "probability": 0.000634365065365489,
            "start_logit": 5.461252689361572,
            "end_logit": -1.8869547843933105,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "sepsis,",
            "probability": 0.0006239333445907617,
            "start_logit": 5.461252689361572,
            "end_logit": -1.9035358428955078,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia management in hemodialysis.",
            "probability": 0.00048662496018166265,
            "start_logit": 5.168751239776611,
            "end_logit": -1.8595842123031616,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "an",
            "probability": 0.0003575407624712528,
            "start_logit": 5.168751239776611,
            "end_logit": -2.1678285598754883,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia of chronic kidney disease and hemodialysis",
            "probability": 0.0003107521699993488,
            "start_logit": 1.595715880393982,
            "end_logit": 1.2649531364440918,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anti-microbic action during sepsis",
            "probability": 0.00030915363747143284,
            "start_logit": -2.383542537689209,
            "end_logit": 5.239054203033447,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anemia control, the response to Epo, and possibly survival. Therefore, anti-hepcidin therapies may improve anemia management",
            "probability": 0.00022328441315496648,
            "start_logit": 0.40827178955078125,
            "end_logit": 2.1218478679656982,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "The anemia of chronic kidney disease",
            "probability": 0.00019446729448950768,
            "start_logit": 0.18512062728405,
            "end_logit": 2.2068166732788086,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        },
        {
            "text": "anti-inflammatory and anti-microbic action during sepsis",
            "probability": 0.0001799230042636404,
            "start_logit": -2.924851894378662,
            "end_logit": 5.239054203033447,
            "question_text": "What are the indications for treatment with anti-hepcidin?"
        }
    ],
    "56c1d84cef6e394741000031": [
        {
            "text": "brainstem reflexes, and respiration",
            "probability": 0.27979155842215564,
            "start_logit": 4.726783275604248,
            "end_logit": 4.590081691741943,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "brainstem reflexes",
            "probability": 0.1901951133047593,
            "start_logit": 4.726783275604248,
            "end_logit": 4.204087257385254,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "respiration",
            "probability": 0.15472606980254594,
            "start_logit": 4.134394645690918,
            "end_logit": 4.590081691741943,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor response, brainstem reflexes, and respiration",
            "probability": 0.09484321112966637,
            "start_logit": 3.644963502883911,
            "end_logit": 4.590081691741943,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor response, brainstem reflexes, and respiration",
            "probability": 0.06477393028351768,
            "start_logit": 3.263641595840454,
            "end_logit": 4.590081691741943,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor response, brainstem reflexes",
            "probability": 0.06447197831385924,
            "start_logit": 3.644963502883911,
            "end_logit": 4.204087257385254,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor response",
            "probability": 0.05664240740564523,
            "start_logit": 3.644963502883911,
            "end_logit": 4.074614524841309,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor response, brainstem reflexes",
            "probability": 0.044031653703004194,
            "start_logit": 3.263641595840454,
            "end_logit": 4.204087257385254,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor response",
            "probability": 0.03868438557365805,
            "start_logit": 3.263641595840454,
            "end_logit": 4.074614524841309,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye",
            "probability": 0.003976211082707152,
            "start_logit": 3.644963502883911,
            "end_logit": 1.4181859493255615,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "brainstem reflexes, and respiration)",
            "probability": 0.002439575267675353,
            "start_logit": 4.726783275604248,
            "end_logit": -0.15213924646377563,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "respiration)",
            "probability": 0.001349096789351209,
            "start_logit": 4.134394645690918,
            "end_logit": -0.15213924646377563,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "brainstem reflex",
            "probability": 0.0012593370130819536,
            "start_logit": 4.726783275604248,
            "end_logit": -0.8133777976036072,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor response, brainstem reflexes, and respiration)",
            "probability": 0.0008269625913078437,
            "start_logit": 3.644963502883911,
            "end_logit": -0.15213924646377563,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor response, brainstem reflexes, and respiration)",
            "probability": 0.0005647807217663512,
            "start_logit": 3.263641595840454,
            "end_logit": -0.15213924646377563,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "eye and motor response, brainstem reflex",
            "probability": 0.00042688766912303365,
            "start_logit": 3.644963502883911,
            "end_logit": -0.8133777976036072,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "motor response, brainstem reflex",
            "probability": 0.0002915463509651207,
            "start_logit": 3.263641595840454,
            "end_logit": -0.8133777976036072,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "(eye and motor response, brainstem reflexes, and respiration",
            "probability": 0.00025925073266184714,
            "start_logit": -2.257221221923828,
            "end_logit": 4.590081691741943,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "reflexes, and respiration",
            "probability": 0.0002250612185824098,
            "start_logit": -2.39864444732666,
            "end_logit": 4.590081691741943,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        },
        {
            "text": "brains",
            "probability": 0.00022098262396590436,
            "start_logit": 4.726783275604248,
            "end_logit": -2.5536344051361084,
            "question_text": "List functions that are evaluated with the Full Outline of Unresponsiveness score?"
        }
    ],
    "5713bf261174fb1755000011": [
        {
            "text": "salivary glands",
            "probability": 0.4456262214838922,
            "start_logit": 1.4492865800857544,
            "end_logit": 0.6171521544456482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "sublingual salivary glands",
            "probability": 0.22044747748819016,
            "start_logit": 0.7454655170440674,
            "end_logit": 0.6171521544456482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "submandibular and sublingual salivary glands",
            "probability": 0.16678064110545412,
            "start_logit": 0.46648547053337097,
            "end_logit": 0.6171521544456482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "salivary glands (SSC)",
            "probability": 0.04675654355837499,
            "start_logit": 1.4492865800857544,
            "end_logit": -1.6373741626739502,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "glands",
            "probability": 0.029459677090386986,
            "start_logit": -1.2671715021133423,
            "end_logit": 0.6171521544456482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "sublingual salivary glands (SSC)",
            "probability": 0.023130061891752984,
            "start_logit": 0.7454655170440674,
            "end_logit": -1.6373741626739502,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "submandibular and sublingual salivary glands (SSC)",
            "probability": 0.01749916395084202,
            "start_logit": 0.46648547053337097,
            "end_logit": -1.6373741626739502,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "submandibular",
            "probability": 0.00987398670148213,
            "start_logit": 0.46648547053337097,
            "end_logit": -2.2096235752105713,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "glandular complex, composed of the submandibular and sublingual salivary glands",
            "probability": 0.009873218986808631,
            "start_logit": -2.360368013381958,
            "end_logit": 0.6171521544456482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "sublingual",
            "probability": 0.004529936570473286,
            "start_logit": 0.7454655170440674,
            "end_logit": -3.2677993774414062,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "salivary glands (SSC),",
            "probability": 0.004311290992265124,
            "start_logit": 1.4492865800857544,
            "end_logit": -4.021090984344482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "SSC",
            "probability": 0.004286075794634805,
            "start_logit": -1.093855857849121,
            "end_logit": -1.4838143587112427,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "submandibular and sublingual",
            "probability": 0.003427146157438117,
            "start_logit": 0.46648547053337097,
            "end_logit": -3.2677993774414062,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "murid glandular complex, composed of the submandibular and sublingual salivary glands",
            "probability": 0.0031456938995594198,
            "start_logit": -3.504159450531006,
            "end_logit": 0.6171521544456482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "glands (SSC)",
            "probability": 0.003091004543012804,
            "start_logit": -1.2671715021133423,
            "end_logit": -1.6373741626739502,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "sublingual salivary glands (SSC),",
            "probability": 0.002132758751937035,
            "start_logit": 0.7454655170440674,
            "end_logit": -4.021090984344482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "submandibular and sublingual salivary glands (SSC),",
            "probability": 0.0016135492953888878,
            "start_logit": 0.46648547053337097,
            "end_logit": -4.021090984344482,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "SSC in the rat",
            "probability": 0.0015274338013729284,
            "start_logit": -1.093855857849121,
            "end_logit": -2.515596866607666,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "soft tissues such as the SSC",
            "probability": 0.0012872772714802346,
            "start_logit": -2.2966980934143066,
            "end_logit": -1.4838143587112427,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        },
        {
            "text": "mammalia",
            "probability": 0.001200840665253275,
            "start_logit": -2.549592971801758,
            "end_logit": -1.300426959991455,
            "question_text": "For the constructions of which organs has 3D printing been tested?"
        }
    ],
    "5503263fe9bde69634000030": [
        {
            "text": "facial dysmorphism",
            "probability": 0.2731952507736608,
            "start_logit": 4.749066352844238,
            "end_logit": 4.863612651824951,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "facial dysmorphism, and neuropathy",
            "probability": 0.16774329134885824,
            "start_logit": 4.749066352844238,
            "end_logit": 4.375860691070557,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts, facial dysmorphism",
            "probability": 0.16209995220991572,
            "start_logit": 4.227092742919922,
            "end_logit": 4.863612651824951,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts",
            "probability": 0.15047127133189955,
            "start_logit": 4.227092742919922,
            "end_logit": 4.7891716957092285,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts, facial dysmorphism, and neuropathy",
            "probability": 0.09953020571983325,
            "start_logit": 4.227092742919922,
            "end_logit": 4.375860691070557,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "neuropathy",
            "probability": 0.08923353134348852,
            "start_logit": 4.117888450622559,
            "end_logit": 4.375860691070557,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "cataracts, facial dysmorphism",
            "probability": 0.020340872766635307,
            "start_logit": 2.1515119075775146,
            "end_logit": 4.863612651824951,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "cataracts",
            "probability": 0.018881664944801892,
            "start_logit": 2.1515119075775146,
            "end_logit": 4.7891716957092285,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "cataracts, facial dysmorphism, and neuropathy",
            "probability": 0.012489400665352724,
            "start_logit": 2.1515119075775146,
            "end_logit": 4.375860691070557,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "dysmorphism",
            "probability": 0.0009680509719479258,
            "start_logit": -0.8935909271240234,
            "end_logit": 4.863612651824951,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "facial dysmorphism,",
            "probability": 0.0008710104612816985,
            "start_logit": 4.749066352844238,
            "end_logit": -0.8846753835678101,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "facial",
            "probability": 0.0006197069686629606,
            "start_logit": 4.749066352844238,
            "end_logit": -1.2250826358795166,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "dysmorphism, and neuropathy",
            "probability": 0.0005943882837207142,
            "start_logit": -0.8935909271240234,
            "end_logit": 4.375860691070557,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "facial dysmorphism, and neuropathy (CCFDN) syndrome,",
            "probability": 0.0005589471929872093,
            "start_logit": 4.749066352844238,
            "end_logit": -1.3282743692398071,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts, facial dysmorphism,",
            "probability": 0.0005168126230169167,
            "start_logit": 4.227092742919922,
            "end_logit": -0.8846753835678101,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts,",
            "probability": 0.0004704222732046487,
            "start_logit": 4.227092742919922,
            "end_logit": -0.978725016117096,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "ital cataracts, facial dysmorphism",
            "probability": 0.00037125012600359915,
            "start_logit": -1.8519996404647827,
            "end_logit": 4.863612651824951,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts, facial",
            "probability": 0.0003677021094617895,
            "start_logit": 4.227092742919922,
            "end_logit": -1.2250826358795166,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "ital cataracts",
            "probability": 0.0003446174886563127,
            "start_logit": -1.8519996404647827,
            "end_logit": 4.7891716957092285,
            "question_text": "List three major features of the CCFDN syndrome."
        },
        {
            "text": "congenital cataracts, facial dysmorphism, and neuropathy (CCFDN) syndrome,",
            "probability": 0.0003316503966101469,
            "start_logit": 4.227092742919922,
            "end_logit": -1.3282743692398071,
            "question_text": "List three major features of the CCFDN syndrome."
        }
    ],
    "5309f8f5970c65fa6b000001": [
        {
            "text": "Nox1- and Nox4-generated ROS play an important role in Ras",
            "probability": 0.1356257911278343,
            "start_logit": 4.329966068267822,
            "end_logit": 4.471931457519531,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4-generated ROS play an important role in Ras",
            "probability": 0.12025563498948758,
            "start_logit": 4.209686279296875,
            "end_logit": 4.471931457519531,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras",
            "probability": 0.10641056196243966,
            "start_logit": 4.087371349334717,
            "end_logit": 4.471931457519531,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1- and Nox4-generated ROS",
            "probability": 0.08972207366698517,
            "start_logit": 4.329966068267822,
            "end_logit": 4.058748722076416,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "ROS play an important role in Ras",
            "probability": 0.08041307894324497,
            "start_logit": 3.8072433471679688,
            "end_logit": 4.471931457519531,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4-generated ROS",
            "probability": 0.07955407929180036,
            "start_logit": 4.209686279296875,
            "end_logit": 4.058748722076416,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1 and Nox4",
            "probability": 0.05657031616483229,
            "start_logit": 4.223726749420166,
            "end_logit": 3.7037556171417236,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "ROS",
            "probability": 0.05319657959402849,
            "start_logit": 3.8072433471679688,
            "end_logit": 4.058748722076416,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1",
            "probability": 0.05172679184418202,
            "start_logit": 4.329966068267822,
            "end_logit": 3.508007764816284,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1- and Nox4",
            "probability": 0.048987348422041346,
            "start_logit": 4.329966068267822,
            "end_logit": 3.4535939693450928,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1 and Nox4 alone was able to induce senescence. The involvement of Nox1 in Ras",
            "probability": 0.043983833410760766,
            "start_logit": 4.223726749420166,
            "end_logit": 3.4520933628082275,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4",
            "probability": 0.04343572591876185,
            "start_logit": 4.209686279296875,
            "end_logit": 3.4535939693450928,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4 alone was able to induce senescence. The involvement of Nox1 in Ras",
            "probability": 0.03125195744751519,
            "start_logit": 3.881986618041992,
            "end_logit": 3.4520933628082275,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4 siRNAs inhibited both Ras",
            "probability": 0.011118389115790878,
            "start_logit": 3.6755449771881104,
            "end_logit": 2.6250534057617188,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1 in Ras",
            "probability": 0.010472378153002573,
            "start_logit": 2.7886457443237305,
            "end_logit": 3.4520933628082275,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox1 and Nox4 alone was able to induce senescence. The involvement of Nox1",
            "probability": 0.010148555685575043,
            "start_logit": 4.223726749420166,
            "end_logit": 1.985602617263794,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced DNA damage response and p38MAPK activation, whereas overexpression of Nox1 and Nox4",
            "probability": 0.009129781269372342,
            "start_logit": 2.3997840881347656,
            "end_logit": 3.7037556171417236,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4 alone was able to induce senescence. The involvement of Nox1",
            "probability": 0.0072108819501334066,
            "start_logit": 3.881986618041992,
            "end_logit": 1.985602617263794,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Ras-induced DNA damage response and p38MAPK activation, whereas overexpression of Nox1",
            "probability": 0.006342517795459322,
            "start_logit": 2.3997840881347656,
            "end_logit": 3.339489698410034,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        },
        {
            "text": "Nox4 siRNAs",
            "probability": 0.0044437232467526375,
            "start_logit": 3.6755449771881104,
            "end_logit": 1.7079455852508545,
            "question_text": "Which oncogenes are able to induce cellular senescence?"
        }
    ],
    "5517f9286487737b43000002": [
        {
            "text": "junctate",
            "probability": 0.2776346575488186,
            "start_logit": 5.362887859344482,
            "end_logit": 4.618166923522949,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin and junctate",
            "probability": 0.2681011660758867,
            "start_logit": 5.327946186065674,
            "end_logit": 4.618166923522949,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin",
            "probability": 0.23442097140248042,
            "start_logit": 5.327946186065674,
            "end_logit": 4.483921051025391,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctate by alternative splicing. Among these three proteins, junctin and junctate",
            "probability": 0.036743750412858905,
            "start_logit": 5.362887859344482,
            "end_logit": 2.5958290100097656,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin and junctate by alternative splicing. Among these three proteins, junctin and junctate",
            "probability": 0.03548203390261762,
            "start_logit": 5.327946186065674,
            "end_logit": 2.5958290100097656,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctate by alternative splicing. Among these three proteins, junctin",
            "probability": 0.03522490229186704,
            "start_logit": 5.362887859344482,
            "end_logit": 2.5536141395568848,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin and junctate by alternative splicing. Among these three proteins, junctin",
            "probability": 0.0340153403855862,
            "start_logit": 5.327946186065674,
            "end_logit": 2.5536141395568848,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl beta-hydroxylase, junctin and junctate",
            "probability": 0.031173341339559794,
            "start_logit": 3.176145076751709,
            "end_logit": 4.618166923522949,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl beta-hydroxylase, junctin",
            "probability": 0.02725719199823342,
            "start_logit": 3.176145076751709,
            "end_logit": 4.483921051025391,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "AbetaH-J-J, encodes three functionally distinct proteins aspartyl beta-hydroxylase, junctin",
            "probability": 0.007700291820022307,
            "start_logit": 1.9120858907699585,
            "end_logit": 4.483921051025391,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "aspartyl beta-hydroxylase",
            "probability": 0.007689367753414457,
            "start_logit": 3.176145076751709,
            "end_logit": 3.21844220161438,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "AbetaH-J-J, encodes three functionally distinct proteins aspartyl beta-hydroxylase",
            "probability": 0.002172284497119078,
            "start_logit": 1.9120858907699585,
            "end_logit": 3.21844220161438,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctate by alternative splicing.",
            "probability": 0.00047165954634191044,
            "start_logit": 5.362887859344482,
            "end_logit": -1.7596369981765747,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin and junctate by alternative splicing.",
            "probability": 0.0004554635774997032,
            "start_logit": 5.327946186065674,
            "end_logit": -1.7596369981765747,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctate by alternative splicing",
            "probability": 0.00032411975534077494,
            "start_logit": 5.362887859344482,
            "end_logit": -2.1347813606262207,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "junctin and junctate by alternative splicing",
            "probability": 0.0003129900464239164,
            "start_logit": 5.327946186065674,
            "end_logit": -2.1347813606262207,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "J, encodes three functionally distinct proteins aspartyl beta-hydroxylase, junctin and junctate",
            "probability": 0.00027236847419798914,
            "start_logit": -1.564017653465271,
            "end_logit": 4.618166923522949,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "J, encodes three functionally distinct proteins aspartyl beta-hydroxylase, junctin",
            "probability": 0.0002381521991695905,
            "start_logit": -1.564017653465271,
            "end_logit": 4.483921051025391,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "J-J, encodes three functionally distinct proteins aspartyl beta-hydroxylase, junctin",
            "probability": 0.00017790617925089212,
            "start_logit": -1.8556712865829468,
            "end_logit": 4.483921051025391,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        },
        {
            "text": "three functionally distinct proteins aspartyl beta-hydroxylase, junctin and junctate",
            "probability": 0.00013204079331074423,
            "start_logit": -2.288062572479248,
            "end_logit": 4.618166923522949,
            "question_text": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?"
        }
    ],
    "56d1d94667f0cb3d66000005": [
        {
            "text": "cancer development",
            "probability": 0.39410260866424823,
            "start_logit": 4.0323357582092285,
            "end_logit": 4.180356502532959,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "tissue homeostasis, organ size, and cancer development",
            "probability": 0.1683877754105414,
            "start_logit": 3.1819939613342285,
            "end_logit": 4.180356502532959,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size, and cancer development",
            "probability": 0.1617116997984734,
            "start_logit": 3.1415395736694336,
            "end_logit": 4.180356502532959,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "tissue homeostasis",
            "probability": 0.08181486307604334,
            "start_logit": 3.1819939613342285,
            "end_logit": 3.4585459232330322,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "tissue homeostasis, organ size",
            "probability": 0.05320538671299239,
            "start_logit": 3.1819939613342285,
            "end_logit": 3.0282466411590576,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size",
            "probability": 0.05109595101435427,
            "start_logit": 3.1415395736694336,
            "end_logit": 3.0282466411590576,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cancer",
            "probability": 0.02286794418700235,
            "start_logit": 4.0323357582092285,
            "end_logit": 1.3334813117980957,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cancer development. Aberrant hyperactivation of YAP/TAZ causes tissue overgrowth and tumorigenesis",
            "probability": 0.016744957387238732,
            "start_logit": 4.0323357582092285,
            "end_logit": 1.021842360496521,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "tissue homeostasis, organ size, and cancer",
            "probability": 0.00977076062224774,
            "start_logit": 3.1819939613342285,
            "end_logit": 1.3334813117980957,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size, and cancer",
            "probability": 0.00938337895785728,
            "start_logit": 3.1415395736694336,
            "end_logit": 1.3334813117980957,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size, and cancer development. Aberrant hyperactivation of YAP/TAZ causes tissue overgrowth and tumorigenesis",
            "probability": 0.00687094036581298,
            "start_logit": 3.1415395736694336,
            "end_logit": 1.021842360496521,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "homeostasis, organ size, and cancer development",
            "probability": 0.005482265366987141,
            "start_logit": -0.2427571415901184,
            "end_logit": 4.180356502532959,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "cancer development. Aberrant hyperactivation of YAP/TAZ causes tissue overgrowth",
            "probability": 0.0039202685982439546,
            "start_logit": 4.0323357582092285,
            "end_logit": -0.4300946295261383,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "tissue homeostasis, organ size,",
            "probability": 0.002848881591234659,
            "start_logit": 3.1819939613342285,
            "end_logit": 0.10101348906755447,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size,",
            "probability": 0.0027359318900669785,
            "start_logit": 3.1415395736694336,
            "end_logit": 0.10101348906755447,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "homeostasis",
            "probability": 0.002663677866478356,
            "start_logit": -0.2427571415901184,
            "end_logit": 3.4585459232330322,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "homeostasis, organ size",
            "probability": 0.0017322281751311495,
            "start_logit": -0.2427571415901184,
            "end_logit": 3.0282466411590576,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "tissue homeostasis, organ size, and cancer development. Aberrant hyperactivation of YAP/TAZ causes tissue overgrowth",
            "probability": 0.0016750087255385008,
            "start_logit": 3.1819939613342285,
            "end_logit": -0.4300946295261383,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "organ size, and cancer development. Aberrant hyperactivation of YAP/TAZ causes tissue overgrowth",
            "probability": 0.0016085996000820657,
            "start_logit": 3.1415395736694336,
            "end_logit": -0.4300946295261383,
            "question_text": "List processes which are under the control of the YAP protein."
        },
        {
            "text": "Hippo pathway that influences tissue homeostasis, organ size, and cancer development",
            "probability": 0.0013768719894248756,
            "start_logit": -1.62446129322052,
            "end_logit": 4.180356502532959,
            "question_text": "List processes which are under the control of the YAP protein."
        }
    ],
    "56d29d4df22319765a000003": [
        {
            "text": "transcriptomics",
            "probability": 0.4208522942589404,
            "start_logit": 3.9680559635162354,
            "end_logit": 4.0107502937316895,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics and transcriptomics",
            "probability": 0.3195069438209992,
            "start_logit": 3.6925530433654785,
            "end_logit": 4.0107502937316895,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics",
            "probability": 0.2544573838239444,
            "start_logit": 3.6925530433654785,
            "end_logit": 3.783104658126831,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "high throughput technologies, such as proteomics and transcriptomics",
            "probability": 0.0007645002471333405,
            "start_logit": -2.342758893966675,
            "end_logit": 4.0107502937316895,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics.",
            "probability": 0.0006532084945859262,
            "start_logit": 3.9680559635162354,
            "end_logit": -2.457390546798706,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "high throughput technologies, such as proteomics",
            "probability": 0.0006088529109630052,
            "start_logit": -2.342758893966675,
            "end_logit": 3.783104658126831,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics and transcriptomics.",
            "probability": 0.0004959094975365729,
            "start_logit": 3.6925530433654785,
            "end_logit": -2.457390546798706,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "pro",
            "probability": 0.0004871314412233965,
            "start_logit": 3.6925530433654785,
            "end_logit": -2.475250005722046,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "trans",
            "probability": 0.0003723953035387501,
            "start_logit": 3.9680559635162354,
            "end_logit": -3.0193309783935547,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "cs and transcriptomics",
            "probability": 0.0002861514698473664,
            "start_logit": -3.3254599571228027,
            "end_logit": 4.0107502937316895,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics and trans",
            "probability": 0.0002827188706110559,
            "start_logit": 3.6925530433654785,
            "end_logit": -3.0193309783935547,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "cs",
            "probability": 0.00022789286994504313,
            "start_logit": -3.3254599571228027,
            "end_logit": 3.783104658126831,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomi",
            "probability": 0.00017139052171576726,
            "start_logit": 3.9680559635162354,
            "end_logit": -3.795342206954956,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "teomics and transcriptomics",
            "probability": 0.0001617334909418395,
            "start_logit": -3.896031379699707,
            "end_logit": 4.0107502937316895,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics and transcriptomi",
            "probability": 0.0001301180070545097,
            "start_logit": 3.6925530433654785,
            "end_logit": -3.795342206954956,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "teomics",
            "probability": 0.00012880559179593413,
            "start_logit": -3.896031379699707,
            "end_logit": 3.783104658126831,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "transcriptomics. This omics",
            "probability": 0.00011639911923563544,
            "start_logit": 3.9680559635162354,
            "end_logit": -4.182261943817139,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomi",
            "probability": 0.0001082146039003018,
            "start_logit": 3.6925530433654785,
            "end_logit": -3.9796676635742188,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "omics and transcriptomics",
            "probability": 9.958658371290592e-05,
            "start_logit": -4.380953788757324,
            "end_logit": 4.0107502937316895,
            "question_text": "List omics technologies comprised in system biology."
        },
        {
            "text": "proteomics and transcriptomics. This omics",
            "probability": 8.836907237471692e-05,
            "start_logit": 3.6925530433654785,
            "end_logit": -4.182261943817139,
            "question_text": "List omics technologies comprised in system biology."
        }
    ],
    "52ea605098d0239505000028": [
        {
            "text": "congenital heart defects",
            "probability": 0.406992762933533,
            "start_logit": -1.6975979804992676,
            "end_logit": -1.9969650506973267,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "autosomal dominant and X-linked transmissions. Different mutations in sarcomere protein genes",
            "probability": 0.11164463977889891,
            "start_logit": -3.9133596420288086,
            "end_logit": -1.07467782497406,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "sarcomere protein genes",
            "probability": 0.07293696880528149,
            "start_logit": -2.5268335342407227,
            "end_logit": -2.8869292736053467,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "sarcomere protein genes were identified",
            "probability": 0.06474553737186658,
            "start_logit": -2.5268335342407227,
            "end_logit": -3.0060601234436035,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "autosomal dominant and X-linked transmissions. Different mutations in sarcomere protein genes were identified",
            "probability": 0.045911707124551095,
            "start_logit": -3.9133596420288086,
            "end_logit": -1.9632786512374878,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "congenital heart defects (CHDs), genetic syndromes, and neuromuscular disorders",
            "probability": 0.04292230279226383,
            "start_logit": -1.6975979804992676,
            "end_logit": -4.246368885040283,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "autosomal dominant and X-linked transmissions. Different mutations in sarcomere protein",
            "probability": 0.028745807220082745,
            "start_logit": -3.9133596420288086,
            "end_logit": -2.431506872177124,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "Different mutations in sarcomere protein genes",
            "probability": 0.028200528248929404,
            "start_logit": -3.477088451385498,
            "end_logit": -2.8869292736053467,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "congenital heart defects (CHDs)",
            "probability": 0.027440109173821725,
            "start_logit": -1.6975979804992676,
            "end_logit": -4.69375467300415,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "congenital heart defects (CHDs), genetic syndromes",
            "probability": 0.025433775813351954,
            "start_logit": -1.6975979804992676,
            "end_logit": -4.76968240737915,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "Different mutations in sarcomere protein genes were identified",
            "probability": 0.025033373137865095,
            "start_logit": -3.477088451385498,
            "end_logit": -3.0060601234436035,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "sarcomere protein",
            "probability": 0.02437795200666411,
            "start_logit": -2.5268335342407227,
            "end_logit": -3.9828457832336426,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "congenital heart defects (CHDs), genetic syndrome",
            "probability": 0.02153035912560778,
            "start_logit": -1.6975979804992676,
            "end_logit": -4.936296463012695,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "genetic syndromes, and neuromuscular disorders",
            "probability": 0.014061720450948912,
            "start_logit": -2.813533306121826,
            "end_logit": -4.246368885040283,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "autosomal dominant and X-linked transmissions. Different",
            "probability": 0.011854375533715291,
            "start_logit": -3.9133596420288086,
            "end_logit": -3.3173017501831055,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "autosomal dominant and X-linked transmissions. Different mutations",
            "probability": 0.011853239414206337,
            "start_logit": -3.9133596420288086,
            "end_logit": -3.3173975944519043,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "defects",
            "probability": 0.01012201893697083,
            "start_logit": -5.3916802406311035,
            "end_logit": -1.9969650506973267,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "Different mutations in sarcomere protein",
            "probability": 0.009425551067940675,
            "start_logit": -3.477088451385498,
            "end_logit": -3.9828457832336426,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "sarcomere protein genes were",
            "probability": 0.008434944458602513,
            "start_logit": -2.5268335342407227,
            "end_logit": -5.04414176940918,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "genetic syndromes",
            "probability": 0.008332326604897843,
            "start_logit": -2.813533306121826,
            "end_logit": -4.76968240737915,
            "question_text": "Which gene mutations are responsible for isolated Non-compaction cardiomyopathy?"
        }
    ],
    "5318367cb166e2b806000012": [
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1",
            "probability": 0.27366056564787644,
            "start_logit": 2.8130452632904053,
            "end_logit": 2.48465895652771,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1 (PINK1",
            "probability": 0.17444820668052938,
            "start_logit": 2.8130452632904053,
            "end_logit": 2.034398317337036,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1",
            "probability": 0.15094271881383217,
            "start_logit": 2.6683177947998047,
            "end_logit": 2.034398317337036,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1 (PINK1)",
            "probability": 0.09759280300507206,
            "start_logit": 2.8130452632904053,
            "end_logit": 1.4535741806030273,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1)",
            "probability": 0.08444296047838058,
            "start_logit": 2.6683177947998047,
            "end_logit": 1.4535741806030273,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1 (PINK1) gene",
            "probability": 0.06555231799214788,
            "start_logit": 2.8130452632904053,
            "end_logit": 1.0556190013885498,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK1) gene",
            "probability": 0.056719672219984224,
            "start_logit": 2.6683177947998047,
            "end_logit": 1.0556190013885498,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase 1 (PINK",
            "probability": 0.02653016145775163,
            "start_logit": 2.8130452632904053,
            "end_logit": 0.15105268359184265,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "PINK",
            "probability": 0.02295543632808195,
            "start_logit": 2.6683177947998047,
            "end_logit": 0.15105268359184265,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "(PINK1",
            "probability": 0.009827521798589476,
            "start_logit": -0.06339582800865173,
            "end_logit": 2.034398317337036,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog-induced putative kinase",
            "probability": 0.007259445868189341,
            "start_logit": 2.8130452632904053,
            "end_logit": -1.1449260711669922,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin",
            "probability": 0.006047757268050287,
            "start_logit": 2.8130452632904053,
            "end_logit": -1.3275420665740967,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "(PINK1)",
            "probability": 0.005497880529515591,
            "start_logit": -0.06339582800865173,
            "end_logit": 1.4535741806030273,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "tensin homolog-induced putative kinase 1",
            "probability": 0.0045786459565276124,
            "start_logit": -1.2774399518966675,
            "end_logit": 2.48465895652771,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "(PINK1) gene",
            "probability": 0.0036928830985099776,
            "start_logit": -0.06339582800865173,
            "end_logit": 1.0556190013885498,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "tensin homolog-induced putative kinase 1 (PINK1",
            "probability": 0.0029187127281211814,
            "start_logit": -1.2774399518966675,
            "end_logit": 2.034398317337036,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "the phosphatase and tensin homolog-induced putative kinase 1",
            "probability": 0.0022223300280488382,
            "start_logit": -2.0002870559692383,
            "end_logit": 2.48465895652771,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "phosphatase and tensin homolog",
            "probability": 0.0017897879905234856,
            "start_logit": 2.8130452632904053,
            "end_logit": -2.5451323986053467,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "1",
            "probability": 0.0016873558563216126,
            "start_logit": -2.2756805419921875,
            "end_logit": 2.48465895652771,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        },
        {
            "text": "tensin homolog-induced putative kinase 1 (PINK1)",
            "probability": 0.0016328362539465371,
            "start_logit": -1.2774399518966675,
            "end_logit": 1.4535741806030273,
            "question_text": "List causative genes for autosomal recessive forms of monogenic Parkinson's disease"
        }
    ],
    "56be06cdef6e394741000004": [
        {
            "text": "retinochoroiditis",
            "probability": 0.1983554927073925,
            "start_logit": 5.507760524749756,
            "end_logit": 6.246361255645752,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "encephalitis",
            "probability": 0.18639817060275551,
            "start_logit": 5.614037990570068,
            "end_logit": 6.077908039093018,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus, retinochoroiditis",
            "probability": 0.16817579904037802,
            "start_logit": 5.342709541320801,
            "end_logit": 6.246361255645752,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "retinochoroiditis and encephalitis",
            "probability": 0.16760459799680016,
            "start_logit": 5.507760524749756,
            "end_logit": 6.077908039093018,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus, retinochoroiditis and encephalitis",
            "probability": 0.1421036383022365,
            "start_logit": 5.342709541320801,
            "end_logit": 6.077908039093018,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus",
            "probability": 0.12310483179150718,
            "start_logit": 5.342709541320801,
            "end_logit": 5.934387683868408,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus,",
            "probability": 0.003905106199670221,
            "start_logit": 5.342709541320801,
            "end_logit": 2.4836363792419434,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "encephalitis.",
            "probability": 0.0033830695849141287,
            "start_logit": 5.614037990570068,
            "end_logit": 2.0688064098358154,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "retinochoroiditis and encephalitis.",
            "probability": 0.003041972010461094,
            "start_logit": 5.507760524749756,
            "end_logit": 2.0688064098358154,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "hydrocephalus, retinochoroiditis and encephalitis.",
            "probability": 0.0025791374190602054,
            "start_logit": 5.342709541320801,
            "end_logit": 2.0688064098358154,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "cephalus, retinochoroiditis",
            "probability": 0.00018618200707042374,
            "start_logit": -1.463330864906311,
            "end_logit": 6.246361255645752,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "lus, retinochoroiditis",
            "probability": 0.00017799808862238722,
            "start_logit": -1.5082827806472778,
            "end_logit": 6.246361255645752,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "cephalus, retinochoroiditis and encephalitis",
            "probability": 0.0001573183581828425,
            "start_logit": -1.463330864906311,
            "end_logit": 6.077908039093018,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "lus, retinochoroiditis and encephalitis",
            "probability": 0.0001504031861208054,
            "start_logit": -1.5082827806472778,
            "end_logit": 6.077908039093018,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "cephalus",
            "probability": 0.00013628539179710858,
            "start_logit": -1.463330864906311,
            "end_logit": 5.934387683868408,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "lus",
            "probability": 0.00013029475634486338,
            "start_logit": -1.5082827806472778,
            "end_logit": 5.934387683868408,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "choroiditis",
            "probability": 0.00011579584162934574,
            "start_logit": -1.9382269382476807,
            "end_logit": 6.246361255645752,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "itis",
            "probability": 9.875210573311528e-05,
            "start_logit": -2.097442865371704,
            "end_logit": 6.246361255645752,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "choroiditis and encephalitis",
            "probability": 9.784410414395505e-05,
            "start_logit": -1.9382269382476807,
            "end_logit": 6.077908039093018,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        },
        {
            "text": "en",
            "probability": 9.731050517949669e-05,
            "start_logit": 5.614037990570068,
            "end_logit": -1.4798253774642944,
            "question_text": "List symptoms of congenital toxoplasmosis triad."
        }
    ],
    "515d1ff7298dcd4e51000009": [
        {
            "text": "pluripotency",
            "probability": 0.3978811533732443,
            "start_logit": 4.781777858734131,
            "end_logit": 4.98461389541626,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "pluripotency and differentiation of stem cells",
            "probability": 0.20654247333160974,
            "start_logit": 4.781777858734131,
            "end_logit": 4.3289666175842285,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "pluripotency and differentiation",
            "probability": 0.1696469765854554,
            "start_logit": 4.781777858734131,
            "end_logit": 4.132180213928223,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "differentiation of stem cells",
            "probability": 0.07661866457564098,
            "start_logit": 3.7901124954223633,
            "end_logit": 4.3289666175842285,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "differentiation",
            "probability": 0.062931970289732,
            "start_logit": 3.7901124954223633,
            "end_logit": 4.132180213928223,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "stem cells",
            "probability": 0.03862871754276751,
            "start_logit": 3.1052677631378174,
            "end_logit": 4.3289666175842285,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "pluripotency and differentiation of stem cells in vitro",
            "probability": 0.016001014653865372,
            "start_logit": 4.781777858734131,
            "end_logit": 1.7711126804351807,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "differentiation of stem cells in vitro",
            "probability": 0.005935710727478738,
            "start_logit": 3.7901124954223633,
            "end_logit": 1.7711126804351807,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "controlling pluripotency",
            "probability": 0.0044616542045808096,
            "start_logit": 0.29114410281181335,
            "end_logit": 4.98461389541626,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "pluripotency and differentiation of stem cells in vitro.",
            "probability": 0.004360660010843909,
            "start_logit": 4.781777858734131,
            "end_logit": 0.47108396887779236,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "pluripotency and differentiation of stem",
            "probability": 0.0040433004642660714,
            "start_logit": 4.781777858734131,
            "end_logit": 0.3955218493938446,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "stem cells in vitro",
            "probability": 0.0029925984011505207,
            "start_logit": 3.1052677631378174,
            "end_logit": 1.7711126804351807,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "controlling pluripotency and differentiation of stem cells",
            "probability": 0.0023160712357240903,
            "start_logit": 0.29114410281181335,
            "end_logit": 4.3289666175842285,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "controlling pluripotency and differentiation",
            "probability": 0.0019023422948281263,
            "start_logit": 0.29114410281181335,
            "end_logit": 4.132180213928223,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "differentiation of stem cells in vitro.",
            "probability": 0.0016176234423359533,
            "start_logit": 3.7901124954223633,
            "end_logit": 0.47108396887779236,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "differentiation of stem",
            "probability": 0.0014998962540395038,
            "start_logit": 3.7901124954223633,
            "end_logit": 0.3955218493938446,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "stem cells in vitro.",
            "probability": 0.0008155547919119035,
            "start_logit": 3.1052677631378174,
            "end_logit": 0.47108396887779236,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "stem",
            "probability": 0.0007562004514389221,
            "start_logit": 3.1052677631378174,
            "end_logit": 0.3955218493938446,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "ripotency",
            "probability": 0.0005354861371008585,
            "start_logit": -1.8289557695388794,
            "end_logit": 4.98461389541626,
            "question_text": "Which cellular processes are regulated by Nanog?"
        },
        {
            "text": "pluripote",
            "probability": 0.0005119312319854112,
            "start_logit": 4.781777858734131,
            "end_logit": -1.6711044311523438,
            "question_text": "Which cellular processes are regulated by Nanog?"
        }
    ],
    "56ed27202ac5ed145900000c": [
        {
            "text": "adipocyte progenitors into adipocytes",
            "probability": 0.3872814167743854,
            "start_logit": 3.547482490539551,
            "end_logit": 2.793699026107788,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "adipocyte progenitors",
            "probability": 0.2629053628951205,
            "start_logit": 3.547482490539551,
            "end_logit": 2.406341552734375,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "adipocytes",
            "probability": 0.1680371262123215,
            "start_logit": 2.7125158309936523,
            "end_logit": 2.793699026107788,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "adipocyte",
            "probability": 0.07883188410078336,
            "start_logit": 3.547482490539551,
            "end_logit": 1.2018649578094482,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "progenitors into adipocytes",
            "probability": 0.030432227707906875,
            "start_logit": 1.0038330554962158,
            "end_logit": 2.793699026107788,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "progenitors",
            "probability": 0.020658868519671678,
            "start_logit": 1.0038330554962158,
            "end_logit": 2.406341552734375,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "progenitor and differentiated",
            "probability": 0.010408618650130553,
            "start_logit": 1.9995145797729492,
            "end_logit": 0.7251495122909546,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "progenitor and differentiated cells",
            "probability": 0.008905018270880746,
            "start_logit": 1.9995145797729492,
            "end_logit": 0.5691303014755249,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "progenitor",
            "probability": 0.007457301186279987,
            "start_logit": 1.9995145797729492,
            "end_logit": 0.3917089104652405,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "differentiation of adipocyte progenitors into adipocytes",
            "probability": 0.006068142726940224,
            "start_logit": -0.6086165308952332,
            "end_logit": 2.793699026107788,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "differentiated",
            "probability": 0.005552155823641757,
            "start_logit": 1.371066689491272,
            "end_logit": 0.7251495122909546,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "differentiated cells",
            "probability": 0.00475010668698931,
            "start_logit": 1.371066689491272,
            "end_logit": 0.5691303014755249,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "differentiation of adipocyte progenitors",
            "probability": 0.0041193488678414715,
            "start_logit": -0.6086165308952332,
            "end_logit": 2.406341552734375,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "ad",
            "probability": 0.0013477547732986346,
            "start_logit": 3.547482490539551,
            "end_logit": -2.8670125007629395,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "differentiation of adipocyte",
            "probability": 0.0012351822303827153,
            "start_logit": -0.6086165308952332,
            "end_logit": 1.2018649578094482,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "itors into adipocytes",
            "probability": 0.0005088686332211557,
            "start_logit": -3.0872344970703125,
            "end_logit": 2.793699026107788,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "adipocyte progenitors into adipocytes.",
            "probability": 0.0004381622998910563,
            "start_logit": 3.547482490539551,
            "end_logit": -3.9906184673309326,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "adipocyte progenitors into ad",
            "probability": 0.0004362487033121872,
            "start_logit": 3.547482490539551,
            "end_logit": -3.994995355606079,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "itors",
            "probability": 0.00034544464797000386,
            "start_logit": -3.0872344970703125,
            "end_logit": 2.406341552734375,
            "question_text": "In which cells are A-type lamins expressed?"
        },
        {
            "text": "adipoc",
            "probability": 0.00028076028903071865,
            "start_logit": 3.547482490539551,
            "end_logit": -4.435706615447998,
            "question_text": "In which cells are A-type lamins expressed?"
        }
    ],
    "55424745ed966d112c000002": [
        {
            "text": "C/G to T/A",
            "probability": 0.40997019439985233,
            "start_logit": 4.549096584320068,
            "end_logit": 2.7545206546783447,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "T/A",
            "probability": 0.13206432659964498,
            "start_logit": 3.4163012504577637,
            "end_logit": 2.7545206546783447,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "C/G",
            "probability": 0.10700965487052945,
            "start_logit": 4.549096584320068,
            "end_logit": 1.4113552570343018,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "C/G to T",
            "probability": 0.10390296560627715,
            "start_logit": 4.549096584320068,
            "end_logit": 1.3818936347961426,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "C/G to T/A transitions",
            "probability": 0.08166682664277475,
            "start_logit": 4.549096584320068,
            "end_logit": 1.14108407497406,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "C",
            "probability": 0.048709028589639776,
            "start_logit": 4.549096584320068,
            "end_logit": 0.6243005990982056,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "T",
            "probability": 0.033470421440237284,
            "start_logit": 3.4163012504577637,
            "end_logit": 1.3818936347961426,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "T/A transitions",
            "probability": 0.026307459940828993,
            "start_logit": 3.4163012504577637,
            "end_logit": 1.14108407497406,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "A",
            "probability": 0.01885830824485288,
            "start_logit": 1.4699656963348389,
            "end_logit": 2.7545206546783447,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "G to T/A",
            "probability": 0.011146117559474599,
            "start_logit": 0.9441033601760864,
            "end_logit": 2.7545206546783447,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "high rate of C/G to T/A",
            "probability": 0.006491817799793944,
            "start_logit": 0.4035547077655792,
            "end_logit": 2.7545206546783447,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "A transitions",
            "probability": 0.0037566101420200325,
            "start_logit": 1.4699656963348389,
            "end_logit": 1.14108407497406,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "AT is primarily due to the high rate of C/G to T/A",
            "probability": 0.0032186485060492326,
            "start_logit": -0.29802632331848145,
            "end_logit": 2.7545206546783447,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "G",
            "probability": 0.0029093387994504273,
            "start_logit": 0.9441033601760864,
            "end_logit": 1.4113552570343018,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "G to T",
            "probability": 0.002824875284216584,
            "start_logit": 0.9441033601760864,
            "end_logit": 1.3818936347961426,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "G to T/A transitions",
            "probability": 0.002220327386975348,
            "start_logit": 0.9441033601760864,
            "end_logit": 1.14108407497406,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "high rate of C/G",
            "probability": 0.0016944821641369547,
            "start_logit": 0.4035547077655792,
            "end_logit": 1.4113552570343018,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "high rate of C/G to T",
            "probability": 0.001645288196039773,
            "start_logit": 0.4035547077655792,
            "end_logit": 1.3818936347961426,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "high rate of C/G to T/A transitions",
            "probability": 0.0012931822022533897,
            "start_logit": 0.4035547077655792,
            "end_logit": 1.14108407497406,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        },
        {
            "text": "AT is primarily due to the high rate of C/G",
            "probability": 0.0008401256249520116,
            "start_logit": -0.29802632331848145,
            "end_logit": 1.4113552570343018,
            "question_text": "Between which types of DNA bases are mutational biases introduced due to directional mutation pressure?"
        }
    ],
    "530cf4e0c8a0b4a00c000004": [
        {
            "text": "Arg403-->Gln",
            "probability": 0.8555665671885075,
            "start_logit": 5.307523250579834,
            "end_logit": 4.72178840637207,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403",
            "probability": 0.05895376298380328,
            "start_logit": 5.307523250579834,
            "end_logit": 2.0467779636383057,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Gln",
            "probability": 0.02537354034725192,
            "start_logit": 1.7894662618637085,
            "end_logit": 4.72178840637207,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense mutation in the alpha-myosin heavy chain (403",
            "probability": 0.022238183174585247,
            "start_logit": 5.307523250579834,
            "end_logit": 1.0718352794647217,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense",
            "probability": 0.011572661198123864,
            "start_logit": 5.307523250579834,
            "end_logit": 0.41867002844810486,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense mutation",
            "probability": 0.00915926765595734,
            "start_logit": 5.307523250579834,
            "end_logit": 0.1847907304763794,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "an Arg403-->Gln",
            "probability": 0.005076632862048443,
            "start_logit": 0.1804075688123703,
            "end_logit": 4.72178840637207,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense mutation in the alpha-myosin heavy chain (403)",
            "probability": 0.005009435770676567,
            "start_logit": 5.307523250579834,
            "end_logit": -0.418652206659317,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg",
            "probability": 0.0018010495336501767,
            "start_logit": 5.307523250579834,
            "end_logit": -1.4416059255599976,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "rg403-->Gln",
            "probability": 0.0010944937616446761,
            "start_logit": -1.353948712348938,
            "end_logit": 4.72178840637207,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "403-->Gln",
            "probability": 0.0007780747091909149,
            "start_logit": -1.6951733827590942,
            "end_logit": 4.72178840637207,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Gln missense mutation in the alpha-myosin heavy chain (403",
            "probability": 0.0006595178676559874,
            "start_logit": 1.7894662618637085,
            "end_logit": 1.0718352794647217,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "A",
            "probability": 0.00047287106405168836,
            "start_logit": 5.307523250579834,
            "end_logit": -2.7789080142974854,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "an Arg403",
            "probability": 0.0003498110164454904,
            "start_logit": 0.1804075688123703,
            "end_logit": 2.0467779636383057,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Gln missense",
            "probability": 0.0003432104491887828,
            "start_logit": 1.7894662618637085,
            "end_logit": 0.41867002844810486,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "403",
            "probability": 0.00033935572121146827,
            "start_logit": 1.125006079673767,
            "end_logit": 1.0718352794647217,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense mutation in the alpha-myosin heavy chain (40",
            "probability": 0.0003337357289181884,
            "start_logit": 5.307523250579834,
            "end_logit": -3.1273813247680664,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "ln",
            "probability": 0.0003273649786291431,
            "start_logit": -2.560920238494873,
            "end_logit": 4.72178840637207,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Arg403-->Gln missense mutation in the alpha-myosin heavy chain",
            "probability": 0.0002788275590652905,
            "start_logit": 5.307523250579834,
            "end_logit": -3.3071372509002686,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        },
        {
            "text": "Gln missense mutation",
            "probability": 0.0002716364293937021,
            "start_logit": 1.7894662618637085,
            "end_logit": 0.1847907304763794,
            "question_text": "Which mutations of alpha-myosin heavy chain gene are implicated in hypertrophic cardiomyopathy?"
        }
    ],
    "530cf4e0c8a0b4a00c000005": [
        {
            "text": "mitral valve",
            "probability": 0.25104220161371427,
            "start_logit": 4.466689586639404,
            "end_logit": 4.003688335418701,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "mitral valve (MV) leaflets",
            "probability": 0.17421034031269955,
            "start_logit": 4.466689586639404,
            "end_logit": 3.6383306980133057,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Myxomatous thickening and elongation of the mitral valve",
            "probability": 0.14865551062651172,
            "start_logit": 3.942700147628784,
            "end_logit": 4.003688335418701,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Myxomatous thickening",
            "probability": 0.10803978406802939,
            "start_logit": 3.942700147628784,
            "end_logit": 3.684556245803833,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Myxomatous thickening and elongation of the mitral valve (MV) leaflets",
            "probability": 0.10315925740426578,
            "start_logit": 3.942700147628784,
            "end_logit": 3.6383306980133057,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "elongation of the mitral valve",
            "probability": 0.07636110125197461,
            "start_logit": 3.2765419483184814,
            "end_logit": 4.003688335418701,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "elongation of the mitral valve (MV) leaflets",
            "probability": 0.05299066591293102,
            "start_logit": 3.2765419483184814,
            "end_logit": 3.6383306980133057,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Myxomatous thickening and elongation",
            "probability": 0.028060331999939448,
            "start_logit": 3.942700147628784,
            "end_logit": 2.336413621902466,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "elongation",
            "probability": 0.01441398199085167,
            "start_logit": 3.2765419483184814,
            "end_logit": 2.336413621902466,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Myxomatous",
            "probability": 0.013222671638941532,
            "start_logit": 3.942700147628784,
            "end_logit": 1.5839896202087402,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "mitral valve (MV)",
            "probability": 0.005378213098195794,
            "start_logit": 4.466689586639404,
            "end_logit": 0.16042345762252808,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "thickening and elongation of the mitral valve",
            "probability": 0.004448309425404511,
            "start_logit": 0.43359264731407166,
            "end_logit": 4.003688335418701,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "valve",
            "probability": 0.0033025289261363455,
            "start_logit": 0.13575704395771027,
            "end_logit": 4.003688335418701,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "thickening",
            "probability": 0.003232940291032658,
            "start_logit": 0.43359264731407166,
            "end_logit": 3.684556245803833,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "Myxomatous thickening and elongation of the mitral valve (MV)",
            "probability": 0.0031847275447365,
            "start_logit": 3.942700147628784,
            "end_logit": 0.16042345762252808,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "thickening and elongation of the mitral valve (MV) leaflets",
            "probability": 0.0030868973177997114,
            "start_logit": 0.43359264731407166,
            "end_logit": 3.6383306980133057,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "MV) leaflets",
            "probability": 0.002443160174787333,
            "start_logit": 0.19971852004528046,
            "end_logit": 3.6383306980133057,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "valve (MV) leaflets",
            "probability": 0.0022917847454191416,
            "start_logit": 0.13575704395771027,
            "end_logit": 3.6383306980133057,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "elongation of the mitral valve (MV)",
            "probability": 0.001635925244066971,
            "start_logit": 3.2765419483184814,
            "end_logit": 0.16042345762252808,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        },
        {
            "text": "thickening and elongation",
            "probability": 0.0008396664125618323,
            "start_logit": 0.43359264731407166,
            "end_logit": 2.336413621902466,
            "question_text": "Which are the cardiac manifestations of Marfan syndrome?"
        }
    ],
    "52e0141498d023950500000e": [
        {
            "text": "post-embryonic growth retardation",
            "probability": 0.5590606393174059,
            "start_logit": 5.161834239959717,
            "end_logit": 5.079735279083252,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth retardation",
            "probability": 0.1353833819540479,
            "start_logit": 3.7436869144439697,
            "end_logit": 5.079735279083252,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "post-embryonic growth retardation phenotype",
            "probability": 0.11801379749579723,
            "start_logit": 5.161834239959717,
            "end_logit": 3.5242788791656494,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "embryonic growth retardation",
            "probability": 0.11680762226765283,
            "start_logit": 3.596104621887207,
            "end_logit": 5.079735279083252,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth retardation phenotype",
            "probability": 0.028578486658850964,
            "start_logit": 3.7436869144439697,
            "end_logit": 3.5242788791656494,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "embryonic growth retardation phenotype",
            "probability": 0.024657273488420266,
            "start_logit": 3.596104621887207,
            "end_logit": 3.5242788791656494,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "a post-embryonic growth retardation",
            "probability": 0.006295939524828015,
            "start_logit": 0.6754812002182007,
            "end_logit": 5.079735279083252,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "retardation",
            "probability": 0.0027188667953431103,
            "start_logit": -0.1642085313796997,
            "end_logit": 5.079735279083252,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "post-embryonic growth",
            "probability": 0.0016221107469294904,
            "start_logit": 5.161834239959717,
            "end_logit": -0.7627944350242615,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "a post-embryonic growth retardation phenotype",
            "probability": 0.0013290288742845973,
            "start_logit": 0.6754812002182007,
            "end_logit": 3.5242788791656494,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "post-embryonic growth retardation phenotype.",
            "probability": 0.0013017813128242248,
            "start_logit": 5.161834239959717,
            "end_logit": -0.9827890992164612,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "exhibit a post-embryonic growth retardation",
            "probability": 0.0009366116450756403,
            "start_logit": -1.2299102544784546,
            "end_logit": 5.079735279083252,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "retardation phenotype",
            "probability": 0.0005739337968693928,
            "start_logit": -0.1642085313796997,
            "end_logit": 3.5242788791656494,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "aberrant morphology",
            "probability": 0.0005303142897775124,
            "start_logit": 2.1166274547576904,
            "end_logit": 1.1643986701965332,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "ryonic growth retardation",
            "probability": 0.00047818096700428283,
            "start_logit": -1.9021897315979004,
            "end_logit": 5.079735279083252,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth",
            "probability": 0.00039281398721157263,
            "start_logit": 3.7436869144439697,
            "end_logit": -0.7627944350242615,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "phenotype",
            "probability": 0.0003649395053564506,
            "start_logit": -0.6169909834861755,
            "end_logit": 3.5242788791656494,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "embryonic growth",
            "probability": 0.00033891654335562333,
            "start_logit": 3.596104621887207,
            "end_logit": -0.7627944350242615,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "growth retardation phenotype.",
            "probability": 0.0003152422909076669,
            "start_logit": 3.7436869144439697,
            "end_logit": -0.9827890992164612,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        },
        {
            "text": "mutants that exhibit a post-embryonic growth retardation",
            "probability": 0.0003001185380572323,
            "start_logit": -2.3680014610290527,
            "end_logit": 5.079735279083252,
            "question_text": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?"
        }
    ],
    "5518e817622b194345000006": [
        {
            "text": "K-Ras",
            "probability": 0.19287686639857535,
            "start_logit": 5.61768913269043,
            "end_logit": 4.880440711975098,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras, N-Ras",
            "probability": 0.18195494866177492,
            "start_logit": 5.61768913269043,
            "end_logit": 4.822147846221924,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras, N-Ras, and H-Ras",
            "probability": 0.17279142519929175,
            "start_logit": 5.61768913269043,
            "end_logit": 4.770473957061768,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N-Ras",
            "probability": 0.15497529974530214,
            "start_logit": 5.45719575881958,
            "end_logit": 4.822147846221924,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N-Ras, and H-Ras",
            "probability": 0.14717051177022367,
            "start_logit": 5.45719575881958,
            "end_logit": 4.770473957061768,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "H-Ras",
            "probability": 0.142391516507606,
            "start_logit": 5.424184322357178,
            "end_logit": 4.770473957061768,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Ras",
            "probability": 0.001411595029746992,
            "start_logit": 0.7003574371337891,
            "end_logit": 4.880440711975098,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Ras, N-Ras",
            "probability": 0.0013316615204545222,
            "start_logit": 0.7003574371337891,
            "end_logit": 4.822147846221924,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Ras, and H-Ras",
            "probability": 0.001320858278237274,
            "start_logit": 0.7438856363296509,
            "end_logit": 4.770473957061768,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Ras, N-Ras, and H-Ras",
            "probability": 0.0012645970538020987,
            "start_logit": 0.7003574371337891,
            "end_logit": 4.770473957061768,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras, N-Ras,",
            "probability": 0.0006326730661567838,
            "start_logit": 5.61768913269043,
            "end_logit": -0.8394127488136292,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N-Ras,",
            "probability": 0.0005388624975003222,
            "start_logit": 5.45719575881958,
            "end_logit": -0.8394127488136292,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras, N-Ras, and H",
            "probability": 0.0002057716948715285,
            "start_logit": 5.61768913269043,
            "end_logit": -1.962599277496338,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K",
            "probability": 0.00020298602313603787,
            "start_logit": 5.61768913269043,
            "end_logit": -1.9762294292449951,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras,",
            "probability": 0.0001902326304701168,
            "start_logit": 5.61768913269043,
            "end_logit": -2.041118860244751,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "K-Ras, N",
            "probability": 0.0001792349736944768,
            "start_logit": 5.61768913269043,
            "end_logit": -2.1006689071655273,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N-Ras, and H",
            "probability": 0.00017526058140408977,
            "start_logit": 5.45719575881958,
            "end_logit": -1.962599277496338,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "H",
            "probability": 0.00016956943119893553,
            "start_logit": 5.424184322357178,
            "end_logit": -1.962599277496338,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "N",
            "probability": 0.00015265863323550417,
            "start_logit": 5.45719575881958,
            "end_logit": -2.1006689071655273,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        },
        {
            "text": "Ras isoforms such as K-Ras",
            "probability": 6.347030331761931e-05,
            "start_logit": -2.401546001434326,
            "end_logit": 4.880440711975098,
            "question_text": "Which are the different members/isoforms of the Ras oncogenes?"
        }
    ],
    "530cefaaad0bf1360c000003": [
        {
            "text": "alemtuzumab",
            "probability": 0.9959114412399133,
            "start_logit": 6.647868633270264,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "monoclonal antibody alemtuzumab",
            "probability": 0.0013641679954464073,
            "start_logit": 0.05475500971078873,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "anti-CD52 monoclonal antibody alemtuzumab",
            "probability": 0.0008464537895366172,
            "start_logit": -0.42248937487602234,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alem",
            "probability": 0.0005915978022977649,
            "start_logit": 6.647868633270264,
            "end_logit": -0.9787036180496216,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "ale",
            "probability": 0.0002811883436613973,
            "start_logit": 6.647868633270264,
            "end_logit": -1.7225059270858765,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtuzuma",
            "probability": 0.0002624755924121399,
            "start_logit": 6.647868633270264,
            "end_logit": -1.791372537612915,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "b",
            "probability": 0.00023177308057222368,
            "start_logit": -1.717786192893982,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "The anti-CD52 monoclonal antibody alemtuzumab",
            "probability": 0.0001406647997303748,
            "start_logit": -2.217165231704712,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "antibody alemtuzumab",
            "probability": 7.596750385446648e-05,
            "start_logit": -2.8332393169403076,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtuzumab reduced disease activity",
            "probability": 5.144121980150039e-05,
            "start_logit": 6.647868633270264,
            "end_logit": -3.421090841293335,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtuzumab compared with interferon beta 1a in a phase 3 trial.",
            "probability": 4.744992869112098e-05,
            "start_logit": 4.995103359222412,
            "end_logit": -1.849090337753296,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtuzu",
            "probability": 4.128153093202645e-05,
            "start_logit": 6.647868633270264,
            "end_logit": -3.641115427017212,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "mtuzumab",
            "probability": 3.655711575304733e-05,
            "start_logit": -3.564669132232666,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "mab",
            "probability": 2.5921572740826582e-05,
            "start_logit": -3.9084694385528564,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "tuzumab",
            "probability": 2.4701464695946405e-05,
            "start_logit": -3.9566824436187744,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtu",
            "probability": 1.7410569282077744e-05,
            "start_logit": 6.647868633270264,
            "end_logit": -4.504453182220459,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "alemtuzumab reduced disease activity in a phase 2 trial",
            "probability": 1.6946297408917155e-05,
            "start_logit": 6.647868633270264,
            "end_logit": -4.5314812660217285,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "zumab",
            "probability": 1.602823616050012e-05,
            "start_logit": -4.389193058013916,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "body alemtuzumab",
            "probability": 1.572156514984281e-05,
            "start_logit": -4.408511638641357,
            "end_logit": 6.449882984161377,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        },
        {
            "text": "monoclonal antibody alem",
            "probability": 8.103519596745227e-07,
            "start_logit": 0.05475500971078873,
            "end_logit": -0.9787036180496216,
            "question_text": "What are the names of anti-CD52 monoclonal antibody that is used for treatment of multiple sclerosis patients?"
        }
    ],
    "530cefaaad0bf1360c000002": [
        {
            "text": "nucleus accumbens",
            "probability": 0.29441624215086687,
            "start_logit": 3.304736375808716,
            "end_logit": 3.1869518756866455,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "cingulate gyrus",
            "probability": 0.11026085944189366,
            "start_logit": 2.677649974822998,
            "end_logit": 2.831892728805542,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "habenula",
            "probability": 0.10550499101352888,
            "start_logit": 2.930820941925049,
            "end_logit": 2.5346310138702393,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "subgenual cingulate gyrus",
            "probability": 0.09171862730518157,
            "start_logit": 2.4935264587402344,
            "end_logit": 2.831892728805542,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "medial forebrain bundle, habenula",
            "probability": 0.06147720815243574,
            "start_logit": 2.3907291889190674,
            "end_logit": 2.5346310138702393,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "cingulate gyrus (Cg25/24), the anterior limb of the capsula interna",
            "probability": 0.052229392928051864,
            "start_logit": 2.677649974822998,
            "end_logit": 2.084689140319824,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "nucleus accumbens (NAcc)",
            "probability": 0.04835698638311047,
            "start_logit": 3.304736375808716,
            "end_logit": 1.380568027496338,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "subgenual cingulate gyrus (Cg25/24), the anterior limb of the capsula interna",
            "probability": 0.043446135361101285,
            "start_logit": 2.4935264587402344,
            "end_logit": 2.084689140319824,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "capsula interna (ALIC), and the nucleus accumbens",
            "probability": 0.03652847800507422,
            "start_logit": 1.2178339958190918,
            "end_logit": 3.1869518756866455,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "medial forebrain bundle",
            "probability": 0.034145715684998586,
            "start_logit": 2.3907291889190674,
            "end_logit": 1.9466016292572021,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "anterior limb of the capsula interna (ALIC), and the nucleus accumbens",
            "probability": 0.025367715731194975,
            "start_logit": 0.8532191514968872,
            "end_logit": 3.1869518756866455,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "the nucleus accumbens",
            "probability": 0.022388961554145173,
            "start_logit": 0.7283098697662354,
            "end_logit": 3.1869518756866455,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "the anterior limb of the capsula interna (ALIC), and the nucleus accumbens",
            "probability": 0.016567187384062217,
            "start_logit": 0.4271658957004547,
            "end_logit": 3.1869518756866455,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "capsula interna",
            "probability": 0.012131791944044274,
            "start_logit": 1.2178339958190918,
            "end_logit": 2.084689140319824,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "cingulate gyrus (Cg25/24), the anterior limb of the capsula interna (ALIC)",
            "probability": 0.010162455663152346,
            "start_logit": 2.677649974822998,
            "end_logit": 0.44774383306503296,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "subgenual cingulate gyrus (Cg25/24), the anterior limb of the capsula interna (ALIC)",
            "probability": 0.008453466517420917,
            "start_logit": 2.4935264587402344,
            "end_logit": 0.44774383306503296,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "anterior limb of the capsula interna",
            "probability": 0.008425093684542938,
            "start_logit": 0.8532191514968872,
            "end_logit": 2.084689140319824,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "cingulate gyrus (Cg25/24)",
            "probability": 0.0067795468147357416,
            "start_logit": 2.677649974822998,
            "end_logit": 0.0429539792239666,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "capsula interna (ALIC), and the nucleus accumbens (NAcc)",
            "probability": 0.005999693157492206,
            "start_logit": 1.2178339958190918,
            "end_logit": 1.380568027496338,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        },
        {
            "text": "subgenual cingulate gyrus (Cg25/24)",
            "probability": 0.005639451122965952,
            "start_logit": 2.4935264587402344,
            "end_logit": 0.0429539792239666,
            "question_text": "Which brain structures have been investigated as potential targets for deep brain stimulation of patients suffering from major depression?"
        }
    ],
    "52ecf2dd98d023950500002e": [
        {
            "text": "DIO1",
            "probability": 0.7167146133802135,
            "start_logit": -0.20750027894973755,
            "end_logit": -0.5522840619087219,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "DIO1 gene",
            "probability": 0.14168090293186641,
            "start_logit": -0.20750027894973755,
            "end_logit": -2.173384428024292,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Polymorphisms in the DIO1",
            "probability": 0.03542415266625673,
            "start_logit": -3.2147841453552246,
            "end_logit": -0.5522840619087219,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "DIO1 gene have been associated with changes in serum thyroid hormone levels, whereas decreased D1",
            "probability": 0.0243123877521935,
            "start_logit": -0.20750027894973755,
            "end_logit": -3.9359757900238037,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "DIO1 gene have been associated with changes in serum thyroid hormone levels,",
            "probability": 0.018899692488425657,
            "start_logit": -0.20750027894973755,
            "end_logit": -4.187816143035889,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "DI",
            "probability": 0.014864575435717793,
            "start_logit": -0.20750027894973755,
            "end_logit": -4.427980899810791,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "the DIO1",
            "probability": 0.007702849306540432,
            "start_logit": -4.7405877113342285,
            "end_logit": -0.5522840619087219,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Polymorphisms in the DIO1 gene",
            "probability": 0.007002683971631288,
            "start_logit": -3.2147841453552246,
            "end_logit": -2.173384428024292,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "D1",
            "probability": 0.005609241179854574,
            "start_logit": -2.763242721557617,
            "end_logit": -2.846803903579712,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "DIO1 gene have been associated with changes in serum thyroid hormone levels, whereas decreased D1 activity",
            "probability": 0.004452242103320393,
            "start_logit": -0.20750027894973755,
            "end_logit": -5.633553981781006,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "in the DIO1",
            "probability": 0.004055498500309373,
            "start_logit": -5.382104396820068,
            "end_logit": -0.5522840619087219,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "DIO1 gene have been associated with changes in serum thyroid hormone levels",
            "probability": 0.0040035362402439795,
            "start_logit": -0.20750027894973755,
            "end_logit": -5.739783763885498,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "D1)",
            "probability": 0.0032651171231371885,
            "start_logit": -2.763242721557617,
            "end_logit": -3.3879237174987793,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "1",
            "probability": 0.0027443309369815385,
            "start_logit": -5.772640705108643,
            "end_logit": -0.5522840619087219,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "(D1",
            "probability": 0.0023548261809329726,
            "start_logit": -3.6311912536621094,
            "end_logit": -2.846803903579712,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "gene",
            "probability": 0.00157367347430297,
            "start_logit": -4.707664966583252,
            "end_logit": -2.173384428024292,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "the DIO1 gene",
            "probability": 0.001522707399185951,
            "start_logit": -4.7405877113342285,
            "end_logit": -2.173384428024292,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "(D1)",
            "probability": 0.0013707350136752973,
            "start_logit": -3.6311912536621094,
            "end_logit": -3.3879237174987793,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Type I deiodinase (D1",
            "probability": 0.0012445760735307185,
            "start_logit": -4.268863201141357,
            "end_logit": -2.846803903579712,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        },
        {
            "text": "Polymorphisms in the DIO1 gene have been associated with changes in serum thyroid hormone levels, whereas decreased D1",
            "probability": 0.00120165784167993,
            "start_logit": -3.2147841453552246,
            "end_logit": -3.9359757900238037,
            "question_text": "Which deiodinase polymorphisms are implicated in arterial hypertension?"
        }
    ],
    "5319abe4b166e2b80600002e": [
        {
            "text": "Twist",
            "probability": 0.4359845122876594,
            "start_logit": 4.261702060699463,
            "end_logit": 4.3972883224487305,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail and Twist",
            "probability": 0.2743922084978085,
            "start_logit": 3.7986538410186768,
            "end_logit": 4.3972883224487305,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail",
            "probability": 0.2014637585864264,
            "start_logit": 3.7986538410186768,
            "end_logit": 4.088339328765869,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "STAT3 activation in MCF-7 cells that constitutively express Twist",
            "probability": 0.0312269194791341,
            "start_logit": 1.9612499475479126,
            "end_logit": 4.0614142417907715,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Vimentin, N-cadherin, Snail and Twist",
            "probability": 0.026365218350187614,
            "start_logit": 1.4561409950256348,
            "end_logit": 4.3972883224487305,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Vimentin, N-cadherin, Snail",
            "probability": 0.019357823656363182,
            "start_logit": 1.4561409950256348,
            "end_logit": 4.088339328765869,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Twist.",
            "probability": 0.002729454726248758,
            "start_logit": 4.261702060699463,
            "end_logit": -0.6762165427207947,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Twist,",
            "probability": 0.0019414464079741257,
            "start_logit": 3.627923011779785,
            "end_logit": -0.3831060826778412,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Snail and Twist.",
            "probability": 0.0017178158609359778,
            "start_logit": 3.7986538410186768,
            "end_logit": -0.6762165427207947,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "STAT3",
            "probability": 0.0016599865758041435,
            "start_logit": 1.9612499475479126,
            "end_logit": 1.1269432306289673,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "N-cadherin, Snail and Twist",
            "probability": 0.0006311939507744547,
            "start_logit": -2.2760467529296875,
            "end_logit": 4.3972883224487305,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Vimentin",
            "probability": 0.0004812307449884715,
            "start_logit": 1.4561409950256348,
            "end_logit": 0.39383426308631897,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "N-cadherin, Snail",
            "probability": 0.0004634340982792631,
            "start_logit": -2.2760467529296875,
            "end_logit": 4.088339328765869,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Vimentin, N-cadherin",
            "probability": 0.000411073388271076,
            "start_logit": 1.4561409950256348,
            "end_logit": 0.23625914752483368,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "STAT3 activation in MCF-7 cells that constitutively express Twist,",
            "probability": 0.0003666895147553469,
            "start_logit": 1.9612499475479126,
            "end_logit": -0.3831060826778412,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Twist, a metastatic regulator and direct transcriptional repressor of E-cadherin",
            "probability": 0.00023880052044462116,
            "start_logit": 3.627923011779785,
            "end_logit": -2.478666067123413,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "IL-6 production and STAT3 activation in MCF-7 cells that constitutively express Twist",
            "probability": 0.0002007093128142908,
            "start_logit": -3.085928201675415,
            "end_logit": 4.0614142417907715,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Vimentin, N-cadherin, Snail and Twist.",
            "probability": 0.000165057858264056,
            "start_logit": 1.4561409950256348,
            "end_logit": -0.6762165427207947,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Twist, a metastatic regulator and direct transcriptional repressor",
            "probability": 0.00012112680737000429,
            "start_logit": 3.627923011779785,
            "end_logit": -3.157456636428833,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        },
        {
            "text": "Twist, a metastatic regulator",
            "probability": 8.153937549657277e-05,
            "start_logit": 3.627923011779785,
            "end_logit": -3.553208589553833,
            "question_text": "Which transcription factors are involved in E-cadherin repression during EMT?"
        }
    ],
    "54ff30dc6ad7dcbc1200000f": [
        {
            "text": "Beckwith-Wiedemann syndrome",
            "probability": 0.20965016621971236,
            "start_logit": 4.856863975524902,
            "end_logit": 5.082338809967041,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi, Angelmann and Beckwith-Wiedemann syndrome",
            "probability": 0.14433319130488512,
            "start_logit": 4.483548164367676,
            "end_logit": 5.082338809967041,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "gestation trophoblastic disease, Prader-Willi, Angelmann and Beckwith-Wiedemann syndrome",
            "probability": 0.10221051335587338,
            "start_logit": 4.138458251953125,
            "end_logit": 5.082338809967041,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "gestation trophoblastic disease",
            "probability": 0.09224519370997752,
            "start_logit": 4.138458251953125,
            "end_logit": 4.979754447937012,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "trophoblastic disease, Prader-Willi, Angelmann and Beckwith-Wiedemann syndrome",
            "probability": 0.07806448695730697,
            "start_logit": 3.8689589500427246,
            "end_logit": 5.082338809967041,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "trophoblastic disease",
            "probability": 0.07045335636045894,
            "start_logit": 3.8689589500427246,
            "end_logit": 4.979754447937012,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Beckwith-Wiedemann syndromes",
            "probability": 0.039171709916680175,
            "start_logit": 4.856863975524902,
            "end_logit": 3.404853343963623,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Angelmann and Beckwith-Wiedemann syndrome",
            "probability": 0.03546579054468712,
            "start_logit": 3.0799922943115234,
            "end_logit": 5.082338809967041,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi, Angelmann",
            "probability": 0.0351991075950643,
            "start_logit": 4.483548164367676,
            "end_logit": 3.6712350845336914,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi, Angelmann and Beckwith-Wiedemann syndromes",
            "probability": 0.026967676692507523,
            "start_logit": 4.483548164367676,
            "end_logit": 3.404853343963623,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi",
            "probability": 0.02531871628955905,
            "start_logit": 4.483548164367676,
            "end_logit": 3.3417582511901855,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "gestation trophoblastic disease, Prader-Willi, Angelmann",
            "probability": 0.024926483121684943,
            "start_logit": 4.138458251953125,
            "end_logit": 3.6712350845336914,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "gestation trophoblastic disease, Prader-Willi, Angelmann and Beckwith-Wiedemann syndromes",
            "probability": 0.01909734035419421,
            "start_logit": 4.138458251953125,
            "end_logit": 3.404853343963623,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "trophoblastic disease, Prader-Willi, Angelmann",
            "probability": 0.019037895933163216,
            "start_logit": 3.8689589500427246,
            "end_logit": 3.6712350845336914,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "gestation trophoblastic disease, Prader-Willi",
            "probability": 0.017929618032217345,
            "start_logit": 4.138458251953125,
            "end_logit": 3.3417582511901855,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "trophoblastic disease, Prader-Willi, Angelmann and Beckwith-Wiedemann syndromes",
            "probability": 0.01458581928659864,
            "start_logit": 3.8689589500427246,
            "end_logit": 3.404853343963623,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "trophoblastic disease, Prader-Willi",
            "probability": 0.013693957569239591,
            "start_logit": 3.8689589500427246,
            "end_logit": 3.3417582511901855,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Beckwith-Wiedemann",
            "probability": 0.013621856768197516,
            "start_logit": 4.856863975524902,
            "end_logit": 2.348574161529541,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Prader-Willi, Angelmann and Beckwith-Wiedemann",
            "probability": 0.009377937038177912,
            "start_logit": 4.483548164367676,
            "end_logit": 2.348574161529541,
            "question_text": "List human diseases involving genomic imprinting."
        },
        {
            "text": "Angelmann",
            "probability": 0.008649182949814009,
            "start_logit": 3.0799922943115234,
            "end_logit": 3.6712350845336914,
            "question_text": "List human diseases involving genomic imprinting."
        }
    ],
    "530cefaaad0bf1360c000011": [
        {
            "text": "explored self-reported ill health among veterans who believed that they had Gulf War syndrome.",
            "probability": 0.20573120072401427,
            "start_logit": -6.41179895401001,
            "end_logit": -5.359859466552734,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "self-reported ill health among veterans who believed that they had Gulf War syndrome.",
            "probability": 0.10944223274264758,
            "start_logit": -7.042972564697266,
            "end_logit": -5.359859466552734,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "ill health among veterans who believed that they had Gulf War syndrome.",
            "probability": 0.09151141435708185,
            "start_logit": -7.221905708312988,
            "end_logit": -5.359859466552734,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "veterans who believed that they had Gulf War syndrome.",
            "probability": 0.07874608289767497,
            "start_logit": -7.372140884399414,
            "end_logit": -5.359859466552734,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "ill health",
            "probability": 0.06262377494337715,
            "start_logit": -6.478952407836914,
            "end_logit": -6.482131481170654,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "Gulf War syndrome.",
            "probability": 0.05967814349795184,
            "start_logit": -7.6494035720825195,
            "end_logit": -5.359859466552734,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "ii) explored self-reported ill health among veterans who believed that they had Gulf War syndrome.",
            "probability": 0.04671897963254989,
            "start_logit": -7.894218921661377,
            "end_logit": -5.359859466552734,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "explored self-reported ill health",
            "probability": 0.04502127069241056,
            "start_logit": -6.41179895401001,
            "end_logit": -6.8792948722839355,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "explored self-reported ill health among veterans",
            "probability": 0.03647202948249102,
            "start_logit": -6.41179895401001,
            "end_logit": -7.089884281158447,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "explored self-reported ill health among veterans who believed that they had Gulf War syndrome",
            "probability": 0.0336047673672831,
            "start_logit": -6.41179895401001,
            "end_logit": -7.171761989593506,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "explored",
            "probability": 0.031034161744711686,
            "start_logit": -6.41179895401001,
            "end_logit": -7.251341342926025,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "explored self",
            "probability": 0.027401894592151595,
            "start_logit": -6.41179895401001,
            "end_logit": -7.375817775726318,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "ill health than veterans who did not serve there.",
            "probability": 0.025629544263409465,
            "start_logit": -6.478952407836914,
            "end_logit": -7.37553071975708,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "ill health than veterans who did not serve there. Many studies of post-Gulf morbidity",
            "probability": 0.024160073075986763,
            "start_logit": -6.478952407836914,
            "end_logit": -7.434575080871582,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "self-reported ill health",
            "probability": 0.023949835358703552,
            "start_logit": -7.042972564697266,
            "end_logit": -6.8792948722839355,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "In a setting where selection bias relating to the ill health of veterans may be reduced,",
            "probability": 0.020863376336531927,
            "start_logit": -7.353724956512451,
            "end_logit": -6.706508636474609,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "examined self-reported adult ill health in a large sample of male UK Gulf War veterans and a demographically similar non-deployed comparison group;",
            "probability": 0.02048340668444049,
            "start_logit": -7.030018329620361,
            "end_logit": -7.048595428466797,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "examined self-reported adult ill health in a large sample of male UK Gulf War veterans",
            "probability": 0.01964926035280053,
            "start_logit": -7.030018329620361,
            "end_logit": -7.090170860290527,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "self-reported ill health among veterans",
            "probability": 0.01940192020059291,
            "start_logit": -7.042972564697266,
            "end_logit": -7.089884281158447,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        },
        {
            "text": "self-reported ill health among veterans who believed that they had Gulf War syndrome",
            "probability": 0.01787663105318877,
            "start_logit": -7.042972564697266,
            "end_logit": -7.171761989593506,
            "question_text": "What memory problems are reported in the \" Gulf war syndrome\"?"
        }
    ],
    "55031628e9bde69634000024": [
        {
            "text": "Pheochromocytoma",
            "probability": 0.8766634134901817,
            "start_logit": 2.4309678077697754,
            "end_logit": 3.790203094482422,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Pheochromocytomas",
            "probability": 0.11549026456795423,
            "start_logit": 2.4309678077697754,
            "end_logit": 1.7632662057876587,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "P",
            "probability": 0.0024632895724696,
            "start_logit": 2.4309678077697754,
            "end_logit": -2.0844223499298096,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Pheochromocytomas are neuroendocrine tumors of the adrenal medulla",
            "probability": 0.0020081769458350327,
            "start_logit": 2.4309678077697754,
            "end_logit": -2.2886927127838135,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "oma",
            "probability": 0.0019178310569205178,
            "start_logit": -3.693960428237915,
            "end_logit": 3.790203094482422,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Pheochromocytomas are neuroendocrine tumors of the adrenal medulla which",
            "probability": 0.0003172694150690159,
            "start_logit": 2.4309678077697754,
            "end_logit": -4.1339240074157715,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "omas",
            "probability": 0.0002526520586488129,
            "start_logit": -3.693960428237915,
            "end_logit": 1.7632662057876587,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "pheochromocytoma",
            "probability": 0.0002233794448677718,
            "start_logit": -1.4036448001861572,
            "end_logit": -0.6501908302307129,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "s",
            "probability": 0.00015279631582619833,
            "start_logit": -4.196867942810059,
            "end_logit": 1.7632662057876587,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Pheochromocytomas are",
            "probability": 0.00012399070771300122,
            "start_logit": 2.4309678077697754,
            "end_logit": -5.0734686851501465,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Pheochromocytomas are neuroendocrine tumors of the adrenal medulla which can occur either sporadically",
            "probability": 0.00011689919599657602,
            "start_logit": 2.4309678077697754,
            "end_logit": -5.132363319396973,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Pheochromocytomas are neuroendocrine tumors",
            "probability": 0.00010564331792791287,
            "start_logit": 2.4309678077697754,
            "end_logit": -5.233606815338135,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "Pheochromocytomas are neuroendocrine tumors of the adrenal medulla which can",
            "probability": 8.781678110828266e-05,
            "start_logit": 2.4309678077697754,
            "end_logit": -5.418422698974609,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "hereditary tumor syndromes. Whereas the genetic background of hereditary pheochromocytoma",
            "probability": 2.9881110505385865e-05,
            "start_logit": -3.813366174697876,
            "end_logit": -0.25211480259895325,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "can occur either sporadically or in the context of hereditary tumor syndromes. Whereas the genetic background of hereditary pheochromocytoma",
            "probability": 1.656833200601686e-05,
            "start_logit": -4.403099536895752,
            "end_logit": -0.25211480259895325,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "occur either sporadically or in the context of hereditary tumor syndromes. Whereas the genetic background of hereditary pheochromocytoma",
            "probability": 7.877342068364307e-06,
            "start_logit": -5.146602153778076,
            "end_logit": -0.25211480259895325,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "which can occur either sporadically or in the context of hereditary tumor syndromes. Whereas the genetic background of hereditary pheochromocytoma",
            "probability": 6.252247557743299e-06,
            "start_logit": -5.377651691436768,
            "end_logit": -0.25211480259895325,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "in the context of hereditary tumor syndromes. Whereas the genetic background of hereditary pheochromocytoma",
            "probability": 5.685558123960069e-06,
            "start_logit": -5.472663402557373,
            "end_logit": -0.25211480259895325,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": ". Whereas the genetic background of hereditary pheochromocytoma",
            "probability": 5.203726038719403e-06,
            "start_logit": -5.561217784881592,
            "end_logit": -0.25211480259895325,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        },
        {
            "text": "pheochromocytoma or paraganglioma",
            "probability": 5.108813181064199e-06,
            "start_logit": -2.4953866004943848,
            "end_logit": -3.3363537788391113,
            "question_text": "Which neuroendocrine tumors are associated with specific tumor syndromes?"
        }
    ],
    "530cefaaad0bf1360c00000c": [
        {
            "text": "vincristine",
            "probability": 0.1388827671351217,
            "start_logit": 4.862227916717529,
            "end_logit": 4.471604347229004,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "vincristine, adriamycin",
            "probability": 0.1380131922101224,
            "start_logit": 4.862227916717529,
            "end_logit": 4.465323448181152,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "adriamycin",
            "probability": 0.09916335739450108,
            "start_logit": 4.531647205352783,
            "end_logit": 4.465323448181152,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "vincristine, adriamycin, and dexamethasone",
            "probability": 0.08342384406697542,
            "start_logit": 4.862227916717529,
            "end_logit": 3.9619083404541016,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "adriamycin, and dexamethasone",
            "probability": 0.05994056315893163,
            "start_logit": 4.531647205352783,
            "end_logit": 3.9619083404541016,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "fludarabine, cyclophosphamide, and rituximab",
            "probability": 0.055536869424213195,
            "start_logit": 4.2713212966918945,
            "end_logit": 4.145927906036377,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "rituximab",
            "probability": 0.047726386612588885,
            "start_logit": 3.983377456665039,
            "end_logit": 4.282309055328369,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "dexamethasone",
            "probability": 0.04487581450073398,
            "start_logit": 4.24219274520874,
            "end_logit": 3.9619083404541016,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "fludarabine",
            "probability": 0.03499975953589788,
            "start_logit": 4.2713212966918945,
            "end_logit": 3.6842219829559326,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "cyclophosphamide, and rituximab",
            "probability": 0.034991974896544584,
            "start_logit": 3.8093929290771484,
            "end_logit": 4.145927906036377,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "pentostatin (6), fludarabine, cyclophosphamide, and rituximab",
            "probability": 0.033112181705274635,
            "start_logit": 3.7541754245758057,
            "end_logit": 4.145927906036377,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "dexamethasone (hyper-CVAD) (4). Seven of 20 patients enrolled on the valaciclovir",
            "probability": 0.029491864663058105,
            "start_logit": 4.24219274520874,
            "end_logit": 3.542123794555664,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "fludarabine, cyclophosphamide",
            "probability": 0.029322809734811956,
            "start_logit": 4.2713212966918945,
            "end_logit": 3.507246494293213,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "rituximab (2), pentostatin",
            "probability": 0.028643540749757862,
            "start_logit": 3.983377456665039,
            "end_logit": 3.7717525959014893,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "rituximab (23), or fractionated cyclophosphamide, vincristine",
            "probability": 0.026756902141139068,
            "start_logit": 3.866375207901001,
            "end_logit": 3.8206193447113037,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "rituximab (2), pentostatin (6), fludarabine",
            "probability": 0.02624294919955704,
            "start_logit": 3.983377456665039,
            "end_logit": 3.6842219829559326,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "alemtuzumab-containing regimens, including single agent (5) or combined with: rituximab",
            "probability": 0.02324489845007373,
            "start_logit": 3.2639787197113037,
            "end_logit": 4.282309055328369,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "pentostatin",
            "probability": 0.02277642322566523,
            "start_logit": 3.7541754245758057,
            "end_logit": 3.7717525959014893,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "rituximab (2), pentostatin (6), fludarabine, cyclophosphamide",
            "probability": 0.02198635123391872,
            "start_logit": 3.983377456665039,
            "end_logit": 3.507246494293213,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        },
        {
            "text": "pentostatin (6), fludarabine",
            "probability": 0.020867549961112845,
            "start_logit": 3.7541754245758057,
            "end_logit": 3.6842219829559326,
            "question_text": "List medication interfering with purine metabolism that are used for treatment of T-cell prolymphocytic leukemia?"
        }
    ],
    "54d670163706e8952800000f": [
        {
            "text": "melatonin receptor 1B",
            "probability": 0.7956676428052311,
            "start_logit": 3.9583981037139893,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "melatonin receptor",
            "probability": 0.0562400127469151,
            "start_logit": 3.9583981037139893,
            "end_logit": 0.45728203654289246,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "melatonin receptor 1B gene",
            "probability": 0.023597258410499627,
            "start_logit": 3.9583981037139893,
            "end_logit": -0.4112159013748169,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "melatonin",
            "probability": 0.022734067037393415,
            "start_logit": 3.9583981037139893,
            "end_logit": -0.44848188757896423,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "melatonin receptor 1B gene polymorphism",
            "probability": 0.018612185317352467,
            "start_logit": 3.9583981037139893,
            "end_logit": -0.6485299468040466,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "melatonin receptor 1B gene polymorphism by",
            "probability": 0.01254538230017818,
            "start_logit": 3.9583981037139893,
            "end_logit": -1.0429937839508057,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "1B",
            "probability": 0.009790215546579004,
            "start_logit": -0.43939998745918274,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "study to comprehensively investigate variations of melatonin receptor 1B",
            "probability": 0.00848200982053564,
            "start_logit": -0.5828360319137573,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "me",
            "probability": 0.008211818180015311,
            "start_logit": 3.9583981037139893,
            "end_logit": -1.4667720794677734,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "A genetic association study to comprehensively investigate variations of melatonin receptor 1B",
            "probability": 0.007970743356713366,
            "start_logit": -0.6450057029724121,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "melatonin receptor 1B gene polymorphism by a set of tagging single nucleotide polymorphisms",
            "probability": 0.007177280504240617,
            "start_logit": 3.9583981037139893,
            "end_logit": -1.6014258861541748,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "to comprehensively investigate variations of melatonin receptor 1B",
            "probability": 0.0064391479724418815,
            "start_logit": -0.8583872318267822,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "genetic association study to comprehensively investigate variations of melatonin receptor 1B",
            "probability": 0.006329316813077189,
            "start_logit": -0.8755911588668823,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "comprehensively investigate variations of melatonin receptor 1B",
            "probability": 0.0035306382120003604,
            "start_logit": -1.4593048095703125,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "variations of melatonin receptor 1B",
            "probability": 0.0032890353142985005,
            "start_logit": -1.5301891565322876,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "investigate variations of melatonin receptor 1B",
            "probability": 0.0032836117859965227,
            "start_logit": -1.5318394899368286,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "association study to comprehensively investigate variations of melatonin receptor 1B",
            "probability": 0.002549715081014577,
            "start_logit": -1.7848018407821655,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "receptor 1B",
            "probability": 0.002386992218349202,
            "start_logit": -1.8507493734359741,
            "end_logit": 3.106835126876831,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "study to comprehensively investigate variations of melatonin receptor",
            "probability": 0.000599532159865842,
            "start_logit": -0.5828360319137573,
            "end_logit": 0.45728203654289246,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        },
        {
            "text": "A genetic association study to comprehensively investigate variations of melatonin receptor",
            "probability": 0.000563394417301547,
            "start_logit": -0.6450057029724121,
            "end_logit": 0.45728203654289246,
            "question_text": "List Genes associated with adolescent idiopathic scoliosis"
        }
    ],
    "5324cf139b2d7acc7e00001f": [
        {
            "text": "hot flashes",
            "probability": 0.809899723425769,
            "start_logit": 0.8570939302444458,
            "end_logit": 1.4307774305343628,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "vasomotor dysregulation (hot flashes",
            "probability": 0.052011412400413196,
            "start_logit": -1.8148952722549438,
            "end_logit": 1.3573193550109863,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "hot flashes has prompted the off-label use of serotonergic and \u03b3-aminobutyric acid-ergic drugs",
            "probability": 0.03508225925790504,
            "start_logit": 0.8570939302444458,
            "end_logit": -1.708437442779541,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "hot flashes)",
            "probability": 0.02588942710981536,
            "start_logit": 0.2902582883834839,
            "end_logit": -1.445462703704834,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "flashes",
            "probability": 0.020906983258905464,
            "start_logit": -2.7262752056121826,
            "end_logit": 1.3573193550109863,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "symptoms of vasomotor dysregulation (hot flashes",
            "probability": 0.01443914492918363,
            "start_logit": -3.0964155197143555,
            "end_logit": 1.3573193550109863,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "Estrogen supplementation is considered a reliable therapeutic approach to symptoms of vasomotor dysregulation (hot flashes",
            "probability": 0.006641412548137467,
            "start_logit": -3.8730337619781494,
            "end_logit": 1.3573193550109863,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "hot flashes has prompted the off-label use of serotonergic",
            "probability": 0.0045740729378331325,
            "start_logit": 0.8570939302444458,
            "end_logit": -3.7457289695739746,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "sex hormone deprivation. Implication of changes in central neurotransmission in the pathogenesis of hot flashes",
            "probability": 0.0036539881822981817,
            "start_logit": -4.543997287750244,
            "end_logit": 1.4307774305343628,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "hot flashes has prompted the off-label use of serotonergic and \u03b3-aminobutyric acid-ergic drugs as a therapeutic alternative",
            "probability": 0.0034704932485251604,
            "start_logit": 0.8570939302444458,
            "end_logit": -4.021836280822754,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "hot flashes) associated with the menopausal transition",
            "probability": 0.0033721985063742753,
            "start_logit": 0.2902582883834839,
            "end_logit": -3.4837324619293213,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "hot flashes) associated with the menopausal transition and sex hormone deprivation",
            "probability": 0.0033542450255297984,
            "start_logit": 0.2902582883834839,
            "end_logit": -3.4890706539154053,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "vasomotor dysregulation (hot flashes)",
            "probability": 0.003154030330535191,
            "start_logit": -1.8148952722549438,
            "end_logit": -1.445462703704834,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "hot flashes has prompted the off-label use",
            "probability": 0.003018123915458106,
            "start_logit": 0.8570939302444458,
            "end_logit": -4.161497592926025,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "changes in central neurotransmission in the pathogenesis of hot flashes",
            "probability": 0.002763788704437983,
            "start_logit": -4.823214054107666,
            "end_logit": 1.4307774305343628,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "supplementation is considered a reliable therapeutic approach to symptoms of vasomotor dysregulation (hot flashes",
            "probability": 0.0026678330710188693,
            "start_logit": -4.785091876983643,
            "end_logit": 1.3573193550109863,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "vasomotor dysregulation",
            "probability": 0.0021735880646955386,
            "start_logit": -1.8148952722549438,
            "end_logit": -1.8177645206451416,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "flashes)",
            "probability": 0.0012678228926168412,
            "start_logit": -2.7262752056121826,
            "end_logit": -1.445462703704834,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "symptoms of vasomotor dysregulation (hot flashes)",
            "probability": 0.0008756059286187886,
            "start_logit": -3.0964155197143555,
            "end_logit": -1.445462703704834,
            "question_text": "List the off-label use of SSRIs"
        },
        {
            "text": "flashes has prompted the off-label use of serotonergic and \u03b3-aminobutyric acid-ergic drugs",
            "probability": 0.0007838462619289743,
            "start_logit": -2.9441440105438232,
            "end_logit": -1.708437442779541,
            "question_text": "List the off-label use of SSRIs"
        }
    ],
    "54cf705ff693c3b16b000014": [
        {
            "text": "\u03b1(v)\u03b2(3)",
            "probability": 0.28767409894056023,
            "start_logit": 3.3276567459106445,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrin \u03b1(v)\u03b2(3)",
            "probability": 0.2624138619001251,
            "start_logit": 3.2357513904571533,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrin",
            "probability": 0.14930047712858205,
            "start_logit": 3.2357513904571533,
            "end_logit": 2.768728733062744,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1(v)\u03b2(3",
            "probability": 0.11668739893532167,
            "start_logit": 3.3276567459106445,
            "end_logit": 2.430361032485962,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrin \u03b1(v)\u03b2(3",
            "probability": 0.10644125106315237,
            "start_logit": 3.2357513904571533,
            "end_logit": 2.430361032485962,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b2(3)",
            "probability": 0.02424305004177362,
            "start_logit": 0.8539584875106812,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b2(3",
            "probability": 0.009833552836530857,
            "start_logit": 0.8539584875106812,
            "end_logit": 2.430361032485962,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "extracellular segment of integrin \u03b1(v)\u03b2(3)",
            "probability": 0.008383892490006362,
            "start_logit": -0.20785918831825256,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "3)",
            "probability": 0.00736929959705611,
            "start_logit": -0.33684882521629333,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "extracellular segment of integrin",
            "probability": 0.00477001915938835,
            "start_logit": -0.20785918831825256,
            "end_logit": 2.768728733062744,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "crystal structure of the extracellular segment of integrin \u03b1(v)\u03b2(3)",
            "probability": 0.003915491174127512,
            "start_logit": -0.9692307114601135,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "extracellular segment of integrin \u03b1(v)\u03b2(3",
            "probability": 0.00340070451672591,
            "start_logit": -0.20785918831825256,
            "end_logit": 2.430361032485962,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "3",
            "probability": 0.0029891617115424297,
            "start_logit": -0.33684882521629333,
            "end_logit": 2.430361032485962,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "the extracellular segment of integrin \u03b1(v)\u03b2(3)",
            "probability": 0.0023163528764055938,
            "start_logit": -1.4941775798797607,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "crystal structure of the extracellular segment of integrin",
            "probability": 0.002227720350811661,
            "start_logit": -0.9692307114601135,
            "end_logit": 2.768728733062744,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "\u03b1(v)\u03b2(3) complexed with the cyclic pentapeptide, Cilengitide",
            "probability": 0.0018956331709092087,
            "start_logit": 3.3276567459106445,
            "end_logit": -1.6895846128463745,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "integrin \u03b1(v)\u03b2(3) complexed with the cyclic pentapeptide, Cilengitide",
            "probability": 0.0017291804265876834,
            "start_logit": 3.2357513904571533,
            "end_logit": -1.6895846128463745,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "crystal structure of the extracellular segment of integrin \u03b1(v)\u03b2(3",
            "probability": 0.0015882155617963757,
            "start_logit": -0.9692307114601135,
            "end_logit": 2.430361032485962,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "v)\u03b2(3)",
            "probability": 0.0014963198473631112,
            "start_logit": -1.9311628341674805,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        },
        {
            "text": "rin \u03b1(v)\u03b2(3)",
            "probability": 0.0013243182712336285,
            "start_logit": -2.0532736778259277,
            "end_logit": 3.332690715789795,
            "question_text": "List receptors of the drug Cilengitide"
        }
    ],
    "5171a1498ed59a060a000012": [
        {
            "text": "BCL6",
            "probability": 0.9693952336121805,
            "start_logit": 3.000796318054199,
            "end_logit": 2.0285041332244873,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "BCL6, but high levels of BCL6",
            "probability": 0.010715334576459231,
            "start_logit": 0.7201370000839233,
            "end_logit": -0.19583310186862946,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "BCL6 gene",
            "probability": 0.005829419468625848,
            "start_logit": 2.554863452911377,
            "end_logit": -2.6393179893493652,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "BCL6/ immunoglobulin variable heavy chain (IGHV) genes, and expression of BCL6",
            "probability": 0.00453377509188991,
            "start_logit": 0.23989126086235046,
            "end_logit": -0.575708270072937,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "B",
            "probability": 0.0024456900260123532,
            "start_logit": 3.000796318054199,
            "end_logit": -3.953840970993042,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "BCL6 which occur exclusively in IGHV mutated cases.",
            "probability": 0.0021474578546827323,
            "start_logit": 2.717804431915283,
            "end_logit": -3.800891637802124,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "6",
            "probability": 0.0014016611474077863,
            "start_logit": -3.5382180213928223,
            "end_logit": 2.0285041332244873,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "BCL6 which occur exclusively in IGHV mutated cases",
            "probability": 0.001257726997022606,
            "start_logit": 2.717804431915283,
            "end_logit": -4.335870265960693,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "BCL6 which occur exclusively in IGHV mutated",
            "probability": 0.0007321048232729149,
            "start_logit": 2.717804431915283,
            "end_logit": -4.877007961273193,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "29% show somatic mutations on BCL6",
            "probability": 0.0005213502525038982,
            "start_logit": -4.6911234855651855,
            "end_logit": 2.192418336868286,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "the BCL6",
            "probability": 0.00030116472671999384,
            "start_logit": -4.661448955535889,
            "end_logit": 1.6139791011810303,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "Out of 68 cases, 29% show somatic mutations on BCL6",
            "probability": 0.00029807689746567896,
            "start_logit": -5.250194072723389,
            "end_logit": 2.192418336868286,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "BCL6 was determined by real time PCR and immunoblot. Out of 68 cases,",
            "probability": 0.00013358449339007664,
            "start_logit": -0.20997977256774902,
            "end_logit": -3.6504132747650146,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "BCL6,",
            "probability": 0.00011970912706918056,
            "start_logit": 0.7201370000839233,
            "end_logit": -4.690199375152588,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "immunoglobulin variable heavy chain (IGHV) genes, and expression of BCL6",
            "probability": 7.357381754140267e-05,
            "start_logit": -3.881129741668701,
            "end_logit": -0.575708270072937,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "two short mutational hot spots. CLL cells express different levels of BCL6",
            "probability": 3.7911056199842404e-05,
            "start_logit": -5.099557399749756,
            "end_logit": -0.020327044650912285,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "single nucleotide substitutions located mainly in two short mutational hot spots. CLL cells express different levels of BCL6",
            "probability": 3.539540656872313e-05,
            "start_logit": -5.16821813583374,
            "end_logit": -0.020327044650912285,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "IGHV mutated cases.",
            "probability": 9.526980096699984e-06,
            "start_logit": -2.7001078128814697,
            "end_logit": -3.800891637802124,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "6 gene",
            "probability": 5.723865971128551e-06,
            "start_logit": -4.371164798736572,
            "end_logit": -2.6393179893493652,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        },
        {
            "text": "IGHV mutated cases",
            "probability": 5.579778919333853e-06,
            "start_logit": -2.7001078128814697,
            "end_logit": -4.335870265960693,
            "question_text": "Which genes are more frequently affected by somatic mutations in Chronic Lymphocytic Leukemia"
        }
    ],
    "54d77bdf3706e89528000019": [
        {
            "text": "5",
            "probability": 0.35147050748486686,
            "start_logit": 1.1149835586547852,
            "end_logit": 1.1119078397750854,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q?15 to 5q?22",
            "probability": 0.16536538410710047,
            "start_logit": 1.1149835586547852,
            "end_logit": 0.3579395115375519,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q?15 to 5",
            "probability": 0.1572685098618114,
            "start_logit": 1.1149835586547852,
            "end_logit": 0.3077366352081299,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q?22",
            "probability": 0.11779033180949548,
            "start_logit": 0.7757322788238525,
            "end_logit": 0.3579395115375519,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q?15",
            "probability": 0.05731445494930591,
            "start_logit": 1.1149835586547852,
            "end_logit": -0.7016651034355164,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q15 to 5",
            "probability": 0.032328259387472094,
            "start_logit": 0.21878571808338165,
            "end_logit": -0.3780783712863922,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "22",
            "probability": 0.027438511160384066,
            "start_logit": -0.681226372718811,
            "end_logit": 0.3579395115375519,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q15",
            "probability": 0.018685586273557087,
            "start_logit": 0.21878571808338165,
            "end_logit": -0.926267683506012,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q15 to 5q22",
            "probability": 0.011593730652383866,
            "start_logit": 0.21878571808338165,
            "end_logit": -1.4035556316375732,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "15 to 5q?22",
            "probability": 0.010170408790209633,
            "start_logit": -1.6736915111541748,
            "end_logit": 0.3579395115375519,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "15 to 5",
            "probability": 0.00967242959436913,
            "start_logit": -1.6736915111541748,
            "end_logit": 0.3077366352081299,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q22",
            "probability": 0.008376500162541684,
            "start_logit": -0.10624858736991882,
            "end_logit": -1.4035556316375732,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q",
            "probability": 0.006519857158782957,
            "start_logit": 1.1149835586547852,
            "end_logit": -2.8753654956817627,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "FISH studies using BAC clones spanning the 5",
            "probability": 0.005281850130815347,
            "start_logit": -2.1134276390075684,
            "end_logit": 0.14246967434883118,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q?15 to 5q?22 identified by standard karyotype analysis",
            "probability": 0.004014270639056488,
            "start_logit": 1.1149835586547852,
            "end_logit": -3.3603622913360596,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "interstitial deletion of the region 5",
            "probability": 0.003593585373567727,
            "start_logit": -3.467991828918457,
            "end_logit": 1.1119078397750854,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "BAC clones spanning the 5",
            "probability": 0.0035930050607572016,
            "start_logit": -2.4987151622772217,
            "end_logit": 0.14246967434883118,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "15",
            "probability": 0.0035249906718383497,
            "start_logit": -1.6736915111541748,
            "end_logit": -0.7016651034355164,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "FISH studies using BAC clones spanning the 5q15 to 5",
            "probability": 0.003138447949959591,
            "start_logit": -2.1134276390075684,
            "end_logit": -0.3780783712863922,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        },
        {
            "text": "5q?22 identified by standard karyotype analysis",
            "probability": 0.0028593787817245866,
            "start_logit": 0.7757322788238525,
            "end_logit": -3.3603622913360596,
            "question_text": "List chromosomes that have been linked to Arnold Chiari syndrome in the literature."
        }
    ],
    "56be0a18ef6e394741000006": [
        {
            "text": "pleural effusion",
            "probability": 0.22464163382597097,
            "start_logit": 5.098384380340576,
            "end_logit": 5.670435428619385,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites, and pleural effusion",
            "probability": 0.20201509358347713,
            "start_logit": 4.992220401763916,
            "end_logit": 5.670435428619385,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites",
            "probability": 0.16824455770568741,
            "start_logit": 4.992220401763916,
            "end_logit": 5.48751163482666,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ovarian tumor, ascites, and pleural effusion",
            "probability": 0.07876576133752324,
            "start_logit": 4.050356388092041,
            "end_logit": 5.670435428619385,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ovarian tumor, ascites",
            "probability": 0.06559861663557999,
            "start_logit": 4.050356388092041,
            "end_logit": 5.48751163482666,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "solid ovarian tumor, ascites, and pleural effusion",
            "probability": 0.05069483967438091,
            "start_logit": 3.6097021102905273,
            "end_logit": 5.670435428619385,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "benign solid ovarian tumor, ascites, and pleural effusion",
            "probability": 0.04404442948292152,
            "start_logit": 3.4690768718719482,
            "end_logit": 5.670435428619385,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "solid ovarian tumor, ascites",
            "probability": 0.04222026546473135,
            "start_logit": 3.6097021102905273,
            "end_logit": 5.48751163482666,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "benign solid ovarian tumor, ascites",
            "probability": 0.036681593569598284,
            "start_logit": 3.4690768718719482,
            "end_logit": 5.48751163482666,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ovarian tumor",
            "probability": 0.03305053565556299,
            "start_logit": 4.050356388092041,
            "end_logit": 4.801994800567627,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "solid ovarian tumor",
            "probability": 0.021271826460629768,
            "start_logit": 3.6097021102905273,
            "end_logit": 4.801994800567627,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "benign solid ovarian tumor",
            "probability": 0.018481278696924754,
            "start_logit": 3.4690768718719482,
            "end_logit": 4.801994800567627,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ascites,",
            "probability": 0.00543622514980638,
            "start_logit": 4.992220401763916,
            "end_logit": 2.055177927017212,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ovarian tumor, ascites,",
            "probability": 0.002119586240469472,
            "start_logit": 4.050356388092041,
            "end_logit": 2.055177927017212,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "solid ovarian tumor, ascites,",
            "probability": 0.00136419788004302,
            "start_logit": 3.6097021102905273,
            "end_logit": 2.055177927017212,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "benign solid ovarian tumor, ascites,",
            "probability": 0.00118523537532106,
            "start_logit": 3.4690768718719482,
            "end_logit": 2.055177927017212,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "triad of benign solid ovarian tumor, ascites, and pleural effusion",
            "probability": 0.0011663253197089934,
            "start_logit": -0.16226395964622498,
            "end_logit": 5.670435428619385,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "pleural effusion.",
            "probability": 0.0010381050826573336,
            "start_logit": 5.098384380340576,
            "end_logit": 0.2933260500431061,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "ovarian tumor,",
            "probability": 0.0010085402532442954,
            "start_logit": 4.050356388092041,
            "end_logit": 1.312461018562317,
            "question_text": "List symptoms of Meigs' Syndrome."
        },
        {
            "text": "triad of benign solid ovarian tumor, ascites",
            "probability": 0.0009713526057611054,
            "start_logit": -0.16226395964622498,
            "end_logit": 5.48751163482666,
            "question_text": "List symptoms of Meigs' Syndrome."
        }
    ],
    "5311b99ae3eabad021000004": [
        {
            "text": "vancomycin",
            "probability": 0.6584436666621271,
            "start_logit": 2.9442665576934814,
            "end_logit": 1.7736170291900635,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated acute kidney injury",
            "probability": 0.22360772553080208,
            "start_logit": 2.9442665576934814,
            "end_logit": 0.6936313509941101,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated acute kidney injury (AKI) in critically ill children.",
            "probability": 0.04188062724928561,
            "start_logit": 2.9442665576934814,
            "end_logit": -0.9814385771751404,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated acute kidney injury (AKI)",
            "probability": 0.019942150322311652,
            "start_logit": 2.9442665576934814,
            "end_logit": -1.723426342010498,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "acute kidney injury",
            "probability": 0.011247273792616882,
            "start_logit": -0.04550096392631531,
            "end_logit": 0.6936313509941101,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated",
            "probability": 0.006291394151978246,
            "start_logit": 2.9442665576934814,
            "end_logit": -2.8770792484283447,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated acute kidney injury (AKI) in critically ill children",
            "probability": 0.006164430510012464,
            "start_logit": 2.9442665576934814,
            "end_logit": -2.8974661827087402,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated acute",
            "probability": 0.005927261556746306,
            "start_logit": 2.9442665576934814,
            "end_logit": -2.936699628829956,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated acute kidney injury (AKI",
            "probability": 0.003436923633822759,
            "start_logit": 2.9442665576934814,
            "end_logit": -3.481685161590576,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated acute kidney",
            "probability": 0.0033130244711253106,
            "start_logit": 2.9442665576934814,
            "end_logit": -3.5184004306793213,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "van",
            "probability": 0.0032081602797487626,
            "start_logit": 2.9442665576934814,
            "end_logit": -3.5505642890930176,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "To determine the rate, risk factors, and outcome of vancomycin",
            "probability": 0.0029629454648770442,
            "start_logit": -2.459428548812866,
            "end_logit": 1.7736170291900635,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "kidney injury",
            "probability": 0.002927374991928518,
            "start_logit": -1.391520619392395,
            "end_logit": 0.6936313509941101,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-associated acute kidney injury (AKI) in critically ill",
            "probability": 0.0028309613412777577,
            "start_logit": 2.9442665576934814,
            "end_logit": -3.675645589828491,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "vancomycin-",
            "probability": 0.002127394325574318,
            "start_logit": 2.9442665576934814,
            "end_logit": -3.9613640308380127,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "acute kidney injury (AKI) in critically ill children.",
            "probability": 0.0021065590652607396,
            "start_logit": -0.04550096392631531,
            "end_logit": -0.9814385771751404,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "To determine the rate, risk factors, and outcome of vancomycin-associated acute kidney injury",
            "probability": 0.0010062174333479229,
            "start_logit": -2.459428548812866,
            "end_logit": 0.6936313509941101,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "acute kidney injury (AKI)",
            "probability": 0.0010030727880985732,
            "start_logit": -0.04550096392631531,
            "end_logit": -1.723426342010498,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "injury",
            "probability": 0.0008138693021667526,
            "start_logit": -2.6715822219848633,
            "end_logit": 0.6936313509941101,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        },
        {
            "text": "determine the rate, risk factors, and outcome of vancomycin",
            "probability": 0.0007589671268914753,
            "start_logit": -3.821409225463867,
            "end_logit": 1.7736170291900635,
            "question_text": "Which medical diagnostic tests are used to test kidney function?"
        }
    ],
    "5131fa145274a5fb07000009": [
        {
            "text": "cystic fibrosis",
            "probability": 0.8009446171502875,
            "start_logit": 6.416309833526611,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fibrosis. Based on the long experience of a region where cystic fibrosis",
            "probability": 0.1950788731823957,
            "start_logit": 6.416309833526611,
            "end_logit": 4.619802951812744,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "fibrosis",
            "probability": 0.0007657622925743278,
            "start_logit": -0.5363654494285583,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "pathologies, including cystic fibrosis",
            "probability": 0.0007499622922699463,
            "start_logit": -0.5572143197059631,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fibrosis.",
            "probability": 0.0005265881744521087,
            "start_logit": 6.416309833526611,
            "end_logit": -1.2949374914169312,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "various pathologies, including cystic fibrosis",
            "probability": 0.000500676826464382,
            "start_logit": -0.9612764120101929,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "fibrosis. Based on the long experience of a region where cystic fibrosis",
            "probability": 0.00018650983096992063,
            "start_logit": -0.5363654494285583,
            "end_logit": 4.619802951812744,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "pathologies, including cystic fibrosis. Based on the long experience of a region where cystic fibrosis",
            "probability": 0.0001826615670704431,
            "start_logit": -0.5572143197059631,
            "end_logit": 4.619802951812744,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fi",
            "probability": 0.00013092513333430665,
            "start_logit": 6.416309833526611,
            "end_logit": -2.6867306232452393,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "c",
            "probability": 0.00012532216857447087,
            "start_logit": 6.416309833526611,
            "end_logit": -2.730468511581421,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "various pathologies, including cystic fibrosis. Based on the long experience of a region where cystic fibrosis",
            "probability": 0.00012194534933353906,
            "start_logit": -0.9612764120101929,
            "end_logit": 4.619802951812744,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "a sign associated with various pathologies, including cystic fibrosis",
            "probability": 0.00011538419518845541,
            "start_logit": -2.4289698600769043,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fibro",
            "probability": 0.00011274913909841673,
            "start_logit": 6.416309833526611,
            "end_logit": -2.836190938949585,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "sis",
            "probability": 0.00010819989983490623,
            "start_logit": -2.4932568073272705,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic",
            "probability": 8.58983851868759e-05,
            "start_logit": 6.416309833526611,
            "end_logit": -3.1081912517547607,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "associated with various pathologies, including cystic fibrosis",
            "probability": 7.629888768909166e-05,
            "start_logit": -2.842578887939453,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "cystic fibrosis in utero.",
            "probability": 6.973700146066201e-05,
            "start_logit": 4.322903156280518,
            "end_logit": -1.223218560218811,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "brosis",
            "probability": 4.126852653812847e-05,
            "start_logit": -3.457137107849121,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "ystic fibrosis",
            "probability": 3.9650176912525036e-05,
            "start_logit": -3.4971418380737305,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        },
        {
            "text": "fetal echogenic bowel, a sign associated with various pathologies, including cystic fibrosis",
            "probability": 3.696982036452077e-05,
            "start_logit": -3.5671353340148926,
            "end_logit": 6.032190799713135,
            "question_text": "Which are the main causes of fetal echogenic bowel?"
        }
    ],
    "51630226298dcd4e5100004d": [
        {
            "text": "directly",
            "probability": 0.2715379730505185,
            "start_logit": 0.9601614475250244,
            "end_logit": -0.7872395515441895,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "directly probes the connectivity",
            "probability": 0.08748756589820582,
            "start_logit": 0.9601614475250244,
            "end_logit": -1.9198448657989502,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "quickly profiles global changes and directly",
            "probability": 0.08653790038712446,
            "start_logit": -0.1833580732345581,
            "end_logit": -0.7872395515441895,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "directly probes the connectivity of modifications",
            "probability": 0.08612288052315784,
            "start_logit": 0.9601614475250244,
            "end_logit": -1.9355664253234863,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "profiles global changes and directly",
            "probability": 0.0627869606415929,
            "start_logit": -0.504193127155304,
            "end_logit": -0.7872395515441895,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "quickly",
            "probability": 0.05680247202354986,
            "start_logit": -0.1833580732345581,
            "end_logit": -1.2082421779632568,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "both quickly profiles global changes and directly",
            "probability": 0.03838956818426517,
            "start_logit": -0.99615478515625,
            "end_logit": -0.7872395515441895,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "quickly profiles global changes",
            "probability": 0.037216097524917724,
            "start_logit": -0.1833580732345581,
            "end_logit": -1.6310806274414062,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "quickly profiles global changes and directly probes the connectivity",
            "probability": 0.02788188398755694,
            "start_logit": -0.1833580732345581,
            "end_logit": -1.9198448657989502,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "quickly profiles global changes and directly probes the connectivity of modifications",
            "probability": 0.02744696504889455,
            "start_logit": -0.1833580732345581,
            "end_logit": -1.9355664253234863,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "profiles global changes",
            "probability": 0.027001875941958447,
            "start_logit": -0.504193127155304,
            "end_logit": -1.6310806274414062,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "directly probe",
            "probability": 0.026460125877613764,
            "start_logit": 0.9601614475250244,
            "end_logit": -3.1157026290893555,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "quickly profiles",
            "probability": 0.026134403652325035,
            "start_logit": -0.1833580732345581,
            "end_logit": -1.9845694303512573,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "both quickly",
            "probability": 0.025198466371704652,
            "start_logit": -0.99615478515625,
            "end_logit": -1.2082421779632568,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "profiles global changes and directly probes the connectivity",
            "probability": 0.020229503428080203,
            "start_logit": -0.504193127155304,
            "end_logit": -1.9198448657989502,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "directly probes",
            "probability": 0.020110542204588036,
            "start_logit": 0.9601614475250244,
            "end_logit": -3.3900973796844482,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "profiles global changes and directly probes the connectivity of modifications",
            "probability": 0.01991395107284717,
            "start_logit": -0.504193127155304,
            "end_logit": -1.9355664253234863,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "profiles",
            "probability": 0.018961631448989668,
            "start_logit": -0.504193127155304,
            "end_logit": -1.9845694303512573,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "probes the connectivity",
            "probability": 0.017022379186034747,
            "start_logit": -0.6768063306808472,
            "end_logit": -1.9198448657989502,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        },
        {
            "text": "probes the connectivity of modifications",
            "probability": 0.0167568535460743,
            "start_logit": -0.6768063306808472,
            "end_logit": -1.9355664253234863,
            "question_text": "What are the advantages of the top down mass spectrometric analysis of histones?"
        }
    ],
    "5505eed08e1671127b000006": [
        {
            "text": "trypsin",
            "probability": 0.9687342615303267,
            "start_logit": 5.978844165802002,
            "end_logit": 4.961411952972412,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion",
            "probability": 0.021017551748293284,
            "start_logit": 5.978844165802002,
            "end_logit": 1.130779504776001,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin dig",
            "probability": 0.003647802184094286,
            "start_logit": 5.978844165802002,
            "end_logit": -0.6204535365104675,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "tryps",
            "probability": 0.002610865128670086,
            "start_logit": 5.978844165802002,
            "end_logit": -0.9548967480659485,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "try",
            "probability": 0.0020466393432903266,
            "start_logit": 5.978844165802002,
            "end_logit": -1.1983792781829834,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion by use of the Advion Biosciences Triversa Nanomate robotic platform.",
            "probability": 0.0005482302203984841,
            "start_logit": 5.978844165802002,
            "end_logit": -2.5156383514404297,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion by use of the Advion Biosciences Triversa Nanomate robotic platform",
            "probability": 0.0005260754288033586,
            "start_logit": 5.978844165802002,
            "end_logit": -2.556889057159424,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion by",
            "probability": 0.00020541563610054338,
            "start_logit": 5.978844165802002,
            "end_logit": -3.497298240661621,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion by use of the Advion Biosciences Triversa Nanomate robotic",
            "probability": 0.00010658748901469182,
            "start_logit": 5.978844165802002,
            "end_logit": -4.153367519378662,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digest",
            "probability": 0.00010067752514874926,
            "start_logit": 5.978844165802002,
            "end_logit": -4.210411071777344,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion by use of the Advion Biosciences Triversa",
            "probability": 7.989332678234622e-05,
            "start_logit": 5.978844165802002,
            "end_logit": -4.441641330718994,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion by use of the Advion Biosciences",
            "probability": 6.557083873421391e-05,
            "start_logit": 5.978844165802002,
            "end_logit": -4.63920259475708,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "psin",
            "probability": 5.7775188011254834e-05,
            "start_logit": -3.7483420372009277,
            "end_logit": 4.961411952972412,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "via trypsin",
            "probability": 5.764023006353442e-05,
            "start_logit": -3.750680685043335,
            "end_logit": 4.961411952972412,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "trypsin digestion by use of the Advion Biosciences Triversa Nanomate robotic platform. Liquid chromatography",
            "probability": 5.7201284109949586e-05,
            "start_logit": 5.978844165802002,
            "end_logit": -4.775757312774658,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "in",
            "probability": 4.6877042978982554e-05,
            "start_logit": -3.9573733806610107,
            "end_logit": 4.961411952972412,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "an automated and integrated method for extraction of endogenous proteins from the surface of dried blood spots and sample preparation via trypsin",
            "probability": 2.5816445107031902e-05,
            "start_logit": -4.553889751434326,
            "end_logit": 4.961411952972412,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "extraction of endogenous proteins from the surface of dried blood spots and sample preparation via trypsin",
            "probability": 2.531844990052986e-05,
            "start_logit": -4.573368072509766,
            "end_logit": 4.961411952972412,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "sample preparation via trypsin",
            "probability": 2.499615945117823e-05,
            "start_logit": -4.586179256439209,
            "end_logit": 4.961411952972412,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        },
        {
            "text": "digestion",
            "probability": 1.4804800720066196e-05,
            "start_logit": -1.2793174982070923,
            "end_logit": 1.130779504776001,
            "question_text": "List the main proteases used for sample digestion in proteomics."
        }
    ],
    "55451e53bf90a13052000003": [
        {
            "text": "Mfd",
            "probability": 0.581291071342761,
            "start_logit": 5.3437819480896,
            "end_logit": 4.8447980880737305,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd, at such lesions is not known: it has been suggested that Mfd",
            "probability": 0.3773919702935873,
            "start_logit": 5.3437819480896,
            "end_logit": 4.412830829620361,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd,",
            "probability": 0.020082756322252735,
            "start_logit": 5.3437819480896,
            "end_logit": 1.4794080257415771,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd-dependent transcription-coupled repair in Escherichia coli. We have investigated the effect of Mfd",
            "probability": 0.013788749993887097,
            "start_logit": 5.021673679351807,
            "end_logit": 1.4255077838897705,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "RNA polymerase, is subject to Mfd",
            "probability": 0.004183872672958786,
            "start_logit": 1.033468246459961,
            "end_logit": 4.221097469329834,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd may promote mutagenesis by increasing the efficiency with which RNA polymerase",
            "probability": 0.0021824929805461255,
            "start_logit": 4.949933052062988,
            "end_logit": -0.34613683819770813,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd may promote mutagenesis by increasing the efficiency with which RNA",
            "probability": 0.00040798297258611357,
            "start_logit": 4.949933052062988,
            "end_logit": -2.023134469985962,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "M",
            "probability": 0.00014495788738743944,
            "start_logit": 5.3437819480896,
            "end_logit": -3.451765537261963,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mf",
            "probability": 0.00012203253014926487,
            "start_logit": 5.3437819480896,
            "end_logit": -3.6239211559295654,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd, at such lesions is not known: it has been suggested that M",
            "probability": 9.225369251767474e-05,
            "start_logit": 5.3437819480896,
            "end_logit": -3.9036664962768555,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "Mfd, at such lesions is not known:",
            "probability": 8.919839645914544e-05,
            "start_logit": 5.3437819480896,
            "end_logit": -3.9373457431793213,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "d",
            "probability": 6.536412627168684e-05,
            "start_logit": -3.749251365661621,
            "end_logit": 4.8447980880737305,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "d, at such lesions is not known: it has been suggested that Mfd",
            "probability": 4.243639308480827e-05,
            "start_logit": -3.749251365661621,
            "end_logit": 4.412830829620361,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "transcription-repair coupling factor, Mfd",
            "probability": 2.4003582346398517e-05,
            "start_logit": -4.751021862030029,
            "end_logit": 4.8447980880737305,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "fd",
            "probability": 2.286366579975743e-05,
            "start_logit": -4.799675941467285,
            "end_logit": 4.8447980880737305,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "transcription-repair coupling factor, Mfd, at such lesions is not known: it has been suggested that Mfd",
            "probability": 1.5583860964673527e-05,
            "start_logit": -4.751021862030029,
            "end_logit": 4.412830829620361,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "RNA polymerase",
            "probability": 1.5009238187404556e-05,
            "start_logit": -0.029624128714203835,
            "end_logit": -0.34613683819770813,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": "fd, at such lesions is not known: it has been suggested that Mfd",
            "probability": 1.484379222335705e-05,
            "start_logit": -4.799675941467285,
            "end_logit": 4.412830829620361,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": ", Mfd",
            "probability": 1.367683547461407e-05,
            "start_logit": -5.313521385192871,
            "end_logit": 4.8447980880737305,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        },
        {
            "text": ", Mfd, at such lesions is not known: it has been suggested that Mfd",
            "probability": 8.879420554702302e-06,
            "start_logit": -5.313521385192871,
            "end_logit": 4.412830829620361,
            "question_text": "Which proteins act as factors that promote transcription-coupled repair in bacteria?"
        }
    ],
    "52eea509c8da89891000000d": [
        {
            "text": "KVLQT1",
            "probability": 0.33226686364021546,
            "start_logit": 4.409604072570801,
            "end_logit": 3.5939133167266846,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KVLQT1 (also known as KCNQ1 and KCNA9",
            "probability": 0.17527030000343663,
            "start_logit": 4.409604072570801,
            "end_logit": 2.9543042182922363,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KVLQT1 (also known as KCNQ1",
            "probability": 0.16448535821200794,
            "start_logit": 4.409604072570801,
            "end_logit": 2.890796422958374,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNA9",
            "probability": 0.11456684540489087,
            "start_logit": 3.984433174133301,
            "end_logit": 2.9543042182922363,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1 and KCNA9",
            "probability": 0.08290722363592551,
            "start_logit": 3.660996913909912,
            "end_logit": 2.9543042182922363,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1",
            "probability": 0.07780567716179451,
            "start_logit": 3.660996913909912,
            "end_logit": 2.890796422958374,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KVLQT1 (also known as KCNQ1 and KCNA9)",
            "probability": 0.008150494504106933,
            "start_logit": 4.409604072570801,
            "end_logit": -0.11394653469324112,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNA9) gene (R518X and A525T",
            "probability": 0.006971203118594854,
            "start_logit": 3.984433174133301,
            "end_logit": 0.15493358671665192,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KVLQT1 (also known as KCNQ1 and KCNA9) gene (R518X",
            "probability": 0.0053847782821408365,
            "start_logit": 4.409604072570801,
            "end_logit": -0.5284489989280701,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNA9)",
            "probability": 0.005327636478097673,
            "start_logit": 3.984433174133301,
            "end_logit": -0.11394653469324112,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1 and KCNA9) gene (R518X and A525T",
            "probability": 0.00504476747982564,
            "start_logit": 3.660996913909912,
            "end_logit": 0.15493358671665192,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1 and KCNA9)",
            "probability": 0.003855387196702041,
            "start_logit": 3.660996913909912,
            "end_logit": -0.11394653469324112,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNA9) gene (R518X",
            "probability": 0.003519803760121063,
            "start_logit": 3.984433174133301,
            "end_logit": -0.5284489989280701,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KVLQT1 (also known as KCNQ1 and KCNA9) gene",
            "probability": 0.003264444802267688,
            "start_logit": 4.409604072570801,
            "end_logit": -1.028935432434082,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1 and KCNA9) gene (R518X",
            "probability": 0.002547134438969818,
            "start_logit": 3.660996913909912,
            "end_logit": -0.5284489989280701,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNA9) gene (R518X and A525T)",
            "probability": 0.002272322327906315,
            "start_logit": 3.984433174133301,
            "end_logit": -0.9660518765449524,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNA9) gene",
            "probability": 0.0021338306774557276,
            "start_logit": 3.984433174133301,
            "end_logit": -1.028935432434082,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1 and KCNA9) gene (R518X and A525T)",
            "probability": 0.0016443844180822078,
            "start_logit": 3.660996913909912,
            "end_logit": -0.9660518765449524,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "KCNQ1 and KCNA9) gene",
            "probability": 0.0015441638159085433,
            "start_logit": 3.660996913909912,
            "end_logit": -1.028935432434082,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        },
        {
            "text": "A525T",
            "probability": 0.001037380641549793,
            "start_logit": 2.0793442726135254,
            "end_logit": 0.15493358671665192,
            "question_text": "Which genes are affected in ROMANO-WARD syndrome?"
        }
    ],
    "54e1252fae9738404b000003": [
        {
            "text": "dystrophic scarring and joint hypermobility",
            "probability": 0.19607737429949632,
            "start_logit": 5.731503009796143,
            "end_logit": 5.581024646759033,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic scarring and joint hypermobility",
            "probability": 0.17220976884452185,
            "start_logit": 5.6017069816589355,
            "end_logit": 5.581024646759033,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "dystrophic scarring",
            "probability": 0.17098128172836757,
            "start_logit": 5.731503009796143,
            "end_logit": 5.4440693855285645,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility",
            "probability": 0.15770299717207006,
            "start_logit": 5.6017069816589355,
            "end_logit": 5.493024826049805,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic scarring",
            "probability": 0.1501685092855606,
            "start_logit": 5.6017069816589355,
            "end_logit": 5.4440693855285645,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "joint hypermobility",
            "probability": 0.13135513682448666,
            "start_logit": 5.330898284912109,
            "end_logit": 5.581024646759033,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "dystrophic scarring and joint hypermobility.",
            "probability": 0.005077559295736315,
            "start_logit": 5.731503009796143,
            "end_logit": 1.9273459911346436,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic scarring and joint hypermobility.",
            "probability": 0.004459491135767164,
            "start_logit": 5.6017069816589355,
            "end_logit": 1.9273459911346436,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "joint hypermobility.",
            "probability": 0.0034015321676387888,
            "start_logit": 5.330898284912109,
            "end_logit": 1.9273459911346436,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "scarring and joint hypermobility",
            "probability": 0.0017322202978558479,
            "start_logit": 1.0023976564407349,
            "end_logit": 5.581024646759033,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "scarring",
            "probability": 0.0015105121017731232,
            "start_logit": 1.0023976564407349,
            "end_logit": 5.4440693855285645,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hyperextensibility, dystrophic scarring and joint hypermobility",
            "probability": 0.0011768448462663483,
            "start_logit": 0.615830659866333,
            "end_logit": 5.581024646759033,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hyperextensibility",
            "probability": 0.0010777086614073984,
            "start_logit": 0.615830659866333,
            "end_logit": 5.493024826049805,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hyperextensibility, dystrophic scarring",
            "probability": 0.0010262195774954378,
            "start_logit": 0.615830659866333,
            "end_logit": 5.4440693855285645,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility,",
            "probability": 0.0009310272111913326,
            "start_logit": 5.6017069816589355,
            "end_logit": 0.36084455251693726,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "hypermobility",
            "probability": 0.00044875608014407917,
            "start_logit": -0.348282128572464,
            "end_logit": 5.581024646759033,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "dystrophic",
            "probability": 0.00021163647747758917,
            "start_logit": 5.731503009796143,
            "end_logit": -1.250369906425476,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin hyperextensibility, dystrophic",
            "probability": 0.00018587493327922491,
            "start_logit": 5.6017069816589355,
            "end_logit": -1.250369906425476,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "skin",
            "probability": 0.00014446632205413252,
            "start_logit": 5.6017069816589355,
            "end_logit": -1.5023975372314453,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        },
        {
            "text": "dystrophic scarring and joint",
            "probability": 0.00012108273741003315,
            "start_logit": 5.731503009796143,
            "end_logit": -1.8087658882141113,
            "question_text": "What are the major clinical Villefranche criteria for classic Ehlers-Danlos syndrome?"
        }
    ],
    "517a8bef8ed59a060a000041": [
        {
            "text": "D1",
            "probability": 0.1929638455310715,
            "start_logit": 2.5120596885681152,
            "end_logit": 2.62341046333313,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D3",
            "probability": 0.1661536670887165,
            "start_logit": 2.688275098800659,
            "end_logit": 2.297605276107788,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D2, and D3",
            "probability": 0.13930944130653122,
            "start_logit": 2.5120596885681152,
            "end_logit": 2.297605276107788,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D2",
            "probability": 0.13765092291682443,
            "start_logit": 2.5120596885681152,
            "end_logit": 2.2856285572052,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D2, and D3",
            "probability": 0.13710956546210745,
            "start_logit": 2.4961423873901367,
            "end_logit": 2.297605276107788,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D2",
            "probability": 0.1354772372179416,
            "start_logit": 2.4961423873901367,
            "end_logit": 2.2856285572052,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinases D1",
            "probability": 0.031874345270238434,
            "start_logit": 0.7113583087921143,
            "end_logit": 2.62341046333313,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinases D1, D2, and D3",
            "probability": 0.02301155026936582,
            "start_logit": 0.7113583087921143,
            "end_logit": 2.297605276107788,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinases D1, D2",
            "probability": 0.02273759124017534,
            "start_logit": 0.7113583087921143,
            "end_logit": 2.2856285572052,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D",
            "probability": 0.0028059770560608156,
            "start_logit": 2.5120596885681152,
            "end_logit": -1.6073405742645264,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "deiodinases D1",
            "probability": 0.0020166806239148194,
            "start_logit": -2.048990249633789,
            "end_logit": 2.62341046333313,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "deiodinases D1, D2, and D3",
            "probability": 0.0014559341426787758,
            "start_logit": -2.048990249633789,
            "end_logit": 2.297605276107788,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "deiodinases D1, D2",
            "probability": 0.001438600833987073,
            "start_logit": -2.048990249633789,
            "end_logit": 2.2856285572052,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D",
            "probability": 0.0012375002939626336,
            "start_logit": 2.5120596885681152,
            "end_logit": -2.4259989261627197,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D2, and D",
            "probability": 0.0012028554563004287,
            "start_logit": 2.5120596885681152,
            "end_logit": -2.4543941020965576,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D2, and D",
            "probability": 0.0011838608164696208,
            "start_logit": 2.4961423873901367,
            "end_logit": -2.4543941020965576,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1,",
            "probability": 0.0009607665054633011,
            "start_logit": 2.5120596885681152,
            "end_logit": -2.6791162490844727,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D1, D2,",
            "probability": 0.0004768441339925001,
            "start_logit": 2.5120596885681152,
            "end_logit": -3.3796579837799072,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "D2,",
            "probability": 0.00046931414979267043,
            "start_logit": 2.4961423873901367,
            "end_logit": -3.3796579837799072,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        },
        {
            "text": "iodothyronine deiodinases D",
            "probability": 0.00046349968440511833,
            "start_logit": 0.7113583087921143,
            "end_logit": -1.6073405742645264,
            "question_text": "Which deiodinases are present in skeletal  muscle?"
        }
    ],
    "5148885ad24251bc05000032": [
        {
            "text": "ORM1",
            "probability": 0.9832908623415094,
            "start_logit": 3.3176536560058594,
            "end_logit": 2.873326063156128,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM1 rs17650 polymorphism",
            "probability": 0.0022893646084624834,
            "start_logit": 3.119987964630127,
            "end_logit": -2.9916388988494873,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM1 is a plasma drug binding protein. Its polymorphism rs17650",
            "probability": 0.0018641455535010612,
            "start_logit": 3.3176536560058594,
            "end_logit": -3.3947761058807373,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM1 rs17650",
            "probability": 0.0017636869598273942,
            "start_logit": 3.119987964630127,
            "end_logit": -3.252506732940674,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM",
            "probability": 0.0016451356239970372,
            "start_logit": 3.3176536560058594,
            "end_logit": -3.5197560787200928,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM1 rs17650 polymorphism also influences warfarin therapy.",
            "probability": 0.0013431550495544547,
            "start_logit": 3.119987964630127,
            "end_logit": -3.5248918533325195,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM1 is a plasma drug binding protein.",
            "probability": 0.001311500150798146,
            "start_logit": 3.3176536560058594,
            "end_logit": -3.7464072704315186,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM1 is a plasma drug binding protein. Its polymorphism rs17650 (S>F)",
            "probability": 0.0010424523582674135,
            "start_logit": 3.3176536560058594,
            "end_logit": -3.9760029315948486,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM1 is a plasma drug binding protein",
            "probability": 0.0007940842453721164,
            "start_logit": 3.3176536560058594,
            "end_logit": -4.248144626617432,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "study was to determine whether the ORM1",
            "probability": 0.0007151051726829435,
            "start_logit": -3.793484687805176,
            "end_logit": 2.7582337856292725,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "determine whether the ORM1",
            "probability": 0.0005555545269653804,
            "start_logit": -4.045947551727295,
            "end_logit": 2.7582337856292725,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "M1",
            "probability": 0.0004969108876187016,
            "start_logit": -4.2725958824157715,
            "end_logit": 2.873326063156128,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "1",
            "probability": 0.00048756658635813033,
            "start_logit": -4.291579723358154,
            "end_logit": 2.873326063156128,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "The aim of this study was to determine whether the ORM1",
            "probability": 0.00047516808379557984,
            "start_logit": -4.202245712280273,
            "end_logit": 2.7582337856292725,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "to determine whether the ORM1",
            "probability": 0.0004734595939651134,
            "start_logit": -4.20584774017334,
            "end_logit": 2.7582337856292725,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "OR",
            "probability": 0.0004684163451635476,
            "start_logit": 3.3176536560058594,
            "end_logit": -4.775976657867432,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "the ORM1",
            "probability": 0.000378204759780377,
            "start_logit": -4.430478572845459,
            "end_logit": 2.7582337856292725,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "ORM1 rs17650 polymorphism also influences warfarin",
            "probability": 0.00029696512000753955,
            "start_logit": 3.119987964630127,
            "end_logit": -5.034053802490234,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "whether the ORM1",
            "probability": 0.0002968863278339669,
            "start_logit": -4.67256498336792,
            "end_logit": 2.7582337856292725,
            "question_text": "Which genes are involved in patient response to warfarin?"
        },
        {
            "text": "rs17650 polymorphism",
            "probability": 1.1375704539226371e-05,
            "start_logit": -2.1845617294311523,
            "end_logit": -2.9916388988494873,
            "question_text": "Which genes are involved in patient response to warfarin?"
        }
    ],
    "571e189dbb137a4b0c000003": [
        {
            "text": "empagliflozin",
            "probability": 0.9928302727400039,
            "start_logit": 5.89540958404541,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflozin,",
            "probability": 0.006389003939004231,
            "start_logit": 5.89540958404541,
            "end_logit": 0.73843914270401,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "zin",
            "probability": 0.00014381476120612125,
            "start_logit": -2.9443793296813965,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "em",
            "probability": 0.00013697466147722973,
            "start_logit": 5.89540958404541,
            "end_logit": -3.1040985584259033,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor approved in 2014",
            "probability": 0.0001150701858384586,
            "start_logit": 5.89540958404541,
            "end_logit": -3.2783522605895996,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflozin, a sodium glucose co-transporter-2 (SGLT2) inhibitor",
            "probability": 9.828854788917274e-05,
            "start_logit": 5.89540958404541,
            "end_logit": -3.4359869956970215,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "flozin",
            "probability": 7.24546851890691e-05,
            "start_logit": -3.629944086074829,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "lozin",
            "probability": 3.0857539050221316e-05,
            "start_logit": -4.483524322509766,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflozin, a sodium glucose co-transporter-2 (SGLT2)",
            "probability": 3.0585214177454864e-05,
            "start_logit": 5.89540958404541,
            "end_logit": -4.603377819061279,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflozin, a",
            "probability": 2.9947739454891422e-05,
            "start_logit": 5.89540958404541,
            "end_logit": -4.624440670013428,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empagliflo",
            "probability": 2.342840062402065e-05,
            "start_logit": 5.89540958404541,
            "end_logit": -4.869945526123047,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "review available studies of empagliflozin",
            "probability": 2.3173908987089747e-05,
            "start_logit": -4.769878387451172,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "To review available studies of empagliflozin",
            "probability": 1.6054631361418247e-05,
            "start_logit": -5.136908054351807,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empaglif",
            "probability": 1.4470949932694358e-05,
            "start_logit": 5.89540958404541,
            "end_logit": -5.351751327514648,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "studies of empagliflozin",
            "probability": 1.2958272715976484e-05,
            "start_logit": -5.351171016693115,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "empa",
            "probability": 1.2811921989228543e-05,
            "start_logit": 5.89540958404541,
            "end_logit": -5.473518371582031,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "pagliflozin",
            "probability": 1.0216230435689548e-05,
            "start_logit": -5.588927745819092,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "gliflozin",
            "probability": 8.223946032096947e-06,
            "start_logit": -5.8058552742004395,
            "end_logit": 5.784420490264893,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "zin,",
            "probability": 9.254684320786013e-07,
            "start_logit": -2.9443793296813965,
            "end_logit": 0.73843914270401,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        },
        {
            "text": "flozin,",
            "probability": 4.662561988513205e-07,
            "start_logit": -3.629944086074829,
            "end_logit": 0.73843914270401,
            "question_text": "List sodium glucose co-transporter-2 (SGLT2) inhibitors that have been FDA approved for type 2 diabetes mellitus treatment."
        }
    ],
    "52bf1f4503868f1b06000016": [
        {
            "text": "delusions",
            "probability": 0.22498756295365518,
            "start_logit": 4.380404949188232,
            "end_logit": 4.485868453979492,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "delusions, hallucinations",
            "probability": 0.15478594231095627,
            "start_logit": 4.380404949188232,
            "end_logit": 4.111866474151611,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "delusions, hallucinations, agitation and aggressive behaviour",
            "probability": 0.11208048580033643,
            "start_logit": 4.380404949188232,
            "end_logit": 3.7890405654907227,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "delusions, hallucinations, agitation",
            "probability": 0.0885860708365338,
            "start_logit": 4.380404949188232,
            "end_logit": 3.553797960281372,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "hallucinations",
            "probability": 0.06569148817837243,
            "start_logit": 3.5233311653137207,
            "end_logit": 4.111866474151611,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "agitation and aggressive behaviour",
            "probability": 0.0590010567065502,
            "start_logit": 3.7387430667877197,
            "end_logit": 3.7890405654907227,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "aggressive behaviour",
            "probability": 0.049940668906339594,
            "start_logit": 3.572023391723633,
            "end_logit": 3.7890405654907227,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "hallucinations, agitation and aggressive behaviour",
            "probability": 0.04756720021245676,
            "start_logit": 3.5233311653137207,
            "end_logit": 3.7890405654907227,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "agitation",
            "probability": 0.04663320069960934,
            "start_logit": 3.7387430667877197,
            "end_logit": 3.553797960281372,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "psychotic disorders and depressive symptoms. Atypical neuroleptic drugs are the preferred treatment for symptoms such as delusions",
            "probability": 0.045354648118642545,
            "start_logit": 2.778872489929199,
            "end_logit": 4.485868453979492,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "hallucinations, agitation",
            "probability": 0.037596119765423354,
            "start_logit": 3.5233311653137207,
            "end_logit": 3.553797960281372,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "depressive symptoms. Atypical neuroleptic drugs are the preferred treatment for symptoms such as delusions",
            "probability": 0.02208289372690271,
            "start_logit": 2.0591630935668945,
            "end_logit": 4.485868453979492,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "depressive symptoms. Atypical neuroleptic drugs are the preferred treatment for symptoms such as delusions, hallucinations",
            "probability": 0.015192490951935127,
            "start_logit": 2.0591630935668945,
            "end_logit": 4.111866474151611,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "depressive symptoms. Atypical neuroleptic drugs are the preferred treatment for symptoms such as delusions, hallucinations, agitation",
            "probability": 0.008694866339656354,
            "start_logit": 2.0591630935668945,
            "end_logit": 3.553797960281372,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "psychotic disorders",
            "probability": 0.007421741841559324,
            "start_logit": 2.778872489929199,
            "end_logit": 2.675769567489624,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "delusions, hallucination",
            "probability": 0.005244732780829641,
            "start_logit": 4.380404949188232,
            "end_logit": 0.7270476222038269,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "delusions, hallucinations,",
            "probability": 0.003156330047164494,
            "start_logit": 4.380404949188232,
            "end_logit": 0.21923330426216125,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "hallucination",
            "probability": 0.002225875918230627,
            "start_logit": 3.5233311653137207,
            "end_logit": 0.7270476222038269,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "delusions,",
            "probability": 0.0019150502843188668,
            "start_logit": 4.380404949188232,
            "end_logit": -0.280432790517807,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        },
        {
            "text": "psychotic disorders and depressive symptoms",
            "probability": 0.0018415736205268636,
            "start_logit": 2.778872489929199,
            "end_logit": 1.2819762229919434,
            "question_text": "For the treatment of which conditions can atypical neuroleptic drugs be used?"
        }
    ],
    "52eeddfcc8da898910000010": [
        {
            "text": "periodic paralysis",
            "probability": 0.3570560439267258,
            "start_logit": 6.622704982757568,
            "end_logit": 6.563472270965576,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, cardiac arrhythmias",
            "probability": 0.19242120227177203,
            "start_logit": 6.622704982757568,
            "end_logit": 5.945266246795654,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, cardiac arrhythmias and dysmorphic features",
            "probability": 0.16296519297925394,
            "start_logit": 6.622704982757568,
            "end_logit": 5.779116153717041,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "dysmorphic features",
            "probability": 0.08907539453123302,
            "start_logit": 6.018651485443115,
            "end_logit": 5.779116153717041,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cardiac arrhythmias",
            "probability": 0.08638144712031157,
            "start_logit": 5.821791172027588,
            "end_logit": 5.945266246795654,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cardiac arrhythmias and dysmorphic features",
            "probability": 0.07315809813882396,
            "start_logit": 5.821791172027588,
            "end_logit": 5.779116153717041,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, cardiac arrhythmias and dysmorphic",
            "probability": 0.013126660351726972,
            "start_logit": 6.622704982757568,
            "end_logit": 3.2602248191833496,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "dysmorphic",
            "probability": 0.007174921394757133,
            "start_logit": 6.018651485443115,
            "end_logit": 3.2602248191833496,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cardiac arrhythmias and dysmorphic",
            "probability": 0.005892801331931683,
            "start_logit": 5.821791172027588,
            "end_logit": 3.2602248191833496,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, cardiac arrhythmia",
            "probability": 0.004322680920385887,
            "start_logit": 6.622704982757568,
            "end_logit": 2.1494553089141846,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis,",
            "probability": 0.0038695583411067803,
            "start_logit": 6.622704982757568,
            "end_logit": 2.038719892501831,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "cardiac arrhythmia",
            "probability": 0.0019405316510542898,
            "start_logit": 5.821791172027588,
            "end_logit": 2.1494553089141846,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmias",
            "probability": 0.000664284247721757,
            "start_logit": 0.953973114490509,
            "end_logit": 5.945266246795654,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "arrhythmias and dysmorphic features",
            "probability": 0.0005625950225077434,
            "start_logit": 0.953973114490509,
            "end_logit": 5.779116153717041,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "polymorphic ventricular tachycardia",
            "probability": 0.0004362202769142831,
            "start_logit": 3.5259041786193848,
            "end_logit": 2.952772378921509,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "paralysis",
            "probability": 0.00030079820673455815,
            "start_logit": -0.45650342106819153,
            "end_logit": 6.563472270965576,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "periodic paralysis, cardiac arrhythmias and dysmorphic features)",
            "probability": 0.00016773847193139903,
            "start_logit": 6.622704982757568,
            "end_logit": -1.0997697114944458,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "premature ventricular contractions, and polymorphic ventricular tachycardia",
            "probability": 0.00016246484788449446,
            "start_logit": 2.5382184982299805,
            "end_logit": 2.952772378921509,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "paralysis, cardiac arrhythmias",
            "probability": 0.0001621032708045539,
            "start_logit": -0.45650342106819153,
            "end_logit": 5.945266246795654,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        },
        {
            "text": "characterized by periodic paralysis",
            "probability": 0.00015926269641824297,
            "start_logit": -1.0923880338668823,
            "end_logit": 6.563472270965576,
            "question_text": "Which are the characteristics of  Andersen syndrome?"
        }
    ],
    "56f56a8609dd18d46b00000b": [
        {
            "text": "SPINK5 gene",
            "probability": 0.38380909036143607,
            "start_logit": 5.460000991821289,
            "end_logit": 5.0489583015441895,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5",
            "probability": 0.36400798810027574,
            "start_logit": 5.460000991821289,
            "end_logit": 4.995988845825195,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene encoding lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.08222268547059296,
            "start_logit": 5.460000991821289,
            "end_logit": 3.508244276046753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene encoding lymphoepithelial Kazal-type-related inhibitor (LEKT",
            "probability": 0.05421450843630496,
            "start_logit": 5.460000991821289,
            "end_logit": 3.091761589050293,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene encoding lymphoepithelial Kazal-type-related inhibitor",
            "probability": 0.028620981481840366,
            "start_logit": 5.460000991821289,
            "end_logit": 2.4529531002044678,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI",
            "probability": 0.024568412605386485,
            "start_logit": 4.252031326293945,
            "end_logit": 3.508244276046753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKT",
            "probability": 0.01619947590908747,
            "start_logit": 4.252031326293945,
            "end_logit": 3.091761589050293,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene encoding lymphoepithelial Kazal-type-related inhibitor (LEKTI)",
            "probability": 0.014792685397766497,
            "start_logit": 5.460000991821289,
            "end_logit": 1.7929458618164062,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK5 gene encoding lymphoepithelial Kazal-type-related inhibitor (LEKTI),",
            "probability": 0.007850559533453205,
            "start_logit": 5.460000991821289,
            "end_logit": 1.159397840499878,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.006404880115622757,
            "start_logit": 2.90762996673584,
            "end_logit": 3.508244276046753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI)",
            "probability": 0.004420103725801868,
            "start_logit": 4.252031326293945,
            "end_logit": 1.7929458618164062,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "lymphoepithelial Kazal-type-related inhibitor (LEKT",
            "probability": 0.004223134103131936,
            "start_logit": 2.90762996673584,
            "end_logit": 3.091761589050293,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "LEKTI),",
            "probability": 0.002345773367740598,
            "start_logit": 4.252031326293945,
            "end_logit": 1.159397840499878,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "lymphoepithelial Kazal-type-related inhibitor",
            "probability": 0.002229481488392993,
            "start_logit": 2.90762996673584,
            "end_logit": 2.4529531002044678,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "lymphoepithelial Kazal-type-related inhibitor (LEKTI)",
            "probability": 0.001152302141660206,
            "start_logit": 2.90762996673584,
            "end_logit": 1.7929458618164062,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "SPINK",
            "probability": 0.0010564225134392148,
            "start_logit": 5.460000991821289,
            "end_logit": -0.8462987542152405,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "(LEKTI",
            "probability": 0.000649631094223946,
            "start_logit": 0.6192191243171692,
            "end_logit": 3.508244276046753,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "lymphoepithelial Kazal-type-related inhibitor (LEKTI),",
            "probability": 0.0006115330868183634,
            "start_logit": 2.90762996673584,
            "end_logit": 1.159397840499878,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "(LEKT",
            "probability": 0.00042834201092697727,
            "start_logit": 0.6192191243171692,
            "end_logit": 3.091761589050293,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        },
        {
            "text": "gene",
            "probability": 0.0001920090560973466,
            "start_logit": -2.14035701751709,
            "end_logit": 5.0489583015441895,
            "question_text": "Mutations in which gene and which protein are associated with Netherton syndrome?"
        }
    ],
    "54fb6fb5d176fff445000004": [
        {
            "text": "CSL",
            "probability": 0.465110229193611,
            "start_logit": 5.610199928283691,
            "end_logit": 4.643709659576416,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL bound to cognate DNA",
            "probability": 0.2926959680831197,
            "start_logit": 5.610199928283691,
            "end_logit": 4.180569648742676,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "DNA",
            "probability": 0.09969767769606308,
            "start_logit": 4.533207893371582,
            "end_logit": 4.180569648742676,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Notch, a Mastermind co-activator and the transcription factor CSL",
            "probability": 0.03255683898540392,
            "start_logit": 2.9509129524230957,
            "end_logit": 4.643709659576416,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Notch, a Mastermind co-activator and the transcription factor CSL bound to cognate DNA",
            "probability": 0.020488165829163737,
            "start_logit": 2.9509129524230957,
            "end_logit": 4.180569648742676,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "transcription factor CSL",
            "probability": 0.013082872005936904,
            "start_logit": 2.039229393005371,
            "end_logit": 4.643709659576416,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Notch",
            "probability": 0.011985038482873505,
            "start_logit": 2.9509129524230957,
            "end_logit": 3.644381284713745,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Mastermind co-activator and the transcription factor CSL",
            "probability": 0.01059353560294185,
            "start_logit": 1.8281694650650024,
            "end_logit": 4.643709659576416,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "transcription factor CSL bound to cognate DNA",
            "probability": 0.008233110447225248,
            "start_logit": 2.039229393005371,
            "end_logit": 4.180569648742676,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "the transcription factor CSL",
            "probability": 0.007095871371873695,
            "start_logit": 1.4274386167526245,
            "end_logit": 4.643709659576416,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL bound to cognate DNA. These complexes form higher-order assemblies on paired, head-to-head CSL",
            "probability": 0.006895516907241488,
            "start_logit": 5.610199928283691,
            "end_logit": 0.432306706905365,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "Mastermind co-activator and the transcription factor CSL bound to cognate DNA",
            "probability": 0.006666559804762629,
            "start_logit": 1.8281694650650024,
            "end_logit": 4.180569648742676,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "CSL bound to cognate DNA.",
            "probability": 0.0054566323436305835,
            "start_logit": 5.610199928283691,
            "end_logit": 0.19826704263687134,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "intracellular Notch, a Mastermind co-activator and the transcription factor CSL",
            "probability": 0.004565119028738791,
            "start_logit": 0.9863700866699219,
            "end_logit": 4.643709659576416,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "the transcription factor CSL bound to cognate DNA",
            "probability": 0.0044654639055880735,
            "start_logit": 1.4274386167526245,
            "end_logit": 4.180569648742676,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "intracellular Notch, a Mastermind co-activator and the transcription factor CSL bound to cognate DNA",
            "probability": 0.0028728500249242134,
            "start_logit": 0.9863700866699219,
            "end_logit": 4.180569648742676,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "DNA. These complexes form higher-order assemblies on paired, head-to-head CSL",
            "probability": 0.0023487410047639905,
            "start_logit": 4.533207893371582,
            "end_logit": 0.432306706905365,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "DNA.",
            "probability": 0.0018586302239281488,
            "start_logit": 4.533207893371582,
            "end_logit": 0.19826704263687134,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "intracellular Notch",
            "probability": 0.0016805417523139104,
            "start_logit": 0.9863700866699219,
            "end_logit": 3.644381284713745,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        },
        {
            "text": "a Mastermind co-activator and the transcription factor CSL",
            "probability": 0.001650637305895493,
            "start_logit": -0.030913041904568672,
            "end_logit": 4.643709659576416,
            "question_text": "Which proteins participate in the formation of the Notch transcriptional activation complex?"
        }
    ],
    "532c0c21d6d3ac6a3400001b": [
        {
            "text": "pharmacophore mapping",
            "probability": 0.38002586531935256,
            "start_logit": 2.1414597034454346,
            "end_logit": 0.891057550907135,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore mapping methods",
            "probability": 0.3415429741090565,
            "start_logit": 2.1414597034454346,
            "end_logit": 0.7842917442321777,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "mapping",
            "probability": 0.05771713168680092,
            "start_logit": 0.2567744255065918,
            "end_logit": 0.891057550907135,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore mapping in the generation of queries for virtual screening. We discuss the pharmacophore mapping",
            "probability": 0.054230057796691856,
            "start_logit": 0.19445571303367615,
            "end_logit": 0.891057550907135,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "mapping methods",
            "probability": 0.05187247135609689,
            "start_logit": 0.2567744255065918,
            "end_logit": 0.7842917442321777,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore mapping in the generation of queries for virtual screening. We discuss the pharmacophore mapping methods",
            "probability": 0.048738512075811986,
            "start_logit": 0.19445571303367615,
            "end_logit": 0.7842917442321777,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "p",
            "probability": 0.024030167749342905,
            "start_logit": 2.1414597034454346,
            "end_logit": -1.869871735572815,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "mapping in the generation of queries for virtual screening. We discuss the pharmacophore mapping",
            "probability": 0.012658255118780933,
            "start_logit": -1.2604700326919556,
            "end_logit": 0.891057550907135,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "mapping in the generation of queries for virtual screening. We discuss the pharmacophore mapping methods",
            "probability": 0.011376431171774415,
            "start_logit": -1.2604700326919556,
            "end_logit": 0.7842917442321777,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "methods",
            "probability": 0.005506544713516962,
            "start_logit": -1.9860764741897583,
            "end_logit": 0.7842917442321777,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore mapping in the generation of queries for virtual screening. We discuss the p",
            "probability": 0.003429128132675826,
            "start_logit": 0.19445571303367615,
            "end_logit": -1.869871735572815,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "the pharmacophore mapping",
            "probability": 0.0022854784853750506,
            "start_logit": -2.9722042083740234,
            "end_logit": 0.891057550907135,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "the pharmacophore mapping methods",
            "probability": 0.0020540420807970347,
            "start_logit": -2.9722042083740234,
            "end_logit": 0.7842917442321777,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore",
            "probability": 0.0013212422431090087,
            "start_logit": 2.1414597034454346,
            "end_logit": -4.770609378814697,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore mapping methods that have been successfully employed in the discovery of first-in-class inhibitors",
            "probability": 0.0011682628278282348,
            "start_logit": 2.1414597034454346,
            "end_logit": -4.8936638832092285,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "mapping in the generation of queries for virtual screening. We discuss the p",
            "probability": 0.0008004191863695077,
            "start_logit": -1.2604700326919556,
            "end_logit": -1.869871735572815,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore mapping methods that have been successfully employed in the discovery of first-in-class inhibitors.",
            "probability": 0.0006989361024348546,
            "start_logit": 2.1414597034454346,
            "end_logit": -5.40737771987915,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "pharmacophore mapping in the generation of queries for virtual screening. We discuss the pharmacophore",
            "probability": 0.00018854254340562,
            "start_logit": 0.19445571303367615,
            "end_logit": -4.770609378814697,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "discuss the pharmacophore mapping",
            "probability": 0.00017810522145973007,
            "start_logit": -5.524160385131836,
            "end_logit": 0.891057550907135,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        },
        {
            "text": "mapping methods that have been successfully employed in the discovery of first-in-class inhibitors",
            "probability": 0.00017743207931884654,
            "start_logit": 0.2567744255065918,
            "end_logit": -4.8936638832092285,
            "question_text": "Which are the main methods for pharmacophore modelling?"
        }
    ],
    "5166f41a298dcd4e5100005b": [
        {
            "text": "suramin",
            "probability": 0.9992798265565784,
            "start_logit": 5.5828471183776855,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "sur",
            "probability": 0.0002653024522890083,
            "start_logit": 5.5828471183776855,
            "end_logit": -3.1360535621643066,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "surami",
            "probability": 0.00012278530188665905,
            "start_logit": 5.5828471183776855,
            "end_logit": -3.906486749649048,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "n",
            "probability": 0.00010484412846701331,
            "start_logit": -3.579468250274658,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "amin",
            "probability": 6.66748317914209e-05,
            "start_logit": -4.032115459442139,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "small-library LOPAC against DOT1L. After hit confirmation and profiling, we found that suramin",
            "probability": 2.8401517465766337e-05,
            "start_logit": -4.885500431060791,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "suramin inhibited DOT1L, NSD2, and PRMT4",
            "probability": 2.7816943764832888e-05,
            "start_logit": 5.5828471183776855,
            "end_logit": -5.3912787437438965,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "DOT1L. After hit confirmation and profiling, we found that suramin",
            "probability": 2.399675918281758e-05,
            "start_logit": -5.0540242195129395,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "suramin inhibited DOT1L, NSD2",
            "probability": 2.3141646281240253e-05,
            "start_logit": 5.5828471183776855,
            "end_logit": -5.575290203094482,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "suramin inhibited DOT1L",
            "probability": 1.9806864062847832e-05,
            "start_logit": 5.5828471183776855,
            "end_logit": -5.730895519256592,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "LOPAC against DOT1L. After hit confirmation and profiling, we found that suramin",
            "probability": 1.625022564516256e-05,
            "start_logit": -5.443836212158203,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "we found that suramin",
            "probability": 7.678936889294212e-06,
            "start_logit": -6.193461894989014,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "a small-library LOPAC against DOT1L. After hit confirmation and profiling, we found that suramin",
            "probability": 6.737619103099352e-06,
            "start_logit": -6.3242363929748535,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "library LOPAC against DOT1L. After hit confirmation and profiling, we found that suramin",
            "probability": 6.70253120495916e-06,
            "start_logit": -6.329457759857178,
            "end_logit": 5.097866058349609,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "ami",
            "probability": 8.192589435095838e-09,
            "start_logit": -4.032115459442139,
            "end_logit": -3.906486749649048,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "small-library LOPAC against DOT1L. After hit confirmation and profiling, we found that sur",
            "probability": 7.54042264453768e-09,
            "start_logit": -4.885500431060791,
            "end_logit": -3.1360535621643066,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "DOT1L. After hit confirmation and profiling, we found that sur",
            "probability": 6.370987274033417e-09,
            "start_logit": -5.0540242195129395,
            "end_logit": -3.1360535621643066,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "LOPAC against DOT1L. After hit confirmation and profiling, we found that sur",
            "probability": 4.3143317810862064e-09,
            "start_logit": -5.443836212158203,
            "end_logit": -3.1360535621643066,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "n inhibited DOT1L, NSD2, and PRMT4 with IC\u2085\u2080 values at a low \u03bcM range",
            "probability": 3.777254384014587e-09,
            "start_logit": -3.579468250274658,
            "end_logit": -5.133366584777832,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        },
        {
            "text": "small-library LOPAC against DOT1L. After hit confirmation and profiling, we found that surami",
            "probability": 3.489802158910982e-09,
            "start_logit": -4.885500431060791,
            "end_logit": -3.906486749649048,
            "question_text": "Which are the inhibitors of histone methyltransferases?"
        }
    ],
    "517539af8ed59a060a000026": [
        {
            "text": "c-MYC, MAX",
            "probability": 0.23178476739893558,
            "start_logit": -0.09890671074390411,
            "end_logit": -0.28420063853263855,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "c-MYC",
            "probability": 0.21971379943253938,
            "start_logit": -0.09890671074390411,
            "end_logit": -0.3376840651035309,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MAX",
            "probability": 0.2011232788706133,
            "start_logit": -0.24079787731170654,
            "end_logit": -0.28420063853263855,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MYC, MAX",
            "probability": 0.12149418748861662,
            "start_logit": -0.7448495030403137,
            "end_logit": -0.28420063853263855,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MYC",
            "probability": 0.11516697081369909,
            "start_logit": -0.7448495030403137,
            "end_logit": -0.3376840651035309,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "C/EBPbeta",
            "probability": 0.052015235671650714,
            "start_logit": -0.5462427139282227,
            "end_logit": -1.3311371803283691,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "C/EBPalpha, C/EBPbeta",
            "probability": 0.012738988582760374,
            "start_logit": -1.9531121253967285,
            "end_logit": -1.3311371803283691,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "C/EBPbeta and PPARgamma",
            "probability": 0.01119697826758291,
            "start_logit": -0.5462427139282227,
            "end_logit": -2.867029905319214,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "EBPbeta",
            "probability": 0.0070205116648141015,
            "start_logit": -2.548943281173706,
            "end_logit": -1.3311371803283691,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "C/EBPalpha",
            "probability": 0.004620341944163734,
            "start_logit": -1.9531121253967285,
            "end_logit": -2.3453357219696045,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PPARgamma",
            "probability": 0.002856954459775076,
            "start_logit": -1.9121304750442505,
            "end_logit": -2.867029905319214,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "c-MYC, MAX and E2F transcription factors,",
            "probability": 0.002846856361444125,
            "start_logit": -0.09890671074390411,
            "end_logit": -4.6837944984436035,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "C/EBPalpha, C/EBPbeta and PPARgamma",
            "probability": 0.002742238432073379,
            "start_logit": -1.9531121253967285,
            "end_logit": -2.867029905319214,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "C/EBPbeta and PPARgamma,",
            "probability": 0.0026674030043657153,
            "start_logit": -0.5462427139282227,
            "end_logit": -4.301568508148193,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "MAX and E2F transcription factors,",
            "probability": 0.002470261925805637,
            "start_logit": -0.24079787731170654,
            "end_logit": -4.6837944984436035,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "C",
            "probability": 0.0022972510524700432,
            "start_logit": -0.5462427139282227,
            "end_logit": -4.450960636138916,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "X",
            "probability": 0.0019969259028646403,
            "start_logit": -4.85310697555542,
            "end_logit": -0.28420063853263855,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "EBPalpha, C/EBPbeta",
            "probability": 0.0019040267397670105,
            "start_logit": -3.8538084030151367,
            "end_logit": -1.3311371803283691,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "c",
            "probability": 0.0017018171920032182,
            "start_logit": -0.09890671074390411,
            "end_logit": -5.198313236236572,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        },
        {
            "text": "PPARgamma, temporally coincident with previous reports. BSEA was also applied to tissue-specific expression profiles of human and mouse,",
            "probability": 0.0016412047940556958,
            "start_logit": -1.9121304750442505,
            "end_logit": -3.4213554859161377,
            "question_text": "Which genes are regulated by MEF-2 in the heart?"
        }
    ],
    "52d2818403868f1b06000033": [
        {
            "text": "transcription activator-like effector nucleases",
            "probability": 0.6647301866126372,
            "start_logit": -3.295607089996338,
            "end_logit": -2.663336992263794,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "site-specific nucleases, especially transcription activator-like effector nucleases",
            "probability": 0.06400022450123655,
            "start_logit": -5.636101722717285,
            "end_logit": -2.663336992263794,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "transcription activator-like effector nucleases,",
            "probability": 0.05969393700485531,
            "start_logit": -3.295607089996338,
            "end_logit": -5.073487758636475,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "transcription",
            "probability": 0.04708557910513967,
            "start_logit": -3.295607089996338,
            "end_logit": -5.310751438140869,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "effector nucleases",
            "probability": 0.03637711760443284,
            "start_logit": -6.201048374176025,
            "end_logit": -2.663336992263794,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "transcription activator-like effector nucleases, to engineer specific alterations in the genomes of pigs and cows.",
            "probability": 0.023655307072902976,
            "start_logit": -3.295607089996338,
            "end_logit": -5.999130725860596,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "nucleases",
            "probability": 0.020862604619259217,
            "start_logit": -6.757030010223389,
            "end_logit": -2.663336992263794,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "ses",
            "probability": 0.01962800709507126,
            "start_logit": -6.818030834197998,
            "end_logit": -2.663336992263794,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "10(-9). Herein we describe our applications of site-specific nucleases",
            "probability": 0.006506134063912586,
            "start_logit": -5.433958530426025,
            "end_logit": -5.151621341705322,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "double-strand DNA breaks with a specificity of 10(-9)",
            "probability": 0.0063993432630260905,
            "start_logit": -5.314853191375732,
            "end_logit": -5.287276744842529,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "double-strand DNA breaks",
            "probability": 0.005874129039947015,
            "start_logit": -5.314853191375732,
            "end_logit": -5.3729143142700195,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "site-specific nucleases, especially transcription activator-like effector nucleases,",
            "probability": 0.005747332446479845,
            "start_logit": -5.636101722717285,
            "end_logit": -5.073487758636475,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "10(-9)",
            "probability": 0.005680788428291026,
            "start_logit": -5.433958530426025,
            "end_logit": -5.287276744842529,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "10(-9). Herein we describe our applications of site-specific nucleases, especially transcription",
            "probability": 0.0055489867171291144,
            "start_logit": -5.433958530426025,
            "end_logit": -5.310751438140869,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "double-strand DNA breaks with a specificity of 10",
            "probability": 0.005347868808401711,
            "start_logit": -5.314853191375732,
            "end_logit": -5.466773986816406,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "site-specific nucleases",
            "probability": 0.0053153679699208456,
            "start_logit": -5.636101722717285,
            "end_logit": -5.151621341705322,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "10",
            "probability": 0.004747379534758846,
            "start_logit": -5.433958530426025,
            "end_logit": -5.466773986816406,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "10(-9). Herein we describe our applications of site-specific nucleases,",
            "probability": 0.0045494808977381415,
            "start_logit": -5.433958530426025,
            "end_logit": -5.5093536376953125,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "site-specific nucleases, especially transcription",
            "probability": 0.004533399707415036,
            "start_logit": -5.636101722717285,
            "end_logit": -5.310751438140869,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        },
        {
            "text": "site-specific nucleases,",
            "probability": 0.003716825507444531,
            "start_logit": -5.636101722717285,
            "end_logit": -5.5093536376953125,
            "question_text": "Which are the newly identified DNA nucleases that can be used to treat thalassemia?"
        }
    ],
    "571cd9537de986d80d00000e": [
        {
            "text": "caspase-5",
            "probability": 0.9691176620436894,
            "start_logit": 4.629618167877197,
            "end_logit": 5.173851490020752,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "Human caspase-5",
            "probability": 0.023116789711155408,
            "start_logit": 0.8937913179397583,
            "end_logit": 5.173851490020752,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "5",
            "probability": 0.006512670765537477,
            "start_logit": -0.3730182349681854,
            "end_logit": 5.173851490020752,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-5 is classified as an inflammatory caspase,",
            "probability": 0.00030561591913919365,
            "start_logit": 4.629618167877197,
            "end_logit": -2.88796067237854,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "-5",
            "probability": 0.00029988053199085066,
            "start_logit": -3.451138973236084,
            "end_logit": 5.173851490020752,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "ca",
            "probability": 0.0001975366161677891,
            "start_logit": 4.629618167877197,
            "end_logit": -3.3243658542633057,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-5 is",
            "probability": 0.00011492282264259144,
            "start_logit": 4.629618167877197,
            "end_logit": -3.8660290241241455,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase",
            "probability": 8.915931976326508e-05,
            "start_logit": 4.629618167877197,
            "end_logit": -4.1198649406433105,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-5 is classified",
            "probability": 6.403673966757964e-05,
            "start_logit": 4.629618167877197,
            "end_logit": -4.450832843780518,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "spase-5",
            "probability": 5.893433695019774e-05,
            "start_logit": -5.078099250793457,
            "end_logit": 5.173851490020752,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "casp",
            "probability": 2.5220209647627643e-05,
            "start_logit": 4.629618167877197,
            "end_logit": -5.382644176483154,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "ase-5",
            "probability": 2.4961889759965674e-05,
            "start_logit": -5.937172889709473,
            "end_logit": 5.173851490020752,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-5 is classified as",
            "probability": 1.4820372128481632e-05,
            "start_logit": 4.629618167877197,
            "end_logit": -5.914287090301514,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-",
            "probability": 1.3182171824638414e-05,
            "start_logit": 4.629618167877197,
            "end_logit": -6.031424522399902,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": ". Human caspase-5",
            "probability": 1.088261181694411e-05,
            "start_logit": -6.767356872558594,
            "end_logit": 5.173851490020752,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-5 is classified as an inflammatory caspase, although its substrate has not been identified",
            "probability": 1.038464697097341e-05,
            "start_logit": 4.629618167877197,
            "end_logit": -6.269961357116699,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "Human caspase-5 is classified as an inflammatory caspase,",
            "probability": 7.289990897724161e-06,
            "start_logit": 0.8937913179397583,
            "end_logit": -2.88796067237854,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "caspase-5 is classified as an inflammatory caspase",
            "probability": 6.668331180751404e-06,
            "start_logit": 4.629618167877197,
            "end_logit": -6.712920188903809,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "Human ca",
            "probability": 4.711927761768663e-06,
            "start_logit": 0.8937913179397583,
            "end_logit": -3.3243658542633057,
            "question_text": "List inflammatory caspase proteins?"
        },
        {
            "text": "Human",
            "probability": 4.669041307013266e-06,
            "start_logit": 0.8937913179397583,
            "end_logit": -3.3335092067718506,
            "question_text": "List inflammatory caspase proteins?"
        }
    ],
    "553c994af32186855800000b": [
        {
            "text": "Anopheles gambiae",
            "probability": 0.2449584736401754,
            "start_logit": 4.866175174713135,
            "end_logit": 4.469676971435547,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Anopheles gambiae), two species of Caenorhabditis",
            "probability": 0.19142565659385014,
            "start_logit": 4.866175174713135,
            "end_logit": 4.223087787628174,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Drosophila and Anopheles gambiae",
            "probability": 0.13296637400053002,
            "start_logit": 4.25518274307251,
            "end_logit": 4.469676971435547,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Drosophila and Anopheles gambiae), two species of Caenorhabditis",
            "probability": 0.10390812397591766,
            "start_logit": 4.25518274307251,
            "end_logit": 4.223087787628174,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Drosophila",
            "probability": 0.09447873044050328,
            "start_logit": 4.25518274307251,
            "end_logit": 4.127955436706543,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Caenorhabditis",
            "probability": 0.08832438591486809,
            "start_logit": 4.092691898345947,
            "end_logit": 4.223087787628174,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Anopheles gambiae), two species of Caenorhabditis, and seven species of Saccharomyces",
            "probability": 0.06054692415263285,
            "start_logit": 4.866175174713135,
            "end_logit": 3.072006940841675,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Caenorhabditis, and seven species of Saccharomyces",
            "probability": 0.02793653677344732,
            "start_logit": 4.092691898345947,
            "end_logit": 3.072006940841675,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Saccharomyces",
            "probability": 0.021335908699335195,
            "start_logit": 3.823148012161255,
            "end_logit": 3.072006940841675,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Fugu rubripes). Parallel searches have been performed with multiple alignments of four insect species (three species of Drosophila",
            "probability": 0.012030750816610236,
            "start_logit": 2.1942739486694336,
            "end_logit": 4.127955436706543,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Saccharaomyces cerevisiae",
            "probability": 0.009972939160697412,
            "start_logit": 2.946941375732422,
            "end_logit": 3.187697410583496,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "insect species (three species of Drosophila and Anopheles gambiae",
            "probability": 0.0024928878042709615,
            "start_logit": 0.27852827310562134,
            "end_logit": 4.469676971435547,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Anopheles gambiae)",
            "probability": 0.0020530754451266804,
            "start_logit": 4.866175174713135,
            "end_logit": -0.31207284331321716,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "insect species (three species of Drosophila",
            "probability": 0.0017713115563878987,
            "start_logit": 0.27852827310562134,
            "end_logit": 4.127955436706543,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Saccharaomyces cerevisiae (47%-68%) genomes. From yeast",
            "probability": 0.0012654963491456376,
            "start_logit": 2.946941375732422,
            "end_logit": 1.123286485671997,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Drosophila and Anopheles gambiae)",
            "probability": 0.001114433779045421,
            "start_logit": 4.25518274307251,
            "end_logit": -0.31207284331321716,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Anopheles",
            "probability": 0.0009467629897966485,
            "start_logit": 4.866175174713135,
            "end_logit": -1.086118221282959,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "Fugu rubripes",
            "probability": 0.0009297000241739827,
            "start_logit": 2.1942739486694336,
            "end_logit": 1.567596197128296,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "chicken",
            "probability": 0.0008475008089796536,
            "start_logit": 1.9019229412078857,
            "end_logit": 1.7673770189285278,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        },
        {
            "text": "chicken, and Fugu rubripes",
            "probability": 0.0006940270745058967,
            "start_logit": 1.9019229412078857,
            "end_logit": 1.567596197128296,
            "question_text": "List invertebrates where ultraconserved elements have been identified."
        }
    ],
    "54e061ee1388e8454a00000c": [
        {
            "text": "Everolimus",
            "probability": 0.8703679295295402,
            "start_logit": 5.522420406341553,
            "end_logit": 5.408298015594482,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus, an orally administered rapamycin",
            "probability": 0.06286999818341237,
            "start_logit": 5.17953634262085,
            "end_logit": 3.123335123062134,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus, an orally administered rapamycin analogue, inhibits the mammalian target of rapamycin",
            "probability": 0.03010528970972423,
            "start_logit": 5.17953634262085,
            "end_logit": 2.3869669437408447,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "rapamycin",
            "probability": 0.015795110599529885,
            "start_logit": 3.7981677055358887,
            "end_logit": 3.123335123062134,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus,",
            "probability": 0.010887842646313307,
            "start_logit": 5.17953634262085,
            "end_logit": 1.36991286277771,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "rapamycin analogue, inhibits the mammalian target of rapamycin",
            "probability": 0.00756348646947223,
            "start_logit": 3.7981677055358887,
            "end_logit": 2.3869669437408447,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus, an orally administered rapamycin analogue,",
            "probability": 0.0013364786829145828,
            "start_logit": 5.17953634262085,
            "end_logit": -0.727695643901825,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "rapamycin analogue,",
            "probability": 0.0003357695120169335,
            "start_logit": 3.7981677055358887,
            "end_logit": -0.727695643901825,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "mus",
            "probability": 0.00020913913306236078,
            "start_logit": -2.811251163482666,
            "end_logit": 5.408298015594482,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "olimus",
            "probability": 0.00012552468184116826,
            "start_logit": -3.125107526779175,
            "end_logit": 5.2116570472717285,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Ever",
            "probability": 0.0001216142039400616,
            "start_logit": 5.522420406341553,
            "end_logit": -3.467519521713257,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus, an orally administered rap",
            "probability": 5.217610831725938e-05,
            "start_logit": 5.17953634262085,
            "end_logit": -3.9708645343780518,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everoli",
            "probability": 4.9203694778048776e-05,
            "start_logit": 5.522420406341553,
            "end_logit": -4.3724045753479,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus, an orally administered rapamycin analogue",
            "probability": 4.584941713106371e-05,
            "start_logit": 5.17953634262085,
            "end_logit": -4.10012674331665,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "Everolimus, an orally administered rapamycin analogue, inhibits the mammalian target of rap",
            "probability": 3.9708928265465355e-05,
            "start_logit": 5.17953634262085,
            "end_logit": -4.243913173675537,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "mus, an orally administered rapamycin",
            "probability": 2.4537873130462953e-05,
            "start_logit": -2.669070243835449,
            "end_logit": 3.123335123062134,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "rapamycin analogue, inhibits the mammalian target of rapamycin (mTOR)",
            "probability": 2.399723803624296e-05,
            "start_logit": 3.7981677055358887,
            "end_logit": -3.3661818504333496,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "rapamycin analogue, inhibits the mammalian target of rapamycin (mTOR),",
            "probability": 1.7683088021927857e-05,
            "start_logit": 3.7981677055358887,
            "end_logit": -3.6715118885040283,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "olimus, an orally administered rapamycin",
            "probability": 1.5551863692988396e-05,
            "start_logit": -3.125107526779175,
            "end_logit": 3.123335123062134,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        },
        {
            "text": "rap",
            "probability": 1.3108436859182235e-05,
            "start_logit": 3.7981677055358887,
            "end_logit": -3.9708645343780518,
            "question_text": "List two chemotherapeutic agents that are used for treatment of Subependymal Giant Cell Astrocytoma"
        }
    ],
    "553d061cf321868558000013": [
        {
            "text": "ancora",
            "probability": 0.30638640392273697,
            "start_logit": 3.5730392932891846,
            "end_logit": 3.5116982460021973,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora",
            "probability": 0.287569187657648,
            "start_logit": 3.36793851852417,
            "end_logit": 3.6534154415130615,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora",
            "probability": 0.24957170994286562,
            "start_logit": 3.36793851852417,
            "end_logit": 3.5116982460021973,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.genereg.net",
            "probability": 0.04551838960317456,
            "start_logit": 3.5730392932891846,
            "end_logit": 1.6049675941467285,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora.genereg.net",
            "probability": 0.037077697253088834,
            "start_logit": 3.36793851852417,
            "end_logit": 1.6049675941467285,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.genereg.net,",
            "probability": 0.01793414319714588,
            "start_logit": 3.5730392932891846,
            "end_logit": 0.6735575199127197,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora.genereg.net,",
            "probability": 0.014608529382395857,
            "start_logit": 3.36793851852417,
            "end_logit": 0.6735575199127197,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.genereg",
            "probability": 0.008219391115214573,
            "start_logit": 3.5730392932891846,
            "end_logit": -0.10665268450975418,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora.genereg",
            "probability": 0.00669523017030022,
            "start_logit": 3.36793851852417,
            "end_logit": -0.10665268450975418,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.genereg.net, a web resource that provides data and tools for exploring genomic organization of HCNEs",
            "probability": 0.00410900192087717,
            "start_logit": 3.5730392932891846,
            "end_logit": -0.7999686598777771,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "web resource that provides data and tools for exploring genomic organization of HCNEs for multiple genomes. Ancora",
            "probability": 0.00372181080475057,
            "start_logit": 0.10898749530315399,
            "end_logit": 2.5651133060455322,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http",
            "probability": 0.003204599702082897,
            "start_logit": 3.36793851852417,
            "end_logit": -0.8434608578681946,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.genereg.net, a web resource",
            "probability": 0.0026560523933688374,
            "start_logit": 3.5730392932891846,
            "end_logit": -1.2363078594207764,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora.genereg.net, a web resource",
            "probability": 0.002163527914502571,
            "start_logit": 3.36793851852417,
            "end_logit": -1.2363078594207764,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "http://ancora",
            "probability": 0.0020483836405951073,
            "start_logit": -1.4347567558288574,
            "end_logit": 3.5116982460021973,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.genereg.net, a web",
            "probability": 0.002035327272541952,
            "start_logit": 3.5730392932891846,
            "end_logit": -1.5024921894073486,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "genereg.net",
            "probability": 0.001786900930566742,
            "start_logit": 0.3354056775569916,
            "end_logit": 1.6049675941467285,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora http://ancora.genereg.net, a web",
            "probability": 0.001657906817006602,
            "start_logit": 3.36793851852417,
            "end_logit": -1.5024921894073486,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "ancora.gene",
            "probability": 0.0016241066623409895,
            "start_logit": 3.5730392932891846,
            "end_logit": -1.7281908988952637,
            "question_text": "List available databases containing information about conserved noncoding elements."
        },
        {
            "text": "Ancora includes a genome browser",
            "probability": 0.001411699696795962,
            "start_logit": 1.9523152112960815,
            "end_logit": -0.2476302981376648,
            "question_text": "List available databases containing information about conserved noncoding elements."
        }
    ],
    "56c1f043ef6e394741000057": [
        {
            "text": "sleep initiation, maintenance and/or quality (non-restorative sleep) resulting in significant daytime distress.",
            "probability": 0.44723954646854897,
            "start_logit": -6.188955783843994,
            "end_logit": -2.6375691890716553,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "distress.",
            "probability": 0.2377029774761252,
            "start_logit": -6.821028232574463,
            "end_logit": -2.6375691890716553,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "Insomnia",
            "probability": 0.15754944745893049,
            "start_logit": -6.1400980949401855,
            "end_logit": -3.7297818660736084,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "nia",
            "probability": 0.09321436747026055,
            "start_logit": -6.66493558883667,
            "end_logit": -3.7297818660736084,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "sleep initiation, maintenance and/or quality (non-restorative sleep) resulting in significant daytime distress",
            "probability": 0.014920048866108314,
            "start_logit": -6.188955783843994,
            "end_logit": -6.037957668304443,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "Insomnia is typified by a difficulty in sleep",
            "probability": 0.008370630132664036,
            "start_logit": -6.1400980949401855,
            "end_logit": -6.664792060852051,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "sleep",
            "probability": 0.007971490406829195,
            "start_logit": -6.188955783843994,
            "end_logit": -6.664792060852051,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "distress",
            "probability": 0.007929844459344193,
            "start_logit": -6.821028232574463,
            "end_logit": -6.037957668304443,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "nia is typified by a difficulty in sleep",
            "probability": 0.0049524959035300836,
            "start_logit": -6.66493558883667,
            "end_logit": -6.664792060852051,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "Insomnia is typified by a difficulty in sleep initiation, maintenance and/or quality (non-restorative sleep",
            "probability": 0.003960770700018551,
            "start_logit": -6.1400980949401855,
            "end_logit": -7.413082599639893,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "Insomnia is typified by a difficulty in sleep initiation",
            "probability": 0.003959592362321894,
            "start_logit": -6.1400980949401855,
            "end_logit": -7.413380146026611,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "sleep initiation, maintenance and/or quality (non-restorative sleep",
            "probability": 0.00377190786577014,
            "start_logit": -6.188955783843994,
            "end_logit": -7.413082599639893,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "sleep initiation",
            "probability": 0.0037707857151678516,
            "start_logit": -6.188955783843994,
            "end_logit": -7.413380146026611,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "nia is typified by a difficulty in sleep initiation, maintenance and/or quality (non-restorative sleep",
            "probability": 0.0023433959398252565,
            "start_logit": -6.66493558883667,
            "end_logit": -7.413082599639893,
            "question_text": "Which receptors are bound by Tasimelteon?"
        },
        {
            "text": "nia is typified by a difficulty in sleep initiation",
            "probability": 0.0023426987745553576,
            "start_logit": -6.66493558883667,
            "end_logit": -7.413380146026611,
            "question_text": "Which receptors are bound by Tasimelteon?"
        }
    ],
    "5318380bb166e2b806000013": [
        {
            "text": "LRPPRC",
            "probability": 0.21715457839384925,
            "start_logit": 4.079750061035156,
            "end_logit": 3.6012051105499268,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP60, LRPPRC",
            "probability": 0.13817692303820556,
            "start_logit": 3.6276755332946777,
            "end_logit": 3.6012051105499268,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "LRPPRC, and TUFM",
            "probability": 0.11804446209199004,
            "start_logit": 4.079750061035156,
            "end_logit": 2.991657018661499,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "GRP75, HSP60, LRPPRC",
            "probability": 0.10408911319118912,
            "start_logit": 3.344388008117676,
            "end_logit": 3.6012051105499268,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "TUFM",
            "probability": 0.09096712847757181,
            "start_logit": 3.8191869258880615,
            "end_logit": 2.991657018661499,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP60, LRPPRC, and TUFM",
            "probability": 0.0751124874926113,
            "start_logit": 3.6276755332946777,
            "end_logit": 2.991657018661499,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP60",
            "probability": 0.07500332679446604,
            "start_logit": 3.6276755332946777,
            "end_logit": 2.9902026653289795,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "GRP75, HSP60, LRPPRC, and TUFM",
            "probability": 0.056582474415995135,
            "start_logit": 3.344388008117676,
            "end_logit": 2.991657018661499,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "GRP75, HSP60",
            "probability": 0.05650024331679683,
            "start_logit": 3.344388008117676,
            "end_logit": 2.9902026653289795,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "GRP75",
            "probability": 0.030622505643034308,
            "start_logit": 3.344388008117676,
            "end_logit": 2.377692937850952,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "CDC37), 12 proteins were identified using the TAP assay; four of which are mitochondrially localized (GRP75",
            "probability": 0.013015622377376308,
            "start_logit": 2.4888031482696533,
            "end_logit": 2.377692937850952,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP90, CDC37",
            "probability": 0.008053297812463842,
            "start_logit": 2.7332029342651367,
            "end_logit": 1.6532244682312012,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "CDC37",
            "probability": 0.0063071372418622975,
            "start_logit": 2.4888031482696533,
            "end_logit": 1.6532244682312012,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP90",
            "probability": 0.0048849249133373655,
            "start_logit": 2.7332029342651367,
            "end_logit": 1.153296709060669,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "(GRP75, HSP60, LRPPRC",
            "probability": 0.0017844022627450662,
            "start_logit": -0.7217758893966675,
            "end_logit": 3.6012051105499268,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "(GRP75, HSP60, LRPPRC, and TUFM",
            "probability": 0.0009699947697139479,
            "start_logit": -0.7217758893966675,
            "end_logit": 2.991657018661499,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "(GRP75, HSP60",
            "probability": 0.0009685850799300801,
            "start_logit": -0.7217758893966675,
            "end_logit": 2.9902026653289795,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "HSP60,",
            "probability": 0.0006370002297034122,
            "start_logit": 3.6276755332946777,
            "end_logit": -1.7783150672912598,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "LRPPRC, and TUFM)",
            "probability": 0.0006008300793928957,
            "start_logit": 4.079750061035156,
            "end_logit": -2.2888474464416504,
            "question_text": "List Parkin binding partners"
        },
        {
            "text": "(GRP75",
            "probability": 0.0005249623777655487,
            "start_logit": -0.7217758893966675,
            "end_logit": 2.377692937850952,
            "question_text": "List Parkin binding partners"
        }
    ],
    "5173b5ea8ed59a060a00001f": [
        {
            "text": "H3K9me2 and H3K27me3",
            "probability": 0.3264643007485061,
            "start_logit": 3.380248546600342,
            "end_logit": 3.1425747871398926,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K27me3",
            "probability": 0.3258879737287727,
            "start_logit": 3.37848162651062,
            "end_logit": 3.1425747871398926,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K9me2",
            "probability": 0.19238203508484247,
            "start_logit": 3.380248546600342,
            "end_logit": 2.6137373447418213,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K9ac",
            "probability": 0.12052302986130287,
            "start_logit": 3.0976054668426514,
            "end_logit": 2.4287381172180176,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "acetylation (H3K9ac",
            "probability": 0.010490272845511989,
            "start_logit": 0.6562130451202393,
            "end_logit": 2.4287381172180176,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K9ac)",
            "probability": 0.007902619725734241,
            "start_logit": 3.0976054668426514,
            "end_logit": -0.2959084212779999,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "(H3K9ac",
            "probability": 0.005412205864022123,
            "start_logit": -0.005578638985753059,
            "end_logit": 2.4287381172180176,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "K9me2 and H3K27me3",
            "probability": 0.0012203992295751818,
            "start_logit": -2.2088940143585205,
            "end_logit": 3.1425747871398926,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K9me",
            "probability": 0.0011664771048732574,
            "start_logit": 3.380248546600342,
            "end_logit": -2.49175763130188,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNAs (siRNAs), we increased the levels of H3K9me2 and H3K27me3",
            "probability": 0.0010900329540060676,
            "start_logit": -2.321864128112793,
            "end_logit": 3.1425747871398926,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "K27me3",
            "probability": 0.001016210912313135,
            "start_logit": -2.391991138458252,
            "end_logit": 3.1425747871398926,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K9me2 and H3K27me3 in the proximity of alternative exon 33 of the human fibronectin gene,",
            "probability": 0.0009252758594643556,
            "start_logit": 3.380248546600342,
            "end_logit": -2.7234091758728027,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H3K27me3 in the proximity of alternative exon 33 of the human fibronectin gene,",
            "probability": 0.000923642414468092,
            "start_logit": 3.37848162651062,
            "end_logit": -2.7234091758728027,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "K9me2",
            "probability": 0.000719168640685506,
            "start_logit": -2.2088940143585205,
            "end_logit": 2.6137373447418213,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "3K9me2 and H3K27me3",
            "probability": 0.0006923376968656138,
            "start_logit": -2.7757534980773926,
            "end_logit": 3.1425747871398926,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "3K27me3",
            "probability": 0.0006914548261225604,
            "start_logit": -2.777029514312744,
            "end_logit": 3.1425747871398926,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "acetylation (H3K9ac)",
            "probability": 0.000687840632721222,
            "start_logit": 0.6562130451202393,
            "end_logit": -0.2959084212779999,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "H",
            "probability": 0.0006481988991165716,
            "start_logit": 3.380248546600342,
            "end_logit": -3.079303503036499,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "RNAs (siRNAs), we increased the levels of H3K9me2",
            "probability": 0.0006423451431609232,
            "start_logit": -2.321864128112793,
            "end_logit": 2.6137373447418213,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        },
        {
            "text": "intragenic histone acetylation (H3K9ac",
            "probability": 0.0005141778279351791,
            "start_logit": -2.359421491622925,
            "end_logit": 2.4287381172180176,
            "question_text": "Which histone modifications have been associated to alternative splicing?"
        }
    ],
    "5324cca79b2d7acc7e00001d": [
        {
            "text": "diagnosis",
            "probability": 0.12706752864458803,
            "start_logit": 3.561788558959961,
            "end_logit": 3.3218066692352295,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "prevention",
            "probability": 0.10384443912303877,
            "start_logit": 3.3298087120056152,
            "end_logit": 3.351961851119995,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "prevention, diagnosis",
            "probability": 0.10075973483196185,
            "start_logit": 3.3298087120056152,
            "end_logit": 3.3218066692352295,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "diagnosis, treatment and monitoring",
            "probability": 0.0943514243232529,
            "start_logit": 3.561788558959961,
            "end_logit": 3.0241143703460693,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "prevention, diagnosis, treatment and monitoring",
            "probability": 0.07481710392290519,
            "start_logit": 3.3298087120056152,
            "end_logit": 3.0241143703460693,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "diagnosis, treatment",
            "probability": 0.07410580013782334,
            "start_logit": 3.561788558959961,
            "end_logit": 2.7825818061828613,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "prevention, diagnosis, treatment",
            "probability": 0.05876309117715311,
            "start_logit": 3.3298087120056152,
            "end_logit": 2.7825818061828613,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "information collection, prevention",
            "probability": 0.05663482990312899,
            "start_logit": 2.723538875579834,
            "end_logit": 3.351961851119995,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "information collection, prevention, diagnosis",
            "probability": 0.05495248943018753,
            "start_logit": 2.723538875579834,
            "end_logit": 3.3218066692352295,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "treatment and monitoring",
            "probability": 0.04922511693326199,
            "start_logit": 2.911166191101074,
            "end_logit": 3.0241143703460693,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "monitoring",
            "probability": 0.040998921903588365,
            "start_logit": 2.7283079624176025,
            "end_logit": 3.0241143703460693,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "information collection, prevention, diagnosis, treatment and monitoring",
            "probability": 0.040803859988092425,
            "start_logit": 2.723538875579834,
            "end_logit": 3.0241143703460693,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "treatment",
            "probability": 0.03866255017750993,
            "start_logit": 2.911166191101074,
            "end_logit": 2.7825818061828613,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "information collection, prevention, diagnosis, treatment",
            "probability": 0.03204829937457646,
            "start_logit": 2.723538875579834,
            "end_logit": 2.7825818061828613,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "diagnosis, treatment and monitoring. Our team has developed a mobile health and fitness",
            "probability": 0.013708366236954593,
            "start_logit": 3.561788558959961,
            "end_logit": 1.0950943231582642,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "prevention, diagnosis, treatment and monitoring. Our team has developed a mobile health and fitness",
            "probability": 0.010870214930191708,
            "start_logit": 3.3298087120056152,
            "end_logit": 1.0950943231582642,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "health care chain, i.e. information collection, prevention",
            "probability": 0.007753931793619587,
            "start_logit": 0.7351147532463074,
            "end_logit": 3.351961851119995,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "health care chain, i.e. information collection, prevention, diagnosis",
            "probability": 0.007523600859402142,
            "start_logit": 0.7351147532463074,
            "end_logit": 3.3218066692352295,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "treatment and monitoring. Our team has developed a mobile health and fitness",
            "probability": 0.00715194217594622,
            "start_logit": 2.911166191101074,
            "end_logit": 1.0950943231582642,
            "question_text": "What are the mobile applications fields of use for patients ?"
        },
        {
            "text": "monitoring. Our team has developed a mobile health and fitness",
            "probability": 0.005956754132816808,
            "start_logit": 2.7283079624176025,
            "end_logit": 1.0950943231582642,
            "question_text": "What are the mobile applications fields of use for patients ?"
        }
    ],
    "54f431d664850a5854000006": [
        {
            "text": "DKC1",
            "probability": 0.9158503725507399,
            "start_logit": 5.618937969207764,
            "end_logit": 5.091279983520508,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 gene",
            "probability": 0.07168524366345373,
            "start_logit": 5.618937969207764,
            "end_logit": 2.5437119007110596,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "the DKC1",
            "probability": 0.006546776710014724,
            "start_logit": 0.6780577898025513,
            "end_logit": 5.091279983520508,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Mutations in the DKC1",
            "probability": 0.0024060973200821243,
            "start_logit": -0.3229089677333832,
            "end_logit": 5.091279983520508,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC",
            "probability": 0.0014066976584053768,
            "start_logit": 5.618937969207764,
            "end_logit": -1.3873281478881836,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "the DKC1 gene",
            "probability": 0.0005124279005975171,
            "start_logit": 0.6780577898025513,
            "end_logit": 2.5437119007110596,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "D",
            "probability": 0.00031243308771387857,
            "start_logit": 5.618937969207764,
            "end_logit": -2.8919379711151123,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "1",
            "probability": 0.0002319380565303004,
            "start_logit": -2.6621999740600586,
            "end_logit": 5.091279983520508,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "Mutations in the DKC1 gene",
            "probability": 0.00018832953268085753,
            "start_logit": -0.3229089677333832,
            "end_logit": 2.5437119007110596,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "C1",
            "probability": 0.00018511952596334232,
            "start_logit": -2.8876686096191406,
            "end_logit": 5.091279983520508,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 gene are responsible for causing X-linked recessive dyskeratosis congenita (DKC)",
            "probability": 0.0001770744480793865,
            "start_logit": 5.618937969207764,
            "end_logit": -3.4597580432891846,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 gene are",
            "probability": 0.0001407107846452712,
            "start_logit": 5.618937969207764,
            "end_logit": -3.689621686935425,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 gene are responsible for causing X-linked recessive",
            "probability": 9.255340744903968e-05,
            "start_logit": 5.618937969207764,
            "end_logit": -4.108542442321777,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 gene are responsible for causing X-linked recessive dyskeratosis congenita",
            "probability": 7.687562935506917e-05,
            "start_logit": 5.618937969207764,
            "end_logit": -4.294139385223389,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "in the DKC1",
            "probability": 6.78365203360227e-05,
            "start_logit": -3.8915696144104004,
            "end_logit": 5.091279983520508,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "DKC1 gene are responsible",
            "probability": 5.4353304420729835e-05,
            "start_logit": 5.618937969207764,
            "end_logit": -4.640822887420654,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "KC1",
            "probability": 2.2460555772252596e-05,
            "start_logit": -4.9969096183776855,
            "end_logit": 5.091279983520508,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "1 gene",
            "probability": 1.8154205747491086e-05,
            "start_logit": -2.6621999740600586,
            "end_logit": 2.5437119007110596,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "C1 gene",
            "probability": 1.4489635778152221e-05,
            "start_logit": -2.8876686096191406,
            "end_logit": 2.5437119007110596,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        },
        {
            "text": "the DKC",
            "probability": 1.005550223496836e-05,
            "start_logit": 0.6780577898025513,
            "end_logit": -1.3873281478881836,
            "question_text": "Which are the genes responsible for Dyskeratosis Congenita?"
        }
    ],
    "5354f289288f4dae47000008": [
        {
            "text": "Cufflinks",
            "probability": 0.9852089951539005,
            "start_logit": 4.982823371887207,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Cufflink",
            "probability": 0.005401803548260371,
            "start_logit": 4.982823371887207,
            "end_logit": 0.18470340967178345,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Cufflinks.",
            "probability": 0.003907004875840597,
            "start_logit": 4.982823371887207,
            "end_logit": -0.13925841450691223,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "software program called Cufflinks",
            "probability": 0.0009148394240317839,
            "start_logit": -1.9990371465682983,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "an open-source software program called Cufflinks",
            "probability": 0.0008779281246562174,
            "start_logit": -2.0402209758758545,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Cu",
            "probability": 0.0007159813638559166,
            "start_logit": 4.982823371887207,
            "end_logit": -1.8361306190490723,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "open-source software program called Cufflinks",
            "probability": 0.000714602046210458,
            "start_logit": -2.2460598945617676,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Cufflinks. To test Cufflink",
            "probability": 0.00043214000867715125,
            "start_logit": 4.982823371887207,
            "end_logit": -2.3410351276397705,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "called Cufflinks",
            "probability": 0.00041468875448828253,
            "start_logit": -2.790257453918457,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Cufflinks. To test Cufflinks",
            "probability": 0.00040264044902114596,
            "start_logit": 4.982823371887207,
            "end_logit": -2.411740779876709,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "program called Cufflinks",
            "probability": 0.0002717688318954337,
            "start_logit": -3.212833881378174,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "in an open-source software program called Cufflinks",
            "probability": 0.000218750338389019,
            "start_logit": -3.42985463142395,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "s",
            "probability": 0.0001781309444342333,
            "start_logit": -3.6352667808532715,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "algorithms in an open-source software program called Cufflinks",
            "probability": 0.00010584450211662183,
            "start_logit": -4.1558146476745605,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Cuff",
            "probability": 9.321640780144506e-05,
            "start_logit": 4.982823371887207,
            "end_logit": -3.874861001968384,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "introduce such algorithms in an open-source software program called Cufflinks",
            "probability": 6.491219985539785e-05,
            "start_logit": -4.644750118255615,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "Here we introduce such algorithms in an open-source software program called Cufflinks",
            "probability": 6.300536689029168e-05,
            "start_logit": -4.67456579208374,
            "end_logit": 5.390824317932129,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "software program called Cufflink",
            "probability": 5.015974144705616e-06,
            "start_logit": -1.9990371465682983,
            "end_logit": 0.18470340967178345,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "an open-source software program called Cufflink",
            "probability": 4.813593138321594e-06,
            "start_logit": -2.0402209758758545,
            "end_logit": 0.18470340967178345,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        },
        {
            "text": "open-source software program called Cufflink",
            "probability": 3.918092392376886e-06,
            "start_logit": -2.2460598945617676,
            "end_logit": 0.18470340967178345,
            "question_text": "Name five programs for transcript quantification from RNASeq experiments"
        }
    ],
    "570a5343cf1c325851000022": [
        {
            "text": "R151C, R160W",
            "probability": 0.1278828414678603,
            "start_logit": 4.845196723937988,
            "end_logit": 4.357065677642822,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R151C",
            "probability": 0.12727110156182744,
            "start_logit": 4.845196723937988,
            "end_logit": 4.352270603179932,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R151C, R160W; NRHC: V60L, R163Q",
            "probability": 0.10020748183756356,
            "start_logit": 4.845196723937988,
            "end_logit": 4.113193988800049,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R160W",
            "probability": 0.09677174529442399,
            "start_logit": 4.566437244415283,
            "end_logit": 4.357065677642822,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R163Q",
            "probability": 0.0853288802431681,
            "start_logit": 4.68446683883667,
            "end_logit": 4.113193988800049,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R160W; NRHC: V60L, R163Q",
            "probability": 0.0758291948917748,
            "start_logit": 4.566437244415283,
            "end_logit": 4.113193988800049,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R151C, R160W; NRHC: V60L",
            "probability": 0.06355829677289346,
            "start_logit": 4.845196723937988,
            "end_logit": 3.6579086780548096,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R160W; NRHC: V60L",
            "probability": 0.04809595435991032,
            "start_logit": 4.566437244415283,
            "end_logit": 3.6579086780548096,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R163Q and the synonymous polymorphism T314T",
            "probability": 0.044577503336007115,
            "start_logit": 4.68446683883667,
            "end_logit": 3.4639103412628174,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "V60L, R163Q",
            "probability": 0.040206058006502406,
            "start_logit": 3.931971549987793,
            "end_logit": 4.113193988800049,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "R160W; NRHC: V60L, R163Q and the synonymous polymorphism T314T",
            "probability": 0.039614678859277164,
            "start_logit": 4.566437244415283,
            "end_logit": 3.4639103412628174,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "V60L",
            "probability": 0.02550137494711025,
            "start_logit": 3.931971549987793,
            "end_logit": 3.6579086780548096,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "V60L, R163Q and the synonymous polymorphism T314T",
            "probability": 0.021004443979634396,
            "start_logit": 3.931971549987793,
            "end_logit": 3.4639103412628174,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "RHC: D84E, R151C, R160W",
            "probability": 0.01799082836570771,
            "start_logit": 2.883944272994995,
            "end_logit": 4.357065677642822,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "RHC: D84E, R151C",
            "probability": 0.01790476750306526,
            "start_logit": 2.883944272994995,
            "end_logit": 4.352270603179932,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "D84E, R151C, R160W",
            "probability": 0.01720292135868188,
            "start_logit": 2.8391613960266113,
            "end_logit": 4.357065677642822,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "D84E, R151C",
            "probability": 0.017120629525198525,
            "start_logit": 2.8391613960266113,
            "end_logit": 4.352270603179932,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "D84E, R151C, R160W; NRHC: V60L, R163Q",
            "probability": 0.013480005681891201,
            "start_logit": 2.8391613960266113,
            "end_logit": 4.113193988800049,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "T314T",
            "probability": 0.011509776513062538,
            "start_logit": 3.3304343223571777,
            "end_logit": 3.4639103412628174,
            "question_text": "List variants of the MC1R gene."
        },
        {
            "text": "RHC: D84E, R151C, R160W; NRHC: V60L",
            "probability": 0.008941515494439636,
            "start_logit": 2.883944272994995,
            "end_logit": 3.6579086780548096,
            "question_text": "List variants of the MC1R gene."
        }
    ],
    "5713b29f1174fb175500000f": [
        {
            "text": "distal hereditary motor neuropathy type V and Silver's syndrome",
            "probability": 0.4497290938604159,
            "start_logit": 5.216970920562744,
            "end_logit": 5.158914089202881,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary motor neuropathy type V",
            "probability": 0.3592203099600556,
            "start_logit": 5.216970920562744,
            "end_logit": 4.934204578399658,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "Silver's syndrome",
            "probability": 0.06702196331830758,
            "start_logit": 3.3133459091186523,
            "end_logit": 5.158914089202881,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary motor neuropathy",
            "probability": 0.06358637705911474,
            "start_logit": 5.216970920562744,
            "end_logit": 3.2026679515838623,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "motor neuropathy type V and Silver's syndrome",
            "probability": 0.012240769404694202,
            "start_logit": 1.6130976676940918,
            "end_logit": 5.158914089202881,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "motor neuron diseases, distal hereditary motor neuropathy type V and Silver's syndrome",
            "probability": 0.010729949354786862,
            "start_logit": 1.481364369392395,
            "end_logit": 5.158914089202881,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "motor neuropathy type V",
            "probability": 0.00977729268515719,
            "start_logit": 1.6130976676940918,
            "end_logit": 4.934204578399658,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "motor neuron diseases, distal hereditary motor neuropathy type V",
            "probability": 0.008570527870448482,
            "start_logit": 1.481364369392395,
            "end_logit": 4.934204578399658,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "autosomal dominant motor neuron diseases, distal hereditary motor neuropathy type V and Silver's syndrome",
            "probability": 0.004010286111825057,
            "start_logit": 0.49718812108039856,
            "end_logit": 5.158914089202881,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "autosomal dominant motor neuron diseases, distal hereditary motor neuropathy type V",
            "probability": 0.0032032088645913134,
            "start_logit": 0.49718812108039856,
            "end_logit": 4.934204578399658,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary motor neuropathy type V and Silver's syndrome.",
            "probability": 0.0020194031467027852,
            "start_logit": 5.216970920562744,
            "end_logit": -0.24692930281162262,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "motor neuropathy",
            "probability": 0.0017307000803068774,
            "start_logit": 1.6130976676940918,
            "end_logit": 3.2026679515838623,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "motor neuron diseases, distal hereditary motor neuropathy",
            "probability": 0.0015170879865522861,
            "start_logit": 1.481364369392395,
            "end_logit": 3.2026679515838623,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "hereditary motor neuropathy type V and Silver's syndrome",
            "probability": 0.0014056196670783657,
            "start_logit": -0.5511962175369263,
            "end_logit": 5.158914089202881,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "hereditary motor neuropathy type V",
            "probability": 0.0011227361969393885,
            "start_logit": -0.5511962175369263,
            "end_logit": 4.934204578399658,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "motor neuron diseases",
            "probability": 0.000978089806504998,
            "start_logit": 1.481364369392395,
            "end_logit": 2.763721466064453,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "type V and Silver's syndrome",
            "probability": 0.0009207613547445902,
            "start_logit": -0.9742288589477539,
            "end_logit": 5.158914089202881,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "distal hereditary",
            "probability": 0.0009133597396854984,
            "start_logit": 5.216970920562744,
            "end_logit": -1.0403567552566528,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "type V",
            "probability": 0.0007354564865070758,
            "start_logit": -0.9742288589477539,
            "end_logit": 4.934204578399658,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        },
        {
            "text": "autosomal dominant motor neuron diseases, distal hereditary motor neuropathy",
            "probability": 0.00056700704558061,
            "start_logit": 0.49718812108039856,
            "end_logit": 3.2026679515838623,
            "question_text": "Which phenotypes are associated with heterozygous mutations of the BSCL2 gene?"
        }
    ],
    "5141bcd423fec9037500000d": [
        {
            "text": "gastrin-17",
            "probability": 0.22057826002274308,
            "start_logit": -0.9216960668563843,
            "end_logit": -1.9962350130081177,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "gastrin-17 (G17) on angiogenesis features in gliomas both in vitro and in vivo.",
            "probability": 0.21525699694249847,
            "start_logit": -0.9216960668563843,
            "end_logit": -2.0206549167633057,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "gastrin-17 (G17)",
            "probability": 0.1250567131208063,
            "start_logit": -0.9216960668563843,
            "end_logit": -2.563720226287842,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "gastrin-17 (G17) on angiogenesis features in gliomas",
            "probability": 0.0676450195389715,
            "start_logit": -0.9216960668563843,
            "end_logit": -3.1782138347625732,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "gastrin-17 (G17) on angiogenesis",
            "probability": 0.0590232365037958,
            "start_logit": -0.9216960668563843,
            "end_logit": -3.314556360244751,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "This study aims to investigate the role of gastrin-17",
            "probability": 0.04007584425840625,
            "start_logit": -2.6271748542785645,
            "end_logit": -1.9962350130081177,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "gastrin-17 (G17",
            "probability": 0.03429483095953026,
            "start_logit": -0.9216960668563843,
            "end_logit": -3.8574929237365723,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "gliomas both in vitro and in vivo.",
            "probability": 0.03142387953693054,
            "start_logit": -2.8459606170654297,
            "end_logit": -2.0206549167633057,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "study aims to investigate the role of gastrin-17",
            "probability": 0.02329227207850379,
            "start_logit": -3.1698269844055176,
            "end_logit": -1.9962350130081177,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "This study aims to investigate the role of gastrin-17 (G17)",
            "probability": 0.022720976029010645,
            "start_logit": -2.6271748542785645,
            "end_logit": -2.563720226287842,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "(G17) on angiogenesis features in gliomas both in vitro and in vivo.",
            "probability": 0.02030039417366422,
            "start_logit": -3.282888412475586,
            "end_logit": -2.0206549167633057,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "gastrin",
            "probability": 0.02015744974030696,
            "start_logit": -0.9216960668563843,
            "end_logit": -4.388913631439209,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "gastrin-17 (",
            "probability": 0.019924204374585315,
            "start_logit": -0.9216960668563843,
            "end_logit": -4.400552272796631,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "to investigate the role of gastrin-17",
            "probability": 0.01896199993828558,
            "start_logit": -3.375511646270752,
            "end_logit": -1.9962350130081177,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "angiogenesis features in gliomas both in vitro and in vivo.",
            "probability": 0.015104895675130906,
            "start_logit": -3.57850980758667,
            "end_logit": -2.0206549167633057,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "investigate the role of gastrin-17",
            "probability": 0.014692048716990072,
            "start_logit": -3.6306421756744385,
            "end_logit": -1.9962350130081177,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "study aims to investigate the role of gastrin-17 (G17)",
            "probability": 0.013205539779635948,
            "start_logit": -3.1698269844055176,
            "end_logit": -2.563720226287842,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "role of gastrin-17",
            "probability": 0.013156356841968508,
            "start_logit": -3.7410435676574707,
            "end_logit": -1.9962350130081177,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "role of gastrin-17 (G17) on angiogenesis features in gliomas both in vitro and in vivo.",
            "probability": 0.012838970913153619,
            "start_logit": -3.7410435676574707,
            "end_logit": -2.0206549167633057,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        },
        {
            "text": "This study aims to investigate the role of gastrin-17 (G17) on angiogenesis features in gliomas",
            "probability": 0.012290110855082246,
            "start_logit": -2.6271748542785645,
            "end_logit": -3.1782138347625732,
            "question_text": "The CXCR2 receptor is targeted in cancer. Name five antagonists."
        }
    ],
    "52bf1af803868f1b06000008": [
        {
            "text": "familial hypertrophic cardiomyopathy",
            "probability": 0.7135393080098674,
            "start_logit": 5.054114818572998,
            "end_logit": 4.808719158172607,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "hypertrophic cardiomyopathy",
            "probability": 0.2331280342979305,
            "start_logit": 3.935465097427368,
            "end_logit": 4.808719158172607,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "familial hypertrophic cardiomyopathy (FHC)",
            "probability": 0.025460157949997068,
            "start_logit": 5.054114818572998,
            "end_logit": 1.4755964279174805,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "cardiomyopathy",
            "probability": 0.011782604746776455,
            "start_logit": 0.950501561164856,
            "end_logit": 4.808719158172607,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "hypertrophic cardiomyopathy (FHC)",
            "probability": 0.008318359632284705,
            "start_logit": 3.935465097427368,
            "end_logit": 1.4755964279174805,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "lial hypertrophic cardiomyopathy",
            "probability": 0.002673419735340089,
            "start_logit": -0.5327642560005188,
            "end_logit": 4.808719158172607,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "familial hypertrophic card",
            "probability": 0.000983861375877904,
            "start_logit": 5.054114818572998,
            "end_logit": -1.7777886390686035,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "amilial hypertrophic cardiomyopathy",
            "probability": 0.0005433491825761619,
            "start_logit": -2.1261258125305176,
            "end_logit": 4.808719158172607,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "familial",
            "probability": 0.00047999226251279893,
            "start_logit": 5.054114818572998,
            "end_logit": -2.4955036640167236,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "cardiomyopathy (FHC)",
            "probability": 0.0004204210960038171,
            "start_logit": 0.950501561164856,
            "end_logit": 1.4755964279174805,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "myopathy",
            "probability": 0.0004199069483467279,
            "start_logit": -2.3838448524475098,
            "end_logit": 4.808719158172607,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "familial hypertrophic",
            "probability": 0.00041328849108653867,
            "start_logit": 5.054114818572998,
            "end_logit": -2.645127773284912,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "hypertrophic card",
            "probability": 0.000321447838970213,
            "start_logit": 3.935465097427368,
            "end_logit": -1.7777886390686035,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "ypertrophic cardiomyopathy",
            "probability": 0.00030823953574418326,
            "start_logit": -2.6930007934570312,
            "end_logit": 4.808719158172607,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "familial h",
            "probability": 0.000280844720004118,
            "start_logit": 5.054114818572998,
            "end_logit": -3.0314717292785645,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "f",
            "probability": 0.0002228290766652194,
            "start_logit": 5.054114818572998,
            "end_logit": -3.262868642807007,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "athy",
            "probability": 0.00020828965567082488,
            "start_logit": -3.0849483013153076,
            "end_logit": 4.808719158172607,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "familial hypertrophic cardiomyopathy (FHC). An Australian cohort of 252 unrelated f",
            "probability": 0.00017072372892642008,
            "start_logit": 5.054114818572998,
            "end_logit": -3.5292270183563232,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "hypertrophic",
            "probability": 0.00016713348515353134,
            "start_logit": 3.8673219680786133,
            "end_logit": -2.3636879920959473,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        },
        {
            "text": "hypertrophic cardiomyopathy (FHC). An Australian cohort of 252 unrelated familial",
            "probability": 0.00015778823026565026,
            "start_logit": 3.935465097427368,
            "end_logit": -2.489370107650757,
            "question_text": "Which diseases are caused by mutations in Calsequestrin 2 (CASQ2) gene?"
        }
    ],
    "550303a5e9bde6963400000c": [
        {
            "text": "chronic obstructive pulmonary disease",
            "probability": 0.84566235919675,
            "start_logit": 5.1605000495910645,
            "end_logit": 4.740762710571289,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic obstructive pulmonary disease (COPD)",
            "probability": 0.07189447494256015,
            "start_logit": 5.1605000495910645,
            "end_logit": 2.2758419513702393,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic obstructive pulmonary",
            "probability": 0.03810164143124997,
            "start_logit": 5.1605000495910645,
            "end_logit": 1.640899896621704,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory Illness Project. This project supported community-based patients suffering from chronic obstructive pulmonary disease",
            "probability": 0.017396934990799702,
            "start_logit": 1.2766739130020142,
            "end_logit": 4.740762710571289,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "obstructive pulmonary disease",
            "probability": 0.017363258842516247,
            "start_logit": 1.2747362852096558,
            "end_logit": 4.740762710571289,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic obstructive",
            "probability": 0.0015519106761343756,
            "start_logit": 5.1605000495910645,
            "end_logit": -1.5598706007003784,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "pulmonary disease",
            "probability": 0.0014926155526491223,
            "start_logit": -1.179090142250061,
            "end_logit": 4.740762710571289,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory Illness Project. This project supported community-based patients suffering from chronic obstructive pulmonary disease (COPD)",
            "probability": 0.0014790104977137827,
            "start_logit": 1.2766739130020142,
            "end_logit": 2.2758419513702393,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "obstructive pulmonary disease (COPD)",
            "probability": 0.0014761475004754685,
            "start_logit": 1.2747362852096558,
            "end_logit": 2.2758419513702393,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory Illness Project. This project supported community-based patients suffering from chronic obstructive pulmonary",
            "probability": 0.0007838255679865236,
            "start_logit": 1.2766739130020142,
            "end_logit": 1.640899896621704,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "obstructive pulmonary",
            "probability": 0.0007823082762296805,
            "start_logit": 1.2747362852096558,
            "end_logit": 1.640899896621704,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "disease",
            "probability": 0.0005164849455749892,
            "start_logit": -2.2403292655944824,
            "end_logit": 4.740762710571289,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic",
            "probability": 0.000460682211090172,
            "start_logit": 5.1605000495910645,
            "end_logit": -2.774404287338257,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory Illness",
            "probability": 0.00030142822986448136,
            "start_logit": 1.2766739130020142,
            "end_logit": 0.6852453351020813,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "tructive pulmonary disease",
            "probability": 0.00021084398945335066,
            "start_logit": -3.1362569332122803,
            "end_logit": 4.740762710571289,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "pulmonary disease (COPD)",
            "probability": 0.00012689557514506943,
            "start_logit": -1.179090142250061,
            "end_logit": 2.2758419513702393,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Illness Project. This project supported community-based patients suffering from chronic obstructive pulmonary disease",
            "probability": 0.00012611721549546275,
            "start_logit": -3.6501636505126953,
            "end_logit": 4.740762710571289,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "Respiratory",
            "probability": 0.00010882994776098327,
            "start_logit": 1.2766739130020142,
            "end_logit": -0.33350005745887756,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic o",
            "probability": 8.645808445733467e-05,
            "start_logit": 5.1605000495910645,
            "end_logit": -4.447453022003174,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        },
        {
            "text": "chronic obstructive pulmonary disease (",
            "probability": 7.777232609314931e-05,
            "start_logit": 5.1605000495910645,
            "end_logit": -4.5533270835876465,
            "question_text": "In which diseases have electronic patient diaries been applied ?"
        }
    ],
    "51bdf045047fa84d1d000003": [
        {
            "text": "MAP1LC3",
            "probability": 0.8824190207292401,
            "start_logit": 5.786729335784912,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "MAP1",
            "probability": 0.07416215738844434,
            "start_logit": 5.786729335784912,
            "end_logit": 1.0914766788482666,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "MAP",
            "probability": 0.01707655888155377,
            "start_logit": 5.786729335784912,
            "end_logit": -0.3770706355571747,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "MAP1LC3 protein family",
            "probability": 0.008181163674133286,
            "start_logit": 5.786729335784912,
            "end_logit": -1.1129429340362549,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "MAP1LC",
            "probability": 0.005665403291657999,
            "start_logit": 5.786729335784912,
            "end_logit": -1.480399250984192,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "MAP1LC3 protein",
            "probability": 0.0031641627045832232,
            "start_logit": 5.786729335784912,
            "end_logit": -2.0628888607025146,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "MAP1LC3 protein family in mammals)",
            "probability": 0.0028778573407520847,
            "start_logit": 5.786729335784912,
            "end_logit": -2.157731294631958,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "MAP1LC3 protein family in mammals",
            "probability": 0.0027626863048543474,
            "start_logit": 5.786729335784912,
            "end_logit": -2.1985738277435303,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "NBR1, which can bind to autophagic effector proteins (Atg8 in yeast, MAP1LC3",
            "probability": 0.0013508323692486093,
            "start_logit": -0.695216715335846,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "yeast, MAP1LC3",
            "probability": 0.0005713191361528157,
            "start_logit": -1.555745005607605,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "3",
            "probability": 0.00036879252340623014,
            "start_logit": -1.9934587478637695,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "autophagic effector proteins (Atg8 in yeast, MAP1LC3",
            "probability": 0.00028650803651471485,
            "start_logit": -2.2459263801574707,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "LC3",
            "probability": 0.00023200457330943165,
            "start_logit": -2.4569358825683594,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "1LC3",
            "probability": 0.00020191595749147643,
            "start_logit": -2.595841407775879,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "MAP1LC3 protein family in mammals) anchored in the membrane of autophagosomes.",
            "probability": 0.00015015634219384688,
            "start_logit": 5.786729335784912,
            "end_logit": -5.110855579376221,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": ", MAP1LC3",
            "probability": 0.0001443296652871938,
            "start_logit": -2.9315929412841797,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "C3",
            "probability": 0.00013400351306467194,
            "start_logit": -3.005826950073242,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "NBR1, which can bind to autophagic effector proteins (Atg8 in yeast, MAP1",
            "probability": 0.00011352955956324492,
            "start_logit": -0.695216715335846,
            "end_logit": 1.0914766788482666,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "(Atg8 in yeast, MAP1LC3",
            "probability": 8.958197682331118e-05,
            "start_logit": -3.408538818359375,
            "end_logit": 3.56788969039917,
            "question_text": "Which are the Atg8 homologs in human?"
        },
        {
            "text": "yeast, MAP1",
            "probability": 4.801603172535874e-05,
            "start_logit": -1.555745005607605,
            "end_logit": 1.0914766788482666,
            "question_text": "Which are the Atg8 homologs in human?"
        }
    ],
    "515db020298dcd4e51000011": [
        {
            "text": "recent clinical trial results",
            "probability": 0.12336824381597715,
            "start_logit": -2.1802175045013428,
            "end_logit": -3.271836519241333,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "recent clinical trial results and clinical guidelines",
            "probability": 0.1203112442208067,
            "start_logit": -2.1802175045013428,
            "end_logit": -3.2969281673431396,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "recent clinical trial results and clinical guidelines, combinations of a high-dose statin",
            "probability": 0.06945051767895721,
            "start_logit": -2.1802175045013428,
            "end_logit": -3.84639573097229,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "recent clinical trial",
            "probability": 0.05823990509271008,
            "start_logit": -2.1802175045013428,
            "end_logit": -4.022439479827881,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "clinical trial results",
            "probability": 0.055696210661601,
            "start_logit": -2.9754791259765625,
            "end_logit": -3.271836519241333,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "recent clinical trial results and clinical guidelines, combinations of a high-dose statin, low to standard doses of antihypertensive therapy",
            "probability": 0.05534806530909921,
            "start_logit": -2.1802175045013428,
            "end_logit": -4.073368549346924,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "clinical trial results and clinical guidelines",
            "probability": 0.05431608812618568,
            "start_logit": -2.9754791259765625,
            "end_logit": -3.2969281673431396,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "cardiac rehabilitation, and diet were evaluated",
            "probability": 0.050911999511914004,
            "start_logit": -3.095029592514038,
            "end_logit": -3.2420995235443115,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "recent",
            "probability": 0.05082585365811312,
            "start_logit": -2.1802175045013428,
            "end_logit": -4.158605098724365,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "evaluated",
            "probability": 0.049879478473629224,
            "start_logit": -3.115518569946289,
            "end_logit": -3.2420995235443115,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "recent clinical trial results and clinical guidelines,",
            "probability": 0.03955815689904242,
            "start_logit": -2.1802175045013428,
            "end_logit": -4.409238338470459,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Based on recent clinical trial results",
            "probability": 0.037082679112075675,
            "start_logit": -3.3822412490844727,
            "end_logit": -3.271836519241333,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "Based on recent clinical trial results and clinical guidelines",
            "probability": 0.0361637900079838,
            "start_logit": -3.3822412490844727,
            "end_logit": -3.2969281673431396,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "stroke. Based on recent clinical trial results",
            "probability": 0.03437414726196671,
            "start_logit": -3.4580864906311035,
            "end_logit": -3.271836519241333,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "stroke. Based on recent clinical trial results and clinical guidelines",
            "probability": 0.03352237413937199,
            "start_logit": -3.4580864906311035,
            "end_logit": -3.2969281673431396,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "clinical trial results and clinical guidelines, combinations of a high-dose statin",
            "probability": 0.03135434649596181,
            "start_logit": -2.9754791259765625,
            "end_logit": -3.84639573097229,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "clinical trial",
            "probability": 0.02629316850610091,
            "start_logit": -2.9754791259765625,
            "end_logit": -4.022439479827881,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "clinical guidelines",
            "probability": 0.02605080674431776,
            "start_logit": -3.7102508544921875,
            "end_logit": -3.2969281673431396,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "clinical trial results and clinical guidelines, combinations of a high-dose statin, low to standard doses of antihypertensive therapy",
            "probability": 0.02498760953236824,
            "start_logit": -2.9754791259765625,
            "end_logit": -4.073368549346924,
            "question_text": "List all clinical trials of the polypill."
        },
        {
            "text": "antihypertensive therapy, aspirin, omega-3 fish oil, cardiac rehabilitation, and diet were evaluated",
            "probability": 0.022265314751817027,
            "start_logit": -3.922098159790039,
            "end_logit": -3.2420995235443115,
            "question_text": "List all clinical trials of the polypill."
        }
    ],
    "533c2a55c45e133714000003": [
        {
            "text": "merlin",
            "probability": 0.12124340806754574,
            "start_logit": 5.844383716583252,
            "end_logit": 5.36818790435791,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "salvador, merlin",
            "probability": 0.11671969131431245,
            "start_logit": 5.806358814239502,
            "end_logit": 5.36818790435791,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAP1",
            "probability": 0.11231478036971652,
            "start_logit": 5.8793044090271,
            "end_logit": 5.256772518157959,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "salvador",
            "probability": 0.08829768961559976,
            "start_logit": 5.806358814239502,
            "end_logit": 5.0891265869140625,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "merlin, LATS",
            "probability": 0.08741500791332214,
            "start_logit": 5.844383716583252,
            "end_logit": 5.041054725646973,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "merlin, LATS, and YAP1",
            "probability": 0.0867290730163685,
            "start_logit": 5.844383716583252,
            "end_logit": 5.033176898956299,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "salvador, merlin, LATS",
            "probability": 0.08415346370168786,
            "start_logit": 5.806358814239502,
            "end_logit": 5.041054725646973,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "salvador, merlin, LATS, and YAP1",
            "probability": 0.08349312174404888,
            "start_logit": 5.806358814239502,
            "end_logit": 5.033176898956299,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "LATS",
            "probability": 0.07459370814293345,
            "start_logit": 5.685772895812988,
            "end_logit": 5.041054725646973,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "LATS, and YAP1",
            "probability": 0.07400838042027112,
            "start_logit": 5.685772895812988,
            "end_logit": 5.033176898956299,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAP1, the ortholog of Drosophila Yorkie",
            "probability": 0.01802726579905585,
            "start_logit": 5.8793044090271,
            "end_logit": 3.4273524284362793,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAP",
            "probability": 0.008447875970292408,
            "start_logit": 5.8793044090271,
            "end_logit": 2.669382095336914,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "merlin, LATS, and YAP1, have been implicated in tumorigenesis. We report here that YAP1",
            "probability": 0.007210553686263739,
            "start_logit": 5.844383716583252,
            "end_logit": 2.545933485031128,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "merlin, LATS, and YAP",
            "probability": 0.006571996085814429,
            "start_logit": 5.844383716583252,
            "end_logit": 2.4532053470611572,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "salvador, merlin, LATS, and YAP",
            "probability": 0.006326788125485405,
            "start_logit": 5.806358814239502,
            "end_logit": 2.4532053470611572,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "LATS, and YAP1, have been implicated in tumorigenesis. We report here that YAP1",
            "probability": 0.006152970182825317,
            "start_logit": 5.685772895812988,
            "end_logit": 2.545933485031128,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAP1, have been implicated in tumorigenesis. We report here that YAP1",
            "probability": 0.006020054164953667,
            "start_logit": 5.663934230804443,
            "end_logit": 2.545933485031128,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "LATS, and YAP",
            "probability": 0.0056080708524082964,
            "start_logit": 5.685772895812988,
            "end_logit": 2.4532053470611572,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "YAP1,",
            "probability": 0.004487112310292671,
            "start_logit": 5.8793044090271,
            "end_logit": 2.0366764068603516,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        },
        {
            "text": "merlin, LATS, and YAP1,",
            "probability": 0.002178988516801776,
            "start_logit": 5.844383716583252,
            "end_logit": 1.3492485284805298,
            "question_text": "Which are the mammalian orthologs of Drosophila Yki?"
        }
    ],
    "5548da00f35db7552600000b": [
        {
            "text": "Myosin 1 beta",
            "probability": 0.2595668630851124,
            "start_logit": 3.916220188140869,
            "end_logit": 3.0213675498962402,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "Myosin 1 beta, VI, VIIa and probably XV",
            "probability": 0.23664815043867354,
            "start_logit": 3.916220188140869,
            "end_logit": 2.9289276599884033,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "Myosin 1 beta, VI, VIIa",
            "probability": 0.17349382476855615,
            "start_logit": 3.916220188140869,
            "end_logit": 2.618495225906372,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "XV",
            "probability": 0.07613503760768661,
            "start_logit": 2.7821543216705322,
            "end_logit": 2.9289276599884033,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "Myosin 1 beta, VI",
            "probability": 0.04262996997052918,
            "start_logit": 3.916220188140869,
            "end_logit": 1.2149107456207275,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "VIIa and probably XV",
            "probability": 0.03839835252576445,
            "start_logit": 2.0976603031158447,
            "end_logit": 2.9289276599884033,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "VI, VIIa and probably XV",
            "probability": 0.03670328215390707,
            "start_logit": 2.0525119304656982,
            "end_logit": 2.9289276599884033,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "VIIa",
            "probability": 0.02815097870892772,
            "start_logit": 2.0976603031158447,
            "end_logit": 2.618495225906372,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "VI, VIIa",
            "probability": 0.0269082720090433,
            "start_logit": 2.0525119304656982,
            "end_logit": 2.618495225906372,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "1 beta",
            "probability": 0.024332070166559888,
            "start_logit": 1.5490010976791382,
            "end_logit": 3.0213675498962402,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "1 beta, VI, VIIa and probably XV",
            "probability": 0.022183645989404747,
            "start_logit": 1.5490010976791382,
            "end_logit": 2.9289276599884033,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "1 beta, VI, VIIa",
            "probability": 0.016263493219275563,
            "start_logit": 1.5490010976791382,
            "end_logit": 2.618495225906372,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "VI",
            "probability": 0.006611755947132972,
            "start_logit": 2.0525119304656982,
            "end_logit": 1.2149107456207275,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "Myosin 1",
            "probability": 0.005987697548487337,
            "start_logit": 3.916220188140869,
            "end_logit": -0.7479398250579834,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "1 beta, VI",
            "probability": 0.003996178126100529,
            "start_logit": 1.5490010976791382,
            "end_logit": 1.2149107456207275,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "My",
            "probability": 0.0006461747419148259,
            "start_logit": 3.916220188140869,
            "end_logit": -2.974332094192505,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "1",
            "probability": 0.0005612930524115458,
            "start_logit": 1.5490010976791382,
            "end_logit": -0.7479398250579834,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "Myosin 1 beta, V",
            "probability": 0.0002964934416482028,
            "start_logit": 3.916220188140869,
            "end_logit": -3.7533769607543945,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "beta",
            "probability": 0.0002544674781390391,
            "start_logit": -3.01137638092041,
            "end_logit": 3.0213675498962402,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        },
        {
            "text": "beta, VI, VIIa and probably XV",
            "probability": 0.00023199902072496516,
            "start_logit": -3.01137638092041,
            "end_logit": 2.9289276599884033,
            "question_text": "Which myosin isozymes are located within the pericuticular necklace of the hair cell?"
        }
    ],
    "530db83b38c1322806000002": [
        {
            "text": "Sef",
            "probability": 0.4119480450411364,
            "start_logit": 5.737082481384277,
            "end_logit": 5.849473476409912,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs, Sef",
            "probability": 0.34030423690483685,
            "start_logit": 5.546025276184082,
            "end_logit": 5.849473476409912,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs",
            "probability": 0.2147793263469053,
            "start_logit": 5.546025276184082,
            "end_logit": 5.389244556427002,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Sef, a known tumor suppressor and inhibitor of growth factor signaling, is\u00a0a spatial regulator of NF-\u03baB. Sef",
            "probability": 0.010871383786693565,
            "start_logit": 4.496251583099365,
            "end_logit": 3.4555411338806152,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Sef sequesters NF-\u03baB in the cytoplasm of resting cells. However, contrary to I\u03baBs",
            "probability": 0.009281809508272752,
            "start_logit": 5.737082481384277,
            "end_logit": 2.0566327571868896,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baB proteins and translocates into the nucleus upon their ligand-induced degradation. Here we reveal that Sef",
            "probability": 0.0062611255630336884,
            "start_logit": 2.839723587036133,
            "end_logit": 4.560295104980469,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs,",
            "probability": 0.0024686783218006913,
            "start_logit": 5.546025276184082,
            "end_logit": 0.9233163595199585,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baB",
            "probability": 0.0008930992819554346,
            "start_logit": 2.839723587036133,
            "end_logit": 2.612877607345581,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Like I\u03baBs, Sef",
            "probability": 0.0008692406792058945,
            "start_logit": -0.4239499866962433,
            "end_logit": 5.849473476409912,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Sef continues to constrain NF-\u03baB nuclear entry upon ligand stimulation. Accordingly, endogenous Sef",
            "probability": 0.0005597049307145551,
            "start_logit": 3.5427169799804688,
            "end_logit": 1.442596197128296,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Like I\u03baBs",
            "probability": 0.0005486118222071271,
            "start_logit": -0.4239499866962433,
            "end_logit": 5.389244556427002,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Sef,",
            "probability": 0.0002341555054552942,
            "start_logit": 4.496251583099365,
            "end_logit": -0.3823626935482025,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Sef sequesters NF-\u03baB",
            "probability": 0.00020948220923261036,
            "start_logit": 5.737082481384277,
            "end_logit": -1.7345402240753174,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs, Sef sequesters NF-\u03baB",
            "probability": 0.00017305018003162064,
            "start_logit": 5.546025276184082,
            "end_logit": -1.7345402240753174,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Sef sequesters NF-\u03baB in the cytoplasm of resting cells.",
            "probability": 0.00014711803847118613,
            "start_logit": 5.737082481384277,
            "end_logit": -2.0879437923431396,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I\u03baBs, Sef sequesters NF-\u03baB in the cytoplasm of resting cells.",
            "probability": 0.0001215320534216251,
            "start_logit": 5.546025276184082,
            "end_logit": -2.0879437923431396,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "f",
            "probability": 0.00011915047073638182,
            "start_logit": -2.4111828804016113,
            "end_logit": 5.849473476409912,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "tumor necrosis factor and interleukin-1, and Sef",
            "probability": 8.540314425607309e-05,
            "start_logit": -0.9233415126800537,
            "end_logit": 4.028627872467041,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "Sef sequesters NF-\u03baB in the cytoplasm of resting cells",
            "probability": 6.525897292190727e-05,
            "start_logit": 5.737082481384277,
            "end_logit": -2.900815486907959,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        },
        {
            "text": "I",
            "probability": 5.9587238711093966e-05,
            "start_logit": 5.546025276184082,
            "end_logit": -2.80068039894104,
            "question_text": "Which proteins cause cytoplasmic sequestration of NF-kB?"
        }
    ],
    "56c1f007ef6e39474100003b": [
        {
            "text": "TTFields), with chemotherapeutic treatment",
            "probability": 0.11805332015764132,
            "start_logit": -3.4711992740631104,
            "end_logit": -3.1730105876922607,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer treatment modality, termed Tumor Treating Fields (TTFields), with chemotherapeutic treatment",
            "probability": 0.10439992823212838,
            "start_logit": -3.594106674194336,
            "end_logit": -3.1730105876922607,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "chemotherapeutic treatment",
            "probability": 0.10054336547333512,
            "start_logit": -3.631746530532837,
            "end_logit": -3.1730105876922607,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "Tumor Treating Fields (TTFields), with chemotherapeutic treatment",
            "probability": 0.08003354957885327,
            "start_logit": -3.8598897457122803,
            "end_logit": -3.1730105876922607,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "TTFields),",
            "probability": 0.06910320091282422,
            "start_logit": -3.4711992740631104,
            "end_logit": -3.7085459232330322,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer treatment modality, termed Tumor Treating Fields (TTFields),",
            "probability": 0.06111110815244807,
            "start_logit": -3.594106674194336,
            "end_logit": -3.7085459232330322,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "TTFields",
            "probability": 0.052994455319600946,
            "start_logit": -3.4711992740631104,
            "end_logit": -3.9739596843719482,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.050556210365626734,
            "start_logit": -3.594106674194336,
            "end_logit": -3.898153781890869,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer treatment modality, termed Tumor Treating Fields (TTFields",
            "probability": 0.04686541068628266,
            "start_logit": -3.594106674194336,
            "end_logit": -3.9739596843719482,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "Tumor Treating Fields (TTFields),",
            "probability": 0.04684810599929573,
            "start_logit": -3.8598897457122803,
            "end_logit": -3.7085459232330322,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "Tumor Treating Fields (TTFields",
            "probability": 0.03592727728082516,
            "start_logit": -3.8598897457122803,
            "end_logit": -3.9739596843719482,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer treatment modality, termed Tumor Treating Fields",
            "probability": 0.030610072630570712,
            "start_logit": -3.594106674194336,
            "end_logit": -4.3999104499816895,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "non-toxic, cancer treatment modality, termed Tumor Treating Fields (TTFields), with chemotherapeutic treatment",
            "probability": 0.029121799181831536,
            "start_logit": -4.870848655700684,
            "end_logit": -3.1730105876922607,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "TTFields), with chemotherapeutic",
            "probability": 0.02817180208570626,
            "start_logit": -3.4711992740631104,
            "end_logit": -4.605825424194336,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "TTFields)",
            "probability": 0.026763018449901834,
            "start_logit": -3.4711992740631104,
            "end_logit": -4.657125949859619,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer treatment modality, termed Tumor Treating Fields (TTFields), with chemotherapeutic",
            "probability": 0.024913607783246115,
            "start_logit": -3.594106674194336,
            "end_logit": -4.605825424194336,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "chemotherapeutic",
            "probability": 0.023993292093465016,
            "start_logit": -3.631746530532837,
            "end_logit": -4.605825424194336,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "cancer treatment modality, termed Tumor Treating Fields (TTFields)",
            "probability": 0.023667756245346276,
            "start_logit": -3.594106674194336,
            "end_logit": -4.657125949859619,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "Tumor Treating Fields",
            "probability": 0.023465847218247043,
            "start_logit": -3.8598897457122803,
            "end_logit": -4.3999104499816895,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        },
        {
            "text": "chemotherapeutic treatment in-vitro, in-vivo and in a pilot clinical trial.",
            "probability": 0.022856872152823598,
            "start_logit": -3.631746530532837,
            "end_logit": -4.654347896575928,
            "question_text": "Tumor-treating fields are effective for treatment of which cancers?"
        }
    ],
    "56e46ad951531f7e3300001a": [
        {
            "text": "Slit2",
            "probability": 0.9197209162462862,
            "start_logit": 4.086416244506836,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Slit2,",
            "probability": 0.04944276718817261,
            "start_logit": 4.086416244506836,
            "end_logit": 1.311422348022461,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is one such tumor suppressive angiocrine factor.",
            "probability": 0.008291056141118837,
            "start_logit": 4.086416244506836,
            "end_logit": -0.4742160737514496,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Slit2, which is negatively regulated by endothelial EphA2",
            "probability": 0.006510889904370842,
            "start_logit": 4.086416244506836,
            "end_logit": -0.7159172892570496,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor,",
            "probability": 0.003262075231799977,
            "start_logit": 4.086416244506836,
            "end_logit": -1.4070298671722412,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Slit",
            "probability": 0.0027118023480626197,
            "start_logit": 4.086416244506836,
            "end_logit": -1.5917799472808838,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "tumor growth and motility. We found that Slit2",
            "probability": 0.002336786640347541,
            "start_logit": -1.888877272605896,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "endothelium regulate tumor growth and motility. We found that Slit2",
            "probability": 0.0018926882272985441,
            "start_logit": -2.099655866622925,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor",
            "probability": 0.0016919643120869167,
            "start_logit": 4.086416244506836,
            "end_logit": -2.0635032653808594,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "secreted from endothelium regulate tumor growth and motility. We found that Slit2",
            "probability": 0.0008404075209098872,
            "start_logit": -2.911522388458252,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "2",
            "probability": 0.0005725211597918282,
            "start_logit": -3.2953596115112305,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "angiocrine factors secreted from endothelium regulate tumor growth and motility. We found that Slit2",
            "probability": 0.0005698740176538934,
            "start_logit": -3.2999939918518066,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "that Slit2",
            "probability": 0.00038790975164958413,
            "start_logit": -3.6846365928649902,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "We found that Slit2",
            "probability": 0.00036569577998502777,
            "start_logit": -3.743607521057129,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "Slit2, which is negatively regulated by endothelial EphA2 receptor, is",
            "probability": 0.00030694009037567256,
            "start_logit": 4.086416244506836,
            "end_logit": -3.770496129989624,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "that angiocrine factors secreted from endothelium regulate tumor growth and motility. We found that Slit2",
            "probability": 0.0002746139193064624,
            "start_logit": -4.030043125152588,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "motility. We found that Slit2",
            "probability": 0.000263305225491776,
            "start_logit": -4.0720953941345215,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "regulate tumor growth and motility. We found that Slit2",
            "probability": 0.0002604233330184823,
            "start_logit": -4.08310079574585,
            "end_logit": 4.234676837921143,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "EphA2 receptor, is one such tumor suppressive angiocrine factor.",
            "probability": 0.00016656276187757837,
            "start_logit": 0.1788557916879654,
            "end_logit": -0.4742160737514496,
            "question_text": "List angiocrine factors"
        },
        {
            "text": "EphA2",
            "probability": 0.0001308002003960023,
            "start_logit": 0.1788557916879654,
            "end_logit": -0.7159172892570496,
            "question_text": "List angiocrine factors"
        }
    ],
    "530cf22aa177c6630c000005": [
        {
            "text": "GINS",
            "probability": 0.13976438724046594,
            "start_logit": 3.4001691341400146,
            "end_logit": 3.1978864669799805,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM-GINS) complex, which unwinds duplex DNA ahead of the moving replication fork. Eukaryotic GINS",
            "probability": 0.0988395151546511,
            "start_logit": 3.053708553314209,
            "end_logit": 3.1978864669799805,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "CMG (Cdc45-MCM-GINS) complex",
            "probability": 0.09656723533356863,
            "start_logit": 3.890989303588867,
            "end_logit": 2.3373477458953857,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "CMG (Cdc45-MCM-GINS",
            "probability": 0.09446626327860051,
            "start_logit": 3.890989303588867,
            "end_logit": 2.3153510093688965,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "GINS complex",
            "probability": 0.09101023603010157,
            "start_logit": 3.6897974014282227,
            "end_logit": 2.4792721271514893,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "CMG (Cdc45",
            "probability": 0.06107770675093314,
            "start_logit": 3.890989303588867,
            "end_logit": 1.8792551755905151,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "CMG",
            "probability": 0.05637679982040292,
            "start_logit": 3.890989303588867,
            "end_logit": 1.799165964126587,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "GINS complex is essential for the establishment of DNA replication forks and replisome progression. GINS",
            "probability": 0.05325145552559619,
            "start_logit": 3.6897974014282227,
            "end_logit": 1.9433252811431885,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "GINS) complex, which unwinds duplex DNA ahead of the moving replication fork. Eukaryotic GINS",
            "probability": 0.05062607751268817,
            "start_logit": 2.3846778869628906,
            "end_logit": 3.1978864669799805,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM-GINS) complex",
            "probability": 0.041802609034166535,
            "start_logit": 3.053708553314209,
            "end_logit": 2.3373477458953857,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM-GINS",
            "probability": 0.04089312754075764,
            "start_logit": 3.053708553314209,
            "end_logit": 2.3153510093688965,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "CMG (Cdc45-MCM-GINS)",
            "probability": 0.0308017643668146,
            "start_logit": 3.890989303588867,
            "end_logit": 1.1946802139282227,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "CMG (Cdc45-MCM",
            "probability": 0.025564025339248005,
            "start_logit": 3.890989303588867,
            "end_logit": 1.0082943439483643,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "GINS) complex",
            "probability": 0.021411498446598023,
            "start_logit": 2.3846778869628906,
            "end_logit": 2.3373477458953857,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "CMG (Cdc45-MCM-GINS) complex,",
            "probability": 0.0213921557926961,
            "start_logit": 3.890989303588867,
            "end_logit": 0.8301325440406799,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "GINS is one of the core components of the eukaryotic replicative helicase, the CMG (Cdc45",
            "probability": 0.018556370696849865,
            "start_logit": 2.699655532836914,
            "end_logit": 1.8792551755905151,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "GINS is one of the core components of the eukaryotic replicative helicase, the CMG",
            "probability": 0.017128161023391934,
            "start_logit": 2.699655532836914,
            "end_logit": 1.799165964126587,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "Cdc45-MCM-GINS) complex",
            "probability": 0.013717703612405846,
            "start_logit": 1.9394370317459106,
            "end_logit": 2.3373477458953857,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "Cdc45-MCM-GINS",
            "probability": 0.013419253399469273,
            "start_logit": 1.9394370317459106,
            "end_logit": 2.3153510093688965,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        },
        {
            "text": "MCM-GINS)",
            "probability": 0.013333654100594101,
            "start_logit": 3.053708553314209,
            "end_logit": 1.1946802139282227,
            "question_text": "List the components of a Replisome Progression Complex (RPC)."
        }
    ],
    "56bf487def6e394741000011": [
        {
            "text": "Aip1, Ede1",
            "probability": 0.2728993195614797,
            "start_logit": 4.348056793212891,
            "end_logit": 3.2732973098754883,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ede1",
            "probability": 0.23594414938004898,
            "start_logit": 4.202548980712891,
            "end_logit": 3.2732973098754883,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1",
            "probability": 0.2126540770901361,
            "start_logit": 4.348056793212891,
            "end_logit": 3.0238611698150635,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede1 and Inn1",
            "probability": 0.11023061815967254,
            "start_logit": 4.348056793212891,
            "end_logit": 2.3667690753936768,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ede1 and Inn1",
            "probability": 0.09530353347569151,
            "start_logit": 4.202548980712891,
            "end_logit": 2.3667690753936768,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Inn1",
            "probability": 0.046410172121612685,
            "start_logit": 3.4830007553100586,
            "end_logit": 2.3667690753936768,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip",
            "probability": 0.008476719666458356,
            "start_logit": 4.348056793212891,
            "end_logit": -0.19848208129405975,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede",
            "probability": 0.005942336320373589,
            "start_logit": 4.348056793212891,
            "end_logit": -0.553703248500824,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ede",
            "probability": 0.0051376437680155365,
            "start_logit": 4.202548980712891,
            "end_logit": -0.553703248500824,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede1 and Inn",
            "probability": 0.0017981486896190653,
            "start_logit": 4.348056793212891,
            "end_logit": -1.7490479946136475,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ede1 and Inn",
            "probability": 0.0015546490321513631,
            "start_logit": 4.202548980712891,
            "end_logit": -1.7490479946136475,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Cdc14",
            "probability": 0.0014590975631147878,
            "start_logit": 1.858406662940979,
            "end_logit": 0.53166264295578,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Inn",
            "probability": 0.0007570708717662246,
            "start_logit": 3.4830007553100586,
            "end_logit": -1.7490479946136475,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1,",
            "probability": 0.00043384466107158865,
            "start_logit": 4.348056793212891,
            "end_logit": -3.1708743572235107,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "A",
            "probability": 0.00022947946294350416,
            "start_logit": 4.348056793212891,
            "end_logit": -3.8077473640441895,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "ip1, Ede1",
            "probability": 0.00017634500117575338,
            "start_logit": -2.99635910987854,
            "end_logit": 3.2732973098754883,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ed",
            "probability": 0.00017519387017251987,
            "start_logit": 4.348056793212891,
            "end_logit": -4.077667713165283,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Ed",
            "probability": 0.0001514696655927045,
            "start_logit": 4.202548980712891,
            "end_logit": -4.077667713165283,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "ip1",
            "probability": 0.00013741508602787316,
            "start_logit": -2.99635910987854,
            "end_logit": 3.0238611698150635,
            "question_text": "Which CDK targets control cytokinesis?"
        },
        {
            "text": "Aip1, Ede1 and Inn1 as cytokinetic regulators. Our results suggest that cytokinesis",
            "probability": 0.00012871655287554772,
            "start_logit": 4.348056793212891,
            "end_logit": -4.385948181152344,
            "question_text": "Which CDK targets control cytokinesis?"
        }
    ],
    "5543a1b2ee40ea110c000001": [
        {
            "text": "crystalline PLBs",
            "probability": 0.34229492577583753,
            "start_logit": 1.205524206161499,
            "end_logit": -0.5896695256233215,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "tubules",
            "probability": 0.3145390257782639,
            "start_logit": 0.5469725131988525,
            "end_logit": -0.015682397410273552,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "crystalline PLBs (so-called 'narrow type",
            "probability": 0.045720744828294364,
            "start_logit": 1.205524206161499,
            "end_logit": -2.602790117263794,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "crystalline",
            "probability": 0.04269538992597719,
            "start_logit": 1.205524206161499,
            "end_logit": -2.6712512969970703,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "crystalline PLBs (so-called 'narrow type'). Rye",
            "probability": 0.03798343764896517,
            "start_logit": 1.205524206161499,
            "end_logit": -2.7881920337677,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "etioplasts",
            "probability": 0.028415303810280193,
            "start_logit": -1.106819748878479,
            "end_logit": -0.7660704255104065,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "loosely packed tubules",
            "probability": 0.0281938717251401,
            "start_logit": -1.8650310039520264,
            "end_logit": -0.015682397410273552,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "oat",
            "probability": 0.024116666462284653,
            "start_logit": -1.4591885805130005,
            "end_logit": -0.5777263045310974,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "leaves of oat",
            "probability": 0.021792881200895065,
            "start_logit": -1.560508370399475,
            "end_logit": -0.5777263045310974,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "tubules ('wide type') during etiolation, exhibited PLBs of the narrow type",
            "probability": 0.017615103665264042,
            "start_logit": 0.5469725131988525,
            "end_logit": -2.898033857345581,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "tubules ('wide type",
            "probability": 0.01723626003891109,
            "start_logit": 0.5469725131988525,
            "end_logit": -2.9197752475738525,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "crystalline PLBs (so-called 'narrow type'). Rye and what, which normally show PLBs",
            "probability": 0.01212784232828879,
            "start_logit": 1.205524206161499,
            "end_logit": -3.9298384189605713,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "Rye and what, which normally show PLBs with more loosely packed tubules",
            "probability": 0.011945020301897211,
            "start_logit": -2.7238211631774902,
            "end_logit": -0.015682397410273552,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "crystal",
            "probability": 0.011328825953237918,
            "start_logit": 1.205524206161499,
            "end_logit": -3.9979918003082275,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "PLBs with more loosely packed tubules",
            "probability": 0.009404466148932318,
            "start_logit": -2.9629509449005127,
            "end_logit": -0.015682397410273552,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "wheat and rye, possessing different types of prolamellar bodies (PLBs), was observed by electron microscopy. Oat",
            "probability": 0.007629961817699404,
            "start_logit": -1.5932515859603882,
            "end_logit": -1.5944836139678955,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "rye, possessing different types of prolamellar bodies (PLBs), was observed by electron microscopy. Oat",
            "probability": 0.007328876923280569,
            "start_logit": -1.6335121393203735,
            "end_logit": -1.5944836139678955,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "narrow type'). Rye and what, which normally show PLBs with more loosely packed tubules",
            "probability": 0.006933155487532674,
            "start_logit": -3.2678205966949463,
            "end_logit": -0.015682397410273552,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "Oat is known to possess unusual crystalline PLBs",
            "probability": 0.006389536992765487,
            "start_logit": -2.775486707687378,
            "end_logit": -0.5896695256233215,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        },
        {
            "text": "PLBs (so-called 'narrow type'). Rye and what, which normally show PLBs with more loosely packed tubules",
            "probability": 0.0063087031862524,
            "start_logit": -3.3622055053710938,
            "end_logit": -0.015682397410273552,
            "question_text": "In what type(s) of plant organelles we can detect prolamellar bodies?"
        }
    ],
    "56cf2be73975bb303a000005": [
        {
            "text": "monoclonal anti-IL-5 antibodies",
            "probability": 0.6165702535836154,
            "start_logit": 4.796305179595947,
            "end_logit": 5.3583855628967285,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 antibodies",
            "probability": 0.193023144319259,
            "start_logit": 3.6349430084228516,
            "end_logit": 5.3583855628967285,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antagonist therapies in current development include two monoclonal anti-IL-5 antibodies",
            "probability": 0.05035411612377154,
            "start_logit": 2.291213274002075,
            "end_logit": 5.3583855628967285,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal anti-IL-5",
            "probability": 0.044763534949453704,
            "start_logit": 4.796305179595947,
            "end_logit": 2.735607147216797,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antibodies",
            "probability": 0.042625482011070706,
            "start_logit": 2.1245851516723633,
            "end_logit": 5.3583855628967285,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5",
            "probability": 0.01401364762015208,
            "start_logit": 3.6349430084228516,
            "end_logit": 2.735607147216797,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two monoclonal anti-IL-5 antibodies",
            "probability": 0.01061586540902106,
            "start_logit": 0.7344825267791748,
            "end_logit": 5.3583855628967285,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antagonist therapies",
            "probability": 0.005885198924726026,
            "start_logit": 2.291213274002075,
            "end_logit": 3.2117457389831543,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "antagonist therapies in current development include two monoclonal anti-IL-5 antibodies",
            "probability": 0.005597550711568568,
            "start_logit": 0.09446203708648682,
            "end_logit": 5.3583855628967285,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antagonist therapies in current development include two monoclonal anti-IL-5",
            "probability": 0.0036557524853891125,
            "start_logit": 2.291213274002075,
            "end_logit": 2.735607147216797,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5",
            "probability": 0.0030946469484212855,
            "start_logit": 2.1245851516723633,
            "end_logit": 2.735607147216797,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "antibodies",
            "probability": 0.0022807359272531795,
            "start_logit": -0.8033689260482788,
            "end_logit": 5.3583855628967285,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal anti-IL-5 antibodies (mepolizumab, reslizumab),",
            "probability": 0.0016237876339860425,
            "start_logit": 4.796305179595947,
            "end_logit": -0.581025242805481,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "anti-IL-5 antibodies (mepolizumab, reslizumab), a monoclonal antibody",
            "probability": 0.0012116319406682867,
            "start_logit": 3.6349430084228516,
            "end_logit": 0.2875436246395111,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "therapies in current development include two monoclonal anti-IL-5 antibodies",
            "probability": 0.001087755294394091,
            "start_logit": -1.5437508821487427,
            "end_logit": 5.3583855628967285,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "IL-5 antagonist",
            "probability": 0.0010167775764511775,
            "start_logit": 2.291213274002075,
            "end_logit": 1.4559435844421387,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "two monoclonal anti-IL-5",
            "probability": 0.0007707210321831829,
            "start_logit": 0.7344825267791748,
            "end_logit": 2.735607147216797,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "antagonist therapies",
            "probability": 0.0006542205874063771,
            "start_logit": 0.09446203708648682,
            "end_logit": 3.2117457389831543,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal antibody directed at the IL-5 receptor",
            "probability": 0.0006133017771612369,
            "start_logit": 2.0109918117523193,
            "end_logit": 1.230628490447998,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        },
        {
            "text": "monoclonal anti-IL-5 antibodies (mepolizumab",
            "probability": 0.0005418751440479569,
            "start_logit": 4.796305179595947,
            "end_logit": -1.6785063743591309,
            "question_text": "What do mepolizumab and reslizumab have in common?"
        }
    ],
    "5713bc991174fb1755000010": [
        {
            "text": "GDAP1",
            "probability": 0.8662421566133782,
            "start_logit": 5.038602828979492,
            "end_logit": 4.189415454864502,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GDAP1 gene",
            "probability": 0.12091313139207796,
            "start_logit": 5.038602828979492,
            "end_logit": 2.220323324203491,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GDAP",
            "probability": 0.01011479852633205,
            "start_logit": 5.038602828979492,
            "end_logit": -0.260749489068985,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "the GDAP1",
            "probability": 0.0009711694947543594,
            "start_logit": -1.754815936088562,
            "end_logit": 4.189415454864502,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "G",
            "probability": 0.0005637118295939358,
            "start_logit": 5.038602828979492,
            "end_logit": -3.147961139678955,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "Glu222Lys mutation within the GDAP1",
            "probability": 0.000391346640446242,
            "start_logit": -2.0051429271698,
            "end_logit": 3.5308351516723633,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "1",
            "probability": 0.0003500139640917922,
            "start_logit": -2.775343894958496,
            "end_logit": 4.189415454864502,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "the GDAP1 gene",
            "probability": 0.00013555925883623556,
            "start_logit": -1.754815936088562,
            "end_logit": 2.220323324203491,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "GDAP1 gene segregates both in autosomal dominant and recessive traits. Our study shows that at least some G",
            "probability": 6.696209996722813e-05,
            "start_logit": 4.383667945861816,
            "end_logit": -4.623442649841309,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mutations in the GDAP1",
            "probability": 5.2739258272757054e-05,
            "start_logit": -4.667956829071045,
            "end_logit": 4.189415454864502,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "1 gene",
            "probability": 4.8856181965041215e-05,
            "start_logit": -2.775343894958496,
            "end_logit": 2.220323324203491,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "P1",
            "probability": 3.65647727338022e-05,
            "start_logit": -5.034231662750244,
            "end_logit": 4.189415454864502,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "1 gene segregates both in autosomal dominant and recessive traits. Our study shows that at least some GDAP1",
            "probability": 2.3745701022990166e-05,
            "start_logit": -3.7446556091308594,
            "end_logit": 2.4681556224823,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "Glu222Lys mutation within the GDAP1 gene",
            "probability": 1.9927092213031943e-05,
            "start_logit": -2.0051429271698,
            "end_logit": 0.5533216595649719,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mutation within the GDAP1",
            "probability": 1.6357246513562668e-05,
            "start_logit": -5.180065631866455,
            "end_logit": 3.5308351516723633,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "a newly identified Glu222Lys mutation within the GDAP1",
            "probability": 1.439001916898679e-05,
            "start_logit": -5.308201789855957,
            "end_logit": 3.5308351516723633,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "gene",
            "probability": 1.2729779265949218e-05,
            "start_logit": -4.120280742645264,
            "end_logit": 2.220323324203491,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "the GDAP",
            "probability": 1.13399973660533e-05,
            "start_logit": -1.754815936088562,
            "end_logit": -0.260749489068985,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "mutations in the GDAP1 gene",
            "probability": 7.361531433641295e-06,
            "start_logit": -4.667956829071045,
            "end_logit": 2.220323324203491,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        },
        {
            "text": "gene segregates both in autosomal dominant and recessive traits. Our study shows that at least some GDAP1",
            "probability": 7.13860056603667e-06,
            "start_logit": -4.946540355682373,
            "end_logit": 2.4681556224823,
            "question_text": "Which genes are associated with autosomal dominant Charcot-Marie-Tooth?"
        }
    ],
    "54fb4b34d176fff445000001": [
        {
            "text": "c-JUN",
            "probability": 0.15272093233571568,
            "start_logit": 5.003622531890869,
            "end_logit": 4.938557147979736,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF2/c-JUN",
            "probability": 0.12935165075014607,
            "start_logit": 4.837544918060303,
            "end_logit": 4.938557147979736,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "c-JUN, IRF3",
            "probability": 0.10708917046767089,
            "start_logit": 5.003622531890869,
            "end_logit": 4.583606719970703,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF3",
            "probability": 0.1057450907428293,
            "start_logit": 4.990992069244385,
            "end_logit": 4.583606719970703,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF2/c-JUN, IRF3",
            "probability": 0.09070243853021268,
            "start_logit": 4.837544918060303,
            "end_logit": 4.583606719970703,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF2",
            "probability": 0.07967216663857081,
            "start_logit": 4.837544918060303,
            "end_logit": 4.453942775726318,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "c-JUN, IRF3, and p50/p65 of NF-kappaB",
            "probability": 0.05854508765124691,
            "start_logit": 5.003622531890869,
            "end_logit": 3.9797420501708984,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF3, and p50/p65 of NF-kappaB",
            "probability": 0.05781028631739149,
            "start_logit": 4.990992069244385,
            "end_logit": 3.9797420501708984,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF2/c-JUN, IRF3, and p50/p65 of NF-kappaB",
            "probability": 0.04958654727404229,
            "start_logit": 4.837544918060303,
            "end_logit": 3.9797420501708984,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "c-JUN, IRF3, and p50/p65",
            "probability": 0.023079951115825108,
            "start_logit": 5.003622531890869,
            "end_logit": 3.0489091873168945,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF3, and p50/p65",
            "probability": 0.022790273885068327,
            "start_logit": 4.990992069244385,
            "end_logit": 3.0489091873168945,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "NF-kappaB",
            "probability": 0.02048223858915054,
            "start_logit": 3.953383445739746,
            "end_logit": 3.9797420501708984,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF2/c-JUN, IRF3, and p50/p65",
            "probability": 0.019548268403063392,
            "start_logit": 4.837544918060303,
            "end_logit": 3.0489091873168945,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "c-JUN and NF-kappaB",
            "probability": 0.01522224318068006,
            "start_logit": 4.091058254241943,
            "end_logit": 3.54526686668396,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF3 in addition to ATF2/c-JUN",
            "probability": 0.015154653439956898,
            "start_logit": 3.898663282394409,
            "end_logit": 3.7332117557525635,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "ATF2/c-JUN and NF-kappaB",
            "probability": 0.013877885696894205,
            "start_logit": 3.9985971450805664,
            "end_logit": 3.54526686668396,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF3 in addition to ATF2/c-JUN and NF-kappaB",
            "probability": 0.012558060790718919,
            "start_logit": 3.898663282394409,
            "end_logit": 3.54526686668396,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "IRF3 in addition to ATF2",
            "probability": 0.010896760594925128,
            "start_logit": 3.898663282394409,
            "end_logit": 3.403369665145874,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "MEKK1 activates IRF3 in addition to ATF2/c-JUN",
            "probability": 0.008293663388624481,
            "start_logit": 3.2958474159240723,
            "end_logit": 3.7332117557525635,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        },
        {
            "text": "MEKK1 activates IRF3 in addition to ATF2/c-JUN and NF-kappaB",
            "probability": 0.0068726302072667075,
            "start_logit": 3.2958474159240723,
            "end_logit": 3.54526686668396,
            "question_text": "Which transcription factors (TFs) participate in the formation of the interferon-beta (IFN-b) enhanceosome?"
        }
    ],
    "56a39a32496b62f23f000005": [
        {
            "text": "ddgraph",
            "probability": 0.9229267247055454,
            "start_logit": 2.9660234451293945,
            "end_logit": 2.5193886756896973,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "ddgraph,",
            "probability": 0.02252938346782329,
            "start_logit": 2.9660234451293945,
            "end_logit": -1.19334077835083,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "PC (NCPC)",
            "probability": 0.012764939657909067,
            "start_logit": 0.4783042371273041,
            "end_logit": 0.7262603640556335,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "R package ddgraph",
            "probability": 0.01132089974203342,
            "start_logit": -1.4348758459091187,
            "end_logit": 2.5193886756896973,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "DDGraph can also be applied to other problems involving highly correlated biological features. Both methods are implemented in the R package ddgraph",
            "probability": 0.0072736290012543085,
            "start_logit": -1.877271056175232,
            "end_logit": 2.5193886756896973,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "PC (NCPC) algorithms",
            "probability": 0.005012043510519513,
            "start_logit": 0.4783042371273041,
            "end_logit": -0.20859824120998383,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "NCPC)",
            "probability": 0.004138506455377345,
            "start_logit": -0.6480631232261658,
            "end_logit": 0.7262603640556335,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "PC (NCPC",
            "probability": 0.0027681934188066516,
            "start_logit": 0.4783042371273041,
            "end_logit": -0.8022470474243164,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "NCPC) algorithms",
            "probability": 0.001624948881765008,
            "start_logit": -0.6480631232261658,
            "end_logit": -0.20859824120998383,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "d",
            "probability": 0.001527087979840292,
            "start_logit": 2.9660234451293945,
            "end_logit": -3.884798526763916,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "Neighbourhood Consistent PC (NCPC)",
            "probability": 0.001522915891920729,
            "start_logit": -1.6477712392807007,
            "end_logit": 0.7262603640556335,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "in the R package ddgraph",
            "probability": 0.0009690653941855525,
            "start_logit": -3.8929495811462402,
            "end_logit": 2.5193886756896973,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "PC",
            "probability": 0.0009247780333816733,
            "start_logit": 0.4783042371273041,
            "end_logit": -1.8986434936523438,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "NCPC",
            "probability": 0.0008974728154211241,
            "start_logit": -0.6480631232261658,
            "end_logit": -0.8022470474243164,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "the R package ddgraph",
            "probability": 0.0008832794496353964,
            "start_logit": -3.985640048980713,
            "end_logit": 2.5193886756896973,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "Twist",
            "probability": 0.0008224114414144305,
            "start_logit": -0.6249350309371948,
            "end_logit": -0.9127171635627747,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "bioc/html/ddgraph",
            "probability": 0.0006533027006875826,
            "start_logit": -2.8578877449035645,
            "end_logit": 1.090035319328308,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "Neighbourhood Consistent PC (NCPC) algorithms",
            "probability": 0.0005979597959508585,
            "start_logit": -1.6477712392807007,
            "end_logit": -0.20859824120998383,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "ddgraph.html).",
            "probability": 0.0005121994757311792,
            "start_logit": 1.6418675184249878,
            "end_logit": -3.6530463695526123,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        },
        {
            "text": "Neighbourhood Consistent PC (NCPC",
            "probability": 0.0003302581807975089,
            "start_logit": -1.6477712392807007,
            "end_logit": -0.8022470474243164,
            "question_text": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor"
        }
    ],
    "515de993298dcd4e51000024": [
        {
            "text": "conflict management",
            "probability": 0.808892291160175,
            "start_logit": -0.845750093460083,
            "end_logit": 0.5560232996940613,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "interventions to include conflict management",
            "probability": 0.05825494867989522,
            "start_logit": -3.4765868186950684,
            "end_logit": 0.5560232996940613,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "conflict",
            "probability": 0.0482949249537,
            "start_logit": -0.845750093460083,
            "end_logit": -2.2623159885406494,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "management",
            "probability": 0.029813279043842917,
            "start_logit": -4.1464619636535645,
            "end_logit": 0.5560232996940613,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "bullying",
            "probability": 0.013658707815370987,
            "start_logit": -2.391289234161377,
            "end_logit": -1.9797260761260986,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "expanding interventions to include conflict management",
            "probability": 0.00905133719057878,
            "start_logit": -5.338503360748291,
            "end_logit": 0.5560232996940613,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "include conflict management",
            "probability": 0.006622949217380432,
            "start_logit": -5.650875091552734,
            "end_logit": 0.5560232996940613,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "peer support/bullying",
            "probability": 0.005089926044006327,
            "start_logit": -3.3784031867980957,
            "end_logit": -1.9797260761260986,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "conflict and cohesion, and peer support/bullying",
            "probability": 0.004727807407817438,
            "start_logit": -3.452204942703247,
            "end_logit": -1.9797260761260986,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "utility of expanding interventions to include conflict management",
            "probability": 0.003717886442825799,
            "start_logit": -6.228260517120361,
            "end_logit": 0.5560232996940613,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "interventions to include conflict",
            "probability": 0.0034781124822465116,
            "start_logit": -3.4765868186950684,
            "end_logit": -2.2623159885406494,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "family conflict and cohesion, and peer support/bullying",
            "probability": 0.001919646105521694,
            "start_logit": -4.353525638580322,
            "end_logit": -1.9797260761260986,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "conflict management for couples, even when conflict",
            "probability": 0.0013345580650023763,
            "start_logit": -0.845750093460083,
            "end_logit": -5.8510422706604,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "conflict management for couples,",
            "probability": 0.001125568534271964,
            "start_logit": -0.845750093460083,
            "end_logit": -6.0213541984558105,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "interventions",
            "probability": 0.0008729224048314136,
            "start_logit": -3.4765868186950684,
            "end_logit": -3.64471435546875,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "peer support",
            "probability": 0.0007860378601489984,
            "start_logit": -3.3784031867980957,
            "end_logit": -3.8477396965026855,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "conflict and cohesion, and peer support",
            "probability": 0.000730115837815262,
            "start_logit": -3.452204942703247,
            "end_logit": -3.8477396965026855,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "support/bullying",
            "probability": 0.0006281105948338103,
            "start_logit": -5.470705509185791,
            "end_logit": -1.9797260761260986,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "expanding interventions to include conflict",
            "probability": 0.0005404102068059834,
            "start_logit": -5.338503360748291,
            "end_logit": -2.2623159885406494,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        },
        {
            "text": "conflict was more predictive of ASD symptomatology than positive family/peer influences. The results point to the utility of expanding interventions",
            "probability": 0.0004604599529288207,
            "start_logit": -4.116207599639893,
            "end_logit": -3.64471435546875,
            "question_text": "List all reported treatment options for anxiety in autism spectrum disorder."
        }
    ],
    "54fc9b236ad7dcbc12000005": [
        {
            "text": "istradefylline",
            "probability": 0.9954752890648367,
            "start_logit": 6.195169925689697,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline,",
            "probability": 0.001336352368382822,
            "start_logit": 6.195169925689697,
            "end_logit": -0.4830766022205353,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefyllin",
            "probability": 0.001167497173196956,
            "start_logit": 6.195169925689697,
            "end_logit": -0.6181581020355225,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "lline",
            "probability": 0.0004963309163989348,
            "start_logit": -1.4085627794265747,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "e",
            "probability": 0.00023324537395921243,
            "start_logit": -2.163714647293091,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "is",
            "probability": 0.00022478228512742276,
            "start_logit": 6.195169925689697,
            "end_logit": -2.265643358230591,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "Adenosine A2A antagonists, such as istradefylline",
            "probability": 0.0001773581590952094,
            "start_logit": -2.4376344680786133,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "antagonists, such as istradefylline",
            "probability": 0.0001769819219512396,
            "start_logit": -2.439758062362671,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline, improve motor function",
            "probability": 0.00012069003380719664,
            "start_logit": 6.195169925689697,
            "end_logit": -2.887550115585327,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "such as istradefylline",
            "probability": 8.216097781753906e-05,
            "start_logit": -3.207125186920166,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefy",
            "probability": 7.777793534714968e-05,
            "start_logit": 6.195169925689697,
            "end_logit": -3.326917886734009,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "tradefylline",
            "probability": 7.157294732745561e-05,
            "start_logit": -3.345088481903076,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "fylline",
            "probability": 6.502653498375011e-05,
            "start_logit": -3.4410102367401123,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment has not been determined.",
            "probability": 6.456946138460417e-05,
            "start_logit": 6.195169925689697,
            "end_logit": -3.5130341053009033,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istra",
            "probability": 4.914589385423781e-05,
            "start_logit": 6.195169925689697,
            "end_logit": -3.785982370376587,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline, improve motor function in PD,",
            "probability": 4.19881905077039e-05,
            "start_logit": 6.195169925689697,
            "end_logit": -3.943387269973755,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment",
            "probability": 3.6780878806958455e-05,
            "start_logit": 6.195169925689697,
            "end_logit": -4.0757975578308105,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "istradefylline, improve motor function in PD, but their effect on cognitive impairment has not been determined",
            "probability": 3.555648910773219e-05,
            "start_logit": 6.195169925689697,
            "end_logit": -4.109652996063232,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": "defylline",
            "probability": 3.400763744131344e-05,
            "start_logit": -4.0892205238342285,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        },
        {
            "text": ", such as istradefylline",
            "probability": 3.2885756665735454e-05,
            "start_logit": -4.122766017913818,
            "end_logit": 6.130199909210205,
            "question_text": "List adenosine A2A receptor antagonists that are used for Parkinson's disease treatment."
        }
    ],
    "54fe09036ad7dcbc12000009": [
        {
            "text": "AFP",
            "probability": 0.6735084285944489,
            "start_logit": 4.038297176361084,
            "end_logit": 3.7717297077178955,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP) and anti-freeze glycoproteins (AFGPs",
            "probability": 0.1881357483557212,
            "start_logit": 4.038297176361084,
            "end_logit": 2.4963929653167725,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFGPs",
            "probability": 0.08367874572631202,
            "start_logit": 3.228118419647217,
            "end_logit": 2.4963929653167725,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP)",
            "probability": 0.011138328527806354,
            "start_logit": 4.038297176361084,
            "end_logit": -0.33037862181663513,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP) and anti-freeze glycoproteins",
            "probability": 0.009925680425290406,
            "start_logit": 4.038297176361084,
            "end_logit": -0.44564542174339294,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "(AFP",
            "probability": 0.007780000436326468,
            "start_logit": -0.4226469397544861,
            "end_logit": 3.7717297077178955,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "anti-freeze glycoproteins (AFGPs",
            "probability": 0.0066415165604352235,
            "start_logit": 0.6944737434387207,
            "end_logit": 2.4963929653167725,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP) and anti-freeze glycoproteins (AFGPs)",
            "probability": 0.005930071064788245,
            "start_logit": 4.038297176361084,
            "end_logit": -0.9607346057891846,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "glycoproteins (AFGPs",
            "probability": 0.004527832742390359,
            "start_logit": 0.31137681007385254,
            "end_logit": 2.4963929653167725,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFGPs)",
            "probability": 0.002637568421239843,
            "start_logit": 3.228118419647217,
            "end_logit": -0.9607346057891846,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "(AFP) and anti-freeze glycoproteins (AFGPs",
            "probability": 0.002173241109024751,
            "start_logit": -0.4226469397544861,
            "end_logit": 2.4963929653167725,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "anti-freeze protein (AFP",
            "probability": 0.0007286113036019602,
            "start_logit": -2.790818214416504,
            "end_logit": 3.7717297077178955,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP) and anti-freeze g",
            "probability": 0.0006189154242073977,
            "start_logit": 4.038297176361084,
            "end_logit": -3.220557451248169,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP) and anti-freeze glycoproteins (AFGPs),",
            "probability": 0.0005360607674413923,
            "start_logit": 4.038297176361084,
            "end_logit": -3.364278554916382,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "(AFGPs",
            "probability": 0.0004159754262237098,
            "start_logit": -2.075995683670044,
            "end_logit": 2.4963929653167725,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "A",
            "probability": 0.0003900887538549103,
            "start_logit": 4.038297176361084,
            "end_logit": -3.6821517944335938,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "anti-freeze glycoproteins",
            "probability": 0.00035039364657859454,
            "start_logit": 0.6944737434387207,
            "end_logit": -0.44564542174339294,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AF",
            "probability": 0.000342166423135107,
            "start_logit": 4.038297176361084,
            "end_logit": -3.8132288455963135,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP) and anti",
            "probability": 0.00028048861903440936,
            "start_logit": 4.038297176361084,
            "end_logit": -4.011992931365967,
            "question_text": "List fish anti-freeze proteins."
        },
        {
            "text": "AFP) and anti-freeze gly",
            "probability": 0.00026013767213918656,
            "start_logit": 4.038297176361084,
            "end_logit": -4.087315082550049,
            "question_text": "List fish anti-freeze proteins."
        }
    ],
    "517295c18ed59a060a000016": [
        {
            "text": "ncRNAs",
            "probability": 0.4439151286215541,
            "start_logit": 0.5508756637573242,
            "end_logit": 0.7866608500480652,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs",
            "probability": 0.2971284536540308,
            "start_logit": 0.20684459805488586,
            "end_logit": 0.7292230725288391,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNA classes such as miRNAs",
            "probability": 0.11546496788006674,
            "start_logit": -0.7383527755737305,
            "end_logit": 0.7292230725288391,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs in a high-throughput manner and by using specialized algorithms ncRNA classes such as miRNAs",
            "probability": 0.08256761195608268,
            "start_logit": -1.0737024545669556,
            "end_logit": 0.7292230725288391,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "(ncRNAs",
            "probability": 0.024258748916480513,
            "start_logit": -2.355980396270752,
            "end_logit": 0.7866608500480652,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs)",
            "probability": 0.0108312064353455,
            "start_logit": 0.5508756637573242,
            "end_logit": -2.9265410900115967,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNA",
            "probability": 0.0070807494965653035,
            "start_logit": -0.7383527755737305,
            "end_logit": -2.062364339828491,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs in a high-throughput manner and by using specialized algorithms ncRNA",
            "probability": 0.005063358934961961,
            "start_logit": -1.0737024545669556,
            "end_logit": -2.062364339828491,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "Small non-coding RNAs (ncRNAs",
            "probability": 0.003195381011782476,
            "start_logit": -4.38305139541626,
            "end_logit": 0.7866608500480652,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs can be detected in deep sequencing data. Typically, such methods are targeted to a certain class of ncRNA",
            "probability": 0.0016327750960176707,
            "start_logit": 0.20684459805488586,
            "end_logit": -4.474660396575928,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs) play important roles in various cellular functions in all clades of life. With next-generation sequencing techniques,",
            "probability": 0.0014647030692929517,
            "start_logit": 0.5508756637573242,
            "end_logit": -4.9273200035095215,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs) play important roles in various cellular functions in all clades of life",
            "probability": 0.001342289896911276,
            "start_logit": 0.5508756637573242,
            "end_logit": -5.0145955085754395,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs) play important roles in various cellular functions in all clades of life. With next-generation sequencing",
            "probability": 0.0009473862949538309,
            "start_logit": 0.5508756637573242,
            "end_logit": -5.363020896911621,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs) play important roles in various cellular functions",
            "probability": 0.0009386462151973951,
            "start_logit": 0.5508756637573242,
            "end_logit": -5.372289180755615,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs) play important roles in various cellular functions in all clades of life. With next-generation sequencing techniques",
            "probability": 0.0008695989790004256,
            "start_logit": 0.5508756637573242,
            "end_logit": -5.448695659637451,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "ncRNAs) play important roles in various cellular functions in all clades of life.",
            "probability": 0.0007802048212698304,
            "start_logit": 0.5508756637573242,
            "end_logit": -5.55717134475708,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "n",
            "probability": 0.0007521852146588225,
            "start_logit": 0.5508756637573242,
            "end_logit": -5.593745231628418,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "miRNAs can be detected in deep sequencing data.",
            "probability": 0.0006049922326278395,
            "start_logit": 0.20684459805488586,
            "end_logit": -5.4674811363220215,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "(ncRNAs)",
            "probability": 0.0005918958387237462,
            "start_logit": -2.355980396270752,
            "end_logit": -2.9265410900115967,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        },
        {
            "text": "mi",
            "probability": 0.0005697154344757616,
            "start_logit": 0.20684459805488586,
            "end_logit": -5.527559757232666,
            "question_text": "Name the major classes of small  non coding RNAs in mammalians?"
        }
    ],
    "5505c9008e1671127b000002": [
        {
            "text": "Rictor",
            "probability": 0.8083739317675221,
            "start_logit": 5.737107753753662,
            "end_logit": 5.591721057891846,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion of mTOR",
            "probability": 0.09479666398355746,
            "start_logit": 5.737107753753662,
            "end_logit": 3.4484305381774902,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion of mTOR),",
            "probability": 0.02496989569437438,
            "start_logit": 5.737107753753662,
            "end_logit": 2.1143672466278076,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin",
            "probability": 0.015873786013138873,
            "start_logit": 5.737107753753662,
            "end_logit": 1.6613653898239136,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion of mTOR)",
            "probability": 0.013759651015391889,
            "start_logit": 5.737107753753662,
            "end_logit": 1.5184367895126343,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2), which contains the regulatory protein Rictor",
            "probability": 0.007389916804218114,
            "start_logit": 1.0421994924545288,
            "end_logit": 5.591721057891846,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTOR",
            "probability": 0.006788058442705438,
            "start_logit": 3.100538492202759,
            "end_logit": 3.4484305381774902,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mammalian target of rapamycin (mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor",
            "probability": 0.00482086490543093,
            "start_logit": 0.6150363683700562,
            "end_logit": 5.591721057891846,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "rapamycin-insensitive companion of mTOR",
            "probability": 0.0037533124106869063,
            "start_logit": 2.508012294769287,
            "end_logit": 3.4484305381774902,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rict",
            "probability": 0.002793748364135304,
            "start_logit": 5.737107753753662,
            "end_logit": -0.0759194865822792,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor",
            "probability": 0.0026285171174095074,
            "start_logit": 0.008502868935465813,
            "end_logit": 5.591721057891846,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "(mTORC2), which contains the regulatory protein Rictor",
            "probability": 0.002443161175272071,
            "start_logit": -0.06462422013282776,
            "end_logit": 5.591721057891846,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "regulatory protein Rictor",
            "probability": 0.0020545067013537704,
            "start_logit": -0.23788121342658997,
            "end_logit": 5.591721057891846,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "rapamycin (mTOR) complex 2 (mTORC2), which contains the regulatory protein Rictor",
            "probability": 0.001925449626657837,
            "start_logit": -0.30275747179985046,
            "end_logit": 5.591721057891846,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "contains the regulatory protein Rictor",
            "probability": 0.001909460314231945,
            "start_logit": -0.31109634041786194,
            "end_logit": 5.591721057891846,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTOR),",
            "probability": 0.001788007131886746,
            "start_logit": 3.100538492202759,
            "end_logit": 2.1143672466278076,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "Rictor (rapamycin-insensitive companion",
            "probability": 0.0010905442085539948,
            "start_logit": 5.737107753753662,
            "end_logit": -1.0166268348693848,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "rapamycin-insensitive companion of mTOR),",
            "probability": 0.0009886404802125597,
            "start_logit": 2.508012294769287,
            "end_logit": 2.1143672466278076,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTOR)",
            "probability": 0.0009852806134603204,
            "start_logit": 3.100538492202759,
            "end_logit": 1.5184367895126343,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        },
        {
            "text": "mTORC2), which contains the regulatory protein Rictor (rapamycin-insensitive companion of mTOR",
            "probability": 0.0008666032298000617,
            "start_logit": 1.0421994924545288,
            "end_logit": 3.4484305381774902,
            "question_text": "List the components of mTOR Complex 2 (mTORC2)."
        }
    ],
    "5326c6fed6d3ac6a3400000c": [
        {
            "text": "diabetic",
            "probability": 0.5837473548596971,
            "start_logit": 3.2535901069641113,
            "end_logit": -0.06958527863025665,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabe",
            "probability": 0.2633055708391248,
            "start_logit": 3.2535901069641113,
            "end_logit": -0.8657383322715759,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetic patients",
            "probability": 0.06949220129075667,
            "start_logit": 3.2535901069641113,
            "end_logit": -2.1978390216827393,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "diabetic patients.",
            "probability": 0.033749182852217494,
            "start_logit": 3.2535901069641113,
            "end_logit": -2.9200973510742188,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "metabolic syndrome in diabetic",
            "probability": 0.012406857436882752,
            "start_logit": -0.5976288318634033,
            "end_logit": -0.06958527863025665,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "di",
            "probability": 0.011848944595218194,
            "start_logit": 3.2535901069641113,
            "end_logit": -3.9668147563934326,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abetic",
            "probability": 0.007738821810923807,
            "start_logit": -1.0696287155151367,
            "end_logit": -0.06958527863025665,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "metabolic syndrome in diabe",
            "probability": 0.005596247507662324,
            "start_logit": -0.5976288318634033,
            "end_logit": -0.8657383322715759,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abe",
            "probability": 0.0034906794481960692,
            "start_logit": -1.0696287155151367,
            "end_logit": -0.8657383322715759,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "metabolic syndrome has created potential confusion concerning its prognostic utility. At present, little data exist about the risk factors associated with metabolic syndrome in diabe",
            "probability": 0.001982606121510636,
            "start_logit": -1.6353129148483276,
            "end_logit": -0.8657383322715759,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "metabolic syndrome in diabetic patients",
            "probability": 0.0014769742889829479,
            "start_logit": -0.5976288318634033,
            "end_logit": -2.1978390216827393,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "metabolic syndrome",
            "probability": 0.0010556430690712066,
            "start_logit": -0.5976288318634033,
            "end_logit": -2.533684492111206,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abetic patients",
            "probability": 0.0009212680084302426,
            "start_logit": -1.0696287155151367,
            "end_logit": -2.1978390216827393,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "metabolic syndrome in diabetic patients.",
            "probability": 0.0007172988395971227,
            "start_logit": -0.5976288318634033,
            "end_logit": -2.9200973510742188,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "little data exist about the risk factors associated with metabolic syndrome in diabetic",
            "probability": 0.0006798160070949523,
            "start_logit": -3.5018112659454346,
            "end_logit": -0.06958527863025665,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "abetic patients.",
            "probability": 0.00044741772306680595,
            "start_logit": -1.0696287155151367,
            "end_logit": -2.9200973510742188,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "metabolic syndrome has created potential confusion concerning its prognostic utility. At present, little data exist about the risk factors associated with metabolic syndrome",
            "probability": 0.000373987106182355,
            "start_logit": -1.6353129148483276,
            "end_logit": -2.533684492111206,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "At present, little data exist about the risk factors associated with metabolic syndrome in diabetic",
            "probability": 0.0003476380757647702,
            "start_logit": -4.172471523284912,
            "end_logit": -0.06958527863025665,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "in diabetic",
            "probability": 0.00031485174203456026,
            "start_logit": -4.271531581878662,
            "end_logit": -0.06958527863025665,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        },
        {
            "text": "little data exist about the risk factors associated with metabolic syndrome in diabe",
            "probability": 0.0003066383775849968,
            "start_logit": -3.5018112659454346,
            "end_logit": -0.8657383322715759,
            "question_text": "Which are the mains risk factors of metabolic syndrome?"
        }
    ],
    "5319a6c9b166e2b806000022": [
        {
            "text": "vatalanib",
            "probability": 0.15875688680091865,
            "start_logit": 4.941592693328857,
            "end_logit": 4.268187522888184,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "sorafenib",
            "probability": 0.15209196593006322,
            "start_logit": 4.715417385101318,
            "end_logit": 4.451474189758301,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "sorafenib, vatalanib",
            "probability": 0.12662104270878038,
            "start_logit": 4.715417385101318,
            "end_logit": 4.268187522888184,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "vatalanib, and AG-013736",
            "probability": 0.09249754738829842,
            "start_logit": 4.941592693328857,
            "end_logit": 3.7279956340789795,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "sorafenib, vatalanib, and AG-013736",
            "probability": 0.07377403358254439,
            "start_logit": 4.715417385101318,
            "end_logit": 3.7279956340789795,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AG-013736",
            "probability": 0.06170073749259196,
            "start_logit": 4.536706447601318,
            "end_logit": 3.7279956340789795,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474, SU11248, AEE 788, sorafenib",
            "probability": 0.06150269823547543,
            "start_logit": 3.8100130558013916,
            "end_logit": 4.451474189758301,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474, SU11248, AEE 788, sorafenib, vatalanib",
            "probability": 0.05120280832953613,
            "start_logit": 3.8100130558013916,
            "end_logit": 4.268187522888184,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AEE 788, sorafenib",
            "probability": 0.044837221178466204,
            "start_logit": 3.4939706325531006,
            "end_logit": 4.451474189758301,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AEE 788, sorafenib, vatalanib",
            "probability": 0.03732830766611449,
            "start_logit": 3.4939706325531006,
            "end_logit": 4.268187522888184,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474",
            "probability": 0.023953172011077897,
            "start_logit": 3.8100130558013916,
            "end_logit": 3.5084939002990723,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AEE 788, sorafenib, vatalanib, and AG-013736",
            "probability": 0.021748832298539557,
            "start_logit": 3.4939706325531006,
            "end_logit": 3.7279956340789795,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474, SU11248",
            "probability": 0.02102514149227806,
            "start_logit": 3.8100130558013916,
            "end_logit": 3.3781120777130127,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248, AEE 788, sorafenib",
            "probability": 0.015921280203166622,
            "start_logit": 2.4585886001586914,
            "end_logit": 4.451474189758301,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "ZD6474, SU11248, AEE 788",
            "probability": 0.015402072901350086,
            "start_logit": 3.8100130558013916,
            "end_logit": 3.0668952465057373,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248, AEE 788, sorafenib, vatalanib",
            "probability": 0.013254934856392269,
            "start_logit": 2.4585886001586914,
            "end_logit": 4.268187522888184,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "AEE 788",
            "probability": 0.011228550439212387,
            "start_logit": 3.4939706325531006,
            "end_logit": 3.0668952465057373,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248, AEE 788, sorafenib, vatalanib, and AG-013736",
            "probability": 0.007722808060260209,
            "start_logit": 2.4585886001586914,
            "end_logit": 3.7279956340789795,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248",
            "probability": 0.005442804602297886,
            "start_logit": 2.4585886001586914,
            "end_logit": 3.3781120777130127,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        },
        {
            "text": "SU11248, AEE 788",
            "probability": 0.003987153822635837,
            "start_logit": 2.4585886001586914,
            "end_logit": 3.0668952465057373,
            "question_text": "Which multiple kinase inhibitors are used in cancer therapy?"
        }
    ],
    "56a37e33496b62f23f000003": [
        {
            "text": "palindromic words",
            "probability": 0.459268984658099,
            "start_logit": -1.202083945274353,
            "end_logit": -3.0227043628692627,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic",
            "probability": 0.2952856616887534,
            "start_logit": -1.202083945274353,
            "end_logit": -3.4643971920013428,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "palindromic words in taxonomically related bacteria shows a pattern of relatedness of their R-M systems",
            "probability": 0.0959503037381984,
            "start_logit": -1.202083945274353,
            "end_logit": -4.588510036468506,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "words",
            "probability": 0.025497121833539423,
            "start_logit": -4.093154430389404,
            "end_logit": -3.0227043628692627,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "avoided palindromic words",
            "probability": 0.021121755818800755,
            "start_logit": -4.281416416168213,
            "end_logit": -3.0227043628692627,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "avoided palindromic",
            "probability": 0.013580171645219923,
            "start_logit": -4.281416416168213,
            "end_logit": -3.4643971920013428,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "a comparison of avoided palindromic words",
            "probability": 0.011505146471721432,
            "start_logit": -4.888925552368164,
            "end_logit": -3.0227043628692627,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "semi-palindromic motifs",
            "probability": 0.010867344186757206,
            "start_logit": -4.005251407623291,
            "end_logit": -3.9634106159210205,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "comparison of avoided palindromic words",
            "probability": 0.00948000853773557,
            "start_logit": -5.0825347900390625,
            "end_logit": -3.0227043628692627,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "type II restriction and modification enzymes in genomes of several bacteria are recognized as semi-palindromic motifs",
            "probability": 0.007712210480968342,
            "start_logit": -4.348208904266357,
            "end_logit": -3.9634106159210205,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "a comparison of avoided palindromic",
            "probability": 0.007397200556134659,
            "start_logit": -4.888925552368164,
            "end_logit": -3.4643971920013428,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "set of most avoided words",
            "probability": 0.006687050145477905,
            "start_logit": -5.005753517150879,
            "end_logit": -3.448498010635376,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "comparison of avoided palindromic",
            "probability": 0.006095143994894877,
            "start_logit": -5.0825347900390625,
            "end_logit": -3.4643971920013428,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "words in taxonomically related bacteria shows a pattern of relatedness of their R-M systems",
            "probability": 0.005326849114793182,
            "start_logit": -4.093154430389404,
            "end_logit": -4.588510036468506,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "semi-palindromic motifs and are avoided at a significant degree",
            "probability": 0.005260917247426098,
            "start_logit": -4.005251407623291,
            "end_logit": -4.688867568969727,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "avoided palindromic words in taxonomically related bacteria shows a pattern of relatedness of their R-M systems",
            "probability": 0.004412749290716235,
            "start_logit": -4.281416416168213,
            "end_logit": -4.588510036468506,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "type II restriction and modification enzymes in genomes of several bacteria are recognized as semi-palindromic motifs and are avoided at a significant degree",
            "probability": 0.0037335065898206057,
            "start_logit": -4.348208904266357,
            "end_logit": -4.688867568969727,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "semi-palindromic motifs and are avoided",
            "probability": 0.0037134719183347454,
            "start_logit": -4.005251407623291,
            "end_logit": -5.037205696105957,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "semi-palindromic motifs and are avoided at a significant degree.",
            "probability": 0.003620174690127266,
            "start_logit": -4.005251407623291,
            "end_logit": -5.062650680541992,
            "question_text": "List types of avoided words in bacterial genomes"
        },
        {
            "text": "Recognition sites for type II restriction and modification enzymes in genomes of several bacteria are recognized as semi-palindromic motifs",
            "probability": 0.00348422739248084,
            "start_logit": -5.142767429351807,
            "end_logit": -3.9634106159210205,
            "question_text": "List types of avoided words in bacterial genomes"
        }
    ],
    "571ce13f7de986d80d000011": [
        {
            "text": "differentiating cells",
            "probability": 0.20816293557884621,
            "start_logit": 1.9646495580673218,
            "end_logit": 0.37662968039512634,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating",
            "probability": 0.14608053232969018,
            "start_logit": 1.9646495580673218,
            "end_logit": 0.022466624155640602,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiated cells, GSDMB is expressed in proliferating cells",
            "probability": 0.09910606979211185,
            "start_logit": 1.0519986152648926,
            "end_logit": 0.547150194644928,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiated cells, GSDMB is expressed in proliferating cells and GSDMD in differentiating cells",
            "probability": 0.08356879412374668,
            "start_logit": 1.0519986152648926,
            "end_logit": 0.37662968039512634,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "proliferating cells",
            "probability": 0.07005971310814053,
            "start_logit": 0.7051558494567871,
            "end_logit": 0.547150194644928,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiated",
            "probability": 0.06514947389142918,
            "start_logit": 1.0519986152648926,
            "end_logit": 0.12764373421669006,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "proliferating cells and GSDMD in differentiating cells",
            "probability": 0.05907615702432944,
            "start_logit": 0.7051558494567871,
            "end_logit": 0.37662968039512634,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiated cells, GSDMB is expressed in proliferating cells and GSDMD in differentiating",
            "probability": 0.05864528138883419,
            "start_logit": 1.0519986152648926,
            "end_logit": 0.022466624155640602,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiated cells",
            "probability": 0.04650930438683127,
            "start_logit": 1.0519986152648926,
            "end_logit": -0.2093881070613861,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating cells. GSDMC, meanwhile, is expressed in both differentiating and differentiated",
            "probability": 0.04485001496493539,
            "start_logit": 1.9646495580673218,
            "end_logit": -1.1583675146102905,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "proliferating cells and GSDMD in differentiating",
            "probability": 0.04145731535784217,
            "start_logit": 0.7051558494567871,
            "end_logit": 0.022466624155640602,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating cells. GSDMC, meanwhile, is expressed in both differentiating and differentiated cells",
            "probability": 0.021068361596238906,
            "start_logit": 1.9646495580673218,
            "end_logit": -1.9139189720153809,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating and differentiated",
            "probability": 0.0104168765746551,
            "start_logit": 0.5047528743743896,
            "end_logit": -1.1583675146102905,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating cells.",
            "probability": 0.008820361072420587,
            "start_logit": 1.9646495580673218,
            "end_logit": -2.7846286296844482,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiated cells, GSDMB is expressed in proliferating",
            "probability": 0.008608986311877197,
            "start_logit": 1.0519986152648926,
            "end_logit": -1.8962339162826538,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating cells. GSDMC, meanwhile, is expressed in both differentiating",
            "probability": 0.007703802285206156,
            "start_logit": 1.9646495580673218,
            "end_logit": -2.9199774265289307,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "gastric cancer",
            "probability": 0.006195833113485512,
            "start_logit": 0.023476792499423027,
            "end_logit": -1.1966416835784912,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "proliferating",
            "probability": 0.0060858342221339025,
            "start_logit": 0.7051558494567871,
            "end_logit": -1.8962339162826538,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiating and differentiated cells",
            "probability": 0.004893343347818442,
            "start_logit": 0.5047528743743896,
            "end_logit": -1.9139189720153809,
            "question_text": "In which cells are gasdermins expressed?"
        },
        {
            "text": "differentiated cells, GSDMB is expressed in proliferating cells and GSDMD in differentiating cells.",
            "probability": 0.0035410095294271557,
            "start_logit": 1.0519986152648926,
            "end_logit": -2.7846286296844482,
            "question_text": "In which cells are gasdermins expressed?"
        }
    ],
    "533c3533c45e133714000004": [
        {
            "text": "Interleukin (IL)-17",
            "probability": 0.5797307454249783,
            "start_logit": 0.4340965151786804,
            "end_logit": -0.14542348682880402,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "MicroRNA (miRNA",
            "probability": 0.11399585136480352,
            "start_logit": -0.2808801531791687,
            "end_logit": -1.0568485260009766,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "MicroRNA",
            "probability": 0.11397848547990795,
            "start_logit": -0.2808801531791687,
            "end_logit": -1.0570008754730225,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miRNA",
            "probability": 0.039673872248868376,
            "start_logit": -1.336349368095398,
            "end_logit": -1.0568485260009766,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "MicroRNA (miRNA)",
            "probability": 0.023111513202954615,
            "start_logit": -0.2808801531791687,
            "end_logit": -2.652679681777954,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "MicroRNA (miRNA)s",
            "probability": 0.017827108486988024,
            "start_logit": -0.2808801531791687,
            "end_logit": -2.912290334701538,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "17",
            "probability": 0.017193977333850738,
            "start_logit": -3.0839080810546875,
            "end_logit": -0.14542348682880402,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "Micro",
            "probability": 0.016754918206564245,
            "start_logit": -0.2808801531791687,
            "end_logit": -2.974318742752075,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "Interleukin (IL)-17 is an important factor in rheumatoid arthritis (RA) pathogenesis.",
            "probability": 0.014437347003598486,
            "start_logit": 0.4340965151786804,
            "end_logit": -3.8381688594818115,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miRNA)",
            "probability": 0.008043478875014203,
            "start_logit": -1.336349368095398,
            "end_logit": -2.652679681777954,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "17 is an important factor in rheumatoid arthritis (RA) pathogenesis. MicroRNA (miRNA",
            "probability": 0.006911136723121694,
            "start_logit": -3.0839080810546875,
            "end_logit": -1.0568485260009766,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "17 is an important factor in rheumatoid arthritis (RA) pathogenesis. MicroRNA",
            "probability": 0.006910083895291607,
            "start_logit": -3.0839080810546875,
            "end_logit": -1.0570008754730225,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "(miRNA",
            "probability": 0.006757151508893388,
            "start_logit": -3.106440782546997,
            "end_logit": -1.0568485260009766,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "Interleukin (IL)-17 is an important factor in rheumatoid arthritis",
            "probability": 0.006336551452664294,
            "start_logit": 0.4340965151786804,
            "end_logit": -4.661652565002441,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "miRNA)s",
            "probability": 0.006204352318191917,
            "start_logit": -1.336349368095398,
            "end_logit": -2.912290334701538,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "Interleukin (IL)-17 is an important factor in rheumatoid arthritis (RA) pathogenesis",
            "probability": 0.006030344736986867,
            "start_logit": 0.4340965151786804,
            "end_logit": -4.711183071136475,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "ukin (IL)-17",
            "probability": 0.004720981438704724,
            "start_logit": -4.376450538635254,
            "end_logit": -0.14542348682880402,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "MicroRNA (miRNA)s are a family",
            "probability": 0.004598067316693488,
            "start_logit": -0.2808801531791687,
            "end_logit": -4.267374515533447,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "MicroRNA (miRNA)s are a family of non coding RNAs and associated with human diseases including RA",
            "probability": 0.0037600714715771513,
            "start_logit": -0.2808801531791687,
            "end_logit": -4.468572616577148,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        },
        {
            "text": "MicroRNA (",
            "probability": 0.0030239615103463333,
            "start_logit": -0.2808801531791687,
            "end_logit": -4.686442852020264,
            "question_text": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?"
        }
    ],
    "52f112bb2059c6d71c000002": [
        {
            "text": "hMTr1",
            "probability": 0.6925886847540129,
            "start_logit": 3.3726625442504883,
            "end_logit": 2.5491456985473633,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransferase responsible for cap1 formation in human cells, which we call hMTr1",
            "probability": 0.13638245615585787,
            "start_logit": 1.7476893663406372,
            "end_logit": 2.5491456985473633,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "hMTr1 (also known as FTSJD2",
            "probability": 0.05704055114892739,
            "start_logit": 3.3726625442504883,
            "end_logit": 0.052471842616796494,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "FTSJD2 and ISG95). We show in vitro that hMTr1",
            "probability": 0.04785371298051405,
            "start_logit": 1.4462157487869263,
            "end_logit": 1.80330491065979,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "hMTr",
            "probability": 0.018536800804614575,
            "start_logit": 3.3726625442504883,
            "end_logit": -1.0715326070785522,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "cap1 formation in human cells, which we call hMTr1",
            "probability": 0.018188653397687944,
            "start_logit": -0.2669757902622223,
            "end_logit": 2.5491456985473633,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "FTSJD2",
            "probability": 0.008308803730540753,
            "start_logit": 1.4462157487869263,
            "end_logit": 0.052471842616796494,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransferase responsible for cap1 formation in human cells, which we call hMTr",
            "probability": 0.0036502104043226215,
            "start_logit": 1.7476893663406372,
            "end_logit": -1.0715326070785522,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "ISG95). We show in vitro that hMTr1",
            "probability": 0.0034717742292854144,
            "start_logit": -1.1772671937942505,
            "end_logit": 1.80330491065979,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "met",
            "probability": 0.003177774167721415,
            "start_logit": 1.7476893663406372,
            "end_logit": -1.2101364135742188,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "hMTr1 (also known as FTSJD",
            "probability": 0.0022265359983615995,
            "start_logit": 3.3726625442504883,
            "end_logit": -3.1908435821533203,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransferase responsible for cap1 formation in human cells,",
            "probability": 0.0017160156387044032,
            "start_logit": 1.7476893663406372,
            "end_logit": -1.8263123035430908,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "cap1 formation in human cells, which we call hMTr1 (also known as FTSJD2",
            "probability": 0.0014979898420220616,
            "start_logit": -0.2669757902622223,
            "end_logit": 0.052471842616796494,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "hMTr1 (also known as FTSJD2 and ISG95). We show in vitro that hMTr",
            "probability": 0.001165711956299532,
            "start_logit": 3.3726625442504883,
            "end_logit": -3.837958574295044,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "ferase responsible for cap1 formation in human cells, which we call hMTr1",
            "probability": 0.0009596022781393751,
            "start_logit": -3.209010124206543,
            "end_logit": 2.5491456985473633,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "hMTr1 catalyzes specific methylation",
            "probability": 0.0009031682406637673,
            "start_logit": 2.184441089630127,
            "end_logit": -2.9049155712127686,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransferase responsible for cap1",
            "probability": 0.0007956159045546906,
            "start_logit": 1.7476893663406372,
            "end_logit": -2.594956159591675,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "hMTr1 catalyzes specific met",
            "probability": 0.0006093588439652917,
            "start_logit": 2.184441089630127,
            "end_logit": -3.298417091369629,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "cap1 formation in human cells, which we call hMTr",
            "probability": 0.0004868105014693773,
            "start_logit": -0.2669757902622223,
            "end_logit": -1.0715326070785522,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        },
        {
            "text": "methyltransferase",
            "probability": 0.00043976902233469796,
            "start_logit": 1.7476893663406372,
            "end_logit": -3.1878230571746826,
            "question_text": "Which are the enzymes involved in the addition of 7-methylguanosine in mRNA?"
        }
    ],
    "5358e067f1005d6b5800000b": [
        {
            "text": "IRSp53",
            "probability": 0.2797603177372339,
            "start_logit": 5.133939743041992,
            "end_logit": 4.936511039733887,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8 activates and synergizes with IRSp53",
            "probability": 0.2595922765847524,
            "start_logit": 5.059118747711182,
            "end_logit": 4.936511039733887,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8",
            "probability": 0.15636765782208287,
            "start_logit": 5.059118747711182,
            "end_logit": 4.4296088218688965,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "IRSp53 in mediating actin bundling in vitro, enhancing IRSp53",
            "probability": 0.12052077175885378,
            "start_logit": 5.133939743041992,
            "end_logit": 4.094399929046631,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Cdc42",
            "probability": 0.035405376885151156,
            "start_logit": 4.2735066413879395,
            "end_logit": 3.729874610900879,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8. Additionally, Eps8 activates and synergizes with IRSp53",
            "probability": 0.03353404676340964,
            "start_logit": 3.0125677585601807,
            "end_logit": 4.936511039733887,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "IRSp53-Eps8 complex, regulated by Cdc42",
            "probability": 0.03321032120553294,
            "start_logit": 4.209503650665283,
            "end_logit": 3.729874610900879,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "IRSp53-Eps8",
            "probability": 0.029494100011472457,
            "start_logit": 4.209503650665283,
            "end_logit": 3.611204147338867,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8. Additionally, Eps8",
            "probability": 0.020199523724961848,
            "start_logit": 3.0125677585601807,
            "end_logit": 4.4296088218688965,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8 complex, regulated by Cdc42",
            "probability": 0.016817123640983617,
            "start_logit": 3.529040575027466,
            "end_logit": 3.729874610900879,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "IMD",
            "probability": 0.0070163544862063346,
            "start_logit": 3.1374006271362305,
            "end_logit": 3.2473607063293457,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8. Collectively, these results support a model whereby the synergic bundling activity of the IRSp53",
            "probability": 0.002420517281100141,
            "start_logit": 1.2660835981369019,
            "end_logit": 4.054415225982666,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "IRSp53. Here, we describe a novel actin crosslinking activity of Eps8. Additionally, Eps8",
            "probability": 0.002165459375531466,
            "start_logit": 0.7795412540435791,
            "end_logit": 4.4296088218688965,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "IRSp53-Eps8 complex,",
            "probability": 0.000672177542200445,
            "start_logit": 4.209503650665283,
            "end_logit": -0.17021887004375458,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "IRSp53 in mediating actin bundling",
            "probability": 0.0006652390530058238,
            "start_logit": 5.133939743041992,
            "end_logit": -1.1050310134887695,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8 activates and synergizes with IRSp53 in mediating actin bundling",
            "probability": 0.0006172816846922059,
            "start_logit": 5.059118747711182,
            "end_logit": -1.1050310134887695,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "IRSp53 in mediating actin bundling in vitro,",
            "probability": 0.0004738216759502814,
            "start_logit": 5.133939743041992,
            "end_logit": -1.4443464279174805,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8 activates and synergizes with IRSp53 in mediating actin bundling in vitro,",
            "probability": 0.0004396636683500805,
            "start_logit": 5.059118747711182,
            "end_logit": -1.4443464279174805,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Eps8 complex,",
            "probability": 0.0003403789070848876,
            "start_logit": 3.529040575027466,
            "end_logit": -0.17021887004375458,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        },
        {
            "text": "Cdc42,",
            "probability": 0.0002875901914436542,
            "start_logit": 4.2735066413879395,
            "end_logit": -1.0832078456878662,
            "question_text": "Which proteins are involved in actin bundling and filopodia formation and function?"
        }
    ],
    "56e0447a51531f7e3300000b": [
        {
            "text": "avocado sunblotch",
            "probability": 0.31562336283406894,
            "start_logit": 3.950763702392578,
            "end_logit": 3.388817548751831,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "avocado sunblotch, peach latent mosaic and chrysanthemum chlorotic mottle viroids",
            "probability": 0.14394794994340224,
            "start_logit": 3.950763702392578,
            "end_logit": 2.603719711303711,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "avocado sunblotch, peach latent mosaic",
            "probability": 0.07528960677580573,
            "start_logit": 3.950763702392578,
            "end_logit": 1.9556100368499756,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "chrysanthemum chlorotic mottle viroids",
            "probability": 0.06955816374097623,
            "start_logit": 3.223475217819214,
            "end_logit": 2.603719711303711,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "peach latent mosaic and chrysanthemum chlorotic mottle viroids",
            "probability": 0.06943038576019889,
            "start_logit": 3.2216365337371826,
            "end_logit": 2.603719711303711,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "chlorotic mottle viroids",
            "probability": 0.0457594124706694,
            "start_logit": 2.8047094345092773,
            "end_logit": 2.603719711303711,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "avocado",
            "probability": 0.041061427007442,
            "start_logit": 3.950763702392578,
            "end_logit": 1.349337100982666,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "peach latent mosaic",
            "probability": 0.036314420901674464,
            "start_logit": 3.2216365337371826,
            "end_logit": 1.9556100368499756,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "sunblotch",
            "probability": 0.031050208284442046,
            "start_logit": 1.6318196058273315,
            "end_logit": 3.388817548751831,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "avocado sunblotch, peach latent mosaic and chrysanthemum chlorotic mottle",
            "probability": 0.029973816458459934,
            "start_logit": 3.950763702392578,
            "end_logit": 1.0345921516418457,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "Viroids",
            "probability": 0.02446628417825773,
            "start_logit": 2.398397445678711,
            "end_logit": 2.383930206298828,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "mottle viroids",
            "probability": 0.019113483431285966,
            "start_logit": 1.9317059516906738,
            "end_logit": 2.603719711303711,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "viroids",
            "probability": 0.016967514542658026,
            "start_logit": 1.812612533569336,
            "end_logit": 2.603719711303711,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "chrysanthemum chlorotic mottle",
            "probability": 0.014483871663189917,
            "start_logit": 3.223475217819214,
            "end_logit": 1.0345921516418457,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "peach latent mosaic and chrysanthemum chlorotic mottle",
            "probability": 0.014457264867158722,
            "start_logit": 3.2216365337371826,
            "end_logit": 1.0345921516418457,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "sunblotch, peach latent mosaic and chrysanthemum chlorotic mottle viroids",
            "probability": 0.01416122617707126,
            "start_logit": 1.6318196058273315,
            "end_logit": 2.603719711303711,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "avocado sunblotch, peach",
            "probability": 0.010068324589578686,
            "start_logit": 3.950763702392578,
            "end_logit": -0.05633774772286415,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "viroids sequenced, avocado sunblotch",
            "probability": 0.00954709624604345,
            "start_logit": 0.4524511396884918,
            "end_logit": 3.388817548751831,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "chlorotic mottle",
            "probability": 0.009528334590260505,
            "start_logit": 2.8047094345092773,
            "end_logit": 1.0345921516418457,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        },
        {
            "text": "avocado sunblotch, peach latent mosaic and chrysanthemum",
            "probability": 0.009197845537355864,
            "start_logit": 3.950763702392578,
            "end_logit": -0.14676278829574585,
            "question_text": "Which are the smallest known subviral pathogens of plants?"
        }
    ],
    "52f893f92059c6d71c00003c": [
        {
            "text": "resistance training",
            "probability": 0.20737497171484875,
            "start_logit": -1.5457569360733032,
            "end_logit": -1.9884979724884033,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Phase II",
            "probability": 0.18308643460940435,
            "start_logit": -0.7459011077880859,
            "end_logit": -2.91292405128479,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "physical exercise [in particular, resistance training",
            "probability": 0.09274129226892128,
            "start_logit": -2.3504717350006104,
            "end_logit": -1.9884979724884033,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "physical exercise",
            "probability": 0.0716758521712408,
            "start_logit": -2.3504717350006104,
            "end_logit": -2.2461578845977783,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Phase II clinical trials on sarcopenia",
            "probability": 0.059877793307214565,
            "start_logit": -0.7459011077880859,
            "end_logit": -4.030576705932617,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "exercise [in particular, resistance training",
            "probability": 0.0578174619071534,
            "start_logit": -2.8229947090148926,
            "end_logit": -1.9884979724884033,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "exercise",
            "probability": 0.04468468953998193,
            "start_logit": -2.8229947090148926,
            "end_logit": -2.2461578845977783,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Phase II clinical trials",
            "probability": 0.04452845040007554,
            "start_logit": -0.7459011077880859,
            "end_logit": -4.326754093170166,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Phase II trial designs is high. In the present report, we discuss which are the major issues related to the design of Phase II",
            "probability": 0.042300259608858234,
            "start_logit": -2.211066246032715,
            "end_logit": -2.91292405128479,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "resistance training], testosterone",
            "probability": 0.029370275169102015,
            "start_logit": -1.5457569360733032,
            "end_logit": -3.9430434703826904,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "resistance training], testosterone, antioxidant supplementations",
            "probability": 0.027498885938683534,
            "start_logit": -1.5457569360733032,
            "end_logit": -4.008881092071533,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "testosterone",
            "probability": 0.02248032913119279,
            "start_logit": -1.8130993843078613,
            "end_logit": -3.9430434703826904,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "testosterone, antioxidant supplementations",
            "probability": 0.02104794739182677,
            "start_logit": -1.8130993843078613,
            "end_logit": -4.008881092071533,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "antioxidant supplementations",
            "probability": 0.018655912576211322,
            "start_logit": -1.9337393045425415,
            "end_logit": -4.008881092071533,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "resistance training], testosterone, antioxidant supplementations), the need for Phase II",
            "probability": 0.0156474052306226,
            "start_logit": -1.5457569360733032,
            "end_logit": -4.572721481323242,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "physical exercise [in particular, resistance training], testosterone",
            "probability": 0.013134840964423359,
            "start_logit": -2.3504717350006104,
            "end_logit": -3.9430434703826904,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "physical exercise [in particular, resistance training], testosterone, antioxidant supplementations",
            "probability": 0.012297926778820486,
            "start_logit": -2.3504717350006104,
            "end_logit": -4.008881092071533,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Phase II clinical trials on sarcopenia with particular focus on the participant's characteristics",
            "probability": 0.012096407703200076,
            "start_logit": -0.7459011077880859,
            "end_logit": -5.629973888397217,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "testosterone, antioxidant supplementations), the need for Phase II",
            "probability": 0.011976694723091987,
            "start_logit": -1.8130993843078613,
            "end_logit": -4.572721481323242,
            "question_text": "List clinical trials for prevention of sarcopenia"
        },
        {
            "text": "Phase II clinical trials on sarcopenia with",
            "probability": 0.011706168865126414,
            "start_logit": -0.7459011077880859,
            "end_logit": -5.662766456604004,
            "question_text": "List clinical trials for prevention of sarcopenia"
        }
    ],
    "56bdfa73ef6e394741000003": [
        {
            "text": "urinary impairment",
            "probability": 0.1889418711411503,
            "start_logit": 4.060249328613281,
            "end_logit": 3.8468611240386963,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance",
            "probability": 0.18794822808115988,
            "start_logit": 3.7570111751556396,
            "end_logit": 4.144826412200928,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance, cognitive and urinary impairment",
            "probability": 0.13951906438694076,
            "start_logit": 3.7570111751556396,
            "end_logit": 3.8468611240386963,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "urinary",
            "probability": 0.10264451067248873,
            "start_logit": 4.060249328613281,
            "end_logit": 3.2366933822631836,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "cognitive and urinary impairment",
            "probability": 0.10252857721450843,
            "start_logit": 3.448951482772827,
            "end_logit": 3.8468611240386963,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance, cognitive and urinary",
            "probability": 0.07579508981776983,
            "start_logit": 3.7570111751556396,
            "end_logit": 3.2366933822631836,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "cognitive and urinary",
            "probability": 0.05569964759302968,
            "start_logit": 3.448951482772827,
            "end_logit": 3.2366933822631836,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance, cognitive",
            "probability": 0.04981539477934226,
            "start_logit": 3.7570111751556396,
            "end_logit": 2.816983938217163,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "cognitive",
            "probability": 0.03660791141732373,
            "start_logit": 3.448951482772827,
            "end_logit": 2.816983938217163,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait",
            "probability": 0.03598933673573623,
            "start_logit": 3.7570111751556396,
            "end_logit": 2.491882562637329,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "rinary impairment",
            "probability": 0.004874826511117085,
            "start_logit": 0.40289443731307983,
            "end_logit": 3.8468611240386963,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "gait disturbance,",
            "probability": 0.004703638239749365,
            "start_logit": 3.7570111751556396,
            "end_logit": 0.4569961726665497,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "ait disturbance",
            "probability": 0.0027562770775993286,
            "start_logit": -0.46527448296546936,
            "end_logit": 4.144826412200928,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "rinary",
            "probability": 0.002648296954109662,
            "start_logit": 0.40289443731307983,
            "end_logit": 3.2366933822631836,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "ait disturbance, cognitive and urinary impairment",
            "probability": 0.0020460591886600375,
            "start_logit": -0.46527448296546936,
            "end_logit": 3.8468611240386963,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "impairment",
            "probability": 0.0020315824954226236,
            "start_logit": -0.4723750352859497,
            "end_logit": 3.8468611240386963,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "disturbance",
            "probability": 0.0016365829804353724,
            "start_logit": -0.9865448474884033,
            "end_logit": 4.144826412200928,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "hydrocephalus is characterized clinically by gait disturbance",
            "probability": 0.0014866832337477479,
            "start_logit": -1.0826077461242676,
            "end_logit": 4.144826412200928,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "disturbance, cognitive and urinary impairment",
            "probability": 0.001214879908967988,
            "start_logit": -0.9865448474884033,
            "end_logit": 3.8468611240386963,
            "question_text": "List symptoms of Hakim Triad."
        },
        {
            "text": "ait disturbance, cognitive and urinary",
            "probability": 0.0011115415707408994,
            "start_logit": -0.46527448296546936,
            "end_logit": 3.2366933822631836,
            "question_text": "List symptoms of Hakim Triad."
        }
    ],
    "56f96333cf1c325851000004": [
        {
            "text": "disulphide bonds",
            "probability": 0.43260933106736393,
            "start_logit": 6.444172382354736,
            "end_logit": 5.477133274078369,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disulphide",
            "probability": 0.19146752283690485,
            "start_logit": 6.444172382354736,
            "end_logit": 4.66201639175415,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions in addition to cross-linking through disulphide bonds",
            "probability": 0.12586377946531993,
            "start_logit": 5.209537506103516,
            "end_logit": 5.477133274078369,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cross-linking through disulphide bonds",
            "probability": 0.076225225230082,
            "start_logit": 4.708029747009277,
            "end_logit": 5.477133274078369,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions in addition to cross-linking through disulphide",
            "probability": 0.05570574728394552,
            "start_logit": 5.209537506103516,
            "end_logit": 4.66201639175415,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions",
            "probability": 0.03576170009604133,
            "start_logit": 5.209537506103516,
            "end_logit": 4.218810558319092,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cross-linking through disulphide",
            "probability": 0.03373633901164357,
            "start_logit": 4.708029747009277,
            "end_logit": 4.66201639175415,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic",
            "probability": 0.016307057321265455,
            "start_logit": 5.209537506103516,
            "end_logit": 3.4335310459136963,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions in addition to cross-linking",
            "probability": 0.015509560559585517,
            "start_logit": 5.209537506103516,
            "end_logit": 3.383389711380005,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cross-linking",
            "probability": 0.009392851159373833,
            "start_logit": 4.708029747009277,
            "end_logit": 3.383389711380005,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "through disulphide bonds",
            "probability": 0.0017373367526475028,
            "start_logit": 0.9266906380653381,
            "end_logit": 5.477133274078369,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "chemical bonds formed between alpha-keratins and KAbetaPs may derive from electrostatic interactions",
            "probability": 0.0014891392421258365,
            "start_logit": 2.030858278274536,
            "end_logit": 4.218810558319092,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "through disulphide",
            "probability": 0.0007689236927511674,
            "start_logit": 0.9266906380653381,
            "end_logit": 4.66201639175415,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "chemical bonds formed between alpha-keratins and KAbetaPs may derive from electrostatic",
            "probability": 0.0006790359215438946,
            "start_logit": 2.030858278274536,
            "end_logit": 3.4335310459136963,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "chemical bonds formed between alpha-keratins and KAbetaPs may derive from electrostatic interactions in addition to cross-linking",
            "probability": 0.0006458276646630276,
            "start_logit": 2.030858278274536,
            "end_logit": 3.383389711380005,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "interactions in addition to cross-linking through disulphide bonds",
            "probability": 0.00046226572098737224,
            "start_logit": -0.3972781002521515,
            "end_logit": 5.477133274078369,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "electrostatic interactions in addition to cross",
            "probability": 0.0004591511236871342,
            "start_logit": 5.209537506103516,
            "end_logit": -0.13644281029701233,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "di",
            "probability": 0.00045161711561877163,
            "start_logit": 6.444172382354736,
            "end_logit": -1.387622356414795,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "disul",
            "probability": 0.00044951907877588637,
            "start_logit": 6.444172382354736,
            "end_logit": -1.392278790473938,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        },
        {
            "text": "cross",
            "probability": 0.00027806965567358095,
            "start_logit": 4.708029747009277,
            "end_logit": -0.13644281029701233,
            "question_text": "What kind of bonds are connecting keratin molecules?"
        }
    ],
    "54c90dabf693c3b16b000004": [
        {
            "text": "SERCA2a",
            "probability": 0.5943962230397922,
            "start_logit": 5.383878231048584,
            "end_logit": 4.575122356414795,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SERCA2a)",
            "probability": 0.12384598116620084,
            "start_logit": 5.383878231048584,
            "end_logit": 3.006614923477173,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SERCA",
            "probability": 0.08740456516808186,
            "start_logit": 5.383878231048584,
            "end_logit": 2.658123731613159,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump (SERCA2a",
            "probability": 0.06647370842732993,
            "start_logit": 3.193138599395752,
            "end_logit": 4.575122356414795,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "(SERCA2a",
            "probability": 0.027305078653126234,
            "start_logit": 2.3034048080444336,
            "end_logit": 4.575122356414795,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Ca2+ ATPase pump (SERCA2a",
            "probability": 0.022025803689343617,
            "start_logit": 2.0885467529296875,
            "end_logit": 4.575122356414795,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "SERCA2",
            "probability": 0.014768483585823444,
            "start_logit": 5.383878231048584,
            "end_logit": 0.8800716400146484,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump (SERCA2a)",
            "probability": 0.013850191711913852,
            "start_logit": 3.193138599395752,
            "end_logit": 3.006614923477173,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump (SERCA",
            "probability": 0.009774802320390366,
            "start_logit": 3.193138599395752,
            "end_logit": 2.658123731613159,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump",
            "probability": 0.00845475684852566,
            "start_logit": 3.193138599395752,
            "end_logit": 2.513045072555542,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "(SERCA2a)",
            "probability": 0.005689175209295229,
            "start_logit": 2.3034048080444336,
            "end_logit": 3.006614923477173,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "cardiac sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump (SERCA2a",
            "probability": 0.005520774204723931,
            "start_logit": 0.7048501968383789,
            "end_logit": 4.575122356414795,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Ca2+ ATPase pump (SERCA2a)",
            "probability": 0.0045892069349476195,
            "start_logit": 2.0885467529296875,
            "end_logit": 3.006614923477173,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "(SERCA",
            "probability": 0.0040151475296252015,
            "start_logit": 2.3034048080444336,
            "end_logit": 2.658123731613159,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Ca2+ ATPase pump (SERCA",
            "probability": 0.0032388425755789686,
            "start_logit": 2.0885467529296875,
            "end_logit": 2.658123731613159,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "Ca2+ ATPase pump",
            "probability": 0.0028014506636159964,
            "start_logit": 2.0885467529296875,
            "end_logit": 2.513045072555542,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "the cardiac sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump (SERCA2a",
            "probability": 0.0022320867245513142,
            "start_logit": -0.20073100924491882,
            "end_logit": 4.575122356414795,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump (SERCA2",
            "probability": 0.001651618623646796,
            "start_logit": 3.193138599395752,
            "end_logit": 0.8800716400146484,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "cardiac sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump (SERCA2a)",
            "probability": 0.0011502860746396683,
            "start_logit": 0.7048501968383789,
            "end_logit": 3.006614923477173,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        },
        {
            "text": "cardiac sarcoplasmic/endoplasmic reticulum Ca2+ ATPase pump (SERCA",
            "probability": 0.0008118168488475644,
            "start_logit": 0.7048501968383789,
            "end_logit": 2.658123731613159,
            "question_text": "Which genes have been proposed as potential candidates for gene therapy of heart failure?"
        }
    ],
    "52f8995b2059c6d71c00004a": [
        {
            "text": "genetic risk factors",
            "probability": 0.1367541029420097,
            "start_logit": -1.9728833436965942,
            "end_logit": -2.496216058731079,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "genetic risk factors have been identified, but their role in RLS in ESRD has not been investigated yet. Therefore, a case-control association study",
            "probability": 0.12211486076202084,
            "start_logit": -1.9728833436965942,
            "end_logit": -2.609438419342041,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "genetic risk factors have been identified",
            "probability": 0.10008209627759189,
            "start_logit": -1.9728833436965942,
            "end_logit": -2.8084096908569336,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "genetic",
            "probability": 0.08867689259911798,
            "start_logit": -1.9728833436965942,
            "end_logit": -2.929401159286499,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "study",
            "probability": 0.07690888203336908,
            "start_logit": -2.4352240562438965,
            "end_logit": -2.609438419342041,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "genetic risk factors have been identified, but their role in RLS in ESRD has not been investigated",
            "probability": 0.07466490289973943,
            "start_logit": -1.9728833436965942,
            "end_logit": -3.1013903617858887,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "study of these variants",
            "probability": 0.05598191824293309,
            "start_logit": -2.4352240562438965,
            "end_logit": -2.9270310401916504,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "case-control association study",
            "probability": 0.046662355726294145,
            "start_logit": -2.9349076747894287,
            "end_logit": -2.609438419342041,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "case-control association study of these variants",
            "probability": 0.03396549415656129,
            "start_logit": -2.9349076747894287,
            "end_logit": -2.9270310401916504,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "these variants",
            "probability": 0.0323506177431218,
            "start_logit": -2.9836196899414062,
            "end_logit": -2.9270310401916504,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "genetic risk factors have been identified,",
            "probability": 0.029547950569812798,
            "start_logit": -1.9728833436965942,
            "end_logit": -4.028386116027832,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "genetic risk factors have been identified, but their role in RLS in ESRD has not been investigated yet. Therefore, a case-control association",
            "probability": 0.02597312528138077,
            "start_logit": -1.9728833436965942,
            "end_logit": -4.1573381423950195,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "genetic risk factors have been identified, but their role in RLS in ESRD has not been investigated yet. Therefore, a case-control",
            "probability": 0.025816065495747623,
            "start_logit": -1.9728833436965942,
            "end_logit": -4.163403511047363,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "a case-control association study",
            "probability": 0.023983064680672125,
            "start_logit": -3.6004974842071533,
            "end_logit": -2.609438419342041,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": ", genetic risk factors",
            "probability": 0.023853815554689232,
            "start_logit": -3.719123601913452,
            "end_logit": -2.496216058731079,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "genetic risk factors have been identified, but their role in RLS in ESRD has not been investigated yet. Therefore, a case",
            "probability": 0.022455711938919612,
            "start_logit": -1.9728833436965942,
            "end_logit": -4.302855491638184,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "their role in RLS in ESRD has not been investigated yet. Therefore, a case-control association study",
            "probability": 0.022017958844535574,
            "start_logit": -3.6859869956970215,
            "end_logit": -2.609438419342041,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "variants",
            "probability": 0.02108970016153891,
            "start_logit": -3.411468029022217,
            "end_logit": -2.9270310401916504,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "identified, but their role in RLS in ESRD has not been investigated yet. Therefore, a case-control association study",
            "probability": 0.0196432290802321,
            "start_logit": -3.800112724304199,
            "end_logit": -2.609438419342041,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        },
        {
            "text": "a case-control association study of these variants",
            "probability": 0.017457255009711757,
            "start_logit": -3.6004974842071533,
            "end_logit": -2.9270310401916504,
            "question_text": "Which genes have been found to be associated with restless leg syndrome"
        }
    ],
    "52bf1dea03868f1b06000012": [
        {
            "text": "Nalmefene Stimulation of the HPA Axis.",
            "probability": 0.33130139395591207,
            "start_logit": -0.16623716056346893,
            "end_logit": 1.2281242609024048,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Stimulation of the HPA Axis.",
            "probability": 0.15954802855975247,
            "start_logit": -0.8969206809997559,
            "end_logit": 1.2281242609024048,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Nalmefene Stimulation of the HPA Axis",
            "probability": 0.11796193089076158,
            "start_logit": -0.16623716056346893,
            "end_logit": 0.19545769691467285,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "HPA Axis.",
            "probability": 0.07921585799479156,
            "start_logit": -1.597089171409607,
            "end_logit": 1.2281242609024048,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Stimulation of the HPA Axis",
            "probability": 0.056808072232944866,
            "start_logit": -0.8969206809997559,
            "end_logit": 0.19545769691467285,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "the HPA Axis.",
            "probability": 0.04382313330534625,
            "start_logit": -2.189103841781616,
            "end_logit": 1.2281242609024048,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": ".",
            "probability": 0.04356196657588568,
            "start_logit": -2.1950812339782715,
            "end_logit": 1.2281242609024048,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Nalmefene Stimulation",
            "probability": 0.04191280315849688,
            "start_logit": -0.16623716056346893,
            "end_logit": -0.8393129110336304,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "HPA Axis",
            "probability": 0.028205301084478673,
            "start_logit": -1.597089171409607,
            "end_logit": 0.19545769691467285,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Axis.",
            "probability": 0.02470907791106643,
            "start_logit": -2.7620949745178223,
            "end_logit": 1.2281242609024048,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Stimulation",
            "probability": 0.02018435550633702,
            "start_logit": -0.8969206809997559,
            "end_logit": -0.8393129110336304,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "the HPA Axis",
            "probability": 0.01560350036761334,
            "start_logit": -2.189103841781616,
            "end_logit": 0.19545769691467285,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Axis",
            "probability": 0.008797821542844276,
            "start_logit": -2.7620949745178223,
            "end_logit": 0.19545769691467285,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Nalmefene Stimulation of the HPA",
            "probability": 0.0075704424498541,
            "start_logit": -0.16623716056346893,
            "end_logit": -2.5506527423858643,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "lmefene Stimulation of the HPA Axis.",
            "probability": 0.005441443253239541,
            "start_logit": -4.275221347808838,
            "end_logit": 1.2281242609024048,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "of the HPA Axis.",
            "probability": 0.005186861900748105,
            "start_logit": -4.323136806488037,
            "end_logit": 1.2281242609024048,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Stimulation of the HPA",
            "probability": 0.003645771464396612,
            "start_logit": -0.8969206809997559,
            "end_logit": -2.5506527423858643,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "Na",
            "probability": 0.0027379634025818064,
            "start_logit": -0.16623716056346893,
            "end_logit": -3.567689895629883,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "lmefene Stimulation of the HPA Axis",
            "probability": 0.0019374598619106996,
            "start_logit": -4.275221347808838,
            "end_logit": 0.19545769691467285,
            "question_text": "What are the side effects of Nalmefene?"
        },
        {
            "text": "of the HPA Axis",
            "probability": 0.0018468145810379367,
            "start_logit": -4.323136806488037,
            "end_logit": 0.19545769691467285,
            "question_text": "What are the side effects of Nalmefene?"
        }
    ],
    "530cf4d5e2bfff940c000004": [
        {
            "text": "network-based methods",
            "probability": 0.6621033572763942,
            "start_logit": 5.012691974639893,
            "end_logit": 4.816038608551025,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network",
            "probability": 0.11487529587176942,
            "start_logit": 5.012691974639893,
            "end_logit": 3.0644640922546387,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based",
            "probability": 0.08722372067501413,
            "start_logit": 5.012691974639893,
            "end_logit": 2.789093255996704,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based methods - which utilize a knowledge network",
            "probability": 0.051769366164651276,
            "start_logit": 5.012691974639893,
            "end_logit": 2.2674155235290527,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based methods - which utilize a knowledge network derived from biological knowledge",
            "probability": 0.04574935076107255,
            "start_logit": 5.012691974639893,
            "end_logit": 2.143794536590576,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based methods - which utilize a knowledge network derived from biological knowledge - have been utilized for gene prioritization",
            "probability": 0.013666329740792328,
            "start_logit": 5.012691974639893,
            "end_logit": 0.9355520606040955,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "knowledge network",
            "probability": 0.005852237294149482,
            "start_logit": 2.8327174186706543,
            "end_logit": 2.2674155235290527,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "knowledge network derived from biological knowledge",
            "probability": 0.00517170822326753,
            "start_logit": 2.8327174186706543,
            "end_logit": 2.143794536590576,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "methods",
            "probability": 0.0037560835267923228,
            "start_logit": -0.15935289859771729,
            "end_logit": 4.816038608551025,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": ", network-based methods",
            "probability": 0.002523982216651576,
            "start_logit": -0.5568917989730835,
            "end_logit": 4.816038608551025,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based methods - which utilize a knowledge network derived from biological knowledge - have been utilized for gene prioritization.",
            "probability": 0.0015670676566579317,
            "start_logit": 5.012691974639893,
            "end_logit": -1.2301769256591797,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "knowledge network derived from biological knowledge - have been utilized for gene prioritization",
            "probability": 0.001544902140173766,
            "start_logit": 2.8327174186706543,
            "end_logit": 0.9355520606040955,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based methods - which utilize a knowledge network derived from biological knowledge - have been utilized for gene",
            "probability": 0.0009017560118680891,
            "start_logit": 5.012691974639893,
            "end_logit": -1.7827943563461304,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based methods - which utilize a knowledge network derived from biological knowledge -",
            "probability": 0.0006962425524392838,
            "start_logit": 5.012691974639893,
            "end_logit": -2.04144024848938,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "network-based methods - which utilize a knowledge network derived from biological knowledge - have been utilized",
            "probability": 0.0005145362627194583,
            "start_logit": 5.012691974639893,
            "end_logit": -2.343872308731079,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "a knowledge network",
            "probability": 0.0004989619281270124,
            "start_logit": 0.3706679046154022,
            "end_logit": 2.2674155235290527,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "a knowledge network derived from biological knowledge",
            "probability": 0.00044093999902765726,
            "start_logit": 0.3706679046154022,
            "end_logit": 2.143794536590576,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": ", network",
            "probability": 0.0004379122998343261,
            "start_logit": -0.5568917989730835,
            "end_logit": 3.0644640922546387,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": "based methods",
            "probability": 0.0003737467501298476,
            "start_logit": -2.4669065475463867,
            "end_logit": 4.816038608551025,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        },
        {
            "text": ", network-based",
            "probability": 0.0003325026484679465,
            "start_logit": -0.5568917989730835,
            "end_logit": 2.789093255996704,
            "question_text": "Which are the most common methods for gene prioritization analysis?"
        }
    ],
    "5537766dbc4f83e82800000d": [
        {
            "text": "microcephaly and growth delay",
            "probability": 0.2683419215456921,
            "start_logit": 5.093173027038574,
            "end_logit": 5.123110771179199,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microcephaly",
            "probability": 0.26001237591708865,
            "start_logit": 5.093173027038574,
            "end_logit": 5.091578006744385,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "growth delay",
            "probability": 0.20354899293450837,
            "start_logit": 4.816817760467529,
            "end_logit": 5.123110771179199,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "osteodysplastic primordial dwarfism",
            "probability": 0.09219500531979943,
            "start_logit": 4.7081618309021,
            "end_logit": 4.439765930175781,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "small patellae",
            "probability": 0.020075980106183947,
            "start_logit": 3.558551549911499,
            "end_logit": 4.0649943351745605,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "primordial dwarfism",
            "probability": 0.01877601386462247,
            "start_logit": 3.1168360710144043,
            "end_logit": 4.439765930175781,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "dwarfism",
            "probability": 0.013483161169724053,
            "start_logit": 2.7856974601745605,
            "end_logit": 4.439765930175781,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "micrognathia",
            "probability": 0.013071596723295465,
            "start_logit": 3.4912667274475098,
            "end_logit": 3.7031967639923096,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microcephaly and growth delay, features also displayed by several related disorders including Majewski",
            "probability": 0.012940671459800593,
            "start_logit": 5.093173027038574,
            "end_logit": 2.091223955154419,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microtia (small ears), micrognathia",
            "probability": 0.012750273150085843,
            "start_logit": 3.4663777351379395,
            "end_logit": 3.7031967639923096,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "patellae",
            "probability": 0.012422277067240818,
            "start_logit": 3.078518867492676,
            "end_logit": 4.0649943351745605,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microcephaly and growth delay, features also displayed by several related disorders including Majewski (microcephalic",
            "probability": 0.00996919614067004,
            "start_logit": 5.093173027038574,
            "end_logit": 1.8303487300872803,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "growth delay, features also displayed by several related disorders including Majewski",
            "probability": 0.009816060898595857,
            "start_logit": 4.816817760467529,
            "end_logit": 2.091223955154419,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microcephaly and growth delay, microtia (small ears), micrognathia",
            "probability": 0.00905840770168759,
            "start_logit": 3.124518394470215,
            "end_logit": 3.7031967639923096,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microcephalic) osteodysplastic primordial dwarfism",
            "probability": 0.008809914842310593,
            "start_logit": 2.360133647918701,
            "end_logit": 4.439765930175781,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microtia",
            "probability": 0.00836058337584824,
            "start_logit": 3.4663777351379395,
            "end_logit": 3.281172275543213,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "growth delay, features also displayed by several related disorders including Majewski (microcephalic",
            "probability": 0.007562067913620599,
            "start_logit": 4.816817760467529,
            "end_logit": 1.8303487300872803,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "micrognathia (small and receding chin), and dental crowding",
            "probability": 0.006470113580042083,
            "start_logit": 3.4912667274475098,
            "end_logit": 2.999948740005493,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microtia (small ears), micrognathia (small and receding chin), and dental crowding",
            "probability": 0.006311066444591053,
            "start_logit": 3.4663777351379395,
            "end_logit": 2.999948740005493,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        },
        {
            "text": "microcephaly and growth delay, features also displayed by several related disorders including Majewski (microcephalic)",
            "probability": 0.006024319844592163,
            "start_logit": 5.093173027038574,
            "end_logit": 1.3266533613204956,
            "question_text": "Which are the characteristics of the Meier-Gorlin syndrome?"
        }
    ],
    "55439140ed966d112c00000a": [
        {
            "text": "C-Phycocyanin",
            "probability": 0.5092253046672921,
            "start_logit": 4.233824729919434,
            "end_logit": 4.117791652679443,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-Phycocyanin (C-PC)",
            "probability": 0.1766204919023125,
            "start_logit": 4.233824729919434,
            "end_logit": 3.0589044094085693,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-PC)",
            "probability": 0.07207256346220076,
            "start_logit": 3.3374948501586914,
            "end_logit": 3.0589044094085693,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Phycocyanin",
            "probability": 0.07067112296004761,
            "start_logit": 2.2589712142944336,
            "end_logit": 4.117791652679443,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-Phycocyanin (C-PC",
            "probability": 0.056282426677862825,
            "start_logit": 4.233824729919434,
            "end_logit": 1.915283441543579,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-Phycocyanin (C-PC),",
            "probability": 0.031652797960828295,
            "start_logit": 4.233824729919434,
            "end_logit": 1.3397276401519775,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Phycocyanin (C-PC)",
            "probability": 0.024511681540742854,
            "start_logit": 2.2589712142944336,
            "end_logit": 3.0589044094085693,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-PC",
            "probability": 0.022966863724909702,
            "start_logit": 3.3374948501586914,
            "end_logit": 1.915283441543579,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-PC),",
            "probability": 0.012916385099016625,
            "start_logit": 3.3374948501586914,
            "end_logit": 1.3397276401519775,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Phycocyanin (C-PC",
            "probability": 0.007810967482929542,
            "start_logit": 2.2589712142944336,
            "end_logit": 1.915283441543579,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "Phycocyanin (C-PC),",
            "probability": 0.004392827214627068,
            "start_logit": 2.2589712142944336,
            "end_logit": 1.3397276401519775,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C",
            "probability": 0.002681511560843936,
            "start_logit": 4.233824729919434,
            "end_logit": -1.1287182569503784,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-Phycocyanin (C-PC), the major light harvesting biliprotein from Spirulina platensis",
            "probability": 0.0022985674336154986,
            "start_logit": 4.233824729919434,
            "end_logit": -1.2828128337860107,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(C-PC)",
            "probability": 0.001835405643654138,
            "start_logit": -0.3329130709171295,
            "end_logit": 3.0589044094085693,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-Phycocyanin (",
            "probability": 0.0010315684787415048,
            "start_logit": 4.233824729919434,
            "end_logit": -2.0840184688568115,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-PC), the major light harvesting biliprotein from Spirulina platensis",
            "probability": 0.0009379639103430211,
            "start_logit": 3.3374948501586914,
            "end_logit": -1.2828128337860107,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "(C-PC",
            "probability": 0.0005848759815493818,
            "start_logit": -0.3329130709171295,
            "end_logit": 1.915283441543579,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-P",
            "probability": 0.0005290458532754323,
            "start_logit": 4.233824729919434,
            "end_logit": -2.751779079437256,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "C-Phycocyanin (C",
            "probability": 0.0005067268634731737,
            "start_logit": 4.233824729919434,
            "end_logit": -2.79488205909729,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        },
        {
            "text": "cyanin",
            "probability": 0.00047090158173391947,
            "start_logit": -2.7521719932556152,
            "end_logit": 4.117791652679443,
            "question_text": "Which are the major phycobiliproteins present in cyanobacteria?"
        }
    ],
    "517539ca8ed59a060a000027": [
        {
            "text": "TRalpha1",
            "probability": 0.9889755804650939,
            "start_logit": 3.7710647583007812,
            "end_logit": 2.774322986602783,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha1.",
            "probability": 0.006128854382907079,
            "start_logit": 3.7710647583007812,
            "end_logit": -2.3093388080596924,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha",
            "probability": 0.00147148832078273,
            "start_logit": 3.7710647583007812,
            "end_logit": -3.736072301864624,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "T",
            "probability": 0.001183127277229591,
            "start_logit": 3.7710647583007812,
            "end_logit": -3.9541854858398438,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha2 resulted in an inevitable, concomitant overexpression of TRalpha1",
            "probability": 0.0009366006032889955,
            "start_logit": -3.191103219985962,
            "end_logit": 2.774322986602783,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "overexpression of TRalpha1",
            "probability": 0.0006909767118472924,
            "start_logit": -3.4952540397644043,
            "end_logit": 2.774322986602783,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "1",
            "probability": 0.0002691650264519466,
            "start_logit": -4.438035488128662,
            "end_logit": 2.774322986602783,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha1:TRalpha2 expressed from the TRalpha",
            "probability": 0.00018763141212104815,
            "start_logit": 1.2443572282791138,
            "end_logit": -3.2689149379730225,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha1:TRalpha2 expressed from the TRalpha gene",
            "probability": 6.435392921037107e-05,
            "start_logit": 1.2443572282791138,
            "end_logit": -4.338996410369873,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "alpha and beta, which each generate variant proteins. In mammals, the alpha gene generates, in addition to the normal receptor TRalpha1",
            "probability": 1.9284269412371776e-05,
            "start_logit": -2.7416062355041504,
            "end_logit": -1.5581412315368652,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha1 and the concomitant decrease in TRalpha2",
            "probability": 1.8583192073793355e-05,
            "start_logit": 0.25220149755477905,
            "end_logit": -4.5889811515808105,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha2 expressed from the TRalpha",
            "probability": 1.4023840722362786e-05,
            "start_logit": -1.3493634462356567,
            "end_logit": -3.2689149379730225,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha gene",
            "probability": 7.497940091547944e-06,
            "start_logit": -0.9054124355316162,
            "end_logit": -4.338996410369873,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha2 resulted in an inevitable, concomitant overexpression of TRalpha1.",
            "probability": 5.804277502788935e-06,
            "start_logit": -3.191103219985962,
            "end_logit": -2.3093388080596924,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha1, a non-hormone-binding variant TRalpha2",
            "probability": 5.737594641883109e-06,
            "start_logit": -1.5325103998184204,
            "end_logit": -3.9794867038726807,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "TRalpha2 expressed from the TRalpha gene",
            "probability": 4.809904924247032e-06,
            "start_logit": -1.3493634462356567,
            "end_logit": -4.338996410369873,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "alpha",
            "probability": 4.5609430238808945e-06,
            "start_logit": -2.7416062355041504,
            "end_logit": -2.999901533126831,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "overexpression of TRalpha1.",
            "probability": 4.282103352744483e-06,
            "start_logit": -3.4952540397644043,
            "end_logit": -2.3093388080596924,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "beta, which each generate variant proteins. In mammals, the alpha gene generates, in addition to the normal receptor TRalpha1",
            "probability": 4.05814897284644e-06,
            "start_logit": -4.300168991088867,
            "end_logit": -1.5581412315368652,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        },
        {
            "text": "alpha and beta",
            "probability": 3.5796563485345983e-06,
            "start_logit": -2.7416062355041504,
            "end_logit": -3.242164134979248,
            "question_text": "Which genes are regulated by TRalpha2  in the heart?"
        }
    ],
    "554143ad182542114d000004": [
        {
            "text": "sequence",
            "probability": 0.38242675996258485,
            "start_logit": -0.0016161220846697688,
            "end_logit": -0.7951961159706116,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-based",
            "probability": 0.22225184535711034,
            "start_logit": -0.0016161220846697688,
            "end_logit": -1.3379220962524414,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-based prediction methods",
            "probability": 0.18646462147751958,
            "start_logit": -0.0016161220846697688,
            "end_logit": -1.5134917497634888,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-based prediction",
            "probability": 0.1115312837731914,
            "start_logit": -0.0016161220846697688,
            "end_logit": -2.027428150177002,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "prediction methods",
            "probability": 0.02338633285872614,
            "start_logit": -2.0777058601379395,
            "end_logit": -1.5134917497634888,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "prediction",
            "probability": 0.013988217742395472,
            "start_logit": -2.0777058601379395,
            "end_logit": -2.027428150177002,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-based prediction methods allow TM protein topology",
            "probability": 0.008687754870700502,
            "start_logit": -0.0016161220846697688,
            "end_logit": -4.5798187255859375,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "based",
            "probability": 0.007608343382455529,
            "start_logit": -3.3761818408966064,
            "end_logit": -1.3379220962524414,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "based prediction methods",
            "probability": 0.006383239997854866,
            "start_logit": -3.3761818408966064,
            "end_logit": -1.5134917497634888,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-based prediction methods allow TM protein topology to be investigated",
            "probability": 0.005945252327727112,
            "start_logit": -0.0016161220846697688,
            "end_logit": -4.959140300750732,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "methods",
            "probability": 0.005065877263235056,
            "start_logit": -3.607330322265625,
            "end_logit": -1.5134917497634888,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-",
            "probability": 0.004523172585449498,
            "start_logit": -0.0016161220846697688,
            "end_logit": -5.232519626617432,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "based prediction",
            "probability": 0.0038180484102125936,
            "start_logit": -3.3761818408966064,
            "end_logit": -2.027428150177002,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "structural data, sequence",
            "probability": 0.0034193174322109227,
            "start_logit": -4.718712329864502,
            "end_logit": -0.7951961159706116,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-based prediction methods allow TM protein topology to be",
            "probability": 0.003392059221274296,
            "start_logit": -0.0016161220846697688,
            "end_logit": -5.520296096801758,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-based prediction methods allow TM protein topology to be investigated.",
            "probability": 0.0030864218799719527,
            "start_logit": -0.0016161220846697688,
            "end_logit": -5.614720821380615,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": ", sequence",
            "probability": 0.002413711888488715,
            "start_logit": -5.06698751449585,
            "end_logit": -0.7951961159706116,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "structural data, sequence-based",
            "probability": 0.0019871768629500827,
            "start_logit": -4.718712329864502,
            "end_logit": -1.3379220962524414,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "data, sequence",
            "probability": 0.0018385410204920865,
            "start_logit": -5.339180946350098,
            "end_logit": -0.7951961159706116,
            "question_text": "List available methods for transmembrane protein topology prediction."
        },
        {
            "text": "sequence-based prediction methods allow TM protein",
            "probability": 0.0017820216854490208,
            "start_logit": -0.0016161220846697688,
            "end_logit": -6.163984775543213,
            "question_text": "List available methods for transmembrane protein topology prediction."
        }
    ],
    "56b739d976d8bf8d13000005": [
        {
            "text": "Brainbow",
            "probability": 0.9927491003462581,
            "start_logit": 3.624234199523926,
            "end_logit": 3.9733569622039795,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow is",
            "probability": 0.0035165326225472197,
            "start_logit": 3.624234199523926,
            "end_logit": -1.6696455478668213,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brain",
            "probability": 0.0015906911799889426,
            "start_logit": 3.624234199523926,
            "end_logit": -2.4629523754119873,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow is a genetic cell-labeling technique",
            "probability": 0.0008103446730035752,
            "start_logit": 3.624234199523926,
            "end_logit": -3.1374166011810303,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "bow",
            "probability": 0.0004479025183025488,
            "start_logit": -4.079423427581787,
            "end_logit": 3.9733569622039795,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow is a",
            "probability": 0.00021244017964466331,
            "start_logit": 3.624234199523926,
            "end_logit": -4.476215839385986,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "tracing axons through the nervous system, following individual cells during development, or analyzing cell lineage. In recent years, Brainbow",
            "probability": 0.00018680433854605246,
            "start_logit": -3.122316837310791,
            "end_logit": 2.1417365074157715,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow is a genetic cell-labeling technique where hundreds of different hues can be generated by stochastic and combinatorial expression",
            "probability": 0.00016609723450456733,
            "start_logit": 3.624234199523926,
            "end_logit": -4.7223029136657715,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow in lineage tracing",
            "probability": 7.369545761115987e-05,
            "start_logit": 1.262325406074524,
            "end_logit": -3.1730263233184814,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "development, or analyzing cell lineage. In recent years, Brainbow",
            "probability": 6.275699518658201e-05,
            "start_logit": -4.213108539581299,
            "end_logit": 2.1417365074157715,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "analyzing cell lineage. In recent years, Brainbow",
            "probability": 5.010142088361095e-05,
            "start_logit": -4.438329219818115,
            "end_logit": 2.1417365074157715,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "following individual cells during development, or analyzing cell lineage. In recent years, Brainbow",
            "probability": 3.562490589337696e-05,
            "start_logit": -4.779333591461182,
            "end_logit": 2.1417365074157715,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "mouse nervous system to other model organisms and a wide variety of tissues. Particularly exciting is the application of Brainbow",
            "probability": 3.493665746663908e-05,
            "start_logit": -4.192019939422607,
            "end_logit": 1.534914493560791,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow and other combinatorial expression strategies",
            "probability": 3.013069386373765e-05,
            "start_logit": 1.8878477811813354,
            "end_logit": -4.69294548034668,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "Brainbow in lineage tracing,",
            "probability": 2.8239264380259484e-05,
            "start_logit": 1.262325406074524,
            "end_logit": -4.132254123687744,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "bow is",
            "probability": 1.5865678616909387e-06,
            "start_logit": -4.079423427581787,
            "end_logit": -1.6696455478668213,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "fluorescent proteins.",
            "probability": 1.0616777458905677e-06,
            "start_logit": -3.409858465194702,
            "end_logit": -2.7409331798553467,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "fluorescent proteins",
            "probability": 8.397985573697308e-07,
            "start_logit": -3.409858465194702,
            "end_logit": -2.975376844406128,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "tracing axons through the nervous system, following individual cells during development",
            "probability": 5.872535659061951e-07,
            "start_logit": -3.122316837310791,
            "end_logit": -3.620623826980591,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        },
        {
            "text": "hundreds of different hues can be generated by stochastic and combinatorial expression of a few spectrally distinct fluorescent proteins.",
            "probability": 5.262141884539211e-07,
            "start_logit": -4.111755847930908,
            "end_logit": -2.7409331798553467,
            "question_text": "List available genetic multicolor cell labeling techiniques in Drosophila"
        }
    ],
    "5319abffb166e2b80600002f": [
        {
            "text": "CCN1",
            "probability": 0.49666834168452134,
            "start_logit": 2.580244302749634,
            "end_logit": 2.1400227546691895,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Sonic Hedgehog",
            "probability": 0.45426912084188253,
            "start_logit": 2.4469125270843506,
            "end_logit": 2.18412184715271,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Hedgehog",
            "probability": 0.020344417682547782,
            "start_logit": -0.6589707136154175,
            "end_logit": 2.18412184715271,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN1 plays a critical role in pancreatic carcinogenesis through the induction of EMT and stemness. CCN1",
            "probability": 0.009253653127009579,
            "start_logit": 2.580244302749634,
            "end_logit": -1.8428813219070435,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Sonic Hedgehog (SHh)",
            "probability": 0.006280654104844323,
            "start_logit": 2.4469125270843506,
            "end_logit": -2.0970938205718994,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN1 regulates the Sonic Hedgehog",
            "probability": 0.0034390488829110525,
            "start_logit": -2.436582326889038,
            "end_logit": 2.18412184715271,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN1 is a matricellular protein and a member of the CCN family of growth factors. CCN1",
            "probability": 0.0019907605669516565,
            "start_logit": 1.718493103981018,
            "end_logit": -2.517631769180298,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN1 plays a critical role in pancreatic carcinogenesis through the induction of EMT and stemness.",
            "probability": 0.001332393670432057,
            "start_logit": 2.580244302749634,
            "end_logit": -3.7809226512908936,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN1 plays a critical role in pancreatic carcinogenesis",
            "probability": 0.0011343437740602602,
            "start_logit": 2.580244302749634,
            "end_logit": -3.941845417022705,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Sonic Hedgehog (SHh",
            "probability": 0.0009955769182608985,
            "start_logit": 2.4469125270843506,
            "end_logit": -3.9390008449554443,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN1 plays a critical role in pancreatic carcinogenesis through the induction",
            "probability": 0.0008847296014339176,
            "start_logit": 2.580244302749634,
            "end_logit": -4.190372943878174,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN1 is a matricellular protein and a member of the CCN family of growth factors.",
            "probability": 0.0007716810370779556,
            "start_logit": 1.718493103981018,
            "end_logit": -3.465332508087158,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CC",
            "probability": 0.0006499985447104331,
            "start_logit": 2.580244302749634,
            "end_logit": -4.498684883117676,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN",
            "probability": 0.0005894587118599789,
            "start_logit": 2.580244302749634,
            "end_logit": -4.596450328826904,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "hog",
            "probability": 0.0005144457363221989,
            "start_logit": -4.336442470550537,
            "end_logit": 2.18412184715271,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "1",
            "probability": 0.0003282422435636175,
            "start_logit": -4.7416815757751465,
            "end_logit": 2.1400227546691895,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Hedgehog (SHh)",
            "probability": 0.00028127874989996573,
            "start_logit": -0.6589707136154175,
            "end_logit": -2.0970938205718994,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "studies found that CCN1",
            "probability": 0.0001797195098180529,
            "start_logit": -5.344036102294922,
            "end_logit": 2.1400227546691895,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "CCN1 regulates the Sonic Hedgehog (SHh)",
            "probability": 4.754775416648608e-05,
            "start_logit": -2.436582326889038,
            "end_logit": -2.0970938205718994,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        },
        {
            "text": "Hedgehog (SHh",
            "probability": 4.458685772580482e-05,
            "start_logit": -0.6589707136154175,
            "end_logit": -3.9390008449554443,
            "question_text": "Which growth factors are known to be involved in the induction of EMT?"
        }
    ],
    "534bb147aeec6fbd07000014": [
        {
            "text": "reduced serum cholesterol and serum triglycerides",
            "probability": 0.4967132476991635,
            "start_logit": 0.5113754868507385,
            "end_logit": -0.7235197424888611,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduced",
            "probability": 0.26438085207635453,
            "start_logit": 0.5113754868507385,
            "end_logit": -1.3541419506072998,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduced serum cholesterol",
            "probability": 0.09981645112464922,
            "start_logit": 0.5113754868507385,
            "end_logit": -2.328199625015259,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduced serum cholesterol and serum triglycerides, probably by stimulation important steps in reverse cholesterol transport",
            "probability": 0.0704437248680381,
            "start_logit": 0.5113754868507385,
            "end_logit": -2.6767184734344482,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduced serum cholesterol and serum triglycerides,",
            "probability": 0.024253686012889783,
            "start_logit": 0.5113754868507385,
            "end_logit": -3.742964029312134,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduction",
            "probability": 0.008958290913360282,
            "start_logit": -1.3877270221710205,
            "end_logit": -2.839850664138794,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "serum triglycerides",
            "probability": 0.007817345136113468,
            "start_logit": -3.6402924060821533,
            "end_logit": -0.7235197424888611,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "triglycerides",
            "probability": 0.006046049673515779,
            "start_logit": -3.8972322940826416,
            "end_logit": -0.7235197424888611,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "serum cholesterol and serum triglycerides",
            "probability": 0.004595206520994649,
            "start_logit": -4.171623706817627,
            "end_logit": -0.7235197424888611,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduced serum cholesterol and serum triglycerides, probably by stimulation important steps in reverse cholesterol transport.",
            "probability": 0.0035181517359582316,
            "start_logit": 0.5113754868507385,
            "end_logit": -5.6735968589782715,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduction cholesterol, triglycerides",
            "probability": 0.0023384653684421926,
            "start_logit": -1.3877270221710205,
            "end_logit": -4.1829352378845215,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "GC1 reduced serum cholesterol and serum triglycerides",
            "probability": 0.002194661200839775,
            "start_logit": -4.910609722137451,
            "end_logit": -0.7235197424888611,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "cholesterol and serum triglycerides",
            "probability": 0.0019363024594644166,
            "start_logit": -5.035857200622559,
            "end_logit": -0.7235197424888611,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "reduction cholesterol",
            "probability": 0.0013275107867021538,
            "start_logit": -1.3877270221710205,
            "end_logit": -4.749124526977539,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "GC1 reduced",
            "probability": 0.0011681315144796613,
            "start_logit": -4.910609722137451,
            "end_logit": -1.3541419506072998,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "serum triglycerides, probably by stimulation important steps in reverse cholesterol transport",
            "probability": 0.0011086535592068536,
            "start_logit": -3.6402924060821533,
            "end_logit": -2.6767184734344482,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "serum cholesterol",
            "probability": 0.0009234245497481306,
            "start_logit": -4.171623706817627,
            "end_logit": -2.328199625015259,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "triglycerides, probably by stimulation important steps in reverse cholesterol transport",
            "probability": 0.0008574489641910841,
            "start_logit": -3.8972322940826416,
            "end_logit": -2.6767184734344482,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "animals, GC1 reduced serum cholesterol and serum triglycerides",
            "probability": 0.0008402912792646351,
            "start_logit": -5.8706440925598145,
            "end_logit": -0.7235197424888611,
            "question_text": "Which are the cardiac effects of thyronamines?"
        },
        {
            "text": "ides",
            "probability": 0.000762104556623283,
            "start_logit": -5.968308925628662,
            "end_logit": -0.7235197424888611,
            "question_text": "Which are the cardiac effects of thyronamines?"
        }
    ],
    "55086ea1098a1b487b000001": [
        {
            "text": "non-small cell lung cancer",
            "probability": 0.5923534598034158,
            "start_logit": 5.417435646057129,
            "end_logit": 4.79516077041626,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung",
            "probability": 0.14756677655100808,
            "start_logit": 5.417435646057129,
            "end_logit": 3.4053380489349365,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "colorectal carcinoma",
            "probability": 0.07172311369037888,
            "start_logit": 4.5789337158203125,
            "end_logit": 3.522372245788574,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "esophageal squamous cell carcinoma as well as colorectal carcinoma",
            "probability": 0.03351391499072332,
            "start_logit": 3.8180813789367676,
            "end_logit": 3.522372245788574,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "esophageal squamous cell carcinoma",
            "probability": 0.03038511371466287,
            "start_logit": 3.8180813789367676,
            "end_logit": 3.4243643283843994,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "colorectal",
            "probability": 0.0270255950430519,
            "start_logit": 4.5789337158203125,
            "end_logit": 2.5463435649871826,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "squamous cell carcinoma as well as colorectal carcinoma",
            "probability": 0.02228647086215295,
            "start_logit": 3.4101004600524902,
            "end_logit": 3.522372245788574,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "squamous cell carcinoma",
            "probability": 0.020205844397244578,
            "start_logit": 3.4101004600524902,
            "end_logit": 3.4243643283843994,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non-small cell lung cancer (NSCLC)",
            "probability": 0.019855364657177042,
            "start_logit": 5.417435646057129,
            "end_logit": 1.3995314836502075,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "esophageal squamous cell carcinoma as well as colorectal",
            "probability": 0.012628195406525584,
            "start_logit": 3.8180813789367676,
            "end_logit": 2.5463435649871826,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "esophageal",
            "probability": 0.008949154485197269,
            "start_logit": 3.8180813789367676,
            "end_logit": 2.2019705772399902,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "squamous cell carcinoma as well as colorectal",
            "probability": 0.00839764345785947,
            "start_logit": 3.4101004600524902,
            "end_logit": 2.5463435649871826,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "lung cancer",
            "probability": 0.0020282585947264285,
            "start_logit": -0.2594902813434601,
            "end_logit": 4.79516077041626,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "esophageal squamous cell",
            "probability": 0.0009492804654221955,
            "start_logit": 3.8180813789367676,
            "end_logit": -0.04163946583867073,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "squamous cell",
            "probability": 0.0006312635046815265,
            "start_logit": 3.4101004600524902,
            "end_logit": -0.04163946583867073,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "lung",
            "probability": 0.0005052786944723617,
            "start_logit": -0.2594902813434601,
            "end_logit": 3.4053380489349365,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "small cell lung cancer",
            "probability": 0.00042494454753487103,
            "start_logit": -1.8224644660949707,
            "end_logit": 4.79516077041626,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non",
            "probability": 0.00024206688361872575,
            "start_logit": 5.417435646057129,
            "end_logit": -3.007483959197998,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.00016917438891742319,
            "start_logit": -2.74349308013916,
            "end_logit": 4.79516077041626,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        },
        {
            "text": "non-small cell",
            "probability": 0.00015908586122863994,
            "start_logit": 5.417435646057129,
            "end_logit": -3.4272539615631104,
            "question_text": "Matuzumab has been tested for treatment of which cancers?"
        }
    ],
    "5171651e8ed59a060a000009": [
        {
            "text": "Human kallikrein-related peptidase 3",
            "probability": 0.5361775575989858,
            "start_logit": 3.6772961616516113,
            "end_logit": 3.198862075805664,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase 3 (hK3",
            "probability": 0.2598863393938755,
            "start_logit": 3.6772961616516113,
            "end_logit": 2.4746410846710205,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3",
            "probability": 0.10212693179892059,
            "start_logit": 2.7432682514190674,
            "end_logit": 2.4746410846710205,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "kallikrein-related peptidase 3",
            "probability": 0.03669180907774804,
            "start_logit": 0.9953843355178833,
            "end_logit": 3.198862075805664,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase 3 (hK3),",
            "probability": 0.018369880133194964,
            "start_logit": 3.6772961616516113,
            "end_logit": -0.1748909205198288,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "kallikrein-related peptidase 3 (hK3",
            "probability": 0.01778459357690384,
            "start_logit": 0.9953843355178833,
            "end_logit": 2.4746410846710205,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3),",
            "probability": 0.007218769173834305,
            "start_logit": 2.7432682514190674,
            "end_logit": -0.1748909205198288,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase 3 (hK3)",
            "probability": 0.004354233317639181,
            "start_logit": 3.6772961616516113,
            "end_logit": -1.614454746246338,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase 3 (hK3), also known as prostate-specific antigen",
            "probability": 0.0036073785096731948,
            "start_logit": 3.6772961616516113,
            "end_logit": -1.8026219606399536,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "(hK3",
            "probability": 0.0028158220332128478,
            "start_logit": -0.8476939797401428,
            "end_logit": 2.4746410846710205,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3)",
            "probability": 0.0017110729640667053,
            "start_logit": 2.7432682514190674,
            "end_logit": -1.614454746246338,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3), also known as prostate-specific antigen (PSA),",
            "probability": 0.0017104485041670768,
            "start_logit": 2.7432682514190674,
            "end_logit": -1.6148197650909424,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein-related peptidase",
            "probability": 0.0014472358519987392,
            "start_logit": 3.6772961616516113,
            "end_logit": -2.7159478664398193,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3), also known as prostate-specific antigen",
            "probability": 0.0014175831630454992,
            "start_logit": 2.7432682514190674,
            "end_logit": -1.8026219606399536,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "kallikrein-related peptidase 3 (hK3),",
            "probability": 0.0012570912845487237,
            "start_logit": 0.9953843355178833,
            "end_logit": -0.1748909205198288,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "3",
            "probability": 0.0010149522976330334,
            "start_logit": -2.59232759475708,
            "end_logit": 3.198862075805664,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human",
            "probability": 0.001005694865595931,
            "start_logit": 3.6772961616516113,
            "end_logit": -3.0799245834350586,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "hK3), also known as prostate-specific antigen (PSA)",
            "probability": 0.0005134970464800104,
            "start_logit": 2.7432682514190674,
            "end_logit": -2.8180863857269287,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "3 (hK3",
            "probability": 0.0004919494177869544,
            "start_logit": -2.59232759475708,
            "end_logit": 2.4746410846710205,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        },
        {
            "text": "Human kallikrein",
            "probability": 0.000397159990688909,
            "start_logit": 3.6772961616516113,
            "end_logit": -4.009019374847412,
            "question_text": "Which are the synonyms of prostate-specific antigen?"
        }
    ],
    "55414c65472cfd8617000001": [
        {
            "text": "MedQA",
            "probability": 0.7199048707847264,
            "start_logit": 5.914534091949463,
            "end_logit": 5.469540119171143,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Onelook is a portal for online definitions, and MedQA",
            "probability": 0.09208550873954972,
            "start_logit": 3.8581326007843018,
            "end_logit": 5.469540119171143,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MedQA, Onelook",
            "probability": 0.03400301092752713,
            "start_logit": 4.51931619644165,
            "end_logit": 3.8120880126953125,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MedQA, Onelook, and PubMed",
            "probability": 0.029324744181078433,
            "start_logit": 4.51931619644165,
            "end_logit": 3.6640706062316895,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Onelook",
            "probability": 0.027677681631787437,
            "start_logit": 3.8581326007843018,
            "end_logit": 4.267448902130127,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "PubMed",
            "probability": 0.018613597684122532,
            "start_logit": 4.06477689743042,
            "end_logit": 3.6640706062316895,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google (i.e., Google and Scholar.Google), MedQA",
            "probability": 0.01644207604957294,
            "start_logit": 3.6167619228363037,
            "end_logit": 3.988036870956421,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google (i.e., Google and Scholar.Google), MedQA, Onelook",
            "probability": 0.013789325850637277,
            "start_logit": 3.6167619228363037,
            "end_logit": 3.8120880126953125,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Onelook, and PubMed",
            "probability": 0.011921060719587595,
            "start_logit": 3.6191911697387695,
            "end_logit": 3.6640706062316895,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google (i.e., Google and Scholar.Google), MedQA, Onelook, and PubMed",
            "probability": 0.011892136665818424,
            "start_logit": 3.6167619228363037,
            "end_logit": 3.6640706062316895,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google",
            "probability": 0.011669317206920748,
            "start_logit": 3.6167619228363037,
            "end_logit": 3.645156145095825,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google), MedQA",
            "probability": 0.0024972418806898477,
            "start_logit": 1.7321051359176636,
            "end_logit": 3.988036870956421,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google), MedQA, Onelook",
            "probability": 0.0020943390552913164,
            "start_logit": 1.7321051359176636,
            "end_logit": 3.8120880126953125,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google), MedQA, Onelook, and PubMed",
            "probability": 0.0018061917268373446,
            "start_logit": 1.7321051359176636,
            "end_logit": 3.6640706062316895,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MedQA is a question answering system that automatically generates short texts",
            "probability": 0.0013355506092597442,
            "start_logit": 5.914534091949463,
            "end_logit": -0.8202353119850159,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google (i.e., Google and Scholar.Google",
            "probability": 0.0013072558160351748,
            "start_logit": 3.6167619228363037,
            "end_logit": 1.4561233520507812,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MedQA is",
            "probability": 0.0010073767981465655,
            "start_logit": 5.914534091949463,
            "end_logit": -1.1022292375564575,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "MedQA is a question answering system",
            "probability": 0.000987060230279333,
            "start_logit": 5.914534091949463,
            "end_logit": -1.122603178024292,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google and Scholar.Google), MedQA",
            "probability": 0.000892852763880553,
            "start_logit": 0.7035846710205078,
            "end_logit": 3.988036870956421,
            "question_text": "List available biomedical question answering systems."
        },
        {
            "text": "Google and Scholar.Google), MedQA, Onelook",
            "probability": 0.0007488006782519922,
            "start_logit": 0.7035846710205078,
            "end_logit": 3.8120880126953125,
            "question_text": "List available biomedical question answering systems."
        }
    ],
    "517a8c238ed59a060a000042": [
        {
            "text": "deiodinases",
            "probability": 0.5278359822014634,
            "start_logit": 2.5485477447509766,
            "end_logit": 0.09294163435697556,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "dei",
            "probability": 0.16258575800921285,
            "start_logit": 2.5485477447509766,
            "end_logit": -1.0846383571624756,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine",
            "probability": 0.15064547592627583,
            "start_logit": 1.3246254920959473,
            "end_logit": 0.06300752609968185,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase in vitro activity studies in the chicken showed the presence of type I and type III iodothyronine",
            "probability": 0.024296122416699168,
            "start_logit": -0.4999869763851166,
            "end_logit": 0.06300752609968185,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinases was also found in the kidney.",
            "probability": 0.021538958671787314,
            "start_logit": 2.5485477447509766,
            "end_logit": -3.105980634689331,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "type III iodothyronine",
            "probability": 0.019480300877029098,
            "start_logit": -0.7208999991416931,
            "end_logit": 0.06300752609968185,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine deiodinase",
            "probability": 0.01728350249261766,
            "start_logit": 1.3246254920959473,
            "end_logit": -2.1021692752838135,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase in vitro activity studies in the chicken showed the presence of type I and type III",
            "probability": 0.015831331323429922,
            "start_logit": -0.4999869763851166,
            "end_logit": -0.36531826853752136,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "type III",
            "probability": 0.012693346377460703,
            "start_logit": -0.7208999991416931,
            "end_logit": -0.36531826853752136,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "type I and type III iodothyronine",
            "probability": 0.008726988931949245,
            "start_logit": -1.52388334274292,
            "end_logit": 0.06300752609968185,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "Co-expression of the deiodinases",
            "probability": 0.008177480071841605,
            "start_logit": -1.6188538074493408,
            "end_logit": 0.09294163435697556,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase protein has been previously reported in the rat, no data were given concerning type III",
            "probability": 0.005933564402651176,
            "start_logit": -0.9261177182197571,
            "end_logit": -0.9205533862113953,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "iodothyronine dei",
            "probability": 0.005748312774406871,
            "start_logit": 1.3246254920959473,
            "end_logit": -3.2030153274536133,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "type I and type III",
            "probability": 0.005686498070269621,
            "start_logit": -1.52388334274292,
            "end_logit": -0.36531826853752136,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase",
            "probability": 0.0032433491479028783,
            "start_logit": -0.3485204577445984,
            "end_logit": -2.1021692752838135,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "Co-expression of the dei",
            "probability": 0.002518854039734909,
            "start_logit": -1.6188538074493408,
            "end_logit": -1.0846383571624756,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "type III iodothyronine deiodinase",
            "probability": 0.002234968071194156,
            "start_logit": -0.7208999991416931,
            "end_logit": -2.1021692752838135,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "deiodinase in vitro activity studies in the chicken showed the presence of type I",
            "probability": 0.0020855243635086724,
            "start_logit": -0.4999869763851166,
            "end_logit": -2.39228892326355,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "the deiodinases",
            "probability": 0.002020298518554384,
            "start_logit": -3.0169925689697266,
            "end_logit": 0.09294163435697556,
            "question_text": "Which dediodinases are present in kidney?"
        },
        {
            "text": "Iodothyronine deiodinase in vitro activity studies in the chicken showed the presence of type I and type III",
            "probability": 0.0014333833120106529,
            "start_logit": -2.90194034576416,
            "end_logit": -0.36531826853752136,
            "question_text": "Which dediodinases are present in kidney?"
        }
    ],
    "530e1c985937551c09000004": [
        {
            "text": "mental retardation",
            "probability": 0.11768240559974939,
            "start_logit": 4.670919418334961,
            "end_logit": 4.902505397796631,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "osteodystrophy, mental retardation",
            "probability": 0.10432642818694039,
            "start_logit": 4.550454616546631,
            "end_logit": 4.902505397796631,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "mental retardation, and seizures",
            "probability": 0.10235346401743306,
            "start_logit": 4.670919418334961,
            "end_logit": 4.762948036193848,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "osteodystrophy, mental retardation, and seizures",
            "probability": 0.09073719439265147,
            "start_logit": 4.550454616546631,
            "end_logit": 4.762948036193848,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.08302356521582192,
            "start_logit": 4.322054386138916,
            "end_logit": 4.902505397796631,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "osteodystrophy",
            "probability": 0.08032015155979329,
            "start_logit": 4.550454616546631,
            "end_logit": 4.641001224517822,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, mental retardation, and seizures",
            "probability": 0.07220917563342819,
            "start_logit": 4.322054386138916,
            "end_logit": 4.762948036193848,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy",
            "probability": 0.06391923366934515,
            "start_logit": 4.322054386138916,
            "end_logit": 4.641001224517822,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "seizures",
            "probability": 0.06344761181353685,
            "start_logit": 4.192701816558838,
            "end_logit": 4.762948036193848,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy",
            "probability": 0.06240779826104317,
            "start_logit": 4.322054386138916,
            "end_logit": 4.617071151733398,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy, osteodystrophy, mental retardation",
            "probability": 0.03507766551769409,
            "start_logit": 3.4604945182800293,
            "end_logit": 4.902505397796631,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy, osteodystrophy, mental retardation, and seizures",
            "probability": 0.030508558667571118,
            "start_logit": 3.4604945182800293,
            "end_logit": 4.762948036193848,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy, osteodystrophy",
            "probability": 0.02700603729762898,
            "start_logit": 3.4604945182800293,
            "end_logit": 4.641001224517822,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy",
            "probability": 0.026367452028902012,
            "start_logit": 3.4604945182800293,
            "end_logit": 4.617071151733398,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness",
            "probability": 0.01734714204951788,
            "start_logit": 3.4604945182800293,
            "end_logit": 4.198368549346924,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "mental retardation, and seizure",
            "probability": 0.0066286089750570935,
            "start_logit": 4.670919418334961,
            "end_logit": 2.0259108543395996,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "osteodystrophy, mental retardation, and seizure",
            "probability": 0.005876316809562864,
            "start_logit": 4.550454616546631,
            "end_logit": 2.0259108543395996,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "onychodystrophy, osteodystrophy, mental retardation, and seizure",
            "probability": 0.004676406355955788,
            "start_logit": 4.322054386138916,
            "end_logit": 2.0259108543395996,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "seizure",
            "probability": 0.004108990478734716,
            "start_logit": 4.192701816558838,
            "end_logit": 2.0259108543395996,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        },
        {
            "text": "Deafness, onychodystrophy, osteodystrophy, mental retardation, and seizure",
            "probability": 0.001975793469632583,
            "start_logit": 3.4604945182800293,
            "end_logit": 2.0259108543395996,
            "question_text": "List common symptoms of patients with the DOORS syndrome."
        }
    ],
    "516c0ebc298dcd4e5100006e": [
        {
            "text": "iodine nutrition, iodine excess is emerging as a new concern.",
            "probability": 0.46095852845672064,
            "start_logit": -5.23180627822876,
            "end_logit": -2.723822593688965,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine excess is emerging as a new concern.",
            "probability": 0.3169248733427949,
            "start_logit": -5.606449604034424,
            "end_logit": -2.723822593688965,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "excess is emerging as a new concern.",
            "probability": 0.1210983890706604,
            "start_logit": -6.568511009216309,
            "end_logit": -2.723822593688965,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine nutrition",
            "probability": 0.01745324909235832,
            "start_logit": -5.23180627822876,
            "end_logit": -5.997604846954346,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine nutrition,",
            "probability": 0.01730834586029272,
            "start_logit": -5.23180627822876,
            "end_logit": -6.005941867828369,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine nutrition, iodine excess",
            "probability": 0.013118880852625952,
            "start_logit": -5.23180627822876,
            "end_logit": -6.283078193664551,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine nutrition, iodine excess is emerging as a new concern",
            "probability": 0.012636973995586172,
            "start_logit": -5.23180627822876,
            "end_logit": -6.3205037117004395,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine excess",
            "probability": 0.00901968267413901,
            "start_logit": -5.606449604034424,
            "end_logit": -6.283078193664551,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine excess is emerging as a new concern",
            "probability": 0.008688355102997876,
            "start_logit": -5.606449604034424,
            "end_logit": -6.3205037117004395,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine",
            "probability": 0.006165036484682415,
            "start_logit": -5.23180627822876,
            "end_logit": -7.038236618041992,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine nutrition, iodine excess is emerging",
            "probability": 0.005056476955484449,
            "start_logit": -5.23180627822876,
            "end_logit": -7.2364606857299805,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "iodine excess is emerging",
            "probability": 0.003476502157456299,
            "start_logit": -5.606449604034424,
            "end_logit": -7.2364606857299805,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "excess",
            "probability": 0.003446460450535075,
            "start_logit": -6.568511009216309,
            "end_logit": -6.283078193664551,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "excess is emerging as a new concern",
            "probability": 0.0033198587272412158,
            "start_logit": -6.568511009216309,
            "end_logit": -6.3205037117004395,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        },
        {
            "text": "excess is emerging",
            "probability": 0.0013283867764246734,
            "start_logit": -6.568511009216309,
            "end_logit": -7.2364606857299805,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the liver?"
        }
    ],
    "5713b0a51174fb175500000e": [
        {
            "text": "non-syndromic sensorineural deafness",
            "probability": 0.1981719692185865,
            "start_logit": 3.3295419216156006,
            "end_logit": 2.9210798740386963,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "non-syndromic sensorineural deafness (DFN2)",
            "probability": 0.14397315678927622,
            "start_logit": 3.3295419216156006,
            "end_logit": 2.601571559906006,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts syndrome, and non-syndromic sensorineural deafness",
            "probability": 0.1384667100550712,
            "start_logit": 2.971036672592163,
            "end_logit": 2.9210798740386963,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts syndrome",
            "probability": 0.13137430424013768,
            "start_logit": 2.971036672592163,
            "end_logit": 2.8685004711151123,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts syndrome, and non-syndromic sensorineural deafness (DFN2)",
            "probability": 0.10059691809826488,
            "start_logit": 2.971036672592163,
            "end_logit": 2.601571559906006,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.08320211117035715,
            "start_logit": 2.461679458618164,
            "end_logit": 2.9210798740386963,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "sensorineural deafness (DFN2)",
            "probability": 0.06044684646351652,
            "start_logit": 2.461679458618164,
            "end_logit": 2.601571559906006,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "X-linked Charcot-Marie-Tooth disease type 5 (CMTX5), Arts syndrome",
            "probability": 0.05018698430207518,
            "start_logit": 2.008741855621338,
            "end_logit": 2.8685004711151123,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease type 5 (CMTX5), Arts syndrome",
            "probability": 0.026783763618080166,
            "start_logit": 1.3807820081710815,
            "end_logit": 2.8685004711151123,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "X-linked Charcot-Marie-Tooth disease type 5",
            "probability": 0.021252117412268734,
            "start_logit": 2.008741855621338,
            "end_logit": 2.0092012882232666,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease type 5",
            "probability": 0.011341818941098538,
            "start_logit": 1.3807820081710815,
            "end_logit": 2.0092012882232666,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "X-linked Charcot-Marie-Tooth disease type 5 (CMTX5)",
            "probability": 0.009161799016419944,
            "start_logit": 2.008741855621338,
            "end_logit": 1.1677873134613037,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Charcot-Marie-Tooth disease type 5 (CMTX5)",
            "probability": 0.00488946412271288,
            "start_logit": 1.3807820081710815,
            "end_logit": 1.1677873134613037,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Arts syndrome,",
            "probability": 0.004009070058889608,
            "start_logit": 2.971036672592163,
            "end_logit": -0.6209907531738281,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "X-linked Charcot-Marie-Tooth disease",
            "probability": 0.0038011937615933565,
            "start_logit": 2.008741855621338,
            "end_logit": 0.28805992007255554,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "non-syndromic sensorineural deafness (DFN2) are allelic syndromes",
            "probability": 0.0029029444005170203,
            "start_logit": 3.3295419216156006,
            "end_logit": -1.3023297786712646,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "deafness",
            "probability": 0.002685788231908998,
            "start_logit": -0.9716190099716187,
            "end_logit": 2.9210798740386963,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Marie-Tooth disease type 5 (CMTX5), Arts syndrome, and non-syndromic sensorineural deafness",
            "probability": 0.002356640172300012,
            "start_logit": -1.1023563146591187,
            "end_logit": 2.9210798740386963,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "Marie-Tooth disease type 5 (CMTX5), Arts syndrome",
            "probability": 0.002235930664180126,
            "start_logit": -1.1023563146591187,
            "end_logit": 2.8685004711151123,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        },
        {
            "text": "DFN2)",
            "probability": 0.0021604692627452673,
            "start_logit": -0.8697595000267029,
            "end_logit": 2.601571559906006,
            "question_text": "Which disease phenotypes are associated to PRPS1 mutations?"
        }
    ],
    "56c8605b5795f9a73e000014": [
        {
            "text": "JAK1 and JAK2",
            "probability": 0.3303914346029056,
            "start_logit": 4.785353183746338,
            "end_logit": 4.337923526763916,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK2",
            "probability": 0.31403052396561026,
            "start_logit": 4.734565258026123,
            "end_logit": 4.337923526763916,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK1",
            "probability": 0.23268747230282333,
            "start_logit": 4.785353183746338,
            "end_logit": 3.9873416423797607,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1 and JAK2",
            "probability": 0.05382065867609462,
            "start_logit": 2.9707324504852295,
            "end_logit": 4.337923526763916,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1",
            "probability": 0.03790471457005302,
            "start_logit": 2.9707324504852295,
            "end_logit": 3.9873416423797607,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAKs) with selectivity for JAK1 and JAK2",
            "probability": 0.0077903465339741575,
            "start_logit": 1.037960410118103,
            "end_logit": 4.337923526763916,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAKs) with selectivity for JAK1",
            "probability": 0.005486570938293827,
            "start_logit": 1.037960410118103,
            "end_logit": 3.9873416423797607,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK",
            "probability": 0.0052437446036534005,
            "start_logit": 4.785353183746338,
            "end_logit": 0.19468127191066742,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK1 and JAK2,",
            "probability": 0.003455869956867479,
            "start_logit": 4.785353183746338,
            "end_logit": -0.2222803682088852,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK2,",
            "probability": 0.00328473604231434,
            "start_logit": 4.734565258026123,
            "end_logit": -0.2222803682088852,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "JAK1 and JAK",
            "probability": 0.0021328302533232413,
            "start_logit": 4.785353183746338,
            "end_logit": -0.7049047350883484,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK",
            "probability": 0.0008542043132475345,
            "start_logit": 2.9707324504852295,
            "end_logit": 0.19468127191066742,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs)",
            "probability": 0.0006703201300887855,
            "start_logit": 2.9707324504852295,
            "end_logit": -0.04773373156785965,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1 and JAK2,",
            "probability": 0.0005629601070048403,
            "start_logit": 2.9707324504852295,
            "end_logit": -0.2222803682088852,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase",
            "probability": 0.0005327797137099477,
            "start_logit": 2.9707324504852295,
            "end_logit": -0.2773810923099518,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family of enzymes (JAKs) with selectivity for JAK1 and JAK",
            "probability": 0.0003474373638533457,
            "start_logit": 2.9707324504852295,
            "end_logit": -0.7049047350883484,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus kinase family",
            "probability": 0.00028526764714116213,
            "start_logit": 2.9707324504852295,
            "end_logit": -0.9020612835884094,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "(JAKs) with selectivity for JAK1 and JAK2",
            "probability": 0.00019205967583528778,
            "start_logit": -2.6648740768432617,
            "end_logit": 4.337923526763916,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "Janus",
            "probability": 0.0001908051677142218,
            "start_logit": 2.9707324504852295,
            "end_logit": -1.3042362928390503,
            "question_text": "Which kinases does baricitinib inhibit?"
        },
        {
            "text": "(JAKs) with selectivity for JAK1",
            "probability": 0.00013526343549167703,
            "start_logit": -2.6648740768432617,
            "end_logit": 3.9873416423797607,
            "question_text": "Which kinases does baricitinib inhibit?"
        }
    ],
    "550b0408c2af5d5b7000000c": [
        {
            "text": "SELEX library",
            "probability": 0.3658891874733479,
            "start_logit": 0.464735209941864,
            "end_logit": 0.28665754199028015,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "A special SELEX library",
            "probability": 0.24995517352152458,
            "start_logit": 0.08368628472089767,
            "end_logit": 0.28665754199028015,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "SELEX library was constructed with the aim to immobilize this library on magnetic beads or other surfaces. For this purpose a docking sequence",
            "probability": 0.05680755391861108,
            "start_logit": 0.464735209941864,
            "end_logit": -1.5760036706924438,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "SELEX",
            "probability": 0.043380763577464114,
            "start_logit": 0.464735209941864,
            "end_logit": -1.8456568717956543,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "special SELEX library",
            "probability": 0.04151674880343765,
            "start_logit": -1.7114983797073364,
            "end_logit": 0.28665754199028015,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "Capture-SELEX procedure allows the selection of DNA aptamers for solute targets. A special SELEX library",
            "probability": 0.03901521035035204,
            "start_logit": -1.7736437320709229,
            "end_logit": 0.28665754199028015,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "A special SELEX",
            "probability": 0.02963532856048423,
            "start_logit": 0.08368628472089767,
            "end_logit": -1.8456568717956543,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "SELEX library was constructed with the aim to immobilize this library on magnetic beads or other surfaces. For this purpose a dock",
            "probability": 0.028226631259759178,
            "start_logit": 0.464735209941864,
            "end_logit": -2.275407075881958,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "library",
            "probability": 0.02268446756039379,
            "start_logit": -2.3159148693084717,
            "end_logit": 0.28665754199028015,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "A special SELEX library was constructed with the aim to immobilize this library on magnetic beads or other surfaces. For this purpose a dock",
            "probability": 0.019282866933516926,
            "start_logit": 0.08368628472089767,
            "end_logit": -2.275407075881958,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "SELEX library was constructed",
            "probability": 0.016581486786932317,
            "start_logit": 0.464735209941864,
            "end_logit": -2.8073861598968506,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "SELEX library was constructed with the aim to immobilize this library on magnetic beads or other surfaces.",
            "probability": 0.015265154363628958,
            "start_logit": 0.464735209941864,
            "end_logit": -2.8901002407073975,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "docking sequence",
            "probability": 0.014411942120485141,
            "start_logit": -0.9068769216537476,
            "end_logit": -1.5760036706924438,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "A special SELEX library was constructed",
            "probability": 0.011327550933366777,
            "start_logit": 0.08368628472089767,
            "end_logit": -2.8073861598968506,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "A special SELEX library was constructed with the aim to immobilize this library on magnetic beads or other surfaces.",
            "probability": 0.010428305723223018,
            "start_logit": 0.08368628472089767,
            "end_logit": -2.8901002407073975,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "SELEX library was constructed with the aim to immobilize this library on magnetic beads",
            "probability": 0.008151386828364755,
            "start_logit": 0.464735209941864,
            "end_logit": -3.5174849033355713,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "A",
            "probability": 0.00760152276301344,
            "start_logit": 0.08368628472089767,
            "end_logit": -3.206275463104248,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "dock",
            "probability": 0.0071610296150887666,
            "start_logit": -0.9068769216537476,
            "end_logit": -2.275407075881958,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "special SELEX library was constructed with the aim to immobilize this library on magnetic beads or other surfaces. For this purpose a docking sequence",
            "probability": 0.006445844881241569,
            "start_logit": -1.7114983797073364,
            "end_logit": -1.5760036706924438,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        },
        {
            "text": "The Capture-SELEX procedure allows the selection of DNA aptamers for solute targets. A special SELEX library",
            "probability": 0.00623184402576391,
            "start_logit": -3.6079230308532715,
            "end_logit": 0.28665754199028015,
            "question_text": "Magnetic beads has been used in numerous applications. List some coatings used."
        }
    ],
    "51477de5d24251bc05000020": [
        {
            "text": "parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 0.2023950168460681,
            "start_logit": 5.335601329803467,
            "end_logit": 5.238805294036865,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pituitary glands and the endocrine pancreas",
            "probability": 0.1533939078257076,
            "start_logit": 5.058389186859131,
            "end_logit": 5.238805294036865,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pancreas",
            "probability": 0.1451826574490245,
            "start_logit": 5.003372669219971,
            "end_logit": 5.238805294036865,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid and pituitary glands",
            "probability": 0.14376380618484422,
            "start_logit": 5.335601329803467,
            "end_logit": 4.896755695343018,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pituitary glands",
            "probability": 0.1089576827445458,
            "start_logit": 5.058389186859131,
            "end_logit": 4.896755695343018,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "endocrine pancreas",
            "probability": 0.09585350467356632,
            "start_logit": 4.58820104598999,
            "end_logit": 5.238805294036865,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid",
            "probability": 0.08296347155626842,
            "start_logit": 5.335601329803467,
            "end_logit": 4.346984386444092,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid and pituitary",
            "probability": 0.022547755274225575,
            "start_logit": 5.335601329803467,
            "end_logit": 3.044219493865967,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pituitary",
            "probability": 0.01708880163211569,
            "start_logit": 5.058389186859131,
            "end_logit": 3.044219493865967,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "the endocrine pancreas",
            "probability": 0.013309279791892245,
            "start_logit": 2.6138415336608887,
            "end_logit": 5.238805294036865,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "parathyroid and pituitary glands and the endocrine pancreas,",
            "probability": 0.0036976162593521655,
            "start_logit": 5.335601329803467,
            "end_logit": 1.2362723350524902,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pituitary glands and the endocrine pancreas,",
            "probability": 0.0028024000615256383,
            "start_logit": 5.058389186859131,
            "end_logit": 1.2362723350524902,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "pancreas,",
            "probability": 0.002652386225337532,
            "start_logit": 5.003372669219971,
            "end_logit": 1.2362723350524902,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "endocrine pancreas,",
            "probability": 0.001751176896150707,
            "start_logit": 4.58820104598999,
            "end_logit": 1.2362723350524902,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "the parathyroid and pituitary glands and the endocrine pancreas",
            "probability": 0.0012930959199917394,
            "start_logit": 0.2824192941188812,
            "end_logit": 5.238805294036865,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "the parathyroid and pituitary glands",
            "probability": 0.0009185028076135499,
            "start_logit": 0.2824192941188812,
            "end_logit": 4.896755695343018,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "the parathyroid",
            "probability": 0.0005300512248251311,
            "start_logit": 0.2824192941188812,
            "end_logit": 4.346984386444092,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "glands and the endocrine pancreas",
            "probability": 0.00035928877431653405,
            "start_logit": -0.998248815536499,
            "end_logit": 5.238805294036865,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "thyroid and pituitary glands and the endocrine pancreas",
            "probability": 0.000284390375092284,
            "start_logit": -1.2320274114608765,
            "end_logit": 5.238805294036865,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        },
        {
            "text": "glands",
            "probability": 0.00025520747753645046,
            "start_logit": -0.998248815536499,
            "end_logit": 4.896755695343018,
            "question_text": "Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome?"
        }
    ],
    "5524562387ecba3764000001": [
        {
            "text": "Sonic Hh, Indian Hh, and Desert Hh",
            "probability": 0.1879521023986011,
            "start_logit": 5.747045040130615,
            "end_logit": 5.384175777435303,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Desert Hh",
            "probability": 0.18129886362273592,
            "start_logit": 5.711004734039307,
            "end_logit": 5.384175777435303,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian Hh, and Desert Hh",
            "probability": 0.143136018970015,
            "start_logit": 5.474653244018555,
            "end_logit": 5.384175777435303,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh, Indian Hh",
            "probability": 0.12320758363519001,
            "start_logit": 5.747045040130615,
            "end_logit": 4.961859226226807,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian Hh",
            "probability": 0.09382945337347565,
            "start_logit": 5.474653244018555,
            "end_logit": 4.961859226226807,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh",
            "probability": 0.08559077479347331,
            "start_logit": 5.747045040130615,
            "end_logit": 4.5975661277771,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, and Desert Hh",
            "probability": 0.040409789050555714,
            "start_logit": 4.209929943084717,
            "end_logit": 5.384175777435303,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh",
            "probability": 0.026489687535220595,
            "start_logit": 4.209929943084717,
            "end_logit": 4.961859226226807,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, Indian Hh, and Desert Hh",
            "probability": 0.022769038932835196,
            "start_logit": 3.6362595558166504,
            "end_logit": 5.384175777435303,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh, Indian",
            "probability": 0.02178776024490708,
            "start_logit": 5.747045040130615,
            "end_logit": 3.229336977005005,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian",
            "probability": 0.016592595793982295,
            "start_logit": 5.474653244018555,
            "end_logit": 3.229336977005005,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, Indian Hh",
            "probability": 0.014925708373619496,
            "start_logit": 3.6362595558166504,
            "end_logit": 4.961859226226807,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh, Indian Hh, and Desert Hh,",
            "probability": 0.009378825261988497,
            "start_logit": 5.747045040130615,
            "end_logit": 2.3864431381225586,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Desert Hh,",
            "probability": 0.009046828103623162,
            "start_logit": 5.711004734039307,
            "end_logit": 2.3864431381225586,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic",
            "probability": 0.008352149680871772,
            "start_logit": 5.747045040130615,
            "end_logit": 2.270507574081421,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Indian Hh, and Desert Hh,",
            "probability": 0.007142499038235992,
            "start_logit": 5.474653244018555,
            "end_logit": 2.3864431381225586,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, Indian",
            "probability": 0.0026394297001450327,
            "start_logit": 3.6362595558166504,
            "end_logit": 3.229336977005005,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Hh, and Desert Hh,",
            "probability": 0.002016451774373974,
            "start_logit": 4.209929943084717,
            "end_logit": 2.3864431381225586,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Sonic Hh, Indian Hh, and Desert",
            "probability": 0.0017481610736648574,
            "start_logit": 5.747045040130615,
            "end_logit": 0.706553041934967,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        },
        {
            "text": "Desert",
            "probability": 0.0016862786424851376,
            "start_logit": 5.711004734039307,
            "end_logit": 0.706553041934967,
            "question_text": "Which are the different homologs or family members of the hedgehog proteins in mammals?"
        }
    ],
    "51486f7dd24251bc0500002e": [
        {
            "text": "Depression",
            "probability": 0.471050032310803,
            "start_logit": -0.7341408133506775,
            "end_logit": -1.5539085865020752,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening",
            "probability": 0.11414428903164105,
            "start_logit": -0.7341408133506775,
            "end_logit": -2.971409559249878,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association, but the best approach remains unclear",
            "probability": 0.09294915492611795,
            "start_logit": -0.7341408133506775,
            "end_logit": -3.1768202781677246,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association, but the best approach remains unclear.",
            "probability": 0.08080136561399576,
            "start_logit": -0.7341408133506775,
            "end_logit": -3.3168790340423584,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association, but the best approach",
            "probability": 0.046525064932126,
            "start_logit": -0.7341408133506775,
            "end_logit": -3.8688817024230957,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association,",
            "probability": 0.04232800540217984,
            "start_logit": -0.7341408133506775,
            "end_logit": -3.96342396736145,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended",
            "probability": 0.029418419430990425,
            "start_logit": -0.7341408133506775,
            "end_logit": -4.32725191116333,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association, but the best",
            "probability": 0.018159431262175167,
            "start_logit": -0.7341408133506775,
            "end_logit": -4.809682846069336,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association, but the",
            "probability": 0.017585833595160562,
            "start_logit": -0.7341408133506775,
            "end_logit": -4.8417792320251465,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients",
            "probability": 0.015346215890660635,
            "start_logit": -0.7341408133506775,
            "end_logit": -4.978003978729248,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been",
            "probability": 0.014102114349916107,
            "start_logit": -0.7341408133506775,
            "end_logit": -5.0625481605529785,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association, but",
            "probability": 0.01085531289008015,
            "start_logit": -0.7341408133506775,
            "end_logit": -5.324218273162842,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has",
            "probability": 0.009793237863027918,
            "start_logit": -0.7341408133506775,
            "end_logit": -5.427180767059326,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association",
            "probability": 0.008179700929257128,
            "start_logit": -0.7341408133506775,
            "end_logit": -5.607217311859131,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "screening",
            "probability": 0.006378291761520814,
            "start_logit": -3.618703842163086,
            "end_logit": -2.971409559249878,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by the American Heart Association, but the best approach remains",
            "probability": 0.005231986237900909,
            "start_logit": -0.7341408133506775,
            "end_logit": -6.054081916809082,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "screening in cardiac patients has been recommended by the American Heart Association, but the best approach remains unclear",
            "probability": 0.005193924585585169,
            "start_logit": -3.618703842163086,
            "end_logit": -3.1768202781677246,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "screening in cardiac patients has been recommended by the American Heart Association, but the best approach remains unclear.",
            "probability": 0.004515115815146191,
            "start_logit": -3.618703842163086,
            "end_logit": -3.3168790340423584,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "the best approach remains unclear",
            "probability": 0.003929104694664566,
            "start_logit": -3.8977818489074707,
            "end_logit": -3.1768202781677246,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        },
        {
            "text": "Depression screening in cardiac patients has been recommended by",
            "probability": 0.0035133984770506386,
            "start_logit": -0.7341408133506775,
            "end_logit": -6.45228910446167,
            "question_text": "Which scales are recommended by the American Heart Association for depression screening in cardiovascular patients? "
        }
    ],
    "52ef7754c8da898910000014": [
        {
            "text": "HU",
            "probability": 0.9485397608741534,
            "start_logit": 5.280660152435303,
            "end_logit": 4.756388187408447,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "HU.",
            "probability": 0.04631808131148571,
            "start_logit": 5.280660152435303,
            "end_logit": 1.7369968891143799,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "DNA and the presence of the histone-like protein HU",
            "probability": 0.0014668854059246659,
            "start_logit": -1.1911221742630005,
            "end_logit": 4.756388187408447,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "H",
            "probability": 0.0012083373530769955,
            "start_logit": 5.280660152435303,
            "end_logit": -1.9092901945114136,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "GalR dimers. The process requires negatively supercoiled DNA and the presence of the histone-like protein HU",
            "probability": 0.0007982514100387858,
            "start_logit": -1.7995952367782593,
            "end_logit": 4.756388187408447,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "protein HU",
            "probability": 0.0007623327820806288,
            "start_logit": -1.8456356525421143,
            "end_logit": 4.756388187408447,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "the histone-like protein HU",
            "probability": 0.0002844678800923292,
            "start_logit": -2.8313984870910645,
            "end_logit": 4.756388187408447,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "U",
            "probability": 0.00020787666437551428,
            "start_logit": -3.145073890686035,
            "end_logit": 4.756388187408447,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "histone-like protein HU",
            "probability": 0.00018530990267168998,
            "start_logit": -3.2599892616271973,
            "end_logit": 4.756388187408447,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "DNA and the presence of the histone-like protein HU.",
            "probability": 7.162938266671638e-05,
            "start_logit": -1.1911221742630005,
            "end_logit": 1.7369968891143799,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "GalR dimers. The process requires negatively supercoiled DNA and the presence of the histone-like protein HU.",
            "probability": 3.897936095278775e-05,
            "start_logit": -1.7995952367782593,
            "end_logit": 1.7369968891143799,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "protein HU.",
            "probability": 3.722542084506922e-05,
            "start_logit": -1.8456356525421143,
            "end_logit": 1.7369968891143799,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "NA and the presence of the histone-like protein HU",
            "probability": 2.701577455579511e-05,
            "start_logit": -5.185597896575928,
            "end_logit": 4.756388187408447,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "the histone-like protein HU.",
            "probability": 1.3890831933581523e-05,
            "start_logit": -2.8313984870910645,
            "end_logit": 1.7369968891143799,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": ".",
            "probability": 1.3646493482246123e-05,
            "start_logit": -2.84914493560791,
            "end_logit": 1.7369968891143799,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "U.",
            "probability": 1.0150811426641862e-05,
            "start_logit": -3.145073890686035,
            "end_logit": 1.7369968891143799,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "histone-like protein HU.",
            "probability": 9.048855402604053e-06,
            "start_logit": -3.2599892616271973,
            "end_logit": 1.7369968891143799,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "DNA",
            "probability": 3.3939223915544773e-06,
            "start_logit": -1.1911221742630005,
            "end_logit": -1.3125221729278564,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "DNA and the presence of the histone-like protein H",
            "probability": 1.8686538000566202e-06,
            "start_logit": -1.1911221742630005,
            "end_logit": -1.9092901945114136,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        },
        {
            "text": "GalR dimers. The process requires negatively supercoiled DNA",
            "probability": 1.8469086430870834e-06,
            "start_logit": -1.7995952367782593,
            "end_logit": -1.3125221729278564,
            "question_text": "Which proteins act as histone-like molecules in prokaryotes?"
        }
    ],
    "5319a724b166e2b806000025": [
        {
            "text": "Huntington disease",
            "probability": 0.18739078679062537,
            "start_logit": 2.7226290702819824,
            "end_logit": 2.825836181640625,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "muscular dystrophy",
            "probability": 0.13552731367079493,
            "start_logit": 2.752058506011963,
            "end_logit": 2.472383737564087,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington disease, inherited ataxias",
            "probability": 0.1353054780937773,
            "start_logit": 2.7226290702819824,
            "end_logit": 2.5001749992370605,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington disease, inherited ataxias, and muscular dystrophy",
            "probability": 0.13159693932107466,
            "start_logit": 2.7226290702819824,
            "end_logit": 2.472383737564087,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "ataxias",
            "probability": 0.10616517052615397,
            "start_logit": 2.4800901412963867,
            "end_logit": 2.5001749992370605,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "ataxias, and muscular dystrophy",
            "probability": 0.10325532787415172,
            "start_logit": 2.4800901412963867,
            "end_logit": 2.472383737564087,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "inherited ataxias",
            "probability": 0.08284081270839096,
            "start_logit": 2.2320148944854736,
            "end_logit": 2.5001749992370605,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "inherited ataxias, and muscular dystrophy",
            "probability": 0.08057025891988626,
            "start_logit": 2.2320148944854736,
            "end_logit": 2.472383737564087,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "mental retardation, Huntington disease",
            "probability": 0.009407552662003204,
            "start_logit": -0.2690542936325073,
            "end_logit": 2.825836181640625,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "mental retardation, Huntington disease, inherited ataxias",
            "probability": 0.006792721416165216,
            "start_logit": -0.2690542936325073,
            "end_logit": 2.5001749992370605,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "mental retardation, Huntington disease, inherited ataxias, and muscular dystrophy",
            "probability": 0.006606542178643459,
            "start_logit": -0.2690542936325073,
            "end_logit": 2.472383737564087,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington disease,",
            "probability": 0.0038555984419956896,
            "start_logit": 2.7226290702819824,
            "end_logit": -1.0578337907791138,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington disease, inherited ataxias,",
            "probability": 0.003300719976581468,
            "start_logit": 2.7226290702819824,
            "end_logit": -1.213219404220581,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "ataxias,",
            "probability": 0.0025898544841620155,
            "start_logit": 2.4800901412963867,
            "end_logit": -1.213219404220581,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "inherited ataxias,",
            "probability": 0.0020208666288686295,
            "start_logit": 2.2320148944854736,
            "end_logit": -1.213219404220581,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington",
            "probability": 0.0013491109423105574,
            "start_logit": 2.7226290702819824,
            "end_logit": -2.1079142093658447,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "Huntington disease, inherited",
            "probability": 0.0003999844228310024,
            "start_logit": 2.7226290702819824,
            "end_logit": -3.3236896991729736,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "dystrophy",
            "probability": 0.0003660404716554928,
            "start_logit": -3.162126064300537,
            "end_logit": 2.472383737564087,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "disease",
            "probability": 0.00033691711284163485,
            "start_logit": -3.5984854698181152,
            "end_logit": 2.825836181640625,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        },
        {
            "text": "muscular dystrophy.",
            "probability": 0.0003220033570866647,
            "start_logit": 2.752058506011963,
            "end_logit": -3.5699827671051025,
            "question_text": "Which trinucleotide repeat disorders are affecting the nervous system?"
        }
    ],
    "53188992b166e2b806000019": [
        {
            "text": "c-kit",
            "probability": 0.2638922980628787,
            "start_logit": 5.0855560302734375,
            "end_logit": 4.564821720123291,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor (PDGFR), and c-kit",
            "probability": 0.23119911407651958,
            "start_logit": 4.953294277191162,
            "end_logit": 4.564821720123291,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "c-kit kinases. Inhibition of BCR-ABL and c-kit",
            "probability": 0.11477362197090661,
            "start_logit": 5.0855560302734375,
            "end_logit": 3.7322423458099365,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "c-kit kinases. Inhibition of BCR-ABL",
            "probability": 0.09270019581538815,
            "start_logit": 5.0855560302734375,
            "end_logit": 3.518651247024536,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor",
            "probability": 0.06037618852974922,
            "start_logit": 4.953294277191162,
            "end_logit": 3.222137212753296,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "BCR-ABL and c-kit",
            "probability": 0.04192666986554725,
            "start_logit": 4.078516483306885,
            "end_logit": 3.7322423458099365,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "BCR-ABL",
            "probability": 0.033863273108245724,
            "start_logit": 4.078516483306885,
            "end_logit": 3.518651247024536,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor (PDGFR)",
            "probability": 0.03163038002562751,
            "start_logit": 4.953294277191162,
            "end_logit": 2.575660467147827,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "c-kit kinases",
            "probability": 0.028201073293909033,
            "start_logit": 5.0855560302734375,
            "end_logit": 2.3286406993865967,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "ABL, platelet-derived growth factor receptor (PDGFR), and c-kit",
            "probability": 0.02743435957657843,
            "start_logit": 2.8218111991882324,
            "end_logit": 4.564821720123291,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor (PDGFR), and c-kit kinases",
            "probability": 0.02470728857727102,
            "start_logit": 4.953294277191162,
            "end_logit": 2.3286406993865967,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "platelet-derived growth factor receptor (PDGFR",
            "probability": 0.00962559134082551,
            "start_logit": 4.953294277191162,
            "end_logit": 1.38596773147583,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "PDGFR), and c-kit",
            "probability": 0.009369036158195282,
            "start_logit": 1.7474251985549927,
            "end_logit": 4.564821720123291,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "ABL",
            "probability": 0.007223392824241773,
            "start_logit": 2.8218111991882324,
            "end_logit": 3.2303502559661865,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "ABL, platelet-derived growth factor receptor",
            "probability": 0.007164309744890374,
            "start_logit": 2.8218111991882324,
            "end_logit": 3.222137212753296,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "PDGFR), and c-kit kinases. Inhibition of BCR-ABL and c-kit",
            "probability": 0.004074837432338552,
            "start_logit": 1.7474251985549927,
            "end_logit": 3.7322423458099365,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "ABL, platelet-derived growth factor receptor (PDGFR)",
            "probability": 0.0037532982019978164,
            "start_logit": 2.8218111991882324,
            "end_logit": 2.575660467147827,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "PDGFR), and c-kit kinases. Inhibition of BCR-ABL",
            "probability": 0.003291158903998064,
            "start_logit": 1.7474251985549927,
            "end_logit": 3.518651247024536,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "ABL, platelet-derived growth factor receptor (PDGFR), and c-kit kinases",
            "probability": 0.002931796004922416,
            "start_logit": 2.8218111991882324,
            "end_logit": 2.3286406993865967,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        },
        {
            "text": "c-kit kinases.",
            "probability": 0.0018621164859690528,
            "start_logit": 5.0855560302734375,
            "end_logit": -0.3890056014060974,
            "question_text": "Which are the cellular targets of imatinib mesylate?"
        }
    ],
    "52ebb2c698d0239505000029": [
        {
            "text": "progressive dyspnea",
            "probability": 0.30570184414152823,
            "start_logit": 5.281793117523193,
            "end_logit": 6.051651477813721,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "recurrent spontaneous pneumothorax and progressive dyspnea",
            "probability": 0.2250113475569756,
            "start_logit": 4.9753336906433105,
            "end_logit": 6.051651477813721,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "dyspnea",
            "probability": 0.13097325106999658,
            "start_logit": 4.434175968170166,
            "end_logit": 6.051651477813721,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "recurrent spontaneous pneumothorax",
            "probability": 0.12069129969132941,
            "start_logit": 4.9753336906433105,
            "end_logit": 5.428736686706543,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "pneumothorax and progressive dyspnea",
            "probability": 0.08285930809458886,
            "start_logit": 3.9763269424438477,
            "end_logit": 6.051651477813721,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "pneumothorax",
            "probability": 0.04444397002212522,
            "start_logit": 3.9763269424438477,
            "end_logit": 5.428736686706543,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "spontaneous pneumothorax and progressive dyspnea",
            "probability": 0.027392790884663013,
            "start_logit": 2.869462728500366,
            "end_logit": 6.051651477813721,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "spontaneous pneumothorax",
            "probability": 0.014692910246251661,
            "start_logit": 2.869462728500366,
            "end_logit": 5.428736686706543,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "progressive dyspnea.",
            "probability": 0.014308597275184513,
            "start_logit": 5.281793117523193,
            "end_logit": 2.9899017810821533,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "recurrent spontaneous pneumothorax and progressive dyspnea.",
            "probability": 0.010531819863830413,
            "start_logit": 4.9753336906433105,
            "end_logit": 2.9899017810821533,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "dyspnea.",
            "probability": 0.006130298325955141,
            "start_logit": 4.434175968170166,
            "end_logit": 2.9899017810821533,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "Pulmonary lymphangioleiomyomatosis",
            "probability": 0.00533142894242017,
            "start_logit": 3.453615188598633,
            "end_logit": 3.830838441848755,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "lymphangioleiomyomatosis",
            "probability": 0.004743515166287883,
            "start_logit": 3.3367743492126465,
            "end_logit": 3.830838441848755,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "pneumothorax and progressive dyspnea.",
            "probability": 0.0038782902123319237,
            "start_logit": 3.9763269424438477,
            "end_logit": 2.9899017810821533,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "spontaneous pneumothorax and progressive dyspnea.",
            "probability": 0.0012821395111719685,
            "start_logit": 2.869462728500366,
            "end_logit": 2.9899017810821533,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "recurrent spontaneous pneumothorax and",
            "probability": 0.0005526935099098978,
            "start_logit": 4.9753336906433105,
            "end_logit": 0.04254898056387901,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "current spontaneous pneumothorax and progressive dyspnea",
            "probability": 0.000451139408455964,
            "start_logit": -1.2367960214614868,
            "end_logit": 6.051651477813721,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "progressive dysp",
            "probability": 0.0004500879726194102,
            "start_logit": 5.281793117523193,
            "end_logit": -0.4692710041999817,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "recurrent spontaneous pneumothorax and progressive dysp",
            "probability": 0.00033128652371293584,
            "start_logit": 4.9753336906433105,
            "end_logit": -0.4692710041999817,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        },
        {
            "text": "current spontaneous pneumothorax",
            "probability": 0.0002419815806611299,
            "start_logit": -1.2367960214614868,
            "end_logit": 5.428736686706543,
            "question_text": "Which are the clinical characteristics of Tuberous Sclerosis?"
        }
    ],
    "54f0920f94afd61504000018": [
        {
            "text": "dexamethasone, cytosine arabinoside and cisplatin",
            "probability": 0.09458263848877459,
            "start_logit": 6.570953845977783,
            "end_logit": 6.639000415802002,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone",
            "probability": 0.08878042367465801,
            "start_logit": 6.570953845977783,
            "end_logit": 6.575692653656006,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cisplatin",
            "probability": 0.08144409386990378,
            "start_logit": 6.421396732330322,
            "end_logit": 6.639000415802002,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cytosine arabinoside and cisplatin",
            "probability": 0.0779176131403604,
            "start_logit": 6.377131938934326,
            "end_logit": 6.639000415802002,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone, cytosine arabinoside",
            "probability": 0.06954075704655206,
            "start_logit": 6.570953845977783,
            "end_logit": 6.33143949508667,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "etoposide, Solu-Medrol, cytosine arabinoside and cisplatin",
            "probability": 0.059938818818613515,
            "start_logit": 6.325277805328369,
            "end_logit": 6.428526878356934,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cytosine arabinoside",
            "probability": 0.05728799589032522,
            "start_logit": 6.377131938934326,
            "end_logit": 6.33143949508667,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cisplatin [ESHAP] 36%, and gemcitabine",
            "probability": 0.04877654884847665,
            "start_logit": 6.2777018547058105,
            "end_logit": 6.270028114318848,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cisplatin [ESHAP] 36%, and gemcitabine, dexamethasone",
            "probability": 0.04461491489392732,
            "start_logit": 6.2777018547058105,
            "end_logit": 6.180846691131592,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cisplatin [DHAP] 15%, etoposide",
            "probability": 0.04362694618248477,
            "start_logit": 6.421396732330322,
            "end_logit": 6.014758586883545,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cytosine arabinoside and cisplatin [DHAP] 15%, etoposide",
            "probability": 0.04173792541141311,
            "start_logit": 6.377131938934326,
            "end_logit": 6.014758586883545,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "etoposide, Solu-Medrol, cytosine arabinoside",
            "probability": 0.041163281540227255,
            "start_logit": 6.325277805328369,
            "end_logit": 6.052749156951904,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "etoposide",
            "probability": 0.039628797523414284,
            "start_logit": 6.325277805328369,
            "end_logit": 6.014758586883545,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cytosine arabinoside and cisplatin [ESHAP] 36%, and gemcitabine",
            "probability": 0.03873445029515066,
            "start_logit": 6.047181606292725,
            "end_logit": 6.270028114318848,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "gemcitabine",
            "probability": 0.0340657780456663,
            "start_logit": 5.918745517730713,
            "end_logit": 6.270028114318848,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "dexamethasone and cisplatin",
            "probability": 0.032027819382734204,
            "start_logit": 6.011516094207764,
            "end_logit": 6.115569114685059,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "gemcitabine, dexamethasone",
            "probability": 0.031159272728051697,
            "start_logit": 5.918745517730713,
            "end_logit": 6.180846691131592,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "gemcitabine, dexamethasone and cisplatin",
            "probability": 0.02919023700905895,
            "start_logit": 5.918745517730713,
            "end_logit": 6.115569114685059,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "cisplatin [DHAP] 15%, etoposide, Solu-Medrol",
            "probability": 0.02399011906155776,
            "start_logit": 6.421396732330322,
            "end_logit": 5.4167256355285645,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        },
        {
            "text": "etoposide, Solu-Medrol",
            "probability": 0.021791568148649337,
            "start_logit": 6.325277805328369,
            "end_logit": 5.4167256355285645,
            "question_text": "List drugs included in the DHAP-R chemotherapy regiment."
        }
    ],
    "57220e400fd6f91b68000015": [
        {
            "text": "respiratory failure",
            "probability": 0.8318343248598843,
            "start_logit": 4.714766502380371,
            "end_logit": 4.742367744445801,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "rapid respiratory failure",
            "probability": 0.16012735390132588,
            "start_logit": 3.0671026706695557,
            "end_logit": 4.742367744445801,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "Myasthenia gravis can present with rapid respiratory failure",
            "probability": 0.0036738344177216363,
            "start_logit": -0.7076308727264404,
            "end_logit": 4.742367744445801,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "failure",
            "probability": 0.0023039760169870655,
            "start_logit": -1.1742304563522339,
            "end_logit": 4.742367744445801,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory",
            "probability": 0.0009791186726596922,
            "start_logit": 4.714766502380371,
            "end_logit": -2.0023679733276367,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory failure as the first manifestation of disease. In the Lambert-Eaton myasthenic syndrome (LEMS),",
            "probability": 0.00024328712658301744,
            "start_logit": 4.714766502380371,
            "end_logit": -3.3947784900665283,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory failure as the first manifestation of LEMS without associated carcinoma.",
            "probability": 0.00020164306908960588,
            "start_logit": 4.1278181076049805,
            "end_logit": -2.9955732822418213,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "rapid respiratory",
            "probability": 0.00018847945741453257,
            "start_logit": 3.0671026706695557,
            "end_logit": -2.0023679733276367,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory failure as the first manifestation of disease. In the Lambert-Eaton myasthenic syndrome (LEMS)",
            "probability": 9.736068197630448e-05,
            "start_logit": 4.714766502380371,
            "end_logit": -4.310598373413086,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory failure as the first manifestation of disease. In the Lambert-Eaton myasthenic syndrome",
            "probability": 6.91895727622235e-05,
            "start_logit": 4.714766502380371,
            "end_logit": -4.652170658111572,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "rapid respiratory failure as the first manifestation of disease. In the Lambert-Eaton myasthenic syndrome (LEMS),",
            "probability": 4.6832551451345174e-05,
            "start_logit": 3.0671026706695557,
            "end_logit": -3.3947784900665283,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory failure as the first manifestation of disease",
            "probability": 4.283414520957135e-05,
            "start_logit": 4.714766502380371,
            "end_logit": -5.131685256958008,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory failure as the first manifestation of LEMS without associated carcinoma",
            "probability": 3.669134428885174e-05,
            "start_logit": 4.1278181076049805,
            "end_logit": -4.699531555175781,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "rapid",
            "probability": 3.5607079544341755e-05,
            "start_logit": 3.0671026706695557,
            "end_logit": -3.6688125133514404,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "vis can present with rapid respiratory failure",
            "probability": 2.6725322827382925e-05,
            "start_logit": -5.63101053237915,
            "end_logit": 4.742367744445801,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "respiratory failure as the first manifestation of LEMS",
            "probability": 2.3174134148327302e-05,
            "start_logit": 4.1278181076049805,
            "end_logit": -5.159035682678223,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "rapid respiratory failure as the first manifestation of disease. In the Lambert-Eaton myasthenic syndrome (LEMS)",
            "probability": 1.8741843072561564e-05,
            "start_logit": 3.0671026706695557,
            "end_logit": -4.310598373413086,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "myasthenic syndrome (LEMS), such a manifestation has rarely been reported. We are reporting a patient who developed respiratory failure",
            "probability": 1.760705002091396e-05,
            "start_logit": -5.131629467010498,
            "end_logit": 3.825674533843994,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "reported. We are reporting a patient who developed respiratory failure",
            "probability": 1.6717478591565422e-05,
            "start_logit": -5.183474063873291,
            "end_logit": 3.825674533843994,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        },
        {
            "text": "rarely been reported. We are reporting a patient who developed respiratory failure",
            "probability": 1.6501274440849705e-05,
            "start_logit": -5.196491241455078,
            "end_logit": 3.825674533843994,
            "question_text": "Which are the most common symptoms in Lambert-Eaton Myasthenic Syndrome?"
        }
    ],
    "553babc0f321868558000007": [
        {
            "text": "P. gingivalis",
            "probability": 0.10796218468521522,
            "start_logit": 4.0380988121032715,
            "end_logit": 4.305553436279297,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. denticola, P. intermedia",
            "probability": 0.09199484466274666,
            "start_logit": 4.145578384399414,
            "end_logit": 4.038025379180908,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "P. intermedia",
            "probability": 0.08358985205693135,
            "start_logit": 4.049767971038818,
            "end_logit": 4.038025379180908,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. forsythensis, T. denticola, P. intermedia",
            "probability": 0.08290040447852444,
            "start_logit": 4.041485786437988,
            "end_logit": 4.038025379180908,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "P. gingivalis, T. forsythensis, T. denticola, P. intermedia",
            "probability": 0.08262009789977565,
            "start_logit": 4.0380988121032715,
            "end_logit": 4.038025379180908,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. denticola, P. intermedia and F. nucleatum",
            "probability": 0.06941552920353318,
            "start_logit": 4.145578384399414,
            "end_logit": 3.7564034461975098,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. forsythensis",
            "probability": 0.06502949248877896,
            "start_logit": 4.041485786437988,
            "end_logit": 3.7952263355255127,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "P. gingivalis, T. forsythensis",
            "probability": 0.06480961184197197,
            "start_logit": 4.0380988121032715,
            "end_logit": 3.7952263355255127,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "P. intermedia and F. nucleatum",
            "probability": 0.06307346719100047,
            "start_logit": 4.049767971038818,
            "end_logit": 3.7564034461975098,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. forsythensis, T. denticola, P. intermedia and F. nucleatum",
            "probability": 0.06255323838156382,
            "start_logit": 4.041485786437988,
            "end_logit": 3.7564034461975098,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. denticola",
            "probability": 0.056508315108346106,
            "start_logit": 4.145578384399414,
            "end_logit": 3.550680637359619,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "T. forsythensis, T. denticola",
            "probability": 0.05092200759787599,
            "start_logit": 4.041485786437988,
            "end_logit": 3.550680637359619,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "P. gingivalis, T. forsythensis, T. denticola",
            "probability": 0.050749827813922364,
            "start_logit": 4.0380988121032715,
            "end_logit": 3.550680637359619,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "F. nucleatum",
            "probability": 0.03834581049868934,
            "start_logit": 3.5521130561828613,
            "end_logit": 3.7564034461975098,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "A. actinomycetemcomitans, P. gingivalis",
            "probability": 0.00965839150672978,
            "start_logit": 1.6241449117660522,
            "end_logit": 4.305553436279297,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "A. actinomycetemcomitans",
            "probability": 0.006966334870766292,
            "start_logit": 1.6241449117660522,
            "end_logit": 3.9788155555725098,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "A. actinomycetemcomitans, P. gingivalis, T. forsythensis",
            "probability": 0.005797924582519835,
            "start_logit": 1.6241449117660522,
            "end_logit": 3.7952263355255127,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "A. actinomycetemcomitans, P. gingivalis, T. forsythensis, T. denticola",
            "probability": 0.004540124001335731,
            "start_logit": 1.6241449117660522,
            "end_logit": 3.550680637359619,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "actinomycetemcomitans, P. gingivalis",
            "probability": 0.0014887478399012043,
            "start_logit": -0.24574682116508484,
            "end_logit": 4.305553436279297,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        },
        {
            "text": "actinomycetemcomitans",
            "probability": 0.0010737932898718548,
            "start_logit": -0.24574682116508484,
            "end_logit": 3.9788155555725098,
            "question_text": "Which types of bacterial microflora are associated with the progression of peri-implantitis?"
        }
    ],
    "5162c8a8298dcd4e51000047": [
        {
            "text": "CNOT7",
            "probability": 0.27398761438570013,
            "start_logit": 3.947648048400879,
            "end_logit": 3.0777652263641357,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT7 (hCaf1/Caf1a) and CNOT8",
            "probability": 0.23970551325810088,
            "start_logit": 3.947648048400879,
            "end_logit": 2.9440934658050537,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT8",
            "probability": 0.22670131399320997,
            "start_logit": 3.8918702602386475,
            "end_logit": 2.9440934658050537,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT7 (hCaf1/Caf1a",
            "probability": 0.039063892746902314,
            "start_logit": 3.947648048400879,
            "end_logit": 1.1298809051513672,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT7 (hCaf1/Caf1a) and CNOT8 (hPop2/Caf1b",
            "probability": 0.033749886780639,
            "start_logit": 3.947648048400879,
            "end_logit": 0.9836593866348267,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "Caf1a) and CNOT8",
            "probability": 0.03268895710690281,
            "start_logit": 1.955274224281311,
            "end_logit": 2.9440934658050537,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT8 (hPop2/Caf1b",
            "probability": 0.031918930759238004,
            "start_logit": 3.8918702602386475,
            "end_logit": 0.9836593866348267,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT8 (hPop2/Caf1b/Calif",
            "probability": 0.02974294349243607,
            "start_logit": 3.8918702602386475,
            "end_logit": 0.9130520224571228,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT7 (hCaf1",
            "probability": 0.02523333207713779,
            "start_logit": 3.947648048400879,
            "end_logit": 0.6928481459617615,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT7 (hCaf1/Caf1a) and CNOT8 (hPop2",
            "probability": 0.011954770328423486,
            "start_logit": 3.947648048400879,
            "end_logit": -0.054187286645174026,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT8 (hPop2",
            "probability": 0.011306215301867081,
            "start_logit": 3.8918702602386475,
            "end_logit": -0.054187286645174026,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT8 (hPop2/Caf1b/Calif)",
            "probability": 0.007468681752175508,
            "start_logit": 3.8918702602386475,
            "end_logit": -0.46882137656211853,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "Caf1a",
            "probability": 0.005327194594215226,
            "start_logit": 1.955274224281311,
            "end_logit": 1.1298809051513672,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "hCaf1/Caf1a) and CNOT8",
            "probability": 0.0051244576947326505,
            "start_logit": 0.10226161032915115,
            "end_logit": 2.9440934658050537,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "CNOT8 (hPop2/Caf1b/Calif),",
            "probability": 0.004613684430035982,
            "start_logit": 3.8918702602386475,
            "end_logit": -0.9505131244659424,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "Caf1a) and CNOT8 (hPop2/Caf1b",
            "probability": 0.004602516589375317,
            "start_logit": 1.955274224281311,
            "end_logit": 0.9836593866348267,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "Calif",
            "probability": 0.004454832864699854,
            "start_logit": 1.9932678937911987,
            "end_logit": 0.9130520224571228,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "Caf1a) and CNOT8 (hPop2/Caf1b/Calif",
            "probability": 0.004288752398172679,
            "start_logit": 1.955274224281311,
            "end_logit": 0.9130520224571228,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "Caf1b",
            "probability": 0.004175584339617219,
            "start_logit": 1.857925295829773,
            "end_logit": 0.9836593866348267,
            "question_text": "What are the known families of deadenylases?"
        },
        {
            "text": "Caf1b/Calif",
            "probability": 0.0038909251064179694,
            "start_logit": 1.857925295829773,
            "end_logit": 0.9130520224571228,
            "question_text": "What are the known families of deadenylases?"
        }
    ],
    "56a3bf0f496b62f23f00000a": [
        {
            "text": "GenomicFeatures",
            "probability": 0.267414212976186,
            "start_logit": 4.865252494812012,
            "end_logit": 4.510623455047607,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges, and GenomicFeatures",
            "probability": 0.18628301089887964,
            "start_logit": 4.503720760345459,
            "end_logit": 4.510623455047607,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges, and GenomicFeatures",
            "probability": 0.1690971547126296,
            "start_logit": 4.406927108764648,
            "end_logit": 4.510623455047607,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges",
            "probability": 0.12966544397517463,
            "start_logit": 4.406927108764648,
            "end_logit": 4.245107650756836,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges",
            "probability": 0.12705675444789993,
            "start_logit": 4.503720760345459,
            "end_logit": 4.127990245819092,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges",
            "probability": 0.1153349173415703,
            "start_logit": 4.406927108764648,
            "end_logit": 4.127990245819092,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicFeature",
            "probability": 0.0007704257539266635,
            "start_logit": 4.865252494812012,
            "end_logit": -1.3389873504638672,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges,",
            "probability": 0.0006643114707425144,
            "start_logit": 4.503720760345459,
            "end_logit": -1.125647783279419,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges,",
            "probability": 0.0006030242854862352,
            "start_logit": 4.406927108764648,
            "end_logit": -1.125647783279419,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges, and GenomicFeature",
            "probability": 0.0005366851205035944,
            "start_logit": 4.503720760345459,
            "end_logit": -1.3389873504638672,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges, and GenomicFeature",
            "probability": 0.0004871723213826814,
            "start_logit": 4.406927108764648,
            "end_logit": -1.3389873504638672,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "G",
            "probability": 0.00032447404232764784,
            "start_logit": 4.865252494812012,
            "end_logit": -2.2037250995635986,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges,",
            "probability": 0.0003198442456657071,
            "start_logit": 4.406927108764648,
            "end_logit": -1.7597711086273193,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "I",
            "probability": 0.00031216120637516656,
            "start_logit": 4.406927108764648,
            "end_logit": -1.7840855121612549,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "Genomic",
            "probability": 0.00023244805238058173,
            "start_logit": 4.865252494812012,
            "end_logit": -2.537263870239258,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges, and G",
            "probability": 0.00022603137241889031,
            "start_logit": 4.503720760345459,
            "end_logit": -2.2037250995635986,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges, and G",
            "probability": 0.0002051784634969896,
            "start_logit": 4.406927108764648,
            "end_logit": -2.2037250995635986,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "GenomicRanges, and Genomic",
            "probability": 0.00016192528659234482,
            "start_logit": 4.503720760345459,
            "end_logit": -2.537263870239258,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "Ranges, and GenomicFeatures",
            "probability": 0.00015783743264700286,
            "start_logit": -2.5697360038757324,
            "end_logit": 4.510623455047607,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        },
        {
            "text": "IRanges, GenomicRanges, and Genomic",
            "probability": 0.00014698659371388385,
            "start_logit": 4.406927108764648,
            "end_logit": -2.537263870239258,
            "question_text": "Which packages are used for performing overlap analysis of genomic regions in R/bioconductor?"
        }
    ],
    "516281e6298dcd4e51000040": [
        {
            "text": "titanium dioxide in addition to antiphosphotyrosine antibodies",
            "probability": 0.4398306216820715,
            "start_logit": 6.312869548797607,
            "end_logit": 6.573050498962402,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "titanium dioxide",
            "probability": 0.3377691194047579,
            "start_logit": 6.312869548797607,
            "end_logit": 6.309023380279541,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "antiphosphotyrosine antibodies",
            "probability": 0.1805863603977143,
            "start_logit": 5.422688961029053,
            "end_logit": 6.573050498962402,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "stable isotope labeling by amino acids in cell culture. By employing titanium dioxide",
            "probability": 0.011532442213400506,
            "start_logit": 2.935671091079712,
            "end_logit": 6.309023380279541,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "titanium dioxide in addition to antiphosphotyrosine antibodies as enrichment methods",
            "probability": 0.007615111283167513,
            "start_logit": 6.312869548797607,
            "end_logit": 2.5167953968048096,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "titanium dioxide in addition to antiphosphotyrosine",
            "probability": 0.00670070204266915,
            "start_logit": 6.312869548797607,
            "end_logit": 2.3888731002807617,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "antiphosphotyrosine antibodies as enrichment methods",
            "probability": 0.0031266245751411827,
            "start_logit": 5.422688961029053,
            "end_logit": 2.5167953968048096,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "antiphosphotyrosine",
            "probability": 0.002751184966084129,
            "start_logit": 5.422688961029053,
            "end_logit": 2.3888731002807617,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "antibodies",
            "probability": 0.002042606167392388,
            "start_logit": 0.9407063722610474,
            "end_logit": 6.573050498962402,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "employing titanium dioxide in addition to antiphosphotyrosine antibodies",
            "probability": 0.0014692931016062397,
            "start_logit": 0.611261248588562,
            "end_logit": 6.573050498962402,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "By employing titanium dioxide in addition to antiphosphotyrosine antibodies",
            "probability": 0.0011514277525420734,
            "start_logit": 0.3674825429916382,
            "end_logit": 6.573050498962402,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "employing titanium dioxide",
            "probability": 0.001128347624317433,
            "start_logit": 0.611261248588562,
            "end_logit": 6.309023380279541,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "By employing titanium dioxide",
            "probability": 0.0008842420669733663,
            "start_logit": 0.3674825429916382,
            "end_logit": 6.309023380279541,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "titanium dioxide in addition to antiphosphotyrosine antibodies as enrichment",
            "probability": 0.0008150771557688311,
            "start_logit": 6.312869548797607,
            "end_logit": 0.2821882963180542,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "titanium dioxide in addition",
            "probability": 0.0007919876510986256,
            "start_logit": 6.312869548797607,
            "end_logit": 0.25345131754875183,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "amino acids in cell culture. By employing titanium dioxide in addition to antiphosphotyrosine antibodies",
            "probability": 0.0004516719901075897,
            "start_logit": -0.5683192014694214,
            "end_logit": 6.573050498962402,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "amino acids in cell culture. By employing titanium dioxide",
            "probability": 0.00034686273041878527,
            "start_logit": -0.5683192014694214,
            "end_logit": 6.309023380279541,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "titanium dioxide in addition to antiphosphotyrosine antibodies as enrichment methods,",
            "probability": 0.0003375661106797459,
            "start_logit": 6.312869548797607,
            "end_logit": -0.5993331074714661,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "antiphosphotyrosine antibodies as enrichment",
            "probability": 0.0003346556827732895,
            "start_logit": 5.422688961029053,
            "end_logit": 0.2821882963180542,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        },
        {
            "text": "dioxide in addition to antiphosphotyrosine antibodies",
            "probability": 0.00033409540131547013,
            "start_logit": -0.8698488473892212,
            "end_logit": 6.573050498962402,
            "question_text": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?"
        }
    ],
    "56c3326750c68dd41600000b": [
        {
            "text": "H3K36me3",
            "probability": 0.9842051912224008,
            "start_logit": 5.5566325187683105,
            "end_logit": 5.4011969566345215,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36me3,",
            "probability": 0.011805550944618923,
            "start_logit": 5.5566325187683105,
            "end_logit": 0.9779323935508728,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36me",
            "probability": 0.0007396105277948128,
            "start_logit": 5.5566325187683105,
            "end_logit": -1.792268991470337,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K9me3",
            "probability": 0.000707019390840954,
            "start_logit": 2.0202441215515137,
            "end_logit": 1.6990537643432617,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H",
            "probability": 0.00036846946093186495,
            "start_logit": 5.5566325187683105,
            "end_logit": -2.48903489112854,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36me3, a mark of transcriptional elongation",
            "probability": 0.0003162875246293533,
            "start_logit": 5.5566325187683105,
            "end_logit": -2.6417410373687744,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36",
            "probability": 0.0003138867672463584,
            "start_logit": 5.5566325187683105,
            "end_logit": -2.649360418319702,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K36me3, a mark of transcriptional elongation.",
            "probability": 0.0003126859993163151,
            "start_logit": 5.5566325187683105,
            "end_logit": -2.653193235397339,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "3",
            "probability": 0.0002839532805209699,
            "start_logit": -2.5941474437713623,
            "end_logit": 5.4011969566345215,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "3K36me3",
            "probability": 0.00026073573022998347,
            "start_logit": -2.6794497966766357,
            "end_logit": 5.4011969566345215,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3",
            "probability": 0.0002308032924811242,
            "start_logit": 5.5566325187683105,
            "end_logit": -2.95682692527771,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "K36me3",
            "probability": 0.0001910210284444385,
            "start_logit": -2.9905736446380615,
            "end_logit": 5.4011969566345215,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "me3",
            "probability": 8.599353162852057e-05,
            "start_logit": -3.7886850833892822,
            "end_logit": 5.4011969566345215,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K9me3 and H3K36me3",
            "probability": 7.126007983012879e-05,
            "start_logit": 1.058023452758789,
            "end_logit": 0.3665526211261749,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K9me3. We have now further investigated this unusual location for H3K9me3",
            "probability": 4.415125105012868e-05,
            "start_logit": 0.8199443221092224,
            "end_logit": 0.1259167343378067,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "36me3",
            "probability": 3.949871535647963e-05,
            "start_logit": -4.5666890144348145,
            "end_logit": 5.4011969566345215,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "The H3K9me3",
            "probability": 1.1924348834630455e-05,
            "start_logit": -2.0622315406799316,
            "end_logit": 1.6990537643432617,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "H3K9me3 histone modification",
            "probability": 5.423353805042638e-06,
            "start_logit": 2.0202441215515137,
            "end_logit": -3.1712899208068848,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "3,",
            "probability": 3.4060223914471064e-06,
            "start_logit": -2.5941474437713623,
            "end_logit": 0.9779323935508728,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        },
        {
            "text": "3K36me3,",
            "probability": 3.1275276474506234e-06,
            "start_logit": -2.6794497966766357,
            "end_logit": 0.9779323935508728,
            "question_text": "Which histone modifications are correlated with transcription elongation?"
        }
    ],
    "54d646403706e89528000008": [
        {
            "text": "major depressive disorder",
            "probability": 0.8801441130616561,
            "start_logit": 4.894014358520508,
            "end_logit": 4.525676250457764,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive",
            "probability": 0.04986296226778676,
            "start_logit": 4.894014358520508,
            "end_logit": 1.6548690795898438,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive disorder (MDD)",
            "probability": 0.047622810699479726,
            "start_logit": 4.894014358520508,
            "end_logit": 1.6089024543762207,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "depressive disorder",
            "probability": 0.016406576513136234,
            "start_logit": 0.9116109609603882,
            "end_logit": 4.525676250457764,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "bipolar disorder",
            "probability": 0.0011360612854438112,
            "start_logit": 1.6940659284591675,
            "end_logit": 1.073106288909912,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "bipolar",
            "probability": 0.0010294187859280915,
            "start_logit": 1.9327514171600342,
            "end_logit": 0.7358478903770447,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "pressive disorder",
            "probability": 0.0009582162103238268,
            "start_logit": -1.928753137588501,
            "end_logit": 4.525676250457764,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "depressive",
            "probability": 0.0009294847212830928,
            "start_logit": 0.9116109609603882,
            "end_logit": 1.6548690795898438,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "depressive disorder (MDD)",
            "probability": 0.0008877265392296991,
            "start_logit": 0.9116109609603882,
            "end_logit": 1.6089024543762207,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "disorder",
            "probability": 0.00021228702333163244,
            "start_logit": -3.435887336730957,
            "end_logit": 4.525676250457764,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major",
            "probability": 0.0001404767693856535,
            "start_logit": 4.894014358520508,
            "end_logit": -4.217122554779053,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "genome-wide association studies (GWAS) of major depressive disorder",
            "probability": 0.00010325427473800205,
            "start_logit": -4.156631946563721,
            "end_logit": 4.525676250457764,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "Prior genome-wide association studies (GWAS) of major depressive disorder",
            "probability": 9.646930103693645e-05,
            "start_logit": -4.224601745605469,
            "end_logit": 4.525676250457764,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "studies (GWAS) of major depressive disorder",
            "probability": 9.379145918993586e-05,
            "start_logit": -4.252752780914307,
            "end_logit": 4.525676250457764,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive disorder (MDD) have met with limited success",
            "probability": 8.196016282598187e-05,
            "start_logit": 4.894014358520508,
            "end_logit": -4.755931377410889,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive disorder (MDD) have met with limited success.",
            "probability": 7.180882071734712e-05,
            "start_logit": 4.894014358520508,
            "end_logit": -4.888157367706299,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major depressive disorder (",
            "probability": 6.929302084562186e-05,
            "start_logit": 4.894014358520508,
            "end_logit": -4.923820495605469,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "pressive",
            "probability": 5.4285994794140644e-05,
            "start_logit": -1.928753137588501,
            "end_logit": 1.6548690795898438,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "pressive disorder (MDD)",
            "probability": 5.184713334579535e-05,
            "start_logit": -1.928753137588501,
            "end_logit": 1.6089024543762207,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        },
        {
            "text": "major de",
            "probability": 4.7155955521578e-05,
            "start_logit": 4.894014358520508,
            "end_logit": -5.308704376220703,
            "question_text": "List disorders that have been associated to the polymorphism rs2535629."
        }
    ],
    "5172f8118ed59a060a000019": [
        {
            "text": "metazoan",
            "probability": 0.2528786701741755,
            "start_logit": 1.0819534063339233,
            "end_logit": 0.8085449934005737,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "metazoan genomes investigated encoded selenoproteins, and these proteins had therefore been believed to be essential for animal",
            "probability": 0.162758175798376,
            "start_logit": 1.0819534063339233,
            "end_logit": 0.36790069937705994,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "animal",
            "probability": 0.15864184396930223,
            "start_logit": 1.0563369989395142,
            "end_logit": 0.36790069937705994,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "all metazoan",
            "probability": 0.1195557130568773,
            "start_logit": 0.33282607793807983,
            "end_logit": 0.8085449934005737,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "all metazoan genomes investigated encoded selenoproteins, and these proteins had therefore been believed to be essential for animal",
            "probability": 0.07694864003361325,
            "start_logit": 0.33282607793807983,
            "end_logit": 0.36790069937705994,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "animal life. Challenging this assumption, recent comparative analyses of insect",
            "probability": 0.0723256537793136,
            "start_logit": 1.0563369989395142,
            "end_logit": -0.41756951808929443,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "animal life. Challenging this assumption, recent comparative analyses of insect genomes have revealed that some insect",
            "probability": 0.05533320579370273,
            "start_logit": 1.0563369989395142,
            "end_logit": -0.6853752136230469,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "insect",
            "probability": 0.018200053357258234,
            "start_logit": -0.3234173655509949,
            "end_logit": -0.41756951808929443,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "metazoan genomes",
            "probability": 0.016389524187888478,
            "start_logit": 1.0819534063339233,
            "end_logit": -1.927722454071045,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "insect genomes have revealed that some insect",
            "probability": 0.013924067675162568,
            "start_logit": -0.3234173655509949,
            "end_logit": -0.6853752136230469,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "metazoan genomes investigated encoded selenoproteins,",
            "probability": 0.007796359349851822,
            "start_logit": 1.0819534063339233,
            "end_logit": -2.670707941055298,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "all metazoan genomes",
            "probability": 0.0077486220945259055,
            "start_logit": 0.33282607793807983,
            "end_logit": -1.927722454071045,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "metazoan genomes investigated encoded selenoproteins, and these proteins had therefore been believed to be essential for animal life",
            "probability": 0.007505626604502039,
            "start_logit": 1.0819534063339233,
            "end_logit": -2.708711862564087,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "animal life",
            "probability": 0.007315801119313951,
            "start_logit": 1.0563369989395142,
            "end_logit": -2.708711862564087,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "some insect",
            "probability": 0.0046040049946946705,
            "start_logit": -1.4301096200942993,
            "end_logit": -0.6853752136230469,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "all",
            "probability": 0.004016482373099001,
            "start_logit": 0.33282607793807983,
            "end_logit": -2.5848309993743896,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "all metazoan genomes investigated encoded selenoproteins,",
            "probability": 0.003685954614824509,
            "start_logit": 0.33282607793807983,
            "end_logit": -2.670707941055298,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "all metazoan genomes investigated encoded selenoproteins, and these proteins had therefore been believed to be essential for animal life",
            "probability": 0.003548502291718982,
            "start_logit": 0.33282607793807983,
            "end_logit": -2.708711862564087,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "metazoan genome",
            "probability": 0.0035168603867833893,
            "start_logit": 1.0819534063339233,
            "end_logit": -3.4667961597442627,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        },
        {
            "text": "metazoan genomes investigated encoded selenoproteins",
            "probability": 0.00330623834501563,
            "start_logit": 1.0819534063339233,
            "end_logit": -3.5285537242889404,
            "question_text": "Which metazaon species or taxa are known to lack selenoproteins"
        }
    ],
    "534df8c9aeec6fbd07000016": [
        {
            "text": "rheumatoid arthritis",
            "probability": 0.8078818975335466,
            "start_logit": 3.380040407180786,
            "end_logit": 3.739763021469116,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "rheumatoid arthritis (RA)",
            "probability": 0.11992447967536102,
            "start_logit": 3.380040407180786,
            "end_logit": 1.8322093486785889,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "Porphyromonas gingivalis has been implicated as an etiologic agent of rheumatoid arthritis",
            "probability": 0.04349598798362126,
            "start_logit": 0.45829322934150696,
            "end_logit": 3.739763021469116,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "arthritis",
            "probability": 0.01421407703571631,
            "start_logit": -0.6601426601409912,
            "end_logit": 3.739763021469116,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "Porphyromonas gingivalis",
            "probability": 0.0030704075380134734,
            "start_logit": 0.45829322934150696,
            "end_logit": 1.088904619216919,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "itis",
            "probability": 0.0029407674226586047,
            "start_logit": -2.2357048988342285,
            "end_logit": 3.739763021469116,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "arthritis (RA)",
            "probability": 0.002109981419039029,
            "start_logit": -0.6601426601409912,
            "end_logit": 1.8322093486785889,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "rheumatoid",
            "probability": 0.0018153239909430706,
            "start_logit": 3.380040407180786,
            "end_logit": -2.358388900756836,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "hritis",
            "probability": 0.0008187303839729482,
            "start_logit": -3.514375925064087,
            "end_logit": 3.739763021469116,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "heumatoid arthritis",
            "probability": 0.0007263177847758591,
            "start_logit": -3.634143114089966,
            "end_logit": 3.739763021469116,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "umatoid arthritis",
            "probability": 0.0007015467104622588,
            "start_logit": -3.6688432693481445,
            "end_logit": 3.739763021469116,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "rheumatoid art",
            "probability": 0.000493243659770922,
            "start_logit": 3.380040407180786,
            "end_logit": -3.661404848098755,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "itis (RA)",
            "probability": 0.0004365365829897696,
            "start_logit": -2.2357048988342285,
            "end_logit": 1.8322093486785889,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "is has been implicated as an etiologic agent of rheumatoid arthritis",
            "probability": 0.0003877606087158917,
            "start_logit": -4.26174259185791,
            "end_logit": 3.739763021469116,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "r",
            "probability": 0.00035822744461663786,
            "start_logit": 3.380040407180786,
            "end_logit": -3.9812400341033936,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "rheumatoid arthritis (RA) because of the expression of peptidylarginine deiminase. The present study",
            "probability": 0.00018139481284012337,
            "start_logit": 3.380040407180786,
            "end_logit": -4.661732196807861,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "hritis (RA)",
            "probability": 0.0001215348624497274,
            "start_logit": -3.514375925064087,
            "end_logit": 1.8322093486785889,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "(RA)",
            "probability": 0.0001098279425407707,
            "start_logit": -3.615662097930908,
            "end_logit": 1.8322093486785889,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "heumatoid arthritis (RA)",
            "probability": 0.00010781685130478971,
            "start_logit": -3.634143114089966,
            "end_logit": 1.8322093486785889,
            "question_text": "List diseases where protein citrullination plays an important role."
        },
        {
            "text": "umatoid arthritis (RA)",
            "probability": 0.00010413975666121914,
            "start_logit": -3.6688432693481445,
            "end_logit": 1.8322093486785889,
            "question_text": "List diseases where protein citrullination plays an important role."
        }
    ],
    "56e30dd551531f7e33000016": [
        {
            "text": "CLOCK",
            "probability": 0.25894606143549365,
            "start_logit": 0.9325675964355469,
            "end_logit": 1.2246493101119995,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, and with CLOCK",
            "probability": 0.19705324829665843,
            "start_logit": 0.9325675964355469,
            "end_logit": 0.9515035152435303,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "RORA",
            "probability": 0.1002250302875752,
            "start_logit": 1.4478965997695923,
            "end_logit": -0.2398815155029297,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "RORA, and NPAS2",
            "probability": 0.09841682855978545,
            "start_logit": 1.4478965997695923,
            "end_logit": -0.2580876648426056,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "NPAS2",
            "probability": 0.07904943589044801,
            "start_logit": 1.2287582159042358,
            "end_logit": -0.2580876648426056,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, and with CLOCK, RORA",
            "probability": 0.05986481622799122,
            "start_logit": 0.9325675964355469,
            "end_logit": -0.2398815155029297,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, and with CLOCK, RORA, and NPAS2",
            "probability": 0.05878477001771146,
            "start_logit": 0.9325675964355469,
            "end_logit": -0.2580876648426056,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, RORA",
            "probability": 0.05203595352923707,
            "start_logit": 0.7924135327339172,
            "end_logit": -0.2398815155029297,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, RORA, and NPAS2",
            "probability": 0.05109715110823727,
            "start_logit": 0.7924135327339172,
            "end_logit": -0.2580876648426056,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock",
            "probability": 0.02087144451385079,
            "start_logit": -0.3591763377189636,
            "end_logit": -0.0018446051981300116,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock",
            "probability": 0.005944982890036904,
            "start_logit": -1.6150106191635132,
            "end_logit": -0.0018446051981300116,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "clock genes. We also used a gene- and pathway-based approach to investigate the overall effect on breast cancer of circadian clock",
            "probability": 0.005866958185418743,
            "start_logit": -0.3591763377189636,
            "end_logit": -1.270890235900879,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK,",
            "probability": 0.002609617710995293,
            "start_logit": 0.9325675964355469,
            "end_logit": -3.3727667331695557,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "RORA, and NPAS",
            "probability": 0.0016789928154645596,
            "start_logit": 1.4478965997695923,
            "end_logit": -4.329105377197266,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "circadian clock genes. We also used a gene- and pathway-based approach to investigate the overall effect on breast cancer of circadian clock",
            "probability": 0.0016711333039612984,
            "start_logit": -1.6150106191635132,
            "end_logit": -1.270890235900879,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "R",
            "probability": 0.001544871469139331,
            "start_logit": 1.4478965997695923,
            "end_logit": -4.41235876083374,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "NPAS",
            "probability": 0.0013485847580016533,
            "start_logit": 1.2287582159042358,
            "end_logit": -4.329105377197266,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "RORA, and N",
            "probability": 0.0010644918149679266,
            "start_logit": 1.4478965997695923,
            "end_logit": -4.784801959991455,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, and with CLOCK, RORA, and NPAS",
            "probability": 0.001002869204005258,
            "start_logit": 0.9325675964355469,
            "end_logit": -4.329105377197266,
            "question_text": "List core circadian clock genes."
        },
        {
            "text": "CLOCK, and with CLOCK, R",
            "probability": 0.0009227579810206149,
            "start_logit": 0.9325675964355469,
            "end_logit": -4.41235876083374,
            "question_text": "List core circadian clock genes."
        }
    ],
    "530e0d6e5937551c09000001": [
        {
            "text": "endovascular coil embolization",
            "probability": 0.20657624970424623,
            "start_logit": -1.8459056615829468,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "coil embolization",
            "probability": 0.17021813121204418,
            "start_logit": -2.039494514465332,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "We aimed to evaluate the results of endovascular coil embolization",
            "probability": 0.11986925176689849,
            "start_logit": -2.3901736736297607,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "evaluate the results of endovascular coil embolization",
            "probability": 0.09147045979562543,
            "start_logit": -2.6605591773986816,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "to evaluate the results of endovascular coil embolization",
            "probability": 0.05142563281166433,
            "start_logit": -3.236438512802124,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "results of endovascular coil embolization",
            "probability": 0.05053996306855673,
            "start_logit": -3.2538108825683594,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "endovascular coil",
            "probability": 0.04076354024689673,
            "start_logit": -1.8459056615829468,
            "end_logit": -2.8364946842193604,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "aimed to evaluate the results of endovascular coil embolization",
            "probability": 0.03400879023219163,
            "start_logit": -3.649956226348877,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "coil",
            "probability": 0.0335890193202161,
            "start_logit": -2.039494514465332,
            "end_logit": -2.8364946842193604,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "endovascular coil embolization for very small aneurysms (<or= 3 mm).",
            "probability": 0.026498673430365067,
            "start_logit": -1.8459056615829468,
            "end_logit": -3.26718807220459,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "We aimed to evaluate the results of endovascular coil",
            "probability": 0.023653711768710287,
            "start_logit": -2.3901736736297607,
            "end_logit": -2.8364946842193604,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "coil embolization for very small aneurysms (<or= 3 mm).",
            "probability": 0.02183481730050148,
            "start_logit": -2.039494514465332,
            "end_logit": -3.26718807220459,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "the results of endovascular coil embolization",
            "probability": 0.01925048567861346,
            "start_logit": -4.219038963317871,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "We aimed to evaluate the results",
            "probability": 0.018526476070563545,
            "start_logit": -2.3901736736297607,
            "end_logit": -3.0808138847351074,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "evaluate the results of endovascular coil",
            "probability": 0.018049798922283773,
            "start_logit": -2.6605591773986816,
            "end_logit": -2.8364946842193604,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "endovascular coil embolization for very small aneurysms",
            "probability": 0.017247731690324203,
            "start_logit": -1.8459056615829468,
            "end_logit": -3.6966021060943604,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "We aimed to evaluate the results of endovascular coil embolization for very small aneurysms (<or= 3 mm).",
            "probability": 0.015376289198108928,
            "start_logit": -2.3901736736297607,
            "end_logit": -3.26718807220459,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "coil embolization for very small aneurysms",
            "probability": 0.014212072589065835,
            "start_logit": -2.039494514465332,
            "end_logit": -3.6966021060943604,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "evaluate the results",
            "probability": 0.014137280908889974,
            "start_logit": -2.6605591773986816,
            "end_logit": -3.0808138847351074,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        },
        {
            "text": "embolization",
            "probability": 0.012751624284233562,
            "start_logit": -4.630916595458984,
            "end_logit": -1.2136131525039673,
            "question_text": "List clinical trials that have directly compared microsurgical clipping with endovascular coiling for treatment of ruptured brain aneurysms?"
        }
    ],
    "5311bf53e3eabad021000006": [
        {
            "text": "flutemetamol",
            "probability": 0.6970578155651754,
            "start_logit": 5.1148529052734375,
            "end_logit": 4.767560958862305,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "(18)F-flutemetamol",
            "probability": 0.17783239011685814,
            "start_logit": 3.748826026916504,
            "end_logit": 4.767560958862305,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol is a positron emission tomography",
            "probability": 0.051434765998353,
            "start_logit": 5.1148529052734375,
            "end_logit": 2.1610069274902344,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol is a positron emission tomography (PET) tracer for in vivo amyloid",
            "probability": 0.020642282427455208,
            "start_logit": 5.1148529052734375,
            "end_logit": 1.248034119606018,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "18)F-flutemetamol",
            "probability": 0.017286185713373647,
            "start_logit": 1.4178922176361084,
            "end_logit": 4.767560958862305,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "(18)F-flutemetamol is a positron emission tomography",
            "probability": 0.01312196372860723,
            "start_logit": 3.748826026916504,
            "end_logit": 2.1610069274902344,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "amyloid",
            "probability": 0.006120809118027948,
            "start_logit": 3.8992056846618652,
            "end_logit": 1.248034119606018,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol is a positron emission tomography (PET) tracer for in vivo amyloid imaging",
            "probability": 0.0026526865430338766,
            "start_logit": 5.1148529052734375,
            "end_logit": -0.8037344813346863,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "(18)F",
            "probability": 0.002259432815252342,
            "start_logit": 3.748826026916504,
            "end_logit": 0.40183329582214355,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flute",
            "probability": 0.0021557263325303415,
            "start_logit": 5.1148529052734375,
            "end_logit": -1.0111796855926514,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "positron emission tomography",
            "probability": 0.0017183423099959025,
            "start_logit": 1.7158986330032349,
            "end_logit": 2.1610069274902344,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "F-flutemetamol",
            "probability": 0.001487311053375393,
            "start_logit": -1.0350456237792969,
            "end_logit": 4.767560958862305,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "18)F-flutemetamol is a positron emission tomography",
            "probability": 0.0012755196159023826,
            "start_logit": 1.4178922176361084,
            "end_logit": 2.1610069274902344,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol is",
            "probability": 0.001003347057517201,
            "start_logit": 5.1148529052734375,
            "end_logit": -1.775965929031372,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "amyloid imaging",
            "probability": 0.0007865694133840723,
            "start_logit": 3.8992056846618652,
            "end_logit": -0.8037344813346863,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol is a positron emission",
            "probability": 0.00072219116147456,
            "start_logit": 5.1148529052734375,
            "end_logit": -2.1047728061676025,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "flutemetamol is a positron emission tomography (PET)",
            "probability": 0.0006911704878510323,
            "start_logit": 5.1148529052734375,
            "end_logit": -2.1486761569976807,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "positron emission tomography (PET) tracer for in vivo amyloid",
            "probability": 0.0006896212431707576,
            "start_logit": 1.7158986330032349,
            "end_logit": 1.248034119606018,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "(18)F-flute",
            "probability": 0.0005499658099965385,
            "start_logit": 3.748826026916504,
            "end_logit": -1.0111796855926514,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        },
        {
            "text": "18)F-flutemetamol is a positron emission tomography (PET) tracer for in vivo amyloid",
            "probability": 0.0005119034886648317,
            "start_logit": 1.4178922176361084,
            "end_logit": 1.248034119606018,
            "question_text": "Which are the biotracers used for detection of Alzheimer's disease using PET?"
        }
    ],
    "515bd543298dcd4e51000001": [
        {
            "text": "16",
            "probability": 0.6456752914313546,
            "start_logit": 0.34545108675956726,
            "end_logit": 0.013399044051766396,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "16p13.3",
            "probability": 0.10597964648507675,
            "start_logit": 0.34545108675956726,
            "end_logit": -1.7936506271362305,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "chromosome 16",
            "probability": 0.07877525979531957,
            "start_logit": -1.758246660232544,
            "end_logit": 0.013399044051766396,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "16p13.3, can be physically delineated by the genetic markers D16S125 and D16S84",
            "probability": 0.04723354783485789,
            "start_logit": 0.34545108675956726,
            "end_logit": -2.6017932891845703,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "16p13.3,",
            "probability": 0.03105151746930992,
            "start_logit": 0.34545108675956726,
            "end_logit": -3.021250009536743,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "700-kb segment on chromosome 16",
            "probability": 0.015894910781936257,
            "start_logit": -3.358846664428711,
            "end_logit": 0.013399044051766396,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "a 700-kb segment on chromosome 16",
            "probability": 0.013587782654189575,
            "start_logit": -3.515674591064453,
            "end_logit": 0.013399044051766396,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "chromosome 16p13.3",
            "probability": 0.012929988642388113,
            "start_logit": -1.758246660232544,
            "end_logit": -1.7936506271362305,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "16p13.3, can be physically delineated by the genetic markers D16S125",
            "probability": 0.010847037619542265,
            "start_logit": 0.34545108675956726,
            "end_logit": -4.073005676269531,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "chromosome 16p13.3, can be physically delineated by the genetic markers D16S125 and D16S84",
            "probability": 0.005762703097244304,
            "start_logit": -1.758246660232544,
            "end_logit": -2.6017932891845703,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "segment on chromosome 16",
            "probability": 0.0049685763115825754,
            "start_logit": -4.521712303161621,
            "end_logit": 0.013399044051766396,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "The interval of interest, a 700-kb segment on chromosome 16",
            "probability": 0.004740420201674354,
            "start_logit": -4.568719863891602,
            "end_logit": 0.013399044051766396,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "D16S84",
            "probability": 0.004596731132005064,
            "start_logit": -1.984307885169983,
            "end_logit": -2.6017932891845703,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "chromosome 16p13.3,",
            "probability": 0.00378842335790985,
            "start_logit": -1.758246660232544,
            "end_logit": -3.021250009536743,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "interval of interest, a 700-kb segment on chromosome 16",
            "probability": 0.0029180382214428874,
            "start_logit": -5.053934097290039,
            "end_logit": 0.013399044051766396,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "700-kb segment on chromosome 16p13.3",
            "probability": 0.0026089538316498087,
            "start_logit": -3.358846664428711,
            "end_logit": -1.7936506271362305,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "interest, a 700-kb segment on chromosome 16",
            "probability": 0.0024402138850395834,
            "start_logit": -5.232759952545166,
            "end_logit": 0.013399044051766396,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "3",
            "probability": 0.002268531144577847,
            "start_logit": -3.4986634254455566,
            "end_logit": -1.7936506271362305,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "a 700-kb segment on chromosome 16p13.3",
            "probability": 0.0022302671657370783,
            "start_logit": -3.515674591064453,
            "end_logit": -1.7936506271362305,
            "question_text": "In which isochores are Alu elements enriched?"
        },
        {
            "text": "D16S84 and chromosomally characterized as a GC-rich isochore enriched for CpG islands",
            "probability": 0.0017021589371619406,
            "start_logit": -1.984307885169983,
            "end_logit": -3.5952413082122803,
            "question_text": "In which isochores are Alu elements enriched?"
        }
    ],
    "52e6c92598d0239505000019": [
        {
            "text": "BREAST CANCER",
            "probability": 0.21506571048041934,
            "start_logit": -3.6157493591308594,
            "end_logit": -2.8315019607543945,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER",
            "probability": 0.10032239658823736,
            "start_logit": -4.3783040046691895,
            "end_logit": -2.8315019607543945,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "EARLY BREAST CANCER",
            "probability": 0.09098707443444234,
            "start_logit": -4.475975513458252,
            "end_logit": -2.8315019607543945,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "BREAST CANCER: An Evidence-Based and Economic AnalysisEpidermal Growth Factor Receptor Mutation (EGFR)",
            "probability": 0.07987351760042694,
            "start_logit": -3.6157493591308594,
            "end_logit": -3.8220012187957764,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "EGFR)",
            "probability": 0.06186714952294685,
            "start_logit": -3.871204376220703,
            "end_logit": -3.8220012187957764,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "BREAST CANCER: An Evidence-Based and Economic AnalysisEpidermal Growth Factor Receptor Mutation (EGFR",
            "probability": 0.046968710591683345,
            "start_logit": -3.6157493591308594,
            "end_logit": -4.352963924407959,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "BREAST CANCER: An Evidence-Based and Economic AnalysisEpidermal Growth Factor Receptor Mutation (EGFR) Testing",
            "probability": 0.041872277548944126,
            "start_logit": -3.6157493591308594,
            "end_logit": -4.4678215980529785,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "EGFR",
            "probability": 0.03638027131360694,
            "start_logit": -3.871204376220703,
            "end_logit": -4.352963924407959,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "EARLY BREAST CANCER: An Evidence-Based and Economic AnalysisEpidermal Growth Factor Receptor Mutation (EGFR)",
            "probability": 0.03379180100359351,
            "start_logit": -4.475975513458252,
            "end_logit": -3.8220012187957764,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Epidermal Growth Factor Receptor Mutation (EGFR)",
            "probability": 0.033761457392291534,
            "start_logit": -4.476873874664307,
            "end_logit": -3.8220012187957764,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "EGFR) Testing",
            "probability": 0.03243275786282649,
            "start_logit": -3.871204376220703,
            "end_logit": -4.4678215980529785,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "BREAST CANCER: An Evidence-Based and Economic AnalysisEpidermal Growth Factor Receptor Mutation",
            "probability": 0.03125645760996801,
            "start_logit": -3.6157493591308594,
            "end_logit": -4.760219573974609,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "LING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER",
            "probability": 0.0292341256142423,
            "start_logit": -5.611356258392334,
            "end_logit": -2.8315019607543945,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "(EGFR)",
            "probability": 0.02852513302325813,
            "start_logit": -4.6454081535339355,
            "end_logit": -3.8220012187957764,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER",
            "probability": 0.026713860253217633,
            "start_logit": -5.701510429382324,
            "end_logit": -2.8315019607543945,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER",
            "probability": 0.024822750368147784,
            "start_logit": -5.774932384490967,
            "end_logit": -2.8315019607543945,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "EGFR) Testing for Prediction of Response to EGFR",
            "probability": 0.02396328331548525,
            "start_logit": -3.871204376220703,
            "end_logit": -4.770467758178711,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "Testing",
            "probability": 0.021448850032119084,
            "start_logit": -4.284702301025391,
            "end_logit": -4.4678215980529785,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "BREAST CANCER: An Evidence-Based and Economic AnalysisEpidermal Growth Factor Receptor",
            "probability": 0.02045083179399006,
            "start_logit": -3.6157493591308594,
            "end_logit": -5.184422016143799,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        },
        {
            "text": "K-RAS testing",
            "probability": 0.020261583650153184,
            "start_logit": -4.130283832550049,
            "end_logit": -4.679184436798096,
            "question_text": "Which are the mutational hotspots of the human KRAS oncogene?"
        }
    ],
    "531778ddb166e2b80600000f": [
        {
            "text": "adrenocortical cancer",
            "probability": 0.8192889968335765,
            "start_logit": 3.489091396331787,
            "end_logit": 2.886087656021118,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC)",
            "probability": 0.07656168671815587,
            "start_logit": 3.489091396331787,
            "end_logit": 0.5157475471496582,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age and family history",
            "probability": 0.019041238864211028,
            "start_logit": 3.489091396331787,
            "end_logit": -0.8757421374320984,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "cancer",
            "probability": 0.018972299080385627,
            "start_logit": -0.2763655185699463,
            "end_logit": 2.886087656021118,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age and family history, is at high risk for a TP53",
            "probability": 0.01412338027337047,
            "start_logit": 3.489091396331787,
            "end_logit": -1.1745176315307617,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "TP53. According to the Chompret criteria for LFS, any patient with adrenocortical cancer",
            "probability": 0.012718907534662578,
            "start_logit": -0.6762558221817017,
            "end_logit": 2.886087656021118,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age",
            "probability": 0.012334936423612617,
            "start_logit": 3.489091396331787,
            "end_logit": -1.3099136352539062,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC),",
            "probability": 0.005801615608793978,
            "start_logit": 3.489091396331787,
            "end_logit": -2.0642127990722656,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "any patient with adrenocortical cancer",
            "probability": 0.005002616488350318,
            "start_logit": -1.6093844175338745,
            "end_logit": 2.886087656021118,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age and family history,",
            "probability": 0.0034903776332674322,
            "start_logit": 3.489091396331787,
            "end_logit": -2.5723392963409424,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC), irrespective of age and family history, is at high risk",
            "probability": 0.0023075631451459156,
            "start_logit": 3.489091396331787,
            "end_logit": -2.986157178878784,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "cancer (ACC)",
            "probability": 0.0017729412016144776,
            "start_logit": -0.2763655185699463,
            "end_logit": 0.5157475471496582,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "cancer (ACC), irrespective of age and family history, is at high risk for a TP53 germline mutation",
            "probability": 0.0016306357871474905,
            "start_logit": -0.2763655185699463,
            "end_logit": 0.43207767605781555,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "adrenocortical cancer (ACC",
            "probability": 0.0014585054402336333,
            "start_logit": 3.489091396331787,
            "end_logit": -3.444936990737915,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "ad",
            "probability": 0.0013559003408601155,
            "start_logit": 3.489091396331787,
            "end_logit": -3.517883539199829,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "TP53. According to the Chompret criteria for LFS, any patient with adrenocortical cancer (ACC)",
            "probability": 0.0011885684023946854,
            "start_logit": -0.6762558221817017,
            "end_logit": 0.5157475471496582,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "mutations in TP53. According to the Chompret criteria for LFS, any patient with adrenocortical cancer",
            "probability": 0.0009166908902027741,
            "start_logit": -3.306330442428589,
            "end_logit": 2.886087656021118,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "TP53 germline mutation",
            "probability": 0.0008072092964371463,
            "start_logit": -0.9795078039169312,
            "end_logit": 0.43207767605781555,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "TP53",
            "probability": 0.0006439592558504546,
            "start_logit": -0.6762558221817017,
            "end_logit": -0.09712183475494385,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        },
        {
            "text": "age and family history, is at high risk for a TP53 germline mutation",
            "probability": 0.0005819707817268352,
            "start_logit": -1.3066705465316772,
            "end_logit": 0.43207767605781555,
            "question_text": "Which are the Chompret criteria for Li-Fraumeni syndrome?"
        }
    ],
    "52fb42752059c6d71c00005e": [
        {
            "text": "thyronamines",
            "probability": 0.5164407655250111,
            "start_logit": 5.669390678405762,
            "end_logit": 4.861251354217529,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "thyronamine",
            "probability": 0.4410381205859797,
            "start_logit": 5.669390678405762,
            "end_logit": 4.7034220695495605,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "the thyronamines",
            "probability": 0.021733057562779476,
            "start_logit": 2.5012645721435547,
            "end_logit": 4.861251354217529,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "the thyronamine",
            "probability": 0.01855993465645765,
            "start_logit": 2.5012645721435547,
            "end_logit": 4.7034220695495605,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "KB - 141 have similar effects. Another class of thyroid hormone analogs, the thyronamines",
            "probability": 0.0004747015681030984,
            "start_logit": -1.3226388692855835,
            "end_logit": 4.861251354217529,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "KB - 141 have similar effects. Another class of thyroid hormone analogs, the thyronamine",
            "probability": 0.0004053930313238773,
            "start_logit": -1.3226388692855835,
            "end_logit": 4.7034220695495605,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "KB- 2115 and KB - 141 have similar effects. Another class of thyroid hormone analogs, the thyronamines",
            "probability": 0.00034488890843165955,
            "start_logit": -1.642102837562561,
            "end_logit": 4.861251354217529,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "KB- 2115 and KB - 141 have similar effects. Another class of thyroid hormone analogs, the thyronamine",
            "probability": 0.0002945335963767612,
            "start_logit": -1.642102837562561,
            "end_logit": 4.7034220695495605,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "thy",
            "probability": 0.0001949304739287179,
            "start_logit": 5.669390678405762,
            "end_logit": -3.0208215713500977,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "thyrona",
            "probability": 0.00011664469102261759,
            "start_logit": 5.669390678405762,
            "end_logit": -3.534332036972046,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "mines",
            "probability": 9.48716480788666e-05,
            "start_logit": -2.93280029296875,
            "end_logit": 4.861251354217529,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "mine",
            "probability": 8.101996619701665e-05,
            "start_logit": -2.93280029296875,
            "end_logit": 4.7034220695495605,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "ronamines",
            "probability": 7.441917984426755e-05,
            "start_logit": -3.1756114959716797,
            "end_logit": 4.861251354217529,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "ronamine",
            "probability": 6.355364914057359e-05,
            "start_logit": -3.1756114959716797,
            "end_logit": 4.7034220695495605,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "s",
            "probability": 3.782362680865278e-05,
            "start_logit": -3.852391242980957,
            "end_logit": 4.861251354217529,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "thyronamines have emerged recently",
            "probability": 1.826899915973955e-05,
            "start_logit": 5.669390678405762,
            "end_logit": -5.388258934020996,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "the thy",
            "probability": 8.203138662622751e-06,
            "start_logit": 2.5012645721435547,
            "end_logit": -3.0208215713500977,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": ", the thyronamines",
            "probability": 7.529956680865678e-06,
            "start_logit": -5.46643590927124,
            "end_logit": 4.861251354217529,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": ", the thyronamine",
            "probability": 6.43054956989449e-06,
            "start_logit": -5.46643590927124,
            "end_logit": 4.7034220695495605,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        },
        {
            "text": "the thyrona",
            "probability": 4.908686443081347e-06,
            "start_logit": 2.5012645721435547,
            "end_logit": -3.534332036972046,
            "question_text": "Which are the thyroid hormone analogs utilized in human studies?"
        }
    ],
    "5509b6d22e93f0133a000005": [
        {
            "text": "irradiation",
            "probability": 0.2963187970682681,
            "start_logit": 6.114371299743652,
            "end_logit": 5.777234077453613,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Surgical resection",
            "probability": 0.16212660684145977,
            "start_logit": 5.5112104415893555,
            "end_logit": 5.777336597442627,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Surgical resection is the treatment of choice, with little efficacy reported for irradiation",
            "probability": 0.162109986475482,
            "start_logit": 5.5112104415893555,
            "end_logit": 5.777234077453613,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "irradiation, conventional cytotoxic agents",
            "probability": 0.1451892279756896,
            "start_logit": 6.114371299743652,
            "end_logit": 5.063836097717285,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Surgical resection is the treatment of choice, with little efficacy reported for irradiation, conventional cytotoxic agents",
            "probability": 0.07943007334125407,
            "start_logit": 5.5112104415893555,
            "end_logit": 5.063836097717285,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "cytotoxic agents",
            "probability": 0.05376068553057879,
            "start_logit": 5.120875835418701,
            "end_logit": 5.063836097717285,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "irradiation, conventional cytotoxic agents or both. Nevertheless, imatinib mesylate",
            "probability": 0.032010449146727064,
            "start_logit": 6.114371299743652,
            "end_logit": 3.5518605709075928,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "conventional cytotoxic agents",
            "probability": 0.016803218986582793,
            "start_logit": 3.9579038619995117,
            "end_logit": 5.063836097717285,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "irradiation, conventional cytotoxic agents or both. Nevertheless, imatinib",
            "probability": 0.015089089473518344,
            "start_logit": 6.114371299743652,
            "end_logit": 2.7997701168060303,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "cytotoxic agents or both. Nevertheless, imatinib mesylate",
            "probability": 0.01185283312173769,
            "start_logit": 5.120875835418701,
            "end_logit": 3.5518605709075928,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "cytotoxic agents or both. Nevertheless, imatinib",
            "probability": 0.005587189941284165,
            "start_logit": 5.120875835418701,
            "end_logit": 2.7997701168060303,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "imatinib mesylate",
            "probability": 0.003765206257413595,
            "start_logit": 3.974111557006836,
            "end_logit": 3.5518605709075928,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "conventional cytotoxic agents or both. Nevertheless, imatinib mesylate",
            "probability": 0.003704672821604846,
            "start_logit": 3.9579038619995117,
            "end_logit": 3.5518605709075928,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Surgical resection is the treatment of choice",
            "probability": 0.003587533591815333,
            "start_logit": 5.5112104415893555,
            "end_logit": 1.9664239883422852,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "imatinib",
            "probability": 0.001774843390792404,
            "start_logit": 3.974111557006836,
            "end_logit": 2.7997701168060303,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "conventional cytotoxic agents or both. Nevertheless, imatinib",
            "probability": 0.0017463091323422666,
            "start_logit": 3.9579038619995117,
            "end_logit": 2.7997701168060303,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "irradiation,",
            "probability": 0.0016474799122879824,
            "start_logit": 6.114371299743652,
            "end_logit": 0.5850449800491333,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Surgical resection is the treatment of choice,",
            "probability": 0.0016109009287764268,
            "start_logit": 5.5112104415893555,
            "end_logit": 1.165752649307251,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "irradiation, conventional cytotoxic",
            "probability": 0.0009835933136493223,
            "start_logit": 6.114371299743652,
            "end_logit": 0.06925541907548904,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        },
        {
            "text": "Surgical resection is the treatment of choice, with little efficacy reported for irradiation,",
            "probability": 0.0009013027487355212,
            "start_logit": 5.5112104415893555,
            "end_logit": 0.5850449800491333,
            "question_text": "What are the treatments of choice for GIST (gastrointestinal stromal tumor)?"
        }
    ],
    "56be0e4aef6e394741000008": [
        {
            "text": "chronic rhinosinusitis",
            "probability": 0.2061815430081339,
            "start_logit": 4.206210613250732,
            "end_logit": 4.61700963973999,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis",
            "probability": 0.151170170995007,
            "start_logit": 4.234079360961914,
            "end_logit": 4.27878999710083,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic rhinosinusitis, and bronchiectasis",
            "probability": 0.14701541052574932,
            "start_logit": 4.206210613250732,
            "end_logit": 4.27878999710083,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus, chronic rhinosinusitis",
            "probability": 0.136664317985034,
            "start_logit": 3.7949812412261963,
            "end_logit": 4.61700963973999,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus",
            "probability": 0.11210235485486088,
            "start_logit": 3.7949812412261963,
            "end_logit": 4.418894290924072,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus, chronic rhinosinusitis, and bronchiectasis",
            "probability": 0.09744694175656013,
            "start_logit": 3.7949812412261963,
            "end_logit": 4.27878999710083,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "rhinosinusitis",
            "probability": 0.07590501861204899,
            "start_logit": 3.2069363594055176,
            "end_logit": 4.61700963973999,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "rhinosinusitis, and bronchiectasis",
            "probability": 0.05412321253107894,
            "start_logit": 3.2069363594055176,
            "end_logit": 4.27878999710083,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic rhinosinusitis,",
            "probability": 0.00634954526180555,
            "start_logit": 4.206210613250732,
            "end_logit": 1.1366357803344727,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus, chronic rhinosinusitis,",
            "probability": 0.0042087000614091175,
            "start_logit": 3.7949812412261963,
            "end_logit": 1.1366357803344727,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "situs inversus,",
            "probability": 0.00352803039506304,
            "start_logit": 3.7949812412261963,
            "end_logit": 0.9602217078208923,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "rhinosinusitis,",
            "probability": 0.0023375630245253535,
            "start_logit": 3.2069363594055176,
            "end_logit": 1.1366357803344727,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis",
            "probability": 0.0005111275399155025,
            "start_logit": -1.79368257522583,
            "end_logit": 4.61700963973999,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "bronchiectasis.",
            "probability": 0.00039956363873010664,
            "start_logit": 4.234079360961914,
            "end_logit": -1.6569983959197998,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "chronic rhinosinusitis, and bronchiectasis.",
            "probability": 0.0003885820330322244,
            "start_logit": 4.206210613250732,
            "end_logit": -1.6569983959197998,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "inversus, chronic rhinosinusitis",
            "probability": 0.00037231964649188674,
            "start_logit": -2.110548973083496,
            "end_logit": 4.61700963973999,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "sinusitis, and bronchiectasis",
            "probability": 0.00036445369461964646,
            "start_logit": -1.79368257522583,
            "end_logit": 4.27878999710083,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "hinosinusitis",
            "probability": 0.00035248649912177787,
            "start_logit": -2.1652894020080566,
            "end_logit": 4.61700963973999,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "inversus",
            "probability": 0.0003054045836239459,
            "start_logit": -2.110548973083496,
            "end_logit": 4.418894290924072,
            "question_text": "List Kartagener Syndrome Triad."
        },
        {
            "text": "usitis",
            "probability": 0.00027325335318881895,
            "start_logit": -2.4199023246765137,
            "end_logit": 4.61700963973999,
            "question_text": "List Kartagener Syndrome Triad."
        }
    ],
    "54dfc6501388e8454a000009": [
        {
            "text": "host-mediated defense",
            "probability": 0.3675232865203591,
            "start_logit": 4.254451751708984,
            "end_logit": 3.6053032875061035,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "host-mediated defense against exogenous viruses",
            "probability": 0.220317270605076,
            "start_logit": 4.254451751708984,
            "end_logit": 3.093585252761841,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "defense",
            "probability": 0.15144765739974794,
            "start_logit": 3.3679051399230957,
            "end_logit": 3.6053032875061035,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "defense against exogenous viruses",
            "probability": 0.0907875384815834,
            "start_logit": 3.3679051399230957,
            "end_logit": 3.093585252761841,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cytidine deaminases play a critical role in host-mediated defense",
            "probability": 0.04706548130519678,
            "start_logit": 2.199204921722412,
            "end_logit": 3.6053032875061035,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cytidine deaminases play a critical role in host-mediated defense against exogenous viruses",
            "probability": 0.028214098973292592,
            "start_logit": 2.199204921722412,
            "end_logit": 3.093585252761841,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "cytidine deaminases",
            "probability": 0.018840358580774257,
            "start_logit": 2.199204921722412,
            "end_logit": 2.6897647380828857,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "host-mediated defense against exogenous viruses,",
            "probability": 0.010609893809373092,
            "start_logit": 4.254451751708984,
            "end_logit": 0.06030355021357536,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "The APOBEC3 cytidine deaminases play a critical role in host-mediated defense",
            "probability": 0.01040918843255897,
            "start_logit": 0.6903539896011353,
            "end_logit": 3.6053032875061035,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "APOBEC3 cytidine deaminases play a critical role in host-mediated defense",
            "probability": 0.007402371258388723,
            "start_logit": 0.3494654595851898,
            "end_logit": 3.6053032875061035,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "The APOBEC3 cytidine deaminases play a critical role in host-mediated defense against exogenous viruses",
            "probability": 0.006239941981331519,
            "start_logit": 0.6903539896011353,
            "end_logit": 3.093585252761841,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "critical role in host-mediated defense",
            "probability": 0.005304125165676541,
            "start_logit": 0.016149921342730522,
            "end_logit": 3.6053032875061035,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "host-mediated defense against exogenous viruses, most notably, human immunodeficiency virus",
            "probability": 0.005066246453306046,
            "start_logit": 4.254451751708984,
            "end_logit": -0.6788831949234009,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "regulate cellular RNA metabolism",
            "probability": 0.004929673314073663,
            "start_logit": 0.7463282942771912,
            "end_logit": 2.801912784576416,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "play a critical role in host-mediated defense",
            "probability": 0.004737547359302065,
            "start_logit": -0.09681536257266998,
            "end_logit": 3.6053032875061035,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "APOBEC3 cytidine deaminases play a critical role in host-mediated defense against exogenous viruses",
            "probability": 0.004437460948650182,
            "start_logit": 0.3494654595851898,
            "end_logit": 3.093585252761841,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "defense against exogenous viruses,",
            "probability": 0.004372086400029052,
            "start_logit": 3.3679051399230957,
            "end_logit": 0.06030355021357536,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "deaminases play a critical role in host-mediated defense",
            "probability": 0.004221976386987453,
            "start_logit": -0.21203157305717468,
            "end_logit": 3.6053032875061035,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "The APOBEC3 cytidine deaminases",
            "probability": 0.00416680839472483,
            "start_logit": 0.6903539896011353,
            "end_logit": 2.6897647380828857,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        },
        {
            "text": "host",
            "probability": 0.003906988229567364,
            "start_logit": 4.254451751708984,
            "end_logit": -0.9387165904045105,
            "question_text": "Which are the main functions of the APOBEC3 family of proteins?"
        }
    ],
    "52e0c9a298d0239505000010": [
        {
            "text": "trimethylated histone H3 lysine 9",
            "probability": 0.2962066008536619,
            "start_logit": 4.757117748260498,
            "end_logit": 3.9763991832733154,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "trimethylated histone H3 lysine 9 (H3K9",
            "probability": 0.1888995156678076,
            "start_logit": 4.757117748260498,
            "end_logit": 3.526557207107544,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "trimethylated histone H3 lysine 9 (H3K9)",
            "probability": 0.15482418646004248,
            "start_logit": 4.757117748260498,
            "end_logit": 3.327632188796997,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9",
            "probability": 0.08101010568508525,
            "start_logit": 3.9104764461517334,
            "end_logit": 3.526557207107544,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9)",
            "probability": 0.06639680183083103,
            "start_logit": 3.9104764461517334,
            "end_logit": 3.327632188796997,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "histone H3 lysine 9",
            "probability": 0.05334493134158135,
            "start_logit": 3.042839527130127,
            "end_logit": 3.9763991832733154,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "histone H3 lysine 9 (H3K9",
            "probability": 0.03401960545347716,
            "start_logit": 3.042839527130127,
            "end_logit": 3.526557207107544,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "histone H3 lysine 9 (H3K9)",
            "probability": 0.02788285464579325,
            "start_logit": 3.042839527130127,
            "end_logit": 3.327632188796997,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9) and binding of the heterochromatin protein 1 (HP1)",
            "probability": 0.019358154778903673,
            "start_logit": 3.9104764461517334,
            "end_logit": 2.095097064971924,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3 lysine 9",
            "probability": 0.018050085657005503,
            "start_logit": 1.959210991859436,
            "end_logit": 3.9763991832733154,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3 lysine 9 (H3K9",
            "probability": 0.01151106163246945,
            "start_logit": 1.959210991859436,
            "end_logit": 3.526557207107544,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "trimethylated histone H3 lysine 9 (H3K9) and binding of the heterochromatin protein 1",
            "probability": 0.010802628808869926,
            "start_logit": 4.757117748260498,
            "end_logit": 0.6651315093040466,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3 lysine 9 (H3K9)",
            "probability": 0.0094345967285199,
            "start_logit": 1.959210991859436,
            "end_logit": 3.327632188796997,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "histone H3 lysine 9 (H3K9) and binding of the heterochromatin protein 1 (HP1)",
            "probability": 0.0081293164885587,
            "start_logit": 3.042839527130127,
            "end_logit": 2.095097064971924,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3K9) and binding of the heterochromatin protein 1",
            "probability": 0.004632738725610391,
            "start_logit": 3.9104764461517334,
            "end_logit": 0.6651315093040466,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "high levels of trimethylated histone H3 lysine 9",
            "probability": 0.003973410979161155,
            "start_logit": 0.445685476064682,
            "end_logit": 3.9763991832733154,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "trimethylated histone H3",
            "probability": 0.0038461232713686276,
            "start_logit": 4.757117748260498,
            "end_logit": -0.36759230494499207,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "H3 lysine 9 (H3K9) and binding of the heterochromatin protein 1 (HP1)",
            "probability": 0.00275068043506909,
            "start_logit": 1.959210991859436,
            "end_logit": 2.095097064971924,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "high levels of trimethylated histone H3 lysine 9 (H3K9",
            "probability": 0.00253395909257102,
            "start_logit": 0.445685476064682,
            "end_logit": 3.526557207107544,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        },
        {
            "text": "(H3K9",
            "probability": 0.002392641463612327,
            "start_logit": 0.38830050826072693,
            "end_logit": 3.526557207107544,
            "question_text": "Which histone modifications are associated with constitutive heterochromatin?"
        }
    ],
    "51487ef9d24251bc05000031": [
        {
            "text": "entacapone",
            "probability": 0.9969459354684055,
            "start_logit": 6.075384616851807,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacap",
            "probability": 0.000993311064925786,
            "start_logit": 6.075384616851807,
            "end_logit": -1.4278812408447266,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone is given in combination with levodopa",
            "probability": 0.0009610298740987757,
            "start_logit": 6.075384616851807,
            "end_logit": -1.4609196186065674,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone is given in combination with levodopa/dopa decarboxylase inhibitor",
            "probability": 0.0003929464427024803,
            "start_logit": 6.075384616851807,
            "end_logit": -2.3552517890930176,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "en",
            "probability": 0.0003056132878262707,
            "start_logit": 6.075384616851807,
            "end_logit": -2.60660457611084,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "one",
            "probability": 9.522340453001957e-05,
            "start_logit": -3.1808414459228516,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone is given in combination with levodopa/dopa decarboxylase",
            "probability": 7.21948604328387e-05,
            "start_logit": 6.075384616851807,
            "end_logit": -4.049556255340576,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "inhibitor entacapone",
            "probability": 4.865131419137307e-05,
            "start_logit": -3.852388381958008,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "capone",
            "probability": 3.959898254895147e-05,
            "start_logit": -4.058263778686523,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "The catechol-O-methyl transferase inhibitor entacapone",
            "probability": 2.3390186430720804e-05,
            "start_logit": -4.584750652313232,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "catechol-O-methyl transferase inhibitor entacapone",
            "probability": 2.2188149371105164e-05,
            "start_logit": -4.637508869171143,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "enta",
            "probability": 2.1782681481854247e-05,
            "start_logit": 6.075384616851807,
            "end_logit": -5.247809886932373,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone is given in combination with le",
            "probability": 2.1381584657893538e-05,
            "start_logit": 6.075384616851807,
            "end_logit": -5.266395092010498,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone is given in combination with levodopa/dopa",
            "probability": 1.297242742126858e-05,
            "start_logit": 6.075384616851807,
            "end_logit": -5.766098976135254,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone is given in combination",
            "probability": 1.0606958601855778e-05,
            "start_logit": 6.075384616851807,
            "end_logit": -5.967414855957031,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "entacapone is given in combination with levodopa/do",
            "probability": 9.286802292560145e-06,
            "start_logit": 6.075384616851807,
            "end_logit": -6.100330829620361,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "methyl transferase inhibitor entacapone",
            "probability": 8.826496801489529e-06,
            "start_logit": -5.559309005737305,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "tacapone",
            "probability": 7.986419665515258e-06,
            "start_logit": -5.659324645996094,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "transferase inhibitor entacapone",
            "probability": 4.913622415059711e-06,
            "start_logit": -6.145055770874023,
            "end_logit": 5.483526706695557,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        },
        {
            "text": "levodopa",
            "probability": 2.159971198813689e-06,
            "start_logit": -0.02252599038183689,
            "end_logit": -1.4609196186065674,
            "question_text": "Which two catechol-O-methyl transferase (COMT) inhibitors can be used for treatment of Parkinson disease?"
        }
    ],
    "5505db6a8e1671127b000003": [
        {
            "text": "melanin granules",
            "probability": 0.3418892658421913,
            "start_logit": 2.983325958251953,
            "end_logit": 0.5030984878540039,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "melanin",
            "probability": 0.2153302785503881,
            "start_logit": 2.983325958251953,
            "end_logit": 0.04078461602330208,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cortex",
            "probability": 0.09312282061118267,
            "start_logit": 1.1726343631744385,
            "end_logit": 1.0132224559783936,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cuticle and cortex",
            "probability": 0.08493336877303267,
            "start_logit": 1.0805821418762207,
            "end_logit": 1.0132224559783936,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cortex layers involved in keratin filaments and melanin granules",
            "probability": 0.05591291021527915,
            "start_logit": 1.1726343631744385,
            "end_logit": 0.5030984878540039,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cuticle and cortex layers involved in keratin filaments and melanin granules",
            "probability": 0.05099579019750505,
            "start_logit": 1.0805821418762207,
            "end_logit": 0.5030984878540039,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cortex layers involved in keratin filaments and melanin",
            "probability": 0.035215327692610814,
            "start_logit": 1.1726343631744385,
            "end_logit": 0.04078461602330208,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cuticle and cortex layers involved in keratin filaments and melanin",
            "probability": 0.032118404422777275,
            "start_logit": 1.0805821418762207,
            "end_logit": 0.04078461602330208,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cortex layers involved in keratin filaments",
            "probability": 0.026885360725302586,
            "start_logit": 1.1726343631744385,
            "end_logit": -0.22911489009857178,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cuticle and cortex layers involved in keratin filaments",
            "probability": 0.024520995413276,
            "start_logit": 1.0805821418762207,
            "end_logit": -0.22911489009857178,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cuticle",
            "probability": 0.007614778261372447,
            "start_logit": 1.0805821418762207,
            "end_logit": -1.398553729057312,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cortex layers",
            "probability": 0.006027863392790866,
            "start_logit": 1.1726343631744385,
            "end_logit": -1.72430419921875,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "melanin granules.",
            "probability": 0.005763884551918021,
            "start_logit": 2.983325958251953,
            "end_logit": -3.5797767639160156,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cuticle and cortex layers",
            "probability": 0.005497758133755358,
            "start_logit": 1.0805821418762207,
            "end_logit": -1.72430419921875,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "me",
            "probability": 0.0034597194835365433,
            "start_logit": 2.983325958251953,
            "end_logit": -4.090200901031494,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cellular hair compartments of cuticle and cortex",
            "probability": 0.0029982773207684185,
            "start_logit": -2.263247013092041,
            "end_logit": 1.0132224559783936,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "filaments and melanin granules",
            "probability": 0.002233866107475303,
            "start_logit": -2.047427177429199,
            "end_logit": 0.5030984878540039,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "hair compartments of cuticle and cortex",
            "probability": 0.0020384264648642364,
            "start_logit": -2.649106740951538,
            "end_logit": 1.0132224559783936,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "cellular hair compartments of cuticle and cortex layers involved in keratin filaments and melanin granules",
            "probability": 0.0018002290903171051,
            "start_logit": -2.263247013092041,
            "end_logit": 0.5030984878540039,
            "question_text": "What are the structures formed when keratin molecules come together?"
        },
        {
            "text": "melani",
            "probability": 0.0016406747496563315,
            "start_logit": 2.983325958251953,
            "end_logit": -4.836280822753906,
            "question_text": "What are the structures formed when keratin molecules come together?"
        }
    ],
    "56c9f9d95795f9a73e00001e": [
        {
            "text": "amyotrophic lateral sclerosis",
            "probability": 0.7150187685017778,
            "start_logit": -0.24989208579063416,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) that stem cells significantly slow the progression of the disease and prolong survival",
            "probability": 0.06265734053336912,
            "start_logit": -0.24989208579063416,
            "end_logit": -2.959672212600708,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) that stem cells significantly slow the progression of the disease",
            "probability": 0.05077217397759607,
            "start_logit": -0.24989208579063416,
            "end_logit": -3.1700046062469482,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic",
            "probability": 0.02608543025286069,
            "start_logit": -0.24989208579063416,
            "end_logit": -3.8359761238098145,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) that stem cells significantly slow the progression",
            "probability": 0.02172612823733662,
            "start_logit": -0.24989208579063416,
            "end_logit": -4.0188374519348145,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "yotrophic lateral sclerosis",
            "probability": 0.013031214948560863,
            "start_logit": -4.254853248596191,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) that stem cells",
            "probability": 0.012471531165670052,
            "start_logit": -0.24989208579063416,
            "end_logit": -4.573904514312744,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "Recently it has been shown in animal models of amyotrophic lateral sclerosis",
            "probability": 0.011366526318684522,
            "start_logit": -4.391528129577637,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "am",
            "probability": 0.01092017200322429,
            "start_logit": -0.24989208579063416,
            "end_logit": -4.7067413330078125,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "it has been shown in animal models of amyotrophic lateral sclerosis",
            "probability": 0.01034747967717744,
            "start_logit": -4.485457897186279,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "lateral sclerosis",
            "probability": 0.00863517378793722,
            "start_logit": -4.666357040405273,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) that stem cells significantly slow the progression of the disease and prolong survival.",
            "probability": 0.008632600431775314,
            "start_logit": -0.24989208579063416,
            "end_logit": -4.941807270050049,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "shown in animal models of amyotrophic lateral sclerosis",
            "probability": 0.008315083726282983,
            "start_logit": -4.704129695892334,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) that",
            "probability": 0.008010864627718686,
            "start_logit": -0.24989208579063416,
            "end_logit": -5.016554355621338,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "animal models of amyotrophic lateral sclerosis",
            "probability": 0.0067703219735897515,
            "start_logit": -4.909652233123779,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "rosis",
            "probability": 0.005949565224657807,
            "start_logit": -5.038882732391357,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS)",
            "probability": 0.005906801733365502,
            "start_logit": -0.24989208579063416,
            "end_logit": -5.321248531341553,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "amyotrophic lateral scle",
            "probability": 0.005782574680211845,
            "start_logit": -0.24989208579063416,
            "end_logit": -5.342504024505615,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "trophic lateral sclerosis",
            "probability": 0.00557644380086855,
            "start_logit": -5.103649616241455,
            "end_logit": -0.5250442624092102,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        },
        {
            "text": "survival",
            "probability": 0.0020238043973350114,
            "start_logit": -3.682593822479248,
            "end_logit": -2.959672212600708,
            "question_text": "Which are the main features of CREST and other ALS-linked proteins?"
        }
    ],
    "54c225bcf693c3b16b000002": [
        {
            "text": "calsequestrin",
            "probability": 0.17803139022855385,
            "start_logit": 3.035149097442627,
            "end_logit": 2.1180617809295654,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2) or the cardiac calsequestrin",
            "probability": 0.14476341259241593,
            "start_logit": 2.8282899856567383,
            "end_logit": 2.1180617809295654,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor",
            "probability": 0.11664600230205299,
            "start_logit": 2.8282899856567383,
            "end_logit": 1.9021047353744507,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2",
            "probability": 0.09855472242501283,
            "start_logit": 3.035149097442627,
            "end_logit": 1.5267138481140137,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2) or the cardiac calsequestrin (CASQ2",
            "probability": 0.08013821566537933,
            "start_logit": 2.8282899856567383,
            "end_logit": 1.5267138481140137,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2) or the cardiac calsequestrin",
            "probability": 0.06899475602136132,
            "start_logit": 2.087219715118408,
            "end_logit": 2.1180617809295654,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "TRDN",
            "probability": 0.06216069274222275,
            "start_logit": 2.3517916202545166,
            "end_logit": 1.7491822242736816,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2",
            "probability": 0.048854944597699956,
            "start_logit": 2.8282899856567383,
            "end_logit": 1.0318166017532349,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "CASQ2",
            "probability": 0.04123230642673033,
            "start_logit": 2.163759231567383,
            "end_logit": 1.5267138481140137,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2) or the cardiac calsequestrin (CASQ2",
            "probability": 0.038194157893938395,
            "start_logit": 2.087219715118408,
            "end_logit": 1.5267138481140137,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2",
            "probability": 0.023284439918847447,
            "start_logit": 2.087219715118408,
            "end_logit": 1.0318166017532349,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2)",
            "probability": 0.022840373144351746,
            "start_logit": 3.035149097442627,
            "end_logit": 0.0646316185593605,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2) or the cardiac calsequestrin (CASQ2)",
            "probability": 0.01857228861166427,
            "start_logit": 2.8282899856567383,
            "end_logit": 0.0646316185593605,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2)",
            "probability": 0.011031030310352356,
            "start_logit": 2.8282899856567383,
            "end_logit": -0.45632675290107727,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "calsequestrin (CASQ2) genes",
            "probability": 0.009847257767470318,
            "start_logit": 3.035149097442627,
            "end_logit": -0.7767050862312317,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "CASQ2)",
            "probability": 0.009555719312236203,
            "start_logit": 2.163759231567383,
            "end_logit": 0.0646316185593605,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2) or the cardiac calsequestrin (CASQ2)",
            "probability": 0.008851618641568382,
            "start_logit": 2.087219715118408,
            "end_logit": 0.0646316185593605,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "ryanodine receptor (RYR2) or the cardiac calsequestrin (CASQ2) genes",
            "probability": 0.008007142095931032,
            "start_logit": 2.8282899856567383,
            "end_logit": -0.7767050862312317,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "RYR2)",
            "probability": 0.005257428180902632,
            "start_logit": 2.087219715118408,
            "end_logit": -0.45632675290107727,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        },
        {
            "text": "triadin in triadin knock-out mice by viral transduction. In this work, we identified TRDN",
            "probability": 0.005182101121307894,
            "start_logit": -0.13272063434123993,
            "end_logit": 1.7491822242736816,
            "question_text": "Mutations of which genes have been associated with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)?"
        }
    ],
    "532c0d7fd6d3ac6a3400001c": [
        {
            "text": "Catalyst/HypoGen",
            "probability": 0.5536628302488172,
            "start_logit": 4.369190692901611,
            "end_logit": 4.274600982666016,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Catalyst/HypoGen program",
            "probability": 0.3066289985294378,
            "start_logit": 4.369190692901611,
            "end_logit": 3.6836836338043213,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "HypoGen",
            "probability": 0.04233575358112579,
            "start_logit": 1.7982667684555054,
            "end_logit": 4.274600982666016,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the Catalyst/HypoGen",
            "probability": 0.03529161067620987,
            "start_logit": 1.6162800788879395,
            "end_logit": 4.274600982666016,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "HypoGen program",
            "probability": 0.023446344983526896,
            "start_logit": 1.7982667684555054,
            "end_logit": 3.6836836338043213,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the Catalyst/HypoGen program",
            "probability": 0.019545164758981333,
            "start_logit": 1.6162800788879395,
            "end_logit": 3.6836836338043213,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Catalyst",
            "probability": 0.00973444089715152,
            "start_logit": 4.369190692901611,
            "end_logit": 0.23371529579162598,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "generated by the Catalyst/HypoGen",
            "probability": 0.001978359917283731,
            "start_logit": -1.2650970220565796,
            "end_logit": 4.274600982666016,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "generated by the Catalyst/HypoGen program",
            "probability": 0.0010956533236931845,
            "start_logit": -1.2650970220565796,
            "end_logit": 3.6836836338043213,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "by the Catalyst/HypoGen",
            "probability": 0.0010218234397124948,
            "start_logit": -1.925776481628418,
            "end_logit": 4.274600982666016,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Catalyst/HypoGen program.",
            "probability": 0.0009659211623272559,
            "start_logit": 4.369190692901611,
            "end_logit": -2.0766279697418213,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Gen",
            "probability": 0.000723720307984398,
            "start_logit": -2.2707154750823975,
            "end_logit": 4.274600982666016,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Three pharmacophore models of opioid agonists were generated by the Catalyst/HypoGen",
            "probability": 0.0006650408206568897,
            "start_logit": -2.355272054672241,
            "end_logit": 4.274600982666016,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "the Catalyst",
            "probability": 0.0006204933391292624,
            "start_logit": 1.6162800788879395,
            "end_logit": 0.23371529579162598,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "by the Catalyst/HypoGen program",
            "probability": 0.0005659052420985903,
            "start_logit": -1.925776481628418,
            "end_logit": 3.6836836338043213,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Gen program",
            "probability": 0.0004008100618799781,
            "start_logit": -2.2707154750823975,
            "end_logit": 3.6836836338043213,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Three pharmacophore models of opioid agonists were generated by the Catalyst/HypoGen program",
            "probability": 0.0003683122465121509,
            "start_logit": -2.355272054672241,
            "end_logit": 3.6836836338043213,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "pharmacophore models of opioid agonists were generated by the Catalyst/HypoGen",
            "probability": 0.00033441795634778346,
            "start_logit": -3.042728900909424,
            "end_logit": 4.274600982666016,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Catalyst/Hypo",
            "probability": 0.0003161811436535421,
            "start_logit": 4.369190692901611,
            "end_logit": -3.193394899368286,
            "question_text": "List programs suitable for pharmacophore modelling"
        },
        {
            "text": "Catalyst/HypoGen program. The best pharmacophore models",
            "probability": 0.0002982173634703108,
            "start_logit": 4.369190692901611,
            "end_logit": -3.251887559890747,
            "question_text": "List programs suitable for pharmacophore modelling"
        }
    ],
    "530c844e970c65fa6b000014": [
        {
            "text": "DNA (mtDNA) disorders",
            "probability": 0.1516905843331324,
            "start_logit": -1.0390979051589966,
            "end_logit": -2.3144052028656006,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "DNA (mtDNA)",
            "probability": 0.11239098951774928,
            "start_logit": -1.0390979051589966,
            "end_logit": -2.6142642498016357,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Mitochondrial DNA (mtDNA) disorders",
            "probability": 0.09073273599297549,
            "start_logit": -1.5530225038528442,
            "end_logit": -2.3144052028656006,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "DNA (mtDNA",
            "probability": 0.08539851109262415,
            "start_logit": -1.0390979051589966,
            "end_logit": -2.8889193534851074,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "DNA (mtDNA) disorders have emerged as major causes of inherited neurologic disease",
            "probability": 0.07938594368692814,
            "start_logit": -1.0390979051589966,
            "end_logit": -2.9619266986846924,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "DNA",
            "probability": 0.07543843635737747,
            "start_logit": -1.0390979051589966,
            "end_logit": -3.0129311084747314,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Mitochondrial DNA (mtDNA)",
            "probability": 0.06722593907020677,
            "start_logit": -1.5530225038528442,
            "end_logit": -2.6142642498016357,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Mitochondrial DNA (mtDNA",
            "probability": 0.05108056373587213,
            "start_logit": -1.5530225038528442,
            "end_logit": -2.8889193534851074,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Mitochondrial DNA (mtDNA) disorders have emerged as major causes of inherited neurologic disease",
            "probability": 0.047484185664950364,
            "start_logit": -1.5530225038528442,
            "end_logit": -2.9619266986846924,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Mitochondrial DNA",
            "probability": 0.045123009841565885,
            "start_logit": -1.5530225038528442,
            "end_logit": -3.0129311084747314,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "mtDNA) disorders",
            "probability": 0.03523455211647126,
            "start_logit": -2.498913526535034,
            "end_logit": -2.3144052028656006,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "mtDNA)",
            "probability": 0.026106077677755735,
            "start_logit": -2.498913526535034,
            "end_logit": -2.6142642498016357,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "DNA (mtDNA) disorders have emerged as major causes of inherited neurologic disease.",
            "probability": 0.02604835324764765,
            "start_logit": -1.0390979051589966,
            "end_logit": -4.076293468475342,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "neurologic disease",
            "probability": 0.020266596836550924,
            "start_logit": -2.404445171356201,
            "end_logit": -2.9619266986846924,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "mtDNA",
            "probability": 0.01983628913416276,
            "start_logit": -2.498913526535034,
            "end_logit": -2.8889193534851074,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "mtDNA) disorders have emerged as major causes of inherited neurologic disease",
            "probability": 0.018439695400008886,
            "start_logit": -2.498913526535034,
            "end_logit": -2.9619266986846924,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "Mitochondrial DNA (mtDNA) disorders have emerged as major causes of inherited neurologic disease.",
            "probability": 0.015580653002695009,
            "start_logit": -1.5530225038528442,
            "end_logit": -4.076293468475342,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "DNA (mtDNA) disorders have emerged as major causes of inherited neurologic",
            "probability": 0.012793386521942661,
            "start_logit": -1.0390979051589966,
            "end_logit": -4.787319660186768,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "D",
            "probability": 0.010597890051482699,
            "start_logit": -1.0390979051589966,
            "end_logit": -4.975593090057373,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        },
        {
            "text": "DNA (mtDNA) disorders have emerged as major causes of inherited",
            "probability": 0.009145606717900582,
            "start_logit": -1.0390979051589966,
            "end_logit": -5.122974395751953,
            "question_text": "List disorders that are caused by mutations in the mitochondrial MTND6 gene."
        }
    ],
    "571653aecb4ef8864c000005": [
        {
            "text": "nanoplasmonics",
            "probability": 0.6266178532309522,
            "start_logit": 3.101914882659912,
            "end_logit": 2.856043577194214,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "genetic mutations. Recently, nanoplasmonics",
            "probability": 0.11535826463032088,
            "start_logit": 1.4096206426620483,
            "end_logit": 2.856043577194214,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "mutations. Recently, nanoplasmonics",
            "probability": 0.08697706006456558,
            "start_logit": 1.1272224187850952,
            "end_logit": 2.856043577194214,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "genetic mutations",
            "probability": 0.06359640496798885,
            "start_logit": 1.4096206426620483,
            "end_logit": 2.2605578899383545,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "mutations",
            "probability": 0.047949996062417524,
            "start_logit": 1.1272224187850952,
            "end_logit": 2.2605578899383545,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "methylation are promising biomarkers for noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations",
            "probability": 0.04523635239836669,
            "start_logit": 1.0689647197723389,
            "end_logit": 2.2605578899383545,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "methylation",
            "probability": 0.002520279628076838,
            "start_logit": 1.0689647197723389,
            "end_logit": -0.6269732713699341,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "existing methods for ctDNA detection are restricted to genetic mutations. Recently, nanoplasmonics",
            "probability": 0.0022043277908488637,
            "start_logit": -2.547999382019043,
            "end_logit": 2.856043577194214,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "nanoplasmonics has emerged as a platform for one-step dual detection",
            "probability": 0.001975378593425965,
            "start_logit": 3.101914882659912,
            "end_logit": -2.9035332202911377,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "restricted to genetic mutations. Recently, nanoplasmonics",
            "probability": 0.0012975052427297833,
            "start_logit": -3.0779786109924316,
            "end_logit": 2.856043577194214,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "existing methods for ctDNA detection are restricted to genetic mutations",
            "probability": 0.0012152343251544513,
            "start_logit": -2.547999382019043,
            "end_logit": 2.2605578899383545,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "nanoplasmonics has emerged as a platform for one-step dual detection with high sensitivity and specificity",
            "probability": 0.0009943807519210526,
            "start_logit": 3.101914882659912,
            "end_logit": -3.589928388595581,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "na",
            "probability": 0.0009750649230453412,
            "start_logit": 3.101914882659912,
            "end_logit": -3.609544515609741,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "restricted to genetic mutations",
            "probability": 0.0007153078206331063,
            "start_logit": -3.0779786109924316,
            "end_logit": 2.2605578899383545,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations. Recently, nanoplasmonics",
            "probability": 0.0006779985044167798,
            "start_logit": -3.72703218460083,
            "end_logit": 2.856043577194214,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "genetic",
            "probability": 0.0003769722337207271,
            "start_logit": 1.4096206426620483,
            "end_logit": -2.8675827980041504,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations",
            "probability": 0.0003737770119267819,
            "start_logit": -3.72703218460083,
            "end_logit": 2.2605578899383545,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "genetic mutations. Recently, nanoplasmonics has emerged as a platform for one-step dual detection",
            "probability": 0.00036366063518703364,
            "start_logit": 1.4096206426620483,
            "end_logit": -2.9035332202911377,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "mutation and methylation",
            "probability": 0.0002999907480019174,
            "start_logit": -1.0594087839126587,
            "end_logit": -0.6269732713699341,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        },
        {
            "text": "mutations. Recently, nanoplasmonics has emerged as a platform for one-step dual detection",
            "probability": 0.0002741904362998453,
            "start_logit": 1.1272224187850952,
            "end_logit": -2.9035332202911377,
            "question_text": "Which are the most common methods for ctDNA (circulating tumour DNA) detection?"
        }
    ],
    "517a8bab8ed59a060a000040": [
        {
            "text": "type 3",
            "probability": 0.38889291407688703,
            "start_logit": 1.2668284177780151,
            "end_logit": 2.059870481491089,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 2 and decreased type 3",
            "probability": 0.3309572770517458,
            "start_logit": 1.1055136919021606,
            "end_logit": 2.059870481491089,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 2",
            "probability": 0.2097372780621431,
            "start_logit": 1.1055136919021606,
            "end_logit": 1.6037368774414062,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "increased type 2 and decreased type 3",
            "probability": 0.016938711490978996,
            "start_logit": -1.8668739795684814,
            "end_logit": 2.059870481491089,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "decreased type 3",
            "probability": 0.014951880256165133,
            "start_logit": -1.9916385412216187,
            "end_logit": 2.059870481491089,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "3",
            "probability": 0.010927787765227962,
            "start_logit": -2.305166721343994,
            "end_logit": 2.059870481491089,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "increased type 2",
            "probability": 0.010734555449712658,
            "start_logit": -1.8668739795684814,
            "end_logit": 1.6037368774414062,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 3 deiodinase",
            "probability": 0.0036899812005196007,
            "start_logit": 1.2668284177780151,
            "end_logit": -2.5978121757507324,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 2 and decreased type 3 deiodinase",
            "probability": 0.003140263260889998,
            "start_logit": 1.1055136919021606,
            "end_logit": -2.5978121757507324,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "2 and decreased type 3",
            "probability": 0.0018147623366467944,
            "start_logit": -4.100521087646484,
            "end_logit": 2.059870481491089,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 3 deiodinase activities",
            "probability": 0.0016455418810376223,
            "start_logit": 1.2668284177780151,
            "end_logit": -3.4053637981414795,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 2 and decreased type 3 deiodinase activities",
            "probability": 0.0014003959457979402,
            "start_logit": 1.1055136919021606,
            "end_logit": -3.4053637981414795,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 2 and decreased",
            "probability": 0.0012895239947349909,
            "start_logit": 1.1055136919021606,
            "end_logit": -3.4878456592559814,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "2",
            "probability": 0.0011500678160295658,
            "start_logit": -4.100521087646484,
            "end_logit": 1.6037368774414062,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 3 deiodinase activities indicate a mild hypothyroid",
            "probability": 0.0005577441490730751,
            "start_logit": 1.2668284177780151,
            "end_logit": -4.487288475036621,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 3 deiodinase activities indicate a mild hypothyroid situation",
            "probability": 0.0005517303608617856,
            "start_logit": 1.2668284177780151,
            "end_logit": -4.498129367828369,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 2 and decreased type 3 deiodinase activities indicate a mild hypothyroid",
            "probability": 0.00047465376248093116,
            "start_logit": 1.1055136919021606,
            "end_logit": -4.487288475036621,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 2 and decreased type 3 deiodinase activities indicate a mild hypothyroid situation",
            "probability": 0.00046953588324186456,
            "start_logit": 1.1055136919021606,
            "end_logit": -4.498129367828369,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 3 deiodinas",
            "probability": 0.0003540103800580581,
            "start_logit": 1.2668284177780151,
            "end_logit": -4.9418625831604,
            "question_text": "Which deiodinases are best known to be present in brain?"
        },
        {
            "text": "type 3 deiodinase activities indicate a mild hypothyroid situation in the brain of Oatp1c1 KO mice.",
            "probability": 0.0003213848757671437,
            "start_logit": 1.2668284177780151,
            "end_logit": -5.038549423217773,
            "question_text": "Which deiodinases are best known to be present in brain?"
        }
    ],
    "5149a61ed24251bc05000044": [
        {
            "text": "Hidden Markov Models",
            "probability": 0.3628560379465768,
            "start_logit": 2.2934858798980713,
            "end_logit": 1.8949450254440308,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Support Vector Machines",
            "probability": 0.14511558631676041,
            "start_logit": 2.381197214126587,
            "end_logit": 0.8907580971717834,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks (NNs) and on Support Vector Machines",
            "probability": 0.13292954322296469,
            "start_logit": 2.2934858798980713,
            "end_logit": 0.8907580971717834,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks",
            "probability": 0.09540286988370247,
            "start_logit": 2.2934858798980713,
            "end_logit": 0.559047520160675,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Neural Networks (NNs) and on Support Vector Machines",
            "probability": 0.061085724437029726,
            "start_logit": 1.5159448385238647,
            "end_logit": 0.8907580971717834,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Neural Networks",
            "probability": 0.04384091962493752,
            "start_logit": 1.5159448385238647,
            "end_logit": 0.559047520160675,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Support Vector Machines (SVMs)",
            "probability": 0.02867629916621099,
            "start_logit": 2.381197214126587,
            "end_logit": -0.7307015061378479,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs",
            "probability": 0.026754651021454228,
            "start_logit": 2.2934858798980713,
            "end_logit": -0.7123528122901917,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks (NNs) and on Support Vector Machines (SVMs)",
            "probability": 0.02626821450570292,
            "start_logit": 2.2934858798980713,
            "end_logit": -0.7307015061378479,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs)",
            "probability": 0.017809910160958918,
            "start_logit": 2.2934858798980713,
            "end_logit": -1.1193060874938965,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Neural Networks (NNs) and on Support Vector Machines (SVMs)",
            "probability": 0.012071153438455098,
            "start_logit": 1.5159448385238647,
            "end_logit": -0.7307015061378479,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "HMMs), on Neural Networks (NNs) and on Support Vector Machines",
            "probability": 0.008302030161574629,
            "start_logit": -0.4798332750797272,
            "end_logit": 0.8907580971717834,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Support Vector Machines (SVMs",
            "probability": 0.006761241429995485,
            "start_logit": 2.381197214126587,
            "end_logit": -2.1755659580230713,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks (NNs) and on Support Vector Machines (SVMs",
            "probability": 0.006193467963859091,
            "start_logit": 2.2934858798980713,
            "end_logit": -2.1755659580230713,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "HMMs), on Neural Networks",
            "probability": 0.005958325621767778,
            "start_logit": -0.4798332750797272,
            "end_logit": 0.559047520160675,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks (NNs)",
            "probability": 0.005437202899056688,
            "start_logit": 2.2934858798980713,
            "end_logit": -2.3057963848114014,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden",
            "probability": 0.004470561617891469,
            "start_logit": 2.2934858798980713,
            "end_logit": -2.50154709815979,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "(HMMs), on Neural Networks (NNs) and on Support Vector Machines",
            "probability": 0.0039571247930084985,
            "start_logit": -1.220815658569336,
            "end_logit": 0.8907580971717834,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Markov Models",
            "probability": 0.003263022966390702,
            "start_logit": -2.4178662300109863,
            "end_logit": 1.8949450254440308,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Neural Networks (NNs) and on Support Vector Machines (SVMs",
            "probability": 0.002846112821701985,
            "start_logit": 1.5159448385238647,
            "end_logit": -2.1755659580230713,
            "question_text": "What are the computational methods for the prediction of beta-barrel transmembrane proteins?"
        }
    ],
    "56c33e5695c1e7cc5b000001": [
        {
            "text": "pericentromeric heterochromatin",
            "probability": 0.2758652863131905,
            "start_logit": 5.72545862197876,
            "end_logit": 5.058759689331055,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar heterochromatin",
            "probability": 0.19669510980098018,
            "start_logit": 5.377302169799805,
            "end_logit": 5.068658351898193,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar heterochromatin, and pericentromeric heterochromatin",
            "probability": 0.19475769600270126,
            "start_logit": 5.377302169799805,
            "end_logit": 5.058759689331055,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "pericentromeric",
            "probability": 0.095909868509144,
            "start_logit": 5.72545862197876,
            "end_logit": 4.002255916595459,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar",
            "probability": 0.07058073899449806,
            "start_logit": 5.377302169799805,
            "end_logit": 4.043760776519775,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar heterochromatin, and pericentromeric",
            "probability": 0.06771125596990263,
            "start_logit": 5.377302169799805,
            "end_logit": 4.002255916595459,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin, perinucleolar heterochromatin",
            "probability": 0.025595941801127148,
            "start_logit": 3.338081121444702,
            "end_logit": 5.068658351898193,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin, perinucleolar heterochromatin, and pericentromeric heterochromatin",
            "probability": 0.025343826073005466,
            "start_logit": 3.338081121444702,
            "end_logit": 5.058759689331055,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin",
            "probability": 0.01352790025917891,
            "start_logit": 3.338081121444702,
            "end_logit": 4.430978775024414,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin, perinucleolar",
            "probability": 0.009184674135577898,
            "start_logit": 3.338081121444702,
            "end_logit": 4.043760776519775,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral heterochromatin, perinucleolar heterochromatin, and pericentromeric",
            "probability": 0.008811268205094003,
            "start_logit": 3.338081121444702,
            "end_logit": 4.002255916595459,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "perinucleolar heterochromatin,",
            "probability": 0.0024329887237626436,
            "start_logit": 5.377302169799805,
            "end_logit": 0.6761239171028137,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "heterochromatin",
            "probability": 0.002164806344744521,
            "start_logit": 0.877876877784729,
            "end_logit": 5.058759689331055,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "heterochromatin, and pericentromeric heterochromatin",
            "probability": 0.0018866369899005434,
            "start_logit": 0.74034184217453,
            "end_logit": 5.058759689331055,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the peripheral heterochromatin, perinucleolar heterochromatin",
            "probability": 0.0018049345756808064,
            "start_logit": 0.6861716508865356,
            "end_logit": 5.068658351898193,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "the peripheral heterochromatin, perinucleolar heterochromatin, and pericentromeric heterochromatin",
            "probability": 0.0017871562732336692,
            "start_logit": 0.6861716508865356,
            "end_logit": 5.058759689331055,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "peripheral",
            "probability": 0.0016166448279479368,
            "start_logit": 3.338081121444702,
            "end_logit": 2.306577444076538,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "heterochromatin, perinucleolar heterochromatin",
            "probability": 0.001450183663670606,
            "start_logit": 0.4673375189304352,
            "end_logit": 5.068658351898193,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "pericentromeric heterochromatin.",
            "probability": 0.0014371829385297135,
            "start_logit": 5.72545862197876,
            "end_logit": -0.19846805930137634,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        },
        {
            "text": "heterochromatin, perinucleolar heterochromatin, and pericentromeric heterochromatin",
            "probability": 0.001435899598129389,
            "start_logit": 0.4673375189304352,
            "end_logit": 5.058759689331055,
            "question_text": "In which nuclear compartments is heterochromatin located?"
        }
    ],
    "5547a7e9f35db75526000006": [
        {
            "text": "UvrABC",
            "probability": 0.8721336917044212,
            "start_logit": 2.7605948448181152,
            "end_logit": 2.200035572052002,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrABC activity. These results point to a specific role for UvrB",
            "probability": 0.04981983273826354,
            "start_logit": 2.7605948448181152,
            "end_logit": -0.6624940037727356,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrC proteins, as described for the classical UvrABC",
            "probability": 0.03794312704165525,
            "start_logit": 0.47354432940483093,
            "end_logit": 1.352231740951538,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA or UvrC proteins, as described for the classical UvrABC",
            "probability": 0.010105339022654498,
            "start_logit": -0.849480152130127,
            "end_logit": 1.352231740951538,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB",
            "probability": 0.008226338605848786,
            "start_logit": 0.9595227241516113,
            "end_logit": -0.6624940037727356,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB protein in the repair of psoralen adducts, which appear to be independent of UvrA or UvrC",
            "probability": 0.006870048810293864,
            "start_logit": 0.9595227241516113,
            "end_logit": -0.8426638245582581,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrC",
            "probability": 0.004225733335620211,
            "start_logit": 0.47354432940483093,
            "end_logit": -0.8426638245582581,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "DNA repair of PUVA-induced lesions may require base excision repair functions, despite proficient UvrABC",
            "probability": 0.0033133964082809903,
            "start_logit": -2.8123741149902344,
            "end_logit": 2.200035572052002,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB protein in the repair of psoralen adducts, which appear to be independent of UvrA",
            "probability": 0.0023363373168367755,
            "start_logit": 0.9595227241516113,
            "end_logit": -1.921250581741333,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA or UvrC",
            "probability": 0.001125433545023705,
            "start_logit": -0.849480152130127,
            "end_logit": -0.8426638245582581,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "U",
            "probability": 0.0010921629396639413,
            "start_logit": 2.7605948448181152,
            "end_logit": -4.4827470779418945,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrABC endonuclease",
            "probability": 0.0009586903223033386,
            "start_logit": 2.1320042610168457,
            "end_logit": -3.984503746032715,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "base excision repair functions, despite proficient UvrABC",
            "probability": 0.00041728882663741903,
            "start_logit": -4.884324550628662,
            "end_logit": 2.200035572052002,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrA",
            "probability": 0.0003827327085244263,
            "start_logit": -0.849480152130127,
            "end_logit": -1.921250581741333,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrABC activity. These results point to a specific role for U",
            "probability": 0.0003203768040790421,
            "start_logit": 2.7605948448181152,
            "end_logit": -5.709164619445801,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrABC activity. These results point to a specific role for UvrB protein",
            "probability": 0.00030875723900017913,
            "start_logit": 2.7605948448181152,
            "end_logit": -5.74610710144043,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrC proteins, as described for the classical UvrABC endonuclease",
            "probability": 0.00018256534684125205,
            "start_logit": 0.47354432940483093,
            "end_logit": -3.984503746032715,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "C",
            "probability": 0.00011057917864262894,
            "start_logit": -6.212371349334717,
            "end_logit": 2.200035572052002,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrC proteins, as described for the classical U",
            "probability": 7.658556581750827e-05,
            "start_logit": 0.47354432940483093,
            "end_logit": -4.853203296661377,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        },
        {
            "text": "UvrB protein",
            "probability": 5.098253959154064e-05,
            "start_logit": 0.9595227241516113,
            "end_logit": -5.74610710144043,
            "question_text": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?"
        }
    ],
    "570921e4cf1c325851000017": [
        {
            "text": "primate genomes",
            "probability": 0.2813191381075542,
            "start_logit": -2.8891305923461914,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genomes",
            "probability": 0.16707911251825908,
            "start_logit": -3.4101529121398926,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "interspersed throughout primate genomes",
            "probability": 0.11059475144473066,
            "start_logit": -3.8227477073669434,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "primate genome",
            "probability": 0.07441804406890848,
            "start_logit": -2.8891305923461914,
            "end_logit": -3.6496381759643555,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "s",
            "probability": 0.05221190017776691,
            "start_logit": -4.573309898376465,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genome",
            "probability": 0.04419784889865636,
            "start_logit": -3.4101529121398926,
            "end_logit": -3.6496381759643555,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "repetitive sequence family originated from a common ancestor. Its members, apparently free from functional constraints, are interspersed throughout primate genomes",
            "probability": 0.03502265313147134,
            "start_logit": -4.972625255584717,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "interspersed throughout primate genome",
            "probability": 0.02925590182797073,
            "start_logit": -3.8227477073669434,
            "end_logit": -3.6496381759643555,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "primate genomes.",
            "probability": 0.024424809890869422,
            "start_logit": -2.8891305923461914,
            "end_logit": -4.763737201690674,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "primate",
            "probability": 0.0228936529956884,
            "start_logit": -2.8891305923461914,
            "end_logit": -4.828476905822754,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "are interspersed throughout primate genomes",
            "probability": 0.021718153160022173,
            "start_logit": -5.450471878051758,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "interspersed",
            "probability": 0.020663129469835926,
            "start_logit": -3.8227477073669434,
            "end_logit": -3.997368574142456,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "members, apparently free from functional constraints, are interspersed throughout primate genomes",
            "probability": 0.01994770484916935,
            "start_logit": -5.535506248474121,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "sequence family originated from a common ancestor. Its members, apparently free from functional constraints, are interspersed throughout primate genomes",
            "probability": 0.019892356479568656,
            "start_logit": -5.538284778594971,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "spersed throughout primate genomes",
            "probability": 0.017359342635541033,
            "start_logit": -5.674489498138428,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "family originated from a common ancestor. Its members, apparently free from functional constraints, are interspersed throughout primate genomes",
            "probability": 0.01662839119110151,
            "start_logit": -5.717508792877197,
            "end_logit": -2.3198468685150146,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "genomes.",
            "probability": 0.014506213787820776,
            "start_logit": -3.4101529121398926,
            "end_logit": -4.763737201690674,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "interspersed throughout primate genomes.",
            "probability": 0.009602104560453887,
            "start_logit": -3.8227477073669434,
            "end_logit": -4.763737201690674,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "repetitive sequence family originated from a common ancestor. Its members, apparently free from functional constraints, are interspersed throughout primate genome",
            "probability": 0.009264628640912018,
            "start_logit": -4.972625255584717,
            "end_logit": -3.6496381759643555,
            "question_text": "In which genomic regions are Alu enriched?"
        },
        {
            "text": "interspersed throughout primate",
            "probability": 0.009000162163699175,
            "start_logit": -3.8227477073669434,
            "end_logit": -4.828476905822754,
            "question_text": "In which genomic regions are Alu enriched?"
        }
    ],
    "56bcdf1ad36b5da378000009": [
        {
            "text": "prostate cancer",
            "probability": 0.16355721246686944,
            "start_logit": 5.2352681159973145,
            "end_logit": 5.201662540435791,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric tumor cells and human melanoma",
            "probability": 0.13842431715004253,
            "start_logit": 5.2352681159973145,
            "end_logit": 5.034823417663574,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor cells and human melanoma",
            "probability": 0.13227114821019773,
            "start_logit": 5.189798355102539,
            "end_logit": 5.034823417663574,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "melanoma",
            "probability": 0.11633052853380065,
            "start_logit": 5.061379909515381,
            "end_logit": 5.034823417663574,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric tumor",
            "probability": 0.0930253328323506,
            "start_logit": 5.2352681159973145,
            "end_logit": 4.63737154006958,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor",
            "probability": 0.08889021697707568,
            "start_logit": 5.189798355102539,
            "end_logit": 4.63737154006958,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric",
            "probability": 0.047171198166239894,
            "start_logit": 5.2352681159973145,
            "end_logit": 3.9582831859588623,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric",
            "probability": 0.04507436751258272,
            "start_logit": 5.189798355102539,
            "end_logit": 3.9582831859588623,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer",
            "probability": 0.03569983578039388,
            "start_logit": 5.2352681159973145,
            "end_logit": 3.6796457767486572,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer",
            "probability": 0.03411292442548089,
            "start_logit": 5.189798355102539,
            "end_logit": 3.6796457767486572,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "melanoma, but the cytotoxic effect of DP on human breast cancer",
            "probability": 0.03000181507416475,
            "start_logit": 5.061379909515381,
            "end_logit": 3.6796457767486572,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate",
            "probability": 0.01687899116645691,
            "start_logit": 5.2352681159973145,
            "end_logit": 2.9305694103240967,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human gastric tumor cells and human melanoma",
            "probability": 0.01305029308169018,
            "start_logit": 2.8737549781799316,
            "end_logit": 5.034823417663574,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human gastric tumor",
            "probability": 0.008770192134435813,
            "start_logit": 2.8737549781799316,
            "end_logit": 4.63737154006958,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human melanoma",
            "probability": 0.008756195861368192,
            "start_logit": 2.474705934524536,
            "end_logit": 5.034823417663574,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "prostate cancer, human gastric tumor cells",
            "probability": 0.008427176231248591,
            "start_logit": 5.2352681159973145,
            "end_logit": 2.235961437225342,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "gastric tumor cells",
            "probability": 0.008052575582285221,
            "start_logit": 5.189798355102539,
            "end_logit": 2.235961437225342,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human gastric",
            "probability": 0.004447180768221893,
            "start_logit": 2.8737549781799316,
            "end_logit": 3.9582831859588623,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human prostate cancer",
            "probability": 0.0036928081902017277,
            "start_logit": 1.4444924592971802,
            "end_logit": 5.201662540435791,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        },
        {
            "text": "human gastric tumor cells and human melanoma, but the cytotoxic effect of DP on human breast cancer",
            "probability": 0.003365689854892715,
            "start_logit": 2.8737549781799316,
            "end_logit": 3.6796457767486572,
            "question_text": "Dracorhodin perchlorate was tested for treatment of which cancers?"
        }
    ],
    "56bcc455d36b5da378000003": [
        {
            "text": "NEABL2",
            "probability": 0.8322430610490126,
            "start_logit": 4.39888858795166,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NEABL2 (neurobeachin-like 2)",
            "probability": 0.0740537249390996,
            "start_logit": 4.39888858795166,
            "end_logit": 2.169537305831909,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NEABL2 (neurobeachin-like 2",
            "probability": 0.054568718886398526,
            "start_logit": 4.39888858795166,
            "end_logit": 1.8642072677612305,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NEABL2 (neurobeachin-like 2),",
            "probability": 0.0220884158890546,
            "start_logit": 4.39888858795166,
            "end_logit": 0.9597997665405273,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "neurobeachin-like 2)",
            "probability": 0.00534281223947912,
            "start_logit": 1.7698498964309692,
            "end_logit": 2.169537305831909,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "neurobeachin-like 2",
            "probability": 0.003937012208348886,
            "start_logit": 1.7698498964309692,
            "end_logit": 1.8642072677612305,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "loss of function mutations in NEABL2",
            "probability": 0.0032230846186632567,
            "start_logit": -1.1548970937728882,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "neurobeachin-like 2),",
            "probability": 0.0015936302847668867,
            "start_logit": 1.7698498964309692,
            "end_logit": 0.9597997665405273,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "neurobeachin-like 2), and we describe here a murine GPS model, the Nbeal2",
            "probability": 0.0004443693011928117,
            "start_logit": 1.7698498964309692,
            "end_logit": -0.31731414794921875,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "linked to loss of function mutations in NEABL2",
            "probability": 0.00036518200805879243,
            "start_logit": -3.3325953483581543,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NEABL",
            "probability": 0.00033463184905381304,
            "start_logit": 4.39888858795166,
            "end_logit": -3.22997784614563,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "2",
            "probability": 0.0003211316977955235,
            "start_logit": -3.4611399173736572,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "loss of function mutations in NEABL2 (neurobeachin-like 2)",
            "probability": 0.00028679292502010426,
            "start_logit": -1.1548970937728882,
            "end_logit": 2.169537305831909,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "mutations in NEABL2",
            "probability": 0.0002201958097041521,
            "start_logit": -3.8384740352630615,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "loss of function mutations in NEABL2 (neurobeachin-like 2",
            "probability": 0.00021133200952281936,
            "start_logit": -1.1548970937728882,
            "end_logit": 1.8642072677612305,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "in NEABL2",
            "probability": 0.00018228061568307554,
            "start_logit": -4.027443885803223,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "L2",
            "probability": 0.00015813942025955338,
            "start_logit": -4.169514179229736,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "been linked to loss of function mutations in NEABL2",
            "probability": 0.0001514245877309368,
            "start_logit": -4.2129034996032715,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "NE",
            "probability": 0.0001371882822258294,
            "start_logit": 4.39888858795166,
            "end_logit": -4.121654510498047,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        },
        {
            "text": "to loss of function mutations in NEABL2",
            "probability": 0.00013687137892931503,
            "start_logit": -4.3139495849609375,
            "end_logit": 4.588871002197266,
            "question_text": "List mutations that are implicated in the Gray Platelet Syndrome."
        }
    ],
    "52f89fd32059c6d71c000051": [
        {
            "text": "FOG-1",
            "probability": 0.11002577848625479,
            "start_logit": 5.821959495544434,
            "end_logit": 4.879287242889404,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "FOG-1 and GATA-1/TAL-1",
            "probability": 0.09235185366407553,
            "start_logit": 5.821959495544434,
            "end_logit": 4.704178333282471,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "Gfi-1b",
            "probability": 0.07895009933812207,
            "start_logit": 5.347506999969482,
            "end_logit": 5.021841049194336,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "Gfi-1b, the repressive MeCP1",
            "probability": 0.0654018584877243,
            "start_logit": 5.347506999969482,
            "end_logit": 4.83357572555542,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MeCP1",
            "probability": 0.06164618977683406,
            "start_logit": 5.288367748260498,
            "end_logit": 4.83357572555542,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "FOG-1/MeCP1",
            "probability": 0.05972116581226745,
            "start_logit": 5.464107990264893,
            "end_logit": 4.626110553741455,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "ACF/WCRF complex, in addition to the known GATA-1/FOG-1",
            "probability": 0.059463009384337434,
            "start_logit": 5.206599235534668,
            "end_logit": 4.879287242889404,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "TAL-1",
            "probability": 0.05247241857125784,
            "start_logit": 5.256641387939453,
            "end_logit": 4.704178333282471,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MeCP1 complex, and the chromatin remodeling ACF/WCRF",
            "probability": 0.04786839669998351,
            "start_logit": 5.288367748260498,
            "end_logit": 4.580619812011719,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "ACF/WCRF",
            "probability": 0.044110021314288754,
            "start_logit": 5.206599235534668,
            "end_logit": 4.580619812011719,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1/MeCP1",
            "probability": 0.041521036557607374,
            "start_logit": 5.100621700286865,
            "end_logit": 4.626110553741455,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "WCRF complex, in addition to the known GATA-1/FOG-1",
            "probability": 0.03633942489808724,
            "start_logit": 4.714148044586182,
            "end_logit": 4.879287242889404,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "GATA-1/TAL-1",
            "probability": 0.03593082351636059,
            "start_logit": 4.877949237823486,
            "end_logit": 4.704178333282471,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "MeCP1 complex, and the chromatin remodeling ACF/WCRF complex",
            "probability": 0.03491377117399838,
            "start_logit": 5.288367748260498,
            "end_logit": 4.265045642852783,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "GATA-1/FOG-1",
            "probability": 0.03342174954034504,
            "start_logit": 4.630451679229736,
            "end_logit": 4.879287242889404,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "ACF/WCRF complex",
            "probability": 0.03217252502312866,
            "start_logit": 5.206599235534668,
            "end_logit": 4.265045642852783,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "WCRF complex, in addition to the known GATA-1/FOG-1 and GATA-1/TAL-1",
            "probability": 0.030502063212795836,
            "start_logit": 4.714148044586182,
            "end_logit": 4.704178333282471,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "Gfi-1b, the repressive MeCP1 complex",
            "probability": 0.028177941682003226,
            "start_logit": 5.347506999969482,
            "end_logit": 3.9915645122528076,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "GATA-1/FOG-1 and GATA-1/TAL-1",
            "probability": 0.028053066883166146,
            "start_logit": 4.630451679229736,
            "end_logit": 4.704178333282471,
            "question_text": "List interaction partners for the protein GATA1."
        },
        {
            "text": "WCRF",
            "probability": 0.02695680597736172,
            "start_logit": 4.714148044586182,
            "end_logit": 4.580619812011719,
            "question_text": "List interaction partners for the protein GATA1."
        }
    ],
    "533675ced6d3ac6a34000056": [
        {
            "text": "H2AX",
            "probability": 0.4877608889345369,
            "start_logit": 3.7128963470458984,
            "end_logit": 3.3919243812561035,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AX (the so-called gamma-H2AX",
            "probability": 0.1507536700534165,
            "start_logit": 3.7128963470458984,
            "end_logit": 2.2177462577819824,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "gamma-H2AX",
            "probability": 0.10740844919322758,
            "start_logit": 3.3738880157470703,
            "end_logit": 2.2177462577819824,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "histone H2AX",
            "probability": 0.08792334471740612,
            "start_logit": 1.999536395072937,
            "end_logit": 3.3919243812561035,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "gamma-H2AX) on the chromatin surrounding the DNA lesion. It is generally believed that histone H2AX",
            "probability": 0.0727595844705711,
            "start_logit": 3.3738880157470703,
            "end_logit": 1.828268051147461,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "histone H2AX (the so-called gamma-H2AX",
            "probability": 0.027174722697578944,
            "start_logit": 1.999536395072937,
            "end_logit": 2.2177462577819824,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AX (the so-called gamma-H2AX)",
            "probability": 0.01794878749391249,
            "start_logit": 3.7128963470458984,
            "end_logit": 0.0896216407418251,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AX) on the chromatin surrounding the DNA lesion. It is generally believed that histone H2AX",
            "probability": 0.016413946247101394,
            "start_logit": 1.8848587274551392,
            "end_logit": 1.828268051147461,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "gamma-H2AX)",
            "probability": 0.0127880895300051,
            "start_logit": 3.3738880157470703,
            "end_logit": 0.0896216407418251,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "phosphorylation of histone H2AX",
            "probability": 0.007100916507412447,
            "start_logit": -0.5167050957679749,
            "end_logit": 3.3919243812561035,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "histone H2AX (the so-called gamma-H2AX)",
            "probability": 0.003235432495487635,
            "start_logit": 1.999536395072937,
            "end_logit": 0.0896216407418251,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AX)",
            "probability": 0.0028848847292898276,
            "start_logit": 1.8848587274551392,
            "end_logit": 0.0896216407418251,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "phosphorylation of histone H2AX (the so-called gamma-H2AX",
            "probability": 0.002194700822720098,
            "start_logit": -0.5167050957679749,
            "end_logit": 2.2177462577819824,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H2AX (the so-called gamma",
            "probability": 0.0013253995620379896,
            "start_logit": 3.7128963470458984,
            "end_logit": -2.5161869525909424,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "gamma",
            "probability": 0.0009443160585705239,
            "start_logit": 3.3738880157470703,
            "end_logit": -2.5161869525909424,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "H",
            "probability": 0.0004192325735833939,
            "start_logit": 3.7128963470458984,
            "end_logit": -3.6672303676605225,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "2AX",
            "probability": 0.000325135515087075,
            "start_logit": -3.6004421710968018,
            "end_logit": 3.3919243812561035,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "phosphorylation of histone H2AX (the so-called gamma-H2AX)",
            "probability": 0.0002613018884764804,
            "start_logit": -0.5167050957679749,
            "end_logit": 0.0896216407418251,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "histone H2AX (the so-called gamma",
            "probability": 0.00023891534812461233,
            "start_logit": 1.999536395072937,
            "end_logit": -2.5161869525909424,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        },
        {
            "text": "AX",
            "probability": 0.00013828116145371785,
            "start_logit": -4.455395221710205,
            "end_logit": 3.3919243812561035,
            "question_text": "What histone variants play a role in the DNA damage reponse?"
        }
    ],
    "52f895602059c6d71c000040": [
        {
            "text": "Fall",
            "probability": 0.20099157917810817,
            "start_logit": -0.7316023111343384,
            "end_logit": -1.8775094747543335,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "Fall detection",
            "probability": 0.18718388770824812,
            "start_logit": -0.7316023111343384,
            "end_logit": -1.9486809968948364,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "fall",
            "probability": 0.11318012824095737,
            "start_logit": -1.9463305473327637,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "early diagnosis of fall conditions. This article is a survey of systems, algorithms and sensors, for the automatic early detection of the fall",
            "probability": 0.1073812243570748,
            "start_logit": -1.998925805091858,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "diagnosis of fall conditions. This article is a survey of systems, algorithms and sensors, for the automatic early detection of the fall",
            "probability": 0.08214123770261035,
            "start_logit": -2.2668709754943848,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "fall conditions. This article is a survey of systems, algorithms and sensors, for the automatic early detection of the fall",
            "probability": 0.056847388897689276,
            "start_logit": -2.6349408626556396,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "early diagnosis",
            "probability": 0.03923852646265113,
            "start_logit": -1.998925805091858,
            "end_logit": -2.2437899112701416,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "diagnosis",
            "probability": 0.030015499902953373,
            "start_logit": -2.2668709754943848,
            "end_logit": -2.2437899112701416,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "automatic early detection of the fall",
            "probability": 0.025947096371729428,
            "start_logit": -3.4192514419555664,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "early diagnosis of fall",
            "probability": 0.022758276822591187,
            "start_logit": -1.998925805091858,
            "end_logit": -2.788520097732544,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "early detection of the fall",
            "probability": 0.022618810171923256,
            "start_logit": -3.5565292835235596,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "enable the early diagnosis of fall conditions. This article is a survey of systems, algorithms and sensors, for the automatic early detection of the fall",
            "probability": 0.02111467520765502,
            "start_logit": -3.625342845916748,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "diagnosis of fall",
            "probability": 0.01740893752496226,
            "start_logit": -2.2668709754943848,
            "end_logit": -2.788520097732544,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "early diagnosis of fall conditions",
            "probability": 0.013644145381344805,
            "start_logit": -1.998925805091858,
            "end_logit": -3.300138473510742,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "algorithms and sensors, for the automatic early detection of the fall",
            "probability": 0.013563461191447688,
            "start_logit": -4.067931652069092,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "early diagnosis of fall conditions. This article is a survey of systems, algorithms and sensors, for the automatic early detection",
            "probability": 0.01063303785180639,
            "start_logit": -1.998925805091858,
            "end_logit": -3.549483060836792,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "diagnosis of fall conditions",
            "probability": 0.010437085214182292,
            "start_logit": -2.2668709754943848,
            "end_logit": -3.300138473510742,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "sensors, for the automatic early detection of the fall",
            "probability": 0.008582162516007803,
            "start_logit": -4.525625228881836,
            "end_logit": -1.2370636463165283,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "telemonitoring systems to enable the early diagnosis",
            "probability": 0.008179099949021038,
            "start_logit": -3.567002773284912,
            "end_logit": -2.2437899112701416,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        },
        {
            "text": "diagnosis of fall conditions. This article is a survey of systems, algorithms and sensors, for the automatic early detection",
            "probability": 0.008133739347036394,
            "start_logit": -2.2668709754943848,
            "end_logit": -3.549483060836792,
            "question_text": "List tele monitoring applications of miniaturised sensors"
        }
    ],
    "551829a76487737b43000009": [
        {
            "text": "Pathogen-specific metabolic pathways",
            "probability": 0.37127329620034405,
            "start_logit": 1.0389100313186646,
            "end_logit": -0.8283381462097168,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen",
            "probability": 0.21269944321580814,
            "start_logit": 1.0389100313186646,
            "end_logit": -1.3853964805603027,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-specific metabolic pathways may be detected by breath tests",
            "probability": 0.10938277630232185,
            "start_logit": 1.0389100313186646,
            "end_logit": -2.0504231452941895,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-specific metabolic pathways may be detected",
            "probability": 0.10341346643178442,
            "start_logit": 1.0389100313186646,
            "end_logit": -2.106541395187378,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-specific metabolic pathways may be",
            "probability": 0.03952266460102,
            "start_logit": 1.0389100313186646,
            "end_logit": -3.0684022903442383,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-specific",
            "probability": 0.03235878200937721,
            "start_logit": 1.0389100313186646,
            "end_logit": -3.2683911323547363,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-specific metabolic pathways may be detected by",
            "probability": 0.02517196289317332,
            "start_logit": 1.0389100313186646,
            "end_logit": -3.519545793533325,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-specific metabolic",
            "probability": 0.021950246978484092,
            "start_logit": 1.0389100313186646,
            "end_logit": -3.6564981937408447,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Path",
            "probability": 0.02079796245201134,
            "start_logit": 1.0389100313186646,
            "end_logit": -3.710421562194824,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-specific metabolic pathways may be detected by breath",
            "probability": 0.019364038571914363,
            "start_logit": 1.0389100313186646,
            "end_logit": -3.7818589210510254,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-specific metabolic pathways may be detected by breath tests based on introduction of stable isotopically-labeled substrates",
            "probability": 0.014729936736048601,
            "start_logit": 1.0389100313186646,
            "end_logit": -4.055394649505615,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "Pathogen-",
            "probability": 0.010198415655709312,
            "start_logit": 1.0389100313186646,
            "end_logit": -4.423044204711914,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "metabolic pathways",
            "probability": 0.00446564527551439,
            "start_logit": -3.3816146850585938,
            "end_logit": -0.8283381462097168,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "breath tests",
            "probability": 0.0033912952395853922,
            "start_logit": -2.4347314834594727,
            "end_logit": -2.0504231452941895,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "detected by breath tests",
            "probability": 0.002438518241597349,
            "start_logit": -2.7645528316497803,
            "end_logit": -2.0504231452941895,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "detected",
            "probability": 0.0023054417966475458,
            "start_logit": -2.7645528316497803,
            "end_logit": -2.106541395187378,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "pathways",
            "probability": 0.0021409252874319577,
            "start_logit": -4.116790294647217,
            "end_logit": -0.8283381462097168,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "by breath tests",
            "probability": 0.0015970501315742999,
            "start_logit": -3.1877851486206055,
            "end_logit": -2.0504231452941895,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "breath tests based on introduction of stable isotopically-labeled substrates and detection of labeled products in exhaled breath using portable infrared spectrometers",
            "probability": 0.0014406679148454599,
            "start_logit": -2.4347314834594727,
            "end_logit": -2.9065282344818115,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        },
        {
            "text": "be detected by breath tests",
            "probability": 0.0013574640648070571,
            "start_logit": -3.350325107574463,
            "end_logit": -2.0504231452941895,
            "question_text": "List the diseases for which there are point-of-care breath tests"
        }
    ],
    "52bf209303868f1b0600001a": [
        {
            "text": "ischaemic stroke",
            "probability": 0.4156471571630797,
            "start_logit": 5.524461269378662,
            "end_logit": 5.163499355316162,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute ischaemic stroke",
            "probability": 0.2421998775830306,
            "start_logit": 4.9843878746032715,
            "end_logit": 5.163499355316162,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ischaemic stroke only when used by physicians trained and experienced in the management of acute stroke",
            "probability": 0.15959213611089612,
            "start_logit": 5.524461269378662,
            "end_logit": 4.206284046173096,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute ischaemic stroke only when used by physicians trained and experienced in the management of acute stroke",
            "probability": 0.09299521279802178,
            "start_logit": 4.9843878746032715,
            "end_logit": 4.206284046173096,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute stroke",
            "probability": 0.038581006455574135,
            "start_logit": 4.104599952697754,
            "end_logit": 4.206284046173096,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "stroke",
            "probability": 0.024928894790429174,
            "start_logit": 2.7106521129608154,
            "end_logit": 5.163499355316162,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "stroke only when used by physicians trained and experienced in the management of acute stroke",
            "probability": 0.009571713656464224,
            "start_logit": 2.7106521129608154,
            "end_logit": 4.206284046173096,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "treatment of acute ischaemic stroke",
            "probability": 0.009506887072241786,
            "start_logit": 1.7466410398483276,
            "end_logit": 5.163499355316162,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "treatment of acute ischaemic stroke only when used by physicians trained and experienced in the management of acute stroke",
            "probability": 0.0036502701617873567,
            "start_logit": 1.7466410398483276,
            "end_logit": 4.206284046173096,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ischaemic stroke,",
            "probability": 0.0009397018988889872,
            "start_logit": 4.414276123046875,
            "end_logit": 0.18165519833564758,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ischaemic",
            "probability": 0.0007224610481507313,
            "start_logit": 5.524461269378662,
            "end_logit": -1.1914291381835938,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute ischaemic",
            "probability": 0.0004209820142038442,
            "start_logit": 4.9843878746032715,
            "end_logit": -1.1914291381835938,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute ischaemic stroke,",
            "probability": 0.00041558123473402496,
            "start_logit": 3.598391532897949,
            "end_logit": 0.18165519833564758,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "the treatment of acute ischaemic stroke",
            "probability": 0.00019620957685233538,
            "start_logit": -2.1339473724365234,
            "end_logit": 5.163499355316162,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "ischaemic stroke only when used by physicians trained and experienced in the management of acute",
            "probability": 0.0001517936001168922,
            "start_logit": 5.524461269378662,
            "end_logit": -2.7515709400177,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "is",
            "probability": 0.00012882334380462878,
            "start_logit": 5.524461269378662,
            "end_logit": -2.9156506061553955,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute",
            "probability": 9.204690700786742e-05,
            "start_logit": 4.9843878746032715,
            "end_logit": -2.7117209434509277,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "Stroke",
            "probability": 9.000973799928755e-05,
            "start_logit": 0.34501734375953674,
            "end_logit": 1.9052691459655762,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "acute ischaemic stroke only when used by physicians trained and experienced in the management of acute",
            "probability": 8.845096311286506e-05,
            "start_logit": 4.9843878746032715,
            "end_logit": -2.7515709400177,
            "question_text": "What are the indications for alteplase?"
        },
        {
            "text": "emic stroke",
            "probability": 8.078388360343875e-05,
            "start_logit": -3.021353244781494,
            "end_logit": 5.163499355316162,
            "question_text": "What are the indications for alteplase?"
        }
    ],
    "55152bd246478f2f2c000002": [
        {
            "text": "Ezrin",
            "probability": 0.9772831231003488,
            "start_logit": 7.011454105377197,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "Ezrin.",
            "probability": 0.020948106497906415,
            "start_logit": 7.011454105377197,
            "end_logit": 2.4901857376098633,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "E",
            "probability": 0.0010294875184129445,
            "start_logit": 7.011454105377197,
            "end_logit": -0.522801399230957,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "rin",
            "probability": 0.0002673518062021022,
            "start_logit": -1.1925121545791626,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "zrin",
            "probability": 0.00018289643610488513,
            "start_logit": -1.5721575021743774,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "metastasis-associated scaffold protein Ezrin",
            "probability": 0.00011241608339506492,
            "start_logit": -2.058870553970337,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "Ez",
            "probability": 6.440066042109702e-05,
            "start_logit": 7.011454105377197,
            "end_logit": -3.2944939136505127,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "the ERK-regulated, metastasis-associated scaffold protein Ezrin",
            "probability": 2.176073935266865e-05,
            "start_logit": -3.70097017288208,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "scaffold protein Ezrin",
            "probability": 1.7185423637994824e-05,
            "start_logit": -3.937016010284424,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "protein Ezrin",
            "probability": 1.5702285910410452e-05,
            "start_logit": -4.027271270751953,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "expression of the ERK-regulated, metastasis-associated scaffold protein Ezrin",
            "probability": 1.4814761192819669e-05,
            "start_logit": -4.085453510284424,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "TGF\u03b21 production, decreased expression of the plasma membrane-cytoskeletal linker Ezrin",
            "probability": 1.1126507411892661e-05,
            "start_logit": -0.9057168960571289,
            "end_logit": 2.8668835163116455,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": ".",
            "probability": 6.634162835347958e-06,
            "start_logit": -1.0461169481277466,
            "end_logit": 2.4901857376098633,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "rin.",
            "probability": 5.730697662067581e-06,
            "start_logit": -1.1925121545791626,
            "end_logit": 2.4901857376098633,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "associated scaffold protein Ezrin",
            "probability": 5.638993096925357e-06,
            "start_logit": -5.051372051239014,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "ERK-regulated, metastasis-associated scaffold protein Ezrin",
            "probability": 4.361723157847687e-06,
            "start_logit": -5.308210372924805,
            "end_logit": 6.332913875579834,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "zrin.",
            "probability": 3.920393109274295e-06,
            "start_logit": -1.5721575021743774,
            "end_logit": 2.4901857376098633,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "metastasis-associated scaffold protein Ezrin.",
            "probability": 2.4096436655598973e-06,
            "start_logit": -2.058870553970337,
            "end_logit": 2.4901857376098633,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "invasion, as well as expression of the ERK-regulated, metastasis-associated scaffold protein Ezrin",
            "probability": 1.656530187653463e-06,
            "start_logit": -5.712090969085693,
            "end_logit": 5.768652439117432,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        },
        {
            "text": "reduced cell migration and invasion, as well as expression of the ERK-regulated, metastasis-associated scaffold protein Ezrin",
            "probability": 1.276035988332547e-06,
            "start_logit": -5.973057746887207,
            "end_logit": 5.768652439117432,
            "question_text": "List scaffold proteins of the ERK signaling pathway."
        }
    ],
    "516c3960298dcd4e51000073": [
        {
            "text": "DNMT1",
            "probability": 0.6308055378554527,
            "start_logit": 3.9606051445007324,
            "end_logit": 3.4396893978118896,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methyltransferase 1 (DNMT1",
            "probability": 0.10180029594089837,
            "start_logit": 2.13662052154541,
            "end_logit": 3.4396893978118896,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase 1 (DNMT1",
            "probability": 0.07148625080660619,
            "start_logit": 1.783112645149231,
            "end_logit": 3.4396893978118896,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methyltransferase 1",
            "probability": 0.044512780884355875,
            "start_logit": 2.13662052154541,
            "end_logit": 2.612452745437622,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1)",
            "probability": 0.04107526972978696,
            "start_logit": 3.9606051445007324,
            "end_logit": 0.7080979943275452,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase 1",
            "probability": 0.03125778553969975,
            "start_logit": 1.783112645149231,
            "end_logit": 2.612452745437622,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "(DNMT1",
            "probability": 0.013364023767852921,
            "start_logit": 0.1061738133430481,
            "end_logit": 3.4396893978118896,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1) is essential for maintaining DNA methylation patterns after cell division. Disruption of DNMT1",
            "probability": 0.012625642272426796,
            "start_logit": 3.9606051445007324,
            "end_logit": -0.4715783894062042,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT",
            "probability": 0.010711526644041992,
            "start_logit": 3.9606051445007324,
            "end_logit": -0.6359878182411194,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "met",
            "probability": 0.007677848068458217,
            "start_logit": 2.13662052154541,
            "end_logit": 0.8550156950950623,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methyltransferase 1 (DNMT1)",
            "probability": 0.00662878551852966,
            "start_logit": 2.13662052154541,
            "end_logit": 0.7080979943275452,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNMT1) is essential for maintaining DNA met",
            "probability": 0.005967696283142649,
            "start_logit": 3.9606051445007324,
            "end_logit": -1.220947265625,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA met",
            "probability": 0.005391542014725279,
            "start_logit": 1.783112645149231,
            "end_logit": 0.8550156950950623,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase 1 (DNMT1)",
            "probability": 0.004654868826667464,
            "start_logit": 1.783112645149231,
            "end_logit": 0.7080979943275452,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "1 (DNMT1",
            "probability": 0.0032054588062632914,
            "start_logit": -1.3215372562408447,
            "end_logit": 3.4396893978118896,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methyltransferase",
            "probability": 0.0025946917367783606,
            "start_logit": 2.13662052154541,
            "end_logit": -0.22985589504241943,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "DNA methyltransferase",
            "probability": 0.0018220456291094902,
            "start_logit": 1.783112645149231,
            "end_logit": -0.22985589504241943,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "methyltransferase 1 (DNMT",
            "probability": 0.001728641422599818,
            "start_logit": 2.13662052154541,
            "end_logit": -0.6359878182411194,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "1",
            "probability": 0.0014016058024022252,
            "start_logit": -1.3215372562408447,
            "end_logit": 2.612452745437622,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        },
        {
            "text": "ferase 1 (DNMT1",
            "probability": 0.0012877024502019499,
            "start_logit": -2.2335329055786133,
            "end_logit": 3.4396893978118896,
            "question_text": "Which are the families of mammalian DNA-(cytosine-5)-methyltransferases?"
        }
    ],
    "54e0ac041388e8454a00000f": [
        {
            "text": "non-LTR retrotransposons",
            "probability": 0.3063037511182397,
            "start_logit": 3.343127727508545,
            "end_logit": 3.0625345706939697,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons, which includes the Long INterspersed Element-1",
            "probability": 0.25818439900216766,
            "start_logit": 3.343127727508545,
            "end_logit": 2.8916313648223877,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Long INterspersed Element-1",
            "probability": 0.1962417373580482,
            "start_logit": 3.068800926208496,
            "end_logit": 2.8916313648223877,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons, which includes the Long INterspersed Element-1 (LINE-1",
            "probability": 0.02704658860345751,
            "start_logit": 3.343127727508545,
            "end_logit": 0.6355181932449341,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons, which includes the Long INterspersed Element-1 (LINE-1 or L1)",
            "probability": 0.024286577587821854,
            "start_logit": 3.343127727508545,
            "end_logit": 0.5278811454772949,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Long INterspersed Element-1 (LINE-1",
            "probability": 0.02055766947059542,
            "start_logit": 3.068800926208496,
            "end_logit": 0.6355181932449341,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons,",
            "probability": 0.01974818746628241,
            "start_logit": 3.343127727508545,
            "end_logit": 0.3210190236568451,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "LTR retrotransposons",
            "probability": 0.018999375389402426,
            "start_logit": 0.5629565715789795,
            "end_logit": 3.0625345706939697,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Long INterspersed Element-1 (LINE-1 or L1)",
            "probability": 0.018459830255952766,
            "start_logit": 3.068800926208496,
            "end_logit": 0.5278811454772949,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "LTR retrotransposons, which includes the Long INterspersed Element-1",
            "probability": 0.016014633508147524,
            "start_logit": 0.5629565715789795,
            "end_logit": 2.8916313648223877,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons, which includes the Long INterspersed Element-1 (LINE-1 or L1",
            "probability": 0.014563627608298076,
            "start_logit": 3.343127727508545,
            "end_logit": 0.016484471037983894,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons, which includes the Long INterspersed Element",
            "probability": 0.013127391495313135,
            "start_logit": 3.343127727508545,
            "end_logit": -0.08734168857336044,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Long INterspersed Element-1 (LINE-1 or L1",
            "probability": 0.011069575060048674,
            "start_logit": 3.068800926208496,
            "end_logit": 0.016484471037983894,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR",
            "probability": 0.010311203415081568,
            "start_logit": 3.343127727508545,
            "end_logit": -0.3288116753101349,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Long INterspersed Element",
            "probability": 0.009977915489765466,
            "start_logit": 3.068800926208496,
            "end_logit": -0.08734168857336044,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "non-LTR retrotransposons, which includes the Long INterspersed Element-1 (LINE-1 or L1),",
            "probability": 0.009036676689189251,
            "start_logit": 3.343127727508545,
            "end_logit": -0.4607512056827545,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "RNA). Only one subclass, the non-LTR retrotransposons",
            "probability": 0.008027891889998544,
            "start_logit": -0.2985275685787201,
            "end_logit": 3.0625345706939697,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "Long INterspersed Element-1 (LINE-1 or L1),",
            "probability": 0.006868630096486136,
            "start_logit": 3.068800926208496,
            "end_logit": -0.4607512056827545,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "DNA or RNA). Only one subclass, the non-LTR retrotransposons",
            "probability": 0.005680288182072444,
            "start_logit": -0.6444475650787354,
            "end_logit": 3.0625345706939697,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        },
        {
            "text": "retrotransposons",
            "probability": 0.005494050313631414,
            "start_logit": -0.6777837872505188,
            "end_logit": 3.0625345706939697,
            "question_text": "Which classes of endogenous retroelements are known to date?"
        }
    ],
    "553a7a59f321868558000002": [
        {
            "text": "Gfi-1b",
            "probability": 0.09189581083468355,
            "start_logit": 5.20327615737915,
            "end_logit": 5.022982120513916,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "FOG-1",
            "probability": 0.08835043599446092,
            "start_logit": 5.578615188598633,
            "end_logit": 4.6082987785339355,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "FOG-1/MeCP1",
            "probability": 0.07217278509826218,
            "start_logit": 5.466322422027588,
            "end_logit": 4.518343448638916,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "FOG-1 and GATA-1/TAL-1",
            "probability": 0.06153865014521337,
            "start_logit": 5.578615188598633,
            "end_logit": 4.246653079986572,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b, the repressive MeCP1",
            "probability": 0.06138188954551581,
            "start_logit": 5.20327615737915,
            "end_logit": 4.619441509246826,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "MeCP1",
            "probability": 0.05907597530016708,
            "start_logit": 5.164985656738281,
            "end_logit": 4.619441509246826,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b, the repressive MeCP1 complex",
            "probability": 0.05874148201779102,
            "start_logit": 5.20327615737915,
            "end_logit": 4.575472831726074,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "MeCP1 complex",
            "probability": 0.0565347591361619,
            "start_logit": 5.164985656738281,
            "end_logit": 4.575472831726074,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "ACF/WCRF complex, in addition to the known GATA-1/FOG-1",
            "probability": 0.054351061125311365,
            "start_logit": 5.09276819229126,
            "end_logit": 4.6082987785339355,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "MeCP1 complex, and the chromatin remodeling ACF/WCRF complex",
            "probability": 0.04583158102710071,
            "start_logit": 5.164985656738281,
            "end_logit": 4.365590572357178,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "ACF/WCRF complex",
            "probability": 0.04263842879897576,
            "start_logit": 5.09276819229126,
            "end_logit": 4.365590572357178,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "MeCP1 complex, and the chromatin remodeling ACF/WCRF",
            "probability": 0.042626882021190984,
            "start_logit": 5.164985656738281,
            "end_logit": 4.293102264404297,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1/MeCP1",
            "probability": 0.039981268149222475,
            "start_logit": 4.875670433044434,
            "end_logit": 4.518343448638916,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "ACF/WCRF",
            "probability": 0.03965700578621015,
            "start_logit": 5.09276819229126,
            "end_logit": 4.293102264404297,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/FOG-1/MeCP1",
            "probability": 0.03536940600062161,
            "start_logit": 4.753106594085693,
            "end_logit": 4.518343448638916,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "Gfi-1b with the suppression of cell proliferation and GATA-1/FOG-1",
            "probability": 0.03370898370713035,
            "start_logit": 4.875670433044434,
            "end_logit": 4.347696781158447,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "TAL-1",
            "probability": 0.031106946295527883,
            "start_logit": 4.89638090133667,
            "end_logit": 4.246653079986572,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/FOG-1",
            "probability": 0.029820633156405235,
            "start_logit": 4.753106594085693,
            "end_logit": 4.347696781158447,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "WCRF complex, in addition to the known GATA-1/FOG-1",
            "probability": 0.02958955478952561,
            "start_logit": 4.484725475311279,
            "end_logit": 4.6082987785339355,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        },
        {
            "text": "GATA-1/TAL-1",
            "probability": 0.025626461070522074,
            "start_logit": 4.702575206756592,
            "end_logit": 4.246653079986572,
            "question_text": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach."
        }
    ],
    "52f129d92059c6d71c000009": [
        {
            "text": "Myotonic dystrophy",
            "probability": 0.7459038276333343,
            "start_logit": 3.698863983154297,
            "end_logit": 3.7011144161224365,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Myotonic dystrophy (DM)",
            "probability": 0.2329742755263565,
            "start_logit": 3.698863983154297,
            "end_logit": 2.5374457836151123,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "DM)",
            "probability": 0.010532523415296584,
            "start_logit": 0.6024038791656494,
            "end_logit": 2.5374457836151123,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Myotonic dystrophy (DM",
            "probability": 0.003388851256836047,
            "start_logit": 3.698863983154297,
            "end_logit": -1.6929912567138672,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "dystrophy",
            "probability": 0.0032602372141939955,
            "start_logit": -1.7339327335357666,
            "end_logit": 3.7011144161224365,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "dystrophy (DM)",
            "probability": 0.0010182966957427752,
            "start_logit": -1.7339327335357666,
            "end_logit": 2.5374457836151123,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "nic dystrophy",
            "probability": 0.0005470666536906378,
            "start_logit": -3.5189173221588135,
            "end_logit": 3.7011144161224365,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "phy",
            "probability": 0.0004710623239768441,
            "start_logit": -3.6684975624084473,
            "end_logit": 3.7011144161224365,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "(DM)",
            "probability": 0.0003020547993288486,
            "start_logit": -2.9492108821868896,
            "end_logit": 2.5374457836151123,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "otonic dystrophy",
            "probability": 0.000280172307687209,
            "start_logit": -4.188083171844482,
            "end_logit": 3.7011144161224365,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Myotonic",
            "probability": 0.00022816171135935003,
            "start_logit": 3.698863983154297,
            "end_logit": -4.391182899475098,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "My",
            "probability": 0.00017719973422072953,
            "start_logit": 3.698863983154297,
            "end_logit": -4.643959999084473,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "nic dystrophy (DM)",
            "probability": 0.00017086982609084637,
            "start_logit": -3.5189173221588135,
            "end_logit": 2.5374457836151123,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "DM",
            "probability": 0.0001532064221809113,
            "start_logit": 0.6024038791656494,
            "end_logit": -1.6929912567138672,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "phy (DM)",
            "probability": 0.00014713076886128395,
            "start_logit": -3.6684975624084473,
            "end_logit": 2.5374457836151123,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "trophy",
            "probability": 0.00012973791764800838,
            "start_logit": -4.957971572875977,
            "end_logit": 3.7011144161224365,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "otonic dystrophy (DM)",
            "probability": 8.750852051943263e-05,
            "start_logit": -4.188083171844482,
            "end_logit": 2.5374457836151123,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "ystrophy",
            "probability": 8.40723745784198e-05,
            "start_logit": -5.391809940338135,
            "end_logit": 3.7011144161224365,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Myotonic d",
            "probability": 7.256183248179201e-05,
            "start_logit": 3.698863983154297,
            "end_logit": -5.536798477172852,
            "question_text": "Which diseases are associated with Alu element insertion?"
        },
        {
            "text": "Myotonic dys",
            "probability": 7.118306561547459e-05,
            "start_logit": 3.698863983154297,
            "end_logit": -5.55598258972168,
            "question_text": "Which diseases are associated with Alu element insertion?"
        }
    ],
    "55192f20622b194345000014": [
        {
            "text": "c-Rel",
            "probability": 0.08191640258691964,
            "start_logit": 5.460690498352051,
            "end_logit": 4.756466388702393,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "RelB, c-Rel",
            "probability": 0.06565873507039899,
            "start_logit": 5.239461898803711,
            "end_logit": 4.756466388702393,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "RelB",
            "probability": 0.06299572560801443,
            "start_logit": 5.239461898803711,
            "end_logit": 4.715062618255615,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "rela, relb",
            "probability": 0.06254806492977419,
            "start_logit": 5.215442657470703,
            "end_logit": 4.731950283050537,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "rela, relb, crel",
            "probability": 0.06250271718405578,
            "start_logit": 5.215442657470703,
            "end_logit": 4.73122501373291,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "relb",
            "probability": 0.059255925355614046,
            "start_logit": 5.161373138427734,
            "end_logit": 4.731950283050537,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "relb, crel",
            "probability": 0.05921296443206905,
            "start_logit": 5.161373138427734,
            "end_logit": 4.73122501373291,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "rela",
            "probability": 0.055672373509688275,
            "start_logit": 5.215442657470703,
            "end_logit": 4.615499019622803,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "RelA (p65), RelB, c-Rel",
            "probability": 0.055278493744838834,
            "start_logit": 5.067375183105469,
            "end_logit": 4.756466388702393,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "crel",
            "probability": 0.05485176549250065,
            "start_logit": 5.084867000579834,
            "end_logit": 4.73122501373291,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "RelA (p65), RelB",
            "probability": 0.053036489664939394,
            "start_logit": 5.067375183105469,
            "end_logit": 4.715062618255615,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "nfkappaB encode the five NF-kB protein family members RelA (p65), RelB",
            "probability": 0.048542564778945564,
            "start_logit": 4.9788360595703125,
            "end_logit": 4.715062618255615,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "crel, nfkappa\u03921, and nfkappaB encode the five NF-kB protein family members RelA",
            "probability": 0.04102166551705974,
            "start_logit": 5.084867000579834,
            "end_logit": 4.440690994262695,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "RelA",
            "probability": 0.040310361170257755,
            "start_logit": 5.067375183105469,
            "end_logit": 4.440690994262695,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "nfkappaB encode the five NF-kB protein family members RelA",
            "probability": 0.036894755492528034,
            "start_logit": 4.9788360595703125,
            "end_logit": 4.440690994262695,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "rela, relb, crel, nfkappa\u03921, and nfkappaB",
            "probability": 0.03434336683309148,
            "start_logit": 5.215442657470703,
            "end_logit": 4.1324238777160645,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "nfkappa\u03921, and nfkappaB encode the five NF-kB protein family members RelA",
            "probability": 0.03423558445140281,
            "start_logit": 4.904032230377197,
            "end_logit": 4.440690994262695,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "relb, crel, nfkappa\u03921, and nfkappaB",
            "probability": 0.03253574645046156,
            "start_logit": 5.161373138427734,
            "end_logit": 4.1324238777160645,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "crel, nfkappa\u03921, and nfkappaB",
            "probability": 0.03013939855133543,
            "start_logit": 5.084867000579834,
            "end_logit": 4.1324238777160645,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        },
        {
            "text": "c-Rel, p50",
            "probability": 0.02904689917610421,
            "start_logit": 5.460690498352051,
            "end_logit": 3.7196788787841797,
            "question_text": "Which proteins are the different members of the NF-kappaB family of transcription factors?"
        }
    ],
    "571e417bbb137a4b0c00000a": [
        {
            "text": "conjugated hyperbilirubinemia",
            "probability": 0.35291300765058436,
            "start_logit": 4.171950817108154,
            "end_logit": 4.664825916290283,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "hyperbilirubinemia",
            "probability": 0.15881475434605855,
            "start_logit": 3.3734676837921143,
            "end_logit": 4.664825916290283,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "chronic fluctuating, nonhemolytic and predominantly conjugated hyperbilirubinemia",
            "probability": 0.13267118993092986,
            "start_logit": 3.193603038787842,
            "end_logit": 4.664825916290283,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "nonhemolytic and predominantly conjugated hyperbilirubinemia",
            "probability": 0.07365920575485459,
            "start_logit": 2.6051783561706543,
            "end_logit": 4.664825916290283,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "conjugated hyperbilirubinemia with normal hepatic histology",
            "probability": 0.07151078444225917,
            "start_logit": 4.171950817108154,
            "end_logit": 3.0684525966644287,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "predominantly conjugated hyperbilirubinemia",
            "probability": 0.06291871899722706,
            "start_logit": 2.447572946548462,
            "end_logit": 4.664825916290283,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "hyperbilirubinemia with normal hepatic histology",
            "probability": 0.03218064343929129,
            "start_logit": 3.3734676837921143,
            "end_logit": 3.0684525966644287,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "chronic fluctuating, nonhemolytic and predominantly conjugated hyperbilirubinemia with normal hepatic histology",
            "probability": 0.026883171374182252,
            "start_logit": 3.193603038787842,
            "end_logit": 3.0684525966644287,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "chronic fluctuating, nonhemolytic",
            "probability": 0.025883810252866693,
            "start_logit": 3.193603038787842,
            "end_logit": 3.0305697917938232,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "nonhemolytic and predominantly conjugated hyperbilirubinemia with normal hepatic histology",
            "probability": 0.01492556939170304,
            "start_logit": 2.6051783561706543,
            "end_logit": 3.0684525966644287,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "nonhemolytic",
            "probability": 0.014370722883605027,
            "start_logit": 2.6051783561706543,
            "end_logit": 3.0305697917938232,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "predominantly conjugated hyperbilirubinemia with normal hepatic histology",
            "probability": 0.012749223899529824,
            "start_logit": 2.447572946548462,
            "end_logit": 3.0684525966644287,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "fluctuating, nonhemolytic and predominantly conjugated hyperbilirubinemia",
            "probability": 0.008102719090826084,
            "start_logit": 0.397928923368454,
            "end_logit": 4.664825916290283,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "chronic fluctuating",
            "probability": 0.005598392510340747,
            "start_logit": 3.193603038787842,
            "end_logit": 1.4994316101074219,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "fluctuating, nonhemolytic and predominantly conjugated hyperbilirubinemia with normal hepatic histology",
            "probability": 0.0016418544676424396,
            "start_logit": 0.397928923368454,
            "end_logit": 3.0684525966644287,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "fluctuating, nonhemolytic",
            "probability": 0.0015808197965844002,
            "start_logit": 0.397928923368454,
            "end_logit": 3.0305697917938232,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "hepatic histology",
            "probability": 0.0014280176496827412,
            "start_logit": 0.25838977098464966,
            "end_logit": 3.0684525966644287,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "conjugated hyperbilirubinemia with normal hepatic histology. In contrast to Dubin-Johnson syndrome",
            "probability": 0.0009243265223127733,
            "start_logit": 4.171950817108154,
            "end_logit": -1.280085563659668,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "conjugated hyperbilirubinemia with",
            "probability": 0.0007172195927263477,
            "start_logit": 4.171950817108154,
            "end_logit": -1.533768892288208,
            "question_text": "What are the symptoms of Rotor syndrome?"
        },
        {
            "text": "normal hepatic histology",
            "probability": 0.0005258480067928948,
            "start_logit": -0.7406405210494995,
            "end_logit": 3.0684525966644287,
            "question_text": "What are the symptoms of Rotor syndrome?"
        }
    ],
    "52fa73e82059c6d71c000059": [
        {
            "text": "DOTAP-DOPC",
            "probability": 0.5002399193702916,
            "start_logit": -0.3786808252334595,
            "end_logit": -1.484537124633789,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DOTAP-DOPC-mediated transfection",
            "probability": 0.27298494706353,
            "start_logit": -0.3786808252334595,
            "end_logit": -2.0902082920074463,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DOTAP-DOPC-mediated",
            "probability": 0.05354366718768511,
            "start_logit": -0.3786808252334595,
            "end_logit": -3.7191274166107178,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "transfection",
            "probability": 0.028014493444848736,
            "start_logit": -2.6553754806518555,
            "end_logit": -2.0902082920074463,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DOTAP",
            "probability": 0.024016243628770525,
            "start_logit": -0.3786808252334595,
            "end_logit": -4.520894527435303,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "lipid-protamine/deoxyribonucleic acid (DNA) (LPD) nanoparticles",
            "probability": 0.02276322828907708,
            "start_logit": -2.1729142665863037,
            "end_logit": -2.780245065689087,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "deoxyribonucleic acid (DNA) (LPD) nanoparticles",
            "probability": 0.01802494845732036,
            "start_logit": -2.406303882598877,
            "end_logit": -2.780245065689087,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "lipoplexes",
            "probability": 0.010431845835194565,
            "start_logit": -2.4554333686828613,
            "end_logit": -3.2780091762542725,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "lipid-protamine/deoxyribonucleic acid (DNA)",
            "probability": 0.007406971624859902,
            "start_logit": -2.1729142665863037,
            "end_logit": -3.9029698371887207,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "nanoparticles",
            "probability": 0.007351724032382636,
            "start_logit": -3.3031258583068848,
            "end_logit": -2.780245065689087,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "lipoplex",
            "probability": 0.0067675393635982265,
            "start_logit": -2.4554333686828613,
            "end_logit": -3.7107348442077637,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "lipid-protamine/deoxyribonucleic acid",
            "probability": 0.006406190623812253,
            "start_logit": -2.1729142665863037,
            "end_logit": -4.048126697540283,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "deoxyribonucleic acid (DNA)",
            "probability": 0.00586517343091441,
            "start_logit": -2.406303882598877,
            "end_logit": -3.9029698371887207,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "DOPC",
            "probability": 0.0056251374394490445,
            "start_logit": -4.866523265838623,
            "end_logit": -1.484537124633789,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "lipoplexes and lipid-protamine/deoxyribonucleic acid (DNA)",
            "probability": 0.005583984368242499,
            "start_logit": -2.4554333686828613,
            "end_logit": -3.9029698371887207,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "lipid-protamine/deoxyribonucleic acid (DNA) (LPD)",
            "probability": 0.005529103018616959,
            "start_logit": -2.1729142665863037,
            "end_logit": -4.195365905761719,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "deoxyribonucleic acid (DNA) (LPD) nanoparticles (NPs)",
            "probability": 0.005164466907555713,
            "start_logit": -2.406303882598877,
            "end_logit": -4.030200004577637,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "deoxyribonucleic acid",
            "probability": 0.005072710001216902,
            "start_logit": -2.406303882598877,
            "end_logit": -4.048126697540283,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "lipoplexes and lipid-protamine/deoxyribonucleic acid",
            "probability": 0.004829513344331988,
            "start_logit": -2.4554333686828613,
            "end_logit": -4.048126697540283,
            "question_text": "List the existing methods for genetic manipulation of cells."
        },
        {
            "text": "deoxyribonucleic acid (DNA) (LPD)",
            "probability": 0.004378192568301383,
            "start_logit": -2.406303882598877,
            "end_logit": -4.195365905761719,
            "question_text": "List the existing methods for genetic manipulation of cells."
        }
    ],
    "554397f6ed966d112c00000c": [
        {
            "text": "azgA",
            "probability": 0.9287893297912467,
            "start_logit": 2.6742959022521973,
            "end_logit": 2.3340413570404053,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "AzgA",
            "probability": 0.03916422870552982,
            "start_logit": 1.1040928363800049,
            "end_logit": 0.738126277923584,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "azgA gene of Aspergillus nidulans",
            "probability": 0.015042238255975997,
            "start_logit": 2.6742959022521973,
            "end_logit": -1.7889784574508667,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "The azgA",
            "probability": 0.005871777649285881,
            "start_logit": -2.3894286155700684,
            "end_logit": 2.3340413570404053,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "azgA gene",
            "probability": 0.0035492239187878876,
            "start_logit": 2.6742959022521973,
            "end_logit": -3.233111619949341,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "NAT family that includes other eukaryotic and prokaryotic nucleobase transporters. Thus AzgA",
            "probability": 0.0019309375889671229,
            "start_logit": -1.9056652784347534,
            "end_logit": 0.738126277923584,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "gA",
            "probability": 0.0017157492150138539,
            "start_logit": -3.6197361946105957,
            "end_logit": 2.3340413570404053,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "a",
            "probability": 0.0015920741634922401,
            "start_logit": 2.6742959022521973,
            "end_logit": -4.0348029136657715,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "azgA gene of As",
            "probability": 0.0012225519760998697,
            "start_logit": 2.6742959022521973,
            "end_logit": -4.298900127410889,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "az",
            "probability": 0.000440826515826156,
            "start_logit": 2.6742959022521973,
            "end_logit": -5.318944454193115,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "azgA gene of Aspergillus nidulan",
            "probability": 0.00031337334280187975,
            "start_logit": 2.6742959022521973,
            "end_logit": -5.660200595855713,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "Aspergillus nidulans",
            "probability": 0.00016342499160741615,
            "start_logit": -1.8479673862457275,
            "end_logit": -1.7889784574508667,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "The azgA gene of Aspergillus nidulans",
            "probability": 9.509656878435997e-05,
            "start_logit": -2.3894286155700684,
            "end_logit": -1.7889784574508667,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "gA gene of Aspergillus nidulans",
            "probability": 2.7787473059733476e-05,
            "start_logit": -3.6197361946105957,
            "end_logit": -1.7889784574508667,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "The azgA gene",
            "probability": 2.2438084730509976e-05,
            "start_logit": -2.3894286155700684,
            "end_logit": -3.233111619949341,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "s",
            "probability": 1.77643189553293e-05,
            "start_logit": -4.067129611968994,
            "end_logit": -1.7889784574508667,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "As",
            "probability": 1.328230167836733e-05,
            "start_logit": -1.8479673862457275,
            "end_logit": -4.298900127410889,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "NAT family",
            "probability": 1.01011580501967e-05,
            "start_logit": -1.9056652784347534,
            "end_logit": -4.514984607696533,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "The a",
            "probability": 1.0065044019509098e-05,
            "start_logit": -2.3894286155700684,
            "end_logit": -4.0348029136657715,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        },
        {
            "text": "The azgA gene of As",
            "probability": 7.728936087117777e-06,
            "start_logit": -2.3894286155700684,
            "end_logit": -4.298900127410889,
            "question_text": "List representatives of the major fungal hypoxanthine-adenine-guanine transporter families."
        }
    ],
    "551910d3622b194345000008": [
        {
            "text": "GDNF",
            "probability": 0.32805006518246305,
            "start_logit": 5.684494972229004,
            "end_logit": 5.834275722503662,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "glial cell-line-derived neurotrophic factor (GDNF",
            "probability": 0.2921648419079962,
            "start_logit": 5.5686469078063965,
            "end_logit": 5.834275722503662,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "glial cell-line-derived neurotrophic factor",
            "probability": 0.22784633533793774,
            "start_logit": 5.5686469078063965,
            "end_logit": 5.585628986358643,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF)",
            "probability": 0.05955366845127471,
            "start_logit": 5.684494972229004,
            "end_logit": 4.127987384796143,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "glial cell-line-derived neurotrophic factor (GDNF)",
            "probability": 0.05303912413012391,
            "start_logit": 5.5686469078063965,
            "end_logit": 4.127987384796143,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF) gene",
            "probability": 0.010028358166860554,
            "start_logit": 5.684494972229004,
            "end_logit": 2.3465263843536377,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "glial cell-line-derived neurotrophic factor (GDNF) gene",
            "probability": 0.008931361366405864,
            "start_logit": 5.5686469078063965,
            "end_logit": 2.3465263843536377,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "(GDNF",
            "probability": 0.006711497754052395,
            "start_logit": 1.795150876045227,
            "end_logit": 5.834275722503662,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF) gene,",
            "probability": 0.004127014784731147,
            "start_logit": 5.684494972229004,
            "end_logit": 1.458663821220398,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "glial cell-line-derived neurotrophic factor (GDNF) gene,",
            "probability": 0.0036755628183225146,
            "start_logit": 5.5686469078063965,
            "end_logit": 1.458663821220398,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "(GDNF)",
            "probability": 0.0012183942467257226,
            "start_logit": 1.795150876045227,
            "end_logit": 4.127987384796143,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "the glial cell-line-derived neurotrophic factor (GDNF",
            "probability": 0.000988705881951651,
            "start_logit": -0.12002964317798615,
            "end_logit": 5.834275722503662,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "neurotrophic factor (GDNF",
            "probability": 0.0009080042193898061,
            "start_logit": -0.20517751574516296,
            "end_logit": 5.834275722503662,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "the glial cell-line-derived neurotrophic factor",
            "probability": 0.0007710476402930326,
            "start_logit": -0.12002964317798615,
            "end_logit": 5.585628986358643,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "neurotrophic factor",
            "probability": 0.0007081120113846593,
            "start_logit": -0.20517751574516296,
            "end_logit": 5.585628986358643,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "GDNF) gene, one of the RET ligands,",
            "probability": 0.00038527908449430157,
            "start_logit": 5.684494972229004,
            "end_logit": -0.9126778244972229,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "glial cell-line-derived neurotrophic factor (GDNF) gene, one of the RET ligands,",
            "probability": 0.0003431336090396017,
            "start_logit": 5.5686469078063965,
            "end_logit": -0.9126778244972229,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "(GDNF) gene",
            "probability": 0.00020516777912018416,
            "start_logit": 1.795150876045227,
            "end_logit": 2.3465263843536377,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "the glial cell-line-derived neurotrophic factor (GDNF)",
            "probability": 0.00017948803715927888,
            "start_logit": -0.12002964317798615,
            "end_logit": 4.127987384796143,
            "question_text": "Which proteins have been identified as RET ligands?"
        },
        {
            "text": "neurotrophic factor (GDNF)",
            "probability": 0.00016483759027397923,
            "start_logit": -0.20517751574516296,
            "end_logit": 4.127987384796143,
            "question_text": "Which proteins have been identified as RET ligands?"
        }
    ],
    "5314b20bdae131f847000005": [
        {
            "text": "fava beans",
            "probability": 0.8343777922975428,
            "start_logit": 5.48527193069458,
            "end_logit": 5.184042930603027,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "fava beans or to the inhalation of pollen",
            "probability": 0.05653815582546198,
            "start_logit": 4.975795269012451,
            "end_logit": 3.001749038696289,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "fava beans consumption",
            "probability": 0.02495909974950963,
            "start_logit": 5.48527193069458,
            "end_logit": 1.6745951175689697,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "beans",
            "probability": 0.02462849146558994,
            "start_logit": 2.377094268798828,
            "end_logit": 4.76943826675415,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "fava beans or to the inhalation of pollen from the Vicia faba plant",
            "probability": 0.018271365682878574,
            "start_logit": 4.975795269012451,
            "end_logit": 1.8721684217453003,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "pollen",
            "probability": 0.009564856037077298,
            "start_logit": 3.198975086212158,
            "end_logit": 3.001749038696289,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "hemolysis as a result of fava beans",
            "probability": 0.008175882880627464,
            "start_logit": 0.8597743511199951,
            "end_logit": 5.184042930603027,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "fava beans or to the inhalation of pollen from the Vicia faba plant. Patients with favism",
            "probability": 0.004985820625934296,
            "start_logit": 4.975795269012451,
            "end_logit": 0.5734313130378723,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "beans or to the inhalation of pollen",
            "probability": 0.004204749561566339,
            "start_logit": 2.377094268798828,
            "end_logit": 3.001749038696289,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "fava beans or to the inhalation of pollen from the Vicia faba",
            "probability": 0.0033278248624009454,
            "start_logit": 4.975795269012451,
            "end_logit": 0.16915220022201538,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "pollen from the Vicia faba plant",
            "probability": 0.003091062660356946,
            "start_logit": 3.198975086212158,
            "end_logit": 1.8721684217453003,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "Favism occurs as the result of intolerance to the ingesting of fava beans",
            "probability": 0.002590822735940328,
            "start_logit": 0.12516579031944275,
            "end_logit": 4.76943826675415,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "beans or to the inhalation of pollen from the Vicia faba plant",
            "probability": 0.001358843699845319,
            "start_logit": 2.377094268798828,
            "end_logit": 1.8721684217453003,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "fava beans consumption.",
            "probability": 0.0012041232701288883,
            "start_logit": 5.48527193069458,
            "end_logit": -1.3568916320800781,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "pollen from the Vicia faba plant. Patients with favism",
            "probability": 0.0008434773971222379,
            "start_logit": 3.198975086212158,
            "end_logit": 0.5734313130378723,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "pollen from the Vicia faba",
            "probability": 0.0005629855671934896,
            "start_logit": 3.198975086212158,
            "end_logit": 0.16915220022201538,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "Favism occurs as the result of intolerance to the ingesting of fava beans or to the inhalation of pollen",
            "probability": 0.00044232350886214757,
            "start_logit": 0.12516579031944275,
            "end_logit": 3.001749038696289,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "beans or to the inhalation of pollen from the Vicia faba plant. Patients with favism",
            "probability": 0.00037079608955876904,
            "start_logit": 2.377094268798828,
            "end_logit": 0.5734313130378723,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "f",
            "probability": 0.00025403534049782953,
            "start_logit": 5.48527193069458,
            "end_logit": -2.9129252433776855,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        },
        {
            "text": "beans or to the inhalation of pollen from the Vicia faba",
            "probability": 0.00024749074190439605,
            "start_logit": 2.377094268798828,
            "end_logit": 0.16915220022201538,
            "question_text": "Which substances are dangerous to g6PD deficient individuals?"
        }
    ],
    "52fb78d82059c6d71c000068": [
        {
            "text": "BrS1",
            "probability": 0.9783822926901442,
            "start_logit": 4.596948146820068,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "BrS1)",
            "probability": 0.008956547486825273,
            "start_logit": 4.596948146820068,
            "end_logit": -1.2347995042800903,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "BrS",
            "probability": 0.0035283653232218164,
            "start_logit": 4.596948146820068,
            "end_logit": -2.1663496494293213,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "(BrS1",
            "probability": 0.0029842408479736062,
            "start_logit": -1.1956069469451904,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "Br",
            "probability": 0.0014928733764315357,
            "start_logit": 4.596948146820068,
            "end_logit": -3.0264816284179688,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "BrS1) culminate in the most common genotype.",
            "probability": 0.0011298227525807837,
            "start_logit": 4.596948146820068,
            "end_logit": -3.3051235675811768,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "Mutations in the SCN5A-encoded sodium channel (BrS1",
            "probability": 0.0010715245924500713,
            "start_logit": -2.21986985206604,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "1",
            "probability": 0.0009282264176817014,
            "start_logit": -2.363431930541992,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "sodium channel (BrS1",
            "probability": 0.0005258279194582322,
            "start_logit": -2.9317336082458496,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "SCN5A-encoded sodium channel (BrS1",
            "probability": 0.0003907087494286476,
            "start_logit": -3.228745222091675,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "BrS1) culminate",
            "probability": 0.0001333385071362693,
            "start_logit": 4.596948146820068,
            "end_logit": -5.4420485496521,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "S1",
            "probability": 0.00012389613520760203,
            "start_logit": -4.377264022827148,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "BrS1) cu",
            "probability": 0.00010746151006420697,
            "start_logit": 4.596948146820068,
            "end_logit": -5.657806873321533,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "channel (BrS1",
            "probability": 5.1670033671514556e-05,
            "start_logit": -5.251829624176025,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "in the SCN5A-encoded sodium channel (BrS1",
            "probability": 4.8476797840155746e-05,
            "start_logit": -5.315622329711914,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "the SCN5A-encoded sodium channel (BrS1",
            "probability": 4.421186761965716e-05,
            "start_logit": -5.407714366912842,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "encoded sodium channel (BrS1",
            "probability": 3.344141431792683e-05,
            "start_logit": -5.686912536621094,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "(BrS1)",
            "probability": 2.7319070537864175e-05,
            "start_logit": -1.1956069469451904,
            "end_logit": -1.2347995042800903,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "5A-encoded sodium channel (BrS1",
            "probability": 2.5244384437920612e-05,
            "start_logit": -5.968103885650635,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        },
        {
            "text": "-encoded sodium channel (BrS1",
            "probability": 1.4510122971153503e-05,
            "start_logit": -6.5218610763549805,
            "end_logit": 3.4587161540985107,
            "question_text": "Which mutations of SCN5A gene are implicated in Brugada syndrome?"
        }
    ],
    "535d5bac7d100faa09000001": [
        {
            "text": "varenicline",
            "probability": 0.14922207218790254,
            "start_logit": -0.7517307996749878,
            "end_logit": -2.1646173000335693,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "nicotine replacement therapy",
            "probability": 0.14253952240215484,
            "start_logit": -0.9522891044616699,
            "end_logit": -2.0098752975463867,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "nicotine replacement therapy, bupropion, and varenicline",
            "probability": 0.12210450897263521,
            "start_logit": -0.9522891044616699,
            "end_logit": -2.1646173000335693,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "bupropion, and varenicline",
            "probability": 0.1098566636635876,
            "start_logit": -1.0579899549484253,
            "end_logit": -2.1646173000335693,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "nicotine replacement therapy, bupropion",
            "probability": 0.08917373512981823,
            "start_logit": -0.9522891044616699,
            "end_logit": -2.478908061981201,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "bupropion",
            "probability": 0.08022905222916656,
            "start_logit": -1.0579899549484253,
            "end_logit": -2.478908061981201,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "varenicline-were associated with an increased risk of cardiovascular disease events using a network meta-analysis",
            "probability": 0.05807693974440896,
            "start_logit": -0.7517307996749878,
            "end_logit": -3.1082842350006104,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "bupropion, and varenicline-were associated with an increased risk of cardiovascular disease events using a network meta-analysis",
            "probability": 0.042755999448111245,
            "start_logit": -1.0579899549484253,
            "end_logit": -3.1082842350006104,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "varenicline-were associated with an increased risk of cardiovascular disease events",
            "probability": 0.03176842511835272,
            "start_logit": -0.7517307996749878,
            "end_logit": -3.7115800380706787,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "nicotine replacement therapy, bupropion, and varenicline-were associated with an increased risk of cardiovascular disease events",
            "probability": 0.0259952692858052,
            "start_logit": -0.9522891044616699,
            "end_logit": -3.7115800380706787,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "varenicline-were associated with an increased risk of cardiovascular disease events using a network",
            "probability": 0.024690361361205032,
            "start_logit": -0.7517307996749878,
            "end_logit": -3.963639974594116,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "bupropion, and varenicline-were associated with an increased risk of cardiovascular disease events",
            "probability": 0.023387781326036798,
            "start_logit": -1.0579899549484253,
            "end_logit": -3.7115800380706787,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "nicotine replacement therapy, bupropion, and varenicline-were associated with an increased risk of cardiovascular disease events using a network",
            "probability": 0.02020347530471619,
            "start_logit": -0.9522891044616699,
            "end_logit": -3.963639974594116,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "bupropion, and varenicline-were associated with an increased risk of cardiovascular disease events using a network",
            "probability": 0.01817694047550048,
            "start_logit": -1.0579899549484253,
            "end_logit": -3.963639974594116,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "varenicline-were associated with an increased risk of cardiovascular disease events using",
            "probability": 0.014121255504004856,
            "start_logit": -0.7517307996749878,
            "end_logit": -4.522371768951416,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "nicotine replacement therapy, bupropion, and varenicline-were associated with an increased risk of cardiovascular disease events using",
            "probability": 0.011555053110523832,
            "start_logit": -0.9522891044616699,
            "end_logit": -4.522371768951416,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "bupropion, and varenicline-were associated with an increased risk of cardiovascular disease events using",
            "probability": 0.010396009073360208,
            "start_logit": -1.0579899549484253,
            "end_logit": -4.522371768951416,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "varenicline-were associated with an increased risk of cardiovascular disease events using a",
            "probability": 0.009433065459317488,
            "start_logit": -0.7517307996749878,
            "end_logit": -4.9258317947387695,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "smoking cessation therapies-nicotine replacement therapy",
            "probability": 0.008595040079076929,
            "start_logit": -3.760723114013672,
            "end_logit": -2.0098752975463867,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        },
        {
            "text": "nicotine replacement therapy, bupropion, and varenicline-were associated with an increased risk of cardiovascular disease events using a",
            "probability": 0.007718830124314985,
            "start_logit": -0.9522891044616699,
            "end_logit": -4.9258317947387695,
            "question_text": "List all articles on network meta-analysis for smoking cessation"
        }
    ],
    "55031270e9bde6963400001a": [
        {
            "text": "Shwachman-Diamond syndrome",
            "probability": 0.12781948277237118,
            "start_logit": 5.783782482147217,
            "end_logit": 5.493216037750244,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita, Shwachman-Diamond syndrome",
            "probability": 0.1205505415207416,
            "start_logit": 5.7252326011657715,
            "end_logit": 5.493216037750244,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "amegakaryocytic thrombocytopenia",
            "probability": 0.11547153539079644,
            "start_logit": 5.860819339752197,
            "end_logit": 5.314584255218506,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome",
            "probability": 0.11335777835609051,
            "start_logit": 5.663712501525879,
            "end_logit": 5.493216037750244,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Shwachman-Diamond syndrome, and amegakaryocytic thrombocytopenia",
            "probability": 0.10690998248018047,
            "start_logit": 5.783782482147217,
            "end_logit": 5.314584255218506,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita, Shwachman-Diamond syndrome, and amegakaryocytic thrombocytopenia",
            "probability": 0.10083013952505657,
            "start_logit": 5.7252326011657715,
            "end_logit": 5.314584255218506,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita",
            "probability": 0.0757579867081666,
            "start_logit": 5.7252326011657715,
            "end_logit": 5.028690814971924,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia, dyskeratosis congenita",
            "probability": 0.0712378140955129,
            "start_logit": 5.663712501525879,
            "end_logit": 5.028690814971924,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia",
            "probability": 0.06591952891413369,
            "start_logit": 5.663712501525879,
            "end_logit": 4.951101779937744,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "pancytopenia include Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome",
            "probability": 0.03146173646284465,
            "start_logit": 4.3819355964660645,
            "end_logit": 5.493216037750244,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "pancytopenia include Fanconi anemia, dyskeratosis congenita",
            "probability": 0.019771606022673326,
            "start_logit": 4.3819355964660645,
            "end_logit": 5.028690814971924,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "pancytopenia include Fanconi anemia",
            "probability": 0.018295549511710352,
            "start_logit": 4.3819355964660645,
            "end_logit": 4.951101779937744,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Shwachman-Diamond syndrome,",
            "probability": 0.004769512397194632,
            "start_logit": 5.783782482147217,
            "end_logit": 2.204841136932373,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis",
            "probability": 0.004531403731847608,
            "start_logit": 5.7252326011657715,
            "end_logit": 2.2121787071228027,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita, Shwachman-Diamond syndrome,",
            "probability": 0.004498275926336211,
            "start_logit": 5.7252326011657715,
            "end_logit": 2.204841136932373,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia, dyskeratosis",
            "probability": 0.004261033201483894,
            "start_logit": 5.663712501525879,
            "end_logit": 2.2121787071228027,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome,",
            "probability": 0.004229881998119631,
            "start_logit": 5.663712501525879,
            "end_logit": 2.204841136932373,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Shwachman-Diamond",
            "probability": 0.0036488512561138157,
            "start_logit": 5.783782482147217,
            "end_logit": 1.9370094537734985,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "dyskeratosis congenita, Shwachman-Diamond",
            "probability": 0.0034413454452519427,
            "start_logit": 5.7252326011657715,
            "end_logit": 1.9370094537734985,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        },
        {
            "text": "Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond",
            "probability": 0.003236014283374175,
            "start_logit": 5.663712501525879,
            "end_logit": 1.9370094537734985,
            "question_text": "Which are the most frequent syndromes associated with inherited bone marrow failure?"
        }
    ],
    "56d2ac03f22319765a000004": [
        {
            "text": "Pseudomonas aeruginosa",
            "probability": 0.15982100894283838,
            "start_logit": 6.174737453460693,
            "end_logit": 6.297353267669678,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.11997125867477237,
            "start_logit": 5.887935161590576,
            "end_logit": 6.297353267669678,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acinetobacter baumannii",
            "probability": 0.08369977873223443,
            "start_logit": 5.887935161590576,
            "end_logit": 5.937337398529053,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterobacter species",
            "probability": 0.06864883486676816,
            "start_logit": 6.300809860229492,
            "end_logit": 5.326230525970459,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa",
            "probability": 0.06343033233151885,
            "start_logit": 5.250625133514404,
            "end_logit": 6.297353267669678,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Pseudomonas aeruginosa and Enterobacter species",
            "probability": 0.06051745000127284,
            "start_logit": 6.174737453460693,
            "end_logit": 5.326230525970459,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterococcus faecium, Staphylococcus aureus",
            "probability": 0.04795192662489232,
            "start_logit": 5.607763767242432,
            "end_logit": 5.660471439361572,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterococcus faecium",
            "probability": 0.046328751658452856,
            "start_logit": 5.607763767242432,
            "end_logit": 5.626035213470459,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.04630799051758477,
            "start_logit": 5.296013355255127,
            "end_logit": 5.937337398529053,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species",
            "probability": 0.04542803662963389,
            "start_logit": 5.887935161590576,
            "end_logit": 5.326230525970459,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella pneumoniae, Acinetobacter baumannii",
            "probability": 0.04425313895766123,
            "start_logit": 5.250625133514404,
            "end_logit": 5.937337398529053,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.04113907088315355,
            "start_logit": 5.607763767242432,
            "end_logit": 5.507230758666992,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Staphylococcus aureus",
            "probability": 0.035108686146141786,
            "start_logit": 5.296013355255127,
            "end_logit": 5.660471439361572,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Staphylococcus aureus, Klebsiella pneumoniae",
            "probability": 0.03012055676675872,
            "start_logit": 5.296013355255127,
            "end_logit": 5.507230758666992,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Enterobacter",
            "probability": 0.02974821450655278,
            "start_logit": 6.300809860229492,
            "end_logit": 4.48999547958374,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Klebsiella pneumoniae",
            "probability": 0.02878399967658577,
            "start_logit": 5.250625133514404,
            "end_logit": 5.507230758666992,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Pseudomonas aeruginosa and Enterobacter",
            "probability": 0.026224568669248282,
            "start_logit": 6.174737453460693,
            "end_logit": 4.48999547958374,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter",
            "probability": 0.019685738015694707,
            "start_logit": 5.887935161590576,
            "end_logit": 4.48999547958374,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Acinetobacter",
            "probability": 0.0015413239577917466,
            "start_logit": 5.887935161590576,
            "end_logit": 1.9427428245544434,
            "question_text": "Which ones are the ESKAPE organisms?"
        },
        {
            "text": "Pseudomonas",
            "probability": 0.001289333440442778,
            "start_logit": 6.174737453460693,
            "end_logit": 1.477424144744873,
            "question_text": "Which ones are the ESKAPE organisms?"
        }
    ],
    "515870cdd24251bc0500008f": [
        {
            "text": "OXA-48",
            "probability": 0.2330200065407332,
            "start_logit": -3.4382925033569336,
            "end_logit": -3.7272861003875732,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA",
            "probability": 0.09494980907092576,
            "start_logit": -3.4382925033569336,
            "end_logit": -4.625061988830566,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenem resistance mechanisms in 39 carbapenemase-producing and 16 other carbapenem-resistant Enterobacteriaceae.",
            "probability": 0.0860037899656608,
            "start_logit": -4.121501445770264,
            "end_logit": -4.0408101081848145,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA-48 producers were poorly detected, but all systems reliably detected isolates with KPC",
            "probability": 0.07699230942765993,
            "start_logit": -3.4382925033569336,
            "end_logit": -4.834704875946045,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenem-resistant Enterobacteriaceae.",
            "probability": 0.06199963427470802,
            "start_logit": -4.448764324188232,
            "end_logit": -4.0408101081848145,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenemase-producing and 16 other carbapenem-resistant Enterobacteriaceae.",
            "probability": 0.061080461689503186,
            "start_logit": -4.463700771331787,
            "end_logit": -4.0408101081848145,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenem",
            "probability": 0.05723249816607792,
            "start_logit": -4.121501445770264,
            "end_logit": -4.448079586029053,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenem resistance mechanisms in 39 carbapenemase-producing and 16 other carbapenem",
            "probability": 0.04484859043727438,
            "start_logit": -4.121501445770264,
            "end_logit": -4.691909313201904,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenem resistance mechanisms in 39 carbapenemase",
            "probability": 0.034270027056391594,
            "start_logit": -4.121501445770264,
            "end_logit": -4.960930347442627,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenemase-producing and 16 other carbapenem",
            "probability": 0.031851766196884124,
            "start_logit": -4.463700771331787,
            "end_logit": -4.691909313201904,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenem resistance mechanisms in 39",
            "probability": 0.02728588857817123,
            "start_logit": -4.121501445770264,
            "end_logit": -5.188831806182861,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenemase",
            "probability": 0.024338800366262223,
            "start_logit": -4.463700771331787,
            "end_logit": -4.960930347442627,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "39 carbapenemase-producing and 16 other carbapenem-resistant Enterobacteriaceae.",
            "probability": 0.02370589344556987,
            "start_logit": -5.4101691246032715,
            "end_logit": -4.0408101081848145,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": ".",
            "probability": 0.023588466941202053,
            "start_logit": -5.415134906768799,
            "end_logit": -4.0408101081848145,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "KPC",
            "probability": 0.0219084407729548,
            "start_logit": -4.695126056671143,
            "end_logit": -4.834704875946045,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenem resistance",
            "probability": 0.02154561240305369,
            "start_logit": -4.121501445770264,
            "end_logit": -5.425029277801514,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "We assessed the ability of three commercial systems to infer carbapenem",
            "probability": 0.01974631289445564,
            "start_logit": -5.185656547546387,
            "end_logit": -4.448079586029053,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "carbapenem resistance mechanisms in 39 carbapenemase-producing and 16 other carbapenem-resistant Enterobacteriaceae",
            "probability": 0.01929758379577213,
            "start_logit": -4.121501445770264,
            "end_logit": -5.535221576690674,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "48",
            "probability": 0.018576530175510964,
            "start_logit": -5.967517852783203,
            "end_logit": -3.7272861003875732,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        },
        {
            "text": "OXA-48 producers were poorly detected,",
            "probability": 0.01775757780122851,
            "start_logit": -3.4382925033569336,
            "end_logit": -6.301598072052002,
            "question_text": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\r\nList the most frequent carbapenemases found in Enterobacteriaceae."
        }
    ],
    "52f4f1d62059c6d71c00001c": [
        {
            "text": "arrhythmia",
            "probability": 0.3110707399654004,
            "start_logit": 4.193705081939697,
            "end_logit": 4.432210922241211,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "life-threatening arrhythmia",
            "probability": 0.19548421334745536,
            "start_logit": 3.7291643619537354,
            "end_logit": 4.432210922241211,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "arrhythmia and thromboembolic complications",
            "probability": 0.1730001958951211,
            "start_logit": 4.193705081939697,
            "end_logit": 3.8454833030700684,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "thromboembolic complications",
            "probability": 0.1675099578448627,
            "start_logit": 4.161455154418945,
            "end_logit": 3.8454833030700684,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "life-threatening arrhythmia and thromboembolic complications",
            "probability": 0.108717416518426,
            "start_logit": 3.7291643619537354,
            "end_logit": 3.8454833030700684,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "arrhythmia and thromboembolic",
            "probability": 0.00971769723789278,
            "start_logit": 4.193705081939697,
            "end_logit": 0.9661392569541931,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "thromboembolic",
            "probability": 0.009409301800186372,
            "start_logit": 4.161455154418945,
            "end_logit": 0.9661392569541931,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "life-threatening arrhythmia and thromboembolic",
            "probability": 0.0061068308781131375,
            "start_logit": 3.7291643619537354,
            "end_logit": 0.9661392569541931,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "significant risk of life-threatening arrhythmia",
            "probability": 0.004097118613041913,
            "start_logit": -0.13603131473064423,
            "end_logit": 4.432210922241211,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "arrhythmia and thromboembolic complications.",
            "probability": 0.002292667822485973,
            "start_logit": 4.193705081939697,
            "end_logit": -0.47809329628944397,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "significant risk of life-threatening arrhythmia and thromboembolic complications",
            "probability": 0.002278588859693573,
            "start_logit": -0.13603131473064423,
            "end_logit": 3.8454833030700684,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "risk of life-threatening arrhythmia",
            "probability": 0.0022395145126631617,
            "start_logit": -0.7400561571121216,
            "end_logit": 4.432210922241211,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "thromboembolic complications.",
            "probability": 0.0022199089909107394,
            "start_logit": 4.161455154418945,
            "end_logit": -0.47809329628944397,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "life-threatening arrhythmia and thromboembolic complications.",
            "probability": 0.0014407667072626113,
            "start_logit": 3.7291643619537354,
            "end_logit": -0.47809329628944397,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "risk of life-threatening arrhythmia and thromboembolic complications",
            "probability": 0.0012454930651587068,
            "start_logit": -0.7400561571121216,
            "end_logit": 3.8454833030700684,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "rrhythmia",
            "probability": 0.0008834133277695805,
            "start_logit": -1.6702773571014404,
            "end_logit": 4.432210922241211,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "a significant risk of life-threatening arrhythmia",
            "probability": 0.0006357011597647752,
            "start_logit": -1.9993419647216797,
            "end_logit": 4.432210922241211,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "associated with a significant risk of life-threatening arrhythmia",
            "probability": 0.0006267046887389555,
            "start_logit": -2.0135951042175293,
            "end_logit": 4.432210922241211,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "cardiomyopathy that is associated with a significant risk of life-threatening arrhythmia",
            "probability": 0.0005324635436817248,
            "start_logit": -2.17655611038208,
            "end_logit": 4.432210922241211,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        },
        {
            "text": "rrhythmia and thromboembolic complications",
            "probability": 0.000491305221370217,
            "start_logit": -1.6702773571014404,
            "end_logit": 3.8454833030700684,
            "question_text": "Which are the clinical characteristics of isolated Non-compaction cardiomyopathy?"
        }
    ],
    "533c384dc45e133714000006": [
        {
            "text": "inactive X chromosome",
            "probability": 0.26703647441910205,
            "start_logit": 2.2239327430725098,
            "end_logit": 2.5599048137664795,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "intergenic regions",
            "probability": 0.2537699262762774,
            "start_logit": 2.291185140609741,
            "end_logit": 2.441695213317871,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "genes that are inactive in liver, and intergenic regions",
            "probability": 0.10797886454789929,
            "start_logit": 1.4366925954818726,
            "end_logit": 2.441695213317871,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "X chromosome",
            "probability": 0.08761100950070626,
            "start_logit": 1.1094541549682617,
            "end_logit": 2.5599048137664795,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "the inactive X chromosome",
            "probability": 0.05697162776455282,
            "start_logit": 0.6791008710861206,
            "end_logit": 2.5599048137664795,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "genes that are active in liver, genes that are inactive in liver, and intergenic regions",
            "probability": 0.03524606631674918,
            "start_logit": 0.3171110153198242,
            "end_logit": 2.441695213317871,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "liver, genes that are inactive in liver, and intergenic regions",
            "probability": 0.03364770222731967,
            "start_logit": 0.2707018554210663,
            "end_logit": 2.441695213317871,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "inactive X chromosome,",
            "probability": 0.021850382380196934,
            "start_logit": 2.2239327430725098,
            "end_logit": 0.056737978011369705,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "inactive X",
            "probability": 0.01930798681243946,
            "start_logit": 2.2239327430725098,
            "end_logit": -0.0669616088271141,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "genes that are inactive in liver",
            "probability": 0.017435042933010327,
            "start_logit": 1.4366925954818726,
            "end_logit": 0.6182418465614319,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "X chromosome, consistent with our previous immunofluorescence studies. This preferential localization was seen on genes that are active in liver",
            "probability": 0.016621841821417085,
            "start_logit": 1.1094541549682617,
            "end_logit": 0.8977157473564148,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "one site showing a small amount of enrichment. In contrast, macroH2A1 was concentrated on the inactive X chromosome",
            "probability": 0.012382064585839288,
            "start_logit": -0.8472034931182861,
            "end_logit": 2.5599048137664795,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "intergenic regions but was absent from four regions",
            "probability": 0.010588378442720169,
            "start_logit": 2.291185140609741,
            "end_logit": -0.7349758148193359,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "intergenic regions but was absent from four regions that escape X inactivation",
            "probability": 0.010086700813661507,
            "start_logit": 2.291185140609741,
            "end_logit": -0.7835150361061096,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "inactive",
            "probability": 0.009680305504512593,
            "start_logit": 2.2239327430725098,
            "end_logit": -0.7573869824409485,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "inactive X chromosome, consistent with our previous immunofluorescence studies. This preferential localization was seen on genes",
            "probability": 0.009663851598967658,
            "start_logit": 2.2239327430725098,
            "end_logit": -0.7590881586074829,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "liver, and intergenic regions",
            "probability": 0.008242098930126786,
            "start_logit": -1.1359878778457642,
            "end_logit": 2.441695213317871,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "genes that are active in liver",
            "probability": 0.007526081063339539,
            "start_logit": 0.3171110153198242,
            "end_logit": 0.8977157473564148,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "liver",
            "probability": 0.007184782899803459,
            "start_logit": 0.2707018554210663,
            "end_logit": 0.8977157473564148,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        },
        {
            "text": "X chromosome,",
            "probability": 0.00716881116135856,
            "start_logit": 1.1094541549682617,
            "end_logit": 0.056737978011369705,
            "question_text": "In which genomic positions is the histone variant macroH2A enriched?"
        }
    ],
    "54e071e11388e8454a00000d": [
        {
            "text": "fludarabin Ara-C amsacrin",
            "probability": 0.5411450471447384,
            "start_logit": 5.806012153625488,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabin",
            "probability": 0.29421938709765855,
            "start_logit": 5.806012153625488,
            "end_logit": 4.749406337738037,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "amsacrin",
            "probability": 0.06021367256756643,
            "start_logit": 3.6102242469787598,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabin Ara-C",
            "probability": 0.05091210365089088,
            "start_logit": 5.806012153625488,
            "end_logit": 2.9951813220977783,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "Ara-C amsacrin",
            "probability": 0.0478396637346894,
            "start_logit": 3.3801798820495605,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "Ara-C",
            "probability": 0.004500859670684235,
            "start_logit": 3.3801798820495605,
            "end_logit": 2.9951813220977783,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "C amsacrin",
            "probability": 0.00036077992451717097,
            "start_logit": -1.50716233253479,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "flu",
            "probability": 0.00014142297151992962,
            "start_logit": 5.806012153625488,
            "end_logit": -2.8909194469451904,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabi",
            "probability": 0.00010487950871860557,
            "start_logit": 5.806012153625488,
            "end_logit": -3.1898624897003174,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "rin",
            "probability": 9.933059922319835e-05,
            "start_logit": -2.7969768047332764,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "crin",
            "probability": 7.627120109281306e-05,
            "start_logit": -3.0611350536346436,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabin Ara-C amsacrin (FLAMSA)",
            "probability": 6.812307610196881e-05,
            "start_logit": 5.806012153625488,
            "end_logit": -3.621358633041382,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "abin Ara-C amsacrin",
            "probability": 5.459032248335336e-05,
            "start_logit": -3.395573854446411,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabin Ara-C amsac",
            "probability": 4.9421628562435384e-05,
            "start_logit": 5.806012153625488,
            "end_logit": -3.942286491394043,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "darabin Ara-C amsacrin",
            "probability": 4.0953432767988464e-05,
            "start_logit": -3.682994842529297,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "n Ara-C amsacrin",
            "probability": 3.778721413950955e-05,
            "start_logit": -3.7634596824645996,
            "end_logit": 5.358767986297607,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabin Ara-C am",
            "probability": 3.6138968352184136e-05,
            "start_logit": 5.806012153625488,
            "end_logit": -4.255302906036377,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "fludarabin A",
            "probability": 3.5943686084018026e-05,
            "start_logit": 5.806012153625488,
            "end_logit": -4.260721206665039,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "C",
            "probability": 3.3942960411621306e-05,
            "start_logit": -1.50716233253479,
            "end_logit": 2.9951813220977783,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        },
        {
            "text": "abin",
            "probability": 2.9680639797521474e-05,
            "start_logit": -3.395573854446411,
            "end_logit": 4.749406337738037,
            "question_text": "Which agents are included in the FLAMSA chemotherapy regimen?"
        }
    ],
    "5506e2ff8e1671127b00000d": [
        {
            "text": "IKKalpha",
            "probability": 0.16252996478972678,
            "start_logit": 3.1915440559387207,
            "end_logit": 2.8220748901367188,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKbeta",
            "probability": 0.14971973177593384,
            "start_logit": 3.265413284301758,
            "end_logit": 2.6661083698272705,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKalpha and IKKbeta",
            "probability": 0.13905866064952205,
            "start_logit": 3.1915440559387207,
            "end_logit": 2.6661083698272705,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKbeta, the IKK complex contains NEMO/IKKgamma",
            "probability": 0.12653941869129892,
            "start_logit": 3.265413284301758,
            "end_logit": 2.497897148132324,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKalpha and IKKbeta, the IKK complex contains NEMO/IKKgamma",
            "probability": 0.11752894474133431,
            "start_logit": 3.1915440559387207,
            "end_logit": 2.497897148132324,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKgamma",
            "probability": 0.09712486919396558,
            "start_logit": 3.000856876373291,
            "end_logit": 2.497897148132324,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "NEMO/IKKgamma",
            "probability": 0.07366526096144906,
            "start_logit": 2.724390745162964,
            "end_logit": 2.497897148132324,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKbeta, the IKK complex contains NEMO",
            "probability": 0.04660914403866853,
            "start_logit": 3.265413284301758,
            "end_logit": 1.4991400241851807,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKalpha and IKKbeta, the IKK complex contains NEMO",
            "probability": 0.04329025351005693,
            "start_logit": 3.1915440559387207,
            "end_logit": 1.4991400241851807,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "NEMO",
            "probability": 0.027133637836399965,
            "start_logit": 2.724390745162964,
            "end_logit": 1.4991400241851807,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKbeta, the IKK complex contains NEMO/IKKgamma,",
            "probability": 0.003920982407765169,
            "start_logit": 3.265413284301758,
            "end_logit": -0.9763144850730896,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKalpha and IKKbeta, the IKK complex contains NEMO/IKKgamma,",
            "probability": 0.003641781584742367,
            "start_logit": 3.1915440559387207,
            "end_logit": -0.9763144850730896,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKgamma,",
            "probability": 0.0030095357431274374,
            "start_logit": 3.000856876373291,
            "end_logit": -0.9763144850730896,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "NEMO/IKKgamma,",
            "probability": 0.002282610393508416,
            "start_logit": 2.724390745162964,
            "end_logit": -0.9763144850730896,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKbeta,",
            "probability": 0.0009677834543144906,
            "start_logit": 3.265413284301758,
            "end_logit": -2.375403642654419,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKalpha and IKKbeta,",
            "probability": 0.0008988706388891177,
            "start_logit": 3.1915440559387207,
            "end_logit": -2.375403642654419,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKgamma, an additional subunit with regulatory and adaptor functions. NEMO",
            "probability": 0.0008041273071783091,
            "start_logit": 3.000856876373291,
            "end_logit": -2.296097993850708,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "NEMO/IKKgamma, an additional subunit with regulatory and adaptor functions. NEMO",
            "probability": 0.0006098978399777123,
            "start_logit": 2.724390745162964,
            "end_logit": -2.296097993850708,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKbeta, the IKK complex contains NEMO/IKK",
            "probability": 0.0003445286207193044,
            "start_logit": 3.265413284301758,
            "end_logit": -3.4082348346710205,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        },
        {
            "text": "IKKalpha and IKKbeta, the IKK complex contains NEMO/IKK",
            "probability": 0.00031999582142154694,
            "start_logit": 3.1915440559387207,
            "end_logit": -3.4082348346710205,
            "question_text": "Which are the subunits of the IkB protein kinase (IKK)?"
        }
    ],
    "53189b05b166e2b80600001e": [
        {
            "text": "lacrimal",
            "probability": 0.3239092780062131,
            "start_logit": 5.497759819030762,
            "end_logit": 4.567935943603516,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary and lacrimal",
            "probability": 0.29981076064944573,
            "start_logit": 5.420447826385498,
            "end_logit": 4.567935943603516,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lacrimal glands",
            "probability": 0.12517161320147394,
            "start_logit": 5.497759819030762,
            "end_logit": 3.6171581745147705,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary",
            "probability": 0.12333802828081734,
            "start_logit": 5.420447826385498,
            "end_logit": 3.679713249206543,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary and lacrimal glands",
            "probability": 0.11585897383566844,
            "start_logit": 5.420447826385498,
            "end_logit": 3.6171581745147705,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "saliva",
            "probability": 0.00942479818401188,
            "start_logit": 5.420447826385498,
            "end_logit": 1.1081287860870361,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "sa",
            "probability": 0.0006332568799667365,
            "start_logit": 5.420447826385498,
            "end_logit": -1.5920946598052979,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lac",
            "probability": 0.0003170866936373652,
            "start_logit": 5.497759819030762,
            "end_logit": -2.361107587814331,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary and lac",
            "probability": 0.0002934957695451153,
            "start_logit": 5.420447826385498,
            "end_logit": -2.361107587814331,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "la",
            "probability": 0.00017374345527092542,
            "start_logit": 5.497759819030762,
            "end_logit": -2.962702989578247,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary and la",
            "probability": 0.0001608171207792323,
            "start_logit": 5.420447826385498,
            "end_logit": -2.962702989578247,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "glands",
            "probability": 0.00015746452648968744,
            "start_logit": -1.18048095703125,
            "end_logit": 3.6171581745147705,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "lacrimal glands leading to xerostomia (dry mouth) and xerophthalmia (dry eyes).",
            "probability": 0.00015568189074459783,
            "start_logit": 5.497759819030762,
            "end_logit": -3.0724680423736572,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "salivary and lacrimal glands leading to xerostomia (dry mouth) and xerophthalmia (dry eyes).",
            "probability": 0.00014409931808926596,
            "start_logit": 5.420447826385498,
            "end_logit": -3.0724680423736572,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "livary and lacrimal",
            "probability": 0.00014259678132581003,
            "start_logit": -2.230437994003296,
            "end_logit": 4.567935943603516,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "rimal",
            "probability": 9.682144441711409e-05,
            "start_logit": -2.6175904273986816,
            "end_logit": 4.567935943603516,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "livary",
            "probability": 5.866235691413566e-05,
            "start_logit": -2.230437994003296,
            "end_logit": 3.679713249206543,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "livary and lacrimal glands",
            "probability": 5.510514939787269e-05,
            "start_logit": -2.230437994003296,
            "end_logit": 3.6171581745147705,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "the salivary and lacrimal",
            "probability": 5.434257980814678e-05,
            "start_logit": -3.195150852203369,
            "end_logit": 4.567935943603516,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        },
        {
            "text": "ry and lacrimal",
            "probability": 4.33738759837516e-05,
            "start_logit": -3.4206016063690186,
            "end_logit": 4.567935943603516,
            "question_text": "Which glands are subject to attack by lymphocytes in Sjogren's syndrome?"
        }
    ],
    "51716a438ed59a060a00000a": [
        {
            "text": "Softberry",
            "probability": 0.44788097894695683,
            "start_logit": 2.820613384246826,
            "end_logit": 1.728540301322937,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Softberry gene finding software",
            "probability": 0.3746170133856493,
            "start_logit": 2.820613384246826,
            "end_logit": 1.5499169826507568,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "EGASP",
            "probability": 0.035619303026224736,
            "start_logit": 1.1481581926345825,
            "end_logit": 0.8693556785583496,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Softberry gene finding",
            "probability": 0.03226944244790138,
            "start_logit": 2.820613384246826,
            "end_logit": -0.9018664956092834,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "ENCODE gene prediction workshop (EGASP",
            "probability": 0.031156843545967275,
            "start_logit": 1.0143043994903564,
            "end_logit": 0.8693556785583496,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "EGASP)",
            "probability": 0.01234601559574811,
            "start_logit": 1.1481581926345825,
            "end_logit": -0.1901986449956894,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "ENCODE gene prediction workshop (EGASP)",
            "probability": 0.010799281391036414,
            "start_logit": 1.0143043994903564,
            "end_logit": -0.1901986449956894,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Softberry gene finding software to predict genes, pseudogenes",
            "probability": 0.008672696746940448,
            "start_logit": 2.820613384246826,
            "end_logit": -2.2158074378967285,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Softberry gene finding software to predict genes, pseudogenes and promoters",
            "probability": 0.007738342920346569,
            "start_logit": 2.820613384246826,
            "end_logit": -2.3297996520996094,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "ENCODE gene prediction",
            "probability": 0.007140166412888378,
            "start_logit": 1.0143043994903564,
            "end_logit": -0.6039421558380127,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "gene finding software",
            "probability": 0.005480194399169176,
            "start_logit": -1.4041502475738525,
            "end_logit": 1.5499169826507568,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "ENCODE gene prediction workshop",
            "probability": 0.004473443130344248,
            "start_logit": 1.0143043994903564,
            "end_logit": -1.0715198516845703,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "(EGASP",
            "probability": 0.004263519741575752,
            "start_logit": -0.9746344685554504,
            "end_logit": 0.8693556785583496,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Softberry gene",
            "probability": 0.0033829029331114003,
            "start_logit": 2.820613384246826,
            "end_logit": -3.1572530269622803,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Soft",
            "probability": 0.002838531193076367,
            "start_logit": 2.820613384246826,
            "end_logit": -3.332700490951538,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Softberry gene finding software to predict genes, pseudogenes and promoters in 44 selected ENCODE sequences",
            "probability": 0.0025897044065392254,
            "start_logit": 2.820613384246826,
            "end_logit": -3.424443483352661,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "Softberry gene finding software to predict genes",
            "probability": 0.0024093586898098,
            "start_logit": 2.820613384246826,
            "end_logit": -3.496626615524292,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "The ENCODE gene prediction workshop (EGASP",
            "probability": 0.002320627392782243,
            "start_logit": -1.5828919410705566,
            "end_logit": 0.8693556785583496,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "software",
            "probability": 0.0021450160785361386,
            "start_logit": -2.3421437740325928,
            "end_logit": 1.5499169826507568,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        },
        {
            "text": "used Softberry",
            "probability": 0.0018566176153959702,
            "start_logit": -2.6651577949523926,
            "end_logit": 1.728540301322937,
            "question_text": "Name five popular  computer  programs used to identify genes in genomic sequences"
        }
    ],
    "514168ab23fec9037500000a": [
        {
            "text": "bFGF",
            "probability": 0.5716845647615815,
            "start_logit": 3.7197422981262207,
            "end_logit": 3.396613359451294,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "bFGF increases lactate production of adipocytes. This result indicates that bFGF",
            "probability": 0.1841884054912571,
            "start_logit": 2.587114095687866,
            "end_logit": 3.396613359451294,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF-1\u03b1 directly upregulates GLUT1. In addition, it was observed that bFGF",
            "probability": 0.07572575915811637,
            "start_logit": 1.8177658319473267,
            "end_logit": 3.27712082862854,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF-1\u03b1",
            "probability": 0.033356711502604906,
            "start_logit": 2.7239608764648438,
            "end_logit": 1.5510663986206055,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Hypoxia-inducible factor-1\u03b1",
            "probability": 0.03328041961631768,
            "start_logit": 2.197736978530884,
            "end_logit": 2.075000524520874,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "bFGF reprograms the metabolism toward glycolysis. Intraperitoneal injection of bFGF",
            "probability": 0.020956037114634733,
            "start_logit": 3.7197422981262207,
            "end_logit": 0.09045275300741196,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1",
            "probability": 0.019708206027620585,
            "start_logit": 2.197736978530884,
            "end_logit": 1.5510663986206055,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "bFGF-induced HIF-1\u03b1",
            "probability": 0.010686633387839636,
            "start_logit": 1.896241545677185,
            "end_logit": 1.2405204772949219,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "bFGF regulates the metabolism of adipocytes via HIF-1\u03b1",
            "probability": 0.009813683615576779,
            "start_logit": 1.9234923124313354,
            "end_logit": 1.1280536651611328,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF-1\u03b1 and GLUT1 in adipose tissues, suggesting that bFGF",
            "probability": 0.008739411473676273,
            "start_logit": 1.8325577974319458,
            "end_logit": 1.103053331375122,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF-1\u03b1)",
            "probability": 0.007132320525169503,
            "start_logit": 2.7239608764648438,
            "end_logit": 0.0084440428763628,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF-1\u03b1-GLUT1 regulation in vivo. We also found that bFGF",
            "probability": 0.004870775624014839,
            "start_logit": 2.9892868995666504,
            "end_logit": -0.6382654309272766,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1)",
            "probability": 0.0042140018015292225,
            "start_logit": 2.197736978530884,
            "end_logit": 0.0084440428763628,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF-1",
            "probability": 0.0037344962301006372,
            "start_logit": 2.7239608764648438,
            "end_logit": -0.6385796666145325,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF-1\u03b1),",
            "probability": 0.0029568231472533973,
            "start_logit": 2.7239608764648438,
            "end_logit": -0.8720771670341492,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF-1\u03b1-GLUT1",
            "probability": 0.0023046797509303648,
            "start_logit": 2.9892868995666504,
            "end_logit": -1.3865768909454346,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Hypoxia-inducible factor-1\u03b1 (HIF-1",
            "probability": 0.002206459144105021,
            "start_logit": 2.197736978530884,
            "end_logit": -0.6385796666145325,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "HIF",
            "probability": 0.0018334223348378247,
            "start_logit": 2.9892868995666504,
            "end_logit": -1.6153342723846436,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1),",
            "probability": 0.0017469851537600383,
            "start_logit": 2.197736978530884,
            "end_logit": -0.8720771670341492,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        },
        {
            "text": "Hypoxia-inducible factor-1",
            "probability": 0.0008602041390739297,
            "start_logit": 2.197736978530884,
            "end_logit": -1.5805542469024658,
            "question_text": "Which are the major transcription factors regulating glycolysis in mammals?"
        }
    ],
    "53215fca9b2d7acc7e000005": [
        {
            "text": "MIB",
            "probability": 0.20474001284285015,
            "start_logit": 4.612376689910889,
            "end_logit": 4.012653827667236,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MIB) complex",
            "probability": 0.18825054002920508,
            "start_logit": 4.612376689910889,
            "end_logit": 3.9286866188049316,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "inter-membrane space bridging (MIB",
            "probability": 0.17127171279700107,
            "start_logit": 4.433887004852295,
            "end_logit": 4.012653827667236,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "inter-membrane space bridging (MIB) complex",
            "probability": 0.15747772981976885,
            "start_logit": 4.433887004852295,
            "end_logit": 3.9286866188049316,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "inter-membrane space bridging",
            "probability": 0.11072590165559919,
            "start_logit": 4.433887004852295,
            "end_logit": 3.576460361480713,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial inter-membrane space bridging (MIB",
            "probability": 0.03304024224587824,
            "start_logit": 2.7883620262145996,
            "end_logit": 4.012653827667236,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial inter-membrane space bridging (MIB) complex",
            "probability": 0.030379227582917195,
            "start_logit": 2.7883620262145996,
            "end_logit": 3.9286866188049316,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial inter-membrane space bridging",
            "probability": 0.021360273414970755,
            "start_logit": 2.7883620262145996,
            "end_logit": 3.576460361480713,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MIB)",
            "probability": 0.01300159004721076,
            "start_logit": 4.612376689910889,
            "end_logit": 1.2559845447540283,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "(MIB",
            "probability": 0.01228598924464973,
            "start_logit": 1.7990952730178833,
            "end_logit": 4.012653827667236,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "(MIB) complex",
            "probability": 0.01129649294236178,
            "start_logit": 1.7990952730178833,
            "end_logit": 3.9286866188049316,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "inter-membrane space bridging (MIB)",
            "probability": 0.010876255039504321,
            "start_logit": 4.433887004852295,
            "end_logit": 1.2559845447540283,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "inter-membrane space",
            "probability": 0.008236326094340695,
            "start_logit": 4.433887004852295,
            "end_logit": 0.9779569506645203,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MIB) complex (Mitofilin, Sam50",
            "probability": 0.006640791594324114,
            "start_logit": 4.612376689910889,
            "end_logit": 0.5841440558433533,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "inter-membrane space bridging (MIB) complex (Mitofilin, Sam50",
            "probability": 0.005555239227032888,
            "start_logit": 4.433887004852295,
            "end_logit": 0.5841440558433533,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "bridging (MIB",
            "probability": 0.004227248156779393,
            "start_logit": 0.7321869730949402,
            "end_logit": 4.012653827667236,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "bridging (MIB) complex",
            "probability": 0.003886791532840193,
            "start_logit": 0.7321869730949402,
            "end_logit": 3.9286866188049316,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "bridging",
            "probability": 0.002732884818149397,
            "start_logit": 0.7321869730949402,
            "end_logit": 3.576460361480713,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "mitochondrial inter-membrane space bridging (MIB)",
            "probability": 0.002098152084571604,
            "start_logit": 2.7883620262145996,
            "end_logit": 1.2559845447540283,
            "question_text": "Which protein complexes contain mitofilin?"
        },
        {
            "text": "MIB) complex (Mitofilin",
            "probability": 0.0019165988300444761,
            "start_logit": 4.612376689910889,
            "end_logit": -0.6585349440574646,
            "question_text": "Which protein complexes contain mitofilin?"
        }
    ],
    "515c4f05298dcd4e51000006": [
        {
            "text": "KCND2",
            "probability": 0.11846377972155787,
            "start_logit": 5.261913776397705,
            "end_logit": 4.971569538116455,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCNA4",
            "probability": 0.1054678172628479,
            "start_logit": 4.972177505493164,
            "end_logit": 5.14510440826416,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND2, KCND3",
            "probability": 0.09998270629633059,
            "start_logit": 5.261913776397705,
            "end_logit": 4.80195951461792,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCNA4, KCND2",
            "probability": 0.08866551103511121,
            "start_logit": 4.972177505493164,
            "end_logit": 4.971569538116455,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND3",
            "probability": 0.087152507986382,
            "start_logit": 5.124576091766357,
            "end_logit": 4.80195951461792,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCNA4, KCND2, KCND3",
            "probability": 0.07483314958609528,
            "start_logit": 4.972177505493164,
            "end_logit": 4.80195951461792,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND2, KCND3 and KCNIP2",
            "probability": 0.06529640846661297,
            "start_logit": 5.261913776397705,
            "end_logit": 4.375899314880371,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND3 and KCNIP2",
            "probability": 0.05691730071300741,
            "start_logit": 5.124576091766357,
            "end_logit": 4.375899314880371,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND2 and KCND3",
            "probability": 0.050515171242608695,
            "start_logit": 4.787439346313477,
            "end_logit": 4.593710422515869,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCNA4, KCND2, KCND3 and KCNIP2",
            "probability": 0.04887181076830042,
            "start_logit": 4.972177505493164,
            "end_logit": 4.375899314880371,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCNIP2",
            "probability": 0.047964015345560586,
            "start_logit": 4.953427791595459,
            "end_logit": 4.375899314880371,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND3 expression and decreased KCNA4",
            "probability": 0.044370357410748934,
            "start_logit": 4.814351558685303,
            "end_logit": 4.437096118927002,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND2 and KCND3 expression and decreased KCNA4",
            "probability": 0.04319217774861634,
            "start_logit": 4.787439346313477,
            "end_logit": 4.437096118927002,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND3 expression and decreased KCNA4 transcription, while KCNIP2",
            "probability": 0.017773685156024475,
            "start_logit": 4.814351558685303,
            "end_logit": 3.5222434997558594,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND2 and KCND3 expression and decreased KCNA4 transcription, while KCNIP2",
            "probability": 0.017301735061547592,
            "start_logit": 4.787439346313477,
            "end_logit": 3.5222434997558594,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCNA4 transcription, while KCNIP2",
            "probability": 0.013433085069859949,
            "start_logit": 4.534353256225586,
            "end_logit": 3.5222434997558594,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "TRalpha1) and beta1 (TRbeta1) in regulation of KCNA4",
            "probability": 0.006178541195636769,
            "start_logit": 2.1348538398742676,
            "end_logit": 5.14510440826416,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND3 transcription, the TRbeta1 aporeceptor suppressed KCND3",
            "probability": 0.005439084433989367,
            "start_logit": 3.5488646030426025,
            "end_logit": 3.6036221981048584,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "TRalpha1) and beta1 (TRbeta1) in regulation of KCNA4, KCND2",
            "probability": 0.005194224425801191,
            "start_logit": 2.1348538398742676,
            "end_logit": 4.971569538116455,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        },
        {
            "text": "KCND2/3",
            "probability": 0.0029869310733604895,
            "start_logit": 3.84706449508667,
            "end_logit": 2.7060580253601074,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the heart?"
        }
    ],
    "56ae40110a360a5e45000009": [
        {
            "text": "DEEP",
            "probability": 0.7147605632080324,
            "start_logit": 2.1558725833892822,
            "end_logit": 2.639328718185425,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble prediction framework. DEEP",
            "probability": 0.15922074210502302,
            "start_logit": 2.1558725833892822,
            "end_logit": 1.1376726627349854,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble prediction framework",
            "probability": 0.030833254223759727,
            "start_logit": 2.1558725833892822,
            "end_logit": -0.5040251016616821,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP-VISTA",
            "probability": 0.021063177317827152,
            "start_logit": 1.1114459037780762,
            "end_logit": 0.15933415293693542,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP uses features derived from histone modification marks or attributes coming from sequence characteristics. Experimental results indicate that DEEP",
            "probability": 0.017045495789266518,
            "start_logit": 0.17635537683963776,
            "end_logit": 0.8827843070030212,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP,",
            "probability": 0.012069672115819927,
            "start_logit": 2.1558725833892822,
            "end_logit": -1.4419230222702026,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP-VISTA, when tested on an independent test set, achieved GM of 80.1% and accuracy of 89.64%. DEEP",
            "probability": 0.011592915272487594,
            "start_logit": 1.1114459037780762,
            "end_logit": -0.43779805302619934,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble prediction",
            "probability": 0.008944869509375909,
            "start_logit": 2.1558725833892822,
            "end_logit": -1.7415387630462646,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble",
            "probability": 0.005021318544147151,
            "start_logit": 2.1558725833892822,
            "end_logit": -2.3189263343811035,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP framework is publicly available at http://cbrc.kaust.edu.sa/deep",
            "probability": 0.00458693309642641,
            "start_logit": 0.0506192110478878,
            "end_logit": -0.3041538894176483,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "deep",
            "probability": 0.0030514627496238023,
            "start_logit": -0.3569713532924652,
            "end_logit": -0.3041538894176483,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel ensemble prediction framework.",
            "probability": 0.002697962245731649,
            "start_logit": 2.1558725833892822,
            "end_logit": -2.940122127532959,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "ensemble prediction framework. DEEP",
            "probability": 0.002662014629905954,
            "start_logit": -1.9353357553482056,
            "end_logit": 1.1376726627349854,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP performs better than four state-of-the-art methods",
            "probability": 0.001719518717962172,
            "start_logit": 0.6063605546951294,
            "end_logit": -1.8410624265670776,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP framework",
            "probability": 0.001364058251376903,
            "start_logit": 0.0506192110478878,
            "end_logit": -1.5169012546539307,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "DEEP, a novel",
            "probability": 0.000970400016365941,
            "start_logit": 2.1558725833892822,
            "end_logit": -3.9626657962799072,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "novel ensemble prediction framework. DEEP",
            "probability": 0.0006653460365185993,
            "start_logit": -3.321866989135742,
            "end_logit": 1.1376726627349854,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "framework. DEEP",
            "probability": 0.0006110757418961799,
            "start_logit": -3.4069533348083496,
            "end_logit": 1.1376726627349854,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "prediction framework. DEEP",
            "probability": 0.0006037186618732167,
            "start_logit": -3.4190659523010254,
            "end_logit": 1.1376726627349854,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        },
        {
            "text": "ensemble prediction framework",
            "probability": 0.0005155017665796232,
            "start_logit": -1.9353357553482056,
            "end_logit": -0.5040251016616821,
            "question_text": "Which computational frameworks are available for predicting enhancers?"
        }
    ],
    "5311d130e3eabad021000009": [
        {
            "text": "amyloid and tau",
            "probability": 0.46131492398207796,
            "start_logit": 5.108263969421387,
            "end_logit": 4.256698131561279,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau",
            "probability": 0.3213468515483039,
            "start_logit": 4.7467041015625,
            "end_logit": 4.256698131561279,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "amyloid",
            "probability": 0.21662503787344004,
            "start_logit": 5.108263969421387,
            "end_logit": 3.5007851123809814,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "am",
            "probability": 0.0002301937650170391,
            "start_logit": 5.108263969421387,
            "end_logit": -3.3462166786193848,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "amyloid and ta",
            "probability": 0.00013252911991250364,
            "start_logit": 5.108263969421387,
            "end_logit": -3.8983356952667236,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "u",
            "probability": 0.00012753508359278012,
            "start_logit": -3.0851807594299316,
            "end_logit": 4.256698131561279,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "ta",
            "probability": 9.231831273684352e-05,
            "start_logit": 4.7467041015625,
            "end_logit": -3.8983356952667236,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "oid and tau",
            "probability": 4.844639056386605e-05,
            "start_logit": -4.053114414215088,
            "end_logit": 4.256698131561279,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "oid",
            "probability": 2.2749537561322572e-05,
            "start_logit": -4.053114414215088,
            "end_logit": 3.5007851123809814,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau as early diagnostic markers in the pathology of dementia has been reported in differential involvement in Alzheimer's disease",
            "probability": 1.102427033944367e-05,
            "start_logit": 4.7467041015625,
            "end_logit": -6.023478984832764,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "amyloid and tau as early diagnostic markers",
            "probability": 9.867429322447683e-06,
            "start_logit": 5.108263969421387,
            "end_logit": -6.495898723602295,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "amyl",
            "probability": 9.565546177798014e-06,
            "start_logit": 5.108263969421387,
            "end_logit": -6.526970386505127,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "amyloid and tau as early diagnostic markers in the pathology of dementia",
            "probability": 7.56574315470924e-06,
            "start_logit": 5.108263969421387,
            "end_logit": -6.761507511138916,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau as early diagnostic markers",
            "probability": 6.873541654089569e-06,
            "start_logit": 4.7467041015625,
            "end_logit": -6.495898723602295,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "yloid and tau",
            "probability": 6.278400477880096e-06,
            "start_logit": -6.096457004547119,
            "end_logit": 4.256698131561279,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "tau as early diagnostic markers in the pathology of dementia",
            "probability": 5.270212637827861e-06,
            "start_logit": 4.7467041015625,
            "end_logit": -6.761507511138916,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "yloid",
            "probability": 2.9482218558319127e-06,
            "start_logit": -6.096457004547119,
            "end_logit": 3.5007851123809814,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "oid and ta",
            "probability": 1.3917948825379917e-08,
            "start_logit": -4.053114414215088,
            "end_logit": -3.8983356952667236,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "u as early diagnostic markers in the pathology of dementia has been reported in differential involvement in Alzheimer's disease",
            "probability": 4.3752762241674306e-09,
            "start_logit": -3.0851807594299316,
            "end_logit": -6.023478984832764,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        },
        {
            "text": "u as early diagnostic markers",
            "probability": 2.7279486486613325e-09,
            "start_logit": -3.0851807594299316,
            "end_logit": -6.495898723602295,
            "question_text": "Which proteins in the cerebro-spinal fluid can be used for early diagnosis of Alzheimer's disease?"
        }
    ],
    "52f509232059c6d71c00001f": [
        {
            "text": "KCNH2",
            "probability": 0.20792357338030368,
            "start_logit": 4.791534900665283,
            "end_logit": 4.670332431793213,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNH2, KCNQ1, and KCNJ2",
            "probability": 0.17651226501099979,
            "start_logit": 4.791534900665283,
            "end_logit": 4.506552219390869,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2",
            "probability": 0.16941961284189078,
            "start_logit": 4.750523090362549,
            "end_logit": 4.506552219390869,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1, and KCNJ2",
            "probability": 0.1536658558632901,
            "start_logit": 4.65292501449585,
            "end_logit": 4.506552219390869,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNH2, KCNQ1",
            "probability": 0.13954064185832804,
            "start_logit": 4.791534900665283,
            "end_logit": 4.271517753601074,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1",
            "probability": 0.12147955926766092,
            "start_logit": 4.65292501449585,
            "end_logit": 4.271517753601074,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "IK1",
            "probability": 0.004577341532128793,
            "start_logit": 3.325028419494629,
            "end_logit": 2.320786714553833,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "IKs",
            "probability": 0.004354647194976405,
            "start_logit": 3.1768455505371094,
            "end_logit": 2.4190948009490967,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "IKs, and IK1",
            "probability": 0.0039469199258934965,
            "start_logit": 3.1768455505371094,
            "end_logit": 2.320786714553833,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "IKr, IKs",
            "probability": 0.0034438962941491028,
            "start_logit": 2.9422054290771484,
            "end_logit": 2.4190948009490967,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "IKr, IKs, and IK1",
            "probability": 0.003121442977462957,
            "start_logit": 2.9422054290771484,
            "end_logit": 2.320786714553833,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNH2, KCNQ1, and KCNJ2)",
            "probability": 0.002220805969829039,
            "start_logit": 4.791534900665283,
            "end_logit": 0.1310320347547531,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "IKr",
            "probability": 0.0021998298191378525,
            "start_logit": 2.9422054290771484,
            "end_logit": 1.9708713293075562,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNJ2)",
            "probability": 0.0021315690871790056,
            "start_logit": 4.750523090362549,
            "end_logit": 0.1310320347547531,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1, and KCNJ2)",
            "probability": 0.0019333616847464774,
            "start_logit": 4.65292501449585,
            "end_logit": 0.1310320347547531,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNH2,",
            "probability": 0.0008777561683285622,
            "start_logit": 4.791534900665283,
            "end_logit": -0.7972245812416077,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNH2, KCNQ1,",
            "probability": 0.0007587627378401168,
            "start_logit": 4.791534900665283,
            "end_logit": -0.9429042935371399,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "(KCNH2",
            "probability": 0.0006661177468435045,
            "start_logit": -0.9519245028495789,
            "end_logit": 4.670332431793213,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "KCNQ1,",
            "probability": 0.0006605542425060876,
            "start_logit": 4.65292501449585,
            "end_logit": -0.9429042935371399,
            "question_text": "Which genes are implicated in short QT syndrome?"
        },
        {
            "text": "(KCNH2, KCNQ1, and KCNJ2",
            "probability": 0.0005654863965054803,
            "start_logit": -0.9519245028495789,
            "end_logit": 4.506552219390869,
            "question_text": "Which genes are implicated in short QT syndrome?"
        }
    ],
    "56be1723ef6e39474100000c": [
        {
            "text": "otitis media",
            "probability": 0.3057235912019465,
            "start_logit": 5.115480899810791,
            "end_logit": 5.988105297088623,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "suppurative otitis media",
            "probability": 0.17582979232697146,
            "start_logit": 4.562315940856934,
            "end_logit": 5.988105297088623,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media, abducens nerve palsy",
            "probability": 0.14130469963384718,
            "start_logit": 5.115480899810791,
            "end_logit": 5.216342449188232,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve palsy",
            "probability": 0.09748950103032135,
            "start_logit": 4.744307041168213,
            "end_logit": 5.216342449188232,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "suppurative otitis media, abducens nerve palsy",
            "probability": 0.08126810199292936,
            "start_logit": 4.562315940856934,
            "end_logit": 5.216342449188232,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media, abducens nerve palsy and pain in the ophthalmic division of the trigeminal nerve",
            "probability": 0.05009048693966627,
            "start_logit": 5.115480899810791,
            "end_logit": 4.17925500869751,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve palsy and pain in the ophthalmic division of the trigeminal nerve",
            "probability": 0.03455862820392834,
            "start_logit": 4.744307041168213,
            "end_logit": 4.17925500869751,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media, abducens nerve palsy and pain",
            "probability": 0.030844119961983104,
            "start_logit": 5.115480899810791,
            "end_logit": 3.6943700313568115,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve palsy and pain",
            "probability": 0.02128009806188241,
            "start_logit": 4.744307041168213,
            "end_logit": 3.6943700313568115,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "suppurative otitis media, abducens nerve palsy and pain",
            "probability": 0.01773927614189675,
            "start_logit": 4.562315940856934,
            "end_logit": 3.6943700313568115,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "pain in the ophthalmic division of the trigeminal nerve",
            "probability": 0.009901873752657601,
            "start_logit": 3.4943737983703613,
            "end_logit": 4.17925500869751,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media, abducens nerve palsy and pain in the ophthalmic division of the trigeminal nerve,",
            "probability": 0.006612923240288954,
            "start_logit": 5.115480899810791,
            "end_logit": 2.154449701309204,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "pain",
            "probability": 0.0060972571946296536,
            "start_logit": 3.4943737983703613,
            "end_logit": 3.6943700313568115,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media,",
            "probability": 0.005898993935746244,
            "start_logit": 5.115480899810791,
            "end_logit": 2.040205717086792,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "abducens nerve palsy and pain in the ophthalmic division of the trigeminal nerve,",
            "probability": 0.004562414333834097,
            "start_logit": 4.744307041168213,
            "end_logit": 2.154449701309204,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "ophthalmic division of the trigeminal nerve",
            "probability": 0.003664651885969783,
            "start_logit": 2.500383138656616,
            "end_logit": 4.17925500869751,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "suppurative otitis media,",
            "probability": 0.0033926687652154025,
            "start_logit": 4.562315940856934,
            "end_logit": 2.040205717086792,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "pain in the ophthalmic division of the trigeminal nerve,",
            "probability": 0.0013072408567364772,
            "start_logit": 3.4943737983703613,
            "end_logit": 2.154449701309204,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "otitis media, abducens",
            "probability": 0.0012626341784714422,
            "start_logit": 5.115480899810791,
            "end_logit": 0.4986240565776825,
            "question_text": "List symptoms of Gradenigo's syndrome."
        },
        {
            "text": "titis media",
            "probability": 0.0011710463610776964,
            "start_logit": -0.4493028223514557,
            "end_logit": 5.988105297088623,
            "question_text": "List symptoms of Gradenigo's syndrome."
        }
    ],
    "550e9d2cb305b40c5c000001": [
        {
            "text": "pro-adrenomedullin",
            "probability": 0.23858753816731765,
            "start_logit": 0.2799434959888458,
            "end_logit": 0.2219330370426178,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "midregional pro-adrenomedullin",
            "probability": 0.1724094532286285,
            "start_logit": -0.04492059350013733,
            "end_logit": 0.2219330370426178,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "adrenomedullin",
            "probability": 0.12333467513532077,
            "start_logit": -0.37989118695259094,
            "end_logit": 0.2219330370426178,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "pro-adrenomedullin (MR-proADM",
            "probability": 0.08400678502892873,
            "start_logit": 0.2799434959888458,
            "end_logit": -0.8219056725502014,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "midregional pro-adrenomedullin (MR-proADM",
            "probability": 0.06070545002302443,
            "start_logit": -0.04492059350013733,
            "end_logit": -0.8219056725502014,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "MR-proADM",
            "probability": 0.05314996978940099,
            "start_logit": -0.17783653736114502,
            "end_logit": -0.8219056725502014,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "pro-adrenomedullin (MR-proADM)",
            "probability": 0.046988170134587,
            "start_logit": 0.2799434959888458,
            "end_logit": -1.402907371520996,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "adrenomedullin (MR-proADM",
            "probability": 0.04342619744640512,
            "start_logit": -0.37989118695259094,
            "end_logit": -0.8219056725502014,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "midregional pro-adrenomedullin (MR-proADM)",
            "probability": 0.03395485272762515,
            "start_logit": -0.04492059350013733,
            "end_logit": -1.402907371520996,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "MR-proADM)",
            "probability": 0.029728787052766232,
            "start_logit": -0.17783653736114502,
            "end_logit": -1.402907371520996,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "adrenomedullin (MR-proADM)",
            "probability": 0.024289913644560672,
            "start_logit": -0.37989118695259094,
            "end_logit": -1.402907371520996,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "plasma levels of midregional pro-adrenomedullin",
            "probability": 0.016952721776741366,
            "start_logit": -2.3643643856048584,
            "end_logit": 0.2219330370426178,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "pro-adrenomedullin (MR-proADM) improve prediction of functional outcome in ischemic stroke.",
            "probability": 0.014316536319541674,
            "start_logit": 0.2799434959888458,
            "end_logit": -2.591387987136841,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "midregional pro-adrenomedullin (MR-proADM) improve prediction of functional outcome in ischemic stroke.",
            "probability": 0.010345495066255293,
            "start_logit": -0.04492059350013733,
            "end_logit": -2.591387987136841,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "pro-adrenomedullin (MR-proADM) improve prediction of functional outcome",
            "probability": 0.009391480912278028,
            "start_logit": 0.2799434959888458,
            "end_logit": -3.013000249862671,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "midregional",
            "probability": 0.009179750116768557,
            "start_logit": -0.04492059350013733,
            "end_logit": -2.7109391689300537,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "MR-proADM) improve prediction of functional outcome in ischemic stroke.",
            "probability": 0.009057881129607197,
            "start_logit": -0.17783653736114502,
            "end_logit": -2.591387987136841,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "adrenomedullin (MR-proADM) improve prediction of functional outcome in ischemic stroke.",
            "probability": 0.007400744270203325,
            "start_logit": -0.37989118695259094,
            "end_logit": -2.591387987136841,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "midregional pro-adrenomedullin (MR-proADM) improve prediction of functional outcome",
            "probability": 0.00678652414761684,
            "start_logit": -0.04492059350013733,
            "end_logit": -3.013000249862671,
            "question_text": "Which variables are included in the SPAN-100 score?"
        },
        {
            "text": "evaluate if plasma levels of midregional pro-adrenomedullin",
            "probability": 0.005987073882422375,
            "start_logit": -3.4051899909973145,
            "end_logit": 0.2219330370426178,
            "question_text": "Which variables are included in the SPAN-100 score?"
        }
    ],
    "516c0ed3298dcd4e5100006f": [
        {
            "text": "D1",
            "probability": 0.9123235243887093,
            "start_logit": 4.113553524017334,
            "end_logit": 3.314129114151001,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRalpha1, for any detectable D1",
            "probability": 0.05156713204653767,
            "start_logit": 1.2404433488845825,
            "end_logit": 3.314129114151001,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRbeta or TRalpha1, for any detectable D1",
            "probability": 0.0215868562901689,
            "start_logit": 0.3696434795856476,
            "end_logit": 3.314129114151001,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "D",
            "probability": 0.0060532082325892266,
            "start_logit": 4.113553524017334,
            "end_logit": -1.7012771368026733,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TR, whether TRbeta or TRalpha1, for any detectable D1",
            "probability": 0.001989818214829676,
            "start_logit": -2.0143978595733643,
            "end_logit": 3.314129114151001,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRalpha1",
            "probability": 0.0013673308669551931,
            "start_logit": 1.2404433488845825,
            "end_logit": -0.31589481234550476,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "D1 expression",
            "probability": 0.0013358787758387827,
            "start_logit": 4.113553524017334,
            "end_logit": -3.2122762203216553,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "D1 expression in liver",
            "probability": 0.0006772181977518088,
            "start_logit": 4.113553524017334,
            "end_logit": -3.891627311706543,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRbeta or TRalpha1",
            "probability": 0.0005723873668102433,
            "start_logit": 0.3696434795856476,
            "end_logit": -0.31589481234550476,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "there was an obligatory requirement for a TR, whether TRbeta or TRalpha1, for any detectable D1",
            "probability": 0.0005379399721799257,
            "start_logit": -3.3224494457244873,
            "end_logit": 3.314129114151001,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRbeta",
            "probability": 0.00047632562490438815,
            "start_logit": 0.3696434795856476,
            "end_logit": -0.4996090829372406,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRalpha1, for any detectable D",
            "probability": 0.0003421446229222987,
            "start_logit": 1.2404433488845825,
            "end_logit": -1.7012771368026733,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "D1 gene is itself T3-inducible and here, the regulation of D1",
            "probability": 0.00026932539001479406,
            "start_logit": 0.6717994213104248,
            "end_logit": -1.3719464540481567,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "D1 remained weakly T3",
            "probability": 0.00018727801128858726,
            "start_logit": 1.1805375814437866,
            "end_logit": -2.2440106868743896,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "an obligatory requirement for a TR, whether TRbeta or TRalpha1, for any detectable D1",
            "probability": 0.00015843760496925288,
            "start_logit": -4.544835567474365,
            "end_logit": 3.314129114151001,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRbeta or TRalpha1, for any detectable D",
            "probability": 0.0001432274108013651,
            "start_logit": 0.3696434795856476,
            "end_logit": -1.7012771368026733,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "1",
            "probability": 0.00013385063770645592,
            "start_logit": -4.71347188949585,
            "end_logit": 3.314129114151001,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": ", there was an obligatory requirement for a TR, whether TRbeta or TRalpha1, for any detectable D1",
            "probability": 0.00012461482385062536,
            "start_logit": -4.784968852996826,
            "end_logit": 3.314129114151001,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRalpha1,",
            "probability": 7.799383624392817e-05,
            "start_logit": 1.2404433488845825,
            "end_logit": -3.1798808574676514,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        },
        {
            "text": "TRalpha1, for any detectable D1 expression",
            "probability": 7.550768492789083e-05,
            "start_logit": 1.2404433488845825,
            "end_logit": -3.2122762203216553,
            "question_text": "Which genes does thyroid hormone receptor alpha1 regulate in the liver?"
        }
    ],
    "516ec97f298dcd4e51000087": [
        {
            "text": "INDELible",
            "probability": 0.8741621825657477,
            "start_logit": 2.404416561126709,
            "end_logit": 2.2569844722747803,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "INDELible should be useful for evaluating the performance of many inference methods, including those for multiple sequence alignment",
            "probability": 0.08559662446241072,
            "start_logit": 2.404416561126709,
            "end_logit": -0.0666356012225151,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "INDELible should be useful for evaluating the performance of many inference methods, including those for multiple sequence alignment, phylogenetic tree inference",
            "probability": 0.015577985826788694,
            "start_logit": 2.404416561126709,
            "end_logit": -1.7704226970672607,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "INDELible should be useful for evaluating the performance of many inference methods, including those for multiple",
            "probability": 0.00428035555946612,
            "start_logit": 2.404416561126709,
            "end_logit": -3.0622453689575195,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "multiple sequence alignment",
            "probability": 0.00358150880703552,
            "start_logit": -0.7694451212882996,
            "end_logit": -0.0666356012225151,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "nonsynonymous/synonymous substitution rate ratio to vary among sites and branches. With its many unique features, INDELible",
            "probability": 0.0033072404695003448,
            "start_logit": -3.1727352142333984,
            "end_logit": 2.2569844722747803,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "alignment",
            "probability": 0.0024891345073738053,
            "start_logit": -1.1332942247390747,
            "end_logit": -0.0666356012225151,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "IN",
            "probability": 0.0019560033597322015,
            "start_logit": 2.404416561126709,
            "end_logit": -3.8453781604766846,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "INDELible should be useful for evaluating the performance of many inference methods, including those for multiple sequence alignment, phylogenetic tree inference, and ancestral",
            "probability": 0.0015583546300454863,
            "start_logit": 2.404416561126709,
            "end_logit": -4.072650909423828,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "INDEL",
            "probability": 0.0015481455834933963,
            "start_logit": 2.404416561126709,
            "end_logit": -4.0792236328125,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "INDELible should be useful for evaluating the performance of many inference methods, including those for multiple sequence alignment, phylogenetic",
            "probability": 0.0009583299770794631,
            "start_logit": 2.404416561126709,
            "end_logit": -4.558844566345215,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "Simulation",
            "probability": 0.0009576563584686886,
            "start_logit": -1.2867058515548706,
            "end_logit": -0.8684253096580505,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "synonymous substitution rate ratio to vary among sites and branches. With its many unique features, INDELible",
            "probability": 0.0007844551959193215,
            "start_logit": -4.611615180969238,
            "end_logit": 2.2569844722747803,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "multiple sequence alignment, phylogenetic tree inference, and ancestral sequence, or genome reconstruction",
            "probability": 0.0007657623015577506,
            "start_logit": -0.7694451212882996,
            "end_logit": -1.6093032360076904,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "multiple sequence alignment, phylogenetic tree inference",
            "probability": 0.0006518095051635975,
            "start_logit": -0.7694451212882996,
            "end_logit": -1.7704226970672607,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "alignment, phylogenetic tree inference, and ancestral sequence, or genome reconstruction",
            "probability": 0.0005322017819721863,
            "start_logit": -1.1332942247390747,
            "end_logit": -1.6093032360076904,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "alignment, phylogenetic tree inference",
            "probability": 0.00045300503752771155,
            "start_logit": -1.1332942247390747,
            "end_logit": -1.7704226970672607,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "INDELible,",
            "probability": 0.00036257818770487325,
            "start_logit": 0.9536957144737244,
            "end_logit": -4.080075740814209,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "ancestral sequence, or genome reconstruction",
            "probability": 0.0002844560060319361,
            "start_logit": -1.7597383260726929,
            "end_logit": -1.6093032360076904,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        },
        {
            "text": "multiple sequence alignment, phylogenetic tree inference, and ancestral sequence",
            "probability": 0.00019220987698037302,
            "start_logit": -0.7694451212882996,
            "end_logit": -2.9915871620178223,
            "question_text": "By which methods can we evaluate the reliability of a phylogenetic tree?"
        }
    ],
    "5324d0169b2d7acc7e000022": [
        {
            "text": "hair loss",
            "probability": 0.20610023566573565,
            "start_logit": -3.3039889335632324,
            "end_logit": -3.9192774295806885,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "hair loss,",
            "probability": 0.11063956717266166,
            "start_logit": -3.3039889335632324,
            "end_logit": -4.541362285614014,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "male pattern hair loss",
            "probability": 0.09842920072617088,
            "start_logit": -4.043014049530029,
            "end_logit": -3.9192774295806885,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "hair",
            "probability": 0.07898521760149091,
            "start_logit": -3.3039889335632324,
            "end_logit": -4.8783793449401855,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "alopecia",
            "probability": 0.06479083785541638,
            "start_logit": -5.034240245819092,
            "end_logit": -3.346224546432495,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "male pattern hair loss,",
            "probability": 0.05283916406168904,
            "start_logit": -4.043014049530029,
            "end_logit": -4.541362285614014,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "alopecia (AGA),",
            "probability": 0.04711254100443271,
            "start_logit": -5.034240245819092,
            "end_logit": -3.6648495197296143,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "male pattern hair",
            "probability": 0.03772170280438909,
            "start_logit": -4.043014049530029,
            "end_logit": -4.8783793449401855,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "alopecia (AGA), or male pattern hair loss",
            "probability": 0.03652917729105422,
            "start_logit": -5.034240245819092,
            "end_logit": -3.9192774295806885,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "AGA),",
            "probability": 0.032672003511854446,
            "start_logit": -5.400260925292969,
            "end_logit": -3.6648495197296143,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "cia",
            "probability": 0.03046340134546958,
            "start_logit": -5.788878440856934,
            "end_logit": -3.346224546432495,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "(AGA),",
            "probability": 0.028658821085110073,
            "start_logit": -5.531318187713623,
            "end_logit": -3.6648495197296143,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "alopecia (AGA)",
            "probability": 0.02608543891371406,
            "start_logit": -5.034240245819092,
            "end_logit": -4.256011486053467,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "AGA), or male pattern hair loss",
            "probability": 0.02533256290774436,
            "start_logit": -5.400260925292969,
            "end_logit": -3.9192774295806885,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "(AGA), or male pattern hair loss",
            "probability": 0.02222090199448359,
            "start_logit": -5.531318187713623,
            "end_logit": -3.9192774295806885,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "cia (AGA),",
            "probability": 0.02215140739846052,
            "start_logit": -5.788878440856934,
            "end_logit": -3.6648495197296143,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "hair loss, affects up to 96% of Caucasian men. Characterized by gradual thinning and eventual loss of hair",
            "probability": 0.02163159076939194,
            "start_logit": -3.3039889335632324,
            "end_logit": -6.173485279083252,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "alopecia (AGA), or male pattern hair loss,",
            "probability": 0.01960974159782378,
            "start_logit": -5.034240245819092,
            "end_logit": -4.541362285614014,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "loss",
            "probability": 0.01939121395538431,
            "start_logit": -5.667531490325928,
            "end_logit": -3.9192774295806885,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        },
        {
            "text": "etic alopecia",
            "probability": 0.018635272337522702,
            "start_logit": -6.280348300933838,
            "end_logit": -3.346224546432495,
            "question_text": "List FDA approved treatments for androgenetic allopecia"
        }
    ],
    "54fc9ca16ad7dcbc12000006": [
        {
            "text": "orexin",
            "probability": 0.5906035961219084,
            "start_logit": 1.9671491384506226,
            "end_logit": 0.2785649001598358,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "OX2R",
            "probability": 0.08111877700392298,
            "start_logit": 1.08952796459198,
            "end_logit": -0.82904452085495,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor",
            "probability": 0.06370832984307649,
            "start_logit": 1.9671491384506226,
            "end_logit": -1.9482648372650146,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin antagonist, almorexant, a dual orexin",
            "probability": 0.06109016995283728,
            "start_logit": -0.3016449511051178,
            "end_logit": 0.2785649001598358,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor, and thus at equilibrium may show more or less selectivity for OX1R",
            "probability": 0.04879959354054198,
            "start_logit": 1.7954986095428467,
            "end_logit": -2.0432076454162598,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "OX1R and OX2R",
            "probability": 0.04196589119712317,
            "start_logit": 0.43047067523002625,
            "end_logit": -0.82904452085495,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor, and thus at equilibrium may show more or less selectivity for OX1R or OX2R",
            "probability": 0.029180482465540482,
            "start_logit": 1.7954986095428467,
            "end_logit": -2.557429552078247,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "OX1R",
            "probability": 0.018072725129499975,
            "start_logit": 0.8021805286407471,
            "end_logit": -2.0432076454162598,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "OX1R or OX2R",
            "probability": 0.010806869493857051,
            "start_logit": 0.8021805286407471,
            "end_logit": -2.557429552078247,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor, and thus at equilibrium may show more or less selectivity for OX1",
            "probability": 0.00911922927255742,
            "start_logit": 1.7954986095428467,
            "end_logit": -3.7205443382263184,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "ore",
            "probability": 0.008924654260836266,
            "start_logit": 1.9671491384506226,
            "end_logit": -3.9137625694274902,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor antagonist",
            "probability": 0.00855693609325691,
            "start_logit": 1.9671491384506226,
            "end_logit": -3.9558379650115967,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin antagonist, almorexant, a dual orexin receptor",
            "probability": 0.006589788350563322,
            "start_logit": -0.3016449511051178,
            "end_logit": -1.9482648372650146,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "OX2",
            "probability": 0.005572970742584882,
            "start_logit": 1.08952796459198,
            "end_logit": -3.507030725479126,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin receptor, and thus at equilibrium may show more or less selectivity for OX1R or OX2",
            "probability": 0.005358114820181224,
            "start_logit": 1.7954986095428467,
            "end_logit": -4.252317428588867,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "OX1",
            "probability": 0.0033772683761986474,
            "start_logit": 0.8021805286407471,
            "end_logit": -3.7205443382263184,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "OX1R and OX2",
            "probability": 0.002883114026938023,
            "start_logit": 0.43047067523002625,
            "end_logit": -3.507030725479126,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "OX1R or OX2",
            "probability": 0.001984355387652681,
            "start_logit": 0.8021805286407471,
            "end_logit": -4.252317428588867,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin cells during wake and almost none during sleep. Less than 10years later, the first orexin",
            "probability": 0.001199103356488822,
            "start_logit": -2.439685344696045,
            "end_logit": -1.5141716003417969,
            "question_text": "Which receptors are targeted by suvorexant?"
        },
        {
            "text": "orexin antagonist, almorexant,",
            "probability": 0.001088030564434116,
            "start_logit": -0.3016449511051178,
            "end_logit": -3.7494168281555176,
            "question_text": "Which receptors are targeted by suvorexant?"
        }
    ],
    "515d7693298dcd4e5100000c": [
        {
            "text": "keratin",
            "probability": 0.3213738563173076,
            "start_logit": -1.0186381340026855,
            "end_logit": -2.164339542388916,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin contaminants",
            "probability": 0.22743154485089664,
            "start_logit": -1.0186381340026855,
            "end_logit": -2.5100953578948975,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis or keratin",
            "probability": 0.089119676560759,
            "start_logit": -2.3012630939483643,
            "end_logit": -2.164339542388916,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis or keratin contaminants",
            "probability": 0.06306868252784538,
            "start_logit": -2.3012630939483643,
            "end_logit": -2.5100953578948975,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "unspecific proteolytic cleavage, missed cleavage, protease autolysis or keratin",
            "probability": 0.03939984999944289,
            "start_logit": -3.117481231689453,
            "end_logit": -2.164339542388916,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "keratin contaminants.",
            "probability": 0.038166181336319924,
            "start_logit": -1.0186381340026855,
            "end_logit": -4.294994831085205,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "missed cleavage, protease autolysis or keratin",
            "probability": 0.03727884511418349,
            "start_logit": -3.1728172302246094,
            "end_logit": -2.164339542388916,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "unspecific proteolytic cleavage, missed cleavage, protease autolysis or keratin contaminants",
            "probability": 0.027882693554946505,
            "start_logit": -3.117481231689453,
            "end_logit": -2.5100953578948975,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "missed cleavage, protease autolysis or keratin contaminants",
            "probability": 0.026381689636275026,
            "start_logit": -3.1728172302246094,
            "end_logit": -2.5100953578948975,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis",
            "probability": 0.0227749348831564,
            "start_logit": -2.3012630939483643,
            "end_logit": -3.5286591053009033,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "unspecific proteolytic cleavage, missed cleavage",
            "probability": 0.016379771638032344,
            "start_logit": -3.117481231689453,
            "end_logit": -3.0420544147491455,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "missed cleavage",
            "probability": 0.015498002401241056,
            "start_logit": -3.1728172302246094,
            "end_logit": -3.0420544147491455,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "unspecific proteolytic cleavage",
            "probability": 0.013471146486053734,
            "start_logit": -3.117481231689453,
            "end_logit": -3.23755145072937,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "proteolytic cleavage, missed cleavage, protease autolysis or keratin",
            "probability": 0.012141645542435511,
            "start_logit": -4.294601917266846,
            "end_logit": -2.164339542388916,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "protease autolysis or keratin contaminants.",
            "probability": 0.010583803471847406,
            "start_logit": -2.3012630939483643,
            "end_logit": -4.294994831085205,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "unspecific proteolytic cleavage, missed cleavage, protease autolysis",
            "probability": 0.010068809187516188,
            "start_logit": -3.117481231689453,
            "end_logit": -3.5286591053009033,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "missed cleavage, protease autolysis",
            "probability": 0.009526776832678073,
            "start_logit": -3.1728172302246094,
            "end_logit": -3.5286591053009033,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "proteolytic cleavage, missed cleavage, protease autolysis or keratin contaminants",
            "probability": 0.008592463725554755,
            "start_logit": -4.294601917266846,
            "end_logit": -2.5100953578948975,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "identifies masses resulting from unspecific proteolytic cleavage, missed cleavage, protease autolysis or keratin",
            "probability": 0.005811957444977538,
            "start_logit": -5.031325817108154,
            "end_logit": -2.164339542388916,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        },
        {
            "text": "proteolytic cleavage, missed cleavage",
            "probability": 0.005047668488530771,
            "start_logit": -4.294601917266846,
            "end_logit": -3.0420544147491455,
            "question_text": "A common problem in proteomics is the contamination of samples with exogenous proteins (often from other species). These proteins can be found in specific databases. List some contaminants."
        }
    ],
    "56c1f030ef6e39474100004d": [
        {
            "text": "neonatal diabetes",
            "probability": 0.4051751853179402,
            "start_logit": 1.6818079948425293,
            "end_logit": 2.0887343883514404,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes",
            "probability": 0.23836935510613258,
            "start_logit": 1.151309847831726,
            "end_logit": 2.0887343883514404,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes mellitus",
            "probability": 0.20388619394913482,
            "start_logit": 1.6818079948425293,
            "end_logit": 1.4019768238067627,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.11994866005568094,
            "start_logit": 1.151309847831726,
            "end_logit": 1.4019768238067627,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "permanent neonatal diabetes",
            "probability": 0.012097283682431221,
            "start_logit": -1.8295305967330933,
            "end_logit": 2.0887343883514404,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neurological features in an infant with permanent neonatal diabetes",
            "probability": 0.0067073332458113775,
            "start_logit": -2.4193100929260254,
            "end_logit": 2.0887343883514404,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "permanent neonatal diabetes mellitus",
            "probability": 0.006087414077933825,
            "start_logit": -1.8295305967330933,
            "end_logit": 1.4019768238067627,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neurological features in an infant with permanent neonatal diabetes mellitus",
            "probability": 0.0033751638713113144,
            "start_logit": -2.4193100929260254,
            "end_logit": 1.4019768238067627,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes mellitus and DEND syndrome",
            "probability": 0.0005160358539289586,
            "start_logit": 1.6818079948425293,
            "end_logit": -4.577164173126221,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "We have verified a lack of clinical response for both glycemic control and neurological features in an infant with permanent neonatal diabetes",
            "probability": 0.0005109545711029272,
            "start_logit": -4.993986129760742,
            "end_logit": 2.0887343883514404,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes mellitus and DEND syndrome due to a V59A mutation in the KCNJ11 gene.",
            "probability": 0.000439900397952503,
            "start_logit": 1.6818079948425293,
            "end_logit": -4.736792087554932,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "lack of clinical response for both glycemic control and neurological features in an infant with permanent neonatal diabetes",
            "probability": 0.00043812177028314513,
            "start_logit": -5.147769927978516,
            "end_logit": 2.0887343883514404,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes mellitus and DEND syndrome due to a V59A mutation",
            "probability": 0.00042047586665472245,
            "start_logit": 1.6818079948425293,
            "end_logit": -4.78195333480835,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neon",
            "probability": 0.0003115588111634922,
            "start_logit": 1.6818079948425293,
            "end_logit": -5.081752300262451,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "diabetes mellitus and DEND syndrome",
            "probability": 0.00030358999803051814,
            "start_logit": 1.151309847831726,
            "end_logit": -4.577164173126221,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "an infant with permanent neonatal diabetes",
            "probability": 0.0002927788003669524,
            "start_logit": -5.550849437713623,
            "end_logit": 2.0887343883514404,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal",
            "probability": 0.00029143850144632336,
            "start_logit": 1.6818079948425293,
            "end_logit": -5.1485114097595215,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes mellitus and DEND syndrome due to a V59A mutation in the KCNJ11 gene",
            "probability": 0.00029037705056801844,
            "start_logit": 1.6818079948425293,
            "end_logit": -5.152160167694092,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "verified a lack of clinical response for both glycemic control and neurological features in an infant with permanent neonatal diabetes",
            "probability": 0.00027349283910606855,
            "start_logit": -5.618991374969482,
            "end_logit": 2.0887343883514404,
            "question_text": "List features of the DEND syndrome."
        },
        {
            "text": "neonatal diabetes mellitus and DEND syndrome due to a V59A mutation in the KCNJ11",
            "probability": 0.0002646862330201251,
            "start_logit": 1.6818079948425293,
            "end_logit": -5.244795322418213,
            "question_text": "List features of the DEND syndrome."
        }
    ],
    "550312b4e9bde6963400001c": [
        {
            "text": "RPL5",
            "probability": 0.08825943965212073,
            "start_logit": 3.9633712768554688,
            "end_logit": 3.9357681274414062,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS26, RPL5",
            "probability": 0.08042149048802175,
            "start_logit": 3.8703720569610596,
            "end_logit": 3.9357681274414062,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19, RPS26, RPL5",
            "probability": 0.0701130023192292,
            "start_logit": 3.733198881149292,
            "end_logit": 3.9357681274414062,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19, RPS26, RPL5",
            "probability": 0.06978840779067165,
            "start_logit": 3.7285585403442383,
            "end_logit": 3.9357681274414062,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL5, RPL11",
            "probability": 0.06412983305685521,
            "start_logit": 3.9633712768554688,
            "end_logit": 3.6163971424102783,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL11",
            "probability": 0.06319568099235845,
            "start_logit": 3.948697566986084,
            "end_logit": 3.6163971424102783,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS26, RPL5, RPL11",
            "probability": 0.058434732641726904,
            "start_logit": 3.8703720569610596,
            "end_logit": 3.6163971424102783,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS26",
            "probability": 0.0512494013827088,
            "start_logit": 3.8703720569610596,
            "end_logit": 3.4851906299591064,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19, RPS26, RPL5, RPL11",
            "probability": 0.05094452391233861,
            "start_logit": 3.733198881149292,
            "end_logit": 3.6163971424102783,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19, RPS26, RPL5, RPL11",
            "probability": 0.050708671600001115,
            "start_logit": 3.7285585403442383,
            "end_logit": 3.6163971424102783,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19",
            "probability": 0.04761673289569473,
            "start_logit": 3.733198881149292,
            "end_logit": 3.5488440990448,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19",
            "probability": 0.047396286894889395,
            "start_logit": 3.7285585403442383,
            "end_logit": 3.5488440990448,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19, RPS26",
            "probability": 0.044680213910486544,
            "start_logit": 3.733198881149292,
            "end_logit": 3.4851906299591064,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS19, RPS26",
            "probability": 0.04447336279171556,
            "start_logit": 3.7285585403442383,
            "end_logit": 3.4851906299591064,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17",
            "probability": 0.03582616121656443,
            "start_logit": 3.733198881149292,
            "end_logit": 3.264338254928589,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL5, RPL11, and RPL35A",
            "probability": 0.028398163030929704,
            "start_logit": 3.9633712768554688,
            "end_logit": 2.801811933517456,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL11, and RPL35A",
            "probability": 0.027984499040884077,
            "start_logit": 3.948697566986084,
            "end_logit": 2.801811933517456,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPL35A",
            "probability": 0.027943749324897568,
            "start_logit": 3.9472403526306152,
            "end_logit": 2.801811933517456,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS26, RPL5, RPL11, and RPL35A",
            "probability": 0.025876241760326282,
            "start_logit": 3.8703720569610596,
            "end_logit": 2.801811933517456,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        },
        {
            "text": "RPS17, RPS19, RPS26, RPL5, RPL11, and RPL35A",
            "probability": 0.02255940529757919,
            "start_logit": 3.733198881149292,
            "end_logit": 2.801811933517456,
            "question_text": "Which genes are known to be involved in Diamond-Blackfan anemia?"
        }
    ],
    "51492168d24251bc05000041": [
        {
            "text": "Signs of Depression Scale",
            "probability": 0.591002374452935,
            "start_logit": 3.5901098251342773,
            "end_logit": 3.0781843662261963,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Signs of Depression",
            "probability": 0.3181037451433373,
            "start_logit": 3.5901098251342773,
            "end_logit": 2.4587419033050537,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Signs of Depression Scale)",
            "probability": 0.024047238652071534,
            "start_logit": 3.5901098251342773,
            "end_logit": -0.12361549586057663,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "(Signs of Depression Scale",
            "probability": 0.018082452046875145,
            "start_logit": 0.1032317578792572,
            "end_logit": 3.0781843662261963,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Signs",
            "probability": 0.017310277505957913,
            "start_logit": 3.5901098251342773,
            "end_logit": -0.45233526825904846,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "(Signs of Depression",
            "probability": 0.009732779369643401,
            "start_logit": 0.1032317578792572,
            "end_logit": 2.4587419033050537,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Depression Scale",
            "probability": 0.006615548993513262,
            "start_logit": -0.9022874236106873,
            "end_logit": 3.0781843662261963,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Depression",
            "probability": 0.0035607824976401892,
            "start_logit": -0.9022874236106873,
            "end_logit": 2.4587419033050537,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Signs of Depression Scale),",
            "probability": 0.003343034649437459,
            "start_logit": 3.5901098251342773,
            "end_logit": -2.09675669670105,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Signs of Depression Scale), when rated by nurses and carers for detecting depression",
            "probability": 0.0021217155726412054,
            "start_logit": 3.5901098251342773,
            "end_logit": -2.551410675048828,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "observational screening tool (Signs of Depression Scale",
            "probability": 0.0009864308737412304,
            "start_logit": -2.8053722381591797,
            "end_logit": 3.0781843662261963,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "an observational screening tool (Signs of Depression Scale",
            "probability": 0.0009215677030123962,
            "start_logit": -2.87338924407959,
            "end_logit": 3.0781843662261963,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Signs of Depression Scale), when rated by nurses and carers for detecting depression in patients who have recently had a stroke.",
            "probability": 0.0008325162237868055,
            "start_logit": 3.5901098251342773,
            "end_logit": -3.486938238143921,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "(Signs of Depression Scale)",
            "probability": 0.0007357551485107854,
            "start_logit": 0.1032317578792572,
            "end_logit": -0.12361549586057663,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "observational screening tool (Signs of Depression",
            "probability": 0.000530940938355043,
            "start_logit": -2.8053722381591797,
            "end_logit": 2.4587419033050537,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "(Signs",
            "probability": 0.0005296294506588526,
            "start_logit": 0.1032317578792572,
            "end_logit": -0.45233526825904846,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Scale",
            "probability": 0.0005086917608099425,
            "start_logit": -3.467623233795166,
            "end_logit": 3.0781843662261963,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "an observational screening tool (Signs of Depression",
            "probability": 0.0004960286970128436,
            "start_logit": -2.87338924407959,
            "end_logit": 2.4587419033050537,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "accuracy and utility of an observational screening tool (Signs of Depression Scale",
            "probability": 0.0002693108846830138,
            "start_logit": -4.1035990715026855,
            "end_logit": 3.0781843662261963,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        },
        {
            "text": "Depression Scale)",
            "probability": 0.0002691794353766238,
            "start_logit": -0.9022874236106873,
            "end_logit": -0.12361549586057663,
            "question_text": "Which depression rating scales were shown to have acceptable psychometric properties for screening of poststroke depression?"
        }
    ],
    "56d8b47a51531f7e33000004": [
        {
            "text": "deafness and goitre",
            "probability": 0.4422616942934292,
            "start_logit": 5.955086708068848,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "goitre",
            "probability": 0.3241310641845906,
            "start_logit": 5.6443328857421875,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "deafness",
            "probability": 0.22202247638501998,
            "start_logit": 5.955086708068848,
            "end_logit": 5.202667713165283,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "deafness and goitre.",
            "probability": 0.005281823251586668,
            "start_logit": 5.955086708068848,
            "end_logit": 1.464160442352295,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "goitre.",
            "probability": 0.0038710180272493394,
            "start_logit": 5.6443328857421875,
            "end_logit": 1.464160442352295,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "deaf",
            "probability": 0.000732745719216831,
            "start_logit": 5.955086708068848,
            "end_logit": -0.5110674500465393,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "by deafness and goitre",
            "probability": 0.0003842567283273311,
            "start_logit": -1.0932594537734985,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "characterized by deafness and goitre",
            "probability": 0.00023561923994192512,
            "start_logit": -1.5823532342910767,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "by deafness",
            "probability": 0.0001929030515001747,
            "start_logit": -1.0932594537734985,
            "end_logit": 5.202667713165283,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "classically characterized by deafness and goitre",
            "probability": 0.00017628459903889569,
            "start_logit": -1.8724706172943115,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "characterized by deafness",
            "probability": 0.00011828464416173076,
            "start_logit": -1.5823532342910767,
            "end_logit": 5.202667713165283,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "deafness and",
            "probability": 0.00010947059358805345,
            "start_logit": 5.955086708068848,
            "end_logit": -2.41221022605896,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "deafness and goit",
            "probability": 0.0001052082651735701,
            "start_logit": 5.955086708068848,
            "end_logit": -2.4519243240356445,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "classically characterized by deafness",
            "probability": 8.849770109456533e-05,
            "start_logit": -1.8724706172943115,
            "end_logit": 5.202667713165283,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "goit",
            "probability": 7.710653532001025e-05,
            "start_logit": 5.6443328857421875,
            "end_logit": -2.4519243240356445,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "ness and goitre",
            "probability": 5.3384241413044526e-05,
            "start_logit": -3.0670547485351562,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "re",
            "probability": 4.5655190444069574e-05,
            "start_logit": -3.2234530448913574,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "itre",
            "probability": 4.3710496500219234e-05,
            "start_logit": -3.266982078552246,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "deafness and go",
            "probability": 3.657654164858905e-05,
            "start_logit": 5.955086708068848,
            "end_logit": -3.5084590911865234,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        },
        {
            "text": "autosomal recessive condition classically characterized by deafness and goitre",
            "probability": 3.222031075546869e-05,
            "start_logit": -3.5719733238220215,
            "end_logit": 5.891790866851807,
            "question_text": "What are the main clinical characteristics of Pendred syndrome?"
        }
    ],
    "54edaee3445c3b5a5f000003": [
        {
            "text": "Rickettsia helvetica",
            "probability": 0.31856572097548214,
            "start_logit": 4.964522838592529,
            "end_logit": 4.668990135192871,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia lusitaniae",
            "probability": 0.24583759657478085,
            "start_logit": 4.874587535858154,
            "end_logit": 4.499767780303955,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia spielmanii",
            "probability": 0.19238079329028165,
            "start_logit": 4.098344802856445,
            "end_logit": 5.030816078186035,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia spielmanii, Borrelia lusitaniae",
            "probability": 0.11311764783484797,
            "start_logit": 4.098344802856445,
            "end_logit": 4.499767780303955,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia lusitaniae, and Rickettsia monacensis",
            "probability": 0.040527949251966705,
            "start_logit": 4.874587535858154,
            "end_logit": 2.6970884799957275,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia spielmanii, Borrelia lusitaniae, and Rickettsia monacensis",
            "probability": 0.018648190329008656,
            "start_logit": 4.098344802856445,
            "end_logit": 2.6970884799957275,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Rickettsia monacensis",
            "probability": 0.016856468897923402,
            "start_logit": 3.9973301887512207,
            "end_logit": 2.6970884799957275,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "spielmanii",
            "probability": 0.00954391828730187,
            "start_logit": 1.094772219657898,
            "end_logit": 5.030816078186035,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "lusitaniae",
            "probability": 0.007308544293221514,
            "start_logit": 1.358960509300232,
            "end_logit": 4.499767780303955,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Rickettsia",
            "probability": 0.0066359407594173865,
            "start_logit": 4.964522838592529,
            "end_logit": 0.7976617813110352,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia burgdorferi",
            "probability": 0.006611437755982307,
            "start_logit": 2.6765923500061035,
            "end_logit": 3.081892967224121,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Rickettsia spp., and \"Candidatus Neoehrlichia mikurensis",
            "probability": 0.005753180340076122,
            "start_logit": 3.276604175567627,
            "end_logit": 2.3428328037261963,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "spielmanii, Borrelia lusitaniae",
            "probability": 0.0056117119038936545,
            "start_logit": 1.094772219657898,
            "end_logit": 4.499767780303955,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Candidatus Neoehrlichia mikurensis",
            "probability": 0.0034130492594643415,
            "start_logit": 2.754457473754883,
            "end_logit": 2.3428328037261963,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia burgdorferi sensu lato",
            "probability": 0.003052588649145146,
            "start_logit": 2.6765923500061035,
            "end_logit": 2.309081792831421,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia lusitaniae, and Rickettsia",
            "probability": 0.0016474918374226738,
            "start_logit": 4.874587535858154,
            "end_logit": -0.5056493282318115,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia spp. and Rickettsia helvetica",
            "probability": 0.001599717245246508,
            "start_logit": -0.32947906851768494,
            "end_logit": 4.668990135192871,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "lusitaniae, and Rickettsia monacensis",
            "probability": 0.0012048617312744178,
            "start_logit": 1.358960509300232,
            "end_logit": 2.6970884799957275,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "spielmanii, Borrelia lusitaniae, and Rickettsia monacensis",
            "probability": 0.0009251277201958719,
            "start_logit": 1.094772219657898,
            "end_logit": 2.6970884799957275,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        },
        {
            "text": "Borrelia spielmanii, Borrelia lusitaniae, and Rickettsia",
            "probability": 0.0007580630630664175,
            "start_logit": 4.098344802856445,
            "end_logit": -0.5056493282318115,
            "question_text": "List the three most prevalent pathogenic species of Borrelia in Europe."
        }
    ],
    "5506eca18e1671127b00000f": [
        {
            "text": "p65",
            "probability": 0.14728688077972502,
            "start_logit": 5.699276447296143,
            "end_logit": 5.458832263946533,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50",
            "probability": 0.14449334169724568,
            "start_logit": 5.699276447296143,
            "end_logit": 5.439683437347412,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50",
            "probability": 0.12395751240288207,
            "start_logit": 5.5459818840026855,
            "end_logit": 5.439683437347412,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunits, and the non-canonical, mediated by the subunits RelB, p52 and p50",
            "probability": 0.06671584757030588,
            "start_logit": 5.699276447296143,
            "end_logit": 4.6668925285339355,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunits, and the non-canonical, mediated by the subunits RelB, p52 and p50",
            "probability": 0.05723399019999704,
            "start_logit": 5.5459818840026855,
            "end_logit": 4.6668925285339355,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunits, and the non-canonical, mediated by the subunits RelB, p52",
            "probability": 0.055710041196926255,
            "start_logit": 5.699276447296143,
            "end_logit": 4.486610412597656,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunits, and the non-canonical, mediated by the subunits RelB",
            "probability": 0.05518608960173938,
            "start_logit": 5.699276447296143,
            "end_logit": 4.477160930633545,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "RelB, p52 and p50",
            "probability": 0.05294308696452755,
            "start_logit": 5.468051433563232,
            "end_logit": 4.6668925285339355,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunits, and the non-canonical, mediated by the subunits RelB, p52",
            "probability": 0.04779236220519006,
            "start_logit": 5.5459818840026855,
            "end_logit": 4.486610412597656,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunits, and the non-canonical, mediated by the subunits RelB",
            "probability": 0.04734287619015298,
            "start_logit": 5.5459818840026855,
            "end_logit": 4.477160930633545,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "RelB, p52",
            "probability": 0.04420930953141387,
            "start_logit": 5.468051433563232,
            "end_logit": 4.486610412597656,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "RelB",
            "probability": 0.04379352204044407,
            "start_logit": 5.468051433563232,
            "end_logit": 4.477160930633545,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p52 and p50",
            "probability": 0.03670160920815932,
            "start_logit": 5.101654529571533,
            "end_logit": 4.6668925285339355,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p52",
            "probability": 0.030647113623571535,
            "start_logit": 5.101654529571533,
            "end_logit": 4.486610412597656,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "the p65",
            "probability": 0.01239926232944008,
            "start_logit": 3.2245311737060547,
            "end_logit": 5.458832263946533,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "the p65 and p50",
            "probability": 0.012164089829840423,
            "start_logit": 3.2245311737060547,
            "end_logit": 5.439683437347412,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p65 and p50 subunits",
            "probability": 0.005983555889516259,
            "start_logit": 5.699276447296143,
            "end_logit": 2.255465030670166,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "the p65 and p50 subunits, and the non-canonical, mediated by the subunits RelB, p52 and p50",
            "probability": 0.005616435701373299,
            "start_logit": 3.2245311737060547,
            "end_logit": 4.6668925285339355,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "p50 subunits",
            "probability": 0.005133154889186068,
            "start_logit": 5.5459818840026855,
            "end_logit": 2.255465030670166,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        },
        {
            "text": "the p65 and p50 subunits, and the non-canonical, mediated by the subunits RelB, p52",
            "probability": 0.004689918148362951,
            "start_logit": 3.2245311737060547,
            "end_logit": 4.486610412597656,
            "question_text": "Which are the subunits of the transcription factor NF-kappaB in the canonical pathway activation?"
        }
    ],
    "5335d4e8d6d3ac6a34000053": [
        {
            "text": "endothelin type A and B",
            "probability": 0.7212416261853132,
            "start_logit": 3.794785976409912,
            "end_logit": 4.3365254402160645,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin type A",
            "probability": 0.18269187137958778,
            "start_logit": 3.794785976409912,
            "end_logit": 2.9633522033691406,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "type A and B",
            "probability": 0.03198377244813369,
            "start_logit": 0.6790404319763184,
            "end_logit": 4.3365254402160645,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "B",
            "probability": 0.02906360937799721,
            "start_logit": 0.5832986235618591,
            "end_logit": 4.3365254402160645,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin type A and B receptor antagonist",
            "probability": 0.008667962431617592,
            "start_logit": 3.794785976409912,
            "end_logit": -0.08481501787900925,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "type A",
            "probability": 0.0081015502020222,
            "start_logit": 0.6790404319763184,
            "end_logit": 2.9633522033691406,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin",
            "probability": 0.00579299029194223,
            "start_logit": 3.794785976409912,
            "end_logit": -0.48780015110969543,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "A and B",
            "probability": 0.004899850308589021,
            "start_logit": -1.1969835758209229,
            "end_logit": 4.3365254402160645,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin type A and B receptor",
            "probability": 0.0028767377978158462,
            "start_logit": 3.794785976409912,
            "end_logit": -1.1877918243408203,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "A",
            "probability": 0.0012411413732323585,
            "start_logit": -1.1969835758209229,
            "end_logit": 2.9633522033691406,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "end",
            "probability": 0.0010938396584010432,
            "start_logit": 3.794785976409912,
            "end_logit": -2.154754638671875,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "nonselective endothelin type A and B",
            "probability": 0.0004988470795658257,
            "start_logit": -3.4816439151763916,
            "end_logit": 4.3365254402160645,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "type A and B receptor antagonist",
            "probability": 0.00038438455010997546,
            "start_logit": 0.6790404319763184,
            "end_logit": -0.08481501787900925,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "B receptor antagonist",
            "probability": 0.00034928970412886375,
            "start_logit": 0.5832986235618591,
            "end_logit": -0.08481501787900925,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin type",
            "probability": 0.0003105932423999046,
            "start_logit": 3.794785976409912,
            "end_logit": -3.413719892501831,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin type A and B receptor antagonists bosentan",
            "probability": 0.0002308936569506823,
            "start_logit": 3.794785976409912,
            "end_logit": -3.7102468013763428,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "othelin type A and B",
            "probability": 0.00020027877748411422,
            "start_logit": -4.394233226776123,
            "end_logit": 4.3365254402160645,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "type A and B receptor",
            "probability": 0.0001275701842181899,
            "start_logit": 0.6790404319763184,
            "end_logit": -1.1877918243408203,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "nonselective endothelin type A",
            "probability": 0.00012635891106305453,
            "start_logit": -3.4816439151763916,
            "end_logit": 2.9633522033691406,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        },
        {
            "text": "endothelin type A and B receptor antagonists bosentan (100 nmol/L) and macitentan",
            "probability": 0.00011683243942723666,
            "start_logit": 3.794785976409912,
            "end_logit": -4.391463279724121,
            "question_text": "Which receptors are targeted by a drug Macitentan?"
        }
    ],
    "518ba4b5310faafe08000005": [
        {
            "text": "corticosteroids",
            "probability": 0.6511530738397241,
            "start_logit": 4.28795862197876,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "acid suppression versus topical corticosteroids",
            "probability": 0.20498905097266143,
            "start_logit": 3.1321704387664795,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "topical corticosteroids",
            "probability": 0.07173821649567275,
            "start_logit": 2.082237482070923,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "acid suppression",
            "probability": 0.06456598087744449,
            "start_logit": 3.1321704387664795,
            "end_logit": 3.1889755725860596,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "suppression versus topical corticosteroids",
            "probability": 0.001424116005713171,
            "start_logit": -1.8372348546981812,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "corticosteroids.",
            "probability": 0.000962038495278386,
            "start_logit": 4.28795862197876,
            "end_logit": -2.173201084136963,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "rticosteroids",
            "probability": 0.0007209959716821626,
            "start_logit": -2.5179078578948975,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "co",
            "probability": 0.0006485384817242767,
            "start_logit": 4.28795862197876,
            "end_logit": -2.5675342082977295,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "acid",
            "probability": 0.0005591089080230859,
            "start_logit": 3.1321704387664795,
            "end_logit": -1.560123085975647,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "oids",
            "probability": 0.0005473905746608982,
            "start_logit": -2.7933788299560547,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "treatment of EoE with acid suppression versus topical corticosteroids",
            "probability": 0.0004907065194623088,
            "start_logit": -2.9026951789855957,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "suppression",
            "probability": 0.00044855784421579735,
            "start_logit": -1.8372348546981812,
            "end_logit": 3.1889755725860596,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "steroids",
            "probability": 0.00034518223335230913,
            "start_logit": -3.2544689178466797,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "acid suppression versus topical corticosteroids.",
            "probability": 0.0003028586765065698,
            "start_logit": 3.1321704387664795,
            "end_logit": -2.173201084136963,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "with acid suppression versus topical corticosteroids",
            "probability": 0.0002883995494642139,
            "start_logit": -3.434194564819336,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "acid suppression versus topical co",
            "probability": 0.00020416595302847807,
            "start_logit": 3.1321704387664795,
            "end_logit": -2.5675342082977295,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "icosteroids",
            "probability": 0.00019104304611455397,
            "start_logit": -3.8460426330566406,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "treatment of EoE with acid suppression",
            "probability": 0.0001545592196349365,
            "start_logit": -2.9026951789855957,
            "end_logit": 3.1889755725860596,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "acid suppression versus topical",
            "probability": 0.0001463568610320942,
            "start_logit": 3.1321704387664795,
            "end_logit": -2.9004194736480713,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        },
        {
            "text": "versus topical corticosteroids",
            "probability": 0.00011965947460385623,
            "start_logit": -4.313891410827637,
            "end_logit": 4.344244480133057,
            "question_text": "Which drugs are utilized to treat eosinophilic esophagitis?"
        }
    ],
    "54db7c4ac0bb8dce23000001": [
        {
            "text": "PKA and Thr17 by Ca(2+) /calmodulin-dependent protein kinase",
            "probability": 0.3264668298927918,
            "start_logit": 4.707148551940918,
            "end_logit": 3.845815420150757,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "PKA",
            "probability": 0.16511515528687404,
            "start_logit": 4.707148551940918,
            "end_logit": 3.164130210876465,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "PKA and Thr17 by Ca(2+) /calmodulin-dependent protein kinase (CaMKII)",
            "probability": 0.13075296663749061,
            "start_logit": 4.707148551940918,
            "end_logit": 2.9307968616485596,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "CaMKII)",
            "probability": 0.08290229952906354,
            "start_logit": 4.251501560211182,
            "end_logit": 2.9307968616485596,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "PKA and Thr17 by Ca(2+) /calmodulin-dependent protein kinase (CaMKII",
            "probability": 0.06394733006598942,
            "start_logit": 4.707148551940918,
            "end_logit": 2.2155468463897705,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "PKA and Thr17",
            "probability": 0.05079004957774666,
            "start_logit": 4.707148551940918,
            "end_logit": 1.9851875305175781,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "CaMKII",
            "probability": 0.040545012840224826,
            "start_logit": 4.251501560211182,
            "end_logit": 2.2155468463897705,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "calmodulin-dependent protein kinase",
            "probability": 0.038732714484305,
            "start_logit": 2.575504779815674,
            "end_logit": 3.845815420150757,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "Ca(2+) /calmodulin-dependent protein kinase",
            "probability": 0.019841202772334858,
            "start_logit": 1.906580924987793,
            "end_logit": 3.845815420150757,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "Thr17 by Ca(2+) /calmodulin-dependent protein kinase",
            "probability": 0.018400540527527636,
            "start_logit": 1.8312002420425415,
            "end_logit": 3.845815420150757,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "calmodulin-dependent protein kinase (CaMKII)",
            "probability": 0.015512808227435792,
            "start_logit": 2.575504779815674,
            "end_logit": 2.9307968616485596,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "Ca(2+) /calmodulin-dependent protein kinase (CaMKII)",
            "probability": 0.007946584113892138,
            "start_logit": 1.906580924987793,
            "end_logit": 2.9307968616485596,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase",
            "probability": 0.007940852135032107,
            "start_logit": 0.9908407926559448,
            "end_logit": 3.845815420150757,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "calmodulin-dependent protein kinase (CaMKII",
            "probability": 0.0075868463521790355,
            "start_logit": 2.575504779815674,
            "end_logit": 2.2155468463897705,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "Thr17 by Ca(2+) /calmodulin-dependent protein kinase (CaMKII)",
            "probability": 0.007369585640592324,
            "start_logit": 1.8312002420425415,
            "end_logit": 2.9307968616485596,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "Ca(2+) /calmodulin-dependent protein kinase (CaMKII",
            "probability": 0.0038864344748450533,
            "start_logit": 1.906580924987793,
            "end_logit": 2.2155468463897705,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "Thr17 by Ca(2+) /calmodulin-dependent protein kinase (CaMKII",
            "probability": 0.0036042419344496017,
            "start_logit": 1.8312002420425415,
            "end_logit": 2.2155468463897705,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "protein kinase (CaMKII)",
            "probability": 0.003180384281692761,
            "start_logit": 0.9908407926559448,
            "end_logit": 2.9307968616485596,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "Thr17",
            "probability": 0.0028626625435648895,
            "start_logit": 1.8312002420425415,
            "end_logit": 1.9851875305175781,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        },
        {
            "text": "phosphorylation at Ser16 by PKA and Thr17 by Ca(2+) /calmodulin-dependent protein kinase",
            "probability": 0.002615498681968163,
            "start_logit": -0.11972501873970032,
            "end_logit": 3.845815420150757,
            "question_text": "Which protein kinases have been found to phosphorylate Phospholamban and affect its biological activity?"
        }
    ],
    "56f8077a8b98c98849000002": [
        {
            "text": "cerebellar ataxia",
            "probability": 0.7876295369329572,
            "start_logit": 4.513233184814453,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "ataxia",
            "probability": 0.1986098408797512,
            "start_logit": 3.135547637939453,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "Anti-glutamic acid decarboxylase antibody (GAD-ab)-associated cerebellar ataxia",
            "probability": 0.004309220120029569,
            "start_logit": -0.6950377225875854,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cerebellar",
            "probability": 0.0022003878233384224,
            "start_logit": 4.513233184814453,
            "end_logit": -1.6190927028656006,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "glutamic acid decarboxylase antibody (GAD-ab)-associated cerebellar ataxia",
            "probability": 0.0017035836805549744,
            "start_logit": -1.6230605840682983,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cerebellar ataxia is a rare neurological disorder characterized by cerebellar symptoms",
            "probability": 0.0007539376354599471,
            "start_logit": 4.513233184814453,
            "end_logit": -2.690171957015991,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "axia",
            "probability": 0.0007031119957175637,
            "start_logit": -2.5080337524414062,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cerebellar ataxia is a rare neurological disorder",
            "probability": 0.0006604544863970887,
            "start_logit": 4.513233184814453,
            "end_logit": -2.8225533962249756,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "associated cerebellar ataxia",
            "probability": 0.0006455566618891602,
            "start_logit": -2.5934369564056396,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "bellar ataxia",
            "probability": 0.0004745935928941883,
            "start_logit": -2.9010910987854004,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cerebellar ataxia is",
            "probability": 0.0003865358250703593,
            "start_logit": 4.513233184814453,
            "end_logit": -3.3582570552825928,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "(GAD-ab)-associated cerebellar ataxia",
            "probability": 0.00029905343429375105,
            "start_logit": -3.3629276752471924,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "r ataxia",
            "probability": 0.00026612273692701896,
            "start_logit": -3.4795923233032227,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "c",
            "probability": 0.0002349275899275345,
            "start_logit": 4.513233184814453,
            "end_logit": -3.8562042713165283,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "ia",
            "probability": 0.00022527376232178093,
            "start_logit": -3.646233558654785,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cerebellar at",
            "probability": 0.00021485970694162126,
            "start_logit": 4.513233184814453,
            "end_logit": -3.9454963207244873,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "ataxia is a rare neurological disorder characterized by cerebellar symptoms",
            "probability": 0.00019011404066313192,
            "start_logit": 3.135547637939453,
            "end_logit": -2.690171957015991,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "ataxia is a rare neurological disorder",
            "probability": 0.00016654119011639987,
            "start_logit": 3.135547637939453,
            "end_logit": -2.8225533962249756,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": ")-associated cerebellar ataxia",
            "probability": 0.0001637001231187062,
            "start_logit": -3.9655137062072754,
            "end_logit": 4.261301517486572,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        },
        {
            "text": "cerebellar atax",
            "probability": 0.00016264778163053542,
            "start_logit": 4.513233184814453,
            "end_logit": -4.2238945960998535,
            "question_text": "List autoimmune disorders associated with GAD65 autoantibodies."
        }
    ],
    "5503145ee9bde69634000022": [
        {
            "text": "gefitinib in patients with advanced thyroid cancer",
            "probability": 0.17471305846218632,
            "start_logit": -1.0640658140182495,
            "end_logit": -1.4108295440673828,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "advanced thyroid cancer",
            "probability": 0.1331599019407395,
            "start_logit": -1.3356600999832153,
            "end_logit": -1.4108295440673828,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "gefitinib in patients with advanced thyroid cancer.",
            "probability": 0.09305292816021105,
            "start_logit": -1.0640658140182495,
            "end_logit": -2.0408060550689697,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "gefitinib",
            "probability": 0.09204786591264583,
            "start_logit": -1.0640658140182495,
            "end_logit": -2.051665782928467,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "advanced thyroid cancer.",
            "probability": 0.07092153785284563,
            "start_logit": -1.3356600999832153,
            "end_logit": -2.0408060550689697,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "gefitinib in patients with advanced",
            "probability": 0.0625384260805913,
            "start_logit": -1.0640658140182495,
            "end_logit": -2.4381933212280273,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "thyroid cancer",
            "probability": 0.04934226802654026,
            "start_logit": -2.328429698944092,
            "end_logit": -1.4108295440673828,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "advanced",
            "probability": 0.04766450062587677,
            "start_logit": -1.3356600999832153,
            "end_logit": -2.4381933212280273,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "efficacy of gefitinib in patients with advanced thyroid cancer",
            "probability": 0.03952421476099023,
            "start_logit": -2.550297260284424,
            "end_logit": -1.4108295440673828,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "To determine the efficacy of gefitinib in patients with advanced thyroid cancer",
            "probability": 0.036053359677219565,
            "start_logit": -2.6422107219696045,
            "end_logit": -1.4108295440673828,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "cancer",
            "probability": 0.0278715765931446,
            "start_logit": -2.8996033668518066,
            "end_logit": -1.4108295440673828,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "thyroid cancer.",
            "probability": 0.02627990467540964,
            "start_logit": -2.328429698944092,
            "end_logit": -2.0408060550689697,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "determine the efficacy of gefitinib in patients with advanced thyroid cancer",
            "probability": 0.024642469722521695,
            "start_logit": -3.0227394104003906,
            "end_logit": -1.4108295440673828,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "efficacy of gefitinib in patients with advanced thyroid cancer.",
            "probability": 0.021050767178568873,
            "start_logit": -2.550297260284424,
            "end_logit": -2.0408060550689697,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "efficacy of gefitinib",
            "probability": 0.020823398391881826,
            "start_logit": -2.550297260284424,
            "end_logit": -2.051665782928467,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "To determine the efficacy of gefitinib in patients with advanced thyroid cancer.",
            "probability": 0.01920217479739596,
            "start_logit": -2.6422107219696045,
            "end_logit": -2.0408060550689697,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "To determine the efficacy of gefitinib",
            "probability": 0.018994772608753572,
            "start_logit": -2.6422107219696045,
            "end_logit": -2.051665782928467,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "cancer.",
            "probability": 0.01484452185349975,
            "start_logit": -2.8996033668518066,
            "end_logit": -2.0408060550689697,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "efficacy of gefitinib in patients with advanced",
            "probability": 0.014147667066103013,
            "start_logit": -2.550297260284424,
            "end_logit": -2.4381933212280273,
            "question_text": "List the different subtypes of thyroid cancer."
        },
        {
            "text": "determine the efficacy of gefitinib in patients with advanced thyroid cancer.",
            "probability": 0.013124685612874665,
            "start_logit": -3.0227394104003906,
            "end_logit": -2.0408060550689697,
            "question_text": "List the different subtypes of thyroid cancer."
        }
    ],
    "55391825bc4f83e828000016": [
        {
            "text": "sensorineural hearing loss and generalized cutaneous pigmentary defects",
            "probability": 0.19959489110101908,
            "start_logit": 2.1401901245117188,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "generalized cutaneous pigmentary defects",
            "probability": 0.1721751187750358,
            "start_logit": 1.9924124479293823,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "sensorineural hearing loss",
            "probability": 0.1431700000138683,
            "start_logit": 2.1401901245117188,
            "end_logit": 1.9229412078857422,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "total colonic aganglionosis with small bowel extension, sensorineural hearing loss and generalized cutaneous pigmentary defects",
            "probability": 0.0842795272428076,
            "start_logit": 1.2780393362045288,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "hearing loss and generalized cutaneous pigmentary defects",
            "probability": 0.08083619216870488,
            "start_logit": 1.2363251447677612,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "total colonic aganglionosis with small bowel extension, sensorineural hearing loss",
            "probability": 0.06045395175177393,
            "start_logit": 1.2780393362045288,
            "end_logit": 1.9229412078857422,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "hearing loss",
            "probability": 0.05798403741735576,
            "start_logit": 1.2363251447677612,
            "end_logit": 1.9229412078857422,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "total colonic aganglionosis",
            "probability": 0.056513293227999355,
            "start_logit": 1.2780393362045288,
            "end_logit": 1.8555351495742798,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "cutaneous pigmentary defects",
            "probability": 0.040130135133915786,
            "start_logit": 0.5360279083251953,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "aganglionosis with small bowel extension, sensorineural hearing loss and generalized cutaneous pigmentary defects",
            "probability": 0.019150042034971747,
            "start_logit": -0.20379473268985748,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "aganglionosis with small bowel extension, sensorineural hearing loss",
            "probability": 0.013736381243470038,
            "start_logit": -0.20379473268985748,
            "end_logit": 1.9229412078857422,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "aganglionosis",
            "probability": 0.012840982576147865,
            "start_logit": -0.20379473268985748,
            "end_logit": 1.8555351495742798,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "total colonic aganglionosis with small bowel extension",
            "probability": 0.01205884077337642,
            "start_logit": 1.2780393362045288,
            "end_logit": 0.3108573257923126,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "colonic aganglionosis with small bowel extension, sensorineural hearing loss and generalized cutaneous pigmentary defects",
            "probability": 0.01052712725404186,
            "start_logit": -0.8021441698074341,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "pigmentary defects",
            "probability": 0.008911437612356207,
            "start_logit": -0.968764066696167,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "colonic aganglionosis with small bowel extension, sensorineural hearing loss",
            "probability": 0.007551139214001011,
            "start_logit": -0.8021441698074341,
            "end_logit": 1.9229412078857422,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "colonic aganglionosis",
            "probability": 0.007058922241485424,
            "start_logit": -0.8021441698074341,
            "end_logit": 1.8555351495742798,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "small bowel extension, sensorineural hearing loss and generalized cutaneous pigmentary defects",
            "probability": 0.005990768079326261,
            "start_logit": -1.365880012512207,
            "end_logit": 2.2551982402801514,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "small bowel extension, sensorineural hearing loss",
            "probability": 0.00429719549067077,
            "start_logit": -1.365880012512207,
            "end_logit": 1.9229412078857422,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        },
        {
            "text": "aganglionosis with small bowel extension",
            "probability": 0.0027400166476716555,
            "start_logit": -0.20379473268985748,
            "end_logit": 0.3108573257923126,
            "question_text": "What are the effects of homozygosity of EDNRB mutations in addition to Hirschsprung disease?"
        }
    ],
    "56be15ffef6e39474100000b": [
        {
            "text": "atrial septal defect",
            "probability": 0.9583937724772635,
            "start_logit": 3.056641101837158,
            "end_logit": 1.8640196323394775,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "Tetralogy of Fallot with an atrial septal defect",
            "probability": 0.02894023298186851,
            "start_logit": -0.4433848559856415,
            "end_logit": 1.8640196323394775,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal",
            "probability": 0.003296793351970684,
            "start_logit": 3.056641101837158,
            "end_logit": -3.808288812637329,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "at",
            "probability": 0.003068837501221315,
            "start_logit": 3.056641101837158,
            "end_logit": -3.8799402713775635,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "an atrial septal defect",
            "probability": 0.0016107476247348865,
            "start_logit": -3.3319191932678223,
            "end_logit": 1.8640196323394775,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "septal defect",
            "probability": 0.0012223776212778442,
            "start_logit": -3.6078197956085205,
            "end_logit": 1.8640196323394775,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect (a subclass of Pentalogy of Fallot)",
            "probability": 0.0012008732486588928,
            "start_logit": 3.056641101837158,
            "end_logit": -4.818190097808838,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect (",
            "probability": 0.0007682572870380471,
            "start_logit": 3.056641101837158,
            "end_logit": -5.264869689941406,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "defect",
            "probability": 0.0005947618791237941,
            "start_logit": -4.328211784362793,
            "end_logit": 1.8640196323394775,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "with an atrial septal defect",
            "probability": 0.00017404819006682006,
            "start_logit": -5.557040691375732,
            "end_logit": 1.8640196323394775,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect was found on necropsy, resulting in the final diagnosis of Tetralogy of Fallot with an at",
            "probability": 0.0001371803061604515,
            "start_logit": -0.05111683905124664,
            "end_logit": -3.8799402713775635,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "necropsy, resulting in the final diagnosis of Tetralogy of Fallot with an atrial septal defect",
            "probability": 0.00010152993068584409,
            "start_logit": -6.096019268035889,
            "end_logit": 1.8640196323394775,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "Tetralogy of Fallot with an atrial septal",
            "probability": 9.955194872822515e-05,
            "start_logit": -0.4433848559856415,
            "end_logit": -3.808288812637329,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "Tetralogy of Fallot with an at",
            "probability": 9.266845718255854e-05,
            "start_logit": -0.4433848559856415,
            "end_logit": -3.8799402713775635,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect was found on necropsy",
            "probability": 7.447402148464415e-05,
            "start_logit": -0.05111683905124664,
            "end_logit": -4.490786075592041,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect was found on necropsy,",
            "probability": 7.217636383771996e-05,
            "start_logit": -0.05111683905124664,
            "end_logit": -4.52212381362915,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect was found on necropsy, resulting in the final diagnosis of Te",
            "probability": 5.0554194427298714e-05,
            "start_logit": -0.05111683905124664,
            "end_logit": -4.878190517425537,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "Tetralogy of Fallot with an atrial septal defect (a subclass of Pentalogy of Fallot)",
            "probability": 3.6262288629078245e-05,
            "start_logit": -0.4433848559856415,
            "end_logit": -4.818190097808838,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "Te",
            "probability": 3.415052300732853e-05,
            "start_logit": -0.4433848559856415,
            "end_logit": -4.878190517425537,
            "question_text": "List Pentalogy of Fallot."
        },
        {
            "text": "atrial septal defect was found on necropsy, resulting in the final diagnosis of Tetralogy of Fallot",
            "probability": 3.074980263213232e-05,
            "start_logit": -0.05111683905124664,
            "end_logit": -5.37535285949707,
            "question_text": "List Pentalogy of Fallot."
        }
    ],
    "5333f728d6d3ac6a34000041": [
        {
            "text": "protein interaction networks",
            "probability": 0.3423166496463191,
            "start_logit": -0.5940725803375244,
            "end_logit": -0.5086483359336853,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "Identification of protein interaction networks",
            "probability": 0.19700810649336611,
            "start_logit": -1.1465638875961304,
            "end_logit": -0.5086483359336853,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "networks",
            "probability": 0.1517525566710307,
            "start_logit": -1.407557487487793,
            "end_logit": -0.5086483359336853,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein interaction",
            "probability": 0.059771847708326935,
            "start_logit": -0.5940725803375244,
            "end_logit": -2.253849744796753,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "interaction networks",
            "probability": 0.047658967257433696,
            "start_logit": -2.5657379627227783,
            "end_logit": -0.5086483359336853,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "Identification",
            "probability": 0.047267468744884265,
            "start_logit": -1.1465638875961304,
            "end_logit": -1.9360709190368652,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "Identification of protein interaction",
            "probability": 0.03439954951298395,
            "start_logit": -1.1465638875961304,
            "end_logit": -2.253849744796753,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein",
            "probability": 0.025250685772643885,
            "start_logit": -0.5940725803375244,
            "end_logit": -3.1155312061309814,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein interaction networks has received considerable attention in the post-genomic era. The currently available biochemical approaches used to detect protein-protein interactions",
            "probability": 0.02055989269637717,
            "start_logit": -0.5940725803375244,
            "end_logit": -3.32104229927063,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "Identification of protein",
            "probability": 0.01453212923434279,
            "start_logit": -1.1465638875961304,
            "end_logit": -3.1155312061309814,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "of protein interaction networks",
            "probability": 0.010361877887479453,
            "start_logit": -4.091675281524658,
            "end_logit": -0.5086483359336853,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "networks has received considerable attention in the post-genomic era. The currently available biochemical approaches used to detect protein-protein interactions",
            "probability": 0.009114415804141811,
            "start_logit": -1.407557487487793,
            "end_logit": -3.32104229927063,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "interaction",
            "probability": 0.008321723573161577,
            "start_logit": -2.5657379627227783,
            "end_logit": -2.253849744796753,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein interaction networks has received considerable attention in the post-genomic era.",
            "probability": 0.007024289346429901,
            "start_logit": -0.5940725803375244,
            "end_logit": -4.395010471343994,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein interaction networks has received considerable attention in the post-genomic era. The currently available biochemical approaches",
            "probability": 0.00607564549460009,
            "start_logit": -0.5940725803375244,
            "end_logit": -4.540096282958984,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "Identification of protein interaction networks has received considerable attention in the post-genomic era.",
            "probability": 0.004042578545424132,
            "start_logit": -1.1465638875961304,
            "end_logit": -4.395010471343994,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "Identification of",
            "probability": 0.003981267003695584,
            "start_logit": -1.1465638875961304,
            "end_logit": -4.410293102264404,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein interaction networks has received considerable attention in the post-genomic era",
            "probability": 0.003595437920412321,
            "start_logit": -0.5940725803375244,
            "end_logit": -5.064718723297119,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "Identification of protein interaction networks has received considerable attention in the post-genomic era. The currently available biochemical approaches",
            "probability": 0.003496620499916678,
            "start_logit": -1.1465638875961304,
            "end_logit": -4.540096282958984,
            "question_text": "List algorithms suitable for predicting protein complexes"
        },
        {
            "text": "protein interaction networks has received considerable attention in the post-genomic era. The currently available biochemical approaches used to detect protein",
            "probability": 0.0034682901870296337,
            "start_logit": -0.5940725803375244,
            "end_logit": -5.100722789764404,
            "question_text": "List algorithms suitable for predicting protein complexes"
        }
    ],
    "51434c74d24251bc0500000c": [
        {
            "text": "Hidden Markov Models",
            "probability": 0.2273222561144744,
            "start_logit": 2.5064165592193604,
            "end_logit": 2.1670572757720947,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Support Vector Machines",
            "probability": 0.18522174526000806,
            "start_logit": 2.978989601135254,
            "end_logit": 1.4896693229675293,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks (NNs) and on Support Vector Machines",
            "probability": 0.11546652815227303,
            "start_logit": 2.5064165592193604,
            "end_logit": 1.4896693229675293,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks",
            "probability": 0.08934169470673829,
            "start_logit": 2.5064165592193604,
            "end_logit": 1.2331569194793701,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Neural Networks (NNs) and on Support Vector Machines",
            "probability": 0.07142259100879915,
            "start_logit": 2.026050090789795,
            "end_logit": 1.4896693229675293,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Neural Networks",
            "probability": 0.05526290106044685,
            "start_logit": 2.026050090789795,
            "end_logit": 1.2331569194793701,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs",
            "probability": 0.042179851793056,
            "start_logit": 2.5064165592193604,
            "end_logit": 0.48263129591941833,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Support Vector Machines (SVMs)",
            "probability": 0.04061445529993725,
            "start_logit": 2.978989601135254,
            "end_logit": -0.02776036225259304,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Support Vector Machines (SVMs",
            "probability": 0.0342448192033215,
            "start_logit": 2.978989601135254,
            "end_logit": -0.19834911823272705,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks (NNs) and on Support Vector Machines (SVMs)",
            "probability": 0.025318896221911323,
            "start_logit": 2.5064165592193604,
            "end_logit": -0.02776036225259304,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks (NNs) and on Support Vector Machines (SVMs",
            "probability": 0.021348089421461543,
            "start_logit": 2.5064165592193604,
            "end_logit": -0.19834911823272705,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "HMMs), on Neural Networks (NNs) and on Support Vector Machines",
            "probability": 0.016587205513786833,
            "start_logit": 0.5660675168037415,
            "end_logit": 1.4896693229675293,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Neural Networks (NNs) and on Support Vector Machines (SVMs)",
            "probability": 0.015661172104066628,
            "start_logit": 2.026050090789795,
            "end_logit": -0.02776036225259304,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs)",
            "probability": 0.014826747547446817,
            "start_logit": 2.5064165592193604,
            "end_logit": -0.5628785490989685,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Neural Networks (NNs) and on Support Vector Machines (SVMs",
            "probability": 0.01320500307723424,
            "start_logit": 2.026050090789795,
            "end_logit": -0.19834911823272705,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "HMMs), on Neural Networks",
            "probability": 0.012834273921325107,
            "start_logit": 0.5660675168037415,
            "end_logit": 1.2331569194793701,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "HMMs",
            "probability": 0.006059295983246525,
            "start_logit": 0.5660675168037415,
            "end_logit": 0.48263129591941833,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "Hidden Markov Models (HMMs), on Neural Networks (NNs)",
            "probability": 0.005319545347381196,
            "start_logit": 2.5064165592193604,
            "end_logit": -1.587923526763916,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "(HMMs), on Neural Networks (NNs) and on Support Vector Machines",
            "probability": 0.004125772615162365,
            "start_logit": -0.8253108263015747,
            "end_logit": 1.4896693229675293,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        },
        {
            "text": "HMMs), on Neural Networks (NNs) and on Support Vector Machines (SVMs)",
            "probability": 0.0036371556479228625,
            "start_logit": 0.5660675168037415,
            "end_logit": -0.02776036225259304,
            "question_text": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?"
        }
    ],
    "5150f401d24251bc05000075": [
        {
            "text": "categorise online suppliers of Viagra based on their legal status, and to quantify the suppliers within each category.",
            "probability": 0.15032532667228513,
            "start_logit": -3.3603897094726562,
            "end_logit": -3.404693365097046,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "categorise online suppliers of Viagra based on their legal status,",
            "probability": 0.10795257689198431,
            "start_logit": -3.3603897094726562,
            "end_logit": -3.7358031272888184,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "categorise online suppliers of Viagra based on their legal status",
            "probability": 0.08875513031118473,
            "start_logit": -3.3603897094726562,
            "end_logit": -3.9316139221191406,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Viagra based on their legal status, and to quantify the suppliers within each category.",
            "probability": 0.0571791028781027,
            "start_logit": -4.327003002166748,
            "end_logit": -3.404693365097046,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "based on their legal status, and to quantify the suppliers within each category.",
            "probability": 0.05549366516171387,
            "start_logit": -4.356922626495361,
            "end_logit": -3.404693365097046,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "categorise online suppliers of Viagra",
            "probability": 0.05213016891589188,
            "start_logit": -3.3603897094726562,
            "end_logit": -4.463751316070557,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "quantify the suppliers within each category.",
            "probability": 0.04955612564291257,
            "start_logit": -4.470085620880127,
            "end_logit": -3.404693365097046,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "legal status, and to quantify the suppliers within each category.",
            "probability": 0.04771254988111601,
            "start_logit": -4.507997035980225,
            "end_logit": -3.404693365097046,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "categorise online suppliers of Viagra based",
            "probability": 0.04435704377145766,
            "start_logit": -3.3603897094726562,
            "end_logit": -4.625223636627197,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Viagra based on their legal status,",
            "probability": 0.04106181996543825,
            "start_logit": -4.327003002166748,
            "end_logit": -3.7358031272888184,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "based on their legal status,",
            "probability": 0.039851462744184586,
            "start_logit": -4.356922626495361,
            "end_logit": -3.7358031272888184,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "to categorise online suppliers of Viagra based on their legal status, and to quantify the suppliers within each category.",
            "probability": 0.0349697387270858,
            "start_logit": -4.818708419799805,
            "end_logit": -3.404693365097046,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "legal status,",
            "probability": 0.0342636388942132,
            "start_logit": -4.507997035980225,
            "end_logit": -3.7358031272888184,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "Viagra based on their legal status",
            "probability": 0.0337597052962752,
            "start_logit": -4.327003002166748,
            "end_logit": -3.9316139221191406,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "based on their legal status",
            "probability": 0.032764588588658855,
            "start_logit": -4.356922626495361,
            "end_logit": -3.9316139221191406,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "legal status",
            "probability": 0.028170459868078198,
            "start_logit": -4.507997035980225,
            "end_logit": -3.9316139221191406,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "categorise online suppliers of Viagra based on their legal status, and to quantify the suppliers within each category",
            "probability": 0.027687087469395744,
            "start_logit": -3.3603897094726562,
            "end_logit": -5.096529006958008,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "categorise online suppliers of Viagra based on their legal",
            "probability": 0.025530499353308384,
            "start_logit": -3.3603897094726562,
            "end_logit": -5.177621364593506,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "to categorise online suppliers of Viagra based on their legal status,",
            "probability": 0.02511269053855532,
            "start_logit": -4.818708419799805,
            "end_logit": -3.7358031272888184,
            "question_text": "What are the generic versions of Viagra?"
        },
        {
            "text": "categorise online suppliers",
            "probability": 0.02336661842815749,
            "start_logit": -3.3603897094726562,
            "end_logit": -5.266186714172363,
            "question_text": "What are the generic versions of Viagra?"
        }
    ],
    "51601071298dcd4e51000038": [
        {
            "text": "pathogens where conventional approaches had failed. Bexsero",
            "probability": 0.12587675996896877,
            "start_logit": -3.0965068340301514,
            "end_logit": -3.8822708129882812,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse vaccinology (RV), the first application of genomic technologies in vaccine research,",
            "probability": 0.11114988330535057,
            "start_logit": -3.123648166656494,
            "end_logit": -3.97955322265625,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse vaccinology (RV),",
            "probability": 0.09455536544734953,
            "start_logit": -3.123648166656494,
            "end_logit": -4.141247272491455,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse vaccinology",
            "probability": 0.09287606781294126,
            "start_logit": -3.123648166656494,
            "end_logit": -4.1591668128967285,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse",
            "probability": 0.07754308215226025,
            "start_logit": -3.123648166656494,
            "end_logit": -4.339599132537842,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Bexsero",
            "probability": 0.05734700911842004,
            "start_logit": -3.8826894760131836,
            "end_logit": -3.8822708129882812,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse vaccinology (RV)",
            "probability": 0.04951987258635259,
            "start_logit": -3.123648166656494,
            "end_logit": -4.788058757781982,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "pathogens where conventional approaches had failed. Bexsero, the first vaccine developed using RV,",
            "probability": 0.048280558705129054,
            "start_logit": -3.0965068340301514,
            "end_logit": -4.840545177459717,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "pathogens where conventional approaches had failed.",
            "probability": 0.04702273759152444,
            "start_logit": -3.0965068340301514,
            "end_logit": -4.866942882537842,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "pathogens where conventional approaches had failed. Bexsero,",
            "probability": 0.04650638532739598,
            "start_logit": -3.0965068340301514,
            "end_logit": -4.877984523773193,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "pathogens",
            "probability": 0.031214737480491285,
            "start_logit": -3.0965068340301514,
            "end_logit": -5.276683807373047,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "(RV), the first application of genomic technologies in vaccine research,",
            "probability": 0.030845786644354493,
            "start_logit": -4.405527591705322,
            "end_logit": -3.97955322265625,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse vaccinology (",
            "probability": 0.030237075866538107,
            "start_logit": -3.123648166656494,
            "end_logit": -5.2813639640808105,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "(RV),",
            "probability": 0.026240555022944506,
            "start_logit": -4.405527591705322,
            "end_logit": -4.141247272491455,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse vaccinology (RV), the first application of genomic technologies in vaccine research",
            "probability": 0.02611659987406548,
            "start_logit": -3.123648166656494,
            "end_logit": -5.42786169052124,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Bexsero, the first vaccine developed using RV,",
            "probability": 0.021995685629245646,
            "start_logit": -3.8826894760131836,
            "end_logit": -4.840545177459717,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse vaccinology (RV), the first application of genomic technologies in vaccine",
            "probability": 0.021838911112661456,
            "start_logit": -3.123648166656494,
            "end_logit": -5.606739521026611,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Bexsero,",
            "probability": 0.02118740666738169,
            "start_logit": -3.8826894760131836,
            "end_logit": -4.877984523773193,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "Reverse vaccinology (RV), the first application of genomic technologies",
            "probability": 0.020379111279943705,
            "start_logit": -3.123648166656494,
            "end_logit": -5.675922393798828,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        },
        {
            "text": "pathogens where conventional approaches had failed. Bexsero, the first vaccine",
            "probability": 0.019266408406680945,
            "start_logit": -3.0965068340301514,
            "end_logit": -5.75921106338501,
            "question_text": "Against which organisms has reverse vaccinology been used?"
        }
    ],
    "515993f3d24251bc050000a0": [
        {
            "text": "thyronamines",
            "probability": 0.5980981198411832,
            "start_logit": 6.126232624053955,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "thyronamine",
            "probability": 0.3725147011562862,
            "start_logit": 6.126232624053955,
            "end_logit": 5.143526554107666,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "the thyronamines",
            "probability": 0.0135536183926475,
            "start_logit": 2.3391313552856445,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "the thyronamine",
            "probability": 0.008441628451305113,
            "start_logit": 2.3391313552856445,
            "end_logit": 5.143526554107666,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "KB - 141 have similar effects. Another class of thyroid hormone analogs, the thyronamines",
            "probability": 0.0022384682958012984,
            "start_logit": 0.5382696390151978,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "KB- 2115 and KB - 141 have similar effects. Another class of thyroid hormone analogs, the thyronamines",
            "probability": 0.0019387915385900023,
            "start_logit": 0.3945426642894745,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "KB - 141 have similar effects. Another class of thyroid hormone analogs, the thyronamine",
            "probability": 0.001394189883893403,
            "start_logit": 0.5382696390151978,
            "end_logit": 5.143526554107666,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "KB- 2115 and KB - 141 have similar effects. Another class of thyroid hormone analogs, the thyronamine",
            "probability": 0.0012075415833006948,
            "start_logit": 0.3945426642894745,
            "end_logit": 5.143526554107666,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "thyrona",
            "probability": 0.00017433376394112045,
            "start_logit": 6.126232624053955,
            "end_logit": -2.523533582687378,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "thy",
            "probability": 0.00011916947850937402,
            "start_logit": 6.126232624053955,
            "end_logit": -2.903958559036255,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "ronamines",
            "probability": 8.093252044445621e-05,
            "start_logit": -2.7816617488861084,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "mines",
            "probability": 6.947361304156374e-05,
            "start_logit": -2.934330463409424,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "ronamine",
            "probability": 5.040737074244133e-05,
            "start_logit": -2.7816617488861084,
            "end_logit": 5.143526554107666,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "mine",
            "probability": 4.327039551185623e-05,
            "start_logit": -2.934330463409424,
            "end_logit": 5.143526554107666,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "s",
            "probability": 3.6415926908361835e-05,
            "start_logit": -3.5802712440490723,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "thyronamines have emerged",
            "probability": 9.274661429472914e-06,
            "start_logit": 6.126232624053955,
            "end_logit": -5.457219123840332,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "141 have similar effects. Another class of thyroid hormone analogs, the thyronamines",
            "probability": 9.152265287390227e-06,
            "start_logit": -4.961276054382324,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "thyronamines have emerged recently",
            "probability": 8.933609672947587e-06,
            "start_logit": 6.126232624053955,
            "end_logit": -5.49468469619751,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": ", the thyronamines",
            "probability": 5.876926999605527e-06,
            "start_logit": -5.404243469238281,
            "end_logit": 5.617004871368408,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        },
        {
            "text": "141 have similar effects. Another class of thyroid hormone analogs, the thyronamine",
            "probability": 5.700324504180901e-06,
            "start_logit": -4.961276054382324,
            "end_logit": 5.143526554107666,
            "question_text": "Which compounds exist that are thyroid hormone analogs?"
        }
    ],
    "53357c98d6d3ac6a3400004a": [
        {
            "text": "gene expression profiles",
            "probability": 0.18101571815182793,
            "start_logit": -3.4822874069213867,
            "end_logit": -4.224356174468994,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "gene expression profiles.",
            "probability": 0.13253184626388573,
            "start_logit": -3.4822874069213867,
            "end_logit": -4.536117076873779,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "gene expression",
            "probability": 0.12783918704961705,
            "start_logit": -3.4822874069213867,
            "end_logit": -4.572166919708252,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "gene",
            "probability": 0.12466159132751317,
            "start_logit": -3.4822874069213867,
            "end_logit": -4.597337245941162,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "gene expression profiles. The subtypes are associated with different clinical parameters and origin of precursor cells.",
            "probability": 0.08170970296771864,
            "start_logit": -3.4822874069213867,
            "end_logit": -5.0197672843933105,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "gene expression profiles. The subtypes are associated with different clinical parameters and origin of precursor cells",
            "probability": 0.0445807235245451,
            "start_logit": -3.4822874069213867,
            "end_logit": -5.625638484954834,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "molecular subtypes characterized by pervasively different gene expression profiles",
            "probability": 0.03379661788897644,
            "start_logit": -5.160510540008545,
            "end_logit": -4.224356174468994,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "different gene expression profiles",
            "probability": 0.027524581479719767,
            "start_logit": -5.3657917976379395,
            "end_logit": -4.224356174468994,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "molecular subtypes characterized by pervasively different gene expression profiles.",
            "probability": 0.02474441563436067,
            "start_logit": -5.160510540008545,
            "end_logit": -4.536117076873779,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "gene expression profiles. The subtypes are associated with different clinical parameters",
            "probability": 0.024320943477660308,
            "start_logit": -3.4822874069213867,
            "end_logit": -6.231602191925049,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "molecular subtypes characterized by pervasively different gene expression",
            "probability": 0.02386827066768546,
            "start_logit": -5.160510540008545,
            "end_logit": -4.572166919708252,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "molecular subtypes characterized by pervasively different gene",
            "probability": 0.02327499628509557,
            "start_logit": -5.160510540008545,
            "end_logit": -4.597337245941162,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "expression profiles",
            "probability": 0.023165734703713407,
            "start_logit": -5.538197040557861,
            "end_logit": -4.224356174468994,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "different gene expression profiles.",
            "probability": 0.020152303006572798,
            "start_logit": -5.3657917976379395,
            "end_logit": -4.536117076873779,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "profiles",
            "probability": 0.019842046515864846,
            "start_logit": -5.693068027496338,
            "end_logit": -4.224356174468994,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "different gene expression",
            "probability": 0.019438754579848,
            "start_logit": -5.3657917976379395,
            "end_logit": -4.572166919708252,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "different gene",
            "probability": 0.01895558111151252,
            "start_logit": -5.3657917976379395,
            "end_logit": -4.597337245941162,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "expression profiles.",
            "probability": 0.01696094472728254,
            "start_logit": -5.538197040557861,
            "end_logit": -4.536117076873779,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "expression",
            "probability": 0.016360395230682993,
            "start_logit": -5.538197040557861,
            "end_logit": -4.572166919708252,
            "question_text": "What genes are related to breast cancer?"
        },
        {
            "text": "molecular subtypes characterized by pervasively different gene expression profiles. The subtypes are associated with different clinical parameters and origin of precursor cells.",
            "probability": 0.015255645405917279,
            "start_logit": -5.160510540008545,
            "end_logit": -5.0197672843933105,
            "question_text": "What genes are related to breast cancer?"
        }
    ],
    "5523e47f7b523f2123000004": [
        {
            "text": "green fluorescent protein",
            "probability": 0.31734539261720235,
            "start_logit": 1.8201900720596313,
            "end_logit": 2.11745548248291,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green fluorescent protein",
            "probability": 0.20432307499405436,
            "start_logit": 1.3799017667770386,
            "end_logit": 2.11745548248291,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP)-namely, the overall large size and oxygen-dependent maturation of fluorescence of GFP",
            "probability": 0.09393621661603054,
            "start_logit": 1.8201900720596313,
            "end_logit": 0.9000807404518127,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP",
            "probability": 0.07340840980212349,
            "start_logit": 1.5736125707626343,
            "end_logit": 0.9000807404518127,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP",
            "probability": 0.06978239575337247,
            "start_logit": 1.8201900720596313,
            "end_logit": 0.6028465032577515,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green fluorescent protein (GFP",
            "probability": 0.04492944915062938,
            "start_logit": 1.3799017667770386,
            "end_logit": 0.6028465032577515,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs",
            "probability": 0.04050757513995738,
            "start_logit": 1.3799017667770386,
            "end_logit": 0.49924203753471375,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent protein (GFP)",
            "probability": 0.03357400471897692,
            "start_logit": 1.8201900720596313,
            "end_logit": -0.12878316640853882,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "Flavin-based fluorescent proteins (FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green fluorescent protein",
            "probability": 0.023013295055394102,
            "start_logit": -0.8037285804748535,
            "end_logit": 2.11745548248291,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green",
            "probability": 0.022800108765533702,
            "start_logit": 1.8201900720596313,
            "end_logit": -0.5157699584960938,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green fluorescent protein (GFP)",
            "probability": 0.02161664874813878,
            "start_logit": 1.3799017667770386,
            "end_logit": -0.12878316640853882,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green",
            "probability": 0.014679867556143025,
            "start_logit": 1.3799017667770386,
            "end_logit": -0.5157699584960938,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP)-namely, the overall large size and oxygen-dependent maturation of fluorescence of GFP",
            "probability": 0.013199422396605095,
            "start_logit": -0.1422528624534607,
            "end_logit": 0.9000807404518127,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "green fluorescent",
            "probability": 0.00726860704815179,
            "start_logit": 1.8201900720596313,
            "end_logit": -1.658970594406128,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "GFP)",
            "probability": 0.004717642308746791,
            "start_logit": -0.1422528624534607,
            "end_logit": -0.12878316640853882,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green fluorescent",
            "probability": 0.004679898235652926,
            "start_logit": 1.3799017667770386,
            "end_logit": -1.658970594406128,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "Flavin-based fluorescent proteins (FbFPs",
            "probability": 0.004562444935313903,
            "start_logit": -0.8037285804748535,
            "end_logit": 0.49924203753471375,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "FbFPs)",
            "probability": 0.002292747935287958,
            "start_logit": 1.3799017667770386,
            "end_logit": -2.3724958896636963,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "(FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green fluorescent protein",
            "probability": 0.0017093769267619702,
            "start_logit": -3.4036717414855957,
            "end_logit": 2.11745548248291,
            "question_text": "List fluorescent reporter proteins."
        },
        {
            "text": "Flavin-based fluorescent proteins (FbFPs) address two major limitations associated with existing fluorescent reporters derived from the green",
            "probability": 0.001653421295922926,
            "start_logit": -0.8037285804748535,
            "end_logit": -0.5157699584960938,
            "question_text": "List fluorescent reporter proteins."
        }
    ],
    "54fb5720d176fff445000002": [
        {
            "text": "Sox2, Klf4",
            "probability": 0.12647788993961676,
            "start_logit": 5.058472633361816,
            "end_logit": 4.747422695159912,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct3/4, Sox2, Klf4",
            "probability": 0.11704986823799413,
            "start_logit": 4.9810051918029785,
            "end_logit": 4.747422695159912,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "c-Myc",
            "probability": 0.1089890163332798,
            "start_logit": 5.147121429443359,
            "end_logit": 4.509953498840332,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4",
            "probability": 0.10413942420071463,
            "start_logit": 5.017719268798828,
            "end_logit": 4.593839168548584,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2",
            "probability": 0.10217823029793444,
            "start_logit": 5.058472633361816,
            "end_logit": 4.534073829650879,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4, and c-Myc",
            "probability": 0.0990754405081125,
            "start_logit": 5.058472633361816,
            "end_logit": 4.503236770629883,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4, and c-Myc",
            "probability": 0.09575998924355862,
            "start_logit": 5.017719268798828,
            "end_logit": 4.509953498840332,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct3/4, Sox2",
            "probability": 0.09456157435006687,
            "start_logit": 4.9810051918029785,
            "end_logit": 4.534073829650879,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct3/4, Sox2, Klf4, and c-Myc",
            "probability": 0.091690075337534,
            "start_logit": 4.9810051918029785,
            "end_logit": 4.503236770629883,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Myc",
            "probability": 0.040696518518960584,
            "start_logit": 4.162016868591309,
            "end_logit": 4.509953498840332,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct",
            "probability": 0.003757254076646389,
            "start_logit": 4.9810051918029785,
            "end_logit": 1.3085110187530518,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct3",
            "probability": 0.003478838600843732,
            "start_logit": 4.9810051918029785,
            "end_logit": 1.2315211296081543,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct3/4",
            "probability": 0.00347739156440297,
            "start_logit": 4.9810051918029785,
            "end_logit": 1.231105089187622,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4, and c-Myc.",
            "probability": 0.0025746863218141145,
            "start_logit": 5.058472633361816,
            "end_logit": 0.8530828952789307,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct3/4, Sox2, Klf4, and c-Myc.",
            "probability": 0.0023827618793006962,
            "start_logit": 4.9810051918029785,
            "end_logit": 0.8530828952789307,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "c-Myc.",
            "probability": 0.0011527155545907107,
            "start_logit": 5.147121429443359,
            "end_logit": -0.039173100143671036,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Klf4, and c-Myc.",
            "probability": 0.001012799572123337,
            "start_logit": 5.017719268798828,
            "end_logit": -0.039173100143671036,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2, Klf4,",
            "probability": 0.0005326180911235991,
            "start_logit": 5.058472633361816,
            "end_logit": -0.7225954532623291,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Sox2,",
            "probability": 0.0005199921478839831,
            "start_logit": 5.058472633361816,
            "end_logit": -0.7465863823890686,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        },
        {
            "text": "Oct3/4, Sox2, Klf4,",
            "probability": 0.0004929152234983763,
            "start_logit": 4.9810051918029785,
            "end_logit": -0.7225954532623291,
            "question_text": "Which transcription factors are known as the four (4) \"Yamanaka factors\" that have been used to create induced pluripotent stem cells  (iPSCs)?"
        }
    ],
    "5363bad27d100faa0900000e": [
        {
            "text": "RNCR2",
            "probability": 0.9929934253154434,
            "start_logit": 5.5766730308532715,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNCR",
            "probability": 0.0032300558808885113,
            "start_logit": 5.5766730308532715,
            "end_logit": -0.45403799414634705,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNCR2 in regulation of mouse retinal cell differentiation.",
            "probability": 0.00131870230848205,
            "start_logit": 5.5766730308532715,
            "end_logit": -1.3498892784118652,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "2",
            "probability": 0.0004786580344254215,
            "start_logit": -2.0608198642730713,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "R",
            "probability": 0.00045799335305036966,
            "start_logit": 5.5766730308532715,
            "end_logit": -2.407438039779663,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNCR2 in regulation of mouse retinal cell differentiation",
            "probability": 0.0002569940586698054,
            "start_logit": 5.5766730308532715,
            "end_logit": -2.9852397441864014,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "highly abundant lncRNA RNCR2",
            "probability": 0.0002385928727088789,
            "start_logit": -2.757047653198242,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNCR2 in regulation of mouse",
            "probability": 0.00021232504010714804,
            "start_logit": 5.5766730308532715,
            "end_logit": -3.1761744022369385,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "NCR2",
            "probability": 0.000147915254202018,
            "start_logit": -3.2351667881011963,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNC",
            "probability": 0.0001449224721434812,
            "start_logit": 5.5766730308532715,
            "end_logit": -3.558093786239624,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "R2",
            "probability": 0.00013714789371941635,
            "start_logit": -3.310746431350708,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "lncRNA RNCR2",
            "probability": 0.00010586429364713165,
            "start_logit": -3.569648265838623,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "investigated the highly abundant lncRNA RNCR2",
            "probability": 6.938884220763525e-05,
            "start_logit": -3.9920802116394043,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "the highly abundant lncRNA RNCR2",
            "probability": 6.693168162644196e-05,
            "start_logit": -4.028133869171143,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "We have investigated the highly abundant lncRNA RNCR2",
            "probability": 5.614844219390434e-05,
            "start_logit": -4.203807353973389,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNA RNCR2",
            "probability": 4.821266802141121e-05,
            "start_logit": -4.356184482574463,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "abundant lncRNA RNCR2",
            "probability": 2.883893249279298e-05,
            "start_logit": -4.87007999420166,
            "end_logit": 5.274186611175537,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "mRNA-like noncoding RNAs",
            "probability": 4.3686631126282e-06,
            "start_logit": -0.09627854824066162,
            "end_logit": -1.386884093284607,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "RNAs",
            "probability": 2.2001737248499155e-06,
            "start_logit": -0.7821992635726929,
            "end_logit": -1.386884093284607,
            "question_text": "Which are the most abundant human lincRNA?"
        },
        {
            "text": "retinal cell differentiation.",
            "probability": 1.3138191328914005e-06,
            "start_logit": -1.334792137145996,
            "end_logit": -1.3498892784118652,
            "question_text": "Which are the most abundant human lincRNA?"
        }
    ],
    "532b15ecd6d3ac6a34000014": [
        {
            "text": "bortezomib",
            "probability": 0.12741139118747893,
            "start_logit": 4.76284646987915,
            "end_logit": 4.370809078216553,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "bortezomib, 17-AAG, digitoxin, staurosporine",
            "probability": 0.08590158068311676,
            "start_logit": 4.76284646987915,
            "end_logit": 3.976590156555176,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "bortezomib, 17-AAG, digitoxin, staurosporine, digoxin",
            "probability": 0.07897573138662736,
            "start_logit": 4.76284646987915,
            "end_logit": 3.892528533935547,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "bortezomib, 17-AAG, digitoxin",
            "probability": 0.07602455187204632,
            "start_logit": 4.76284646987915,
            "end_logit": 3.8544442653656006,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "bortezomib showed similar inhibitory effect on cell lines and 3 primary chordoma cell cultures. The combination treatment of bortezomib",
            "probability": 0.07030074016700932,
            "start_logit": 4.441861629486084,
            "end_logit": 4.0971550941467285,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "bortezomib, 17-AAG, digitoxin, staurosporine, digoxin, rubitecan",
            "probability": 0.06295890823626071,
            "start_logit": 4.76284646987915,
            "end_logit": 3.665870189666748,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "trimetrexate",
            "probability": 0.05553603720740864,
            "start_logit": 4.266380786895752,
            "end_logit": 4.036885738372803,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "rubitecan, and trimetrexate",
            "probability": 0.04127178372106102,
            "start_logit": 3.9695277214050293,
            "end_logit": 4.036885738372803,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "digoxin, rubitecan, and trimetrexate",
            "probability": 0.040832958700936825,
            "start_logit": 3.9588382244110107,
            "end_logit": 4.036885738372803,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "staurosporine, digoxin, rubitecan, and trimetrexate",
            "probability": 0.04042836076482549,
            "start_logit": 3.948880195617676,
            "end_logit": 4.036885738372803,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "staurosporine",
            "probability": 0.03806274400129747,
            "start_logit": 3.948880195617676,
            "end_logit": 3.976590156555176,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "digoxin",
            "probability": 0.035344131320474176,
            "start_logit": 3.9588382244110107,
            "end_logit": 3.892528533935547,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "digitoxin, staurosporine, digoxin, rubitecan, and trimetrexate",
            "probability": 0.03499857585975214,
            "start_logit": 3.8046560287475586,
            "end_logit": 4.036885738372803,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "staurosporine, digoxin",
            "probability": 0.03499392004407251,
            "start_logit": 3.948880195617676,
            "end_logit": 3.892528533935547,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "digitoxin, staurosporine",
            "probability": 0.03295067641027779,
            "start_logit": 3.8046560287475586,
            "end_logit": 3.976590156555176,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "digitoxin, staurosporine, digoxin",
            "probability": 0.030294014947005964,
            "start_logit": 3.8046560287475586,
            "end_logit": 3.892528533935547,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "digitoxin",
            "probability": 0.029161982678911593,
            "start_logit": 3.8046560287475586,
            "end_logit": 3.8544442653656006,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "rubitecan",
            "probability": 0.02847890150053204,
            "start_logit": 3.9695277214050293,
            "end_logit": 3.665870189666748,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "digoxin, rubitecan",
            "probability": 0.028176097662235396,
            "start_logit": 3.9588382244110107,
            "end_logit": 3.665870189666748,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        },
        {
            "text": "staurosporine, digoxin, rubitecan",
            "probability": 0.027896911648669594,
            "start_logit": 3.948880195617676,
            "end_logit": 3.665870189666748,
            "question_text": "Which drugs have been found effective for the treatment of chordoma?"
        }
    ],
    "56c830635795f9a73e00000e": [
        {
            "text": "FUS",
            "probability": 0.24140190984519425,
            "start_logit": 3.6911189556121826,
            "end_logit": 3.9266693592071533,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS to cytoplasmic stress granules where it is able to bind and sequester wild-type FUS",
            "probability": 0.18505047954041504,
            "start_logit": 3.6911189556121826,
            "end_logit": 3.660834789276123,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS. While FUS",
            "probability": 0.13352884725286532,
            "start_logit": 3.825810670852661,
            "end_logit": 3.199831962585449,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS. While FUS interacts with itself directly by protein-protein interaction, the recruitment of FUS",
            "probability": 0.11624566404921884,
            "start_logit": 3.825810670852661,
            "end_logit": 3.061220169067383,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS interacts with itself directly by protein-protein interaction, the recruitment of FUS",
            "probability": 0.08330991067680953,
            "start_logit": 3.4926724433898926,
            "end_logit": 3.061220169067383,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "PABP",
            "probability": 0.08099335626210777,
            "start_logit": 3.590118408203125,
            "end_logit": 2.9355738162994385,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS interacts with itself directly by protein-protein interaction, the recruitment of FUS to stress granules and interaction with PABP",
            "probability": 0.07347323314843511,
            "start_logit": 3.4926724433898926,
            "end_logit": 2.9355738162994385,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS to stress granules and interaction with PABP",
            "probability": 0.04798686106702261,
            "start_logit": 3.066678524017334,
            "end_logit": 2.9355738162994385,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS protein, followed by cellular stress, contributes to the formation of cytoplasmic aggregates that may sequester FUS",
            "probability": 0.019329932734031507,
            "start_logit": 2.872281312942505,
            "end_logit": 2.220698595046997,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "mutant FUS",
            "probability": 0.00421485355264097,
            "start_logit": -0.3567294180393219,
            "end_logit": 3.9266693592071533,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "mutant FUS to cytoplasmic stress granules where it is able to bind and sequester wild-type FUS",
            "probability": 0.003230963133676138,
            "start_logit": -0.3567294180393219,
            "end_logit": 3.660834789276123,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "PABP are RNA",
            "probability": 0.002858868758385629,
            "start_logit": 3.590118408203125,
            "end_logit": -0.4083673059940338,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "oxidative stress recruits mutant FUS",
            "probability": 0.002731053574627876,
            "start_logit": -0.7906568050384521,
            "end_logit": 3.9266693592071533,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "RNA dependent. These findings support a two-hit hypothesis, whereby cytoplasmic mislocalization of FUS",
            "probability": 0.0018023406408646187,
            "start_logit": 0.07094141840934753,
            "end_logit": 2.6494698524475098,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS to stress granules and interaction with PABP are RNA",
            "probability": 0.0016938196445834314,
            "start_logit": 3.066678524017334,
            "end_logit": -0.4083673059940338,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS protein",
            "probability": 0.0008531147726030927,
            "start_logit": 2.872281312942505,
            "end_logit": -0.8998174071311951,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS.",
            "probability": 0.00047652647001875136,
            "start_logit": 3.825810670852661,
            "end_logit": -2.4357175827026367,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS to cytoplasmic stress granules where it is able to bind and sequester wild-type FUS.",
            "probability": 0.00041647713295984073,
            "start_logit": 3.6911189556121826,
            "end_logit": -2.4357175827026367,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS is a predominantly nuclear DNA- and RNA-binding protein that is involved in RNA processing. Large FUS",
            "probability": 0.00022138676711665133,
            "start_logit": 0.35123196244239807,
            "end_logit": 0.27224910259246826,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        },
        {
            "text": "FUS, disrupt RNA",
            "probability": 0.00018040097642253941,
            "start_logit": 1.6670981645584106,
            "end_logit": -1.2483463287353516,
            "question_text": "Which components of the stress granules are known to be related to motor neuron degeneration in Amyotrophic Lateral Sclerosis?"
        }
    ],
    "5720a8da0fd6f91b68000010": [
        {
            "text": "Kleine-Levin syndrome",
            "probability": 0.785497333572399,
            "start_logit": 4.57198429107666,
            "end_logit": 4.543722629547119,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy with and without cataplexy, Kleine-Levin syndrome",
            "probability": 0.08923675716405269,
            "start_logit": 2.3969602584838867,
            "end_logit": 4.543722629547119,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "cataplexy, Kleine-Levin syndrome",
            "probability": 0.04700818462703776,
            "start_logit": 1.7559889554977417,
            "end_logit": 4.543722629547119,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Kleine-Levin syndrome (KLS)",
            "probability": 0.0312214154100781,
            "start_logit": 4.57198429107666,
            "end_logit": 1.318509817123413,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy",
            "probability": 0.00964179139768246,
            "start_logit": 2.3969602584838867,
            "end_logit": 2.3185365200042725,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy with and without cataplexy",
            "probability": 0.009179429320188923,
            "start_logit": 2.3969602584838867,
            "end_logit": 2.269394636154175,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Kleine-Levin syndrome (KLS), idiopathic",
            "probability": 0.008341608641409095,
            "start_logit": 4.57198429107666,
            "end_logit": -0.0013383531477302313,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "cataplexy",
            "probability": 0.004835544477047733,
            "start_logit": 1.7559889554977417,
            "end_logit": 2.269394636154175,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy with and without cataplexy, Kleine-Levin syndrome (KLS)",
            "probability": 0.0035469221169677698,
            "start_logit": 2.3969602584838867,
            "end_logit": 1.318509817123413,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Kleine-Levin",
            "probability": 0.0032905409621027315,
            "start_logit": 4.57198429107666,
            "end_logit": -0.9315424561500549,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "cataplexy, Kleine-Levin syndrome (KLS)",
            "probability": 0.0018684494487582106,
            "start_logit": 1.7559889554977417,
            "end_logit": 1.318509817123413,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Kleine-Levin syndrome (KLS",
            "probability": 0.0014736560341188888,
            "start_logit": 4.57198429107666,
            "end_logit": -1.7348480224609375,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy with and without cataplexy, Kleine-Levin syndrome (KLS), idiopathic",
            "probability": 0.0009476519815867429,
            "start_logit": 2.3969602584838867,
            "end_logit": -0.0013383531477302313,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "hypocretin-1 in narcolepsy with and without cataplexy, Kleine-Levin syndrome",
            "probability": 0.0009154410890735243,
            "start_logit": -2.1826820373535156,
            "end_logit": 4.543722629547119,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "CSF hypocretin-1 in narcolepsy with and without cataplexy, Kleine-Levin syndrome",
            "probability": 0.0006904456676807832,
            "start_logit": -2.4647507667541504,
            "end_logit": 4.543722629547119,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "syndrome",
            "probability": 0.0006823334025791985,
            "start_logit": -2.476569652557373,
            "end_logit": 4.543722629547119,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "cataplexy, Kleine-Levin syndrome (KLS), idiopathic",
            "probability": 0.0004992045960468055,
            "start_logit": 1.7559889554977417,
            "end_logit": -0.0013383531477302313,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Kleine-Levin syndrome (KLS),",
            "probability": 0.0004427580771819544,
            "start_logit": 4.57198429107666,
            "end_logit": -2.937326192855835,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "narcolepsy with and without cataplexy, Kleine-Levin",
            "probability": 0.0003738232992314357,
            "start_logit": 2.3969602584838867,
            "end_logit": -0.9315424561500549,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        },
        {
            "text": "Kleine-Levin syndrome (KLS), idiopathic and other hypersomnias, and several neurological conditions",
            "probability": 0.000306708714776034,
            "start_logit": 4.57198429107666,
            "end_logit": -3.3044512271881104,
            "question_text": "Which could be some of the possible causes of hypersomnia?"
        }
    ],
    "54d8d60d014675820d000007": [
        {
            "text": "vemurafenib",
            "probability": 0.38345477426202174,
            "start_logit": 5.619329452514648,
            "end_logit": 5.570234775543213,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "vemurafenib and dabrafenib",
            "probability": 0.31137155134509037,
            "start_logit": 5.619329452514648,
            "end_logit": 5.361999988555908,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "dabrafenib",
            "probability": 0.3042037460891786,
            "start_logit": 5.59604024887085,
            "end_logit": 5.361999988555908,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "ve",
            "probability": 0.00010696358281373251,
            "start_logit": 5.619329452514648,
            "end_logit": -2.6142537593841553,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "ib",
            "probability": 0.00010157516259669134,
            "start_logit": -2.6168484687805176,
            "end_logit": 5.570234775543213,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "ib and dabrafenib",
            "probability": 8.248069414895286e-05,
            "start_logit": -2.6168484687805176,
            "end_logit": 5.361999988555908,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "vemurafenib and dabrafenib.",
            "probability": 8.181426250395569e-05,
            "start_logit": 5.619329452514648,
            "end_logit": -2.8822906017303467,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "dabrafenib.",
            "probability": 7.993088973514912e-05,
            "start_logit": 5.59604024887085,
            "end_logit": -2.8822906017303467,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "vemurafenib and da",
            "probability": 7.392515176027215e-05,
            "start_logit": 5.619329452514648,
            "end_logit": -2.983689069747925,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "da",
            "probability": 7.222338713520501e-05,
            "start_logit": 5.59604024887085,
            "end_logit": -2.983689069747925,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Phase III studies of the BRAF inhibitors vemurafenib",
            "probability": 6.23883899115102e-05,
            "start_logit": -3.1042683124542236,
            "end_logit": 5.570234775543213,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "Phase III studies of the BRAF inhibitors vemurafenib and dabrafenib",
            "probability": 5.0660393497657154e-05,
            "start_logit": -3.1042683124542236,
            "end_logit": 5.361999988555908,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "studies of the BRAF inhibitors vemurafenib",
            "probability": 4.130549915631989e-05,
            "start_logit": -3.5166518688201904,
            "end_logit": 5.570234775543213,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "in the Phase III studies of the BRAF inhibitors vemurafenib",
            "probability": 3.809456452118163e-05,
            "start_logit": -3.5975759029388428,
            "end_logit": 5.570234775543213,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "fenib",
            "probability": 3.5139367977345274e-05,
            "start_logit": -3.6783254146575928,
            "end_logit": 5.570234775543213,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "studies of the BRAF inhibitors vemurafenib and dabrafenib",
            "probability": 3.354074121554226e-05,
            "start_logit": -3.5166518688201904,
            "end_logit": 5.361999988555908,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "in the Phase III studies of the BRAF inhibitors vemurafenib and dabrafenib",
            "probability": 3.093340974983073e-05,
            "start_logit": -3.5975759029388428,
            "end_logit": 5.361999988555908,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "fenib and dabrafenib",
            "probability": 2.853374179901468e-05,
            "start_logit": -3.6783254146575928,
            "end_logit": 5.361999988555908,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "inhibitors vemurafenib",
            "probability": 2.7824839887513002e-05,
            "start_logit": -3.9117183685302734,
            "end_logit": 5.570234775543213,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        },
        {
            "text": "inhibitors vemurafenib and dabrafenib",
            "probability": 2.2594225299131352e-05,
            "start_logit": -3.9117183685302734,
            "end_logit": 5.361999988555908,
            "question_text": "List BRAF inhibitors that have been tested in clinical trials for treatment of melanoma patients"
        }
    ],
    "531375a6e3eabad021000011": [
        {
            "text": "myocardial replacement fibrosis",
            "probability": 0.9233475721203651,
            "start_logit": 4.913239002227783,
            "end_logit": 4.1323933601379395,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "fibrosis",
            "probability": 0.050992179377369926,
            "start_logit": 2.0169055461883545,
            "end_logit": 4.1323933601379395,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "replacement fibrosis",
            "probability": 0.008630458800689534,
            "start_logit": 0.24053093791007996,
            "end_logit": 4.1323933601379395,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement fibrosis (anindependent predictor of adverse cardiac outcomes",
            "probability": 0.004917903567569765,
            "start_logit": 4.913239002227783,
            "end_logit": -1.1027300357818604,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement fibrosis (anindependent predictor of adverse cardiac outcomes)",
            "probability": 0.004691659329670888,
            "start_logit": 4.913239002227783,
            "end_logit": -1.1498260498046875,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement fibrosis (anindependent predictor of adverse cardiac outcomes) using late gadolinium enhancement",
            "probability": 0.003910763084075053,
            "start_logit": 4.913239002227783,
            "end_logit": -1.3318798542022705,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "my",
            "probability": 0.000603041326098806,
            "start_logit": 4.913239002227783,
            "end_logit": -3.2013819217681885,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement fibrosis (anindependent predictor of adverse cardiac outcomes) using late gadolinium",
            "probability": 0.00048797529769205295,
            "start_logit": 4.913239002227783,
            "end_logit": -3.413102865219116,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial",
            "probability": 0.00027426245670613726,
            "start_logit": 4.913239002227783,
            "end_logit": -3.9892821311950684,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "fibrosis (anindependent predictor of adverse cardiac outcomes",
            "probability": 0.0002715928740704314,
            "start_logit": 2.0169055461883545,
            "end_logit": -1.1027300357818604,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "fibrosis (anindependent predictor of adverse cardiac outcomes)",
            "probability": 0.00025909846014616757,
            "start_logit": 2.0169055461883545,
            "end_logit": -1.1498260498046875,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "detect myocardial replacement fibrosis",
            "probability": 0.0002510700252373016,
            "start_logit": -3.29679012298584,
            "end_logit": 4.1323933601379395,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement fibrosis (anindependent predictor of adverse cardiac outcomes) using late",
            "probability": 0.00021683452386889293,
            "start_logit": 4.913239002227783,
            "end_logit": -4.224233150482178,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "fibrosis (anindependent predictor of adverse cardiac outcomes) using late gadolinium enhancement",
            "probability": 0.00021597320305679629,
            "start_logit": 2.0169055461883545,
            "end_logit": -1.3318798542022705,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "ial replacement fibrosis",
            "probability": 0.0002046305048896106,
            "start_logit": -3.5013160705566406,
            "end_logit": 4.1323933601379395,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement fi",
            "probability": 0.00020219547768945457,
            "start_logit": 4.913239002227783,
            "end_logit": -4.294132709503174,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement",
            "probability": 0.0001945231247890115,
            "start_logit": 4.913239002227783,
            "end_logit": -4.3328166007995605,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "sis",
            "probability": 0.0001370673249792849,
            "start_logit": -3.9020497798919678,
            "end_logit": 4.1323933601379395,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "myocardial replacement fibrosis (",
            "probability": 0.00012475198490626734,
            "start_logit": 4.913239002227783,
            "end_logit": -4.777040004730225,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        },
        {
            "text": "ardial replacement fibrosis",
            "probability": 6.644713612953872e-05,
            "start_logit": -4.626115322113037,
            "end_logit": 4.1323933601379395,
            "question_text": "which are the risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy?"
        }
    ],
    "56d1e23c67f0cb3d66000009": [
        {
            "text": "Vgll1",
            "probability": 0.45085798557491524,
            "start_logit": 4.578052997589111,
            "end_logit": 4.114323616027832,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ",
            "probability": 0.14255029059622978,
            "start_logit": 4.008344650268555,
            "end_logit": 3.532574415206909,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Vgll1 interacts with TEAD",
            "probability": 0.1163648539898039,
            "start_logit": 4.578052997589111,
            "end_logit": 2.759901762008667,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Vgll1 and the transcription factor TEAD4",
            "probability": 0.11118515680765749,
            "start_logit": 4.4061479568481445,
            "end_logit": 2.886273145675659,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ-TEAD",
            "probability": 0.06304696229759454,
            "start_logit": 4.008344650268555,
            "end_logit": 2.716759443283081,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TEAD4",
            "probability": 0.04872766366321412,
            "start_logit": 3.58119797706604,
            "end_logit": 2.886273145675659,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ, Vgll1",
            "probability": 0.024555926654900598,
            "start_logit": 3.1805689334869385,
            "end_logit": 2.6016085147857666,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TEAD",
            "probability": 0.02321409521473149,
            "start_logit": 3.0092244148254395,
            "end_logit": 2.716759443283081,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Vgll1 and the transcription factor TEAD",
            "probability": 0.00877194935563676,
            "start_logit": 4.4061479568481445,
            "end_logit": 0.3466353118419647,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Vgll",
            "probability": 0.003536951450879597,
            "start_logit": 4.4061479568481445,
            "end_logit": -0.5616585612297058,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Vgll1-TEAD",
            "probability": 0.0023427015244159425,
            "start_logit": 2.657168388366699,
            "end_logit": 0.7753605842590332,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ, despite having a varied primary sequence. Vgll1",
            "probability": 0.001939705342440094,
            "start_logit": 0.8781465888023376,
            "end_logit": 2.3656136989593506,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "Vgll1 and the transcription factor TEAD4,",
            "probability": 0.0005895835035206638,
            "start_logit": 4.4061479568481445,
            "end_logit": -2.3532626628875732,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "YAP/TAZ",
            "probability": 0.0005675410823453478,
            "start_logit": -1.5177923440933228,
            "end_logit": 3.532574415206909,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TEAD in a manner similar to the transcription coactivators, as well as oncogenes YAP and TAZ",
            "probability": 0.0004137262627834543,
            "start_logit": 2.6485347747802734,
            "end_logit": -0.9498612880706787,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TAZ, despite having a varied primary sequence. Vgll1-TEAD",
            "probability": 0.0003954554902744059,
            "start_logit": 0.8781465888023376,
            "end_logit": 0.7753605842590332,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "transcription cofactor Vgll1",
            "probability": 0.0003226552839156243,
            "start_logit": -2.7545111179351807,
            "end_logit": 4.204564571380615,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TEAD4,",
            "probability": 0.00025838904657600584,
            "start_logit": 3.58119797706604,
            "end_logit": -2.3532626628875732,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "YAP/TAZ-TEAD",
            "probability": 0.00025101135235363394,
            "start_logit": -1.5177923440933228,
            "end_logit": 2.716759443283081,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        },
        {
            "text": "TEAD in a manner similar to the transcription coactivators, as well as oncogenes YAP and TAZ,",
            "probability": 0.00010739550581138975,
            "start_logit": 2.6485347747802734,
            "end_logit": -2.2985475063323975,
            "question_text": "Which are the coactivators of the Yes-associated protein (yap)?"
        }
    ],
    "531b3ff3b166e2b80600003d": [
        {
            "text": "E-cadherin",
            "probability": 0.4987594902900399,
            "start_logit": 3.182671308517456,
            "end_logit": 2.2258188724517822,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "TCF4",
            "probability": 0.20385409445807012,
            "start_logit": 2.7757742404937744,
            "end_logit": 1.7379964590072632,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "TCF4/ITF2",
            "probability": 0.15154908318840457,
            "start_logit": 2.7757742404937744,
            "end_logit": 1.441501498222351,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "ITF2",
            "probability": 0.08313766933389811,
            "start_logit": 2.1753625869750977,
            "end_logit": 1.441501498222351,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Snail",
            "probability": 0.008837926053665119,
            "start_logit": 0.9543271064758301,
            "end_logit": 0.42109131813049316,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E2-2 (TCF4",
            "probability": 0.007983169259964725,
            "start_logit": -0.46429479122161865,
            "end_logit": 1.7379964590072632,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "bHLH factor E2-2 (TCF4",
            "probability": 0.006564384828290843,
            "start_logit": -0.6599714756011963,
            "end_logit": 1.7379964590072632,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "TCF4/ITF2)",
            "probability": 0.00653926432252041,
            "start_logit": 2.7757742404937744,
            "end_logit": -1.7015833854675293,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E2-2 (TCF4/ITF2",
            "probability": 0.005934842689825665,
            "start_logit": -0.46429479122161865,
            "end_logit": 1.441501498222351,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "bHLH factor E2-2 (TCF4/ITF2",
            "probability": 0.00488009085649232,
            "start_logit": -0.6599714756011963,
            "end_logit": 1.441501498222351,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "cadherin",
            "probability": 0.004632234372530496,
            "start_logit": -1.4964133501052856,
            "end_logit": 2.2258188724517822,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "ITF2)",
            "probability": 0.0035873473035583237,
            "start_logit": 2.1753625869750977,
            "end_logit": -1.7015833854675293,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Snail1 and E47",
            "probability": 0.003312685788330288,
            "start_logit": 0.9543271064758301,
            "end_logit": -0.5602016448974609,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "Snail1",
            "probability": 0.00225062795307172,
            "start_logit": 0.9543271064758301,
            "end_logit": -0.9467516541481018,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "TCF4/ITF2) as a new EMT regulator. Both isoforms of E2-2",
            "probability": 0.0021949162811168927,
            "start_logit": 2.7757742404937744,
            "end_logit": -2.793264150619507,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E2-2",
            "probability": 0.0014566791177054032,
            "start_logit": -0.46429479122161865,
            "end_logit": 0.036820244044065475,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E-cadherin downregulation. Here, we report the identification of class I bHLH factor E2-2",
            "probability": 0.001395895029484379,
            "start_logit": -0.5069182515144348,
            "end_logit": 0.036820244044065475,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "ITF2) as a new EMT regulator. Both isoforms of E2-2",
            "probability": 0.0012040998213643278,
            "start_logit": 2.1753625869750977,
            "end_logit": -2.793264150619507,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "bHLH factor E2-2",
            "probability": 0.0011977952600739036,
            "start_logit": -0.6599714756011963,
            "end_logit": 0.036820244044065475,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        },
        {
            "text": "E2-2 expression is dispensable for maintenance of the EMT driven by Snail",
            "probability": 0.0007277037915922891,
            "start_logit": -1.542586326599121,
            "end_logit": 0.42109131813049316,
            "question_text": "Which proteins are related to the loss of cell-cell adhesion during EMT (epithelial-mesenchymal transition)?"
        }
    ],
    "5314c7afdae131f84700000a": [
        {
            "text": "Spontaneous periodic hypothermia",
            "probability": 0.5674491617615747,
            "start_logit": -1.4955631494522095,
            "end_logit": -0.936314046382904,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "periodic hypothermia",
            "probability": 0.24662948983364544,
            "start_logit": -2.328827142715454,
            "end_logit": -0.936314046382904,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "Spontaneous periodic hypothermia is a rare syndrome of recurrent, centrally mediated hypothermia",
            "probability": 0.06820737124553669,
            "start_logit": -1.4955631494522095,
            "end_logit": -3.054912567138672,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "periodic hypothermia is a rare syndrome of recurrent, centrally mediated hypothermia",
            "probability": 0.029644856855474314,
            "start_logit": -2.328827142715454,
            "end_logit": -3.054912567138672,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "diencephalic epilepsy",
            "probability": 0.026005936689978533,
            "start_logit": -3.096620559692383,
            "end_logit": -2.4180829524993896,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "centrally mediated hypothermia",
            "probability": 0.01123740660505772,
            "start_logit": -3.298867702484131,
            "end_logit": -3.054912567138672,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "periodic hypo- and hyperthermia",
            "probability": 0.008859304237441164,
            "start_logit": -2.54909348487854,
            "end_logit": -4.042466640472412,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "hyperhidrosis",
            "probability": 0.006356652058664576,
            "start_logit": -3.6182403564453125,
            "end_logit": -3.305286169052124,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "recurrent, centrally mediated hypothermia",
            "probability": 0.005820584488488171,
            "start_logit": -3.9567151069641113,
            "end_logit": -3.054912567138672,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "Spontaneous periodic hypothermia is a rare syndrome of recurrent, centrally mediated hypothermia without an identifiable systemic cause",
            "probability": 0.005005037413852065,
            "start_logit": -1.4955631494522095,
            "end_logit": -5.667020320892334,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "episodic spontaneous hypothermia with hyperhidrosis",
            "probability": 0.004423341064372731,
            "start_logit": -3.980846881866455,
            "end_logit": -3.305286169052124,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "Spontaneous periodic hypothermia is a rare syndrome",
            "probability": 0.0032927582794667377,
            "start_logit": -1.4955631494522095,
            "end_logit": -6.085739612579346,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "Spontaneous periodic",
            "probability": 0.0030296538463091896,
            "start_logit": -1.4955631494522095,
            "end_logit": -6.1690168380737305,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "centrally mediated hypothermia without an identifiable systemic cause or brain lesion",
            "probability": 0.002827047032666305,
            "start_logit": -3.298867702484131,
            "end_logit": -4.434927940368652,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "Spontaneous periodic hypothermia is a rare",
            "probability": 0.0027989858718981612,
            "start_logit": -1.4955631494522095,
            "end_logit": -6.248208045959473,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "periodic hypothermia is a rare syndrome of recurrent, centrally mediated hypothermia without an identifiable systemic cause",
            "probability": 0.0021753311259543225,
            "start_logit": -2.328827142715454,
            "end_logit": -5.667020320892334,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "spontaneous periodic hypothermia\" and \"episodic spontaneous hypothermia with hyperhidrosis",
            "probability": 0.001871924743932961,
            "start_logit": -4.840775012969971,
            "end_logit": -3.305286169052124,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "spontaneous periodic hypothermia",
            "probability": 0.0014697190532386864,
            "start_logit": -4.840775012969971,
            "end_logit": -3.547182083129883,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "recurrent, centrally mediated hypothermia without an identifiable systemic cause or brain lesion",
            "probability": 0.0014643117122021664,
            "start_logit": -3.9567151069641113,
            "end_logit": -4.434927940368652,
            "question_text": "List common features of Shapiro syndrome"
        },
        {
            "text": "periodic hypothermia is a rare syndrome",
            "probability": 0.0014311260802454234,
            "start_logit": -2.328827142715454,
            "end_logit": -6.085739612579346,
            "question_text": "List common features of Shapiro syndrome"
        }
    ],
    "52f5417b2059c6d71c000024": [
        {
            "text": "BTBR T+ tf/J (BTBR)",
            "probability": 0.3880113662528267,
            "start_logit": 1.4081729650497437,
            "end_logit": 0.604678213596344,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR T+ tf/J (BTBR) mice",
            "probability": 0.1803726744406157,
            "start_logit": 1.4081729650497437,
            "end_logit": -0.16133129596710205,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR",
            "probability": 0.12354035648977948,
            "start_logit": 1.4081729650497437,
            "end_logit": -0.539788544178009,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR T+ tf/J",
            "probability": 0.10834763632398482,
            "start_logit": 1.4081729650497437,
            "end_logit": -0.6710115075111389,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR T+ tf/J (BTBR",
            "probability": 0.028356115183699904,
            "start_logit": 1.4081729650497437,
            "end_logit": -2.0115137100219727,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "T+ tf/J (BTBR)",
            "probability": 0.02408973173929756,
            "start_logit": -1.371075987815857,
            "end_logit": 0.604678213596344,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "(BTBR)",
            "probability": 0.023139775557964846,
            "start_logit": -1.4113086462020874,
            "end_logit": 0.604678213596344,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "mice",
            "probability": 0.022880719188468342,
            "start_logit": -0.656557559967041,
            "end_logit": -0.16133129596710205,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR)",
            "probability": 0.01525522638735056,
            "start_logit": -1.827939510345459,
            "end_logit": 0.604678213596344,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR T",
            "probability": 0.013470942437213756,
            "start_logit": 1.4081729650497437,
            "end_logit": -2.755821466445923,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "J (BTBR)",
            "probability": 0.01307938738585373,
            "start_logit": -1.9818241596221924,
            "end_logit": 0.604678213596344,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "T+ tf/J (BTBR) mice",
            "probability": 0.011198458906852787,
            "start_logit": -1.371075987815857,
            "end_logit": -0.16133129596710205,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "(BTBR) mice",
            "probability": 0.010756858088085205,
            "start_logit": -1.4113086462020874,
            "end_logit": -0.16133129596710205,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR) mice",
            "probability": 0.007091611798017597,
            "start_logit": -1.827939510345459,
            "end_logit": -0.16133129596710205,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "T+ tf/J",
            "probability": 0.006726775864424182,
            "start_logit": -1.371075987815857,
            "end_logit": -0.6710115075111389,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": ")",
            "probability": 0.006595653884022789,
            "start_logit": -2.6664507389068604,
            "end_logit": 0.604678213596344,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "J (BTBR) mice",
            "probability": 0.006080141686607365,
            "start_logit": -1.9818241596221924,
            "end_logit": -0.16133129596710205,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "tf/J (BTBR)",
            "probability": 0.003882656860615039,
            "start_logit": -3.1963419914245605,
            "end_logit": 0.604678213596344,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "J",
            "probability": 0.003652265967125314,
            "start_logit": -1.9818241596221924,
            "end_logit": -0.6710115075111389,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        },
        {
            "text": "BTBR T+ tf",
            "probability": 0.003471645557193992,
            "start_logit": 1.4081729650497437,
            "end_logit": -4.111727714538574,
            "question_text": "List mouse models for autism spectrum disorder (ASD)."
        }
    ],
    "5717ab7ccb4ef8864c00000c": [
        {
            "text": "stabilize and induce degradation",
            "probability": 0.3583642478053726,
            "start_logit": 5.203109264373779,
            "end_logit": 3.9281656742095947,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "induce degradation",
            "probability": 0.09862623387806602,
            "start_logit": 3.9128966331481934,
            "end_logit": 3.9281656742095947,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "degradation",
            "probability": 0.07605590546314255,
            "start_logit": 3.6530280113220215,
            "end_logit": 3.9281656742095947,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "invasion and apoptosis",
            "probability": 0.06051389054224092,
            "start_logit": 3.439088821411133,
            "end_logit": 3.9135091304779053,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "stabilize and induce degradation of specific mRNAs",
            "probability": 0.058985354859568,
            "start_logit": 5.203109264373779,
            "end_logit": 2.1239049434661865,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "Regulation of mRNAs is one way to control protein levels and thereby important cellular processes such as growth, invasion and apoptosis",
            "probability": 0.05113624941574384,
            "start_logit": 3.27070951461792,
            "end_logit": 3.9135091304779053,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "stabilize",
            "probability": 0.044271356460136,
            "start_logit": 5.203109264373779,
            "end_logit": 1.8369536399841309,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "apoptosis",
            "probability": 0.03896032651691911,
            "start_logit": 2.9987597465515137,
            "end_logit": 3.9135091304779053,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "both stabilize and induce degradation",
            "probability": 0.0378372907882917,
            "start_logit": 2.9548544883728027,
            "end_logit": 3.9281656742095947,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "growth, invasion and apoptosis",
            "probability": 0.03396714759708934,
            "start_logit": 2.861609697341919,
            "end_logit": 3.9135091304779053,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "invasion",
            "probability": 0.028813299496962083,
            "start_logit": 3.439088821411133,
            "end_logit": 3.171473264694214,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "Regulation of mRNAs is one way to control protein levels and thereby important cellular processes such as growth, invasion",
            "probability": 0.024348196031763806,
            "start_logit": 3.27070951461792,
            "end_logit": 3.171473264694214,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "induce degradation of specific mRNAs",
            "probability": 0.01623349270856939,
            "start_logit": 3.9128966331481934,
            "end_logit": 2.1239049434661865,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "growth, invasion",
            "probability": 0.016173238706066642,
            "start_logit": 2.861609697341919,
            "end_logit": 3.171473264694214,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "Regulation of mRNAs is one way to control protein levels and thereby important cellular processes such as growth",
            "probability": 0.013006532196571798,
            "start_logit": 3.27070951461792,
            "end_logit": 2.5444672107696533,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "degradation of specific mRNAs",
            "probability": 0.012518504846347459,
            "start_logit": 3.6530280113220215,
            "end_logit": 2.1239049434661865,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "control protein levels and thereby important cellular processes such as growth, invasion and apoptosis",
            "probability": 0.008824752301079018,
            "start_logit": 1.513776421546936,
            "end_logit": 3.9135091304779053,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "growth",
            "probability": 0.008639562030750518,
            "start_logit": 2.861609697341919,
            "end_logit": 2.5444672107696533,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "Regulation of mRNAs is one way to control protein levels",
            "probability": 0.0064965481429861685,
            "start_logit": 3.27070951461792,
            "end_logit": 1.8502864837646484,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        },
        {
            "text": "both stabilize and induce degradation of specific mRNAs",
            "probability": 0.006227870212332573,
            "start_logit": 2.9548544883728027,
            "end_logit": 2.1239049434661865,
            "question_text": "Which are the main functions of G3BP1 and G3BP2 proteins?"
        }
    ],
    "56c6dc6f5795f9a73e000007": [
        {
            "text": "H3K9me3",
            "probability": 0.5642505123054795,
            "start_logit": 4.900033950805664,
            "end_logit": 4.54990291595459,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3.3 and H3K9me3",
            "probability": 0.28020631494555304,
            "start_logit": 4.200061798095703,
            "end_logit": 4.54990291595459,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3.3",
            "probability": 0.09271933320276053,
            "start_logit": 4.200061798095703,
            "end_logit": 3.4439537525177,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K9me3, and establishes an important role for H3.3",
            "probability": 0.024597787457776073,
            "start_logit": 4.900033950805664,
            "end_logit": 1.4170610904693604,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3.3 and H3K9me3, and establishes an important role for H3.3",
            "probability": 0.012215239913908792,
            "start_logit": 4.200061798095703,
            "end_logit": 1.4170610904693604,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "both H3.3 and H3K9me3",
            "probability": 0.006648900215370495,
            "start_logit": 0.4589870870113373,
            "end_logit": 4.54990291595459,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3",
            "probability": 0.004438323234175692,
            "start_logit": 4.900033950805664,
            "end_logit": -0.29531875252723694,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K9me3,",
            "probability": 0.0027811904479875184,
            "start_logit": 4.900033950805664,
            "end_logit": -0.7627163529396057,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3.3 and H3",
            "probability": 0.002204067468019067,
            "start_logit": 4.200061798095703,
            "end_logit": -0.29531875252723694,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "both H3.3",
            "probability": 0.0022000988615143518,
            "start_logit": 0.4589870870113373,
            "end_logit": 3.4439537525177,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "presence of both H3.3 and H3K9me3",
            "probability": 0.0021387182265545264,
            "start_logit": -0.675257682800293,
            "end_logit": 4.54990291595459,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3.3 and H3K9me3,",
            "probability": 0.0013811367638961848,
            "start_logit": 4.200061798095703,
            "end_logit": -0.7627163529396057,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "K9me3",
            "probability": 0.0012738157228805512,
            "start_logit": -1.193447470664978,
            "end_logit": 4.54990291595459,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "presence of both H3.3",
            "probability": 0.0007076947138513208,
            "start_logit": -0.675257682800293,
            "end_logit": 3.4439537525177,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "3 and H3K9me3",
            "probability": 0.00044268193545943946,
            "start_logit": -2.250368118286133,
            "end_logit": 4.54990291595459,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K9me3, and establishes an important role for H3",
            "probability": 0.00044143269318715943,
            "start_logit": 4.900033950805664,
            "end_logit": -2.603325128555298,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "the presence of both H3.3 and H3K9me3",
            "probability": 0.0003785948320836248,
            "start_logit": -2.4067530632019043,
            "end_logit": 4.54990291595459,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H",
            "probability": 0.0003520243272079655,
            "start_logit": 4.900033950805664,
            "end_logit": -2.829650402069092,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "H3K9me3. Importantly, H3K9me3",
            "probability": 0.00032044465278779184,
            "start_logit": 1.6306086778640747,
            "end_logit": 0.34578415751457214,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        },
        {
            "text": "3K9me3",
            "probability": 0.0003016880795464154,
            "start_logit": -2.6338260173797607,
            "end_logit": 4.54990291595459,
            "question_text": "Which post-translational histone modifications are characteristic of facultative heterochromatin?"
        }
    ],
    "56f5692f09dd18d46b00000a": [
        {
            "text": "TREX1",
            "probability": 0.37264505814874427,
            "start_logit": 3.42525053024292,
            "end_logit": 3.1900336742401123,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "SAMHD1",
            "probability": 0.23113996154723981,
            "start_logit": 3.4669952392578125,
            "end_logit": 2.6706860065460205,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2-A, -B, -C and SAMHD1",
            "probability": 0.22168971237186286,
            "start_logit": 3.42525053024292,
            "end_logit": 2.6706860065460205,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2-A, -B, -C and SAMHD1",
            "probability": 0.08949907956169048,
            "start_logit": 2.518200159072876,
            "end_logit": 2.6706860065460205,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2",
            "probability": 0.02979545517871306,
            "start_logit": 3.42525053024292,
            "end_logit": 0.663763165473938,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2",
            "probability": 0.012028820756207897,
            "start_logit": 2.518200159072876,
            "end_logit": 0.663763165473938,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2-A",
            "probability": 0.006940348432225168,
            "start_logit": 3.42525053024292,
            "end_logit": -0.7932407259941101,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2-A, -B, -C",
            "probability": 0.006005773099486048,
            "start_logit": 3.42525053024292,
            "end_logit": -0.937871515750885,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2-A, -B",
            "probability": 0.004231940132657849,
            "start_logit": 3.42525053024292,
            "end_logit": -1.2879321575164795,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "SAMHD1,",
            "probability": 0.003354787398885288,
            "start_logit": 3.4669952392578125,
            "end_logit": -1.5619490146636963,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2-A, -B, -C and SAMHD1,",
            "probability": 0.0032176255829982456,
            "start_logit": 3.42525053024292,
            "end_logit": -1.5619490146636963,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "SAMHD",
            "probability": 0.0031872229286165035,
            "start_logit": 3.4669952392578125,
            "end_logit": -1.6131874322891235,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH2-A, -B, -C and SAMHD",
            "probability": 0.003056912052681081,
            "start_logit": 3.42525053024292,
            "end_logit": -1.6131874322891235,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2-A",
            "probability": 0.002801910787270306,
            "start_logit": 2.518200159072876,
            "end_logit": -0.7932407259941101,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2-A, -B, -C",
            "probability": 0.002424610320025765,
            "start_logit": 2.518200159072876,
            "end_logit": -0.937871515750885,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1, RNASEH",
            "probability": 0.002279661121520726,
            "start_logit": 3.42525053024292,
            "end_logit": -1.9065659046173096,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2-A, -B",
            "probability": 0.0017084904057150458,
            "start_logit": 2.518200159072876,
            "end_logit": -1.2879321575164795,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "TREX1,",
            "probability": 0.0014595160426312183,
            "start_logit": 3.42525053024292,
            "end_logit": -2.352487802505493,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2-A, -B, -C and SAMHD1,",
            "probability": 0.0012989981581528758,
            "start_logit": 2.518200159072876,
            "end_logit": -1.5619490146636963,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        },
        {
            "text": "RNASEH2-A, -B, -C and SAMHD",
            "probability": 0.0012341159726756863,
            "start_logit": 2.518200159072876,
            "end_logit": -1.6131874322891235,
            "question_text": "Mutations in which genes have been associated with Aicardi-Goutieres syndrome?"
        }
    ],
    "530a3e18970c65fa6b000005": [
        {
            "text": "Geobacter",
            "probability": 0.9943685842657225,
            "start_logit": 1.6260274648666382,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "G",
            "probability": 0.0025006772534454493,
            "start_logit": 1.6260274648666382,
            "end_logit": -4.7489800453186035,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "a proteomics-based approach for simultaneously documenting the strain membership and microbial physiology of the dominant Geobacter",
            "probability": 0.0005210901446057437,
            "start_logit": -5.927912712097168,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "we report a proteomics-based approach for simultaneously documenting the strain membership and microbial physiology of the dominant Geobacter",
            "probability": 0.00036276118435173507,
            "start_logit": -6.290091037750244,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "proteomics-based approach for simultaneously documenting the strain membership and microbial physiology of the dominant Geobacter",
            "probability": 0.00034815857444281243,
            "start_logit": -6.331177711486816,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "cter",
            "probability": 0.00034623696160486993,
            "start_logit": -6.33671236038208,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "report a proteomics-based approach for simultaneously documenting the strain membership and microbial physiology of the dominant Geobacter",
            "probability": 0.0003451723944935681,
            "start_logit": -6.339791774749756,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "approach for simultaneously documenting the strain membership and microbial physiology of the dominant Geobacter",
            "probability": 0.00029018237165430374,
            "start_logit": -6.513326168060303,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "cs-based approach for simultaneously documenting the strain membership and microbial physiology of the dominant Geobacter",
            "probability": 0.0002674766914778401,
            "start_logit": -6.594803333282471,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Here, we report a proteomics-based approach for simultaneously documenting the strain membership and microbial physiology of the dominant Geobacter",
            "probability": 0.00023952458665402166,
            "start_logit": -6.705179691314697,
            "end_logit": 1.2365663051605225,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Geobacter-dominated samples were obtained from two wells down-gradient of acetate addition.",
            "probability": 0.00017245932332244585,
            "start_logit": 0.32767927646636963,
            "end_logit": -6.124787330627441,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "acetate amendment of the U-contaminated Rifle, CO, aquifer. Three planktonic Geobacter",
            "probability": 4.849562064839522e-05,
            "start_logit": -6.469377040863037,
            "end_logit": -0.5964189171791077,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "planktonic Geobacter",
            "probability": 4.6168302388727335e-05,
            "start_logit": -6.518557071685791,
            "end_logit": -0.5964189171791077,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Geobacter genomes. Genome-specific peptides indicate early proliferation of multiple M21 and Geobacter",
            "probability": 3.553280245656332e-05,
            "start_logit": -3.3373515605926514,
            "end_logit": -4.039461612701416,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "metagenomics-independent community proteogenomics",
            "probability": 3.535519006734534e-05,
            "start_logit": -3.765275001525879,
            "end_logit": -3.616549253463745,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "metagenomics",
            "probability": 2.311558897963956e-05,
            "start_logit": -3.765275001525879,
            "end_logit": -4.041487216949463,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "proteogenomics",
            "probability": 2.0771908868567468e-05,
            "start_logit": -4.297118663787842,
            "end_logit": -3.616549253463745,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "metagenomics-independent community proteogenomics can be used to diagnose the status of the subsurface consortia",
            "probability": 1.231330877694643e-05,
            "start_logit": -3.765275001525879,
            "end_logit": -4.671313762664795,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "Geobacter genomes. Genome-specific peptides indicate early proliferation of multiple M21 and Geobacter bemidjiensis",
            "probability": 8.689201253768819e-06,
            "start_logit": -3.3373515605926514,
            "end_logit": -5.447836875915527,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        },
        {
            "text": "proteogenomics can be used to diagnose the status of the subsurface consortia",
            "probability": 7.234324785075831e-06,
            "start_logit": -4.297118663787842,
            "end_logit": -4.671313762664795,
            "question_text": "List bacteria that may be useful in uranium bioremediation."
        }
    ],
    "570a922dcf1c325851000028": [
        {
            "text": "necroptosis",
            "probability": 0.15035135783959414,
            "start_logit": 5.706320285797119,
            "end_logit": 5.3096771240234375,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis",
            "probability": 0.1466316041139113,
            "start_logit": 5.706320285797119,
            "end_logit": 5.28462553024292,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis",
            "probability": 0.1442632614111776,
            "start_logit": 5.690036773681641,
            "end_logit": 5.28462553024292,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis, and pro-survival",
            "probability": 0.07381739872227631,
            "start_logit": 5.706320285797119,
            "end_logit": 4.598296642303467,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis, and pro-survival",
            "probability": 0.07262512575591858,
            "start_logit": 5.690036773681641,
            "end_logit": 4.598296642303467,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis, and pro-survival/inflammation NF-\u03baB",
            "probability": 0.04549688417472853,
            "start_logit": 5.706320285797119,
            "end_logit": 4.114346027374268,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis, and pro-survival/inflammation NF-\u03baB activation",
            "probability": 0.04547521642561421,
            "start_logit": 5.706320285797119,
            "end_logit": 4.113869667053223,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis, and pro-survival/inflammation NF-\u03baB",
            "probability": 0.0447620343155629,
            "start_logit": 5.690036773681641,
            "end_logit": 4.114346027374268,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis, and pro-survival/inflammation NF-\u03baB activation",
            "probability": 0.044740716536400896,
            "start_logit": 5.690036773681641,
            "end_logit": 4.113869667053223,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "necroptosis, apoptosis, and pro-survival/inflammation",
            "probability": 0.042638872357785504,
            "start_logit": 5.706320285797119,
            "end_logit": 4.049468517303467,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "apoptosis, and pro-survival/inflammation",
            "probability": 0.04195018411208572,
            "start_logit": 5.690036773681641,
            "end_logit": 4.049468517303467,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival",
            "probability": 0.03646410893713968,
            "start_logit": 5.001054286956787,
            "end_logit": 4.598296642303467,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival/inflammation NF-\u03baB",
            "probability": 0.022474421607423564,
            "start_logit": 5.001054286956787,
            "end_logit": 4.114346027374268,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival/inflammation NF-\u03baB activation",
            "probability": 0.022463718234264893,
            "start_logit": 5.001054286956787,
            "end_logit": 4.113869667053223,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "pro-survival/inflammation",
            "probability": 0.021062629048480497,
            "start_logit": 5.001054286956787,
            "end_logit": 4.049468517303467,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "NF-\u03baB",
            "probability": 0.01729224396140705,
            "start_logit": 4.738934516906738,
            "end_logit": 4.114346027374268,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "NF-\u03baB activation",
            "probability": 0.017284008584181207,
            "start_logit": 4.738934516906738,
            "end_logit": 4.113869667053223,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "inflammation NF-\u03baB",
            "probability": 0.0034753951690000536,
            "start_logit": 3.1343846321105957,
            "end_logit": 4.114346027374268,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "inflammation NF-\u03baB activation",
            "probability": 0.003473740022895854,
            "start_logit": 3.1343846321105957,
            "end_logit": 4.113869667053223,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        },
        {
            "text": "inflammation",
            "probability": 0.0032570786701514127,
            "start_logit": 3.1343846321105957,
            "end_logit": 4.049468517303467,
            "question_text": "Which major signaling pathways are regulated by RIP1?"
        }
    ],
    "5173eb428ed59a060a000021": [
        {
            "text": "Alagille syndrome",
            "probability": 0.7999698798731171,
            "start_logit": 6.076361179351807,
            "end_logit": 5.819482803344727,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille syndrome, which includes tetralogy of Fallot",
            "probability": 0.12585628424137946,
            "start_logit": 6.076361179351807,
            "end_logit": 3.9700493812561035,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "tetralogy of Fallot",
            "probability": 0.030833777196229695,
            "start_logit": 4.669831275939941,
            "end_logit": 3.9700493812561035,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille syndrome,",
            "probability": 0.023459354642155532,
            "start_logit": 6.076361179351807,
            "end_logit": 2.290178060531616,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille",
            "probability": 0.012916997872427434,
            "start_logit": 6.076361179351807,
            "end_logit": 1.6934528350830078,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille Syndrome",
            "probability": 0.0033974147717342326,
            "start_logit": 3.4093470573425293,
            "end_logit": 3.024937629699707,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille syndrome, which includes tetralogy of Fallot among its more severe cardiac pathologies.",
            "probability": 0.0007449400560332275,
            "start_logit": 6.076361179351807,
            "end_logit": -1.1595427989959717,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "autosomal dominant disorder called Alagille syndrome",
            "probability": 0.0006756759955349168,
            "start_logit": -1.000254511833191,
            "end_logit": 5.819482803344727,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille syndrome, which includes tetralogy",
            "probability": 0.0005797744575694074,
            "start_logit": 6.076361179351807,
            "end_logit": -1.4102073907852173,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "mutations in the gene encoding the human Notch ligand jagged 1 result in a multisystem autosomal dominant disorder called Alagille syndrome",
            "probability": 0.000480667727290079,
            "start_logit": -1.340791940689087,
            "end_logit": 5.819482803344727,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "tetralogy of Fallot among its more severe cardiac pathologies.",
            "probability": 0.00018250432110503603,
            "start_logit": 4.669831275939941,
            "end_logit": -1.1595427989959717,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "tetralogy",
            "probability": 0.00014204007814559721,
            "start_logit": 4.669831275939941,
            "end_logit": -1.4102073907852173,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "syndrome",
            "probability": 0.00012974096442723183,
            "start_logit": -2.650428295135498,
            "end_logit": 5.819482803344727,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille syndrome, which includes tetralogy of Fallot among its more severe cardiac pathologies",
            "probability": 0.00012831809608383047,
            "start_logit": 6.076361179351807,
            "end_logit": -2.9183342456817627,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "autosomal dominant disorder called Alagille syndrome, which includes tetralogy of Fallot",
            "probability": 0.00010630158995812116,
            "start_logit": -1.000254511833191,
            "end_logit": 3.9700493812561035,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Al",
            "probability": 0.00010229873984681757,
            "start_logit": 6.076361179351807,
            "end_logit": -3.144949197769165,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Alagille syndrome, which includes te",
            "probability": 9.27545862905023e-05,
            "start_logit": 6.076361179351807,
            "end_logit": -3.242889404296875,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "multisystem autosomal dominant disorder called Alagille syndrome",
            "probability": 8.399284587431875e-05,
            "start_logit": -3.0852365493774414,
            "end_logit": 5.819482803344727,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "Fallot",
            "probability": 5.8800475354151535e-05,
            "start_logit": -1.5923848152160645,
            "end_logit": 3.9700493812561035,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        },
        {
            "text": "called Alagille syndrome",
            "probability": 5.8481469443391886e-05,
            "start_logit": -3.447258234024048,
            "end_logit": 5.819482803344727,
            "question_text": "What type of cancers and inherited diseases have been associated to mutations in the Notch pathway?"
        }
    ],
    "51bdb644047fa84d1d000001": [
        {
            "text": "gp210",
            "probability": 0.5046320356546965,
            "start_logit": 4.961063861846924,
            "end_logit": 4.352367401123047,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "gp210 homodimer or a heterodimer of gp210",
            "probability": 0.4901177443474222,
            "start_logit": 4.931879997253418,
            "end_logit": 4.352367401123047,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "210 homodimer or a heterodimer of gp210",
            "probability": 0.0012298103368869884,
            "start_logit": -1.0559056997299194,
            "end_logit": 4.352367401123047,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "210",
            "probability": 0.001085334864304635,
            "start_logit": -1.0559056997299194,
            "end_logit": 4.227396011352539,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "g",
            "probability": 0.0006688764847582499,
            "start_logit": 4.961063861846924,
            "end_logit": -2.27361798286438,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "gp210 homodimer or a heterodimer of g",
            "probability": 0.0006496381735484364,
            "start_logit": 4.931879997253418,
            "end_logit": -2.27361798286438,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "gp",
            "probability": 0.00029914292019659597,
            "start_logit": 4.961063861846924,
            "end_logit": -3.078295946121216,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "gp210 homodimer or a heterodimer of gp",
            "probability": 0.00029053893317343936,
            "start_logit": 4.931879997253418,
            "end_logit": -3.078295946121216,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "gp210 co-localizes with cytoplasmically dispersed nucleoporins,",
            "probability": 0.0002447884240137131,
            "start_logit": 4.751638412475586,
            "end_logit": -3.0693976879119873,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "gp21",
            "probability": 0.00019564033277312851,
            "start_logit": 4.961063861846924,
            "end_logit": -3.502939462661743,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "gp210 homodimer or a heterodimer of gp21",
            "probability": 0.00019001330043928695,
            "start_logit": 4.931879997253418,
            "end_logit": -3.502939462661743,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "p210 homodimer or a heterodimer of gp210",
            "probability": 8.353804733130314e-05,
            "start_logit": -3.7452187538146973,
            "end_logit": 4.352367401123047,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "p210",
            "probability": 7.601834820821246e-05,
            "start_logit": -3.8395462036132812,
            "end_logit": 4.352367401123047,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "0 homodimer or a heterodimer of gp210",
            "probability": 6.0281738892300265e-05,
            "start_logit": -4.071491718292236,
            "end_logit": 4.352367401123047,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "NPCs. In addition, we demonstrate that gp210",
            "probability": 6.025848901742957e-05,
            "start_logit": -3.793269634246826,
            "end_logit": 4.07375955581665,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "0",
            "probability": 5.405563291933043e-05,
            "start_logit": -4.180507183074951,
            "end_logit": 4.352367401123047,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "The glycoprotein gp210",
            "probability": 3.324075576615755e-05,
            "start_logit": -3.8977270126342773,
            "end_logit": 3.58335018157959,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "glycoprotein gp210",
            "probability": 1.1977512724412034e-05,
            "start_logit": -4.918472766876221,
            "end_logit": 3.58335018157959,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "gp210 (95% of its mass) did not reveal any sorting determinants. Surprisingly, the TM of g",
            "probability": 1.1787532013024725e-05,
            "start_logit": 2.4630703926086426,
            "end_logit": -3.8141815662384033,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        },
        {
            "text": "210 (95% of its mass) did not reveal any sorting determinants. Surprisingly, the TM of gp210",
            "probability": 5.278170914756112e-06,
            "start_logit": -4.354340076446533,
            "end_logit": 2.199766159057617,
            "question_text": "Which are the known human transmembrane nucleoporins?"
        }
    ],
    "534ab91eaeec6fbd07000012": [
        {
            "text": "VHL, and the mismatch repair gene hMLH1",
            "probability": 0.3203710398513246,
            "start_logit": 0.48927417397499084,
            "end_logit": -0.1405315101146698,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "hMLH1",
            "probability": 0.25637693989836263,
            "start_logit": 0.266443133354187,
            "end_logit": -0.1405315101146698,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "p16(INK4a), VHL, and the mismatch repair gene hMLH1",
            "probability": 0.1741560656010884,
            "start_logit": -0.12025382369756699,
            "end_logit": -0.1405315101146698,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "VHL",
            "probability": 0.10315093641788953,
            "start_logit": 0.48927417397499084,
            "end_logit": -1.273818016052246,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "p16(INK4a), VHL",
            "probability": 0.056073611578451144,
            "start_logit": -0.12025382369756699,
            "end_logit": -1.273818016052246,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "p16(INK4a)",
            "probability": 0.014795145081410532,
            "start_logit": -0.12025382369756699,
            "end_logit": -2.606184244155884,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Methylation-specific PCR (MSP)",
            "probability": 0.013743693027916701,
            "start_logit": -0.6633804440498352,
            "end_logit": -2.1367766857147217,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Met",
            "probability": 0.012929034180118436,
            "start_logit": -0.6633804440498352,
            "end_logit": -2.1978812217712402,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Methylation-specific PCR",
            "probability": 0.010536765630322806,
            "start_logit": -0.6633804440498352,
            "end_logit": -2.4024860858917236,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "p16",
            "probability": 0.010185381219020143,
            "start_logit": -0.12025382369756699,
            "end_logit": -2.979529857635498,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "PCR (MSP)",
            "probability": 0.006642907161162593,
            "start_logit": -1.3904107809066772,
            "end_logit": -2.1367766857147217,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "PCR",
            "probability": 0.005092863738951918,
            "start_logit": -1.3904107809066772,
            "end_logit": -2.4024860858917236,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Methylation-specific PCR (MSP",
            "probability": 0.0029788812174109712,
            "start_logit": -0.6633804440498352,
            "end_logit": -3.665808916091919,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Methylation-specific P",
            "probability": 0.002495257839922119,
            "start_logit": -0.6633804440498352,
            "end_logit": -3.8429646492004395,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Methylation-specific",
            "probability": 0.0022347965091594974,
            "start_logit": -0.6633804440498352,
            "end_logit": -3.9532065391540527,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Methylation-specific PCR (MSP) can determine the presence or absence of methylation",
            "probability": 0.001855208783608562,
            "start_logit": -0.6633804440498352,
            "end_logit": -4.139359474182129,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Methylation-specific PCR (MSP) can determine the presence or absence of met",
            "probability": 0.0017618843869587695,
            "start_logit": -0.6633804440498352,
            "end_logit": -4.190972805023193,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "Methylation-specific PCR (MSP) can determine the presence or absence of methylation of a gene locus",
            "probability": 0.0016048367790940773,
            "start_logit": -0.6633804440498352,
            "end_logit": -4.284334659576416,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "16(INK4a), VHL, and the mismatch repair gene hMLH1",
            "probability": 0.0015749320236374533,
            "start_logit": -4.825993537902832,
            "end_logit": -0.1405315101146698,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        },
        {
            "text": "PCR (MSP",
            "probability": 0.001439819074188945,
            "start_logit": -1.3904107809066772,
            "end_logit": -3.665808916091919,
            "question_text": "Which genes were found to be methylated in bladder cancer cells?"
        }
    ],
    "51740da48ed59a060a000024": [
        {
            "text": "spliced alignment",
            "probability": 0.3684299368011894,
            "start_logit": -1.3853315114974976,
            "end_logit": -1.1327567100524902,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "alignment",
            "probability": 0.13518504295744674,
            "start_logit": -2.387937545776367,
            "end_logit": -1.1327567100524902,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "GC-donor splice site models",
            "probability": 0.1265614386168223,
            "start_logit": -0.9892517328262329,
            "end_logit": -2.5973591804504395,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ab initio or spliced alignment",
            "probability": 0.10305370660641422,
            "start_logit": -2.659331798553467,
            "end_logit": -1.1327567100524902,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "spliced alignment approaches",
            "probability": 0.05576023653933857,
            "start_logit": -1.3853315114974976,
            "end_logit": -3.0209462642669678,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "GC-donor splice site models for Arabidopsis and rice,",
            "probability": 0.05426112801137808,
            "start_logit": -0.9892517328262329,
            "end_logit": -3.4442789554595947,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "alignment approaches",
            "probability": 0.02045965655596405,
            "start_logit": -2.387937545776367,
            "end_logit": -3.0209462642669678,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ab initio",
            "probability": 0.01817846668472847,
            "start_logit": -2.659331798553467,
            "end_logit": -2.867769241333008,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "based on ab initio or spliced alignment",
            "probability": 0.017892847083684185,
            "start_logit": -4.410181045532227,
            "end_logit": -1.1327567100524902,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "ab initio or spliced alignment approaches",
            "probability": 0.015596721337359856,
            "start_logit": -2.659331798553467,
            "end_logit": -3.0209462642669678,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "training and implementation of GC-donor splice site models",
            "probability": 0.015023822542537715,
            "start_logit": -3.120342493057251,
            "end_logit": -2.5973591804504395,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "GC",
            "probability": 0.012554437446848483,
            "start_logit": -0.9892517328262329,
            "end_logit": -4.908012866973877,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "GC-donor splice site",
            "probability": 0.010386655709169731,
            "start_logit": -0.9892517328262329,
            "end_logit": -5.097565174102783,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "G",
            "probability": 0.008711095659428167,
            "start_logit": -0.9892517328262329,
            "end_logit": -5.273489475250244,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "models",
            "probability": 0.0074208749185466156,
            "start_logit": -3.8256826400756836,
            "end_logit": -2.5973591804504395,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "GC-donor splice site models for Arabidopsis and rice",
            "probability": 0.0072971791663322206,
            "start_logit": -0.9892517328262329,
            "end_logit": -5.450599193572998,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "spliced alignment approaches,",
            "probability": 0.00710988907853345,
            "start_logit": -1.3853315114974976,
            "end_logit": -5.0805206298828125,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "training and implementation of GC-donor splice site models for Arabidopsis and rice,",
            "probability": 0.006441215958906699,
            "start_logit": -3.120342493057251,
            "end_logit": -3.4442789554595947,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "whether based on ab initio or spliced alignment",
            "probability": 0.004864749488358284,
            "start_logit": -5.71256685256958,
            "end_logit": -1.1327567100524902,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        },
        {
            "text": "Most current gene prediction software, whether based on ab initio or spliced alignment",
            "probability": 0.004810898837012676,
            "start_logit": -5.723698139190674,
            "end_logit": -1.1327567100524902,
            "question_text": "Which are the bioinformatics tools for gene structure prediction?\r\n"
        }
    ],
    "51766e438ed59a060a000031": [
        {
            "text": "tRNA(Sec)",
            "probability": 0.5924363694964843,
            "start_logit": 0.2544265389442444,
            "end_logit": -2.038945436477661,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "tRNA(Sec) gene",
            "probability": 0.11225999349784338,
            "start_logit": 0.2544265389442444,
            "end_logit": -3.70237135887146,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "tRNA",
            "probability": 0.10102831022718187,
            "start_logit": 0.2544265389442444,
            "end_logit": -3.807788133621216,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "glutathione peroxidase",
            "probability": 0.09372268200543582,
            "start_logit": -1.1260148286819458,
            "end_logit": -2.5024073123931885,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "tRNA(Sec",
            "probability": 0.0502409187956756,
            "start_logit": 0.2544265389442444,
            "end_logit": -4.506359100341797,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "tRNA(Sec) gene.",
            "probability": 0.017213448215808124,
            "start_logit": 0.2544265389442444,
            "end_logit": -5.577497959136963,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "t",
            "probability": 0.012892947114951005,
            "start_logit": 0.2544265389442444,
            "end_logit": -5.866508483886719,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "glutathione peroxidase gene",
            "probability": 0.006033895912570407,
            "start_logit": -1.1260148286819458,
            "end_logit": -5.245354652404785,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "phospholipid glutathione peroxidase",
            "probability": 0.0022251262898196076,
            "start_logit": -4.866541385650635,
            "end_logit": -2.5024073123931885,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "UGA",
            "probability": 0.0017082764791269628,
            "start_logit": -2.733088970184326,
            "end_logit": -4.900188446044922,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "UGA codon as a site for selenocysteine incorporation.",
            "probability": 0.001610175725633789,
            "start_logit": -3.3408846855163574,
            "end_logit": -4.351534366607666,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "the tRNA(Sec)",
            "probability": 0.0014050904036822206,
            "start_logit": -5.78971529006958,
            "end_logit": -2.038945436477661,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "termination",
            "probability": 0.001371173686395659,
            "start_logit": -3.9018170833587646,
            "end_logit": -3.9512782096862793,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "UGA codons",
            "probability": 0.0012098410408702914,
            "start_logit": -2.733088970184326,
            "end_logit": -5.245184421539307,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "overexpression of the tRNA(Sec)",
            "probability": 0.0010412152183629003,
            "start_logit": -6.089428424835205,
            "end_logit": -2.038945436477661,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "UGA codon as a site for selenocysteine incorporation",
            "probability": 0.0009182076163605066,
            "start_logit": -3.3408846855163574,
            "end_logit": -4.913209438323975,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "Sec)",
            "probability": 0.0009114129363557862,
            "start_logit": -6.222576141357422,
            "end_logit": -2.038945436477661,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "selenocysteine incorporation.",
            "probability": 0.0007897122179934693,
            "start_logit": -4.053314685821533,
            "end_logit": -4.351534366607666,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "termination at UGA",
            "probability": 0.0005308673196033245,
            "start_logit": -3.9018170833587646,
            "end_logit": -4.900188446044922,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        },
        {
            "text": "selenocysteine incorporation",
            "probability": 0.00045033579984515946,
            "start_logit": -4.053314685821533,
            "end_logit": -4.913209438323975,
            "question_text": "Name the factors required for selenoprotein synthesis in eukaryotes"
        }
    ],
    "552435602c8b63434a000009": [
        {
            "text": "p16",
            "probability": 0.4610350517210379,
            "start_logit": 5.1648736000061035,
            "end_logit": 5.606905460357666,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p15 and p16",
            "probability": 0.32655386881390214,
            "start_logit": 4.8199944496154785,
            "end_logit": 5.606905460357666,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p15",
            "probability": 0.19430626635718862,
            "start_logit": 4.8199944496154785,
            "end_logit": 5.0877461433410645,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p16 CDK4",
            "probability": 0.005739623241136001,
            "start_logit": 5.1648736000061035,
            "end_logit": 1.220824956893921,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p15 and p16 CDK4",
            "probability": 0.004065409274046357,
            "start_logit": 4.8199944496154785,
            "end_logit": 1.220824956893921,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "16",
            "probability": 0.0015523752206238234,
            "start_logit": -0.5288143157958984,
            "end_logit": 5.606905460357666,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "The p15 and p16",
            "probability": 0.0013997163091019167,
            "start_logit": -0.6323308944702148,
            "end_logit": 5.606905460357666,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "15 and p16",
            "probability": 0.0012557307327029053,
            "start_logit": -0.7408828139305115,
            "end_logit": 5.606905460357666,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p16 CDK4 inhibitor genes",
            "probability": 0.0011411394953063424,
            "start_logit": 5.1648736000061035,
            "end_logit": -0.39454129338264465,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "The p15",
            "probability": 0.0008328599840777003,
            "start_logit": -0.6323308944702148,
            "end_logit": 5.0877461433410645,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p15 and p16 CDK4 inhibitor genes",
            "probability": 0.0008082758906455298,
            "start_logit": 4.8199944496154785,
            "end_logit": -0.39454129338264465,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "15",
            "probability": 0.000747185605571643,
            "start_logit": -0.7408828139305115,
            "end_logit": 5.0877461433410645,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p16 CDK4 inhibitor",
            "probability": 0.00013320177983923122,
            "start_logit": 5.1648736000061035,
            "end_logit": -2.5424587726593018,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p",
            "probability": 0.00011612349933702103,
            "start_logit": 5.1648736000061035,
            "end_logit": -2.6796696186065674,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p15 and p16 CDK4 inhibitor",
            "probability": 9.434761278350261e-05,
            "start_logit": 4.8199944496154785,
            "end_logit": -2.5424587726593018,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p15 and p",
            "probability": 8.225096514279292e-05,
            "start_logit": 4.8199944496154785,
            "end_logit": -2.6796696186065674,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "CDK4",
            "probability": 7.370702013406971e-05,
            "start_logit": 0.8098227977752686,
            "end_logit": 1.220824956893921,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p16 C",
            "probability": 2.5487408788042128e-05,
            "start_logit": 5.1648736000061035,
            "end_logit": -4.196139335632324,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "16 CDK4",
            "probability": 1.9326185421249482e-05,
            "start_logit": -0.5288143157958984,
            "end_logit": 1.220824956893921,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        },
        {
            "text": "p15 and p16 C",
            "probability": 1.8052883212907367e-05,
            "start_logit": 4.8199944496154785,
            "end_logit": -4.196139335632324,
            "question_text": "Which genes/proteins have been found to inhibit cyclin dependent kinase 4 (CDK4)?"
        }
    ],
    "54f21b69c409818c32000007": [
        {
            "text": "alcoholic cirrhosis",
            "probability": 0.6235439312553348,
            "start_logit": 3.44150447845459,
            "end_logit": 2.7630300521850586,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "cirrhosis",
            "probability": 0.35051684180756437,
            "start_logit": 2.8654940128326416,
            "end_logit": 2.7630300521850586,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Porphyria cutanea tarda",
            "probability": 0.01047731545880696,
            "start_logit": 0.7750166058540344,
            "end_logit": 1.3433111906051636,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "alcoholic",
            "probability": 0.004588690810652951,
            "start_logit": 3.44150447845459,
            "end_logit": -2.148794412612915,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hereditary hemochromatosis",
            "probability": 0.0025979628177104763,
            "start_logit": 0.784061074256897,
            "end_logit": -0.06021815910935402,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Porphyria cutanea tarda (PCT)",
            "probability": 0.0015036930800022713,
            "start_logit": 0.7750166058540344,
            "end_logit": -0.5979771614074707,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "alcoholic c",
            "probability": 0.0012709599217988934,
            "start_logit": 3.44150447845459,
            "end_logit": -3.432616710662842,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Porphyria cutanea",
            "probability": 0.001003510383583529,
            "start_logit": 0.7750166058540344,
            "end_logit": -1.002397060394287,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "alcoholic cirrhosis, but also PCT",
            "probability": 0.0009398699866012248,
            "start_logit": 3.44150447845459,
            "end_logit": -3.734402894973755,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "c",
            "probability": 0.0007144530409526388,
            "start_logit": 2.8654940128326416,
            "end_logit": -3.432616710662842,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "cirrhosis, but also PCT",
            "probability": 0.0005283352830488487,
            "start_logit": 2.8654940128326416,
            "end_logit": -3.734402894973755,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hemochromatosis",
            "probability": 0.0003779849454926715,
            "start_logit": -1.143567442893982,
            "end_logit": -0.06021815910935402,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hosis",
            "probability": 0.00036410989647820145,
            "start_logit": -4.004214286804199,
            "end_logit": 2.7630300521850586,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "hepatitis C virus (HCV), alcoholism, hereditary hemochromatosis",
            "probability": 0.00035673183522602934,
            "start_logit": -1.2014374732971191,
            "end_logit": -0.06021815910935402,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "cutanea tarda",
            "probability": 0.0002986549127896342,
            "start_logit": -2.7826623916625977,
            "end_logit": 1.3433111906051636,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "Porphyria",
            "probability": 0.0002914083754097009,
            "start_logit": 0.7750166058540344,
            "end_logit": -2.2389309406280518,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "HH, and alcoholic cirrhosis",
            "probability": 0.00019000154595027842,
            "start_logit": -4.654637813568115,
            "end_logit": 2.7630300521850586,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "is",
            "probability": 0.00017538484854990685,
            "start_logit": -4.734687328338623,
            "end_logit": 2.7630300521850586,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "irrhosis",
            "probability": 0.00017202442228358584,
            "start_logit": -4.75403356552124,
            "end_logit": 2.7630300521850586,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        },
        {
            "text": "alcoholism, hereditary hemochromatosis",
            "probability": 8.813537176329121e-05,
            "start_logit": -2.599547863006592,
            "end_logit": -0.06021815910935402,
            "question_text": "Which disorders are associated to mutated Hepcidin (HAMP)?"
        }
    ],
    "52e203bc98d0239505000011": [
        {
            "text": "CpG",
            "probability": 0.9938517142689037,
            "start_logit": 4.8138556480407715,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "C",
            "probability": 0.0032791733589547308,
            "start_logit": 4.8138556480407715,
            "end_logit": -1.6047823429107666,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "G",
            "probability": 0.00043852440414222915,
            "start_logit": -2.91207218170166,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG in an AU context",
            "probability": 0.0003360645102667391,
            "start_logit": 4.8138556480407715,
            "end_logit": -3.8828258514404297,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG in an AU context--which is found in both the ssRNA",
            "probability": 0.00028273639389460575,
            "start_logit": 4.8138556480407715,
            "end_logit": -4.055613994598389,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG in an AU context--which is found in both the ssRNA viruses and innate genes,",
            "probability": 0.0002451400254809475,
            "start_logit": 4.8138556480407715,
            "end_logit": -4.198299407958984,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "motif pattern of CpG",
            "probability": 0.00023883969677149558,
            "start_logit": -3.5196950435638428,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG in an AU context--which is found in both the ssRNA viruses and innate genes",
            "probability": 0.0002100132839148881,
            "start_logit": 4.8138556480407715,
            "end_logit": -4.3529582023620605,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG in",
            "probability": 0.0001825364982365791,
            "start_logit": 4.8138556480407715,
            "end_logit": -4.493178844451904,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "under-represented motif pattern of CpG",
            "probability": 0.0001735830607152421,
            "start_logit": -3.8388314247131348,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG in an AU context--which is found in both the ssRNA viruses",
            "probability": 0.0001636967680245002,
            "start_logit": 4.8138556480407715,
            "end_logit": -4.602113246917725,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "influenza genome. We argue that the significant under-represented motif pattern of CpG",
            "probability": 0.00015002035604109423,
            "start_logit": -3.9847166538238525,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "significant under-represented motif pattern of CpG",
            "probability": 0.00010706704146695674,
            "start_logit": -4.322032451629639,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "CpG in an AU context-",
            "probability": 0.00010599672899523396,
            "start_logit": 4.8138556480407715,
            "end_logit": -5.0367207527160645,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "H1N1 influenza genome. We argue that the significant under-represented motif pattern of CpG",
            "probability": 0.00010384911687250393,
            "start_logit": -4.352548599243164,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "pattern of CpG",
            "probability": 7.476380454383138e-05,
            "start_logit": -4.681153774261475,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "the significant under-represented motif pattern of CpG",
            "probability": 3.294095116344876e-05,
            "start_logit": -5.5007710456848145,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "We argue that the significant under-represented motif pattern of CpG",
            "probability": 2.1918473502785547e-05,
            "start_logit": -5.908157825469971,
            "end_logit": 4.1092143058776855,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "motif pattern of C",
            "probability": 7.880418773438943e-07,
            "start_logit": -3.5196950435638428,
            "end_logit": -1.6047823429107666,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        },
        {
            "text": "influenza",
            "probability": 6.332162310948148e-07,
            "start_logit": -2.072301149368286,
            "end_logit": -3.2709155082702637,
            "question_text": "Which are the most under-represented oligonucleotides in higher eukaryote genomes?"
        }
    ],
    "515df86a298dcd4e5100002e": [
        {
            "text": "epilepsy",
            "probability": 0.23757845307905165,
            "start_logit": 4.353382110595703,
            "end_logit": 4.463022708892822,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "epilepsy, and insulin-dependent diabetes",
            "probability": 0.1776215010557296,
            "start_logit": 4.353382110595703,
            "end_logit": 4.172179698944092,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "epilepsy, and insulin-dependent diabetes mellitus",
            "probability": 0.176807996174351,
            "start_logit": 4.353382110595703,
            "end_logit": 4.16758918762207,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "insulin-dependent diabetes",
            "probability": 0.14363959937404042,
            "start_logit": 4.007641315460205,
            "end_logit": 4.305572986602783,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "insulin-dependent diabetes mellitus",
            "probability": 0.11049641169317581,
            "start_logit": 3.88330078125,
            "end_logit": 4.16758918762207,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "diabetes",
            "probability": 0.07686761813867071,
            "start_logit": 3.382418632507324,
            "end_logit": 4.305572986602783,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "diabetes mellitus",
            "probability": 0.07010864188749473,
            "start_logit": 3.428363800048828,
            "end_logit": 4.16758918762207,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "epilepsy,",
            "probability": 0.0010543712858047515,
            "start_logit": 4.353382110595703,
            "end_logit": -0.9545305371284485,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "epilepsy, and insulin-dependent diabetes mellitus.",
            "probability": 0.0008327508517642851,
            "start_logit": 4.353382110595703,
            "end_logit": -1.1904959678649902,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "pilepsy",
            "probability": 0.0007314019326369744,
            "start_logit": -1.4299079179763794,
            "end_logit": 4.463022708892822,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "autoimmune diseases, primarily insulin-dependent diabetes",
            "probability": 0.000613454965656858,
            "start_logit": -0.6202130913734436,
            "end_logit": 3.4774715900421143,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "autoimmune diseases, primarily insulin-dependent diabetes mellitus",
            "probability": 0.0005816342193658412,
            "start_logit": -0.6202130913734436,
            "end_logit": 3.424206495285034,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "pilepsy, and insulin-dependent diabetes",
            "probability": 0.0005468202501799015,
            "start_logit": -1.4299079179763794,
            "end_logit": 4.172179698944092,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "pilepsy, and insulin-dependent diabetes mellitus",
            "probability": 0.0005443158183396456,
            "start_logit": -1.4299079179763794,
            "end_logit": 4.16758918762207,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "insulin-dependent diabetes mellitus.",
            "probability": 0.0005204288434084846,
            "start_logit": 3.88330078125,
            "end_logit": -1.1904959678649902,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "epilepsy, and insulin",
            "probability": 0.0004376208535315166,
            "start_logit": 4.353382110595703,
            "end_logit": -1.8338775634765625,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "insulin",
            "probability": 0.00034329817987092655,
            "start_logit": 4.007641315460205,
            "end_logit": -1.7308902740478516,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "diabetes mellitus.",
            "probability": 0.0003302058306813045,
            "start_logit": 3.428363800048828,
            "end_logit": -1.1904959678649902,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "e",
            "probability": 0.00018204091250136704,
            "start_logit": 4.353382110595703,
            "end_logit": -2.710999011993408,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        },
        {
            "text": "psy",
            "probability": 0.00016143465374382818,
            "start_logit": -2.9407706260681152,
            "end_logit": 4.463022708892822,
            "question_text": "List co-morbidities that may occur together with \"Stiff man Syndrome\""
        }
    ],
    "56be2570ef6e39474100000d": [
        {
            "text": "depressive symptoms postplacement. We know little about personality traits that may be associated with depression",
            "probability": 0.2853639792285641,
            "start_logit": -1.2731355428695679,
            "end_logit": -1.5890998840332031,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depression",
            "probability": 0.13360492648184655,
            "start_logit": -2.0320138931274414,
            "end_logit": -1.5890998840332031,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depressive",
            "probability": 0.12735998090721037,
            "start_logit": -1.2731355428695679,
            "end_logit": -2.395847797393799,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depressive symptoms postplacement. We know little about personality traits that may be associated with depression in adoptive parents.",
            "probability": 0.10130412724088507,
            "start_logit": -1.2731355428695679,
            "end_logit": -2.6247382164001465,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "pressive symptoms postplacement. We know little about personality traits that may be associated with depression",
            "probability": 0.06616674115910197,
            "start_logit": -2.7347230911254883,
            "end_logit": -1.5890998840332031,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depression in adoptive parents.",
            "probability": 0.04742970892442368,
            "start_logit": -2.0320138931274414,
            "end_logit": -2.6247382164001465,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depressive symptoms",
            "probability": 0.03942207696939829,
            "start_logit": -1.2731355428695679,
            "end_logit": -3.5685393810272217,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "pressive",
            "probability": 0.02953068888896417,
            "start_logit": -2.7347230911254883,
            "end_logit": -2.395847797393799,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "pressive symptoms postplacement. We know little about personality traits that may be associated with depression in adoptive parents.",
            "probability": 0.023489173313383023,
            "start_logit": -2.7347230911254883,
            "end_logit": -2.6247382164001465,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depressive symptoms postplacement. We know little about personality traits",
            "probability": 0.021836693549411368,
            "start_logit": -1.2731355428695679,
            "end_logit": -4.159273624420166,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depressive symptoms postplacement. We",
            "probability": 0.01987505684455881,
            "start_logit": -1.2731355428695679,
            "end_logit": -4.253399848937988,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depressive symptoms postplacement. We know little",
            "probability": 0.01820974412332895,
            "start_logit": -1.2731355428695679,
            "end_logit": -4.340908527374268,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "personality traits that may be associated with depression",
            "probability": 0.01663787021586131,
            "start_logit": -4.115219593048096,
            "end_logit": -1.5890998840332031,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "We know little about personality traits that may be associated with depression",
            "probability": 0.015448446710205507,
            "start_logit": -4.189392566680908,
            "end_logit": -1.5890998840332031,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depressive symptoms postplacement. We know little about personality",
            "probability": 0.015366721726458326,
            "start_logit": -1.2731355428695679,
            "end_logit": -4.5106611251831055,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "de",
            "probability": 0.012625285122261324,
            "start_logit": -1.2731355428695679,
            "end_logit": -4.7071638107299805,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "pressive symptoms",
            "probability": 0.009140713448977851,
            "start_logit": -2.7347230911254883,
            "end_logit": -3.5685393810272217,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "personality traits that may be associated with depression in adoptive parents.",
            "probability": 0.005906438948326223,
            "start_logit": -4.115219593048096,
            "end_logit": -2.6247382164001465,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "depressive symptoms postplacement. We know little about personality traits that may be associated with depression in adoptive parents",
            "probability": 0.00579743223712071,
            "start_logit": -1.2731355428695679,
            "end_logit": -5.485450267791748,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        },
        {
            "text": "We know little about personality traits that may be associated with depression in adoptive parents.",
            "probability": 0.0054841939597120686,
            "start_logit": -4.189392566680908,
            "end_logit": -2.6247382164001465,
            "question_text": "What personality traits can be evaluated with the Ten Item Personality Inventory."
        }
    ],
    "5322d3cb9b2d7acc7e000010": [
        {
            "text": "HDAC6",
            "probability": 0.860712363352304,
            "start_logit": 5.178728103637695,
            "end_logit": 4.789339542388916,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC",
            "probability": 0.07635348911561243,
            "start_logit": 5.178728103637695,
            "end_logit": 2.366952896118164,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6, the tubulin deacetylase",
            "probability": 0.03248975132777126,
            "start_logit": 5.178728103637695,
            "end_logit": 1.5125038623809814,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6,",
            "probability": 0.01853105196450304,
            "start_logit": 5.178728103637695,
            "end_logit": 0.951026976108551,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6, the tubulin deacetylase,",
            "probability": 0.00861654788250352,
            "start_logit": 5.178728103637695,
            "end_logit": 0.18526369333267212,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6 as well as its depletion enhance microtubule acetylation, only pharmacological inhibition of HDAC",
            "probability": 0.0011859318762638587,
            "start_logit": 3.6373324394226074,
            "end_logit": -0.2564963102340698,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "tubulin deacetylase",
            "probability": 0.0005781342878421082,
            "start_logit": 1.149854302406311,
            "end_logit": 1.5125038623809814,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "H",
            "probability": 0.00030211775354907407,
            "start_logit": 5.178728103637695,
            "end_logit": -3.1653592586517334,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "deacetylase",
            "probability": 0.0002975448969987661,
            "start_logit": 0.48561325669288635,
            "end_logit": 1.5125038623809814,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6, the tubulin de",
            "probability": 0.00024449593151342684,
            "start_logit": 5.178728103637695,
            "end_logit": -3.3769774436950684,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "6",
            "probability": 0.0001976652284116748,
            "start_logit": -3.2002127170562744,
            "end_logit": 4.789339542388916,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "tubulin deacetylase,",
            "probability": 0.00015332594341682583,
            "start_logit": 1.149854302406311,
            "end_logit": 0.18526369333267212,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6-specific inhibitor, and siRNA-mediated depletion of HDAC6",
            "probability": 0.00010142337629530391,
            "start_logit": 0.8518416285514832,
            "end_logit": 0.07001396268606186,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "deacetylase,",
            "probability": 7.891134118939773e-05,
            "start_logit": 0.48561325669288635,
            "end_logit": 0.18526369333267212,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "C6",
            "probability": 6.675429003801789e-05,
            "start_logit": -4.285768985748291,
            "end_logit": 4.789339542388916,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "deacetylase function, HDAC6",
            "probability": 3.628510377182323e-05,
            "start_logit": -2.5282111167907715,
            "end_logit": 2.422170400619507,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "DAC6",
            "probability": 2.9198633141824817e-05,
            "start_logit": -5.11266565322876,
            "end_logit": 4.789339542388916,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "HDAC6-specific inhibitor, and siRNA-mediated depletion of HDAC",
            "probability": 1.162457460529095e-05,
            "start_logit": 0.8518416285514832,
            "end_logit": -2.096168279647827,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "6, the tubulin deacetylase",
            "probability": 7.46137082570725e-06,
            "start_logit": -3.2002127170562744,
            "end_logit": 1.5125038623809814,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        },
        {
            "text": "C",
            "probability": 5.921749442504498e-06,
            "start_logit": -4.285768985748291,
            "end_logit": 2.366952896118164,
            "question_text": "Which are the enzymes involved in the control of tubulin acetylation?"
        }
    ],
    "515de748298dcd4e51000023": [
        {
            "text": "imatinib",
            "probability": 0.2752901212886099,
            "start_logit": 3.155506134033203,
            "end_logit": 3.2023425102233887,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autoimmune disorders and AL amyloidosis",
            "probability": 0.13163134062409018,
            "start_logit": 3.1126794815063477,
            "end_logit": 2.5073487758636475,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autoimmune disorders",
            "probability": 0.10631218939557287,
            "start_logit": 3.1126794815063477,
            "end_logit": 2.2937235832214355,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "imatinib for chronic myeloid leukaemia",
            "probability": 0.10395066259253376,
            "start_logit": 3.155506134033203,
            "end_logit": 2.22843337059021,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autoimmune disorders and AL amyloidosis for autologous, and solid tumours",
            "probability": 0.07481268386416409,
            "start_logit": 3.1126794815063477,
            "end_logit": 1.942331075668335,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autoimmune disorders and AL amyloidosis for autologous, and solid tumours for allogeneic transplants",
            "probability": 0.05548113687882441,
            "start_logit": 3.1126794815063477,
            "end_logit": 1.643386721611023,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "solid tumours",
            "probability": 0.0516169845172039,
            "start_logit": 2.7415428161621094,
            "end_logit": 1.942331075668335,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "allogeneic transplants. The introduction of alternative therapies has challenged well-established indications such as imatinib",
            "probability": 0.051018663209794805,
            "start_logit": 1.4698721170425415,
            "end_logit": 3.2023425102233887,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "chronic myeloid leukaemia",
            "probability": 0.04879134773142958,
            "start_logit": 2.3991427421569824,
            "end_logit": 2.22843337059021,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "solid tumours for allogeneic transplants",
            "probability": 0.038279190577774735,
            "start_logit": 2.7415428161621094,
            "end_logit": 1.643386721611023,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "AL amyloidosis",
            "probability": 0.017698683075428205,
            "start_logit": 1.106164574623108,
            "end_logit": 2.5073487758636475,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "allogeneic transplants",
            "probability": 0.010732062137354807,
            "start_logit": 1.4698721170425415,
            "end_logit": 1.643386721611023,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "AL amyloidosis for autologous, and solid tumours",
            "probability": 0.010059048061474483,
            "start_logit": 1.106164574623108,
            "end_logit": 1.942331075668335,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "AL amyloidosis for autologous, and solid tumours for allogeneic transplants",
            "probability": 0.007459796835823287,
            "start_logit": 1.106164574623108,
            "end_logit": 1.643386721611023,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autoimmune disorders and AL amyloidosis for autologous,",
            "probability": 0.0059874638451035914,
            "start_logit": 3.1126794815063477,
            "end_logit": -0.582988440990448,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autologous, and solid tumours",
            "probability": 0.0027169589286889268,
            "start_logit": -0.20279474556446075,
            "end_logit": 1.942331075668335,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "transplants. The introduction of alternative therapies has challenged well-established indications such as imatinib",
            "probability": 0.0025033566230331164,
            "start_logit": -1.5446869134902954,
            "end_logit": 3.2023425102233887,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autologous, and solid tumours for allogeneic transplants",
            "probability": 0.002014898576428966,
            "start_logit": -0.20279474556446075,
            "end_logit": 1.643386721611023,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autoimmune",
            "probability": 0.0020075408603348922,
            "start_logit": 3.1126794815063477,
            "end_logit": -1.6757458448410034,
            "question_text": "List all approved indications for Glivec"
        },
        {
            "text": "autoimmune disorders and AL amyloidosis for autologous",
            "probability": 0.0016358703763315614,
            "start_logit": 3.1126794815063477,
            "end_logit": -1.8804813623428345,
            "question_text": "List all approved indications for Glivec"
        }
    ],
    "54dfbed11388e8454a000008": [
        {
            "text": "A3",
            "probability": 0.571182836975357,
            "start_logit": 1.22085440158844,
            "end_logit": 0.5069401860237122,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3 proteins",
            "probability": 0.26053778567255126,
            "start_logit": 1.22085440158844,
            "end_logit": -0.27802127599716187,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC3",
            "probability": 0.11133103578390448,
            "start_logit": 0.06478419899940491,
            "end_logit": 0.02780909277498722,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "some A3",
            "probability": 0.008065523562851796,
            "start_logit": -3.0392563343048096,
            "end_logit": 0.5069401860237122,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3 proteins could restrict engineered human Long INterspersed Element-1",
            "probability": 0.006885729720066901,
            "start_logit": 1.22085440158844,
            "end_logit": -3.911318063735962,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "overexpression of some A3",
            "probability": 0.005804315720666234,
            "start_logit": -3.368253231048584,
            "end_logit": 0.5069401860237122,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3B",
            "probability": 0.0053897546550067165,
            "start_logit": -1.2140291929244995,
            "end_logit": -1.7213857173919678,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3DE, A3F",
            "probability": 0.004879211905250789,
            "start_logit": -1.057278037071228,
            "end_logit": -1.9776530265808105,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3DE",
            "probability": 0.00371192548987113,
            "start_logit": -1.057278037071228,
            "end_logit": -2.2510859966278076,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "some A3 proteins",
            "probability": 0.0036789859801859815,
            "start_logit": -3.0392563343048096,
            "end_logit": -0.27802127599716187,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3F",
            "probability": 0.003668630391518471,
            "start_logit": -1.3424433469772339,
            "end_logit": -1.9776530265808105,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "overexpression of some A3 proteins",
            "probability": 0.0026475647854103906,
            "start_logit": -3.368253231048584,
            "end_logit": -0.27802127599716187,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "APOBEC3 (A3)",
            "probability": 0.0022124361533228756,
            "start_logit": 0.06478419899940491,
            "end_logit": -3.8906047344207764,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3C",
            "probability": 0.002152552308989318,
            "start_logit": -2.1035454273223877,
            "end_logit": -1.7497150897979736,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3B and A3C",
            "probability": 0.0017451128185682432,
            "start_logit": -2.313380479812622,
            "end_logit": -1.7497150897979736,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3C, whereas human embryonic stem cells (hESCs) express A3B, A3C",
            "probability": 0.001376664152087729,
            "start_logit": -2.1035454273223877,
            "end_logit": -2.1967060565948486,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3C, whereas human embryonic stem cells (hESCs) express A3B, A3C, A3DE",
            "probability": 0.0013038003574905952,
            "start_logit": -2.1035454273223877,
            "end_logit": -2.2510859966278076,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3C, A3DE, A3F",
            "probability": 0.0012392473846253832,
            "start_logit": -2.427757501602173,
            "end_logit": -1.9776530265808105,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3B and A3C, whereas human embryonic stem cells (hESCs) express A3B, A3C",
            "probability": 0.0011160863541567942,
            "start_logit": -2.313380479812622,
            "end_logit": -2.1967060565948486,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        },
        {
            "text": "A3C, whereas human embryonic stem cells (hESCs) express A3B",
            "probability": 0.0010707998281176228,
            "start_logit": -2.1035454273223877,
            "end_logit": -2.4479634761810303,
            "question_text": "Which proteins induce inhibition of LINE-1 and Alu retrotransposition?"
        }
    ],
    "5149aafcd24251bc05000045": [
        {
            "text": "PPInterFinder",
            "probability": 0.6994350095767783,
            "start_logit": 5.10821533203125,
            "end_logit": 4.95237922668457,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--a web-based text mining tool to extract human PPIs from biomedical literature. PPInterFinder",
            "probability": 0.2722057628243556,
            "start_logit": 5.10821533203125,
            "end_logit": 4.008664608001709,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "ppinterfinder",
            "probability": 0.021686871188227503,
            "start_logit": 3.3788864612579346,
            "end_logit": 3.2081422805786133,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--a web-based text mining tool to extract human PPIs from biomedical literature.",
            "probability": 0.0012044303575104475,
            "start_logit": 5.10821533203125,
            "end_logit": -1.4118869304656982,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--a web-based text mining tool to extract human PPIs",
            "probability": 0.0010711577446177612,
            "start_logit": 5.10821533203125,
            "end_logit": -1.52915358543396,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInter",
            "probability": 0.0009316503054639854,
            "start_logit": 5.10821533203125,
            "end_logit": -1.6686913967132568,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder-",
            "probability": 0.0007585662290027835,
            "start_logit": 5.10821533203125,
            "end_logit": -1.8742188215255737,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--a web-based text mining tool",
            "probability": 0.0006048673103023114,
            "start_logit": 5.10821533203125,
            "end_logit": -2.100639820098877,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PP",
            "probability": 0.00047947347035116086,
            "start_logit": 5.10821533203125,
            "end_logit": -2.332960367202759,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--a web-based text mining tool to extract human PPIs from biomedical literature. PP",
            "probability": 0.00021580586683195809,
            "start_logit": 5.10821533203125,
            "end_logit": -3.131269693374634,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--",
            "probability": 0.00021466511172066815,
            "start_logit": 5.10821533203125,
            "end_logit": -3.1365697383880615,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "web-based text mining tool to extract human PPIs from biomedical literature. PPInterFinder",
            "probability": 0.0002080128455402911,
            "start_logit": -2.068498373031616,
            "end_logit": 4.008664608001709,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--a web",
            "probability": 0.00020682095568626412,
            "start_logit": 5.10821533203125,
            "end_logit": -3.173795461654663,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--a web-based text mining",
            "probability": 0.00020637532926759704,
            "start_logit": 5.10821533203125,
            "end_logit": -3.175952434539795,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder--a web-based text mining tool to extract human PPIs from biomedical literature. PPInter",
            "probability": 0.0002030894246162718,
            "start_logit": 5.10821533203125,
            "end_logit": -3.192002534866333,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "Finder",
            "probability": 0.00015285435577125193,
            "start_logit": -3.3203272819519043,
            "end_logit": 4.95237922668457,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "PPInterFinder uses relation keyword co-occurrences with protein names to extract information on PPIs",
            "probability": 6.202055149290797e-05,
            "start_logit": 4.053221225738525,
            "end_logit": -3.3231890201568604,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "Finder--a web-based text mining tool to extract human PPIs from biomedical literature. PPInterFinder",
            "probability": 5.9487780771676826e-05,
            "start_logit": -3.3203272819519043,
            "end_logit": 4.008664608001709,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "a web-based text mining tool to extract human PPIs from biomedical literature. PPInterFinder",
            "probability": 5.838161022296418e-05,
            "start_logit": -3.339097261428833,
            "end_logit": 4.008664608001709,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        },
        {
            "text": "pp",
            "probability": 3.4697161468301264e-05,
            "start_logit": 3.3788864612579346,
            "end_logit": -3.2296621799468994,
            "question_text": "Which are the available biomedical text mining tools for the detection of protein-protein interactions?"
        }
    ],
    "51600ab3298dcd4e51000036": [
        {
            "text": "amyotrophic lateral sclerosis",
            "probability": 0.326632765140275,
            "start_logit": 5.90189790725708,
            "end_logit": 5.88218355178833,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "frontotemporal dementia",
            "probability": 0.2839758169723915,
            "start_logit": 6.031079292297363,
            "end_logit": 5.6130547523498535,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) and frontotemporal dementia",
            "probability": 0.24956207902990077,
            "start_logit": 5.90189790725708,
            "end_logit": 5.6130547523498535,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "frontotemporal dementia (FTD)",
            "probability": 0.04719696568876974,
            "start_logit": 6.031079292297363,
            "end_logit": 3.818495273590088,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)",
            "probability": 0.041477380034573144,
            "start_logit": 5.90189790725708,
            "end_logit": 3.818495273590088,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS)",
            "probability": 0.027489455614366873,
            "start_logit": 5.90189790725708,
            "end_logit": 3.40714955329895,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "dementia",
            "probability": 0.013960143919692428,
            "start_logit": 3.0183966159820557,
            "end_logit": 5.6130547523498535,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "lateral sclerosis",
            "probability": 0.0026756581028358037,
            "start_logit": 1.0972567796707153,
            "end_logit": 5.88218355178833,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "dementia (FTD)",
            "probability": 0.00232018500945828,
            "start_logit": 3.0183966159820557,
            "end_logit": 3.818495273590088,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "lateral sclerosis (ALS) and frontotemporal dementia",
            "probability": 0.002044322769120042,
            "start_logit": 1.0972567796707153,
            "end_logit": 5.6130547523498535,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "amyotrophic",
            "probability": 0.0004999506877565429,
            "start_logit": 5.90189790725708,
            "end_logit": -0.5998987555503845,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "frontotemporal dementia (FTD).",
            "probability": 0.0003862593962727786,
            "start_logit": 6.031079292297363,
            "end_logit": -0.987080454826355,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "lateral sclerosis (ALS) and frontotemporal dementia (FTD)",
            "probability": 0.0003397677753676815,
            "start_logit": 1.0972567796707153,
            "end_logit": 3.818495273590088,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).",
            "probability": 0.0003394503764665308,
            "start_logit": 5.90189790725708,
            "end_logit": -0.987080454826355,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "lateral sclerosis (ALS)",
            "probability": 0.00022518373080403692,
            "start_logit": 1.0972567796707153,
            "end_logit": 3.40714955329895,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS",
            "probability": 0.00022475278757108736,
            "start_logit": 5.90189790725708,
            "end_logit": -1.399407148361206,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "both amyotrophic lateral sclerosis",
            "probability": 0.00020208544226248986,
            "start_logit": -1.4860032796859741,
            "end_logit": 5.88218355178833,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia",
            "probability": 0.0001544023395541631,
            "start_logit": -1.4860032796859741,
            "end_logit": 5.6130547523498535,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "frontotemporal dementia (FTD",
            "probability": 0.00015143695789626398,
            "start_logit": 6.031079292297363,
            "end_logit": -1.9234201908111572,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        },
        {
            "text": "rosis",
            "probability": 0.00014193822466495248,
            "start_logit": -1.8393019437789917,
            "end_logit": 5.88218355178833,
            "question_text": "Which are the most commonly reported pathological states associated with the formation of DNA G-quadruplexes?"
        }
    ],
    "56c1f000ef6e394741000037": [
        {
            "text": "trifluorothymidine",
            "probability": 0.3937288370638277,
            "start_logit": 4.1939897537231445,
            "end_logit": 3.520350694656372,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "bevacizumab",
            "probability": 0.21030440177246773,
            "start_logit": 3.729828119277954,
            "end_logit": 3.3574059009552,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "bevacizumab, and the anti-epidermal growth factor receptor antibody, cetuximab",
            "probability": 0.1080714557074283,
            "start_logit": 3.729828119277954,
            "end_logit": 2.6916425228118896,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "TPI",
            "probability": 0.08765218013261346,
            "start_logit": 3.2297921180725098,
            "end_logit": 2.982262372970581,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine phosphorylase inhibitor TPI",
            "probability": 0.05692273666567399,
            "start_logit": 4.1939897537231445,
            "end_logit": 1.5863831043243408,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "cetuximab",
            "probability": 0.04977428921013757,
            "start_logit": 2.9545340538024902,
            "end_logit": 2.6916425228118896,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine phosphorylase inhibitor",
            "probability": 0.0482863579548169,
            "start_logit": 4.1939897537231445,
            "end_logit": 1.421837329864502,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase inhibitor TPI",
            "probability": 0.014241925700658934,
            "start_logit": 2.8084850311279297,
            "end_logit": 1.5863831043243408,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase inhibitor",
            "probability": 0.012081125445302432,
            "start_logit": 2.8084850311279297,
            "end_logit": 1.421837329864502,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine phosphorylase inhibitor TPI in a 1:0.5 ratio,",
            "probability": 0.0052746824565770055,
            "start_logit": 4.1939897537231445,
            "end_logit": -0.7923932671546936,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "antivascular endothelial growth factor antibody, bevacizumab",
            "probability": 0.0028551609208157433,
            "start_logit": -0.5695996880531311,
            "end_logit": 3.3574059009552,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "TPI in a 1:0.5 ratio,",
            "probability": 0.002355947221425651,
            "start_logit": 3.2297921180725098,
            "end_logit": -0.6341712474822998,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine phosphorylase",
            "probability": 0.0019925895935953564,
            "start_logit": 4.1939897537231445,
            "end_logit": -1.7658766508102417,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "fluoropyrimidines",
            "probability": 0.001619390033936826,
            "start_logit": 1.4527002573013306,
            "end_logit": 0.7680273056030273,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase inhibitor TPI in a 1:0.5 ratio,",
            "probability": 0.0013197122984854542,
            "start_logit": 2.8084850311279297,
            "end_logit": -0.7923932671546936,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine phosphorylase inhibitor TPI in a 1:0.5 ratio",
            "probability": 0.001059405095413971,
            "start_logit": 4.1939897537231445,
            "end_logit": -2.39760422706604,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "TPI in a 1:0.5 ratio",
            "probability": 0.0008262485981112071,
            "start_logit": 3.2297921180725098,
            "end_logit": -1.6819736957550049,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "trifluorothymidine and the thymidine phosphorylase inhibitor TPI in a 1:0.5",
            "probability": 0.0006727883915295654,
            "start_logit": 4.1939897537231445,
            "end_logit": -2.8516361713409424,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "thymidine phosphorylase",
            "probability": 0.0004985409101211425,
            "start_logit": 2.8084850311279297,
            "end_logit": -1.7658766508102417,
            "question_text": "Which drugs are included in TAS-102?"
        },
        {
            "text": "the thymidine phosphorylase inhibitor TPI",
            "probability": 0.0004622248270611807,
            "start_logit": -0.6194089651107788,
            "end_logit": 1.5863831043243408,
            "question_text": "Which drugs are included in TAS-102?"
        }
    ],
    "515db20e298dcd4e51000014": [
        {
            "text": "sertraline",
            "probability": 0.9346939486677349,
            "start_logit": 5.098053455352783,
            "end_logit": 4.51581335067749,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "sertraline and attention placebo",
            "probability": 0.05135067870043828,
            "start_logit": 5.098053455352783,
            "end_logit": 1.6142723560333252,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "panic disorder",
            "probability": 0.0024195992128781224,
            "start_logit": 2.189216375350952,
            "end_logit": 1.4680331945419312,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "panic disorder, social phobia",
            "probability": 0.0019535953112342864,
            "start_logit": 2.189216375350952,
            "end_logit": 1.2541027069091797,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "post traumatic stress disorder (PTSD), panic disorder",
            "probability": 0.001856863001176722,
            "start_logit": 1.924502968788147,
            "end_logit": 1.4680331945419312,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "post traumatic stress disorder",
            "probability": 0.0016705799580001297,
            "start_logit": 1.924502968788147,
            "end_logit": 1.3623155355453491,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "post traumatic stress disorder (PTSD), panic disorder, social phobia",
            "probability": 0.0014992395572770388,
            "start_logit": 1.924502968788147,
            "end_logit": 1.2541027069091797,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "post traumatic stress",
            "probability": 0.0006464554025540996,
            "start_logit": 1.924502968788147,
            "end_logit": 0.4128936231136322,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "panic disorder, social phobia and depression",
            "probability": 0.0005329900600865471,
            "start_logit": 2.189216375350952,
            "end_logit": -0.04482122138142586,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "se",
            "probability": 0.00045263771999578726,
            "start_logit": 5.098053455352783,
            "end_logit": -3.1170690059661865,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "web-based program for treating GAD relative to sertraline",
            "probability": 0.00041552844037656114,
            "start_logit": -2.6203699111938477,
            "end_logit": 4.51581335067749,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "post traumatic stress disorder (PTSD), panic disorder, social phobia and depression",
            "probability": 0.00040903035399504346,
            "start_logit": 1.924502968788147,
            "end_logit": -0.04482122138142586,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "attention placebo",
            "probability": 0.0003593565032051273,
            "start_logit": 0.1359349638223648,
            "end_logit": 1.6142723560333252,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "panic",
            "probability": 0.000338750301862363,
            "start_logit": 2.189216375350952,
            "end_logit": -0.4980607330799103,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "social phobia",
            "probability": 0.00032295365390613265,
            "start_logit": 0.3892984986305237,
            "end_logit": 1.2541027069091797,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "post traumatic stress disorder (PTSD), panic",
            "probability": 0.0002599657409449454,
            "start_logit": 1.924502968788147,
            "end_logit": -0.4980607330799103,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "ine",
            "probability": 0.00024563528849664196,
            "start_logit": -3.14607310295105,
            "end_logit": 4.51581335067749,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "a web-based program for treating GAD relative to sertraline",
            "probability": 0.00020902921253078183,
            "start_logit": -3.3074469566345215,
            "end_logit": 4.51581335067749,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "sertraline and attention placebo.",
            "probability": 0.00018736109449433067,
            "start_logit": 5.098053455352783,
            "end_logit": -3.9991233348846436,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        },
        {
            "text": "sertraline and attention",
            "probability": 0.00017580181881177406,
            "start_logit": 5.098053455352783,
            "end_logit": -4.062803745269775,
            "question_text": "What are the current treatments for generalised anxiety disorder in teenagers?"
        }
    ],
    "54cf6d40f693c3b16b00000e": [
        {
            "text": "icatibant and ecallantide",
            "probability": 0.35449908235672817,
            "start_logit": 5.515644550323486,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ecallantide",
            "probability": 0.32111834487246776,
            "start_logit": 5.416748523712158,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant",
            "probability": 0.32057384882038364,
            "start_logit": 5.515644550323486,
            "end_logit": 5.437641143798828,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant and ecallantide,",
            "probability": 0.0014721670172495498,
            "start_logit": 5.515644550323486,
            "end_logit": 0.05426395311951637,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ecallantide,",
            "probability": 0.0013335431866627534,
            "start_logit": 5.416748523712158,
            "end_logit": 0.05426395311951637,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin. Medications recently developed, primarily icatibant and ecallantide",
            "probability": 0.00029470764586534754,
            "start_logit": -1.57683265209198,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "bradykinin. Medications recently developed, primarily icatibant",
            "probability": 0.0002665043973704266,
            "start_logit": -1.57683265209198,
            "end_logit": 5.437641143798828,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "i",
            "probability": 5.6699955600623764e-05,
            "start_logit": 5.515644550323486,
            "end_logit": -3.202453374862671,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "nt and ecallantide",
            "probability": 5.456098863264871e-05,
            "start_logit": -3.2634973526000977,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "nt",
            "probability": 4.933955260231841e-05,
            "start_logit": -3.2634973526000977,
            "end_logit": 5.437641143798828,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "ide",
            "probability": 4.7274358997559336e-05,
            "start_logit": -3.406848430633545,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "icatibant and e",
            "probability": 4.078851492444765e-05,
            "start_logit": 5.515644550323486,
            "end_logit": -3.5318262577056885,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "e",
            "probability": 3.6947741346095444e-05,
            "start_logit": 5.416748523712158,
            "end_logit": -3.5318262577056885,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "lantide",
            "probability": 2.7533101586158575e-05,
            "start_logit": -3.94742751121521,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "primarily icatibant and ecallantide",
            "probability": 2.4924146156045166e-05,
            "start_logit": -4.0469794273376465,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "primarily bradykinin. Medications recently developed, primarily icatibant and ecallantide",
            "probability": 2.3297931990209214e-05,
            "start_logit": -4.114451885223389,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "primarily icatibant",
            "probability": 2.253892847532084e-05,
            "start_logit": -4.0469794273376465,
            "end_logit": 5.437641143798828,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "primarily bradykinin. Medications recently developed, primarily icatibant",
            "probability": 2.1068341497542262e-05,
            "start_logit": -4.114451885223389,
            "end_logit": 5.437641143798828,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "kinins, primarily bradykinin. Medications recently developed, primarily icatibant and ecallantide",
            "probability": 1.933945467341554e-05,
            "start_logit": -4.300669193267822,
            "end_logit": 5.538234233856201,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        },
        {
            "text": "kinins, primarily bradykinin. Medications recently developed, primarily icatibant",
            "probability": 1.7488686790183195e-05,
            "start_logit": -4.300669193267822,
            "end_logit": 5.437641143798828,
            "question_text": "Which drugs acting via bradykinin system are effective for treatment of ACE-inhibitor-induced angioedema?"
        }
    ],
    "515bf6d6298dcd4e51000004": [
        {
            "text": "T-cell lymphoma",
            "probability": 0.6373832644783919,
            "start_logit": 3.8973114490509033,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "murine T-cell lymphoma",
            "probability": 0.18834559343098575,
            "start_logit": 2.6782188415527344,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "lymphoma",
            "probability": 0.06956908789109252,
            "start_logit": 1.6822606325149536,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "T-cell lymphomas",
            "probability": 0.06697012806821177,
            "start_logit": 3.8973114490509033,
            "end_logit": 1.5083277225494385,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "murine T-cell lymphomas",
            "probability": 0.019789550834032093,
            "start_logit": 2.6782188415527344,
            "end_logit": 1.5083277225494385,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "lymphomas",
            "probability": 0.007309653367613787,
            "start_logit": 1.6822606325149536,
            "end_logit": 1.5083277225494385,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "oma",
            "probability": 0.0018921025419643884,
            "start_logit": -1.9223710298538208,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "ymphoma",
            "probability": 0.0015296682544235453,
            "start_logit": -2.1350088119506836,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "cell lymphoma",
            "probability": 0.0013862405679319044,
            "start_logit": -2.233464241027832,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "leukemic",
            "probability": 0.0010152415417928919,
            "start_logit": 0.7837629318237305,
            "end_logit": 0.43275612592697144,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "T",
            "probability": 0.0008404126077602842,
            "start_logit": 3.8973114490509033,
            "end_logit": -2.869781255722046,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "in murine T-cell lymphoma",
            "probability": 0.0006493601462710344,
            "start_logit": -2.9918274879455566,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "T-cell lymph",
            "probability": 0.0005320600399065265,
            "start_logit": 3.8973114490509033,
            "end_logit": -3.326917886734009,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "Cot oncogene has been identified in murine T-cell lymphoma",
            "probability": 0.0005124925824454996,
            "start_logit": -3.2285287380218506,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "T-cell lymphomas as a target of MoMuLV insertion.",
            "probability": 0.0004473608209106535,
            "start_logit": 3.8973114490509033,
            "end_logit": -3.5003087520599365,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "T-cell",
            "probability": 0.00040200625317183874,
            "start_logit": 3.8973114490509033,
            "end_logit": -3.6072065830230713,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "Tpl2/Cot oncogene has been identified in murine T-cell lymphoma",
            "probability": 0.0004009827753738612,
            "start_logit": -3.4738965034484863,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "T-cell l",
            "probability": 0.0003704439793121163,
            "start_logit": 3.8973114490509033,
            "end_logit": -3.688971996307373,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "T-cell malignancies",
            "probability": 0.00033550994198389703,
            "start_logit": -0.7343060374259949,
            "end_logit": 0.8435948491096497,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        },
        {
            "text": "identified in murine T-cell lymphoma",
            "probability": 0.0003188398764235583,
            "start_logit": -3.7031259536743164,
            "end_logit": 3.7614521980285645,
            "question_text": "Which forms of cancer is the Tpl2 gene associated with?"
        }
    ],
    "530cf4fe960c95ad0c000007": [
        {
            "text": "diuretic",
            "probability": 0.5504591238511374,
            "start_logit": 4.2172980308532715,
            "end_logit": 4.020665645599365,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension, diuretics are mainly used in the combination treatment. The most frequently used diuretic",
            "probability": 0.2412870962540664,
            "start_logit": 3.3925328254699707,
            "end_logit": 4.020665645599365,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension",
            "probability": 0.080735293148356,
            "start_logit": 3.3925328254699707,
            "end_logit": 2.925853967666626,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "diuretic in combination is again hydrochlorothiazide, which is combined with reninangiotensin system blockers",
            "probability": 0.04736157675278941,
            "start_logit": 4.2172980308532715,
            "end_logit": 1.5677242279052734,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "heart failure",
            "probability": 0.017070704212415605,
            "start_logit": 2.813995361328125,
            "end_logit": 1.9505794048309326,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "cerebrovascular accident",
            "probability": 0.010668998342498185,
            "start_logit": 2.5185868740081787,
            "end_logit": 1.7759662866592407,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "heart failure. In the case of hypertension treatment, their main indication is higher age and isolated systolic hypertension",
            "probability": 0.0091198542181541,
            "start_logit": 2.3518948554992676,
            "end_logit": 1.7857699394226074,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "renal insufficiency, loop diuretics are administered. In the case of hypertension",
            "probability": 0.006598129327650428,
            "start_logit": 0.8881431818008423,
            "end_logit": 2.925853967666626,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension treatment, their main indication is higher age and isolated systolic hypertension. In the case of heart failure",
            "probability": 0.005168678557217083,
            "start_logit": 1.619248628616333,
            "end_logit": 1.9505794048309326,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension treatment, their main indication is higher age and isolated systolic hypertension",
            "probability": 0.004383325102617365,
            "start_logit": 1.619248628616333,
            "end_logit": 1.7857699394226074,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "systolic hypertension. In the case of heart failure",
            "probability": 0.004103228038780554,
            "start_logit": 1.3884055614471436,
            "end_logit": 1.9505794048309326,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "heart failure. In the case of hypertension",
            "probability": 0.0037871943669232724,
            "start_logit": 2.3518948554992676,
            "end_logit": 0.9069415926933289,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension. In the case of heart failure",
            "probability": 0.003593782516026103,
            "start_logit": 1.255836844444275,
            "end_logit": 1.9505794048309326,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "systolic hypertension",
            "probability": 0.0034797641728051506,
            "start_logit": 1.3884055614471436,
            "end_logit": 1.7857699394226074,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension and heart failure",
            "probability": 0.0027881855758282313,
            "start_logit": 1.3094969987869263,
            "end_logit": 1.6431050300598145,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "secondary prevention following a cerebrovascular accident",
            "probability": 0.002492778566799356,
            "start_logit": 1.0646426677703857,
            "end_logit": 1.7759662866592407,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "heart failure they are used for the treatment of swellings and shortness of breath",
            "probability": 0.0023349622417355356,
            "start_logit": 2.813995361328125,
            "end_logit": -0.03878866508603096,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "reninangiotensin system blockers",
            "probability": 0.0017260321065387801,
            "start_logit": 0.9053119421005249,
            "end_logit": 1.5677242279052734,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "diuretic in combination is again hydrochlorothiazide,",
            "probability": 0.001505896996753344,
            "start_logit": 4.2172980308532715,
            "end_logit": -1.880698323249817,
            "question_text": "What are the indications for hydrochlorothiazide?"
        },
        {
            "text": "hypertension and heart failure. In the case of hypertension",
            "probability": 0.0013353956509080185,
            "start_logit": 1.3094969987869263,
            "end_logit": 0.9069415926933289,
            "question_text": "What are the indications for hydrochlorothiazide?"
        }
    ],
    "52bf1cb303868f1b0600000b": [
        {
            "text": "syndactyly, symbrachyphalangism",
            "probability": 0.29581660692852624,
            "start_logit": 5.2031569480896,
            "end_logit": 5.6482086181640625,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly",
            "probability": 0.28842590792246975,
            "start_logit": 5.2031569480896,
            "end_logit": 5.6229071617126465,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symbrachyphalangism",
            "probability": 0.2719024778314267,
            "start_logit": 5.118860721588135,
            "end_logit": 5.6482086181640625,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly, symbrachyphalangism, and growth disturbances",
            "probability": 0.050655405828587234,
            "start_logit": 5.2031569480896,
            "end_logit": 3.883514881134033,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symbrachyphalangism, and growth disturbances",
            "probability": 0.046560368950743884,
            "start_logit": 5.118860721588135,
            "end_logit": 3.883514881134033,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "growth disturbances",
            "probability": 0.024265958982189174,
            "start_logit": 4.4671854972839355,
            "end_logit": 3.883514881134033,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly, symbrachyphalangism, and growth disturbance",
            "probability": 0.004855778438155667,
            "start_logit": 5.2031569480896,
            "end_logit": 1.5386383533477783,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symbrachyphalangism, and growth disturbance",
            "probability": 0.004463232145225521,
            "start_logit": 5.118860721588135,
            "end_logit": 1.5386383533477783,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly, symbrachyphalangism,",
            "probability": 0.003149237619131519,
            "start_logit": 5.2031569480896,
            "end_logit": 1.105629324913025,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symbrachyphalangism,",
            "probability": 0.0028946499008715024,
            "start_logit": 5.118860721588135,
            "end_logit": 1.105629324913025,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "growth disturbance",
            "probability": 0.0023261114678581243,
            "start_logit": 4.4671854972839355,
            "end_logit": 1.5386383533477783,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly,",
            "probability": 0.0014326996139313857,
            "start_logit": 5.2031569480896,
            "end_logit": 0.3180294334888458,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly, symbrachyphalangism, and growth",
            "probability": 0.0008259875746836205,
            "start_logit": 5.2031569480896,
            "end_logit": -0.23270662128925323,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symbrachyphalangism, and growth",
            "probability": 0.0007592138607306482,
            "start_logit": 5.118860721588135,
            "end_logit": -0.23270662128925323,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "langism",
            "probability": 0.0006247152362881918,
            "start_logit": -0.9570420980453491,
            "end_logit": 5.6482086181640625,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "growth",
            "probability": 0.00039568097973383977,
            "start_logit": 4.4671854972839355,
            "end_logit": -0.23270662128925323,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "brachyphalangism",
            "probability": 0.0002818405422807553,
            "start_logit": -1.752996563911438,
            "end_logit": 5.6482086181640625,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "syndactyly, symbrachyphalangism, and growth disturbances.",
            "probability": 0.00012739707264368172,
            "start_logit": 5.2031569480896,
            "end_logit": -2.101977586746216,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "y, symbrachyphalangism",
            "probability": 0.00011963094671481626,
            "start_logit": -2.609926462173462,
            "end_logit": 5.6482086181640625,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        },
        {
            "text": "symbrachyphalangism, and growth disturbances.",
            "probability": 0.00011709815780780951,
            "start_logit": 5.118860721588135,
            "end_logit": -2.101977586746216,
            "question_text": "What hand deformities do patients with Apert syndrome present with?"
        }
    ],
    "5539029cbc4f83e828000012": [
        {
            "text": "PCDH10",
            "probability": 0.6163338589581893,
            "start_logit": 4.348826885223389,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PCDH10 down-regulation in medulloblastoma. We examined the role of PCDH10",
            "probability": 0.36395348522273185,
            "start_logit": 4.348826885223389,
            "end_logit": 3.6152470111846924,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PCDH10 down-regulation",
            "probability": 0.004778051096905686,
            "start_logit": 4.348826885223389,
            "end_logit": -0.7177463173866272,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "CDH10",
            "probability": 0.0024548255072783212,
            "start_logit": -1.1769062280654907,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DH10",
            "probability": 0.0018558552255712368,
            "start_logit": -1.4566162824630737,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "CDH10 down-regulation in medulloblastoma. We examined the role of PCDH10",
            "probability": 0.0014496076858373848,
            "start_logit": -1.1769062280654907,
            "end_logit": 3.6152470111846924,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PCDH10 down-regulation in medulloblastoma.",
            "probability": 0.0014124711207879467,
            "start_logit": 4.348826885223389,
            "end_logit": -1.9364383220672607,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "down-regulation in medulloblastoma. We examined the role of PCDH10",
            "probability": 0.001350713650078831,
            "start_logit": -1.2475661039352417,
            "end_logit": 3.6152470111846924,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "DH10 down-regulation in medulloblastoma. We examined the role of PCDH10",
            "probability": 0.0010959076279813658,
            "start_logit": -1.4566162824630737,
            "end_logit": 3.6152470111846924,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PCDH10 as a mediator of medulloblastoma cell proliferation, cell cycle progression, and cell migration.",
            "probability": 0.0007801522309294867,
            "start_logit": 4.160104274749756,
            "end_logit": -2.341322660446167,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PCDH10 down-regulation in medulloblastoma",
            "probability": 0.0007763901246531334,
            "start_logit": 4.348826885223389,
            "end_logit": -2.534879207611084,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PCDH10 down",
            "probability": 0.0005495677239988327,
            "start_logit": 4.348826885223389,
            "end_logit": -2.8804023265838623,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "epigenetic mechanisms contributing to PCDH10",
            "probability": 0.0004970146528499438,
            "start_logit": -2.7740976810455322,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "10",
            "probability": 0.0004880866836580505,
            "start_logit": -2.792224168777466,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "genetic and epigenetic mechanisms contributing to PCDH10",
            "probability": 0.00042542607719402376,
            "start_logit": -2.929625988006592,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "The aim of this study was to investigate the genetic and epigenetic mechanisms contributing to PCDH10",
            "probability": 0.0004074935794134404,
            "start_logit": -2.9726920127868652,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "investigate the genetic and epigenetic mechanisms contributing to PCDH10",
            "probability": 0.00040037333945709035,
            "start_logit": -2.9903197288513184,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "to investigate the genetic and epigenetic mechanisms contributing to PCDH10",
            "probability": 0.00037097865346979417,
            "start_logit": -3.066572666168213,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "PCDH",
            "probability": 0.00031000631967082344,
            "start_logit": 4.348826885223389,
            "end_logit": -3.452941656112671,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        },
        {
            "text": "study was to investigate the genetic and epigenetic mechanisms contributing to PCDH10",
            "probability": 0.00030973451934345684,
            "start_logit": -3.2470016479492188,
            "end_logit": 4.142009735107422,
            "question_text": "Which genes are thought to be involved in medulloblastoma development?"
        }
    ],
    "5300aad02059c6d71c000080": [
        {
            "text": "baseball",
            "probability": 0.9627871838828869,
            "start_logit": 5.132850170135498,
            "end_logit": 5.311668872833252,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseballs",
            "probability": 0.03125280790782175,
            "start_logit": 5.132850170135498,
            "end_logit": 1.8839457035064697,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseballs and the use of chest protectors,",
            "probability": 0.0039067747937144145,
            "start_logit": 5.132850170135498,
            "end_logit": -0.19545134902000427,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseballs and the use of chest protectors",
            "probability": 0.0008328635877864253,
            "start_logit": 5.132850170135498,
            "end_logit": -1.7410489320755005,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "safety baseball",
            "probability": 0.0004977963375963272,
            "start_logit": -2.43454647064209,
            "end_logit": 5.311668872833252,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "use of safety baseball",
            "probability": 0.00019791714705318263,
            "start_logit": -3.356889009475708,
            "end_logit": 5.311668872833252,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "athletics-related deaths. Several measures, such as the use of safety baseball",
            "probability": 0.00012248439794447226,
            "start_logit": -3.8367538452148438,
            "end_logit": 5.311668872833252,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseballs and the use of chest protectors, can help protect young athletes from commotio cordis",
            "probability": 0.00011691274655369783,
            "start_logit": 5.132850170135498,
            "end_logit": -3.704490900039673,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "athletes, occurring less frequently than all of the other athletics-related deaths. Several measures, such as the use of safety baseball",
            "probability": 6.841156240568907e-05,
            "start_logit": -4.419195652008057,
            "end_logit": 5.311668872833252,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "the use of safety baseball",
            "probability": 5.9264050994562455e-05,
            "start_logit": -4.562734603881836,
            "end_logit": 5.311668872833252,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseballs and the use of chest protector",
            "probability": 4.185801224672842e-05,
            "start_logit": 5.132850170135498,
            "end_logit": -4.731635570526123,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "baseballs and the use of chest protectors, can help protect young athletes",
            "probability": 3.482736324147143e-05,
            "start_logit": 5.132850170135498,
            "end_logit": -4.915515422821045,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "death in young athletes, occurring less frequently than all of the other athletics-related deaths. Several measures, such as the use of safety baseball",
            "probability": 2.4215003029972704e-05,
            "start_logit": -5.457765102386475,
            "end_logit": 5.311668872833252,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "young athletes, occurring less frequently than all of the other athletics-related deaths. Several measures, such as the use of safety baseball",
            "probability": 2.1858361860730894e-05,
            "start_logit": -5.560153961181641,
            "end_logit": 5.311668872833252,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "safety baseballs",
            "probability": 1.615884961552169e-05,
            "start_logit": -2.43454647064209,
            "end_logit": 1.8839457035064697,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "use of safety baseballs",
            "probability": 6.424541873907646e-06,
            "start_logit": -3.356889009475708,
            "end_logit": 1.8839457035064697,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "chest protectors,",
            "probability": 4.024878522212466e-06,
            "start_logit": -1.7451225519180298,
            "end_logit": -0.19545134902000427,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "athletics-related deaths. Several measures, such as the use of safety baseballs",
            "probability": 3.9759371798299955e-06,
            "start_logit": -3.8367538452148438,
            "end_logit": 1.8839457035064697,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "athletes, occurring less frequently than all of the other athletics-related deaths. Several measures, such as the use of safety baseballs",
            "probability": 2.2206916069616408e-06,
            "start_logit": -4.419195652008057,
            "end_logit": 1.8839457035064697,
            "question_text": "Which sports have a risk for commotio cordis?"
        },
        {
            "text": "safety baseballs and the use of chest protectors,",
            "probability": 2.019946065631514e-06,
            "start_logit": -2.43454647064209,
            "end_logit": -0.19545134902000427,
            "question_text": "Which sports have a risk for commotio cordis?"
        }
    ],
    "553e1aa5a3cf796f71000003": [
        {
            "text": "G x C to A x T transition, and a G x C to T x A transversion",
            "probability": 0.31416660530587626,
            "start_logit": 4.34820556640625,
            "end_logit": 4.105196475982666,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G x C to A x T transition",
            "probability": 0.3138387007249914,
            "start_logit": 4.34820556640625,
            "end_logit": 4.104152202606201,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G x C to T x A transversion",
            "probability": 0.1437521649856594,
            "start_logit": 3.566372871398926,
            "end_logit": 4.105196475982666,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G x C to A x T",
            "probability": 0.067560799230544,
            "start_logit": 4.34820556640625,
            "end_logit": 2.56830096244812,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "T x A transversion",
            "probability": 0.028746785696864834,
            "start_logit": 1.956808090209961,
            "end_logit": 4.105196475982666,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "transversion",
            "probability": 0.02361266699930067,
            "start_logit": 1.7600654363632202,
            "end_logit": 4.105196475982666,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "a G x C to A x T transition, and a G x C to T x A transversion",
            "probability": 0.021383631229020116,
            "start_logit": 1.6609078645706177,
            "end_logit": 4.105196475982666,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "a G x C to A x T transition",
            "probability": 0.021361312527676535,
            "start_logit": 1.6609078645706177,
            "end_logit": 4.104152202606201,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "a G x C to T x A transversion",
            "probability": 0.02083620027430496,
            "start_logit": 1.6349740028381348,
            "end_logit": 4.105196475982666,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G x C",
            "probability": 0.009471778308448253,
            "start_logit": 4.34820556640625,
            "end_logit": 0.6035897135734558,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "A x T transition, and a G x C to T x A transversion",
            "probability": 0.007654776150565302,
            "start_logit": 0.6336119174957275,
            "end_logit": 4.105196475982666,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "A x T transition",
            "probability": 0.007646786643969034,
            "start_logit": 0.6336119174957275,
            "end_logit": 4.104152202606201,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "a G x C to A x T",
            "probability": 0.004598500260322853,
            "start_logit": 1.6609078645706177,
            "end_logit": 2.56830096244812,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G x C to A x T transition, and a G x C to T x A transversion to a lesser extent",
            "probability": 0.004089437265633142,
            "start_logit": 4.34820556640625,
            "end_logit": -0.23631958663463593,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G x C to A x T transition, and a G x C to T x A",
            "probability": 0.002348746271803289,
            "start_logit": 4.34820556640625,
            "end_logit": -0.7908452749252319,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G x C to A x T transition, and a G x C",
            "probability": 0.0019293554801726152,
            "start_logit": 4.34820556640625,
            "end_logit": -0.9875409603118896,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "G x C to T x A transversion to a lesser extent",
            "probability": 0.0018711901601872888,
            "start_logit": 3.566372871398926,
            "end_logit": -0.23631958663463593,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "T transition, and a G x C to T x A transversion",
            "probability": 0.0017431199926810402,
            "start_logit": -0.8460412621498108,
            "end_logit": 4.105196475982666,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "T transition",
            "probability": 0.0017413006489921223,
            "start_logit": -0.8460412621498108,
            "end_logit": 4.104152202606201,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        },
        {
            "text": "A x T",
            "probability": 0.0016461418429867271,
            "start_logit": 0.6336119174957275,
            "end_logit": 2.56830096244812,
            "question_text": "What types of DNA mutations are induced by 2-hydroxy-dATP (2-OH-dATP)?"
        }
    ],
    "56c08702ef6e394741000024": [
        {
            "text": "erythropoietic protoporphyria",
            "probability": 0.8753956323089215,
            "start_logit": 5.744250774383545,
            "end_logit": 5.6031813621521,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphyria (EPP)",
            "probability": 0.10931790639013449,
            "start_logit": 5.744250774383545,
            "end_logit": 3.522765636444092,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "protoporphyria",
            "probability": 0.005614742395084205,
            "start_logit": 0.6949705481529236,
            "end_logit": 5.6031813621521,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphyria (EPP) patients from sunlight induced phototoxic skin reactions",
            "probability": 0.004229194943453858,
            "start_logit": 5.744250774383545,
            "end_logit": 0.2705170810222626,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic",
            "probability": 0.0026128202793407568,
            "start_logit": 5.744250774383545,
            "end_logit": -0.21106436848640442,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "protoporphyria (EPP)",
            "probability": 0.0007011594082684792,
            "start_logit": 0.6949705481529236,
            "end_logit": 3.522765636444092,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protop",
            "probability": 0.0003019185108504349,
            "start_logit": 5.744250774383545,
            "end_logit": -2.3690927028656006,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "er",
            "probability": 0.00029206835863398875,
            "start_logit": 5.744250774383545,
            "end_logit": -2.402261972427368,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "phyria",
            "probability": 0.00026429677348062945,
            "start_logit": -2.36110782623291,
            "end_logit": 5.6031813621521,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic pro",
            "probability": 0.0002509523459696933,
            "start_logit": 5.744250774383545,
            "end_logit": -2.5539867877960205,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "ria",
            "probability": 0.00024571441190049425,
            "start_logit": -2.4340105056762695,
            "end_logit": 5.6031813621521,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphy",
            "probability": 0.00015968518325458546,
            "start_logit": 5.744250774383545,
            "end_logit": -3.0060455799102783,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphyria (EPP) patients",
            "probability": 0.00015198669368276458,
            "start_logit": 5.744250774383545,
            "end_logit": -3.0554568767547607,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphyria (",
            "probability": 0.0001399977433709688,
            "start_logit": 5.744250774383545,
            "end_logit": -3.1376235485076904,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "toporphyria",
            "probability": 8.094753312998972e-05,
            "start_logit": -3.544379234313965,
            "end_logit": 5.6031813621521,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "ythropoietic protoporphyria",
            "probability": 6.539031369533096e-05,
            "start_logit": -3.7578063011169434,
            "end_logit": 5.6031813621521,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "erythropoietic protoporphyria (EPP) patients from sunlight induced phototoxic",
            "probability": 5.230741058795099e-05,
            "start_logit": 5.744250774383545,
            "end_logit": -4.122111797332764,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "opoietic protoporphyria",
            "probability": 4.249319159881462e-05,
            "start_logit": -4.188836574554443,
            "end_logit": 5.6031813621521,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "eryt",
            "probability": 4.0672728910845155e-05,
            "start_logit": 5.744250774383545,
            "end_logit": -4.373692035675049,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        },
        {
            "text": "hropoietic protoporphyria",
            "probability": 4.0113075730475066e-05,
            "start_logit": -4.246478080749512,
            "end_logit": 5.6031813621521,
            "question_text": "Which diseases can be treated with Afamelanotide?"
        }
    ],
    "56c1f034ef6e394741000050": [
        {
            "text": "Parkinsonism",
            "probability": 0.39841324224263425,
            "start_logit": 1.8648844957351685,
            "end_logit": 2.253072500228882,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "depression, Parkinsonism",
            "probability": 0.1483488711938872,
            "start_logit": 0.8769614696502686,
            "end_logit": 2.253072500228882,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Parkinsonian syndrome with frontal cognitive impairment thought to resemble progressive supranuclear palsy",
            "probability": 0.08573121538758974,
            "start_logit": 1.2245866060256958,
            "end_logit": 1.3570976257324219,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Parkinsonian syndrome",
            "probability": 0.06378623599167221,
            "start_logit": 1.2245866060256958,
            "end_logit": 1.061418056488037,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Parkinsonism, and respiratory insufficiency",
            "probability": 0.05754665479895088,
            "start_logit": 1.8648844957351685,
            "end_logit": 0.3181787431240082,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "mood disorder and a Parkinsonian syndrome with frontal cognitive impairment thought to resemble progressive supranuclear palsy",
            "probability": 0.052534551901274006,
            "start_logit": 0.7348406910896301,
            "end_logit": 1.3570976257324219,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "mood disorder and a Parkinsonian syndrome",
            "probability": 0.0390870619311959,
            "start_logit": 0.7348406910896301,
            "end_logit": 1.061418056488037,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "depression",
            "probability": 0.02762542864278062,
            "start_logit": 0.8769614696502686,
            "end_logit": 0.5722424387931824,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Parkinsonian syndrome with frontal cognitive impairment",
            "probability": 0.024349546467952527,
            "start_logit": 1.2245866060256958,
            "end_logit": 0.09839385002851486,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "depression, Parkinsonism, and respiratory insufficiency",
            "probability": 0.02142745364675811,
            "start_logit": 0.8769614696502686,
            "end_logit": 0.3181787431240082,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "supranuclear palsy",
            "probability": 0.01873219729447226,
            "start_logit": -0.29638656973838806,
            "end_logit": 1.3570976257324219,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "mood disorder and a Parkinsonian syndrome with frontal cognitive impairment",
            "probability": 0.014920965565575177,
            "start_logit": 0.7348406910896301,
            "end_logit": 0.09839385002851486,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "mood disorder",
            "probability": 0.014851703246427256,
            "start_logit": 0.7348406910896301,
            "end_logit": 0.09374109655618668,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "frontal cognitive impairment thought to resemble progressive supranuclear palsy",
            "probability": 0.007793376591821235,
            "start_logit": -1.1733561754226685,
            "end_logit": 1.3570976257324219,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "progressive supranuclear palsy",
            "probability": 0.007491551275005017,
            "start_logit": -1.2128545045852661,
            "end_logit": 1.3570976257324219,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "respiratory insufficiency",
            "probability": 0.006008221565945322,
            "start_logit": -0.39458271861076355,
            "end_logit": 0.3181787431240082,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "cognitive impairment thought to resemble progressive supranuclear palsy",
            "probability": 0.00395966573821074,
            "start_logit": -1.850470781326294,
            "end_logit": 1.3570976257324219,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "Parkinsonian",
            "probability": 0.0027312421727753375,
            "start_logit": 1.2245866060256958,
            "end_logit": -2.089362859725952,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "mood",
            "probability": 0.0024473243740406204,
            "start_logit": 0.7348406910896301,
            "end_logit": -1.7093781232833862,
            "question_text": "List features of the Perry syndrome."
        },
        {
            "text": "frontal cognitive impairment",
            "probability": 0.002213489971031889,
            "start_logit": -1.1733561754226685,
            "end_logit": 0.09839385002851486,
            "question_text": "List features of the Perry syndrome."
        }
    ],
    "571f5d3e0fd6f91b6800000a": [
        {
            "text": "Huntington's disease",
            "probability": 0.3864273270667477,
            "start_logit": 5.229085922241211,
            "end_logit": 4.954713821411133,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia and Huntington's disease",
            "probability": 0.3542429685430432,
            "start_logit": 5.142125129699707,
            "end_logit": 4.954713821411133,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia",
            "probability": 0.21084407404078367,
            "start_logit": 5.142125129699707,
            "end_logit": 4.435849666595459,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Huntington's",
            "probability": 0.014983790376481121,
            "start_logit": 5.229085922241211,
            "end_logit": 1.704738974571228,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia and Huntington's",
            "probability": 0.013735835980550412,
            "start_logit": 5.142125129699707,
            "end_logit": 1.704738974571228,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Huntington's disease,",
            "probability": 0.006401474877648707,
            "start_logit": 5.229085922241211,
            "end_logit": 0.8542984127998352,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's ataxia and Huntington's disease,",
            "probability": 0.005868315475836665,
            "start_logit": 5.142125129699707,
            "end_logit": 0.8542984127998352,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia and Huntington's disease",
            "probability": 0.0025560097940554825,
            "start_logit": 0.2105894684791565,
            "end_logit": 4.954713821411133,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's",
            "probability": 0.0023104456678755933,
            "start_logit": 5.142125129699707,
            "end_logit": -0.0778287723660469,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia",
            "probability": 0.0015213273547342678,
            "start_logit": 0.2105894684791565,
            "end_logit": 4.435849666595459,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "ataxia and Huntington's disease",
            "probability": 0.0002882437664474104,
            "start_logit": -1.9718066453933716,
            "end_logit": 4.954713821411133,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "ataxia",
            "probability": 0.0001715615987653615,
            "start_logit": -1.9718066453933716,
            "end_logit": 4.435849666595459,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "Friedreich's atax",
            "probability": 0.00014499784472436487,
            "start_logit": 5.142125129699707,
            "end_logit": -2.8463056087493896,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "diseases Friedreich's ataxia and Huntington's disease",
            "probability": 0.00013968054191027866,
            "start_logit": -2.6962552070617676,
            "end_logit": 4.954713821411133,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia and Huntington's",
            "probability": 9.910974786662715e-05,
            "start_logit": 0.2105894684791565,
            "end_logit": 1.704738974571228,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "diseases Friedreich's ataxia",
            "probability": 8.313732984373714e-05,
            "start_logit": -2.6962552070617676,
            "end_logit": 4.435849666595459,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "disease",
            "probability": 6.202671139675606e-05,
            "start_logit": -3.5080480575561523,
            "end_logit": 4.954713821411133,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "neurodegenerative diseases Friedreich's ataxia and Huntington's disease,",
            "probability": 4.234232761919543e-05,
            "start_logit": 0.2105894684791565,
            "end_logit": 0.8542984127998352,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "cancer",
            "probability": 3.926848217527303e-05,
            "start_logit": 0.8393633365631104,
            "end_logit": 0.15015952289104462,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        },
        {
            "text": "treatment of the neurodegenerative diseases Friedreich's ataxia and Huntington's disease",
            "probability": 3.8062471494356676e-05,
            "start_logit": -3.996384382247925,
            "end_logit": 4.954713821411133,
            "question_text": "For which diseases members of the 2-aminobenzamide class of histone deacetylase (HDAC) inhibitors show promise as therapeutics?"
        }
    ],
    "52fc94db2059c6d71c000074": [
        {
            "text": "vasogenic edema",
            "probability": 0.3320909370169969,
            "start_logit": -1.8875190019607544,
            "end_logit": -1.5072271823883057,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "Cerebral vasogenic edema",
            "probability": 0.20302347101080712,
            "start_logit": -2.379606246948242,
            "end_logit": -1.5072271823883057,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "vasogenic edema (VE) has been reported to occur during antiamyloid immunotherapy",
            "probability": 0.08688145962965993,
            "start_logit": -1.8875190019607544,
            "end_logit": -2.8480913639068604,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "Cerebral vasogenic edema (VE) has been reported to occur during antiamyloid immunotherapy",
            "probability": 0.05311489575397864,
            "start_logit": -2.379606246948242,
            "end_logit": -2.8480913639068604,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "vasogenic edema (VE)",
            "probability": 0.04887807051029473,
            "start_logit": -1.8875190019607544,
            "end_logit": -3.423307180404663,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "antiamyloid immunotherapy",
            "probability": 0.04292980370340734,
            "start_logit": -2.5924973487854004,
            "end_logit": -2.8480913639068604,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "edema",
            "probability": 0.0412350978118163,
            "start_logit": -3.9736380577087402,
            "end_logit": -1.5072271823883057,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "vasogenic edema (VE) has been reported to occur during antiamyloid immunotherapy.",
            "probability": 0.036012462142529136,
            "start_logit": -1.8875190019607544,
            "end_logit": -3.7287709712982178,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "Cerebral vasogenic edema (VE)",
            "probability": 0.029881560817190008,
            "start_logit": -2.379606246948242,
            "end_logit": -3.423307180404663,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "Cerebral vasogenic edema (VE) has been reported to occur during antiamyloid immunotherapy.",
            "probability": 0.022016183667931136,
            "start_logit": -2.379606246948242,
            "end_logit": -3.7287709712982178,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "vasogenic edema (VE",
            "probability": 0.01843187854936556,
            "start_logit": -1.8875190019607544,
            "end_logit": -4.39855432510376,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "antiamyloid immunotherapy.",
            "probability": 0.017794451626908233,
            "start_logit": -2.5924973487854004,
            "end_logit": -3.7287709712982178,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "Cerebral vasogenic edema (VE",
            "probability": 0.011268311005278382,
            "start_logit": -2.379606246948242,
            "end_logit": -4.39855432510376,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "edema (VE) has been reported to occur during antiamyloid immunotherapy",
            "probability": 0.010787905017953067,
            "start_logit": -3.9736380577087402,
            "end_logit": -2.8480913639068604,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "immunotherapy",
            "probability": 0.010732328062518282,
            "start_logit": -3.9788031578063965,
            "end_logit": -2.8480913639068604,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "vasogenic edema (",
            "probability": 0.008180430468010964,
            "start_logit": -1.8875190019607544,
            "end_logit": -5.210891246795654,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "vasogenic edema (VE) has been reported to occur",
            "probability": 0.007561091975781979,
            "start_logit": -1.8875190019607544,
            "end_logit": -5.289620399475098,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "vasogenic edema (VE) has been reported to occur during antiamyloid",
            "probability": 0.0071795269020278225,
            "start_logit": -1.8875190019607544,
            "end_logit": -5.341402530670166,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "edema (VE)",
            "probability": 0.006069096725279502,
            "start_logit": -3.9736380577087402,
            "end_logit": -3.423307180404663,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        },
        {
            "text": "vasogenic ed",
            "probability": 0.005931037602265101,
            "start_logit": -1.8875190019607544,
            "end_logit": -5.532436847686768,
            "question_text": "List anti-amyloid-beta monoclonal antibodies that have been investigated in clinical trials for treatment of Alzheimer disease."
        }
    ],
    "516e5f25298dcd4e5100007d": [
        {
            "text": "F14512",
            "probability": 0.9327528513001536,
            "start_logit": -0.21147125959396362,
            "end_logit": -1.4143908023834229,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F",
            "probability": 0.02397388843960441,
            "start_logit": -0.21147125959396362,
            "end_logit": -5.075565814971924,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512 as a novel targeted cytotoxic drug",
            "probability": 0.01369522633748808,
            "start_logit": -0.21147125959396362,
            "end_logit": -5.635483741760254,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512 in vivo was evidenced with a MX1 human breast tumor xenograft model,",
            "probability": 0.006933832233357359,
            "start_logit": -1.1334656476974487,
            "end_logit": -5.3941240310668945,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "breast tumor xenograft model, with partial and complete tumor regressions. This work supports the clinical development of F14512",
            "probability": 0.005165961460246636,
            "start_logit": -5.407520294189453,
            "end_logit": -1.4143908023834229,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512 combines an epipodophyllotoxin",
            "probability": 0.005155667652200521,
            "start_logit": -3.011523485183716,
            "end_logit": -3.812382221221924,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "epipodophyllotoxin",
            "probability": 0.004638824443931341,
            "start_logit": -3.117159128189087,
            "end_logit": -3.812382221221924,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "spermine tail of F14512",
            "probability": 0.0013293826464989432,
            "start_logit": -4.550541400909424,
            "end_logit": -3.628746271133423,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512 combines an epipodophyllotoxin core-targeting topoisomerase II with a spermine",
            "probability": 0.001237413291887914,
            "start_logit": -3.011523485183716,
            "end_logit": -5.239455699920654,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "epipodophyllotoxin core-targeting topoisomerase II with a spermine",
            "probability": 0.0011133656032318567,
            "start_logit": -3.117159128189087,
            "end_logit": -5.239455699920654,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "spermine",
            "probability": 0.0010105482447841268,
            "start_logit": -3.2140536308288574,
            "end_logit": -5.239455699920654,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512 combines an epipodophyllotoxin core-targeting topoisomerase II with a sperm",
            "probability": 0.0006380251498038379,
            "start_logit": -3.011523485183716,
            "end_logit": -5.901856422424316,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "epipodophyllotoxin core-targeting topoisomerase II with a sperm",
            "probability": 0.0005740646722039495,
            "start_logit": -3.117159128189087,
            "end_logit": -5.901856422424316,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "sperm",
            "probability": 0.0005210508077529204,
            "start_logit": -3.2140536308288574,
            "end_logit": -5.901856422424316,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "F14512 combines an e",
            "probability": 0.0003306784230130046,
            "start_logit": -3.011523485183716,
            "end_logit": -6.559087753295898,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "e",
            "probability": 0.00029752871116482373,
            "start_logit": -3.117159128189087,
            "end_logit": -6.559087753295898,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "polyamine-containing drug to cancer cells. F14512 combines an epipodophyllotoxin",
            "probability": 0.00020135740635341716,
            "start_logit": -6.254293918609619,
            "end_logit": -3.812382221221924,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "an epipodophyllotoxin",
            "probability": 0.00015547405221772362,
            "start_logit": -6.512896537780762,
            "end_logit": -3.812382221221924,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "toxin",
            "probability": 0.00014208206150157892,
            "start_logit": -6.602970600128174,
            "end_logit": -3.812382221221924,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        },
        {
            "text": "breast tumor xenograft model, with partial and complete tumor regressions. This work supports the clinical development of F",
            "probability": 0.0001327770626041166,
            "start_logit": -5.407520294189453,
            "end_logit": -5.075565814971924,
            "question_text": "Which anticancer drugs target human topoisomerase II?"
        }
    ],
    "52fc8b772059c6d71c00006e": [
        {
            "text": "quinoline-3-carbonitriles",
            "probability": 0.41643986361302315,
            "start_logit": 2.7366390228271484,
            "end_logit": 1.3131389617919922,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphthyridine-3-carbonitriles and quinoline-3-carbonitriles",
            "probability": 0.2661311183666501,
            "start_logit": 2.288886070251465,
            "end_logit": 1.3131389617919922,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphthyridine-3-carbonitriles",
            "probability": 0.16310599357841946,
            "start_logit": 2.288886070251465,
            "end_logit": 0.8235501050949097,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "[1,7]naphthyridine-3-carbonitriles and quinoline-3-carbonitriles",
            "probability": 0.03647962535346424,
            "start_logit": 0.30165085196495056,
            "end_logit": 1.3131389617919922,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphthyridine",
            "probability": 0.02888629925443523,
            "start_logit": 2.288886070251465,
            "end_logit": -0.9074827432632446,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "[1,7]naphthyridine-3-carbonitriles",
            "probability": 0.02235757161794165,
            "start_logit": 0.30165085196495056,
            "end_logit": 0.8235501050949097,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "quinoline",
            "probability": 0.011664867687440367,
            "start_logit": 2.7366390228271484,
            "end_logit": -2.262021541595459,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "quinoline-3-carbonitriles as Tumor Progression Loci-2 (Tpl2) kinase inhibitors",
            "probability": 0.00950353555842978,
            "start_logit": 2.7366390228271484,
            "end_logit": -2.4669392108917236,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,7]naphthyridine-3-carbonitriles and quinoline-3-carbonitriles",
            "probability": 0.00892559055946661,
            "start_logit": -1.1061805486679077,
            "end_logit": 1.3131389617919922,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphthyridine-3-carbonitriles and quinoline",
            "probability": 0.00745458001144255,
            "start_logit": 2.288886070251465,
            "end_logit": -2.262021541595459,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "1,7]naphthyridine-3-carbonitriles",
            "probability": 0.005470300975740372,
            "start_logit": -1.1061805486679077,
            "end_logit": 0.8235501050949097,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "q",
            "probability": 0.004895468461435077,
            "start_logit": 2.7366390228271484,
            "end_logit": -3.130293130874634,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "[1,7]naphthyridine",
            "probability": 0.003959557157829542,
            "start_logit": 0.30165085196495056,
            "end_logit": -0.9074827432632446,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphthyridine-3-carbonitriles and q",
            "probability": 0.0031285105255462334,
            "start_logit": 2.288886070251465,
            "end_logit": -3.130293130874634,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "nap",
            "probability": 0.0025095154628818734,
            "start_logit": 2.288886070251465,
            "end_logit": -3.3507604598999023,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "3-carbonitriles and quinoline-3-carbonitriles",
            "probability": 0.002289624218615804,
            "start_logit": -2.4667153358459473,
            "end_logit": 1.3131389617919922,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "3-carbonitriles",
            "probability": 0.0022270858985545695,
            "start_logit": -2.4944090843200684,
            "end_logit": 1.3131389617919922,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "quinoline-3",
            "probability": 0.0019506102822680533,
            "start_logit": 2.7366390228271484,
            "end_logit": -4.0504608154296875,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "naphthyridine-3",
            "probability": 0.001358316104289104,
            "start_logit": 2.288886070251465,
            "end_logit": -3.964604377746582,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        },
        {
            "text": "quinoline-3-carbonitriles as Tumor Progression Loci-2 (Tpl2) kinase",
            "probability": 0.0012619653121259532,
            "start_logit": 2.7366390228271484,
            "end_logit": -4.48593282699585,
            "question_text": "Which are the known inhibitors of the TPL2/MAP3K8 protein?"
        }
    ],
    "5324d0429b2d7acc7e000023": [
        {
            "text": "pruritus",
            "probability": 0.2429583258838019,
            "start_logit": 4.995940685272217,
            "end_logit": 5.501697063446045,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "pruritus and scaling of the scalp. The most common causes of these symptoms include irritant contact dermatitis",
            "probability": 0.10407344251543714,
            "start_logit": 4.995940685272217,
            "end_logit": 4.653903961181641,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "pruritus and scaling",
            "probability": 0.0926745847473665,
            "start_logit": 4.995940685272217,
            "end_logit": 4.537901401519775,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "scaling of the scalp. The most common causes of these symptoms include irritant contact dermatitis",
            "probability": 0.07239256404756107,
            "start_logit": 4.6329474449157715,
            "end_logit": 4.653903961181641,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "scaling",
            "probability": 0.06446361963004849,
            "start_logit": 4.6329474449157715,
            "end_logit": 4.537901401519775,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "scaling of the scalp. The most common causes of these symptoms include irritant contact dermatitis, allergic contact dermatitis",
            "probability": 0.055002735414172346,
            "start_logit": 4.6329474449157715,
            "end_logit": 4.379183292388916,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "pruritus and scaling of the scalp",
            "probability": 0.05137533791912906,
            "start_logit": 4.995940685272217,
            "end_logit": 3.947965383529663,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alopecia. However, some patients present with complaints of pruritus",
            "probability": 0.04409969292654064,
            "start_logit": 3.289503574371338,
            "end_logit": 5.501697063446045,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "alopecia. However, some patients present with complaints of pruritus",
            "probability": 0.038014734496503416,
            "start_logit": 3.141024589538574,
            "end_logit": 5.501697063446045,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "irritant contact dermatitis",
            "probability": 0.03661397729562375,
            "start_logit": 3.9512739181518555,
            "end_logit": 4.653903961181641,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "scaling of the scalp",
            "probability": 0.03573622963633569,
            "start_logit": 4.6329474449157715,
            "end_logit": 3.947965383529663,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "irritant contact dermatitis, allergic contact dermatitis",
            "probability": 0.027818726027283934,
            "start_logit": 3.9512739181518555,
            "end_logit": 4.379183292388916,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "allergic contact dermatitis",
            "probability": 0.025971580424106987,
            "start_logit": 3.8825674057006836,
            "end_logit": 4.379183292388916,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "irritant contact dermatitis, allergic contact dermatitis, or an exacerbation of seborrheic dermatitis",
            "probability": 0.020871308707828443,
            "start_logit": 3.9512739181518555,
            "end_logit": 4.091849327087402,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "seborrheic dermatitis",
            "probability": 0.019508765320736556,
            "start_logit": 3.8837623596191406,
            "end_logit": 4.091849327087402,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "allergic contact dermatitis, or an exacerbation of seborrheic dermatitis",
            "probability": 0.01948546716805402,
            "start_logit": 3.8825674057006836,
            "end_logit": 4.091849327087402,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alopecia. However, some patients present with complaints of pruritus and scaling",
            "probability": 0.016821488683652505,
            "start_logit": 3.289503574371338,
            "end_logit": 4.537901401519775,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "alopecia. However, some patients present with complaints of pruritus and scaling",
            "probability": 0.014500428091646323,
            "start_logit": 3.141024589538574,
            "end_logit": 4.537901401519775,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alopecia. However, some patients present with complaints of pruritus and scaling of the scalp",
            "probability": 0.00932520677358644,
            "start_logit": 3.289503574371338,
            "end_logit": 3.947965383529663,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        },
        {
            "text": "androgenetic alopecia",
            "probability": 0.008291784290584917,
            "start_logit": 3.289503574371338,
            "end_logit": 3.8305094242095947,
            "question_text": "What are the reported adverse effects of topical minoxidil?"
        }
    ],
    "553fca6054168f6c79000002": [
        {
            "text": "MutY, MutM",
            "probability": 0.18327826817057935,
            "start_logit": 5.587465763092041,
            "end_logit": 5.186013698577881,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutM",
            "probability": 0.17355482870993114,
            "start_logit": 5.53295373916626,
            "end_logit": 5.186013698577881,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY, MutM, and MutT",
            "probability": 0.17227188902735638,
            "start_logit": 5.587465763092041,
            "end_logit": 5.124082088470459,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutM, and MutT",
            "probability": 0.16313236964816846,
            "start_logit": 5.53295373916626,
            "end_logit": 5.124082088470459,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY",
            "probability": 0.1520008488031177,
            "start_logit": 5.587465763092041,
            "end_logit": 4.998894214630127,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutT",
            "probability": 0.13637845589669806,
            "start_logit": 5.353825569152832,
            "end_logit": 5.124082088470459,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "GO repair enzymes MutY, MutM",
            "probability": 0.004245106663560068,
            "start_logit": 1.822227120399475,
            "end_logit": 5.186013698577881,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "GO repair enzymes MutY, MutM, and MutT",
            "probability": 0.003990175984058675,
            "start_logit": 1.822227120399475,
            "end_logit": 5.124082088470459,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "GO repair enzymes MutY",
            "probability": 0.003520656445314892,
            "start_logit": 1.822227120399475,
            "end_logit": 4.998894214630127,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "RulAB in stationary-phase mutagenesis in P. putida. Our results demonstrated that the GO repair enzymes MutY",
            "probability": 0.0018264520042071792,
            "start_logit": 1.1659549474716187,
            "end_logit": 4.998894214630127,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY, MutM,",
            "probability": 0.0013295108598075935,
            "start_logit": 5.587465763092041,
            "end_logit": 0.2598192095756531,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutM,",
            "probability": 0.0012589764833828784,
            "start_logit": 5.53295373916626,
            "end_logit": 0.2598192095756531,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "Mut",
            "probability": 0.0012129307905240968,
            "start_logit": 5.587465763092041,
            "end_logit": 0.1680476814508438,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY, Mut",
            "probability": 0.0006374164972417354,
            "start_logit": 5.587465763092041,
            "end_logit": -0.475323885679245,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "Dps",
            "probability": 0.00029464479774424137,
            "start_logit": 2.295379877090454,
            "end_logit": 2.045109272003174,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutY, MutM, and MutT are involved in the prevention of base substitution mutations",
            "probability": 0.00026274461983531874,
            "start_logit": 5.587465763092041,
            "end_logit": -1.3615646362304688,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutM, and MutT are involved in the prevention of base substitution mutations",
            "probability": 0.0002488052617756824,
            "start_logit": 5.53295373916626,
            "end_logit": -1.3615646362304688,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "MutT are involved in the prevention of base substitution mutations",
            "probability": 0.00020800088598677617,
            "start_logit": 5.353825569152832,
            "end_logit": -1.3615646362304688,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "the GO repair enzymes MutY, MutM",
            "probability": 0.00017934429171190873,
            "start_logit": -1.3419877290725708,
            "end_logit": 5.186013698577881,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        },
        {
            "text": "the GO repair enzymes MutY, MutM, and MutT",
            "probability": 0.00016857415899810063,
            "start_logit": -1.3419877290725708,
            "end_logit": 5.124082088470459,
            "question_text": "Which proteins compose the error prevention GO (8-oxo-G) system in Pseudomonas putida?"
        }
    ],
    "52ee065d98d0239505000033": [
        {
            "text": "Breast lesion segmentation",
            "probability": 0.16441214923597916,
            "start_logit": -1.9451767206192017,
            "end_logit": -1.0880839824676514,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "segmentation",
            "probability": 0.146419877449485,
            "start_logit": -2.061074733734131,
            "end_logit": -1.0880839824676514,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Bayesian, Support Vector Machine",
            "probability": 0.11573195332652833,
            "start_logit": -1.5826257467269897,
            "end_logit": -1.8017345666885376,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Bayesian",
            "probability": 0.09507753004778143,
            "start_logit": -1.5826257467269897,
            "end_logit": -1.9983186721801758,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Support Vector Machine",
            "probability": 0.08300545840884979,
            "start_logit": -1.9149961471557617,
            "end_logit": -1.8017345666885376,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Breast lesion segmentation in magnetic resonance (MR) images is one of the most important parts of clinical diagnostic tools. Pixel classification",
            "probability": 0.042316181696304335,
            "start_logit": -1.9451767206192017,
            "end_logit": -2.4452908039093018,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "self-training",
            "probability": 0.04018178457740318,
            "start_logit": -2.6271934509277344,
            "end_logit": -1.8150298595428467,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Pixel classification",
            "probability": 0.03987697782056425,
            "start_logit": -2.004547119140625,
            "end_logit": -2.4452908039093018,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "segmentation in magnetic resonance (MR) images is one of the most important parts of clinical diagnostic tools. Pixel classification",
            "probability": 0.03768535456105535,
            "start_logit": -2.061074733734131,
            "end_logit": -2.4452908039093018,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "improved self-training",
            "probability": 0.03682856215540514,
            "start_logit": -2.7143335342407227,
            "end_logit": -1.8150298595428467,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "magnetic resonance (MR) images is one of the most important parts of clinical diagnostic tools. Pixel classification",
            "probability": 0.03556383160828591,
            "start_logit": -2.1190171241760254,
            "end_logit": -2.4452908039093018,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "classifier in this approach has an important role in its performance; in this paper, we present a semi-supervised algorithm improved self-training",
            "probability": 0.030816582586299213,
            "start_logit": -2.89255428314209,
            "end_logit": -1.8150298595428467,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "semi-supervised algorithm improved self-training",
            "probability": 0.026498552561132475,
            "start_logit": -3.0435171127319336,
            "end_logit": -1.8150298595428467,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Bayesian, Support Vector Machine, and Fuzzy c-Means",
            "probability": 0.022277873898282237,
            "start_logit": -1.5826257467269897,
            "end_logit": -3.4494173526763916,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "classification",
            "probability": 0.01607947450698994,
            "start_logit": -2.9128026962280273,
            "end_logit": -2.4452908039093018,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Support Vector Machine, and Fuzzy c-Means",
            "probability": 0.01597817268394443,
            "start_logit": -1.9149961471557617,
            "end_logit": -3.4494173526763916,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "self-training (IMPST)",
            "probability": 0.013176242960933638,
            "start_logit": -2.6271934509277344,
            "end_logit": -2.930028200149536,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Breast lesion segmentation in magnetic resonance (MR) images is one of the most important parts of clinical diagnostic tools. Pixel classification methods",
            "probability": 0.01309768552047733,
            "start_logit": -1.9451767206192017,
            "end_logit": -3.6180248260498047,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "Breast lesion segmentation in magnetic resonance",
            "probability": 0.01254095246361307,
            "start_logit": -1.9451767206192017,
            "end_logit": -3.6614608764648438,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        },
        {
            "text": "K nearest neighbors, Bayesian, Support Vector Machine",
            "probability": 0.012434801930685784,
            "start_logit": -3.813403367996216,
            "end_logit": -1.8017345666885376,
            "question_text": "List five applications of machine learning algorithms in medical diagnosis."
        }
    ],
    "56d094f33975bb303a000012": [
        {
            "text": "cell division",
            "probability": 0.17567466405768986,
            "start_logit": -0.25279852747917175,
            "end_logit": 1.376067042350769,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division",
            "probability": 0.17204292264043142,
            "start_logit": -0.27368831634521484,
            "end_logit": 1.376067042350769,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "kinetic force of ring contraction",
            "probability": 0.10648719196943035,
            "start_logit": -1.3301252126693726,
            "end_logit": 1.9527846574783325,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "contraction",
            "probability": 0.10134302170463998,
            "start_logit": -1.379638910293579,
            "end_logit": 1.9527846574783325,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "assembly and at least the initial kinetic force of ring contraction",
            "probability": 0.08861098607651884,
            "start_logit": -1.5138940811157227,
            "end_logit": 1.9527846574783325,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "ring contraction",
            "probability": 0.08363603831969943,
            "start_logit": -1.571675419807434,
            "end_logit": 1.9527846574783325,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "contracting the cell membrane at the site of cell division",
            "probability": 0.05016330559296402,
            "start_logit": -0.9433267116546631,
            "end_logit": 0.8132452368736267,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "force of ring contraction",
            "probability": 0.04801985214406876,
            "start_logit": -2.126535415649414,
            "end_logit": 1.9527846574783325,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division plane and rearrange to achieve the goal of contracting the cell membrane at the site of cell division",
            "probability": 0.03231190087607275,
            "start_logit": -1.3831748962402344,
            "end_logit": 0.8132452368736267,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "dividing the parent cell into two daughter cells",
            "probability": 0.02644179911465917,
            "start_logit": 0.005477277562022209,
            "end_logit": -0.7758964896202087,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "Bacterial cell division",
            "probability": 0.017362508379652856,
            "start_logit": -2.5671191215515137,
            "end_logit": 1.376067042350769,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "function of FtsZ is thought to underpin the assembly and at least the initial kinetic force of ring contraction",
            "probability": 0.0171685036682375,
            "start_logit": -3.155073404312134,
            "end_logit": 1.9527846574783325,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "biochemical function of FtsZ is thought to underpin the assembly and at least the initial kinetic force of ring contraction",
            "probability": 0.016203876129983034,
            "start_logit": -3.2128994464874268,
            "end_logit": 1.9527846574783325,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "rearrange to achieve the goal of contracting the cell membrane at the site of cell division",
            "probability": 0.013856718817191502,
            "start_logit": -2.2298402786254883,
            "end_logit": 0.8132452368736267,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "initial kinetic force of ring contraction",
            "probability": 0.010684743769945798,
            "start_logit": -3.629333019256592,
            "end_logit": 1.9527846574783325,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "division, thus dividing the parent cell into two daughter cells",
            "probability": 0.010654646822092773,
            "start_logit": -0.9034726619720459,
            "end_logit": -0.7758964896202087,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "contracting the cell membrane at the site of cell division, thus dividing the parent cell into two daughter cells",
            "probability": 0.01023836632833875,
            "start_logit": -0.9433267116546631,
            "end_logit": -0.7758964896202087,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell division, thus dividing the parent cell into two daughter cells",
            "probability": 0.009296708267430462,
            "start_logit": -1.0398083925247192,
            "end_logit": -0.7758964896202087,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "cell membrane at the site of cell division",
            "probability": 0.006974079160804602,
            "start_logit": -2.916410207748413,
            "end_logit": 0.8132452368736267,
            "question_text": "List functional roles of the FtsZ protein."
        },
        {
            "text": "rearrange to achieve the goal of contracting the cell membrane at the site of cell division, thus dividing the parent cell into two daughter cells",
            "probability": 0.002828166160148152,
            "start_logit": -2.2298402786254883,
            "end_logit": -0.7758964896202087,
            "question_text": "List functional roles of the FtsZ protein."
        }
    ],
    "550e866271445a662f000005": [
        {
            "text": "melanoma",
            "probability": 0.9965883631645125,
            "start_logit": 5.542696475982666,
            "end_logit": 4.96195650100708,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melan",
            "probability": 0.0009750243558615629,
            "start_logit": 5.542696475982666,
            "end_logit": -1.9676741361618042,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "lanoma",
            "probability": 0.0004142134095174085,
            "start_logit": -2.2430152893066406,
            "end_logit": 4.96195650100708,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "me",
            "probability": 0.0003194565214834537,
            "start_logit": 5.542696475982666,
            "end_logit": -3.0835154056549072,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "oma",
            "probability": 0.0003169921053400805,
            "start_logit": -2.5105197429656982,
            "end_logit": 4.96195650100708,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. Intetumumab (CNTO 95)",
            "probability": 0.0003088421653853503,
            "start_logit": 5.542696475982666,
            "end_logit": -3.1173062324523926,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis.",
            "probability": 0.0002685469484152906,
            "start_logit": 5.542696475982666,
            "end_logit": -3.257110834121704,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. Intetumumab",
            "probability": 0.0002032460737611903,
            "start_logit": 5.542696475982666,
            "end_logit": -3.535719156265259,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis",
            "probability": 0.0001356651472853872,
            "start_logit": 5.542696475982666,
            "end_logit": -3.9399468898773193,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. Intetumumab (CNTO 95) is",
            "probability": 0.00011437289434307321,
            "start_logit": 5.542696475982666,
            "end_logit": -4.110672473907471,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. Intetumumab (CNTO 95",
            "probability": 8.295893767018523e-05,
            "start_logit": 5.542696475982666,
            "end_logit": -4.431790828704834,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. Intetumumab (CNTO 95) is a",
            "probability": 8.234907140225689e-05,
            "start_logit": 5.542696475982666,
            "end_logit": -4.439169406890869,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. In",
            "probability": 4.7097498478999356e-05,
            "start_logit": 5.542696475982666,
            "end_logit": -4.9979166984558105,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "angiogenesis and melanoma",
            "probability": 4.658416797386221e-05,
            "start_logit": -4.428135871887207,
            "end_logit": 4.96195650100708,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. Intetumumab (",
            "probability": 4.38210790245928e-05,
            "start_logit": 5.542696475982666,
            "end_logit": -5.070021629333496,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. Intetumumab (CNTO 95) is a fully human",
            "probability": 2.8413097701452753e-05,
            "start_logit": 5.542696475982666,
            "end_logit": -5.503286361694336,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "melanoma tumourigenesis. Intetumumab (CNTO 95) is a fully human anti",
            "probability": 2.280065811361929e-05,
            "start_logit": 5.542696475982666,
            "end_logit": -5.723347187042236,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "Intetumumab (CNTO 95)",
            "probability": 5.111017968238378e-07,
            "start_logit": -0.8613203763961792,
            "end_logit": -3.1173062324523926,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "lan",
            "probability": 4.0525073112585026e-07,
            "start_logit": -2.2430152893066406,
            "end_logit": -1.9676741361618042,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        },
        {
            "text": "Intetumumab",
            "probability": 3.3635120180925293e-07,
            "start_logit": -0.8613203763961792,
            "end_logit": -3.535719156265259,
            "question_text": "Intetumumab has been tested in clinical trials for treatment of which cancers?"
        }
    ],
    "56acc7ca0a360a5e45000002": [
        {
            "text": "Insyght",
            "probability": 0.9741096283689958,
            "start_logit": 3.5476248264312744,
            "end_logit": 3.329716444015503,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Insyght is a comparative genomic visualization tool that combines three complementary displays: (i) a table",
            "probability": 0.0080106301163121,
            "start_logit": 3.5476248264312744,
            "end_logit": -1.4710379838943481,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Insyght is",
            "probability": 0.0047020818008790865,
            "start_logit": 3.5476248264312744,
            "end_logit": -2.0038020610809326,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Insyght is a comparative genomic visualization tool",
            "probability": 0.004292706968180298,
            "start_logit": 3.5476248264312744,
            "end_logit": -2.0948898792266846,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Insyght is a comparative genomic visualization",
            "probability": 0.0029553975868222555,
            "start_logit": 3.5476248264312744,
            "end_logit": -2.4681742191314697,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Ins",
            "probability": 0.0022242751563345832,
            "start_logit": 3.5476248264312744,
            "end_logit": -2.7523763179779053,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Insyght is a comparative genomic",
            "probability": 0.0016284881480774208,
            "start_logit": 3.5476248264312744,
            "end_logit": -3.064155340194702,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "Insyght is a comparative",
            "probability": 0.0012167973812755796,
            "start_logit": 3.5476248264312744,
            "end_logit": -3.3555850982666016,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "a table for thoroughly browsing amongst homologues",
            "probability": 0.0001436070999228632,
            "start_logit": -1.105033278465271,
            "end_logit": -0.8398234844207764,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "table for thoroughly browsing amongst homologues",
            "probability": 0.00011576757967567918,
            "start_logit": -1.320529818534851,
            "end_logit": -0.8398234844207764,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "a table for thoroughly browsing amongst homologues, (ii) a comparator of orthologue functional annotations",
            "probability": 8.056693268312859e-05,
            "start_logit": -1.105033278465271,
            "end_logit": -1.4178162813186646,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "(i) a table for thoroughly browsing amongst homologues",
            "probability": 8.051969324978813e-05,
            "start_logit": -1.683612585067749,
            "end_logit": -0.8398234844207764,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "a table",
            "probability": 7.639113063573625e-05,
            "start_logit": -1.105033278465271,
            "end_logit": -1.4710379838943481,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "table for thoroughly browsing amongst homologues, (ii) a comparator of orthologue functional annotations",
            "probability": 6.494831246943275e-05,
            "start_logit": -1.320529818534851,
            "end_logit": -1.4178162813186646,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "table",
            "probability": 6.158202698291417e-05,
            "start_logit": -1.320529818534851,
            "end_logit": -1.4710379838943481,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "browsing amongst homologues",
            "probability": 5.38404350196428e-05,
            "start_logit": -2.086089611053467,
            "end_logit": -0.8398234844207764,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "orthologue functional annotations",
            "probability": 4.7842196820614196e-05,
            "start_logit": -1.626213550567627,
            "end_logit": -1.4178162813186646,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "homologues",
            "probability": 4.7035839653792654e-05,
            "start_logit": -2.2212045192718506,
            "end_logit": -0.8398234844207764,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "comparator of orthologue functional annotations",
            "probability": 4.427470526296816e-05,
            "start_logit": -1.7037080526351929,
            "end_logit": -1.4178162813186646,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        },
        {
            "text": "a comparator of orthologue functional annotations",
            "probability": 4.361852074605986e-05,
            "start_logit": -1.7186397314071655,
            "end_logit": -1.4178162813186646,
            "question_text": "List available tools for genomic visualisation in comparative genomics"
        }
    ],
    "515ffc2b298dcd4e51000035": [
        {
            "text": "Aspergillus terreus",
            "probability": 0.8932738424754945,
            "start_logit": 4.993622779846191,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "fungus Aspergillus terreus",
            "probability": 0.08287943258563409,
            "start_logit": 2.616116523742676,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus",
            "probability": 0.014179539981895773,
            "start_logit": 4.993622779846191,
            "end_logit": 1.26863431930542,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "fungus",
            "probability": 0.003641036661576772,
            "start_logit": 2.616116523742676,
            "end_logit": 2.286608934402466,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "fungus Aspergillus",
            "probability": 0.0013156012995612521,
            "start_logit": 2.616116523742676,
            "end_logit": 1.26863431930542,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "pergillus terreus",
            "probability": 0.0011070371759033094,
            "start_logit": -1.6995831727981567,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "gillus terreus",
            "probability": 0.000990575700240744,
            "start_logit": -1.8107393980026245,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "us",
            "probability": 0.0005530217483405558,
            "start_logit": -2.3936283588409424,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "As",
            "probability": 0.0004412022355602861,
            "start_logit": 4.993622779846191,
            "end_logit": -2.2014176845550537,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "the fungus Aspergillus terreus",
            "probability": 0.00042817255112073845,
            "start_logit": -2.6494994163513184,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "terreus",
            "probability": 0.00042475824648313736,
            "start_logit": -2.657505512237549,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergill",
            "probability": 0.00022950987428881244,
            "start_logit": 4.993622779846191,
            "end_logit": -2.8549749851226807,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "us terreus",
            "probability": 0.0001512486988890815,
            "start_logit": -3.6901001930236816,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Asper",
            "probability": 0.00013502905637234911,
            "start_logit": 4.993622779846191,
            "end_logit": -3.3854310512542725,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "Aspergillus terre",
            "probability": 9.100581919929629e-05,
            "start_logit": 4.993622779846191,
            "end_logit": -3.7799975872039795,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "rreus",
            "probability": 6.0372994628615774e-05,
            "start_logit": -4.608483791351318,
            "end_logit": 5.411727428436279,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "fungus As",
            "probability": 4.093547711798459e-05,
            "start_logit": 2.616116523742676,
            "end_logit": -2.2014176845550537,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "fungus Aspergill",
            "probability": 2.12943078027932e-05,
            "start_logit": 2.616116523742676,
            "end_logit": -2.8549749851226807,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "the fungus",
            "probability": 1.8810359910471822e-05,
            "start_logit": -2.6494994163513184,
            "end_logit": 2.286608934402466,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        },
        {
            "text": "pergillus",
            "probability": 1.7572749979630788e-05,
            "start_logit": -1.6995831727981567,
            "end_logit": 1.26863431930542,
            "question_text": "Which species may be used for the biotechnological production of itaconic acid?"
        }
    ],
    "5321badd9b2d7acc7e00000a": [
        {
            "text": "prostate cancer",
            "probability": 0.7148890087333947,
            "start_logit": 5.118853569030762,
            "end_logit": 4.510518550872803,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor cell lines derived from this strain, can be used as a future prostate cancer",
            "probability": 0.18147570045979924,
            "start_logit": 3.7478480339050293,
            "end_logit": 4.510518550872803,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor",
            "probability": 0.044883155155562765,
            "start_logit": 3.7478480339050293,
            "end_logit": 3.113459348678589,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate",
            "probability": 0.02787488436961758,
            "start_logit": 5.118853569030762,
            "end_logit": 1.2661173343658447,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate adenocarcinoma",
            "probability": 0.010710855264084194,
            "start_logit": 3.225909471511841,
            "end_logit": 2.2025930881500244,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor cell lines derived from this strain, can be used as a future prostate",
            "probability": 0.00707608328623609,
            "start_logit": 3.7478480339050293,
            "end_logit": 1.2661173343658447,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "cancer",
            "probability": 0.0027487440198660567,
            "start_logit": -0.44212964177131653,
            "end_logit": 4.510518550872803,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate cancer immunotherapy",
            "probability": 0.002437531100991377,
            "start_logit": 5.118853569030762,
            "end_logit": -1.1706230640411377,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "tumor cell lines derived from this strain, can be used as a future prostate cancer",
            "probability": 0.0018282915421455302,
            "start_logit": -0.8498917818069458,
            "end_logit": 4.510518550872803,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "adenocarcinoma",
            "probability": 0.0014781631373539414,
            "start_logit": 1.2454519271850586,
            "end_logit": 2.2025930881500244,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate adenocarcinomas",
            "probability": 0.0008768178263808549,
            "start_logit": 3.225909471511841,
            "end_logit": -0.30012068152427673,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "pro",
            "probability": 0.0007868495302808899,
            "start_logit": 5.118853569030762,
            "end_logit": -2.3013269901275635,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor cell lines derived from this strain, can be used as a future prostate cancer immunotherapy",
            "probability": 0.0006187711078796617,
            "start_logit": 3.7478480339050293,
            "end_logit": -1.1706230640411377,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor cell lines derived from this strain,",
            "probability": 0.00047339559899220094,
            "start_logit": 3.7478480339050293,
            "end_logit": -1.4384270906448364,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "tumor",
            "probability": 0.0004521789570053148,
            "start_logit": -0.8498917818069458,
            "end_logit": 3.113459348678589,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor cell lines",
            "probability": 0.00038463237606212045,
            "start_logit": 3.7478480339050293,
            "end_logit": -1.6460704803466797,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "Lew-TRAP strain, and prostate tumor cell lines derived from this strain, can be used as a future prostate cancer",
            "probability": 0.00030147106830686135,
            "start_logit": -2.6523549556732178,
            "end_logit": 4.510518550872803,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor antigen (prostatic acid phosphatase",
            "probability": 0.0002782977359552236,
            "start_logit": 3.1082537174224854,
            "end_logit": -1.3300726413726807,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor cell",
            "probability": 0.00022542573792880415,
            "start_logit": 3.7478480339050293,
            "end_logit": -2.1803677082061768,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        },
        {
            "text": "prostate tumor cell lines derived from this strain, can be used as a future pro",
            "probability": 0.0001997429921564804,
            "start_logit": 3.7478480339050293,
            "end_logit": -2.3013269901275635,
            "question_text": "Which types of cancer can be recognized and treated by the use of immunotherapy?"
        }
    ],
    "5540eda30083d1bf0e000006": [
        {
            "text": "MutL",
            "probability": 0.4080339674349278,
            "start_logit": 2.9986720085144043,
            "end_logit": 1.9337162971496582,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutS and MutL",
            "probability": 0.3109272513495603,
            "start_logit": 2.7268805503845215,
            "end_logit": 1.9337162971496582,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutS",
            "probability": 0.20720594561500458,
            "start_logit": 2.7268805503845215,
            "end_logit": 1.527870535850525,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD2",
            "probability": 0.027165888282105633,
            "start_logit": 1.851521611213684,
            "end_logit": 0.3714783489704132,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD2 and our recently described YycJ",
            "probability": 0.017173441618550573,
            "start_logit": 1.851521611213684,
            "end_logit": -0.08711963146924973,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "YycJ",
            "probability": 0.014169686171512947,
            "start_logit": 1.6592624187469482,
            "end_logit": -0.08711963146924973,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD2 helicase being associated with MMR. RecD2",
            "probability": 0.006891310194950416,
            "start_logit": 0.47982075810432434,
            "end_logit": 0.3714783489704132,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD2 helicase being associated with MMR. RecD2 and our recently described YycJ",
            "probability": 0.004356475005687913,
            "start_logit": 0.47982075810432434,
            "end_logit": -0.08711963146924973,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD2 and our recently described YycJ protein",
            "probability": 0.000740015160019126,
            "start_logit": 1.851521611213684,
            "end_logit": -3.2315683364868164,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD",
            "probability": 0.0006763407278731155,
            "start_logit": 1.851521611213684,
            "end_logit": -3.3215420246124268,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "YycJ protein",
            "probability": 0.0006105813157629579,
            "start_logit": 1.6592624187469482,
            "end_logit": -3.2315683364868164,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutH-independent MMR in other bacteria is less clear, as MMR components other than MutS and MutL",
            "probability": 0.000327077630901248,
            "start_logit": -4.1302361488342285,
            "end_logit": 1.9337162971496582,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "M",
            "probability": 0.0002999448645555402,
            "start_logit": 2.9986720085144043,
            "end_logit": -5.281790733337402,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD2 and our recently described YycJ protein are likely to be two additional components in the B. anthracis",
            "probability": 0.0002678012398244809,
            "start_logit": 1.851521611213684,
            "end_logit": -4.2479939460754395,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutS and M",
            "probability": 0.00022856193291687977,
            "start_logit": 2.7268805503845215,
            "end_logit": -5.281790733337402,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "YycJ protein are likely to be two additional components in the B. anthracis",
            "probability": 0.00022096092378804356,
            "start_logit": 1.6592624187469482,
            "end_logit": -4.2479939460754395,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "MutH-independent MMR in other bacteria is less clear, as MMR components other than MutS",
            "probability": 0.00021796876763373606,
            "start_logit": -4.1302361488342285,
            "end_logit": 1.527870535850525,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD2 helicase being associated with MMR. RecD2 and our recently described YycJ protein",
            "probability": 0.00018772344065100418,
            "start_logit": 0.47982075810432434,
            "end_logit": -3.2315683364868164,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "RecD2 helicase being associated with MMR. RecD",
            "probability": 0.000171570820907864,
            "start_logit": 0.47982075810432434,
            "end_logit": -3.3215420246124268,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        },
        {
            "text": "Mut",
            "probability": 0.00012748750286581455,
            "start_logit": 2.9986720085144043,
            "end_logit": -6.137371063232422,
            "question_text": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?"
        }
    ],
    "56cdf3745795f9a73e000039": [
        {
            "text": "Raptor",
            "probability": 0.16177965056995708,
            "start_logit": 5.273825645446777,
            "end_logit": 4.6557297706604,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR",
            "probability": 0.1474903388666444,
            "start_logit": 5.120481014251709,
            "end_logit": 4.716601848602295,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, Raptor",
            "probability": 0.13878009034750527,
            "start_logit": 5.120481014251709,
            "end_logit": 4.6557297706604,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Raptor (regulatory associated protein of mTOR",
            "probability": 0.09564882693961561,
            "start_logit": 5.273825645446777,
            "end_logit": 4.130177974700928,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Raptor (regulatory associated protein of mTOR) and mLST8",
            "probability": 0.08830679183869947,
            "start_logit": 5.273825645446777,
            "end_logit": 4.05031156539917,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, Raptor (regulatory associated protein of mTOR",
            "probability": 0.08205081910825807,
            "start_logit": 5.120481014251709,
            "end_logit": 4.130177974700928,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mLST8",
            "probability": 0.0814614560409596,
            "start_logit": 5.193138599395752,
            "end_logit": 4.05031156539917,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, Raptor (regulatory associated protein of mTOR) and mLST8",
            "probability": 0.07575257151624037,
            "start_logit": 5.120481014251709,
            "end_logit": 4.05031156539917,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mLST8 (mammalian lethal with SEC13 protein 8) and complex 2 (mTORC2) consisting of mTOR",
            "probability": 0.035420321850853614,
            "start_logit": 5.193138599395752,
            "end_logit": 3.2174673080444336,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR) and mLST8",
            "probability": 0.017279978534102895,
            "start_logit": 3.642557144165039,
            "end_logit": 4.05031156539917,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "Raptor (regulatory associated protein of mTOR)",
            "probability": 0.01074561317912324,
            "start_logit": 5.273825645446777,
            "end_logit": 1.9439921379089355,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, Raptor (regulatory associated protein of mTOR)",
            "probability": 0.00921795270656247,
            "start_logit": 5.120481014251709,
            "end_logit": 1.9439921379089355,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR have been identified: complex 1 (mTORC1), consisting of mTOR",
            "probability": 0.009013384352321454,
            "start_logit": 2.3254289627075195,
            "end_logit": 4.716601848602295,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTORC1), consisting of mTOR",
            "probability": 0.008489965732390317,
            "start_logit": 2.2656033039093018,
            "end_logit": 4.716601848602295,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR have been identified: complex 1 (mTORC1), consisting of mTOR, Raptor",
            "probability": 0.008481086316324502,
            "start_logit": 2.3254289627075195,
            "end_logit": 4.6557297706604,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTORC1), consisting of mTOR, Raptor",
            "probability": 0.00798857891603106,
            "start_logit": 2.2656033039093018,
            "end_logit": 4.6557297706604,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTORC2) consisting of mTOR",
            "probability": 0.00649477087112512,
            "start_logit": 3.4968502521514893,
            "end_logit": 3.2174673080444336,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR, Rictor",
            "probability": 0.005860458005684853,
            "start_logit": 4.164868354797363,
            "end_logit": 2.4466795921325684,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTOR have been identified: complex 1 (mTORC1), consisting of mTOR, Raptor (regulatory associated protein of mTOR",
            "probability": 0.005014264491684515,
            "start_logit": 2.3254289627075195,
            "end_logit": 4.130177974700928,
            "question_text": "Which are the main components of mTORC1?"
        },
        {
            "text": "mTORC1), consisting of mTOR, Raptor (regulatory associated protein of mTOR",
            "probability": 0.004723079815916057,
            "start_logit": 2.2656033039093018,
            "end_logit": 4.130177974700928,
            "question_text": "Which are the main components of mTORC1?"
        }
    ],
    "5508685b4b2a315d4100000a": [
        {
            "text": "ulcerative colitis",
            "probability": 0.4100779357066027,
            "start_logit": 5.139538764953613,
            "end_logit": 5.257652759552002,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease or ulcerative colitis",
            "probability": 0.28501585084139974,
            "start_logit": 4.775736331939697,
            "end_logit": 5.257652759552002,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease",
            "probability": 0.2799228843628529,
            "start_logit": 4.775736331939697,
            "end_logit": 5.239622116088867,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's",
            "probability": 0.007323390683304163,
            "start_logit": 4.775736331939697,
            "end_logit": 1.5961813926696777,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "inflammatory bowel disease. Here, we discuss the current treatment options available for patients with Crohn's disease or ulcerative colitis",
            "probability": 0.005664981634115959,
            "start_logit": 0.8574951887130737,
            "end_logit": 5.257652759552002,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "inflammatory bowel disease. Here, we discuss the current treatment options available for patients with Crohn's disease",
            "probability": 0.005563753714760025,
            "start_logit": 0.8574951887130737,
            "end_logit": 5.239622116088867,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease and ulcerative colitis",
            "probability": 0.002096621372090787,
            "start_logit": 2.2509865760803223,
            "end_logit": 2.870184898376465,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative colitis are chronic, relapsing inflammatory disorders of the GI tract. In both Crohn's disease",
            "probability": 0.0019221596195991197,
            "start_logit": 2.9450912475585938,
            "end_logit": 2.089202404022217,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "colitis",
            "probability": 0.00041686905109835417,
            "start_logit": -1.7517915964126587,
            "end_logit": 5.257652759552002,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative",
            "probability": 0.0003847355042290185,
            "start_logit": 5.139538764953613,
            "end_logit": -1.7138936519622803,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease or ulcerative",
            "probability": 0.000267402138809984,
            "start_logit": 4.775736331939697,
            "end_logit": -1.7138936519622803,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "hn's disease or ulcerative colitis",
            "probability": 0.0002026307497701615,
            "start_logit": -2.4731783866882324,
            "end_logit": 5.257652759552002,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "hn's disease",
            "probability": 0.0001990099279349699,
            "start_logit": -2.4731783866882324,
            "end_logit": 5.239622116088867,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "disease or ulcerative colitis",
            "probability": 0.00017479202374588788,
            "start_logit": -2.620966911315918,
            "end_logit": 5.257652759552002,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "disease",
            "probability": 0.00017166865388758995,
            "start_logit": -2.620966911315918,
            "end_logit": 5.239622116088867,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "inflammatory bowel disease. Here, we discuss the current treatment options available for patients with Crohn's",
            "probability": 0.00014555988236408595,
            "start_logit": 0.8574951887130737,
            "end_logit": 1.5961813926696777,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative co",
            "probability": 0.0001288657043114411,
            "start_logit": 5.139538764953613,
            "end_logit": -2.8076789379119873,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "is",
            "probability": 0.00012399049831061587,
            "start_logit": -2.9643588066101074,
            "end_logit": 5.257652759552002,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "ulcerative colitis,",
            "probability": 0.0001073325941767007,
            "start_logit": 5.139538764953613,
            "end_logit": -2.9905173778533936,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        },
        {
            "text": "Crohn's disease or ulcerative co",
            "probability": 8.956533663610678e-05,
            "start_logit": 4.775736331939697,
            "end_logit": -2.8076789379119873,
            "question_text": "List the diseases that can be treated using Vedolizumab."
        }
    ],
    "553fac39c6a5098552000001": [
        {
            "text": "PolC",
            "probability": 0.2051135871740009,
            "start_logit": 0.919020414352417,
            "end_logit": -1.3381876945495605,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PolC-PolE DNA polymerases). The segD",
            "probability": 0.2042809008543589,
            "start_logit": 0.919020414352417,
            "end_logit": -1.3422555923461914,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "segD",
            "probability": 0.12518109532001093,
            "start_logit": 0.42928585410118103,
            "end_logit": -1.3422555923461914,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DNA polymerase I",
            "probability": 0.11666454258885853,
            "start_logit": 0.05384177714586258,
            "end_logit": -1.0372703075408936,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DNA polymerase I to the replicase (PolC",
            "probability": 0.08634796800695815,
            "start_logit": 0.05384177714586258,
            "end_logit": -1.3381876945495605,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DNA polymerase I to the replicase (PolC-PolE DNA polymerases). The segD",
            "probability": 0.08599742676452313,
            "start_logit": 0.05384177714586258,
            "end_logit": -1.3422555923461914,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "segC locus includes functions that promote the shift from the use of DNA polymerase I",
            "probability": 0.04425075808697756,
            "start_logit": -0.91558837890625,
            "end_logit": -1.0372703075408936,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "segC locus includes functions that promote the shift from the use of DNA polymerase I to the replicase (PolC",
            "probability": 0.032751708092179886,
            "start_logit": -0.91558837890625,
            "end_logit": -1.3381876945495605,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "P",
            "probability": 0.018334105743249125,
            "start_logit": 0.919020414352417,
            "end_logit": -3.752988576889038,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "replicase (PolC",
            "probability": 0.01589924220569173,
            "start_logit": -1.6382720470428467,
            "end_logit": -1.3381876945495605,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "replicase (PolC-PolE DNA polymerases). The segD",
            "probability": 0.015834697083841155,
            "start_logit": -1.6382720470428467,
            "end_logit": -1.3422555923461914,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "segC",
            "probability": 0.010057018893762237,
            "start_logit": -0.91558837890625,
            "end_logit": -2.518872022628784,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DNA polymerase I to the replicase (P",
            "probability": 0.007718224803953552,
            "start_logit": 0.05384177714586258,
            "end_logit": -3.752988576889038,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PolC-PolE DNA polymerases). The segD locus",
            "probability": 0.0065155965399397876,
            "start_logit": 0.919020414352417,
            "end_logit": -4.787552833557129,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "D",
            "probability": 0.005484505802164087,
            "start_logit": 0.05384177714586258,
            "end_logit": -4.094645977020264,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "I",
            "probability": 0.004473346803597977,
            "start_logit": -3.2073240280151367,
            "end_logit": -1.0372703075408936,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "PolC-PolE DNA polymerases). The segD locus,",
            "probability": 0.004243600213230655,
            "start_logit": 0.919020414352417,
            "end_logit": -5.216339588165283,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "segD locus",
            "probability": 0.0039926860911702906,
            "start_logit": 0.42928585410118103,
            "end_logit": -4.787552833557129,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "DNA polymerase I to the replicase",
            "probability": 0.0035480908805069628,
            "start_logit": 0.05384177714586258,
            "end_logit": -4.530163288116455,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        },
        {
            "text": "I to the replicase (PolC",
            "probability": 0.003310898051024415,
            "start_logit": -3.2073240280151367,
            "end_logit": -1.3381876945495605,
            "question_text": "Which genes code for the alpha subunit of the DNA polymerase III in most Firmicutes?"
        }
    ],
    "56cf4b623975bb303a00000a": [
        {
            "text": "dopamine",
            "probability": 0.3540580627842996,
            "start_logit": 5.591619968414307,
            "end_logit": 5.120841026306152,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "serotonin",
            "probability": 0.3278806286891281,
            "start_logit": 5.644880771636963,
            "end_logit": 4.990768909454346,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine and serotonin",
            "probability": 0.31087434712383333,
            "start_logit": 5.591619968414307,
            "end_logit": 4.990768909454346,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "amine neurotransmitters such as dopamine",
            "probability": 0.0016860056499916419,
            "start_logit": 0.24452126026153564,
            "end_logit": 5.120841026306152,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "amine neurotransmitters such as dopamine and serotonin",
            "probability": 0.0014803670944998693,
            "start_logit": 0.24452126026153564,
            "end_logit": 4.990768909454346,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "biogenic amine neurotransmitters such as dopamine",
            "probability": 0.0007717735048932361,
            "start_logit": -0.5369051098823547,
            "end_logit": 5.120841026306152,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "biogenic amine neurotransmitters such as dopamine and serotonin",
            "probability": 0.0006776419171883822,
            "start_logit": -0.5369051098823547,
            "end_logit": 4.990768909454346,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "serotoni",
            "probability": 0.00029803751670556117,
            "start_logit": 5.644880771636963,
            "end_logit": -2.0124166011810303,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine and serotoni",
            "probability": 0.0002825791166580195,
            "start_logit": 5.591619968414307,
            "end_logit": -2.0124166011810303,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "se",
            "probability": 0.000265471045230462,
            "start_logit": 5.644880771636963,
            "end_logit": -2.1281301975250244,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine and se",
            "probability": 0.00025170177999307334,
            "start_logit": 5.591619968414307,
            "end_logit": -2.1281301975250244,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "pamine",
            "probability": 0.00024210849793491668,
            "start_logit": -1.696210265159607,
            "end_logit": 5.120841026306152,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "do",
            "probability": 0.00024111225999441814,
            "start_logit": 5.591619968414307,
            "end_logit": -2.171112537384033,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "serotonin.",
            "probability": 0.00021462466623310347,
            "start_logit": 5.644880771636963,
            "end_logit": -2.340745210647583,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "pamine and serotonin",
            "probability": 0.00021257903474013683,
            "start_logit": -1.696210265159607,
            "end_logit": 4.990768909454346,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopamine and serotonin.",
            "probability": 0.0002034926651770783,
            "start_logit": 5.591619968414307,
            "end_logit": -2.340745210647583,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "mine",
            "probability": 0.00011020237318242439,
            "start_logit": -2.4832777976989746,
            "end_logit": 5.120841026306152,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "mine and serotonin",
            "probability": 9.676122200175585e-05,
            "start_logit": -2.4832777976989746,
            "end_logit": 4.990768909454346,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "rotonin",
            "probability": 8.731560110432558e-05,
            "start_logit": -2.5859949588775635,
            "end_logit": 4.990768909454346,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        },
        {
            "text": "dopa",
            "probability": 6.518745721059459e-05,
            "start_logit": 5.591619968414307,
            "end_logit": -3.4791080951690674,
            "question_text": "List the neurotransmitters that are metabolized by MAOA."
        }
    ],
    "52bf1d6003868f1b0600000e": [
        {
            "text": "Pfeiffer syndrome type 1",
            "probability": 0.6602452065222327,
            "start_logit": 1.162257432937622,
            "end_logit": 1.5285980701446533,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "sporadic Pfeiffer syndrome type 1",
            "probability": 0.16402316293634267,
            "start_logit": -0.2303462028503418,
            "end_logit": 1.5285980701446533,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "type 1",
            "probability": 0.07452973083439841,
            "start_logit": -1.019155740737915,
            "end_logit": 1.5285980701446533,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "1",
            "probability": 0.020556442739884464,
            "start_logit": -2.3071794509887695,
            "end_logit": 1.5285980701446533,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "syndrome type 1",
            "probability": 0.017152446145504027,
            "start_logit": -2.488213062286377,
            "end_logit": 1.5285980701446533,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "Pfeiffer syndrome",
            "probability": 0.015249966551893843,
            "start_logit": 1.162257432937622,
            "end_logit": -2.239435911178589,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant disorder, consists of craniosynostosis",
            "probability": 0.009767178895846535,
            "start_logit": -0.26123538613319397,
            "end_logit": -1.2614927291870117,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant",
            "probability": 0.008297217996574692,
            "start_logit": -0.26123538613319397,
            "end_logit": -1.4246001243591309,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis",
            "probability": 0.007428571688079589,
            "start_logit": -0.5349294543266296,
            "end_logit": -1.2614927291870117,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "sporadic Pfeiffer syndrome",
            "probability": 0.0037885133035507027,
            "start_logit": -0.2303462028503418,
            "end_logit": -2.239435911178589,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant disorder, consists of craniosynostosis, broadening of the thumbs and great toes",
            "probability": 0.0036727789847348508,
            "start_logit": -0.26123538613319397,
            "end_logit": -2.2395718097686768,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, broadening of the thumbs and great toes",
            "probability": 0.0027933861223917215,
            "start_logit": -0.5349294543266296,
            "end_logit": -2.2395718097686768,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, broadening of the thumbs and great toes, and partial soft tissue syndactyly of the hands and feet",
            "probability": 0.002623502831042965,
            "start_logit": -0.5349294543266296,
            "end_logit": -2.3023159503936768,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant disorder, consists of craniosynostosis, broadening of the thumbs",
            "probability": 0.0018368974411797875,
            "start_logit": -0.26123538613319397,
            "end_logit": -2.9324424266815186,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant disorder, consists of craniosynostosis,",
            "probability": 0.0014146630498549303,
            "start_logit": -0.26123538613319397,
            "end_logit": -3.193629026412964,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "P",
            "probability": 0.0014116969441818278,
            "start_logit": 1.162257432937622,
            "end_logit": -4.619220733642578,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "craniosynostosis, broadening of the thumbs",
            "probability": 0.0013970793891424197,
            "start_logit": -0.5349294543266296,
            "end_logit": -2.9324424266815186,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "Pfeiffer syndrome type",
            "probability": 0.001360353543284383,
            "start_logit": 1.162257432937622,
            "end_logit": -4.65626859664917,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "Pfeiffer syndrome type 1 with impaired intelligence (IQ = 77)",
            "probability": 0.0013237348075582618,
            "start_logit": 1.162257432937622,
            "end_logit": -4.683556079864502,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        },
        {
            "text": "autosomal dominant disorder,",
            "probability": 0.0011274692723212342,
            "start_logit": -0.26123538613319397,
            "end_logit": -3.4205448627471924,
            "question_text": "Which are the subtypes of Pfeiffer syndrome?"
        }
    ],
    "515c4f1f298dcd4e51000007": [
        {
            "text": "KCND3",
            "probability": 0.11053674614897681,
            "start_logit": 5.122612953186035,
            "end_logit": 4.927302837371826,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2, KCND3",
            "probability": 0.0972820316523385,
            "start_logit": 4.994879245758057,
            "end_logit": 4.927302837371826,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND3 and KCNIP2",
            "probability": 0.09050200838911908,
            "start_logit": 5.122612953186035,
            "end_logit": 4.7273268699646,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2, KCND3 and KCNIP2",
            "probability": 0.07964970520160351,
            "start_logit": 4.994879245758057,
            "end_logit": 4.7273268699646,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCNIP2",
            "probability": 0.07767158325572927,
            "start_logit": 4.969730377197266,
            "end_logit": 4.7273268699646,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCNA4, KCND2, KCND3",
            "probability": 0.06937894861773872,
            "start_logit": 4.656848430633545,
            "end_logit": 4.927302837371826,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2",
            "probability": 0.06508486779383788,
            "start_logit": 4.994879245758057,
            "end_logit": 4.525380611419678,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2 and KCND3",
            "probability": 0.0627008073400968,
            "start_logit": 4.82777738571167,
            "end_logit": 4.65516471862793,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCNA4, KCND2, KCND3 and KCNIP2",
            "probability": 0.056804043981612824,
            "start_logit": 4.656848430633545,
            "end_logit": 4.7273268699646,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCNA4",
            "probability": 0.05467982873241988,
            "start_logit": 4.656848430633545,
            "end_logit": 4.68921422958374,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND3 expression and decreased KCNA4",
            "probability": 0.05151613209940361,
            "start_logit": 4.842979907989502,
            "end_logit": 4.443482875823975,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2 and KCND3 expression and decreased KCNA4",
            "probability": 0.05073888001913021,
            "start_logit": 4.82777738571167,
            "end_logit": 4.443482875823975,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCNA4, KCND2",
            "probability": 0.04641679066282586,
            "start_logit": 4.656848430633545,
            "end_logit": 4.525380611419678,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND3 expression and decreased KCNA4 transcription, while KCNIP2",
            "probability": 0.021664609111891258,
            "start_logit": 4.842979907989502,
            "end_logit": 3.57726788520813,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCND2 and KCND3 expression and decreased KCNA4 transcription, while KCNIP2",
            "probability": 0.021337743296964858,
            "start_logit": 4.82777738571167,
            "end_logit": 3.57726788520813,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "KCNA4 transcription, while KCNIP2",
            "probability": 0.016238488647122067,
            "start_logit": 4.554684162139893,
            "end_logit": 3.57726788520813,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "TRbeta1) in regulation of KCNA4, KCND2, KCND3",
            "probability": 0.008485194535231066,
            "start_logit": 2.5555877685546875,
            "end_logit": 4.927302837371826,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "TRbeta1) in regulation of KCNA4, KCND2, KCND3 and KCNIP2",
            "probability": 0.006947256670427128,
            "start_logit": 2.5555877685546875,
            "end_logit": 4.7273268699646,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "TRbeta1) in regulation of KCNA4",
            "probability": 0.006687460579779855,
            "start_logit": 2.5555877685546875,
            "end_logit": 4.68921422958374,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        },
        {
            "text": "TRbeta1) in regulation of KCNA4, KCND2",
            "probability": 0.005676873263750698,
            "start_logit": 2.5555877685546875,
            "end_logit": 4.525380611419678,
            "question_text": "Which genes does thyroid hormone receptor beta1 regulate in the heart?"
        }
    ],
    "553f96191d53b76422000004": [
        {
            "text": "TUNEL",
            "probability": 0.7421371819556224,
            "start_logit": 3.6287145614624023,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "modified TUNEL",
            "probability": 0.12210735407396427,
            "start_logit": 1.8240810632705688,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL procedure",
            "probability": 0.07432812439186391,
            "start_logit": 3.6287145614624023,
            "end_logit": 1.4291636943817139,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "a modified TUNEL",
            "probability": 0.022695986078119873,
            "start_logit": 0.1413685381412506,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "modified TUNEL procedure",
            "probability": 0.012229559202052896,
            "start_logit": 1.8240810632705688,
            "end_logit": 1.4291636943817139,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "detection assay for nuclear DNA fragmentation using a modified TUNEL",
            "probability": 0.005177444679848312,
            "start_logit": -1.3365079164505005,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "an in situ detection assay for nuclear DNA fragmentation using a modified TUNEL",
            "probability": 0.003709773213272093,
            "start_logit": -1.6698487997055054,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "in situ detection assay for nuclear DNA fragmentation using a modified TUNEL",
            "probability": 0.003672727287406498,
            "start_logit": -1.6798850297927856,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "using a modified TUNEL",
            "probability": 0.002757181261689273,
            "start_logit": -1.9666106700897217,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "a modified TUNEL procedure",
            "probability": 0.002273097369902941,
            "start_logit": 0.1413685381412506,
            "end_logit": 1.4291636943817139,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "nuclear DNA fragmentation using a modified TUNEL",
            "probability": 0.00226539979078741,
            "start_logit": -2.1630682945251465,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "Apoptotic cells were identified by means of an in situ detection assay for nuclear DNA fragmentation using a modified TUNEL",
            "probability": 0.0014300429563764254,
            "start_logit": -2.623115062713623,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "DNA fragmentation using a modified TUNEL",
            "probability": 0.0011542607751444285,
            "start_logit": -2.8373594284057617,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNE",
            "probability": 0.0008298439289971025,
            "start_logit": 3.6287145614624023,
            "end_logit": -3.065843343734741,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "L",
            "probability": 0.0007445014157679788,
            "start_logit": -3.275860071182251,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "assay for nuclear DNA fragmentation using a modified TUNEL",
            "probability": 0.000626270786708465,
            "start_logit": -3.448791980743408,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "TUNEL procedure and by electron microscopical examination for typical morphological features of programmed cell death. TUNEL",
            "probability": 0.0005862747764693616,
            "start_logit": 3.6287145614624023,
            "end_logit": -3.413292407989502,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "detection assay for nuclear DNA fragmentation using a modified TUNEL procedure",
            "probability": 0.0005185426111944504,
            "start_logit": -1.3365079164505005,
            "end_logit": 1.4291636943817139,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "fragmentation using a modified TUNEL",
            "probability": 0.00038488423320215013,
            "start_logit": -3.9356322288513184,
            "end_logit": 3.730208396911621,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        },
        {
            "text": "an in situ detection assay for nuclear DNA fragmentation using a modified TUNEL procedure",
            "probability": 0.0003715492116094802,
            "start_logit": -1.6698487997055054,
            "end_logit": 1.4291636943817139,
            "question_text": "Which assays can be used for detecting DNA fragmentation resulting from programmed cell death (apoptosis)?"
        }
    ],
    "54de15f91388e8454a000002": [
        {
            "text": "APOBEC3F",
            "probability": 0.5525874166653748,
            "start_logit": 4.823747634887695,
            "end_logit": 3.387056589126587,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G) and APOBEC3F",
            "probability": 0.2401512301404893,
            "start_logit": 3.9904048442840576,
            "end_logit": 3.387056589126587,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G",
            "probability": 0.07556351425024789,
            "start_logit": 3.9904048442840576,
            "end_logit": 2.2307612895965576,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F (A3F)",
            "probability": 0.047349160918777874,
            "start_logit": 4.823747634887695,
            "end_logit": 0.9299940466880798,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F (A3F",
            "probability": 0.02780819914815938,
            "start_logit": 4.823747634887695,
            "end_logit": 0.3977758586406708,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G) and APOBEC3F (A3F)",
            "probability": 0.020577665900145342,
            "start_logit": 3.9904048442840576,
            "end_logit": 0.9299940466880798,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G) and APOBEC3F (A3F",
            "probability": 0.01208527923730522,
            "start_logit": 3.9904048442840576,
            "end_logit": 0.3977758586406708,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G)",
            "probability": 0.006663217123729294,
            "start_logit": 3.9904048442840576,
            "end_logit": -0.19760984182357788,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F (A3F),",
            "probability": 0.0048142292848670715,
            "start_logit": 4.823747634887695,
            "end_logit": -1.355979084968567,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "A3G) and APOBEC3F",
            "probability": 0.002201182852409499,
            "start_logit": -0.7018691301345825,
            "end_logit": 3.387056589126587,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G) and APOBEC3F (A3F),",
            "probability": 0.0020922356356140306,
            "start_logit": 3.9904048442840576,
            "end_logit": -1.355979084968567,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3G (A3G",
            "probability": 0.0016420546324928714,
            "start_logit": 3.9904048442840576,
            "end_logit": -1.5982639789581299,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "A3F)",
            "probability": 0.0010730187772589057,
            "start_logit": 1.0366744995117188,
            "end_logit": 0.9299940466880798,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "F",
            "probability": 0.001004505469282577,
            "start_logit": -1.4863686561584473,
            "end_logit": 3.387056589126587,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "A",
            "probability": 0.0009393411397497886,
            "start_logit": 4.823747634887695,
            "end_logit": -2.9901316165924072,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "(A3G) and APOBEC3F",
            "probability": 0.0009120819536580572,
            "start_logit": -1.582889437675476,
            "end_logit": 3.387056589126587,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3",
            "probability": 0.0008910573711177416,
            "start_logit": 4.823747634887695,
            "end_logit": -3.0429015159606934,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "A3F",
            "probability": 0.0006301847650249824,
            "start_logit": 1.0366744995117188,
            "end_logit": 0.3977758586406708,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "G (A3G) and APOBEC3F",
            "probability": 0.0005750737297255938,
            "start_logit": -2.044121026992798,
            "end_logit": 3.387056589126587,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        },
        {
            "text": "APOBEC3F (A3F), are potent",
            "probability": 0.0004393510045698955,
            "start_logit": 4.823747634887695,
            "end_logit": -3.750011682510376,
            "question_text": "Which are the APOBEC3 protein family members able to inhibit Vif-deficient HIV-1 replication?"
        }
    ],
    "5306158358348c0f52000001": [
        {
            "text": "maternal chromosome 15 uniparental disomy",
            "probability": 0.46601990396621,
            "start_logit": 4.115866184234619,
            "end_logit": 3.8966193199157715,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15q11-13 deletions of paternal origin and maternal chromosome 15 uniparental disomy",
            "probability": 0.1373980524912604,
            "start_logit": 2.8945200443267822,
            "end_logit": 3.8966193199157715,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions of paternal origin and maternal chromosome 15 uniparental disomy",
            "probability": 0.07593069352723943,
            "start_logit": 2.3014588356018066,
            "end_logit": 3.8966193199157715,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "maternal chromosome 15",
            "probability": 0.06342262708004906,
            "start_logit": 4.115866184234619,
            "end_logit": 1.9022116661071777,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "chromosome 15 uniparental disomy",
            "probability": 0.051395366474468594,
            "start_logit": 1.91118586063385,
            "end_logit": 3.8966193199157715,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15q11-13 deletions",
            "probability": 0.04527944711746413,
            "start_logit": 2.8945200443267822,
            "end_logit": 2.786590337753296,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions",
            "probability": 0.0250229152438511,
            "start_logit": 2.3014588356018066,
            "end_logit": 2.786590337753296,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15q11-13 deletions of paternal origin",
            "probability": 0.020106688184389314,
            "start_logit": 2.8945200443267822,
            "end_logit": 1.9747896194458008,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15q11-13 deletions of paternal origin and maternal chromosome 15",
            "probability": 0.018699084246217208,
            "start_logit": 2.8945200443267822,
            "end_logit": 1.9022116661071777,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "maternal chromosome 15 uniparental disomy. In contrast, maternal deletions",
            "probability": 0.018684931447306246,
            "start_logit": 4.115866184234619,
            "end_logit": 0.680108368396759,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions of paternal origin",
            "probability": 0.011111618765293216,
            "start_logit": 2.3014588356018066,
            "end_logit": 1.9747896194458008,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "uniparental disomy",
            "probability": 0.010978241585800448,
            "start_logit": 0.36755311489105225,
            "end_logit": 3.8966193199157715,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "deletions of paternal origin and maternal chromosome 15",
            "probability": 0.010333730423361439,
            "start_logit": 2.3014588356018066,
            "end_logit": 1.9022116661071777,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "paternal origin and maternal chromosome 15 uniparental disomy",
            "probability": 0.009634605391043374,
            "start_logit": 0.23699918389320374,
            "end_logit": 3.8966193199157715,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15 uniparental disomy",
            "probability": 0.00928920768111156,
            "start_logit": 0.20049110054969788,
            "end_logit": 3.8966193199157715,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "maternal chromosome 15 uniparental disomy. In contrast, maternal deletions and paternal chromosome 15 uniparental disomy",
            "probability": 0.007244413829792228,
            "start_logit": 4.115866184234619,
            "end_logit": -0.2673783600330353,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "chromosome 15",
            "probability": 0.006994613607295677,
            "start_logit": 1.91118586063385,
            "end_logit": 1.9022116661071777,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "15q11-13 deletions of paternal origin and maternal chromosome 15 uniparental disomy. In contrast, maternal deletions",
            "probability": 0.005508934639793267,
            "start_logit": 2.8945200443267822,
            "end_logit": 0.680108368396759,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "maternal",
            "probability": 0.0035922373352354244,
            "start_logit": 4.115866184234619,
            "end_logit": -0.9688338041305542,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        },
        {
            "text": "13 deletions of paternal origin and maternal chromosome 15 uniparental disomy",
            "probability": 0.0033526869628181127,
            "start_logit": -0.818600058555603,
            "end_logit": 3.8966193199157715,
            "question_text": "Which genetic defects are observed in Prader-Willi syndrome?"
        }
    ],
    "5149af96d24251bc05000046": [
        {
            "text": "STRING",
            "probability": 0.9058155187466892,
            "start_logit": -0.7567393183708191,
            "end_logit": -0.7572672963142395,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "database STRING",
            "probability": 0.03649165073122383,
            "start_logit": -2.5045766830444336,
            "end_logit": -2.221182107925415,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "gene-fusion events. The database STRING",
            "probability": 0.010502280872230438,
            "start_logit": -3.750067710876465,
            "end_logit": -2.221182107925415,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "The database STRING",
            "probability": 0.008547897558335455,
            "start_logit": -3.955974817276001,
            "end_logit": -2.221182107925415,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "STRING contains a unique scoring-framework based on benchmarks of the different types of associations against a common reference set,",
            "probability": 0.0069431951164249835,
            "start_logit": -1.4337676763534546,
            "end_logit": -4.95131254196167,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "STRING is updated continuously, and currently contains 261 033 orthologs in 89 fully sequenced genomes. The database",
            "probability": 0.006635405581037107,
            "start_logit": -0.7567393183708191,
            "end_logit": -5.673683166503906,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "interactions provides a high-level view of functional linkage, facilitating the analysis of modularity in biological processes. STRING",
            "probability": 0.006102028553857972,
            "start_logit": -5.756953716278076,
            "end_logit": -0.7572672963142395,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "database",
            "probability": 0.005517874384675782,
            "start_logit": -2.5045766830444336,
            "end_logit": -4.1102728843688965,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "interactions is very large, it is essential to be able to assess and compare the significance of individual predictions. Thus, STRING",
            "probability": 0.0029701344763082985,
            "start_logit": -5.6403632164001465,
            "end_logit": -1.593871831893921,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "STRING contains a unique scoring-framework based on benchmarks of the different types of associations against a common reference set",
            "probability": 0.0029613054941348854,
            "start_logit": -1.4337676763534546,
            "end_logit": -5.8034443855285645,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "gene-fusion events. The database",
            "probability": 0.0015880417970778728,
            "start_logit": -3.750067710876465,
            "end_logit": -4.1102728843688965,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "database STRING is a precomputed global resource for the exploration and analysis of these associations.",
            "probability": 0.0014455576219458291,
            "start_logit": -2.5045766830444336,
            "end_logit": -5.449770450592041,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "The database",
            "probability": 0.0012925210023347728,
            "start_logit": -3.955974817276001,
            "end_logit": -4.1102728843688965,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "STRING is a precomputed global resource for the exploration and analysis of these associations.",
            "probability": 0.0007649661650993363,
            "start_logit": -3.140995502471924,
            "end_logit": -5.449770450592041,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "gene-fusion events",
            "probability": 0.000509041579311557,
            "start_logit": -3.750067710876465,
            "end_logit": -5.248000144958496,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "gene-fusion events.",
            "probability": 0.0004752417708639761,
            "start_logit": -3.750067710876465,
            "end_logit": -5.31670618057251,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "gene-fusion events. The database STRING is a precomputed global resource for the exploration and analysis of these associations.",
            "probability": 0.0004160308415338011,
            "start_logit": -3.750067710876465,
            "end_logit": -5.449770450592041,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "gene",
            "probability": 0.0003546867320812397,
            "start_logit": -3.750067710876465,
            "end_logit": -5.609294891357422,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "The database STRING is a precomputed global resource for the exploration and analysis of these associations.",
            "probability": 0.00033861111293853374,
            "start_logit": -3.955974817276001,
            "end_logit": -5.449770450592041,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        },
        {
            "text": "gene-fusion",
            "probability": 0.00032800986189499795,
            "start_logit": -3.750067710876465,
            "end_logit": -5.687486171722412,
            "question_text": "Which are the state-of-the-art computational tools for the prediction of gene fusion events?"
        }
    ],
    "56e460d051531f7e33000019": [
        {
            "text": "wheel-running activity cycles",
            "probability": 0.18266359946525698,
            "start_logit": 4.003300189971924,
            "end_logit": 3.982131242752075,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "acceleration of wheel-running activity cycles",
            "probability": 0.15906605592138723,
            "start_logit": 3.864973545074463,
            "end_logit": 3.982131242752075,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "wheel-running activity cycles to about 20 hours",
            "probability": 0.11440229445553016,
            "start_logit": 4.003300189971924,
            "end_logit": 3.5142061710357666,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "acceleration of wheel-running activity cycles to about 20 hours",
            "probability": 0.09962314232650155,
            "start_logit": 3.864973545074463,
            "end_logit": 3.5142061710357666,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "wheel-running activity",
            "probability": 0.08545335778540843,
            "start_logit": 4.003300189971924,
            "end_logit": 3.2224557399749756,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "acceleration of wheel-running activity",
            "probability": 0.07441399724935045,
            "start_logit": 3.864973545074463,
            "end_logit": 3.2224557399749756,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "dramatic acceleration of wheel-running activity cycles",
            "probability": 0.07001895707967469,
            "start_logit": 3.044420003890991,
            "end_logit": 3.982131242752075,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "dramatic acceleration of wheel-running activity cycles to about 20 hours",
            "probability": 0.0438529042937296,
            "start_logit": 3.044420003890991,
            "end_logit": 3.5142061710357666,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "dramatic acceleration of wheel-running activity",
            "probability": 0.03275614303345996,
            "start_logit": 3.044420003890991,
            "end_logit": 3.2224557399749756,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "wheel-running",
            "probability": 0.03248905372124796,
            "start_logit": 4.003300189971924,
            "end_logit": 2.2553882598876953,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "acceleration of wheel-running",
            "probability": 0.02829192926880831,
            "start_logit": 3.864973545074463,
            "end_logit": 2.2553882598876953,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "a dramatic acceleration of wheel-running activity cycles",
            "probability": 0.015215288185710538,
            "start_logit": 1.517954707145691,
            "end_logit": 3.982131242752075,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "dramatic acceleration of wheel-running",
            "probability": 0.012453765636540999,
            "start_logit": 3.044420003890991,
            "end_logit": 2.2553882598876953,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "a dramatic acceleration of wheel-running activity cycles to about 20 hours",
            "probability": 0.00952934183024508,
            "start_logit": 1.517954707145691,
            "end_logit": 3.5142061710357666,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "wheel-running activity cycles to about 20 hours.",
            "probability": 0.008234096105931472,
            "start_logit": 4.003300189971924,
            "end_logit": 0.8827686309814453,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "acceleration of wheel-running activity cycles to about 20 hours.",
            "probability": 0.0071703677989620055,
            "start_logit": 3.864973545074463,
            "end_logit": 0.8827686309814453,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "a dramatic acceleration of wheel-running activity",
            "probability": 0.007117988854637242,
            "start_logit": 1.517954707145691,
            "end_logit": 3.2224557399749756,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "resulting in a dramatic acceleration of wheel-running activity cycles",
            "probability": 0.00704262579890146,
            "start_logit": 0.7476350665092468,
            "end_logit": 3.982131242752075,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "20 hours",
            "probability": 0.005794291485081721,
            "start_logit": 1.0204522609710693,
            "end_logit": 3.5142061710357666,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        },
        {
            "text": "resulting in a dramatic acceleration of wheel-running activity cycles to about 20 hours",
            "probability": 0.004410799703633798,
            "start_logit": 0.7476350665092468,
            "end_logit": 3.5142061710357666,
            "question_text": "List the results of mutated casein kinase 1 epsilon. "
        }
    ],
    "514a11add24251bc05000054": [
        {
            "text": "breast cancer",
            "probability": 0.9951198402858235,
            "start_logit": 3.988994836807251,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "cancer",
            "probability": 0.0012382569840986995,
            "start_logit": -2.7001636028289795,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast",
            "probability": 0.0009049580225085619,
            "start_logit": 3.988994836807251,
            "end_logit": -3.1109325885772705,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast carcinoma",
            "probability": 0.0007334880915136883,
            "start_logit": 0.9600901007652283,
            "end_logit": -0.2921050488948822,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancer patients",
            "probability": 0.0007326772191979403,
            "start_logit": 3.988994836807251,
            "end_logit": -3.322115898132324,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancer patients with estrogen receptor (ER)-positive and node-negative disease",
            "probability": 0.0003765372473193634,
            "start_logit": 3.988994836807251,
            "end_logit": -3.9878041744232178,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancer patients with estrogen receptor",
            "probability": 0.00020854024597586655,
            "start_logit": 3.988994836807251,
            "end_logit": -4.578689098358154,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "predictive and prognostic information to breast cancer",
            "probability": 0.00012590938963691028,
            "start_logit": -4.986061096191406,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "prognostic information to breast cancer",
            "probability": 0.0001209611685829888,
            "start_logit": -5.026154041290283,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "provide predictive and prognostic information to breast cancer",
            "probability": 7.349291801810875e-05,
            "start_logit": -5.524434566497803,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "one of the molecular tests that provide predictive and prognostic information to breast cancer",
            "probability": 6.913046952824624e-05,
            "start_logit": -5.585628032684326,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "The Oncotype DX assay is one of the molecular tests that provide predictive and prognostic information to breast cancer",
            "probability": 6.704509617403712e-05,
            "start_logit": -5.616258144378662,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "information to breast cancer",
            "probability": 4.553311087646366e-05,
            "start_logit": -6.003183841705322,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancer patients with est",
            "probability": 4.2331192211370476e-05,
            "start_logit": 3.988994836807251,
            "end_logit": -6.173296928405762,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "tests that provide predictive and prognostic information to breast cancer",
            "probability": 3.713792251554779e-05,
            "start_logit": -6.206984996795654,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "assay is one of the molecular tests that provide predictive and prognostic information to breast cancer",
            "probability": 3.640415741114947e-05,
            "start_logit": -6.226940631866455,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "molecular tests that provide predictive and prognostic information to breast cancer",
            "probability": 3.202935040459662e-05,
            "start_logit": -6.354970932006836,
            "end_logit": 3.8917973041534424,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "FOXA1 expression in our diverse cohort of ER-positive breast cancer",
            "probability": 1.4031553245760244e-05,
            "start_logit": -6.0659918785095215,
            "end_logit": 2.7774741649627686,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "breast cancer patients was observed",
            "probability": 1.1579576283327614e-05,
            "start_logit": 2.635010004043579,
            "end_logit": -6.115593433380127,
            "question_text": "Which diseases can Oncotype DX be used for?"
        },
        {
            "text": "ER-positive breast cancer",
            "probability": 1.0115998673806069e-05,
            "start_logit": -6.393182277679443,
            "end_logit": 2.7774741649627686,
            "question_text": "Which diseases can Oncotype DX be used for?"
        }
    ],
    "5165932e298dcd4e51000059": [
        {
            "text": "5-methylcytosine",
            "probability": 0.5807881588585131,
            "start_logit": 1.865805983543396,
            "end_logit": 1.5521489381790161,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-fluorocytosine",
            "probability": 0.12041876010232942,
            "start_logit": 1.8735774755477905,
            "end_logit": -0.029033293947577477,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-methylcytosine, and 5-fluorocytosine",
            "probability": 0.11948655368019014,
            "start_logit": 1.865805983543396,
            "end_logit": -0.029033293947577477,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methylcytosine",
            "probability": 0.10563671865409639,
            "start_logit": 0.16142593324184418,
            "end_logit": 1.5521489381790161,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "DZCyt",
            "probability": 0.026937375668946415,
            "start_logit": 0.5595206618309021,
            "end_logit": -0.21243706345558167,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methylcytosine, and 5-fluorocytosine",
            "probability": 0.02173282506115408,
            "start_logit": 0.16142593324184418,
            "end_logit": -0.029033293947577477,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5",
            "probability": 0.0053741373131357874,
            "start_logit": 1.865805983543396,
            "end_logit": -3.13063907623291,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "fluorocytosine",
            "probability": 0.0036548670983821267,
            "start_logit": -1.621338129043579,
            "end_logit": -0.029033293947577477,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-methylcytosine, and 5",
            "probability": 0.003433149097011383,
            "start_logit": 1.865805983543396,
            "end_logit": -3.57875919342041,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "cytosine, 5-methylcytosine",
            "probability": 0.0033038501473498234,
            "start_logit": -3.3034915924072266,
            "end_logit": 1.5521489381790161,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-fluorocytosine.",
            "probability": 0.0015890450047983224,
            "start_logit": 1.8735774755477905,
            "end_logit": -4.356875419616699,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "5-methylcytosine, and 5-fluorocytosine.",
            "probability": 0.001576743616233264,
            "start_logit": 1.865805983543396,
            "end_logit": -4.356875419616699,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "DZCyt can occupy the active site of M.HhaI",
            "probability": 0.0011532738941890048,
            "start_logit": 0.5595206618309021,
            "end_logit": -3.363347053527832,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "ine",
            "probability": 0.0010901946695379627,
            "start_logit": -4.412223815917969,
            "end_logit": 1.5521489381790161,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "cytosine",
            "probability": 0.0010008463802726466,
            "start_logit": -4.497734069824219,
            "end_logit": 1.5521489381790161,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "met",
            "probability": 0.0008180088828159038,
            "start_logit": -1.077588677406311,
            "end_logit": -2.0697245597839355,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "cytosine, 5-methylcytosine, and 5-fluorocytosine",
            "probability": 0.0006797068121335242,
            "start_logit": -3.3034915924072266,
            "end_logit": -0.029033293947577477,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methylcytosine, and 5",
            "probability": 0.000624438704073005,
            "start_logit": 0.16142593324184418,
            "end_logit": -3.57875919342041,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methylation by murine DNA C5-MTase",
            "probability": 0.00041456016741797175,
            "start_logit": -1.077588677406311,
            "end_logit": -2.7493796348571777,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        },
        {
            "text": "methylcytosine, and 5-fluorocytosine.",
            "probability": 0.0002867861874199339,
            "start_logit": 0.16142593324184418,
            "end_logit": -4.356875419616699,
            "question_text": "Which are the DNA (cytosine-5-)-methyltransferases inhibitors?"
        }
    ],
    "5131bef65274a5fb07000008": [
        {
            "text": "H3K4me2",
            "probability": 0.9318877301718889,
            "start_logit": 0.45407113432884216,
            "end_logit": 0.044164810329675674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H",
            "probability": 0.01832990573817008,
            "start_logit": 0.45407113432884216,
            "end_logit": -3.8845136165618896,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "2",
            "probability": 0.012555941461862485,
            "start_logit": -3.852947235107422,
            "end_logit": 0.044164810329675674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "me2",
            "probability": 0.011622363131965135,
            "start_logit": -3.9302101135253906,
            "end_logit": 0.044164810329675674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3K4me2 as a mark for active enhancers,",
            "probability": 0.006049202158722212,
            "start_logit": 0.45407113432884216,
            "end_logit": -4.993121147155762,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "H3K4me",
            "probability": 0.005790899783582976,
            "start_logit": 0.45407113432884216,
            "end_logit": -5.036759853363037,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "K4me2",
            "probability": 0.00529366210766979,
            "start_logit": -4.716630935668945,
            "end_logit": 0.044164810329675674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "3K4me2",
            "probability": 0.003257922011499652,
            "start_logit": -5.202051639556885,
            "end_logit": 0.044164810329675674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "Using H3K4me2",
            "probability": 0.0017305746173252202,
            "start_logit": -5.83468770980835,
            "end_logit": 0.044164810329675674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "4me2",
            "probability": 0.0014126309818831822,
            "start_logit": -6.037687301635742,
            "end_logit": 0.044164810329675674,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "various histone modifications",
            "probability": 0.00040802711333200783,
            "start_logit": -3.869898796081543,
            "end_logit": -3.365499258041382,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modifications",
            "probability": 0.00035689378955108613,
            "start_logit": -4.003794193267822,
            "end_logit": -3.365499258041382,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "various histone modifications and polymerase II",
            "probability": 0.00021442793765204352,
            "start_logit": -3.869898796081543,
            "end_logit": -4.008859157562256,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modifications and polymerase II",
            "probability": 0.00018755616172004658,
            "start_logit": -4.003794193267822,
            "end_logit": -4.008859157562256,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "various histone modifications and polymerase II binding.",
            "probability": 0.00017666390658588216,
            "start_logit": -3.869898796081543,
            "end_logit": -4.2025837898254395,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "polymerase II",
            "probability": 0.0001550739840671676,
            "start_logit": -4.193970203399658,
            "end_logit": -4.008859157562256,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modifications and polymerase II binding.",
            "probability": 0.00015452466034292963,
            "start_logit": -4.003794193267822,
            "end_logit": -4.2025837898254395,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "various histone modifications and polymerase II binding",
            "probability": 0.00015199135747986887,
            "start_logit": -3.869898796081543,
            "end_logit": -4.353009223937988,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "histone modifications and polymerase II binding",
            "probability": 0.0001329440367504837,
            "start_logit": -4.003794193267822,
            "end_logit": -4.353009223937988,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        },
        {
            "text": "modifications",
            "probability": 0.0001310648879486155,
            "start_logit": -5.005539894104004,
            "end_logit": -3.365499258041382,
            "question_text": "Which are the main histone modifications associated with enhancers?"
        }
    ],
    "5516757c46478f2f2c000008": [
        {
            "text": "Upf1, Upf2, and Upf3",
            "probability": 0.12432170234568875,
            "start_logit": 5.151161193847656,
            "end_logit": 4.685851097106934,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf3",
            "probability": 0.1151902182178192,
            "start_logit": 5.074873447418213,
            "end_logit": 4.685851097106934,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf2, and Upf3",
            "probability": 0.10891958667337517,
            "start_logit": 5.0188984870910645,
            "end_logit": 4.685851097106934,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1",
            "probability": 0.08568586073170915,
            "start_logit": 5.151161193847656,
            "end_logit": 4.313666343688965,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1, Upf2",
            "probability": 0.0762195950086947,
            "start_logit": 5.151161193847656,
            "end_logit": 4.196597099304199,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf2",
            "probability": 0.06677681071061177,
            "start_logit": 5.0188984870910645,
            "end_logit": 4.196597099304199,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Dcp2/Dcp1",
            "probability": 0.05822030620929858,
            "start_logit": 5.128539562225342,
            "end_logit": 3.9498343467712402,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf3, as well as the decapping enzyme, Dcp2/Dcp1",
            "probability": 0.05517820746422465,
            "start_logit": 5.074873447418213,
            "end_logit": 3.9498343467712402,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1, Upf2, and Upf3, as well as the decapping enzyme, Dcp2",
            "probability": 0.052854284320531665,
            "start_logit": 5.151161193847656,
            "end_logit": 3.830517292022705,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf2, and Upf3, as well as the decapping enzyme, Dcp2/Dcp1",
            "probability": 0.05217446102078298,
            "start_logit": 5.0188984870910645,
            "end_logit": 3.9498343467712402,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Dcp2",
            "probability": 0.051672056547061855,
            "start_logit": 5.128539562225342,
            "end_logit": 3.830517292022705,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf3, as well as the decapping enzyme, Dcp2",
            "probability": 0.048972113715910946,
            "start_logit": 5.074873447418213,
            "end_logit": 3.830517292022705,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf2, and Upf3, as well as the decapping enzyme, Dcp2",
            "probability": 0.046306209563490595,
            "start_logit": 5.0188984870910645,
            "end_logit": 3.830517292022705,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Dcp1",
            "probability": 0.035100288869228634,
            "start_logit": 4.622514724731445,
            "end_logit": 3.9498343467712402,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1, Upf2, and Upf3,",
            "probability": 0.004683422644453395,
            "start_logit": 5.151161193847656,
            "end_logit": 1.4070076942443848,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf3,",
            "probability": 0.0043394231758568805,
            "start_logit": 5.074873447418213,
            "end_logit": 1.4070076942443848,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf2, and Upf3,",
            "probability": 0.0041031971813912296,
            "start_logit": 5.0188984870910645,
            "end_logit": 1.4070076942443848,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1, Upf2,",
            "probability": 0.0037919596421903973,
            "start_logit": 5.151161193847656,
            "end_logit": 1.1958614587783813,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf2,",
            "probability": 0.003322176813192749,
            "start_logit": 5.0188984870910645,
            "end_logit": 1.1958614587783813,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        },
        {
            "text": "Upf1, Upf2, and Upf3, as well as the decapping enzyme, Dcp2/Dcp",
            "probability": 0.0021681191444868093,
            "start_logit": 5.151161193847656,
            "end_logit": 0.6368385553359985,
            "question_text": "Which are the main NMD factors in Saccharomyces cerevisiae?"
        }
    ],
    "5160412d298dcd4e5100003c": [
        {
            "text": "H4 Lys 20",
            "probability": 0.6483977505423906,
            "start_logit": 2.395266056060791,
            "end_logit": 2.5426318645477295,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "Lys 20",
            "probability": 0.08953230323453318,
            "start_logit": 0.415361225605011,
            "end_logit": 2.5426318645477295,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "met",
            "probability": 0.05621626990735977,
            "start_logit": 2.40086030960083,
            "end_logit": 0.09173950552940369,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 met",
            "probability": 0.05590265986535258,
            "start_logit": 2.395266056060791,
            "end_logit": 0.09173950552940369,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 methylation by PR-Set7 during mitosis acts to antagonize H4 Lys 16",
            "probability": 0.04634671595835264,
            "start_logit": 2.015451192855835,
            "end_logit": 0.28409284353256226,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4",
            "probability": 0.020695679480608135,
            "start_logit": 2.395266056060791,
            "end_logit": -0.9019474983215332,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "20",
            "probability": 0.019726022215701095,
            "start_logit": -1.097299575805664,
            "end_logit": 2.5426318645477295,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 methylation at mitosis. This increase closely followed the cell cycle-regulated expression of the H4 Lys 20",
            "probability": 0.010730678689949584,
            "start_logit": -1.7061314582824707,
            "end_logit": 2.5426318645477295,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methylation by PR-Set7 during mitosis acts to antagonize H4 Lys 16",
            "probability": 0.008890862655737073,
            "start_logit": 0.3643248379230499,
            "end_logit": 0.28409284353256226,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 16",
            "probability": 0.007853967073077997,
            "start_logit": 0.24031952023506165,
            "end_logit": 0.28409284353256226,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "Lys 20 met",
            "probability": 0.007719172206404031,
            "start_logit": 0.415361225605011,
            "end_logit": 0.09173950552940369,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 methylation",
            "probability": 0.004543826399728961,
            "start_logit": 2.015451192855835,
            "end_logit": -2.038288116455078,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "Lys 20 methylation by PR-Set7 during mitosis acts to antagonize H4 Lys 16",
            "probability": 0.0042074831532223295,
            "start_logit": -0.3838346004486084,
            "end_logit": 0.28409284353256226,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methylation at mitosis. This increase closely followed the cell cycle-regulated expression of the H4 Lys 20",
            "probability": 0.0031979973583195044,
            "start_logit": -2.9167134761810303,
            "end_logit": 2.5426318645477295,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methyltransferase, PR-Set7. Localization of PR-Set7 to mitotic chromosomes",
            "probability": 0.003120093623696811,
            "start_logit": 2.40086030960083,
            "end_logit": -2.7996037006378174,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methyl",
            "probability": 0.0030619143930287916,
            "start_logit": 2.40086030960083,
            "end_logit": -2.8184263706207275,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 methyl",
            "probability": 0.0030448330907118185,
            "start_logit": 2.395266056060791,
            "end_logit": -2.8184263706207275,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H",
            "probability": 0.00242272117226625,
            "start_logit": 2.395266056060791,
            "end_logit": -3.0469810962677,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "methyltransferase, PR-Set7.",
            "probability": 0.002200662836968524,
            "start_logit": 2.40086030960083,
            "end_logit": -3.1487081050872803,
            "question_text": "Which histone marks are deposited by Set7?"
        },
        {
            "text": "H4 Lys 20 methyltransferase, PR-Set7.",
            "probability": 0.002188386142590141,
            "start_logit": 2.395266056060791,
            "end_logit": -3.1487081050872803,
            "question_text": "Which histone marks are deposited by Set7?"
        }
    ],
    "54df6ed91388e8454a000007": [
        {
            "text": "radiotherapy",
            "probability": 0.9016223328106268,
            "start_logit": 5.304916858673096,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "temozolomide with radiotherapy",
            "probability": 0.07106730465260214,
            "start_logit": 2.7643485069274902,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radio",
            "probability": 0.010338173775167273,
            "start_logit": 5.304916858673096,
            "end_logit": 0.8370469212532043,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "temozolomide",
            "probability": 0.009946310949706296,
            "start_logit": 2.7643485069274902,
            "end_logit": 3.3389737606048584,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherapy (Stupp regime), in the treatment of patients with newly diagnosed glioblastoma",
            "probability": 0.0016343859617078825,
            "start_logit": 5.304916858673096,
            "end_logit": -1.0075291395187378,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherapy (Stupp regime),",
            "probability": 0.001562315831904407,
            "start_logit": 5.304916858673096,
            "end_logit": -1.0526270866394043,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "temozolomide with radio",
            "probability": 0.0008148712809065582,
            "start_logit": 2.7643485069274902,
            "end_logit": 0.8370469212532043,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "administration of temozolomide with radiotherapy",
            "probability": 0.0005494840482768602,
            "start_logit": -2.0980544090270996,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "y",
            "probability": 0.0005355488181167107,
            "start_logit": -2.12374210357666,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "concomitant administration of temozolomide with radiotherapy",
            "probability": 0.00041297131196465885,
            "start_logit": -2.3836560249328613,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "with radiotherapy",
            "probability": 0.00029364557647882907,
            "start_logit": -2.724660634994507,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "the concomitant administration of temozolomide with radiotherapy",
            "probability": 0.000202197291568981,
            "start_logit": -3.097790241241455,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherap",
            "probability": 0.0001686436756720154,
            "start_logit": 5.304916858673096,
            "end_logit": -3.27876353263855,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "de with radiotherapy",
            "probability": 0.00014382858403587154,
            "start_logit": -3.4384119510650635,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherapy (Stupp regime), in the treatment of patients with newly diagnosed glioblastoma multiforme",
            "probability": 0.00013509493049947328,
            "start_logit": 5.304916858673096,
            "end_logit": -3.5005738735198975,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "temozolomide with radiotherapy (Stupp regime), in the treatment of patients with newly diagnosed glioblastoma",
            "probability": 0.0001288248980019733,
            "start_logit": 2.7643485069274902,
            "end_logit": -1.0075291395187378,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "temozolomide with radiotherapy (Stupp regime),",
            "probability": 0.00012314421587520088,
            "start_logit": 2.7643485069274902,
            "end_logit": -1.0526270866394043,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "therapy",
            "probability": 0.00011492821897376743,
            "start_logit": -3.662726402282715,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "radiotherapy (Stupp regime)",
            "probability": 0.00011040073765831971,
            "start_logit": 5.304916858673096,
            "end_logit": -3.702434778213501,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        },
        {
            "text": "zolomide with radiotherapy",
            "probability": 9.559243025606399e-05,
            "start_logit": -3.846940517425537,
            "end_logit": 5.305399417877197,
            "question_text": "List non-surgical treatment modalities that are included in the Stupp protocol."
        }
    ],
    "54e22b62ae9738404b000011": [
        {
            "text": "COL5A1, COL5A2",
            "probability": 0.16124900183243698,
            "start_logit": 3.70013689994812,
            "end_logit": 3.4891531467437744,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2",
            "probability": 0.1589914466243701,
            "start_logit": 3.686037540435791,
            "end_logit": 3.4891531467437744,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1",
            "probability": 0.15428768796019748,
            "start_logit": 3.70013689994812,
            "end_logit": 3.4450223445892334,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "tenascin X genes and since they have been inferred in the COL1A2",
            "probability": 0.11826040629006958,
            "start_logit": 3.8018321990966797,
            "end_logit": 3.077397108078003,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2, and tenascin X genes and since they have been inferred in the COL1A2",
            "probability": 0.10532958799658429,
            "start_logit": 3.686037540435791,
            "end_logit": 3.077397108078003,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL1A2",
            "probability": 0.10016523649491596,
            "start_logit": 3.6357643604278564,
            "end_logit": 3.077397108078003,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "tenascin X",
            "probability": 0.041618790221721005,
            "start_logit": 3.8018321990966797,
            "end_logit": 2.03305983543396,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1, COL5A2, and tenascin X",
            "probability": 0.03759445079108103,
            "start_logit": 3.70013689994812,
            "end_logit": 2.03305983543396,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2, and tenascin X",
            "probability": 0.03706811235044985,
            "start_logit": 3.686037540435791,
            "end_logit": 2.03305983543396,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "tenascin",
            "probability": 0.02742771075519047,
            "start_logit": 3.8018321990966797,
            "end_logit": 1.6160619258880615,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1, COL5A2, and tenascin",
            "probability": 0.024775581337293687,
            "start_logit": 3.70013689994812,
            "end_logit": 1.6160619258880615,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2, and tenascin",
            "probability": 0.02442871256883449,
            "start_logit": 3.686037540435791,
            "end_logit": 1.6160619258880615,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "tenascin X genes and since they have been inferred in the COL1A2 gene",
            "probability": 0.00162515639734349,
            "start_logit": 3.8018321990966797,
            "end_logit": -1.2098878622055054,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2, and tenascin X genes and since they have been inferred in the COL1A2 gene",
            "probability": 0.0014474586984111935,
            "start_logit": 3.686037540435791,
            "end_logit": -1.2098878622055054,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "tenascin X genes",
            "probability": 0.0014047882139608104,
            "start_logit": 3.8018321990966797,
            "end_logit": -1.3556053638458252,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL1A2 gene",
            "probability": 0.001376489223974579,
            "start_logit": 3.6357643604278564,
            "end_logit": -1.2098878622055054,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1, COL5A2, and tenascin X genes",
            "probability": 0.0012689518628553834,
            "start_logit": 3.70013689994812,
            "end_logit": -1.3556053638458252,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A2, and tenascin X genes",
            "probability": 0.001251185992343191,
            "start_logit": 3.686037540435791,
            "end_logit": -1.3556053638458252,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1,",
            "probability": 0.0002473530933830973,
            "start_logit": 3.70013689994812,
            "end_logit": -2.9907350540161133,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        },
        {
            "text": "COL5A1, COL5A2,",
            "probability": 0.0001818912945833666,
            "start_logit": 3.70013689994812,
            "end_logit": -3.298142671585083,
            "question_text": "Which genes are associated with Ehlers-Danlos syndrome type I/II?"
        }
    ],
    "551adceb622b194345000018": [
        {
            "text": "Blood pressure",
            "probability": 0.14226218595804038,
            "start_logit": 4.419145107269287,
            "end_logit": 4.3257246017456055,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Age, Blood pressure",
            "probability": 0.1269034194514631,
            "start_logit": 4.3048996925354,
            "end_logit": 4.3257246017456055,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Blood pressure, Clinical features, Duration of symptoms and Diabetes",
            "probability": 0.09630534401784974,
            "start_logit": 4.419145107269287,
            "end_logit": 3.9355766773223877,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Age",
            "probability": 0.08781187067219677,
            "start_logit": 4.3048996925354,
            "end_logit": 3.9574949741363525,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes",
            "probability": 0.08590812368733959,
            "start_logit": 4.3048996925354,
            "end_logit": 3.9355766773223877,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Duration of symptoms and Diabetes",
            "probability": 0.0740085388566502,
            "start_logit": 4.155801773071289,
            "end_logit": 3.9355766773223877,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Blood pressure, Clinical features",
            "probability": 0.05441612708966472,
            "start_logit": 4.419145107269287,
            "end_logit": 3.364713430404663,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Age, Blood pressure, Clinical features",
            "probability": 0.04854130810994723,
            "start_logit": 4.3048996925354,
            "end_logit": 3.364713430404663,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Blood pressure, Clinical features, Duration of symptoms",
            "probability": 0.04637208543778814,
            "start_logit": 4.419145107269287,
            "end_logit": 3.2047505378723145,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Clinical features, Duration of symptoms and Diabetes",
            "probability": 0.045213253113408035,
            "start_logit": 3.6630115509033203,
            "end_logit": 3.9355766773223877,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Diabetes",
            "probability": 0.04341553700878784,
            "start_logit": 3.622438669204712,
            "end_logit": 3.9355766773223877,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Age, Blood pressure, Clinical features, Duration of symptoms",
            "probability": 0.04136570916242213,
            "start_logit": 4.3048996925354,
            "end_logit": 3.2047505378723145,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Duration of symptoms",
            "probability": 0.0356359278084335,
            "start_logit": 4.155801773071289,
            "end_logit": 3.2047505378723145,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Clinical features",
            "probability": 0.02554718175452839,
            "start_logit": 3.6630115509033203,
            "end_logit": 3.364713430404663,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Clinical features, Duration of symptoms",
            "probability": 0.021770680097531213,
            "start_logit": 3.6630115509033203,
            "end_logit": 3.2047505378723145,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Blood pressure, Clinical features, Duration",
            "probability": 0.007456565557289924,
            "start_logit": 4.419145107269287,
            "end_logit": 1.3771477937698364,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Age, Blood pressure, Clinical features, Duration",
            "probability": 0.006651547354004474,
            "start_logit": 4.3048996925354,
            "end_logit": 1.3771477937698364,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Duration",
            "probability": 0.00573020664026254,
            "start_logit": 4.155801773071289,
            "end_logit": 1.3771477937698364,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Clinical features, Duration",
            "probability": 0.0035006944768919915,
            "start_logit": 3.6630115509033203,
            "end_logit": 1.3771477937698364,
            "question_text": "Which factors are considered in the ABCD2 score?"
        },
        {
            "text": "Blood pressure, Clinical features, Duration of symptoms and Diabetes)",
            "probability": 0.0011836937455003038,
            "start_logit": 4.419145107269287,
            "end_logit": -0.46330729126930237,
            "question_text": "Which factors are considered in the ABCD2 score?"
        }
    ],
    "532f0b2cd6d3ac6a3400002c": [
        {
            "text": "cardiovascular",
            "probability": 0.2082679801257686,
            "start_logit": 2.731569766998291,
            "end_logit": 1.643805742263794,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "joint hypermobility",
            "probability": 0.15036024063588216,
            "start_logit": 2.4394402503967285,
            "end_logit": 1.6101436614990234,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "joint hypermobility and an overgrowth of the long bones",
            "probability": 0.08767679624939409,
            "start_logit": 2.4394402503967285,
            "end_logit": 1.0707669258117676,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "flaccidity",
            "probability": 0.08438880343339016,
            "start_logit": 1.5208576917648315,
            "end_logit": 1.9511269330978394,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "joint ligaments flaccidity",
            "probability": 0.07778486212329756,
            "start_logit": 1.439369797706604,
            "end_logit": 1.9511269330978394,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "flaccidity, joint hypermobility",
            "probability": 0.06000641423716667,
            "start_logit": 1.5208576917648315,
            "end_logit": 1.6101436614990234,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "joint ligaments flaccidity, joint hypermobility",
            "probability": 0.05531054438561528,
            "start_logit": 1.439369797706604,
            "end_logit": 1.6101436614990234,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "overgrowth of the long bones",
            "probability": 0.04104810209605777,
            "start_logit": 1.6805275678634644,
            "end_logit": 1.0707669258117676,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ligaments flaccidity",
            "probability": 0.03995415254341323,
            "start_logit": 0.7731555700302124,
            "end_logit": 1.9511269330978394,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ocular, cardiovascular",
            "probability": 0.03850666162456997,
            "start_logit": 1.043575406074524,
            "end_logit": 1.643805742263794,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "flaccidity, joint hypermobility and an overgrowth of the long bones",
            "probability": 0.034990434522311285,
            "start_logit": 1.5208576917648315,
            "end_logit": 1.0707669258117676,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "joint ligaments flaccidity, joint hypermobility and an overgrowth of the long bones",
            "probability": 0.032252218472330514,
            "start_logit": 1.439369797706604,
            "end_logit": 1.0707669258117676,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ligaments flaccidity, joint hypermobility",
            "probability": 0.02841023133960421,
            "start_logit": 0.7731555700302124,
            "end_logit": 1.6101436614990234,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ocular",
            "probability": 0.019726410307969334,
            "start_logit": 1.043575406074524,
            "end_logit": 0.974932849407196,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "ligaments flaccidity, joint hypermobility and an overgrowth of the long bones",
            "probability": 0.0165663346508784,
            "start_logit": 0.7731555700302124,
            "end_logit": 1.0707669258117676,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "joint hypermobility and an overgrowth",
            "probability": 0.0068405934097646405,
            "start_logit": 2.4394402503967285,
            "end_logit": -1.4800158739089966,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "long bones",
            "probability": 0.005175716709090937,
            "start_logit": -0.3902392089366913,
            "end_logit": 1.0707669258117676,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardiovascular and musculoskeletal systems.",
            "probability": 0.00459669848483969,
            "start_logit": 2.731569766998291,
            "end_logit": -2.1696815490722656,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "joint ligaments",
            "probability": 0.004385987530385886,
            "start_logit": 1.439369797706604,
            "end_logit": -0.9244050979614258,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        },
        {
            "text": "cardiovascular and musculoskeletal systems",
            "probability": 0.0037508171182697924,
            "start_logit": 2.731569766998291,
            "end_logit": -2.3730461597442627,
            "question_text": "Which are the musculoskeletal manifestations of Marfan syndrome?"
        }
    ],
    "5512c1ee6a8cde6b72000009": [
        {
            "text": "p38\u03b3, and p38\u03b4",
            "probability": 0.13719682286792007,
            "start_logit": 6.089267730712891,
            "end_logit": 5.735467433929443,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38\u03b3, and p38\u03b4",
            "probability": 0.13096070005397817,
            "start_logit": 6.04274845123291,
            "end_logit": 5.735467433929443,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b3",
            "probability": 0.120877965063293,
            "start_logit": 6.089267730712891,
            "end_logit": 5.608832359313965,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b4",
            "probability": 0.12062427375411842,
            "start_logit": 5.960531711578369,
            "end_logit": 5.735467433929443,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38\u03b3",
            "probability": 0.1153835970460411,
            "start_logit": 6.04274845123291,
            "end_logit": 5.608832359313965,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2",
            "probability": 0.0971398918203177,
            "start_logit": 6.04274845123291,
            "end_logit": 5.436722278594971,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2, p38\u03b3, and p38\u03b4",
            "probability": 0.08874407563134729,
            "start_logit": 5.6536078453063965,
            "end_logit": 5.735467433929443,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2, p38\u03b3",
            "probability": 0.07818842338694207,
            "start_logit": 5.6536078453063965,
            "end_logit": 5.608832359313965,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2",
            "probability": 0.0658257775269223,
            "start_logit": 5.6536078453063965,
            "end_logit": 5.436722278594971,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1",
            "probability": 0.024681277230772677,
            "start_logit": 5.6536078453063965,
            "end_logit": 4.455755710601807,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38",
            "probability": 0.0035387741875147535,
            "start_logit": 6.04274845123291,
            "end_logit": 2.1243505477905273,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b3, and p38",
            "probability": 0.003163810593927169,
            "start_logit": 6.089267730712891,
            "end_logit": 1.9658280611038208,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38\u03b3, and p38",
            "probability": 0.00302000324466534,
            "start_logit": 6.04274845123291,
            "end_logit": 1.9658280611038208,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b2, p38",
            "probability": 0.00282190504179646,
            "start_logit": 6.04274845123291,
            "end_logit": 1.8979823589324951,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38",
            "probability": 0.0023980113424075205,
            "start_logit": 5.6536078453063965,
            "end_logit": 2.1243505477905273,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2, p38\u03b3, and p38",
            "probability": 0.002046471928151196,
            "start_logit": 5.6536078453063965,
            "end_logit": 1.9658280611038208,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "p38\u03b1, p38\u03b2, p38",
            "probability": 0.0019122328633738707,
            "start_logit": 5.6536078453063965,
            "end_logit": 1.8979823589324951,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "\u03b1, p38\u03b2, p38\u03b3, and p38\u03b4",
            "probability": 0.0005627514180026022,
            "start_logit": 0.5929338932037354,
            "end_logit": 5.735467433929443,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "\u03b1, p38\u03b2, p38\u03b3",
            "probability": 0.000495815025615603,
            "start_logit": 0.5929338932037354,
            "end_logit": 5.608832359313965,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        },
        {
            "text": "\u03b1, p38\u03b2",
            "probability": 0.0004174199728924142,
            "start_logit": 0.5929338932037354,
            "end_logit": 5.436722278594971,
            "question_text": "Which proteins are the different isoforms of the p38 MAP kinase?"
        }
    ],
    "515db70c298dcd4e51000017": [
        {
            "text": "partial seizures",
            "probability": 0.7203133062373168,
            "start_logit": 4.365742206573486,
            "end_logit": 4.514919757843018,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "seizures",
            "probability": 0.24849558204032055,
            "start_logit": 3.301481008529663,
            "end_logit": 4.514919757843018,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "partial seizure",
            "probability": 0.021905927956325694,
            "start_logit": 4.365742206573486,
            "end_logit": 1.0219907760620117,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "seizure",
            "probability": 0.007557164737210949,
            "start_logit": 3.301481008529663,
            "end_logit": 1.0219907760620117,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "partial",
            "probability": 0.0009390517330420893,
            "start_logit": 4.365742206573486,
            "end_logit": -2.1276512145996094,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "s",
            "probability": 0.0004758831508156302,
            "start_logit": -2.9565269947052,
            "end_logit": 4.514919757843018,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "partial seizures in patients with or without intellectual disability.",
            "probability": 6.181110533363737e-05,
            "start_logit": 4.365742206573486,
            "end_logit": -4.848438739776611,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "It is concluded that gabapentin is equally effective as an add-on medication against partial seizures",
            "probability": 4.7538564951080436e-05,
            "start_logit": -5.260158061981201,
            "end_logit": 4.514919757843018,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "partial seizures in patients with or without intellectual disability",
            "probability": 4.725718248824178e-05,
            "start_logit": 4.365742206573486,
            "end_logit": -5.116917133331299,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "seizures in patients with or without intellectual disability. However, children with intellectual disability who also are less than 10 years of age with baseline attention deficit",
            "probability": 3.4412486880369736e-05,
            "start_logit": 3.301481008529663,
            "end_logit": -4.3698410987854,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "refractory partial seizures",
            "probability": 3.403167637831773e-05,
            "start_logit": -1.4527095556259155,
            "end_logit": 0.3732217252254486,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "seizures in patients with or without intellectual disability.",
            "probability": 2.1323757958425515e-05,
            "start_logit": 3.301481008529663,
            "end_logit": -4.848438739776611,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "gabapentin is equally effective as an add-on medication against partial seizures",
            "probability": 1.9595796875740786e-05,
            "start_logit": -6.146384239196777,
            "end_logit": 4.514919757843018,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "seizures in patients with or without intellectual disability",
            "probability": 1.6302907313130115e-05,
            "start_logit": 3.301481008529663,
            "end_logit": -5.116917133331299,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "Behavioural side-effects",
            "probability": 7.858208373638636e-06,
            "start_logit": -2.3455278873443604,
            "end_logit": -0.19969305396080017,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "attention deficit disorder and behavioural problems. Behavioural adverse effects",
            "probability": 7.671908067602518e-06,
            "start_logit": -1.3829902410507202,
            "end_logit": -1.1862239837646484,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "behavioural problems. Behavioural adverse effects",
            "probability": 5.0586020875692584e-06,
            "start_logit": -1.7994654178619385,
            "end_logit": -1.1862239837646484,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "behavioural side-effects",
            "probability": 3.7037041769938218e-06,
            "start_logit": -1.3791576623916626,
            "end_logit": -1.9182884693145752,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "refractory partial seizure",
            "probability": 3.4841467863791564e-06,
            "start_logit": -1.4527095556259155,
            "end_logit": -1.9058468341827393,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        },
        {
            "text": "attention deficit disorder",
            "probability": 3.0340972970921717e-06,
            "start_logit": -1.3829902410507202,
            "end_logit": -2.113875389099121,
            "question_text": "What are the reported adverse effects of gabapentin used in children?"
        }
    ],
    "54fb5c69d176fff445000003": [
        {
            "text": "Gata4, Mef2c",
            "probability": 0.18208020930622076,
            "start_logit": 5.650991439819336,
            "end_logit": 5.117585182189941,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2c",
            "probability": 0.1766843130059942,
            "start_logit": 5.620908737182617,
            "end_logit": 5.117585182189941,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4",
            "probability": 0.17271985795335557,
            "start_logit": 5.650991439819336,
            "end_logit": 5.0648088455200195,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2c and Tbx5",
            "probability": 0.16005930268210705,
            "start_logit": 5.650991439819336,
            "end_logit": 4.988682270050049,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2c and Tbx5",
            "probability": 0.155315989817683,
            "start_logit": 5.620908737182617,
            "end_logit": 4.988682270050049,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5",
            "probability": 0.14505857068792793,
            "start_logit": 5.552584648132324,
            "end_logit": 4.988682270050049,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2c and Tbx5 (collectively referred to here as GMT",
            "probability": 0.0012593559978574123,
            "start_logit": 5.650991439819336,
            "end_logit": 0.14373835921287537,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2c and Tbx5 (collectively referred to here as GMT",
            "probability": 0.001222035333544694,
            "start_logit": 5.620908737182617,
            "end_logit": 0.14373835921287537,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 (collectively referred to here as GMT",
            "probability": 0.0011413293571526175,
            "start_logit": 5.552584648132324,
            "end_logit": 0.14373835921287537,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2c and Tbx5 (collectively referred to here as GMT)",
            "probability": 0.0009296184799446282,
            "start_logit": 5.650991439819336,
            "end_logit": -0.15984313189983368,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2c and Tbx5 (collectively referred to here as GMT)",
            "probability": 0.0009020694951556257,
            "start_logit": 5.620908737182617,
            "end_logit": -0.15984313189983368,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 (collectively referred to here as GMT)",
            "probability": 0.000842494786158572,
            "start_logit": 5.552584648132324,
            "end_logit": -0.15984313189983368,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4, Mef2c and Tbx5 (collectively referred to here as GMT).",
            "probability": 0.00031118482155776235,
            "start_logit": 5.650991439819336,
            "end_logit": -1.2542303800582886,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Mef2c and Tbx5 (collectively referred to here as GMT).",
            "probability": 0.000301962946024292,
            "start_logit": 5.620908737182617,
            "end_logit": -1.2542303800582886,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Tbx5 (collectively referred to here as GMT).",
            "probability": 0.00028202063034473714,
            "start_logit": 5.552584648132324,
            "end_logit": -1.2542303800582886,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "GMT",
            "probability": 0.0002590227212141771,
            "start_logit": 4.069551467895508,
            "end_logit": 0.14373835921287537,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "Gata4,",
            "probability": 0.00021011767867335895,
            "start_logit": 5.650991439819336,
            "end_logit": -1.6469496488571167,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "GMT)",
            "probability": 0.0001912027328062225,
            "start_logit": 4.069551467895508,
            "end_logit": -0.15984313189983368,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "cardiomyocyte-like cells by the introduction of three transcription factors: Gata4, Mef2c",
            "probability": 0.00011538822074620314,
            "start_logit": -1.7129088640213013,
            "end_logit": 5.117585182189941,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        },
        {
            "text": "4, Mef2c",
            "probability": 0.00011395334553114028,
            "start_logit": -1.7254220247268677,
            "end_logit": 5.117585182189941,
            "question_text": "Which are the 3 basic transcription factors that have been used for the direct reprogramming of fibroblasts into cardiomyocytes or cardiomyocyte like-cells?"
        }
    ],
    "5357b9bcf1005d6b58000008": [
        {
            "text": "T68A, T68D",
            "probability": 0.20853711502754346,
            "start_logit": 3.1743383407592773,
            "end_logit": 1.9690380096435547,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68D",
            "probability": 0.17844981161058887,
            "start_logit": 3.018528699874878,
            "end_logit": 1.9690380096435547,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68A",
            "probability": 0.1472119406781893,
            "start_logit": 3.1743383407592773,
            "end_logit": 1.6207942962646484,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68A, T68D and Q69E",
            "probability": 0.0662258747594951,
            "start_logit": 3.1743383407592773,
            "end_logit": 0.8219922184944153,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S19, S33/35",
            "probability": 0.05746476378778259,
            "start_logit": 1.8902112245559692,
            "end_logit": 1.9642200469970703,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68D and Q69E",
            "probability": 0.05667094259464287,
            "start_logit": 3.018528699874878,
            "end_logit": 0.8219922184944153,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S19",
            "probability": 0.05591188370888113,
            "start_logit": 1.8902112245559692,
            "end_logit": 1.9368250370025635,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68A, T68",
            "probability": 0.0468015056757663,
            "start_logit": 3.1743383407592773,
            "end_logit": 0.4748363494873047,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68",
            "probability": 0.040049081286222414,
            "start_logit": 3.018528699874878,
            "end_logit": 0.4748363494873047,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S33/35",
            "probability": 0.021671782299584615,
            "start_logit": 0.9150503277778625,
            "end_logit": 1.9642200469970703,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S19, S33/35, T432, in Chk2 wildtype and Chk2 mutants (T68A",
            "probability": 0.01950409386030951,
            "start_logit": 1.1530894041061401,
            "end_logit": 1.6207942962646484,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "Q69E",
            "probability": 0.019027093935395676,
            "start_logit": 1.9271310567855835,
            "end_logit": 0.8219922184944153,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S33/35, T432, in Chk2 wildtype and Chk2 mutants (T68A",
            "probability": 0.017883532458700488,
            "start_logit": 1.0663453340530396,
            "end_logit": 1.6207942962646484,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T432, in Chk2 wildtype and Chk2 mutants (T68A, T68D",
            "probability": 0.015132069564514445,
            "start_logit": 0.551037609577179,
            "end_logit": 1.9690380096435547,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S19, S33",
            "probability": 0.014709528116420349,
            "start_logit": 1.8902112245559692,
            "end_logit": 0.6015435457229614,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T432, in Chk2 wildtype and Chk2 mutants (T68A",
            "probability": 0.010682133618158625,
            "start_logit": 0.551037609577179,
            "end_logit": 1.6207942962646484,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "T68, S19",
            "probability": 0.00769598614861098,
            "start_logit": 0.20258411765098572,
            "end_logit": 1.641374111175537,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S33/35, T432, in Chk2 wildtype and Chk2 mutants (T68A, T68",
            "probability": 0.005685518729070236,
            "start_logit": 1.0663453340530396,
            "end_logit": 0.4748363494873047,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S33",
            "probability": 0.005547428894790932,
            "start_logit": 0.9150503277778625,
            "end_logit": 0.6015435457229614,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        },
        {
            "text": "S19, S33/35, T432, in Chk2 wildtype and Chk2 mutants (T68",
            "probability": 0.005137913245332481,
            "start_logit": 1.1530894041061401,
            "end_logit": 0.28681692481040955,
            "question_text": "Which are the major intramolecular phosphorylation sites of human Chk2 involved in cell cycle control?"
        }
    ],
    "5542644fed966d112c000004": [
        {
            "text": "DNA",
            "probability": 0.7582068203976804,
            "start_logit": 0.921760618686676,
            "end_logit": -0.35905444622039795,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "DNA base composition asymmetry",
            "probability": 0.19113434588031697,
            "start_logit": 0.921760618686676,
            "end_logit": -1.7370340824127197,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "DNA base",
            "probability": 0.011288813682196128,
            "start_logit": 0.921760618686676,
            "end_logit": -4.566198348999023,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "DNA base composition asymmetry is the basis of numerous in silico methods used to detect the origin",
            "probability": 0.010865341690187337,
            "start_logit": 0.921760618686676,
            "end_logit": -4.604432582855225,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "DNA replication",
            "probability": 0.006054583075983639,
            "start_logit": -0.42616549134254456,
            "end_logit": -3.841269016265869,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "DNA base composition",
            "probability": 0.0055453787208864305,
            "start_logit": 0.921760618686676,
            "end_logit": -5.277045726776123,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "D",
            "probability": 0.0052486069864123505,
            "start_logit": 0.921760618686676,
            "end_logit": -5.332047939300537,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "DNA base composition asymmetry is the basis of numerous in silico methods",
            "probability": 0.0049511967179478285,
            "start_logit": 0.921760618686676,
            "end_logit": -5.390381336212158,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "DNA base composition asymmetry is the basis of numerous in silico methods used to detect the origin and terminus of replication",
            "probability": 0.004797230857878438,
            "start_logit": 0.921760618686676,
            "end_logit": -5.421971797943115,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "base composition asymmetry",
            "probability": 0.0007467822677790819,
            "start_logit": -4.623197555541992,
            "end_logit": -1.7370340824127197,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "composition asymmetry",
            "probability": 0.000362399917005439,
            "start_logit": -5.346222877502441,
            "end_logit": -1.7370340824127197,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "BLAST",
            "probability": 0.00028444559643254667,
            "start_logit": -3.274925708770752,
            "end_logit": -4.050537586212158,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "dnaA gene and its binding sites; making BLAST",
            "probability": 0.00011933469458977798,
            "start_logit": -4.143535614013672,
            "end_logit": -4.050537586212158,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "origin",
            "probability": 8.49664674750679e-05,
            "start_logit": -3.9293160438537598,
            "end_logit": -4.604432582855225,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "BLAST analyses of the intergenic sequences compared to related species; studying the gene order around the origin sequence",
            "probability": 7.20465892947854e-05,
            "start_logit": -3.274925708770752,
            "end_logit": -5.423766613006592,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "origin and terminus of replication in prokaryotes.",
            "probability": 5.601415775047459e-05,
            "start_logit": -3.9293160438537598,
            "end_logit": -5.021084785461426,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "dnaA",
            "probability": 5.2176441432055226e-05,
            "start_logit": -4.143535614013672,
            "end_logit": -4.877838611602783,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "base",
            "probability": 4.410659865079802e-05,
            "start_logit": -4.623197555541992,
            "end_logit": -4.566198348999023,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "origin and terminus of replication in prokaryotes. However, the composition asymmetry",
            "probability": 4.295721167258998e-05,
            "start_logit": -3.9293160438537598,
            "end_logit": -5.286484718322754,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        },
        {
            "text": "base composition asymmetry is the basis of numerous in silico methods used to detect the origin",
            "probability": 4.245204842814327e-05,
            "start_logit": -4.623197555541992,
            "end_logit": -4.604432582855225,
            "question_text": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?"
        }
    ],
    "55242d512c8b63434a000006": [
        {
            "text": "5-HT(2)",
            "probability": 0.2931705680541179,
            "start_logit": 1.3788087368011475,
            "end_logit": 0.5278924703598022,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2",
            "probability": 0.1610264743744847,
            "start_logit": 1.3788087368011475,
            "end_logit": -0.07129332423210144,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2) receptor antagonist",
            "probability": 0.15407042695649487,
            "start_logit": 1.3788087368011475,
            "end_logit": -0.11545229703187943,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2) receptor",
            "probability": 0.13476223616034072,
            "start_logit": 1.3788087368011475,
            "end_logit": -0.24935010075569153,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2) receptor antagonists",
            "probability": 0.07095369514846181,
            "start_logit": 1.3788087368011475,
            "end_logit": -0.890834629535675,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5",
            "probability": 0.05719529481824537,
            "start_logit": 1.3788087368011475,
            "end_logit": -1.1063904762268066,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2C)",
            "probability": 0.024195569694675016,
            "start_logit": 0.04992479085922241,
            "end_logit": -0.637808620929718,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2A) and 5-HT(2C)",
            "probability": 0.016261571065147924,
            "start_logit": -0.34744003415107727,
            "end_logit": -0.637808620929718,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2C) serotonin receptors",
            "probability": 0.014675838576786298,
            "start_logit": 0.04992479085922241,
            "end_logit": -1.1377756595611572,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2A) and 5-HT(2C) serotonin receptors",
            "probability": 0.009863466534105728,
            "start_logit": -0.34744003415107727,
            "end_logit": -1.1377756595611572,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2A)",
            "probability": 0.00826530010960613,
            "start_logit": -0.34744003415107727,
            "end_logit": -1.3145473003387451,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "antagonist",
            "probability": 0.008246547682707652,
            "start_logit": -1.5488064289093018,
            "end_logit": -0.11545229703187943,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2) receptor antagonists (0.01\u03bcM altanserin",
            "probability": 0.007457547459694318,
            "start_logit": 1.3788087368011475,
            "end_logit": -3.1436355113983154,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2C) serotonin",
            "probability": 0.007155194712982492,
            "start_logit": 0.04992479085922241,
            "end_logit": -1.8561395406723022,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "2)",
            "probability": 0.007090224677402851,
            "start_logit": -2.343228816986084,
            "end_logit": 0.5278924703598022,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2) receptor antagonists (0.01\u03bcM",
            "probability": 0.006522204757508844,
            "start_logit": 1.3788087368011475,
            "end_logit": -3.2776496410369873,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "receptor antagonist",
            "probability": 0.005173839386021297,
            "start_logit": -2.014986038208008,
            "end_logit": -0.11545229703187943,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "5-HT(2A) and 5-HT(2C) serotonin",
            "probability": 0.004808926128974055,
            "start_logit": -0.34744003415107727,
            "end_logit": -1.8561395406723022,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "serotonin receptors",
            "probability": 0.004579622718767258,
            "start_logit": -1.1146610975265503,
            "end_logit": -1.1377756595611572,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        },
        {
            "text": "receptor",
            "probability": 0.004525450983474943,
            "start_logit": -2.014986038208008,
            "end_logit": -0.24935010075569153,
            "question_text": "Which receptors can be evaluated with the [18F]altanserin?"
        }
    ],
    "550316a6e9bde69634000029": [
        {
            "text": "rheumatoid arthritis",
            "probability": 0.4216380038013188,
            "start_logit": 5.933627605438232,
            "end_logit": 5.628678798675537,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid factor-positive (RF+) rheumatoid arthritis",
            "probability": 0.31485854556093656,
            "start_logit": 5.641603946685791,
            "end_logit": 5.628678798675537,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis (RA)",
            "probability": 0.12514256266105075,
            "start_logit": 5.933627605438232,
            "end_logit": 4.413985252380371,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid factor-positive (RF+) rheumatoid arthritis (RA)",
            "probability": 0.09345031736226896,
            "start_logit": 5.641603946685791,
            "end_logit": 4.413985252380371,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis (RA),",
            "probability": 0.014669820087540211,
            "start_logit": 5.933627605438232,
            "end_logit": 2.2703239917755127,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid factor-positive (RF+) rheumatoid arthritis (RA),",
            "probability": 0.010954700892142576,
            "start_logit": 5.641603946685791,
            "end_logit": 2.2703239917755127,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis (RA), among other autoimmune diseases",
            "probability": 0.0072449960987020405,
            "start_logit": 5.933627605438232,
            "end_logit": 1.564842700958252,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "RF+ RA",
            "probability": 0.004922768121497702,
            "start_logit": 4.002309322357178,
            "end_logit": 3.1097209453582764,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis (RA), among other autoimmune diseases.",
            "probability": 0.0015857268433602616,
            "start_logit": 5.933627605438232,
            "end_logit": 0.04557454213500023,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid factor-positive (RF+)",
            "probability": 0.001075158547431105,
            "start_logit": 5.641603946685791,
            "end_logit": -0.05097654089331627,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "arthritis",
            "probability": 0.0010132786425522684,
            "start_logit": -0.09732827544212341,
            "end_logit": 5.628678798675537,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid",
            "probability": 0.0007374767878109505,
            "start_logit": 5.933627605438232,
            "end_logit": -0.719989001750946,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid factor-positive (RF+) rheumatoid",
            "probability": 0.000550711431848357,
            "start_logit": 5.641603946685791,
            "end_logit": -0.719989001750946,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid arthritis (RA), among other autoimmune",
            "probability": 0.0005418911060031166,
            "start_logit": 5.933627605438232,
            "end_logit": -1.0281585454940796,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid art",
            "probability": 0.000452775872046872,
            "start_logit": 5.933627605438232,
            "end_logit": -1.2078263759613037,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid factor-positive (RF+) rheumatoid art",
            "probability": 0.00033811077571873493,
            "start_logit": 5.641603946685791,
            "end_logit": -1.2078263759613037,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "arthritis (RA)",
            "probability": 0.0003007420699165759,
            "start_logit": -0.09732827544212341,
            "end_logit": 4.413985252380371,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "rheumatoid factor",
            "probability": 0.00023855357119045235,
            "start_logit": 5.641603946685791,
            "end_logit": -1.5566060543060303,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "(RA)",
            "probability": 0.00017022268914123234,
            "start_logit": -0.6664737462997437,
            "end_logit": 4.413985252380371,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        },
        {
            "text": "RF",
            "probability": 0.00011363707752294853,
            "start_logit": 4.002309322357178,
            "end_logit": -0.6588954925537109,
            "question_text": "Which diseases have been associated with the PTPN22 620W allele?"
        }
    ],
    "513f45abbee46bd34c000013": [
        {
            "text": "orbital",
            "probability": 0.9273530603274897,
            "start_logit": 1.5948299169540405,
            "end_logit": 1.7183635234832764,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital and thyroid tissues",
            "probability": 0.030273490732077444,
            "start_logit": 1.5948299169540405,
            "end_logit": -1.7036983966827393,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital and thyroid",
            "probability": 0.018414356375162935,
            "start_logit": 1.5948299169540405,
            "end_logit": -2.2008402347564697,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "infiltrate the orbital",
            "probability": 0.003915775202573419,
            "start_logit": -3.8724911212921143,
            "end_logit": 1.7183635234832764,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital and thyroid tissues in GD. These cells may be involved in the pathogenesis of thyroid-associated ophthalmopathy",
            "probability": 0.0030917942713823755,
            "start_logit": 1.5948299169540405,
            "end_logit": -3.9852192401885986,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "the orbital",
            "probability": 0.00287209094474379,
            "start_logit": -4.182464122772217,
            "end_logit": 1.7183635234832764,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "thyroid tissues",
            "probability": 0.0025631618118441553,
            "start_logit": -0.8742009401321411,
            "end_logit": -1.7036983966827393,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital and thy",
            "probability": 0.0023042813486763643,
            "start_logit": 1.5948299169540405,
            "end_logit": -4.279201984405518,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "fibrocytes represent a subset of peripheral blood mononuclear cells and infiltrate the orbital",
            "probability": 0.0020285023439163942,
            "start_logit": -4.530206680297852,
            "end_logit": 1.7183635234832764,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital and thyroid tissues in GD.",
            "probability": 0.001629629766606165,
            "start_logit": 1.5948299169540405,
            "end_logit": -4.625617980957031,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "thyroid",
            "probability": 0.0015590859827900557,
            "start_logit": -0.8742009401321411,
            "end_logit": -2.2008402347564697,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "pluripotent fibrocytes represent a subset of peripheral blood mononuclear cells and infiltrate the orbital",
            "probability": 0.0010968071509223569,
            "start_logit": -5.145101070404053,
            "end_logit": 1.7183635234832764,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "orbital and thyroid tissues in GD. These cells may be involved in the pathogenesis of thyroid-associated op",
            "probability": 0.0009431411608588792,
            "start_logit": 1.5948299169540405,
            "end_logit": -5.172510147094727,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "peripheral blood mononuclear cells and infiltrate the orbital",
            "probability": 0.0006246487178388247,
            "start_logit": -5.708070278167725,
            "end_logit": 1.7183635234832764,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "tes represent a subset of peripheral blood mononuclear cells and infiltrate the orbital",
            "probability": 0.00035057834070052426,
            "start_logit": -6.285675525665283,
            "end_logit": 1.7183635234832764,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "thyroid tissues in GD. These cells may be involved in the pathogenesis of thyroid-associated ophthalmopathy",
            "probability": 0.00026177255462941495,
            "start_logit": -0.8742009401321411,
            "end_logit": -3.9852192401885986,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "rate the orbital",
            "probability": 0.00025692031987541945,
            "start_logit": -6.596493721008301,
            "end_logit": 1.7183635234832764,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "thy",
            "probability": 0.00019509629758070199,
            "start_logit": -0.8742009401321411,
            "end_logit": -4.279201984405518,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "thyroid tissues in GD.",
            "probability": 0.00013797565738871072,
            "start_logit": -0.8742009401321411,
            "end_logit": -4.625617980957031,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        },
        {
            "text": "infiltrate the orbital and thyroid tissues",
            "probability": 0.0001278306929424936,
            "start_logit": -3.8724911212921143,
            "end_logit": -1.7036983966827393,
            "question_text": "Which extra thyroid tissues have thyrotropin (TSH) receptors?"
        }
    ],
    "56ddbbaf51531f7e33000009": [
        {
            "text": "H3K27me3",
            "probability": 0.31149613708055796,
            "start_logit": 3.9580960273742676,
            "end_logit": 3.312952995300293,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac and H3K27me3",
            "probability": 0.28295693502409974,
            "start_logit": 3.862003803253174,
            "end_logit": 3.312952995300293,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac",
            "probability": 0.20892807223866333,
            "start_logit": 3.862003803253174,
            "end_logit": 3.009648323059082,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K4me1",
            "probability": 0.18236673492304742,
            "start_logit": 3.9640321731567383,
            "end_logit": 2.7716495990753174,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27me3,",
            "probability": 0.0036189153144543192,
            "start_logit": 3.9580960273742676,
            "end_logit": -1.1422595977783203,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac and H3K27me3,",
            "probability": 0.003287351153330509,
            "start_logit": 3.862003803253174,
            "end_logit": -1.1422595977783203,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "P300 and the histone modification H3K4me1",
            "probability": 0.0031650155833510972,
            "start_logit": -0.08982953429222107,
            "end_logit": 2.7716495990753174,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K4me1, indicate the presence of enhancers, only a fraction of enhancers are functionally active. Individual chromatin marks",
            "probability": 0.0008554138905647286,
            "start_logit": 3.9640321731567383,
            "end_logit": -2.5905399322509766,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27me3, have been identified to distinguish active from inactive enhancers",
            "probability": 0.0006246533905441601,
            "start_logit": 3.9580960273742676,
            "end_logit": -2.8989923000335693,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac and H3K27me3, have been identified to distinguish active from inactive enhancers",
            "probability": 0.0005674227953429711,
            "start_logit": 3.862003803253174,
            "end_logit": -2.8989923000335693,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H",
            "probability": 0.000402330588923684,
            "start_logit": 3.9640321731567383,
            "end_logit": -3.34485125541687,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K4me1,",
            "probability": 0.00030463185122489936,
            "start_logit": 3.9640321731567383,
            "end_logit": -3.623021364212036,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "Individual chromatin marks, such as H3K27ac and H3K27me3",
            "probability": 0.00023181010204322613,
            "start_logit": -3.2451276779174805,
            "end_logit": 3.312952995300293,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27me3, have been identified to distinguish active from inactive enhancers.",
            "probability": 0.00020479324949350739,
            "start_logit": 3.9580960273742676,
            "end_logit": -4.014188289642334,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K27ac and H3K27me3, have been identified to distinguish active from inactive enhancers.",
            "probability": 0.00018603014064127034,
            "start_logit": 3.862003803253174,
            "end_logit": -4.014188289642334,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K4me1, indicate the presence of enhancers, only a fraction of enhancers are functionally active. Individual",
            "probability": 0.00018464133454260915,
            "start_logit": 3.9640321731567383,
            "end_logit": -4.1237101554870605,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "H3K4me1, indicate the presence of enhancers",
            "probability": 0.00017825924689572294,
            "start_logit": 3.9640321731567383,
            "end_logit": -4.158886432647705,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "Individual chromatin marks, such as H3K27ac",
            "probability": 0.00017116257546829195,
            "start_logit": -3.2451276779174805,
            "end_logit": 3.009648323059082,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "K27me3",
            "probability": 0.00013838235213013377,
            "start_logit": -3.7610256671905518,
            "end_logit": 3.312952995300293,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        },
        {
            "text": "histone modification H3K4me1",
            "probability": 0.00013130716468037534,
            "start_logit": -3.2722034454345703,
            "end_logit": 2.7716495990753174,
            "question_text": "Which histone modifications distinguish between promoters and enhancers?"
        }
    ],
    "517843638ed59a060a000036": [
        {
            "text": "Long Interspersed Element-1",
            "probability": 0.13910447176848723,
            "start_logit": 5.539622783660889,
            "end_logit": 4.52101469039917,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA",
            "probability": 0.09756664160840699,
            "start_logit": 5.539622783660889,
            "end_logit": 4.166325092315674,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA elements",
            "probability": 0.0950403915168965,
            "start_logit": 5.539622783660889,
            "end_logit": 4.140091419219971,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1), Alu",
            "probability": 0.0903847685358034,
            "start_logit": 5.539622783660889,
            "end_logit": 4.089865207672119,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, and SVA",
            "probability": 0.08013811861692127,
            "start_logit": 5.342838764190674,
            "end_logit": 4.166325092315674,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, and SVA elements",
            "probability": 0.07806313759726063,
            "start_logit": 5.342838764190674,
            "end_logit": 4.140091419219971,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA",
            "probability": 0.07541080744237567,
            "start_logit": 5.282037734985352,
            "end_logit": 4.166325092315674,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu",
            "probability": 0.07423915779695196,
            "start_logit": 5.342838764190674,
            "end_logit": 4.089865207672119,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA elements",
            "probability": 0.07345822860947089,
            "start_logit": 5.282037734985352,
            "end_logit": 4.140091419219971,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1)",
            "probability": 0.04525963600071208,
            "start_logit": 5.539622783660889,
            "end_logit": 3.398205041885376,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1",
            "probability": 0.03228478354353343,
            "start_logit": 5.539622783660889,
            "end_logit": 3.0603854656219482,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1), Alu, and SVA",
            "probability": 0.01834362251112897,
            "start_logit": 3.8683691024780273,
            "end_logit": 4.166325092315674,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element",
            "probability": 0.018011952309656683,
            "start_logit": 5.539622783660889,
            "end_logit": 2.476824998855591,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1), Alu, and SVA elements",
            "probability": 0.017868659170345285,
            "start_logit": 3.8683691024780273,
            "end_logit": 4.140091419219971,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1), Alu",
            "probability": 0.016993349852411868,
            "start_logit": 3.8683691024780273,
            "end_logit": 4.089865207672119,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA elements). LINE-1",
            "probability": 0.012081848755665621,
            "start_logit": 5.539622783660889,
            "end_logit": 2.077493667602539,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Alu, and SVA elements). LINE-1",
            "probability": 0.009923644113725507,
            "start_logit": 5.342838764190674,
            "end_logit": 2.077493667602539,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "SVA elements). LINE-1",
            "probability": 0.00933825286021631,
            "start_logit": 5.282037734985352,
            "end_logit": 2.077493667602539,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "LINE-1)",
            "probability": 0.008509319005981113,
            "start_logit": 3.8683691024780273,
            "end_logit": 3.398205041885376,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        },
        {
            "text": "Long Interspersed Element-1 (LINE-1), Alu, and SVA elements). LINE-1 or L1",
            "probability": 0.007979208384048316,
            "start_logit": 5.539622783660889,
            "end_logit": 1.6626286506652832,
            "question_text": "What are the major classes of retrotransposons active in the human genome?"
        }
    ],
    "55031286e9bde6963400001b": [
        {
            "text": "reticulocytopenia",
            "probability": 0.4863247144435786,
            "start_logit": 5.007399082183838,
            "end_logit": 5.678527355194092,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "short stature and physical malformation. All patients had anemia with reticulocytopenia",
            "probability": 0.3144218398809317,
            "start_logit": 4.571258068084717,
            "end_logit": 5.678527355194092,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "short stature and physical malformation",
            "probability": 0.06478611594068052,
            "start_logit": 4.571258068084717,
            "end_logit": 4.098883152008057,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "macrocytic anemia",
            "probability": 0.03676560500420355,
            "start_logit": 4.476588726043701,
            "end_logit": 3.627023935317993,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "short stature",
            "probability": 0.03569378008661046,
            "start_logit": 4.571258068084717,
            "end_logit": 3.5027682781219482,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "anemia with reticulocytopenia",
            "probability": 0.015122153325622707,
            "start_logit": 1.5366833209991455,
            "end_logit": 5.678527355194092,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "physical malformation. All patients had anemia with reticulocytopenia",
            "probability": 0.014177146095261208,
            "start_logit": 1.4721537828445435,
            "end_logit": 5.678527355194092,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "macrocytic",
            "probability": 0.011867561664450948,
            "start_logit": 4.476588726043701,
            "end_logit": 2.496269941329956,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "reticulocytopenia. Thirty-four patients (75.6%) had mean corpuscular volume",
            "probability": 0.01078419162952644,
            "start_logit": 5.007399082183838,
            "end_logit": 1.869732141494751,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "physical malformation",
            "probability": 0.002921178220264147,
            "start_logit": 1.4721537828445435,
            "end_logit": 4.098883152008057,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "mean corpuscular volume. Eleven patients (24.4%) had macrocytic anemia",
            "probability": 0.001762288623586303,
            "start_logit": 1.4386392831802368,
            "end_logit": 3.627023935317993,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "macrocytic anemia. Bone marrow examination showed a marked erythroid hypoplasia",
            "probability": 0.0015560320166482624,
            "start_logit": 4.476588726043701,
            "end_logit": 0.46460017561912537,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "malformation. All patients had anemia with reticulocytopenia",
            "probability": 0.0011402378863977145,
            "start_logit": -1.0482405424118042,
            "end_logit": 5.678527355194092,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "14 cases (31.1%) had short stature and physical malformation. All patients had anemia with reticulocytopenia",
            "probability": 0.0006373408649604537,
            "start_logit": -1.6299281120300293,
            "end_logit": 5.678527355194092,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "mean corpuscular volume. Eleven patients (24.4%) had macrocytic",
            "probability": 0.0005688487625480295,
            "start_logit": 1.4386392831802368,
            "end_logit": 2.496269941329956,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "anemia with reticulocytopenia. Thirty-four patients (75.6%) had mean corpuscular volume",
            "probability": 0.0003353319181016364,
            "start_logit": 1.5366833209991455,
            "end_logit": 1.869732141494751,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "enia",
            "probability": 0.0003186029714817405,
            "start_logit": -2.323287010192871,
            "end_logit": 5.678527355194092,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "mean corpuscular volume",
            "probability": 0.0003040149274914289,
            "start_logit": 1.4386392831802368,
            "end_logit": 1.869732141494751,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "short",
            "probability": 0.0002780715495017542,
            "start_logit": 4.571258068084717,
            "end_logit": -1.352084994316101,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        },
        {
            "text": "malformation",
            "probability": 0.00023494418815211192,
            "start_logit": -1.0482405424118042,
            "end_logit": 4.098883152008057,
            "question_text": "Which are the clinical characteristics of Diamond-Blackfan anemia?"
        }
    ],
    "533ec7abc45e133714000015": [
        {
            "text": "NELF",
            "probability": 0.3542007190092454,
            "start_logit": 4.9471330642700195,
            "end_logit": 4.8040642738342285,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF and DSIF",
            "probability": 0.2996079657630429,
            "start_logit": 4.9471330642700195,
            "end_logit": 4.6366753578186035,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF",
            "probability": 0.27469644033180496,
            "start_logit": 4.860324859619141,
            "end_logit": 4.6366753578186035,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "P-TEFb",
            "probability": 0.05923930015390264,
            "start_logit": 4.106250286102295,
            "end_logit": 3.856668472290039,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "TEFb",
            "probability": 0.007840978304705086,
            "start_logit": 2.084028720855713,
            "end_logit": 3.856668472290039,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "P-TEFb is recruited to initiate productive elongation. However, the mechanism of P-TEFb",
            "probability": 0.0012010671466120483,
            "start_logit": 4.106250286102295,
            "end_logit": -0.041706252843141556,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "P-TEF",
            "probability": 0.0009371142504713827,
            "start_logit": 4.106250286102295,
            "end_logit": -0.28986677527427673,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "P-TEFb is recruited to initiate productive elongation. However, the mechanism of P-TEFb recruitment and regulation of NELF",
            "probability": 0.0006214818479894577,
            "start_logit": 4.106250286102295,
            "end_logit": -0.7005652785301208,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NELF and DSIF,",
            "probability": 0.00035638930267364123,
            "start_logit": 4.9471330642700195,
            "end_logit": -2.0975310802459717,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF,",
            "probability": 0.0003267565752714691,
            "start_logit": 4.860324859619141,
            "end_logit": -2.0975310802459717,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "TEFb is recruited to initiate productive elongation. However, the mechanism of P-TEFb",
            "probability": 0.0001589745559892252,
            "start_logit": 2.084028720855713,
            "end_logit": -0.041706252843141556,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF, are detected near the transcription start site (TSS) of many active and silent genes. Active transcription starts when the pause release factor",
            "probability": 0.00012473747930559454,
            "start_logit": 4.860324859619141,
            "end_logit": -3.060535192489624,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "TEF",
            "probability": 0.00012403746310112352,
            "start_logit": 2.084028720855713,
            "end_logit": -0.28986677527427673,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "LF",
            "probability": 0.00011775361278189164,
            "start_logit": -3.061891555786133,
            "end_logit": 4.8040642738342285,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "LF and DSIF",
            "probability": 9.960431612198597e-05,
            "start_logit": -3.061891555786133,
            "end_logit": 4.6366753578186035,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "NE",
            "probability": 9.521572455124846e-05,
            "start_logit": 4.9471330642700195,
            "end_logit": -3.417409658432007,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "pause release factor P-TEFb",
            "probability": 8.612491782416726e-05,
            "start_logit": -2.4272913932800293,
            "end_logit": 3.856668472290039,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "TEFb is recruited to initiate productive elongation. However, the mechanism of P-TEFb recruitment and regulation of NELF",
            "probability": 8.226001445313041e-05,
            "start_logit": 2.084028720855713,
            "end_logit": -0.7005652785301208,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "F",
            "probability": 4.2069371183120495e-05,
            "start_logit": -3.9237771034240723,
            "end_logit": 4.6366753578186035,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        },
        {
            "text": "DSIF, are detected near the transcription start site (TSS) of many active and silent genes. Active transcription starts when the pause",
            "probability": 4.100985896947971e-05,
            "start_logit": 4.860324859619141,
            "end_logit": -4.172934055328369,
            "question_text": "Which factors play a role in promoter proximal pausing of RNA polymerase II?"
        }
    ],
    "54ecb640445c3b5a5f000001": [
        {
            "text": "pancytopenia",
            "probability": 0.6501840867451539,
            "start_logit": 4.934340000152588,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "Bone marrow failure resulting in pancytopenia",
            "probability": 0.19787561270215429,
            "start_logit": 3.744723081588745,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cancer predisposition. Bone marrow failure resulting in pancytopenia",
            "probability": 0.085141852779217,
            "start_logit": 2.9014031887054443,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "Bone marrow failure",
            "probability": 0.03870621137063112,
            "start_logit": 3.744723081588745,
            "end_logit": 3.120051860809326,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cancer predisposition. Bone marrow failure",
            "probability": 0.01665449574688115,
            "start_logit": 2.9014031887054443,
            "end_logit": 3.120051860809326,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cancer",
            "probability": 0.0030972269568735993,
            "start_logit": 2.9014031887054443,
            "end_logit": 1.4378788471221924,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cancer predisposition",
            "probability": 0.002307867749483163,
            "start_logit": 2.9014031887054443,
            "end_logit": 1.1436957120895386,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "chromosomal instability syndrome with cancer predisposition. Bone marrow failure resulting in pancytopenia",
            "probability": 0.0013750095179733653,
            "start_logit": -1.2244548797607422,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "hereditary chromosomal instability syndrome with cancer predisposition. Bone marrow failure resulting in pancytopenia",
            "probability": 0.0011505482789384435,
            "start_logit": -1.4026769399642944,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "hypogonadism",
            "probability": 0.0008221578385916056,
            "start_logit": 1.4407371282577515,
            "end_logit": 1.5722148418426514,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "enia",
            "probability": 0.0004736609629798863,
            "start_logit": -2.2901790142059326,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "instability syndrome with cancer predisposition. Bone marrow failure resulting in pancytopenia",
            "probability": 0.0004470418282592353,
            "start_logit": -2.3480186462402344,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "failure resulting in pancytopenia",
            "probability": 0.0003510892436734028,
            "start_logit": -2.589630365371704,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "pan",
            "probability": 0.0003028175044539915,
            "start_logit": 4.934340000152588,
            "end_logit": -2.9201900959014893,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "chromosomal instability syndrome with cancer predisposition. Bone marrow failure",
            "probability": 0.0002689639633329472,
            "start_logit": -1.2244548797607422,
            "end_logit": 3.120051860809326,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "hereditary chromosomal instability syndrome with cancer predisposition. Bone marrow failure",
            "probability": 0.00022505736946846312,
            "start_logit": -1.4026769399642944,
            "end_logit": 3.120051860809326,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "topenia",
            "probability": 0.0001850299545020554,
            "start_logit": -3.2301530838012695,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "syndrome with cancer predisposition. Bone marrow failure resulting in pancytopenia",
            "probability": 0.00015421582142822739,
            "start_logit": -3.4123177528381348,
            "end_logit": 4.75169038772583,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "cancer predisposition.",
            "probability": 0.00015348107915621204,
            "start_logit": 2.9014031887054443,
            "end_logit": -1.5668063163757324,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        },
        {
            "text": "hypogonadism and impaired fertility",
            "probability": 0.0001235725868479163,
            "start_logit": 1.4407371282577515,
            "end_logit": -0.3228888213634491,
            "question_text": "Which are the main clinical features of Fanconi anemia?"
        }
    ],
    "513f3d1fbee46bd34c000010": [
        {
            "text": "levothyroxine",
            "probability": 0.22495925660783495,
            "start_logit": -1.5020115375518799,
            "end_logit": -4.779412746429443,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "le",
            "probability": 0.13149417012104822,
            "start_logit": -1.5020115375518799,
            "end_logit": -5.316369533538818,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine (L-T(4)",
            "probability": 0.12777114162549802,
            "start_logit": -1.5020115375518799,
            "end_logit": -5.345091342926025,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine (L-T(4))",
            "probability": 0.12611052186500715,
            "start_logit": -1.5020115375518799,
            "end_logit": -5.358173370361328,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine (L-T(4",
            "probability": 0.07296949279301401,
            "start_logit": -1.5020115375518799,
            "end_logit": -5.905290603637695,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levo",
            "probability": 0.0649363187391756,
            "start_logit": -1.5020115375518799,
            "end_logit": -6.02192497253418,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine (L-T(4)) by pharmacists",
            "probability": 0.05506285240793604,
            "start_logit": -1.5020115375518799,
            "end_logit": -6.186856746673584,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine (",
            "probability": 0.04989342454161447,
            "start_logit": -1.5020115375518799,
            "end_logit": -6.28544282913208,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxin",
            "probability": 0.04634307936030079,
            "start_logit": -1.5020115375518799,
            "end_logit": -6.359260082244873,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "levothyroxine (L",
            "probability": 0.04457225193127481,
            "start_logit": -1.5020115375518799,
            "end_logit": -6.398220539093018,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "generic substitution of levothyroxine",
            "probability": 0.009312337836992621,
            "start_logit": -4.686590671539307,
            "end_logit": -4.779412746429443,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "substitution of levothyroxine",
            "probability": 0.008762986370144962,
            "start_logit": -4.74739408493042,
            "end_logit": -4.779412746429443,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "generic substitution of le",
            "probability": 0.005443288505779736,
            "start_logit": -4.686590671539307,
            "end_logit": -5.316369533538818,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "generic substitution of levothyroxine (L-T(4)",
            "probability": 0.005289171268507063,
            "start_logit": -4.686590671539307,
            "end_logit": -5.345091342926025,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "generic substitution of levothyroxine (L-T(4))",
            "probability": 0.005220428810598628,
            "start_logit": -4.686590671539307,
            "end_logit": -5.358173370361328,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "substitution of le",
            "probability": 0.005122179179908157,
            "start_logit": -4.74739408493042,
            "end_logit": -5.316369533538818,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "substitution of levothyroxine (L-T(4)",
            "probability": 0.0049771535941460126,
            "start_logit": -4.74739408493042,
            "end_logit": -5.345091342926025,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "substitution of levothyroxine (L-T(4))",
            "probability": 0.004912466376795615,
            "start_logit": -4.74739408493042,
            "end_logit": -5.358173370361328,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "generic substitution",
            "probability": 0.0034354036710808502,
            "start_logit": -4.686590671539307,
            "end_logit": -5.776618480682373,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        },
        {
            "text": "pharmacokinetic standard used is too insensitive.",
            "probability": 0.00341207439334194,
            "start_logit": -6.712917804718018,
            "end_logit": -3.7571053504943848,
            "question_text": "Which drugs may interfere thyroxine absorption?"
        }
    ],
    "553f7a71ab98a37113000009": [
        {
            "text": "nucleotide excision repair",
            "probability": 0.7728856543695869,
            "start_logit": 5.138463497161865,
            "end_logit": 4.97636079788208,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide excision repair (NER)",
            "probability": 0.07941472024106587,
            "start_logit": 5.138463497161865,
            "end_logit": 2.700913429260254,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "excision repair",
            "probability": 0.05481962416460794,
            "start_logit": 2.4923806190490723,
            "end_logit": 4.97636079788208,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide excision repair (NER",
            "probability": 0.05439139345081111,
            "start_logit": 5.138463497161865,
            "end_logit": 2.3224356174468994,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide excision",
            "probability": 0.015268209624397159,
            "start_logit": 5.138463497161865,
            "end_logit": 1.0520025491714478,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "excision repair (NER)",
            "probability": 0.00563276739856646,
            "start_logit": 2.4923806190490723,
            "end_logit": 2.700913429260254,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "excision repair (NER",
            "probability": 0.003857900233890166,
            "start_logit": 2.4923806190490723,
            "end_logit": 2.3224356174468994,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "NER)",
            "probability": 0.003173573872858846,
            "start_logit": 1.9186381101608276,
            "end_logit": 2.700913429260254,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "repair",
            "probability": 0.002310749350624624,
            "start_logit": -0.6740957498550415,
            "end_logit": 4.97636079788208,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "NER",
            "probability": 0.0021735907982789755,
            "start_logit": 1.9186381101608276,
            "end_logit": 2.3224356174468994,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "Escherichia coli nucleotide excision repair",
            "probability": 0.0012923431653486066,
            "start_logit": -1.2552106380462646,
            "end_logit": 4.97636079788208,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "excision",
            "probability": 0.001082951285929364,
            "start_logit": 2.4923806190490723,
            "end_logit": 1.0520025491714478,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "n",
            "probability": 0.0009379734636473388,
            "start_logit": 5.138463497161865,
            "end_logit": -1.7378039360046387,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide ex",
            "probability": 0.0005978473013733349,
            "start_logit": 5.138463497161865,
            "end_logit": -2.188190221786499,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "tide excision repair",
            "probability": 0.00046868827948372824,
            "start_logit": -2.2694849967956543,
            "end_logit": 4.97636079788208,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "cision repair",
            "probability": 0.0004111631399352524,
            "start_logit": -2.400432825088501,
            "end_logit": 4.97636079788208,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts",
            "probability": 0.0003839359427093447,
            "start_logit": 5.138463497161865,
            "end_logit": -2.631049871444702,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "leotide excision repair",
            "probability": 0.00035066007135390296,
            "start_logit": -2.559605598449707,
            "end_logit": 4.97636079788208,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "nucleotide excision repair (NER) is responsible for removing bulky DNA adducts by dual incisions",
            "probability": 0.00030882219934995705,
            "start_logit": 5.138463497161865,
            "end_logit": -2.848759889602661,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        },
        {
            "text": "repair (NER)",
            "probability": 0.0002374316461815547,
            "start_logit": -0.6740957498550415,
            "end_logit": 2.700913429260254,
            "question_text": "In which types of DNA repair is the UvrAB complex involved?"
        }
    ],
    "53355befd6d3ac6a34000046": [
        {
            "text": "GalaxyDock",
            "probability": 0.847433089713026,
            "start_logit": 4.789331436157227,
            "end_logit": 4.750194072723389,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking program called GalaxyDock",
            "probability": 0.12574271579282498,
            "start_logit": 2.881357431411743,
            "end_logit": 4.750194072723389,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "dock",
            "probability": 0.012536535882453946,
            "start_logit": 2.881357431411743,
            "end_logit": 2.444603443145752,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "GalaxyDock is higher or comparable to previous flexible dock",
            "probability": 0.0035742498416101456,
            "start_logit": 3.1307950019836426,
            "end_logit": 0.9402739405632019,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "galaxydock",
            "probability": 0.002551788453032447,
            "start_logit": 1.8890050649642944,
            "end_logit": 1.8451030254364014,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking tests show that the performance of GalaxyDock",
            "probability": 0.001917482244580975,
            "start_logit": 0.4522993862628937,
            "end_logit": 2.9960272312164307,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "a new docking program called GalaxyDock",
            "probability": 0.001665854582414221,
            "start_logit": -1.4425421953201294,
            "end_logit": 4.750194072723389,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "GalaxyDock that accounts for the flexibility of preselected receptor side-chains by global optimization of an AutoDock",
            "probability": 0.001063152546331381,
            "start_logit": 4.789331436157227,
            "end_logit": -1.930779218673706,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "new docking program called GalaxyDock",
            "probability": 0.0009571890226752727,
            "start_logit": -1.996634840965271,
            "end_logit": 4.750194072723389,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "Galaxy",
            "probability": 0.0008487926402963793,
            "start_logit": 4.789331436157227,
            "end_logit": -2.1559581756591797,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking tests show that the performance of GalaxyDock is higher or comparable to previous flexible dock",
            "probability": 0.00024543078750775685,
            "start_logit": 0.4522993862628937,
            "end_logit": 0.9402739405632019,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking",
            "probability": 0.00022037095392404095,
            "start_logit": 2.881357431411743,
            "end_logit": -1.5964868068695068,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking program",
            "probability": 0.00019917874879062862,
            "start_logit": 2.881357431411743,
            "end_logit": -1.6975964307785034,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking methods tested on the same sets, increasing the binding conformation prediction accuracy by 10%-60% compared to rigid-receptor dock",
            "probability": 0.00017073489190616543,
            "start_logit": 0.5362763404846191,
            "end_logit": 0.49339401721954346,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docked conformation has been less popular because of the large increase in computational complexity. In this paper, we present a new dock",
            "probability": 0.000170669896207233,
            "start_logit": -1.4153138399124146,
            "end_logit": 2.444603443145752,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "a new dock",
            "probability": 0.00016608553120321489,
            "start_logit": -1.4425421953201294,
            "end_logit": 2.444603443145752,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking program called GalaxyDock that accounts for the flexibility of preselected receptor side-chains by global optimization of an AutoDock",
            "probability": 0.0001577513199573497,
            "start_logit": 2.881357431411743,
            "end_logit": -1.930779218673706,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "GalaxyDock is higher or comparable to previous flexible docking methods",
            "probability": 0.00014115144110973018,
            "start_logit": 3.1307950019836426,
            "end_logit": -2.291403293609619,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "docking program called Galaxy",
            "probability": 0.0001259444468612524,
            "start_logit": 2.881357431411743,
            "end_logit": -2.1559581756591797,
            "question_text": "List programs suitable for protein docking"
        },
        {
            "text": "GalaxyDock is higher or comparable to previous flexible docking",
            "probability": 0.0001118312632865944,
            "start_logit": 3.1307950019836426,
            "end_logit": -2.524245500564575,
            "question_text": "List programs suitable for protein docking"
        }
    ],
    "52f89f4f2059c6d71c00004e": [
        {
            "text": "NBEAL2",
            "probability": 0.8469015796712065,
            "start_logit": 4.876278400421143,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL2 gene",
            "probability": 0.14576309367475263,
            "start_logit": 4.876278400421143,
            "end_logit": 3.0856645107269287,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the NBEAL2",
            "probability": 0.0039028853034075053,
            "start_logit": -0.5035899877548218,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "NBEAL",
            "probability": 0.001002757837825636,
            "start_logit": 4.876278400421143,
            "end_logit": -1.8935641050338745,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "the NBEAL2 gene",
            "probability": 0.0006717387825669977,
            "start_logit": -0.5035899877548218,
            "end_logit": 3.0856645107269287,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "2",
            "probability": 0.0005221501376537578,
            "start_logit": -2.515106201171875,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "biallelic mutations in the NBEAL2",
            "probability": 0.00035758655951934537,
            "start_logit": -2.893683910369873,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "N",
            "probability": 0.00016928852797136286,
            "start_logit": 4.876278400421143,
            "end_logit": -3.672468900680542,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "in the NBEAL2",
            "probability": 0.00011240462884302632,
            "start_logit": -4.0509562492370605,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "mutations in the NBEAL2",
            "probability": 0.00010570208267593816,
            "start_logit": -4.112436771392822,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "in biallelic mutations in the NBEAL2",
            "probability": 0.00010402065824400837,
            "start_logit": -4.128471851348877,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "2 gene",
            "probability": 8.986902522564432e-05,
            "start_logit": -2.515106201171875,
            "end_logit": 3.0856645107269287,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "identified in biallelic mutations in the NBEAL2",
            "probability": 6.464711616859543e-05,
            "start_logit": -4.6041178703308105,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "biallelic mutations in the NBEAL2 gene",
            "probability": 6.154543151553287e-05,
            "start_logit": -2.893683910369873,
            "end_logit": 3.0856645107269287,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "The genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the NBEAL2",
            "probability": 4.127107977371965e-05,
            "start_logit": -5.052899360656738,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "recently identified in biallelic mutations in the NBEAL2",
            "probability": 4.010984729580613e-05,
            "start_logit": -5.08143949508667,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "genetic defect responsible for gray platelet syndrome was recently identified in biallelic mutations in the NBEAL2",
            "probability": 3.0298539988092415e-05,
            "start_logit": -5.361961841583252,
            "end_logit": 4.845266342163086,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "gene",
            "probability": 2.151201197606778e-05,
            "start_logit": -3.94484806060791,
            "end_logit": 3.0856645107269287,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "in the NBEAL2 gene",
            "probability": 1.9346340633681185e-05,
            "start_logit": -4.0509562492370605,
            "end_logit": 3.0856645107269287,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        },
        {
            "text": "mutations in the NBEAL2 gene",
            "probability": 1.819274275611916e-05,
            "start_logit": -4.112436771392822,
            "end_logit": 3.0856645107269287,
            "question_text": "Which genes have been found mutated in Gray platelet syndrome patients?"
        }
    ],
    "550712739d0faaa527000008": [
        {
            "text": "RYR2-S4153R",
            "probability": 0.58663233017837,
            "start_logit": 3.1129751205444336,
            "end_logit": 4.067089557647705,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "S4153R",
            "probability": 0.35768783774830143,
            "start_logit": 2.6182374954223633,
            "end_logit": 4.067089557647705,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "S4153R mutation",
            "probability": 0.0336453915009942,
            "start_logit": 3.2297723293304443,
            "end_logit": 1.0917701721191406,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2-S4153R mutation",
            "probability": 0.013283590041499722,
            "start_logit": 3.1129751205444336,
            "end_logit": 0.27922073006629944,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "the S4153R",
            "probability": 0.004361224157231929,
            "start_logit": -0.6081739068031311,
            "end_logit": 2.8865931034088135,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "R",
            "probability": 0.0008279940792268618,
            "start_logit": -3.4501724243164062,
            "end_logit": 4.067089557647705,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "The novel RYR2-S4153R",
            "probability": 0.0008215511658011402,
            "start_logit": -3.457984209060669,
            "end_logit": 4.067089557647705,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "the S4153R mutation",
            "probability": 0.000724647359368387,
            "start_logit": -0.6081739068031311,
            "end_logit": 1.0917701721191406,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "-S4153R",
            "probability": 0.0005048427127563848,
            "start_logit": -3.9449315071105957,
            "end_logit": 4.067089557647705,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "S",
            "probability": 0.0003443862734525126,
            "start_logit": 3.2297723293304443,
            "end_logit": -3.4900972843170166,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor 2",
            "probability": 0.0002631265554613264,
            "start_logit": 0.9287848472595215,
            "end_logit": -1.4582386016845703,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2-S4153R mutation has been implicated as a cause of CPVT and atrial fibrillation.",
            "probability": 0.00020383852917233287,
            "start_logit": 3.1129751205444336,
            "end_logit": -3.897735834121704,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2 mutations. We conclude that the S4153R",
            "probability": 0.00020159048848909845,
            "start_logit": -3.682443618774414,
            "end_logit": 2.8865931034088135,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor 2 (RYR2)",
            "probability": 0.00016259189154643045,
            "start_logit": 0.9287848472595215,
            "end_logit": -1.939630389213562,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "S4153R mutation has been implicated as a cause of CPVT and atrial fibrillation.",
            "probability": 0.00012428664258459264,
            "start_logit": 2.6182374954223633,
            "end_logit": -3.897735834121704,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor",
            "probability": 6.060456969373367e-05,
            "start_logit": 0.9287848472595215,
            "end_logit": -2.9265034198760986,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor 2 (RYR2) gene can cause catecholaminergic polymorphic ventricular tachycardia",
            "probability": 4.5096480948681525e-05,
            "start_logit": 0.9287848472595215,
            "end_logit": -3.222069501876831,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "ryanodine receptor 2 (RYR2",
            "probability": 3.882667027769471e-05,
            "start_logit": 0.9287848472595215,
            "end_logit": -3.3717663288116455,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "RYR2 mutations. We conclude that the S4153R mutation",
            "probability": 3.349564477560051e-05,
            "start_logit": -3.682443618774414,
            "end_logit": 1.0917701721191406,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        },
        {
            "text": "The S4153R",
            "probability": 3.2747310047869916e-05,
            "start_logit": -3.0729222297668457,
            "end_logit": 0.45965418219566345,
            "question_text": "Which mutations in the cardiac isoform of the ryanodine receptor (RyR2) have been found to be related to CPVT?"
        }
    ],
    "511a20f3df1ebcce7d00000c": [
        {
            "text": "corneal endothelial deposits",
            "probability": 0.8726637140135362,
            "start_logit": 4.495354175567627,
            "end_logit": 4.27068567276001,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "endothelial deposits",
            "probability": 0.04270155615254356,
            "start_logit": 1.478039264678955,
            "end_logit": 4.27068567276001,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corneal endothelial deposits associated with rifabutin",
            "probability": 0.03196438439523793,
            "start_logit": 4.495354175567627,
            "end_logit": 0.9637576937675476,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corneal endothelial deposits associated with rifabutin therapy for Crohn's disease.",
            "probability": 0.018126073927274264,
            "start_logit": 4.495354175567627,
            "end_logit": 0.3964868485927582,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corneal",
            "probability": 0.008973384589874022,
            "start_logit": 4.495354175567627,
            "end_logit": -0.3066016733646393,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corneal endothelial deposits associated",
            "probability": 0.005853341832268242,
            "start_logit": 4.495354175567627,
            "end_logit": -0.7338518500328064,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corneal endothelial deposits associated with rifabutin therapy",
            "probability": 0.0044887015193131735,
            "start_logit": 4.495354175567627,
            "end_logit": -0.9993011355400085,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corn",
            "probability": 0.0026936195057163438,
            "start_logit": 4.495354175567627,
            "end_logit": -1.5099787712097168,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "rifabutin",
            "probability": 0.001572981035118258,
            "start_logit": 1.4837044477462769,
            "end_logit": 0.9637576937675476,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "endothelial deposits associated with rifabutin",
            "probability": 0.0015640950038557093,
            "start_logit": 1.478039264678955,
            "end_logit": 0.9637576937675476,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corneal endothelial",
            "probability": 0.001412371901982131,
            "start_logit": 4.495354175567627,
            "end_logit": -2.1555941104888916,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "deposits",
            "probability": 0.0011736439903967076,
            "start_logit": -2.1160826683044434,
            "end_logit": 4.27068567276001,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "eal endothelial deposits",
            "probability": 0.0010002049183371795,
            "start_logit": -2.275991201400757,
            "end_logit": 4.27068567276001,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corneal endothelial deposits associated with rifabutin therapy for Crohn's disease",
            "probability": 0.0009944354487311608,
            "start_logit": 4.495354175567627,
            "end_logit": -2.5064446926116943,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "rifabutin therapy for Crohn's disease.",
            "probability": 0.0008919918549409533,
            "start_logit": 1.4837044477462769,
            "end_logit": 0.3964868485927582,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "endothelial deposits associated with rifabutin therapy for Crohn's disease.",
            "probability": 0.000886952844722786,
            "start_logit": 1.478039264678955,
            "end_logit": 0.3964868485927582,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "case of corneal endothelial deposits",
            "probability": 0.0008040791763042472,
            "start_logit": -2.494253635406494,
            "end_logit": 4.27068567276001,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "a case of corneal endothelial deposits",
            "probability": 0.0007784477732421639,
            "start_logit": -2.5266494750976562,
            "end_logit": 4.27068567276001,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "corneal endothelial deposits associated with",
            "probability": 0.0007338184059232001,
            "start_logit": 4.495354175567627,
            "end_logit": -2.8103582859039307,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        },
        {
            "text": "report a case of corneal endothelial deposits",
            "probability": 0.0007222017106820911,
            "start_logit": -2.601646900177002,
            "end_logit": 4.27068567276001,
            "question_text": "Which are the most widely reported side-effects in the treatment of Crohn's disease?"
        }
    ],
    "518cca6f310faafe0800000a": [
        {
            "text": "miR-23",
            "probability": 0.3629503106030738,
            "start_logit": 0.2632085084915161,
            "end_logit": 0.21170932054519653,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-107 by 37%, 40%, and 56%, respectively, and reduced miR-23",
            "probability": 0.18672982677864872,
            "start_logit": -0.40139463543891907,
            "end_logit": 0.21170932054519653,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-1, and miR-107 by 37%, 40%, and 56%, respectively, and reduced miR-23",
            "probability": 0.1575614366511338,
            "start_logit": -0.5712419748306274,
            "end_logit": 0.21170932054519653,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-107",
            "probability": 0.05523403582581672,
            "start_logit": -0.40139463543891907,
            "end_logit": -1.0063741207122803,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-1, and miR-107",
            "probability": 0.04660612708151978,
            "start_logit": -0.5712419748306274,
            "end_logit": -1.0063741207122803,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-181, miR-1, and miR-107",
            "probability": 0.03893700541237468,
            "start_logit": -0.7510288953781128,
            "end_logit": -1.0063741207122803,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-181",
            "probability": 0.027268712661083418,
            "start_logit": -0.7510288953781128,
            "end_logit": -1.3625792264938354,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-23 expression by 84% (P<or=0.05 for all), with no change in miR-133",
            "probability": 0.024384415166698623,
            "start_logit": 0.2632085084915161,
            "end_logit": -2.488612413406372,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNA-23",
            "probability": 0.015585321405499241,
            "start_logit": -0.7853981256484985,
            "end_logit": -1.887620449066162,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-133. Importantly, decreased expression of miRNA-23",
            "probability": 0.014818971799389713,
            "start_logit": -0.8358194231987,
            "end_logit": -1.887620449066162,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNA",
            "probability": 0.013883314222332972,
            "start_logit": -0.712741494178772,
            "end_logit": -2.0759189128875732,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-1",
            "probability": 0.012291245742563284,
            "start_logit": -0.5712419748306274,
            "end_logit": -2.339218854904175,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-181, miR-1",
            "probability": 0.01026869924561446,
            "start_logit": -0.7510288953781128,
            "end_logit": -2.339218854904175,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNA-mediated post-transcriptional regulation",
            "probability": 0.00976743755381271,
            "start_logit": -0.712741494178772,
            "end_logit": -2.4275524616241455,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR-133",
            "probability": 0.00812476068690324,
            "start_logit": -0.8358194231987,
            "end_logit": -2.488612413406372,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "23",
            "probability": 0.005358821105328439,
            "start_logit": -3.9523134231567383,
            "end_logit": 0.21170932054519653,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNA-",
            "probability": 0.002694902659156486,
            "start_logit": -0.712741494178772,
            "end_logit": -3.7152445316314697,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miRNA-mediated post-transcriptional regulation is potentially involved in the complex regulatory networks that govern skeletal muscle adaptation to endurance exercise",
            "probability": 0.0025923509921339993,
            "start_logit": -0.712741494178772,
            "end_logit": -3.7540414333343506,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "miR- 181",
            "probability": 0.002527976186156578,
            "start_logit": -2.2395668029785156,
            "end_logit": -2.2523622512817383,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        },
        {
            "text": "mi",
            "probability": 0.00241432822075949,
            "start_logit": -0.712741494178772,
            "end_logit": -3.825185537338257,
            "question_text": "Which microRNAs are involved in exercise adaptation?"
        }
    ],
    "5717cdd2070aa3d072000001": [
        {
            "text": "cyclosporine A",
            "probability": 0.9844906139631528,
            "start_logit": 7.108731746673584,
            "end_logit": 7.174290180206299,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclosporine A,",
            "probability": 0.01044200972184006,
            "start_logit": 7.108731746673584,
            "end_logit": 2.628002882003784,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclosporine A, an MPTP inhibitor",
            "probability": 0.0015205892280498465,
            "start_logit": 7.108731746673584,
            "end_logit": 0.7012637257575989,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclosporine A, an MPTP inhibitor,",
            "probability": 0.000787925149705175,
            "start_logit": 7.108731746673584,
            "end_logit": 0.04381363466382027,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclosporine",
            "probability": 0.0006901962690352719,
            "start_logit": 7.108731746673584,
            "end_logit": -0.08861345797777176,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "A",
            "probability": 0.0005076926692415033,
            "start_logit": -0.46127161383628845,
            "end_logit": 7.174290180206299,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "yclosporine A",
            "probability": 0.0004858587223927827,
            "start_logit": -0.5052300095558167,
            "end_logit": 7.174290180206299,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "c",
            "probability": 0.0003788581858033691,
            "start_logit": 7.108731746673584,
            "end_logit": -0.6884275078773499,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "closporine A",
            "probability": 0.00023785949385821727,
            "start_logit": -1.2194677591323853,
            "end_logit": 7.174290180206299,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cy",
            "probability": 0.00016495798580114463,
            "start_logit": 7.108731746673584,
            "end_logit": -1.5198986530303955,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "resveratrol",
            "probability": 8.213399430179339e-05,
            "start_logit": 2.671146869659424,
            "end_logit": 2.2203474044799805,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "losporine A",
            "probability": 6.224512648455883e-05,
            "start_logit": -2.560067653656006,
            "end_logit": 7.174290180206299,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "porine A",
            "probability": 5.050666989146035e-05,
            "start_logit": -2.769042491912842,
            "end_logit": 7.174290180206299,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclospor",
            "probability": 3.882605589370385e-05,
            "start_logit": 7.108731746673584,
            "end_logit": -2.9664978981018066,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyc",
            "probability": 1.5907595207372513e-05,
            "start_logit": 7.108731746673584,
            "end_logit": -3.858792781829834,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclosporine A, an MPTP",
            "probability": 1.5786567478038475e-05,
            "start_logit": 7.108731746673584,
            "end_logit": -3.8664300441741943,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "cyclos",
            "probability": 1.4971629766471854e-05,
            "start_logit": 7.108731746673584,
            "end_logit": -3.9194324016571045,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "A,",
            "probability": 5.384847466026855e-06,
            "start_logit": -0.46127161383628845,
            "end_logit": 2.628002882003784,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "yclosporine A,",
            "probability": 5.153265486445876e-06,
            "start_logit": -0.5052300095558167,
            "end_logit": 2.628002882003784,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        },
        {
            "text": "closporine A,",
            "probability": 2.5228591436753107e-06,
            "start_logit": -1.2194677591323853,
            "end_logit": 2.628002882003784,
            "question_text": "List inhibtors targeting the mitochondrial permeability transition pore."
        }
    ],
    "56d1fd67f22319765a000002": [
        {
            "text": "Agromyces",
            "probability": 0.16908443137135565,
            "start_logit": 4.390024662017822,
            "end_logit": 5.069162368774414,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Curtobacterium, Microbacterium, Agromyces",
            "probability": 0.11890161438263763,
            "start_logit": 4.0379228591918945,
            "end_logit": 5.069162368774414,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Afipia, Curtobacterium, Microbacterium, Agromyces",
            "probability": 0.10418035275258612,
            "start_logit": 3.905750036239624,
            "end_logit": 5.069162368774414,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Microbacterium, Agromyces",
            "probability": 0.1037618714158579,
            "start_logit": 3.9017250537872314,
            "end_logit": 5.069162368774414,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Sphingomonas, Afipia, Curtobacterium, Microbacterium, Agromyces",
            "probability": 0.09787386782357332,
            "start_logit": 3.843306064605713,
            "end_logit": 5.069162368774414,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Sphingomonas",
            "probability": 0.08889439389847187,
            "start_logit": 3.843306064605713,
            "end_logit": 4.972931861877441,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Curtobacterium",
            "probability": 0.04997794977794262,
            "start_logit": 4.0379228591918945,
            "end_logit": 4.202447891235352,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Afipia, Curtobacterium",
            "probability": 0.04379015764211016,
            "start_logit": 3.905750036239624,
            "end_logit": 4.202447891235352,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Sphingomonas, Afipia, Curtobacterium",
            "probability": 0.04113935101770846,
            "start_logit": 3.843306064605713,
            "end_logit": 4.202447891235352,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Clostridium algidicarnis",
            "probability": 0.02926727505671186,
            "start_logit": 3.862684965133667,
            "end_logit": 3.842573881149292,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Curtobacterium, Microbacterium",
            "probability": 0.028501280955971504,
            "start_logit": 4.0379228591918945,
            "end_logit": 3.640815019607544,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Afipia",
            "probability": 0.025813621686258375,
            "start_logit": 3.905750036239624,
            "end_logit": 3.673941135406494,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Afipia, Curtobacterium, Microbacterium",
            "probability": 0.024972524715587533,
            "start_logit": 3.905750036239624,
            "end_logit": 3.640815019607544,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Microbacterium",
            "probability": 0.024872212754182717,
            "start_logit": 3.9017250537872314,
            "end_logit": 3.640815019607544,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Sphingomonas, Afipia",
            "probability": 0.024251012117117852,
            "start_logit": 3.843306064605713,
            "end_logit": 3.673941135406494,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Sphingomonas, Afipia, Curtobacterium, Microbacterium",
            "probability": 0.023460830364424545,
            "start_logit": 3.843306064605713,
            "end_logit": 3.640815019607544,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Clostridium",
            "probability": 0.0009365273218222192,
            "start_logit": 3.862684965133667,
            "end_logit": 0.40052729845046997,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Afipia,",
            "probability": 0.00012001746655791809,
            "start_logit": 3.905750036239624,
            "end_logit": -1.6970791816711426,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Sphingomonas, Afipia,",
            "probability": 0.00011275229300006585,
            "start_logit": 3.843306064605713,
            "end_logit": -1.6970791816711426,
            "question_text": "List bacterial species identified in the iceman tissues."
        },
        {
            "text": "Curtobacterium, Microbacterium,",
            "probability": 8.795518612139382e-05,
            "start_logit": 4.0379228591918945,
            "end_logit": -2.140061855316162,
            "question_text": "List bacterial species identified in the iceman tissues."
        }
    ],
    "56df03c751531f7e3300000a": [
        {
            "text": "fate",
            "probability": 0.7083534984554305,
            "start_logit": -0.8316011428833008,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "has been linked to diverse effects on mRNA fate",
            "probability": 0.062409102627602416,
            "start_logit": -3.260833263397217,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "effects on mRNA fate",
            "probability": 0.05604726363520788,
            "start_logit": -3.368349075317383,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "diverse effects on mRNA fate",
            "probability": 0.04917662682501515,
            "start_logit": -3.4991259574890137,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mRNA fate",
            "probability": 0.04583870558213344,
            "start_logit": -3.56941556930542,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "(m6A) is the most abundant modified base in eukaryotic mRNA and has been linked to diverse effects on mRNA fate",
            "probability": 0.01569734642644385,
            "start_logit": -4.641052722930908,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "linked to diverse effects on mRNA fate",
            "probability": 0.015486675714851135,
            "start_logit": -4.654564380645752,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "been linked to diverse effects on mRNA fate",
            "probability": 0.013875005903712908,
            "start_logit": -4.764455318450928,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "fate.",
            "probability": 0.007397766470635465,
            "start_logit": -0.8316011428833008,
            "end_logit": -3.7983293533325195,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "modified base in eukaryotic mRNA and has been linked to diverse effects on mRNA fate",
            "probability": 0.007330217223683876,
            "start_logit": -5.402539253234863,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "on mRNA fate",
            "probability": 0.006925026247981196,
            "start_logit": -5.459402561187744,
            "end_logit": 0.7634357810020447,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "has been linked to diverse effects",
            "probability": 0.002184167180828287,
            "start_logit": -3.260833263397217,
            "end_logit": -2.589040756225586,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "effects",
            "probability": 0.0019615182505942513,
            "start_logit": -3.368349075317383,
            "end_logit": -2.589040756225586,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mutational signatures at N(6),2'-O-dimethyladenosine",
            "probability": 0.0017254386450537085,
            "start_logit": -2.4644031524658203,
            "end_logit": -3.6212241649627686,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "diverse effects",
            "probability": 0.0017210626311350385,
            "start_logit": -3.4991259574890137,
            "end_logit": -2.589040756225586,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "mutation",
            "probability": 0.0011092898656132391,
            "start_logit": -2.4644031524658203,
            "end_logit": -4.062985420227051,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "has been linked to diverse",
            "probability": 0.0008524610037523245,
            "start_logit": -3.260833263397217,
            "end_logit": -3.5299031734466553,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "diverse",
            "probability": 0.0006717154212992149,
            "start_logit": -3.4991259574890137,
            "end_logit": -3.5299031734466553,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "has been linked to diverse effects on mRNA fate.",
            "probability": 0.0006517762217418823,
            "start_logit": -3.260833263397217,
            "end_logit": -3.7983293533325195,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        },
        {
            "text": "effects on mRNA fate.",
            "probability": 0.0005853356672840591,
            "start_logit": -3.368349075317383,
            "end_logit": -3.7983293533325195,
            "question_text": "Which properties of the mRNA does N6-methyladenosine (m6A) affect?"
        }
    ],
    "517775c78ed59a060a000033": [
        {
            "text": "rivastigmine",
            "probability": 0.6887655355471095,
            "start_logit": 2.679610252380371,
            "end_logit": 2.943021059036255,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "rivastigmine and nicotine",
            "probability": 0.16612480400509338,
            "start_logit": 2.679610252380371,
            "end_logit": 1.5208594799041748,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "nicotine",
            "probability": 0.06847280284370899,
            "start_logit": 1.7933075428009033,
            "end_logit": 1.5208594799041748,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "rivastigmine and nicotine, AF150(S) and AF267B",
            "probability": 0.02013259514501403,
            "start_logit": 2.679610252380371,
            "end_logit": -0.5895397067070007,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "AF150",
            "probability": 0.010870487357526375,
            "start_logit": 1.4925106763839722,
            "end_logit": -0.018728746101260185,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "nicotine, AF150(S) and AF267B",
            "probability": 0.008298190185100189,
            "start_logit": 1.7933075428009033,
            "end_logit": -0.5895397067070007,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "AF150(S)",
            "probability": 0.007453276785083853,
            "start_logit": 1.4925106763839722,
            "end_logit": -0.39612650871276855,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "prolonged treatment",
            "probability": 0.004726292366886541,
            "start_logit": 0.32145366072654724,
            "end_logit": 0.3194177746772766,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "prolonged treatment with AF150",
            "probability": 0.0033702755937103507,
            "start_logit": 0.32145366072654724,
            "end_logit": -0.018728746101260185,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "rivastigmine and nicotine, AF150(S)",
            "probability": 0.003233156249935384,
            "start_logit": 2.679610252380371,
            "end_logit": -2.4184210300445557,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "rivastigmine and nicotine,",
            "probability": 0.0031396300366003495,
            "start_logit": 2.679610252380371,
            "end_logit": -2.447774887084961,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "AF267B",
            "probability": 0.00277865237449454,
            "start_logit": 0.6992361545562744,
            "end_logit": -0.5895397067070007,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "prolonged treatment with AF150(S)",
            "probability": 0.002310806867784457,
            "start_logit": 0.32145366072654724,
            "end_logit": -0.39612650871276855,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "AF150(S) restored cognitive and behavioral impairments and decreased",
            "probability": 0.0020361458842565027,
            "start_logit": 1.4925106763839722,
            "end_logit": -1.6937215328216553,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "Cevimeline",
            "probability": 0.001829330578651191,
            "start_logit": 0.3415045738220215,
            "end_logit": -0.6498240828514099,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "treatment",
            "probability": 0.0017390610397904024,
            "start_logit": -0.6783420443534851,
            "end_logit": 0.3194177746772766,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "nicotine, AF150(S)",
            "probability": 0.0013326322447185155,
            "start_logit": 1.7933075428009033,
            "end_logit": -2.4184210300445557,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "nicotine,",
            "probability": 0.0012940829022241092,
            "start_logit": 1.7933075428009033,
            "end_logit": -2.447774887084961,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "treatment with AF150",
            "probability": 0.0012401084239820662,
            "start_logit": -0.6783420443534851,
            "end_logit": -0.018728746101260185,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        },
        {
            "text": "mine",
            "probability": 0.0008521335683293159,
            "start_logit": -4.015302658081055,
            "end_logit": 2.943021059036255,
            "question_text": "List some ways to reverse Tau hyperphosphorylation in Tauopathies?"
        }
    ],
    "54e0dfa91388e8454a000018": [
        {
            "text": "CRSP130/Sur2",
            "probability": 0.26188514746429065,
            "start_logit": 3.9635512828826904,
            "end_logit": 3.6433355808258057,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Sur2",
            "probability": 0.09570644404526717,
            "start_logit": 2.9569308757781982,
            "end_logit": 3.6433355808258057,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CDK8",
            "probability": 0.09010810150901043,
            "start_logit": 3.573484420776367,
            "end_logit": 2.9665064811706543,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP130",
            "probability": 0.08382182632009072,
            "start_logit": 3.9635512828826904,
            "end_logit": 2.5041229724884033,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP130/Sur2 subunit",
            "probability": 0.08125994707093237,
            "start_logit": 3.9635512828826904,
            "end_logit": 2.4730827808380127,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP70 and CDK8",
            "probability": 0.07812719892727511,
            "start_logit": 3.4308125972747803,
            "end_logit": 2.9665064811706543,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP130/Sur2 subunit. The CRSP130/Sur2",
            "probability": 0.06375887243176565,
            "start_logit": 3.9635512828826904,
            "end_logit": 2.2305378913879395,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP70",
            "probability": 0.042137590585780545,
            "start_logit": 3.4308125972747803,
            "end_logit": 2.3491084575653076,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP130/Sur2 subunit is common to two distinct types of Mediator complexes, characterized by CRSP70",
            "probability": 0.034137023591329946,
            "start_logit": 3.220254898071289,
            "end_logit": 2.3491084575653076,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Sur2 subunit",
            "probability": 0.02969660804657128,
            "start_logit": 2.9569308757781982,
            "end_logit": 2.4730827808380127,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Sur2 subunit. The CRSP130/Sur2",
            "probability": 0.023300805776364855,
            "start_logit": 2.9569308757781982,
            "end_logit": 2.2305378913879395,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP130/Sur2 subunit. The CRSP130",
            "probability": 0.0228333213758649,
            "start_logit": 3.9635512828826904,
            "end_logit": 1.2036504745483398,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "C/EBPbeta interacts with multisubunit Mediator complexes through the CRSP130/Sur2",
            "probability": 0.021238599213317267,
            "start_logit": 1.4514654874801636,
            "end_logit": 3.6433355808258057,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "130/Sur2",
            "probability": 0.014170480638217532,
            "start_logit": 1.0468062162399292,
            "end_logit": 3.6433355808258057,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP130/Sur2 subunit. The CRSP130/Sur2 subunit",
            "probability": 0.013670280907588995,
            "start_logit": 3.9635512828826904,
            "end_logit": 0.6906537413597107,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CDK8 proteins as transcriptionally active and inactive Mediator, respectively. Knockdown of CRSP130/Sur2",
            "probability": 0.010641824521980576,
            "start_logit": 3.573484420776367,
            "end_logit": 0.8302883505821228,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Sur2 subunit is common to two distinct types of Mediator complexes, characterized by CRSP70 and CDK8",
            "probability": 0.008944049390229802,
            "start_logit": 1.263462781906128,
            "end_logit": 2.9665064811706543,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CDK8 proteins",
            "probability": 0.008686160068112183,
            "start_logit": 3.573484420776367,
            "end_logit": 0.6272273659706116,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "Sur2 subunit. The CRSP130",
            "probability": 0.00834448236483053,
            "start_logit": 2.9569308757781982,
            "end_logit": 1.2036504745483398,
            "question_text": "List components of the CRSP/Med complex."
        },
        {
            "text": "CRSP70 and CDK8 proteins",
            "probability": 0.007531235751179313,
            "start_logit": 3.4308125972747803,
            "end_logit": 0.6272273659706116,
            "question_text": "List components of the CRSP/Med complex."
        }
    ],
    "517539e68ed59a060a000028": [
        {
            "text": "DNA",
            "probability": 0.4757083948785226,
            "start_logit": 0.6509633660316467,
            "end_logit": -0.6880105137825012,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "DNA. We studied the coordination of the two genomes by measuring transcript levels for nuclear (IV, Va, and VIc",
            "probability": 0.23248277044398707,
            "start_logit": 0.6509633660316467,
            "end_logit": -1.4039994478225708,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "VIc",
            "probability": 0.09709547141607396,
            "start_logit": -0.2221580147743225,
            "end_logit": -1.4039994478225708,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "Va, and VIc",
            "probability": 0.0622307084314614,
            "start_logit": -0.6670041680335999,
            "end_logit": -1.4039994478225708,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "DNA. We studied the coordination of the two genomes by measuring transcript levels for nuclear (IV, Va",
            "probability": 0.030090910219780775,
            "start_logit": 0.6509633660316467,
            "end_logit": -3.4485924243927,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "subunit VIc",
            "probability": 0.022178756538553467,
            "start_logit": -1.2980788946151733,
            "end_logit": -1.804638385772705,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "mitochondrial DNA",
            "probability": 0.015386489319866397,
            "start_logit": -2.7803518772125244,
            "end_logit": -0.6880105137825012,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "DNA was unaltered despite the observed changes in mitochondrial transcripts, indicating that mitochondrial gene expression is regulated by transcriptional mechanisms",
            "probability": 0.014347247183067869,
            "start_logit": -0.028977902606129646,
            "end_logit": -3.5093162059783936,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "Va",
            "probability": 0.008054698663252667,
            "start_logit": -0.6670041680335999,
            "end_logit": -3.4485924243927,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "mitochondrial DNA. We studied the coordination of the two genomes by measuring transcript levels for nuclear (IV, Va, and VIc",
            "probability": 0.007519509226661447,
            "start_logit": -2.7803518772125244,
            "end_logit": -1.4039994478225708,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "DNA.",
            "probability": 0.007422097518936263,
            "start_logit": 0.6509633660316467,
            "end_logit": -4.848353862762451,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "DNA was unaltered despite the observed changes in mitochondrial transcripts,",
            "probability": 0.006626459754536454,
            "start_logit": -0.028977902606129646,
            "end_logit": -4.281803607940674,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "DNA was unaltered despite the observed changes in mitochondrial transcripts, indicating that mitochondrial gene expression is regulated by transcription",
            "probability": 0.006497127441454015,
            "start_logit": -0.028977902606129646,
            "end_logit": -4.301514148712158,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "DNA was unaltered despite the observed changes in mitochondrial transcripts, indicating that mitochondrial gene expression",
            "probability": 0.0036560565946307686,
            "start_logit": -0.028977902606129646,
            "end_logit": -4.876489162445068,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "DNA was unaltered despite the observed changes in mitochondrial transcripts, indicating that mitochondrial gene",
            "probability": 0.002471842478683589,
            "start_logit": -0.028977902606129646,
            "end_logit": -5.267910480499268,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "mitochondria involves the expression of genes located on nuclear chromosomes as well as on mitochondrial DNA",
            "probability": 0.0021448337765320492,
            "start_logit": -4.750779628753662,
            "end_logit": -0.6880105137825012,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "VIc) and mitochondrial (II and III) subunits of cytochrome-c oxidase",
            "probability": 0.002141039205332741,
            "start_logit": -0.2221580147743225,
            "end_logit": -5.218402862548828,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "NA",
            "probability": 0.0014882155997915586,
            "start_logit": -5.1162638664245605,
            "end_logit": -0.6880105137825012,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "Va, and VIc) and mitochondrial (II and III) subunits of cytochrome-c oxidase",
            "probability": 0.0013722409972802528,
            "start_logit": -0.6670041680335999,
            "end_logit": -5.218402862548828,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        },
        {
            "text": "IV, Va, and VIc",
            "probability": 0.0010851303115951005,
            "start_logit": -4.716152667999268,
            "end_logit": -1.4039994478225708,
            "question_text": "Which mitochondrial genes are regulated by thyroid hormone?"
        }
    ],
    "518cb5ab310faafe08000008": [
        {
            "text": "rifabutin and levofloxacin",
            "probability": 0.3618397790802945,
            "start_logit": 5.793929576873779,
            "end_logit": 5.876627445220947,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin",
            "probability": 0.30316357689695345,
            "start_logit": 5.617000579833984,
            "end_logit": 5.876627445220947,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "rifabutin",
            "probability": 0.24178019339248027,
            "start_logit": 5.793929576873779,
            "end_logit": 5.47345495223999,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "salvage treatments using rifabutin and levofloxacin",
            "probability": 0.033111568292283414,
            "start_logit": 3.4026107788085938,
            "end_logit": 5.876627445220947,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "salvage treatments using rifabutin",
            "probability": 0.022125044973178805,
            "start_logit": 3.4026107788085938,
            "end_logit": 5.47345495223999,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "triple therapy. When initial treatment fails, salvage treatments using rifabutin and levofloxacin",
            "probability": 0.008459785184507174,
            "start_logit": 2.0380518436431885,
            "end_logit": 5.876627445220947,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "triple therapy. When initial treatment fails, salvage treatments using rifabutin",
            "probability": 0.005652801643776967,
            "start_logit": 2.0380518436431885,
            "end_logit": 5.47345495223999,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy",
            "probability": 0.004906719125236488,
            "start_logit": 3.7053816318511963,
            "end_logit": 3.664579391479492,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "rifabutin and levofloxacin are the best options",
            "probability": 0.003935560493902355,
            "start_logit": 5.793929576873779,
            "end_logit": 1.3554792404174805,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "levofloxacin are the best options",
            "probability": 0.0032973671370748274,
            "start_logit": 5.617000579833984,
            "end_logit": 1.3554792404174805,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "Sequential therapy and quadruple therapy",
            "probability": 0.0026317781761619444,
            "start_logit": 3.0824358463287354,
            "end_logit": 3.664579391479492,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "salvage treatments",
            "probability": 0.0023680052384205614,
            "start_logit": 3.4026107788085938,
            "end_logit": 3.238792657852173,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "Sequential therapy",
            "probability": 0.0018189223470558371,
            "start_logit": 3.0824358463287354,
            "end_logit": 3.295163869857788,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "bismuth-based or non-bismuth-based) are the best current options to replace initial treatment with triple therapy",
            "probability": 0.0011461793383046595,
            "start_logit": 3.3513810634613037,
            "end_logit": 2.564408540725708,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy (either bismuth-based",
            "probability": 0.001040328712633549,
            "start_logit": 3.7053816318511963,
            "end_logit": 2.1135106086730957,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "bismuth-based",
            "probability": 0.0007301802661913503,
            "start_logit": 3.3513810634613037,
            "end_logit": 2.1135106086730957,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "triple therapy. When initial treatment fails, salvage treatments",
            "probability": 0.0006050095681361687,
            "start_logit": 2.0380518436431885,
            "end_logit": 3.238792657852173,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "Sequential therapy and quadruple therapy (either bismuth-based",
            "probability": 0.0005579928934309372,
            "start_logit": 3.0824358463287354,
            "end_logit": 2.1135106086730957,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "quadruple therapy (either bismuth-based or non-bismuth-based",
            "probability": 0.0004565045817076732,
            "start_logit": 3.7053816318511963,
            "end_logit": 1.2898173332214355,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        },
        {
            "text": "triple therapy is failing. Sequential therapy and quadruple therapy",
            "probability": 0.00037270265826916713,
            "start_logit": 1.127801775932312,
            "end_logit": 3.664579391479492,
            "question_text": "Which are the best treatment options to treat Helicobacter pylori?"
        }
    ],
    "570a6d03cf1c325851000025": [
        {
            "text": "gremlin-1",
            "probability": 0.10197063661783944,
            "start_logit": 4.572642803192139,
            "end_logit": 4.255385875701904,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A, midkine",
            "probability": 0.08920676416887167,
            "start_logit": 4.572642803192139,
            "end_logit": 4.121657848358154,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A, midkine",
            "probability": 0.08252866000807677,
            "start_logit": 4.494831562042236,
            "end_logit": 4.121657848358154,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A",
            "probability": 0.05910032088378665,
            "start_logit": 4.572642803192139,
            "end_logit": 3.709937334060669,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A",
            "probability": 0.05467601402235638,
            "start_logit": 4.494831562042236,
            "end_logit": 3.709937334060669,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "carbonic anhydrase, gremlin-1",
            "probability": 0.05338678415929135,
            "start_logit": 3.9255211353302,
            "end_logit": 4.255385875701904,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "midkine",
            "probability": 0.04911902452897008,
            "start_logit": 3.9759323596954346,
            "end_logit": 4.121657848358154,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "carbonic anhydrase, gremlin-1, fetuin A, midkine",
            "probability": 0.0467042515590138,
            "start_logit": 3.9255211353302,
            "end_logit": 4.121657848358154,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A, midkine, annexin A1 and A2",
            "probability": 0.043200870368321986,
            "start_logit": 4.572642803192139,
            "end_logit": 3.396561622619629,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "carbonic anhydrase",
            "probability": 0.04299656229430943,
            "start_logit": 3.9255211353302,
            "end_logit": 4.038942813873291,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A, midkine, annexin A1",
            "probability": 0.04175752011694751,
            "start_logit": 4.572642803192139,
            "end_logit": 3.3625805377960205,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "gremlin-1, fetuin A, midkine, annexin A1 and A2, and collagen \u03b11",
            "probability": 0.04036005414760247,
            "start_logit": 4.572642803192139,
            "end_logit": 3.3285415172576904,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A, midkine, annexin A1 and A2",
            "probability": 0.03996681166386644,
            "start_logit": 4.494831562042236,
            "end_logit": 3.396561622619629,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A, midkine, annexin A1",
            "probability": 0.03863151200046018,
            "start_logit": 4.494831562042236,
            "end_logit": 3.3625805377960205,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "alkaline phosphatase, carbonic anhydrase, gremlin-1",
            "probability": 0.03783389896370788,
            "start_logit": 3.5811634063720703,
            "end_logit": 4.255385875701904,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "fetuin A, midkine, annexin A1 and A2, and collagen \u03b11",
            "probability": 0.037338661677601165,
            "start_logit": 4.494831562042236,
            "end_logit": 3.3285415172576904,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "annexin A1 and A2",
            "probability": 0.03727327869233518,
            "start_logit": 4.425058841705322,
            "end_logit": 3.396561622619629,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "annexin A1",
            "probability": 0.0360279705373962,
            "start_logit": 4.425058841705322,
            "end_logit": 3.3625805377960205,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "annexin A1 and A2, and collagen \u03b11",
            "probability": 0.03482225088188097,
            "start_logit": 4.425058841705322,
            "end_logit": 3.3285415172576904,
            "question_text": "List sclerostin interaction partners."
        },
        {
            "text": "alkaline phosphatase, carbonic anhydrase, gremlin-1, fetuin A, midkine",
            "probability": 0.03309815270736433,
            "start_logit": 3.5811634063720703,
            "end_logit": 4.121657848358154,
            "question_text": "List sclerostin interaction partners."
        }
    ],
    "56cd765b5795f9a73e000038": [
        {
            "text": "low ATP",
            "probability": 0.5341617324949761,
            "start_logit": 5.352941036224365,
            "end_logit": 4.527665615081787,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "low ATP conditions",
            "probability": 0.4180350425998354,
            "start_logit": 5.352941036224365,
            "end_logit": 4.282532215118408,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "ATP",
            "probability": 0.01622999684556981,
            "start_logit": 1.8591035604476929,
            "end_logit": 4.527665615081787,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "ATP conditions",
            "probability": 0.01270159768099221,
            "start_logit": 1.8591035604476929,
            "end_logit": 4.282532215118408,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "low",
            "probability": 0.005911367076318779,
            "start_logit": 5.352941036224365,
            "end_logit": 0.023844072595238686,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "under low ATP",
            "probability": 0.004119727118883999,
            "start_logit": 0.4880293011665344,
            "end_logit": 4.527665615081787,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "low ATP conditions in cultured cells in an AMPK- and TSC2-dependent manner,",
            "probability": 0.003253291458561036,
            "start_logit": 5.352941036224365,
            "end_logit": -0.5733658075332642,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "under low ATP conditions",
            "probability": 0.0032240989888929704,
            "start_logit": 0.4880293011665344,
            "end_logit": 4.282532215118408,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "conditions",
            "probability": 0.000817945218252195,
            "start_logit": -0.8835841417312622,
            "end_logit": 4.282532215118408,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "low AT",
            "probability": 0.00041848673932165563,
            "start_logit": 5.352941036224365,
            "end_logit": -2.624143123626709,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "repression of mTOR under low ATP",
            "probability": 0.0002551111770762047,
            "start_logit": -2.293813467025757,
            "end_logit": 4.527665615081787,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "repression of mTOR under low ATP conditions",
            "probability": 0.00019965004096909625,
            "start_logit": -2.293813467025757,
            "end_logit": 4.282532215118408,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "P",
            "probability": 0.00014626980848726908,
            "start_logit": -2.850059986114502,
            "end_logit": 4.527665615081787,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "low ATP conditions in cultured cells",
            "probability": 0.00013989528186993558,
            "start_logit": 5.352941036224365,
            "end_logit": -3.7198941707611084,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "P conditions",
            "probability": 0.00011447077149544852,
            "start_logit": -2.850059986114502,
            "end_logit": 4.282532215118408,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "ATP conditions in cultured cells in an AMPK- and TSC2-dependent manner,",
            "probability": 9.884817069081493e-05,
            "start_logit": 1.8591035604476929,
            "end_logit": -0.5733658075332642,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "mTOR under low ATP",
            "probability": 4.859535855431914e-05,
            "start_logit": -3.9519848823547363,
            "end_logit": 4.527665615081787,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "under low",
            "probability": 4.559147122022175e-05,
            "start_logit": 0.4880293011665344,
            "end_logit": 0.023844072595238686,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "low ATP conditions in cultured cells in an AMPK- and TSC2-dependent manner",
            "probability": 4.025096399147645e-05,
            "start_logit": 5.352941036224365,
            "end_logit": -4.965654373168945,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        },
        {
            "text": "mTOR under low ATP conditions",
            "probability": 3.803073404102407e-05,
            "start_logit": -3.9519848823547363,
            "end_logit": 4.282532215118408,
            "question_text": "Under which conditions does AMPK phosphorylate TSC2?"
        }
    ],
    "5326300fd6d3ac6a34000005": [
        {
            "text": "qualitative determination of beta-2-transferrin",
            "probability": 0.4880028645957255,
            "start_logit": 4.0463995933532715,
            "end_logit": 4.3654351234436035,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "beta-2-transferrin",
            "probability": 0.16473458703615376,
            "start_logit": 2.960413932800293,
            "end_logit": 4.3654351234436035,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "qualitative determination of beta-2-transferrin. Faster and more efficient methods (beta-trace",
            "probability": 0.09350669868685729,
            "start_logit": 4.0463995933532715,
            "end_logit": 2.713146924972534,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "transferrin",
            "probability": 0.07887109793595896,
            "start_logit": 2.223893165588379,
            "end_logit": 4.3654351234436035,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "beta-2-transferrin. Faster and more efficient methods (beta-trace",
            "probability": 0.03156495281242745,
            "start_logit": 2.960413932800293,
            "end_logit": 2.713146924972534,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "beta-trace",
            "probability": 0.030159081947076553,
            "start_logit": 2.9148526191711426,
            "end_logit": 2.713146924972534,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "cerebrospinal fluid detection is qualitative determination of beta-2-transferrin",
            "probability": 0.019237771873301765,
            "start_logit": 0.8129539489746094,
            "end_logit": 4.3654351234436035,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "determination of beta-2-transferrin",
            "probability": 0.01698844131185205,
            "start_logit": 0.6886115074157715,
            "end_logit": 4.3654351234436035,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "transferrin. Faster and more efficient methods (beta-trace",
            "probability": 0.01511256700492722,
            "start_logit": 2.223893165588379,
            "end_logit": 2.713146924972534,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "qualitative determination of beta-2-transferrin. Faster and more efficient methods (beta-trace)",
            "probability": 0.012120495366934263,
            "start_logit": 4.0463995933532715,
            "end_logit": 0.6700116991996765,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "radiological methods increases the rate of correct diagnosis. In surgery the use of intrathecal sodium-fluorescein",
            "probability": 0.009313366501996934,
            "start_logit": 2.2196402549743652,
            "end_logit": 2.233323812484741,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "qualitative determination",
            "probability": 0.006447112311341,
            "start_logit": 4.0463995933532715,
            "end_logit": 0.038746174424886703,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "qualitative determination of beta-2-transferrin.",
            "probability": 0.00617464683664187,
            "start_logit": 4.0463995933532715,
            "end_logit": -0.004434464033693075,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "intrathecal sodium-fluorescein",
            "probability": 0.005971120294589858,
            "start_logit": 1.775124192237854,
            "end_logit": 2.233323812484741,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "beta-2-transferrin. Faster and more efficient methods (beta-trace)",
            "probability": 0.004091502209929896,
            "start_logit": 2.960413932800293,
            "end_logit": 0.6700116991996765,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "beta-trace)",
            "probability": 0.003909270866621992,
            "start_logit": 2.9148526191711426,
            "end_logit": 0.6700116991996765,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "beta-trace) are under clinical investigation. The major problem is localisation of the site of leakage. Combination of several radiological",
            "probability": 0.0039020374584421065,
            "start_logit": 2.9148526191711426,
            "end_logit": 0.6681596636772156,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "cerebrospinal fluid detection is qualitative determination of beta-2-transferrin. Faster and more efficient methods (beta-trace",
            "probability": 0.0036861679888980778,
            "start_logit": 0.8129539489746094,
            "end_logit": 2.713146924972534,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "determination of beta-2-transferrin. Faster and more efficient methods (beta-trace",
            "probability": 0.003255171594582116,
            "start_logit": 0.6886115074157715,
            "end_logit": 2.713146924972534,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        },
        {
            "text": "sodium-fluorescein",
            "probability": 0.0029510453657414313,
            "start_logit": 1.070349097251892,
            "end_logit": 2.233323812484741,
            "question_text": "What imaging modalities have been listed as method of choice  to diagnose CSF leak?"
        }
    ],
    "51be411b047fa84d1d000006": [
        {
            "text": "We have developed a novel algorithm",
            "probability": 0.1534242533352295,
            "start_logit": -2.942600965499878,
            "end_logit": -3.1236393451690674,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "novel algorithm",
            "probability": 0.12057312281296943,
            "start_logit": -3.183551549911499,
            "end_logit": -3.1236393451690674,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "a novel algorithm",
            "probability": 0.11136543438874043,
            "start_logit": -3.262990951538086,
            "end_logit": -3.1236393451690674,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "We have developed a novel",
            "probability": 0.07539849591768875,
            "start_logit": -2.942600965499878,
            "end_logit": -3.834059000015259,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "novel",
            "probability": 0.059254204668233924,
            "start_logit": -3.183551549911499,
            "end_logit": -3.834059000015259,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "algorithm",
            "probability": 0.056213461121902966,
            "start_logit": -3.9466516971588135,
            "end_logit": -3.1236393451690674,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "a novel",
            "probability": 0.054729197422158794,
            "start_logit": -3.262990951538086,
            "end_logit": -3.834059000015259,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "developed a novel algorithm",
            "probability": 0.05347286973148889,
            "start_logit": -3.996633529663086,
            "end_logit": -3.1236393451690674,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "We have developed",
            "probability": 0.047923057770072566,
            "start_logit": -2.942600965499878,
            "end_logit": -4.287249565124512,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "We",
            "probability": 0.04003779599344042,
            "start_logit": -2.942600965499878,
            "end_logit": -4.46702241897583,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "We have developed a novel algorithm that evaluates the relative rareness of a nucleotide sequence used to produce a given protein sequence.",
            "probability": 0.03566956158634443,
            "start_logit": -2.942600965499878,
            "end_logit": -4.58254861831665,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "We have developed a",
            "probability": 0.02874810378401538,
            "start_logit": -2.942600965499878,
            "end_logit": -4.798274517059326,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "novel algorithm that evaluates the relative rareness of a nucleotide sequence used to produce a given protein sequence.",
            "probability": 0.02803201147368745,
            "start_logit": -3.183551549911499,
            "end_logit": -4.58254861831665,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "developed a novel",
            "probability": 0.026278595870676373,
            "start_logit": -3.996633529663086,
            "end_logit": -3.834059000015259,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "a novel algorithm that evaluates the relative rareness of a nucleotide sequence used to produce a given protein sequence.",
            "probability": 0.02589131857685918,
            "start_logit": -3.262990951538086,
            "end_logit": -4.58254861831665,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "a",
            "probability": 0.020867268350096786,
            "start_logit": -3.262990951538086,
            "end_logit": -4.798274517059326,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "developed",
            "probability": 0.016702596685769778,
            "start_logit": -3.996633529663086,
            "end_logit": -4.287249565124512,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "We have developed a novel algorithm that evaluates the relative rareness of a nucleotide sequence used to produce a given protein sequence",
            "probability": 0.01669006141467129,
            "start_logit": -2.942600965499878,
            "end_logit": -5.3420329093933105,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "We have developed a novel algorithm that evaluates the relative rareness of a nucleotide sequence used to produce a given protein sequence. We",
            "probability": 0.01561219595105681,
            "start_logit": -2.942600965499878,
            "end_logit": -5.408793926239014,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        },
        {
            "text": "novel algorithm that evaluates the relative rareness of a nucleotide sequence used to produce a given protein sequence",
            "probability": 0.01311639314489712,
            "start_logit": -3.183551549911499,
            "end_logit": -5.3420329093933105,
            "question_text": "Which are currently available software tools for detecting rare codon clusters in coding sequences?"
        }
    ],
    "54db7217c4c6ce8e1d000003": [
        {
            "text": "RyR2, expressed in cardiac muscle; and RyR3",
            "probability": 0.17916169343824984,
            "start_logit": 5.56502628326416,
            "end_logit": 5.329866409301758,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR3",
            "probability": 0.16363746697888384,
            "start_logit": 5.474390983581543,
            "end_logit": 5.329866409301758,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1, expressed in skeletal muscle; RyR2, expressed in cardiac muscle; and RyR3",
            "probability": 0.15882196490426115,
            "start_logit": 5.444521427154541,
            "end_logit": 5.329866409301758,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2",
            "probability": 0.149745315306858,
            "start_logit": 5.56502628326416,
            "end_logit": 5.150513648986816,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1, expressed in skeletal muscle; RyR2",
            "probability": 0.1327451463302916,
            "start_logit": 5.444521427154541,
            "end_logit": 5.150513648986816,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1",
            "probability": 0.11824869364057228,
            "start_logit": 5.444521427154541,
            "end_logit": 5.034872531890869,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three isoforms: RyR1, expressed in skeletal muscle; RyR2, expressed in cardiac muscle; and RyR3",
            "probability": 0.017149132346251643,
            "start_logit": 3.2186851501464844,
            "end_logit": 5.329866409301758,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three isoforms: RyR1, expressed in skeletal muscle; RyR2",
            "probability": 0.014333433565772706,
            "start_logit": 3.2186851501464844,
            "end_logit": 5.150513648986816,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three isoforms: RyR1",
            "probability": 0.012768148903307845,
            "start_logit": 3.2186851501464844,
            "end_logit": 5.034872531890869,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2,",
            "probability": 0.007446226411662854,
            "start_logit": 5.56502628326416,
            "end_logit": 2.149285078048706,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2, expressed in cardiac muscle; and RyR3,",
            "probability": 0.0074345539727019025,
            "start_logit": 5.56502628326416,
            "end_logit": 2.1477162837982178,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR3,",
            "probability": 0.006790355442973322,
            "start_logit": 5.474390983581543,
            "end_logit": 2.1477162837982178,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1, expressed in skeletal muscle; RyR2,",
            "probability": 0.006600877046464763,
            "start_logit": 5.444521427154541,
            "end_logit": 2.149285078048706,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1, expressed in skeletal muscle; RyR2, expressed in cardiac muscle; and RyR3,",
            "probability": 0.0065905297470201865,
            "start_logit": 5.444521427154541,
            "end_logit": 2.1477162837982178,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1,",
            "probability": 0.0042596401329430345,
            "start_logit": 5.444521427154541,
            "end_logit": 1.7112672328948975,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "three",
            "probability": 0.004069442716180022,
            "start_logit": 3.2186851501464844,
            "end_logit": 3.8914248943328857,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2, expressed in cardiac muscle;",
            "probability": 0.0029812378099680725,
            "start_logit": 5.56502628326416,
            "end_logit": 1.2339162826538086,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1, expressed in skeletal muscle;",
            "probability": 0.002850298895238907,
            "start_logit": 5.444521427154541,
            "end_logit": 1.3095064163208008,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR1, expressed in skeletal muscle; RyR2, expressed in cardiac muscle;",
            "probability": 0.0026427861767738766,
            "start_logit": 5.444521427154541,
            "end_logit": 1.2339162826538086,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        },
        {
            "text": "RyR2, expressed in cardiac muscle; and RyR3, expressed in various cells at lower levels than the other isoforms",
            "probability": 0.0017230562336238838,
            "start_logit": 5.56502628326416,
            "end_logit": 0.6856772899627686,
            "question_text": "How many and which are the different isoforms for the ryanodine receptor?"
        }
    ],
    "5506a7a48e1671127b000008": [
        {
            "text": "protein phosphatase 2B",
            "probability": 0.6470305495919664,
            "start_logit": 5.040485858917236,
            "end_logit": 4.629912853240967,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 1",
            "probability": 0.30460317813645715,
            "start_logit": 4.956809043884277,
            "end_logit": 3.9602060317993164,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase (protein phosphatase 2B",
            "probability": 0.010811631054212926,
            "start_logit": 0.9487148523330688,
            "end_logit": 4.629912853240967,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 2B)",
            "probability": 0.010630916109578874,
            "start_logit": 5.040485858917236,
            "end_logit": 0.5212857127189636,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "Protein phosphatase 2B",
            "probability": 0.009795034840031412,
            "start_logit": 2.336137294769287,
            "end_logit": 3.1437435150146484,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "2B",
            "probability": 0.009106657787594605,
            "start_logit": 0.7770981192588806,
            "end_logit": 4.629912853240967,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "(protein phosphatase 2B",
            "probability": 0.0028365885625972263,
            "start_logit": -0.3893055319786072,
            "end_logit": 4.629912853240967,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "1",
            "probability": 0.002524289256052926,
            "start_logit": 0.16375871002674103,
            "end_logit": 3.9602060317993164,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein",
            "probability": 0.0005228618604947687,
            "start_logit": 4.956809043884277,
            "end_logit": -2.4072418212890625,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "phosphatase 2B",
            "probability": 0.0004204738185482584,
            "start_logit": -2.298280715942383,
            "end_logit": 4.629912853240967,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 2",
            "probability": 0.0003744044017638749,
            "start_logit": 5.040485858917236,
            "end_logit": -2.824899435043335,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase",
            "probability": 0.0003492289809831058,
            "start_logit": 4.956809043884277,
            "end_logit": -2.810831308364868,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 2B) is also able to dephosphorylate PLN phosphorylated by protein kinase A",
            "probability": 0.0002288791879742146,
            "start_logit": 5.040485858917236,
            "end_logit": -3.3170416355133057,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "phosphatase 1",
            "probability": 0.00019298670582038892,
            "start_logit": -2.407334804534912,
            "end_logit": 3.9602060317993164,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase (protein phosphatase 2B)",
            "probability": 0.00017763850998617897,
            "start_logit": 0.9487148523330688,
            "end_logit": 0.5212857127189636,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "2B)",
            "probability": 0.00014962526118683813,
            "start_logit": 0.7770981192588806,
            "end_logit": 0.5212857127189636,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "B",
            "probability": 8.226787374100121e-05,
            "start_logit": -3.9296822547912598,
            "end_logit": 4.629912853240967,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "protein phosphatase 2B) is also able to dephosphorylate PLN",
            "probability": 7.742441684043762e-05,
            "start_logit": 5.040485858917236,
            "end_logit": -4.400933742523193,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "(protein phosphatase 2B)",
            "probability": 4.66060452097337e-05,
            "start_logit": -0.3893055319786072,
            "end_logit": 0.5212857127189636,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        },
        {
            "text": "calcium/calmodulin-stimulated protein phosphatase (protein phosphatase 2B",
            "probability": 3.875759895948553e-05,
            "start_logit": -3.370253086090088,
            "end_logit": 3.3178298473358154,
            "question_text": "Which protein phosphatases have been found to dephosphorylate phospholamban?"
        }
    ],
    "532c0ac4d6d3ac6a3400001a": [
        {
            "text": "new scaffold recognition",
            "probability": 0.21212484388263797,
            "start_logit": 2.626911163330078,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "better VS performance and new scaffold recognition",
            "probability": 0.18709568819393815,
            "start_logit": 2.501356363296509,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "scaffold recognition",
            "probability": 0.15262075566668332,
            "start_logit": 2.29769229888916,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "recall, F-score, and MCC) is constructed. The resultant queries showed significantly better VS performance and new scaffold recognition",
            "probability": 0.14224933468250311,
            "start_logit": 2.2273175716400146,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "better VS performance",
            "probability": 0.08598552123549827,
            "start_logit": 2.501356363296509,
            "end_logit": 3.2373926639556885,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "recall, F-score, and MCC) is constructed. The resultant queries showed significantly better VS performance",
            "probability": 0.06537501374910983,
            "start_logit": 2.2273175716400146,
            "end_logit": 3.2373926639556885,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "F-score, and MCC) is constructed. The resultant queries showed significantly better VS performance and new scaffold recognition",
            "probability": 0.03239790236053729,
            "start_logit": 0.7478298544883728,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "MCC) is constructed. The resultant queries showed significantly better VS performance and new scaffold recognition",
            "probability": 0.02912763753393438,
            "start_logit": 0.6414236426353455,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "recall",
            "probability": 0.01787544693805985,
            "start_logit": 2.2273175716400146,
            "end_logit": 1.9406806230545044,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "F-score, and MCC) is constructed. The resultant queries showed significantly better VS performance",
            "probability": 0.014889442660591662,
            "start_logit": 0.7478298544883728,
            "end_logit": 3.2373926639556885,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "recognition",
            "probability": 0.01454237126861566,
            "start_logit": -0.05319727957248688,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "MCC) is constructed. The resultant queries showed significantly better VS performance",
            "probability": 0.013386492868386467,
            "start_logit": 0.6414236426353455,
            "end_logit": 3.2373926639556885,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "significantly better VS performance and new scaffold recognition",
            "probability": 0.008790491663549699,
            "start_logit": -0.5565931797027588,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "better",
            "probability": 0.004982825256697472,
            "start_logit": 2.501356363296509,
            "end_logit": 0.3892107903957367,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "significantly better VS performance",
            "probability": 0.004039938145571399,
            "start_logit": -0.5565931797027588,
            "end_logit": 3.2373926639556885,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "recall, F-score, and MCC) is constructed. The resultant queries showed significantly better",
            "probability": 0.00378845490479536,
            "start_logit": 2.2273175716400146,
            "end_logit": 0.3892107903957367,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "performance and new scaffold recognition",
            "probability": 0.0031638689207432735,
            "start_logit": -1.5784682035446167,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "VS performance and new scaffold recognition",
            "probability": 0.0027487936888816334,
            "start_logit": -1.7191016674041748,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "queries showed significantly better VS performance and new scaffold recognition",
            "probability": 0.002517068031204789,
            "start_logit": -1.8071690797805786,
            "end_logit": 4.014833927154541,
            "question_text": "What are the main benefits of pharmacophore models?"
        },
        {
            "text": "recall, F-score",
            "probability": 0.0022981083480603636,
            "start_logit": 2.2273175716400146,
            "end_logit": -0.11066114157438278,
            "question_text": "What are the main benefits of pharmacophore models?"
        }
    ],
    "52e7b7cb98d023950500001c": [
        {
            "text": "alcohol",
            "probability": 0.5854981668191688,
            "start_logit": 1.146890640258789,
            "end_logit": 0.5436564087867737,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption and insulin resistance. This association may be further confounded by the presence of obesity. We aimed to clarify whether regular alcohol",
            "probability": 0.28716413268742147,
            "start_logit": 0.43448153138160706,
            "end_logit": 0.5436564087867737,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption",
            "probability": 0.034499096549853774,
            "start_logit": 1.146890640258789,
            "end_logit": -2.2878735065460205,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "regular alcohol",
            "probability": 0.018400716075365697,
            "start_logit": -2.313182830810547,
            "end_logit": 0.5436564087867737,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption and insulin resistance. This association may be further confounded by the presence of obesity. We aimed to clarify whether regular alcohol consumption",
            "probability": 0.0169204682451177,
            "start_logit": 0.43448153138160706,
            "end_logit": -2.2878735065460205,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption improves insulin resistance",
            "probability": 0.013229370915790442,
            "start_logit": 1.146890640258789,
            "end_logit": -3.2463672161102295,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption improves insulin resistance in healthy Japanese men and whether obesity",
            "probability": 0.012433975870136437,
            "start_logit": 1.146890640258789,
            "end_logit": -3.3083739280700684,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption improves insulin resistance in healthy Japanese men and whether obesity affects this relationship.",
            "probability": 0.010547474674388789,
            "start_logit": 1.146890640258789,
            "end_logit": -3.4729201793670654,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "insulin resistance. This association may be further confounded by the presence of obesity. We aimed to clarify whether regular alcohol",
            "probability": 0.004914800322158234,
            "start_logit": -3.6333212852478027,
            "end_logit": 0.5436564087867737,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption and insulin resistance",
            "probability": 0.003247126754503799,
            "start_logit": 0.43448153138160706,
            "end_logit": -3.938627004623413,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption and insulin resistance. This association may be further confounded by the presence of obesity",
            "probability": 0.002096957012669773,
            "start_logit": 0.43448153138160706,
            "end_logit": -4.37591028213501,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption improves insulin",
            "probability": 0.0018256430694289344,
            "start_logit": 1.146890640258789,
            "end_logit": -5.226874351501465,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "obesity. We aimed to clarify whether regular alcohol",
            "probability": 0.0016698570994776324,
            "start_logit": -4.712834358215332,
            "end_logit": 0.5436564087867737,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "We aimed to clarify whether regular alcohol",
            "probability": 0.0012809778687054045,
            "start_logit": -4.9779486656188965,
            "end_logit": 0.5436564087867737,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption and insulin resistance. This association may be further confounded by the presence of obesity.",
            "probability": 0.0011997364169266023,
            "start_logit": 0.43448153138160706,
            "end_logit": -4.934295654296875,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption improves insulin resistance in healthy Japanese men and whether obesity affects this relationship",
            "probability": 0.0011722604371971113,
            "start_logit": 1.146890640258789,
            "end_logit": -5.669872760772705,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "regular alcohol consumption",
            "probability": 0.0010842187327745267,
            "start_logit": -2.313182830810547,
            "end_logit": -2.2878735065460205,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "consumption and insulin resistance. This association may be further confounded by the presence of obesity. We aimed to clarify whether regular alcohol",
            "probability": 0.0010149254446544316,
            "start_logit": -5.210757255554199,
            "end_logit": 0.5436564087867737,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption improves insulin resistance in healthy Japanese men",
            "probability": 0.0009370028495299631,
            "start_logit": 1.146890640258789,
            "end_logit": -5.893875598907471,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        },
        {
            "text": "alcohol consumption and insulin resistance.",
            "probability": 0.0008630921547306728,
            "start_logit": 0.43448153138160706,
            "end_logit": -5.263631343841553,
            "question_text": "Which drugs affect insulin resistance in obesity?"
        }
    ],
    "5895f9cf78275d0c4a000002": [
        {
            "text": "lymphedema",
            "probability": 0.5780631846026265,
            "start_logit": 4.868656635284424,
            "end_logit": 5.296644687652588,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "intrahepatic cholestasis associated with lymphedema",
            "probability": 0.08142554960224632,
            "start_logit": 2.9086625576019287,
            "end_logit": 5.296644687652588,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "Lymphedema",
            "probability": 0.08073830178166022,
            "start_logit": 4.185466289520264,
            "end_logit": 4.011364936828613,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "Lymphedema Cholestasis",
            "probability": 0.05899856498504612,
            "start_logit": 4.185466289520264,
            "end_logit": 3.697664976119995,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "lymphedema of the lower extremities",
            "probability": 0.04433286405095657,
            "start_logit": 4.868656635284424,
            "end_logit": 2.7286877632141113,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "cholestasis associated with lymphedema",
            "probability": 0.038176427911271724,
            "start_logit": 2.1511917114257812,
            "end_logit": 5.296644687652588,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "intrahepatic cholestasis",
            "probability": 0.03466772616117964,
            "start_logit": 2.9086625576019287,
            "end_logit": 4.442764759063721,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "familial intrahepatic cholestasis associated with lymphedema",
            "probability": 0.019467143351416437,
            "start_logit": 1.4777015447616577,
            "end_logit": 5.296644687652588,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "cholestasis",
            "probability": 0.01625398852209248,
            "start_logit": 2.1511917114257812,
            "end_logit": 4.442764759063721,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "idiopathic familial intrahepatic cholestasis associated with lymphedema",
            "probability": 0.014201451489641595,
            "start_logit": 1.1623176336288452,
            "end_logit": 5.296644687652588,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "familial intrahepatic cholestasis",
            "probability": 0.008288327166891062,
            "start_logit": 1.4777015447616577,
            "end_logit": 4.442764759063721,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "intrahepatic cholestasis associated with lymphedema of the lower extremities",
            "probability": 0.006244694208077414,
            "start_logit": 2.9086625576019287,
            "end_logit": 2.7286877632141113,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "idiopathic familial intrahepatic cholestasis",
            "probability": 0.006046407224012024,
            "start_logit": 1.1623176336288452,
            "end_logit": 4.442764759063721,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "Lymphedema Cholestasis Syndrome",
            "probability": 0.004723831340958629,
            "start_logit": 4.185466289520264,
            "end_logit": 1.1727720499038696,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "cholestasis associated with lymphedema of the lower extremities",
            "probability": 0.0029278294027753993,
            "start_logit": 2.1511917114257812,
            "end_logit": 2.7286877632141113,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "familial intrahepatic cholestasis associated with lymphedema of the lower extremities",
            "probability": 0.0014929755823355137,
            "start_logit": 1.4777015447616577,
            "end_logit": 2.7286877632141113,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "Cholestasis",
            "probability": 0.0013618420625521018,
            "start_logit": 0.4167914092540741,
            "end_logit": 3.697664976119995,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "idiopathic familial intrahepatic cholestasis associated with lymphedema of the lower extremities",
            "probability": 0.0010891387567767878,
            "start_logit": 1.1623176336288452,
            "end_logit": 2.7286877632141113,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "patic cholestasis associated with lymphedema",
            "probability": 0.0009756897560385868,
            "start_logit": -1.5156371593475342,
            "end_logit": 5.296644687652588,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        },
        {
            "text": "associated with lymphedema",
            "probability": 0.0005240620414451038,
            "start_logit": -2.137171745300293,
            "end_logit": 5.296644687652588,
            "question_text": "List two most common symptoms of Aagenaes syndrome."
        }
    ],
    "58a2fac960087bc10a000009": [
        {
            "text": "hepatotoxicity",
            "probability": 0.887673320070186,
            "start_logit": 5.294500827789307,
            "end_logit": 3.9318509101867676,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity in 30-50% of patients, as indicated by an increase in transaminase levels",
            "probability": 0.07054315442917465,
            "start_logit": 5.294500827789307,
            "end_logit": 1.3994717597961426,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "patotoxicity",
            "probability": 0.019156525299948077,
            "start_logit": 1.458540439605713,
            "end_logit": 3.9318509101867676,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity in 30-50% of patients, as indicated by an increase in transaminase",
            "probability": 0.009020925042513265,
            "start_logit": 5.294500827789307,
            "end_logit": -0.6572059988975525,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "he",
            "probability": 0.0031890438742903727,
            "start_logit": 5.294500827789307,
            "end_logit": -1.6970317363739014,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity in 30-50% of patients, as indicated by an increase",
            "probability": 0.00267326341927081,
            "start_logit": 5.294500827789307,
            "end_logit": -1.87345290184021,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "transaminase levels",
            "probability": 0.00197003228676908,
            "start_logit": 1.716326117515564,
            "end_logit": 1.3994717597961426,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "patotoxicity in 30-50% of patients, as indicated by an increase in transaminase levels",
            "probability": 0.001522363793083,
            "start_logit": 1.458540439605713,
            "end_logit": 1.3994717597961426,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepa",
            "probability": 0.0009525348746933606,
            "start_logit": 5.294500827789307,
            "end_logit": -2.905381441116333,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "increase in transaminase levels",
            "probability": 0.0007086523131253064,
            "start_logit": 0.6938859224319458,
            "end_logit": 1.3994717597961426,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity in 30-50% of patients,",
            "probability": 0.0006725238005769518,
            "start_logit": 5.294500827789307,
            "end_logit": -3.2534706592559814,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepato",
            "probability": 0.00044216181426495754,
            "start_logit": 5.294500827789307,
            "end_logit": -3.6728322505950928,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "reversible hepatotoxicity",
            "probability": 0.00035505658592659356,
            "start_logit": -2.529581069946289,
            "end_logit": 3.9318509101867676,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "totoxicity",
            "probability": 0.00029736526253553244,
            "start_logit": -2.706897020339966,
            "end_logit": 3.9318509101867676,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "transaminase",
            "probability": 0.00025192399934592473,
            "start_logit": 1.716326117515564,
            "end_logit": -0.6572059988975525,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "patotoxicity in 30-50% of patients, as indicated by an increase in transaminase",
            "probability": 0.00019467699985866073,
            "start_logit": 1.458540439605713,
            "end_logit": -0.6572059988975525,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "city",
            "probability": 0.000131802319996785,
            "start_logit": -3.520555019378662,
            "end_logit": 3.9318509101867676,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "increase in transaminase",
            "probability": 9.062111624630142e-05,
            "start_logit": 0.6938859224319458,
            "end_logit": -0.6572059988975525,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity in 30-50% of patients, as indicated by an increase in transaminase levels.",
            "probability": 8.282763726364706e-05,
            "start_logit": 5.294500827789307,
            "end_logit": -5.3477463722229,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        },
        {
            "text": "hepatotoxicity in 30-50% of patients, as indicated by an increase in trans",
            "probability": 7.122506093078328e-05,
            "start_logit": 5.294500827789307,
            "end_logit": -5.498663425445557,
            "question_text": "Which are the side effects during tacrine administration in patients with Alzheimer's Disease?"
        }
    ],
    "589c215778275d0c4a00003c": [
        {
            "text": "gluconolactonase",
            "probability": 0.9445373027272085,
            "start_logit": 3.0420732498168945,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "g",
            "probability": 0.01577184208922167,
            "start_logit": 3.0420732498168945,
            "end_logit": -2.7154297828674316,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "gluconolacton",
            "probability": 0.01351295948785501,
            "start_logit": 3.0420732498168945,
            "end_logit": -2.870006799697876,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "gluconolactonase (GNL)",
            "probability": 0.006657370472387198,
            "start_logit": 3.0420732498168945,
            "end_logit": -3.5779314041137695,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "senescence marker protein-30 (SMP30)/gluconolactonase",
            "probability": 0.0030354804950268738,
            "start_logit": -2.6982522010803223,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "gluconola",
            "probability": 0.00294424070792957,
            "start_logit": 3.0420732498168945,
            "end_logit": -4.393805027008057,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "gluconolactonase (GNL) knockout (KO) mice placed in an AA-deficient state.",
            "probability": 0.002914421780450756,
            "start_logit": 3.0420732498168945,
            "end_logit": -4.403984546661377,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "gluconolactonase (GNL) knockout",
            "probability": 0.002903408387917228,
            "start_logit": 3.0420732498168945,
            "end_logit": -4.40777063369751,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "luconolactonase",
            "probability": 0.002034157289828156,
            "start_logit": -3.0985403060913086,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "ctonase",
            "probability": 0.0016572117765716427,
            "start_logit": -3.30348539352417,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "synthetic enzymes in the adrenal glands of senescence marker protein-30 (SMP30)/gluconolactonase",
            "probability": 0.0010564362026460208,
            "start_logit": -3.753720760345459,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "conolactonase",
            "probability": 0.0007962327463456391,
            "start_logit": -4.03648567199707,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "olactonase",
            "probability": 0.0005549333879299178,
            "start_logit": -4.397529125213623,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "(SMP30)/gluconolactonase",
            "probability": 0.0004396831161190631,
            "start_logit": -4.6303229331970215,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "in the adrenal glands of senescence marker protein-30 (SMP30)/gluconolactonase",
            "probability": 0.00040212872185505275,
            "start_logit": -4.719604969024658,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "30 (SMP30)/gluconolactonase",
            "probability": 0.0003159705589988673,
            "start_logit": -4.960728168487549,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "SMP30)/gluconolactonase",
            "probability": 0.00029003744681205116,
            "start_logit": -5.046367168426514,
            "end_logit": 1.3770391941070557,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "catecholamine synthetic enzymes in the adrenal glands of senescence marker protein-30 (SMP30)/g",
            "probability": 7.637075622711298e-05,
            "start_logit": -2.2883083820343018,
            "end_logit": -2.7154297828674316,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "senescence marker protein-30 (SMP30)/g",
            "probability": 5.068631899898937e-05,
            "start_logit": -2.6982522010803223,
            "end_logit": -2.7154297828674316,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        },
        {
            "text": "catecholamine synthetic enzymes in the adrenal glands of senescence marker protein-30",
            "probability": 4.912552967090073e-05,
            "start_logit": -2.2883083820343018,
            "end_logit": -3.1566507816314697,
            "question_text": "Which enzymes synthesize catecholamines in adrenal glands?"
        }
    ],
    "5896deff78275d0c4a000013": [
        {
            "text": "ledipasvir",
            "probability": 0.4189501660670087,
            "start_logit": 5.580589294433594,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir and 90 mg ledipasvir",
            "probability": 0.35027504825794625,
            "start_logit": 5.401556015014648,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir",
            "probability": 0.22746687880153288,
            "start_logit": 5.401556015014648,
            "end_logit": 5.282662868499756,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir and 90 mg",
            "probability": 0.0007933108523839965,
            "start_logit": 5.401556015014648,
            "end_logit": -0.3758819103240967,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "400 mg sofosbuvir and 90 mg ledipasvir",
            "probability": 0.0005766746232413777,
            "start_logit": -1.007639765739441,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "400 mg sofosbuvir",
            "probability": 0.00037448963974210324,
            "start_logit": -1.007639765739441,
            "end_logit": 5.282662868499756,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "vir and 90 mg ledipasvir",
            "probability": 0.00037057101901742033,
            "start_logit": -1.4498728513717651,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "90 mg ledipasvir",
            "probability": 0.0003299771330484827,
            "start_logit": -1.565894603729248,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "vir",
            "probability": 0.00024064698153469988,
            "start_logit": -1.4498728513717651,
            "end_logit": 5.282662868499756,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "400/90 mg film-coated tablets containing 400 mg sofosbuvir and 90 mg ledipasvir",
            "probability": 0.00011209695144075575,
            "start_logit": -2.6455538272857666,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "film-coated tablets containing 400 mg sofosbuvir and 90 mg ledipasvir",
            "probability": 0.00010915274992008035,
            "start_logit": -2.6721696853637695,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "400/90 mg film-coated tablets containing 400 mg sofosbuvir",
            "probability": 7.279520420940305e-05,
            "start_logit": -2.6455538272857666,
            "end_logit": 5.282662868499756,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "film-coated tablets containing 400 mg sofosbuvir",
            "probability": 7.088325434656961e-05,
            "start_logit": -2.6721696853637695,
            "end_logit": 5.282662868499756,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "tablets containing 400 mg sofosbuvir and 90 mg ledipasvir",
            "probability": 6.788552010593866e-05,
            "start_logit": -3.147095203399658,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "led",
            "probability": 4.6884716250378906e-05,
            "start_logit": 5.580589294433594,
            "end_logit": -3.3834385871887207,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "tablets containing 400 mg sofosbuvir",
            "probability": 4.408452001110036e-05,
            "start_logit": -3.147095203399658,
            "end_logit": 5.282662868499756,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "sofosbuvir and 90 mg led",
            "probability": 3.919928329741942e-05,
            "start_logit": 5.401556015014648,
            "end_logit": -3.3834385871887207,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "so",
            "probability": 2.8722211762600575e-05,
            "start_logit": 5.401556015014648,
            "end_logit": -3.6944262981414795,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "containing 400 mg sofosbuvir and 90 mg ledipasvir",
            "probability": 1.7720162885521226e-05,
            "start_logit": -4.490214824676514,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        },
        {
            "text": "90 mg film-coated tablets containing 400 mg sofosbuvir and 90 mg ledipasvir",
            "probability": 1.2812050314339177e-05,
            "start_logit": -4.8145318031311035,
            "end_logit": 5.714376926422119,
            "question_text": "Which two drugs are included in the Harvoni pill?"
        }
    ],
    "58a7fb2860087bc10a000034": [
        {
            "text": "histamine decarboxylase (HDC)",
            "probability": 0.307905814649402,
            "start_logit": 3.0385570526123047,
            "end_logit": 2.682640790939331,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "HDC)",
            "probability": 0.1392827703202109,
            "start_logit": 2.245269298553467,
            "end_logit": 2.682640790939331,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histamine decarboxylase (HDC) gene",
            "probability": 0.13301575208420996,
            "start_logit": 3.0385570526123047,
            "end_logit": 1.8433144092559814,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histamine decarboxylase",
            "probability": 0.12741177737215195,
            "start_logit": 3.0385570526123047,
            "end_logit": 1.8002710342407227,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histamine decarboxylase (HDC",
            "probability": 0.06502754307681237,
            "start_logit": 3.0385570526123047,
            "end_logit": 1.1276577711105347,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "HDC) gene",
            "probability": 0.060170355884999256,
            "start_logit": 2.245269298553467,
            "end_logit": 1.8433144092559814,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "HDC",
            "probability": 0.029415541753143926,
            "start_logit": 2.245269298553467,
            "end_logit": 1.1276577711105347,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "the histamine decarboxylase (HDC)",
            "probability": 0.027942210825302682,
            "start_logit": 0.6389015913009644,
            "end_logit": 2.682640790939331,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histamine decarboxylase (HDC) gene,",
            "probability": 0.025877159503843804,
            "start_logit": 3.0385570526123047,
            "end_logit": 0.20620755851268768,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "histamine decarboxylase (HDC) gene, the key enzyme in histamine production,",
            "probability": 0.01337002016736826,
            "start_logit": 3.0385570526123047,
            "end_logit": -0.45413824915885925,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "the histamine decarboxylase (HDC) gene",
            "probability": 0.012071075020311925,
            "start_logit": 0.6389015913009644,
            "end_logit": 1.8433144092559814,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "(HDC)",
            "probability": 0.012007677833791372,
            "start_logit": -0.20569062232971191,
            "end_logit": 2.682640790939331,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "HDC) gene,",
            "probability": 0.011705665473766133,
            "start_logit": 2.245269298553467,
            "end_logit": 0.20620755851268768,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "the histamine decarboxylase",
            "probability": 0.011562518717007654,
            "start_logit": 0.6389015913009644,
            "end_logit": 1.8002710342407227,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "HDC) gene, the key enzyme in histamine production,",
            "probability": 0.006047997015803541,
            "start_logit": 2.245269298553467,
            "end_logit": -0.45413824915885925,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "the histamine decarboxylase (HDC",
            "probability": 0.005901198456328899,
            "start_logit": 0.6389015913009644,
            "end_logit": 1.1276577711105347,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "(HDC) gene",
            "probability": 0.005187333989341271,
            "start_logit": -0.20569062232971191,
            "end_logit": 1.8433144092559814,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "(HDC",
            "probability": 0.0025359371289510983,
            "start_logit": -0.20569062232971191,
            "end_logit": 1.1276577711105347,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "the histamine decarboxylase (HDC) gene,",
            "probability": 0.0023483318989597807,
            "start_logit": 0.6389015913009644,
            "end_logit": 0.20620755851268768,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        },
        {
            "text": "the histamine decarboxylase (HDC) gene, the key enzyme in histamine production,",
            "probability": 0.00121331882829345,
            "start_logit": 0.6389015913009644,
            "end_logit": -0.45413824915885925,
            "question_text": "Which mutated genes are associated with the Tourette's syndrome?"
        }
    ],
    "588fd8f3621ea6ff7e000001": [
        {
            "text": "DeepBlue",
            "probability": 0.14116182888836923,
            "start_logit": -2.189883232116699,
            "end_logit": -2.7775700092315674,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "DeepBlue Epigenomic Data Server, which streamlines epigenomic data analysis as well as software development. DeepBlue",
            "probability": 0.11014966728710071,
            "start_logit": -2.189883232116699,
            "end_logit": -3.025636911392212,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ROADMAP",
            "probability": 0.0673125154757675,
            "start_logit": -2.797973155975342,
            "end_logit": -2.910040855407715,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "DeepBlue Epigenomic",
            "probability": 0.06494778480518154,
            "start_logit": -2.189883232116699,
            "end_logit": -3.5538933277130127,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "BLUEPRINT",
            "probability": 0.05906755779569035,
            "start_logit": -2.6918632984161377,
            "end_logit": -3.146815061569214,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "BLUEPRINT and DEEP",
            "probability": 0.05662128359536849,
            "start_logit": -2.6918632984161377,
            "end_logit": -3.1891119480133057,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ROADMAP, BLUEPRINT",
            "probability": 0.053120981321180726,
            "start_logit": -2.797973155975342,
            "end_logit": -3.146815061569214,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE, ROADMAP",
            "probability": 0.05279768108729114,
            "start_logit": -3.0408520698547363,
            "end_logit": -2.910040855407715,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ROADMAP, BLUEPRINT and DEEP",
            "probability": 0.05092098370910298,
            "start_logit": -2.797973155975342,
            "end_logit": -3.1891119480133057,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "DeepBlue Epigenomic Data Server,",
            "probability": 0.04768441438051024,
            "start_logit": -2.189883232116699,
            "end_logit": -3.862872362136841,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE, ROADMAP, BLUEPRINT",
            "probability": 0.041666317341079444,
            "start_logit": -3.0408520698547363,
            "end_logit": -3.146815061569214,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE, ROADMAP, BLUEPRINT and DEEP",
            "probability": 0.0399407129494697,
            "start_logit": -3.0408520698547363,
            "end_logit": -3.1891119480133057,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "Deep",
            "probability": 0.03589226995843094,
            "start_logit": -2.189883232116699,
            "end_logit": -4.1469550132751465,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "DEEP",
            "probability": 0.02953779975559105,
            "start_logit": -3.3425774574279785,
            "end_logit": -3.1891119480133057,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "BLUEPRINT and DEEP.",
            "probability": 0.029042062710750903,
            "start_logit": -2.6918632984161377,
            "end_logit": -3.8567516803741455,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "DeepBlue Epigenomic Data Server, which streamlines epigenomic data analysis as well as software development. Deep",
            "probability": 0.02658932552391055,
            "start_logit": -2.189883232116699,
            "end_logit": -4.446967124938965,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "DeepBlue Epigenomic Data Server",
            "probability": 0.026411721105605804,
            "start_logit": -2.189883232116699,
            "end_logit": -4.45366907119751,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ROADMAP, BLUEPRINT and DEEP.",
            "probability": 0.026118277585177548,
            "start_logit": -2.797973155975342,
            "end_logit": -3.8567516803741455,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE",
            "probability": 0.020530513168984767,
            "start_logit": -3.0408520698547363,
            "end_logit": -3.854595899581909,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        },
        {
            "text": "ENCODE, ROADMAP, BLUEPRINT and DEEP.",
            "probability": 0.02048630155543634,
            "start_logit": -3.0408520698547363,
            "end_logit": -3.8567516803741455,
            "question_text": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?"
        }
    ],
    "58846be0e56acf5176000005": [
        {
            "text": "Essential Tremor",
            "probability": 0.9769487115287396,
            "start_logit": 3.345076560974121,
            "end_logit": 3.203794479370117,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Tremor",
            "probability": 0.015136770212331353,
            "start_logit": -0.8222306966781616,
            "end_logit": 3.203794479370117,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Essential",
            "probability": 0.002672799255502875,
            "start_logit": 3.345076560974121,
            "end_logit": -2.6975133419036865,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Essential Tremor (ET)",
            "probability": 0.0026568889096427128,
            "start_logit": 3.345076560974121,
            "end_logit": -2.703483819961548,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "or",
            "probability": 0.0016474276273371388,
            "start_logit": -3.04014253616333,
            "end_logit": 3.203794479370117,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Essential T",
            "probability": 0.00037688313251107444,
            "start_logit": 3.345076560974121,
            "end_logit": -4.656459808349609,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "remor",
            "probability": 0.00022967568110810496,
            "start_logit": -5.010444641113281,
            "end_logit": 3.203794479370117,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Essential Tremor (",
            "probability": 0.00015825239213503527,
            "start_logit": 3.345076560974121,
            "end_logit": -5.524203777313232,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Essential Trem",
            "probability": 0.00011526548061169537,
            "start_logit": 3.345076560974121,
            "end_logit": -5.841156959533691,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Tremor (ET)",
            "probability": 4.116563789927294e-05,
            "start_logit": -0.8222306966781616,
            "end_logit": -2.703483819961548,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "T",
            "probability": 5.839399045623226e-06,
            "start_logit": -0.8222306966781616,
            "end_logit": -4.656459808349609,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "or (ET)",
            "probability": 4.480309089779981e-06,
            "start_logit": -3.04014253616333,
            "end_logit": -2.703483819961548,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Tremor (",
            "probability": 2.45195071863229e-06,
            "start_logit": -0.8222306966781616,
            "end_logit": -5.524203777313232,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "Trem",
            "probability": 1.7859147290372789e-06,
            "start_logit": -0.8222306966781616,
            "end_logit": -5.841156959533691,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "remor (ET)",
            "probability": 6.246210909023847e-07,
            "start_logit": -5.010444641113281,
            "end_logit": -2.703483819961548,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "or (",
            "probability": 2.6686084931468603e-07,
            "start_logit": -3.04014253616333,
            "end_logit": -5.524203777313232,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "(ET)",
            "probability": 2.0736712108808594e-07,
            "start_logit": -6.113099098205566,
            "end_logit": -2.703483819961548,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "focused ultrasound technique",
            "probability": 1.7921683926246823e-07,
            "start_logit": -4.359633445739746,
            "end_logit": -4.602843761444092,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "development of MRI-guided focused ultrasound technique",
            "probability": 1.787431785694275e-07,
            "start_logit": -4.362279891967773,
            "end_logit": -4.602843761444092,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        },
        {
            "text": "focused ultrasound",
            "probability": 1.457595183414406e-07,
            "start_logit": -4.359633445739746,
            "end_logit": -4.809482097625732,
            "question_text": "Which diseases that can be treated using the focused ultrasound thalamotomy."
        }
    ],
    "58839d892305cd7e21000006": [
        {
            "text": "protein-coding and microRNA genes related to reproduction",
            "probability": 0.3518725489159161,
            "start_logit": 2.8859574794769287,
            "end_logit": 2.7626049518585205,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "reproduction",
            "probability": 0.2347916891721141,
            "start_logit": 2.481387138366699,
            "end_logit": 2.7626049518585205,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA genes related to reproduction",
            "probability": 0.14903551978239607,
            "start_logit": 2.0268731117248535,
            "end_logit": 2.7626049518585205,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding",
            "probability": 0.07282177878648921,
            "start_logit": 2.8859574794769287,
            "end_logit": 1.1873509883880615,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "both protein-coding and microRNA genes related to reproduction",
            "probability": 0.05010368256773007,
            "start_logit": 0.936782956123352,
            "end_logit": 2.7626049518585205,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA",
            "probability": 0.038600150674336774,
            "start_logit": 2.8859574794769287,
            "end_logit": 0.5525920987129211,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA genes",
            "probability": 0.03291642087093808,
            "start_logit": 2.8859574794769287,
            "end_logit": 0.39330756664276123,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA",
            "probability": 0.016349083033480063,
            "start_logit": 2.0268731117248535,
            "end_logit": 0.5525920987129211,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "microRNA genes",
            "probability": 0.013941740863248309,
            "start_logit": 2.0268731117248535,
            "end_logit": 0.39330756664276123,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "both protein-coding",
            "probability": 0.010369206974448009,
            "start_logit": 0.936782956123352,
            "end_logit": 1.1873509883880615,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein",
            "probability": 0.009988429433033881,
            "start_logit": 2.8859574794769287,
            "end_logit": -0.7992367148399353,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "both protein-coding and microRNA",
            "probability": 0.005496335825036681,
            "start_logit": 0.936782956123352,
            "end_logit": 0.5525920987129211,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "both protein-coding and microRNA genes",
            "probability": 0.004687020648994672,
            "start_logit": 0.936782956123352,
            "end_logit": 0.39330756664276123,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "related to reproduction",
            "probability": 0.0017269660786409066,
            "start_logit": -2.43094539642334,
            "end_logit": 2.7626049518585205,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and microRNA genes related to reproduction exhibited evidence of rapid sequence evolution",
            "probability": 0.001510584629315878,
            "start_logit": 2.8859574794769287,
            "end_logit": -2.6881673336029053,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "both protein",
            "probability": 0.0014222680888428484,
            "start_logit": 0.936782956123352,
            "end_logit": -0.7992367148399353,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "proteases (reproductive and immunity pathways). In addition, both protein-coding and microRNA genes related to reproduction",
            "probability": 0.001217659809525741,
            "start_logit": -2.7803807258605957,
            "end_logit": 2.7626049518585205,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "growth hormone/insulin-like growth factor genes",
            "probability": 0.001180953512638024,
            "start_logit": -0.32067444920539856,
            "end_logit": 0.27229002118110657,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "reproduction exhibited evidence of rapid sequence evolution",
            "probability": 0.0010079579036421506,
            "start_logit": 2.481387138366699,
            "end_logit": -2.6881673336029053,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        },
        {
            "text": "protein-coding and micro",
            "probability": 0.0009600024292325613,
            "start_logit": 2.8859574794769287,
            "end_logit": -3.1414835453033447,
            "question_text": "Which genes of the marmoset genome exhibit rapid sequence evolution?"
        }
    ],
    "58919aad621ea6ff7e00000d": [
        {
            "text": "fulvestrant",
            "probability": 0.49867641655327394,
            "start_logit": 0.6392382383346558,
            "end_logit": 0.24097663164138794,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "ICI 182,780 (ICI, fulvestrant",
            "probability": 0.3053153563966134,
            "start_logit": 0.14862601459026337,
            "end_logit": 0.24097663164138794,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "ICI 182,780",
            "probability": 0.08816953273815549,
            "start_logit": 0.14862601459026337,
            "end_logit": -1.001107096672058,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "ICI",
            "probability": 0.031534011213353356,
            "start_logit": 0.14862601459026337,
            "end_logit": -2.029301881790161,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "SERDs), compounds that target the receptor for degradation. Currently, ICI 182,780 (ICI, fulvestrant",
            "probability": 0.02229965993019998,
            "start_logit": -2.4681477546691895,
            "end_logit": 0.24097663164138794,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "ICI, fulvestrant",
            "probability": 0.014033199766129378,
            "start_logit": -2.931293249130249,
            "end_logit": 0.24097663164138794,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "182,780 (ICI, fulvestrant",
            "probability": 0.006599777476782109,
            "start_logit": -3.685683250427246,
            "end_logit": 0.24097663164138794,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "SERDs), compounds that target the receptor for degradation. Currently, ICI 182,780",
            "probability": 0.006439736996757594,
            "start_logit": -2.4681477546691895,
            "end_logit": -1.001107096672058,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "fulvestrant)",
            "probability": 0.00458317915287413,
            "start_logit": 0.6392382383346558,
            "end_logit": -4.448587894439697,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "(SERDs), compounds that target the receptor for degradation. Currently, ICI 182,780 (ICI, fulvestrant",
            "probability": 0.0032880818335783405,
            "start_logit": -4.382414817810059,
            "end_logit": 0.24097663164138794,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "ICI 182",
            "probability": 0.0031204882283694386,
            "start_logit": 0.14862601459026337,
            "end_logit": -4.342379093170166,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "SERDs",
            "probability": 0.0029971983608100394,
            "start_logit": -2.4681477546691895,
            "end_logit": -1.7659168243408203,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "ICI 182,780 (ICI, fulvestrant)",
            "probability": 0.002806058056968098,
            "start_logit": 0.14862601459026337,
            "end_logit": -4.448587894439697,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "SERDs), compounds that target the receptor for degradation. Currently, ICI",
            "probability": 0.0023031849252266854,
            "start_logit": -2.4681477546691895,
            "end_logit": -2.029301881790161,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "182,780",
            "probability": 0.0019058959338677274,
            "start_logit": -3.685683250427246,
            "end_logit": -1.001107096672058,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "f",
            "probability": 0.0017264699415811457,
            "start_logit": 0.6392382383346558,
            "end_logit": -5.424901962280273,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "(ICI, fulvestrant",
            "probability": 0.001312259599273406,
            "start_logit": -5.300968647003174,
            "end_logit": 0.24097663164138794,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "ICI 182,780 (ICI, f",
            "probability": 0.0010570337157012426,
            "start_logit": 0.14862601459026337,
            "end_logit": -5.424901962280273,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "(SERDs), compounds that target the receptor for degradation. Currently, ICI 182,780",
            "probability": 0.0009495383471469423,
            "start_logit": -4.382414817810059,
            "end_logit": -1.001107096672058,
            "question_text": "List selective estrogen receptor degraders."
        },
        {
            "text": "nt",
            "probability": 0.0008829208333375061,
            "start_logit": -5.697238922119141,
            "end_logit": 0.24097663164138794,
            "question_text": "List selective estrogen receptor degraders."
        }
    ],
    "587d2700fe8a08052f000001": [
        {
            "text": "dbSUPER",
            "probability": 0.31516875645577336,
            "start_logit": 0.32508227229118347,
            "end_logit": -0.3254494369029999,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER (http://bioinfo.au.tsinghua.edu.cn/dbsuper",
            "probability": 0.2448952110005539,
            "start_logit": 0.32508227229118347,
            "end_logit": -0.5777272582054138,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbsuper",
            "probability": 0.16610882064110105,
            "start_logit": -0.0631050169467926,
            "end_logit": -0.5777272582054138,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbsuper/),",
            "probability": 0.034145559641461196,
            "start_logit": -0.0631050169467926,
            "end_logit": -2.1597378253936768,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers and also links to external databases such as GeneCards, UniProt",
            "probability": 0.026702813541910436,
            "start_logit": -0.4667230546474457,
            "end_logit": -2.001983404159546,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbsuper/), the first integrated and interactive database of super-enhancers,",
            "probability": 0.02579693383496851,
            "start_logit": -0.0631050169467926,
            "end_logit": -2.440114736557007,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbsuper/)",
            "probability": 0.021485741836911314,
            "start_logit": -0.0631050169467926,
            "end_logit": -2.622980833053589,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbsuper/), the first integrated and interactive database of super-enhancers",
            "probability": 0.021047405637856453,
            "start_logit": -0.0631050169467926,
            "end_logit": -2.6435930728912354,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers and also links to external databases",
            "probability": 0.01739649519714077,
            "start_logit": -0.4667230546474457,
            "end_logit": -2.43048357963562,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers and also links to external databases such as GeneCards",
            "probability": 0.01535741979931313,
            "start_logit": -0.4667230546474457,
            "end_logit": -2.5551536083221436,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "GeneCards, UniProt and Entrez. dbSUPER",
            "probability": 0.014853008806266978,
            "start_logit": -1.4905978441238403,
            "end_logit": -1.5646750926971436,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbsuper/), the first integrated and interactive database",
            "probability": 0.013979162319689348,
            "start_logit": -0.0631050169467926,
            "end_logit": -3.052802562713623,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "a centralized resource to integrate all these findings is not currently available. We developed dbSUPER",
            "probability": 0.012846749314619318,
            "start_logit": -2.8749351501464844,
            "end_logit": -0.3254494369029999,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers",
            "probability": 0.012518329132068289,
            "start_logit": -0.4667230546474457,
            "end_logit": -2.7595584392547607,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER lists genes associated with super-enhancers and also links to external databases such as GeneCards, UniProt and Entrez",
            "probability": 0.010494446036510426,
            "start_logit": -0.4667230546474457,
            "end_logit": -2.935906171798706,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "bioinfo.au.tsinghua.edu.cn/dbsuper",
            "probability": 0.010351483658178288,
            "start_logit": -2.838618278503418,
            "end_logit": -0.5777272582054138,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "We developed dbSUPER",
            "probability": 0.009808932818360601,
            "start_logit": -3.1447324752807617,
            "end_logit": -0.3254494369029999,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "GeneCards, UniProt",
            "probability": 0.009591661684179026,
            "start_logit": -1.4905978441238403,
            "end_logit": -2.001983404159546,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "GeneCards, UniProt and Entrez.",
            "probability": 0.009470998675044832,
            "start_logit": -1.4905978441238403,
            "end_logit": -2.0146431922912598,
            "question_text": "List all the available databases of super enhancers"
        },
        {
            "text": "dbSUPER also provides an overlap analysis tool to annotate user-defined regions. We believe dbSUPER",
            "probability": 0.007980069968092843,
            "start_logit": -1.3763508796691895,
            "end_logit": -2.3001773357391357,
            "question_text": "List all the available databases of super enhancers"
        }
    ],
    "58a2efec60087bc10a000008": [
        {
            "text": "acidosis",
            "probability": 0.8093639438299638,
            "start_logit": 3.2136573791503906,
            "end_logit": 2.5061328411102295,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "acidosis by treatment with kainic acid",
            "probability": 0.05397644574921822,
            "start_logit": 3.2136573791503906,
            "end_logit": -0.20156808197498322,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "dementia",
            "probability": 0.04887039303268712,
            "start_logit": 1.167762279510498,
            "end_logit": 1.7449510097503662,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "induction of acidosis",
            "probability": 0.042017190700502784,
            "start_logit": 0.2554875314235687,
            "end_logit": 2.5061328411102295,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "acidosis by treatment with kainic acid or pH 6.0 medium activated asparaginyl endopeptidase",
            "probability": 0.02408367739270376,
            "start_logit": 3.2136573791503906,
            "end_logit": -1.008581519126892,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "acid",
            "probability": 0.006111754948556895,
            "start_logit": 3.2136573791503906,
            "end_logit": -2.379901885986328,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "acidosis by treatment",
            "probability": 0.004997649470344189,
            "start_logit": 3.2136573791503906,
            "end_logit": -2.581148147583008,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "an induction of acidosis",
            "probability": 0.0029006971258076597,
            "start_logit": -2.417640209197998,
            "end_logit": 2.5061328411102295,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "induction of acidosis by treatment with kainic acid",
            "probability": 0.0028021245963196846,
            "start_logit": 0.2554875314235687,
            "end_logit": -0.20156808197498322,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "induction of acidosis by treatment with kainic acid or pH 6.0 medium activated asparaginyl endopeptidase",
            "probability": 0.0012502761872367442,
            "start_logit": 0.2554875314235687,
            "end_logit": -1.008581519126892,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "acidosis by treatment with kainic acid or pH 6.0 medium",
            "probability": 0.0010979295099862408,
            "start_logit": 3.2136573791503906,
            "end_logit": -4.096689701080322,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "treatment with kainic acid",
            "probability": 0.000381498409224522,
            "start_logit": -1.7385389804840088,
            "end_logit": -0.20156808197498322,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "brain acidosis",
            "probability": 0.0003704796751549012,
            "start_logit": -2.3465025424957275,
            "end_logit": 0.37708738446235657,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "Neurofibrillary pathology",
            "probability": 0.0003700439053981071,
            "start_logit": -1.453184962272644,
            "end_logit": -0.5174071192741394,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "induction of acid",
            "probability": 0.000317284671680663,
            "start_logit": 0.2554875314235687,
            "end_logit": -2.379901885986328,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "Finally, an induction of acidosis",
            "probability": 0.00029246758612434424,
            "start_logit": -4.7119927406311035,
            "end_logit": 2.5061328411102295,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "induction of acidosis by treatment",
            "probability": 0.00025944717756519426,
            "start_logit": 0.2554875314235687,
            "end_logit": -2.581148147583008,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "an induction of acidosis by treatment with kainic acid",
            "probability": 0.00019344736350024932,
            "start_logit": -2.417640209197998,
            "end_logit": -0.20156808197498322,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "asparaginyl endopeptidase",
            "probability": 0.00017181255487816764,
            "start_logit": -1.729228138923645,
            "end_logit": -1.008581519126892,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        },
        {
            "text": "kainic acid",
            "probability": 0.00017143611314663466,
            "start_logit": -2.5384349822998047,
            "end_logit": -0.20156808197498322,
            "question_text": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?"
        }
    ],
    "58a45d6060087bc10a00001d": [
        {
            "text": "Stevens-Johnson syndrome",
            "probability": 0.27104761081746076,
            "start_logit": 3.2187085151672363,
            "end_logit": 3.1237599849700928,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson syndrome (SJS), but also acute generalized exanthematous pustulosis",
            "probability": 0.22137688854586382,
            "start_logit": 3.2187085151672363,
            "end_logit": 2.9213321208953857,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome",
            "probability": 0.14486129790510655,
            "start_logit": 2.592190742492676,
            "end_logit": 3.1237599849700928,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "acute generalized exanthematous pustulosis",
            "probability": 0.12401265226819388,
            "start_logit": 2.639225482940674,
            "end_logit": 2.9213321208953857,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "toxic epidermal necrolysis",
            "probability": 0.06199185469746918,
            "start_logit": 2.592190742492676,
            "end_logit": 2.2749862670898438,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Johnson syndrome",
            "probability": 0.04642047282456978,
            "start_logit": 1.45415461063385,
            "end_logit": 3.1237599849700928,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Johnson syndrome (SJS), but also acute generalized exanthematous pustulosis",
            "probability": 0.03791370751337049,
            "start_logit": 1.45415461063385,
            "end_logit": 2.9213321208953857,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "exanthematous pustulosis",
            "probability": 0.028994125819953025,
            "start_logit": 1.185935139656067,
            "end_logit": 2.9213321208953857,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson syndrome (SJS)",
            "probability": 0.01956560364142886,
            "start_logit": 3.2187085151672363,
            "end_logit": 0.49523860216140747,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS)",
            "probability": 0.010456829813943812,
            "start_logit": 2.592190742492676,
            "end_logit": 0.49523860216140747,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "generalized exanthematous pustulosis",
            "probability": 0.007703332584829668,
            "start_logit": -0.139505073428154,
            "end_logit": 2.9213321208953857,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "bullous reactions like toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome",
            "probability": 0.00729952006482702,
            "start_logit": -0.3957773745059967,
            "end_logit": 3.1237599849700928,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Johnson syndrome (SJS)",
            "probability": 0.0033508672863562577,
            "start_logit": 1.45415461063385,
            "end_logit": 0.49523860216140747,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "bullous reactions like toxic epidermal necrolysis",
            "probability": 0.003123752125405097,
            "start_logit": -0.3957773745059967,
            "end_logit": 2.2749862670898438,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "epidermal necrolysis (TEN) and Stevens-Johnson syndrome",
            "probability": 0.002998411677744247,
            "start_logit": -1.2855032682418823,
            "end_logit": 3.1237599849700928,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "acute generalized exanthematous pustulosis (AGEP)",
            "probability": 0.002708913483362064,
            "start_logit": 2.639225482940674,
            "end_logit": -0.9025038480758667,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson syndrome (SJS), but also acute generalized exanthematous",
            "probability": 0.0021263177255076574,
            "start_logit": 3.2187085151672363,
            "end_logit": -1.7241427898406982,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "Stevens-Johnson",
            "probability": 0.0014065311389776156,
            "start_logit": 3.2187085151672363,
            "end_logit": -2.1374080181121826,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "pustulosis",
            "probability": 0.0013581716170731764,
            "start_logit": -1.8750187158584595,
            "end_logit": 2.9213321208953857,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        },
        {
            "text": "epidermal necrolysis",
            "probability": 0.00128313844855703,
            "start_logit": -1.2855032682418823,
            "end_logit": 2.2749862670898438,
            "question_text": "Which diseases are involved in the severe cutaneous reactions (SCAR) spectrum?"
        }
    ],
    "58a0da5278275d0c4a000054": [
        {
            "text": "epidermal necrolysis",
            "probability": 0.5169887010333887,
            "start_logit": 3.7409229278564453,
            "end_logit": 4.229401111602783,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "toxic epidermal necrolysis",
            "probability": 0.4545557301242289,
            "start_logit": 3.61222243309021,
            "end_logit": 4.229401111602783,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "dermatology",
            "probability": 0.018983438310806688,
            "start_logit": 2.5582990646362305,
            "end_logit": 2.1075708866119385,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "necrolysis",
            "probability": 0.006509531869661527,
            "start_logit": -0.6338305473327637,
            "end_logit": 4.229401111602783,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "is",
            "probability": 0.0004457243561487687,
            "start_logit": -3.315152645111084,
            "end_logit": 4.229401111602783,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "ermal necrolysis",
            "probability": 0.00044324268385423647,
            "start_logit": -3.3207359313964844,
            "end_logit": 4.229401111602783,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "pidermal necrolysis",
            "probability": 0.0004402882207266934,
            "start_logit": -3.3274238109588623,
            "end_logit": 4.229401111602783,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "mal necrolysis",
            "probability": 0.0003350044891568885,
            "start_logit": -3.6007094383239746,
            "end_logit": 4.229401111602783,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "toxic",
            "probability": 0.00016372812395730476,
            "start_logit": 3.61222243309021,
            "end_logit": -3.699467420578003,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "epidermal necrolysis can lead to an increase in mortality,",
            "probability": 0.00016308004899292435,
            "start_logit": 3.7409229278564453,
            "end_logit": -3.8321340084075928,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "e",
            "probability": 0.00015252456519009372,
            "start_logit": 3.7409229278564453,
            "end_logit": -3.8990495204925537,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "toxic epidermal necrolysis can lead to an increase in mortality,",
            "probability": 0.0001433860558083769,
            "start_logit": 3.61222243309021,
            "end_logit": -3.8321340084075928,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "toxic e",
            "probability": 0.0001341052811275773,
            "start_logit": 3.61222243309021,
            "end_logit": -3.8990495204925537,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "epidermal",
            "probability": 0.00010493674922522842,
            "start_logit": 3.7409229278564453,
            "end_logit": -4.273017406463623,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "epidermal ne",
            "probability": 9.432560948477201e-05,
            "start_logit": 3.7409229278564453,
            "end_logit": -4.379622459411621,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "toxic epidermal",
            "probability": 9.226430010093437e-05,
            "start_logit": 3.61222243309021,
            "end_logit": -4.273017406463623,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "toxic epidermal ne",
            "probability": 8.293459064590728e-05,
            "start_logit": 3.61222243309021,
            "end_logit": -4.379622459411621,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "bone marrow transplantation",
            "probability": 7.244976503035505e-05,
            "start_logit": -0.5130081176757812,
            "end_logit": -0.38955071568489075,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "der",
            "probability": 4.758075928619677e-05,
            "start_logit": 2.5582990646362305,
            "end_logit": -3.8813228607177734,
            "question_text": "For what indications is thalidomide currently marketed?"
        },
        {
            "text": "epidermal necrolysis can lead to an increase in mortality, and its use as a prophylactic agent for the prevention",
            "probability": 4.702306317806332e-05,
            "start_logit": 3.7409229278564453,
            "end_logit": -5.075736999511719,
            "question_text": "For what indications is thalidomide currently marketed?"
        }
    ],
    "58932cd87d9090f353000001": [
        {
            "text": "myelodysplastic syndrome",
            "probability": 0.8015512462782688,
            "start_logit": 4.796572685241699,
            "end_logit": 4.470777988433838,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "myelodysplastic syndromes",
            "probability": 0.13143288855434168,
            "start_logit": 4.796572685241699,
            "end_logit": 2.6627254486083984,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "myelodysplastic syndromes (MDS)",
            "probability": 0.053712455573954675,
            "start_logit": 4.796572685241699,
            "end_logit": 1.767874002456665,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "myelodysplastic syndromes (MDS),",
            "probability": 0.0072471347785524245,
            "start_logit": 4.796572685241699,
            "end_logit": -0.23516473174095154,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "myelodysplastic",
            "probability": 0.0020717086998273673,
            "start_logit": 4.796572685241699,
            "end_logit": -1.4873971939086914,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "syndrome",
            "probability": 0.0013433347303617984,
            "start_logit": -1.5948210954666138,
            "end_logit": 4.470777988433838,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "myelodysplastic syndromes (MDS), deletion of the short arm of chromosome 12 (del(12p))",
            "probability": 0.0010194545783307673,
            "start_logit": 4.796572685241699,
            "end_logit": -2.196503162384033,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "elodysplastic syndrome",
            "probability": 0.0003963211252603526,
            "start_logit": -2.81550669670105,
            "end_logit": 4.470777988433838,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "my",
            "probability": 0.00033526171569074246,
            "start_logit": 4.796572685241699,
            "end_logit": -3.308614730834961,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "syndromes",
            "probability": 0.00022027083698841182,
            "start_logit": -1.5948210954666138,
            "end_logit": 2.6627254486083984,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "myelodysplastic syndromes (MDS), deletion of the short arm of chromosome 12 (del(12p)",
            "probability": 0.00012098641189556335,
            "start_logit": 4.796572685241699,
            "end_logit": -4.327847957611084,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "syndromes (MDS)",
            "probability": 9.001770923634666e-05,
            "start_logit": -1.5948210954666138,
            "end_logit": 1.767874002456665,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "lastic syndrome",
            "probability": 7.763152819162678e-05,
            "start_logit": -4.445757865905762,
            "end_logit": 4.470777988433838,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "splastic syndrome",
            "probability": 7.234377381737485e-05,
            "start_logit": -4.516302108764648,
            "end_logit": 4.470777988433838,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "dysplastic syndrome",
            "probability": 7.075691471293589e-05,
            "start_logit": -4.53848123550415,
            "end_logit": 4.470777988433838,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "elodysplastic syndromes",
            "probability": 6.498602619599899e-05,
            "start_logit": -2.81550669670105,
            "end_logit": 2.6627254486083984,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "myelo",
            "probability": 6.109422369978544e-05,
            "start_logit": 4.796572685241699,
            "end_logit": -5.011108875274658,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "myelodysplastic syndromes (MDS), deletion of the short arm of chromosome 12",
            "probability": 5.03160252104959e-05,
            "start_logit": 4.796572685241699,
            "end_logit": -5.205202579498291,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "In myelodysplastic syndrome",
            "probability": 3.314126736716902e-05,
            "start_logit": -5.296952247619629,
            "end_logit": 4.470777988433838,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        },
        {
            "text": "(MDS)",
            "probability": 2.864924809604659e-05,
            "start_logit": -2.7397003173828125,
            "end_logit": 1.767874002456665,
            "question_text": "Which human syndromes have been detected with Fluorescence in situ hybridization (FISH)?"
        }
    ],
    "589a246378275d0c4a00002c": [
        {
            "text": "Epilepsy",
            "probability": 0.2048153365741288,
            "start_logit": 5.303643226623535,
            "end_logit": 5.795827388763428,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy, Ataxia",
            "probability": 0.13895097350252492,
            "start_logit": 5.303643226623535,
            "end_logit": 5.407839775085449,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Ataxia",
            "probability": 0.12063344744835752,
            "start_logit": 5.162278652191162,
            "end_logit": 5.407839775085449,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy, Ataxia, Sensorineural deafness",
            "probability": 0.10629875755123087,
            "start_logit": 5.303643226623535,
            "end_logit": 5.13997220993042,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Ataxia, Sensorineural deafness",
            "probability": 0.09228568364545568,
            "start_logit": 5.162278652191162,
            "end_logit": 5.13997220993042,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Sensorineural deafness",
            "probability": 0.07647498424079555,
            "start_logit": 4.974353313446045,
            "end_logit": 5.13997220993042,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy, Ataxia, Sensorineural deafness, and (a renal salt-wasting) Tubulopathy",
            "probability": 0.07359772062737045,
            "start_logit": 5.303643226623535,
            "end_logit": 4.772332668304443,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Ataxia, Sensorineural deafness, and (a renal salt-wasting) Tubulopathy",
            "probability": 0.06389553480501135,
            "start_logit": 5.162278652191162,
            "end_logit": 4.772332668304443,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Sensorineural deafness, and (a renal salt-wasting) Tubulopathy",
            "probability": 0.05294873293720312,
            "start_logit": 4.974353313446045,
            "end_logit": 4.772332668304443,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Tubulopathy",
            "probability": 0.03993819512859481,
            "start_logit": 4.692362308502197,
            "end_logit": 4.772332668304443,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "renal salt-wasting) Tubulopathy",
            "probability": 0.01470844759491326,
            "start_logit": 3.693451166152954,
            "end_logit": 4.772332668304443,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "deafness",
            "probability": 0.0028730311417713332,
            "start_logit": 1.692757248878479,
            "end_logit": 5.13997220993042,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy, Ataxia, Sensorineural deafness,",
            "probability": 0.0020498620828490904,
            "start_logit": 5.303643226623535,
            "end_logit": 1.1914911270141602,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "deafness, and (a renal salt-wasting) Tubulopathy",
            "probability": 0.0019891911081266747,
            "start_logit": 1.692757248878479,
            "end_logit": 4.772332668304443,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "salt-wasting) Tubulopathy",
            "probability": 0.001854356779819501,
            "start_logit": 1.622567057609558,
            "end_logit": 4.772332668304443,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Ataxia, Sensorineural deafness,",
            "probability": 0.0017796343819301349,
            "start_logit": 5.162278652191162,
            "end_logit": 1.1914911270141602,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Sensorineural deafness,",
            "probability": 0.001474741324291925,
            "start_logit": 4.974353313446045,
            "end_logit": 1.1914911270141602,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy, Ataxia, Sensorineural deafness, and (a renal salt-wasting",
            "probability": 0.0012009407417576906,
            "start_logit": 5.303643226623535,
            "end_logit": 0.6568238139152527,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Epilepsy, Ataxia,",
            "probability": 0.0011878043690252628,
            "start_logit": 5.303643226623535,
            "end_logit": 0.6458251476287842,
            "question_text": "List symptoms of EAST syndrome."
        },
        {
            "text": "Ataxia, Sensorineural deafness, and (a renal salt-wasting",
            "probability": 0.0010426240148420792,
            "start_logit": 5.162278652191162,
            "end_logit": 0.6568238139152527,
            "question_text": "List symptoms of EAST syndrome."
        }
    ],
    "589c42b178275d0c4a00003f": [
        {
            "text": "heparin-induced extracorporeal LDL precipitation",
            "probability": 0.3871159355576557,
            "start_logit": -1.3887012004852295,
            "end_logit": -2.750985622406006,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low-density lipoprotein (LDL) apheresis performed with the heparin-induced extracorporeal LDL precipitation",
            "probability": 0.16085025882017626,
            "start_logit": -2.266951560974121,
            "end_logit": -2.750985622406006,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low-density lipoprotein (LDL) apheresis",
            "probability": 0.09472156265498617,
            "start_logit": -2.266951560974121,
            "end_logit": -3.280517816543579,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "heparin",
            "probability": 0.0904776910520745,
            "start_logit": -1.3887012004852295,
            "end_logit": -4.204606533050537,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low-density lipoprotein (LDL) apheresis performed with the heparin",
            "probability": 0.03759431913391383,
            "start_logit": -2.266951560974121,
            "end_logit": -4.204606533050537,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "he",
            "probability": 0.027789443295691187,
            "start_logit": -1.3887012004852295,
            "end_logit": -5.385053634643555,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low-density lipoprotein (LDL)",
            "probability": 0.027018095484122786,
            "start_logit": -2.266951560974121,
            "end_logit": -4.534952640533447,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "heparin-induced extracorporeal LDL precipitation (HELP) system",
            "probability": 0.02255630622199113,
            "start_logit": -1.3887012004852295,
            "end_logit": -5.593695163726807,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "extracorporeal LDL precipitation",
            "probability": 0.02170970137947898,
            "start_logit": -4.2696661949157715,
            "end_logit": -2.750985622406006,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low-density lipoprotein",
            "probability": 0.01871184495079019,
            "start_logit": -2.266951560974121,
            "end_logit": -4.9023027420043945,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "heparin-induced",
            "probability": 0.015470230311694491,
            "start_logit": -1.3887012004852295,
            "end_logit": -5.970792293548584,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "LDL precipitation",
            "probability": 0.014523172105944192,
            "start_logit": -4.671679973602295,
            "end_logit": -2.750985622406006,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "apheresis performed with the heparin-induced extracorporeal LDL precipitation",
            "probability": 0.013225365229128169,
            "start_logit": -4.765288829803467,
            "end_logit": -2.750985622406006,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "heparin-induced extracorporeal",
            "probability": 0.012544703026131275,
            "start_logit": -1.3887012004852295,
            "end_logit": -6.180411338806152,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low-density lipoprotein (LDL) apheresis performed with the he",
            "probability": 0.011546771227956337,
            "start_logit": -2.266951560974121,
            "end_logit": -5.385053634643555,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "heparin-induced extracorporeal LDL precipitation (HELP)",
            "probability": 0.01094627672743962,
            "start_logit": -1.3887012004852295,
            "end_logit": -6.316710472106934,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low",
            "probability": 0.009553926756633406,
            "start_logit": -2.266951560974121,
            "end_logit": -5.574507236480713,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low-density lipoprotein (LDL) apheresis performed",
            "probability": 0.009328294648518936,
            "start_logit": -2.266951560974121,
            "end_logit": -5.59840726852417,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "apheresis",
            "probability": 0.0077881581936802185,
            "start_logit": -4.765288829803467,
            "end_logit": -3.280517816543579,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        },
        {
            "text": "low-density",
            "probability": 0.006527943221992855,
            "start_logit": -2.266951560974121,
            "end_logit": -5.955367565155029,
            "question_text": "Which are the lipid lowering drugs administered in patients with Coronary Artery Disease (CAD)?"
        }
    ],
    "58a326da60087bc10a00000e": [
        {
            "text": "sibutramine",
            "probability": 0.9968242785301287,
            "start_logit": 6.740726470947266,
            "end_logit": 6.407210826873779,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "orlistat (Europe; USA) remains the only drug currently marketed for the treatment of obesity, with sibutramine",
            "probability": 0.0006461667567646835,
            "start_logit": -0.6005457043647766,
            "end_logit": 6.407210826873779,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutram",
            "probability": 0.000398368105307782,
            "start_logit": 6.740726470947266,
            "end_logit": -1.4177424907684326,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious, non-fatal cardiovascular events",
            "probability": 0.0002947279050252462,
            "start_logit": 6.740726470947266,
            "end_logit": -1.7190663814544678,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "ramine",
            "probability": 0.0002534803540952321,
            "start_logit": -1.536316990852356,
            "end_logit": 6.407210826873779,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "with sibutramine",
            "probability": 0.00022278769064120602,
            "start_logit": -1.66538405418396,
            "end_logit": 6.407210826873779,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "si",
            "probability": 0.00021360914409217975,
            "start_logit": 6.740726470947266,
            "end_logit": -2.040971040725708,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious, non-fatal",
            "probability": 0.00018753225689793185,
            "start_logit": 6.740726470947266,
            "end_logit": -2.171168088912964,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious, non-fatal cardiovascular events.",
            "probability": 0.000156148501961805,
            "start_logit": 6.740726470947266,
            "end_logit": -2.354311466217041,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibut",
            "probability": 0.00010632967950064787,
            "start_logit": 6.740726470947266,
            "end_logit": -2.738574504852295,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious, non-fatal cardiovascular",
            "probability": 0.00010006449697473877,
            "start_logit": 6.740726470947266,
            "end_logit": -2.7993040084838867,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn",
            "probability": 9.389561172922047e-05,
            "start_logit": 6.740726470947266,
            "end_logit": -2.8629353046417236,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "ine",
            "probability": 9.303652319757623e-05,
            "start_logit": -2.5386111736297607,
            "end_logit": 6.407210826873779,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "butramine",
            "probability": 8.715557790555044e-05,
            "start_logit": -2.6039085388183594,
            "end_logit": 6.407210826873779,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due to the increased incidence",
            "probability": 8.475265689670015e-05,
            "start_logit": 6.740726470947266,
            "end_logit": -2.9653818607330322,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": ", with sibutramine",
            "probability": 6.81964867739225e-05,
            "start_logit": -2.849210262298584,
            "end_logit": 6.407210826873779,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "obesity, with sibutramine",
            "probability": 5.353616584269493e-05,
            "start_logit": -3.0912458896636963,
            "end_logit": 6.407210826873779,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due",
            "probability": 4.648225247813545e-05,
            "start_logit": 6.740726470947266,
            "end_logit": -3.5660483837127686,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious,",
            "probability": 4.2394103806424415e-05,
            "start_logit": 6.740726470947266,
            "end_logit": -3.658109664916992,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        },
        {
            "text": "sibutramine having recently been withdrawn from sale globally due to the increased incidence of serious, non-fatal card",
            "probability": 2.7057199979514192e-05,
            "start_logit": 6.740726470947266,
            "end_logit": -4.107165813446045,
            "question_text": "List drugs withdrawn from the market for cardiovascular adverse events."
        }
    ],
    "589aec4778275d0c4a000037": [
        {
            "text": "viral meningitis",
            "probability": 0.44570606880402525,
            "start_logit": -2.9623639583587646,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "meningitis",
            "probability": 0.15767627343729668,
            "start_logit": -4.001479625701904,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "children with viral meningitis",
            "probability": 0.07207932122431573,
            "start_logit": -4.784256458282471,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "hospitalization of children with viral meningitis",
            "probability": 0.0719783439307787,
            "start_logit": -4.785658359527588,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "study examined the burden of hospitalization of children with viral meningitis",
            "probability": 0.04317380771207107,
            "start_logit": -5.296789646148682,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "itis",
            "probability": 0.03306559148311878,
            "start_logit": -5.563530445098877,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "This study examined the burden of hospitalization of children with viral meningitis",
            "probability": 0.023753307008121866,
            "start_logit": -5.894301891326904,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "burden of hospitalization of children with viral meningitis",
            "probability": 0.022348795738755867,
            "start_logit": -5.955251216888428,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "examined the burden of hospitalization of children with viral meningitis",
            "probability": 0.02224229114135593,
            "start_logit": -5.960028171539307,
            "end_logit": -0.9704828858375549,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral",
            "probability": 0.02135690223690162,
            "start_logit": -2.9623639583587646,
            "end_logit": -4.008767604827881,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral meningitis in Department of Pediatric Infectious Diseases",
            "probability": 0.020340434421704436,
            "start_logit": -2.9623639583587646,
            "end_logit": -4.057531833648682,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral meningitis in Department of Pediatric Infectious Diseases, Medical University of Bialystok from 2003 to 2005",
            "probability": 0.01884597117166621,
            "start_logit": -2.9623639583587646,
            "end_logit": -4.133843421936035,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral meningitis in Department of Pediatric Infectious Diseases, Medical University of Bialystok from 2003 to 2005.",
            "probability": 0.008207790617029717,
            "start_logit": -2.9623639583587646,
            "end_logit": -4.96505880355835,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral meningitis in Department of Pediatric Infectious Diseases, Medical University of Bialystok from 2003",
            "probability": 0.008205513113370044,
            "start_logit": -2.9623639583587646,
            "end_logit": -4.965336322784424,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "meningitis in Department of Pediatric Infectious Diseases",
            "probability": 0.0071957824319423,
            "start_logit": -4.001479625701904,
            "end_logit": -4.057531833648682,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "viral meningitis in Department of Pediatric Infectious Diseases, Medical University of Bialystok",
            "probability": 0.00696445985712207,
            "start_logit": -2.9623639583587646,
            "end_logit": -5.129322528839111,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "meningitis in Department of Pediatric Infectious Diseases, Medical University of Bialystok from 2003 to 2005",
            "probability": 0.0066670900659457554,
            "start_logit": -4.001479625701904,
            "end_logit": -4.133843421936035,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "children with viral",
            "probability": 0.0034538255689913026,
            "start_logit": -4.784256458282471,
            "end_logit": -4.008767604827881,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "hospitalization of children with viral",
            "probability": 0.003448987038988775,
            "start_logit": -4.785658359527588,
            "end_logit": -4.008767604827881,
            "question_text": "Which are the types of viral meningitis?"
        },
        {
            "text": "children with viral meningitis in Department of Pediatric Infectious Diseases",
            "probability": 0.0032894429964982386,
            "start_logit": -4.784256458282471,
            "end_logit": -4.057531833648682,
            "question_text": "Which are the types of viral meningitis?"
        }
    ],
    "58a0c09778275d0c4a000052": [
        {
            "text": "antidiabetic",
            "probability": 0.4006163765016496,
            "start_logit": 3.04978609085083,
            "end_logit": 2.767484188079834,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabetic drugs",
            "probability": 0.24377707630412532,
            "start_logit": 3.04978609085083,
            "end_logit": 2.2707340717315674,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabetic drugs for management of type 2 diabetes",
            "probability": 0.20315037447975196,
            "start_logit": 3.04978609085083,
            "end_logit": 2.088426351547241,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "type 2 diabetes",
            "probability": 0.062011651601687624,
            "start_logit": 1.8631619215011597,
            "end_logit": 2.088426351547241,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "oral antidiabetic",
            "probability": 0.029684687135119053,
            "start_logit": 0.4474131166934967,
            "end_logit": 2.767484188079834,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "oral antidiabetic drugs",
            "probability": 0.018063281146900912,
            "start_logit": 0.4474131166934967,
            "end_logit": 2.2707340717315674,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "oral antidiabetic drugs for management of type 2 diabetes",
            "probability": 0.015052942569333235,
            "start_logit": 0.4474131166934967,
            "end_logit": 2.088426351547241,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "diabetes",
            "probability": 0.0052040357355568456,
            "start_logit": -0.6147259473800659,
            "end_logit": 2.088426351547241,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "drugs",
            "probability": 0.004469410397000802,
            "start_logit": -0.949211597442627,
            "end_logit": 2.2707340717315674,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "drugs for management of type 2 diabetes",
            "probability": 0.003724560199096312,
            "start_logit": -0.949211597442627,
            "end_logit": 2.088426351547241,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabetic drugs for management of type 2 diabetes in the U.S. from 1990 through 2001.",
            "probability": 0.0022016985592700333,
            "start_logit": 3.04978609085083,
            "end_logit": -2.436290979385376,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "anti",
            "probability": 0.002097579183680114,
            "start_logit": 3.04978609085083,
            "end_logit": -2.484736204147339,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabetic drugs for management",
            "probability": 0.0019016118041370268,
            "start_logit": 3.04978609085083,
            "end_logit": -2.5828182697296143,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabetic drugs for management of type 2 diabetes in the U.S. from 1990 through 2001",
            "probability": 0.00159167852010583,
            "start_logit": 3.04978609085083,
            "end_logit": -2.7607309818267822,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabetic drugs for management of type 2",
            "probability": 0.001431657090627985,
            "start_logit": 3.04978609085083,
            "end_logit": -2.866687536239624,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "management of type 2 diabetes",
            "probability": 0.001217517320395533,
            "start_logit": -2.0673465728759766,
            "end_logit": 2.088426351547241,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabetic drugs for management of type 2 diabetes in the U.S. from 1990",
            "probability": 0.0009971499406205755,
            "start_logit": 3.04978609085083,
            "end_logit": -3.2283742427825928,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "use of oral antidiabetic",
            "probability": 0.0009953525908616835,
            "start_logit": -2.947876453399658,
            "end_logit": 2.767484188079834,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "diabetic",
            "probability": 0.0009765821137895313,
            "start_logit": -2.966914653778076,
            "end_logit": 2.767484188079834,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        },
        {
            "text": "antidiabet",
            "probability": 0.0008347768062901413,
            "start_logit": 3.04978609085083,
            "end_logit": -3.406111001968384,
            "question_text": "What are the different classes of orally administered drugs used to treat diabetes"
        }
    ],
    "5883bce3e56acf5176000003": [
        {
            "text": "ChIP-nexus",
            "probability": 0.3331949458197357,
            "start_logit": -1.6484689712524414,
            "end_logit": -2.3987109661102295,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-nexus, an extension of the ChIP-exo",
            "probability": 0.291578961917189,
            "start_logit": -1.6484689712524414,
            "end_logit": -2.532127857208252,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-exo",
            "probability": 0.11146743453958322,
            "start_logit": -2.6100473403930664,
            "end_logit": -2.532127857208252,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-nexus, an extension of the ChIP-exo protocol",
            "probability": 0.04214788365601798,
            "start_logit": -1.6484689712524414,
            "end_logit": -4.466254234313965,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-nexus,",
            "probability": 0.03640646437409939,
            "start_logit": -1.6484689712524414,
            "end_logit": -4.612692356109619,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP",
            "probability": 0.03252083313705154,
            "start_logit": -1.6484689712524414,
            "end_logit": -4.725557804107666,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-nexus, an extension of the ChIP-exo protocol,",
            "probability": 0.030775970576269244,
            "start_logit": -1.6484689712524414,
            "end_logit": -4.780704498291016,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-exo protocol",
            "probability": 0.016112672984079895,
            "start_logit": -2.6100473403930664,
            "end_logit": -4.466254234313965,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "software packages",
            "probability": 0.012978828396413723,
            "start_logit": -3.571941375732422,
            "end_logit": -3.720646858215332,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "random barcodes",
            "probability": 0.012962011986558598,
            "start_logit": -3.659108877182007,
            "end_logit": -3.6347758769989014,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-exo protocol,",
            "probability": 0.011765315518808685,
            "start_logit": -2.6100473403930664,
            "end_logit": -4.780704498291016,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "software",
            "probability": 0.008978197920103312,
            "start_logit": -3.571941375732422,
            "end_logit": -4.08916711807251,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-exo protocol, can be used to map the borders of protein-bound DNA sequences at nucleotide resolution",
            "probability": 0.00896382481231591,
            "start_logit": -2.6100473403930664,
            "end_logit": -5.052663326263428,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "only a very limited number of software packages",
            "probability": 0.008657033951668313,
            "start_logit": -3.976888656616211,
            "end_logit": -3.720646858215332,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-exo data, which have not yet been systematically tested",
            "probability": 0.007489447042798677,
            "start_logit": -3.4893929958343506,
            "end_logit": -4.353019714355469,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "ChIP-exo data,",
            "probability": 0.007384121499320099,
            "start_logit": -3.4893929958343506,
            "end_logit": -4.367182731628418,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "software packages are available for the analysis of ChIP-exo",
            "probability": 0.006932396896149799,
            "start_logit": -3.571941375732422,
            "end_logit": -4.3477606773376465,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "software packages are available for the analysis of ChIP-exo data, which have not yet been systematically tested",
            "probability": 0.006896034862697479,
            "start_logit": -3.571941375732422,
            "end_logit": -4.353019714355469,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "software packages are available for the analysis of ChIP-exo data,",
            "probability": 0.006799054589573148,
            "start_logit": -3.571941375732422,
            "end_logit": -4.367182731628418,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        },
        {
            "text": "only a very limited number of software",
            "probability": 0.005988565519566378,
            "start_logit": -3.976888656616211,
            "end_logit": -4.08916711807251,
            "question_text": "Which pipelines are used for analyzing data from ChIP-nexus experiments?"
        }
    ],
    "5884fe4ce56acf5176000010": [
        {
            "text": "cervical cancer",
            "probability": 0.6611310894316266,
            "start_logit": 4.968959331512451,
            "end_logit": 4.6135334968566895,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical cancer and its clinical significance in tumor progression. In our study, SPAG5 expression in cervical cancer",
            "probability": 0.1774355296271527,
            "start_logit": 4.1824421882629395,
            "end_logit": 4.084705829620361,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical cancer patients, and SPAG5 is a regulator of mTOR activity during taxol treatment in cervical cancer",
            "probability": 0.09464581651023027,
            "start_logit": 3.8072099685668945,
            "end_logit": 3.831472396850586,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical",
            "probability": 0.04815786766560606,
            "start_logit": 4.968959331512451,
            "end_logit": 1.9940658807754517,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical cancer and its clinical significance in tumor progression. In our study, SPAG5 expression in cervical",
            "probability": 0.006833512419896769,
            "start_logit": 4.1824421882629395,
            "end_logit": 0.8279373049736023,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical cancer patients, and SPAG5 is a regulator of mTOR activity during taxol treatment in cervical",
            "probability": 0.006353779238486263,
            "start_logit": 3.8072099685668945,
            "end_logit": 1.1303805112838745,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "pelvic lymph node metastasis-positive cervical cancer",
            "probability": 0.0017458841338313562,
            "start_logit": -0.9677317142486572,
            "end_logit": 4.6135334968566895,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer",
            "probability": 0.0006707504167204613,
            "start_logit": -1.9243509769439697,
            "end_logit": 4.6135334968566895,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical cancer.",
            "probability": 0.0005918287639580525,
            "start_logit": 4.968959331512451,
            "end_logit": -2.404956579208374,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer. The aim of this study is to examine the role of SPAG5 in the proliferation and tumorigenicity of cervical cancer",
            "probability": 0.0005163496841553225,
            "start_logit": -1.9243509769439697,
            "end_logit": 4.3519206047058105,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "vical cancer",
            "probability": 0.00043184422644311455,
            "start_logit": -2.364683151245117,
            "end_logit": 4.6135334968566895,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cervical cancer patients,",
            "probability": 0.0003594886710387106,
            "start_logit": 3.8072099685668945,
            "end_logit": -1.7417418956756592,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "c",
            "probability": 0.0003565348354440266,
            "start_logit": 4.968959331512451,
            "end_logit": -2.9117419719696045,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer and its clinical significance in tumor progression. In our study, SPAG5 expression in cervical cancer",
            "probability": 0.00028244002931274625,
            "start_logit": -2.2604541778564453,
            "end_logit": 4.084705829620361,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer patients, and SPAG5 is a regulator of mTOR activity during taxol treatment in cervical cancer",
            "probability": 0.00017949479603047793,
            "start_logit": -2.460540771484375,
            "end_logit": 3.831472396850586,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "pelvic lymph node metastasis-positive cervical",
            "probability": 0.00012717304997532865,
            "start_logit": -0.9677317142486572,
            "end_logit": 1.9940658807754517,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "vical cancer patients, and SPAG5 is a regulator of mTOR activity during taxol treatment in cervical cancer",
            "probability": 0.00011275161588571426,
            "start_logit": -2.925499677658081,
            "end_logit": 3.831472396850586,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "vical",
            "probability": 3.145623831891254e-05,
            "start_logit": -2.364683151245117,
            "end_logit": 1.9940658807754517,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer. The aim of this study is to examine the role of SPAG5 in the proliferation and tumorigenicity of cervical",
            "probability": 2.4358770356723744e-05,
            "start_logit": -1.9243509769439697,
            "end_logit": 1.2980283498764038,
            "question_text": "SPAG5 was implicated in which cancers?"
        },
        {
            "text": "cancer patients, and SPAG5 is a regulator of mTOR activity during taxol treatment in cervical",
            "probability": 1.2049875530541842e-05,
            "start_logit": -2.460540771484375,
            "end_logit": 1.1303805112838745,
            "question_text": "SPAG5 was implicated in which cancers?"
        }
    ],
    "58a3275960087bc10a00000f": [
        {
            "text": "microcephaly",
            "probability": 0.30474045565745356,
            "start_logit": 4.496841907501221,
            "end_logit": 4.819047451019287,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "microcephaly, other malformations, and, in some cases, death",
            "probability": 0.20757457350491315,
            "start_logit": 4.496841907501221,
            "end_logit": 4.435077667236328,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "microcephaly, other malformations",
            "probability": 0.14586794707239117,
            "start_logit": 4.496841907501221,
            "end_logit": 4.08228874206543,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "death",
            "probability": 0.14298366166231175,
            "start_logit": 4.124081611633301,
            "end_logit": 4.435077667236328,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "malformations, and, in some cases, death",
            "probability": 0.07996146173737913,
            "start_logit": 3.542896032333374,
            "end_logit": 4.435077667236328,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "malformations",
            "probability": 0.05619095861113729,
            "start_logit": 3.542896032333374,
            "end_logit": 4.08228874206543,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "resulting in microcephaly",
            "probability": 0.012764308466023664,
            "start_logit": 1.324034333229065,
            "end_logit": 4.819047451019287,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "other malformations, and, in some cases, death",
            "probability": 0.010256194804192506,
            "start_logit": 1.489233136177063,
            "end_logit": 4.435077667236328,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "resulting in microcephaly, other malformations, and, in some cases, death",
            "probability": 0.008694434351369029,
            "start_logit": 1.324034333229065,
            "end_logit": 4.435077667236328,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "other malformations",
            "probability": 0.0072072896771563175,
            "start_logit": 1.489233136177063,
            "end_logit": 4.08228874206543,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "resulting in microcephaly, other malformations",
            "probability": 0.006109800773647542,
            "start_logit": 1.324034333229065,
            "end_logit": 4.08228874206543,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "microcephaly, other malformations,",
            "probability": 0.003983904745784441,
            "start_logit": 4.496841907501221,
            "end_logit": 0.48184943199157715,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "microcephaly,",
            "probability": 0.003155686407068362,
            "start_logit": 4.496841907501221,
            "end_logit": 0.24879303574562073,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "microcephaly, other malformations, and, in some cases, death.",
            "probability": 0.0028476217267207476,
            "start_logit": 4.496841907501221,
            "end_logit": 0.1460711658000946,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "death.",
            "probability": 0.0019615282095523613,
            "start_logit": 4.124081611633301,
            "end_logit": 0.1460711658000946,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "malformations,",
            "probability": 0.001534671812238437,
            "start_logit": 3.542896032333374,
            "end_logit": 0.48184943199157715,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "in microcephaly",
            "probability": 0.0012336032057598941,
            "start_logit": -1.0126792192459106,
            "end_logit": 4.819047451019287,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "malformations, and, in some cases, death.",
            "probability": 0.0010969551419471953,
            "start_logit": 3.542896032333374,
            "end_logit": 0.1460711658000946,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "autopsies have provided crucial direct evidence that Zika virus can infect an unborn child, resulting in microcephaly",
            "probability": 0.0009946711314046243,
            "start_logit": -1.2279616594314575,
            "end_logit": 4.819047451019287,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        },
        {
            "text": "in microcephaly, other malformations, and, in some cases, death",
            "probability": 0.0008402713015489339,
            "start_logit": -1.0126792192459106,
            "end_logit": 4.435077667236328,
            "question_text": "What are some of the effects of Zika Virus in infected individuals?"
        }
    ],
    "58a80bc838c171fb5b000001": [
        {
            "text": "Cdk1",
            "probability": 0.9298123384785139,
            "start_logit": 5.8140950202941895,
            "end_logit": 5.768065929412842,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1",
            "probability": 0.03995831527660242,
            "start_logit": 3.3235585689544678,
            "end_logit": 5.111456394195557,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Plk1 activation and the potential role of Bora phosphorylation by Cdk1",
            "probability": 0.015735742885107932,
            "start_logit": 1.7350469827651978,
            "end_logit": 5.768065929412842,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 contributes to Plk1",
            "probability": 0.005609600935357797,
            "start_logit": 5.261893272399902,
            "end_logit": 1.2097644805908203,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora A kinase",
            "probability": 0.004752361152741553,
            "start_logit": 3.3235585689544678,
            "end_logit": 2.9822611808776855,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "mitotic kinase Cdk1",
            "probability": 0.0005801964614056304,
            "start_logit": -0.908666729927063,
            "end_logit": 5.111456394195557,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 contributes to Plk1 activation through SPAT-1",
            "probability": 0.0004990878808798305,
            "start_logit": 5.261893272399902,
            "end_logit": -1.2096881866455078,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Plk1",
            "probability": 0.00047702548894474874,
            "start_logit": 2.7972283363342285,
            "end_logit": 1.2097644805908203,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora A",
            "probability": 0.00045605668709501515,
            "start_logit": 3.3235585689544678,
            "end_logit": 0.6384814381599426,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 is essential for Plk1",
            "probability": 0.0004051101572691526,
            "start_logit": 4.650660991668701,
            "end_logit": -0.8070790767669678,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "the Aurora A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1",
            "probability": 0.0003259882151757183,
            "start_logit": -1.4851722717285156,
            "end_logit": 5.111456394195557,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1",
            "probability": 0.00028599179252025605,
            "start_logit": -1.6160703897476196,
            "end_logit": 5.111456394195557,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk",
            "probability": 0.0002446254468789076,
            "start_logit": 5.8140950202941895,
            "end_logit": -2.4749438762664795,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Cdk1 contributes to Plk1 activation through SPAT",
            "probability": 0.00024096969183504555,
            "start_logit": 5.261893272399902,
            "end_logit": -1.9377992153167725,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "C",
            "probability": 0.00018432493048507775,
            "start_logit": 5.8140950202941895,
            "end_logit": -2.757972002029419,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "1",
            "probability": 0.000129850042366011,
            "start_logit": -3.062262773513794,
            "end_logit": 5.768065929412842,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1",
            "probability": 0.00011889471412056523,
            "start_logit": -2.493795156478882,
            "end_logit": 5.111456394195557,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Aurora A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase",
            "probability": 8.100738793542012e-05,
            "start_logit": 3.3235585689544678,
            "end_logit": -1.0895953178405762,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "kinase Cdk1",
            "probability": 6.007127366966055e-05,
            "start_logit": -3.176501750946045,
            "end_logit": 5.111456394195557,
            "question_text": "List kinases that phosphorylates the protein Bora."
        },
        {
            "text": "Plk1 activation through SPAT-1",
            "probability": 4.244110109552997e-05,
            "start_logit": 2.7972283363342285,
            "end_logit": -1.2096881866455078,
            "question_text": "List kinases that phosphorylates the protein Bora."
        }
    ],
    "58a94483ee23e0236b000003": [
        {
            "text": "Porphyromonas gingivalis",
            "probability": 0.1906495874073355,
            "start_logit": -1.2760008573532104,
            "end_logit": -0.8339780569076538,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotypes of Porphyromonas gingivalis",
            "probability": 0.10483212925798102,
            "start_logit": -1.8740776777267456,
            "end_logit": -0.8339780569076538,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "different fimA genotypes of Porphyromonas gingivalis",
            "probability": 0.10269396041396583,
            "start_logit": -1.8946846723556519,
            "end_logit": -0.8339780569076538,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "chronic periodontitis",
            "probability": 0.08384449903710349,
            "start_logit": -1.1567600965499878,
            "end_logit": -1.7746920585632324,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "Porphyromonas gingivalis in adult Spanish patients with chronic periodontitis",
            "probability": 0.07441988074877773,
            "start_logit": -1.2760008573532104,
            "end_logit": -1.7746920585632324,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotypes",
            "probability": 0.04310241861413438,
            "start_logit": -1.8740776777267456,
            "end_logit": -1.7227592468261719,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "different fimA genotypes",
            "probability": 0.04222329644772635,
            "start_logit": -1.8946846723556519,
            "end_logit": -1.7227592468261719,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "prevalence of the different fimA genotypes of Porphyromonas gingivalis",
            "probability": 0.04162737810809591,
            "start_logit": -2.797679901123047,
            "end_logit": -0.8339780569076538,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotypes of Porphyromonas gingivalis in adult Spanish patients with chronic periodontitis",
            "probability": 0.040921119547721735,
            "start_logit": -1.8740776777267456,
            "end_logit": -1.7746920585632324,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "different fimA genotypes of Porphyromonas gingivalis in adult Spanish patients with chronic periodontitis",
            "probability": 0.04008648742207026,
            "start_logit": -1.8946846723556519,
            "end_logit": -1.7746920585632324,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "different fimA",
            "probability": 0.03917420761296508,
            "start_logit": -1.8946846723556519,
            "end_logit": -1.797712802886963,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimA genotypes of Porphyromonas gingivalis",
            "probability": 0.03633502821844641,
            "start_logit": -2.9336557388305664,
            "end_logit": -0.8339780569076538,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "genotype",
            "probability": 0.03016627785260318,
            "start_logit": -1.8740776777267456,
            "end_logit": -2.07961368560791,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "different fimA genotype",
            "probability": 0.029551002784731453,
            "start_logit": -1.8946846723556519,
            "end_logit": -2.07961368560791,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "determine the prevalence of the different fimA genotypes of Porphyromonas gingivalis",
            "probability": 0.022280515239579652,
            "start_logit": -3.4227254390716553,
            "end_logit": -0.8339780569076538,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "prevalence of the different fimA genotypes",
            "probability": 0.017115369970293767,
            "start_logit": -2.797679901123047,
            "end_logit": -1.7227592468261719,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "prevalence of the different fimA",
            "probability": 0.0158794104912929,
            "start_logit": -2.797679901123047,
            "end_logit": -1.797712802886963,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "chronic periodontitis, patients with gingivitis",
            "probability": 0.015878836930758908,
            "start_logit": -1.1567600965499878,
            "end_logit": -3.438668727874756,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "fimA genotypes",
            "probability": 0.01493938554633174,
            "start_logit": -2.9336557388305664,
            "end_logit": -1.7227592468261719,
            "question_text": "Which fimA genotypes are associated with disease?"
        },
        {
            "text": "periodontitis",
            "probability": 0.014279208348084795,
            "start_logit": -2.926919460296631,
            "end_logit": -1.7746920585632324,
            "question_text": "Which fimA genotypes are associated with disease?"
        }
    ],
    "58bd645702b8c60953000010": [
        {
            "text": "Gordon syndrome",
            "probability": 0.3290004058423614,
            "start_logit": 4.1991448402404785,
            "end_logit": 5.671127796173096,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 3",
            "probability": 0.2996275640804329,
            "start_logit": 5.277573108673096,
            "end_logit": 4.499180793762207,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome (GS), or distal arthrogryposis type 3",
            "probability": 0.10191223298227248,
            "start_logit": 4.1991448402404785,
            "end_logit": 4.499180793762207,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis",
            "probability": 0.06733691115919102,
            "start_logit": 5.277573108673096,
            "end_logit": 3.0063490867614746,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome",
            "probability": 0.06334239758818765,
            "start_logit": 3.952829599380493,
            "end_logit": 4.269938945770264,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 5 (DA5) and Marden-Walker syndrome",
            "probability": 0.031596388835796296,
            "start_logit": 3.257317543029785,
            "end_logit": 4.269938945770264,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome (GS), or distal arthrogryposis",
            "probability": 0.022903283279104056,
            "start_logit": 4.1991448402404785,
            "end_logit": 3.0063490867614746,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 3,",
            "probability": 0.01625756688800575,
            "start_logit": 5.277573108673096,
            "end_logit": 1.585198998451233,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome (GS),",
            "probability": 0.01212490114070101,
            "start_logit": 4.1991448402404785,
            "end_logit": 2.3703300952911377,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "arthrogryposis type 3",
            "probability": 0.011758118175216046,
            "start_logit": 2.039576768875122,
            "end_logit": 4.499180793762207,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome (GS)",
            "probability": 0.010260147220306522,
            "start_logit": 4.1991448402404785,
            "end_logit": 2.203336000442505,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 5",
            "probability": 0.009874966456786087,
            "start_logit": 3.257317543029785,
            "end_logit": 3.1068990230560303,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Marden-Walker syndrome (MWS)",
            "probability": 0.00821100851100501,
            "start_logit": 3.952829599380493,
            "end_logit": 2.2268598079681396,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "Gordon syndrome (GS), or distal arthrogryposis type 3,",
            "probability": 0.005529681321210327,
            "start_logit": 4.1991448402404785,
            "end_logit": 1.585198998451233,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type 5 (DA5) and Marden-Walker syndrome (MWS)",
            "probability": 0.0040958067191338545,
            "start_logit": 3.257317543029785,
            "end_logit": 2.2268598079681396,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "arthrogryposis",
            "probability": 0.002642465026185812,
            "start_logit": 2.039576768875122,
            "end_logit": 3.0063490867614746,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "distal arthrogryposis type",
            "probability": 0.0010046481015542565,
            "start_logit": 5.277573108673096,
            "end_logit": -1.1987221240997314,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "type 3",
            "probability": 0.001001183645255619,
            "start_logit": -0.42378419637680054,
            "end_logit": 4.499180793762207,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "syndrome",
            "probability": 0.0008823363544145621,
            "start_logit": -1.7220960855484009,
            "end_logit": 5.671127796173096,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        },
        {
            "text": "arthrogryposis type 3,",
            "probability": 0.0006379866728794545,
            "start_logit": 2.039576768875122,
            "end_logit": 1.585198998451233,
            "question_text": "Please list 3 diseases associated with the PIEZO2 gene."
        }
    ],
    "58bc666702b8c60953000004": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.31880938244795565,
            "start_logit": 5.520380020141602,
            "end_logit": 5.382811546325684,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease (PD), and Alzheimer's disease",
            "probability": 0.24951930101552944,
            "start_logit": 5.275322914123535,
            "end_logit": 5.382811546325684,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease",
            "probability": 0.20831016236398553,
            "start_logit": 5.275322914123535,
            "end_logit": 5.202303409576416,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS), Parkinson's disease",
            "probability": 0.10979079627779681,
            "start_logit": 4.634871482849121,
            "end_logit": 5.202303409576416,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis",
            "probability": 0.08130794041650537,
            "start_logit": 4.634871482849121,
            "end_logit": 4.901970386505127,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease (PD)",
            "probability": 0.006539024281082552,
            "start_logit": 5.275322914123535,
            "end_logit": 1.7410632371902466,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Alzheimer's",
            "probability": 0.0064215234973845434,
            "start_logit": 5.520380020141602,
            "end_logit": 1.4778735637664795,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease (PD), and Alzheimer's",
            "probability": 0.005025868568293336,
            "start_logit": 5.275322914123535,
            "end_logit": 1.4778735637664795,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD)",
            "probability": 0.0034464217902411003,
            "start_logit": 4.634871482849121,
            "end_logit": 1.7410632371902466,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's",
            "probability": 0.002991181111815366,
            "start_logit": 5.275322914123535,
            "end_logit": 0.9589436054229736,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Alzheimer's",
            "probability": 0.002648906351176053,
            "start_logit": 4.634871482849121,
            "end_logit": 1.4778735637664795,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS)",
            "probability": 0.0022541804590696045,
            "start_logit": 4.634871482849121,
            "end_logit": 1.316513180732727,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "amyotrophic lateral sclerosis (ALS), Parkinson's",
            "probability": 0.0015765152902309483,
            "start_logit": 4.634871482849121,
            "end_logit": 0.9589436054229736,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Alzheimer's disease (AD)",
            "probability": 0.0004097383162116349,
            "start_logit": 5.520380020141602,
            "end_logit": -1.274018406867981,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "Parkinson's disease (PD), and Alzheimer's disease (AD)",
            "probability": 0.000320685725982663,
            "start_logit": 5.275322914123535,
            "end_logit": -1.274018406867981,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "lateral sclerosis (ALS), Parkinson's disease (PD), and Alzheimer's disease",
            "probability": 0.00018842343142991006,
            "start_logit": -1.9132769107818604,
            "end_logit": 5.382811546325684,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "lateral sclerosis (ALS), Parkinson's disease",
            "probability": 0.0001573045268826759,
            "start_logit": -1.9132769107818604,
            "end_logit": 5.202303409576416,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "lateral sclerosis",
            "probability": 0.00011649525764127961,
            "start_logit": -1.9132769107818604,
            "end_logit": 4.901970386505127,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "neurodegenerative disorders caused by protein misfolding and aggregation, including amyotrophic lateral sclerosis",
            "probability": 8.87527827135829e-05,
            "start_logit": -2.185272693634033,
            "end_logit": 4.901970386505127,
            "question_text": "List diseases that could be targeted by disaggregases?"
        },
        {
            "text": "disease",
            "probability": 7.739608807207424e-05,
            "start_logit": -2.803032398223877,
            "end_logit": 5.382811546325684,
            "question_text": "List diseases that could be targeted by disaggregases?"
        }
    ],
    "58bbb71f22d3005309000016": [
        {
            "text": "RMBase",
            "probability": 0.8582905015256591,
            "start_logit": 3.092825412750244,
            "end_logit": 3.2090530395507812,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase (RNA Modification Base, http://mirlab.sysu.edu.cn/rmbase",
            "probability": 0.12674882830408415,
            "start_logit": 3.092825412750244,
            "end_logit": 1.2963178157806396,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "rmbase",
            "probability": 0.008242774744956874,
            "start_logit": 0.3599550426006317,
            "end_logit": 1.2963178157806396,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase (RNA Modification Base,",
            "probability": 0.0010017510132560572,
            "start_logit": 3.092825412750244,
            "end_logit": -3.544140100479126,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "R",
            "probability": 0.0009754528039776795,
            "start_logit": 3.092825412750244,
            "end_logit": -3.5707430839538574,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase (",
            "probability": 0.0009481566342558421,
            "start_logit": 3.092825412750244,
            "end_logit": -3.5991251468658447,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase (RNA Modification Base",
            "probability": 0.0009099916512918036,
            "start_logit": 3.092825412750244,
            "end_logit": -3.640209436416626,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Modification Base, http://mirlab.sysu.edu.cn/rmbase",
            "probability": 0.0008868332862220663,
            "start_logit": -1.8694802522659302,
            "end_logit": 1.2963178157806396,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "novel resource, RMBase",
            "probability": 0.00047870498643880503,
            "start_logit": -4.398787975311279,
            "end_logit": 3.2090530395507812,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "a novel resource, RMBase",
            "probability": 0.0004245854315324052,
            "start_logit": -4.518759250640869,
            "end_logit": 3.2090530395507812,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "se",
            "probability": 0.00035301414114364936,
            "start_logit": -4.703364372253418,
            "end_logit": 3.2090530395507812,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase provides a genome browser",
            "probability": 0.0002172711392285339,
            "start_logit": 0.6765499114990234,
            "end_logit": -2.6562232971191406,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "(RNA Modification Base, http://mirlab.sysu.edu.cn/rmbase",
            "probability": 0.0001156782786370401,
            "start_logit": -3.9063243865966797,
            "end_logit": 1.2963178157806396,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "mirlab.sysu.edu.cn/rmbase",
            "probability": 0.00010141534579418905,
            "start_logit": -4.037912845611572,
            "end_logit": 1.2963178157806396,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "rmbase/),",
            "probability": 8.976732744769092e-05,
            "start_logit": 0.3599550426006317,
            "end_logit": -3.223553419113159,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "rmbase/)",
            "probability": 6.246333456791472e-05,
            "start_logit": 0.3599550426006317,
            "end_logit": -3.5861947536468506,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "se (RNA Modification Base, http://mirlab.sysu.edu.cn/rmbase",
            "probability": 5.2131683486179755e-05,
            "start_logit": -4.703364372253418,
            "end_logit": 1.2963178157806396,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase provides a genome",
            "probability": 5.120493669882329e-05,
            "start_logit": 0.6765499114990234,
            "end_logit": -4.10153341293335,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RMBase provides a genome browser and a web-based modTool",
            "probability": 3.981543914476109e-05,
            "start_logit": 0.6765499114990234,
            "end_logit": -4.353114604949951,
            "question_text": "List RNA modifications databases"
        },
        {
            "text": "RNA Modification Base, http://mirlab.sysu.edu.cn/rmbase/),",
            "probability": 9.657992176058735e-06,
            "start_logit": -1.8694802522659302,
            "end_logit": -3.223553419113159,
            "question_text": "List RNA modifications databases"
        }
    ],
    "58bc9a5002b8c60953000008": [
        {
            "text": "elevated liver enzymes",
            "probability": 0.3194375496153331,
            "start_logit": 5.926548480987549,
            "end_logit": 5.897875785827637,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver enzymes and low platelets",
            "probability": 0.24460089293767753,
            "start_logit": 5.926548480987549,
            "end_logit": 5.630941867828369,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "haemolysis, elevated liver enzymes",
            "probability": 0.14079903915919056,
            "start_logit": 5.107320308685303,
            "end_logit": 5.897875785827637,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "haemolysis, elevated liver enzymes and low platelets",
            "probability": 0.10781315704611806,
            "start_logit": 5.107320308685303,
            "end_logit": 5.630941867828369,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "low platelets",
            "probability": 0.08906660476742648,
            "start_logit": 4.916305065155029,
            "end_logit": 5.630941867828369,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "haemolysis",
            "probability": 0.03707381892701831,
            "start_logit": 5.107320308685303,
            "end_logit": 4.563453197479248,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes",
            "probability": 0.028539036923385372,
            "start_logit": 3.5112595558166504,
            "end_logit": 5.897875785827637,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "liver enzymes and low platelets",
            "probability": 0.021853016101105033,
            "start_logit": 3.5112595558166504,
            "end_logit": 5.630941867828369,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "platelets",
            "probability": 0.004841654428394547,
            "start_logit": 2.0041770935058594,
            "end_logit": 5.630941867828369,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "(haemolysis, elevated liver enzymes",
            "probability": 0.002089295031347498,
            "start_logit": 0.8968133926391602,
            "end_logit": 5.897875785827637,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "(haemolysis, elevated liver enzymes and low platelets",
            "probability": 0.0015998226598383622,
            "start_logit": 0.8968133926391602,
            "end_logit": 5.630941867828369,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "(haemolysis",
            "probability": 0.0005501326297384762,
            "start_logit": 0.8968133926391602,
            "end_logit": 4.563453197479248,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "imaging findings of the HELLP (haemolysis, elevated liver enzymes",
            "probability": 0.00043400939612100737,
            "start_logit": -0.6747024059295654,
            "end_logit": 5.897875785827637,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "imaging findings of the HELLP (haemolysis, elevated liver enzymes and low platelets",
            "probability": 0.00033233126776228234,
            "start_logit": -0.6747024059295654,
            "end_logit": 5.630941867828369,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "haemolysis,",
            "probability": 0.00029564994059713267,
            "start_logit": 5.107320308685303,
            "end_logit": -0.26803699135780334,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated",
            "probability": 0.00024468713610523374,
            "start_logit": 5.926548480987549,
            "end_logit": -1.276460886001587,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "elevated liver",
            "probability": 0.00013145491827713852,
            "start_logit": 5.926548480987549,
            "end_logit": -1.8977773189544678,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "imaging findings of the HELLP (haemolysis",
            "probability": 0.00011427908784393507,
            "start_logit": -0.6747024059295654,
            "end_logit": 4.563453197479248,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "haemolysis, elevated",
            "probability": 0.00010785117059568536,
            "start_logit": 5.107320308685303,
            "end_logit": -1.276460886001587,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        },
        {
            "text": "enzymes",
            "probability": 7.571685612424302e-05,
            "start_logit": -2.4207677841186523,
            "end_logit": 5.897875785827637,
            "question_text": "Please list the 3 findings in HELLP syndrome."
        }
    ],
    "58bbbe6822d300530900001a": [
        {
            "text": "Bacteroidetes and Proteobacteria",
            "probability": 0.3256274962072098,
            "start_logit": 4.9756903648376465,
            "end_logit": 5.042114734649658,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Proteobacteria",
            "probability": 0.2155770846028914,
            "start_logit": 4.5632548332214355,
            "end_logit": 5.042114734649658,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes",
            "probability": 0.14593667111212755,
            "start_logit": 4.9756903648376465,
            "end_logit": 4.239533424377441,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes",
            "probability": 0.14332550220967366,
            "start_logit": 3.9069643020629883,
            "end_logit": 5.290205001831055,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes and a smaller abundance of Bacteroidetes and Proteobacteria",
            "probability": 0.1118353852539892,
            "start_logit": 3.9069643020629883,
            "end_logit": 5.042114734649658,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes and a smaller abundance of Bacteroidetes",
            "probability": 0.050121331971682975,
            "start_logit": 3.9069643020629883,
            "end_logit": 4.239533424377441,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes and Proteobacteria phyla",
            "probability": 0.0023873255704188524,
            "start_logit": 4.9756903648376465,
            "end_logit": 0.1265343874692917,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Proteobacteria phyla",
            "probability": 0.0015804951745885022,
            "start_logit": 4.5632548332214355,
            "end_logit": 0.1265343874692917,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes and a smaller abundance of Bacteroidetes and Proteobacteria phyla",
            "probability": 0.0008199168620717371,
            "start_logit": 3.9069643020629883,
            "end_logit": 0.1265343874692917,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "B",
            "probability": 0.0006887328606743347,
            "start_logit": 4.9756903648376465,
            "end_logit": -1.1165411472320557,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "higher abundance of Firmicutes",
            "probability": 0.0004929719252115365,
            "start_logit": -1.765457034111023,
            "end_logit": 5.290205001831055,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "higher abundance of Firmicutes and a smaller abundance of Bacteroidetes and Proteobacteria",
            "probability": 0.0003846608197805559,
            "start_logit": -1.765457034111023,
            "end_logit": 5.042114734649658,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Firmicutes and a smaller abundance of B",
            "probability": 0.00023654238572525944,
            "start_logit": 3.9069643020629883,
            "end_logit": -1.1165411472320557,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bact",
            "probability": 0.00019465965004297224,
            "start_logit": 4.9756903648376465,
            "end_logit": -2.3801419734954834,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "higher abundance of Firmicutes and a smaller abundance of Bacteroidetes",
            "probability": 0.00017239367129584992,
            "start_logit": -1.765457034111023,
            "end_logit": 4.239533424377441,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes and Proteobact",
            "probability": 0.00015283663559418546,
            "start_logit": 4.9756903648376465,
            "end_logit": -2.6220250129699707,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "utes",
            "probability": 0.00014803976000438618,
            "start_logit": -2.968428373336792,
            "end_logit": 5.290205001831055,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "utes and a smaller abundance of Bacteroidetes and Proteobacteria",
            "probability": 0.00011551387113772965,
            "start_logit": -2.968428373336792,
            "end_logit": 5.042114734649658,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Bacteroidetes and Proteob",
            "probability": 0.0001012561199949551,
            "start_logit": 4.9756903648376465,
            "end_logit": -3.0337414741516113,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        },
        {
            "text": "Proteobact",
            "probability": 0.00010118333588433462,
            "start_logit": 4.5632548332214355,
            "end_logit": -2.6220250129699707,
            "question_text": "List the three most abundant bacterial phyla present in mouse feces."
        }
    ],
    "58b53bf722d3005309000004": [
        {
            "text": "facial nerve paralysis",
            "probability": 0.29132475087356086,
            "start_logit": 4.514960765838623,
            "end_logit": 5.5110955238342285,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial nerve paralysis, swelling of the lips and lingua plicata",
            "probability": 0.1176698118903019,
            "start_logit": 4.514960765838623,
            "end_logit": 4.604539394378662,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "recurrent facial nerve paralysis",
            "probability": 0.11663921843068424,
            "start_logit": 3.5996077060699463,
            "end_logit": 5.5110955238342285,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial nerve paralysis, swelling of the lips",
            "probability": 0.09312492734439284,
            "start_logit": 4.514960765838623,
            "end_logit": 4.370598793029785,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "swelling of the lips and lingua plicata",
            "probability": 0.09175235804786003,
            "start_logit": 4.266171455383301,
            "end_logit": 4.604539394378662,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "swelling of the lips",
            "probability": 0.07261362570078093,
            "start_logit": 4.266171455383301,
            "end_logit": 4.370598793029785,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "lingua plicata",
            "probability": 0.060323231262761144,
            "start_logit": 3.8467955589294434,
            "end_logit": 4.604539394378662,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "recurrent facial nerve paralysis, swelling of the lips and lingua plicata",
            "probability": 0.04711207973443787,
            "start_logit": 3.5996077060699463,
            "end_logit": 4.604539394378662,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "recurrent facial nerve paralysis, swelling of the lips",
            "probability": 0.0372849155771818,
            "start_logit": 3.5996077060699463,
            "end_logit": 4.370598793029785,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial nerve paralysis,",
            "probability": 0.01281965177090374,
            "start_logit": 4.514960765838623,
            "end_logit": 2.387636184692383,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "paralysis",
            "probability": 0.012427793814956602,
            "start_logit": 1.3604575395584106,
            "end_logit": 5.5110955238342285,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial nerve paralysis, swelling",
            "probability": 0.007781850807327551,
            "start_logit": 4.514960765838623,
            "end_logit": 1.888451099395752,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "lips and lingua plicata",
            "probability": 0.007331137358312219,
            "start_logit": 1.7392089366912842,
            "end_logit": 4.604539394378662,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "swelling",
            "probability": 0.006067853343851506,
            "start_logit": 4.266171455383301,
            "end_logit": 1.888451099395752,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "lips",
            "probability": 0.005801926788844107,
            "start_logit": 1.7392089366912842,
            "end_logit": 4.370598793029785,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "recurrent facial nerve paralysis,",
            "probability": 0.005132671215295126,
            "start_logit": 3.5996077060699463,
            "end_logit": 2.387636184692383,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "paralysis, swelling of the lips and lingua plicata",
            "probability": 0.00501974568254962,
            "start_logit": 1.3604575395584106,
            "end_logit": 4.604539394378662,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "paralysis, swelling of the lips",
            "probability": 0.003972671022968555,
            "start_logit": 1.3604575395584106,
            "end_logit": 4.370598793029785,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "recurrent facial nerve paralysis, swelling",
            "probability": 0.0031156604215369812,
            "start_logit": 3.5996077060699463,
            "end_logit": 1.888451099395752,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        },
        {
            "text": "facial",
            "probability": 0.0026841189114923197,
            "start_logit": 4.514960765838623,
            "end_logit": 0.8240094184875488,
            "question_text": "List the classical triad of symptoms of the Melkersson\u2013Rosenthal syndrome."
        }
    ],
    "58850e50e56acf5176000013": [
        {
            "text": "clinical",
            "probability": 0.15374222354718092,
            "start_logit": -3.3211307525634766,
            "end_logit": -3.188793420791626,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "an acute clinical",
            "probability": 0.11495041203650944,
            "start_logit": -3.6119072437286377,
            "end_logit": -3.188793420791626,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "developed an acute clinical",
            "probability": 0.10417658253149309,
            "start_logit": -3.7103207111358643,
            "end_logit": -3.188793420791626,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "clinical score",
            "probability": 0.08168200008491362,
            "start_logit": -3.3211307525634766,
            "end_logit": -3.821237087249756,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "an acute clinical score",
            "probability": 0.06107222433169491,
            "start_logit": -3.6119072437286377,
            "end_logit": -3.821237087249756,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "acute clinical",
            "probability": 0.05675752682523401,
            "start_logit": -4.317619800567627,
            "end_logit": -3.188793420791626,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "developed an acute clinical score",
            "probability": 0.05534817584170071,
            "start_logit": -3.7103207111358643,
            "end_logit": -3.821237087249756,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "clinical score to predict likelihood of functional independence",
            "probability": 0.05472574826624863,
            "start_logit": -3.3211307525634766,
            "end_logit": -4.221736431121826,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "an acute clinical score to predict likelihood of functional independence",
            "probability": 0.04091749922090237,
            "start_logit": -3.6119072437286377,
            "end_logit": -4.221736431121826,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "developed an acute clinical score to predict likelihood of functional independence",
            "probability": 0.03708247024999596,
            "start_logit": -3.7103207111358643,
            "end_logit": -4.221736431121826,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "developed",
            "probability": 0.03570707378085128,
            "start_logit": -3.7103207111358643,
            "end_logit": -4.2595319747924805,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "acute clinical score",
            "probability": 0.030154815014338067,
            "start_logit": -4.317619800567627,
            "end_logit": -3.821237087249756,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "an",
            "probability": 0.027862944383473327,
            "start_logit": -3.6119072437286377,
            "end_logit": -4.605996608734131,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "developed an",
            "probability": 0.025251465164069124,
            "start_logit": -3.7103207111358643,
            "end_logit": -4.605996608734131,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "clinical score to predict likelihood of functional independence.",
            "probability": 0.0252272205445707,
            "start_logit": -3.3211307525634766,
            "end_logit": -4.996147155761719,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "an acute",
            "probability": 0.020255988299536065,
            "start_logit": -3.6119072437286377,
            "end_logit": -4.924843788146973,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "acute clinical score to predict likelihood of functional independence",
            "probability": 0.020203286082299963,
            "start_logit": -4.317619800567627,
            "end_logit": -4.221736431121826,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "an acute clinical score to predict likelihood of functional independence.",
            "probability": 0.018861958213088895,
            "start_logit": -3.6119072437286377,
            "end_logit": -4.996147155761719,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "developed an acute",
            "probability": 0.0183574777981079,
            "start_logit": -3.7103207111358643,
            "end_logit": -4.924843788146973,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        },
        {
            "text": "score",
            "probability": 0.017662907783790868,
            "start_logit": -4.852497577667236,
            "end_logit": -3.821237087249756,
            "question_text": "Which factors are considered in the FUNC score for intracerebral hemorrhage?"
        }
    ],
    "589dee3778275d0c4a000050": [
        {
            "text": "BMP",
            "probability": 0.5293316921276534,
            "start_logit": 4.996520519256592,
            "end_logit": 4.519713401794434,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway in these patients, exhibit a defect in BMP",
            "probability": 0.17317135611111428,
            "start_logit": 4.996520519256592,
            "end_logit": 3.4023797512054443,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway in these patients, exhibit a defect in BMPRIA internalization and increased activation of downstream signaling, suggesting that altered BMP",
            "probability": 0.14380656942967723,
            "start_logit": 4.996520519256592,
            "end_logit": 3.216567277908325,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway",
            "probability": 0.07470270957379063,
            "start_logit": 4.996520519256592,
            "end_logit": 2.561614513397217,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMPRIA internalization and increased activation of downstream signaling, suggesting that altered BMP",
            "probability": 0.05429944328530079,
            "start_logit": 4.0225653648376465,
            "end_logit": 3.216567277908325,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "the BMP",
            "probability": 0.008633557298231467,
            "start_logit": 0.880561888217926,
            "end_logit": 4.519713401794434,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway in these patients, exhibit a defect in BMPRIA",
            "probability": 0.003311694070892528,
            "start_logit": 4.996520519256592,
            "end_logit": -0.5544419884681702,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "the BMP pathway in these patients, exhibit a defect in BMP",
            "probability": 0.0028244763116076505,
            "start_logit": 0.880561888217926,
            "end_logit": 3.4023797512054443,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway in these patients,",
            "probability": 0.002427633516366514,
            "start_logit": 4.996520519256592,
            "end_logit": -0.864984929561615,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "the BMP pathway in these patients, exhibit a defect in BMPRIA internalization and increased activation of downstream signaling, suggesting that altered BMP",
            "probability": 0.002345527909055945,
            "start_logit": 0.880561888217926,
            "end_logit": 3.216567277908325,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMPRIA",
            "probability": 0.0012504515273110033,
            "start_logit": 4.0225653648376465,
            "end_logit": -0.5544419884681702,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "the BMP pathway",
            "probability": 0.001218423406401538,
            "start_logit": 0.880561888217926,
            "end_logit": 2.561614513397217,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway in these patients, exhibit a defect in BMPRIA internalization and increased activation of downstream signaling,",
            "probability": 0.001039849835823841,
            "start_logit": 4.996520519256592,
            "end_logit": -1.7128255367279053,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMPRIA internalization and increased activation of downstream signaling,",
            "probability": 0.0003926334339903509,
            "start_logit": 4.0225653648376465,
            "end_logit": -1.7128255367279053,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "B",
            "probability": 0.00037639016650782933,
            "start_logit": 4.996520519256592,
            "end_logit": -2.7290308475494385,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway in these patients, exhibit a defect in BMPRIA internalization and increased activation of downstream signaling, suggesting that altered BMP receptor",
            "probability": 0.0002065828862150059,
            "start_logit": 4.996520519256592,
            "end_logit": -3.3289554119110107,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "MP",
            "probability": 0.00020582970358311387,
            "start_logit": -2.8558008670806885,
            "end_logit": 4.519713401794434,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway in these patients, exhibit a defect in B",
            "probability": 0.0001943817322898624,
            "start_logit": 4.996520519256592,
            "end_logit": -3.3898332118988037,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "BMP pathway in these patients, exhibit a defect in BMPRIA internalization and increased activation of downstream signaling, suggesting that altered B",
            "probability": 0.00013909536980113453,
            "start_logit": 4.996520519256592,
            "end_logit": -3.7244973182678223,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        },
        {
            "text": "lymphocytes, a model system for exploring the BMP",
            "probability": 0.00012170230438591707,
            "start_logit": -3.381272077560425,
            "end_logit": 4.519713401794434,
            "question_text": "What genes are drug targets for Fibrodysplasia Ossificans Progressiva (FOP)?"
        }
    ],
    "58b52c8822d3005309000001": [
        {
            "text": "Ascher's syndrome",
            "probability": 0.6585206802067055,
            "start_logit": 5.737923622131348,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome was diagnosed. To our knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 0.29783648161994947,
            "start_logit": 4.944472312927246,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's",
            "probability": 0.023906415644693053,
            "start_logit": 5.737923622131348,
            "end_logit": 3.593970537185669,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome was diagnosed. To our knowledge, this is the first reported case of Ascher's",
            "probability": 0.010812420836236316,
            "start_logit": 4.944472312927246,
            "end_logit": 3.593970537185669,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher",
            "probability": 0.004760146781322107,
            "start_logit": 5.737923622131348,
            "end_logit": 1.9801021814346313,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome was diagnosed. To our knowledge, this is the first reported case of Ascher",
            "probability": 0.0021529245959268613,
            "start_logit": 4.944472312927246,
            "end_logit": 1.9801021814346313,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "syndrome",
            "probability": 0.0004210745750158406,
            "start_logit": -1.6170176267623901,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "syndrome was diagnosed. To our knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 0.0003547258206828293,
            "start_logit": -1.788482427597046,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "cher's syndrome was diagnosed. To our knowledge, this is the first reported case of Ascher's syndrome",
            "probability": 0.0003485358734213841,
            "start_logit": -1.8060864210128784,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "cher's syndrome",
            "probability": 0.00024851472213760544,
            "start_logit": -2.1443254947662354,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "first reported case of Ascher's syndrome",
            "probability": 0.00018369683263920003,
            "start_logit": -2.4465408325195312,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "this is the first reported case of Ascher's syndrome",
            "probability": 9.833567548172364e-05,
            "start_logit": -3.0714406967163086,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome associated with iris coloboma",
            "probability": 7.24582543947247e-05,
            "start_logit": 5.737923622131348,
            "end_logit": -2.204921007156372,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome associated with iris coloboma,",
            "probability": 6.139736399504017e-05,
            "start_logit": 5.737923622131348,
            "end_logit": -2.3705646991729736,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher'",
            "probability": 5.2676609862138595e-05,
            "start_logit": 5.737923622131348,
            "end_logit": -2.5237600803375244,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "Ascher's syndrome associated",
            "probability": 4.655218304831662e-05,
            "start_logit": 5.737923622131348,
            "end_logit": -2.647357702255249,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "s syndrome",
            "probability": 3.71332322595817e-05,
            "start_logit": -4.045315265655518,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "reported case of Ascher's syndrome",
            "probability": 3.0796628839478924e-05,
            "start_logit": -4.232422351837158,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "As",
            "probability": 2.923845563874871e-05,
            "start_logit": 5.737923622131348,
            "end_logit": -3.1124467849731445,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        },
        {
            "text": "case of Ascher's syndrome",
            "probability": 2.5794087750192645e-05,
            "start_logit": -4.409682273864746,
            "end_logit": 6.909819602966309,
            "question_text": "Which syndromes are associated with heterochromia iridum?"
        }
    ],
    "58a8071760087bc10a000037": [
        {
            "text": "CID and HCD",
            "probability": 0.3196543588273228,
            "start_logit": 4.176121711730957,
            "end_logit": 3.487454652786255,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID",
            "probability": 0.31447739167168864,
            "start_logit": 4.176121711730957,
            "end_logit": 3.4711265563964844,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD",
            "probability": 0.30043313801130184,
            "start_logit": 4.11410665512085,
            "end_logit": 3.487454652786255,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID and HCD fragmentation techniques",
            "probability": 0.02036145554398199,
            "start_logit": 4.176121711730957,
            "end_logit": 0.733858048915863,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD fragmentation techniques",
            "probability": 0.019137095473991856,
            "start_logit": 4.11410665512085,
            "end_logit": 0.733858048915863,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "MS(2) spectra, using the CID and HCD",
            "probability": 0.006102566984041204,
            "start_logit": 0.21759092807769775,
            "end_logit": 3.487454652786255,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "MS(2) spectra, using the CID",
            "probability": 0.006003732765238935,
            "start_logit": 0.21759092807769775,
            "end_logit": 3.4711265563964844,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "C",
            "probability": 0.002957677896497772,
            "start_logit": 4.176121711730957,
            "end_logit": -1.1953811645507812,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID and HCD fragmentation",
            "probability": 0.0024492348588503817,
            "start_logit": 4.176121711730957,
            "end_logit": -1.3840099573135376,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD fragmentation",
            "probability": 0.002301959269601526,
            "start_logit": 4.11410665512085,
            "end_logit": -1.3840099573135376,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID and H",
            "probability": 0.0011640108594728556,
            "start_logit": 4.176121711730957,
            "end_logit": -2.1279139518737793,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "H",
            "probability": 0.0010940174145398543,
            "start_logit": 4.11410665512085,
            "end_logit": -2.1279139518737793,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "CID and HCD fragment",
            "probability": 0.0006670638177014441,
            "start_logit": 4.176121711730957,
            "end_logit": -2.68465518951416,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "HCD fragment",
            "probability": 0.0006269524268058057,
            "start_logit": 4.11410665512085,
            "end_logit": -2.68465518951416,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "fragmentation techniques",
            "probability": 0.0005926446615252145,
            "start_logit": 0.6393177509307861,
            "end_logit": 0.733858048915863,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "LC-MS(2)",
            "probability": 0.0005911109400155683,
            "start_logit": 1.6642495393753052,
            "end_logit": -0.2936650216579437,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "MS(3)",
            "probability": 0.00047115360707635634,
            "start_logit": 2.4914605617523193,
            "end_logit": -1.3476955890655518,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "MS(2) spectra, using the CID and HCD fragmentation techniques",
            "probability": 0.0003887234536878344,
            "start_logit": 0.21759092807769775,
            "end_logit": 0.733858048915863,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "using the CID and HCD",
            "probability": 0.0002647233778583291,
            "start_logit": -2.9201884269714355,
            "end_logit": 3.487454652786255,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        },
        {
            "text": "the CID and HCD",
            "probability": 0.0002609881388000127,
            "start_logit": -2.934398889541626,
            "end_logit": 3.487454652786255,
            "question_text": "List peptide fragmentations methods in mass spectrometry"
        }
    ],
    "588f220e3b87a8a73800000d": [
        {
            "text": "CIRCexplorer",
            "probability": 0.1454149454931703,
            "start_logit": 4.195153713226318,
            "end_logit": 3.707040309906006,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "CIRCexplorer, CIRI",
            "probability": 0.1322938046301535,
            "start_logit": 4.195153713226318,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer",
            "probability": 0.1259628560281418,
            "start_logit": 4.051549434661865,
            "end_logit": 3.707040309906006,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI",
            "probability": 0.11459692406119154,
            "start_logit": 4.051549434661865,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "CIRI",
            "probability": 0.11201747097594004,
            "start_logit": 4.028783321380615,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder, find_circ",
            "probability": 0.10659830384746521,
            "start_logit": 4.051549434661865,
            "end_logit": 3.540120840072632,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder",
            "probability": 0.07052941263307913,
            "start_logit": 4.051549434661865,
            "end_logit": 3.1270830631256104,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "find_circ, CIRCexplorer",
            "probability": 0.045886519318401084,
            "start_logit": 3.041733741760254,
            "end_logit": 3.707040309906006,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI",
            "probability": 0.04174606813129418,
            "start_logit": 3.041733741760254,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "find_circ",
            "probability": 0.038832281857063417,
            "start_logit": 3.041733741760254,
            "end_logit": 3.540120840072632,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA",
            "probability": 0.014475387685275093,
            "start_logit": 4.051549434661865,
            "end_logit": 1.5435030460357666,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.013046788122973404,
            "start_logit": 4.195153713226318,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.011301525358278632,
            "start_logit": 4.051549434661865,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "CIRI, and MapSplice",
            "probability": 0.011047140219303229,
            "start_logit": 4.028783321380615,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.004116988753924353,
            "start_logit": 3.041733741760254,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "RNAseq datasets to scrutinize and compare the output from five different algorithms; circRNA_finder",
            "probability": 0.003183816063286572,
            "start_logit": 0.9536001086235046,
            "end_logit": 3.1270830631256104,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circ, CIRCexplorer",
            "probability": 0.002686803236283502,
            "start_logit": 0.20391446352005005,
            "end_logit": 3.707040309906006,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circ, CIRCexplorer, CIRI",
            "probability": 0.002444366507273822,
            "start_logit": 0.20391446352005005,
            "end_logit": 3.612474203109741,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "circ",
            "probability": 0.002273754952775238,
            "start_logit": 0.20391446352005005,
            "end_logit": 3.540120840072632,
            "question_text": "List available circular RNA prediction tools."
        },
        {
            "text": "MapSplice",
            "probability": 0.0015448421247258673,
            "start_logit": 2.0615334510803223,
            "end_logit": 1.2959909439086914,
            "question_text": "List available circular RNA prediction tools."
        }
    ],
    "589a245878275d0c4a000025": [
        {
            "text": "Tokuhashi",
            "probability": 0.8717045807378774,
            "start_logit": 5.139345169067383,
            "end_logit": 5.096791744232178,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi Scoring System (TSS)",
            "probability": 0.04750225248124524,
            "start_logit": 5.139345169067383,
            "end_logit": 2.1871182918548584,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "The Tokuhashi",
            "probability": 0.045334650245713363,
            "start_logit": 2.1829662322998047,
            "end_logit": 5.096791744232178,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi Scoring System",
            "probability": 0.016214152799748978,
            "start_logit": 5.139345169067383,
            "end_logit": 1.1122256517410278,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi Scoring System (TSS",
            "probability": 0.006216895291346007,
            "start_logit": 5.139345169067383,
            "end_logit": 0.15361179411411285,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi Scoring",
            "probability": 0.006175859972174667,
            "start_logit": 5.139345169067383,
            "end_logit": 0.14698930084705353,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "The Tokuhashi Scoring System (TSS)",
            "probability": 0.0024704447466571042,
            "start_logit": 2.1829662322998047,
            "end_logit": 2.1871182918548584,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "TSS)",
            "probability": 0.0015107163436334134,
            "start_logit": 1.6911519765853882,
            "end_logit": 2.1871182918548584,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "The Tokuhashi Scoring System",
            "probability": 0.0008432477727545731,
            "start_logit": 2.1829662322998047,
            "end_logit": 1.1122256517410278,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "The Tokuhashi Scoring System (TSS",
            "probability": 0.0003233214323696934,
            "start_logit": 2.1829662322998047,
            "end_logit": 0.15361179411411285,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "The Tokuhashi Scoring",
            "probability": 0.00032118731275685477,
            "start_logit": 2.1829662322998047,
            "end_logit": 0.14698930084705353,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "hashi",
            "probability": 0.00020905370500236983,
            "start_logit": -3.1962695121765137,
            "end_logit": 5.096791744232178,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "TSS",
            "probability": 0.00019771620992082732,
            "start_logit": 1.6911519765853882,
            "end_logit": 0.15361179411411285,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi Scoring System (",
            "probability": 0.0001723049958129092,
            "start_logit": 5.139345169067383,
            "end_logit": -3.432147979736328,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "(TSS)",
            "probability": 0.00017226902313472505,
            "start_logit": -0.4801298975944519,
            "end_logit": 2.1871182918548584,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "To",
            "probability": 0.00015002689255578806,
            "start_logit": 5.139345169067383,
            "end_logit": -3.5705995559692383,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi Scoring System (T",
            "probability": 0.00013604613298361483,
            "start_logit": 5.139345169067383,
            "end_logit": -3.6684200763702393,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Tokuhashi Scoring System (TSS) is a widely used prognostic tool",
            "probability": 0.00013535480461404446,
            "start_logit": 5.139345169067383,
            "end_logit": -3.6735146045684814,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "Toku",
            "probability": 0.0001230561555489872,
            "start_logit": 5.139345169067383,
            "end_logit": -3.768773317337036,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        },
        {
            "text": "kuhashi",
            "probability": 8.686294414957185e-05,
            "start_logit": -4.07452917098999,
            "end_logit": 5.096791744232178,
            "question_text": "List scales that are used for scoring of patients with spinal metastasis?"
        }
    ],
    "589c4c9078275d0c4a000040": [
        {
            "text": "myalgia",
            "probability": 0.9310044711752996,
            "start_logit": 4.920080184936523,
            "end_logit": 4.67992639541626,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Statin intolerance can be defined as the occurrence of myalgia",
            "probability": 0.06632560165994206,
            "start_logit": 2.2783920764923096,
            "end_logit": 4.67992639541626,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "myalgia or other adverse symptoms",
            "probability": 0.0008737096238768217,
            "start_logit": 4.920080184936523,
            "end_logit": -2.2913448810577393,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Statin intolerance",
            "probability": 0.0008031658737301307,
            "start_logit": 2.2783920764923096,
            "end_logit": 0.266156405210495,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "gia",
            "probability": 0.00044322981479487394,
            "start_logit": -2.7298507690429688,
            "end_logit": 4.67992639541626,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "my",
            "probability": 0.00037505622637849404,
            "start_logit": 4.920080184936523,
            "end_logit": -3.137017011642456,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Statin intolerance can be defined as the occurrence of myalgia or other adverse symptoms",
            "probability": 6.22438648512146e-05,
            "start_logit": 2.2783920764923096,
            "end_logit": -2.2913448810577393,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Statin intolerance can be defined as the occurrence of my",
            "probability": 2.671934522447332e-05,
            "start_logit": 2.2783920764923096,
            "end_logit": -3.137017011642456,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "algia",
            "probability": 2.478230932922035e-05,
            "start_logit": -5.613809108734131,
            "end_logit": 4.67992639541626,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "intolerance can be defined as the occurrence of myalgia",
            "probability": 2.4086877215563483e-05,
            "start_logit": -5.642271995544434,
            "end_logit": 4.67992639541626,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "ance can be defined as the occurrence of myalgia",
            "probability": 1.493482336252188e-05,
            "start_logit": -6.120243549346924,
            "end_logit": 4.67992639541626,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "myalgia or other adverse symptoms that are attributed to statin therapy and that lead to its discontinuation",
            "probability": 1.4741027283406337e-05,
            "start_logit": 4.920080184936523,
            "end_logit": -6.373458385467529,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "hyperlipidemia",
            "probability": 3.0624323860904704e-06,
            "start_logit": -1.2075730562210083,
            "end_logit": -1.817230224609375,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "S",
            "probability": 2.883824619581732e-06,
            "start_logit": 2.2783920764923096,
            "end_logit": -5.363287448883057,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "gia or other adverse symptoms",
            "probability": 4.159530558285646e-07,
            "start_logit": -2.7298507690429688,
            "end_logit": -2.2913448810577393,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "intolerance",
            "probability": 2.9167858715335964e-07,
            "start_logit": -5.642271995544434,
            "end_logit": 0.266156405210495,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "hyperlipidemia and increased cardiovascular risk",
            "probability": 2.5435422254643484e-07,
            "start_logit": -1.2075730562210083,
            "end_logit": -4.305467128753662,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "ance",
            "probability": 1.808523429077256e-07,
            "start_logit": -6.120243549346924,
            "end_logit": 0.266156405210495,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "Muscle problems",
            "probability": 8.671051789958759e-08,
            "start_logit": -3.7692325115203857,
            "end_logit": -2.819960355758667,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        },
        {
            "text": "lipidemia",
            "probability": 8.157297939188257e-08,
            "start_logit": -4.8330397605896,
            "end_logit": -1.817230224609375,
            "question_text": "What are the side effects during statins administration in patients with atherosclerosis?"
        }
    ],
    "58962ed178275d0c4a000006": [
        {
            "text": "valsartan",
            "probability": 0.7092556172516294,
            "start_logit": 6.920510768890381,
            "end_logit": 6.344178676605225,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril in combination with valsartan",
            "probability": 0.13837267252383895,
            "start_logit": 5.286245346069336,
            "end_logit": 6.344178676605225,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "neprilysin inhibition (sacubitril in combination with valsartan",
            "probability": 0.0803404891687465,
            "start_logit": 4.742568492889404,
            "end_logit": 6.344178676605225,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril",
            "probability": 0.037032936038794394,
            "start_logit": 5.286245346069336,
            "end_logit": 5.026035785675049,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "neprilysin inhibition (sacubitril",
            "probability": 0.021501674734215066,
            "start_logit": 4.742568492889404,
            "end_logit": 5.026035785675049,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "neprilysin inhibition",
            "probability": 0.008123772232302116,
            "start_logit": 4.742568492889404,
            "end_logit": 4.052699565887451,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan (Entresto\u00ae)) for heart failure",
            "probability": 0.0013675648943989272,
            "start_logit": 6.920510768890381,
            "end_logit": 0.09299439191818237,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "neprilysin",
            "probability": 0.0011711897525582163,
            "start_logit": 4.742568492889404,
            "end_logit": 2.1159250736236572,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "(sacubitril in combination with valsartan",
            "probability": 0.0003637164506892704,
            "start_logit": -0.6550859212875366,
            "end_logit": 6.344178676605225,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril in combination",
            "probability": 0.0003057495747389784,
            "start_logit": 5.286245346069336,
            "end_logit": 0.22923921048641205,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan (Entresto\u00ae)",
            "probability": 0.0002843814514961058,
            "start_logit": 6.920510768890381,
            "end_logit": -1.4774761199951172,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "sacubitril in combination with valsartan (Entresto\u00ae)) for heart failure",
            "probability": 0.0002668059366537592,
            "start_logit": 5.286245346069336,
            "end_logit": 0.09299439191818237,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "combination with valsartan",
            "probability": 0.00026215882780189763,
            "start_logit": -0.982509970664978,
            "end_logit": 6.344178676605225,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "ril in combination with valsartan",
            "probability": 0.00023765293812802837,
            "start_logit": -1.0806491374969482,
            "end_logit": 6.344178676605225,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan (Entresto\u00ae)) for heart failure,",
            "probability": 0.00021624043923318403,
            "start_logit": 6.920510768890381,
            "end_logit": -1.751401662826538,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "valsartan (Entresto\u00ae))",
            "probability": 0.00020482695247793137,
            "start_logit": 6.920510768890381,
            "end_logit": -1.8056271076202393,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "artan",
            "probability": 0.00020193287825173188,
            "start_logit": -1.2435251474380493,
            "end_logit": 6.344178676605225,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "neprilysin inhibition (sacubitril in combination",
            "probability": 0.00017752110983788237,
            "start_logit": 4.742568492889404,
            "end_logit": 0.22923921048641205,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "v",
            "probability": 0.00015818678087696614,
            "start_logit": 6.920510768890381,
            "end_logit": -2.064016103744507,
            "question_text": "Entresto is composed of which two drugs?"
        },
        {
            "text": "neprilysin inhibition (sacubitril in combination with valsartan (Entresto\u00ae)) for heart failure",
            "probability": 0.00015491006333057358,
            "start_logit": 4.742568492889404,
            "end_logit": 0.09299439191818237,
            "question_text": "Entresto is composed of which two drugs?"
        }
    ],
    "58ca746d02b8c6095300002d": [
        {
            "text": "pre-adipocytes",
            "probability": 0.28272789376660945,
            "start_logit": 5.026853561401367,
            "end_logit": 4.6604108810424805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "pre-adipocytes, we confirmed that the expression of CIDEC was elevated during the differentiation of pre-adipocytes",
            "probability": 0.24926497136781484,
            "start_logit": 4.900885105133057,
            "end_logit": 4.6604108810424805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "pre-adipocytes, and knockdown of CIDEC in human primary pre-adipocytes",
            "probability": 0.16817629543525245,
            "start_logit": 5.026853561401367,
            "end_logit": 4.140938758850098,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipocytes",
            "probability": 0.06487243596929834,
            "start_logit": 3.5547914505004883,
            "end_logit": 4.6604108810424805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipocytes, we confirmed that the expression of CIDEC was elevated during the differentiation of pre-adipocytes",
            "probability": 0.048894915013990674,
            "start_logit": 3.2720420360565186,
            "end_logit": 4.6604108810424805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "primary pre-adipocytes",
            "probability": 0.048252441025067254,
            "start_logit": 3.195732355117798,
            "end_logit": 4.723493576049805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "primary pre-adipocytes, we confirmed that the expression of CIDEC was elevated during the differentiation of pre-adipocytes",
            "probability": 0.04530256813894836,
            "start_logit": 3.195732355117798,
            "end_logit": 4.6604108810424805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipocytes, and knockdown of CIDEC in human primary pre-adipocytes",
            "probability": 0.038588360744424365,
            "start_logit": 3.5547914505004883,
            "end_logit": 4.140938758850098,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "human primary pre-adipocytes",
            "probability": 0.015101856670205402,
            "start_logit": 2.0341036319732666,
            "end_logit": 4.723493576049805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "human primary pre-adipocytes, we confirmed that the expression of CIDEC was elevated during the differentiation of pre-adipocytes",
            "probability": 0.014178617211742576,
            "start_logit": 2.0341036319732666,
            "end_logit": 4.6604108810424805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "pre-adipocytes,",
            "probability": 0.007123820475269686,
            "start_logit": 4.900885105133057,
            "end_logit": 1.1053385734558105,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipocytic tumors, suggesting that the expression of CIDEC should be positively correlated with the differentiation of adipocytes",
            "probability": 0.004165131014134203,
            "start_logit": 3.90045428276062,
            "end_logit": 1.569072961807251,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "differentiation of pre-adipocytes",
            "probability": 0.002180312727609202,
            "start_logit": 0.16183695197105408,
            "end_logit": 4.6604108810424805,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "pre-adipocytes, we confirmed that the expression of CIDEC was elevated during the differentiation",
            "probability": 0.002008004953933573,
            "start_logit": 4.900885105133057,
            "end_logit": -0.16096392273902893,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "pre-adipocytes, we confirmed that the expression of CIDEC was elevated during the differentiation of pre-adipocytes,",
            "probability": 0.0019784607750760286,
            "start_logit": 4.900885105133057,
            "end_logit": -0.17578643560409546,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipocytic tumors",
            "probability": 0.0018792560801429794,
            "start_logit": 3.90045428276062,
            "end_logit": 0.7732012271881104,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipocytes,",
            "probability": 0.0013973828524797404,
            "start_logit": 3.2720420360565186,
            "end_logit": 1.1053385734558105,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "adipose tissues",
            "probability": 0.0013156345596237204,
            "start_logit": 3.013401508331299,
            "end_logit": 1.303697109222412,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "differentiation of pre-adipocytes, and knockdown of CIDEC in human primary pre-adipocytes",
            "probability": 0.0012969251549064921,
            "start_logit": 0.16183695197105408,
            "end_logit": 4.140938758850098,
            "question_text": "Which cells express CIDEC protein in humans?"
        },
        {
            "text": "primary pre-adipocytes,",
            "probability": 0.0012947160634709666,
            "start_logit": 3.195732355117798,
            "end_logit": 1.1053385734558105,
            "question_text": "Which cells express CIDEC protein in humans?"
        }
    ],
    "58a71f7460087bc10a00002e": [
        {
            "text": "Cse4",
            "probability": 0.0869360412154682,
            "start_logit": 4.698047161102295,
            "end_logit": 4.7893829345703125,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3, as well as Cse4",
            "probability": 0.07912846661432914,
            "start_logit": 4.5801286697387695,
            "end_logit": 4.813201427459717,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3",
            "probability": 0.07541013649877093,
            "start_logit": 4.5801286697387695,
            "end_logit": 4.76507043838501,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3, as well as Cse4, H4",
            "probability": 0.06362524277358218,
            "start_logit": 4.5801286697387695,
            "end_logit": 4.595139026641846,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4, H4, H2A, and H2B, but not histone chaperone Scm3",
            "probability": 0.05714597274226707,
            "start_logit": 4.698047161102295,
            "end_logit": 4.369819164276123,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4, H4",
            "probability": 0.054300630876014076,
            "start_logit": 4.698047161102295,
            "end_logit": 4.318746089935303,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4 at the CEN DNA. Our results favor a H3-Cse4",
            "probability": 0.053337552003601116,
            "start_logit": 4.6519036293029785,
            "end_logit": 4.346994400024414,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3 and Cse4",
            "probability": 0.05328218697268823,
            "start_logit": 4.33457088470459,
            "end_logit": 4.663288593292236,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Scm3 (HJURP in human) with the centromeric DNA. H3",
            "probability": 0.0520087577743863,
            "start_logit": 4.485584259033203,
            "end_logit": 4.4880852699279785,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Scm3",
            "probability": 0.04620767997450727,
            "start_logit": 4.485584259033203,
            "end_logit": 4.369819164276123,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4 at the CEN DNA. Our results favor a H3",
            "probability": 0.043693138861639426,
            "start_logit": 4.6519036293029785,
            "end_logit": 4.147544860839844,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H2B, but not histone chaperone Scm3",
            "probability": 0.042713441620647816,
            "start_logit": 4.406951904296875,
            "end_logit": 4.369819164276123,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3-Cse4",
            "probability": 0.03959847041048061,
            "start_logit": 4.354053497314453,
            "end_logit": 4.346994400024414,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3 and Cse4 at the CEN DNA. Our results favor a H3-Cse4",
            "probability": 0.03883445542197228,
            "start_logit": 4.33457088470459,
            "end_logit": 4.346994400024414,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H4, H2A, and H2B, but not histone chaperone Scm3",
            "probability": 0.03866909349141799,
            "start_logit": 4.307478904724121,
            "end_logit": 4.369819164276123,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H4",
            "probability": 0.03674372963179112,
            "start_logit": 4.307478904724121,
            "end_logit": 4.318746089935303,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H2A, and H2B, but not histone chaperone Scm3",
            "probability": 0.036232972877294024,
            "start_logit": 4.24240779876709,
            "end_logit": 4.369819164276123,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "Cse4, H4, H2A, and H2B",
            "probability": 0.03489729547622628,
            "start_logit": 4.698047161102295,
            "end_logit": 3.876619577407837,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3, as well as Cse4, H4, H2A, and H2B",
            "probability": 0.03364566034230157,
            "start_logit": 4.5801286697387695,
            "end_logit": 3.958012819290161,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        },
        {
            "text": "H3, as well as Cse4, H4, H2A",
            "probability": 0.03358907442061448,
            "start_logit": 4.5801286697387695,
            "end_logit": 3.956329584121704,
            "question_text": "Which protein complexes recognize centromeric (CEN) DNA in yeast?"
        }
    ],
    "58c66a4b02b8c60953000025": [
        {
            "text": "astrocytic proliferation",
            "probability": 0.506290219466692,
            "start_logit": 1.7005332708358765,
            "end_logit": 1.5360448360443115,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Diffuse astrocytic proliferation",
            "probability": 0.24287577725343357,
            "start_logit": 0.9659733176231384,
            "end_logit": 1.5360448360443115,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "astrocytic proliferation in the white matter and focal reaction in gray matter",
            "probability": 0.07238001613559555,
            "start_logit": 1.7005332708358765,
            "end_logit": -0.40913498401641846,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Diffuse astrocytic proliferation in the white matter and focal reaction in gray matter",
            "probability": 0.03472188875200136,
            "start_logit": 0.9659733176231384,
            "end_logit": -0.40913498401641846,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Astrocytic reaction to perinatal brain damage",
            "probability": 0.028463667078211206,
            "start_logit": -0.09660002589225769,
            "end_logit": 0.45469650626182556,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "astrocytic proliferation in the white matter",
            "probability": 0.026109356306375668,
            "start_logit": 1.7005332708358765,
            "end_logit": -1.4287714958190918,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Diffuse astrocytic proliferation in the white matter",
            "probability": 0.012525089292022189,
            "start_logit": 0.9659733176231384,
            "end_logit": -1.4287714958190918,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Astrocytic reaction",
            "probability": 0.011166322163369201,
            "start_logit": -0.09660002589225769,
            "end_logit": -0.4810296297073364,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "astrocytic",
            "probability": 0.009364252628719011,
            "start_logit": 1.7005332708358765,
            "end_logit": -2.4541656970977783,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "astrocytic proliferation in the white matter and focal reaction in gray matter,",
            "probability": 0.009037135529025169,
            "start_logit": 1.7005332708358765,
            "end_logit": -2.489722967147827,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "astrocytic proliferation in the white matter and focal reaction",
            "probability": 0.007706554928372019,
            "start_logit": 1.7005332708358765,
            "end_logit": -2.648993968963623,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "trocytic reaction to perinatal brain damage",
            "probability": 0.006097127146062347,
            "start_logit": -1.6374107599258423,
            "end_logit": 0.45469650626182556,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "focal reaction in gray matter",
            "probability": 0.005888282688261656,
            "start_logit": -0.8084325790405273,
            "end_logit": -0.40913498401641846,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "proliferation",
            "probability": 0.005287590337697383,
            "start_logit": -2.8612141609191895,
            "end_logit": 1.5360448360443115,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Diffuse astrocytic",
            "probability": 0.004492186592096046,
            "start_logit": 0.9659733176231384,
            "end_logit": -2.4541656970977783,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Diffuse astrocytic proliferation in the white matter and focal reaction in gray matter,",
            "probability": 0.0043352631185896474,
            "start_logit": 0.9659733176231384,
            "end_logit": -2.489722967147827,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "astrocytes usually proliferate. Diffuse astrocytic proliferation",
            "probability": 0.003945490061939916,
            "start_logit": -3.154003620147705,
            "end_logit": 1.5360448360443115,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Diffuse astrocytic proliferation in the white matter and focal reaction",
            "probability": 0.003696961636245418,
            "start_logit": 0.9659733176231384,
            "end_logit": -2.648993968963623,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "Astrocytic",
            "probability": 0.0032249104289107096,
            "start_logit": -0.09660002589225769,
            "end_logit": -1.7230267524719238,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        },
        {
            "text": "trocytic reaction",
            "probability": 0.0023919084563799155,
            "start_logit": -1.6374107599258423,
            "end_logit": -0.4810296297073364,
            "question_text": "Which are the main brain dysfunctions caused by hyperbilirubinemia?"
        }
    ],
    "58adb9919ef3c34033000004": [
        {
            "text": "CHD3 and CHD4",
            "probability": 0.3514322039075454,
            "start_logit": 3.951707363128662,
            "end_logit": 2.9634311199188232,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4",
            "probability": 0.2681592461381716,
            "start_logit": 3.681271553039551,
            "end_logit": 2.9634311199188232,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD3",
            "probability": 0.15646103362114225,
            "start_logit": 3.951707363128662,
            "end_logit": 2.154221296310425,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD3 and CHD4 proteins which contain helicase/ATPase domains found in SWI2",
            "probability": 0.10305753485845154,
            "start_logit": 3.951707363128662,
            "end_logit": 1.7367017269134521,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4 proteins which contain helicase/ATPase domains found in SWI2",
            "probability": 0.07863773026267999,
            "start_logit": 3.681271553039551,
            "end_logit": 1.7367017269134521,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "SWI2",
            "probability": 0.025255383236501464,
            "start_logit": 2.545459270477295,
            "end_logit": 1.7367017269134521,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD3 and CHD4 proteins",
            "probability": 0.007567924281261378,
            "start_logit": 3.951707363128662,
            "end_logit": -0.8746668696403503,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4 proteins",
            "probability": 0.0057746809982949406,
            "start_logit": 3.681271553039551,
            "end_logit": -0.8746668696403503,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4 proteins which contain helicase/ATPase domains found in SWI2-related chromatin remodelling factors",
            "probability": 0.0010256349115562152,
            "start_logit": 3.681271553039551,
            "end_logit": -2.6028380393981934,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD3 and CHD4 proteins which contain helicase/ATPase domains found in SWI",
            "probability": 0.0005439465865469727,
            "start_logit": 3.951707363128662,
            "end_logit": -3.5074899196624756,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4 proteins which contain helicase/ATPase domains found in SWI",
            "probability": 0.00041505674484584745,
            "start_logit": 3.681271553039551,
            "end_logit": -3.5074899196624756,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "SWI2-related chromatin remodelling factors",
            "probability": 0.00032939407922332283,
            "start_logit": 2.545459270477295,
            "end_logit": -2.6028380393981934,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CH",
            "probability": 0.0002545258210580376,
            "start_logit": 3.951707363128662,
            "end_logit": -4.26693868637085,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "histone deacetylase complex. This activity is derived from the CHD3 and CHD4",
            "probability": 0.00023247334475004288,
            "start_logit": -3.3692891597747803,
            "end_logit": 2.9634311199188232,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "CHD4 proteins which contain helicase/ATPase domains found in SWI2-related chromatin remodelling factors,",
            "probability": 0.00017450755487881882,
            "start_logit": 3.681271553039551,
            "end_logit": -4.373937129974365,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "4",
            "probability": 0.00017189249029225773,
            "start_logit": -3.6711955070495605,
            "end_logit": 2.9634311199188232,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "3 and CHD4",
            "probability": 0.0001400714016090994,
            "start_logit": -3.8759124279022217,
            "end_logit": 2.9634311199188232,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "SWI",
            "probability": 0.0001333000980694816,
            "start_logit": 2.545459270477295,
            "end_logit": -3.5074899196624756,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "the CHD3 and CHD4",
            "probability": 0.00012996027005332533,
            "start_logit": -3.950835943222046,
            "end_logit": 2.9634311199188232,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        },
        {
            "text": "histone deacetylase complex. This activity is derived from the CHD3",
            "probability": 0.00010349939306792967,
            "start_logit": -3.3692891597747803,
            "end_logit": 2.154221296310425,
            "question_text": "Which proteins form part of the NRD complex in S. cerevisiae?"
        }
    ],
    "58bfcb8702b8c60953000016": [
        {
            "text": "psoriasis",
            "probability": 0.20764985962055738,
            "start_logit": 4.43646240234375,
            "end_logit": 4.393291473388672,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "psoriasis, vitiligo, and lichen planus",
            "probability": 0.17346296040872541,
            "start_logit": 4.43646240234375,
            "end_logit": 4.213402271270752,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "psoriasis, vitiligo",
            "probability": 0.16572010624188602,
            "start_logit": 4.43646240234375,
            "end_logit": 4.167738437652588,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "vitiligo, and lichen planus",
            "probability": 0.14512037572241324,
            "start_logit": 4.25806188583374,
            "end_logit": 4.213402271270752,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "vitiligo",
            "probability": 0.13864264754800662,
            "start_logit": 4.25806188583374,
            "end_logit": 4.167738437652588,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus",
            "probability": 0.12308515325563116,
            "start_logit": 4.093374729156494,
            "end_logit": 4.213402271270752,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "vitiligo, and lichen planus. We herein report a 27-year-old female patient with plaque psoriasis",
            "probability": 0.02348948202116414,
            "start_logit": 4.25806188583374,
            "end_logit": 2.3923914432525635,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus. We herein report a 27-year-old female patient with plaque psoriasis",
            "probability": 0.019922815663051274,
            "start_logit": 4.093374729156494,
            "end_logit": 2.3923914432525635,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus. We herein report a 27-year-old female patient with plaque psoriasis who developed psoriatic",
            "probability": 0.0008979301299561708,
            "start_logit": 4.093374729156494,
            "end_logit": -0.7071371674537659,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "striae are a form of injury to the skin that can result in koebnerization of psoriasis",
            "probability": 0.0005895663334377284,
            "start_logit": -1.4277589321136475,
            "end_logit": 4.393291473388672,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "striae are a form of injury to the skin that can result in koebnerization of psoriasis, vitiligo",
            "probability": 0.0004705179940524599,
            "start_logit": -1.4277589321136475,
            "end_logit": 4.167738437652588,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "plaque psoriasis",
            "probability": 0.00032280837842293427,
            "start_logit": -0.029187249019742012,
            "end_logit": 2.3923914432525635,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "psoriasis who developed psoriatic",
            "probability": 0.0001318305897574402,
            "start_logit": 2.174800157546997,
            "end_logit": -0.7071371674537659,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "psoriasis, vitiligo, and lichen planus.",
            "probability": 0.00010745225782751253,
            "start_logit": 4.43646240234375,
            "end_logit": -3.1732704639434814,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "ps",
            "probability": 9.500528547658168e-05,
            "start_logit": 4.43646240234375,
            "end_logit": -3.296384572982788,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "vitiligo, and lichen planus.",
            "probability": 8.989534129596156e-05,
            "start_logit": 4.25806188583374,
            "end_logit": -3.1732704639434814,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "lichen planus.",
            "probability": 7.624554309000309e-05,
            "start_logit": 4.093374729156494,
            "end_logit": -3.1732704639434814,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "sis",
            "probability": 4.75984964365091e-05,
            "start_logit": -3.944344997406006,
            "end_logit": 4.393291473388672,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "sis, vitiligo, and lichen planus",
            "probability": 3.97620114839877e-05,
            "start_logit": -3.944344997406006,
            "end_logit": 4.213402271270752,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        },
        {
            "text": "sis, vitiligo",
            "probability": 3.798715732736959e-05,
            "start_logit": -3.944344997406006,
            "end_logit": 4.167738437652588,
            "question_text": "Which are the causes of the Koebner phenomenon?"
        }
    ],
    "58c6a6c502b8c60953000027": [
        {
            "text": "acoustic trauma",
            "probability": 0.46335465641070794,
            "start_logit": 2.7180392742156982,
            "end_logit": 1.7544313669204712,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acoustic trauma or noise-induced hearing loss",
            "probability": 0.21397658557881394,
            "start_logit": 2.7180392742156982,
            "end_logit": 0.9818052053451538,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "noise-induced hearing loss",
            "probability": 0.1033774917668567,
            "start_logit": 1.9905599355697632,
            "end_logit": 0.9818052053451538,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "hearing loss",
            "probability": 0.04472594388911753,
            "start_logit": 1.152726411819458,
            "end_logit": 0.9818052053451538,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acoustic trauma or noise",
            "probability": 0.043983834699786735,
            "start_logit": 2.7180392742156982,
            "end_logit": -0.6002392172813416,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acoustic trauma or noise-induced hearing loss may cause the later development of M\u00e9ni\u00e8re's Disease.",
            "probability": 0.023942547058954416,
            "start_logit": 2.7180392742156982,
            "end_logit": -1.208404302597046,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "noise",
            "probability": 0.02124970121030937,
            "start_logit": 1.9905599355697632,
            "end_logit": -0.6002392172813416,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acoustic trauma or noise-induced hearing",
            "probability": 0.0155066457296412,
            "start_logit": 2.7180392742156982,
            "end_logit": -1.6427927017211914,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acoustic",
            "probability": 0.01514298965038303,
            "start_logit": 2.7180392742156982,
            "end_logit": -1.6665236949920654,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "noise-induced hearing loss may cause the later development of M\u00e9ni\u00e8re's Disease.",
            "probability": 0.011567249074329109,
            "start_logit": 1.9905599355697632,
            "end_logit": -1.208404302597046,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "trauma",
            "probability": 0.010132684309766691,
            "start_logit": -1.104687213897705,
            "end_logit": 1.7544313669204712,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "noise-induced hearing",
            "probability": 0.007491652121241555,
            "start_logit": 1.9905599355697632,
            "end_logit": -1.6427927017211914,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acute acoustic trauma",
            "probability": 0.005593120086073782,
            "start_logit": -1.6989161968231201,
            "end_logit": 1.7544313669204712,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "hearing loss may cause the later development of M\u00e9ni\u00e8re's Disease.",
            "probability": 0.005004533619529712,
            "start_logit": 1.152726411819458,
            "end_logit": -1.208404302597046,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "trauma or noise-induced hearing loss",
            "probability": 0.0046792606081638,
            "start_logit": -1.104687213897705,
            "end_logit": 0.9818052053451538,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "hearing",
            "probability": 0.0032412395259802914,
            "start_logit": 1.152726411819458,
            "end_logit": -1.6427927017211914,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acute acoustic trauma or noise-induced hearing loss",
            "probability": 0.002582895676545299,
            "start_logit": -1.6989161968231201,
            "end_logit": 0.9818052053451538,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acoustic trauma or noise-induced",
            "probability": 0.0021467640333363283,
            "start_logit": 2.7180392742156982,
            "end_logit": -3.6200997829437256,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "acoustic trauma or noise-induced hearing loss may cause the later development of M\u00e9ni\u00e8re's Disease",
            "probability": 0.0012630490365050998,
            "start_logit": 2.7180392742156982,
            "end_logit": -4.1505327224731445,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        },
        {
            "text": "noise-induced",
            "probability": 0.001037155913958016,
            "start_logit": 1.9905599355697632,
            "end_logit": -3.6200997829437256,
            "question_text": "Which are the typical symptoms of M\u00e9ni\u00e8re's disease?"
        }
    ],
    "58ce5c7c1f5fb2b734000001": [
        {
            "text": "hydroxamate molecules and siderophores",
            "probability": 0.4582837195301506,
            "start_logit": 2.3987550735473633,
            "end_logit": 1.3870046138763428,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxamate molecules",
            "probability": 0.25078784275470895,
            "start_logit": 2.3987550735473633,
            "end_logit": 0.7841234803199768,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "siderophores",
            "probability": 0.23256881953299371,
            "start_logit": 1.7204527854919434,
            "end_logit": 1.3870046138763428,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxamate",
            "probability": 0.026847582211491885,
            "start_logit": 2.3987550735473633,
            "end_logit": -1.450308084487915,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxamate molecules and siderophores have been successfully used as metalloenzyme inhibitors",
            "probability": 0.005228154305681338,
            "start_logit": 2.3987550735473633,
            "end_logit": -3.086425542831421,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "metals, hydroxamate molecules and siderophores",
            "probability": 0.005049244901244709,
            "start_logit": -2.109494686126709,
            "end_logit": 1.3870046138763428,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "h",
            "probability": 0.003991735809685988,
            "start_logit": 2.3987550735473633,
            "end_logit": -3.356257677078247,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "metals, hydroxamate molecules",
            "probability": 0.0027631119814197636,
            "start_logit": -2.109494686126709,
            "end_logit": 0.7841234803199768,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "siderophores have been successfully used as metalloenzyme inhibitors",
            "probability": 0.002653172310932709,
            "start_logit": 1.7204527854919434,
            "end_logit": -3.086425542831421,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxamate molecules and side",
            "probability": 0.0016177530594545042,
            "start_logit": 2.3987550735473633,
            "end_logit": -4.259445667266846,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "molecules and siderophores",
            "probability": 0.001504743716779398,
            "start_logit": -3.32011079788208,
            "end_logit": 1.3870046138763428,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxamate molecules and siderophore",
            "probability": 0.0014722962692168102,
            "start_logit": 2.3987550735473633,
            "end_logit": -4.353660583496094,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "Based on their ability to chelate metals, hydroxamate molecules and siderophores",
            "probability": 0.0012943869467469799,
            "start_logit": -3.470696210861206,
            "end_logit": 1.3870046138763428,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxamate molecules and siderophores have been successfully used",
            "probability": 0.0012446662161656882,
            "start_logit": 2.3987550735473633,
            "end_logit": -4.521616458892822,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxamate molecules and siderophores have been",
            "probability": 0.0008305311579103816,
            "start_logit": 2.3987550735473633,
            "end_logit": -4.926173686981201,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "molecules",
            "probability": 0.0008234449851648735,
            "start_logit": -3.32011079788208,
            "end_logit": 0.7841234803199768,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "side",
            "probability": 0.0008209737839235421,
            "start_logit": 1.7204527854919434,
            "end_logit": -4.259445667266846,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "hydroxamate molecules and siderophores have been successfully used as metalloenzyme inhibitors.",
            "probability": 0.0007623319567516801,
            "start_logit": 2.3987550735473633,
            "end_logit": -5.011857032775879,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "siderophore",
            "probability": 0.0007471576901872835,
            "start_logit": 1.7204527854919434,
            "end_logit": -4.353660583496094,
            "question_text": "List metalloenzyme inhibitors."
        },
        {
            "text": "Based on their ability to chelate metals, hydroxamate molecules",
            "probability": 0.0007083308793891658,
            "start_logit": -3.470696210861206,
            "end_logit": 0.7841234803199768,
            "question_text": "List metalloenzyme inhibitors."
        }
    ],
    "58de71fa8acda3452900002c": [
        {
            "text": "INO80",
            "probability": 0.5746712641831031,
            "start_logit": 6.917579174041748,
            "end_logit": 6.210232734680176,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 complex",
            "probability": 0.3092097986563731,
            "start_logit": 6.917579174041748,
            "end_logit": 5.590454578399658,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "the INO80",
            "probability": 0.056998952839200145,
            "start_logit": 4.606813907623291,
            "end_logit": 6.210232734680176,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "the INO80 complex",
            "probability": 0.030669072615083087,
            "start_logit": 4.606813907623291,
            "end_logit": 5.590454578399658,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 complex,",
            "probability": 0.01600193066440285,
            "start_logit": 6.917579174041748,
            "end_logit": 2.6291439533233643,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO",
            "probability": 0.0034490698764272684,
            "start_logit": 6.917579174041748,
            "end_logit": 1.0945391654968262,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 complex, which removes H2A.Z(Htz1",
            "probability": 0.0019144281501088534,
            "start_logit": 6.917579174041748,
            "end_logit": 0.505853533744812,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "the INO80 complex,",
            "probability": 0.0015871566026065215,
            "start_logit": 4.606813907623291,
            "end_logit": 2.6291439533233643,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "Htz1) is not required for CENP-A(Cse4) mislocalization. Instead, the INO80",
            "probability": 0.0014914329510448277,
            "start_logit": 0.9635183811187744,
            "end_logit": 6.210232734680176,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 complex, which removes H2A.Z(Htz",
            "probability": 0.0014539934913996007,
            "start_logit": 6.917579174041748,
            "end_logit": 0.2307484745979309,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 complex, which removes H2A.Z(Htz1) from nucleosomes,",
            "probability": 0.0012708822933267213,
            "start_logit": 6.917579174041748,
            "end_logit": 0.09614595025777817,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "the INO",
            "probability": 0.0003420970970334524,
            "start_logit": 4.606813907623291,
            "end_logit": 1.0945391654968262,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "IN",
            "probability": 0.00019210372422229273,
            "start_logit": 6.917579174041748,
            "end_logit": -1.7932852506637573,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "the INO80 complex, which removes H2A.Z(Htz1",
            "probability": 0.00018988316737431914,
            "start_logit": 4.606813907623291,
            "end_logit": 0.505853533744812,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "the INO80 complex, which removes H2A.Z(Htz",
            "probability": 0.00014421480872651331,
            "start_logit": 4.606813907623291,
            "end_logit": 0.2307484745979309,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "the INO80 complex, which removes H2A.Z(Htz1) from nucleosomes,",
            "probability": 0.00012605286607548843,
            "start_logit": 4.606813907623291,
            "end_logit": 0.09614595025777817,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "80",
            "probability": 0.0001159772352012892,
            "start_logit": -1.5905803442001343,
            "end_logit": 6.210232734680176,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "80 complex",
            "probability": 6.240315077575769e-05,
            "start_logit": -1.5905803442001343,
            "end_logit": 5.590454578399658,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "O80",
            "probability": 5.655047013447695e-05,
            "start_logit": -2.308840751647949,
            "end_logit": 6.210232734680176,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        },
        {
            "text": "INO80 complex, which removes H2A.Z(Htz1) from nucleosomes",
            "probability": 5.273515738027882e-05,
            "start_logit": 6.917579174041748,
            "end_logit": -3.08603835105896,
            "question_text": "Which proteins remove H2A.Z in the yeast Saccharomyces cerevisiae?"
        }
    ],
    "58ca6d3902b8c6095300002c": [
        {
            "text": "congenital malformation or obstruction of intestinal lymphatic drainage",
            "probability": 0.3600671018025901,
            "start_logit": -2.3270273208618164,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "congenital malformation or obstruction of intestinal lymphatic drainage;",
            "probability": 0.13822337176142585,
            "start_logit": -2.3270273208618164,
            "end_logit": -4.024628162384033,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "congenital malformation",
            "probability": 0.11666702433469713,
            "start_logit": -2.3270273208618164,
            "end_logit": -4.1941752433776855,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "congenital malformation or obstruction",
            "probability": 0.07471575625209377,
            "start_logit": -2.3270273208618164,
            "end_logit": -4.639808177947998,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "congenital malformation or obstruction of intestinal lymphatic drainage; it is responsible for protein losing enteropathy",
            "probability": 0.06387011871306153,
            "start_logit": -2.3270273208618164,
            "end_logit": -4.796647548675537,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Primary intestinal lymphangiectasia",
            "probability": 0.04362542431952889,
            "start_logit": -4.107212543487549,
            "end_logit": -3.3976738452911377,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "(PIL) is rare disorder characterized by congenital malformation or obstruction of intestinal lymphatic drainage",
            "probability": 0.025856965513890166,
            "start_logit": -4.960737705230713,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "characterized by congenital malformation or obstruction of intestinal lymphatic drainage",
            "probability": 0.019715800590816693,
            "start_logit": -5.231897354125977,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Primary intestinal lymphangiectasia (PIL) is rare disorder characterized by congenital malformation",
            "probability": 0.019670867004057353,
            "start_logit": -4.107212543487549,
            "end_logit": -4.1941752433776855,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "malformation or obstruction of intestinal lymphatic drainage",
            "probability": 0.01887130344639235,
            "start_logit": -5.275675296783447,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "rare disorder characterized by congenital malformation or obstruction of intestinal lymphatic drainage",
            "probability": 0.015900659994936815,
            "start_logit": -5.446957111358643,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "intestinal lymphatic drainage",
            "probability": 0.014540785078091511,
            "start_logit": -5.536360263824463,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "Primary intestinal lymphangiectasia (PIL)",
            "probability": 0.013496040497388548,
            "start_logit": -4.107212543487549,
            "end_logit": -4.57091760635376,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "drainage",
            "probability": 0.012289978225772168,
            "start_logit": -5.704533576965332,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "by congenital malformation or obstruction of intestinal lymphatic drainage",
            "probability": 0.011237431970950182,
            "start_logit": -5.7940673828125,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "hypogammaglobulinemia",
            "probability": 0.011108900674709913,
            "start_logit": -4.404871463775635,
            "end_logit": -4.4679083824157715,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": ") is rare disorder characterized by congenital malformation or obstruction of intestinal lymphatic drainage",
            "probability": 0.010595694521101054,
            "start_logit": -5.852869987487793,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "obstruction of intestinal lymphatic drainage",
            "probability": 0.010357443810283206,
            "start_logit": -5.875612258911133,
            "end_logit": -3.067208766937256,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "(PIL) is rare disorder characterized by congenital malformation or obstruction of intestinal lymphatic drainage;",
            "probability": 0.00992603028423381,
            "start_logit": -4.960737705230713,
            "end_logit": -4.024628162384033,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        },
        {
            "text": "intestinal lymphangiectasia",
            "probability": 0.009263301203978795,
            "start_logit": -5.656792163848877,
            "end_logit": -3.3976738452911377,
            "question_text": "Which diseases are associated with Primary intestinal lymphangiectasia (PIL)?"
        }
    ],
    "58c99acf02b8c60953000028": [
        {
            "text": "surgical repair",
            "probability": 0.23355235836208468,
            "start_logit": 1.5331355333328247,
            "end_logit": 0.5276228189468384,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical",
            "probability": 0.18184002285773318,
            "start_logit": 1.5331355333328247,
            "end_logit": 0.27734383940696716,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair earlier or later than 3\u00a0months after injury may result in similar outcomes and patient satisfaction.",
            "probability": 0.162463747876506,
            "start_logit": 1.5331355333328247,
            "end_logit": 0.1646714210510254,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair earlier or later than 3\u00a0months",
            "probability": 0.07707993809689415,
            "start_logit": 1.5331355333328247,
            "end_logit": -0.5809404253959656,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair earlier or later than 3\u00a0months after injury",
            "probability": 0.07382547200384278,
            "start_logit": 1.5331355333328247,
            "end_logit": -0.6240796446800232,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair earlier or later than 3\u00a0months after injury may result in similar outcomes",
            "probability": 0.06994193625318307,
            "start_logit": 1.5331355333328247,
            "end_logit": -0.6781180500984192,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "repair",
            "probability": 0.034248790259273944,
            "start_logit": -0.386619508266449,
            "end_logit": 0.5276228189468384,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "repair earlier or later than 3\u00a0months after injury may result in similar outcomes and patient satisfaction.",
            "probability": 0.023824151743874308,
            "start_logit": -0.386619508266449,
            "end_logit": 0.1646714210510254,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair earlier",
            "probability": 0.023806131280463005,
            "start_logit": 1.5331355333328247,
            "end_logit": -1.7558403015136719,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "earlier or later than 3\u00a0months after injury may result in similar outcomes and patient satisfaction.",
            "probability": 0.01402385121361325,
            "start_logit": -0.9165598154067993,
            "end_logit": 0.1646714210510254,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair earlier or later than 3\u00a0months after injury may result in similar outcomes and patient",
            "probability": 0.013275445320960639,
            "start_logit": 1.5331355333328247,
            "end_logit": -2.339867353439331,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "patient satisfaction",
            "probability": 0.012199399296419798,
            "start_logit": -1.055932641029358,
            "end_logit": 0.1646714210510254,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "injury may result in similar outcomes and patient satisfaction",
            "probability": 0.011982364445593911,
            "start_logit": -1.0738834142684937,
            "end_logit": 0.1646714210510254,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "repair earlier or later than 3\u00a0months",
            "probability": 0.011303224046171364,
            "start_logit": -0.386619508266449,
            "end_logit": -0.5809404253959656,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "repair earlier or later than 3\u00a0months after injury",
            "probability": 0.010825979768235053,
            "start_logit": -0.386619508266449,
            "end_logit": -0.6240796446800232,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "repair earlier or later than 3\u00a0months after injury may result in similar outcomes",
            "probability": 0.010256486904529813,
            "start_logit": -0.386619508266449,
            "end_logit": -0.6781180500984192,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "investigate whether surgical repair",
            "probability": 0.010233833902060141,
            "start_logit": -1.5945714712142944,
            "end_logit": 0.5276228189468384,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "3\u00a0months after injury may result in similar outcomes and patient satisfaction.",
            "probability": 0.00959309547788433,
            "start_logit": -1.2962757349014282,
            "end_logit": 0.1646714210510254,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "investigate whether surgical",
            "probability": 0.007967894667061371,
            "start_logit": -1.5945714712142944,
            "end_logit": 0.27734383940696716,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        },
        {
            "text": "surgical repair earlier or later",
            "probability": 0.007755876223615211,
            "start_logit": 1.5331355333328247,
            "end_logit": -2.8773326873779297,
            "question_text": "Please list 2 treatments for a torn rotator cuff"
        }
    ],
    "58948cb47d9090f353000008": [
        {
            "text": "Mcidas",
            "probability": 0.38775333055915895,
            "start_logit": 5.193896293640137,
            "end_logit": 4.565976619720459,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas and GemC1",
            "probability": 0.28058357179550975,
            "start_logit": 5.193896293640137,
            "end_logit": 4.242478847503662,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1",
            "probability": 0.20500161938794972,
            "start_logit": 4.880042552947998,
            "end_logit": 4.242478847503662,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas, which is mutated in human mucociliary clearance disorder, and GemC1",
            "probability": 0.07797484133211446,
            "start_logit": 4.636742115020752,
            "end_logit": 3.5191476345062256,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas function. Our results suggest that Mcidas",
            "probability": 0.01025806032133748,
            "start_logit": 2.124922275543213,
            "end_logit": 4.002645015716553,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas and GemC",
            "probability": 0.009250276710967105,
            "start_logit": 5.193896293640137,
            "end_logit": 0.830260694026947,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas function. Our results suggest that Mcidas and GemC1",
            "probability": 0.007007192539261631,
            "start_logit": 2.124922275543213,
            "end_logit": 3.62151837348938,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC",
            "probability": 0.006758491573116545,
            "start_logit": 4.880042552947998,
            "end_logit": 0.830260694026947,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1 (Gmnc or Lynkeas)",
            "probability": 0.003831399158523777,
            "start_logit": 4.119378566741943,
            "end_logit": 1.0233550071716309,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas,",
            "probability": 0.0030140890166357715,
            "start_logit": 4.636742115020752,
            "end_logit": 0.2660590410232544,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1 and Mcidas function. Our results suggest that Mcidas",
            "probability": 0.0028808178204030974,
            "start_logit": 0.8549327254295349,
            "end_logit": 4.002645015716553,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1 and Mcidas function. Our results suggest that Mcidas and GemC1",
            "probability": 0.0019678618087389604,
            "start_logit": 0.8549327254295349,
            "end_logit": 3.62151837348938,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1 and Mcidas",
            "probability": 0.0014241749693049736,
            "start_logit": 1.9104650020599365,
            "end_logit": 2.242631196975708,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1 (Gmnc or Lynkeas),",
            "probability": 0.0006516031356310393,
            "start_logit": 4.119378566741943,
            "end_logit": -0.7481946349143982,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "GemC1 (Gmnc or Lynkeas",
            "probability": 0.0005023919959346088,
            "start_logit": 4.119378566741943,
            "end_logit": -1.0082496404647827,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas, which is mutated in human mucociliary clearance disorder, and GemC",
            "probability": 0.0004220087341823119,
            "start_logit": 4.636742115020752,
            "end_logit": -1.699967861175537,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas operate in hierarchical order, upstream of Foxj1",
            "probability": 0.0002055409235301035,
            "start_logit": 2.3834774494171143,
            "end_logit": -0.16608405113220215,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Notch signaling inhibits GemC1 and Mcidas function. Our results suggest that Mcidas",
            "probability": 0.00019214213826013716,
            "start_logit": -1.852661371231079,
            "end_logit": 4.002645015716553,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Mcidas operate in hierarchical order, upstream of Foxj1 and c-Myb",
            "probability": 0.0001893354418417349,
            "start_logit": 2.3834774494171143,
            "end_logit": -0.2482089400291443,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        },
        {
            "text": "Notch signaling inhibits GemC1 and Mcidas function. Our results suggest that Mcidas and GemC1",
            "probability": 0.00013125063759799227,
            "start_logit": -1.852661371231079,
            "end_logit": 3.62151837348938,
            "question_text": "Which are the key players on radial glial specification to ependymal cells?"
        }
    ],
    "58cd59cb02b8c60953000039": [
        {
            "text": "attention deficit hyperactivity disorder",
            "probability": 0.8307910301173628,
            "start_logit": 5.165134906768799,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention deficit hyperactivity disorder (ADHD)",
            "probability": 0.16273468342391958,
            "start_logit": 5.165134906768799,
            "end_logit": 3.5612783432006836,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "hyperactivity disorder",
            "probability": 0.0013576461632189576,
            "start_logit": -1.2514909505844116,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention deficit hyperactivity disorder (ADHD),",
            "probability": 0.0013310125564235515,
            "start_logit": 5.165134906768799,
            "end_logit": -1.2449028491973877,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention deficit hyperactivity",
            "probability": 0.0013275052046683824,
            "start_logit": 5.165134906768799,
            "end_logit": -1.2475414276123047,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention",
            "probability": 0.0005013675481164165,
            "start_logit": 5.165134906768799,
            "end_logit": -2.2212586402893066,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "disorder",
            "probability": 0.0003925819730485977,
            "start_logit": -2.492253303527832,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "ivity disorder",
            "probability": 0.0002994645460522887,
            "start_logit": -2.763002634048462,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "neuropsychological diseases, including attention deficit hyperactivity disorder",
            "probability": 0.00029072547560724064,
            "start_logit": -2.792619228363037,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "hyperactivity disorder (ADHD)",
            "probability": 0.00026593464609496963,
            "start_logit": -1.2514909505844116,
            "end_logit": 3.5612783432006836,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention deficit h",
            "probability": 0.000118506844130363,
            "start_logit": 5.165134906768799,
            "end_logit": -3.6636273860931396,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "attention deficit hyperactivity disorder (ADHD), a common mental disorder",
            "probability": 0.00010193416137606957,
            "start_logit": 5.165134906768799,
            "end_logit": -3.8142709732055664,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "Dysfunction of dopaminergic system is implicated in many neuropsychological diseases, including attention deficit hyperactivity disorder",
            "probability": 9.360045697484418e-05,
            "start_logit": -3.9259634017944336,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "disorder (ADHD)",
            "probability": 7.689864332427403e-05,
            "start_logit": -2.492253303527832,
            "end_logit": 3.5612783432006836,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "deficit hyperactivity disorder",
            "probability": 6.50150425136174e-05,
            "start_logit": -4.290380001068115,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "ivity disorder (ADHD)",
            "probability": 5.8658876097425644e-05,
            "start_logit": -2.763002634048462,
            "end_logit": 3.5612783432006836,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "neuropsychological diseases, including attention deficit hyperactivity disorder (ADHD)",
            "probability": 5.6947073958573304e-05,
            "start_logit": -2.792619228363037,
            "end_logit": 3.5612783432006836,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "activity disorder",
            "probability": 5.250659999627627e-05,
            "start_logit": -4.504059791564941,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "diseases, including attention deficit hyperactivity disorder",
            "probability": 4.371439624657367e-05,
            "start_logit": -4.687321186065674,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        },
        {
            "text": "yperactivity disorder",
            "probability": 4.026625086907991e-05,
            "start_logit": -4.769484996795654,
            "end_logit": 5.191535472869873,
            "question_text": "List diseases associated with the  Dopamine Receptor D4 (DRD4)."
        }
    ],
    "58b548d722d3005309000005": [
        {
            "text": "Corynebacterium diphtheriae",
            "probability": 0.9313846426776164,
            "start_logit": 3.853947401046753,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Co",
            "probability": 0.022800980815631276,
            "start_logit": 3.853947401046753,
            "end_logit": -1.7292251586914062,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium dip",
            "probability": 0.017963044211382468,
            "start_logit": 3.853947401046753,
            "end_logit": -1.967712163925171,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium",
            "probability": 0.015193479543903743,
            "start_logit": 3.853947401046753,
            "end_logit": -2.135162353515625,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "diphtheriae",
            "probability": 0.00782500648059649,
            "start_logit": -0.9254003763198853,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacteri",
            "probability": 0.001368882946355356,
            "start_logit": 3.853947401046753,
            "end_logit": -4.542033672332764,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "toxin (tox) and its regulatory element (dtxR) from 72 Corynebacterium diphtheriae",
            "probability": 0.0009438983132026479,
            "start_logit": -3.040461778640747,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Coryn",
            "probability": 0.0007344308757652611,
            "start_logit": 3.853947401046753,
            "end_logit": -5.1646881103515625,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebact",
            "probability": 0.0003137330195462639,
            "start_logit": 3.853947401046753,
            "end_logit": -6.015241622924805,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "iae",
            "probability": 0.00030561218239585165,
            "start_logit": -4.168163299560547,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Corynebacterium diphther",
            "probability": 0.00024342322145639726,
            "start_logit": 3.853947401046753,
            "end_logit": -6.268982410430908,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "Coryneb",
            "probability": 0.0002232644014321721,
            "start_logit": 3.853947401046753,
            "end_logit": -6.355427265167236,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "dip",
            "probability": 0.0001509160994551227,
            "start_logit": -0.9254003763198853,
            "end_logit": -1.967712163925171,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "(tox) and its regulatory element (dtxR) from 72 Corynebacterium diphtheriae",
            "probability": 0.00012455848907806785,
            "start_logit": -5.065704822540283,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "um diphtheriae",
            "probability": 0.0001044570263745172,
            "start_logit": -5.24170446395874,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "ia toxin (tox) and its regulatory element (dtxR) from 72 Corynebacterium diphtheriae",
            "probability": 8.016257391675349e-05,
            "start_logit": -5.506423473358154,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "erium diphtheriae",
            "probability": 6.710883442153768e-05,
            "start_logit": -5.684164524078369,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "ebacterium diphtheriae",
            "probability": 6.663804575590852e-05,
            "start_logit": -5.69120454788208,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "rynebacterium diphtheriae",
            "probability": 5.678463684410864e-05,
            "start_logit": -5.851214408874512,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        },
        {
            "text": "heriae",
            "probability": 4.897560486995871e-05,
            "start_logit": -5.999157905578613,
            "end_logit": 1.980643630027771,
            "question_text": "Which bacteria cause diphtheria?"
        }
    ],
    "589a245a78275d0c4a000026": [
        {
            "text": "Migraine Prevention (CHAMP) study is to determine the most effective preventive agent",
            "probability": 0.39899157776410554,
            "start_logit": -1.8118972778320312,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine",
            "probability": 0.14723749604037606,
            "start_logit": -1.8118972778320312,
            "end_logit": -3.101447820663452,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine Prevention",
            "probability": 0.09126482129619219,
            "start_logit": -1.8118972778320312,
            "end_logit": -3.5797293186187744,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "the most effective preventive agent",
            "probability": 0.0354830849782112,
            "start_logit": -4.231781482696533,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "determine the most effective preventive agent",
            "probability": 0.030823593605996454,
            "start_logit": -4.372557163238525,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Prevention (CHAMP) study is to determine the most effective preventive agent",
            "probability": 0.030709309861458405,
            "start_logit": -4.376271724700928,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "agent",
            "probability": 0.030287142385249446,
            "start_logit": -4.3901143074035645,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "most effective preventive agent",
            "probability": 0.028943000077935568,
            "start_logit": -4.435509204864502,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Childhood and Adolescent Migraine Prevention (CHAMP) study is to determine the most effective preventive agent",
            "probability": 0.02517111507494014,
            "start_logit": -4.575140476226807,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Mi",
            "probability": 0.025060581195555705,
            "start_logit": -1.8118972778320312,
            "end_logit": -4.872198581695557,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "to determine the most effective preventive agent",
            "probability": 0.0233860175353086,
            "start_logit": -4.6486992835998535,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine Prevention (CHAMP) study is to determine the most effective preventive agent to use in children and adolescents",
            "probability": 0.022894973303517568,
            "start_logit": -1.8118972778320312,
            "end_logit": -4.9625773429870605,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine Prevention (CHAMP) study is to determine the most effective preventive agent to use in children and adolescents.",
            "probability": 0.0193460357664572,
            "start_logit": -1.8118972778320312,
            "end_logit": -5.131007194519043,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "preventive agent",
            "probability": 0.01871331029021749,
            "start_logit": -4.871602535247803,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "The aim of the Childhood and Adolescent Migraine Prevention (CHAMP) study is to determine the most effective preventive agent",
            "probability": 0.016107385135198573,
            "start_logit": -5.021559715270996,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine Prevention (CHAMP)",
            "probability": 0.014553041498402445,
            "start_logit": -1.8118972778320312,
            "end_logit": -5.415694713592529,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine Prevention (CHAMP) study",
            "probability": 0.01133795254014931,
            "start_logit": -1.8118972778320312,
            "end_logit": -5.66533899307251,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine Prevention (CHAMP) study is to determine the most effective",
            "probability": 0.01082137087091667,
            "start_logit": -1.8118972778320312,
            "end_logit": -5.711971759796143,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "Migraine Prevention (CHAMP) study is to determine",
            "probability": 0.009459112765855164,
            "start_logit": -1.8118972778320312,
            "end_logit": -5.846516132354736,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        },
        {
            "text": "study is to determine the most effective preventive agent",
            "probability": 0.009409078013956488,
            "start_logit": -5.559162616729736,
            "end_logit": -2.1045544147491455,
            "question_text": "List drug that were evaluated in the CHAMP trial for migraine."
        }
    ],
    "589a246178275d0c4a00002b": [
        {
            "text": "apixaban",
            "probability": 0.9083181567289972,
            "start_logit": 3.376131534576416,
            "end_logit": 3.2370927333831787,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "rivaroxaban",
            "probability": 0.08426721225659504,
            "start_logit": 2.2574028968811035,
            "end_logit": 1.9782195091247559,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban has also been finished this year and will be presented soon. A phase III study of using edoxaban",
            "probability": 0.0056322442211826345,
            "start_logit": 3.376131534576416,
            "end_logit": -1.845993995666504,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "ban",
            "probability": 0.0004838738998372142,
            "start_logit": -4.161394119262695,
            "end_logit": 3.2370927333831787,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "Rivaroxaban",
            "probability": 0.0003768046493442909,
            "start_logit": -0.6478360891342163,
            "end_logit": -0.5265627503395081,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "a phase III clinical study of apixaban",
            "probability": 0.00019536960472007532,
            "start_logit": -5.954653263092041,
            "end_logit": 4.123420715332031,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "a",
            "probability": 0.000113761921952348,
            "start_logit": 3.376131534576416,
            "end_logit": -5.748149394989014,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "pixaban",
            "probability": 9.3794646658268e-05,
            "start_logit": -5.80211067199707,
            "end_logit": 3.2370927333831787,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "phase III clinical study of apixaban",
            "probability": 8.481019407677434e-05,
            "start_logit": -6.789130687713623,
            "end_logit": 4.123420715332031,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban has also been finished this year and will be presented soon. A phase III study of using edoxaban,",
            "probability": 8.063743852892695e-05,
            "start_logit": 3.376131534576416,
            "end_logit": -6.092294216156006,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": ", a phase III clinical study of apixaban",
            "probability": 7.729460741830322e-05,
            "start_logit": -6.881922245025635,
            "end_logit": 4.123420715332031,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "study of apixaban",
            "probability": 6.598632548197334e-05,
            "start_logit": -6.153770923614502,
            "end_logit": 3.2370927333831787,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "apixaban has also been finished this year and will be presented soon.",
            "probability": 6.335905962204064e-05,
            "start_logit": 3.376131534576416,
            "end_logit": -6.333439350128174,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "rivaroxaban has made a similar outcome and safety end points compared to the initial ROCKET AF study. ARISTOTLE study,",
            "probability": 5.919776982570659e-05,
            "start_logit": 2.2574028968811035,
            "end_logit": -5.282644748687744,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "edoxaban",
            "probability": 2.7684225620817783e-05,
            "start_logit": -1.939268946647644,
            "end_logit": -1.845993995666504,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "r",
            "probability": 2.748683715582519e-05,
            "start_logit": 2.2574028968811035,
            "end_logit": -6.049821376800537,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "warfarin",
            "probability": 1.2792427650960707e-05,
            "start_logit": -1.8629118204116821,
            "end_logit": -2.6943604946136475,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "rivaroxaban has made a similar outcome and safety end points compared to the initial ROCKET AF study. ARISTOTLE study",
            "probability": 1.0871508644615745e-05,
            "start_logit": 2.2574028968811035,
            "end_logit": -6.977383136749268,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "Darexaban",
            "probability": 5.661300710476918e-06,
            "start_logit": -3.335082530975342,
            "end_logit": -2.0373895168304443,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        },
        {
            "text": "ban has also been finished this year and will be presented soon. A phase III study of using edoxaban",
            "probability": 3.0003759761375825e-06,
            "start_logit": -4.161394119262695,
            "end_logit": -1.845993995666504,
            "question_text": "Which two drugs were compared in the ARISTOTLE Trial?"
        }
    ],
    "58cea0768acda34529000001": [
        {
            "text": "Tay-Sachs disease",
            "probability": 0.7013766716377241,
            "start_logit": 6.319594860076904,
            "end_logit": 6.03765869140625,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs",
            "probability": 0.2402518690024832,
            "start_logit": 6.319594860076904,
            "end_logit": 4.966301441192627,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD)",
            "probability": 0.056005654388581086,
            "start_logit": 6.319594860076904,
            "end_logit": 3.510066270828247,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD) is a recessively inherited neurodegenerative disorder",
            "probability": 0.0005258438072950299,
            "start_logit": 6.319594860076904,
            "end_logit": -1.1581374406814575,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease",
            "probability": 0.00047672607834524735,
            "start_logit": -0.9742634296417236,
            "end_logit": 6.03765869140625,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "disease",
            "probability": 0.0002987918424612834,
            "start_logit": -1.4414583444595337,
            "end_logit": 6.03765869140625,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Ta",
            "probability": 0.0002124436671607076,
            "start_logit": 6.319594860076904,
            "end_logit": -2.064464807510376,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs",
            "probability": 0.0001632993168381701,
            "start_logit": -0.9742634296417236,
            "end_logit": 4.966301441192627,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (",
            "probability": 0.0001232721387002681,
            "start_logit": 6.319594860076904,
            "end_logit": -2.6087472438812256,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD",
            "probability": 0.00010796022592672049,
            "start_logit": 6.319594860076904,
            "end_logit": -2.7413787841796875,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD) is",
            "probability": 9.049563894114708e-05,
            "start_logit": 6.319594860076904,
            "end_logit": -2.917840003967285,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "chs disease",
            "probability": 7.986545323984021e-05,
            "start_logit": -2.760862112045288,
            "end_logit": 6.03765869140625,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD) is a recessively inherited neurodegenerative",
            "probability": 7.724778088735848e-05,
            "start_logit": 6.319594860076904,
            "end_logit": -3.0761234760284424,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Sachs disease (TSD)",
            "probability": 3.8067071605738164e-05,
            "start_logit": -0.9742634296417236,
            "end_logit": 3.510066270828247,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD) is a recessively inherited neurodegenerative disorder caused by mutations in the HEXA",
            "probability": 3.341031974676227e-05,
            "start_logit": 6.319594860076904,
            "end_logit": -3.9142768383026123,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "(TSD)",
            "probability": 3.2363370532148646e-05,
            "start_logit": -1.1365858316421509,
            "end_logit": 3.510066270828247,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay",
            "probability": 2.7779267921490525e-05,
            "start_logit": 6.319594860076904,
            "end_logit": -4.098851680755615,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "chs",
            "probability": 2.7357374696820476e-05,
            "start_logit": -2.760862112045288,
            "end_logit": 4.966301441192627,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "Tay-Sachs disease (TSD) is a recessively inherited neurodegenerative disorder caused by mutations",
            "probability": 2.7022778517433818e-05,
            "start_logit": 6.319594860076904,
            "end_logit": -4.126461505889893,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        },
        {
            "text": "disease (TSD)",
            "probability": 2.3858838395551152e-05,
            "start_logit": -1.4414583444595337,
            "end_logit": 3.510066270828247,
            "question_text": "Which disease(s) are caused by HEX A deficiency?"
        }
    ],
    "58c1b2f702b8c6095300001e": [
        {
            "text": "antidepressant",
            "probability": 0.46046177915162884,
            "start_logit": 5.631650447845459,
            "end_logit": 5.157223701477051,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "attention-deficit hyperactivity disorder",
            "probability": 0.11263313276991777,
            "start_logit": 4.7162251472473145,
            "end_logit": 4.664555072784424,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant, the indication for which it was developed, and as a tobacco use cessation",
            "probability": 0.0763027134751995,
            "start_logit": 5.631650447845459,
            "end_logit": 3.3597023487091064,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "attention-deficit hyperactivity disorder (ADHD) and obesity",
            "probability": 0.07084489077999333,
            "start_logit": 4.7162251472473145,
            "end_logit": 4.200911998748779,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant, the indication for which it was developed, and as a tobacco use cessation agent",
            "probability": 0.035071642020684,
            "start_logit": 5.631650447845459,
            "end_logit": 2.5823867321014404,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "psychostimulant drug abuse, attention-deficit hyperactivity disorder",
            "probability": 0.033015570557924964,
            "start_logit": 3.4890685081481934,
            "end_logit": 4.664555072784424,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "an antidepressant",
            "probability": 0.031133530809767426,
            "start_logit": 2.9377059936523438,
            "end_logit": 5.157223701477051,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "obesity",
            "probability": 0.029725520979970277,
            "start_logit": 3.847738265991211,
            "end_logit": 4.200911998748779,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepress",
            "probability": 0.028543085829001294,
            "start_logit": 5.631650447845459,
            "end_logit": 2.376408576965332,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "tobacco use cessation",
            "probability": 0.025409544600276588,
            "start_logit": 4.532066822052002,
            "end_logit": 3.3597023487091064,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "psychostimulant drug abuse, attention-deficit hyperactivity disorder (ADHD) and obesity",
            "probability": 0.020766398240856323,
            "start_logit": 3.4890685081481934,
            "end_logit": 4.200911998748779,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "as an antidepressant",
            "probability": 0.016603250584990313,
            "start_logit": 2.309019088745117,
            "end_logit": 5.157223701477051,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "attention-deficit hyperactivity disorder (ADHD)",
            "probability": 0.015280184016450222,
            "start_logit": 4.7162251472473145,
            "end_logit": 2.666975975036621,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "tobacco use cessation agent",
            "probability": 0.011679197390786825,
            "start_logit": 4.532066822052002,
            "end_logit": 2.5823867321014404,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "psychostimulant drug abuse",
            "probability": 0.0074556950537716426,
            "start_logit": 3.4890685081481934,
            "end_logit": 3.176553964614868,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "antidepressant, the indication for which it was developed,",
            "probability": 0.0063041361115408374,
            "start_logit": 5.631650447845459,
            "end_logit": 0.866199791431427,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "an antidepressant, the indication for which it was developed, and as a tobacco use cessation",
            "probability": 0.005159109807606224,
            "start_logit": 2.9377059936523438,
            "end_logit": 3.3597023487091064,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "tobacco use cessation agent. In clinical trials, bupropion is being tested as a candidate treatment for psychostimulant",
            "probability": 0.004873140589329084,
            "start_logit": 4.532066822052002,
            "end_logit": 1.7083160877227783,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "psychostimulant drug abuse, attention-deficit hyperactivity disorder (ADHD)",
            "probability": 0.004479001703377355,
            "start_logit": 3.4890685081481934,
            "end_logit": 2.666975975036621,
            "question_text": "List 3 indications for Bupropion"
        },
        {
            "text": "depressant",
            "probability": 0.00425847552692699,
            "start_logit": 0.9483318328857422,
            "end_logit": 5.157223701477051,
            "question_text": "List 3 indications for Bupropion"
        }
    ],
    "587d2b7efe8a08052f000003": [
        {
            "text": "130 transcription factor flexible models",
            "probability": 0.2866495119818566,
            "start_logit": 0.5119707584381104,
            "end_logit": -0.8626163601875305,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130",
            "probability": 0.1471590446827943,
            "start_logit": 0.5119707584381104,
            "end_logit": -1.529362678527832,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models trained on ChIP-seq data for vertebrates",
            "probability": 0.10996868474640606,
            "start_logit": 0.5119707584381104,
            "end_logit": -1.8206809759140015,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models trained on ChIP-seq data",
            "probability": 0.10399609608064798,
            "start_logit": 0.5119707584381104,
            "end_logit": -1.8765232563018799,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "59",
            "probability": 0.09445399587966648,
            "start_logit": -0.5105735063552856,
            "end_logit": -0.950219452381134,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models trained on ChIP-seq data for vertebrates,",
            "probability": 0.09410064492772348,
            "start_logit": 0.5119707584381104,
            "end_logit": -1.9765117168426514,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "130 transcription factor flexible models trained",
            "probability": 0.05217385305726256,
            "start_logit": 0.5119707584381104,
            "end_logit": -2.5662951469421387,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "59 profiles",
            "probability": 0.02862306470830428,
            "start_logit": -0.5105735063552856,
            "end_logit": -2.1441195011138916,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we introduced 130 transcription factor flexible models",
            "probability": 0.012033189985968674,
            "start_logit": -2.658620834350586,
            "end_logit": -0.8626163601875305,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "164 in plants) and updated 59",
            "probability": 0.009576135860070214,
            "start_logit": -2.799412250518799,
            "end_logit": -0.950219452381134,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "introduced 130 transcription factor flexible models",
            "probability": 0.009261881716606997,
            "start_logit": -2.920382261276245,
            "end_logit": -0.8626163601875305,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "updated 59",
            "probability": 0.007956455252921069,
            "start_logit": -2.9847028255462646,
            "end_logit": -0.950219452381134,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "59 profiles (58 in vertebrates and 1 in fungi).",
            "probability": 0.007149015014894284,
            "start_logit": -0.5105735063552856,
            "end_logit": -3.531357765197754,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we introduced 130",
            "probability": 0.006177553663282702,
            "start_logit": -2.658620834350586,
            "end_logit": -1.529362678527832,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "ChIP-seq data for vertebrates, which capture dinucleotide dependencies within TF binding sites",
            "probability": 0.006112674826092696,
            "start_logit": -2.6558597087860107,
            "end_logit": -1.5426816940307617,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "transcription factor flexible models",
            "probability": 0.005418341018442901,
            "start_logit": -3.4564998149871826,
            "end_logit": -0.8626163601875305,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "(DBDs) following a published hierarchical structural classification. In addition, we introduced 130 transcription factor flexible models",
            "probability": 0.005189565564014202,
            "start_logit": -3.4996395111083984,
            "end_logit": -0.8626163601875305,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "introduced 130",
            "probability": 0.004754829882519366,
            "start_logit": -2.920382261276245,
            "end_logit": -1.529362678527832,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "ChIP-seq data for vertebrates",
            "probability": 0.0046291125409928,
            "start_logit": -2.6558597087860107,
            "end_logit": -1.8206809759140015,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        },
        {
            "text": "we introduced 130 transcription factor flexible models trained on ChIP-seq data for vertebrates",
            "probability": 0.004616348609532452,
            "start_logit": -2.658620834350586,
            "end_logit": -1.8206809759140015,
            "question_text": "Which are the additions of the JASPAR 2016 open-access database of transcription factor binding profiles?"
        }
    ],
    "58add1d79ef3c34033000008": [
        {
            "text": "sequencing",
            "probability": 0.16076351445334888,
            "start_logit": -4.4849700927734375,
            "end_logit": -4.634865760803223,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "whole exome sequencing",
            "probability": 0.13354144438963622,
            "start_logit": -4.670492649078369,
            "end_logit": -4.634865760803223,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "se",
            "probability": 0.1071267777238568,
            "start_logit": -4.4849700927734375,
            "end_logit": -5.040787220001221,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "whole exome se",
            "probability": 0.08898701100617383,
            "start_logit": -4.670492649078369,
            "end_logit": -5.040787220001221,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "Sanger sequencing",
            "probability": 0.05917513224529249,
            "start_logit": -4.985542297363281,
            "end_logit": -5.133726596832275,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "quencing",
            "probability": 0.05519522739980087,
            "start_logit": -5.554028034210205,
            "end_logit": -4.634865760803223,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "whole",
            "probability": 0.04844793227969534,
            "start_logit": -4.670492649078369,
            "end_logit": -5.648787975311279,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "Sanger sequencing, Droplet Digital polymerase-chain reaction",
            "probability": 0.04402442411134198,
            "start_logit": -4.985542297363281,
            "end_logit": -5.429483413696289,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "performed whole exome sequencing",
            "probability": 0.03986757744183897,
            "start_logit": -5.879341125488281,
            "end_logit": -4.634865760803223,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "whole exome",
            "probability": 0.037256637255440546,
            "start_logit": -4.670492649078369,
            "end_logit": -5.911447525024414,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "HGG.\u00a0We performed whole exome sequencing",
            "probability": 0.03171017772275197,
            "start_logit": -6.108266830444336,
            "end_logit": -4.634865760803223,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "Sanger sequencing, Droplet Digital polymerase-chain reaction, immunohistochemistry, and fluorescent in-situ hybridization",
            "probability": 0.027572805859399134,
            "start_logit": -4.985542297363281,
            "end_logit": -5.897397994995117,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "Sanger sequencing, Droplet Digital polymerase-chain reaction, immunohistochemistry",
            "probability": 0.027242569196912664,
            "start_logit": -4.985542297363281,
            "end_logit": -5.909447193145752,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "performed whole exome se",
            "probability": 0.026566258653420247,
            "start_logit": -5.879341125488281,
            "end_logit": -5.040787220001221,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "Sang",
            "probability": 0.025893696064862262,
            "start_logit": -4.985542297363281,
            "end_logit": -5.960228443145752,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "Sanger sequencing, Droplet Digital polymerase-chain reaction, immunohistochemistry, and fluorescent in-situ hybridization.",
            "probability": 0.02036985352655437,
            "start_logit": -4.985542297363281,
            "end_logit": -6.200171947479248,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "sequencing, Droplet Digital polymerase-chain reaction",
            "probability": 0.018213739265357142,
            "start_logit": -5.868110656738281,
            "end_logit": -5.429483413696289,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "Validation was performed using Sanger sequencing",
            "probability": 0.016428258939531985,
            "start_logit": -6.267040729522705,
            "end_logit": -5.133726596832275,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "MRI-guided autopsy protocol. Validation was performed using Sanger sequencing",
            "probability": 0.015986605855666875,
            "start_logit": -6.294292449951172,
            "end_logit": -5.133726596832275,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        },
        {
            "text": "Sanger sequencing,",
            "probability": 0.015630356609117373,
            "start_logit": -4.985542297363281,
            "end_logit": -6.465013027191162,
            "question_text": "Which driver mutations have been identified for Diffuse Intrinsic Pontine Glioma (DIPG)?"
        }
    ],
    "58dfd83a6fddd3e83e000003": [
        {
            "text": "ANGPTL3",
            "probability": 0.901678666969657,
            "start_logit": 4.0290632247924805,
            "end_logit": 4.395687580108643,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene",
            "probability": 0.07318336478850021,
            "start_logit": 4.0290632247924805,
            "end_logit": 1.8843975067138672,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Mutations of the ANGPTL3",
            "probability": 0.011920839278965839,
            "start_logit": -0.2969069182872772,
            "end_logit": 4.395687580108643,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "the ANGPTL3",
            "probability": 0.006843363762123164,
            "start_logit": -0.8519155979156494,
            "end_logit": 4.395687580108643,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "3",
            "probability": 0.0011484314809717987,
            "start_logit": -2.6367979049682617,
            "end_logit": 4.395687580108643,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "Mutations of the ANGPTL3 gene",
            "probability": 0.0009675366197468183,
            "start_logit": -0.2969069182872772,
            "end_logit": 1.8843975067138672,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL",
            "probability": 0.0007220720715366057,
            "start_logit": 4.0290632247924805,
            "end_logit": -2.734200954437256,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "L3",
            "probability": 0.0005913146665990077,
            "start_logit": -3.3006019592285156,
            "end_logit": 4.395687580108643,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "the ANGPTL3 gene",
            "probability": 0.0005554311141318332,
            "start_logit": -0.8519155979156494,
            "end_logit": 1.8843975067138672,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene have been associated with a novel form of primary hypobetalipoproteinemia,",
            "probability": 0.0004426581331577075,
            "start_logit": 4.0290632247924805,
            "end_logit": -3.2235281467437744,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "AN",
            "probability": 0.0003869464428492847,
            "start_logit": 4.0290632247924805,
            "end_logit": -3.358039617538452,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene have been",
            "probability": 0.00038439939308875117,
            "start_logit": 4.0290632247924805,
            "end_logit": -3.3646438121795654,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene have",
            "probability": 0.0003058694469653213,
            "start_logit": 4.0290632247924805,
            "end_logit": -3.593167543411255,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "of the ANGPTL3",
            "probability": 0.00020818067487516305,
            "start_logit": -4.344543933868408,
            "end_logit": 4.395687580108643,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene have been associated with a novel form of primary hypobetalipoproteinemia",
            "probability": 0.00015103104136702234,
            "start_logit": 4.0290632247924805,
            "end_logit": -4.298840522766113,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "ANGPTL3 gene have been associated",
            "probability": 0.0001452372378044191,
            "start_logit": 4.0290632247924805,
            "end_logit": -4.337957382202148,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "PTL3",
            "probability": 0.00013521419093344037,
            "start_logit": -4.776090145111084,
            "end_logit": 4.395687580108643,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "3 gene",
            "probability": 9.321067813328336e-05,
            "start_logit": -2.6367979049682617,
            "end_logit": 1.8843975067138672,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "GPTL3",
            "probability": 8.823886143848e-05,
            "start_logit": -5.202902793884277,
            "end_logit": 4.395687580108643,
            "question_text": "List genes associated with hypolipidemia."
        },
        {
            "text": "L3 gene",
            "probability": 4.79931471551182e-05,
            "start_logit": -3.3006019592285156,
            "end_logit": 1.8843975067138672,
            "question_text": "List genes associated with hypolipidemia."
        }
    ],
    "58c6665602b8c60953000024": [
        {
            "text": "diabetes",
            "probability": 0.7362030823411941,
            "start_logit": 3.307633876800537,
            "end_logit": 3.5491912364959717,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "impaired fasting glucose and diabetes",
            "probability": 0.23596503049063747,
            "start_logit": 2.169811487197876,
            "end_logit": 3.5491912364959717,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "impaired fasting glucose",
            "probability": 0.02063337849041141,
            "start_logit": 2.169811487197876,
            "end_logit": 1.1124176979064941,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "malaria is endemic. Glucose-6-phosphate dehydrogenase-deficient males had more impaired fasting glucose and diabetes",
            "probability": 0.0027772593586358964,
            "start_logit": -2.2724075317382812,
            "end_logit": 3.5491912364959717,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Glucose-6-phosphate dehydrogenase-deficient males had more impaired fasting glucose and diabetes",
            "probability": 0.0017610044644603424,
            "start_logit": -2.727987766265869,
            "end_logit": 3.5491912364959717,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "glucose and diabetes",
            "probability": 0.0008672788148468076,
            "start_logit": -3.4362668991088867,
            "end_logit": 3.5491912364959717,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "impaired",
            "probability": 0.00061392201546671,
            "start_logit": 2.169811487197876,
            "end_logit": -2.4023797512054443,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "fasting glucose and diabetes",
            "probability": 0.00028201178346688613,
            "start_logit": -4.559678554534912,
            "end_logit": 3.5491912364959717,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "malaria is endemic. Glucose-6-phosphate dehydrogenase-deficient males had more impaired fasting glucose",
            "probability": 0.00024285057575531468,
            "start_logit": -2.2724075317382812,
            "end_logit": 1.1124176979064941,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Glucose-6-phosphate dehydrogenase-deficient males had more impaired fasting glucose",
            "probability": 0.00015398667998797473,
            "start_logit": -2.727987766265869,
            "end_logit": 1.1124176979064941,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "more impaired fasting glucose and diabetes",
            "probability": 0.00014587486143943288,
            "start_logit": -5.218878269195557,
            "end_logit": 3.5491912364959717,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "glucose",
            "probability": 7.583705096573472e-05,
            "start_logit": -3.4362668991088867,
            "end_logit": 1.1124176979064941,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "malaria",
            "probability": 6.420178992410283e-05,
            "start_logit": -1.3591971397399902,
            "end_logit": -1.1312079429626465,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "males had more impaired fasting glucose and diabetes",
            "probability": 6.1091779916306e-05,
            "start_logit": -6.089250087738037,
            "end_logit": 3.5491912364959717,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "diabetes.",
            "probability": 5.845433229201937e-05,
            "start_logit": 3.307633876800537,
            "end_logit": -5.891824245452881,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "Plasmodium vivax malaria",
            "probability": 3.135838496232281e-05,
            "start_logit": -2.075746536254883,
            "end_logit": -1.1312079429626465,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "fasting glucose",
            "probability": 2.465982291922314e-05,
            "start_logit": -4.559678554534912,
            "end_logit": 1.1124176979064941,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "impaired fasting glucose and diabetes.",
            "probability": 1.8735561738932984e-05,
            "start_logit": 2.169811487197876,
            "end_logit": -5.891824245452881,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "more impaired fasting glucose",
            "probability": 1.2755666473365697e-05,
            "start_logit": -5.218878269195557,
            "end_logit": 1.1124176979064941,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        },
        {
            "text": "malaria is endemic. Glucose-6-phosphate dehydrogenase-deficient males had more impaired",
            "probability": 7.2257345055846436e-06,
            "start_logit": -2.2724075317382812,
            "end_logit": -2.4023797512054443,
            "question_text": "Which are the symptoms of glucose-6-phosphate dehydrogenase (G6PD) deficiency?"
        }
    ],
    "58d8e9bd8acda3452900000b": [
        {
            "text": "heart failure",
            "probability": 0.3855895592427085,
            "start_logit": 6.557787895202637,
            "end_logit": 6.0299811363220215,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, systemic thromboembolic events, and fatal left ventricular arrhythmias",
            "probability": 0.23490907738797948,
            "start_logit": 6.557787895202637,
            "end_logit": 5.5344061851501465,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, systemic thromboembolic events",
            "probability": 0.166029267025625,
            "start_logit": 6.557787895202637,
            "end_logit": 5.187371730804443,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "left ventricular arrhythmias",
            "probability": 0.07804685887308678,
            "start_logit": 5.455898761749268,
            "end_logit": 5.5344061851501465,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "systemic thromboembolic events, and fatal left ventricular arrhythmias",
            "probability": 0.05156029729842805,
            "start_logit": 5.041341304779053,
            "end_logit": 5.5344061851501465,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "systemic thromboembolic events",
            "probability": 0.03644183725579339,
            "start_logit": 5.041341304779053,
            "end_logit": 5.187371730804443,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "fatal left ventricular arrhythmias",
            "probability": 0.018572383916391585,
            "start_logit": 4.020265102386475,
            "end_logit": 5.5344061851501465,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "ventricular arrhythmias",
            "probability": 0.00811683514465947,
            "start_logit": 3.1925296783447266,
            "end_logit": 5.5344061851501465,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "thromboembolic events, and fatal left ventricular arrhythmias",
            "probability": 0.0039305991835995365,
            "start_logit": 2.467381238937378,
            "end_logit": 5.5344061851501465,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure,",
            "probability": 0.0029241475260405815,
            "start_logit": 6.557787895202637,
            "end_logit": 1.1482106447219849,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "thromboembolic events",
            "probability": 0.0027780727278866107,
            "start_logit": 2.467381238937378,
            "end_logit": 5.187371730804443,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, systemic thromboembolic events,",
            "probability": 0.0025590117544672278,
            "start_logit": 6.557787895202637,
            "end_logit": 1.0148288011550903,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, systemic thromboembolic events, and fatal left ventricular arrhythmia",
            "probability": 0.0022840764624964664,
            "start_logit": 6.557787895202637,
            "end_logit": 0.9011694192886353,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "arrhythmias",
            "probability": 0.002085197757633908,
            "start_logit": 1.8334530591964722,
            "end_logit": 5.5344061851501465,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "heart failure, systemic thromboembolic",
            "probability": 0.0016513023248127623,
            "start_logit": 6.557787895202637,
            "end_logit": 0.5767719149589539,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "left ventricular arrhythmia",
            "probability": 0.000758868049314994,
            "start_logit": 5.455898761749268,
            "end_logit": 0.9011694192886353,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "systemic thromboembolic events,",
            "probability": 0.0005616786218634815,
            "start_logit": 5.041341304779053,
            "end_logit": 1.0148288011550903,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "systemic thromboembolic events, and fatal left ventricular arrhythmia",
            "probability": 0.0005013329530222996,
            "start_logit": 5.041341304779053,
            "end_logit": 0.9011694192886353,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "systemic thromboembolic",
            "probability": 0.00036244507766002666,
            "start_logit": 5.041341304779053,
            "end_logit": 0.5767719149589539,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        },
        {
            "text": "failure",
            "probability": 0.00033715141652946104,
            "start_logit": -0.48420873284339905,
            "end_logit": 6.0299811363220215,
            "question_text": "Which are the clinical symptoms of left ventricular noncompaction?"
        }
    ],
    "58d8d8108acda34529000009": [
        {
            "text": "ADAMTSL4",
            "probability": 0.6001437436233134,
            "start_logit": 4.867347240447998,
            "end_logit": 4.72028923034668,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4. Here we report a novel founder mutation in ADAMTSL4",
            "probability": 0.3705057327789624,
            "start_logit": 4.867347240447998,
            "end_logit": 4.2379889488220215,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4. Here we report a novel founder mutation in ADAMTSL4 gene",
            "probability": 0.01609990239858792,
            "start_logit": 4.867347240447998,
            "end_logit": 1.101933240890503,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4 gene",
            "probability": 0.01018921126414867,
            "start_logit": 4.409863471984863,
            "end_logit": 1.101933240890503,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL",
            "probability": 0.0004879309278322369,
            "start_logit": 4.867347240447998,
            "end_logit": -2.3944613933563232,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4.",
            "probability": 0.0003995048007676285,
            "start_logit": 4.867347240447998,
            "end_logit": -2.594409465789795,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "EL is ADAMTSL4",
            "probability": 0.00029044365450310285,
            "start_logit": -2.766167640686035,
            "end_logit": 4.72028923034668,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "autosomal-recessive isolated EL is ADAMTSL4",
            "probability": 0.00024004676511060746,
            "start_logit": -2.9567434787750244,
            "end_logit": 4.72028923034668,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4. Here we report a novel founder mutation in ADAMTSL",
            "probability": 0.00019200934271601202,
            "start_logit": 4.867347240447998,
            "end_logit": -3.3270912170410156,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "EL is ADAMTSL4. Here we report a novel founder mutation in ADAMTSL4",
            "probability": 0.00017930877424961563,
            "start_logit": -2.766167640686035,
            "end_logit": 4.2379889488220215,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "4",
            "probability": 0.00017076850153537602,
            "start_logit": -3.2972683906555176,
            "end_logit": 4.72028923034668,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "AD",
            "probability": 0.00016749724468016023,
            "start_logit": 4.867347240447998,
            "end_logit": -3.4636683464050293,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "autosomal-recessive isolated EL is ADAMTSL4. Here we report a novel founder mutation in ADAMTSL4",
            "probability": 0.00014819566737722824,
            "start_logit": -2.9567434787750244,
            "end_logit": 4.2379889488220215,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "only gene shown to cause autosomal-recessive isolated EL is ADAMTSL4",
            "probability": 0.00013884559302213004,
            "start_logit": -3.5042147636413574,
            "end_logit": 4.72028923034668,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "L4",
            "probability": 0.00012942529689254192,
            "start_logit": -3.5744733810424805,
            "end_logit": 4.72028923034668,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4 gene in children of Bukharian Jewish origin presenting with early-onset bilateral EL",
            "probability": 0.00012942363060391757,
            "start_logit": 4.409863471984863,
            "end_logit": -3.2640604972839355,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "the only gene shown to cause autosomal-recessive isolated EL is ADAMTSL4",
            "probability": 0.00010892229277005597,
            "start_logit": -3.7469425201416016,
            "end_logit": 4.72028923034668,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "4. Here we report a novel founder mutation in ADAMTSL4",
            "probability": 0.00010542592415433459,
            "start_logit": -3.2972683906555176,
            "end_logit": 4.2379889488220215,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4. Here we report a novel founder mutation",
            "probability": 8.84657912611835e-05,
            "start_logit": 4.867347240447998,
            "end_logit": -4.102019309997559,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        },
        {
            "text": "ADAMTSL4 gene in children of Bukharian Jewish origin presenting with early-onset bilateral EL.",
            "probability": 8.519572751121307e-05,
            "start_logit": 4.409863471984863,
            "end_logit": -3.6822001934051514,
            "question_text": "Which mutated genes are associated with isolated ectopia lentis?"
        }
    ],
    "5880b2a6c872c95565000004": [
        {
            "text": "interleukin-4 and interleukin-13",
            "probability": 0.3496840948936261,
            "start_logit": 6.082331657409668,
            "end_logit": 5.140883922576904,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13",
            "probability": 0.29233769397539033,
            "start_logit": 5.9032111167907715,
            "end_logit": 5.140883922576904,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4",
            "probability": 0.2873179562904293,
            "start_logit": 6.082331657409668,
            "end_logit": 4.944443225860596,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 receptor \u03b1 monoclonal antibody, inhibits interleukin-4",
            "probability": 0.04122525814493252,
            "start_logit": 4.140793323516846,
            "end_logit": 4.944443225860596,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signalling",
            "probability": 0.0067271625871418,
            "start_logit": 6.082331657409668,
            "end_logit": 1.190007209777832,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signalling,",
            "probability": 0.00653948182790116,
            "start_logit": 6.082331657409668,
            "end_logit": 1.1617116928100586,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling",
            "probability": 0.005623942370958551,
            "start_logit": 5.9032111167907715,
            "end_logit": 1.190007209777832,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling,",
            "probability": 0.005467040295167403,
            "start_logit": 5.9032111167907715,
            "end_logit": 1.1617116928100586,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin-13 signalling, key drivers of type-2-mediated inflammation",
            "probability": 0.0019196707192705874,
            "start_logit": 6.082331657409668,
            "end_logit": -0.06399256736040115,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-13 signalling, key drivers of type-2-mediated inflammation",
            "probability": 0.0016048545514612469,
            "start_logit": 5.9032111167907715,
            "end_logit": -0.06399256736040115,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 receptor \u03b1 monoclonal antibody,",
            "probability": 0.00025335026133197603,
            "start_logit": 4.140793323516846,
            "end_logit": -0.14759021997451782,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "13",
            "probability": 0.0002140211222341164,
            "start_logit": -1.3163790702819824,
            "end_logit": 5.140883922576904,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "inhibits interleukin-4 and interleukin-13",
            "probability": 0.00018926088804446388,
            "start_logit": -1.439327359199524,
            "end_logit": 5.140883922576904,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "4 and interleukin-13",
            "probability": 0.0001740669010060337,
            "start_logit": -1.5230140686035156,
            "end_logit": 5.140883922576904,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "inhibits interleukin-4",
            "probability": 0.0001555062193354516,
            "start_logit": -1.439327359199524,
            "end_logit": 4.944443225860596,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "inter",
            "probability": 0.0001487159561660215,
            "start_logit": 6.082331657409668,
            "end_logit": -2.62186336517334,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "4",
            "probability": 0.00014302207902843245,
            "start_logit": -1.5230140686035156,
            "end_logit": 4.944443225860596,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin-4 and interleukin",
            "probability": 9.938695519972363e-05,
            "start_logit": 6.082331657409668,
            "end_logit": -3.0248806476593018,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "ukin-4 and interleukin-13",
            "probability": 9.242595789236835e-05,
            "start_logit": -2.156045913696289,
            "end_logit": 5.140883922576904,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        },
        {
            "text": "interleukin",
            "probability": 8.308800348257484e-05,
            "start_logit": 5.9032111167907715,
            "end_logit": -3.0248806476593018,
            "question_text": "Signaling of which pathways is inhibited by Dupilumab?"
        }
    ],
    "58e0035f6fddd3e83e000009": [
        {
            "text": "actin filaments, microtubules, and intermediate filaments",
            "probability": 0.2081259884055062,
            "start_logit": 5.584789276123047,
            "end_logit": 5.515601634979248,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "microtubules, and intermediate filaments",
            "probability": 0.1791301291186041,
            "start_logit": 5.434758186340332,
            "end_logit": 5.515601634979248,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments",
            "probability": 0.1740393659886332,
            "start_logit": 5.584789276123047,
            "end_logit": 5.336739540100098,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments, microtubules",
            "probability": 0.16579504665587536,
            "start_logit": 5.584789276123047,
            "end_logit": 5.288210391998291,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "microtubules",
            "probability": 0.1426966826306552,
            "start_logit": 5.434758186340332,
            "end_logit": 5.288210391998291,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "intermediate filaments",
            "probability": 0.09227980842229813,
            "start_logit": 4.77147102355957,
            "end_logit": 5.515601634979248,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "Fibrillar polymers-actin filaments, microtubules, and intermediate filaments",
            "probability": 0.011356318749889228,
            "start_logit": 2.676419973373413,
            "end_logit": 5.515601634979248,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "Fibrillar polymers-actin filaments",
            "probability": 0.009496394613366122,
            "start_logit": 2.676419973373413,
            "end_logit": 5.336739540100098,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "Fibrillar polymers-actin filaments, microtubules",
            "probability": 0.009046546331871087,
            "start_logit": 2.676419973373413,
            "end_logit": 5.288210391998291,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "Fibrillar polymers",
            "probability": 0.00240968118734036,
            "start_logit": 2.676419973373413,
            "end_logit": 3.9653217792510986,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin",
            "probability": 0.0012237892688520809,
            "start_logit": 5.584789276123047,
            "end_logit": 0.3794100284576416,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments, microtubules,",
            "probability": 0.0007909666273400091,
            "start_logit": 5.584789276123047,
            "end_logit": -0.0570414774119854,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments,",
            "probability": 0.0007357264487270215,
            "start_logit": 5.584789276123047,
            "end_logit": -0.1294388771057129,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "microtubules,",
            "probability": 0.0006807701199134543,
            "start_logit": 5.434758186340332,
            "end_logit": -0.0570414774119854,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "actin filaments, microtubules, and intermediate filaments-",
            "probability": 0.0005976670098199666,
            "start_logit": 5.584789276123047,
            "end_logit": -0.3372634947299957,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "microtubules, and intermediate filaments-",
            "probability": 0.0005144007697413932,
            "start_logit": 5.434758186340332,
            "end_logit": -0.3372634947299957,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "polymers-actin filaments, microtubules, and intermediate filaments",
            "probability": 0.0003098268267703933,
            "start_logit": -0.9250960946083069,
            "end_logit": 5.515601634979248,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "intermediate filaments-",
            "probability": 0.00026499620537083864,
            "start_logit": 4.77147102355957,
            "end_logit": -0.3372634947299957,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "polymers-actin filaments",
            "probability": 0.0002590837641685057,
            "start_logit": -0.9250960946083069,
            "end_logit": 5.336739540100098,
            "question_text": "List the three main structures of the cytoskeleton."
        },
        {
            "text": "polymers-actin filaments, microtubules",
            "probability": 0.00024681085525732533,
            "start_logit": -0.9250960946083069,
            "end_logit": 5.288210391998291,
            "question_text": "List the three main structures of the cytoskeleton."
        }
    ],
    "5880b583c872c95565000005": [
        {
            "text": "percutaneous coronary intervention",
            "probability": 0.3893508645323974,
            "start_logit": 4.12300968170166,
            "end_logit": 4.023890972137451,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "percutaneous coronary intervention (PCI) and coronary artery bypass graft",
            "probability": 0.24173045267367818,
            "start_logit": 4.12300968170166,
            "end_logit": 3.5472333431243896,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG)",
            "probability": 0.14245224374063026,
            "start_logit": 4.12300968170166,
            "end_logit": 3.0184168815612793,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "coronary artery bypass graft",
            "probability": 0.12768395901629306,
            "start_logit": 3.4847445487976074,
            "end_logit": 3.5472333431243896,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "coronary artery bypass graft (CABG)",
            "probability": 0.07524441480325822,
            "start_logit": 3.4847445487976074,
            "end_logit": 3.0184168815612793,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "percutaneous coronary intervention (PCI)",
            "probability": 0.015245599940532192,
            "start_logit": 4.12300968170166,
            "end_logit": 0.7837010025978088,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "coronary intervention",
            "probability": 0.0021387746469868113,
            "start_logit": -1.0812381505966187,
            "end_logit": 4.023890972137451,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "coronary intervention (PCI) and coronary artery bypass graft",
            "probability": 0.0013278690525164829,
            "start_logit": -1.0812381505966187,
            "end_logit": 3.5472333431243896,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "bypass graft",
            "probability": 0.0010010431737224271,
            "start_logit": -1.3637709617614746,
            "end_logit": 3.5472333431243896,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "coronary intervention (PCI) and coronary artery bypass graft (CABG)",
            "probability": 0.000782515913210446,
            "start_logit": -1.0812381505966187,
            "end_logit": 3.0184168815612793,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "bypass graft (CABG)",
            "probability": 0.0005899167630753746,
            "start_logit": -1.3637709617614746,
            "end_logit": 3.0184168815612793,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "percutaneous coronary intervention (PCI) and coronary artery bypass",
            "probability": 0.00040735584476202463,
            "start_logit": 4.12300968170166,
            "end_logit": -2.838658094406128,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG",
            "probability": 0.0004056469980720229,
            "start_logit": 4.12300968170166,
            "end_logit": -2.8428618907928467,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "intervention",
            "probability": 0.00030973016736938634,
            "start_logit": -3.0135250091552734,
            "end_logit": 4.023890972137451,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "comparing percutaneous coronary intervention",
            "probability": 0.00030657205870500875,
            "start_logit": -3.023773670196533,
            "end_logit": 4.023890972137451,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "coronary artery bypass",
            "probability": 0.0002151686161687539,
            "start_logit": 3.4847445487976074,
            "end_logit": -2.838658094406128,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "coronary artery bypass graft (CABG",
            "probability": 0.0002142659896758235,
            "start_logit": 3.4847445487976074,
            "end_logit": -2.8428618907928467,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "(PCI) and coronary artery bypass graft",
            "probability": 0.0002109717160677608,
            "start_logit": -2.920844793319702,
            "end_logit": 3.5472333431243896,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "intervention (PCI) and coronary artery bypass graft",
            "probability": 0.00019229754030420529,
            "start_logit": -3.0135250091552734,
            "end_logit": 3.5472333431243896,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        },
        {
            "text": "comparing percutaneous coronary intervention (PCI) and coronary artery bypass graft",
            "probability": 0.00019033681257357726,
            "start_logit": -3.023773670196533,
            "end_logit": 3.5472333431243896,
            "question_text": "Which treatment methods were compared in the EXCEL Trial?"
        }
    ],
    "58add7699ef3c34033000009": [
        {
            "text": "Pti1p and Ref2p",
            "probability": 0.30070368818436044,
            "start_logit": 4.964794635772705,
            "end_logit": 4.453011989593506,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti1p",
            "probability": 0.30027269018416486,
            "start_logit": 4.964794635772705,
            "end_logit": 4.451577663421631,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ref2p",
            "probability": 0.23044364722301,
            "start_logit": 4.698675632476807,
            "end_logit": 4.453011989593506,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti1",
            "probability": 0.04201116433626815,
            "start_logit": 4.964794635772705,
            "end_logit": 2.4848220348358154,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti1p and Ref2",
            "probability": 0.02575111155135673,
            "start_logit": 4.964794635772705,
            "end_logit": 1.9953644275665283,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti",
            "probability": 0.021731148652429574,
            "start_logit": 4.964794635772705,
            "end_logit": 1.8256332874298096,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti1p probably acts by uncoupling cleavage and polyadenylation, and functions in coordination with the Nrd1",
            "probability": 0.020407390842696806,
            "start_logit": 4.607645511627197,
            "end_logit": 2.1199328899383545,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ref2",
            "probability": 0.019734310881823976,
            "start_logit": 4.698675632476807,
            "end_logit": 1.9953644275665283,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Nrd1p",
            "probability": 0.012539483685343732,
            "start_logit": 3.2426133155822754,
            "end_logit": 2.997950315475464,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti1p and Ref2p,",
            "probability": 0.005218748373371196,
            "start_logit": 4.964794635772705,
            "end_logit": 0.3991442322731018,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Nrd1",
            "probability": 0.005211485476639197,
            "start_logit": 3.2426133155822754,
            "end_logit": 2.1199328899383545,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti1p and Ref",
            "probability": 0.00403067241032721,
            "start_logit": 4.964794635772705,
            "end_logit": 0.14081984758377075,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ref2p,",
            "probability": 0.003999376982571236,
            "start_logit": 4.698675632476807,
            "end_logit": 0.3991442322731018,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ref",
            "probability": 0.0030888974345651935,
            "start_logit": 4.698675632476807,
            "end_logit": 0.14081984758377075,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "snoRNA 3' end maturation. We also provide evidence that Pti1p",
            "probability": 0.002342894544062943,
            "start_logit": 0.4137149155139923,
            "end_logit": 4.149353504180908,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Ref2p, although they were found associated with the pre-mRNA 3' end processing complex, are essential for yeast snoRNA",
            "probability": 0.0012569868681431772,
            "start_logit": 4.698675632476807,
            "end_logit": -0.7582768797874451,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "snoRNA 3' end maturation. We also provide evidence that Pti1",
            "probability": 0.00045980935569098246,
            "start_logit": 0.4137149155139923,
            "end_logit": 2.5210230350494385,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti1p probably acts by uncoupling cleavage and polyadenylation, and functions in coordination with the Nrd",
            "probability": 0.0003956165777130583,
            "start_logit": 4.607645511627197,
            "end_logit": -1.82327401638031,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "snoRNA 3' end maturation. We also provide evidence that Pti",
            "probability": 0.00028611874276558734,
            "start_logit": 0.4137149155139923,
            "end_logit": 2.0466179847717285,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        },
        {
            "text": "Pti1p and Ref2p, although they were found associated with the pre-mRNA 3' end processing complex,",
            "probability": 0.00011475769269563939,
            "start_logit": 4.964794635772705,
            "end_logit": -3.41804575920105,
            "question_text": "Which proteins does the yeast Cleavage and Polyadenylation Complex contain?"
        }
    ],
    "587d30fb31b33e8760000001": [
        {
            "text": "DEEP",
            "probability": 0.6469612156069763,
            "start_logit": -0.24649503827095032,
            "end_logit": 0.3789413869380951,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP, a novel ensemble prediction framework. DEEP",
            "probability": 0.17259602427309792,
            "start_logit": -0.24649503827095032,
            "end_logit": -0.9423912167549133,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP uses features derived from histone modification marks or attributes coming from sequence characteristics. Experimental results indicate that DEEP",
            "probability": 0.07719089677352003,
            "start_logit": -1.1233874559402466,
            "end_logit": -0.8701710104942322,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP-VISTA",
            "probability": 0.02876234986643477,
            "start_logit": -0.44097235798835754,
            "end_logit": -2.5398004055023193,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP,",
            "probability": 0.020106187792095075,
            "start_logit": -0.24649503827095032,
            "end_logit": -3.0923173427581787,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP, a novel ensemble prediction framework.",
            "probability": 0.011284929318225778,
            "start_logit": -0.24649503827095032,
            "end_logit": -3.66987681388855,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP, a novel ensemble prediction framework",
            "probability": 0.0076598428222118715,
            "start_logit": -0.24649503827095032,
            "end_logit": -4.057353496551514,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP-VISTA, when tested on an independent test set, achieved GM of 80.1% and accuracy of 89.64%. DEEP",
            "probability": 0.006656057862659776,
            "start_logit": -0.44097235798835754,
            "end_logit": -4.003340244293213,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP, a novel ensemble prediction",
            "probability": 0.005013241710065295,
            "start_logit": -0.24649503827095032,
            "end_logit": -4.48126220703125,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP, a novel ensemble",
            "probability": 0.003778855990394189,
            "start_logit": -0.24649503827095032,
            "end_logit": -4.763923645019531,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "developed DEEP",
            "probability": 0.0034283723655531046,
            "start_logit": -5.486695766448975,
            "end_logit": 0.3789413869380951,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP-VISTA,",
            "probability": 0.003056500101307017,
            "start_logit": -0.44097235798835754,
            "end_logit": -4.781597137451172,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP performs better than four state-of-the-art methods",
            "probability": 0.0025521851477174518,
            "start_logit": -0.989559531211853,
            "end_logit": -4.413330554962158,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "deep",
            "probability": 0.001979154440724888,
            "start_logit": -2.798063278198242,
            "end_logit": -2.85910701751709,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "novel ensemble prediction framework. DEEP",
            "probability": 0.0018508591612053278,
            "start_logit": -4.781798839569092,
            "end_logit": -0.9423912167549133,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "a novel ensemble prediction framework. DEEP",
            "probability": 0.0017509583448464929,
            "start_logit": -4.83728551864624,
            "end_logit": -0.9423912167549133,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP performs better than four state-of-the-art methods on the ENCODE data. We report the first computational enhancer prediction",
            "probability": 0.0016227619611876203,
            "start_logit": -0.989559531211853,
            "end_logit": -4.866150856018066,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "ensemble prediction framework. DEEP",
            "probability": 0.0015922205560199435,
            "start_logit": -4.932319164276123,
            "end_logit": -0.9423912167549133,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "DEEP framework is publicly available at http://cbrc.kaust.edu.sa/deep",
            "probability": 0.0011532888914708875,
            "start_logit": -3.3381152153015137,
            "end_logit": -2.85910701751709,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        },
        {
            "text": "framework. DEEP",
            "probability": 0.0010040970142863104,
            "start_logit": -5.393360137939453,
            "end_logit": -0.9423912167549133,
            "question_text": "Which deep learning-based algorithms are used for enhancer prediction?"
        }
    ],
    "58a6c94860087bc10a00002a": [
        {
            "text": "K27M",
            "probability": 0.3512777924677311,
            "start_logit": 4.266873836517334,
            "end_logit": 3.591967821121216,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M) in histone 3.3 (H3.3",
            "probability": 0.23724432832346487,
            "start_logit": 4.266873836517334,
            "end_logit": 3.1994810104370117,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "lysine 27 mutation (K27M",
            "probability": 0.0893414304597958,
            "start_logit": 2.897761821746826,
            "end_logit": 3.591967821121216,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M) in histone 3.3",
            "probability": 0.063063075599383,
            "start_logit": 4.266873836517334,
            "end_logit": 1.8745259046554565,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "lysine 27 mutation (K27M) in histone 3.3 (H3.3",
            "probability": 0.060338991292308554,
            "start_logit": 2.897761821746826,
            "end_logit": 3.1994810104370117,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M)",
            "probability": 0.03691422545840358,
            "start_logit": 4.266873836517334,
            "end_logit": 1.3389874696731567,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "H3.3",
            "probability": 0.027159707063452408,
            "start_logit": 2.099517822265625,
            "end_logit": 3.1994810104370117,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M) in histone 3.3 (H3.3)",
            "probability": 0.023744714494648916,
            "start_logit": 4.266873836517334,
            "end_logit": 0.8977504372596741,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "lysine 27",
            "probability": 0.021667343310723047,
            "start_logit": 2.897761821746826,
            "end_logit": 2.1753087043762207,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "(K27M",
            "probability": 0.01657318153931487,
            "start_logit": 1.2130823135375977,
            "end_logit": 3.591967821121216,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "lysine 27 mutation (K27M) in histone 3.3",
            "probability": 0.016039002476254404,
            "start_logit": 2.897761821746826,
            "end_logit": 1.8745259046554565,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "(K27M) in histone 3.3 (H3.3",
            "probability": 0.01119311669222242,
            "start_logit": 1.2130823135375977,
            "end_logit": 3.1994810104370117,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "3.3 (H3.3",
            "probability": 0.009403193440264435,
            "start_logit": 1.038832664489746,
            "end_logit": 3.1994810104370117,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "lysine 27 mutation (K27M)",
            "probability": 0.009388494739735484,
            "start_logit": 2.897761821746826,
            "end_logit": 1.3389874696731567,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "histone 3.3 (H3.3",
            "probability": 0.007137536896768932,
            "start_logit": 0.7631510496139526,
            "end_logit": 3.1994810104370117,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "lysine 27 mutation (K27M) in histone 3.3 (H3.3)",
            "probability": 0.006039057419225427,
            "start_logit": 2.897761821746826,
            "end_logit": 0.8977504372596741,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M) in histone 3.3 (H3",
            "probability": 0.0038121621667156842,
            "start_logit": 4.266873836517334,
            "end_logit": -0.9314129948616028,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "K27M) in histone 3",
            "probability": 0.003617590137766446,
            "start_logit": 4.266873836517334,
            "end_logit": -0.9838014245033264,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "(H3.3",
            "probability": 0.003069758912960053,
            "start_logit": -0.08061766624450684,
            "end_logit": 3.1994810104370117,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        },
        {
            "text": "(K27M) in histone 3.3",
            "probability": 0.0029752971088604237,
            "start_logit": 1.2130823135375977,
            "end_logit": 1.8745259046554565,
            "question_text": "Which histone mutations have been associated with pediatric gliomas?"
        }
    ],
    "58da5b588acda34529000015": [
        {
            "text": "headache",
            "probability": 0.3682900680744207,
            "start_logit": 5.950811862945557,
            "end_logit": 6.315692901611328,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, increased sweating, and palpitations",
            "probability": 0.17966861169512618,
            "start_logit": 5.950811862945557,
            "end_logit": 5.597936153411865,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "palpitations",
            "probability": 0.16737024971510628,
            "start_logit": 5.879906177520752,
            "end_logit": 5.597936153411865,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, increased sweating",
            "probability": 0.10485690727028066,
            "start_logit": 5.950811862945557,
            "end_logit": 5.059418678283691,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "increased sweating, and palpitations",
            "probability": 0.06274241964358279,
            "start_logit": 4.898735523223877,
            "end_logit": 5.597936153411865,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "increased sweating",
            "probability": 0.03661728120682452,
            "start_logit": 4.898735523223877,
            "end_logit": 5.059418678283691,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, increased sweating,",
            "probability": 0.01726783704784994,
            "start_logit": 5.950811862945557,
            "end_logit": 3.2556676864624023,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache",
            "probability": 0.011651625371557608,
            "start_logit": 2.4973866939544678,
            "end_logit": 6.315692901611328,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, increased sweating, and palpitations.",
            "probability": 0.00891445791127064,
            "start_logit": 5.950811862945557,
            "end_logit": 2.594496488571167,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache,",
            "probability": 0.008908763732644038,
            "start_logit": 5.950811862945557,
            "end_logit": 2.593857526779175,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "palpitations.",
            "probability": 0.0083042610092403,
            "start_logit": 5.879906177520752,
            "end_logit": 2.594496488571167,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "increased sweating,",
            "probability": 0.006030134413414608,
            "start_logit": 4.898735523223877,
            "end_logit": 3.2556676864624023,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache, increased sweating, and palpitations",
            "probability": 0.005684191717264671,
            "start_logit": 2.4973866939544678,
            "end_logit": 5.597936153411865,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "sweating, and palpitations",
            "probability": 0.003326397982708628,
            "start_logit": 1.9615877866744995,
            "end_logit": 5.597936153411865,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache, increased sweating",
            "probability": 0.003317367225028139,
            "start_logit": 2.4973866939544678,
            "end_logit": 5.059418678283691,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "increased sweating, and palpitations.",
            "probability": 0.00311303490290826,
            "start_logit": 4.898735523223877,
            "end_logit": 2.594496488571167,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "sweating",
            "probability": 0.0019413285466288765,
            "start_logit": 1.9615877866744995,
            "end_logit": 5.059418678283691,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, increased sweating, and",
            "probability": 0.0008924953841458965,
            "start_logit": 5.950811862945557,
            "end_logit": 0.2930881083011627,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "headache, increased sweating, and palpit",
            "probability": 0.0005562630660708892,
            "start_logit": 5.950811862945557,
            "end_logit": -0.17969191074371338,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        },
        {
            "text": "episodic headache, increased sweating,",
            "probability": 0.0005463040839265707,
            "start_logit": 2.4973866939544678,
            "end_logit": 3.2556676864624023,
            "question_text": "Which are the triad symptoms of pheochromocytoma?"
        }
    ],
    "58da5dc58acda34529000016": [
        {
            "text": "CRS type I",
            "probability": 0.3893791527089554,
            "start_logit": 3.5895800590515137,
            "end_logit": 3.8014516830444336,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type II",
            "probability": 0.2411431216779522,
            "start_logit": 3.0914998054504395,
            "end_logit": 3.820369005203247,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type I",
            "probability": 0.16094796466752925,
            "start_logit": 2.7061076164245605,
            "end_logit": 3.8014516830444336,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type II",
            "probability": 0.11830181292786351,
            "start_logit": 2.3793482780456543,
            "end_logit": 3.820369005203247,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type II: chronic abnormalities in heart function (CHF-CHD) leading to kidney injury or dysfunction. CRS type III",
            "probability": 0.022702457983967642,
            "start_logit": 2.3793482780456543,
            "end_logit": 2.169603109359741,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type III",
            "probability": 0.013729868913832453,
            "start_logit": 1.8764487504959106,
            "end_logit": 2.169603109359741,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type III",
            "probability": 0.011967606756141596,
            "start_logit": 1.7390786409378052,
            "end_logit": 2.169603109359741,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type II: chronic abnormalities in heart function (CHF-CHD) leading to kidney injury or dysfunction. CRS type II",
            "probability": 0.0077405168068342255,
            "start_logit": 2.3793482780456543,
            "end_logit": 1.0935983657836914,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "I: acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction. CRS type II",
            "probability": 0.005716924191803215,
            "start_logit": -0.650459885597229,
            "end_logit": 3.820369005203247,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "I",
            "probability": 0.0056097918188083426,
            "start_logit": -0.650459885597229,
            "end_logit": 3.8014516830444336,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "II",
            "probability": 0.005589357012301787,
            "start_logit": -0.6730265617370605,
            "end_logit": 3.820369005203247,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type I: acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction.",
            "probability": 0.005485455895813968,
            "start_logit": 3.5895800590515137,
            "end_logit": -0.4610016644001007,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "type I: acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction.",
            "probability": 0.0022673863137317655,
            "start_logit": 2.7061076164245605,
            "end_logit": -0.4610016644001007,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type I: acute worsening of heart function (AHF-ACS) leading to kidney injury and/or dysfunction",
            "probability": 0.001876840906289977,
            "start_logit": 3.5895800590515137,
            "end_logit": -1.5335118770599365,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type II: chronic abnormalities in heart function (CHF-CHD) leading to kidney injury or dysfunction.",
            "probability": 0.001543117851802504,
            "start_logit": 3.0914998054504395,
            "end_logit": -1.2312166690826416,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type I: acute worsening of heart function",
            "probability": 0.001513258983886961,
            "start_logit": 3.5895800590515137,
            "end_logit": -1.7488362789154053,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type I: acute worsening of heart function (AHF-ACS)",
            "probability": 0.0012550678313794266,
            "start_logit": 3.5895800590515137,
            "end_logit": -1.9359122514724731,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "CRS type I:",
            "probability": 0.0011332805254122408,
            "start_logit": 3.5895800590515137,
            "end_logit": -2.037985324859619,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "II: chronic abnormalities in heart function (CHF-CHD) leading to kidney injury or dysfunction. CRS type III",
            "probability": 0.001072613678427319,
            "start_logit": -0.6730265617370605,
            "end_logit": 2.169603109359741,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        },
        {
            "text": "kidney injury and/or dysfunction. CRS type II",
            "probability": 0.0010244025472659576,
            "start_logit": -2.369781255722046,
            "end_logit": 3.820369005203247,
            "question_text": "List the types of the Cardiorenal syndrome (CRS) according to the five-part classification system."
        }
    ],
    "58dcecf58acda34529000023": [
        {
            "text": "Rix1",
            "probability": 0.11209596188420998,
            "start_logit": 4.740746974945068,
            "end_logit": 3.5881896018981934,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex members (Ipi1p-Ipi2p/Rix1-Ipi3p",
            "probability": 0.09371326735192323,
            "start_logit": 4.740746974945068,
            "end_logit": 3.409074068069458,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex members (Ipi1p-Ipi2p/Rix1",
            "probability": 0.08464092305790605,
            "start_logit": 4.740746974945068,
            "end_logit": 3.3072521686553955,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex members (Ipi1p",
            "probability": 0.08065132637128075,
            "start_logit": 4.740746974945068,
            "end_logit": 3.25896954536438,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex members (Ipi1p-Ipi2p",
            "probability": 0.07280075780059483,
            "start_logit": 4.740746974945068,
            "end_logit": 3.1565606594085693,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex",
            "probability": 0.057914086109871976,
            "start_logit": 4.740746974945068,
            "end_logit": 2.927794933319092,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1-Ipi3p",
            "probability": 0.05606627760383238,
            "start_logit": 4.227041721343994,
            "end_logit": 3.409074068069458,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi1p-Ipi2p/Rix1-Ipi3p",
            "probability": 0.04892648340289386,
            "start_logit": 4.090826034545898,
            "end_logit": 3.409074068069458,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi1p-Ipi2p/Rix1",
            "probability": 0.044189929923655245,
            "start_logit": 4.090826034545898,
            "end_logit": 3.3072521686553955,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi3p",
            "probability": 0.04339667578595347,
            "start_logit": 3.9708900451660156,
            "end_logit": 3.409074068069458,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi1p",
            "probability": 0.042107013154363805,
            "start_logit": 4.090826034545898,
            "end_logit": 3.25896954536438,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi2p/Rix1-Ipi3p",
            "probability": 0.03933526666247306,
            "start_logit": 3.872628688812256,
            "end_logit": 3.409074068069458,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi1p-Ipi2p",
            "probability": 0.03800833295965323,
            "start_logit": 4.090826034545898,
            "end_logit": 3.1565606594085693,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex members (Ipi1",
            "probability": 0.03786385358442102,
            "start_logit": 4.740746974945068,
            "end_logit": 2.502831220626831,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi2p/Rix1",
            "probability": 0.03552723507694743,
            "start_logit": 3.872628688812256,
            "end_logit": 3.3072521686553955,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi2p",
            "probability": 0.030557436553381945,
            "start_logit": 3.872628688812256,
            "end_logit": 3.1565606594085693,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex members (Ipi1p-Ipi2p/Rix1-Ipi3",
            "probability": 0.027067276819825504,
            "start_logit": 4.740746974945068,
            "end_logit": 2.1671597957611084,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Ipi1",
            "probability": 0.019768227662054293,
            "start_logit": 4.090826034545898,
            "end_logit": 2.502831220626831,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex members (Ipi1p-Ipi2p/Rix",
            "probability": 0.017909082555261593,
            "start_logit": 4.740746974945068,
            "end_logit": 1.7541422843933105,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        },
        {
            "text": "Rix1 complex members (Ipi1p-Ipi2",
            "probability": 0.017460585679496245,
            "start_logit": 4.740746974945068,
            "end_logit": 1.7287803888320923,
            "question_text": "Which are the components of the pre-replication complex (pre-RC) in eukaryotes?"
        }
    ],
    "58eb2887eda5a57672000003": [
        {
            "text": "variant detection, as well as an alignment at the best possible location in the reference genome",
            "probability": 0.08104110232084073,
            "start_logit": -5.965082168579102,
            "end_logit": -6.315124988555908,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "variant detection, as well as an alignment at the best possible location in the reference genome.",
            "probability": 0.07505398195761916,
            "start_logit": -5.965082168579102,
            "end_logit": -6.391873836517334,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "alignment at the best possible location in the reference genome",
            "probability": 0.07002345040518954,
            "start_logit": -6.111208438873291,
            "end_logit": -6.315124988555908,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "alignment at the best possible location in the reference genome.",
            "probability": 0.06485028748146492,
            "start_logit": -6.111208438873291,
            "end_logit": -6.391873836517334,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "SNP-calls, variant detection, as well as an alignment at the best possible location in the reference genome",
            "probability": 0.06127933209396855,
            "start_logit": -6.244596004486084,
            "end_logit": -6.315124988555908,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "variant detection, as well as an alignment",
            "probability": 0.05986673433714315,
            "start_logit": -5.965082168579102,
            "end_logit": -6.617960453033447,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "variant detection",
            "probability": 0.057054812000524896,
            "start_logit": -5.965082168579102,
            "end_logit": -6.666069030761719,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "SNP-calls, variant detection, as well as an alignment at the best possible location in the reference genome.",
            "probability": 0.056752163453395066,
            "start_logit": -6.244596004486084,
            "end_logit": -6.391873836517334,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "variant",
            "probability": 0.051837992601664676,
            "start_logit": -5.965082168579102,
            "end_logit": -6.761958122253418,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "alignment",
            "probability": 0.05172776754912865,
            "start_logit": -6.111208438873291,
            "end_logit": -6.617960453033447,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "SNP-calls, variant detection, as well as an alignment",
            "probability": 0.04526830694260881,
            "start_logit": -6.244596004486084,
            "end_logit": -6.617960453033447,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "SNP-calls, variant detection",
            "probability": 0.04314206830871296,
            "start_logit": -6.244596004486084,
            "end_logit": -6.666069030761719,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "alignment at the best possible location in the reference genome. Thus, there is a need for novel reference-guided bioinformatics algorithms",
            "probability": 0.04026761121984389,
            "start_logit": -6.111208438873291,
            "end_logit": -6.868407726287842,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "SNP-calls, variant",
            "probability": 0.0391973637173145,
            "start_logit": -6.244596004486084,
            "end_logit": -6.761958122253418,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "bases ({A, C, G, T}), while simultaneously aligning possible sequence reads to a source reference genome whenever available.",
            "probability": 0.037694549981285436,
            "start_logit": -6.4677300453186035,
            "end_logit": -6.57791805267334,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "bases",
            "probability": 0.03684859887798781,
            "start_logit": -6.4677300453186035,
            "end_logit": -6.600615978240967,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "SNP-calls",
            "probability": 0.03572435671463121,
            "start_logit": -6.244596004486084,
            "end_logit": -6.854734897613525,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "reference genome",
            "probability": 0.03262189844604948,
            "start_logit": -6.875054836273193,
            "end_logit": -6.315124988555908,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "reference genome.",
            "probability": 0.03021187159695685,
            "start_logit": -6.875054836273193,
            "end_logit": -6.391873836517334,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        },
        {
            "text": "aligning possible sequence reads to a source reference genome whenever available.",
            "probability": 0.02953574999366973,
            "start_logit": -6.711644172668457,
            "end_logit": -6.57791805267334,
            "question_text": "Which NGS alignment software implement the Burrows-Wheeler Transform?"
        }
    ],
    "58da14178acda34529000011": [
        {
            "text": "22",
            "probability": 0.48339595216983383,
            "start_logit": 1.4830976724624634,
            "end_logit": 1.9239238500595093,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;22",
            "probability": 0.28967617194719664,
            "start_logit": 0.9710252285003662,
            "end_logit": 1.9239238500595093,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13",
            "probability": 0.1334075420758742,
            "start_logit": 0.9710252285003662,
            "end_logit": 1.148568868637085,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "t(13;22",
            "probability": 0.01921587059282059,
            "start_logit": -1.7420018911361694,
            "end_logit": 1.9239238500595093,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "21",
            "probability": 0.009950158499697026,
            "start_logit": -0.34166279435157776,
            "end_logit": -0.13456329703330994,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "t(13",
            "probability": 0.008849682206873264,
            "start_logit": -1.7420018911361694,
            "end_logit": 1.148568868637085,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "22)",
            "probability": 0.008212413587965553,
            "start_logit": 1.4830976724624634,
            "end_logit": -2.1512653827667236,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "14) and t(14;21",
            "probability": 0.006205000585688239,
            "start_logit": -0.8138957619667053,
            "end_logit": -0.13456329703330994,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;14) and t(14;21",
            "probability": 0.005132225857160742,
            "start_logit": -1.0037118196487427,
            "end_logit": -0.13456329703330994,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;22)",
            "probability": 0.004921308339324281,
            "start_logit": 0.9710252285003662,
            "end_logit": -2.1512653827667236,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "14;21",
            "probability": 0.004820911041688871,
            "start_logit": -1.0662883520126343,
            "end_logit": -0.13456329703330994,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "14",
            "probability": 0.004328533921730294,
            "start_logit": -0.8138957619667053,
            "end_logit": -0.4946899116039276,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "22) Robertsonian translocation constitutes a rare form of rearrangement between acrocentric human chromosomes",
            "probability": 0.004166186098023987,
            "start_logit": 1.4830976724624634,
            "end_logit": -2.829911231994629,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "The t(13;22",
            "probability": 0.0037869388528055012,
            "start_logit": -3.366180419921875,
            "end_logit": 1.9239238500595093,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;14",
            "probability": 0.0035801791490463804,
            "start_logit": -1.0037118196487427,
            "end_logit": -0.4946899116039276,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;22) Robertsonian translocation constitutes a rare form of rearrangement between acrocentric human chromosomes",
            "probability": 0.002496596910003107,
            "start_logit": 0.9710252285003662,
            "end_logit": -2.829911231994629,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "22) Robertsonian translocation",
            "probability": 0.0022702972674827036,
            "start_logit": 1.4830976724624634,
            "end_logit": -3.4370014667510986,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "14) and t(14",
            "probability": 0.00210167445321002,
            "start_logit": -0.8138957619667053,
            "end_logit": -1.2171844244003296,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "The t(13",
            "probability": 0.0017440378369695652,
            "start_logit": -3.366180419921875,
            "end_logit": 1.148568868637085,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        },
        {
            "text": "13;14) and t(14",
            "probability": 0.0017383186066052966,
            "start_logit": -1.0037118196487427,
            "end_logit": -1.2171844244003296,
            "question_text": "List the human acrocentric chromosomes that are involved in Robertsonian translocation."
        }
    ],
    "58ea59273e8b6dc87c000012": [
        {
            "text": "Adenoviral vectors",
            "probability": 0.8098234636526772,
            "start_logit": 1.241440773010254,
            "end_logit": 0.9993544220924377,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Adenoviral",
            "probability": 0.07049914512472802,
            "start_logit": 1.241440773010254,
            "end_logit": -1.4418612718582153,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "vectors",
            "probability": 0.04164030091485662,
            "start_logit": -1.7263070344924927,
            "end_logit": 0.9993544220924377,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adenoviral vectors",
            "probability": 0.030422279300828577,
            "start_logit": 0.6325395107269287,
            "end_logit": -1.6733853816986084,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Ad",
            "probability": 0.0103794217238362,
            "start_logit": 1.241440773010254,
            "end_logit": -3.3576366901397705,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adenoviral",
            "probability": 0.009684365988868744,
            "start_logit": 0.6325395107269287,
            "end_logit": -2.8180477619171143,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "ad",
            "probability": 0.007298490695957192,
            "start_logit": 0.6325395107269287,
            "end_logit": -3.100893020629883,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "Adenovir",
            "probability": 0.006657717851432426,
            "start_logit": 1.241440773010254,
            "end_logit": -3.801685094833374,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "genetically engineered adenoviral vectors",
            "probability": 0.003272881356406869,
            "start_logit": -1.596964955329895,
            "end_logit": -1.6733853816986084,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adenovir",
            "probability": 0.0025108585468438106,
            "start_logit": 0.6325395107269287,
            "end_logit": -4.167935848236084,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adenoviral vector in its entirety,",
            "probability": 0.002017300947382002,
            "start_logit": -0.3252132833003998,
            "end_logit": -3.4290473461151123,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "viral vectors",
            "probability": 0.0017578224174849178,
            "start_logit": -4.891299724578857,
            "end_logit": 0.9993544220924377,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "genetically engineered adenoviral",
            "probability": 0.0010418608211491247,
            "start_logit": -1.596964955329895,
            "end_logit": -2.8180477619171143,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "genetically engineered ad",
            "probability": 0.0007851842359509434,
            "start_logit": -1.596964955329895,
            "end_logit": -3.100893020629883,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adenoviral vector",
            "probability": 0.0005853594278481181,
            "start_logit": -0.3252132833003998,
            "end_logit": -4.666337013244629,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adenoviral vectors for various purposes, the need for a comprehensive protocol for viral vector production is especially apparent. Here,",
            "probability": 0.0004983598518456415,
            "start_logit": -0.11807113140821457,
            "end_logit": -5.0343828201293945,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "adenoviral vector in its entirety, including the more complex process of adenoviral fiber modification",
            "probability": 0.0003806455430637194,
            "start_logit": -0.3252132833003998,
            "end_logit": -5.096694469451904,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "some genetically engineered adenoviral vectors",
            "probability": 0.00028082359602466043,
            "start_logit": -4.052664279937744,
            "end_logit": -1.6733853816986084,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "genetically engineered adenovir",
            "probability": 0.00027012249954315985,
            "start_logit": -1.596964955329895,
            "end_logit": -4.167935848236084,
            "question_text": "List viral vectors used in gene therapy."
        },
        {
            "text": "genetically",
            "probability": 0.00019359550327266282,
            "start_logit": -1.596964955329895,
            "end_logit": -4.501040458679199,
            "question_text": "List viral vectors used in gene therapy."
        }
    ],
    "58dd07488acda34529000025": [
        {
            "text": "thrombocytopenia",
            "probability": 0.43700940558367235,
            "start_logit": 3.456230640411377,
            "end_logit": 4.490097522735596,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, neurological symptoms",
            "probability": 0.17140398811423088,
            "start_logit": 3.456230640411377,
            "end_logit": 3.554166078567505,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "neurological symptoms",
            "probability": 0.13439678506885963,
            "start_logit": 3.2130038738250732,
            "end_logit": 3.554166078567505,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, neurological symptoms and renal involvement",
            "probability": 0.0782736289212769,
            "start_logit": 3.456230640411377,
            "end_logit": 2.7703535556793213,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "neurological symptoms and renal involvement",
            "probability": 0.06137385832400665,
            "start_logit": 3.2130038738250732,
            "end_logit": 2.7703535556793213,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "renal involvement",
            "probability": 0.04626919136351126,
            "start_logit": 2.9304962158203125,
            "end_logit": 2.7703535556793213,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "haemolytic anaemia associated with thrombocytopenia",
            "probability": 0.017263223724476945,
            "start_logit": 0.22485436499118805,
            "end_logit": 4.490097522735596,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 0.01115457415743243,
            "start_logit": -0.21187442541122437,
            "end_logit": 4.490097522735596,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia,",
            "probability": 0.01031209453616917,
            "start_logit": 3.456230640411377,
            "end_logit": 0.7434602379798889,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "haemolytic anaemia associated with thrombocytopenia, neurological symptoms",
            "probability": 0.006770987892426518,
            "start_logit": 0.22485436499118805,
            "end_logit": 3.554166078567505,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "microangiopathic haemolytic anaemia associated with thrombocytopenia, neurological symptoms",
            "probability": 0.004375051135904636,
            "start_logit": -0.21187442541122437,
            "end_logit": 3.554166078567505,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, neurological symptoms and renal",
            "probability": 0.00318837398374016,
            "start_logit": 3.456230640411377,
            "end_logit": -0.43034613132476807,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "anaemia associated with thrombocytopenia",
            "probability": 0.0031788473810288815,
            "start_logit": -1.4672054052352905,
            "end_logit": 4.490097522735596,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "haemolytic anaemia associated with thrombocytopenia, neurological symptoms and renal involvement",
            "probability": 0.0030920505383401253,
            "start_logit": 0.22485436499118805,
            "end_logit": 2.7703535556793213,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "neurological symptoms and renal",
            "probability": 0.002499983913596541,
            "start_logit": 3.2130038738250732,
            "end_logit": -0.43034613132476807,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "a microangiopathic haemolytic anaemia associated with thrombocytopenia",
            "probability": 0.002138423994184494,
            "start_logit": -1.8636549711227417,
            "end_logit": 4.490097522735596,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "microangiopathic haemolytic anaemia associated with thrombocytopenia, neurological symptoms and renal involvement",
            "probability": 0.0019979180933362324,
            "start_logit": -0.21187442541122437,
            "end_logit": 2.7703535556793213,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "renal",
            "probability": 0.001884715044200708,
            "start_logit": 2.9304962158203125,
            "end_logit": -0.43034613132476807,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "enia",
            "probability": 0.0018766932731537353,
            "start_logit": -1.9942127466201782,
            "end_logit": 4.490097522735596,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        },
        {
            "text": "thrombocytopenia, neurological",
            "probability": 0.0015402049564518406,
            "start_logit": 3.456230640411377,
            "end_logit": -1.1579416990280151,
            "question_text": "List the classical symptoms of the Moschcowitz syndrome (Thrombotic thrombocytopenic purpura)."
        }
    ],
    "5895b7157d9090f353000009": [
        {
            "text": "microcephaly",
            "probability": 0.2520780865507286,
            "start_logit": 3.159548282623291,
            "end_logit": 3.5701286792755127,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly, blepharophimosis",
            "probability": 0.15848515937867755,
            "start_logit": 3.159548282623291,
            "end_logit": 3.106050729751587,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "blepharophimosis",
            "probability": 0.14415712883931064,
            "start_logit": 3.064791202545166,
            "end_logit": 3.106050729751587,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "psychomotor retardation, microcephaly",
            "probability": 0.12782897396541015,
            "start_logit": 2.4805026054382324,
            "end_logit": 3.5701286792755127,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "psychomotor retardation, microcephaly, blepharophimosis",
            "probability": 0.08036793514792051,
            "start_logit": 2.4805026054382324,
            "end_logit": 3.106050729751587,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly, blepharophimosis and delayed growth",
            "probability": 0.05972010641059836,
            "start_logit": 3.159548282623291,
            "end_logit": 2.130058526992798,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "blepharophimosis and delayed growth",
            "probability": 0.05432104247413987,
            "start_logit": 3.064791202545166,
            "end_logit": 2.130058526992798,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "psychomotor retardation",
            "probability": 0.04604694285828567,
            "start_logit": 2.4805026054382324,
            "end_logit": 2.5490968227386475,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "psychomotor retardation, microcephaly, blepharophimosis and delayed growth",
            "probability": 0.03028410772245223,
            "start_logit": 2.4805026054382324,
            "end_logit": 2.130058526992798,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "delayed growth",
            "probability": 0.014983667896801616,
            "start_logit": 1.776840329170227,
            "end_logit": 2.130058526992798,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "micro-brachycephaly",
            "probability": 0.004915666632568454,
            "start_logit": 1.3539286851882935,
            "end_logit": 1.43843674659729,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "blepharophimosis and delayed growth as the main features; the infant also presented preauricular tags and large clitoris",
            "probability": 0.0046619221908819385,
            "start_logit": 3.064791202545166,
            "end_logit": -0.32542529702186584,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly,",
            "probability": 0.004161105717782387,
            "start_logit": 3.159548282623291,
            "end_logit": -0.533829391002655,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "micro-brachycephaly, the mongoloid slanted eyes with different anomalies, the micrognathia",
            "probability": 0.0028125536622628008,
            "start_logit": 1.3539286851882935,
            "end_logit": 0.8801022171974182,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly, blepharophimosis and delayed growth as the main features; the infant also presented preauricular tags",
            "probability": 0.002736577928080825,
            "start_logit": 3.159548282623291,
            "end_logit": -0.9529020190238953,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "microcephaly, blepharophimosis and delayed growth as the main features",
            "probability": 0.002676124588501617,
            "start_logit": 3.159548282623291,
            "end_logit": -0.9752405285835266,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "blepharophimosis and delayed growth as the main features; the infant also presented preauricular tags",
            "probability": 0.0024891744974970607,
            "start_logit": 3.064791202545166,
            "end_logit": -0.9529020190238953,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "micrognathia",
            "probability": 0.0024439487484580235,
            "start_logit": 1.2134509086608887,
            "end_logit": 0.8801022171974182,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "blepharophimosis and delayed growth as the main features",
            "probability": 0.0024341865106303298,
            "start_logit": 3.064791202545166,
            "end_logit": -0.9752405285835266,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        },
        {
            "text": "psychomotor retardation,",
            "probability": 0.002395588279011187,
            "start_logit": 2.4805026054382324,
            "end_logit": -0.4069357216358185,
            "question_text": "List features of the Kaufman Oculocerebrofacial Syndrome."
        }
    ],
    "58f4b73b70f9fc6f0f000014": [
        {
            "text": "mumps, rubella",
            "probability": 0.28234612005166027,
            "start_logit": 5.263638019561768,
            "end_logit": 5.101246356964111,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella",
            "probability": 0.2270403058123351,
            "start_logit": 5.0456318855285645,
            "end_logit": 5.101246356964111,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps",
            "probability": 0.20496980574270773,
            "start_logit": 5.263638019561768,
            "end_logit": 4.780975341796875,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "Measles, mumps, rubella",
            "probability": 0.11566616536951373,
            "start_logit": 4.371212482452393,
            "end_logit": 5.101246356964111,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "Measles, mumps",
            "probability": 0.08396811488840478,
            "start_logit": 4.371212482452393,
            "end_logit": 4.780975341796875,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "Measles",
            "probability": 0.08161105400700362,
            "start_logit": 4.371212482452393,
            "end_logit": 4.752502918243408,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "asles, mumps, rubella",
            "probability": 0.0013426801224822775,
            "start_logit": -0.0848279669880867,
            "end_logit": 5.101246356964111,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "asles, mumps",
            "probability": 0.0009747216778804437,
            "start_logit": -0.0848279669880867,
            "end_logit": 4.780975341796875,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "asles",
            "probability": 0.0009473603593580605,
            "start_logit": -0.0848279669880867,
            "end_logit": 4.752502918243408,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps, rubella (MMR) vaccine",
            "probability": 0.0001652681678483703,
            "start_logit": 5.263638019561768,
            "end_logit": -2.3420732021331787,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mum",
            "probability": 0.0001351794366284406,
            "start_logit": 5.263638019561768,
            "end_logit": -2.543039560317993,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella (MMR) vaccine",
            "probability": 0.00013289552327644136,
            "start_logit": 5.0456318855285645,
            "end_logit": -2.3420732021331787,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps, rub",
            "probability": 0.00011626304812056189,
            "start_logit": 5.263638019561768,
            "end_logit": -2.6937873363494873,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps, rubella (MMR) vaccine is a live vaccine preparation containing attenuated strains of all 3 viruses.",
            "probability": 9.885763815557167e-05,
            "start_logit": 5.263638019561768,
            "end_logit": -2.855961799621582,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "mumps,",
            "probability": 9.591233133880939e-05,
            "start_logit": 5.263638019561768,
            "end_logit": -2.8862080574035645,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rub",
            "probability": 9.348950144998243e-05,
            "start_logit": 5.0456318855285645,
            "end_logit": -2.6937873363494873,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "rubella (MMR) vaccine is a live vaccine preparation containing attenuated strains of all 3 viruses.",
            "probability": 7.94934543269782e-05,
            "start_logit": 5.0456318855285645,
            "end_logit": -2.855961799621582,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "les, mumps, rubella",
            "probability": 7.635846717051159e-05,
            "start_logit": -2.9518120288848877,
            "end_logit": 5.101246356964111,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "Measles,",
            "probability": 7.225049412156315e-05,
            "start_logit": 4.371212482452393,
            "end_logit": -2.2770779132843018,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        },
        {
            "text": "Measles, mumps, rubella (MMR) vaccine",
            "probability": 6.770390621683965e-05,
            "start_logit": 4.371212482452393,
            "end_logit": -2.3420732021331787,
            "question_text": "The MMR vaccine protects against what 3 viruses?"
        }
    ],
    "5895bfdc7d9090f35300000c": [
        {
            "text": "achalasia",
            "probability": 0.24176388911415514,
            "start_logit": 4.456939697265625,
            "end_logit": 4.7824273109436035,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency due to adrenocorticotropic hormone (ACTH) resistance, achalasia",
            "probability": 0.2045905945257871,
            "start_logit": 4.289988994598389,
            "end_logit": 4.7824273109436035,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and alacrimia",
            "probability": 0.1725290175837994,
            "start_logit": 4.456939697265625,
            "end_logit": 4.44503116607666,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrimia",
            "probability": 0.15108586349668024,
            "start_logit": 4.324222564697266,
            "end_logit": 4.44503116607666,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.1431029372015103,
            "start_logit": 4.289988994598389,
            "end_logit": 4.424980640411377,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency due to adrenocorticotropic hormone (ACTH) resistance",
            "probability": 0.02805969456194633,
            "start_logit": 4.289988994598389,
            "end_logit": 2.795750617980957,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance, achalasia",
            "probability": 0.02764618174698092,
            "start_logit": 2.288465738296509,
            "end_logit": 4.7824273109436035,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance, achalasia, and alacrimia",
            "probability": 0.019729036433963117,
            "start_logit": 2.288465738296509,
            "end_logit": 4.44503116607666,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance",
            "probability": 0.003791686599388438,
            "start_logit": 2.288465738296509,
            "end_logit": 2.795750617980957,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency due to adrenocorticotropic hormone (ACTH) resistance,",
            "probability": 0.002756021593595976,
            "start_logit": 4.289988994598389,
            "end_logit": 0.47520461678504944,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency due to adrenocorticotropic hormone",
            "probability": 0.0016523351263712386,
            "start_logit": 4.289988994598389,
            "end_logit": -0.03639405593276024,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency due to adrenocorticotropic hormone (ACTH)",
            "probability": 0.0005775689260939531,
            "start_logit": 4.289988994598389,
            "end_logit": -1.0875110626220703,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia,",
            "probability": 0.0004385480348304661,
            "start_logit": 4.456939697265625,
            "end_logit": -1.529820203781128,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenocorticotropic hormone (ACTH) resistance,",
            "probability": 0.0003724192407366739,
            "start_logit": 2.288465738296509,
            "end_logit": 0.47520461678504944,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "adrenal insufficiency due to adrenocorticotropic hormone (ACTH) resistance, achalasia,",
            "probability": 0.00037111747127676167,
            "start_logit": 4.289988994598389,
            "end_logit": -1.529820203781128,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "insufficiency due to adrenocorticotropic hormone (ACTH) resistance, achalasia",
            "probability": 0.000367125933991444,
            "start_logit": -2.0330722332000732,
            "end_logit": 4.7824273109436035,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, and alacrimia.",
            "probability": 0.00033742934349460736,
            "start_logit": 4.456939697265625,
            "end_logit": -1.7919334173202515,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "alacrimia.",
            "probability": 0.0002954911842944836,
            "start_logit": 4.324222564697266,
            "end_logit": -1.7919334173202515,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "achalasia, alacrimia",
            "probability": 0.0002710512382779197,
            "start_logit": 1.128958821296692,
            "end_logit": 1.3169991970062256,
            "question_text": "List cardinal features of the Triple A syndrome."
        },
        {
            "text": "insufficiency due to adrenocorticotropic hormone (ACTH) resistance, achalasia, and alacrimia",
            "probability": 0.00026199064282578216,
            "start_logit": -2.0330722332000732,
            "end_logit": 4.44503116607666,
            "question_text": "List cardinal features of the Triple A syndrome."
        }
    ],
    "5895dd6a7d9090f35300000f": [
        {
            "text": "idiopathic retinal vasculitis, aneurysms, and neuroretinitis",
            "probability": 0.22303523916672338,
            "start_logit": 5.3475661277771,
            "end_logit": 5.905548095703125,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "neuroretinitis",
            "probability": 0.19726876772433258,
            "start_logit": 5.224803447723389,
            "end_logit": 5.905548095703125,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "aneurysms, and neuroretinitis",
            "probability": 0.14822174427927498,
            "start_logit": 4.938945770263672,
            "end_logit": 5.905548095703125,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic retinal vasculitis, aneurysms",
            "probability": 0.1446057635036548,
            "start_logit": 5.3475661277771,
            "end_logit": 5.472229480743408,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic retinal vasculitis",
            "probability": 0.12826752131366595,
            "start_logit": 5.3475661277771,
            "end_logit": 5.352336406707764,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "aneurysms",
            "probability": 0.09610014354424906,
            "start_logit": 4.938945770263672,
            "end_logit": 5.472229480743408,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "retinal vasculitis, aneurysms, and neuroretinitis",
            "probability": 0.02339814575523302,
            "start_logit": 3.092893123626709,
            "end_logit": 5.905548095703125,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "retinal vasculitis, aneurysms",
            "probability": 0.01517027867052,
            "start_logit": 3.092893123626709,
            "end_logit": 5.472229480743408,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "retinal vasculitis",
            "probability": 0.013456268931189562,
            "start_logit": 3.092893123626709,
            "end_logit": 5.352336406707764,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "vasculitis, aneurysms, and neuroretinitis",
            "probability": 0.0036516747865115422,
            "start_logit": 1.2354222536087036,
            "end_logit": 5.905548095703125,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "vasculitis, aneurysms",
            "probability": 0.002367577529646859,
            "start_logit": 1.2354222536087036,
            "end_logit": 5.472229480743408,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "vasculitis",
            "probability": 0.0021000774373564966,
            "start_logit": 1.2354222536087036,
            "end_logit": 5.352336406707764,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic retinal vasculitis, aneurysms,",
            "probability": 0.0008399782795602953,
            "start_logit": 5.3475661277771,
            "end_logit": 0.32383906841278076,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "aneurysms,",
            "probability": 0.0005582214102950022,
            "start_logit": 4.938945770263672,
            "end_logit": 0.32383906841278076,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic retinal vasculitis,",
            "probability": 0.00032112111186702005,
            "start_logit": 5.3475661277771,
            "end_logit": -0.6377186179161072,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic retinal v",
            "probability": 0.00018792084015161584,
            "start_logit": 5.3475661277771,
            "end_logit": -1.1735161542892456,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic retinal",
            "probability": 0.00012631124491640055,
            "start_logit": 5.3475661277771,
            "end_logit": -1.5707879066467285,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "idiopathic",
            "probability": 0.00011771565934248142,
            "start_logit": 5.3475661277771,
            "end_logit": -1.6412649154663086,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "retinitis",
            "probability": 0.00010937896807871963,
            "start_logit": -2.272700309753418,
            "end_logit": 5.905548095703125,
            "question_text": "List 3 features of IRVAN syndrome."
        },
        {
            "text": "litis, aneurysms, and neuroretinitis",
            "probability": 9.614984343031014e-05,
            "start_logit": -2.401611089706421,
            "end_logit": 5.905548095703125,
            "question_text": "List 3 features of IRVAN syndrome."
        }
    ],
    "58dbb3f18acda34529000019": [
        {
            "text": "alirocumab",
            "probability": 0.3637313775391411,
            "start_logit": 6.268599987030029,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evolocumab and alirocumab",
            "probability": 0.32867803854856437,
            "start_logit": 6.167263031005859,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evolocumab",
            "probability": 0.3044165675647193,
            "start_logit": 6.167263031005859,
            "end_logit": 5.944863319396973,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "monoclonal antibodies directed to PCSK9 (ie, evolocumab and alirocumab",
            "probability": 0.0011244611107600812,
            "start_logit": 0.48948827385902405,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "monoclonal antibodies directed to PCSK9 (ie, evolocumab",
            "probability": 0.001041458666387343,
            "start_logit": 0.48948827385902405,
            "end_logit": 5.944863319396973,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "alirocumab)",
            "probability": 0.00013920367846950325,
            "start_logit": 6.268599987030029,
            "end_logit": -1.8466877937316895,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evolocumab and alirocumab)",
            "probability": 0.0001257884109631918,
            "start_logit": 6.167263031005859,
            "end_logit": -1.8466877937316895,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "b and alirocumab",
            "probability": 9.203631554114241e-05,
            "start_logit": -2.013387680053711,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "b",
            "probability": 8.524262646832807e-05,
            "start_logit": -2.013387680053711,
            "end_logit": 5.944863319396973,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "e",
            "probability": 8.237004144252931e-05,
            "start_logit": 6.167263031005859,
            "end_logit": -2.2700672149658203,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "ab",
            "probability": 7.860188425739711e-05,
            "start_logit": -2.171175241470337,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "al",
            "probability": 6.480958631663033e-05,
            "start_logit": 6.268599987030029,
            "end_logit": -2.6111724376678467,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "antibodies directed to PCSK9 (ie, evolocumab and alirocumab",
            "probability": 6.138613388583426e-05,
            "start_logit": -2.418386936187744,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "evolocumab and al",
            "probability": 5.856378917268882e-05,
            "start_logit": 6.167263031005859,
            "end_logit": -2.6111724376678467,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "antibodies directed to PCSK9 (ie, evolocumab",
            "probability": 5.685489744345316e-05,
            "start_logit": -2.418386936187744,
            "end_logit": 5.944863319396973,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "locumab and alirocumab",
            "probability": 3.966735097550807e-05,
            "start_logit": -2.8550424575805664,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "cumab",
            "probability": 3.908250710639669e-05,
            "start_logit": -2.8698959350585938,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "locumab",
            "probability": 3.67392932052105e-05,
            "start_logit": -2.8550424575805664,
            "end_logit": 5.944863319396973,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "volocumab and alirocumab",
            "probability": 2.4789967132287537e-05,
            "start_logit": -3.325131893157959,
            "end_logit": 6.021544933319092,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        },
        {
            "text": "volocumab",
            "probability": 2.296008804779982e-05,
            "start_logit": -3.325131893157959,
            "end_logit": 5.944863319396973,
            "question_text": "Which are the Proprotein Convertase Subtilisin Kexin 9 (PCSK9) inhibitors that are FDA approved?"
        }
    ],
    "5895dfc97d9090f353000010": [
        {
            "text": "tenofovir",
            "probability": 0.10908039274337683,
            "start_logit": 5.028937816619873,
            "end_logit": 4.159294605255127,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir",
            "probability": 0.09725103961278557,
            "start_logit": 4.566376209259033,
            "end_logit": 4.50706672668457,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine",
            "probability": 0.09028988368982485,
            "start_logit": 4.60585355758667,
            "end_logit": 4.393319129943848,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir/cobicistat/emtricitabine",
            "probability": 0.08679491836812107,
            "start_logit": 4.566376209259033,
            "end_logit": 4.393319129943848,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine, a nucleoside reverse transcriptase inhibitor; and tenofovir",
            "probability": 0.07069899282162817,
            "start_logit": 4.5952839851379395,
            "end_logit": 4.159294605255127,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "tenofovir DF), a nucleotide reverse transcriptase inhibitor (elvitegravir",
            "probability": 0.05927991307370248,
            "start_logit": 4.071351051330566,
            "end_logit": 4.50706672668457,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "cobicistat/emtricitabine",
            "probability": 0.05554646694203568,
            "start_logit": 4.1200480461120605,
            "end_logit": 4.393319129943848,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine/tenofovir",
            "probability": 0.054803250142163945,
            "start_logit": 4.60585355758667,
            "end_logit": 3.894043207168579,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "cobicistat, a pharmacokinetic enhancer; emtricitabine",
            "probability": 0.05354597575532113,
            "start_logit": 4.215620994567871,
            "end_logit": 4.261066913604736,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir/cobicistat/emtricitabine/tenofovir",
            "probability": 0.052681911062566644,
            "start_logit": 4.566376209259033,
            "end_logit": 3.894043207168579,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir/cobicistat",
            "probability": 0.04315771677841701,
            "start_logit": 4.566376209259033,
            "end_logit": 3.6946322917938232,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "tenofovir disoproxil fumarate",
            "probability": 0.04047190005193269,
            "start_logit": 5.028937816619873,
            "end_logit": 3.1678173542022705,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "tenofovir disoproxil fumarate (tenofovir",
            "probability": 0.033873555526598056,
            "start_logit": 5.028937816619873,
            "end_logit": 2.9898440837860107,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "cobicistat/emtricitabine/tenofovir",
            "probability": 0.033715038694649216,
            "start_logit": 4.1200480461120605,
            "end_logit": 3.894043207168579,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "cobicistat",
            "probability": 0.029916030594858655,
            "start_logit": 4.215620994567871,
            "end_logit": 3.6789207458496094,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "elvitegravir, an HIV-1 integrase strand transfer inhibitor (INSTI); cobicistat",
            "probability": 0.0281268235804643,
            "start_logit": 4.153950214385986,
            "end_logit": 3.6789207458496094,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "tenofovir DF), a nucleotide reverse transcriptase inhibitor (elvitegravir/cobicistat",
            "probability": 0.026307026734834833,
            "start_logit": 4.071351051330566,
            "end_logit": 3.6946322917938232,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine, a nucleoside reverse transcriptase inhibitor; and tenofovir disoproxil fumarate",
            "probability": 0.026231318931724118,
            "start_logit": 4.5952839851379395,
            "end_logit": 3.1678173542022705,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "tenofovir disoproxil",
            "probability": 0.0049922105905356425,
            "start_logit": 5.028937816619873,
            "end_logit": 1.0750882625579834,
            "question_text": "List active ingredients of the Stribild polypill."
        },
        {
            "text": "emtricitabine, a nucleoside reverse transcriptase inhibitor; and tenofovir disoproxil",
            "probability": 0.003235634304459045,
            "start_logit": 4.5952839851379395,
            "end_logit": 1.0750882625579834,
            "question_text": "List active ingredients of the Stribild polypill."
        }
    ],
    "5895e4637d9090f353000012": [
        {
            "text": "Metaphyseal dysplasia",
            "probability": 0.18327681278350402,
            "start_logit": 3.798560380935669,
            "end_logit": 4.205982685089111,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Adrenal hypoplasia congenita",
            "probability": 0.16363380654045898,
            "start_logit": 4.111369609832764,
            "end_logit": 3.7798068523406982,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Adrenal hypoplasia congenita, and Genital abnormalities",
            "probability": 0.12191836816035893,
            "start_logit": 4.111369609832764,
            "end_logit": 3.485527515411377,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Metaphyseal dysplasia, Adrenal hypoplasia congenita",
            "probability": 0.11968003604083921,
            "start_logit": 3.798560380935669,
            "end_logit": 3.7798068523406982,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital abnormalities",
            "probability": 0.08916980545743364,
            "start_logit": 3.798560380935669,
            "end_logit": 3.485527515411377,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine growth retardation, Metaphyseal dysplasia",
            "probability": 0.062045175605508825,
            "start_logit": 2.715425491333008,
            "end_logit": 4.205982685089111,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Adrenal hypoplasia",
            "probability": 0.056999485960573915,
            "start_logit": 4.111369609832764,
            "end_logit": 2.7252180576324463,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Genital abnormalities",
            "probability": 0.05323107505539253,
            "start_logit": 3.2826602458953857,
            "end_logit": 3.485527515411377,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Metaphyseal dysplasia, Adrenal hypoplasia",
            "probability": 0.04168882138902091,
            "start_logit": 3.798560380935669,
            "end_logit": 2.7252180576324463,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine growth retardation, Metaphyseal dysplasia, Adrenal hypoplasia congenita",
            "probability": 0.04051559354318845,
            "start_logit": 2.715425491333008,
            "end_logit": 3.7798068523406982,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine growth retardation",
            "probability": 0.016354623979921327,
            "start_logit": 2.715425491333008,
            "end_logit": 2.8726305961608887,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "growth retardation, Metaphyseal dysplasia",
            "probability": 0.014763457949925389,
            "start_logit": 1.2797178030014038,
            "end_logit": 4.205982685089111,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine growth retardation, Metaphyseal dysplasia, Adrenal hypoplasia",
            "probability": 0.014113025017102996,
            "start_logit": 2.715425491333008,
            "end_logit": 2.7252180576324463,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "growth retardation, Metaphyseal dysplasia, Adrenal hypoplasia congenita",
            "probability": 0.00964056037804208,
            "start_logit": 1.2797178030014038,
            "end_logit": 3.7798068523406982,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "growth retardation",
            "probability": 0.0038915322756048767,
            "start_logit": 1.2797178030014038,
            "end_logit": 2.8726305961608887,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "growth retardation, Metaphyseal dysplasia, Adrenal hypoplasia",
            "probability": 0.0033581507240950685,
            "start_logit": 1.2797178030014038,
            "end_logit": 2.7252180576324463,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Metaphyseal dysplasia,",
            "probability": 0.002789452383141755,
            "start_logit": 3.798560380935669,
            "end_logit": 0.020830335095524788,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine growth retardation,",
            "probability": 0.0010086462280654517,
            "start_logit": 2.715425491333008,
            "end_logit": 0.08672899007797241,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Adrenal hypoplasia congenita,",
            "probability": 0.0009772499652435471,
            "start_logit": 4.111369609832764,
            "end_logit": -1.340837001800537,
            "question_text": "List clinical features of the IMAGe syndrome."
        },
        {
            "text": "Intrauterine growth retardation, Metaphyseal dysplasia,",
            "probability": 0.000944320562578076,
            "start_logit": 2.715425491333008,
            "end_logit": 0.020830335095524788,
            "question_text": "List clinical features of the IMAGe syndrome."
        }
    ],
    "58e7a1393e8b6dc87c00000b": [
        {
            "text": "interferon-\u03b3",
            "probability": 0.2564582147034918,
            "start_logit": 0.45890673995018005,
            "end_logit": -1.2537360191345215,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Toll-like receptor, inflammasome and interferon-\u03b3",
            "probability": 0.14505736619302606,
            "start_logit": -0.1109297126531601,
            "end_logit": -1.2537360191345215,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Toll-like receptor",
            "probability": 0.13140810319399593,
            "start_logit": -0.1109297126531601,
            "end_logit": -1.3525575399398804,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Toll-like receptor, inflammasome",
            "probability": 0.06810025480508289,
            "start_logit": -0.1109297126531601,
            "end_logit": -2.0098843574523926,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "interferon-\u03b3 pathways",
            "probability": 0.058172934518702056,
            "start_logit": 0.45890673995018005,
            "end_logit": -2.737281560897827,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "interferon-\u03b3 pathways contributes to the differences in treatment response",
            "probability": 0.05307668580905068,
            "start_logit": 0.45890673995018005,
            "end_logit": -2.8289639949798584,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Toll-like receptor, inflammasome and interferon-\u03b3 pathways",
            "probability": 0.03290365518124851,
            "start_logit": -0.1109297126531601,
            "end_logit": -2.737281560897827,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "interferon-\u03b3 pathways contributes to the differences",
            "probability": 0.030522994100156492,
            "start_logit": 0.45890673995018005,
            "end_logit": -3.3822214603424072,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Toll-like receptor, inflammasome and interferon-\u03b3 pathways contributes to the differences in treatment response",
            "probability": 0.030021125502324678,
            "start_logit": -0.1109297126531601,
            "end_logit": -2.8289639949798584,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "inflammasome and interferon-\u03b3",
            "probability": 0.029547626888553332,
            "start_logit": -1.70205557346344,
            "end_logit": -1.2537360191345215,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Toll",
            "probability": 0.026443437961076795,
            "start_logit": -0.1109297126531601,
            "end_logit": -2.955857276916504,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "genetic variation within genes related to the Toll-like receptor, inflammasome and interferon-\u03b3",
            "probability": 0.0249842454522759,
            "start_logit": -1.8698135614395142,
            "end_logit": -1.2537360191345215,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "genetic variation within genes related to the Toll-like receptor",
            "probability": 0.02263333735322321,
            "start_logit": -1.8698135614395142,
            "end_logit": -1.3525575399398804,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "Toll-like receptor, inflammasome and interferon-\u03b3 pathways contributes to the differences",
            "probability": 0.01726435293801369,
            "start_logit": -0.1109297126531601,
            "end_logit": -3.3822214603424072,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "interferon-\u03b3 pathways contributes",
            "probability": 0.01474063802699582,
            "start_logit": 0.45890673995018005,
            "end_logit": -4.110093593597412,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "inflammasome",
            "probability": 0.013871759654855369,
            "start_logit": -1.70205557346344,
            "end_logit": -2.0098843574523926,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "interferon-\u03b3 pathways contributes to the differences in treatment response to tumour necrosis factor inhibitors",
            "probability": 0.01336278565611701,
            "start_logit": 0.45890673995018005,
            "end_logit": -4.20822811126709,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "genetic variation within genes related to the Toll-like receptor, inflammasome",
            "probability": 0.011729383526436328,
            "start_logit": -1.8698135614395142,
            "end_logit": -2.0098843574523926,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "genetic variation",
            "probability": 0.009892239961510592,
            "start_logit": -1.8698135614395142,
            "end_logit": -2.1802308559417725,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        },
        {
            "text": "determine whether genetic variation within genes related to the Toll-like receptor, inflammasome and interferon-\u03b3",
            "probability": 0.009808858573862869,
            "start_logit": -2.8047730922698975,
            "end_logit": -1.2537360191345215,
            "question_text": "Which gene mutations are predictive of response to anti-TNF therapy in Rheumatoid Arthritis patients?"
        }
    ],
    "5895e9977d9090f353000013": [
        {
            "text": "macular dystrophy",
            "probability": 0.20190336932926198,
            "start_logit": 5.706448078155518,
            "end_logit": 5.8517937660217285,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia, ectrodactyly, and macular dystrophy",
            "probability": 0.17178201075404978,
            "start_logit": 5.544885158538818,
            "end_logit": 5.8517937660217285,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectrodactyly, and macular dystrophy",
            "probability": 0.1403139417184401,
            "start_logit": 5.342541217803955,
            "end_logit": 5.8517937660217285,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia",
            "probability": 0.1129735976715721,
            "start_logit": 5.544885158538818,
            "end_logit": 5.4327216148376465,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia, ectrodactyly",
            "probability": 0.11238825942464765,
            "start_logit": 5.544885158538818,
            "end_logit": 5.427526950836182,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectrodactyly",
            "probability": 0.09180029744398116,
            "start_logit": 5.342541217803955,
            "end_logit": 5.427526950836182,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "hypotrichosis with juvenile macular dystrophy (HJMD) and ectodermal dysplasia",
            "probability": 0.03733529832005159,
            "start_logit": 4.4376702308654785,
            "end_logit": 5.4327216148376465,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "macular dystrophy (HJMD) and ectodermal dysplasia",
            "probability": 0.0321553867948556,
            "start_logit": 4.288311004638672,
            "end_logit": 5.4327216148376465,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "macular dystrophy (HJMD) and ectodermal dysplasia, ectrodactyly",
            "probability": 0.03198878346342594,
            "start_logit": 4.288311004638672,
            "end_logit": 5.427526950836182,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "hypotrichosis with juvenile macular dystrophy",
            "probability": 0.02199114683176257,
            "start_logit": 4.4376702308654785,
            "end_logit": 4.9034223556518555,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "juvenile macular dystrophy (HJMD) and ectodermal dysplasia",
            "probability": 0.012609186341683483,
            "start_logit": 3.352156639099121,
            "end_logit": 5.4327216148376465,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "juvenile macular dystrophy (HJMD) and ectodermal dysplasia, ectrodactyly",
            "probability": 0.012543855687614725,
            "start_logit": 3.352156639099121,
            "end_logit": 5.427526950836182,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "juvenile macular dystrophy",
            "probability": 0.007427032345958056,
            "start_logit": 3.352156639099121,
            "end_logit": 4.9034223556518555,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "hypotrichosis",
            "probability": 0.0056959900781291,
            "start_logit": 4.4376702308654785,
            "end_logit": 3.5525448322296143,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "macular dystrophy (EEM) syndromes. Both syndromes feature sparse hair heralding progressive macular dystrophy",
            "probability": 0.0052901039223464,
            "start_logit": 5.706448078155518,
            "end_logit": 2.2098424434661865,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia,",
            "probability": 0.000617261372045223,
            "start_logit": 5.544885158538818,
            "end_logit": 0.22310474514961243,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectodermal dysplasia, ectrodactyly,",
            "probability": 0.0004429719493264598,
            "start_logit": 5.544885158538818,
            "end_logit": -0.10868135839700699,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "ectrodactyly,",
            "probability": 0.00036182566502663535,
            "start_logit": 5.342541217803955,
            "end_logit": -0.10868135839700699,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "hypotrichosis with juvenile macular dystrophy (HJMD) and ectodermal dysplasia,",
            "probability": 0.00020399135675708242,
            "start_logit": 4.4376702308654785,
            "end_logit": 0.22310474514961243,
            "question_text": "List clinical features of EEM syndrome."
        },
        {
            "text": "macular dystrophy (HJMD) and ectodermal dysplasia,",
            "probability": 0.00017568952906447008,
            "start_logit": 4.288311004638672,
            "end_logit": 0.22310474514961243,
            "question_text": "List clinical features of EEM syndrome."
        }
    ],
    "58e640573e8b6dc87c000003": [
        {
            "text": "CIRCexplorer",
            "probability": 0.1037963026833303,
            "start_logit": 5.187463760375977,
            "end_logit": 4.894156455993652,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer",
            "probability": 0.09941834650746732,
            "start_logit": 5.144370079040527,
            "end_logit": 4.894156455993652,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRCexplorer, CIRI",
            "probability": 0.09114222295847144,
            "start_logit": 5.187463760375977,
            "end_logit": 4.7641472816467285,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find_circ",
            "probability": 0.08842282128462256,
            "start_logit": 5.144370079040527,
            "end_logit": 4.776949882507324,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI",
            "probability": 0.08729799491211923,
            "start_logit": 5.144370079040527,
            "end_logit": 4.7641472816467285,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRI",
            "probability": 0.0802008350679192,
            "start_logit": 5.059576511383057,
            "end_logit": 4.7641472816467285,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder",
            "probability": 0.07044369344067601,
            "start_logit": 5.144370079040527,
            "end_logit": 4.549633502960205,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.053429222648646926,
            "start_logit": 5.187463760375977,
            "end_logit": 4.23008394241333,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "find_circ, CIRCexplorer",
            "probability": 0.05276107101801584,
            "start_logit": 4.510807037353516,
            "end_logit": 4.894156455993652,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.0511756665082145,
            "start_logit": 5.144370079040527,
            "end_logit": 4.23008394241333,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "CIRI, and MapSplice",
            "probability": 0.047015182802856784,
            "start_logit": 5.059576511383057,
            "end_logit": 4.23008394241333,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "find_circ",
            "probability": 0.04692577293126559,
            "start_logit": 4.510807037353516,
            "end_logit": 4.776949882507324,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI",
            "probability": 0.046328830352683,
            "start_logit": 4.510807037353516,
            "end_logit": 4.7641472816467285,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "MapSplice",
            "probability": 0.03238707444316535,
            "start_logit": 4.686865329742432,
            "end_logit": 4.23008394241333,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "find_circ, CIRCexplorer, CIRI, and MapSplice",
            "probability": 0.027158799858247457,
            "start_logit": 4.510807037353516,
            "end_logit": 4.23008394241333,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA",
            "probability": 0.01862419253949067,
            "start_logit": 5.144370079040527,
            "end_logit": 3.2192811965942383,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circ, CIRCexplorer",
            "probability": 0.000959157179490934,
            "start_logit": 0.5033330917358398,
            "end_logit": 4.894156455993652,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circ",
            "probability": 0.0008530757837500276,
            "start_logit": 0.5033330917358398,
            "end_logit": 4.776949882507324,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circ, CIRCexplorer, CIRI",
            "probability": 0.0008422238099567772,
            "start_logit": 0.5033330917358398,
            "end_logit": 4.7641472816467285,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        },
        {
            "text": "circRNA_finder, find",
            "probability": 0.0008175132696097766,
            "start_logit": 5.144370079040527,
            "end_logit": 0.09333164244890213,
            "question_text": "Which are the most common methods for circular RNA detection from RNASeq?"
        }
    ],
    "58adca6d9ef3c34033000007": [
        {
            "text": "MTREC",
            "probability": 0.6803211404195197,
            "start_logit": 4.285632133483887,
            "end_logit": 3.598088502883911,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "MTREC complex",
            "probability": 0.1764026863327648,
            "start_logit": 4.285632133483887,
            "end_logit": 2.248292922973633,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "TRAMP",
            "probability": 0.04342089794356099,
            "start_logit": 2.661863327026367,
            "end_logit": 2.470233201980591,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "MTREC complex in RNA",
            "probability": 0.037687709635561444,
            "start_logit": 4.285632133483887,
            "end_logit": 0.704857587814331,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "TRAMP complex has only a minor role in this process. The MTREC",
            "probability": 0.02303022550831119,
            "start_logit": 2.661863327026367,
            "end_logit": 1.8360998630523682,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "TRAMP complex",
            "probability": 0.016285348891148316,
            "start_logit": 2.661863327026367,
            "end_logit": 1.489558219909668,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "MTREC complex,",
            "probability": 0.006310117882688644,
            "start_logit": 3.615025281906128,
            "end_logit": -0.41171523928642273,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA",
            "probability": 0.002557777798639666,
            "start_logit": 1.595436930656433,
            "end_logit": 0.704857587814331,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "the MTREC",
            "probability": 0.00247321713735744,
            "start_logit": -0.7662053108215332,
            "end_logit": 3.0328807830810547,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA degradation machinery. Our study reveals the central role of the evolutionarily conserved MTREC",
            "probability": 0.0023198347056009746,
            "start_logit": -1.3954368829727173,
            "end_logit": 3.598088502883911,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA processing to the RNA degradation machinery. Our study reveals the central role of the evolutionarily conserved MTREC",
            "probability": 0.001805908522790747,
            "start_logit": -1.6458690166473389,
            "end_logit": 3.598088502883911,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "MTREC complex in RNA quality control",
            "probability": 0.0016240154100663087,
            "start_logit": 4.285632133483887,
            "end_logit": -2.439574718475342,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "the MTREC complex",
            "probability": 0.001248559107589745,
            "start_logit": -0.7662053108215332,
            "end_logit": 2.349351167678833,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "TRAMP complex has only a minor role in this process. The MTREC complex",
            "probability": 0.0011472202033958301,
            "start_logit": 2.661863327026367,
            "end_logit": -1.1633658409118652,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNAs for degradation by the nuclear exosome, while the TRAMP",
            "probability": 0.0009501800687208254,
            "start_logit": -1.1601812839508057,
            "end_logit": 2.470233201980591,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA degradation machinery. Our study reveals the central role of the evolutionarily conserved MTREC complex",
            "probability": 0.00060151750343028,
            "start_logit": -1.3954368829727173,
            "end_logit": 2.248292922973633,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNAs for degradation by the nuclear exosome, while the TRAMP complex has only a minor role in this process. The MTREC",
            "probability": 0.0005039707213007626,
            "start_logit": -1.1601812839508057,
            "end_logit": 1.8360998630523682,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "RNA processing to the RNA degradation machinery. Our study reveals the central role of the evolutionarily conserved MTREC complex",
            "probability": 0.0004682599081002812,
            "start_logit": -1.6458690166473389,
            "end_logit": 2.248292922973633,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "the evolutionarily conserved MTREC",
            "probability": 0.00042395255488524415,
            "start_logit": -3.095066547393799,
            "end_logit": 3.598088502883911,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        },
        {
            "text": "MTREC complex physically interacts with the nuclear exosome and with various RNA-binding and RNA-processing complexes, coupling RNA",
            "probability": 0.0004174597445670768,
            "start_logit": 2.262014389038086,
            "end_logit": -1.7744258642196655,
            "question_text": "Which proteins control the degradation of cryptic unstable transcripts (CUTs) in yeast?"
        }
    ],
    "58eb6061eda5a57672000005": [
        {
            "text": "read error correction",
            "probability": 0.1590875233651411,
            "start_logit": 1.0723505020141602,
            "end_logit": 0.8725103735923767,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "genome, transcriptome and metagenome assemblies, and read error correction",
            "probability": 0.13589700234564153,
            "start_logit": 0.9147932529449463,
            "end_logit": 0.8725103735923767,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "metagenome assemblies, and read error correction",
            "probability": 0.11209206658608915,
            "start_logit": 0.7222165465354919,
            "end_logit": 0.8725103735923767,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "genome, transcriptome and metagenome assemblies",
            "probability": 0.10739206905176873,
            "start_logit": 0.9147932529449463,
            "end_logit": 0.6370994448661804,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "transcriptome and metagenome assemblies, and read error correction",
            "probability": 0.09827457016314645,
            "start_logit": 0.5906612873077393,
            "end_logit": 0.8725103735923767,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "metagenome assemblies",
            "probability": 0.08858031264259757,
            "start_logit": 0.7222165465354919,
            "end_logit": 0.6370994448661804,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "transcriptome and metagenome assemblies",
            "probability": 0.07766109069978316,
            "start_logit": 0.5906612873077393,
            "end_logit": 0.6370994448661804,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "genome",
            "probability": 0.07569499208792263,
            "start_logit": 0.9147932529449463,
            "end_logit": 0.2873251140117645,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "genome, transcriptome",
            "probability": 0.02001109540745438,
            "start_logit": 0.9147932529449463,
            "end_logit": -1.0430999994277954,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "genome, transcriptome and metagenome",
            "probability": 0.01711017272036742,
            "start_logit": 0.9147932529449463,
            "end_logit": -1.1997137069702148,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "transcriptome",
            "probability": 0.014471119787171412,
            "start_logit": 0.5906612873077393,
            "end_logit": -1.0430999994277954,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "metagenome",
            "probability": 0.014113001661308694,
            "start_logit": 0.7222165465354919,
            "end_logit": -1.1997137069702148,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "tracking the frequencies of observed spaced seeds. These data structure designs will have applications in genome, transcriptome and metagenome assemblies",
            "probability": 0.013832805348324215,
            "start_logit": -1.1346501111984253,
            "end_logit": 0.6370994448661804,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "transcriptome and metagenome",
            "probability": 0.012373303608526804,
            "start_logit": 0.5906612873077393,
            "end_logit": -1.1997137069702148,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "tracking the frequencies of observed spaced seeds. These data structure designs will have applications in genome",
            "probability": 0.009750013205262201,
            "start_logit": -1.1346501111984253,
            "end_logit": 0.2873251140117645,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "genome, transcriptome and metagenome assemblies,",
            "probability": 0.009749707817783232,
            "start_logit": 0.9147932529449463,
            "end_logit": -1.7621495723724365,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "read",
            "probability": 0.009538046939516225,
            "start_logit": 1.0723505020141602,
            "end_logit": -1.9416553974151611,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "assemblies, and read error correction",
            "probability": 0.008181578977258115,
            "start_logit": -1.895218849182129,
            "end_logit": 0.8725103735923767,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "genome, transcriptome and metagenome assemblies, and read",
            "probability": 0.00814766588789762,
            "start_logit": 0.9147932529449463,
            "end_logit": -1.9416553974151611,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        },
        {
            "text": "metagenome assemblies,",
            "probability": 0.00804186169703928,
            "start_logit": 0.7222165465354919,
            "end_logit": -1.7621495723724365,
            "question_text": "In which fields of DNA sequencing are Bloom filters applied?"
        }
    ],
    "589a246c78275d0c4a000032": [
        {
            "text": "phentermine/topiramate",
            "probability": 0.3490041987848778,
            "start_logit": 6.816431522369385,
            "end_logit": 7.0031232833862305,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "topiramate",
            "probability": 0.29355262198500737,
            "start_logit": 6.643404483795166,
            "end_logit": 7.0031232833862305,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine",
            "probability": 0.2457703105689928,
            "start_logit": 6.816431522369385,
            "end_logit": 6.65243673324585,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "Lorcaserin (Belviq(\u00ae)), phentermine/topiramate",
            "probability": 0.033446409769334794,
            "start_logit": 4.471292018890381,
            "end_logit": 7.0031232833862305,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "Lorcaserin (Belviq(\u00ae)), phentermine",
            "probability": 0.023553110664705793,
            "start_logit": 4.471292018890381,
            "end_logit": 6.65243673324585,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine/topiramate combination",
            "probability": 0.01896185923923834,
            "start_logit": 6.816431522369385,
            "end_logit": 4.090468883514404,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "topiramate combination",
            "probability": 0.01594910180670937,
            "start_logit": 6.643404483795166,
            "end_logit": 4.090468883514404,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "Lorcaserin",
            "probability": 0.008724189405499834,
            "start_logit": 4.471292018890381,
            "end_logit": 5.659278392791748,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine/topiramate combination (Qsymia(\u00ae)), and bupropion",
            "probability": 0.0035410612856514733,
            "start_logit": 6.816431522369385,
            "end_logit": 2.412465810775757,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "topiramate combination (Qsymia(\u00ae)), and bupropion",
            "probability": 0.002978439309990421,
            "start_logit": 6.643404483795166,
            "end_logit": 2.412465810775757,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "Lorcaserin (Belviq(\u00ae)), phentermine/topiramate combination",
            "probability": 0.0018171876335932847,
            "start_logit": 4.471292018890381,
            "end_logit": 4.090468883514404,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine/topiramate combination (Qsymia(\u00ae)), and bupropion/naltrexone",
            "probability": 0.0007690061894273579,
            "start_logit": 6.816431522369385,
            "end_logit": 0.8853830695152283,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "topiramate combination (Qsymia(\u00ae)), and bupropion/naltrexone",
            "probability": 0.0006468225425799133,
            "start_logit": 6.643404483795166,
            "end_logit": 0.8853830695152283,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "/topiramate",
            "probability": 0.0005780102702892552,
            "start_logit": 0.41318392753601074,
            "end_logit": 7.0031232833862305,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "serin (Belviq(\u00ae)), phentermine/topiramate",
            "probability": 0.00022985270729732472,
            "start_logit": -0.5089690089225769,
            "end_logit": 7.0031232833862305,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "serin (Belviq(\u00ae)), phentermine",
            "probability": 0.00016186329979487636,
            "start_logit": -0.5089690089225769,
            "end_logit": 6.65243673324585,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "mate",
            "probability": 0.00010758049730125081,
            "start_logit": -1.268168330192566,
            "end_logit": 7.0031232833862305,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phentermine/topiramate combination (Qsymia(\u00ae))",
            "probability": 7.76714844124472e-05,
            "start_logit": 6.816431522369385,
            "end_logit": -1.4072277545928955,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "phenter",
            "probability": 6.537191462725086e-05,
            "start_logit": 6.816431522369385,
            "end_logit": -1.5796232223510742,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        },
        {
            "text": "topiramate combination (Qsymia(\u00ae))",
            "probability": 6.533064066886937e-05,
            "start_logit": 6.643404483795166,
            "end_logit": -1.4072277545928955,
            "question_text": "Which 2 medications are included in the Qsymia pill?"
        }
    ],
    "58da2a348acda34529000014": [
        {
            "text": "alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol",
            "probability": 0.21396796247535965,
            "start_logit": 5.087239742279053,
            "end_logit": 4.698374271392822,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "alpha-fetoprotein",
            "probability": 0.21203475020194937,
            "start_logit": 5.087239742279053,
            "end_logit": 4.689298152923584,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "alpha-fetoprotein, human chorionic gonadotropin",
            "probability": 0.17643033835756491,
            "start_logit": 5.087239742279053,
            "end_logit": 4.505474090576172,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "unconjugated estriol",
            "probability": 0.13743599731054648,
            "start_logit": 4.644571781158447,
            "end_logit": 4.698374271392822,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "human chorionic gonadotropin, and unconjugated estriol",
            "probability": 0.11357360488316928,
            "start_logit": 4.453864574432373,
            "end_logit": 4.698374271392822,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "human chorionic gonadotropin",
            "probability": 0.09364873743812689,
            "start_logit": 4.453864574432373,
            "end_logit": 4.505474090576172,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "estriol",
            "probability": 0.04491458294795955,
            "start_logit": 3.5261759757995605,
            "end_logit": 4.698374271392822,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "alpha-fetoprotein, human chorionic gonadotropin,",
            "probability": 0.0023548768273489594,
            "start_logit": 5.087239742279053,
            "end_logit": 0.18903639912605286,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "human chorionic gonadotropin,",
            "probability": 0.001249962130983331,
            "start_logit": 4.453864574432373,
            "end_logit": 0.18903639912605286,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "alpha-fetoprotein,",
            "probability": 0.0008529959078112407,
            "start_logit": 5.087239742279053,
            "end_logit": -0.8264525532722473,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "fetoprotein, human chorionic gonadotropin, and unconjugated estriol",
            "probability": 0.00046825415044259196,
            "start_logit": -1.0373306274414062,
            "end_logit": 4.698374271392822,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "fetoprotein",
            "probability": 0.00046402344851769443,
            "start_logit": -1.0373306274414062,
            "end_logit": 4.689298152923584,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "triple marker screening of alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol",
            "probability": 0.0004037175278248022,
            "start_logit": -1.1856263875961304,
            "end_logit": 4.698374271392822,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "triple marker screening of alpha-fetoprotein",
            "probability": 0.0004000699178239749,
            "start_logit": -1.1856263875961304,
            "end_logit": 4.689298152923584,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "fetoprotein, human chorionic gonadotropin",
            "probability": 0.00038610564518243886,
            "start_logit": -1.0373306274414062,
            "end_logit": 4.505474090576172,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "triple marker screening of alpha-fetoprotein, human chorionic gonadotropin",
            "probability": 0.0003328910515900811,
            "start_logit": -1.1856263875961304,
            "end_logit": 4.505474090576172,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "unconjugated estriol for the prenatal diagnosis of fetal chromosomal abnormalities",
            "probability": 0.00031347398606024717,
            "start_logit": 4.644571781158447,
            "end_logit": -1.384822964668274,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "gonadotropin, and unconjugated estriol",
            "probability": 0.00029189883533157975,
            "start_logit": -1.5099345445632935,
            "end_logit": 4.698374271392822,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "gonadotropin",
            "probability": 0.000240689352218608,
            "start_logit": -1.5099345445632935,
            "end_logit": 4.505474090576172,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        },
        {
            "text": "chorionic gonadotropin, and unconjugated estriol",
            "probability": 0.0002350676041881597,
            "start_logit": -1.7264686822891235,
            "end_logit": 4.698374271392822,
            "question_text": "Which markers are screened with the triple test for the detection of syndromes in fetus?"
        }
    ],
    "5a6d0b2db750ff445500002d": [
        {
            "text": "CDC48",
            "probability": 0.45237873353331176,
            "start_logit": 5.435028553009033,
            "end_logit": 4.625488758087158,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC48-dependent dissolution of the CMG helicase (CDC45",
            "probability": 0.1294531216533978,
            "start_logit": 5.435028553009033,
            "end_logit": 3.3742878437042236,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC48-dependent dissolution of the CMG",
            "probability": 0.10613120268922319,
            "start_logit": 5.435028553009033,
            "end_logit": 3.175645112991333,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC48-dependent dissolution of the CMG helicase",
            "probability": 0.06176154382424513,
            "start_logit": 5.435028553009033,
            "end_logit": 2.6342499256134033,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CMG helicase (CDC45",
            "probability": 0.04300109587749991,
            "start_logit": 4.332935333251953,
            "end_logit": 3.3742878437042236,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CMG",
            "probability": 0.03525413651014784,
            "start_logit": 4.332935333251953,
            "end_logit": 3.175645112991333,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC48-dependent dissolution of the CMG helicase (CDC45-MCM-GINS",
            "probability": 0.03394808302036124,
            "start_logit": 5.435028553009033,
            "end_logit": 2.035801410675049,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC45",
            "probability": 0.032573402776811,
            "start_logit": 4.055205821990967,
            "end_logit": 3.3742878437042236,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CMG helicase",
            "probability": 0.02051564329703492,
            "start_logit": 4.332935333251953,
            "end_logit": 2.6342499256134033,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC48-dependent dissolution of the CMG helicase (CDC45-MCM-GINS)",
            "probability": 0.01720299702096087,
            "start_logit": 5.435028553009033,
            "end_logit": 1.3560526371002197,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC48-dependent dissolution of the CMG helicase (CDC45-MCM",
            "probability": 0.015536492623606476,
            "start_logit": 5.435028553009033,
            "end_logit": 1.2541606426239014,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CMG helicase (CDC45-MCM-GINS",
            "probability": 0.01127670583892454,
            "start_logit": 4.332935333251953,
            "end_logit": 2.035801410675049,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC45-MCM-GINS",
            "probability": 0.008542123724784046,
            "start_logit": 4.055205821990967,
            "end_logit": 2.035801410675049,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "ubiquitylation and CDC48",
            "probability": 0.005891025019119201,
            "start_logit": 1.0939388275146484,
            "end_logit": 4.625488758087158,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CMG helicase (CDC45-MCM-GINS)",
            "probability": 0.00571440622543896,
            "start_logit": 4.332935333251953,
            "end_logit": 1.3560526371002197,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CMG helicase (CDC45-MCM",
            "probability": 0.005160835060405332,
            "start_logit": 4.332935333251953,
            "end_logit": 1.2541606426239014,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "MCM-GINS",
            "probability": 0.004924815535263559,
            "start_logit": 3.5044829845428467,
            "end_logit": 2.035801410675049,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC45-MCM-GINS)",
            "probability": 0.004328672370160106,
            "start_logit": 4.055205821990967,
            "end_logit": 1.3560526371002197,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "CDC45-MCM",
            "probability": 0.003909341277398261,
            "start_logit": 4.055205821990967,
            "end_logit": 1.2541606426239014,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        },
        {
            "text": "MCM-GINS)",
            "probability": 0.002495622121906173,
            "start_logit": 3.5044829845428467,
            "end_logit": 1.3560526371002197,
            "question_text": "Which factors drive replisome disassembly during DNA replication termination and mitosis?"
        }
    ],
    "5a7238d32dc08e987e000009": [
        {
            "text": "SGLT2",
            "probability": 0.1915159147770786,
            "start_logit": 3.305515766143799,
            "end_logit": 3.020141839981079,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT1 inhibitory effect because of their relatively weak selectivity for SGLT2",
            "probability": 0.14758153970668483,
            "start_logit": 3.0449256896972656,
            "end_logit": 3.020141839981079,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT2 over SGLT1",
            "probability": 0.14488517638303522,
            "start_logit": 3.305515766143799,
            "end_logit": 2.741112470626831,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT1",
            "probability": 0.13858239141329448,
            "start_logit": 3.0449256896972656,
            "end_logit": 2.957226037979126,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT1 inhibitory effect because of their relatively weak selectivity for SGLT2 over SGLT1",
            "probability": 0.11164804468689554,
            "start_logit": 3.0449256896972656,
            "end_logit": 2.741112470626831,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT2 dual inhibitor) also have a mild or moderate intestinal and renal SGLT1",
            "probability": 0.07937466580946936,
            "start_logit": 2.487639904022217,
            "end_logit": 2.957226037979126,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "Sodium glucose cotransporter 2",
            "probability": 0.04691023902220462,
            "start_logit": 2.5247411727905273,
            "end_logit": 2.394181489944458,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT1/SGLT2 dual inhibitor) also have a mild or moderate intestinal and renal SGLT1",
            "probability": 0.04261455907496312,
            "start_logit": 1.8656566143035889,
            "end_logit": 2.957226037979126,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT1/SGLT2",
            "probability": 0.04142049254301336,
            "start_logit": 1.8656566143035889,
            "end_logit": 2.9288058280944824,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "Sodium glucose",
            "probability": 0.028560844816455017,
            "start_logit": 2.5247411727905273,
            "end_logit": 1.8979822397232056,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "Sodium glucose cotransporter 2 (SGLT2",
            "probability": 0.007889344232732614,
            "start_logit": 2.5247411727905273,
            "end_logit": 0.6114585399627686,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "glucose cotransporter 2",
            "probability": 0.004642430438304189,
            "start_logit": 0.21174323558807373,
            "end_logit": 2.394181489944458,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "glucose",
            "probability": 0.002826498821650256,
            "start_logit": 0.21174323558807373,
            "end_logit": 1.8979822397232056,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "cotransporter 2",
            "probability": 0.0023378854393776845,
            "start_logit": -0.47424793243408203,
            "end_logit": 2.394181489944458,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "Sodium glucose cotransporter",
            "probability": 0.0022556781001865692,
            "start_logit": 2.5247411727905273,
            "end_logit": -0.6406038403511047,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT2 over SGLT1. Recent evidence shows that these SGLT2",
            "probability": 0.002220661387397345,
            "start_logit": 3.305515766143799,
            "end_logit": -1.4370239973068237,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT1. Recent evidence shows that these SGLT2",
            "probability": 0.0018118504515185333,
            "start_logit": 3.1020593643188477,
            "end_logit": -1.4370239973068237,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT2 inhibitors such as canagliflozin and sotagliflozin (a SGLT1",
            "probability": 0.0011741447234211192,
            "start_logit": -0.8127889633178711,
            "end_logit": 2.044015645980835,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "Sodium glucose cotransporter 2 (SGLT2)",
            "probability": 0.0009276936780679949,
            "start_logit": 2.5247411727905273,
            "end_logit": -1.5291081666946411,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        },
        {
            "text": "SGLT2 over SGLT1. Recent evidence shows that these SGLT2 inhibitors with low SGLT2",
            "probability": 0.0008199444942496799,
            "start_logit": 3.305515766143799,
            "end_logit": -2.433347702026367,
            "question_text": "Which two cotransporters are inhibited by sotagliflozin?"
        }
    ],
    "5a894f6abc7bade53a000004": [
        {
            "text": "oesophageal cancer",
            "probability": 0.5728936353288944,
            "start_logit": 4.01642370223999,
            "end_logit": 4.330883979797363,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "head and neck as well as oesophageal cancer",
            "probability": 0.36172373407264036,
            "start_logit": 3.5566043853759766,
            "end_logit": 4.330883979797363,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "cancer",
            "probability": 0.04737728544293948,
            "start_logit": 1.5238665342330933,
            "end_logit": 4.330883979797363,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "head and neck",
            "probability": 0.008266981533817502,
            "start_logit": 3.5566043853759766,
            "end_logit": 0.5522726774215698,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "odds ratios of up to 7 for head and neck as well as oesophageal cancer",
            "probability": 0.003004914464060613,
            "start_logit": -1.2340272665023804,
            "end_logit": 4.330883979797363,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "head",
            "probability": 0.0015386837260648308,
            "start_logit": 3.5566043853759766,
            "end_logit": -1.129069447517395,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oesophageal cancer. Previous animal toxicology based risk assessments may have underestimated the risk of acetaldehyde",
            "probability": 0.001518236980374463,
            "start_logit": 4.01642370223999,
            "end_logit": -1.6022663116455078,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "neck as well as oesophageal cancer",
            "probability": 0.0010588863770340257,
            "start_logit": -2.2770586013793945,
            "end_logit": 4.330883979797363,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "o",
            "probability": 0.00046459610196839587,
            "start_logit": 4.01642370223999,
            "end_logit": -2.786402940750122,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "heavy drinkers, which is associated with odds ratios of up to 7 for head and neck as well as oesophageal cancer",
            "probability": 0.000441900205744354,
            "start_logit": -3.1509475708007812,
            "end_logit": 4.330883979797363,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "acetaldehyde",
            "probability": 0.00042981676272105176,
            "start_logit": 1.231328010559082,
            "end_logit": -0.07911669462919235,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "acetaldehyde increase",
            "probability": 0.00029488478648001347,
            "start_logit": 1.231328010559082,
            "end_logit": -0.455890953540802,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "head and neck as well as o",
            "probability": 0.0002933449186307015,
            "start_logit": 3.5566043853759766,
            "end_logit": -2.786402940750122,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "oesophageal",
            "probability": 0.00018432190273519092,
            "start_logit": 4.01642370223999,
            "end_logit": -3.7108876705169678,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "acetaldehyde-exposure due to alcohol consumption and cancer",
            "probability": 0.0001361181274108347,
            "start_logit": -0.95674067735672,
            "end_logit": 0.9591161012649536,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "cancer. Previous animal toxicology based risk assessments may have underestimated the risk of acetaldehyde",
            "probability": 0.00012555549992789318,
            "start_logit": 1.5238665342330933,
            "end_logit": -1.6022663116455078,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "head and neck as well as oesophageal",
            "probability": 0.00011638042878669863,
            "start_logit": 3.5566043853759766,
            "end_logit": -3.7108876705169678,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "odds ratios of up to 7 for head and neck",
            "probability": 6.867553894072538e-05,
            "start_logit": -1.2340272665023804,
            "end_logit": 0.5522726774215698,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "alcohol consumption and cancer",
            "probability": 3.78475803264108e-05,
            "start_logit": -2.236696720123291,
            "end_logit": 0.9591161012649536,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        },
        {
            "text": "neck",
            "probability": 2.420022050196268e-05,
            "start_logit": -2.2770586013793945,
            "end_logit": 0.5522726774215698,
            "question_text": "Which are the effects of ALDH2 deficiency?"
        }
    ],
    "5a76196faacfb9cd4c000001": [
        {
            "text": "autoimmune hemolytic anemia accompanied by immune thrombocytopenia",
            "probability": 0.367161715822479,
            "start_logit": 3.8999531269073486,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "immune thrombocytopenia",
            "probability": 0.3525786152268352,
            "start_logit": 3.859424352645874,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia accompanied by immune thrombocytopenia",
            "probability": 0.11143168507905617,
            "start_logit": 2.7075624465942383,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "thrombocytopenia",
            "probability": 0.06747108613824351,
            "start_logit": 2.2058498859405518,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "autoimmune hemolytic anemia",
            "probability": 0.062164702224435035,
            "start_logit": 3.8999531269073486,
            "end_logit": 3.111433744430542,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia",
            "probability": 0.01886666616585858,
            "start_logit": 2.7075624465942383,
            "end_logit": 3.111433744430542,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "anemia accompanied by immune thrombocytopenia",
            "probability": 0.007241982453607178,
            "start_logit": -0.02595427818596363,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "autoimmune disorder with autoimmune hemolytic anemia accompanied by immune thrombocytopenia",
            "probability": 0.0025791434249861412,
            "start_logit": -1.0583919286727905,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "autoimmune hemolytic anemia accompanied",
            "probability": 0.002010999530482179,
            "start_logit": 3.8999531269073486,
            "end_logit": -0.3197217285633087,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "autoimmune",
            "probability": 0.0013718707323375078,
            "start_logit": 3.8999531269073486,
            "end_logit": -0.7021782994270325,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "anemia",
            "probability": 0.001226150939333613,
            "start_logit": -0.02595427818596363,
            "end_logit": 3.111433744430542,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hematological autoimmune disorder with autoimmune hemolytic anemia accompanied by immune thrombocytopenia",
            "probability": 0.0008700659734699316,
            "start_logit": -2.1450355052948,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "a hematological autoimmune disorder with autoimmune hemolytic anemia accompanied by immune thrombocytopenia",
            "probability": 0.0008366967656200517,
            "start_logit": -2.184142827987671,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "accompanied by immune thrombocytopenia",
            "probability": 0.0007106003540716584,
            "start_logit": -2.34749436378479,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "autoimmune hemolytic anemia accompanied by",
            "probability": 0.0006908091971209122,
            "start_logit": 3.8999531269073486,
            "end_logit": -1.3882452249526978,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "Evans syndrome refers to a hematological autoimmune disorder with autoimmune hemolytic anemia",
            "probability": 0.0006771182442355027,
            "start_logit": -0.6197435855865479,
            "end_logit": 3.111433744430542,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "hemolytic anemia accompanied",
            "probability": 0.0006103279746169561,
            "start_logit": 2.7075624465942383,
            "end_logit": -0.3197217285633087,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "with autoimmune hemolytic anemia accompanied by immune thrombocytopenia",
            "probability": 0.0005320484934366391,
            "start_logit": -2.6368699073791504,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "enia",
            "probability": 0.0005235086984575893,
            "start_logit": -2.6530508995056152,
            "end_logit": 4.887448787689209,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        },
        {
            "text": "autoimmune hemolytic",
            "probability": 0.00044420656131675794,
            "start_logit": 3.8999531269073486,
            "end_logit": -1.8298192024230957,
            "question_text": "List the two most important hematological features of the Evans syndrome"
        }
    ],
    "5a82fc89faa1ab7d2e000028": [
        {
            "text": "macroH2A",
            "probability": 0.4353285088250283,
            "start_logit": -2.0768423080444336,
            "end_logit": -1.2217458486557007,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "canonical",
            "probability": 0.18264553372800768,
            "start_logit": -1.6380773782730103,
            "end_logit": -2.529064416885376,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H2A histone with the variants macroH2A",
            "probability": 0.13974108465670027,
            "start_logit": -3.2131519317626953,
            "end_logit": -1.2217458486557007,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "macroH2A and H2A.Z has been shown to affect DNA",
            "probability": 0.04932196621608178,
            "start_logit": -2.0768423080444336,
            "end_logit": -3.399477243423462,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "canonical nucleosome",
            "probability": 0.045364681246576624,
            "start_logit": -1.6380773782730103,
            "end_logit": -3.921877861022949,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "DNA",
            "probability": 0.022136203899862133,
            "start_logit": -2.877997398376465,
            "end_logit": -3.399477243423462,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "canonical H2A histone with the variants macroH2A",
            "probability": 0.017674381201950366,
            "start_logit": -5.280827045440674,
            "end_logit": -1.2217458486557007,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H2A histone with the variants macroH2A and H2A.Z has been shown to affect DNA",
            "probability": 0.0158324229098596,
            "start_logit": -3.2131519317626953,
            "end_logit": -3.399477243423462,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "macroH2A and H2A.Z has been shown to affect DNA accessibility and nucleosome stability;",
            "probability": 0.01458466646316719,
            "start_logit": -2.0768423080444336,
            "end_logit": -4.617876052856445,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "H2A",
            "probability": 0.01310083770482601,
            "start_logit": -3.2131519317626953,
            "end_logit": -3.5888609886169434,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "canonical nucleosome along with three variant-containing structures: H2A.Z, macroH2A",
            "probability": 0.013079613668542335,
            "start_logit": -1.6380773782730103,
            "end_logit": -5.165556907653809,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "histone with the variants macroH2A",
            "probability": 0.00884449629245958,
            "start_logit": -5.973147869110107,
            "end_logit": -1.2217458486557007,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "replacement of the canonical H2A histone with the variants macroH2A",
            "probability": 0.008595473203199819,
            "start_logit": -6.001707553863525,
            "end_logit": -1.2217458486557007,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "DNA accessibility and nucleosome stability;",
            "probability": 0.006545747775458365,
            "start_logit": -2.877997398376465,
            "end_logit": -4.617876052856445,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "study of the canonical",
            "probability": 0.006458300571619267,
            "start_logit": -4.980258464813232,
            "end_logit": -2.529064416885376,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "macroH2A and H2A.Z has been shown to affect DNA accessibility",
            "probability": 0.0049329055990182035,
            "start_logit": -2.0768423080444336,
            "end_logit": -5.701918601989746,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "macroH2A and H2A.Z has been shown to affect DNA accessibility and nucleosome stability",
            "probability": 0.004330258269422812,
            "start_logit": -2.0768423080444336,
            "end_logit": -5.83221960067749,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "DNA accessibility and nucleosome stability; however, the processes by which this occurs remain poorly understood. In this study,",
            "probability": 0.004157737669806354,
            "start_logit": -2.877997398376465,
            "end_logit": -5.071720600128174,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "an extensive molecular dynamics study of the canonical",
            "probability": 0.003734962622107898,
            "start_logit": -5.527886867523193,
            "end_logit": -2.529064416885376,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        },
        {
            "text": "extensive molecular dynamics study of the canonical",
            "probability": 0.0035902174763055455,
            "start_logit": -5.56741189956665,
            "end_logit": -2.529064416885376,
            "question_text": "Which yeast nucleosomes are preferentially marked by H2A.Z?"
        }
    ],
    "5a882b5761bb38fb24000013": [
        {
            "text": "Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.8932393166279173,
            "start_logit": 4.422385215759277,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Aicardi-Gouti\u00e8res",
            "probability": 0.04181708019496962,
            "start_logit": 4.422385215759277,
            "end_logit": 1.6274223327636719,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "systemic lupus erythematosus (SLE) and interferonopathies such as Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.04096416906380013,
            "start_logit": 1.3402284383773804,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "syndrome",
            "probability": 0.0053150719382127,
            "start_logit": -0.7019227743148804,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Aicardi-Gouti\u00e8res syndrome.",
            "probability": 0.004641021422088914,
            "start_logit": 4.422385215759277,
            "end_logit": -0.57094806432724,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "lupus erythematosus (SLE) and interferonopathies such as Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.0024484627586198516,
            "start_logit": -1.4770089387893677,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferon (IFN) is implicated in the pathogenesis of systemic lupus erythematosus",
            "probability": 0.0023630903362494115,
            "start_logit": 1.51565420627594,
            "end_logit": 1.6608186960220337,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.0019828683520340547,
            "start_logit": 1.3402284383773804,
            "end_logit": 1.6608186960220337,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "systemic lupus erythematosus (SLE) and interferonopathies such as Aicardi-Gouti\u00e8res",
            "probability": 0.0019177413163227136,
            "start_logit": 1.3402284383773804,
            "end_logit": 1.6274223327636719,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Gouti\u00e8res syndrome",
            "probability": 0.0011533343428738443,
            "start_logit": -2.2298121452331543,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferon (IFN) is implicated in the pathogenesis of systemic lupus erythematosus (SLE)",
            "probability": 0.0007371138680736315,
            "start_logit": 1.51565420627594,
            "end_logit": 0.4958355724811554,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "A",
            "probability": 0.0006769786087156555,
            "start_logit": 4.422385215759277,
            "end_logit": -2.4959981441497803,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "systemic lupus erythematosus (SLE)",
            "probability": 0.0006185120130313736,
            "start_logit": 1.3402284383773804,
            "end_logit": 0.4958355724811554,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "s syndrome",
            "probability": 0.0005797825128033226,
            "start_logit": -2.917571544647217,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I",
            "probability": 0.00041278322202397804,
            "start_logit": 1.51565420627594,
            "end_logit": -0.08398424088954926,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "erythematosus (SLE) and interferonopathies such as Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.00033004253955821664,
            "start_logit": -3.4810030460357666,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "(SLE) and interferonopathies such as Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.0002551487100892407,
            "start_logit": -3.7383780479431152,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "Type I interferon",
            "probability": 0.00021177078595532276,
            "start_logit": 1.51565420627594,
            "end_logit": -0.7514023184776306,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "sus (SLE) and interferonopathies such as Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.00018874650710111443,
            "start_logit": -4.039819717407227,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        },
        {
            "text": "interferonopathies such as Aicardi-Gouti\u00e8res syndrome",
            "probability": 0.00014696487955940916,
            "start_logit": -4.2900309562683105,
            "end_logit": 4.688971996307373,
            "question_text": "List the four most important interferonopathies"
        }
    ],
    "5a6d1143b750ff445500002e": [
        {
            "text": "Ufd1-Npl4",
            "probability": 0.6885744457231144,
            "start_logit": 4.290733814239502,
            "end_logit": 4.0139055252075195,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1",
            "probability": 0.1612781340054267,
            "start_logit": 4.290733814239502,
            "end_logit": 2.5624125003814697,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Npl4",
            "probability": 0.09759237803456053,
            "start_logit": 2.336909770965576,
            "end_logit": 4.0139055252075195,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "ubiquitin-binding Ufd1-Npl4",
            "probability": 0.021576175157823865,
            "start_logit": 0.8277000784873962,
            "end_logit": 4.0139055252075195,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4 complex",
            "probability": 0.01787018275568552,
            "start_logit": 4.290733814239502,
            "end_logit": 0.3624156415462494,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "ubiquitin-binding Ufd1",
            "probability": 0.0050535788686926365,
            "start_logit": 0.8277000784873962,
            "end_logit": 2.5624125003814697,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Npl4 complex",
            "probability": 0.0025327597355258662,
            "start_logit": 2.336909770965576,
            "end_logit": 0.3624156415462494,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "the ubiquitin-binding Ufd1-Npl4",
            "probability": 0.0017927447042947403,
            "start_logit": -1.6601418256759644,
            "end_logit": 4.0139055252075195,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4-Cdc48 to the CMG helicase, supporting a model whereby Ufd1",
            "probability": 0.0009927534652730955,
            "start_logit": 1.8592774868011475,
            "end_logit": -0.09653450548648834,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "ubiquitin-binding Ufd1-Npl4 complex",
            "probability": 0.0005599542585901272,
            "start_logit": 0.8277000784873962,
            "end_logit": 0.3624156415462494,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4 complex recruits Cdc48",
            "probability": 0.0004777054771794048,
            "start_logit": 4.290733814239502,
            "end_logit": -3.259478807449341,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "the ubiquitin-binding Ufd1",
            "probability": 0.00041989725650235605,
            "start_logit": -1.6601418256759644,
            "end_logit": 2.5624125003814697,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "We demonstrate that the ubiquitin-binding Ufd1-Npl4",
            "probability": 0.000414560934119533,
            "start_logit": -3.124424934387207,
            "end_logit": 4.0139055252075195,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "U",
            "probability": 0.00031128630353481526,
            "start_logit": 4.290733814239502,
            "end_logit": -3.6877601146698,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "4",
            "probability": 0.00014049207056975583,
            "start_logit": -4.206493854522705,
            "end_logit": 4.0139055252075195,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4 complex recruits Cdc48 to ubiquitylated CMG.",
            "probability": 0.00013412055488748302,
            "start_logit": 4.290733814239502,
            "end_logit": -4.529734134674072,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "We demonstrate that the ubiquitin-binding Ufd1",
            "probability": 9.70985988539431e-05,
            "start_logit": -3.124424934387207,
            "end_logit": 2.5624125003814697,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Npl4 complex recruits Cdc48",
            "probability": 6.77056980659711e-05,
            "start_logit": 2.336909770965576,
            "end_logit": -3.259478807449341,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "Ufd1-Npl4-Cdc48",
            "probability": 6.750030894514715e-05,
            "start_logit": 1.8592774868011475,
            "end_logit": -2.7848846912384033,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        },
        {
            "text": "the ubiquitin-binding Ufd1-Npl4 complex",
            "probability": 4.652608835402063e-05,
            "start_logit": -1.6601418256759644,
            "end_logit": 0.3624156415462494,
            "question_text": "List the partners of budding yeast Cdc48 that are important for disassembly of ubiquitylated CMG helicase at the end of chromosome replication"
        }
    ],
    "58f8a08370f9fc6f0f00001b": [
        {
            "text": "ocular ptosis",
            "probability": 0.19740122801629886,
            "start_logit": 4.383199214935303,
            "end_logit": 4.42210054397583,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "ocular ptosis, cardiac defect, and anal atresia",
            "probability": 0.16156709225015306,
            "start_logit": 4.383199214935303,
            "end_logit": 4.221782684326172,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "cardiac defect, and anal atresia",
            "probability": 0.11797076572834177,
            "start_logit": 4.068715572357178,
            "end_logit": 4.221782684326172,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "anal atresia",
            "probability": 0.11247116336029477,
            "start_logit": 4.020975589752197,
            "end_logit": 4.221782684326172,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "ocular ptosis, cardiac defect",
            "probability": 0.10921062909686334,
            "start_logit": 4.383199214935303,
            "end_logit": 3.8301405906677246,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "cardiac defect",
            "probability": 0.07974186674278459,
            "start_logit": 4.068715572357178,
            "end_logit": 3.8301405906677246,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "ptosis",
            "probability": 0.032006595403370475,
            "start_logit": 3.2675585746765137,
            "end_logit": 3.71844482421875,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "ptosis, epicanthus",
            "probability": 0.02661603919458025,
            "start_logit": 3.2675585746765137,
            "end_logit": 3.5340168476104736,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "congenital heart defect, and anal atresia",
            "probability": 0.018333786404104782,
            "start_logit": 2.7566490173339844,
            "end_logit": 3.6721580028533936,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "epicanthus",
            "probability": 0.01828487778069962,
            "start_logit": 2.8921189308166504,
            "end_logit": 3.5340168476104736,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "retardation of growth and development, ocular ptosis",
            "probability": 0.017839644461639954,
            "start_logit": 1.9793840646743774,
            "end_logit": 4.42210054397583,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "cleft uvula, congenital heart defect, and anal atresia",
            "probability": 0.01754686252005697,
            "start_logit": 2.7127785682678223,
            "end_logit": 3.6721580028533936,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "retardation of growth and development, ocular ptosis, cardiac defect, and anal atresia",
            "probability": 0.01460122366718879,
            "start_logit": 1.9793840646743774,
            "end_logit": 4.221782684326172,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "ptosis, epicanthus, broad nasal bridge, low-set and abnormal ears, cleft uvula, congenital heart defect",
            "probability": 0.013931214784734147,
            "start_logit": 3.2675585746765137,
            "end_logit": 2.8866348266601562,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "ptosis, epicanthus, broad nasal bridge, low-set and abnormal ears",
            "probability": 0.013385050713662664,
            "start_logit": 3.2675585746765137,
            "end_logit": 2.8466413021087646,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "ptosis, epicanthus, broad nasal bridge",
            "probability": 0.010736544062303344,
            "start_logit": 3.2675585746765137,
            "end_logit": 2.6261560916900635,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "retardation of growth and development, ocular ptosis, cardiac defect",
            "probability": 0.009869638674989445,
            "start_logit": 1.9793840646743774,
            "end_logit": 3.8301405906677246,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "broad nasal bridge, low-set and abnormal ears, cleft uvula, congenital heart defect, and anal atresia",
            "probability": 0.009719852861527831,
            "start_logit": 2.1220738887786865,
            "end_logit": 3.6721580028533936,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "epicanthus, broad nasal bridge, low-set and abnormal ears, cleft uvula, congenital heart defect",
            "probability": 0.009570565996439075,
            "start_logit": 2.8921189308166504,
            "end_logit": 2.8866348266601562,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        },
        {
            "text": "epicanthus, broad nasal bridge, low-set and abnormal ears",
            "probability": 0.009195358279966186,
            "start_logit": 2.8921189308166504,
            "end_logit": 2.8466413021087646,
            "question_text": "Which are the main manifestations of Ohdo syndrome?"
        }
    ],
    "5a43b2d7966455904c00000c": [
        {
            "text": "RNA-seq",
            "probability": 0.44164031241550944,
            "start_logit": -0.11947216093540192,
            "end_logit": -1.4935505390167236,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "algorithms that are used to detect genome-wide circRNA expression from RNA sequencing (RNA-seq",
            "probability": 0.05461398602527779,
            "start_logit": -2.2096779346466064,
            "end_logit": -1.4935505390167236,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "algorithms",
            "probability": 0.05401884686107943,
            "start_logit": -2.2096779346466064,
            "end_logit": -1.5045075416564941,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq) data have been developed in the past few years, but there is little overlap in their predictions",
            "probability": 0.04972660533916868,
            "start_logit": -0.11947216093540192,
            "end_logit": -3.6775062084198,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq) data have been developed in the past few years, but there is little overlap",
            "probability": 0.04859892348922583,
            "start_logit": -0.11947216093540192,
            "end_logit": -3.7004449367523193,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq) data have been developed in the past few years, but there is little overlap in their predictions and no",
            "probability": 0.03700844629291331,
            "start_logit": -0.11947216093540192,
            "end_logit": -3.972900152206421,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq) data have been developed in the past few years, but there is little overlap in their predictions and no clear gold-standard",
            "probability": 0.03357049343121095,
            "start_logit": -0.11947216093540192,
            "end_logit": -4.070398807525635,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq) data have been developed in the past few years,",
            "probability": 0.031516295608470926,
            "start_logit": -0.11947216093540192,
            "end_logit": -4.133541584014893,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "Numerous algorithms that are used to detect genome-wide circRNA expression from RNA sequencing (RNA-seq",
            "probability": 0.030192054508112777,
            "start_logit": -2.802389144897461,
            "end_logit": -1.4935505390167236,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "Numerous algorithms",
            "probability": 0.029863045853130647,
            "start_logit": -2.802389144897461,
            "end_logit": -1.5045075416564941,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "algorithms that are used to detect genome-wide circRNA expression from RNA sequencing",
            "probability": 0.028671277708332513,
            "start_logit": -2.2096779346466064,
            "end_logit": -2.1379446983337402,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq)",
            "probability": 0.024298077104871373,
            "start_logit": -0.11947216093540192,
            "end_logit": -4.393649101257324,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq) data have been developed in the past few years, but there is little overlap in their predictions and no clear gold",
            "probability": 0.021762519066547623,
            "start_logit": -0.11947216093540192,
            "end_logit": -4.503857135772705,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "R",
            "probability": 0.02148316822449358,
            "start_logit": -0.11947216093540192,
            "end_logit": -4.5167765617370605,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "(RNA-seq",
            "probability": 0.019548887105952085,
            "start_logit": -3.2370495796203613,
            "end_logit": -1.4935505390167236,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq) data have been developed",
            "probability": 0.017332219167473798,
            "start_logit": -0.11947216093540192,
            "end_logit": -4.731479167938232,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "sequencing (RNA-seq",
            "probability": 0.01665343787265977,
            "start_logit": -3.3973512649536133,
            "end_logit": -1.4935505390167236,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "Numerous algorithms that are used to detect genome-wide circRNA expression from RNA sequencing",
            "probability": 0.01585023988153062,
            "start_logit": -2.802389144897461,
            "end_logit": -2.1379446983337402,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA sequencing (RNA-seq",
            "probability": 0.013675529449788778,
            "start_logit": -3.594359874725342,
            "end_logit": -1.4935505390167236,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        },
        {
            "text": "RNA-seq) data",
            "probability": 0.009975634594250039,
            "start_logit": -0.11947216093540192,
            "end_logit": -5.283900737762451,
            "question_text": "Which are the best methods for the prediction of circular RNA (circRNA)?"
        }
    ],
    "5a68ff52b750ff445500001c": [
        {
            "text": "abductor pollicis longus",
            "probability": 0.3188673231187107,
            "start_logit": 4.545334815979004,
            "end_logit": 4.264077663421631,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis brevis and/or abductor pollicis longus",
            "probability": 0.2855256838642598,
            "start_logit": 4.434891700744629,
            "end_logit": 4.264077663421631,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis brevis",
            "probability": 0.21527522188498965,
            "start_logit": 4.434891700744629,
            "end_logit": 3.9816629886627197,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor pollicis longus (APL)",
            "probability": 0.07419646485854381,
            "start_logit": 4.545334815979004,
            "end_logit": 2.8060190677642822,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis brevis and/or abductor pollicis longus (APL)",
            "probability": 0.06643827960119734,
            "start_logit": 4.434891700744629,
            "end_logit": 2.8060190677642822,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis",
            "probability": 0.006227237563149415,
            "start_logit": 4.434891700744629,
            "end_logit": 0.438678503036499,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor pollicis",
            "probability": 0.005575503685744985,
            "start_logit": 4.545334815979004,
            "end_logit": 0.21768522262573242,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis brevis and/or abductor pollicis",
            "probability": 0.004992513774035645,
            "start_logit": 4.434891700744629,
            "end_logit": 0.21768522262573242,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "pollicis brevis and/or abductor pollicis longus",
            "probability": 0.003119503327148898,
            "start_logit": -0.08176648616790771,
            "end_logit": 4.264077663421631,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "pollicis longus",
            "probability": 0.003086384391548969,
            "start_logit": -0.09243997931480408,
            "end_logit": 4.264077663421631,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "longus",
            "probability": 0.0026670287026246417,
            "start_logit": -0.2384752780199051,
            "end_logit": 4.264077663421631,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "brevis and/or abductor pollicis longus",
            "probability": 0.00255727299101254,
            "start_logit": -0.28049883246421814,
            "end_logit": 4.264077663421631,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "pollicis brevis",
            "probability": 0.002351983757938222,
            "start_logit": -0.08176648616790771,
            "end_logit": 3.9816629886627197,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "brevis",
            "probability": 0.001928084027713718,
            "start_logit": -0.28049883246421814,
            "end_logit": 3.9816629886627197,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "abductor",
            "probability": 0.001664529744715404,
            "start_logit": 4.545334815979004,
            "end_logit": -0.9911547899246216,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor pollicis brevis and/or abductor",
            "probability": 0.0014904819629176342,
            "start_logit": 4.434891700744629,
            "end_logit": -0.9911547899246216,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "tendinosis of the enclosed extensor pollicis brevis and/or abductor pollicis longus",
            "probability": 0.0011576449891985867,
            "start_logit": -1.0730525255203247,
            "end_logit": 4.264077663421631,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "bductor pollicis longus",
            "probability": 0.0011525406779028169,
            "start_logit": -1.0774714946746826,
            "end_logit": 4.264077663421631,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "tendinosis of the enclosed extensor pollicis brevis",
            "probability": 0.0008728191402642744,
            "start_logit": -1.0730525255203247,
            "end_logit": 3.9816629886627197,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        },
        {
            "text": "extensor",
            "probability": 0.0008534979363829807,
            "start_logit": 4.434891700744629,
            "end_logit": -1.5486664772033691,
            "question_text": "Which tendons are affected in the Dequervain's tenosynovitis?"
        }
    ],
    "590c740d70f9fc6f0f00001d": [
        {
            "text": "Sterol delta 24-methyltransferase",
            "probability": 0.9475535606303784,
            "start_logit": -0.6995677947998047,
            "end_logit": -0.9452153444290161,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Sterol delta 24-methyltransferase,",
            "probability": 0.016137956155008057,
            "start_logit": -0.6995677947998047,
            "end_logit": -5.017924785614014,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "methyltransferase",
            "probability": 0.008499989376048499,
            "start_logit": -5.413386344909668,
            "end_logit": -0.9452153444290161,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Sterol delta 24",
            "probability": 0.007081039122211597,
            "start_logit": -0.6995677947998047,
            "end_logit": -5.841678142547607,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "S",
            "probability": 0.006971975840517644,
            "start_logit": -0.6995677947998047,
            "end_logit": -5.8572001457214355,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "Sterol delta 24-methyltransferase, an enzyme",
            "probability": 0.004874800132980328,
            "start_logit": -0.6995677947998047,
            "end_logit": -6.215019702911377,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "delta 24-methyltransferase",
            "probability": 0.0033081083183240977,
            "start_logit": -6.357074737548828,
            "end_logit": -0.9452153444290161,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "ferase",
            "probability": 0.001900655373089858,
            "start_logit": -6.911252498626709,
            "end_logit": -0.9452153444290161,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "24-methyltransferase",
            "probability": 0.0016079760237693163,
            "start_logit": -7.078474998474121,
            "end_logit": -0.9452153444290161,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "ase",
            "probability": 0.0015509598000559874,
            "start_logit": -7.114577293395996,
            "end_logit": -0.9452153444290161,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "methyltransferase,",
            "probability": 0.00014476485717329618,
            "start_logit": -5.413386344909668,
            "end_logit": -5.017924785614014,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "enzymes",
            "probability": 6.506461983419497e-05,
            "start_logit": -5.993119716644287,
            "end_logit": -5.237921237945557,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "delta 24-methyltransferase,",
            "probability": 5.634099138587542e-05,
            "start_logit": -6.357074737548828,
            "end_logit": -5.017924785614014,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "methyltransferase, an enzyme that catalyzes one of the late steps in sterol biosynthesis,",
            "probability": 4.8657543520441767e-05,
            "start_logit": -5.413386344909668,
            "end_logit": -6.10822868347168,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "methyltransferase, an enzyme",
            "probability": 4.372918963348802e-05,
            "start_logit": -5.413386344909668,
            "end_logit": -6.215019702911377,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "analyzed for sterol composition and the activity of three enzymes",
            "probability": 3.34344416162662e-05,
            "start_logit": -6.658914089202881,
            "end_logit": -5.237921237945557,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "ferase,",
            "probability": 3.237040559089768e-05,
            "start_logit": -6.911252498626709,
            "end_logit": -5.017924785614014,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "were isolated and analyzed for sterol composition and the activity of three enzymes",
            "probability": 3.0383701141555975e-05,
            "start_logit": -6.754594326019287,
            "end_logit": -5.237921237945557,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "activity of three enzymes",
            "probability": 2.9619606920531995e-05,
            "start_logit": -6.780064105987549,
            "end_logit": -5.237921237945557,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        },
        {
            "text": "methyltransferase, an enzyme that catalyzes one of the late steps in sterol biosynthesis",
            "probability": 2.8613870799475525e-05,
            "start_logit": -5.413386344909668,
            "end_logit": -6.639143943786621,
            "question_text": "Which proteins are controlling sterol metabolism in S. cerevisiae?"
        }
    ],
    "5925227670f9fc6f0f000020": [
        {
            "text": "glucosyltransferase (HmdUGT",
            "probability": 0.262566423298568,
            "start_logit": 4.228997230529785,
            "end_logit": 4.341903209686279,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "HmdUGT",
            "probability": 0.2045328670134398,
            "start_logit": 3.979221820831299,
            "end_logit": 4.341903209686279,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JPB1 and JBP2",
            "probability": 0.07751194551340447,
            "start_logit": 4.151543140411377,
            "end_logit": 3.1992852687835693,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP2",
            "probability": 0.07510100711599281,
            "start_logit": 4.119945049285889,
            "end_logit": 3.1992852687835693,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JPB1",
            "probability": 0.07270595894197443,
            "start_logit": 4.151543140411377,
            "end_logit": 3.1352765560150146,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylases (JPB1 and JBP2",
            "probability": 0.061345509664018014,
            "start_logit": 3.917633056640625,
            "end_logit": 3.1992852687835693,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylases (JPB1",
            "probability": 0.05754189341222601,
            "start_logit": 3.917633056640625,
            "end_logit": 3.1352765560150146,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylase",
            "probability": 0.028469035207725698,
            "start_logit": 3.917633056640625,
            "end_logit": 2.4315803050994873,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "glucosyltransferase (HmdUGT)",
            "probability": 0.02770822565701038,
            "start_logit": 4.228997230529785,
            "end_logit": 2.0931284427642822,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "glucosyltransferase",
            "probability": 0.024778482169217186,
            "start_logit": 4.228997230529785,
            "end_logit": 1.981374740600586,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "HmdUGT)",
            "probability": 0.021584034859778632,
            "start_logit": 3.979221820831299,
            "end_logit": 2.0931284427642822,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JPB",
            "probability": 0.016447971443498507,
            "start_logit": 4.151543140411377,
            "end_logit": 1.6490553617477417,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylases (JPB",
            "probability": 0.013017466978249667,
            "start_logit": 3.917633056640625,
            "end_logit": 1.6490553617477417,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JPB1 and JBP",
            "probability": 0.011285669103158275,
            "start_logit": 4.151543140411377,
            "end_logit": 1.272386908531189,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP",
            "probability": 0.010934638654869742,
            "start_logit": 4.119945049285889,
            "end_logit": 1.272386908531189,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "(HmdUGT",
            "probability": 0.0094342906354563,
            "start_logit": 0.9028441309928894,
            "end_logit": 4.341903209686279,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylases (JPB1 and JBP",
            "probability": 0.008931850677299525,
            "start_logit": 3.917633056640625,
            "end_logit": 1.272386908531189,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "thymidine hydroxylases",
            "probability": 0.006992767041309615,
            "start_logit": 3.917633056640625,
            "end_logit": 1.027639627456665,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JBP2) that catalyze the first step have been characterized, but the identity of the glucosyltransferase",
            "probability": 0.004999603606312875,
            "start_logit": 4.119945049285889,
            "end_logit": 0.48980993032455444,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        },
        {
            "text": "JPB1 and JBP2)",
            "probability": 0.004110359006490168,
            "start_logit": 4.151543140411377,
            "end_logit": 0.26236358284950256,
            "question_text": "Which enzymes are responsible for base J creation in Trypanosoma brucei?"
        }
    ],
    "5a737b483b9d13c70800000b": [
        {
            "text": "Pembrolizumab",
            "probability": 0.9950129821866754,
            "start_logit": 5.3094635009765625,
            "end_logit": 5.485613822937012,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab",
            "probability": 0.003333103067773675,
            "start_logit": 2.630089521408081,
            "end_logit": 2.4661357402801514,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizumab is a potent immune-modulating antibody",
            "probability": 0.0007236783031139072,
            "start_logit": 5.3094635009765625,
            "end_logit": -1.7405502796173096,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "b",
            "probability": 0.00028024772692959986,
            "start_logit": -2.8653736114501953,
            "end_logit": 5.485613822937012,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizumab is a potent immune-modulating antibody active in advanced melanoma,",
            "probability": 0.00022462835002589904,
            "start_logit": 5.3094635009765625,
            "end_logit": -2.910449981689453,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "P",
            "probability": 0.0001345732446286406,
            "start_logit": 5.3094635009765625,
            "end_logit": -3.422788619995117,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "embrolizumab",
            "probability": 0.00013193984572671525,
            "start_logit": -3.618701457977295,
            "end_logit": 5.485613822937012,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizumab is a potent immune-modulating antibody active in advanced melanoma",
            "probability": 6.184479983625411e-05,
            "start_logit": 5.3094635009765625,
            "end_logit": -4.2002692222595215,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pem",
            "probability": 2.8250943917949183e-05,
            "start_logit": 5.3094635009765625,
            "end_logit": -4.983770370483398,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizuma",
            "probability": 1.8360226447248153e-05,
            "start_logit": 5.3094635009765625,
            "end_logit": -5.414710521697998,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizumab is",
            "probability": 1.8150009814849875e-05,
            "start_logit": 5.3094635009765625,
            "end_logit": -5.4262261390686035,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "mab",
            "probability": 1.1421093460522781e-05,
            "start_logit": -6.065585613250732,
            "end_logit": 5.485613822937012,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizumab is a potent immune-modulating antibody active in advanced me",
            "probability": 1.0001163382750832e-05,
            "start_logit": 5.3094635009765625,
            "end_logit": -6.022195816040039,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "Pembrolizumab is a",
            "probability": 8.567074266366465e-06,
            "start_logit": 5.3094635009765625,
            "end_logit": -6.176970958709717,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "p",
            "probability": 9.150305224197268e-07,
            "start_logit": 2.630089521408081,
            "end_logit": -5.734321117401123,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "pembrolizumab exposure. Both models indicated that exposure to the drug was not a significant predictor of tumor size response,",
            "probability": 6.441286431462638e-07,
            "start_logit": 2.630089521408081,
            "end_logit": -6.0853800773620605,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "antibody",
            "probability": 2.2922179968587828e-07,
            "start_logit": -2.74794864654541,
            "end_logit": -1.7405502796173096,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "b is a potent immune-modulating antibody",
            "probability": 2.0382568178180135e-07,
            "start_logit": -2.8653736114501953,
            "end_logit": -1.7405502796173096,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "melanoma,",
            "probability": 1.637967922946044e-07,
            "start_logit": -1.9141124486923218,
            "end_logit": -2.910449981689453,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        },
        {
            "text": "embrolizumab is a potent immune-modulating antibody",
            "probability": 9.596056069417848e-08,
            "start_logit": -3.618701457977295,
            "end_logit": -1.7405502796173096,
            "question_text": "Which drugs were tested in the KEYNOTE-006 study?"
        }
    ],
    "58ee2515eda5a57672000016": [
        {
            "text": "Prevotella intermedia",
            "probability": 0.6653687532271384,
            "start_logit": 3.9783897399902344,
            "end_logit": 4.359422206878662,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "Prevotella intermedia and P. nigrescens",
            "probability": 0.18660078010240366,
            "start_logit": 3.9783897399902344,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "intermedia",
            "probability": 0.08782977399789846,
            "start_logit": 1.9534488916397095,
            "end_logit": 4.359422206878662,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "P. nigrescens",
            "probability": 0.025208585753040646,
            "start_logit": 1.9766029119491577,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "intermedia and P. nigrescens",
            "probability": 0.024631611064896034,
            "start_logit": 1.9534488916397095,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "nigrescens",
            "probability": 0.003509586994958304,
            "start_logit": 0.004916636273264885,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "Prevotella",
            "probability": 0.003066374816472668,
            "start_logit": 3.9783897399902344,
            "end_logit": -1.020423173904419,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "oral anaerobes, Prevotella intermedia",
            "probability": 0.001418626279402588,
            "start_logit": -2.172262668609619,
            "end_logit": 4.359422206878662,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "Pre",
            "probability": 0.0005919027787241104,
            "start_logit": 3.9783897399902344,
            "end_logit": -2.665332078933716,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "media",
            "probability": 0.0005446958327546808,
            "start_logit": -3.12947940826416,
            "end_logit": 4.359422206878662,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "oral anaerobes, Prevotella intermedia and P. nigrescens",
            "probability": 0.0003978497173580473,
            "start_logit": -2.172262668609619,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "la intermedia",
            "probability": 0.00020042129109388123,
            "start_logit": -4.1292853355407715,
            "end_logit": 4.359422206878662,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "media and P. nigrescens",
            "probability": 0.0001527584017397561,
            "start_logit": -3.12947940826416,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "cens",
            "probability": 0.0001445340218964918,
            "start_logit": -3.1848220825195312,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "anaerobes, Prevotella intermedia",
            "probability": 0.00010395161583974809,
            "start_logit": -4.785781383514404,
            "end_logit": 4.359422206878662,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "Prevotella intermedia and P",
            "probability": 8.521568840421318e-05,
            "start_logit": 3.9783897399902344,
            "end_logit": -4.603488922119141,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "la intermedia and P. nigrescens",
            "probability": 5.620758276648777e-05,
            "start_logit": -4.1292853355407715,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": ", Prevotella intermedia",
            "probability": 3.081507926199456e-05,
            "start_logit": -6.001702785491943,
            "end_logit": 4.359422206878662,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "anaerobes, Prevotella intermedia and P. nigrescens",
            "probability": 2.9152935893851063e-05,
            "start_logit": -4.785781383514404,
            "end_logit": 3.088052272796631,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        },
        {
            "text": "Prevotella inter",
            "probability": 2.8402818055977556e-05,
            "start_logit": 3.9783897399902344,
            "end_logit": -5.702186107635498,
            "question_text": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?"
        }
    ],
    "5a67afb7b750ff445500000d": [
        {
            "text": "polyneuropathy, organomegaly",
            "probability": 0.2862197647120047,
            "start_logit": 1.5208433866500854,
            "end_logit": 1.9845386743545532,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy",
            "probability": 0.2736657057268109,
            "start_logit": 1.5208433866500854,
            "end_logit": 1.9396860599517822,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly",
            "probability": 0.18047914629092243,
            "start_logit": 1.0596987009048462,
            "end_logit": 1.9845386743545532,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy",
            "probability": 0.07189199391893177,
            "start_logit": 1.5208433866500854,
            "end_logit": 0.6029436588287354,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy of various forms, production of monoclonal (M) component, and skin changes",
            "probability": 0.04643522629389996,
            "start_logit": 1.0596987009048462,
            "end_logit": 0.626981794834137,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly, endocrinopathy",
            "probability": 0.04533231903358067,
            "start_logit": 1.0596987009048462,
            "end_logit": 0.6029436588287354,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "ascites",
            "probability": 0.019317541930550013,
            "start_logit": 0.531098484992981,
            "end_logit": 0.27853724360466003,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "endocrinopathy of various forms, production of monoclonal (M) component, and skin changes",
            "probability": 0.014800295391318434,
            "start_logit": -0.08371251821517944,
            "end_logit": 0.626981794834137,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "endocrinopathy",
            "probability": 0.01444876586202012,
            "start_logit": -0.08371251821517944,
            "end_logit": 0.6029436588287354,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "sclerotic bone lesions, a persistent lambda-paraprotein and refractory ascites",
            "probability": 0.009164503166816931,
            "start_logit": -0.44833412766456604,
            "end_logit": 0.5122939348220825,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly,",
            "probability": 0.005818334488210472,
            "start_logit": 1.5208433866500854,
            "end_logit": -1.9112071990966797,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "skin changes",
            "probability": 0.004814454443956004,
            "start_logit": -1.2067369222640991,
            "end_logit": 0.626981794834137,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy of various forms",
            "probability": 0.004237798617535953,
            "start_logit": 1.5208433866500854,
            "end_logit": -2.228177309036255,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy,",
            "probability": 0.0039606321084472524,
            "start_logit": 1.5208433866500854,
            "end_logit": -2.2958176136016846,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "monoclonal (M) component, and skin changes",
            "probability": 0.003784566358805643,
            "start_logit": -1.4474283456802368,
            "end_logit": 0.626981794834137,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "organomegaly,",
            "probability": 0.0036688173590103366,
            "start_logit": 1.0596987009048462,
            "end_logit": -1.9112071990966797,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "refractory ascites",
            "probability": 0.0033869865706974245,
            "start_logit": -1.4437311887741089,
            "end_logit": 0.5122939348220825,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "sclerotic bone lesions",
            "probability": 0.0031968077810218373,
            "start_logit": -0.44833412766456604,
            "end_logit": -0.5408909916877747,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "polyneuropathy, organomegaly, endocrinopathy of various forms,",
            "probability": 0.0026953558748371237,
            "start_logit": 1.5208433866500854,
            "end_logit": -2.6806910037994385,
            "question_text": "List main clinical features of the POEMS syndrome."
        },
        {
            "text": "refractory ascites. In this case ascites",
            "probability": 0.0026809840706218313,
            "start_logit": -1.4437311887741089,
            "end_logit": 0.27853724360466003,
            "question_text": "List main clinical features of the POEMS syndrome."
        }
    ],
    "5a678d63b750ff4455000003": [
        {
            "text": "redness, swelling, heat, and pain",
            "probability": 0.2900265505731227,
            "start_logit": 6.117839813232422,
            "end_logit": 5.61342716217041,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness",
            "probability": 0.17407095118352534,
            "start_logit": 6.117839813232422,
            "end_logit": 5.102917671203613,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, swelling, heat",
            "probability": 0.11289187123331156,
            "start_logit": 6.117839813232422,
            "end_logit": 4.669885158538818,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, swelling",
            "probability": 0.10990333713588725,
            "start_logit": 6.117839813232422,
            "end_logit": 4.6430559158325195,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, and pain",
            "probability": 0.07594656623811988,
            "start_logit": 4.777897357940674,
            "end_logit": 5.61342716217041,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling, heat, and pain",
            "probability": 0.075212598610269,
            "start_logit": 4.768186092376709,
            "end_logit": 5.61342716217041,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "pain",
            "probability": 0.049040073107327435,
            "start_logit": 4.340505123138428,
            "end_logit": 5.61342716217041,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat",
            "probability": 0.029561948585132544,
            "start_logit": 4.777897357940674,
            "end_logit": 4.669885158538818,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling, heat",
            "probability": 0.029276254124508082,
            "start_logit": 4.768186092376709,
            "end_logit": 4.669885158538818,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling",
            "probability": 0.028501237440488998,
            "start_logit": 4.768186092376709,
            "end_logit": 4.6430559158325195,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, swelling, heat, and pain,",
            "probability": 0.009711110668485937,
            "start_logit": 6.117839813232422,
            "end_logit": 2.2167253494262695,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, swelling, heat,",
            "probability": 0.0035974476735317305,
            "start_logit": 6.117839813232422,
            "end_logit": 1.2236793041229248,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat, and pain,",
            "probability": 0.002542958595247409,
            "start_logit": 4.777897357940674,
            "end_logit": 2.2167253494262695,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling, heat, and pain,",
            "probability": 0.0025183827733198617,
            "start_logit": 4.768186092376709,
            "end_logit": 2.2167253494262695,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "pain,",
            "probability": 0.0016420344144176128,
            "start_logit": 4.340505123138428,
            "end_logit": 2.2167253494262695,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, swelling,",
            "probability": 0.001480772090057129,
            "start_logit": 6.117839813232422,
            "end_logit": 0.33601832389831543,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "redness, swelling, heat, and pain, phenomena explained at the cellular level.",
            "probability": 0.001204080463905935,
            "start_logit": 6.117839813232422,
            "end_logit": 0.12917086482048035,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "red",
            "probability": 0.000996868521254129,
            "start_logit": 6.117839813232422,
            "end_logit": -0.05968170240521431,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "heat,",
            "probability": 0.0009420302985576626,
            "start_logit": 4.777897357940674,
            "end_logit": 1.2236793041229248,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        },
        {
            "text": "swelling, heat,",
            "probability": 0.0009329262695298305,
            "start_logit": 4.768186092376709,
            "end_logit": 1.2236793041229248,
            "question_text": "What are the 4 cardinal signs of inflammation according to Celsus?"
        }
    ],
    "5a70dbe599e2c3af26000004": [
        {
            "text": "SMAD4",
            "probability": 0.3513603344471565,
            "start_logit": 4.363422870635986,
            "end_logit": 4.49147367477417,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "BMPR1A. Products of the SMAD4",
            "probability": 0.19116160463657048,
            "start_logit": 4.739307880401611,
            "end_logit": 3.5068955421447754,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "BMPR1A",
            "probability": 0.1498781013782696,
            "start_logit": 4.739307880401611,
            "end_logit": 3.263598680496216,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 and BMPR1A. Products of the SMAD4",
            "probability": 0.13126709729804026,
            "start_logit": 4.363422870635986,
            "end_logit": 3.5068955421447754,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 and BMPR1A",
            "probability": 0.1029184880189224,
            "start_logit": 4.363422870635986,
            "end_logit": 3.263598680496216,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "BMPR1A. Products of the SMAD4 gene",
            "probability": 0.02453971639866271,
            "start_logit": 4.739307880401611,
            "end_logit": 1.4540692567825317,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 and BMPR1A. Products of the SMAD4 gene",
            "probability": 0.016850964116427617,
            "start_logit": 4.363422870635986,
            "end_logit": 1.4540692567825317,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene",
            "probability": 0.009782453802346923,
            "start_logit": 3.8196053504943848,
            "end_logit": 1.4540692567825317,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "BMPR1",
            "probability": 0.006240777041208446,
            "start_logit": 4.739307880401611,
            "end_logit": 0.08488107472658157,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 and BMPR1",
            "probability": 0.004285424830164691,
            "start_logit": 4.363422870635986,
            "end_logit": 0.08488107472658157,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 gene are involved in signal transduction in the transforming growth factor \u03b2 pathway and BMPR1A",
            "probability": 0.002405791970836439,
            "start_logit": 3.8196053504943848,
            "end_logit": 0.05135805532336235,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "BMPR1A.",
            "probability": 0.0019073574509411084,
            "start_logit": 4.739307880401611,
            "end_logit": -1.1005048751831055,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 and BMPR1A.",
            "probability": 0.0013097466751800348,
            "start_logit": 4.363422870635986,
            "end_logit": -1.1005048751831055,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "BMPR1A. Products of the SMAD",
            "probability": 0.0011352892877156886,
            "start_logit": 4.739307880401611,
            "end_logit": -1.6193361282348633,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD",
            "probability": 0.0011039480215099995,
            "start_logit": 4.363422870635986,
            "end_logit": -1.2714457511901855,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "BMPR",
            "probability": 0.0010655443532973858,
            "start_logit": 4.739307880401611,
            "end_logit": -1.6827378273010254,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "mutations in SMAD4",
            "probability": 0.000929012783728892,
            "start_logit": -1.5720221996307373,
            "end_logit": 4.49147367477417,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 and BMPR1A. Products of the SMAD",
            "probability": 0.0007795819127764763,
            "start_logit": 4.363422870635986,
            "end_logit": -1.6193361282348633,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "SMAD4 and BMPR",
            "probability": 0.0007316893712290335,
            "start_logit": 4.363422870635986,
            "end_logit": -1.6827378273010254,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        },
        {
            "text": "mutations in SMAD4 and BMPR1A. Products of the SMAD4",
            "probability": 0.0003470762050154082,
            "start_logit": -1.5720221996307373,
            "end_logit": 3.5068955421447754,
            "question_text": "Which two genes are implicated in Juvenile polyposis syndrome?"
        }
    ],
    "5a70ce4ab750ff4455000064": [
        {
            "text": "COL1A1 or COL1A2",
            "probability": 0.34502354934378304,
            "start_logit": 3.9107553958892822,
            "end_logit": 2.784928321838379,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A1",
            "probability": 0.3163940054947428,
            "start_logit": 3.9107553958892822,
            "end_logit": 2.6983039379119873,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A2",
            "probability": 0.30727362019102056,
            "start_logit": 3.7948813438415527,
            "end_logit": 2.784928321838379,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "LEPRE1",
            "probability": 0.007127184705571696,
            "start_logit": 1.6734670400619507,
            "end_logit": 1.1425203084945679,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP) and prolyl-3-hydroxylase-1 (P3H1, encoded by the LEPRE1",
            "probability": 0.005526860880813866,
            "start_logit": 1.4191707372665405,
            "end_logit": 1.1425203084945679,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP",
            "probability": 0.003964468943317881,
            "start_logit": 1.4191707372665405,
            "end_logit": 0.810272216796875,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP) and prolyl-3-hydroxylase-1 (P3H1",
            "probability": 0.002550804629406002,
            "start_logit": 1.4191707372665405,
            "end_logit": 0.3693091571331024,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A1 or COL1A2)",
            "probability": 0.0016704295987598498,
            "start_logit": 3.9107553958892822,
            "end_logit": -2.5456035137176514,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A2)",
            "probability": 0.0014876635263343704,
            "start_logit": 3.7948813438415527,
            "end_logit": -2.5456035137176514,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1",
            "probability": 0.0013410571570709375,
            "start_logit": 3.9107553958892822,
            "end_logit": -2.765226125717163,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A1 or COL1A",
            "probability": 0.0009939314266567251,
            "start_logit": 3.9107553958892822,
            "end_logit": -3.0647714138031006,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A1 or COL1",
            "probability": 0.0009164250207602831,
            "start_logit": 3.9107553958892822,
            "end_logit": -3.1459593772888184,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A",
            "probability": 0.0008851827890337045,
            "start_logit": 3.7948813438415527,
            "end_logit": -3.0647714138031006,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "P3H1, encoded by the LEPRE1",
            "probability": 0.0008562736645997419,
            "start_logit": -0.4456145167350769,
            "end_logit": 1.1425203084945679,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A1 or COL1A2) encoding the chains of type I collagen",
            "probability": 0.0008406872367646155,
            "start_logit": 3.9107553958892822,
            "end_logit": -3.232219934463501,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "COL1A2) encoding the chains of type I collagen",
            "probability": 0.0007487054468611267,
            "start_logit": 3.7948813438415527,
            "end_logit": -3.232219934463501,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CRTAP) and prolyl-3-hydroxylase-1",
            "probability": 0.000724168402635245,
            "start_logit": 1.4191707372665405,
            "end_logit": -0.889831006526947,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "(COL1A1 or COL1A2",
            "probability": 0.0005964481475168564,
            "start_logit": -2.449620246887207,
            "end_logit": 2.784928321838379,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "(COL1A1",
            "probability": 0.000546955762357958,
            "start_logit": -2.449620246887207,
            "end_logit": 2.6983039379119873,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        },
        {
            "text": "CO",
            "probability": 0.0005315776319927438,
            "start_logit": 3.9107553958892822,
            "end_logit": -3.6905903816223145,
            "question_text": "List the 6 genes associated with the autosomal recessive form of Osteogenesis imperfecta"
        }
    ],
    "5a736efc3b9d13c708000006": [
        {
            "text": "microcephaly",
            "probability": 0.08154118229454908,
            "start_logit": -4.328995227813721,
            "end_logit": -4.502936840057373,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "congenital cardiac defects, and genital anomalies in boys. Here, we report a male neonate,",
            "probability": 0.07937243659192841,
            "start_logit": -4.625014305114746,
            "end_logit": -4.233874797821045,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "genital anomalies in boys. Here, we report a male neonate,",
            "probability": 0.07046444725783031,
            "start_logit": -4.7440571784973145,
            "end_logit": -4.233874797821045,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "male neonate,",
            "probability": 0.06504180151356187,
            "start_logit": -4.8241353034973145,
            "end_logit": -4.233874797821045,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "congenital cardiac defects, and genital anomalies in boys. Here,",
            "probability": 0.054887057043595894,
            "start_logit": -4.625014305114746,
            "end_logit": -4.602748394012451,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "genital anomalies in boys. Here, we report a male neonate, with the classical features of Emanuel syndrome",
            "probability": 0.05224972315006231,
            "start_logit": -4.7440571784973145,
            "end_logit": -4.5329484939575195,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "Here, we report a male neonate,",
            "probability": 0.05028044827565963,
            "start_logit": -5.081549167633057,
            "end_logit": -4.233874797821045,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "genital anomalies in boys. Here,",
            "probability": 0.04872706826514749,
            "start_logit": -4.7440571784973145,
            "end_logit": -4.602748394012451,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "male neonate, with the classical features of Emanuel syndrome",
            "probability": 0.0482288055113817,
            "start_logit": -4.8241353034973145,
            "end_logit": -4.5329484939575195,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "genital anomalies in boys. Here, we report a male neonate, with the classical features of Emanuel syndrome.",
            "probability": 0.04463820537920474,
            "start_logit": -4.7440571784973145,
            "end_logit": -4.690392971038818,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "microcephaly, severe mental retardation, developmental delay",
            "probability": 0.043843321952278635,
            "start_logit": -4.328995227813721,
            "end_logit": -5.123422622680664,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "microcephaly, severe mental retardation, developmental delay, renal anomalies",
            "probability": 0.04316480860391276,
            "start_logit": -4.328995227813721,
            "end_logit": -5.13901948928833,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "congenital cardiac defects, and genital anomalies in boys. Here, we report a male neonate",
            "probability": 0.0415277221006384,
            "start_logit": -4.625014305114746,
            "end_logit": -4.881664752960205,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "male neonate, with the classical features of Emanuel syndrome.",
            "probability": 0.041203037945823265,
            "start_logit": -4.8241353034973145,
            "end_logit": -4.690392971038818,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "microcephaly, severe mental retardation",
            "probability": 0.040360769673764355,
            "start_logit": -4.328995227813721,
            "end_logit": -5.206186771392822,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "we report a male neonate,",
            "probability": 0.04020357130906568,
            "start_logit": -5.305209636688232,
            "end_logit": -4.233874797821045,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "a male neonate,",
            "probability": 0.03973575393648529,
            "start_logit": -5.316914081573486,
            "end_logit": -4.233874797821045,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "microcephaly,",
            "probability": 0.03952154472561488,
            "start_logit": -4.328995227813721,
            "end_logit": -5.227199077606201,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "report a male neonate,",
            "probability": 0.03772510266850783,
            "start_logit": -5.368839740753174,
            "end_logit": -4.233874797821045,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        },
        {
            "text": "Here, we report a male neonate, with the classical features of Emanuel syndrome",
            "probability": 0.03728319180098733,
            "start_logit": -5.081549167633057,
            "end_logit": -4.5329484939575195,
            "question_text": "Which chromosomes are implicated in the Emanuel syndrome?"
        }
    ],
    "5a8a9abdfcd1d6a10c000019": [
        {
            "text": "TAB3",
            "probability": 0.20115454703611513,
            "start_logit": 4.564602375030518,
            "end_logit": 4.788354873657227,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TGF-\u03b2-activated kinase 1 (TAK1)-binding protein (TAB)2 and TAB3",
            "probability": 0.139574274751786,
            "start_logit": 4.19912576675415,
            "end_logit": 4.788354873657227,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB2- and TAB3",
            "probability": 0.06435143684028036,
            "start_logit": 4.089014530181885,
            "end_logit": 4.124228477478027,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAK1)-binding protein (TAB)2 and TAB3",
            "probability": 0.06379863834765685,
            "start_logit": 3.4162607192993164,
            "end_logit": 4.788354873657227,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB)2 and TAB3",
            "probability": 0.06257957933540845,
            "start_logit": 3.396967887878418,
            "end_logit": 4.788354873657227,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB3 are implicated in NF-\u03baB signaling via TAK1",
            "probability": 0.05558716744958403,
            "start_logit": 4.564602375030518,
            "end_logit": 3.5022337436676025,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "K63-linked polyubiquitin recognition controls B cell activation via MAPKs",
            "probability": 0.0438947811625925,
            "start_logit": 4.106129169464111,
            "end_logit": 3.7245500087738037,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB3-mediated K63-linked polyubiquitin recognition controls B cell activation via MAPKs",
            "probability": 0.0438412731671896,
            "start_logit": 4.104909420013428,
            "end_logit": 3.7245500087738037,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB2- and TAB3-mediated K63-linked polyubiquitin recognition controls B cell activation via MAPKs",
            "probability": 0.04314992992788658,
            "start_logit": 4.089014530181885,
            "end_logit": 3.7245500087738037,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TGF-\u03b2-activated kinase 1 (TAK1)-binding protein (TAB)2",
            "probability": 0.04217352312412791,
            "start_logit": 4.19912576675415,
            "end_logit": 3.591550588607788,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "MAPKs",
            "probability": 0.03486586805082794,
            "start_logit": 3.8758420944213867,
            "end_logit": 3.7245500087738037,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TGF-\u03b2-activated kinase 1 (TAK1",
            "probability": 0.0300354327094582,
            "start_logit": 4.19912576675415,
            "end_logit": 3.252135753631592,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB2",
            "probability": 0.028657652791369236,
            "start_logit": 4.089014530181885,
            "end_logit": 3.3152897357940674,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAK1",
            "probability": 0.023741528423470902,
            "start_logit": 3.7138757705688477,
            "end_logit": 3.5022337436676025,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "K63-linked polyubiquitin recognition controls B cell activation via MAPKs, but not the TAK",
            "probability": 0.021771081443970525,
            "start_logit": 4.106129169464111,
            "end_logit": 3.0233371257781982,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB3-mediated K63-linked polyubiquitin recognition controls B cell activation via MAPKs, but not the TAK",
            "probability": 0.021744542368140413,
            "start_logit": 4.104909420013428,
            "end_logit": 3.0233371257781982,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "K63",
            "probability": 0.02005540809504674,
            "start_logit": 4.106129169464111,
            "end_logit": 2.941253423690796,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB3-mediated K63",
            "probability": 0.020030960435080562,
            "start_logit": 4.104909420013428,
            "end_logit": 2.941253423690796,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAB2- and TAB3-mediated K63",
            "probability": 0.019715087558379904,
            "start_logit": 4.089014530181885,
            "end_logit": 2.941253423690796,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        },
        {
            "text": "TAK1)-binding protein (TAB)2",
            "probability": 0.01927728698162804,
            "start_logit": 3.4162607192993164,
            "end_logit": 3.591550588607788,
            "question_text": "List polyubiquitin binding proteins involved in NF-kappaB signaling."
        }
    ],
    "5a7723b79e632bc06600000b": [
        {
            "text": "excessive weight gain",
            "probability": 0.2733896480930424,
            "start_logit": 5.7393879890441895,
            "end_logit": 5.853297710418701,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate in the prednisone-treated patients and excessive weight gain",
            "probability": 0.24066435573415845,
            "start_logit": 5.611893177032471,
            "end_logit": 5.853297710418701,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "weight gain",
            "probability": 0.1430318162602684,
            "start_logit": 5.091557025909424,
            "end_logit": 5.853297710418701,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate",
            "probability": 0.12703533775984016,
            "start_logit": 5.611893177032471,
            "end_logit": 5.214359760284424,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline in growth rate in the prednisone-treated patients and excessive weight gain",
            "probability": 0.07578171674115913,
            "start_logit": 4.4563469886779785,
            "end_logit": 5.853297710418701,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "growth rate in the prednisone-treated patients and excessive weight gain",
            "probability": 0.061225016835655295,
            "start_logit": 4.243045806884766,
            "end_logit": 5.853297710418701,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline in growth rate",
            "probability": 0.04000158624598222,
            "start_logit": 4.4563469886779785,
            "end_logit": 5.214359760284424,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "growth rate",
            "probability": 0.03231779242648123,
            "start_logit": 4.243045806884766,
            "end_logit": 5.214359760284424,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline",
            "probability": 0.002134658211106373,
            "start_logit": 5.611893177032471,
            "end_logit": 1.1282010078430176,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth",
            "probability": 0.0015549180794001106,
            "start_logit": 5.611893177032471,
            "end_logit": 0.8113173246383667,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline",
            "probability": 0.0006721729248179323,
            "start_logit": 4.4563469886779785,
            "end_logit": 1.1282010078430176,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "a decline in growth",
            "probability": 0.0004896211617601072,
            "start_logit": 4.4563469886779785,
            "end_logit": 0.8113173246383667,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "growth",
            "probability": 0.00039557119000412273,
            "start_logit": 4.243045806884766,
            "end_logit": 0.8113173246383667,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "excessive weight",
            "probability": 0.00029347060561823627,
            "start_logit": 5.7393879890441895,
            "end_logit": -0.9835781455039978,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate in the prednisone-treated patients and excessive weight",
            "probability": 0.0002583415821362388,
            "start_logit": 5.611893177032471,
            "end_logit": -0.9835781455039978,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate in the prednisone-treated patients",
            "probability": 0.00021682001936484355,
            "start_logit": 5.611893177032471,
            "end_logit": -1.1587932109832764,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "weight",
            "probability": 0.00015353775840953472,
            "start_logit": 5.091557025909424,
            "end_logit": -0.9835781455039978,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "excessive weight gain in one control and three treated patients",
            "probability": 0.0001352166166015914,
            "start_logit": 5.7393879890441895,
            "end_logit": -1.7584775686264038,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "gain",
            "probability": 0.0001293708393582983,
            "start_logit": -1.9165823459625244,
            "end_logit": 5.853297710418701,
            "question_text": "What are the prednisone side effects in DMD patients?"
        },
        {
            "text": "decline in growth rate in the prednisone-treated patients and excessive weight gain in one control and three treated patients",
            "probability": 0.00011903091483515055,
            "start_logit": 5.611893177032471,
            "end_logit": -1.7584775686264038,
            "question_text": "What are the prednisone side effects in DMD patients?"
        }
    ],
    "5a7727f39e632bc06600000d": [
        {
            "text": "steroid side effects",
            "probability": 0.465857856501644,
            "start_logit": -1.149226188659668,
            "end_logit": -1.0805997848510742,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "clinical outcomes and steroid side effects",
            "probability": 0.17515725599517298,
            "start_logit": -2.127422571182251,
            "end_logit": -1.0805997848510742,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "steroid",
            "probability": 0.15882505855112108,
            "start_logit": -1.149226188659668,
            "end_logit": -2.156677007675171,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "clinical outcomes and steroid",
            "probability": 0.05971641574963731,
            "start_logit": -2.127422571182251,
            "end_logit": -2.156677007675171,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "ambulatory function",
            "probability": 0.033848103249327605,
            "start_logit": -2.505675792694092,
            "end_logit": -2.3461477756500244,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "clinical outcomes",
            "probability": 0.027712124957237776,
            "start_logit": -2.127422571182251,
            "end_logit": -2.9244139194488525,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "evaluate clinical outcomes and steroid side effects",
            "probability": 0.013304464705315003,
            "start_logit": -4.705007076263428,
            "end_logit": -1.0805997848510742,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "To evaluate clinical outcomes and steroid side effects",
            "probability": 0.012691456264354676,
            "start_logit": -4.752177715301514,
            "end_logit": -1.0805997848510742,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "clinical",
            "probability": 0.00813568567159256,
            "start_logit": -2.127422571182251,
            "end_logit": -4.150023937225342,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "steroid side effects in a cohort of patients with Duchenne muscular dystrophy",
            "probability": 0.0063831805815654785,
            "start_logit": -1.149226188659668,
            "end_logit": -5.370813846588135,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "outcomes and steroid side effects",
            "probability": 0.005723128579677619,
            "start_logit": -5.548591136932373,
            "end_logit": -1.0805997848510742,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "s",
            "probability": 0.005405277206640596,
            "start_logit": -1.149226188659668,
            "end_logit": -5.537104606628418,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "evaluate clinical outcomes and steroid",
            "probability": 0.004535895136944035,
            "start_logit": -4.705007076263428,
            "end_logit": -2.156677007675171,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "ambulatory function in DMD, less frequent dosing is often used because of side effect concerns.",
            "probability": 0.0044342294074555845,
            "start_logit": -2.505675792694092,
            "end_logit": -4.378676891326904,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "To evaluate clinical outcomes and steroid",
            "probability": 0.0043269019855587875,
            "start_logit": -4.752177715301514,
            "end_logit": -2.156677007675171,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "side effects",
            "probability": 0.0035636609888063052,
            "start_logit": -6.022318363189697,
            "end_logit": -1.0805997848510742,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "extend ambulatory function",
            "probability": 0.002816989616505361,
            "start_logit": -4.991889953613281,
            "end_logit": -2.3461477756500244,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "effects",
            "probability": 0.002607446405659757,
            "start_logit": -6.33473539352417,
            "end_logit": -1.0805997848510742,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "steroid side effects in a cohort",
            "probability": 0.0025548651409459697,
            "start_logit": -1.149226188659668,
            "end_logit": -6.286480903625488,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        },
        {
            "text": "clinical outcomes and steroid side effects in a cohort of patients with Duchenne muscular dystrophy",
            "probability": 0.0024000033048379773,
            "start_logit": -2.127422571182251,
            "end_logit": -5.370813846588135,
            "question_text": "What are the side effects of deflazacort in DMD patients?"
        }
    ],
    "5a86f074faa1ab7d2e00003a": [
        {
            "text": "chordoma",
            "probability": 0.37569133437528834,
            "start_logit": 3.8467228412628174,
            "end_logit": 3.6768856048583984,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "childhood chordoma",
            "probability": 0.24082327227215117,
            "start_logit": 3.4020183086395264,
            "end_logit": 3.6768856048583984,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordomas",
            "probability": 0.14758809685189744,
            "start_logit": 3.8467228412628174,
            "end_logit": 2.7425429821014404,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "childhood chordomas",
            "probability": 0.09460598416887785,
            "start_logit": 3.4020183086395264,
            "end_logit": 2.7425429821014404,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordomas (CCs)",
            "probability": 0.08194544729716245,
            "start_logit": 3.8467228412628174,
            "end_logit": 2.1541714668273926,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "childhood chordomas (CCs)",
            "probability": 0.05252815000037921,
            "start_logit": 3.4020183086395264,
            "end_logit": 2.1541714668273926,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordomas (CCs).",
            "probability": 0.0018303394717180475,
            "start_logit": 3.8467228412628174,
            "end_logit": -1.6473808288574219,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "childhood chordomas (CCs).",
            "probability": 0.0011732725794194262,
            "start_logit": 3.4020183086395264,
            "end_logit": -1.6473808288574219,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "Loss of SMARCB1/INI1 expression is considered to be a hallmark for childhood chordoma",
            "probability": 0.0010252552954521227,
            "start_logit": -2.057103395462036,
            "end_logit": 3.6768856048583984,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "childhood",
            "probability": 0.0004102126083510425,
            "start_logit": 3.4020183086395264,
            "end_logit": -2.6982574462890625,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "Loss of SMARCB1/INI1 expression is considered to be a hallmark for childhood chordomas",
            "probability": 0.0004027654193693897,
            "start_logit": -2.057103395462036,
            "end_logit": 2.7425429821014404,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordomas (",
            "probability": 0.00033751190560979687,
            "start_logit": 3.8467228412628174,
            "end_logit": -3.3380367755889893,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "oma",
            "probability": 0.00032818690049015787,
            "start_logit": -3.1962170600891113,
            "end_logit": 3.6768856048583984,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chord",
            "probability": 0.00023905245656183433,
            "start_logit": 3.8467228412628174,
            "end_logit": -3.6829545497894287,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "Loss of SMARCB1/INI1 expression is considered to be a hallmark for childhood chordomas (CCs)",
            "probability": 0.00022362773929643996,
            "start_logit": -2.057103395462036,
            "end_logit": 2.1541714668273926,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "childhood chordomas (",
            "probability": 0.00021634973741121,
            "start_logit": 3.4020183086395264,
            "end_logit": -3.3380367755889893,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "(CCs)",
            "probability": 0.00019750296532436567,
            "start_logit": -2.181332588195801,
            "end_logit": 2.1541714668273926,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "childhood chord",
            "probability": 0.00015323588692735078,
            "start_logit": 3.4020183086395264,
            "end_logit": -3.6829545497894287,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "chordomas (CCs). Although",
            "probability": 0.00015147580458676474,
            "start_logit": 3.8467228412628174,
            "end_logit": -4.139211654663086,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        },
        {
            "text": "omas",
            "probability": 0.00012892626372553202,
            "start_logit": -3.1962170600891113,
            "end_logit": 2.7425429821014404,
            "question_text": "With which cancers has the loss of SMARCB1 been associated?"
        }
    ],
    "5a75fbf383b0d9ea6600000a": [
        {
            "text": "Janus kinase inhibitor,",
            "probability": 0.11848158841768368,
            "start_logit": -2.4220542907714844,
            "end_logit": -2.6931159496307373,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, an oral, small-molecule Janus kinase inhibitor,",
            "probability": 0.09926090709358794,
            "start_logit": -2.59906005859375,
            "end_logit": -2.6931159496307373,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis",
            "probability": 0.09361132623608139,
            "start_logit": -2.4220542907714844,
            "end_logit": -2.9287221431732178,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib,",
            "probability": 0.08922274776801328,
            "start_logit": -2.59906005859375,
            "end_logit": -2.799731731414795,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative colitis",
            "probability": 0.0778772387528762,
            "start_logit": -2.606071949005127,
            "end_logit": -2.9287221431732178,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Janus kinase inhibitor",
            "probability": 0.05319776482101191,
            "start_logit": -2.4220542907714844,
            "end_logit": -3.4938571453094482,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2 trial",
            "probability": 0.05292061011428272,
            "start_logit": -2.4220542907714844,
            "end_logit": -3.4990806579589844,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative colitis in a phase 2",
            "probability": 0.05199468743595077,
            "start_logit": -2.4220542907714844,
            "end_logit": -3.5167319774627686,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, an oral, small-molecule Janus kinase inhibitor",
            "probability": 0.04456775488922195,
            "start_logit": -2.59906005859375,
            "end_logit": -3.4938571453094482,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative colitis in a phase 2 trial",
            "probability": 0.04402577289017575,
            "start_logit": -2.606071949005127,
            "end_logit": -3.4990806579589844,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative colitis in a phase 2",
            "probability": 0.043255478264658885,
            "start_logit": -2.606071949005127,
            "end_logit": -3.5167319774627686,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Janus kinase inhibitor, was shown to have potential efficacy as induction therapy",
            "probability": 0.03762262617858277,
            "start_logit": -2.4220542907714844,
            "end_logit": -3.8402678966522217,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy",
            "probability": 0.03151929385487304,
            "start_logit": -2.59906005859375,
            "end_logit": -3.8402678966522217,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "phase 2 trial",
            "probability": 0.026605529258004905,
            "start_logit": -3.1097280979156494,
            "end_logit": -3.4990806579589844,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "phase 2",
            "probability": 0.026140027011227855,
            "start_logit": -3.1097280979156494,
            "end_logit": -3.5167319774627686,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative",
            "probability": 0.025979765179611227,
            "start_logit": -2.4220542907714844,
            "end_logit": -4.210555553436279,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib, an oral, small-molecule Janus kinase inhibitor, was shown to have potential efficacy as induction therapy for ulcerative",
            "probability": 0.021765196535985434,
            "start_logit": -2.59906005859375,
            "end_logit": -4.210555553436279,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "ulcerative",
            "probability": 0.02161311517512089,
            "start_logit": -2.606071949005127,
            "end_logit": -4.210555553436279,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "Tofacitinib",
            "probability": 0.020546404404182424,
            "start_logit": -2.59906005859375,
            "end_logit": -4.268181800842285,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        },
        {
            "text": "in a phase 2 trial",
            "probability": 0.019792165718867234,
            "start_logit": -3.4055609703063965,
            "end_logit": -3.4990806579589844,
            "question_text": "Name the phase 3 clinical trials for tofacitinib in colitis."
        }
    ],
    "5a76155c83b0d9ea6600001e": [
        {
            "text": "assess baricitinib on patient-reported outcomes (PROs) in patients with moderately to severely active rheumatoid arthritis,",
            "probability": 0.2254352950946261,
            "start_logit": -3.1264657974243164,
            "end_logit": -3.3223369121551514,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "assess baricitinib on patient-reported outcomes",
            "probability": 0.14688893676086084,
            "start_logit": -3.1264657974243164,
            "end_logit": -3.7506933212280273,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "assess",
            "probability": 0.08154346695421048,
            "start_logit": -3.1264657974243164,
            "end_logit": -4.339233875274658,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "assess baricitinib on patient-reported outcomes (PROs)",
            "probability": 0.08056529255397958,
            "start_logit": -3.1264657974243164,
            "end_logit": -4.351302146911621,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "assess baricitinib",
            "probability": 0.06943609315986325,
            "start_logit": -3.1264657974243164,
            "end_logit": -4.499963283538818,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "assess baricitinib on patient-reported outcomes (PROs) in patients with moderately to severely active rheumatoid arthritis",
            "probability": 0.0674843527103377,
            "start_logit": -3.1264657974243164,
            "end_logit": -4.5284743309021,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "patient-reported outcomes (PROs) in patients with moderately to severely active rheumatoid arthritis,",
            "probability": 0.03909604856179472,
            "start_logit": -4.878477573394775,
            "end_logit": -3.3223369121551514,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "To assess baricitinib on patient-reported outcomes",
            "probability": 0.0367109064876269,
            "start_logit": -4.513068675994873,
            "end_logit": -3.7506933212280273,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "patient-reported outcomes",
            "probability": 0.02547416988268181,
            "start_logit": -4.878477573394775,
            "end_logit": -3.7506933212280273,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "baricitinib on patient-reported outcomes (PROs) in patients with moderately to severely active rheumatoid arthritis,",
            "probability": 0.025337017815397423,
            "start_logit": -5.312232494354248,
            "end_logit": -3.3223369121551514,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "moderately to severely active rheumatoid arthritis,",
            "probability": 0.024065000686818504,
            "start_logit": -5.36374044418335,
            "end_logit": -3.3223369121551514,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "assess baricitinib on",
            "probability": 0.022992473850915972,
            "start_logit": -3.1264657974243164,
            "end_logit": -5.605203151702881,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "on patient-reported outcomes (PROs) in patients with moderately to severely active rheumatoid arthritis,",
            "probability": 0.02229417312618025,
            "start_logit": -5.440173625946045,
            "end_logit": -3.3223369121551514,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "rheumatoid arthritis,",
            "probability": 0.02180908153536112,
            "start_logit": -5.462172508239746,
            "end_logit": -3.3223369121551514,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "To assess",
            "probability": 0.020379578313011213,
            "start_logit": -4.513068675994873,
            "end_logit": -4.339233875274658,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "To assess baricitinib on patient-reported outcomes (PROs)",
            "probability": 0.020135110147284554,
            "start_logit": -4.513068675994873,
            "end_logit": -4.351302146911621,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "assess baricitinib on patient-reported outcomes (PROs) in",
            "probability": 0.018768308528820787,
            "start_logit": -3.1264657974243164,
            "end_logit": -5.808200359344482,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "tumour necrosis factor inhibitors",
            "probability": 0.017365141320509307,
            "start_logit": -4.587698459625244,
            "end_logit": -4.424672603607178,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "To assess baricitinib",
            "probability": 0.017353668554411495,
            "start_logit": -4.513068675994873,
            "end_logit": -4.499963283538818,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        },
        {
            "text": "To assess baricitinib on patient-reported outcomes (PROs) in patients with moderately to severely active rheumatoid arthritis",
            "probability": 0.01686588395530789,
            "start_logit": -4.513068675994873,
            "end_logit": -4.5284743309021,
            "question_text": "Which phase III clinical trials for rheumatoid arthritis involve baricitinib? (November 2017)"
        }
    ],
    "5a67a207b750ff4455000008": [
        {
            "text": "American Academy of Pediatrics",
            "probability": 0.1690081017104076,
            "start_logit": -1.7811607122421265,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "premature infants. The 2014 American Academy of Pediatrics",
            "probability": 0.1079692477641505,
            "start_logit": -2.2292609214782715,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "palivizumab reduced RSV hospitalization rates for premature infants. The 2014 American Academy of Pediatrics",
            "probability": 0.09703077968360295,
            "start_logit": -2.3360791206359863,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "2014 American Academy of Pediatrics",
            "probability": 0.08748904391897928,
            "start_logit": -2.43959379196167,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "hospitalization rates for premature infants. The 2014 American Academy of Pediatrics",
            "probability": 0.07579160207162743,
            "start_logit": -2.5831198692321777,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "premature infants",
            "probability": 0.07155247561086647,
            "start_logit": -2.2292609214782715,
            "end_logit": -0.7685821652412415,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "palivizumab reduced RSV hospitalization rates for premature infants",
            "probability": 0.064303425656723,
            "start_logit": -2.3360791206359863,
            "end_logit": -0.7685821652412415,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "Pediatrics",
            "probability": 0.057203342165453565,
            "start_logit": -2.864495038986206,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "hospitalization rates for premature infants",
            "probability": 0.05022797575273341,
            "start_logit": -2.5831198692321777,
            "end_logit": -0.7685821652412415,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "clinical trials, palivizumab reduced RSV hospitalization rates for premature infants. The 2014 American Academy of Pediatrics",
            "probability": 0.03587190681494795,
            "start_logit": -3.33115291595459,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "reduced RSV hospitalization rates for premature infants. The 2014 American Academy of Pediatrics",
            "probability": 0.031331060190745115,
            "start_logit": -3.4664974212646484,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "Academy of Pediatrics",
            "probability": 0.02985235295856896,
            "start_logit": -3.514843702316284,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "clinical trials, palivizumab reduced RSV hospitalization rates for premature infants",
            "probability": 0.02377272964889618,
            "start_logit": -3.33115291595459,
            "end_logit": -0.7685821652412415,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "reduced RSV hospitalization rates for premature infants",
            "probability": 0.02076345780474391,
            "start_logit": -3.4664974212646484,
            "end_logit": -0.7685821652412415,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "The 2014 American Academy of Pediatrics",
            "probability": 0.018311262441230085,
            "start_logit": -4.003591060638428,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "In clinical trials, palivizumab reduced RSV hospitalization rates for premature infants",
            "probability": 0.016746143422027578,
            "start_logit": -3.6815240383148193,
            "end_logit": -0.7685821652412415,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "hospitalization of infants. In clinical trials, palivizumab reduced RSV hospitalization rates for premature infants",
            "probability": 0.015227298308031488,
            "start_logit": -3.776602268218994,
            "end_logit": -0.7685821652412415,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "trials, palivizumab reduced RSV hospitalization rates for premature infants. The 2014 American Academy of Pediatrics",
            "probability": 0.010161913213183866,
            "start_logit": -4.592460632324219,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "RSV hospitalization rates for premature infants. The 2014 American Academy of Pediatrics",
            "probability": 0.009109162660410852,
            "start_logit": -4.701826572418213,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        },
        {
            "text": "infants. The 2014 American Academy of Pediatrics",
            "probability": 0.008276718202669973,
            "start_logit": -4.797660827636719,
            "end_logit": -0.3571668267250061,
            "question_text": "List indications for palivizumab for treatment of RSV-induced bronchiolitis. "
        }
    ],
    "5a89a20ffcd1d6a10c00000e": [
        {
            "text": "Vascular endothelial growth factors",
            "probability": 0.718069016045949,
            "start_logit": 3.1566362380981445,
            "end_logit": 1.9126358032226562,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vascular endothelial growth",
            "probability": 0.10806792225411528,
            "start_logit": 3.1566362380981445,
            "end_logit": 0.018830055370926857,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vascular endothelial growth factors (VEGFs)",
            "probability": 0.03329873651846821,
            "start_logit": 3.1566362380981445,
            "end_logit": -1.1584104299545288,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vegfc",
            "probability": 0.02366759023449446,
            "start_logit": 1.4150105714797974,
            "end_logit": 0.2418023943901062,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vegfd",
            "probability": 0.019569810343050408,
            "start_logit": 1.2157742977142334,
            "end_logit": 0.2509201467037201,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vegfc",
            "probability": 0.01897814515679308,
            "start_logit": 1.0943703651428223,
            "end_logit": 0.34162405133247375,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vegfc and vegfd",
            "probability": 0.017332513965609326,
            "start_logit": 1.0943703651428223,
            "end_logit": 0.2509201467037201,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "endothelial growth factors",
            "probability": 0.013487644458203125,
            "start_logit": -0.8181554079055786,
            "end_logit": 1.9126358032226562,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vegfd",
            "probability": 0.012714996796477336,
            "start_logit": 1.2007269859313965,
            "end_logit": -0.16523848474025726,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vegfa controls the formation of intersegmental arteries by primary angiogenesis and Vegfc",
            "probability": 0.00965900553197576,
            "start_logit": 0.5187946557998657,
            "end_logit": 0.2418023943901062,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vascular",
            "probability": 0.00891184642389293,
            "start_logit": 3.1566362380981445,
            "end_logit": -2.476548433303833,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vegfa",
            "probability": 0.004230895076419563,
            "start_logit": 0.5187946557998657,
            "end_logit": -0.5836747288703918,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "growth factors",
            "probability": 0.003101244421203927,
            "start_logit": -2.288125991821289,
            "end_logit": 1.9126358032226562,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vascular endothelial growth factors (VEGFs",
            "probability": 0.0024913353534541044,
            "start_logit": 3.1566362380981445,
            "end_logit": -3.7511110305786133,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "endothelial growth",
            "probability": 0.0020298629799213814,
            "start_logit": -0.8181554079055786,
            "end_logit": 0.018830055370926857,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vascular endothelial growth factors (VEGFs) control angiogenesis and lymphangiogenesis during development and in pathological conditions.",
            "probability": 0.001405075689756992,
            "start_logit": 3.1566362380981445,
            "end_logit": -4.323838710784912,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "Vascular endothelial growth factors (",
            "probability": 0.0013317129770940104,
            "start_logit": 3.1566362380981445,
            "end_logit": -4.3774638175964355,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "endothelial growth factors (VEGFs)",
            "probability": 0.0006254573154285,
            "start_logit": -0.8181554079055786,
            "end_logit": -1.1584104299545288,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vegfd cooperatively control lymphangiogenesis throughout the embryo,",
            "probability": 0.000544732172843066,
            "start_logit": 1.2157742977142334,
            "end_logit": -3.330528974533081,
            "question_text": "List factors that promote lymphangiogenesis."
        },
        {
            "text": "vegfc and vegfd cooperatively control lymphangiogenesis throughout the embryo,",
            "probability": 0.0004824562848495887,
            "start_logit": 1.0943703651428223,
            "end_logit": -3.330528974533081,
            "question_text": "List factors that promote lymphangiogenesis."
        }
    ],
    "5a86ebf2faa1ab7d2e000038": [
        {
            "text": "PER2 play essential roles in a negative limb of the feedback loop that generates the circadian rhythm in mammals. In addition, the proteins CLOCK",
            "probability": 0.11859801632742571,
            "start_logit": 3.6229605674743652,
            "end_logit": 3.9002912044525146,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK",
            "probability": 0.11512434194659532,
            "start_logit": 3.593233585357666,
            "end_logit": 3.9002912044525146,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "Clock",
            "probability": 0.07869988426349452,
            "start_logit": 3.347566604614258,
            "end_logit": 3.765587091445923,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "BMAL1",
            "probability": 0.07792972003015108,
            "start_logit": 3.9935662746429443,
            "end_logit": 3.109753131866455,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "PER",
            "probability": 0.05444195100326484,
            "start_logit": 3.688279151916504,
            "end_logit": 3.056367874145508,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "PER1",
            "probability": 0.05243645051473578,
            "start_logit": 3.688279151916504,
            "end_logit": 3.0188348293304443,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "CLOCK and BMAL1",
            "probability": 0.05222047743458261,
            "start_logit": 3.593233585357666,
            "end_logit": 3.109753131866455,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "Bmal1",
            "probability": 0.050734384956128406,
            "start_logit": 3.890268564224243,
            "end_logit": 2.7838473320007324,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "PER1 and PER2",
            "probability": 0.04805785607197005,
            "start_logit": 3.688279151916504,
            "end_logit": 2.931638479232788,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "PER2",
            "probability": 0.0450191086122411,
            "start_logit": 3.6229605674743652,
            "end_logit": 2.931638479232788,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock proteins PER",
            "probability": 0.043163179180553256,
            "start_logit": 3.456131935119629,
            "end_logit": 3.056367874145508,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock proteins PER1",
            "probability": 0.04157315943772891,
            "start_logit": 3.456131935119629,
            "end_logit": 3.0188348293304443,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock",
            "probability": 0.04145511904508471,
            "start_logit": 3.456131935119629,
            "end_logit": 3.015991449356079,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock proteins PER1 and PER2",
            "probability": 0.03810168104635499,
            "start_logit": 3.456131935119629,
            "end_logit": 2.931638479232788,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock genes Clock",
            "probability": 0.0373090559228429,
            "start_logit": 2.601161003112793,
            "end_logit": 3.765587091445923,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "Clock and Bmal1",
            "probability": 0.029485597546735316,
            "start_logit": 3.347566604614258,
            "end_logit": 2.7838473320007324,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "Id2 is involved in stabilization of the amplitudes of the circadian oscillations by suppressing transcriptional activation of clock genes Clock",
            "probability": 0.020697534891415736,
            "start_logit": 2.011939525604248,
            "end_logit": 3.765587091445923,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "PER1 and PER",
            "probability": 0.019994753206542298,
            "start_logit": 3.688279151916504,
            "end_logit": 2.0547027587890625,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "BMAL1 (also known as ARNTL) form a heterodimer that drives the Per",
            "probability": 0.019105300436033805,
            "start_logit": 3.9935662746429443,
            "end_logit": 1.703911542892456,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        },
        {
            "text": "clock proteins PER1 and PER",
            "probability": 0.015852428126118614,
            "start_logit": 3.456131935119629,
            "end_logit": 2.0547027587890625,
            "question_text": "Which are the main transcriptional activators of circadian oscillations?"
        }
    ],
    "5a7600b983b0d9ea6600000c": [
        {
            "text": "NCT01186744",
            "probability": 0.26098959037886943,
            "start_logit": 0.06577193737030029,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "NCT01186744; OPT Retreatment)",
            "probability": 0.11680490797091941,
            "start_logit": 0.06577193737030029,
            "end_logit": -0.5957170724868774,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Phase 3 withdrawal/re-treatment study (NCT01186744",
            "probability": 0.0985778428025231,
            "start_logit": -0.9078620672225952,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "A Phase 3 withdrawal/re-treatment study (NCT01186744",
            "probability": 0.07539749354893338,
            "start_logit": -1.1759345531463623,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "01186744",
            "probability": 0.0725255205054257,
            "start_logit": -1.2147700786590576,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Phase 3 withdrawal/re-treatment study",
            "probability": 0.06084911738721543,
            "start_logit": -0.9078620672225952,
            "end_logit": -0.27419084310531616,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "A Phase 3 withdrawal/re-treatment study",
            "probability": 0.04654058970281543,
            "start_logit": -1.1759345531463623,
            "end_logit": -0.27419084310531616,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Phase 3 withdrawal/re-treatment study (NCT01186744; OPT Retreatment)",
            "probability": 0.044118142182626725,
            "start_logit": -0.9078620672225952,
            "end_logit": -0.5957170724868774,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "(NCT01186744",
            "probability": 0.043487199887392275,
            "start_logit": -1.726241946220398,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "A Phase 3 withdrawal/re-treatment study (NCT01186744; OPT Retreatment)",
            "probability": 0.03374386419947491,
            "start_logit": -1.1759345531463623,
            "end_logit": -0.5957170724868774,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "01186744; OPT Retreatment)",
            "probability": 0.032458523483184655,
            "start_logit": -1.2147700786590576,
            "end_logit": -0.5957170724868774,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "44",
            "probability": 0.02034939884025295,
            "start_logit": -2.485657215118408,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "(NCT01186744; OPT Retreatment)",
            "probability": 0.019462532484096677,
            "start_logit": -1.726241946220398,
            "end_logit": -0.5957170724868774,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "NCT01186744; OPT Retreatment",
            "probability": 0.017387665243162688,
            "start_logit": 0.06577193737030029,
            "end_logit": -2.5004611015319824,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "withdrawal/re-treatment study (NCT01186744",
            "probability": 0.011427411533678834,
            "start_logit": -3.0626935958862305,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Janus kinase inhibitor being investigated for psoriasis. A Phase 3 withdrawal/re-treatment study (NCT01186744",
            "probability": 0.011106533138401462,
            "start_logit": -3.091175079345703,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "44; OPT Retreatment)",
            "probability": 0.009107296790453611,
            "start_logit": -2.485657215118408,
            "end_logit": -0.5957170724868774,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "study (NCT01186744",
            "probability": 0.008790950525385881,
            "start_logit": -3.3249857425689697,
            "end_logit": 0.20825836062431335,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "NCT01186744;",
            "probability": 0.008656883361300993,
            "start_logit": 0.06577193737030029,
            "end_logit": -3.1978673934936523,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        },
        {
            "text": "Tofacitinib is an oral Janus kinase inhibitor being investigated for psoriasis. A Phase 3 withdrawal/re-treatment study",
            "probability": 0.008218536033886415,
            "start_logit": -2.909867286682129,
            "end_logit": -0.27419084310531616,
            "question_text": "Which clinical trials for psoriasis involved tofacitinib? (November 2017)"
        }
    ],
    "5a7244aa2dc08e987e00000f": [
        {
            "text": "inflammation is essential for targeted and valid treatment options that could replace previous serendipitous therapeutic approaches in refractory PRP.",
            "probability": 0.16122534529552573,
            "start_logit": -4.944667339324951,
            "end_logit": -4.507881164550781,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inflammation",
            "probability": 0.14404908112743253,
            "start_logit": -4.944667339324951,
            "end_logit": -4.620530128479004,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "mediators of inflammation",
            "probability": 0.09745556416229224,
            "start_logit": -5.335424900054932,
            "end_logit": -4.620530128479004,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "Insight into pathogenic mediators of inflammation",
            "probability": 0.09204588162140802,
            "start_logit": -5.392534255981445,
            "end_logit": -4.620530128479004,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "Insight",
            "probability": 0.04708864936421353,
            "start_logit": -5.392534255981445,
            "end_logit": -5.290785312652588,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "targeted and valid treatment options that could replace previous serendipitous therapeutic approaches in refractory PRP.",
            "probability": 0.04649974453554815,
            "start_logit": -6.188023567199707,
            "end_logit": -4.507881164550781,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "pathogenic mediators of inflammation",
            "probability": 0.04602528894591524,
            "start_logit": -6.085630416870117,
            "end_logit": -4.620530128479004,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "treatment options that could replace previous serendipitous therapeutic approaches in refractory PRP.",
            "probability": 0.041772275115588536,
            "start_logit": -6.2952375411987305,
            "end_logit": -4.507881164550781,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "psoriasis rather than any knowledge of its pathomechanism. Insight into pathogenic mediators of inflammation",
            "probability": 0.04044260203043507,
            "start_logit": -6.214937686920166,
            "end_logit": -4.620530128479004,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "mediators",
            "probability": 0.037856084531090135,
            "start_logit": -5.335424900054932,
            "end_logit": -5.566134929656982,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "Insight into pathogenic mediators",
            "probability": 0.03575472273287571,
            "start_logit": -5.392534255981445,
            "end_logit": -5.566134929656982,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "essential for targeted and valid treatment options that could replace previous serendipitous therapeutic approaches in refractory PRP.",
            "probability": 0.029182669062336797,
            "start_logit": -6.653895378112793,
            "end_logit": -4.507881164550781,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inflammation is essential for targeted and valid treatment",
            "probability": 0.0289870788373576,
            "start_logit": -4.944667339324951,
            "end_logit": -6.223834037780762,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inflammation is essential for targeted and valid treatment options that could replace previous serendipitous therapeutic approaches",
            "probability": 0.027476338121843046,
            "start_logit": -4.944667339324951,
            "end_logit": -6.2773590087890625,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inflammation is essential for targeted",
            "probability": 0.02632625519334631,
            "start_logit": -4.944667339324951,
            "end_logit": -6.320117473602295,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "psoriasis rather than any knowledge of its pathomechanism. Insight",
            "probability": 0.02068954604857264,
            "start_logit": -6.214937686920166,
            "end_logit": -5.290785312652588,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "inflammation is essential for targeted and valid treatment options",
            "probability": 0.020400433134005837,
            "start_logit": -4.944667339324951,
            "end_logit": -6.575128078460693,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "mediators of inflammation is essential for targeted and valid treatment",
            "probability": 0.019611038816779697,
            "start_logit": -5.335424900054932,
            "end_logit": -6.223834037780762,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "mediators of inflammation is essential for targeted and valid treatment options that could replace previous serendipitous therapeutic approaches",
            "probability": 0.018588956012911138,
            "start_logit": -5.335424900054932,
            "end_logit": -6.2773590087890625,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        },
        {
            "text": "Insight into pathogenic mediators of inflammation is essential for targeted and valid treatment",
            "probability": 0.018522445310522162,
            "start_logit": -5.392534255981445,
            "end_logit": -6.223834037780762,
            "question_text": "Which two interleukins are inhibited by Ustekinumab?"
        }
    ],
    "5a8842a261bb38fb24000015": [
        {
            "text": "programmed cell death protein 1",
            "probability": 0.3067443370852689,
            "start_logit": 5.4770026206970215,
            "end_logit": 3.9092788696289062,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand 1",
            "probability": 0.18709218905517105,
            "start_logit": 5.4770026206970215,
            "end_logit": 3.414865732192993,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein ligand 1",
            "probability": 0.11857072336299565,
            "start_logit": 5.020910739898682,
            "end_logit": 3.414865732192993,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein 1",
            "probability": 0.05357546759692923,
            "start_logit": 3.732079267501831,
            "end_logit": 3.9092788696289062,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1",
            "probability": 0.052827566967277965,
            "start_logit": 5.4770026206970215,
            "end_logit": 2.1502974033355713,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein ligand 1",
            "probability": 0.046434689455228384,
            "start_logit": 4.0834479331970215,
            "end_logit": 3.414865732192993,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand",
            "probability": 0.04625817934812334,
            "start_logit": 5.4770026206970215,
            "end_logit": 2.017502546310425,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand 1",
            "probability": 0.0326772178016689,
            "start_logit": 3.732079267501831,
            "end_logit": 3.414865732192993,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death",
            "probability": 0.030421590132015647,
            "start_logit": 5.4770026206970215,
            "end_logit": 1.598416805267334,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein ligand",
            "probability": 0.02931638041364065,
            "start_logit": 5.020910739898682,
            "end_logit": 2.017502546310425,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein",
            "probability": 0.019146594029989448,
            "start_logit": 5.4770026206970215,
            "end_logit": 1.1353890895843506,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein ligand",
            "probability": 0.011480886527876126,
            "start_logit": 4.0834479331970215,
            "end_logit": 2.017502546310425,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death",
            "probability": 0.011005675600844906,
            "start_logit": 5.4770026206970215,
            "end_logit": 0.5816753506660461,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand 1 (PD-L1",
            "probability": 0.010033340583064461,
            "start_logit": 5.4770026206970215,
            "end_logit": 0.4891778528690338,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein 1 (PD-1",
            "probability": 0.009226777026019727,
            "start_logit": 3.732079267501831,
            "end_logit": 2.1502974033355713,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death protein 1 (PD-1) and anti-programmed cell death protein ligand",
            "probability": 0.008079378456689823,
            "start_logit": 3.732079267501831,
            "end_logit": 2.017502546310425,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "PD-1) and anti-programmed cell death protein ligand 1",
            "probability": 0.007898943979538766,
            "start_logit": 2.3121302127838135,
            "end_logit": 3.414865732192993,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein 1 (PD-1) and anti-programmed cell death protein",
            "probability": 0.0075379912403854684,
            "start_logit": 5.4770026206970215,
            "end_logit": 0.20321998000144958,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "programmed cell death protein ligand 1 (PD-L1",
            "probability": 0.006358685825897511,
            "start_logit": 5.020910739898682,
            "end_logit": 0.4891778528690338,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        },
        {
            "text": "anti-programmed cell death",
            "probability": 0.005313385511373923,
            "start_logit": 3.732079267501831,
            "end_logit": 1.598416805267334,
            "question_text": "List proteins that are targeted by \"immune checkpoints inhibitors\"."
        }
    ],
    "5a86c938faa1ab7d2e000034": [
        {
            "text": "EgrIAA4",
            "probability": 0.7207813320476731,
            "start_logit": 3.072782516479492,
            "end_logit": 2.9814136028289795,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4, for functional characterization. We showed that EgrIAA4",
            "probability": 0.20916551804595013,
            "start_logit": 1.835572600364685,
            "end_logit": 2.9814136028289795,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA",
            "probability": 0.04975458083138973,
            "start_logit": 3.072782516479492,
            "end_logit": 0.3081803321838379,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4, for functional characterization. We showed that EgrIAA",
            "probability": 0.014438418715966976,
            "start_logit": 1.835572600364685,
            "end_logit": 0.3081803321838379,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4,",
            "probability": 0.0035077453558022163,
            "start_logit": 1.835572600364685,
            "end_logit": -1.106738805770874,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "4",
            "probability": 0.0006842744161322214,
            "start_logit": -3.8869495391845703,
            "end_logit": 2.9814136028289795,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "4, for functional characterization. We showed that EgrIAA4",
            "probability": 0.0006279440651354025,
            "start_logit": -3.9728574752807617,
            "end_logit": 2.9814136028289795,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "E",
            "probability": 0.00025765519726162655,
            "start_logit": 3.072782516479492,
            "end_logit": -4.955055236816406,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4 protein is localized in the nucleus and functions as an auxin-responsive repressor",
            "probability": 0.00021894342240334798,
            "start_logit": 3.072782516479492,
            "end_logit": -5.11786413192749,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4 protein",
            "probability": 0.00016796302510823616,
            "start_logit": 3.072782516479492,
            "end_logit": -5.382933616638184,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4 protein is localized in the nucleus and functions as an auxin-responsive repressor.",
            "probability": 0.00013830096935682444,
            "start_logit": 3.072782516479492,
            "end_logit": -5.577245235443115,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4, for functional characterization. We showed that E",
            "probability": 7.476967065636362e-05,
            "start_logit": 1.835572600364685,
            "end_logit": -4.955055236816406,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "We showed that EgrIAA4",
            "probability": 7.247228208616738e-05,
            "start_logit": -6.132104396820068,
            "end_logit": 2.9814136028289795,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "EgrIAA4, for functional characterization. We showed that EgrIAA4 protein",
            "probability": 4.874165242254843e-05,
            "start_logit": 1.835572600364685,
            "end_logit": -5.382933616638184,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "4, for functional characterization. We showed that EgrIAA",
            "probability": 4.334614723942988e-05,
            "start_logit": -3.9728574752807617,
            "end_logit": 0.3081803321838379,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "4,",
            "probability": 1.0530740911598935e-05,
            "start_logit": -3.9728574752807617,
            "end_logit": -1.106738805770874,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "We showed that EgrIAA",
            "probability": 5.002665658456592e-06,
            "start_logit": -6.132104396820068,
            "end_logit": 0.3081803321838379,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "auxin-responsive repressor. Overexpressing a stabilized version of EgrIAA4",
            "probability": 2.028425725367765e-06,
            "start_logit": -5.073235988616943,
            "end_logit": -1.6533989906311035,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "4, for functional characterization. We showed that E",
            "probability": 2.2446898216979438e-07,
            "start_logit": -3.9728574752807617,
            "end_logit": -4.955055236816406,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        },
        {
            "text": "4 protein is localized in the nucleus and functions as an auxin-responsive repressor",
            "probability": 2.0785413809958686e-07,
            "start_logit": -3.8869495391845703,
            "end_logit": -5.11786413192749,
            "question_text": "Which genes belong to the AUX/IAA family of transcription repressors in plants?"
        }
    ],
    "5a76018c83b0d9ea6600000e": [
        {
            "text": "parapagus twins must result from two nearly parallel notochords in close proximity; craniopagi and pygopagi",
            "probability": 0.28902192128336807,
            "start_logit": 0.9594247341156006,
            "end_logit": 0.6660983562469482,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "parapagus",
            "probability": 0.2558345915861161,
            "start_logit": 0.9594247341156006,
            "end_logit": 0.5441269278526306,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "pygopagi",
            "probability": 0.1839633226138419,
            "start_logit": 0.5076586008071899,
            "end_logit": 0.6660983562469482,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "craniopagi and pygopagi",
            "probability": 0.07214954897368488,
            "start_logit": -0.4283367693424225,
            "end_logit": 0.6660983562469482,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "parapagus twins must result from two nearly parallel notochords in close proximity; craniopagi",
            "probability": 0.04952502222505592,
            "start_logit": 0.9594247341156006,
            "end_logit": -1.097926139831543,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "pygopagi from fusion at the cranial and caudal neuropores, respectively; cephalopagi",
            "probability": 0.04348233587177394,
            "start_logit": 0.5076586008071899,
            "end_logit": -0.7762832641601562,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "dicephalus or diprosopos. These anterolaterally united parapagus",
            "probability": 0.03617251493645738,
            "start_logit": -0.996806800365448,
            "end_logit": 0.5441269278526306,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "parapagus twins",
            "probability": 0.016684555411491324,
            "start_logit": 0.9594247341156006,
            "end_logit": -2.1859207153320312,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "dicephalus",
            "probability": 0.012705820537143678,
            "start_logit": -0.996806800365448,
            "end_logit": -0.5021124482154846,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "craniopagi",
            "probability": 0.0123631038108912,
            "start_logit": -0.4283367693424225,
            "end_logit": -1.097926139831543,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "anterolaterally united parapagus",
            "probability": 0.009348948027538242,
            "start_logit": -2.3498425483703613,
            "end_logit": 0.5441269278526306,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "diprosopos. These anterolaterally united parapagus",
            "probability": 0.006055825033801807,
            "start_logit": -2.784085750579834,
            "end_logit": 0.5441269278526306,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "dicephalus or diprosopos. These anterolaterally united parapagus twins",
            "probability": 0.0023590333351272788,
            "start_logit": -0.996806800365448,
            "end_logit": -2.1859207153320312,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "parapagus, from the Greek para, meaning \"side,\" combined with pagus",
            "probability": 0.002233071624143839,
            "start_logit": 0.5107952356338501,
            "end_logit": -3.748396635055542,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "twins must result from two nearly parallel notochords in close proximity; craniopagi and pygopagi",
            "probability": 0.0021442631784741577,
            "start_logit": -3.944281816482544,
            "end_logit": 0.6660983562469482,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "ischiopagi",
            "probability": 0.001845845416540029,
            "start_logit": -1.6728200912475586,
            "end_logit": -1.755221962928772,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "anterolaterally united parapagus twins must result from two nearly parallel notochords in close proximity; craniopagi",
            "probability": 0.0018097898957845661,
            "start_logit": -2.3498425483703613,
            "end_logit": -1.097926139831543,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "pagus, meaning \"fixed\"; this is the group formerly called dicephalus",
            "probability": 0.0010124802497679056,
            "start_logit": -3.5264639854431152,
            "end_logit": -0.5021124482154846,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "cephalopagi and ischiopagi",
            "probability": 0.0006783032883678889,
            "start_logit": -2.6739182472229004,
            "end_logit": -1.755221962928772,
            "question_text": "List the ten types of conjoined twins."
        },
        {
            "text": "anterolaterally united parapagus twins",
            "probability": 0.0006097027006299463,
            "start_logit": -2.3498425483703613,
            "end_logit": -2.1859207153320312,
            "question_text": "List the ten types of conjoined twins."
        }
    ],
    "5a6a2dcab750ff4455000023": [
        {
            "text": "HCNEs",
            "probability": 0.5323101922192892,
            "start_logit": -0.3074676990509033,
            "end_logit": -0.8319439888000488,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs and target genes",
            "probability": 0.23427613171001352,
            "start_logit": -0.3074676990509033,
            "end_logit": -1.652669906616211,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "target genes",
            "probability": 0.06660668274318617,
            "start_logit": -1.565163254737854,
            "end_logit": -1.652669906616211,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "whole genome duplication in teleosts, GRBs, including HCNEs",
            "probability": 0.03596531475787734,
            "start_logit": -3.002139091491699,
            "end_logit": -0.8319439888000488,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs and target genes, were often maintained in both copies, while bystander genes",
            "probability": 0.03268367480887569,
            "start_logit": -0.3074676990509033,
            "end_logit": -3.6222946643829346,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "whole genome duplication in teleosts, GRBs, including HCNEs and target genes",
            "probability": 0.015828768527012323,
            "start_logit": -3.002139091491699,
            "end_logit": -1.652669906616211,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs and target genes, were often maintained in both copies, while bystander genes were typically lost from one GRB,",
            "probability": 0.012159487836603922,
            "start_logit": -0.3074676990509033,
            "end_logit": -4.611060619354248,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs and target genes,",
            "probability": 0.012093015287700026,
            "start_logit": -0.3074676990509033,
            "end_logit": -4.616542339324951,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "target genes, were often maintained in both copies, while bystander genes",
            "probability": 0.009292244766832988,
            "start_logit": -1.565163254737854,
            "end_logit": -3.6222946643829346,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs and target genes, were often maintained in both copies,",
            "probability": 0.009221907241383796,
            "start_logit": -0.3074676990509033,
            "end_logit": -4.8875885009765625,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs and target genes, were often maintained in both copies",
            "probability": 0.007578448902628611,
            "start_logit": -0.3074676990509033,
            "end_logit": -5.083861827850342,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "HCNEs and target",
            "probability": 0.007553649091150957,
            "start_logit": -0.3074676990509033,
            "end_logit": -5.08713960647583,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "duplication in teleosts, GRBs, including HCNEs",
            "probability": 0.004879653073152689,
            "start_logit": -4.999619960784912,
            "end_logit": -0.8319439888000488,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "target genes, were often maintained in both copies, while bystander genes were typically lost from one GRB,",
            "probability": 0.0034570450806947956,
            "start_logit": -1.565163254737854,
            "end_logit": -4.611060619354248,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "target genes,",
            "probability": 0.0034381463736705012,
            "start_logit": -1.565163254737854,
            "end_logit": -4.616542339324951,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "After whole genome duplication in teleosts, GRBs, including HCNEs",
            "probability": 0.0031181968212145904,
            "start_logit": -5.447439193725586,
            "end_logit": -0.8319439888000488,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "target genes, were often maintained in both copies,",
            "probability": 0.0026218661091529684,
            "start_logit": -1.565163254737854,
            "end_logit": -4.8875885009765625,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "GRBs, including HCNEs",
            "probability": 0.0025728535361828663,
            "start_logit": -5.639678478240967,
            "end_logit": -0.8319439888000488,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "whole genome duplication",
            "probability": 0.0021881040891911997,
            "start_logit": -3.002139091491699,
            "end_logit": -3.6314635276794434,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        },
        {
            "text": "target genes, were often maintained in both copies",
            "probability": 0.0021546170241859763,
            "start_logit": -1.565163254737854,
            "end_logit": -5.083861827850342,
            "question_text": "Which are the constitutive parts of a Genomic Regulatory Block (GRB)?"
        }
    ],
    "5a7636d39e632bc066000004": [
        {
            "text": "mutational signatures",
            "probability": 0.13933605392837892,
            "start_logit": -4.055444717407227,
            "end_logit": -4.098697185516357,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutational patterns called mutational signatures",
            "probability": 0.10903240374576896,
            "start_logit": -4.30068826675415,
            "end_logit": -4.098697185516357,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutational patterns",
            "probability": 0.09283592575579781,
            "start_logit": -4.30068826675415,
            "end_logit": -4.2595086097717285,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutagenic processes often produce characteristic mutational patterns called mutational signatures",
            "probability": 0.09282627591641372,
            "start_logit": -4.46160364151001,
            "end_logit": -4.098697185516357,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutagenic processes often produce characteristic mutational patterns",
            "probability": 0.07903717576709661,
            "start_logit": -4.46160364151001,
            "end_logit": -4.2595086097717285,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "DNA maintenance machinery. These mutagenic processes often produce characteristic mutational patterns called mutational signatures",
            "probability": 0.04291965032272077,
            "start_logit": -5.233003616333008,
            "end_logit": -4.098697185516357,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "signatures",
            "probability": 0.03991384303563355,
            "start_logit": -5.305610179901123,
            "end_logit": -4.098697185516357,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutation",
            "probability": 0.03936301782674643,
            "start_logit": -4.055444717407227,
            "end_logit": -5.362759113311768,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "patterns called mutational signatures",
            "probability": 0.03831085709883185,
            "start_logit": -5.34660005569458,
            "end_logit": -4.098697185516357,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "DNA maintenance machinery. These mutagenic processes often produce characteristic mutational patterns",
            "probability": 0.0365440486858892,
            "start_logit": -5.233003616333008,
            "end_logit": -4.2595086097717285,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "patterns",
            "probability": 0.03261987962368617,
            "start_logit": -5.34660005569458,
            "end_logit": -4.2595086097717285,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutational signatures. The decomposition of a cancer genome's mutation",
            "probability": 0.031861764391499486,
            "start_logit": -4.055444717407227,
            "end_logit": -5.574179172515869,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutational patterns called mutation",
            "probability": 0.030802109944521597,
            "start_logit": -4.30068826675415,
            "end_logit": -5.362759113311768,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "characteristic mutational patterns called mutational signatures",
            "probability": 0.03075582010125586,
            "start_logit": -5.566254138946533,
            "end_logit": -4.098697185516357,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutagenic processes often produce characteristic mutation",
            "probability": 0.030531526257372994,
            "start_logit": -4.46160364151001,
            "end_logit": -5.210667133331299,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutational signatures. The decomposition of a cancer genome's mutation catalog into mutations consistent with such signatures",
            "probability": 0.028018572590276944,
            "start_logit": -4.055444717407227,
            "end_logit": -5.702718257904053,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutational signatures. The decomposition of a cancer genome's mutation catalog into mutations",
            "probability": 0.02794786574619528,
            "start_logit": -4.055444717407227,
            "end_logit": -5.705245018005371,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutagenic processes often produce characteristic mutational patterns called mutation",
            "probability": 0.02622381107165883,
            "start_logit": -4.46160364151001,
            "end_logit": -5.362759113311768,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "characteristic mutational patterns",
            "probability": 0.026187123583338055,
            "start_logit": -5.566254138946533,
            "end_logit": -4.2595086097717285,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        },
        {
            "text": "mutational patterns called mutational signatures. The decomposition of a cancer genome's mutation",
            "probability": 0.024932274606916986,
            "start_logit": -4.30068826675415,
            "end_logit": -5.574179172515869,
            "question_text": "Which R packages have been developed for the discovery of mutational signatures in cancer?"
        }
    ],
    "5a981e66fcd1d6a10c00002f": [
        {
            "text": "obesity",
            "probability": 0.31256511510520096,
            "start_logit": -0.7443954944610596,
            "end_logit": -0.896041214466095,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "abdominal obesity",
            "probability": 0.17513107688907048,
            "start_logit": -1.3236736059188843,
            "end_logit": -0.896041214466095,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "Weight loss and exercise, the main lifestyle treatments of MetS, counter abdominal obesity",
            "probability": 0.07683278993691822,
            "start_logit": -2.1475768089294434,
            "end_logit": -0.896041214466095,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesity and insulin resistance",
            "probability": 0.06318838219759366,
            "start_logit": -0.7443954944610596,
            "end_logit": -2.4947335720062256,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesity and insulin",
            "probability": 0.04992600060578459,
            "start_logit": -0.7443954944610596,
            "end_logit": -2.7303121089935303,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesity and insulin resistance and reduce the incidence of cardiovascular events and the development of diabetes",
            "probability": 0.044810242415328036,
            "start_logit": -0.7443954944610596,
            "end_logit": -2.8384172916412354,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance",
            "probability": 0.03585726664703732,
            "start_logit": -1.3109697103500366,
            "end_logit": -2.4947335720062256,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "abdominal obesity and insulin resistance",
            "probability": 0.03540462094568086,
            "start_logit": -1.3236736059188843,
            "end_logit": -2.4947335720062256,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "exercise, the main lifestyle treatments of MetS, counter abdominal obesity",
            "probability": 0.034451902521526724,
            "start_logit": -2.949644088745117,
            "end_logit": -0.896041214466095,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin",
            "probability": 0.02833131430305774,
            "start_logit": -1.3109697103500366,
            "end_logit": -2.7303121089935303,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "abdominal obesity and insulin",
            "probability": 0.027973672775071463,
            "start_logit": -1.3236736059188843,
            "end_logit": -2.7303121089935303,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "insulin resistance and reduce the incidence of cardiovascular events and the development of diabetes",
            "probability": 0.025428294805528155,
            "start_logit": -1.3109697103500366,
            "end_logit": -2.8384172916412354,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "abdominal obesity and insulin resistance and reduce the incidence of cardiovascular events and the development of diabetes",
            "probability": 0.025107299665272587,
            "start_logit": -1.3236736059188843,
            "end_logit": -2.8384172916412354,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "Weight loss and exercise, the main lifestyle treatments of MetS, counter abdominal obesity and insulin resistance",
            "probability": 0.015532570530807237,
            "start_logit": -2.1475768089294434,
            "end_logit": -2.4947335720062256,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "Weight loss and exercise, the main lifestyle treatments of MetS, counter abdominal obesity and insulin",
            "probability": 0.012272495334751672,
            "start_logit": -2.1475768089294434,
            "end_logit": -2.7303121089935303,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "Weight loss and exercise",
            "probability": 0.010994265566566486,
            "start_logit": -2.1475768089294434,
            "end_logit": -2.840298891067505,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "exercise, the main lifestyle treatments of MetS, counter abdominal obesity and insulin resistance",
            "probability": 0.00696482070058191,
            "start_logit": -2.949644088745117,
            "end_logit": -2.4947335720062256,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "obesity and insulin resistance and reduce the incidence of cardiovascular events",
            "probability": 0.006806307046475681,
            "start_logit": -0.7443954944610596,
            "end_logit": -4.723004341125488,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "Weight loss",
            "probability": 0.006311198514524924,
            "start_logit": -2.1475768089294434,
            "end_logit": -3.3953471183776855,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        },
        {
            "text": "o",
            "probability": 0.006110363493221354,
            "start_logit": -0.7443954944610596,
            "end_logit": -4.830867767333984,
            "question_text": "According to guidelines, insulin resistance is one risk factor in the diagnosis of metabolic syndrome, name 3 more risk factors."
        }
    ],
    "5a8861eb8cb19eca6b000001": [
        {
            "text": "post-synaptic density (PSD)-95",
            "probability": 0.7695376345026272,
            "start_logit": 3.7915279865264893,
            "end_logit": 3.501699209213257,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD)-95",
            "probability": 0.12202637924169935,
            "start_logit": 1.9499753713607788,
            "end_logit": 3.501699209213257,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post-synaptic density (PSD)-95 protein",
            "probability": 0.03274853769362353,
            "start_logit": 3.7915279865264893,
            "end_logit": 0.34476765990257263,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "(PSD)-95",
            "probability": 0.023229321397751156,
            "start_logit": 0.2911534607410431,
            "end_logit": 3.501699209213257,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post-synaptic density",
            "probability": 0.01744439170515231,
            "start_logit": 3.7915279865264893,
            "end_logit": -0.2850724458694458,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "density (PSD)-95",
            "probability": 0.012346117774436885,
            "start_logit": -0.34092020988464355,
            "end_logit": 3.501699209213257,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD)-95 protein",
            "probability": 0.005192969519672721,
            "start_logit": 1.9499753713607788,
            "end_logit": 0.34476765990257263,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post-synaptic density (PSD)",
            "probability": 0.004576943865165278,
            "start_logit": 3.7915279865264893,
            "end_logit": -1.6230591535568237,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "synaptic density (PSD)-95",
            "probability": 0.002724888355733151,
            "start_logit": -1.8518344163894653,
            "end_logit": 3.501699209213257,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post-synaptic density (PSD)-95 protein,",
            "probability": 0.0019468966380175618,
            "start_logit": 3.7915279865264893,
            "end_logit": -2.477854013442993,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post",
            "probability": 0.0013245747304703546,
            "start_logit": 3.7915279865264893,
            "end_logit": -2.862999200820923,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "95",
            "probability": 0.0012313918804783524,
            "start_logit": -2.6461167335510254,
            "end_logit": 3.501699209213257,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post-synaptic density (PSD)-95 protein, a post-synaptic marker.",
            "probability": 0.0011263983353236122,
            "start_logit": 3.7915279865264893,
            "end_logit": -3.0250654220581055,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "post-synaptic density (PSD)-95 protein, a post-synaptic marker",
            "probability": 0.0010010040056155957,
            "start_logit": 3.7915279865264893,
            "end_logit": -3.143087148666382,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "(PSD)-95 protein",
            "probability": 0.0009885498425079976,
            "start_logit": 0.2911534607410431,
            "end_logit": 0.34476765990257263,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD)",
            "probability": 0.0007257707262356389,
            "start_logit": 1.9499753713607788,
            "end_logit": -1.6230591535568237,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "-95",
            "probability": 0.0007142354506307829,
            "start_logit": -3.1908044815063477,
            "end_logit": 3.501699209213257,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "density (PSD)-95 protein",
            "probability": 0.000525402898023802,
            "start_logit": -0.34092020988464355,
            "end_logit": 0.34476765990257263,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "PSD)-95 protein,",
            "probability": 0.0003087214150983922,
            "start_logit": 1.9499753713607788,
            "end_logit": -2.477854013442993,
            "question_text": "List the two most important synaptic markers."
        },
        {
            "text": "density",
            "probability": 0.0002798700217363898,
            "start_logit": -0.34092020988464355,
            "end_logit": -0.2850724458694458,
            "question_text": "List the two most important synaptic markers."
        }
    ],
    "5a68f965b750ff445500001a": [
        {
            "text": "Gardnerella vaginalis",
            "probability": 0.4568871107161791,
            "start_logit": 5.351490497589111,
            "end_logit": 5.348378658294678,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "lactobacilli from the normal vaginal flora and overgrowth of Gardnerella vaginalis",
            "probability": 0.36711980731281785,
            "start_logit": 5.132742404937744,
            "end_logit": 5.348378658294678,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "lactobacilli",
            "probability": 0.08966505109222069,
            "start_logit": 5.132742404937744,
            "end_logit": 3.9387714862823486,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Gardnerella",
            "probability": 0.045205130711898266,
            "start_logit": 5.351490497589111,
            "end_logit": 3.0351529121398926,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "lactobacilli from the normal vaginal flora and overgrowth of Gardnerella",
            "probability": 0.03632341225491952,
            "start_logit": 5.132742404937744,
            "end_logit": 3.0351529121398926,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Gardnerella vaginalis and other anaerobic species",
            "probability": 0.0019604485323968532,
            "start_logit": 5.351490497589111,
            "end_logit": -0.10288438946008682,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "vaginalis",
            "probability": 0.0011181707117128494,
            "start_logit": -0.6612517833709717,
            "end_logit": 5.348378658294678,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "overgrowth of Gardnerella vaginalis",
            "probability": 0.0005720809935433455,
            "start_logit": -1.3314205408096313,
            "end_logit": 5.348378658294678,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "G",
            "probability": 0.00021836731921701647,
            "start_logit": 5.351490497589111,
            "end_logit": -2.2976343631744385,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "lactobacilli from the normal vaginal flora and overgrowth of G",
            "probability": 0.00017546340501640425,
            "start_logit": 5.132742404937744,
            "end_logit": -2.2976343631744385,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "la",
            "probability": 0.00017213397414656735,
            "start_logit": 5.132742404937744,
            "end_logit": -2.3167917728424072,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Depopulation of lactobacilli from the normal vaginal flora and overgrowth of Gardnerella vaginalis",
            "probability": 0.00012878973350038026,
            "start_logit": -2.8225200176239014,
            "end_logit": 5.348378658294678,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "is",
            "probability": 0.00012290371336731961,
            "start_logit": -2.86929988861084,
            "end_logit": 5.348378658294678,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "lactobacilli from the normal vaginal flora",
            "probability": 5.925447664091068e-05,
            "start_logit": 5.132742404937744,
            "end_logit": -3.383223533630371,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "lactobacilli from the normal vaginal flora and overgrowth",
            "probability": 5.8352332669727784e-05,
            "start_logit": 5.132742404937744,
            "end_logit": -3.3985655307769775,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "overgrowth of Gardnerella",
            "probability": 5.6602595005103033e-05,
            "start_logit": -1.3314205408096313,
            "end_logit": 3.0351529121398926,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "i from the normal vaginal flora and overgrowth of Gardnerella vaginalis",
            "probability": 4.269906217919065e-05,
            "start_logit": -3.9265241622924805,
            "end_logit": 5.348378658294678,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "ella vaginalis",
            "probability": 4.266776938361623e-05,
            "start_logit": -3.9272572994232178,
            "end_logit": 5.348378658294678,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Gardnerella vaginalis and other anaerobic",
            "probability": 4.0097790636849873e-05,
            "start_logit": 5.351490497589111,
            "end_logit": -3.9924917221069336,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        },
        {
            "text": "Depopulation of lactobacilli",
            "probability": 3.1455502548314537e-05,
            "start_logit": -2.8225200176239014,
            "end_logit": 3.9387714862823486,
            "question_text": "Clue cells are characteristics to which causative bacteria of vaginitis?"
        }
    ],
    "5a68fd01b750ff445500001b": [
        {
            "text": "p24",
            "probability": 0.40050845502515303,
            "start_logit": 4.108672618865967,
            "end_logit": 3.846332550048828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core protein p24",
            "probability": 0.20129853093221778,
            "start_logit": 3.420726776123047,
            "end_logit": 3.846332550048828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p24",
            "probability": 0.09973309284034326,
            "start_logit": 4.108672618865967,
            "end_logit": 2.4560952186584473,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p24 antigen",
            "probability": 0.08188006253303697,
            "start_logit": 4.108672618865967,
            "end_logit": 2.2588531970977783,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 antigen",
            "probability": 0.054579914238096425,
            "start_logit": 3.703083038330078,
            "end_logit": 2.2588531970977783,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core protein p24 (p24",
            "probability": 0.050126594887557996,
            "start_logit": 3.420726776123047,
            "end_logit": 2.4560952186584473,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core protein p24 (p24 antigen",
            "probability": 0.041153528954846495,
            "start_logit": 3.420726776123047,
            "end_logit": 2.2588531970977783,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core protein",
            "probability": 0.03342286073026704,
            "start_logit": 3.420726776123047,
            "end_logit": 2.050783634185791,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p24 antigen)",
            "probability": 0.010421520352005246,
            "start_logit": 4.108672618865967,
            "end_logit": 0.19747060537338257,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 antigen)",
            "probability": 0.0069468154938636135,
            "start_logit": 3.703083038330078,
            "end_logit": 0.19747060537338257,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core protein p24 (p24 antigen)",
            "probability": 0.005237933708058961,
            "start_logit": 3.420726776123047,
            "end_logit": 0.19747060537338257,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "(p24",
            "probability": 0.004468520131754991,
            "start_logit": 1.0032323598861694,
            "end_logit": 2.4560952186584473,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "(p24 antigen",
            "probability": 0.0036686188846459713,
            "start_logit": 1.0032323598861694,
            "end_logit": 2.2588531970977783,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "24",
            "probability": 0.0016799497263992064,
            "start_logit": -1.3652983903884888,
            "end_logit": 3.846332550048828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "HIV core protein p24",
            "probability": 0.0014842731707114163,
            "start_logit": -1.489137053489685,
            "end_logit": 3.846332550048828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "protein p24",
            "probability": 0.0011694405371473996,
            "start_logit": -1.7275367975234985,
            "end_logit": 3.846332550048828,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 (p24 antigen) detection,",
            "probability": 0.0007919911102753828,
            "start_logit": 4.108672618865967,
            "end_logit": -2.3796074390411377,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "p24 antigen) detection,",
            "probability": 0.0005279283569028053,
            "start_logit": 3.703083038330078,
            "end_logit": -2.3796074390411377,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "(p24 antigen)",
            "probability": 0.0004669340152819582,
            "start_logit": 1.0032323598861694,
            "end_logit": 0.19747060537338257,
            "question_text": "What is included in the fourth generation HIV test?"
        },
        {
            "text": "core",
            "probability": 0.0004330343714341047,
            "start_logit": 3.420726776123047,
            "end_logit": -2.2953946590423584,
            "question_text": "What is included in the fourth generation HIV test?"
        }
    ],
    "5a6f7e6ab750ff4455000052": [
        {
            "text": "beneficence, non-maleficence, respect for autonomy and justice",
            "probability": 0.18621082077986773,
            "start_logit": 4.676784515380859,
            "end_logit": 4.815189838409424,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "respect for autonomy and justice",
            "probability": 0.17212260933735327,
            "start_logit": 4.598112106323242,
            "end_logit": 4.815189838409424,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "non-maleficence, respect for autonomy and justice",
            "probability": 0.12435631981977802,
            "start_logit": 4.2730560302734375,
            "end_logit": 4.815189838409424,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, non-maleficence, respect for autonomy",
            "probability": 0.09449033527445394,
            "start_logit": 4.676784515380859,
            "end_logit": 4.136807918548584,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence",
            "probability": 0.0931053658164916,
            "start_logit": 4.676784515380859,
            "end_logit": 4.122042179107666,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, non-maleficence",
            "probability": 0.09283804185147843,
            "start_logit": 4.676784515380859,
            "end_logit": 4.119166851043701,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "respect for autonomy",
            "probability": 0.08734144984961448,
            "start_logit": 4.598112106323242,
            "end_logit": 4.136807918548584,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "non-maleficence, respect for autonomy",
            "probability": 0.06310304795422743,
            "start_logit": 4.2730560302734375,
            "end_logit": 4.136807918548584,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "non-maleficence",
            "probability": 0.06199960440307871,
            "start_logit": 4.2730560302734375,
            "end_logit": 4.119166851043701,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "autonomy and justice",
            "probability": 0.011791798479799623,
            "start_logit": 1.917309284210205,
            "end_logit": 4.815189838409424,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "autonomy",
            "probability": 0.005983599595225703,
            "start_logit": 1.917309284210205,
            "end_logit": 4.136807918548584,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, non-maleficence,",
            "probability": 0.0014045298186800331,
            "start_logit": 4.676784515380859,
            "end_logit": -0.07198704034090042,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "non-maleficence,",
            "probability": 0.000937980717751461,
            "start_logit": 4.2730560302734375,
            "end_logit": -0.07198704034090042,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, non-maleficence, respect for autonomy and justice-",
            "probability": 0.0009120838852981795,
            "start_logit": 4.676784515380859,
            "end_logit": -0.5037129521369934,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "respect for autonomy and justice-",
            "probability": 0.0008430780639631173,
            "start_logit": 4.598112106323242,
            "end_logit": -0.5037129521369934,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence,",
            "probability": 0.0008288201228709177,
            "start_logit": 4.676784515380859,
            "end_logit": -0.5994417667388916,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "justice",
            "probability": 0.0007527353870725903,
            "start_logit": -0.8341364860534668,
            "end_logit": 4.815189838409424,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "non-maleficence, respect for autonomy and justice-",
            "probability": 0.0006091128048712675,
            "start_logit": 4.2730560302734375,
            "end_logit": -0.5037129521369934,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "beneficence, non-maleficence, respect",
            "probability": 0.00019158024282077982,
            "start_logit": 4.676784515380859,
            "end_logit": -2.064138174057007,
            "question_text": "List four principles of medical ethics."
        },
        {
            "text": "respect",
            "probability": 0.00017708579530283395,
            "start_logit": 4.598112106323242,
            "end_logit": -2.064138174057007,
            "question_text": "List four principles of medical ethics."
        }
    ],
    "5a70d12899e2c3af26000001": [
        {
            "text": "facial nerve palsy, parotid gland enlargement, anterior uveitis",
            "probability": 0.16340148144843392,
            "start_logit": 3.3392863273620605,
            "end_logit": 3.7131853103637695,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid gland enlargement, anterior uveitis",
            "probability": 0.13654716573464584,
            "start_logit": 3.1597461700439453,
            "end_logit": 3.7131853103637695,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "anterior uveitis",
            "probability": 0.10222258982450066,
            "start_logit": 2.8702287673950195,
            "end_logit": 3.7131853103637695,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial nerve palsy",
            "probability": 0.09312182787520346,
            "start_logit": 3.3392863273620605,
            "end_logit": 3.150883674621582,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis",
            "probability": 0.09152095412914314,
            "start_logit": 2.759644031524658,
            "end_logit": 3.7131853103637695,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial nerve palsy, parotid gland enlargement, anterior uveitis, and low grade fever",
            "probability": 0.0805865934993841,
            "start_logit": 3.3392863273620605,
            "end_logit": 3.006307363510132,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid gland enlargement, anterior uveitis, and low grade fever",
            "probability": 0.06734254084485473,
            "start_logit": 3.1597461700439453,
            "end_logit": 3.006307363510132,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial nerve palsy, parotid gland enlargement",
            "probability": 0.058937653077862674,
            "start_logit": 3.3392863273620605,
            "end_logit": 2.693455219268799,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "anterior uveitis, and low grade fever",
            "probability": 0.05041429379721371,
            "start_logit": 2.8702287673950195,
            "end_logit": 3.006307363510132,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid gland enlargement",
            "probability": 0.04925150868582353,
            "start_logit": 3.1597461700439453,
            "end_logit": 2.693455219268799,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "uveitis, and low grade fever",
            "probability": 0.045136444674209075,
            "start_logit": 2.759644031524658,
            "end_logit": 3.006307363510132,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "fever",
            "probability": 0.0270025382240965,
            "start_logit": 2.245884895324707,
            "end_logit": 3.006307363510132,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "low grade fever",
            "probability": 0.010970813265615645,
            "start_logit": 1.3451924324035645,
            "end_logit": 3.006307363510132,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial nerve palsy,",
            "probability": 0.006185129313874736,
            "start_logit": 3.3392863273620605,
            "end_logit": 0.4391229748725891,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial nerve palsy, parotid gland enlargement,",
            "probability": 0.00465601366851386,
            "start_logit": 3.3392863273620605,
            "end_logit": 0.15513470768928528,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid gland enlargement,",
            "probability": 0.0038908182742392874,
            "start_logit": 3.1597461700439453,
            "end_logit": 0.15513470768928528,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial nerve palsy, parotid gland",
            "probability": 0.0031755722672840853,
            "start_logit": 3.3392863273620605,
            "end_logit": -0.22753708064556122,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "parotid gland",
            "probability": 0.0026536809142701993,
            "start_logit": 3.1597461700439453,
            "end_logit": -0.22753708064556122,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "enlargement, anterior uveitis",
            "probability": 0.0015782785339360384,
            "start_logit": -1.3005892038345337,
            "end_logit": 3.7131853103637695,
            "question_text": "List symptoms of Heerfordt syndrome."
        },
        {
            "text": "facial",
            "probability": 0.0014041019468949004,
            "start_logit": 3.3392863273620605,
            "end_logit": -1.0436270236968994,
            "question_text": "List symptoms of Heerfordt syndrome."
        }
    ],
    "5a8afbf2fcd1d6a10c00001c": [
        {
            "text": "tiger",
            "probability": 0.24179963958041903,
            "start_logit": -2.312668800354004,
            "end_logit": -1.911152720451355,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "stifle joint of a Bengal tiger",
            "probability": 0.24133036719848772,
            "start_logit": -2.3146114349365234,
            "end_logit": -1.911152720451355,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger (Panthera tigris",
            "probability": 0.10303727398742837,
            "start_logit": -2.312668800354004,
            "end_logit": -2.7641713619232178,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "stifle joint of a Bengal tiger (Panthera tigris",
            "probability": 0.10283730451238823,
            "start_logit": -2.3146114349365234,
            "end_logit": -2.7641713619232178,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "Panthera tigris",
            "probability": 0.053553027843811316,
            "start_logit": -2.9670872688293457,
            "end_logit": -2.7641713619232178,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger (Panthera tigris)",
            "probability": 0.043507775106514046,
            "start_logit": -2.312668800354004,
            "end_logit": -3.6263225078582764,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "stifle joint of a Bengal tiger (Panthera tigris)",
            "probability": 0.043423337440303314,
            "start_logit": -2.3146114349365234,
            "end_logit": -3.6263225078582764,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "Panthera tigris)",
            "probability": 0.0226129147398223,
            "start_logit": -2.9670872688293457,
            "end_logit": -3.6263225078582764,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "Bengal tiger",
            "probability": 0.020112349901730803,
            "start_logit": -4.799444198608398,
            "end_logit": -1.911152720451355,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "the stifle joint of a Bengal tiger",
            "probability": 0.016579307732005333,
            "start_logit": -4.9926228523254395,
            "end_logit": -1.911152720451355,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "stifle",
            "probability": 0.014404329857274835,
            "start_logit": -2.3146114349365234,
            "end_logit": -4.729790687561035,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "stifle joint",
            "probability": 0.013106951589541446,
            "start_logit": -2.3146114349365234,
            "end_logit": -4.824176788330078,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger (Panthera tigris) by low-field magnetic resonance imaging (MRI),",
            "probability": 0.012729822085423245,
            "start_logit": -2.312668800354004,
            "end_logit": -4.8553147315979,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "stifle joint of a Bengal tiger (Panthera tigris) by low-field magnetic resonance imaging (MRI),",
            "probability": 0.012705116697350896,
            "start_logit": -2.3146114349365234,
            "end_logit": -4.8553147315979,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "joint of a Bengal tiger",
            "probability": 0.011544039410004992,
            "start_logit": -5.35460901260376,
            "end_logit": -1.911152720451355,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger (Panthera tigris) by low-field magnetic resonance imaging",
            "probability": 0.01121649337623868,
            "start_logit": -2.312668800354004,
            "end_logit": -4.981876850128174,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "stifle joint of a Bengal tiger (Panthera tigris) by low-field magnetic resonance imaging",
            "probability": 0.011194724979177716,
            "start_logit": -2.3146114349365234,
            "end_logit": -4.981876850128174,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "Bengal tiger (Panthera tigris",
            "probability": 0.00857040858684341,
            "start_logit": -4.799444198608398,
            "end_logit": -2.7641713619232178,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "tiger (Panthera tigris) by low-field magnetic resonance imaging (MRI)",
            "probability": 0.007875049434338388,
            "start_logit": -2.312668800354004,
            "end_logit": -5.335562705993652,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        },
        {
            "text": "stifle joint of a Bengal tiger (Panthera tigris) by low-field magnetic resonance imaging (MRI)",
            "probability": 0.007859765940896083,
            "start_logit": -2.3146114349365234,
            "end_logit": -5.335562705993652,
            "question_text": "In quadruped mammals, what bones make up the stifle?"
        }
    ],
    "5a8dc6b4fcd1d6a10c000026": [
        {
            "text": "Infliximab",
            "probability": 0.9629750833683741,
            "start_logit": 4.702047824859619,
            "end_logit": 5.423764705657959,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "fliximab",
            "probability": 0.033418889505384124,
            "start_logit": 1.3411415815353394,
            "end_logit": 5.423764705657959,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "liximab",
            "probability": 0.0014589564563733985,
            "start_logit": -1.7902582883834839,
            "end_logit": 5.423764705657959,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Monoclonal antibody biologic therapies",
            "probability": 0.0007324093232590749,
            "start_logit": 2.244946002960205,
            "end_logit": 0.6994232535362244,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Monoclonal antibody",
            "probability": 0.00036692103049739793,
            "start_logit": 2.244946002960205,
            "end_logit": 0.008230360224843025,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "b",
            "probability": 0.0003285487613294143,
            "start_logit": -3.2810497283935547,
            "end_logit": 5.423764705657959,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "In",
            "probability": 0.0002378085561148836,
            "start_logit": 4.702047824859619,
            "end_logit": -2.882552146911621,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "imab",
            "probability": 0.00010299286012016421,
            "start_logit": -4.441075325012207,
            "end_logit": 5.423764705657959,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "biosimilar therapy approval, as well as the true bioequivalence of these agents. Infliximab",
            "probability": 9.973603450693982e-05,
            "start_logit": -4.473207950592041,
            "end_logit": 5.423764705657959,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Inflix",
            "probability": 6.264402072657705e-05,
            "start_logit": 4.702047824859619,
            "end_logit": -4.216549873352051,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Inf",
            "probability": 5.592252023762915e-05,
            "start_logit": 4.702047824859619,
            "end_logit": -4.330050945281982,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Inflixima",
            "probability": 4.644337586387606e-05,
            "start_logit": 4.702047824859619,
            "end_logit": -4.51578426361084,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Infliximab biosimilars",
            "probability": 3.6522287892591135e-05,
            "start_logit": 4.702047824859619,
            "end_logit": -4.7560954093933105,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Monoclonal antibody biologic therapies,",
            "probability": 3.641337061871217e-05,
            "start_logit": 2.244946002960205,
            "end_logit": -2.3019802570343018,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Mon",
            "probability": 2.0105096949832854e-05,
            "start_logit": 2.244946002960205,
            "end_logit": -2.8959429264068604,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "antibody biologic therapies",
            "probability": 8.291116362109502e-06,
            "start_logit": -2.236208915710449,
            "end_logit": 0.6994232535362244,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "antibody",
            "probability": 4.153667714143699e-06,
            "start_logit": -2.236208915710449,
            "end_logit": 0.008230360224843025,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "Monoclonal antibody biologic therapies, introduced nearly 20 years ago,",
            "probability": 3.2698972507675124e-06,
            "start_logit": 2.244946002960205,
            "end_logit": -4.712157726287842,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "biologic therapies",
            "probability": 2.7147651952282774e-06,
            "start_logit": -3.3526880741119385,
            "end_logit": 0.6994232535362244,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        },
        {
            "text": "flix",
            "probability": 2.173985228684916e-06,
            "start_logit": 1.3411415815353394,
            "end_logit": -4.216549873352051,
            "question_text": "List 2 approved drug treatments for Inflammatory Bowel Disease (IBD)."
        }
    ],
    "5a75dff883b0d9ea66000003": [
        {
            "text": "CR Cistrome",
            "probability": 0.4737723564054072,
            "start_logit": 3.3451998233795166,
            "end_logit": 2.225998640060425,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CR Cistrome database",
            "probability": 0.3243648541715493,
            "start_logit": 3.3451998233795166,
            "end_logit": 1.8471406698226929,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "cistrome",
            "probability": 0.04373976007239231,
            "start_logit": 2.533059597015381,
            "end_logit": 0.6556694507598877,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CR Cistrome database,",
            "probability": 0.04073082357541231,
            "start_logit": 3.3451998233795166,
            "end_logit": -0.22774316370487213,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CR-HM ChIP-Seq linkage pairs is currently available. Therefore, we constructed the CR Cistrome",
            "probability": 0.017463911464900957,
            "start_logit": 0.0446094274520874,
            "end_logit": 2.225998640060425,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "the CR Cistrome",
            "probability": 0.012958655242047977,
            "start_logit": -0.25376319885253906,
            "end_logit": 2.225998640060425,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome",
            "probability": 0.012699854322282211,
            "start_logit": -0.27393659949302673,
            "end_logit": 2.225998640060425,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CR-HM ChIP-Seq linkage pairs is currently available. Therefore, we constructed the CR Cistrome database",
            "probability": 0.01195654203752272,
            "start_logit": 0.0446094274520874,
            "end_logit": 1.8471406698226929,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CR Cistrome database, available online at http://compbio.tongji.edu.cn/cr",
            "probability": 0.010374947585108913,
            "start_logit": 3.3451998233795166,
            "end_logit": -1.5953342914581299,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "the CR Cistrome database",
            "probability": 0.008872050597754762,
            "start_logit": -0.25376319885253906,
            "end_logit": 1.8471406698226929,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "Cistrome database",
            "probability": 0.008694864399648571,
            "start_logit": -0.27393659949302673,
            "end_logit": 1.8471406698226929,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CR",
            "probability": 0.006687597208161976,
            "start_logit": 3.3451998233795166,
            "end_logit": -2.0344736576080322,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "ChIP-Seq linkage pairs is currently available. Therefore, we constructed the CR Cistrome",
            "probability": 0.004987255864482233,
            "start_logit": -1.2086412906646729,
            "end_logit": 2.225998640060425,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "cr and http://cistrome",
            "probability": 0.004388477561807548,
            "start_logit": 0.23378443717956543,
            "end_logit": 0.6556694507598877,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "cistrome.org/cr",
            "probability": 0.003958767007290592,
            "start_logit": 2.533059597015381,
            "end_logit": -1.7466554641723633,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "ChIP-Seq linkage pairs is currently available. Therefore, we constructed the CR Cistrome database",
            "probability": 0.003414489045905256,
            "start_logit": -1.2086412906646729,
            "end_logit": 1.8471406698226929,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "C",
            "probability": 0.0033117959113168898,
            "start_logit": 3.3451998233795166,
            "end_logit": -2.7372376918792725,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "CR Cistrome database, available online at http://compbio",
            "probability": 0.0031832748913250036,
            "start_logit": 3.3451998233795166,
            "end_logit": -2.776817798614502,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "constructed the CR Cistrome",
            "probability": 0.0022350689916620474,
            "start_logit": -2.0112550258636475,
            "end_logit": 2.225998640060425,
            "question_text": "Name curated data resources for ChIP-seq data"
        },
        {
            "text": "cistrome.org/cr/,",
            "probability": 0.0022046536440209217,
            "start_logit": 2.533059597015381,
            "end_logit": -2.332017660140991,
            "question_text": "Name curated data resources for ChIP-seq data"
        }
    ],
    "5a760e5583b0d9ea66000018": [
        {
            "text": "colocalization of histones and transcription start sites",
            "probability": 0.3439203975326387,
            "start_logit": 2.1624131202697754,
            "end_logit": 1.2248289585113525,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "colocalization of histones",
            "probability": 0.15304181267917907,
            "start_logit": 2.1624131202697754,
            "end_logit": 0.4151298999786377,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "colocalization of histones and transcription start sites indicate chromatin regulation of transcription factor activity",
            "probability": 0.14510627427100106,
            "start_logit": 2.1624131202697754,
            "end_logit": 0.361885130405426,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "transcription start sites",
            "probability": 0.09980425347278295,
            "start_logit": 0.9252136945724487,
            "end_logit": 1.2248289585113525,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "colocalization",
            "probability": 0.058734557179968186,
            "start_logit": 2.1624131202697754,
            "end_logit": -0.5425530076026917,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "transcription start sites indicate chromatin regulation of transcription factor activity",
            "probability": 0.04210923074564009,
            "start_logit": 0.9252136945724487,
            "end_logit": 0.361885130405426,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "histones and transcription start sites",
            "probability": 0.04202900972422578,
            "start_logit": 0.060362979769706726,
            "end_logit": 1.2248289585113525,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "transcription factor activity",
            "probability": 0.02010064478131764,
            "start_logit": 0.18569861352443695,
            "end_logit": 0.361885130405426,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "histones",
            "probability": 0.018702571523679195,
            "start_logit": 0.060362979769706726,
            "end_logit": 0.4151298999786377,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "colocalization of histones and transcription start sites indicate chromatin regulation",
            "probability": 0.018282940705439767,
            "start_logit": 2.1624131202697754,
            "end_logit": -1.7096128463745117,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "histones and transcription start sites indicate chromatin regulation of transcription factor activity",
            "probability": 0.01773280403295446,
            "start_logit": 0.060362979769706726,
            "end_logit": 0.361885130405426,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "colocalization of histones and transcription start sites indicate chromatin regulation of transcription",
            "probability": 0.007360594574012373,
            "start_logit": 2.1624131202697754,
            "end_logit": -2.6194405555725098,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "colocalization of histones and transcription start sites indicate chromatin regulation of transcription factor",
            "probability": 0.006387754185225717,
            "start_logit": 2.1624131202697754,
            "end_logit": -2.7611985206604004,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "chromatin regulation of transcription factor activity",
            "probability": 0.006315747164730912,
            "start_logit": -0.9720072150230408,
            "end_logit": 0.361885130405426,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "transcription start sites indicate chromatin regulation",
            "probability": 0.005305632528586509,
            "start_logit": 0.9252136945724487,
            "end_logit": -1.7096128463745117,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "colocalization of histones and transcription",
            "probability": 0.0041444341966747535,
            "start_logit": 2.1624131202697754,
            "end_logit": -3.193814992904663,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "co",
            "probability": 0.004080005601427606,
            "start_logit": 2.1624131202697754,
            "end_logit": -3.2094829082489014,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "transcription start sites indicate chromatin regulation of transcription factor activity. Therefore, statistical algorithms to perform spatial, genome-wide correlation",
            "probability": 0.0024044188813970957,
            "start_logit": 0.9252136945724487,
            "end_logit": -2.5010735988616943,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "histones and transcription start sites indicate chromatin regulation",
            "probability": 0.00223427833361773,
            "start_logit": 0.060362979769706726,
            "end_logit": -1.7096128463745117,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        },
        {
            "text": "colocalization of histones and transcription start sites indicate chromatin",
            "probability": 0.0022026378855005617,
            "start_logit": 2.1624131202697754,
            "end_logit": -3.825925588607788,
            "question_text": "Which comparisons demonstrate the applicability of StereoGene in regulatory genomics?"
        }
    ],
    "5a75ee7e83b0d9ea66000005": [
        {
            "text": "fatty liver degeneration",
            "probability": 0.21415413984897522,
            "start_logit": 5.13840389251709,
            "end_logit": 4.976935863494873,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipidaemia, anaemia and fatty liver degeneration",
            "probability": 0.1741647881348198,
            "start_logit": 4.9317097663879395,
            "end_logit": 4.976935863494873,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipidaemia, anaemia",
            "probability": 0.15835940645810131,
            "start_logit": 4.9317097663879395,
            "end_logit": 4.881801128387451,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipidaemia",
            "probability": 0.15036117305203384,
            "start_logit": 4.9317097663879395,
            "end_logit": 4.829974174499512,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "anaemia and fatty liver degeneration",
            "probability": 0.14698091041693756,
            "start_logit": 4.76201057434082,
            "end_logit": 4.976935863494873,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "anaemia",
            "probability": 0.1336424542731332,
            "start_logit": 4.76201057434082,
            "end_logit": 4.881801128387451,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "liver degeneration",
            "probability": 0.006392268562146529,
            "start_logit": 1.626797080039978,
            "end_logit": 4.976935863494873,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "fatty liver",
            "probability": 0.0030583372300526813,
            "start_logit": 5.13840389251709,
            "end_logit": 0.728111207485199,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipidaemia, anaemia and fatty liver",
            "probability": 0.0024872489324399387,
            "start_logit": 4.9317097663879395,
            "end_logit": 0.728111207485199,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipidaemia,",
            "probability": 0.0024213948989549473,
            "start_logit": 4.9317097663879395,
            "end_logit": 0.7012777328491211,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "anaemia and fatty liver",
            "probability": 0.0020990357260997363,
            "start_logit": 4.76201057434082,
            "end_logit": 0.728111207485199,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "(hyperlipidaemia, anaemia and fatty liver degeneration",
            "probability": 0.0012354982167216344,
            "start_logit": -0.016817839816212654,
            "end_logit": 4.976935863494873,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "(hyperlipidaemia, anaemia",
            "probability": 0.001123377270316128,
            "start_logit": -0.016817839816212654,
            "end_logit": 4.881801128387451,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "(hyperlipidaemia",
            "probability": 0.0010666390328345635,
            "start_logit": -0.016817839816212654,
            "end_logit": 4.829974174499512,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "fatty liver degeneration)",
            "probability": 0.0007075604088718297,
            "start_logit": 5.13840389251709,
            "end_logit": -0.7356924414634705,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipidaemia, anaemia and fatty liver degeneration)",
            "probability": 0.0005754365000398959,
            "start_logit": 4.9317097663879395,
            "end_logit": -0.7356924414634705,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "anaemia and fatty liver degeneration)",
            "probability": 0.00048562158613558906,
            "start_logit": 4.76201057434082,
            "end_logit": -0.7356924414634705,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "fatty",
            "probability": 0.00025753100704377916,
            "start_logit": 5.13840389251709,
            "end_logit": -1.746375322341919,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "yperlipidaemia, anaemia and fatty liver degeneration",
            "probability": 0.00021773662214963368,
            "start_logit": -1.7527612447738647,
            "end_logit": 4.976935863494873,
            "question_text": "List symptoms of the Zieve's syndrome."
        },
        {
            "text": "hyperlipidaemia, anaemia and fatty",
            "probability": 0.00020944182219198514,
            "start_logit": 4.9317097663879395,
            "end_logit": -1.746375322341919,
            "question_text": "List symptoms of the Zieve's syndrome."
        }
    ],
    "5a75df9883b0d9ea66000002": [
        {
            "text": "chondromas",
            "probability": 0.36898418781377457,
            "start_logit": 4.193481922149658,
            "end_logit": 3.7280776500701904,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondroma",
            "probability": 0.2832702729665736,
            "start_logit": 4.193481922149658,
            "end_logit": 3.4637253284454346,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondromas. These chondromas",
            "probability": 0.19584215548045497,
            "start_logit": 3.560037136077881,
            "end_logit": 3.7280776500701904,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondromas. These chondroma",
            "probability": 0.1503486129582045,
            "start_logit": 3.560037136077881,
            "end_logit": 3.4637253284454346,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "multiple chondroma",
            "probability": 0.00033191480444101206,
            "start_logit": -1.931792140007019,
            "end_logit": 2.8397209644317627,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondromas were possibly components of Carney's triad,",
            "probability": 0.0003066932088728702,
            "start_logit": 4.193481922149658,
            "end_logit": -3.3645834922790527,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondromas. These chondromas were possibly components of Carney's triad,",
            "probability": 0.00016278057727285103,
            "start_logit": 3.560037136077881,
            "end_logit": -3.3645834922790527,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "ch",
            "probability": 0.00013294318711257603,
            "start_logit": 4.193481922149658,
            "end_logit": -4.200509548187256,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "multiple chondromas",
            "probability": 0.0001108208746199886,
            "start_logit": -1.931792140007019,
            "end_logit": 1.742757797241211,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "romas",
            "probability": 7.366414413874934e-05,
            "start_logit": -4.3255109786987305,
            "end_logit": 3.7280776500701904,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondromas. These ch",
            "probability": 7.05609648880363e-05,
            "start_logit": 3.560037136077881,
            "end_logit": -4.200509548187256,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "s",
            "probability": 5.841265187998643e-05,
            "start_logit": -4.557494640350342,
            "end_logit": 3.7280776500701904,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "roma",
            "probability": 5.655218545181671e-05,
            "start_logit": -4.3255109786987305,
            "end_logit": 3.4637253284454346,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chondromas.",
            "probability": 4.6568927650285985e-05,
            "start_logit": 3.560037136077881,
            "end_logit": -4.616053104400635,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "These chondromas",
            "probability": 4.390759424841507e-05,
            "start_logit": -4.842939853668213,
            "end_logit": 3.7280776500701904,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "romas. These chondromas",
            "probability": 4.0025872193720795e-05,
            "start_logit": -4.9355010986328125,
            "end_logit": 3.7280776500701904,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "These chondroma",
            "probability": 3.3707992425765896e-05,
            "start_logit": -4.842939853668213,
            "end_logit": 3.4637253284454346,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "s. These chondromas",
            "probability": 3.086728871475546e-05,
            "start_logit": -5.1953301429748535,
            "end_logit": 3.7280776500701904,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "romas. These chondroma",
            "probability": 3.072798270630179e-05,
            "start_logit": -4.9355010986328125,
            "end_logit": 3.4637253284454346,
            "question_text": "Which cancers compose Carney's triad?"
        },
        {
            "text": "chond",
            "probability": 2.4622524374895657e-05,
            "start_logit": 4.193481922149658,
            "end_logit": -5.886769771575928,
            "question_text": "Which cancers compose Carney's triad?"
        }
    ],
    "5a981bcffcd1d6a10c00002d": [
        {
            "text": "ataxia",
            "probability": 0.5039323744697741,
            "start_logit": 4.079477310180664,
            "end_logit": 4.164098262786865,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ocular abnormalities, and ataxia",
            "probability": 0.3198494987484909,
            "start_logit": 3.6248857975006104,
            "end_logit": 4.164098262786865,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ocular abnormalities",
            "probability": 0.09664111985568302,
            "start_logit": 3.6248857975006104,
            "end_logit": 2.967252016067505,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "consciousness, ocular abnormalities, and ataxia",
            "probability": 0.033911305296041847,
            "start_logit": 1.3807836771011353,
            "end_logit": 4.164098262786865,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "changes in consciousness, ocular abnormalities, and ataxia",
            "probability": 0.01901163205652372,
            "start_logit": 0.8020862340927124,
            "end_logit": 4.164098262786865,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "consciousness, ocular abnormalities",
            "probability": 0.010246151807023587,
            "start_logit": 1.3807836771011353,
            "end_logit": 2.967252016067505,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "changes in consciousness, ocular abnormalities",
            "probability": 0.005744281042851949,
            "start_logit": 0.8020862340927124,
            "end_logit": 2.967252016067505,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "consciousness",
            "probability": 0.0046612329200738396,
            "start_logit": 1.3807836771011353,
            "end_logit": 2.1796298027038574,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "changes in consciousness",
            "probability": 0.002613218348057602,
            "start_logit": 0.8020862340927124,
            "end_logit": 2.1796298027038574,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ocular",
            "probability": 0.0005396007390160695,
            "start_logit": 3.6248857975006104,
            "end_logit": -2.2206780910491943,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "cular abnormalities, and ataxia",
            "probability": 0.0004813354984012371,
            "start_logit": -2.8741555213928223,
            "end_logit": 4.164098262786865,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "at",
            "probability": 0.0003983222572023418,
            "start_logit": 4.079477310180664,
            "end_logit": -2.978837728500366,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "abnormalities, and ataxia",
            "probability": 0.0003818355404290665,
            "start_logit": -3.1057300567626953,
            "end_logit": 4.164098262786865,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ocular abnormalities,",
            "probability": 0.0003187688146529026,
            "start_logit": 3.6248857975006104,
            "end_logit": -2.7470414638519287,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ocular abnormalities, and at",
            "probability": 0.000252817998527257,
            "start_logit": 3.6248857975006104,
            "end_logit": -2.978837728500366,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "consciousness,",
            "probability": 0.00023111076449486517,
            "start_logit": 1.3807836771011353,
            "end_logit": -0.8245083689689636,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "ia",
            "probability": 0.00022577551165143801,
            "start_logit": -3.631178855895996,
            "end_logit": 4.164098262786865,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "axia",
            "probability": 0.00022557336635852364,
            "start_logit": -3.6320745944976807,
            "end_logit": 4.164098262786865,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "o",
            "probability": 0.00018861156005434224,
            "start_logit": 3.6248857975006104,
            "end_logit": -3.271817922592163,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        },
        {
            "text": "cular abnormalities",
            "probability": 0.00014543340469126923,
            "start_logit": -2.8741555213928223,
            "end_logit": 2.967252016067505,
            "question_text": "List 3 symptoms of Wernicke encephalopathy."
        }
    ],
    "5a7486a90384be9551000003": [
        {
            "text": "fibroblast growth factor and vascular endothelial growth factor receptor",
            "probability": 0.29608227649854224,
            "start_logit": 6.317054271697998,
            "end_logit": 5.434115886688232,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "vascular endothelial growth factor receptor",
            "probability": 0.2894941109055501,
            "start_logit": 6.294551849365234,
            "end_logit": 5.434115886688232,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "fibroblast growth factor",
            "probability": 0.25177783092261835,
            "start_logit": 6.317054271697998,
            "end_logit": 5.2720255851745605,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "fibroblast growth factor and vascular endothelial growth factor",
            "probability": 0.06039471677244326,
            "start_logit": 6.317054271697998,
            "end_logit": 3.8443801403045654,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "vascular endothelial growth factor",
            "probability": 0.059050866003176855,
            "start_logit": 6.294551849365234,
            "end_logit": 3.8443801403045654,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "epidermal growth factor receptor and dovitinib is a novel small molecule inhibitor of fibroblast growth factor",
            "probability": 0.028832202331391308,
            "start_logit": 4.150000095367432,
            "end_logit": 5.2720255851745605,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "epidermal growth factor receptor",
            "probability": 0.005007289279953979,
            "start_logit": 4.150000095367432,
            "end_logit": 3.5214273929595947,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "fibroblast growth factor and vascular endothelial growth factor receptor.",
            "probability": 0.0034498043399786935,
            "start_logit": 6.317054271697998,
            "end_logit": 0.9817960262298584,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "vascular endothelial growth factor receptor.",
            "probability": 0.0033730422908483586,
            "start_logit": 6.294551849365234,
            "end_logit": 0.9817960262298584,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "epidermal growth factor",
            "probability": 0.0004943098176114051,
            "start_logit": 4.150000095367432,
            "end_logit": 1.2059398889541626,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "endothelial growth factor receptor",
            "probability": 0.0003542318336988847,
            "start_logit": -0.41138678789138794,
            "end_logit": 5.434115886688232,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "dovitinib is a novel small molecule inhibitor of fibroblast growth factor and vascular endothelial growth factor receptor",
            "probability": 0.00031888163064260403,
            "start_logit": -0.5165184140205383,
            "end_logit": 5.434115886688232,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "dovitinib is a novel small molecule inhibitor of fibroblast growth factor",
            "probability": 0.0002711655903005653,
            "start_logit": -0.5165184140205383,
            "end_logit": 5.2720255851745605,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "fibroblast growth",
            "probability": 0.00026069423942789115,
            "start_logit": 6.317054271697998,
            "end_logit": -1.600928544998169,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "fibroblast growth factor and vascular endothelial growth",
            "probability": 0.00017544208292675215,
            "start_logit": 6.317054271697998,
            "end_logit": -1.9969677925109863,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "vascular endothelial growth",
            "probability": 0.00017153829811406484,
            "start_logit": 6.294551849365234,
            "end_logit": -1.9969677925109863,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "broblast growth factor and vascular endothelial growth factor receptor",
            "probability": 0.00014311395724778933,
            "start_logit": -1.3176971673965454,
            "end_logit": 5.434115886688232,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "broblast growth factor",
            "probability": 0.00012169901608676041,
            "start_logit": -1.3176971673965454,
            "end_logit": 5.2720255851745605,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "growth factor receptor and dovitinib is a novel small molecule inhibitor of fibroblast growth factor and vascular endothelial growth factor receptor",
            "probability": 0.00011891495543600937,
            "start_logit": -1.5029298067092896,
            "end_logit": 5.434115886688232,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        },
        {
            "text": "mal growth factor receptor and dovitinib is a novel small molecule inhibitor of fibroblast growth factor and vascular endothelial growth factor receptor",
            "probability": 0.00010786923400423475,
            "start_logit": -1.6004186868667603,
            "end_logit": 5.434115886688232,
            "question_text": "Which molecules are inhibited by anticancer drug Dovitinib?"
        }
    ],
    "5a7240aa2dc08e987e00000d": [
        {
            "text": "Bezlotoxumab",
            "probability": 0.935946037996001,
            "start_logit": 5.022951602935791,
            "end_logit": 5.423680782318115,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "bezlotoxumab",
            "probability": 0.05622820787207586,
            "start_logit": 3.7673146724700928,
            "end_logit": 3.867178440093994,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxumab (Zinplava\u2122)",
            "probability": 0.00667150796731108,
            "start_logit": 5.022951602935791,
            "end_logit": 0.4799688756465912,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxumab (Zinplava\u2122) is a human monoclonal antibody against Clostridium difficile toxin B",
            "probability": 0.0004940857988593915,
            "start_logit": 5.022951602935791,
            "end_logit": -2.1229231357574463,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxumab (",
            "probability": 0.00015950387242024682,
            "start_logit": 5.022951602935791,
            "end_logit": -3.2535641193389893,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "B",
            "probability": 0.00015313137900123568,
            "start_logit": -3.6950652599334717,
            "end_logit": 5.423680782318115,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Be",
            "probability": 0.000148866982799742,
            "start_logit": 5.022951602935791,
            "end_logit": -3.3225791454315186,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxumab (Zinplava\u2122) is",
            "probability": 3.4068833835337494e-05,
            "start_logit": 5.022951602935791,
            "end_logit": -4.7972493171691895,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxuma",
            "probability": 2.9486845805594388e-05,
            "start_logit": 5.022951602935791,
            "end_logit": -4.941688060760498,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxumab (Zinplava\u2122) is a human monoclonal antibody against Clostridium difficile",
            "probability": 2.242562872289385e-05,
            "start_logit": 5.022951602935791,
            "end_logit": -5.215427875518799,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotox",
            "probability": 2.2134588826585413e-05,
            "start_logit": 5.022951602935791,
            "end_logit": -5.228490829467773,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "lotoxumab",
            "probability": 1.7685300554861856e-05,
            "start_logit": -5.853627681732178,
            "end_logit": 5.423680782318115,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxumab (Zinplava\u2122) is a human monoclonal antibody",
            "probability": 1.574431720425254e-05,
            "start_logit": 5.022951602935791,
            "end_logit": -5.56915283203125,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "Bezlotoxumab (Zinplava\u2122) is a human monoclonal antibody against Clostridium difficile toxin",
            "probability": 1.5170437838340811e-05,
            "start_logit": 5.022951602935791,
            "end_logit": -5.606283664703369,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "oxumab",
            "probability": 1.319124499675449e-05,
            "start_logit": -6.14680814743042,
            "end_logit": 5.423680782318115,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "b",
            "probability": 1.1708789166905745e-05,
            "start_logit": -4.709519386291504,
            "end_logit": 3.867178440093994,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "be",
            "probability": 9.57285171556467e-06,
            "start_logit": 3.7673146724700928,
            "end_logit": -4.81106424331665,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "(Zinplava\u2122)",
            "probability": 6.579646007675075e-06,
            "start_logit": -1.898668646812439,
            "end_logit": 0.4799688756465912,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": "(Zinplava\u2122) is a human monoclonal antibody against Clostridium difficile toxin B",
            "probability": 4.872825858625797e-07,
            "start_logit": -1.898668646812439,
            "end_logit": -2.1229231357574463,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        },
        {
            "text": ")",
            "probability": 4.0236427088553635e-07,
            "start_logit": -4.693047046661377,
            "end_logit": 0.4799688756465912,
            "question_text": "List two human monoclonal antibodies against Clostridium difficile toxins."
        }
    ],
    "5aa80873d6d6b54f79000013": [
        {
            "text": "rDNA",
            "probability": 0.3620378480042308,
            "start_logit": 3.3310089111328125,
            "end_logit": 2.707383394241333,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 alters rDNA",
            "probability": 0.316765161290966,
            "start_logit": 3.197420835494995,
            "end_logit": 2.707383394241333,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2",
            "probability": 0.2030336543792283,
            "start_logit": 3.197420835494995,
            "end_logit": 2.26259446144104,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN",
            "probability": 0.0832923987635614,
            "start_logit": 3.197420835494995,
            "end_logit": 1.3715800046920776,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "rDNA transcription and promotes ribosomal biogenesis, and this effect can be reversed by re-introduction of PTEN\u03b2",
            "probability": 0.010036188767371147,
            "start_logit": 3.3310089111328125,
            "end_logit": -0.8781679272651672,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "rDNA transcription and promotes ribosomal biogenesis,",
            "probability": 0.0037570147890995226,
            "start_logit": 3.3310089111328125,
            "end_logit": -1.8607406616210938,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 regulates pre-rRNA synthesis and cellular proliferation. These results demonstrate the complexity of the PTEN",
            "probability": 0.0033770317705978823,
            "start_logit": 1.5490823984146118,
            "end_logit": -0.18544170260429382,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 alters rDNA transcription and promotes ribosomal biogenesis,",
            "probability": 0.003287201606688778,
            "start_logit": 3.197420835494995,
            "end_logit": -1.8607406616210938,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Disruption of PTEN\u03b2 alters rDNA",
            "probability": 0.002889279360936979,
            "start_logit": -1.4997327327728271,
            "end_logit": 2.707383394241333,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Disruption of PTEN\u03b2",
            "probability": 0.0018519111911889609,
            "start_logit": -1.4997327327728271,
            "end_logit": 2.26259446144104,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "rDNA transcription and promotes ribosomal biogenesis",
            "probability": 0.0016182059366725335,
            "start_logit": 3.3310089111328125,
            "end_logit": -2.703047275543213,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 alters rDNA transcription and promotes ribosomal biogenesis",
            "probability": 0.001415849937673046,
            "start_logit": 3.197420835494995,
            "end_logit": -2.703047275543213,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "rDNA transcription and promotes ribosomal biogenesis, and this effect can be reversed by re-introduction of PTEN",
            "probability": 0.001286204311211326,
            "start_logit": 3.3310089111328125,
            "end_logit": -2.9326698780059814,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 alters rDNA transcription and promotes ribosomal biogenesis, and this effect can be reversed by re-introduction of PTEN",
            "probability": 0.001125364981423794,
            "start_logit": 3.197420835494995,
            "end_logit": -2.9326698780059814,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "rDNA transcription",
            "probability": 0.0010273756846553067,
            "start_logit": 3.3310089111328125,
            "end_logit": -3.157357692718506,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 alters rDNA transcription",
            "probability": 0.0008989027701116261,
            "start_logit": 3.197420835494995,
            "end_logit": -3.157357692718506,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "Disruption of PTEN",
            "probability": 0.0007597268831260011,
            "start_logit": -1.4997327327728271,
            "end_logit": 1.3715800046920776,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "PTEN\u03b2 regulates pre-rRNA",
            "probability": 0.0006684420359009249,
            "start_logit": 1.5490823984146118,
            "end_logit": -1.8052444458007812,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "rDNA transcription and promotes ribosomal biogenesis, and this effect can be reversed by re-introduction of PTEN\u03b2.",
            "probability": 0.0004395068492641233,
            "start_logit": 3.3310089111328125,
            "end_logit": -4.006467342376709,
            "question_text": "List ribosomal biogenesis proteins."
        },
        {
            "text": "nucleolin, which is a multifunctional nucleolar phosphoprotein. Disruption of PTEN\u03b2",
            "probability": 0.0004327306860914569,
            "start_logit": -2.9535906314849854,
            "end_logit": 2.26259446144104,
            "question_text": "List ribosomal biogenesis proteins."
        }
    ],
    "5aacdcf1fcf4565872000009": [
        {
            "text": "Bdf1",
            "probability": 0.9907264797836121,
            "start_logit": 4.088275909423828,
            "end_logit": 3.222221612930298,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf1 has been explored in Saccharomyces cerevisiae. Mutation of Bdf1",
            "probability": 0.00396935359208973,
            "start_logit": 4.088275909423828,
            "end_logit": -2.2976136207580566,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf1 has been explored in Saccharomyces cerevisiae.",
            "probability": 0.002325398496094181,
            "start_logit": 4.088275909423828,
            "end_logit": -2.8323254585266113,
            "question_text": "List BET proteins."
        },
        {
            "text": "B",
            "probability": 0.000756473163876989,
            "start_logit": 4.088275909423828,
            "end_logit": -3.9553050994873047,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bdf1 has been explored in Saccharomyces cerevisiae",
            "probability": 0.0006430426314721619,
            "start_logit": 4.088275909423828,
            "end_logit": -4.117761135101318,
            "question_text": "List BET proteins."
        },
        {
            "text": "in this study, the role of the BET protein Bdf1",
            "probability": 0.0003471957507031888,
            "start_logit": -3.8680291175842285,
            "end_logit": 3.222221612930298,
            "question_text": "List BET proteins."
        },
        {
            "text": "1",
            "probability": 0.00027173979961339726,
            "start_logit": -4.113072872161865,
            "end_logit": 3.222221612930298,
            "question_text": "List BET proteins."
        },
        {
            "text": ", the role of the BET protein Bdf1",
            "probability": 0.00021929942253750878,
            "start_logit": -4.327479839324951,
            "end_logit": 3.222221612930298,
            "question_text": "List BET proteins."
        },
        {
            "text": "BET protein Bdf1",
            "probability": 0.0002152839213373424,
            "start_logit": -4.3459601402282715,
            "end_logit": 3.222221612930298,
            "question_text": "List BET proteins."
        },
        {
            "text": "the BET protein Bdf1",
            "probability": 0.0001625863676811402,
            "start_logit": -4.626708507537842,
            "end_logit": 3.222221612930298,
            "question_text": "List BET proteins."
        },
        {
            "text": "study, the role of the BET protein Bdf1",
            "probability": 0.00015714596736104497,
            "start_logit": -4.66074275970459,
            "end_logit": 3.222221612930298,
            "question_text": "List BET proteins."
        },
        {
            "text": "Extra-terminal motif",
            "probability": 0.00011575291105894034,
            "start_logit": -1.2749805450439453,
            "end_logit": -0.4692578613758087,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bromodomain and Extra-terminal motif",
            "probability": 5.453240889185345e-05,
            "start_logit": -2.0276432037353516,
            "end_logit": -0.4692578613758087,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bromodomain",
            "probability": 1.1498228427153018e-05,
            "start_logit": -2.0276432037353516,
            "end_logit": -2.025860071182251,
            "question_text": "List BET proteins."
        },
        {
            "text": "motif",
            "probability": 9.20577406008744e-06,
            "start_logit": -3.806607484817505,
            "end_logit": -0.4692578613758087,
            "question_text": "List BET proteins."
        },
        {
            "text": "Extra-terminal motif (BET)",
            "probability": 5.519933756507561e-06,
            "start_logit": -1.2749805450439453,
            "end_logit": -3.512349843978882,
            "question_text": "List BET proteins."
        },
        {
            "text": "Extra-terminal motif (BET) proteins play a central role in transcription regulation and chromatin signalling pathways",
            "probability": 2.751711131123148e-06,
            "start_logit": -1.2749805450439453,
            "end_logit": -4.208492755889893,
            "question_text": "List BET proteins."
        },
        {
            "text": "Bromodomain and Extra-terminal motif (BET)",
            "probability": 2.60049861305467e-06,
            "start_logit": -2.0276432037353516,
            "end_logit": -3.512349843978882,
            "question_text": "List BET proteins."
        },
        {
            "text": "Extra-terminal motif (BET) proteins",
            "probability": 2.0876237718219503e-06,
            "start_logit": -1.2749805450439453,
            "end_logit": -4.484689235687256,
            "question_text": "List BET proteins."
        },
        {
            "text": "Extra",
            "probability": 2.052013910682956e-06,
            "start_logit": -1.2749805450439453,
            "end_logit": -4.501893997192383,
            "question_text": "List BET proteins."
        }
    ],
    "5a9eb008d6d6b54f79000001": [
        {
            "text": "Asian origin that is becoming widespread in North America and Europe",
            "probability": 0.3698238810098466,
            "start_logit": 3.3067917823791504,
            "end_logit": 0.941080629825592,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian",
            "probability": 0.2295676081146198,
            "start_logit": 3.3067917823791504,
            "end_logit": 0.464251309633255,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian origin that is becoming widespread in North America",
            "probability": 0.18809015500402299,
            "start_logit": 3.3067917823791504,
            "end_logit": 0.2649751305580139,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian origin",
            "probability": 0.07250262927403213,
            "start_logit": 3.3067917823791504,
            "end_logit": -0.688323438167572,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Europe",
            "probability": 0.046864867883842795,
            "start_logit": 1.2410331964492798,
            "end_logit": 0.941080629825592,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "As",
            "probability": 0.02891540977880832,
            "start_logit": 3.3067917823791504,
            "end_logit": -1.6075716018676758,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "North America and Europe",
            "probability": 0.022299598107195555,
            "start_logit": 0.49833354353904724,
            "end_logit": 0.941080629825592,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian origin that is becoming widespread in North America and Europe.",
            "probability": 0.011728433782825919,
            "start_logit": 3.3067917823791504,
            "end_logit": -2.50993013381958,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "North America",
            "probability": 0.011341438668202595,
            "start_logit": 0.49833354353904724,
            "end_logit": 0.2649751305580139,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "America and Europe",
            "probability": 0.007258877520778731,
            "start_logit": -0.624009907245636,
            "end_logit": 0.941080629825592,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "America",
            "probability": 0.003691820534440116,
            "start_logit": -0.624009907245636,
            "end_logit": 0.2649751305580139,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian origin that is becoming widespread in North",
            "probability": 0.0017739316319640719,
            "start_logit": 3.3067917823791504,
            "end_logit": -4.39874792098999,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Europe.",
            "probability": 0.0014862520457457986,
            "start_logit": 1.2410331964492798,
            "end_logit": -2.50993013381958,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian origin that is becoming widespread in North America and Europe. Despite the economic importance of pentatomid pests worldwide",
            "probability": 0.0013463788027331058,
            "start_logit": 3.3067917823791504,
            "end_logit": -4.674527645111084,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian origin that is becoming widespread in North America and Euro",
            "probability": 0.0011647371158972888,
            "start_logit": 3.3067917823791504,
            "end_logit": -4.819450855255127,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "North America and Europe.",
            "probability": 0.0007071997597064582,
            "start_logit": 0.49833354353904724,
            "end_logit": -2.50993013381958,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian origin that is becoming widespread",
            "probability": 0.0005523975807524088,
            "start_logit": 3.3067917823791504,
            "end_logit": -5.565433502197266,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "Asian origin that",
            "probability": 0.00035896893805386666,
            "start_logit": 3.3067917823791504,
            "end_logit": -5.996465682983398,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "origin that is becoming widespread in North America and Europe",
            "probability": 0.0002952095606066502,
            "start_logit": -3.8263049125671387,
            "end_logit": 0.941080629825592,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        },
        {
            "text": "America and Europe.",
            "probability": 0.00023020488592468753,
            "start_logit": -0.624009907245636,
            "end_logit": -2.50993013381958,
            "question_text": "List the continent of origin for the brown marmorated stinkbug(Halyomorpha halys)"
        }
    ],
    "5aa55b65d6d6b54f7900000e": [
        {
            "text": "streptococcal pharyngotonsillitis",
            "probability": 0.21181748295383657,
            "start_logit": -1.4609508514404297,
            "end_logit": -0.4449131190776825,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "signs",
            "probability": 0.11492557705936172,
            "start_logit": -1.4722933769226074,
            "end_logit": -1.0450108051300049,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "pharyngotonsillitis",
            "probability": 0.11235075619597236,
            "start_logit": -2.095050096511841,
            "end_logit": -0.4449131190776825,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "clinical symptoms",
            "probability": 0.08980508299790002,
            "start_logit": -1.4189658164978027,
            "end_logit": -1.3449815511703491,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "signs and clinical symptoms",
            "probability": 0.08514145219611216,
            "start_logit": -1.4722933769226074,
            "end_logit": -1.3449815511703491,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "clinical symptoms of children with scarlet fever",
            "probability": 0.04639597434216035,
            "start_logit": -1.4189658164978027,
            "end_logit": -2.0054104328155518,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "signs and clinical symptoms of children with scarlet fever",
            "probability": 0.04398660409497603,
            "start_logit": -1.4722933769226074,
            "end_logit": -2.0054104328155518,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "age, signs",
            "probability": 0.04271498838927429,
            "start_logit": -2.4620282649993896,
            "end_logit": -1.0450108051300049,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "age, signs and clinical symptoms",
            "probability": 0.031644967422042036,
            "start_logit": -2.4620282649993896,
            "end_logit": -1.3449815511703491,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "symptoms",
            "probability": 0.027909299695157024,
            "start_logit": -2.5876474380493164,
            "end_logit": -1.3449815511703491,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "clinical symptoms of children with scarlet fever at the present time,",
            "probability": 0.023949137292080657,
            "start_logit": -1.4189658164978027,
            "end_logit": -2.6666908264160156,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "signs and clinical symptoms of children with scarlet fever at the present time,",
            "probability": 0.022705444500724904,
            "start_logit": -1.4722933769226074,
            "end_logit": -2.6666908264160156,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "clinical",
            "probability": 0.022585116032922882,
            "start_logit": -1.4189658164978027,
            "end_logit": -2.725332021713257,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "to check whether they are equivalent to those with traditional streptococcal pharyngotonsillitis",
            "probability": 0.02233599331681993,
            "start_logit": -3.7104763984680176,
            "end_logit": -0.4449131190776825,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "signs and clinical",
            "probability": 0.021412257668151313,
            "start_logit": -1.4722933769226074,
            "end_logit": -2.725332021713257,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "age",
            "probability": 0.019519840081019438,
            "start_logit": -2.4620282649993896,
            "end_logit": -1.8281292915344238,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "describe the age, signs",
            "probability": 0.017251742620439173,
            "start_logit": -3.3686649799346924,
            "end_logit": -1.0450108051300049,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "age, signs and clinical symptoms of children with scarlet fever",
            "probability": 0.016348730467805418,
            "start_logit": -2.4620282649993896,
            "end_logit": -2.0054104328155518,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "symptoms of children with scarlet fever",
            "probability": 0.014418773518581883,
            "start_logit": -2.5876474380493164,
            "end_logit": -2.0054104328155518,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        },
        {
            "text": "describe the age, signs and clinical symptoms",
            "probability": 0.012780779154661661,
            "start_logit": -3.3686649799346924,
            "end_logit": -1.3449815511703491,
            "question_text": "Please list 6 symptoms of Scarlet fever."
        }
    ],
    "5a736f0c3b9d13c708000007": [
        {
            "text": "MCV/RBC",
            "probability": 0.8188990411433361,
            "start_logit": 1.7747962474822998,
            "end_logit": 0.5054182410240173,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(MCV/RBC",
            "probability": 0.054162316634011484,
            "start_logit": -0.9411791563034058,
            "end_logit": 0.5054182410240173,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "RBC",
            "probability": 0.03888567827660613,
            "start_logit": -1.2725385427474976,
            "end_logit": 0.5054182410240173,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV",
            "probability": 0.031607846640631605,
            "start_logit": 1.7747962474822998,
            "end_logit": -2.7491371631622314,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV/RBC), England and Fraser formula (MCV - RBC - 5",
            "probability": 0.016687558322219527,
            "start_logit": 1.7747962474822998,
            "end_logit": -3.3878791332244873,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "M",
            "probability": 0.015940263463930685,
            "start_logit": 1.7747962474822998,
            "end_logit": -3.433694362640381,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "RBC), England and Fraser formula (MCV - RBC - 5 x Hb- 3.4",
            "probability": 0.006843355855578526,
            "start_logit": -1.2725385427474976,
            "end_logit": -1.2319295406341553,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV/RBC), England and Fraser formula (MCV - RBC",
            "probability": 0.0033814928757893593,
            "start_logit": 1.7747962474822998,
            "end_logit": -4.984225273132324,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV/RBC)",
            "probability": 0.003307029738115338,
            "start_logit": 1.7747962474822998,
            "end_logit": -5.0064921379089355,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(MCV",
            "probability": 0.0020905558705734436,
            "start_logit": -0.9411791563034058,
            "end_logit": -2.7491371631622314,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "5 x Hb- 3.4",
            "probability": 0.0012855720525126748,
            "start_logit": -2.944612979888916,
            "end_logit": -1.2319295406341553,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "MCV - RBC - 5 x Hb- 3.4",
            "probability": 0.0012676813868725432,
            "start_logit": -2.958627223968506,
            "end_logit": -1.2319295406341553,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(MCV/RBC), England and Fraser formula (MCV - RBC - 5",
            "probability": 0.0011037219147731108,
            "start_logit": -0.9411791563034058,
            "end_logit": -3.3878791332244873,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(M",
            "probability": 0.001054295528002529,
            "start_logit": -0.9411791563034058,
            "end_logit": -3.433694362640381,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "C",
            "probability": 0.0010454753914815765,
            "start_logit": -4.888692855834961,
            "end_logit": 0.5054182410240173,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "RBC), England and Fraser formula (MCV - RBC - 5",
            "probability": 0.0007924139503618593,
            "start_logit": -1.2725385427474976,
            "end_logit": -3.3878791332244873,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "Bessman index (RDW), Mentzer formula (MCV/RBC",
            "probability": 0.0005222404069630669,
            "start_logit": -5.582791805267334,
            "end_logit": 0.5054182410240173,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "Hb- 3.4",
            "probability": 0.0004190857741332728,
            "start_logit": -4.065496444702148,
            "end_logit": -1.2319295406341553,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "4",
            "probability": 0.0003761731650914631,
            "start_logit": -4.173522472381592,
            "end_logit": -1.2319295406341553,
            "question_text": "What is included in the Mentzer index?"
        },
        {
            "text": "(RDW), Mentzer formula (MCV/RBC",
            "probability": 0.00032820160901590116,
            "start_logit": -6.0472917556762695,
            "end_logit": 0.5054182410240173,
            "question_text": "What is included in the Mentzer index?"
        }
    ],
    "5a7339372dc08e987e000013": [
        {
            "text": "sofosbuvir/velpatasvir",
            "probability": 0.21051252292638642,
            "start_logit": 5.36577033996582,
            "end_logit": 4.964048862457275,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir",
            "probability": 0.20772729280552404,
            "start_logit": 5.36577033996582,
            "end_logit": 4.950729846954346,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir/velpatasvir/voxilaprevir",
            "probability": 0.1926010083342543,
            "start_logit": 5.36577033996582,
            "end_logit": 4.875124454498291,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "velpatasvir",
            "probability": 0.1350567556421213,
            "start_logit": 4.921920299530029,
            "end_logit": 4.964048862457275,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "voxilaprevir",
            "probability": 0.12905235681483684,
            "start_logit": 4.965367794036865,
            "end_logit": 4.875124454498291,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "velpatasvir/voxilaprevir",
            "probability": 0.12356541528943457,
            "start_logit": 4.921920299530029,
            "end_logit": 4.875124454498291,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX)",
            "probability": 0.00032386403692534444,
            "start_logit": 5.36577033996582,
            "end_logit": -1.512927770614624,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "voxilaprevir (SOF/VEL/VOX)",
            "probability": 0.00021700518400323288,
            "start_logit": 4.965367794036865,
            "end_logit": -1.512927770614624,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "velpatasvir/voxilaprevir (SOF/VEL/VOX)",
            "probability": 0.00020777873680984072,
            "start_logit": 4.921920299530029,
            "end_logit": -1.512927770614624,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "vir/velpatasvir",
            "probability": 0.00011347295953662244,
            "start_logit": -2.1599655151367188,
            "end_logit": 4.964048862457275,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "vir",
            "probability": 0.00011197163172765729,
            "start_logit": -2.1599655151367188,
            "end_logit": 4.950729846954346,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "vir/velpatasvir/voxilaprevir",
            "probability": 0.00010381808227659664,
            "start_logit": -2.1599655151367188,
            "end_logit": 4.875124454498291,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "vir/voxilaprevir",
            "probability": 9.896891018194666e-05,
            "start_logit": -2.2077999114990234,
            "end_logit": 4.875124454498291,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "so",
            "probability": 5.289297778760996e-05,
            "start_logit": 5.36577033996582,
            "end_logit": -3.3249809741973877,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "voxilaprevir (SOF/VEL/VOX) (Vosevi)",
            "probability": 4.771954168284986e-05,
            "start_logit": 4.965367794036865,
            "end_logit": -3.027508020401001,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "velpatasvir/voxilaprevir (SOF/VEL/VOX) (Vosevi)",
            "probability": 4.5690641620153056e-05,
            "start_logit": 4.921920299530029,
            "end_logit": -3.027508020401001,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir/velpatasvir/v",
            "probability": 4.524833083909658e-05,
            "start_logit": 5.36577033996582,
            "end_logit": -3.481085777282715,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "/velpatasvir",
            "probability": 4.2794626724364744e-05,
            "start_logit": -3.135117530822754,
            "end_logit": 4.964048862457275,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "/velpatasvir/voxilaprevir",
            "probability": 3.915343440771408e-05,
            "start_logit": -3.135117530822754,
            "end_logit": 4.875124454498291,
            "question_text": "List drugs that are included in the Vosevi polypill."
        },
        {
            "text": "sofosbuvir/ve",
            "probability": 3.4269092919064926e-05,
            "start_logit": 5.36577033996582,
            "end_logit": -3.759007692337036,
            "question_text": "List drugs that are included in the Vosevi polypill."
        }
    ],
    "5a76344e9e632bc066000003": [
        {
            "text": "NGC",
            "probability": 0.7618973745346265,
            "start_logit": 4.348508358001709,
            "end_logit": 4.643871307373047,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool for the compression of mapped short read data stored in the wide-spread SAM format. NGC",
            "probability": 0.20456957372014034,
            "start_logit": 4.348508358001709,
            "end_logit": 3.328967571258545,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC,",
            "probability": 0.027049844975158444,
            "start_logit": 4.348508358001709,
            "end_logit": 1.3057407140731812,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool for the compression of mapped short read data stored in the wide-spread SAM format.",
            "probability": 0.002002170913850138,
            "start_logit": 4.348508358001709,
            "end_logit": -1.297708511352539,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool",
            "probability": 0.0014801011196811037,
            "start_logit": 4.348508358001709,
            "end_logit": -1.599830150604248,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NG",
            "probability": 0.0011256362393279172,
            "start_logit": 4.348508358001709,
            "end_logit": -1.8735921382904053,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool for the compression",
            "probability": 0.00038571898465124754,
            "start_logit": 4.348508358001709,
            "end_logit": -2.944586753845215,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool for the compression of mapped short read data stored in the wide-spread SAM format. NG",
            "probability": 0.0002846544074590486,
            "start_logit": 4.348508358001709,
            "end_logit": -3.248420000076294,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "C",
            "probability": 0.00026033263695356243,
            "start_logit": -3.633098602294922,
            "end_logit": 4.643871307373047,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a",
            "probability": 0.00020334526984283868,
            "start_logit": 4.348508358001709,
            "end_logit": -3.5847904682159424,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "compression of mapped short read data stored in the wide-spread SAM format. NGC",
            "probability": 0.0001715454205105353,
            "start_logit": -2.735306978225708,
            "end_logit": 3.328967571258545,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "a tool for the compression of mapped short read data stored in the wide-spread SAM format. NGC",
            "probability": 9.190055755414512e-05,
            "start_logit": -3.359447956085205,
            "end_logit": 3.328967571258545,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool for the compression of mapped short read data stored in the wide-spread SAM format",
            "probability": 9.110158970905052e-05,
            "start_logit": 4.348508358001709,
            "end_logit": -4.387720584869385,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "present NGC",
            "probability": 8.647163332524945e-05,
            "start_logit": -4.7352423667907715,
            "end_logit": 4.643871307373047,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "C, a tool for the compression of mapped short read data stored in the wide-spread SAM format. NGC",
            "probability": 6.989935698303152e-05,
            "start_logit": -3.633098602294922,
            "end_logit": 3.328967571258545,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool for the compression of mapped short read data stored in the wide-spread SAM",
            "probability": 6.451696788549495e-05,
            "start_logit": 4.348508358001709,
            "end_logit": -4.732767581939697,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "tool for the compression of mapped short read data stored in the wide-spread SAM format. NGC",
            "probability": 5.4478521057386714e-05,
            "start_logit": -3.8823485374450684,
            "end_logit": 3.328967571258545,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": "NGC, a tool for the compression of mapped short read data",
            "probability": 5.4453951994734145e-05,
            "start_logit": 4.348508358001709,
            "end_logit": -4.902340412139893,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": ", a tool for the compression of mapped short read data stored in the wide-spread SAM format. NGC",
            "probability": 3.008186575860948e-05,
            "start_logit": -4.476232528686523,
            "end_logit": 3.328967571258545,
            "question_text": "Which algorithms are used for compression of SAM files?"
        },
        {
            "text": ". NGC",
            "probability": 2.6797333530777566e-05,
            "start_logit": -4.59185266494751,
            "end_logit": 3.328967571258545,
            "question_text": "Which algorithms are used for compression of SAM files?"
        }
    ],
    "5aa13fd3d6d6b54f79000003": [
        {
            "text": "buprenorphine",
            "probability": 0.20826850095812088,
            "start_logit": 5.13857889175415,
            "end_logit": 5.519313812255859,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine",
            "probability": 0.20825837156812213,
            "start_logit": 5.138530254364014,
            "end_logit": 5.519313812255859,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine, and oral and injectable naltrexone",
            "probability": 0.1544027795831996,
            "start_logit": 5.13857889175415,
            "end_logit": 5.22005033493042,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine, and oral and injectable naltrexone",
            "probability": 0.15439527001759515,
            "start_logit": 5.138530254364014,
            "end_logit": 5.22005033493042,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone",
            "probability": 0.13334402535555198,
            "start_logit": 5.138530254364014,
            "end_logit": 5.073466777801514,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naltrexone",
            "probability": 0.12106910239565925,
            "start_logit": 4.895375728607178,
            "end_logit": 5.22005033493042,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "injectable naltrexone",
            "probability": 0.008278926372626913,
            "start_logit": 2.2127275466918945,
            "end_logit": 5.22005033493042,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "oral and injectable naltrexone",
            "probability": 0.005308785933975021,
            "start_logit": 1.768377423286438,
            "end_logit": 5.22005033493042,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine,",
            "probability": 0.002507848962558598,
            "start_logit": 5.13857889175415,
            "end_logit": 1.099911093711853,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine,",
            "probability": 0.0025077269902964317,
            "start_logit": 5.138530254364014,
            "end_logit": 1.099911093711853,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone,",
            "probability": 0.0004052621892858476,
            "start_logit": 5.138530254364014,
            "end_logit": -0.7226867079734802,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine, and oral",
            "probability": 0.0003207406896669896,
            "start_logit": 5.13857889175415,
            "end_logit": -0.9566366076469421,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine, and oral",
            "probability": 0.00032072509005629885,
            "start_logit": 5.138530254364014,
            "end_logit": -0.9566366076469421,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "buprenorphine, and oral and injectable naltrexone)",
            "probability": 0.00013320783885592712,
            "start_logit": 5.13857889175415,
            "end_logit": -1.83535897731781,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "methadone, buprenorphine, and oral and injectable naltrexone)",
            "probability": 0.00013320136013185484,
            "start_logit": 5.138530254364014,
            "end_logit": -1.83535897731781,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "naltrexone)",
            "probability": 0.00010444989090149461,
            "start_logit": 4.895375728607178,
            "end_logit": -1.83535897731781,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "(ie, methadone, buprenorphine",
            "probability": 6.73727916842302e-05,
            "start_logit": -2.897763252258301,
            "end_logit": 5.519313812255859,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "hadone, buprenorphine",
            "probability": 6.358416280726763e-05,
            "start_logit": -2.9556400775909424,
            "end_logit": 5.519313812255859,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "xone",
            "probability": 5.588099209439846e-05,
            "start_logit": -2.7855167388916016,
            "end_logit": 5.22005033493042,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        },
        {
            "text": "phine",
            "probability": 5.423685680997314e-05,
            "start_logit": -3.1146438121795654,
            "end_logit": 5.519313812255859,
            "question_text": "List 4 drugs used to treat opioid addiction or overdose"
        }
    ],
    "5aa82388fcf4565872000001": [
        {
            "text": "NLRP3",
            "probability": 0.8441829658643922,
            "start_logit": 3.681056022644043,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NLRP3 inflammasome",
            "probability": 0.11441018570022049,
            "start_logit": 3.681056022644043,
            "end_logit": 1.1288596391677856,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "activation of NLRP3",
            "probability": 0.00885041557713301,
            "start_logit": -0.8768488168716431,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "nuclear factor E2-related factor-2 (Nrf2) on the activation of NLRP3",
            "probability": 0.008799264708177969,
            "start_logit": -0.8826450705528259,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "negative regulation of nuclear factor E2-related factor-2 (Nrf2) on the activation of NLRP3",
            "probability": 0.006702138330617796,
            "start_logit": -1.1548866033554077,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "inflammasome",
            "probability": 0.00340451984093903,
            "start_logit": 0.16636982560157776,
            "end_logit": 1.1288596391677856,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "NLRP3 inflammasome.",
            "probability": 0.0030258103966206216,
            "start_logit": 3.681056022644043,
            "end_logit": -2.503751516342163,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "(Nrf2) on the activation of NLRP3",
            "probability": 0.0016377340011681887,
            "start_logit": -2.563999652862549,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "activation of NLRP3 inflammasome",
            "probability": 0.001199476571606836,
            "start_logit": -0.8768488168716431,
            "end_logit": 1.1288596391677856,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "nuclear factor E2-related factor-2 (Nrf2) on the activation of NLRP3 inflammasome",
            "probability": 0.001192544211381015,
            "start_logit": -0.8826450705528259,
            "end_logit": 1.1288596391677856,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "the activation of NLRP3",
            "probability": 0.0009747970164572525,
            "start_logit": -3.082839250564575,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "3",
            "probability": 0.0009541916785720128,
            "start_logit": -3.104203939437866,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "negative regulation of nuclear factor E2-related factor-2 (Nrf2) on the activation of NLRP3 inflammasome",
            "probability": 0.0009083254720845952,
            "start_logit": -1.1548866033554077,
            "end_logit": 1.1288596391677856,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "elucidate the negative regulation of nuclear factor E2-related factor-2 (Nrf2) on the activation of NLRP3",
            "probability": 0.0008145520421503177,
            "start_logit": -3.262430191040039,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "regulation of nuclear factor E2-related factor-2 (Nrf2) on the activation of NLRP3",
            "probability": 0.0007478846138332331,
            "start_logit": -3.3478198051452637,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "the negative regulation of nuclear factor E2-related factor-2 (Nrf2) on the activation of NLRP3",
            "probability": 0.000701003288823536,
            "start_logit": -3.4125559329986572,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": ") on the activation of NLRP3",
            "probability": 0.0006128782678274787,
            "start_logit": -3.5469021797180176,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "te the negative regulation of nuclear factor E2-related factor-2 (Nrf2) on the activation of NLRP3",
            "probability": 0.0003360301311698616,
            "start_logit": -4.147867679595947,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "on the activation of NLRP3",
            "probability": 0.00032332394511651503,
            "start_logit": -4.186413764953613,
            "end_logit": 3.12743878364563,
            "question_text": "Which proteins are regulated by Nrf2?"
        },
        {
            "text": "(Nrf2) on the activation of NLRP3 inflammasome",
            "probability": 0.000221958341707782,
            "start_logit": -2.563999652862549,
            "end_logit": 1.1288596391677856,
            "question_text": "Which proteins are regulated by Nrf2?"
        }
    ],
    "5a9d96564e03427e73000001": [
        {
            "text": "Hypertension",
            "probability": 0.8487300389316222,
            "start_logit": 4.722860813140869,
            "end_logit": 4.833113193511963,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 0.12458340073968584,
            "start_logit": 4.722860813140869,
            "end_logit": 2.9143474102020264,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "stroke",
            "probability": 0.012304890408461798,
            "start_logit": 2.4078822135925293,
            "end_logit": 2.9143474102020264,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "ypertension",
            "probability": 0.007329001994907931,
            "start_logit": -0.029040994122624397,
            "end_logit": 4.833113193511963,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "tension",
            "probability": 0.0015800196482619858,
            "start_logit": -1.5634430646896362,
            "end_logit": 4.833113193511963,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "ypertension is one of the major risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 0.0010758096811359981,
            "start_logit": -0.029040994122624397,
            "end_logit": 2.9143474102020264,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension is one of the major risk factors for central nervous system",
            "probability": 0.0007303997284479008,
            "start_logit": 4.722860813140869,
            "end_logit": -2.2247912883758545,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertens",
            "probability": 0.0006562613976589851,
            "start_logit": 4.722860813140869,
            "end_logit": -2.3318240642547607,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "hypertension",
            "probability": 0.0005449807772915189,
            "start_logit": 1.5500844717025757,
            "end_logit": 0.6551436185836792,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "H",
            "probability": 0.0005125939958564159,
            "start_logit": 4.722860813140869,
            "end_logit": -2.5788991451263428,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "ion",
            "probability": 0.0005030028648712371,
            "start_logit": -2.7080397605895996,
            "end_logit": 4.833113193511963,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension is one of the major risk factors",
            "probability": 0.0004637194023437222,
            "start_logit": 4.722860813140869,
            "end_logit": -2.6791036128997803,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension is one of the major risk factors for central nervous system (CNS) disorders",
            "probability": 0.00026801949322143145,
            "start_logit": 4.722860813140869,
            "end_logit": -3.227323532104492,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "tension is one of the major risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 0.00023192795351486216,
            "start_logit": -1.5634430646896362,
            "end_logit": 2.9143474102020264,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "central nervous system (CNS) disorders like stroke",
            "probability": 0.00015020573998189823,
            "start_logit": -1.9978638887405396,
            "end_logit": 2.9143474102020264,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension is one of the major risk",
            "probability": 9.557012378495076e-05,
            "start_logit": 4.722860813140869,
            "end_logit": -4.258522987365723,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "ion is one of the major risk factors for central nervous system (CNS) disorders like stroke",
            "probability": 7.383479388374993e-05,
            "start_logit": -2.7080397605895996,
            "end_logit": 2.9143474102020264,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hyper",
            "probability": 6.926639658063446e-05,
            "start_logit": 4.722860813140869,
            "end_logit": -4.580423355102539,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension is one",
            "probability": 6.382942342355521e-05,
            "start_logit": 4.722860813140869,
            "end_logit": -4.662168979644775,
            "question_text": "List major risk factors for Alzheimer's disease. "
        },
        {
            "text": "Hypertension is one of the major risk factors for central",
            "probability": 3.3226505063514005e-05,
            "start_logit": 4.722860813140869,
            "end_logit": -5.315035343170166,
            "question_text": "List major risk factors for Alzheimer's disease. "
        }
    ],
    "5a9d2dd21d1251d03b00001a": [
        {
            "text": "simian-human immunodeficiency\u00a0viruses",
            "probability": 0.5406204783703448,
            "start_logit": 1.359525203704834,
            "end_logit": 1.6601464748382568,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "simian-human immunodeficiency\u00a0viruses (SHIVs)",
            "probability": 0.07402582593284364,
            "start_logit": 1.359525203704834,
            "end_logit": -0.3281570076942444,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V1V2 glycan site",
            "probability": 0.0626955587257879,
            "start_logit": 1.1534605026245117,
            "end_logit": -0.2882157266139984,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER), and the V1V2 glycan site",
            "probability": 0.04032325259521795,
            "start_logit": 0.7120981812477112,
            "end_logit": -0.2882157266139984,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER)",
            "probability": 0.03918791220240346,
            "start_logit": 0.7120981812477112,
            "end_logit": -0.31677567958831787,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "immunodeficiency\u00a0viruses",
            "probability": 0.03796101312728508,
            "start_logit": -1.2966326475143433,
            "end_logit": 1.6601464748382568,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region",
            "probability": 0.03061048352769764,
            "start_logit": 0.7120981812477112,
            "end_logit": -0.5638014674186707,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V1V2",
            "probability": 0.027122699270726934,
            "start_logit": 1.1534605026245117,
            "end_logit": -1.1261353492736816,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER), and the V1V2",
            "probability": 0.0174442253324685,
            "start_logit": 0.7120981812477112,
            "end_logit": -1.1261353492736816,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "V1V2 glycan",
            "probability": 0.016277140816181132,
            "start_logit": 1.1534605026245117,
            "end_logit": -1.6367446184158325,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the V1V2 glycan site",
            "probability": 0.01621951414602818,
            "start_logit": -0.19861501455307007,
            "end_logit": -0.2882157266139984,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "MPER), and the V1V2 glycan site",
            "probability": 0.013875798849979725,
            "start_logit": -0.35468387603759766,
            "end_logit": -0.2882157266139984,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "MPER)",
            "probability": 0.013485112238582229,
            "start_logit": -0.35468387603759766,
            "end_logit": -0.31677567958831787,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER",
            "probability": 0.01200732670850517,
            "start_logit": 0.7120981812477112,
            "end_logit": -1.4996269941329956,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the membrane-proximal external region (MPER), and the V1V2 glycan site",
            "probability": 0.011359350994440838,
            "start_logit": -0.5547888278961182,
            "end_logit": -0.2882157266139984,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the membrane-proximal external region (MPER)",
            "probability": 0.01103951741976349,
            "start_logit": -0.5547888278961182,
            "end_logit": -0.31677567958831787,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "membrane-proximal external region (MPER), and the V1V2 glycan",
            "probability": 0.010468799927750473,
            "start_logit": 0.7120981812477112,
            "end_logit": -1.6367446184158325,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "the membrane-proximal external region",
            "probability": 0.00862319391719664,
            "start_logit": -0.5547888278961182,
            "end_logit": -0.5638014674186707,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site",
            "probability": 0.008445290633991721,
            "start_logit": -0.8512211441993713,
            "end_logit": -0.2882157266139984,
            "question_text": "What do the trispecific HIV antibodies target?"
        },
        {
            "text": "CD4 binding site, the membrane-proximal external region (MPER)",
            "probability": 0.00820750526280453,
            "start_logit": -0.8512211441993713,
            "end_logit": -0.31677567958831787,
            "question_text": "What do the trispecific HIV antibodies target?"
        }
    ],
    "5ac7185f0340b9f058000004": [
        {
            "text": "osteogenic",
            "probability": 0.1263688927469828,
            "start_logit": 2.4671578407287598,
            "end_logit": 1.355351209640503,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "osteogenic genes such as RUNX2",
            "probability": 0.12398149743635434,
            "start_logit": 2.4671578407287598,
            "end_logit": 1.3362782001495361,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "osteogenic genes such as RUNX2 and BMP2",
            "probability": 0.09502110724344454,
            "start_logit": 2.4671578407287598,
            "end_logit": 1.0702449083328247,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "RUNX2",
            "probability": 0.0837695583699828,
            "start_logit": 2.0750951766967773,
            "end_logit": 1.3362782001495361,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "Osteogenic activity in the aortic valve is under the control of NOTCH1, which regulates the expression of key pro-osteogenic",
            "probability": 0.08049051348622326,
            "start_logit": 2.016091823577881,
            "end_logit": 1.355351209640503,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "pro-osteogenic",
            "probability": 0.07058407489122323,
            "start_logit": 1.8847570419311523,
            "end_logit": 1.355351209640503,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "pro-osteogenic genes such as RUNX2",
            "probability": 0.06925058145199724,
            "start_logit": 1.8847570419311523,
            "end_logit": 1.3362782001495361,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "RUNX2 and BMP2",
            "probability": 0.0642021297871185,
            "start_logit": 2.0750951766967773,
            "end_logit": 1.0702449083328247,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "pro-osteogenic genes such as RUNX2 and BMP2",
            "probability": 0.05307458824813023,
            "start_logit": 1.8847570419311523,
            "end_logit": 1.0702449083328247,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "RUNX2 and BMP2. Long noncoding RNAs (lncRNAs) may reprogram cells",
            "probability": 0.04964091835657792,
            "start_logit": 2.0750951766967773,
            "end_logit": 0.8130239844322205,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "Osteogenic activity",
            "probability": 0.04417545901980124,
            "start_logit": 2.016091823577881,
            "end_logit": 0.7553812861442566,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "BMP2",
            "probability": 0.022911415361325085,
            "start_logit": 1.0446940660476685,
            "end_logit": 1.0702449083328247,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "Osteogenic",
            "probability": 0.018974673697195212,
            "start_logit": 2.016091823577881,
            "end_logit": -0.08968299627304077,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "BMP2. Long noncoding RNAs (lncRNAs) may reprogram cells",
            "probability": 0.017715046263362122,
            "start_logit": 1.0446940660476685,
            "end_logit": 0.8130239844322205,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "steogenic",
            "probability": 0.015370749275015727,
            "start_logit": 0.36041879653930664,
            "end_logit": 1.355351209640503,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "steogenic genes such as RUNX2",
            "probability": 0.015080360921186503,
            "start_logit": 0.36041879653930664,
            "end_logit": 1.3362782001495361,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "RUNX2 and BMP2. Long noncoding RNAs (lncRNAs) may reprogram",
            "probability": 0.014729899574623628,
            "start_logit": 2.0750951766967773,
            "end_logit": -0.40191206336021423,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "RUNX2 and BMP2. Long noncoding RNAs (lncRNAs) may reprogram cells by altering the gene",
            "probability": 0.013556488813392125,
            "start_logit": 2.0750951766967773,
            "end_logit": -0.48492616415023804,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "steogenic genes such as RUNX2 and BMP2",
            "probability": 0.011557793880474109,
            "start_logit": 0.36041879653930664,
            "end_logit": 1.0702449083328247,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        },
        {
            "text": "reprogram cells",
            "probability": 0.009544251175589375,
            "start_logit": 0.426218718290329,
            "end_logit": 0.8130239844322205,
            "question_text": "Which cellular functions are affected by lncRNA H19 in the heart?"
        }
    ],
    "5ac721230340b9f058000005": [
        {
            "text": "gastric cancer tumorigenesis",
            "probability": 0.1518349021207218,
            "start_logit": -3.2813467979431152,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "tumorigenesis",
            "probability": 0.12676557392508497,
            "start_logit": -3.461801052093506,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "gastric cancer",
            "probability": 0.10341899926914613,
            "start_logit": -3.2813467979431152,
            "end_logit": -3.017364740371704,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Our collective findings indicate that circular RNAs play a critical role in gastric cancer tumorigenesis",
            "probability": 0.06881478362042784,
            "start_logit": -4.0727219581604,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "cancer tumorigenesis",
            "probability": 0.06138611538239498,
            "start_logit": -4.186956882476807,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circular RNAs play a critical role in gastric cancer tumorigenesis",
            "probability": 0.05192262893248706,
            "start_logit": -4.354385852813721,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "Our collective findings indicate that circular RNAs play a critical role in gastric cancer",
            "probability": 0.04687167415097383,
            "start_logit": -4.0727219581604,
            "end_logit": -3.017364740371704,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "cancer",
            "probability": 0.04181180040423138,
            "start_logit": -4.186956882476807,
            "end_logit": -3.017364740371704,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "collective findings indicate that circular RNAs play a critical role in gastric cancer tumorigenesis",
            "probability": 0.04096712745151488,
            "start_logit": -4.591370582580566,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "findings indicate that circular RNAs play a critical role in gastric cancer tumorigenesis",
            "probability": 0.035556674276230826,
            "start_logit": -4.733012676239014,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "306",
            "probability": 0.035488065365560165,
            "start_logit": -3.756749391555786,
            "end_logit": -3.6115543842315674,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "circular RNAs play a critical role in gastric cancer",
            "probability": 0.03536595505130687,
            "start_logit": -4.354385852813721,
            "end_logit": -3.017364740371704,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "critical role in gastric cancer tumorigenesis",
            "probability": 0.032985623199966764,
            "start_logit": -4.808068752288818,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "play a critical role in gastric cancer tumorigenesis",
            "probability": 0.028733719185771153,
            "start_logit": -4.946069240570068,
            "end_logit": -2.633359670639038,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "collective findings indicate that circular RNAs play a critical role in gastric cancer",
            "probability": 0.02790385652304522,
            "start_logit": -4.591370582580566,
            "end_logit": -3.017364740371704,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "findings indicate that circular RNAs play a critical role in gastric cancer",
            "probability": 0.02421864551315787,
            "start_logit": -4.733012676239014,
            "end_logit": -3.017364740371704,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "analysis of the expression profiles of circular RNAs in advanced gastric adenocarcinoma and adjacent normal mucosa tissues revealed differential expression of 306",
            "probability": 0.023146935196930594,
            "start_logit": -4.184083461761475,
            "end_logit": -3.6115543842315674,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "critical role in gastric cancer",
            "probability": 0.022467430702444054,
            "start_logit": -4.808068752288818,
            "end_logit": -3.017364740371704,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "306 circular RNAs,",
            "probability": 0.020768149793135703,
            "start_logit": -3.756749391555786,
            "end_logit": -4.147330284118652,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        },
        {
            "text": "play a critical role in gastric cancer",
            "probability": 0.019571339935467738,
            "start_logit": -4.946069240570068,
            "end_logit": -3.017364740371704,
            "question_text": "Name 4 circular RNA molecules associated with carcinogenesis."
        }
    ],
    "5abcf755fcf4565872000028": [
        {
            "text": "herpes zoster",
            "probability": 0.25413321502151304,
            "start_logit": 4.276374340057373,
            "end_logit": 3.9895365238189697,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes labialis and herpes zoster",
            "probability": 0.24566558776941494,
            "start_logit": 4.242486953735352,
            "end_logit": 3.9895365238189697,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes labialis",
            "probability": 0.22011594322158676,
            "start_logit": 4.242486953735352,
            "end_logit": 3.8797197341918945,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex and herpes zoster",
            "probability": 0.06357968699518197,
            "start_logit": 3.3637545108795166,
            "end_logit": 3.516591787338257,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex",
            "probability": 0.04079632688238373,
            "start_logit": 3.3637545108795166,
            "end_logit": 3.072889804840088,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes",
            "probability": 0.03183961386366521,
            "start_logit": 4.242486953735352,
            "end_logit": 1.9462765455245972,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes labialis. In herpes zoster",
            "probability": 0.027944291623393104,
            "start_logit": 3.0837578773498535,
            "end_logit": 2.9745073318481445,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus infection and for the treatment of herpes labialis",
            "probability": 0.025995953236084793,
            "start_logit": 2.7441062927246094,
            "end_logit": 3.241886854171753,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes zoster. The less frequent dosing regimen makes it an attractive option in the treatment of genital herpes",
            "probability": 0.02091106713267359,
            "start_logit": 3.383493423461914,
            "end_logit": 2.3848373889923096,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus infection and for the treatment of herpes labialis. In herpes zoster",
            "probability": 0.019896848628594845,
            "start_logit": 2.7441062927246094,
            "end_logit": 2.9745073318481445,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes labialis and herpes",
            "probability": 0.010347201619350092,
            "start_logit": 4.242486953735352,
            "end_logit": 0.8222814202308655,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus infection",
            "probability": 0.008553776719959112,
            "start_logit": 2.7441062927246094,
            "end_logit": 2.1303188800811768,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "genital herpes",
            "probability": 0.007708808502383929,
            "start_logit": 1.998810887336731,
            "end_logit": 2.7716050148010254,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "postherpetic neuralgia. Valacyclovir has an acceptable safety profile in patients with herpes simplex",
            "probability": 0.006109664763003125,
            "start_logit": 1.4650343656539917,
            "end_logit": 3.072889804840088,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus",
            "probability": 0.00549392118458104,
            "start_logit": 2.7441062927246094,
            "end_logit": 1.6875882148742676,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "genital herpes. In addition, valacyclovir is also indicated in the reduction of the sexual transmission of herpes simplex",
            "probability": 0.0028416258365472585,
            "start_logit": 1.998810887336731,
            "end_logit": 1.7736177444458008,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "Genital herpes",
            "probability": 0.0027866608278137896,
            "start_logit": 1.297199010848999,
            "end_logit": 2.4556972980499268,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "zoster",
            "probability": 0.0019505882360138132,
            "start_logit": -0.593353271484375,
            "end_logit": 3.9895365238189697,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes simplex virus infection and for the treatment of herpes",
            "probability": 0.0017492153539796584,
            "start_logit": 2.7441062927246094,
            "end_logit": 0.5431132912635803,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        },
        {
            "text": "herpes zoster-associated pain and postherpetic neuralgia",
            "probability": 0.0015800025818759906,
            "start_logit": 2.2129459381103516,
            "end_logit": 0.9725328087806702,
            "question_text": "Please list 3 diseases treated with Valtrex(valacyclovir)"
        }
    ],
    "5ace20fa0340b9f05800000c": [
        {
            "text": "PPARA",
            "probability": 0.18619950933669827,
            "start_logit": 4.891167163848877,
            "end_logit": 4.619295597076416,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN1 and PPARA",
            "probability": 0.17097899205705405,
            "start_logit": 4.805889129638672,
            "end_logit": 4.619295597076416,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1 and PPARA",
            "probability": 0.16709442166179259,
            "start_logit": 4.782907485961914,
            "end_logit": 4.619295597076416,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN1",
            "probability": 0.16308831357448292,
            "start_logit": 4.805889129638672,
            "end_logit": 4.572046756744385,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1",
            "probability": 0.15938301605750402,
            "start_logit": 4.782907485961914,
            "end_logit": 4.572046756744385,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1",
            "probability": 0.13672117674966947,
            "start_logit": 4.805889129638672,
            "end_logit": 4.395698547363281,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "PPARA)",
            "probability": 0.003951001170920179,
            "start_logit": 4.891167163848877,
            "end_logit": 0.7664458751678467,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN1 and PPARA)",
            "probability": 0.0036280342532945113,
            "start_logit": 4.805889129638672,
            "end_logit": 0.7664458751678467,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1 and PPARA)",
            "probability": 0.0035456068492971853,
            "start_logit": 4.782907485961914,
            "end_logit": 0.7664458751678467,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1,",
            "probability": 0.002328891134378792,
            "start_logit": 4.805889129638672,
            "end_logit": 0.32314714789390564,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "(EPAS1, EGLN1 and PPARA",
            "probability": 0.0007215283120680555,
            "start_logit": -0.6620352268218994,
            "end_logit": 4.619295597076416,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "(EPAS1, EGLN1",
            "probability": 0.0006882297889097164,
            "start_logit": -0.6620352268218994,
            "end_logit": 4.572046756744385,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS",
            "probability": 0.0006605048414247786,
            "start_logit": 4.805889129638672,
            "end_logit": -0.9369959235191345,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "(EPAS1",
            "probability": 0.0005769609394540665,
            "start_logit": -0.6620352268218994,
            "end_logit": 4.395698547363281,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN",
            "probability": 8.290015596941834e-05,
            "start_logit": 4.805889129638672,
            "end_logit": -3.0123634338378906,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN",
            "probability": 8.101669948294017e-05,
            "start_logit": 4.782907485961914,
            "end_logit": -3.0123634338378906,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "PPARA) are associated with decreased haemoglobin levels",
            "probability": 7.544933462283746e-05,
            "start_logit": 4.891167163848877,
            "end_logit": -3.191817045211792,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EPAS1, EGLN1 and PPARA) are associated with decreased haemoglobin levels",
            "probability": 6.928187529141686e-05,
            "start_logit": 4.805889129638672,
            "end_logit": -3.191817045211792,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "EGLN1 and PPARA) are associated with decreased haemoglobin levels",
            "probability": 6.77078203829903e-05,
            "start_logit": 4.782907485961914,
            "end_logit": -3.191817045211792,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        },
        {
            "text": "Three of these genes (EPAS1, EGLN1 and PPARA",
            "probability": 5.7457387301708095e-05,
            "start_logit": -3.1923632621765137,
            "end_logit": 4.619295597076416,
            "question_text": "Which genes are responsible for the high-altitude adaptation of Tibetans?"
        }
    ],
    "5a99566e1d1251d03b00000f": [
        {
            "text": "antisocial behavior",
            "probability": 0.3948637498488865,
            "start_logit": 5.7750043869018555,
            "end_logit": 4.715987682342529,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial",
            "probability": 0.3071869256416156,
            "start_logit": 5.7750043869018555,
            "end_logit": 4.464903354644775,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial behavior that is often associated with alcoholism",
            "probability": 0.20008411911808457,
            "start_logit": 5.7750043869018555,
            "end_logit": 4.036184787750244,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial behavior that is often associated with alcoholism,",
            "probability": 0.04908192794112429,
            "start_logit": 5.7750043869018555,
            "end_logit": 2.6309378147125244,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "alcoholism",
            "probability": 0.0343227184532589,
            "start_logit": 4.012073993682861,
            "end_logit": 4.036184787750244,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "alcoholism,",
            "probability": 0.008419584729121488,
            "start_logit": 4.012073993682861,
            "end_logit": 2.6309378147125244,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "alcoholism, and an interaction between early life stress and a serotonin transporter promoter variant predicts alcohol abuse",
            "probability": 0.0020341452908892678,
            "start_logit": 4.012073993682861,
            "end_logit": 1.2104530334472656,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "depression",
            "probability": 0.0007923659401634605,
            "start_logit": 2.347588539123535,
            "end_logit": 1.9321308135986328,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial behavior that is often associated with alcohol",
            "probability": 0.0006989709609693478,
            "start_logit": 5.7750043869018555,
            "end_logit": -1.620699167251587,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "anti",
            "probability": 0.0005622317884924913,
            "start_logit": 5.7750043869018555,
            "end_logit": -1.8383941650390625,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial behavior that",
            "probability": 0.0003694327501289442,
            "start_logit": 5.7750043869018555,
            "end_logit": -2.2583396434783936,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "alcohol abuse in nonhuman primates and depression",
            "probability": 0.00030595481936051346,
            "start_logit": 1.3960026502609253,
            "end_logit": 1.9321308135986328,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial behavior that is often associated with alcoholism, and",
            "probability": 0.0002647275099751668,
            "start_logit": 5.7750043869018555,
            "end_logit": -2.5916073322296143,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "behavior",
            "probability": 0.00019712093505118745,
            "start_logit": -1.8274742364883423,
            "end_logit": 4.715987682342529,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "antisocial behavior that is",
            "probability": 0.00018278862055069522,
            "start_logit": 5.7750043869018555,
            "end_logit": -2.961977958679199,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "alcohol abuse",
            "probability": 0.00017303910636448137,
            "start_logit": 1.3960026502609253,
            "end_logit": 1.362210988998413,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "alcoholism, and an interaction between early life stress and a serotonin transporter promoter variant predicts alcohol",
            "probability": 0.00015633663868132246,
            "start_logit": 4.012073993682861,
            "end_logit": -1.3553663492202759,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "alcohol",
            "probability": 0.00011990248704444204,
            "start_logit": 4.012073993682861,
            "end_logit": -1.620699167251587,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "behavior that is often associated with alcoholism",
            "probability": 9.988450108307966e-05,
            "start_logit": -1.8274742364883423,
            "end_logit": 4.036184787750244,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        },
        {
            "text": "cial behavior",
            "probability": 8.407291915439403e-05,
            "start_logit": -2.6796071529388428,
            "end_logit": 4.715987682342529,
            "question_text": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?"
        }
    ],
    "5abd2ce0fcf456587200002a": [
        {
            "text": "Actinobacteria",
            "probability": 0.16961082180906312,
            "start_logit": 5.872351169586182,
            "end_logit": 5.319509029388428,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Proteobacteria",
            "probability": 0.16525769268246954,
            "start_logit": 5.780611038208008,
            "end_logit": 5.38524866104126,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Proteobacteria, Actinobacteria",
            "probability": 0.15474311164520138,
            "start_logit": 5.780611038208008,
            "end_logit": 5.319509029388428,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes, Proteobacteria",
            "probability": 0.15332569652476702,
            "start_logit": 5.705669403076172,
            "end_logit": 5.38524866104126,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes, Proteobacteria, Actinobacteria",
            "probability": 0.14357029309974834,
            "start_logit": 5.705669403076172,
            "end_logit": 5.319509029388428,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes",
            "probability": 0.059927876862109174,
            "start_logit": 5.705669403076172,
            "end_logit": 4.445826053619385,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes",
            "probability": 0.05216348091261819,
            "start_logit": 4.435024738311768,
            "end_logit": 5.577711582183838,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes, Bacteroidetes, Proteobacteria",
            "probability": 0.04303095453158865,
            "start_logit": 4.435024738311768,
            "end_logit": 5.38524866104126,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria",
            "probability": 0.040293094337674744,
            "start_logit": 4.435024738311768,
            "end_logit": 5.319509029388428,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Firmicutes, Bacteroidetes",
            "probability": 0.016818796867565586,
            "start_logit": 4.435024738311768,
            "end_logit": 4.445826053619385,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Actinobacter",
            "probability": 0.0001907513707816124,
            "start_logit": 5.872351169586182,
            "end_logit": -1.470781922340393,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Proteobacteria, Actinobacter",
            "probability": 0.00017403052677006126,
            "start_logit": 5.780611038208008,
            "end_logit": -1.470781922340393,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes, Proteobacteria, Actinobacter",
            "probability": 0.0001614651112481756,
            "start_logit": 5.705669403076172,
            "end_logit": -1.470781922340393,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "(Firmicutes",
            "probability": 0.00013988554109640802,
            "start_logit": -1.4862886667251587,
            "end_logit": 5.577711582183838,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Bacteroidetes,",
            "probability": 0.0001277178140368448,
            "start_logit": 5.705669403076172,
            "end_logit": -1.7052477598190308,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "(Firmicutes, Bacteroidetes, Proteobacteria",
            "probability": 0.00011539506668716451,
            "start_logit": -1.4862886667251587,
            "end_logit": 5.38524866104126,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "(Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria",
            "probability": 0.00010805301343512934,
            "start_logit": -1.4862886667251587,
            "end_logit": 5.319509029388428,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Actinobacteria)",
            "probability": 8.692832883769487e-05,
            "start_logit": 5.872351169586182,
            "end_logit": -2.25666880607605,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Proteobacteria, Actinobacteria)",
            "probability": 7.930838345683561e-05,
            "start_logit": 5.780611038208008,
            "end_logit": -2.25666880607605,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        },
        {
            "text": "Proteobacteria,",
            "probability": 7.464557084424957e-05,
            "start_logit": 5.780611038208008,
            "end_logit": -2.3172614574432373,
            "question_text": "Which are the two main bacterial phyla in human gut?"
        }
    ],
    "5aac5469fcf4565872000005": [
        {
            "text": "myalgia",
            "probability": 0.18493030005961478,
            "start_logit": 5.269895076751709,
            "end_logit": 5.119943618774414,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache, myalgia",
            "probability": 0.16039098581624428,
            "start_logit": 5.127530574798584,
            "end_logit": 5.119943618774414,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache",
            "probability": 0.15698872535100486,
            "start_logit": 5.127530574798584,
            "end_logit": 5.098503112792969,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "myalgia, gastrointestinal symptoms",
            "probability": 0.0724803758192834,
            "start_logit": 5.269895076751709,
            "end_logit": 4.1832804679870605,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache, myalgia, gastrointestinal symptoms",
            "probability": 0.06286259702298218,
            "start_logit": 5.127530574798584,
            "end_logit": 4.1832804679870605,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fever, headache, myalgia",
            "probability": 0.053072119953446246,
            "start_logit": 4.0215678215026855,
            "end_logit": 5.119943618774414,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fever, headache",
            "probability": 0.051946338634719744,
            "start_logit": 4.0215678215026855,
            "end_logit": 5.098503112792969,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "gastrointestinal symptoms",
            "probability": 0.048035477256684916,
            "start_logit": 4.858519077301025,
            "end_logit": 4.1832804679870605,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "myalgia, gastrointestinal",
            "probability": 0.030884764137717804,
            "start_logit": 5.269895076751709,
            "end_logit": 3.3302276134490967,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache, myalgia, gastrointestinal",
            "probability": 0.026786512351701562,
            "start_logit": 5.127530574798584,
            "end_logit": 3.3302276134490967,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "myalgia, gastrointestinal symptoms, hepatic and renal dysfunction",
            "probability": 0.025392022029496433,
            "start_logit": 5.269895076751709,
            "end_logit": 3.134399652481079,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache, myalgia, gastrointestinal symptoms, hepatic and renal dysfunction",
            "probability": 0.022022629303396202,
            "start_logit": 5.127530574798584,
            "end_logit": 3.134399652481079,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fever, headache, myalgia, gastrointestinal symptoms",
            "probability": 0.020800740595304516,
            "start_logit": 4.0215678215026855,
            "end_logit": 4.1832804679870605,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fever",
            "probability": 0.02057128982012231,
            "start_logit": 4.0215678215026855,
            "end_logit": 4.1721882820129395,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "gastrointestinal",
            "probability": 0.020468497418037936,
            "start_logit": 4.858519077301025,
            "end_logit": 3.3302276134490967,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "gastrointestinal symptoms, hepatic and renal dysfunction",
            "probability": 0.01682825016995307,
            "start_logit": 4.858519077301025,
            "end_logit": 3.134399652481079,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fever, headache, myalgia, gastrointestinal",
            "probability": 0.00886344696635685,
            "start_logit": 4.0215678215026855,
            "end_logit": 3.3302276134490967,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "fever, headache, myalgia, gastrointestinal symptoms, hepatic and renal dysfunction",
            "probability": 0.0072871154082136055,
            "start_logit": 4.0215678215026855,
            "end_logit": 3.134399652481079,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "headache,",
            "probability": 0.004751970468988628,
            "start_logit": 5.127530574798584,
            "end_logit": 1.6008884906768799,
            "question_text": "What are 7 symptoms of yellow fever?"
        },
        {
            "text": "myalgia, gastrointestinal symptoms, hepatic and renal dysfunction, and (in the fatal case), shock",
            "probability": 0.004635841416730438,
            "start_logit": 5.269895076751709,
            "end_logit": 1.4337823390960693,
            "question_text": "What are 7 symptoms of yellow fever?"
        }
    ],
    "5a7d5580faa1ab7d2e00001a": [
        {
            "text": "[(18)F]THK523, [(18)F]THK5117",
            "probability": 0.09904612328856693,
            "start_logit": 3.009861469268799,
            "end_logit": 3.1907246112823486,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5117, [(18)F]THK5105 and [(18)F]THK5351",
            "probability": 0.07433935800077039,
            "start_logit": 2.6620495319366455,
            "end_logit": 3.251591444015503,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5117",
            "probability": 0.06998619291814497,
            "start_logit": 2.66257381439209,
            "end_logit": 3.1907246112823486,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5117",
            "probability": 0.06994951000201957,
            "start_logit": 2.6620495319366455,
            "end_logit": 3.1907246112823486,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5105 and [(18)F]THK5351",
            "probability": 0.06957443027512893,
            "start_logit": 2.595806121826172,
            "end_logit": 3.251591444015503,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5117, [(18)F]THK5105",
            "probability": 0.06877963700789873,
            "start_logit": 2.66257381439209,
            "end_logit": 3.1733343601226807,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5117, [(18)F]THK5105",
            "probability": 0.06874358650207328,
            "start_logit": 2.6620495319366455,
            "end_logit": 3.1733343601226807,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5105",
            "probability": 0.06433733078379864,
            "start_logit": 2.595806121826172,
            "end_logit": 3.1733343601226807,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK523",
            "probability": 0.061298865097497005,
            "start_logit": 3.009861469268799,
            "end_logit": 2.71090030670166,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5351",
            "probability": 0.05367394077969968,
            "start_logit": 2.336336612701416,
            "end_logit": 3.251591444015503,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]THK5351",
            "probability": 0.04817723283098427,
            "start_logit": 2.2282955646514893,
            "end_logit": 3.251591444015503,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK523, [(18)F]THK5117",
            "probability": 0.04701136076833862,
            "start_logit": 2.264665126800537,
            "end_logit": 3.1907246112823486,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK523, [(18)F]THK5117, [(18)F]THK5105",
            "probability": 0.04620088897642249,
            "start_logit": 2.264665126800537,
            "end_logit": 3.1733343601226807,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5105 and [(18)F]THK5351",
            "probability": 0.03981382301581574,
            "start_logit": 2.037623167037964,
            "end_logit": 3.251591444015503,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5105",
            "probability": 0.036816903724640755,
            "start_logit": 2.037623167037964,
            "end_logit": 3.1733343601226807,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK523",
            "probability": 0.02909496067193169,
            "start_logit": 2.264665126800537,
            "end_logit": 2.71090030670166,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5351, [(18)F]AV1451(T807)",
            "probability": 0.013833515644507613,
            "start_logit": 2.336336612701416,
            "end_logit": 1.8957581520080566,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]AV1451(T807)",
            "probability": 0.01358204531648656,
            "start_logit": 2.317991018295288,
            "end_logit": 1.8957581520080566,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "THK5351, [(18)F]AV1451(T807) and [(11)C]PBB3",
            "probability": 0.012988199136901513,
            "start_logit": 2.336336612701416,
            "end_logit": 1.832705020904541,
            "question_text": "What in vivo tau tracers are being used?"
        },
        {
            "text": "[(18)F]AV1451(T807) and [(11)C]PBB3",
            "probability": 0.012752095258372545,
            "start_logit": 2.317991018295288,
            "end_logit": 1.832705020904541,
            "question_text": "What in vivo tau tracers are being used?"
        }
    ],
    "5ac2776195d0062724000006": [
        {
            "text": "dentatorubral-pallidoluysian atrophy",
            "probability": 0.4511433893359074,
            "start_logit": 4.994290828704834,
            "end_logit": 4.805689811706543,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA)",
            "probability": 0.3516399453304539,
            "start_logit": 4.994290828704834,
            "end_logit": 4.556512355804443,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "DRPLA)",
            "probability": 0.06043097201757355,
            "start_logit": 3.233184814453125,
            "end_logit": 4.556512355804443,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA",
            "probability": 0.044657584435347314,
            "start_logit": 4.994290828704834,
            "end_logit": 2.4929287433624268,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "pallidoluysian atrophy",
            "probability": 0.03245669857435151,
            "start_logit": 2.362412452697754,
            "end_logit": 4.805689811706543,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "pallidoluysian atrophy (DRPLA)",
            "probability": 0.025298102514795282,
            "start_logit": 2.362412452697754,
            "end_logit": 4.556512355804443,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "atrophy",
            "probability": 0.01012613228865253,
            "start_logit": 1.1976250410079956,
            "end_logit": 4.805689811706543,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "atrophy (DRPLA)",
            "probability": 0.007892729204415968,
            "start_logit": 1.1976250410079956,
            "end_logit": 4.556512355804443,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "DRPLA",
            "probability": 0.007674615103380238,
            "start_logit": 3.233184814453125,
            "end_logit": 2.4929287433624268,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "pallidoluysian atrophy (DRPLA",
            "probability": 0.003212809477736829,
            "start_logit": 2.362412452697754,
            "end_logit": 2.4929287433624268,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "(DRPLA)",
            "probability": 0.0021882750960635754,
            "start_logit": -0.08520333468914032,
            "end_logit": 4.556512355804443,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "atrophy (DRPLA",
            "probability": 0.0010023611525144095,
            "start_logit": 1.1976250410079956,
            "end_logit": 2.4929287433624268,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA) is expansion of the CAG repeat",
            "probability": 0.0006136641889140641,
            "start_logit": 4.994290828704834,
            "end_logit": -1.794402837753296,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian",
            "probability": 0.0006010456376616956,
            "start_logit": 4.994290828704834,
            "end_logit": -1.8151798248291016,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "(DRPLA",
            "probability": 0.0002779066518691201,
            "start_logit": -0.08520333468914032,
            "end_logit": 2.4929287433624268,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA) is expansion of the CAG",
            "probability": 0.0002441928151762215,
            "start_logit": 4.994290828704834,
            "end_logit": -2.7158925533294678,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "den",
            "probability": 0.00015767810622969119,
            "start_logit": 4.994290828704834,
            "end_logit": -3.1532950401306152,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "hy",
            "probability": 0.00014602428582761187,
            "start_logit": -3.0414767265319824,
            "end_logit": 4.805689811706543,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral",
            "probability": 0.00011793970339921692,
            "start_logit": 4.994290828704834,
            "end_logit": -3.4436771869659424,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        },
        {
            "text": "dentatorubral-pallidoluysian atrophy (DRPLA) is expansion of the CAG repeat.",
            "probability": 0.00011793407972999588,
            "start_logit": 4.994290828704834,
            "end_logit": -3.4437248706817627,
            "question_text": "List diseases caused by protein glutamine expanded repeats"
        }
    ],
    "5abd44b1fcf4565872000030": [
        {
            "text": "Crescerin",
            "probability": 0.247347189298999,
            "start_logit": 3.6561338901519775,
            "end_logit": 3.49863338470459,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "CLASP, and Crescerin",
            "probability": 0.2331971037944894,
            "start_logit": 3.5972249507904053,
            "end_logit": 3.49863338470459,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "CLASP",
            "probability": 0.15365475962994912,
            "start_logit": 3.5972249507904053,
            "end_logit": 3.0814576148986816,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "XMAP215",
            "probability": 0.13359057147987285,
            "start_logit": 3.0194177627563477,
            "end_logit": 3.519336223602295,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "XMAP215, CLASP, and Crescerin",
            "probability": 0.13085329981466556,
            "start_logit": 3.0194177627563477,
            "end_logit": 3.49863338470459,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "XMAP215, CLASP",
            "probability": 0.08621990583350984,
            "start_logit": 3.0194177627563477,
            "end_logit": 3.0814576148986816,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "XMAP",
            "probability": 0.0042815912737921395,
            "start_logit": 3.0194177627563477,
            "end_logit": 0.07888127118349075,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "215",
            "probability": 0.0018299514129416945,
            "start_logit": -1.271072506904602,
            "end_logit": 3.519336223602295,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "215, CLASP, and Crescerin",
            "probability": 0.0017924556967705415,
            "start_logit": -1.271072506904602,
            "end_logit": 3.49863338470459,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "215, CLASP",
            "probability": 0.0011810581896305645,
            "start_logit": -1.271072506904602,
            "end_logit": 3.0814576148986816,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MAP215",
            "probability": 0.0010546854469260564,
            "start_logit": -1.8221193552017212,
            "end_logit": 3.519336223602295,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MAP215, CLASP, and Crescerin",
            "probability": 0.0010330749353637775,
            "start_logit": -1.8221193552017212,
            "end_logit": 3.49863338470459,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "MAP215, CLASP",
            "probability": 0.0006806983375442654,
            "start_logit": -1.8221193552017212,
            "end_logit": 3.0814576148986816,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "X",
            "probability": 0.0006144099097646871,
            "start_logit": 3.0194177627563477,
            "end_logit": -1.8625364303588867,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "Crescerin use arrayed tubulin-binding tumor overexpressed gene (TOG) domains to modulate microtubule dynamics.",
            "probability": 0.0006093601375310752,
            "start_logit": 3.6561338901519775,
            "end_logit": -2.507505416870117,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "Crescerin use arrayed tubulin-binding tumor overexpressed gene",
            "probability": 0.0005058768363291578,
            "start_logit": 3.6561338901519775,
            "end_logit": -2.6936216354370117,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "CLASP, and Crescerin use arrayed tubulin-binding tumor overexpressed gene",
            "probability": 0.0004769369461727534,
            "start_logit": 3.5972249507904053,
            "end_logit": -2.6936216354370117,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "C",
            "probability": 0.0003759756307531878,
            "start_logit": 3.6561338901519775,
            "end_logit": -2.9903905391693115,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "CLASP, and C",
            "probability": 0.0003544670486753116,
            "start_logit": 3.5972249507904053,
            "end_logit": -2.9903905391693115,
            "question_text": "List proteins with HEAT repeats"
        },
        {
            "text": "Crescerin use arrayed tubulin-binding tumor overexpressed gene (TOG) domains",
            "probability": 0.0003466283463190403,
            "start_logit": 3.6561338901519775,
            "end_logit": -3.0716617107391357,
            "question_text": "List proteins with HEAT repeats"
        }
    ],
    "5ac0f7b919833b0d7b000006": [
        {
            "text": "TSOAC",
            "probability": 0.9364113697867036,
            "start_logit": 3.687652349472046,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "(TSOAC",
            "probability": 0.02672886559256435,
            "start_logit": 0.13134156167507172,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "anticoagulant (TSOAC",
            "probability": 0.015735797867901826,
            "start_logit": -0.39846429228782654,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "target-specific oral anticoagulant (TSOAC",
            "probability": 0.005913086526264498,
            "start_logit": -1.3772345781326294,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "TSOAC)",
            "probability": 0.004934225554759323,
            "start_logit": 3.687652349472046,
            "end_logit": -2.2262861728668213,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "oral anticoagulant (TSOAC",
            "probability": 0.004062930443749931,
            "start_logit": -1.7524980306625366,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "TSOAC) reversal agents",
            "probability": 0.0018856055303953674,
            "start_logit": 3.687652349472046,
            "end_logit": -3.188232898712158,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "TSOAC) reversal",
            "probability": 0.0008398845013509044,
            "start_logit": 3.687652349472046,
            "end_logit": -3.9969727993011475,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "T",
            "probability": 0.0007863079904302811,
            "start_logit": 3.687652349472046,
            "end_logit": -4.0628886222839355,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "AC",
            "probability": 0.00046709234996931254,
            "start_logit": -3.91563081741333,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "TSOAC) reversal agents that are currently in development or have been approved by the Food and Drug Administration (FDA) are reviewed.",
            "probability": 0.00041804134302220186,
            "start_logit": 3.687652349472046,
            "end_logit": -4.694656848907471,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "TSOAC) reversal agents that are currently in development or have been approved by the Food and Drug Administration (FDA)",
            "probability": 0.0004168915528881916,
            "start_logit": 3.687652349472046,
            "end_logit": -4.697411060333252,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "TSOAC) reversal agents that are currently in development or have been approved by the Food and Drug Administration (FDA) are reviewed",
            "probability": 0.0003517048013524005,
            "start_logit": 3.687652349472046,
            "end_logit": -4.86744499206543,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "anticoagulant",
            "probability": 0.00022950615813730943,
            "start_logit": -0.39846429228782654,
            "end_logit": -1.208190679550171,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "The available clinical data on target-specific oral anticoagulant (TSOAC",
            "probability": 0.00021105588575671974,
            "start_logit": -4.7100348472595215,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "SOAC",
            "probability": 0.00015734455214806207,
            "start_logit": -5.003719806671143,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "(TSOAC)",
            "probability": 0.00014084221519715138,
            "start_logit": 0.13134156167507172,
            "end_logit": -2.2262861728668213,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "available clinical data on target-specific oral anticoagulant (TSOAC",
            "probability": 0.00014028862677816132,
            "start_logit": -5.11845588684082,
            "end_logit": 3.0195729732513428,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "target-specific oral anticoagulant",
            "probability": 8.624219647258376e-05,
            "start_logit": -1.3772345781326294,
            "end_logit": -1.208190679550171,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        },
        {
            "text": "anticoagulant (TSOAC)",
            "probability": 8.291652415755508e-05,
            "start_logit": -0.39846429228782654,
            "end_logit": -2.2262861728668213,
            "question_text": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017."
        }
    ],
    "5ace34eb0340b9f058000010": [
        {
            "text": "keratins 5",
            "probability": 0.3461038695705464,
            "start_logit": 3.3396594524383545,
            "end_logit": 3.553744077682495,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratins 5 or 14",
            "probability": 0.24117081497395787,
            "start_logit": 3.3396594524383545,
            "end_logit": 3.1925106048583984,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratin 14",
            "probability": 0.16094806649099233,
            "start_logit": 3.108335018157959,
            "end_logit": 3.019411325454712,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratin 14 (KRT14",
            "probability": 0.08639797389023131,
            "start_logit": 3.108335018157959,
            "end_logit": 2.39729380607605,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14",
            "probability": 0.03872448946741851,
            "start_logit": 1.510626196861267,
            "end_logit": 3.1925106048583984,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "KRT14",
            "probability": 0.0325608699414822,
            "start_logit": 2.1324820518493652,
            "end_logit": 2.39729380607605,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "5",
            "probability": 0.02265173913012939,
            "start_logit": 0.6131571531295776,
            "end_logit": 3.553744077682495,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Mutant keratins 5",
            "probability": 0.02200144515116124,
            "start_logit": 0.5840286612510681,
            "end_logit": 3.553744077682495,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "5 or 14",
            "probability": 0.015784100863620323,
            "start_logit": 0.6131571531295776,
            "end_logit": 3.1925106048583984,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "Mutant keratins 5 or 14",
            "probability": 0.015330965424611777,
            "start_logit": 0.5840286612510681,
            "end_logit": 3.1925106048583984,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratin 14 (KRT14)",
            "probability": 0.010279081155923584,
            "start_logit": 3.108335018157959,
            "end_logit": 0.26844045519828796,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "KRT14)",
            "probability": 0.0038738851105605747,
            "start_logit": 2.1324820518493652,
            "end_logit": 0.26844045519828796,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "14 (KRT14",
            "probability": 0.0008389039472117279,
            "start_logit": -1.5262882709503174,
            "end_logit": 2.39729380607605,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "(KRT14",
            "probability": 0.000719194313449713,
            "start_logit": -1.6802529096603394,
            "end_logit": 2.39729380607605,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratins",
            "probability": 0.00069613904142405,
            "start_logit": 3.3396594524383545,
            "end_logit": -2.655200719833374,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratins 5 or 14 are implicated in the etiology of epidermolysis bullosa simplex (EBS).",
            "probability": 0.0005052016842947186,
            "start_logit": 3.3396594524383545,
            "end_logit": -2.975792407989502,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratins 5 or 14 are implicated in the etiology of epidermolysis bullosa simplex (EBS)",
            "probability": 0.0004912545260187738,
            "start_logit": 3.3396594524383545,
            "end_logit": -3.0037877559661865,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratins 5 or 14 are",
            "probability": 0.00035897487577364145,
            "start_logit": 3.3396594524383545,
            "end_logit": -3.317497730255127,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "k",
            "probability": 0.00029531488200148067,
            "start_logit": 3.3396594524383545,
            "end_logit": -3.5127079486846924,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        },
        {
            "text": "keratins 5 or 14 are implicated in the etiology of epidermolysis bullosa simplex",
            "probability": 0.0002677155591902222,
            "start_logit": 3.3396594524383545,
            "end_logit": -3.6108250617980957,
            "question_text": "Which genes are associated with Epidermolysis Bullosa Simplex?"
        }
    ],
    "5aae6a86fcf456587200000e": [
        {
            "text": "UV-B",
            "probability": 0.34364173295774675,
            "start_logit": 4.015363693237305,
            "end_logit": 3.1161365509033203,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-C",
            "probability": 0.15735623412012242,
            "start_logit": 2.8940446376800537,
            "end_logit": 3.4563682079315186,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-C, UV-B",
            "probability": 0.11197555461935944,
            "start_logit": 2.8940446376800537,
            "end_logit": 3.1161365509033203,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-B, and UV-A",
            "probability": 0.10977008167872437,
            "start_logit": 4.015363693237305,
            "end_logit": 1.974924921989441,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "C",
            "probability": 0.04175344119163338,
            "start_logit": 1.5673142671585083,
            "end_logit": 3.4563682079315186,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-A",
            "probability": 0.03795727442982212,
            "start_logit": 2.953436851501465,
            "end_logit": 1.974924921989441,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-C, UV-B, and UV-A",
            "probability": 0.035768547873371616,
            "start_logit": 2.8940446376800537,
            "end_logit": 1.974924921989441,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "infrared radiation. Ultraviolet radiation is made up of UV-C",
            "probability": 0.030393740910129915,
            "start_logit": 1.2497690916061401,
            "end_logit": 3.4563682079315186,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "C, UV-B",
            "probability": 0.02971197652792632,
            "start_logit": 1.5673142671585083,
            "end_logit": 3.1161365509033203,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "visible and infrared radiation. Ultraviolet radiation is made up of UV-C",
            "probability": 0.025315128718060218,
            "start_logit": 1.066934585571289,
            "end_logit": 3.4563682079315186,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "infrared radiation. Ultraviolet radiation is made up of UV-C, UV-B",
            "probability": 0.02162835183746747,
            "start_logit": 1.2497690916061401,
            "end_logit": 3.1161365509033203,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "visible and infrared radiation. Ultraviolet radiation is made up of UV-C, UV-B",
            "probability": 0.01801438369643071,
            "start_logit": 1.066934585571289,
            "end_logit": 3.1161365509033203,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "C, UV-B, and UV-A",
            "probability": 0.00949094879203114,
            "start_logit": 1.5673142671585083,
            "end_logit": 1.974924921989441,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "infrared radiation. Ultraviolet radiation is made up of UV-C, UV-B, and UV-A",
            "probability": 0.006908782374423981,
            "start_logit": 1.2497690916061401,
            "end_logit": 1.974924921989441,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "visible and infrared radiation. Ultraviolet radiation is made up of UV-C, UV-B, and UV-A",
            "probability": 0.005754366190419079,
            "start_logit": 1.066934585571289,
            "end_logit": 1.974924921989441,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "B",
            "probability": 0.0048646516812493506,
            "start_logit": -0.24224083125591278,
            "end_logit": 3.1161365509033203,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "UV-B, and UV-A.",
            "probability": 0.0036903979881331584,
            "start_logit": 4.015363693237305,
            "end_logit": -1.4177287817001343,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "infrared radiation",
            "probability": 0.0022909061917588576,
            "start_logit": 1.2497690916061401,
            "end_logit": 0.8710789680480957,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "visible and infrared radiation",
            "probability": 0.0019081094787528326,
            "start_logit": 1.066934585571289,
            "end_logit": 0.8710789680480957,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        },
        {
            "text": "infrared",
            "probability": 0.0018053887424367406,
            "start_logit": 1.2497690916061401,
            "end_logit": 0.6329074501991272,
            "question_text": "What are the 3 types of ultraviolet (UV) solar radiation?"
        }
    ],
    "5aaef38dfcf456587200000f": [
        {
            "text": "diabetes",
            "probability": 0.21581819316876952,
            "start_logit": 1.6839834451675415,
            "end_logit": 1.8014538288116455,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "diabetes, and lung disease",
            "probability": 0.13231426041253858,
            "start_logit": 1.6839834451675415,
            "end_logit": 1.3121973276138306,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "alcohol, diabetes",
            "probability": 0.11540354999720256,
            "start_logit": 1.0579822063446045,
            "end_logit": 1.8014538288116455,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "lung disease",
            "probability": 0.11242384600875968,
            "start_logit": 1.521079659461975,
            "end_logit": 1.3121973276138306,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "cardiovascular disease, alcohol, diabetes",
            "probability": 0.1070190768735655,
            "start_logit": 0.9825541973114014,
            "end_logit": 1.8014538288116455,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "alcohol, diabetes, and lung disease",
            "probability": 0.07075184507230362,
            "start_logit": 1.0579822063446045,
            "end_logit": 1.3121973276138306,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "cardiovascular disease, alcohol, diabetes, and lung disease",
            "probability": 0.06561147509693593,
            "start_logit": 0.9825541973114014,
            "end_logit": 1.3121973276138306,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "cardiovascular disease",
            "probability": 0.037390096728847466,
            "start_logit": 0.9825541973114014,
            "end_logit": 0.7498525977134705,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "alcohol",
            "probability": 0.03347123169222574,
            "start_logit": 1.0579822063446045,
            "end_logit": 0.5637050271034241,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "cardiovascular disease, alcohol",
            "probability": 0.0310394291822917,
            "start_logit": 0.9825541973114014,
            "end_logit": 0.5637050271034241,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "increasing age, cardiovascular disease, alcohol, diabetes",
            "probability": 0.013734051617561301,
            "start_logit": -1.0705746412277222,
            "end_logit": 1.8014538288116455,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "diabetes,",
            "probability": 0.011396166049676469,
            "start_logit": 1.6839834451675415,
            "end_logit": -1.1397055387496948,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "diabetes, and lung",
            "probability": 0.008930178756247565,
            "start_logit": 1.6839834451675415,
            "end_logit": -1.3835461139678955,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "increasing age, cardiovascular disease, alcohol, diabetes, and lung disease",
            "probability": 0.008420100527967057,
            "start_logit": -1.0705746412277222,
            "end_logit": 1.3121973276138306,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "lung",
            "probability": 0.007587731195359,
            "start_logit": 1.521079659461975,
            "end_logit": -1.3835461139678955,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "alcohol,",
            "probability": 0.006301661039045512,
            "start_logit": 1.0579822063446045,
            "end_logit": -1.1061680316925049,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "alcohol, diabetes,",
            "probability": 0.006093823691044476,
            "start_logit": 1.0579822063446045,
            "end_logit": -1.1397055387496948,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "cardiovascular disease, alcohol,",
            "probability": 0.0058438232375443554,
            "start_logit": 0.9825541973114014,
            "end_logit": -1.1061680316925049,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "cardiovascular disease, alcohol, diabetes,",
            "probability": 0.005651086002654615,
            "start_logit": 0.9825541973114014,
            "end_logit": -1.1397055387496948,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        },
        {
            "text": "increasing age, cardiovascular disease",
            "probability": 0.0047983736494595355,
            "start_logit": -1.0705746412277222,
            "end_logit": 0.7498525977134705,
            "question_text": "Please list 10 conditions which play a role in causing atrial fibrillation."
        }
    ],
    "5abce6acfcf4565872000022": [
        {
            "text": "carbamazepine",
            "probability": 0.08146664250312644,
            "start_logit": 5.018860340118408,
            "end_logit": 4.947432041168213,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "carbamazepine, simvastatin",
            "probability": 0.07345113239522284,
            "start_logit": 5.018860340118408,
            "end_logit": 4.84385871887207,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "carbamazepine, simvastatin, paracetamol, amiodarone",
            "probability": 0.06795004745327944,
            "start_logit": 5.018860340118408,
            "end_logit": 4.7660112380981445,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "carbamazepine, simvastatin, paracetamol",
            "probability": 0.061843944604364015,
            "start_logit": 5.018860340118408,
            "end_logit": 4.6718525886535645,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin",
            "probability": 0.06101278658210442,
            "start_logit": 4.8333234786987305,
            "end_logit": 4.84385871887207,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "carbamazepine, simvastatin, paracetamol, amiodarone, fluconazole",
            "probability": 0.05789137607953469,
            "start_logit": 5.018860340118408,
            "end_logit": 4.605806827545166,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "amiodarone",
            "probability": 0.05744680574059579,
            "start_logit": 4.85094690322876,
            "end_logit": 4.7660112380981445,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, paracetamol, amiodarone",
            "probability": 0.05644326517940036,
            "start_logit": 4.8333234786987305,
            "end_logit": 4.7660112380981445,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, paracetamol",
            "probability": 0.05137118068157869,
            "start_logit": 4.8333234786987305,
            "end_logit": 4.6718525886535645,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "amiodarone, fluconazole",
            "probability": 0.04894293323317315,
            "start_logit": 4.85094690322876,
            "end_logit": 4.605806827545166,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, paracetamol, amiodarone, fluconazole",
            "probability": 0.048087947163013636,
            "start_logit": 4.8333234786987305,
            "end_logit": 4.605806827545166,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "fluconazole",
            "probability": 0.04768822597527958,
            "start_logit": 4.824976444244385,
            "end_logit": 4.605806827545166,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "paracetamol, amiodarone",
            "probability": 0.04392629397611983,
            "start_logit": 4.5826005935668945,
            "end_logit": 4.7660112380981445,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "paracetamol",
            "probability": 0.0399790050654785,
            "start_logit": 4.5826005935668945,
            "end_logit": 4.6718525886535645,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "paracetamol, amiodarone, fluconazole",
            "probability": 0.03742386796860173,
            "start_logit": 4.5826005935668945,
            "end_logit": 4.605806827545166,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "amiodarone, fluconazole, lactulose, or bezafibrate",
            "probability": 0.0372465344990601,
            "start_logit": 4.85094690322876,
            "end_logit": 4.3327107429504395,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "fluconazole, lactulose, or bezafibrate",
            "probability": 0.03629167760593711,
            "start_logit": 4.824976444244385,
            "end_logit": 4.3327107429504395,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "bezafibrate",
            "probability": 0.0315907275005669,
            "start_logit": 4.686251640319824,
            "end_logit": 4.3327107429504395,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "amiodarone, fluconazole, lactulose",
            "probability": 0.03023690777613271,
            "start_logit": 4.85094690322876,
            "end_logit": 4.124215126037598,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        },
        {
            "text": "simvastatin, paracetamol, amiodarone, fluconazole, lactulose",
            "probability": 0.029708698017430122,
            "start_logit": 4.8333234786987305,
            "end_logit": 4.124215126037598,
            "question_text": "Please list 7 classes of drugs that interact with Warfarin."
        }
    ],
    "5ad303970340b9f05800001a": [
        {
            "text": "anorexia-cachexia",
            "probability": 0.34407222997045034,
            "start_logit": 4.268734455108643,
            "end_logit": 4.204737663269043,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "anorexia",
            "probability": 0.1850578752140188,
            "start_logit": 4.268734455108643,
            "end_logit": 3.584554672241211,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "cachexia",
            "probability": 0.15539196199966418,
            "start_logit": 3.4738335609436035,
            "end_logit": 4.204737663269043,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "anorexia-cachexia syndrome",
            "probability": 0.09526455892957007,
            "start_logit": 4.268734455108643,
            "end_logit": 2.920543909072876,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "cancer-anorexia-cachexia",
            "probability": 0.06744264586089938,
            "start_logit": 2.639160394668579,
            "end_logit": 4.204737663269043,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "cachexia syndrome",
            "probability": 0.043023950879063584,
            "start_logit": 3.4738335609436035,
            "end_logit": 2.920543909072876,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "cancer-anorexia",
            "probability": 0.03627375781794845,
            "start_logit": 2.639160394668579,
            "end_logit": 3.584554672241211,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "cancer-anorexia-cachexia syndrome",
            "probability": 0.018673096377273917,
            "start_logit": 2.639160394668579,
            "end_logit": 2.920543909072876,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "sickness",
            "probability": 0.009067150909164922,
            "start_logit": 2.633551597595215,
            "end_logit": 2.2037270069122314,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "sickness conditions",
            "probability": 0.0063632713362649545,
            "start_logit": 2.633551597595215,
            "end_logit": 1.849611520767212,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "acute sickness",
            "probability": 0.00613243427446339,
            "start_logit": 2.242485284805298,
            "end_logit": 2.2037270069122314,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "The cancer-anorexia-cachexia",
            "probability": 0.005805533271415507,
            "start_logit": 0.18669432401657104,
            "end_logit": 4.204737663269043,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "cancer anorexia",
            "probability": 0.005350769449711942,
            "start_logit": 0.9466661810874939,
            "end_logit": 3.363194704055786,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "orexia-cachexia",
            "probability": 0.005162052243364384,
            "start_logit": 0.06921707093715668,
            "end_logit": 4.204737663269043,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "acute sickness conditions",
            "probability": 0.004303705059191036,
            "start_logit": 2.242485284805298,
            "end_logit": 1.849611520767212,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "anorexia-cachexia syndrome (CACS)",
            "probability": 0.0035193188539765245,
            "start_logit": 4.268734455108643,
            "end_logit": -0.37784647941589355,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "The cancer-anorexia",
            "probability": 0.003122482891992515,
            "start_logit": 0.18669432401657104,
            "end_logit": 3.584554672241211,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "orexia",
            "probability": 0.0027763891900918986,
            "start_logit": 0.06921707093715668,
            "end_logit": 3.584554672241211,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "The cancer-anorexia-cachexia syndrome",
            "probability": 0.0016073996047278809,
            "start_logit": 0.18669432401657104,
            "end_logit": 2.920543909072876,
            "question_text": "In what states are GDF15 expression increased?"
        },
        {
            "text": "cachexia syndrome (CACS)",
            "probability": 0.0015894158667463182,
            "start_logit": 3.4738335609436035,
            "end_logit": -0.37784647941589355,
            "question_text": "In what states are GDF15 expression increased?"
        }
    ],
    "5c34ad63da8336e21a000007": [
        {
            "text": "Tn916",
            "probability": 0.35618286857393594,
            "start_logit": 1.177357792854309,
            "end_logit": 0.30809101462364197,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding DNA",
            "probability": 0.1964996715874427,
            "start_logit": 1.4490183591842651,
            "end_logit": -0.558353066444397,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion into noncoding DNA",
            "probability": 0.1497549353429099,
            "start_logit": 1.177357792854309,
            "end_logit": -0.558353066444397,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding DNA for H. influenzae",
            "probability": 0.07053058361493639,
            "start_logit": 1.4490183591842651,
            "end_logit": -1.5829674005508423,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion into noncoding DNA for H. influenzae",
            "probability": 0.05375226789756876,
            "start_logit": 1.177357792854309,
            "end_logit": -1.5829674005508423,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding DNA for H. influenzae,",
            "probability": 0.02465392895544843,
            "start_logit": 1.4490183591842651,
            "end_logit": -2.634077548980713,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding",
            "probability": 0.023014630123715886,
            "start_logit": 1.4490183591842651,
            "end_logit": -2.702883720397949,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion into noncoding DNA for H. influenzae,",
            "probability": 0.018789077390538575,
            "start_logit": 1.177357792854309,
            "end_logit": -2.634077548980713,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion into noncoding",
            "probability": 0.017539746597410144,
            "start_logit": 1.177357792854309,
            "end_logit": -2.702883720397949,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding, intergenic DNA",
            "probability": 0.014718659169085458,
            "start_logit": -0.08659326285123825,
            "end_logit": -1.614286184310913,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "Tn916 has a marked preference for insertion",
            "probability": 0.014285646296908096,
            "start_logit": 1.177357792854309,
            "end_logit": -2.908097982406616,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "DNA",
            "probability": 0.012988113495604395,
            "start_logit": -1.2676078081130981,
            "end_logit": -0.558353066444397,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "intergenic, nonprotein-coding regions of the genome. These data support the hypothesis that Tn916",
            "probability": 0.007687100085689462,
            "start_logit": -2.6585428714752197,
            "end_logit": 0.30809101462364197,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "insertion into noncoding DNA",
            "probability": 0.007570669564588991,
            "start_logit": -1.8073608875274658,
            "end_logit": -0.558353066444397,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "intergenic DNA",
            "probability": 0.0067990522341065274,
            "start_logit": -0.8589260578155518,
            "end_logit": -1.614286184310913,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "A's and T's",
            "probability": 0.006468231421469124,
            "start_logit": -0.8377716541290283,
            "end_logit": -1.6853210926055908,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "regions rich in stretches of A's and T's",
            "probability": 0.005098565320452098,
            "start_logit": -1.075715184211731,
            "end_logit": -1.6853210926055908,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "DNA for H. influenzae",
            "probability": 0.00466188679859631,
            "start_logit": -1.2676078081130981,
            "end_logit": -1.5829674005508423,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "A's and T's. Although Tn916 integrated at multiple dispersed positions throughout the chromosome",
            "probability": 0.00452715443135739,
            "start_logit": -0.8377716541290283,
            "end_logit": -2.0421302318573,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        },
        {
            "text": "noncoding, intergenic",
            "probability": 0.004477211098235357,
            "start_logit": -0.08659326285123825,
            "end_logit": -2.8044018745422363,
            "question_text": "Which genomic positions are preferentially selected for transposon insertion?"
        }
    ],
    "5c55de1607647bbc4b00000a": [
        {
            "text": "myelokathexis",
            "probability": 0.19776316264718038,
            "start_logit": 5.217971324920654,
            "end_logit": 5.260815143585205,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts, hypogammaglobulinemia, infections, and myelokathexis",
            "probability": 0.14776321337809714,
            "start_logit": 4.926512241363525,
            "end_logit": 5.260815143585205,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia, infections, and myelokathexis",
            "probability": 0.145372780712964,
            "start_logit": 4.910202503204346,
            "end_logit": 5.260815143585205,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts",
            "probability": 0.12304351079395949,
            "start_logit": 4.926512241363525,
            "end_logit": 5.077742099761963,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts, hypogammaglobulinemia",
            "probability": 0.09340391998615533,
            "start_logit": 4.926512241363525,
            "end_logit": 4.80213737487793,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia",
            "probability": 0.09189288231797015,
            "start_logit": 4.910202503204346,
            "end_logit": 4.80213737487793,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "infections, and myelokathexis",
            "probability": 0.06306072644794848,
            "start_logit": 4.0749993324279785,
            "end_logit": 5.260815143585205,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts, hypogammaglobulinemia, infections",
            "probability": 0.05506702132346039,
            "start_logit": 4.926512241363525,
            "end_logit": 4.273755073547363,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia, infections",
            "probability": 0.05417617709008305,
            "start_logit": 4.910202503204346,
            "end_logit": 4.273755073547363,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "infections",
            "probability": 0.02350088556274466,
            "start_logit": 4.0749993324279785,
            "end_logit": 4.273755073547363,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts, hypogammaglobulinemia, infections,",
            "probability": 0.0009093522677190858,
            "start_logit": 4.926512241363525,
            "end_logit": 0.17018133401870728,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia, infections,",
            "probability": 0.000894641262759371,
            "start_logit": 4.910202503204346,
            "end_logit": 0.17018133401870728,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts, hypogammaglobulinemia,",
            "probability": 0.0008484893923542805,
            "start_logit": 4.926512241363525,
            "end_logit": 0.1009063646197319,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "hypogammaglobulinemia,",
            "probability": 0.0008347629937931399,
            "start_logit": 4.910202503204346,
            "end_logit": 0.1009063646197319,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts,",
            "probability": 0.0004160477178104895,
            "start_logit": 4.926512241363525,
            "end_logit": -0.6117512583732605,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "infections,",
            "probability": 0.00038808315878135206,
            "start_logit": 4.0749993324279785,
            "end_logit": 0.17018133401870728,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "myelokathexi",
            "probability": 0.00017387888022540692,
            "start_logit": 5.217971324920654,
            "end_logit": -1.7756513357162476,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "Warts, h",
            "probability": 0.00017206076289388246,
            "start_logit": 4.926512241363525,
            "end_logit": -1.4947035312652588,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "h",
            "probability": 0.00016927725772634915,
            "start_logit": 4.910202503204346,
            "end_logit": -1.4947035312652588,
            "question_text": "List four features of the WHIM syndrome."
        },
        {
            "text": "War",
            "probability": 0.0001491260453736285,
            "start_logit": 4.926512241363525,
            "end_logit": -1.6377593278884888,
            "question_text": "List four features of the WHIM syndrome."
        }
    ],
    "5be47df8133db5eb78000019": [
        {
            "text": "16S rRNA sequencing",
            "probability": 0.15135814826381355,
            "start_logit": -3.025949478149414,
            "end_logit": -2.722235918045044,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "16S rRNA",
            "probability": 0.11836795905939941,
            "start_logit": -3.025949478149414,
            "end_logit": -2.9680867195129395,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "sequencing",
            "probability": 0.08440163485932964,
            "start_logit": -3.610011577606201,
            "end_logit": -2.722235918045044,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "with 16S rRNA sequencing",
            "probability": 0.07971504531905395,
            "start_logit": -3.667140007019043,
            "end_logit": -2.722235918045044,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "with 16S rRNA",
            "probability": 0.062340265978265925,
            "start_logit": -3.667140007019043,
            "end_logit": -2.9680867195129395,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "16S rRNA se",
            "probability": 0.05596405132635793,
            "start_logit": -3.025949478149414,
            "end_logit": -3.717175245285034,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "16",
            "probability": 0.053608884309117914,
            "start_logit": -3.025949478149414,
            "end_logit": -3.7601699829101562,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "profiled with 16S rRNA sequencing",
            "probability": 0.048836576575033284,
            "start_logit": -4.157118797302246,
            "end_logit": -2.722235918045044,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "quencing",
            "probability": 0.042597847227543575,
            "start_logit": -4.293794631958008,
            "end_logit": -2.722235918045044,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "profiled with 16S rRNA",
            "probability": 0.0381921023938478,
            "start_logit": -4.157118797302246,
            "end_logit": -2.9680867195129395,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "se",
            "probability": 0.031207156532221666,
            "start_logit": -3.610011577606201,
            "end_logit": -3.717175245285034,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "with 16S rRNA se",
            "probability": 0.02947430937079622,
            "start_logit": -3.667140007019043,
            "end_logit": -3.717175245285034,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "16S rRNA sequencing from faecal samples",
            "probability": 0.029078539947701574,
            "start_logit": -3.025949478149414,
            "end_logit": -4.371884346008301,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "with 16",
            "probability": 0.028233925237753057,
            "start_logit": -3.667140007019043,
            "end_logit": -3.7601699829101562,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "RNA sequencing",
            "probability": 0.027654640492576203,
            "start_logit": -4.725804805755615,
            "end_logit": -2.722235918045044,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Infant gut microbiota were profiled with 16S rRNA sequencing",
            "probability": 0.027594863673329684,
            "start_logit": -4.727968692779541,
            "end_logit": -2.722235918045044,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "with",
            "probability": 0.02624791482207806,
            "start_logit": -3.667140007019043,
            "end_logit": -3.8331077098846436,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "16S",
            "probability": 0.021918873409275477,
            "start_logit": -3.025949478149414,
            "end_logit": -4.654536724090576,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "RNA",
            "probability": 0.02162700450009584,
            "start_logit": -4.725804805755615,
            "end_logit": -2.9680867195129395,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        },
        {
            "text": "Infant gut microbiota were profiled with 16S rRNA",
            "probability": 0.021580256702409123,
            "start_logit": -4.727968692779541,
            "end_logit": -2.9680867195129395,
            "question_text": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?"
        }
    ],
    "5ad4eddf133db5eb78000009": [
        {
            "text": "DNA methylation",
            "probability": 0.17891818338796112,
            "start_logit": -3.9691407680511475,
            "end_logit": -4.488122940063477,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "DNA methylation, histone modification",
            "probability": 0.13443649463335586,
            "start_logit": -3.9691407680511475,
            "end_logit": -4.773959636688232,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "epigenetic biomarkers, such as DNA methylation",
            "probability": 0.09560117112423044,
            "start_logit": -4.595884323120117,
            "end_logit": -4.488122940063477,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "histone modification",
            "probability": 0.08631263360147381,
            "start_logit": -4.412256717681885,
            "end_logit": -4.773959636688232,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "epigenetic biomarkers, such as DNA methylation, histone modification",
            "probability": 0.07183331557149006,
            "start_logit": -4.595884323120117,
            "end_logit": -4.773959636688232,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "DNA",
            "probability": 0.05541178620686508,
            "start_logit": -3.9691407680511475,
            "end_logit": -5.660259246826172,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "methylation",
            "probability": 0.03918311471875559,
            "start_logit": -5.487823486328125,
            "end_logit": -4.488122940063477,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "epigenetic biomarkers",
            "probability": 0.0388640469483717,
            "start_logit": -4.595884323120117,
            "end_logit": -5.388238430023193,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "DNA methylation, histone modification and non coding RNA",
            "probability": 0.03124229588145254,
            "start_logit": -3.9691407680511475,
            "end_logit": -6.233278751373291,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "epigenetic biomarkers, such as DNA",
            "probability": 0.029608123417925496,
            "start_logit": -4.595884323120117,
            "end_logit": -5.660259246826172,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "methylation, histone modification",
            "probability": 0.02944161678740025,
            "start_logit": -5.487823486328125,
            "end_logit": -4.773959636688232,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "DNA methylation, histone modification and non coding RNA mediated regulation",
            "probability": 0.02791927878151613,
            "start_logit": -3.9691407680511475,
            "end_logit": -6.345734119415283,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "DNA methylation,",
            "probability": 0.027620600990984786,
            "start_logit": -3.9691407680511475,
            "end_logit": -6.356489658355713,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "epigenetic biomarkers,",
            "probability": 0.027156988764578803,
            "start_logit": -4.595884323120117,
            "end_logit": -5.746673583984375,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "epigenetic",
            "probability": 0.027138593812784537,
            "start_logit": -4.595884323120117,
            "end_logit": -5.747351169586182,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "DNA methylation, histone modification and non coding RNA mediated regulation serve crucial roles in several disease progression including AD.",
            "probability": 0.024661056609088284,
            "start_logit": -3.9691407680511475,
            "end_logit": -6.4698262214660645,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "histone modification and non coding RNA",
            "probability": 0.02005857743196152,
            "start_logit": -4.412256717681885,
            "end_logit": -6.233278751373291,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "Studies have implicated that epigenetic biomarkers, such as DNA methylation",
            "probability": 0.019973365523879367,
            "start_logit": -6.161669731140137,
            "end_logit": -4.488122940063477,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "histone modification and non coding RNA mediated regulation",
            "probability": 0.017925091594053637,
            "start_logit": -4.412256717681885,
            "end_logit": -6.345734119415283,
            "question_text": "List the main PPI databases."
        },
        {
            "text": "epigenetic biomarkers, such as DNA methylation, histone modification and non coding RNA",
            "probability": 0.01669366421187103,
            "start_logit": -4.595884323120117,
            "end_logit": -6.233278751373291,
            "question_text": "List the main PPI databases."
        }
    ],
    "5c5f03371a4c55d80b000009": [
        {
            "text": "Pcp1",
            "probability": 0.9332099726590796,
            "start_logit": 4.852566242218018,
            "end_logit": 4.14896297454834,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp",
            "probability": 0.035765454367893586,
            "start_logit": 4.852566242218018,
            "end_logit": 0.8873152136802673,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid-GlpG",
            "probability": 0.010246935760020646,
            "start_logit": 4.852566242218018,
            "end_logit": -0.3626885414123535,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein",
            "probability": 0.007813446673004534,
            "start_logit": 4.852566242218018,
            "end_logit": -0.6338210701942444,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid-GlpG superfamily",
            "probability": 0.005244658545597274,
            "start_logit": 4.852566242218018,
            "end_logit": -1.0324571132659912,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "The newly identified Pcp1",
            "probability": 0.0014530839049727313,
            "start_logit": -1.6123758554458618,
            "end_logit": 4.14896297454834,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid-G",
            "probability": 0.0011148646037706033,
            "start_logit": 4.852566242218018,
            "end_logit": -2.5809342861175537,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid",
            "probability": 0.0008346415185193033,
            "start_logit": 4.852566242218018,
            "end_logit": -2.870420217514038,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the r",
            "probability": 0.0007770151218967647,
            "start_logit": 4.852566242218018,
            "end_logit": -2.941962718963623,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "P",
            "probability": 0.0007337303580210303,
            "start_logit": 4.852566242218018,
            "end_logit": -2.9992809295654297,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "cp1",
            "probability": 0.0006275786185676728,
            "start_logit": -2.4519503116607666,
            "end_logit": 4.14896297454834,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the rhomboid-GlpG super",
            "probability": 0.0005864487946195678,
            "start_logit": 4.852566242218018,
            "end_logit": -3.223337173461914,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "1",
            "probability": 0.0005837787311269582,
            "start_logit": -2.5242972373962402,
            "end_logit": 4.14896297454834,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pcp1 protein belongs to the",
            "probability": 0.00030666789841576946,
            "start_logit": 4.852566242218018,
            "end_logit": -3.871657133102417,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "Pc",
            "probability": 0.00024945271985376595,
            "start_logit": 4.852566242218018,
            "end_logit": -4.078153133392334,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "newly identified Pcp1",
            "probability": 0.0001554412610087622,
            "start_logit": -3.8475513458251953,
            "end_logit": 4.14896297454834,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "p1",
            "probability": 0.00013922241435955458,
            "start_logit": -3.9577465057373047,
            "end_logit": 4.14896297454834,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "GlpG",
            "probability": 5.8122987207929983e-05,
            "start_logit": -0.3196065127849579,
            "end_logit": -0.3626885414123535,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "The newly identified Pcp",
            "probability": 5.5689724304959395e-05,
            "start_logit": -1.6123758554458618,
            "end_logit": 0.8873152136802673,
            "question_text": "List intramembrane rhomboid peptidases"
        },
        {
            "text": "rhomboid-GlpG",
            "probability": 4.3793337759170315e-05,
            "start_logit": -0.6026860475540161,
            "end_logit": -0.3626885414123535,
            "question_text": "List intramembrane rhomboid peptidases"
        }
    ],
    "5c34a029da8336e21a000003": [
        {
            "text": "Skin",
            "probability": 0.9605686564407895,
            "start_logit": 4.6661057472229,
            "end_logit": 4.934305191040039,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "cutaneous manifestations to systemic disease. Skin",
            "probability": 0.024943836673290806,
            "start_logit": 1.015207052230835,
            "end_logit": 4.934305191040039,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is one of the most commonly affected organs",
            "probability": 0.008596338256072686,
            "start_logit": 4.6661057472229,
            "end_logit": 0.21811605989933014,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is one of the most commonly affected organs in SLE.",
            "probability": 0.002607642829258929,
            "start_logit": 4.6661057472229,
            "end_logit": -0.9747735857963562,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is one",
            "probability": 0.0017250742388118863,
            "start_logit": 4.6661057472229,
            "end_logit": -1.3879501819610596,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is",
            "probability": 0.0004246793466116371,
            "start_logit": 4.6661057472229,
            "end_logit": -2.7896411418914795,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "cutaneous manifestations to systemic disease. Skin is one of the most commonly affected organs",
            "probability": 0.00022322783073346726,
            "start_logit": 1.015207052230835,
            "end_logit": 0.21811605989933014,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is one of the most commonly",
            "probability": 0.00019284295071034919,
            "start_logit": 4.6661057472229,
            "end_logit": -3.579099416732788,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "systemic disease. Skin",
            "probability": 0.00013161841191508848,
            "start_logit": -4.2292680740356445,
            "end_logit": 4.934305191040039,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": ". Skin",
            "probability": 9.937689624950998e-05,
            "start_logit": -4.510255336761475,
            "end_logit": 4.934305191040039,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "aneous manifestations to systemic disease. Skin",
            "probability": 8.385437831012002e-05,
            "start_logit": -4.680093288421631,
            "end_logit": 4.934305191040039,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is one of the",
            "probability": 7.2898461262971e-05,
            "start_logit": 4.6661057472229,
            "end_logit": -4.551908016204834,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "cutaneous",
            "probability": 6.944489464102894e-05,
            "start_logit": 1.015207052230835,
            "end_logit": -0.949543297290802,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "cutaneous manifestations to systemic disease. Skin is one of the most commonly affected organs in SLE.",
            "probability": 6.771469837077918e-05,
            "start_logit": 1.015207052230835,
            "end_logit": -0.9747735857963562,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "cutaneous manifestations to systemic disease. Skin is one",
            "probability": 4.479635034279048e-05,
            "start_logit": 1.015207052230835,
            "end_logit": -1.3879501819610596,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "organs",
            "probability": 3.30690375415664e-05,
            "start_logit": -0.8943884372711182,
            "end_logit": 0.21811605989933014,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is one of the most commonly affected",
            "probability": 3.232888148816923e-05,
            "start_logit": 4.6661057472229,
            "end_logit": -5.365014553070068,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "autoimmune disease with wide clinical features ranging from cutaneous manifestations to systemic disease. Skin",
            "probability": 2.8263995761006803e-05,
            "start_logit": -5.7675862312316895,
            "end_logit": 4.934305191040039,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is one of the most",
            "probability": 2.8151992597225952e-05,
            "start_logit": 4.6661057472229,
            "end_logit": -5.503357410430908,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        },
        {
            "text": "Skin is one of the most commonly affected organs in SLE",
            "probability": 2.6183435240442065e-05,
            "start_logit": 4.6661057472229,
            "end_logit": -5.575848579406738,
            "question_text": "Which organs are mostly affected in Systemic Lupus Erythematosus (SLE)?"
        }
    ],
    "5be94f3d133db5eb78000022": [
        {
            "text": "breast cancer",
            "probability": 0.9925914920387902,
            "start_logit": 4.874016284942627,
            "end_logit": 5.120293140411377,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "dsHIC1-2998, an saRNA, showed activating efficacy in breast cancer",
            "probability": 0.004022094155789109,
            "start_logit": -0.8694688677787781,
            "end_logit": 5.35526180267334,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "cancer",
            "probability": 0.0019280996553143032,
            "start_logit": -1.3697680234909058,
            "end_logit": 5.120293140411377,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast",
            "probability": 0.00035703305051875236,
            "start_logit": 4.874016284942627,
            "end_logit": -2.809952974319458,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer cells.",
            "probability": 0.0002793260581465733,
            "start_logit": 4.874016284942627,
            "end_logit": -3.055401563644409,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer cells",
            "probability": 0.00018456929312709938,
            "start_logit": 4.874016284942627,
            "end_logit": -3.4697563648223877,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer cells. A group of differentially expressed genes were characterized by cDNA microarray. Upon saRNA treatment,",
            "probability": 0.00011594571270815978,
            "start_logit": 4.874016284942627,
            "end_logit": -3.934659242630005,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "2998, an saRNA, showed activating efficacy in breast cancer",
            "probability": 8.936841592771533e-05,
            "start_logit": -4.441290855407715,
            "end_logit": 5.120293140411377,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "efficacy in breast cancer",
            "probability": 7.955488789036635e-05,
            "start_logit": -4.557610988616943,
            "end_logit": 5.120293140411377,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer cells. A group of differentially expressed genes were characterized by cDNA microarray.",
            "probability": 7.879450177072624e-05,
            "start_logit": 4.874016284942627,
            "end_logit": -4.3209381103515625,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "cancer, and commonly downregulated in human breast cancer",
            "probability": 7.513021247360214e-05,
            "start_logit": -0.41418787837028503,
            "end_logit": 0.9196456074714661,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer cells. A group of differentially expressed genes were characterized by cDNA microarray",
            "probability": 6.925988795371882e-05,
            "start_logit": 4.874016284942627,
            "end_logit": -4.449915409088135,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "breast cancer cells. A group of differentially expressed genes were characterized by cDNA microarray. Upon saRNA treatment",
            "probability": 6.855365911314745e-05,
            "start_logit": 4.874016284942627,
            "end_logit": -4.460164546966553,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "showed activating efficacy in breast cancer",
            "probability": 5.0884447146965826e-05,
            "start_logit": -5.004500865936279,
            "end_logit": 5.120293140411377,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "dsHIC1-2998, an saRNA,",
            "probability": 3.4769706007702206e-06,
            "start_logit": -0.8694688677787781,
            "end_logit": -1.6981347799301147,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "dsHIC1-2998",
            "probability": 2.330224203769026e-06,
            "start_logit": -0.8694688677787781,
            "end_logit": -2.0983316898345947,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "dsHIC1-2998, an saRNA, showed activating efficacy in breast",
            "probability": 1.33356165220526e-06,
            "start_logit": -0.8694688677787781,
            "end_logit": -2.656442880630493,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "dsHIC1",
            "probability": 1.1885565191883294e-06,
            "start_logit": -0.8694688677787781,
            "end_logit": -2.7715566158294678,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "dsHIC1-2998,",
            "probability": 8.219161731136104e-07,
            "start_logit": -0.8694688677787781,
            "end_logit": -3.1404130458831787,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        },
        {
            "text": "dsHIC1-2998, an saRNA, showed activating efficacy in breast cancer cells",
            "probability": 7.42794180580117e-07,
            "start_logit": -0.8694688677787781,
            "end_logit": -3.2416324615478516,
            "question_text": "List 3 diseases for which saRNAs have been evaluated as a potential treatment."
        }
    ],
    "5c34a761da8336e21a000005": [
        {
            "text": "folate",
            "probability": 0.564275758161699,
            "start_logit": 2.4337410926818848,
            "end_logit": 0.4617781937122345,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "thymidylate",
            "probability": 0.12961375775775796,
            "start_logit": 1.721763253211975,
            "end_logit": -0.2972280979156494,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "thymidylate synthase",
            "probability": 0.11705389673895752,
            "start_logit": 1.721763253211975,
            "end_logit": -0.399152547121048,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "folate and thymidylate",
            "probability": 0.06231028180630009,
            "start_logit": 0.9893307685852051,
            "end_logit": -0.2972280979156494,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "folate and thymidylate synthase",
            "probability": 0.05627227709855851,
            "start_logit": 0.9893307685852051,
            "end_logit": -0.399152547121048,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "reduced folate",
            "probability": 0.04488798882741827,
            "start_logit": -0.09763172268867493,
            "end_logit": 0.4617781937122345,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "folate carrier 1",
            "probability": 0.006552437737022872,
            "start_logit": 2.4337410926818848,
            "end_logit": -3.9939277172088623,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "f",
            "probability": 0.004683062819605115,
            "start_logit": 2.4337410926818848,
            "end_logit": -4.329812526702881,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "major histocompatibility complex II transactivator (MHC2TA), reduced folate",
            "probability": 0.003203578297076795,
            "start_logit": -2.7375335693359375,
            "end_logit": 0.4617781937122345,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "folate carrier",
            "probability": 0.002028293267698692,
            "start_logit": 2.4337410926818848,
            "end_logit": -5.16657018661499,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "thy",
            "probability": 0.0019151117586919256,
            "start_logit": 1.721763253211975,
            "end_logit": -4.5120110511779785,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "folate carrier 1 (RFC1/SLC19A1",
            "probability": 0.001650479101806826,
            "start_logit": 2.4337410926818848,
            "end_logit": -5.37269926071167,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "thymidylate synthase (TYMS)",
            "probability": 0.0010506814483153114,
            "start_logit": 1.721763253211975,
            "end_logit": -5.1123480796813965,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "folate and thy",
            "probability": 0.0009206673383984221,
            "start_logit": 0.9893307685852051,
            "end_logit": -4.5120110511779785,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "late",
            "probability": 0.0008317577908781624,
            "start_logit": -3.327009677886963,
            "end_logit": -0.2972280979156494,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "late synthase",
            "probability": 0.000751158613480199,
            "start_logit": -3.327009677886963,
            "end_logit": -0.399152547121048,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "reduced folate carrier 1",
            "probability": 0.0005212447064712495,
            "start_logit": -0.09763172268867493,
            "end_logit": -3.9939277172088623,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "folate and thymidylate synthase (TYMS)",
            "probability": 0.0005051026855924946,
            "start_logit": 0.9893307685852051,
            "end_logit": -5.1123480796813965,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "olate",
            "probability": 0.0004893282967723795,
            "start_logit": -4.504255771636963,
            "end_logit": 0.3495103418827057,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        },
        {
            "text": "MHC2TA), reduced folate",
            "probability": 0.00048313574749820915,
            "start_logit": -4.6292595863342285,
            "end_logit": 0.4617781937122345,
            "question_text": "Which metabolic pathways have been associated with Systemic Lupus Erythematosus?"
        }
    ],
    "5be44d8b133db5eb78000015": [
        {
            "text": "Streptococcus",
            "probability": 0.2027111376636151,
            "start_logit": 6.4531474113464355,
            "end_logit": 6.386742115020752,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, and Pseudomonas",
            "probability": 0.19389724961179713,
            "start_logit": 6.4531474113464355,
            "end_logit": 6.342288494110107,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Pseudomonas",
            "probability": 0.1804661822805211,
            "start_logit": 6.381362438201904,
            "end_logit": 6.342288494110107,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus",
            "probability": 0.15088777537455164,
            "start_logit": 6.157901763916016,
            "end_logit": 6.386742115020752,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, and Pseudomonas",
            "probability": 0.1443271691056152,
            "start_logit": 6.157901763916016,
            "end_logit": 6.342288494110107,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus",
            "probability": 0.1071255819105937,
            "start_logit": 6.157901763916016,
            "end_logit": 6.044207572937012,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, and Pseudomonas genera",
            "probability": 0.004670725807307211,
            "start_logit": 6.4531474113464355,
            "end_logit": 2.61627459526062,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Pseudomonas genera",
            "probability": 0.0043471893315218686,
            "start_logit": 6.381362438201904,
            "end_logit": 2.61627459526062,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, and Pseudomonas genera",
            "probability": 0.0034766487651930796,
            "start_logit": 6.157901763916016,
            "end_logit": 2.61627459526062,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus, and Pseudomona",
            "probability": 0.001453579009960276,
            "start_logit": 6.4531474113464355,
            "end_logit": 1.448988914489746,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Pseudomona",
            "probability": 0.0013528910549057646,
            "start_logit": 6.381362438201904,
            "end_logit": 1.448988914489746,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococcus,",
            "probability": 0.0012467771941535855,
            "start_logit": 6.4531474113464355,
            "end_logit": 1.2955220937728882,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus, and Pseudomona",
            "probability": 0.0010819696720759744,
            "start_logit": 6.157901763916016,
            "end_logit": 1.448988914489746,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococcus,",
            "probability": 0.0009280370056712799,
            "start_logit": 6.157901763916016,
            "end_logit": 1.2955220937728882,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Streptococ",
            "probability": 0.0006349748966033088,
            "start_logit": 6.4531474113464355,
            "end_logit": 0.6207903027534485,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococcus, Streptococ",
            "probability": 0.00047264275003058333,
            "start_logit": 6.157901763916016,
            "end_logit": 0.6207903027534485,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "Staphylococ",
            "probability": 0.0003241529230042192,
            "start_logit": 6.157901763916016,
            "end_logit": 0.243665874004364,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "the Staphylococcus, Streptococcus",
            "probability": 0.00022325827777147024,
            "start_logit": -0.3580605685710907,
            "end_logit": 6.386742115020752,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "the Staphylococcus, Streptococcus, and Pseudomonas",
            "probability": 0.00021355099927854008,
            "start_logit": -0.3580605685710907,
            "end_logit": 6.342288494110107,
            "question_text": "What are the 3 main bacteria found in human milk?"
        },
        {
            "text": "the Staphylococcus",
            "probability": 0.0001585063658288877,
            "start_logit": -0.3580605685710907,
            "end_logit": 6.044207572937012,
            "question_text": "What are the 3 main bacteria found in human milk?"
        }
    ],
    "5be2a070133db5eb78000013": [
        {
            "text": "duodenum",
            "probability": 0.8294011522265753,
            "start_logit": 3.936601161956787,
            "end_logit": 3.646801710128784,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "duodenum (6.2%)",
            "probability": 0.12689398039219632,
            "start_logit": 3.936601161956787,
            "end_logit": 1.7694497108459473,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "the duodenum",
            "probability": 0.017639541590246395,
            "start_logit": 0.08604028820991516,
            "end_logit": 3.646801710128784,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "liver, networks relating to differential metabolism between the sexes were seen. The estrogen receptor was implicated in differential gene expression in the duodenum",
            "probability": 0.008867823694297585,
            "start_logit": 1.2862344980239868,
            "end_logit": 1.7588938474655151,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "duodenum (6.2%),",
            "probability": 0.006500210840073425,
            "start_logit": 3.936601161956787,
            "end_logit": -1.2020676136016846,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "liver",
            "probability": 0.0044085428177267835,
            "start_logit": 1.2862344980239868,
            "end_logit": 1.0600086450576782,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "the duodenum (6.2%)",
            "probability": 0.00269875637219827,
            "start_logit": 0.08604028820991516,
            "end_logit": 1.7694497108459473,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "female",
            "probability": 0.001286180743355478,
            "start_logit": 0.8302393555641174,
            "end_logit": 0.28413674235343933,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "male-only). The frequency of SDE probesets varied widely between tissues, and was highest in the duodenum",
            "probability": 0.0008595956446395532,
            "start_logit": -2.9353959560394287,
            "end_logit": 3.646801710128784,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "um",
            "probability": 0.0002665449555466387,
            "start_logit": -4.1063151359558105,
            "end_logit": 3.646801710128784,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "denum",
            "probability": 0.0002330769301028407,
            "start_logit": -4.240489482879639,
            "end_logit": 3.646801710128784,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "duo",
            "probability": 0.00022689332253739876,
            "start_logit": 3.936601161956787,
            "end_logit": -4.557177543640137,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "duoden",
            "probability": 0.00020994420669063834,
            "start_logit": 3.936601161956787,
            "end_logit": -4.634815692901611,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "the duodenum (6.2%),",
            "probability": 0.0001382452136110883,
            "start_logit": 0.08604028820991516,
            "end_logit": -1.2020676136016846,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "highest in the duodenum",
            "probability": 8.663348239788877e-05,
            "start_logit": -5.2301716804504395,
            "end_logit": 3.646801710128784,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "(female",
            "probability": 7.74711293719456e-05,
            "start_logit": -1.9792877435684204,
            "end_logit": 0.28413674235343933,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "female-only",
            "probability": 6.579954378378631e-05,
            "start_logit": 0.8302393555641174,
            "end_logit": -2.688682794570923,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "female-only)",
            "probability": 6.316739418394566e-05,
            "start_logit": 0.8302393555641174,
            "end_logit": -2.7295074462890625,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "um (6.2%)",
            "probability": 4.077996548711603e-05,
            "start_logit": -4.1063151359558105,
            "end_logit": 1.7694497108459473,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        },
        {
            "text": "denum (6.2%)",
            "probability": 3.5659534977669774e-05,
            "start_logit": -4.240489482879639,
            "end_logit": 1.7694497108459473,
            "question_text": "In which tissues is the lincRNA Xist expressed?"
        }
    ],
    "5c0e82b2133db5eb7800002d": [
        {
            "text": "cytokines",
            "probability": 0.9838723799375899,
            "start_logit": 4.373340606689453,
            "end_logit": 4.559153079986572,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "cytokines and other factors of the senescence-associated secretory phenotype",
            "probability": 0.005631542784695176,
            "start_logit": 4.373340606689453,
            "end_logit": -0.6039596796035767,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "cytokines and other factors",
            "probability": 0.0038690732866647234,
            "start_logit": 4.373340606689453,
            "end_logit": -0.9793280959129333,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "secrete cytokines",
            "probability": 0.0023914234363522535,
            "start_logit": -1.6462668180465698,
            "end_logit": 4.559153079986572,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "c",
            "probability": 0.0012690040575410021,
            "start_logit": 4.373340606689453,
            "end_logit": -2.0941107273101807,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "okines",
            "probability": 0.0010076960634206483,
            "start_logit": -2.510488986968994,
            "end_logit": 4.559153079986572,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "nes",
            "probability": 0.0003282935815200262,
            "start_logit": -3.632002592086792,
            "end_logit": 4.559153079986572,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "cytoki",
            "probability": 0.00030345302007570447,
            "start_logit": 4.373340606689453,
            "end_logit": -3.524871587753296,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "ytokines",
            "probability": 0.00027484001299658167,
            "start_logit": -3.8097217082977295,
            "end_logit": 4.559153079986572,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "Senescent cells secrete cytokines",
            "probability": 0.00027442992386434817,
            "start_logit": -3.8112149238586426,
            "end_logit": 4.559153079986572,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "cytokines and other factors of the senescence-associated secretory phenotype (SASP)",
            "probability": 0.0002328718366599082,
            "start_logit": 4.373340606689453,
            "end_logit": -3.7896101474761963,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "cytokines and other factors of the senescence",
            "probability": 0.00016311735974213718,
            "start_logit": 4.373340606689453,
            "end_logit": -4.145628452301025,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "cytokines and other factors of the senescence-associated secretory phenotype (SASP) that contribute to tumor suppression",
            "probability": 0.0001356946284958762,
            "start_logit": 4.373340606689453,
            "end_logit": -4.329691410064697,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "cytokines and other factors of the senescence-associated secretory phenotype (SASP) that",
            "probability": 0.00013312133649656858,
            "start_logit": 4.373340606689453,
            "end_logit": -4.348837375640869,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "cells secrete cytokines",
            "probability": 6.190253632312658e-05,
            "start_logit": -5.300349712371826,
            "end_logit": 4.559153079986572,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "secrete cytokines and other factors of the senescence-associated secretory phenotype",
            "probability": 1.3688160855775579e-05,
            "start_logit": -1.6462668180465698,
            "end_logit": -0.6039596796035767,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "senescence-associated secretory phenotype",
            "probability": 1.3569520649638152e-05,
            "start_logit": -1.654971957206726,
            "end_logit": -0.6039596796035767,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "secrete cytokines and other factors",
            "probability": 9.40426088115349e-06,
            "start_logit": -1.6462668180465698,
            "end_logit": -0.9793280959129333,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "immune cells",
            "probability": 7.2930159669342375e-06,
            "start_logit": -0.8258850574493408,
            "end_logit": -2.053955554962158,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        },
        {
            "text": "oncogene",
            "probability": 7.201239208373775e-06,
            "start_logit": -0.3758361041545868,
            "end_logit": -2.5166685581207275,
            "question_text": "What forms part of the senescence associated secretory phenotype, or SASP?"
        }
    ],
    "5c61cdd7e842deac67000004": [
        {
            "text": "rilpivirine",
            "probability": 0.4994188553649928,
            "start_logit": 4.765050888061523,
            "end_logit": 4.893508434295654,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Dolutegravir/rilpivirine",
            "probability": 0.3123333207649657,
            "start_logit": 4.2956767082214355,
            "end_logit": 4.893508434295654,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Dolutegravir",
            "probability": 0.17770361475225377,
            "start_logit": 4.2956767082214355,
            "end_logit": 4.329554557800293,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "/rilpivirine",
            "probability": 0.002858220381713102,
            "start_logit": -0.3981950581073761,
            "end_logit": 4.893508434295654,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "vir/rilpivirine",
            "probability": 0.0023986423989349843,
            "start_logit": -0.5734913349151611,
            "end_logit": 4.893508434295654,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "virine",
            "probability": 0.001595119467339925,
            "start_logit": -0.9814456105232239,
            "end_logit": 4.893508434295654,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "vir",
            "probability": 0.0013647196646992398,
            "start_logit": -0.5734913349151611,
            "end_logit": 4.329554557800293,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "rilpivir",
            "probability": 0.0011155828158113704,
            "start_logit": 4.765050888061523,
            "end_logit": -1.2105597257614136,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "Dolutegravir/rilpivir",
            "probability": 0.0006976782748742015,
            "start_logit": 4.2956767082214355,
            "end_logit": -1.2105597257614136,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "ine",
            "probability": 0.0005025035345738522,
            "start_logit": -2.1365468502044678,
            "end_logit": 4.893508434295654,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "/rilpivir",
            "probability": 6.384583816545385e-06,
            "start_logit": -0.3981950581073761,
            "end_logit": -1.2105597257614136,
            "question_text": "List two medication included in the Juluca pill."
        },
        {
            "text": "vir/rilpivir",
            "probability": 5.357996024344737e-06,
            "start_logit": -0.5734913349151611,
            "end_logit": -1.2105597257614136,
            "question_text": "List two medication included in the Juluca pill."
        }
    ],
    "5c61f379e842deac67000006": [
        {
            "text": "c.1482delinsGCCAGG",
            "probability": 0.37406712799612485,
            "start_logit": 1.2875165939331055,
            "end_logit": 0.13222330808639526,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23)",
            "probability": 0.20439614435956543,
            "start_logit": 1.2875165939331055,
            "end_logit": -0.4721519649028778,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG",
            "probability": 0.17416569726216063,
            "start_logit": 0.5230884552001953,
            "end_logit": 0.13222330808639526,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23)",
            "probability": 0.09516686801853846,
            "start_logit": 0.5230884552001953,
            "end_logit": -0.4721519649028778,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.05344517815721407,
            "start_logit": -0.6582622528076172,
            "end_logit": 0.13222330808639526,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23",
            "probability": 0.016001593951354927,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.0195236206054688,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1558C>T (p.Gln520Ter), and c.1482delinsGCCAGG",
            "probability": 0.009083606759802456,
            "start_logit": -2.4304473400115967,
            "end_logit": 0.13222330808639526,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delinsGCCAGG (p.Ile494MetfsTer23).",
            "probability": 0.00879635627357415,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.6178743839263916,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482",
            "probability": 0.008276441006718826,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.6787989139556885,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23",
            "probability": 0.007450343960382893,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.0195236206054688,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482delins",
            "probability": 0.007227922969760528,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.814260244369507,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1516C>T (p.Arg506Ter)",
            "probability": 0.006910688691611336,
            "start_logit": -0.7239497900009155,
            "end_logit": -1.8476762771606445,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1482del",
            "probability": 0.006593513840269952,
            "start_logit": 1.2875165939331055,
            "end_logit": -3.906125545501709,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1516C>T",
            "probability": 0.006505202842123624,
            "start_logit": -0.7239497900009155,
            "end_logit": -1.9081432819366455,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T (p.Gln520Ter)",
            "probability": 0.0043457544040511505,
            "start_logit": -0.6582622528076172,
            "end_logit": -2.3772337436676025,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delinsGCCAGG (p.Ile494MetfsTer23).",
            "probability": 0.004095584479610552,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.6178743839263916,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482",
            "probability": 0.003853511872337673,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.6787989139556885,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482delins",
            "probability": 0.0033653217552935327,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.814260244369507,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "c.1558C>T",
            "probability": 0.0031832006069254333,
            "start_logit": -0.6582622528076172,
            "end_logit": -2.6885459423065186,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        },
        {
            "text": "1482del",
            "probability": 0.003069940792579398,
            "start_logit": 0.5230884552001953,
            "end_logit": -3.906125545501709,
            "question_text": "Which de novo truncating mutations in WASF1 cause intellectual disability?"
        }
    ],
    "5c72d4c77c78d6947100007c": [
        {
            "text": "Nup60p, Nup2p, and Nup1p",
            "probability": 0.17550980764054347,
            "start_logit": 5.0471601486206055,
            "end_logit": 4.595705509185791,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup60p",
            "probability": 0.14240325638952103,
            "start_logit": 5.0471601486206055,
            "end_logit": 4.386673450469971,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup2p, and Nup1p",
            "probability": 0.13516869411515756,
            "start_logit": 4.785988807678223,
            "end_logit": 4.595705509185791,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup60p, Nup2p",
            "probability": 0.12450459309158063,
            "start_logit": 5.0471601486206055,
            "end_logit": 4.252353191375732,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup1p",
            "probability": 0.12266840719792298,
            "start_logit": 4.688950061798096,
            "end_logit": 4.595705509185791,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup2p",
            "probability": 0.0958870816723545,
            "start_logit": 4.785988807678223,
            "end_logit": 4.252353191375732,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup60p, Nup2p, and Nup1",
            "probability": 0.04955633709807094,
            "start_logit": 5.0471601486206055,
            "end_logit": 3.331120729446411,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup2p, and Nup1",
            "probability": 0.038165760994939485,
            "start_logit": 4.785988807678223,
            "end_logit": 3.331120729446411,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup1",
            "probability": 0.0346362235826383,
            "start_logit": 4.688950061798096,
            "end_logit": 3.331120729446411,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup60",
            "probability": 0.020319278091583817,
            "start_logit": 5.0471601486206055,
            "end_logit": 2.4395806789398193,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup60p, Nup2",
            "probability": 0.012641882605601926,
            "start_logit": 5.0471601486206055,
            "end_logit": 1.9650259017944336,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "nucleoporins Nup60p, Nup2p, and Nup1p",
            "probability": 0.011899856945510254,
            "start_logit": 2.3559916019439697,
            "end_logit": 4.595705509185791,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup2",
            "probability": 0.0097361326180475,
            "start_logit": 4.785988807678223,
            "end_logit": 1.9650259017944336,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "nucleoporins Nup60p",
            "probability": 0.009655177692865667,
            "start_logit": 2.3559916019439697,
            "end_logit": 4.386673450469971,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "nucleoporins Nup60p, Nup2p",
            "probability": 0.008441618544093948,
            "start_logit": 2.3559916019439697,
            "end_logit": 4.252353191375732,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "nucleoporins Nup60p, Nup2p, and Nup1",
            "probability": 0.0033600020998159922,
            "start_logit": 2.3559916019439697,
            "end_logit": 3.331120729446411,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup60p, Nup2p, and Nup",
            "probability": 0.0016476650053705317,
            "start_logit": 5.0471601486206055,
            "end_logit": -0.07263027876615524,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "nucleoporins Nup60",
            "probability": 0.0013776808588446775,
            "start_logit": 2.3559916019439697,
            "end_logit": 2.4395806789398193,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup2p, and Nup",
            "probability": 0.0012689474742705565,
            "start_logit": 4.785988807678223,
            "end_logit": -0.07263027876615524,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        },
        {
            "text": "Nup",
            "probability": 0.0011515962812659972,
            "start_logit": 4.688950061798096,
            "end_logit": -0.07263027876615524,
            "question_text": "Which proteins form the nuclear pore basket in human cells?"
        }
    ],
    "5c641179e842deac67000012": [
        {
            "text": "drastically reduced dbcAMP-induced neurite outgrowth",
            "probability": 0.4071248024820839,
            "start_logit": 5.150230407714844,
            "end_logit": 5.995071887969971,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "neurite outgrowth",
            "probability": 0.2775824410947149,
            "start_logit": 4.767228603363037,
            "end_logit": 5.995071887969971,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "reduced dbcAMP-induced neurite outgrowth",
            "probability": 0.18759808617049606,
            "start_logit": 4.375412464141846,
            "end_logit": 5.995071887969971,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "dbcAMP-induced neurite outgrowth",
            "probability": 0.04450531186858873,
            "start_logit": 2.9367191791534424,
            "end_logit": 5.995071887969971,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "drastically reduced dbcAMP-induced neurite outgrowth.",
            "probability": 0.023980668592662843,
            "start_logit": 5.150230407714844,
            "end_logit": 3.1632001399993896,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "neurite outgrowth.",
            "probability": 0.016350299678260568,
            "start_logit": 4.767228603363037,
            "end_logit": 3.1632001399993896,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "reduced dbcAMP-induced neurite outgrowth.",
            "probability": 0.011049996231242741,
            "start_logit": 4.375412464141846,
            "end_logit": 3.1632001399993896,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "drastically reduced",
            "probability": 0.0097299753578786,
            "start_logit": 5.150230407714844,
            "end_logit": 2.2611634731292725,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "outgrowth",
            "probability": 0.004773529663484691,
            "start_logit": 0.7041966319084167,
            "end_logit": 5.995071887969971,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "reduced",
            "probability": 0.0044834526034665725,
            "start_logit": 4.375412464141846,
            "end_logit": 2.2611634731292725,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "drastically reduced dbcAMP",
            "probability": 0.0035438746818432,
            "start_logit": 5.150230407714844,
            "end_logit": 1.2511727809906006,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "dbcAMP-induced neurite outgrowth.",
            "probability": 0.002621474122988852,
            "start_logit": 2.9367191791534424,
            "end_logit": 3.1632001399993896,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "reduced dbcAMP",
            "probability": 0.0016329737316141937,
            "start_logit": 4.375412464141846,
            "end_logit": 1.2511727809906006,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "drastically reduced dbcAMP-induced",
            "probability": 0.001607503174354884,
            "start_logit": 5.150230407714844,
            "end_logit": 0.4606342613697052,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "drastically",
            "probability": 0.0009836564363397851,
            "start_logit": 5.150230407714844,
            "end_logit": -0.030526483431458473,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "reduced dbcAMP-induced",
            "probability": 0.0007407176305237366,
            "start_logit": 4.375412464141846,
            "end_logit": 0.4606342613697052,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "induced neurite outgrowth",
            "probability": 0.000634495911914435,
            "start_logit": -1.3138138055801392,
            "end_logit": 5.995071887969971,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "wth",
            "probability": 0.00038816503699982556,
            "start_logit": -1.8052140474319458,
            "end_logit": 5.995071887969971,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "dbcAMP",
            "probability": 0.00038740270054062357,
            "start_logit": 2.9367191791534424,
            "end_logit": 1.2511727809906006,
            "question_text": "What are the effects of STEF depletion?"
        },
        {
            "text": "outgrowth.",
            "probability": 0.0002811728300004746,
            "start_logit": 0.7041966319084167,
            "end_logit": 3.1632001399993896,
            "question_text": "What are the effects of STEF depletion?"
        }
    ],
    "5c53131e7e3cb0e231000012": [
        {
            "text": "cough",
            "probability": 0.11837209442958371,
            "start_logit": 4.825622081756592,
            "end_logit": 4.915858745574951,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough, conjunctivitis",
            "probability": 0.10948203346170313,
            "start_logit": 4.825622081756592,
            "end_logit": 4.8377861976623535,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough, conjunctivitis, coryza",
            "probability": 0.10855091771998349,
            "start_logit": 4.825622081756592,
            "end_logit": 4.829245090484619,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever, cough",
            "probability": 0.10227660802267405,
            "start_logit": 4.679470062255859,
            "end_logit": 4.915858745574951,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever, cough, conjunctivitis",
            "probability": 0.0945953611435755,
            "start_logit": 4.679470062255859,
            "end_logit": 4.8377861976623535,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever, cough, conjunctivitis, coryza",
            "probability": 0.09379085261309368,
            "start_logit": 4.679470062255859,
            "end_logit": 4.829245090484619,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "coryza",
            "probability": 0.07999433593493989,
            "start_logit": 4.520358562469482,
            "end_logit": 4.829245090484619,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever",
            "probability": 0.0781467093847029,
            "start_logit": 4.679470062255859,
            "end_logit": 4.64676570892334,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "conjunctivitis",
            "probability": 0.06990927378302147,
            "start_logit": 4.3770599365234375,
            "end_logit": 4.8377861976623535,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "conjunctivitis, coryza",
            "probability": 0.06931471389722678,
            "start_logit": 4.3770599365234375,
            "end_logit": 4.829245090484619,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough, conjunctivitis, coryza, eruption",
            "probability": 0.012133615670226736,
            "start_logit": 4.825622081756592,
            "end_logit": 2.638005495071411,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough, conjunctivitis, coryza, eruption and increased serum immunoglobulin M (IgM) antibodies",
            "probability": 0.01104146300500234,
            "start_logit": 4.825622081756592,
            "end_logit": 2.5436832904815674,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever, cough, conjunctivitis, coryza, eruption",
            "probability": 0.010483763591255734,
            "start_logit": 4.679470062255859,
            "end_logit": 2.638005495071411,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "coryza, eruption",
            "probability": 0.008941615127873613,
            "start_logit": 4.520358562469482,
            "end_logit": 2.638005495071411,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "coryza, eruption and increased serum immunoglobulin M (IgM) antibodies",
            "probability": 0.00813677598851628,
            "start_logit": 4.520358562469482,
            "end_logit": 2.5436832904815674,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "conjunctivitis, coryza, eruption",
            "probability": 0.007747867234897126,
            "start_logit": 4.3770599365234375,
            "end_logit": 2.638005495071411,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "conjunctivitis, coryza, eruption and increased serum immunoglobulin M (IgM) antibodies",
            "probability": 0.0070504779256938335,
            "start_logit": 4.3770599365234375,
            "end_logit": 2.5436832904815674,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough,",
            "probability": 0.0038383594894608668,
            "start_logit": 4.825622081756592,
            "end_logit": 1.4870707988739014,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "fever, cough,",
            "probability": 0.0033164437179679365,
            "start_logit": 4.679470062255859,
            "end_logit": 1.4870707988739014,
            "question_text": "Please list symptoms of measles."
        },
        {
            "text": "cough, conjunctivitis,",
            "probability": 0.0028767178586007265,
            "start_logit": 4.825622081756592,
            "end_logit": 1.1986757516860962,
            "question_text": "Please list symptoms of measles."
        }
    ],
    "5c641c60e842deac67000013": [
        {
            "text": "MyGene2, matchbox",
            "probability": 0.07188278287570725,
            "start_logit": 3.8419933319091797,
            "end_logit": 3.5889549255371094,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral, DECIPHER, MyGene2, matchbox",
            "probability": 0.06598024231179049,
            "start_logit": 3.7563118934631348,
            "end_logit": 3.5889549255371094,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene2, matchbox, Australian Genomics Health Alliance Patient Archive, and Monarch Initiative",
            "probability": 0.06361819209171977,
            "start_logit": 3.8419933319091797,
            "end_logit": 3.466817617416382,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene",
            "probability": 0.05541986375306491,
            "start_logit": 3.8419933319091797,
            "end_logit": 3.3288562297821045,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral, DECIPHER",
            "probability": 0.05357641051116631,
            "start_logit": 3.7563118934631348,
            "end_logit": 3.3807084560394287,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "matchbox",
            "probability": 0.05271938315795608,
            "start_logit": 3.531939744949341,
            "end_logit": 3.5889549255371094,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene2",
            "probability": 0.052136623016336314,
            "start_logit": 3.8419933319091797,
            "end_logit": 3.2677857875823975,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "PhenomeCentral, DECIPHER, MyGene2, matchbox",
            "probability": 0.05202482028633351,
            "start_logit": 3.5186774730682373,
            "end_logit": 3.5889549255371094,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral, DECIPHER, MyGene",
            "probability": 0.05086914964931595,
            "start_logit": 3.7563118934631348,
            "end_logit": 3.3288562297821045,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "DECIPHER, MyGene2, matchbox",
            "probability": 0.04962592228806577,
            "start_logit": 3.4714698791503906,
            "end_logit": 3.5889549255371094,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral, DECIPHER, MyGene2",
            "probability": 0.04785550701180331,
            "start_logit": 3.7563118934631348,
            "end_logit": 3.2677857875823975,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "matchbox, Australian Genomics Health Alliance Patient Archive, and Monarch Initiative",
            "probability": 0.04665806901910136,
            "start_logit": 3.531939744949341,
            "end_logit": 3.466817617416382,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher, PhenomeCentral",
            "probability": 0.04647797264924974,
            "start_logit": 3.7563118934631348,
            "end_logit": 3.2385780811309814,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "GeneMatcher",
            "probability": 0.0456984383806895,
            "start_logit": 3.7563118934631348,
            "end_logit": 3.2216637134552,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "DECIPHER, MyGene2, matchbox, Australian Genomics Health Alliance Patient Archive, and Monarch Initiative",
            "probability": 0.043920273124510176,
            "start_logit": 3.4714698791503906,
            "end_logit": 3.466817617416382,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "PhenomeCentral, DECIPHER",
            "probability": 0.04224451185339423,
            "start_logit": 3.5186774730682373,
            "end_logit": 3.3807084560394287,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "MyGene2, matchbox, Australian Genomics Health Alliance Patient Archive",
            "probability": 0.04062501676923573,
            "start_logit": 3.8419933319091797,
            "end_logit": 3.0183022022247314,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "DECIPHER",
            "probability": 0.04029659018129329,
            "start_logit": 3.4714698791503906,
            "end_logit": 3.3807084560394287,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "PhenomeCentral, DECIPHER, MyGene",
            "probability": 0.04010986131451887,
            "start_logit": 3.5186774730682373,
            "end_logit": 3.3288562297821045,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        },
        {
            "text": "DECIPHER, MyGene",
            "probability": 0.0382603697547475,
            "start_logit": 3.4714698791503906,
            "end_logit": 3.3288562297821045,
            "question_text": "Which databases can exchange data using Matchmaker Exchange's API?"
        }
    ],
    "5c5315727e3cb0e231000014": [
        {
            "text": "MERTK",
            "probability": 0.8218725710994956,
            "start_logit": 5.461372375488281,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and MERTK",
            "probability": 0.10353197431165574,
            "start_logit": 3.389667510986328,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL (also known as UFO) and MERTK",
            "probability": 0.051799864511818706,
            "start_logit": 2.697174549102783,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL",
            "probability": 0.01271805288284129,
            "start_logit": 3.389667510986328,
            "end_logit": 1.8924672603607178,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL",
            "probability": 0.0063631879964174175,
            "start_logit": 2.697174549102783,
            "end_logit": 1.8924672603607178,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "ME",
            "probability": 0.002315310437880579,
            "start_logit": 5.461372375488281,
            "end_logit": -1.8827162981033325,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and ME",
            "probability": 0.00029166158989523143,
            "start_logit": 3.389667510986328,
            "end_logit": -1.8827162981033325,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (TAM)",
            "probability": 0.0002454518635556565,
            "start_logit": 5.461372375488281,
            "end_logit": -4.1269145011901855,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3",
            "probability": 0.00018517119842546405,
            "start_logit": 2.697174549102783,
            "end_logit": -1.6445367336273193,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "TYRO3, AXL (also known as UFO) and ME",
            "probability": 0.000145926231392013,
            "start_logit": 2.697174549102783,
            "end_logit": -1.8827162981033325,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERT",
            "probability": 0.00012745660031500663,
            "start_logit": 5.461372375488281,
            "end_logit": -4.7822394371032715,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (TAM) family",
            "probability": 7.93549189099014e-05,
            "start_logit": 5.461372375488281,
            "end_logit": -5.25608491897583,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "K",
            "probability": 6.98239215951552e-05,
            "start_logit": -3.911991596221924,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (",
            "probability": 5.3024856975077035e-05,
            "start_logit": 5.461372375488281,
            "end_logit": -5.659254550933838,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "MERTK (TAM) family of receptor tyrosine kinases",
            "probability": 5.0595779319744445e-05,
            "start_logit": 5.461372375488281,
            "end_logit": -5.706147193908691,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "L (also known as UFO) and MERTK",
            "probability": 4.322543809355085e-05,
            "start_logit": -4.391539096832275,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO)",
            "probability": 3.432033282163536e-05,
            "start_logit": 3.389667510986328,
            "end_logit": -4.0225725173950195,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "AXL (also known as UFO) and MERTK (TAM)",
            "probability": 3.091977628404863e-05,
            "start_logit": 3.389667510986328,
            "end_logit": -4.1269145011901855,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "A",
            "probability": 2.159731225421386e-05,
            "start_logit": 3.389667510986328,
            "end_logit": -4.48574161529541,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        },
        {
            "text": "3, AXL (also known as UFO) and MERTK",
            "probability": 2.0508940053590804e-05,
            "start_logit": -5.1371073722839355,
            "end_logit": 3.9893252849578857,
            "question_text": "What membrane proteins constitute TAM family of receptor tyrosine kinases (RTKs)?"
        }
    ],
    "5c645313e842deac67000019": [
        {
            "text": "clustered protocadherin (Pcdh) cell surface proteins are encoded by three closely linked gene clusters (",
            "probability": 0.09462422024386796,
            "start_logit": -4.958364963531494,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "clustered protocadherin",
            "probability": 0.09345080234099178,
            "start_logit": -4.958364963531494,
            "end_logit": -4.573976993560791,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "protocadherin (Pcdh) cell surface proteins are encoded by three closely linked gene clusters (",
            "probability": 0.07001648570193915,
            "start_logit": -5.259547710418701,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "protocadherin",
            "probability": 0.06914822388052187,
            "start_logit": -5.259547710418701,
            "end_logit": -4.573976993560791,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "are encoded by three closely linked gene clusters (",
            "probability": 0.06484000335303274,
            "start_logit": -5.336355686187744,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "cell surface proteins are encoded by three closely linked gene clusters (",
            "probability": 0.06149252500095469,
            "start_logit": -5.389362812042236,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "encoded by three closely linked gene clusters (",
            "probability": 0.0586111984086464,
            "start_logit": -5.437352657318115,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "by three closely linked gene clusters (",
            "probability": 0.05509363662077333,
            "start_logit": -5.499244213104248,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "clustered protocadherin (Pcdh) cell surface proteins are encoded by three closely linked gene clusters",
            "probability": 0.045693398675957134,
            "start_logit": -4.958364963531494,
            "end_logit": -5.289458274841309,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "gene clusters (",
            "probability": 0.044146380276705637,
            "start_logit": -5.720767498016357,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "The vertebrate clustered protocadherin (Pcdh) cell surface proteins are encoded by three closely linked gene clusters (",
            "probability": 0.03917913328615617,
            "start_logit": -5.840134143829346,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "(",
            "probability": 0.03882973923182514,
            "start_logit": -5.84909200668335,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "The vertebrate clustered protocadherin",
            "probability": 0.03869327991480301,
            "start_logit": -5.840134143829346,
            "end_logit": -4.573976993560791,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "clusters (",
            "probability": 0.03821753337851538,
            "start_logit": -5.864984035491943,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "protocadherin (Pcdh) cell surface proteins are encoded by three closely linked gene clusters",
            "probability": 0.0338104893950287,
            "start_logit": -5.259547710418701,
            "end_logit": -5.289458274841309,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "clustered protocadherin (Pcdh) cell surface proteins are",
            "probability": 0.03324300357067072,
            "start_logit": -4.958364963531494,
            "end_logit": -5.60756778717041,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "are encoded by three closely linked gene clusters",
            "probability": 0.031310800931567205,
            "start_logit": -5.336355686187744,
            "end_logit": -5.289458274841309,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "vertebrate clustered protocadherin (Pcdh) cell surface proteins are encoded by three closely linked gene clusters (",
            "probability": 0.03013928572940999,
            "start_logit": -6.1024489402771,
            "end_logit": -4.561498641967773,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "vertebrate clustered protocadherin",
            "probability": 0.029765533878523983,
            "start_logit": -6.1024489402771,
            "end_logit": -4.573976993560791,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        },
        {
            "text": "cell surface proteins are encoded by three closely linked gene clusters",
            "probability": 0.02969432618010895,
            "start_logit": -5.389362812042236,
            "end_logit": -5.289458274841309,
            "question_text": "What are the effects of the deletion of all three Pcdh clusters (tricluster deletion) in mice?"
        }
    ],
    "5c6ffdd47c78d69471000058": [
        {
            "text": "miR-423-5p",
            "probability": 0.5628178599132083,
            "start_logit": 4.2229790687561035,
            "end_logit": 3.4918060302734375,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c-miRNAs such as miR-423-5p",
            "probability": 0.1420380138468037,
            "start_logit": 2.8461177349090576,
            "end_logit": 3.4918060302734375,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "c-miRNAs",
            "probability": 0.08553270140289629,
            "start_logit": 2.8461177349090576,
            "end_logit": 2.984610080718994,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs such as miR-423-5p",
            "probability": 0.047504992940829216,
            "start_logit": 1.7508578300476074,
            "end_logit": 3.4918060302734375,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs",
            "probability": 0.028606640337403427,
            "start_logit": 1.7508578300476074,
            "end_logit": 2.984610080718994,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-133",
            "probability": 0.020908990537333284,
            "start_logit": 2.3607354164123535,
            "end_logit": 2.0612728595733643,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-1, miR-133",
            "probability": 0.018800180746305527,
            "start_logit": 2.254422664642334,
            "end_logit": 2.0612728595733643,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-423",
            "probability": 0.011239625524463353,
            "start_logit": 4.2229790687561035,
            "end_logit": -0.42170450091362,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "MicroRNAs",
            "probability": 0.00990720574664712,
            "start_logit": 1.5518711805343628,
            "end_logit": 2.123220205307007,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs play a crucial role in the pathogenesis of heart failure. Some miRNAs as miR-1, miR-133",
            "probability": 0.009687592977926363,
            "start_logit": 1.5914021730422974,
            "end_logit": 2.0612728595733643,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "MicroRNAs (miRNAs",
            "probability": 0.008579290538879703,
            "start_logit": 1.5518711805343628,
            "end_logit": 1.97930908203125,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-133 and miR-208a",
            "probability": 0.008264895915551452,
            "start_logit": 2.3607354164123535,
            "end_logit": 1.133110761642456,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-208a",
            "probability": 0.008151809130178298,
            "start_logit": 2.3469581604003906,
            "end_logit": 1.133110761642456,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-1",
            "probability": 0.0074672408539683335,
            "start_logit": 2.254422664642334,
            "end_logit": 1.1379319429397583,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-1, miR-133 and miR-208a",
            "probability": 0.007431326576208151,
            "start_logit": 2.254422664642334,
            "end_logit": 1.133110761642456,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs in response to exercise suggests a potential value of circulating miRNAs",
            "probability": 0.006569531865930844,
            "start_logit": 1.5902739763259888,
            "end_logit": 1.6739976406097412,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs as miR-1, miR-133",
            "probability": 0.005631691659847087,
            "start_logit": 1.0489660501480103,
            "end_logit": 2.0612728595733643,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs play a crucial role in the pathogenesis of heart failure. Some miRNAs as miR-1",
            "probability": 0.003847813541665239,
            "start_logit": 1.5914021730422974,
            "end_logit": 1.1379319429397583,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miR-206 change their expression quickly in response to physical activity. The differential regulation of miRNAs",
            "probability": 0.0038108775643847363,
            "start_logit": 1.3963803052902222,
            "end_logit": 1.3233082294464111,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        },
        {
            "text": "miRNAs) are a class of non-coding small RNAs representing one of the most exciting areas of modern medical science. miRNAs",
            "probability": 0.0032017183795696263,
            "start_logit": 2.1887450218200684,
            "end_logit": 0.35677167773246765,
            "question_text": "What micro-RNAs are useful in the diagnosis and prognosis of Heart Failure?"
        }
    ],
    "5c5f11c31a4c55d80b000015": [
        {
            "text": "CPSF) 160",
            "probability": 0.23526016942405298,
            "start_logit": 4.527200222015381,
            "end_logit": 4.700150489807129,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "polyadenylation specificity factor (CPSF) 160",
            "probability": 0.11344439767887998,
            "start_logit": 3.797821044921875,
            "end_logit": 4.700150489807129,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF 73",
            "probability": 0.10617986617094757,
            "start_logit": 4.346511363983154,
            "end_logit": 4.085281848907471,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF complex to the 3'-end of pre-mRNA and then defines cleavage by CPSF 73",
            "probability": 0.09280517433528745,
            "start_logit": 4.1763529777526855,
            "end_logit": 4.120808124542236,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF",
            "probability": 0.042541943870161004,
            "start_logit": 4.527200222015381,
            "end_logit": 2.9899489879608154,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF complex",
            "probability": 0.04214293309357815,
            "start_logit": 4.1763529777526855,
            "end_logit": 3.3313727378845215,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF complex to pre-mRNA and then CPSF 73",
            "probability": 0.03725860054919099,
            "start_logit": 3.299259662628174,
            "end_logit": 4.085281848907471,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF 160",
            "probability": 0.03654671862604687,
            "start_logit": 3.932591199874878,
            "end_logit": 3.4326589107513428,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF) 160 and 73 subunits and also the targeted pre-mRNA",
            "probability": 0.03554646358116079,
            "start_logit": 4.527200222015381,
            "end_logit": 2.8102991580963135,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF 160. The data support a model where Star-PAP binds to the RNA, recruits the CPSF complex",
            "probability": 0.03302633361662387,
            "start_logit": 3.932591199874878,
            "end_logit": 3.3313727378845215,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF) 160 and 73",
            "probability": 0.031556781242757674,
            "start_logit": 4.527200222015381,
            "end_logit": 2.69124698638916,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF 160. The data support a model where Star-PAP binds to the RNA, recruits the CPSF",
            "probability": 0.027495723560369258,
            "start_logit": 3.932591199874878,
            "end_logit": 3.1480979919433594,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF 160. The data support a model where Star-PAP binds to the RNA",
            "probability": 0.02549482876238794,
            "start_logit": 3.932591199874878,
            "end_logit": 3.072543144226074,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "RNA, recruits the CPSF complex",
            "probability": 0.024656840325058865,
            "start_logit": 3.6403403282165527,
            "end_logit": 3.3313727378845215,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "polyadenylation specificity factor",
            "probability": 0.021318249185840535,
            "start_logit": 3.797821044921875,
            "end_logit": 3.0284011363983154,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "RNA, recruits the CPSF",
            "probability": 0.020527790741771367,
            "start_logit": 3.6403403282165527,
            "end_logit": 3.1480979919433594,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "polyadenylation specificity factor (CPSF",
            "probability": 0.020514076863304816,
            "start_logit": 3.797821044921875,
            "end_logit": 2.9899489879608154,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "RNA",
            "probability": 0.019033960269586196,
            "start_logit": 3.6403403282165527,
            "end_logit": 3.072543144226074,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "CPSF) 160 and 73 subunits",
            "probability": 0.017508349639525796,
            "start_logit": 4.527200222015381,
            "end_logit": 2.1021363735198975,
            "question_text": "List proteins interacting with Star-PAP"
        },
        {
            "text": "polyadenylation specificity factor (CPSF) 160 and 73 subunits and also the targeted pre-mRNA",
            "probability": 0.017140798463468006,
            "start_logit": 3.797821044921875,
            "end_logit": 2.8102991580963135,
            "question_text": "List proteins interacting with Star-PAP"
        }
    ],
    "5c654b3de842deac67000024": [
        {
            "text": "Multiple Myeloma",
            "probability": 0.26449835068787797,
            "start_logit": 6.98222017288208,
            "end_logit": 6.332045555114746,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM), and non-Hodgkin's lymphoma",
            "probability": 0.1546020485522699,
            "start_logit": 6.98222017288208,
            "end_logit": 5.795064926147461,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia (CLL), Multiple Myeloma",
            "probability": 0.14845299735404693,
            "start_logit": 6.404653549194336,
            "end_logit": 6.332045555114746,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia",
            "probability": 0.12130509059125553,
            "start_logit": 6.404653549194336,
            "end_logit": 6.1300859451293945,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "non-Hodgkin's lymphoma",
            "probability": 0.08291544387325572,
            "start_logit": 6.359187126159668,
            "end_logit": 5.795064926147461,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM), and non-Hodgkin's lymphoma (NHL)",
            "probability": 0.06281526790488454,
            "start_logit": 6.98222017288208,
            "end_logit": 4.894408702850342,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM)",
            "probability": 0.05058195460446571,
            "start_logit": 6.98222017288208,
            "end_logit": 4.677805423736572,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia (CLL)",
            "probability": 0.03858795595811772,
            "start_logit": 6.404653549194336,
            "end_logit": 4.98471736907959,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "non-Hodgkin's lymphoma (NHL)",
            "probability": 0.033688789179207194,
            "start_logit": 6.359187126159668,
            "end_logit": 4.894408702850342,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia (CLL), Multiple Myeloma (MM)",
            "probability": 0.028389752728251744,
            "start_logit": 6.404653549194336,
            "end_logit": 4.677805423736572,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "leukemia (CLL), Multiple Myeloma",
            "probability": 0.0021305359686910395,
            "start_logit": 2.1607587337493896,
            "end_logit": 6.332045555114746,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "leukemia",
            "probability": 0.001740920448198344,
            "start_logit": 2.1607587337493896,
            "end_logit": 6.1300859451293945,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Myeloma",
            "probability": 0.0016283562215462276,
            "start_logit": 1.8919562101364136,
            "end_logit": 6.332045555114746,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "lymphatic leukemia (CLL), Multiple Myeloma",
            "probability": 0.0015897671745390154,
            "start_logit": 1.867972731590271,
            "end_logit": 6.332045555114746,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Multiple Myeloma (MM),",
            "probability": 0.0014266281324703083,
            "start_logit": 6.98222017288208,
            "end_logit": 1.1095242500305176,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "(CLL), Multiple Myeloma",
            "probability": 0.0013492728854479466,
            "start_logit": 1.7039510011672974,
            "end_logit": 6.332045555114746,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "lymphatic leukemia",
            "probability": 0.0012990431622376568,
            "start_logit": 1.867972731590271,
            "end_logit": 6.1300859451293945,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "leukemia (CLL), Multiple Myeloma (MM), and non-Hodgkin's lymphoma",
            "probability": 0.0012453205262615095,
            "start_logit": 2.1607587337493896,
            "end_logit": 5.795064926147461,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "Myeloma (MM), and non-Hodgkin's lymphoma",
            "probability": 0.0009517912189968838,
            "start_logit": 1.8919562101364136,
            "end_logit": 5.795064926147461,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        },
        {
            "text": "chronic lymphatic leukemia (CLL), Multiple Myeloma (MM),",
            "probability": 0.0008007128279780607,
            "start_logit": 6.404653549194336,
            "end_logit": 1.1095242500305176,
            "question_text": "Name 3 diseases for which lucatumumab is being tested?"
        }
    ],
    "5c658a8f7c78d69471000007": [
        {
            "text": "Acute myeloid leukemia",
            "probability": 0.9910975311654138,
            "start_logit": 0.34904757142066956,
            "end_logit": 0.13857607543468475,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Acute",
            "probability": 0.002940014669644299,
            "start_logit": 0.34904757142066956,
            "end_logit": -5.681822299957275,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "leukemia",
            "probability": 0.002601347760384538,
            "start_logit": -5.593735694885254,
            "end_logit": 0.13857607543468475,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "mia",
            "probability": 0.001624097436736153,
            "start_logit": -6.064813137054443,
            "end_logit": 0.13857607543468475,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "myeloid leukemia",
            "probability": 0.0013002683238528307,
            "start_logit": -6.287194728851318,
            "end_logit": 0.13857607543468475,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "toxicity",
            "probability": 6.846885990866269e-05,
            "start_logit": -4.454759120941162,
            "end_logit": -4.637806415557861,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Idhifa",
            "probability": 6.370096582546765e-05,
            "start_logit": -3.880899429321289,
            "end_logit": -5.2838454246521,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "pharmacokinetics, mode of action and toxicity",
            "probability": 3.872972044180904e-05,
            "start_logit": -5.02453088760376,
            "end_logit": -4.637806415557861,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Idhifa to treat R/R AML with IDH2 mutation",
            "probability": 3.700315008293283e-05,
            "start_logit": -3.880899429321289,
            "end_logit": -5.827042102813721,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Idhifa to treat R/R AML with IDH2",
            "probability": 3.099902628224825e-05,
            "start_logit": -3.880899429321289,
            "end_logit": -6.00408935546875,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Enasidenib formerly known as AG-221 which is being marketed under the name Idhifa",
            "probability": 2.4730599311768326e-05,
            "start_logit": -4.827057838439941,
            "end_logit": -5.2838454246521,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "toxicity studies",
            "probability": 2.4521301037859603e-05,
            "start_logit": -4.454759120941162,
            "end_logit": -5.664643287658691,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "toxicity studies.",
            "probability": 2.4432795647999084e-05,
            "start_logit": -4.454759120941162,
            "end_logit": -5.668259143829346,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Idhifa to treat R/R AML",
            "probability": 2.3596819972012133e-05,
            "start_logit": -3.880899429321289,
            "end_logit": -6.276933193206787,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "pharmacokinetics",
            "probability": 2.2018779538680218e-05,
            "start_logit": -5.02453088760376,
            "end_logit": -5.202517986297607,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "AG-221 which is being marketed under the name Idhifa",
            "probability": 1.754736110732249e-05,
            "start_logit": -5.170195579528809,
            "end_logit": -5.2838454246521,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "Enasidenib formerly known as AG-221",
            "probability": 1.7161028035752187e-05,
            "start_logit": -4.827057838439941,
            "end_logit": -5.649245738983154,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "IDH2 mutation",
            "probability": 1.6139130458921873e-05,
            "start_logit": -4.710655689239502,
            "end_logit": -5.827042102813721,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "pharmacokinetics, mode of action and toxicity studies",
            "probability": 1.3870584895566336e-05,
            "start_logit": -5.02453088760376,
            "end_logit": -5.664643287658691,
            "question_text": "Name 4 side effects of enasidenib"
        },
        {
            "text": "pharmacokinetics, mode of action and toxicity studies.",
            "probability": 1.3820521421288194e-05,
            "start_logit": -5.02453088760376,
            "end_logit": -5.668259143829346,
            "question_text": "Name 4 side effects of enasidenib"
        }
    ],
    "5c76c1457c78d694710000a6": [
        {
            "text": "psoriasis",
            "probability": 0.13883199029982488,
            "start_logit": 5.0706281661987305,
            "end_logit": 5.112545967102051,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "Beh\u00e7et's disease",
            "probability": 0.11686706783583246,
            "start_logit": 4.736894130706787,
            "end_logit": 5.274052619934082,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, birdshot chorioretinopathy, Beh\u00e7et's disease",
            "probability": 0.10930353720320544,
            "start_logit": 4.669985771179199,
            "end_logit": 5.274052619934082,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "Beh\u00e7et's disease and psoriasis",
            "probability": 0.09943761510805181,
            "start_logit": 4.736894130706787,
            "end_logit": 5.112545967102051,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "birdshot chorioretinopathy, Beh\u00e7et's disease",
            "probability": 0.09789639790305225,
            "start_logit": 4.55976676940918,
            "end_logit": 5.274052619934082,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, birdshot chorioretinopathy, Beh\u00e7et's disease and psoriasis",
            "probability": 0.09300210284756089,
            "start_logit": 4.669985771179199,
            "end_logit": 5.112545967102051,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis",
            "probability": 0.09276147818818938,
            "start_logit": 4.669985771179199,
            "end_logit": 5.109955310821533,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, birdshot chorioretinopathy",
            "probability": 0.0878553368331732,
            "start_logit": 4.669985771179199,
            "end_logit": 5.055615425109863,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "birdshot chorioretinopathy, Beh\u00e7et's disease and psoriasis",
            "probability": 0.08329621436915774,
            "start_logit": 4.55976676940918,
            "end_logit": 5.112545967102051,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "birdshot chorioretinopathy",
            "probability": 0.07868657531674812,
            "start_logit": 4.55976676940918,
            "end_logit": 5.055615425109863,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis,",
            "probability": 0.0002814038599447004,
            "start_logit": 4.669985771179199,
            "end_logit": -0.688040554523468,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "chorioretinopathy, Beh\u00e7et's disease",
            "probability": 0.00028097109800961467,
            "start_logit": -1.2936464548110962,
            "end_logit": 5.274052619934082,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "chorioretinopathy, Beh\u00e7et's disease and psoriasis",
            "probability": 0.00023906731312548933,
            "start_logit": -1.2936464548110962,
            "end_logit": 5.112545967102051,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "chorioretinopathy",
            "probability": 0.0002258372518185743,
            "start_logit": -1.2936464548110962,
            "end_logit": 5.055615425109863,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "psoriasis.",
            "probability": 0.000222701767577128,
            "start_logit": 5.0706281661987305,
            "end_logit": -1.322640299797058,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, birdshot chorioretinopathy,",
            "probability": 0.00019419589196213694,
            "start_logit": 4.669985771179199,
            "end_logit": -1.0589640140533447,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "birdshot chorioretinopathy,",
            "probability": 0.00017392921397703847,
            "start_logit": 4.55976676940918,
            "end_logit": -1.0589640140533447,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "Beh\u00e7et's disease and psoriasis.",
            "probability": 0.00015950886103694502,
            "start_logit": 4.736894130706787,
            "end_logit": -1.322640299797058,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "ankylosing spondylitis, birdshot chorioretinopathy, Beh\u00e7et's disease and psoriasis.",
            "probability": 0.00014918559222418481,
            "start_logit": 4.669985771179199,
            "end_logit": -1.322640299797058,
            "question_text": "List MHC-I-associated inflammatory disorders."
        },
        {
            "text": "Beh\u00e7et's",
            "probability": 0.00013488324552795306,
            "start_logit": 4.736894130706787,
            "end_logit": -1.4903302192687988,
            "question_text": "List MHC-I-associated inflammatory disorders."
        }
    ],
    "5c6e146a7c78d6947100004c": [
        {
            "text": "glecaprevir",
            "probability": 0.23514061425529859,
            "start_logit": 4.124802112579346,
            "end_logit": 3.930060625076294,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir",
            "probability": 0.22735372610677385,
            "start_logit": 4.124802112579346,
            "end_logit": 3.8963840007781982,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pibrentasvir",
            "probability": 0.19743106721343426,
            "start_logit": 3.983684539794922,
            "end_logit": 3.8963840007781982,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [glecaprevir",
            "probability": 0.12004995071150468,
            "start_logit": 4.124802112579346,
            "end_logit": 3.257784843444824,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pibrentasvir [glecaprevir",
            "probability": 0.10424984139807499,
            "start_logit": 3.983684539794922,
            "end_logit": 3.257784843444824,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pibrentasvir [glecaprevir/pibrentasvir",
            "probability": 0.08748255786888273,
            "start_logit": 3.983684539794922,
            "end_logit": 3.0824339389801025,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir/pibrentasvir",
            "probability": 0.02664922891865754,
            "start_logit": 2.7950053215026855,
            "end_logit": 3.0824339389801025,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir",
            "probability": 0.00024037073967709494,
            "start_logit": -2.7609543800354004,
            "end_logit": 3.930060625076294,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir and the HCV NS5A inhibitor pibrentasvir",
            "probability": 0.0002324106513275277,
            "start_logit": -2.7609543800354004,
            "end_logit": 3.8963840007781982,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "g",
            "probability": 0.00022396695618753627,
            "start_logit": 4.124802112579346,
            "end_logit": -3.0263798236846924,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir and the HCV NS5A inhibitor",
            "probability": 0.00019872786473022975,
            "start_logit": 4.124802112579346,
            "end_logit": -3.145941972732544,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir and the HCV NS5A inhibitor pibrentasvir [glecaprevir",
            "probability": 0.00012272016700353127,
            "start_logit": -2.7609543800354004,
            "end_logit": 3.257784843444824,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir [glecaprevir",
            "probability": 0.0001072810440885744,
            "start_logit": -2.895409107208252,
            "end_logit": 3.257784843444824,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir and the HCV NS5A inhibitor pibrentasvir [glecaprevir/pibrentasvir",
            "probability": 0.00010298216253942061,
            "start_logit": -2.7609543800354004,
            "end_logit": 3.0824339389801025,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir [glecaprevir/pibrentasvir",
            "probability": 9.002622950643809e-05,
            "start_logit": -2.895409107208252,
            "end_logit": 3.0824339389801025,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir and the HCV NS5A inhibitor p",
            "probability": 7.070771389594187e-05,
            "start_logit": 4.124802112579346,
            "end_logit": -4.179323673248291,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "glecaprevir and the HCV NS5A inhibitor pibrentasvir [g",
            "probability": 6.842229260729521e-05,
            "start_logit": 4.124802112579346,
            "end_logit": -4.212179660797119,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "vir/pibrentasvir",
            "probability": 6.457898805337568e-05,
            "start_logit": -3.227621078491211,
            "end_logit": 3.0824339389801025,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "p",
            "probability": 6.140167418299486e-05,
            "start_logit": 3.983684539794922,
            "end_logit": -4.179323673248291,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        },
        {
            "text": "pibrentasvir [g",
            "probability": 5.9417043573343424e-05,
            "start_logit": 3.983684539794922,
            "end_logit": -4.212179660797119,
            "question_text": "Which two drugs are included in the MAVYRET pill?"
        }
    ],
    "5c61bd04e842deac67000002": [
        {
            "text": "valsartan",
            "probability": 0.5929657118662327,
            "start_logit": 4.264132022857666,
            "end_logit": 3.572483539581299,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril/valsartan",
            "probability": 0.2902270555313367,
            "start_logit": 3.549659013748169,
            "end_logit": 3.572483539581299,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril",
            "probability": 0.11374169935610544,
            "start_logit": 3.549659013748169,
            "end_logit": 2.6357500553131104,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "v",
            "probability": 0.00039381329333605935,
            "start_logit": 4.264132022857666,
            "end_logit": -3.7445313930511475,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "ril/valsartan",
            "probability": 0.00038704271825044776,
            "start_logit": -3.0702247619628906,
            "end_logit": 3.572483539581299,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan (S/V) on the renin-angiotensin-aldosterone",
            "probability": 0.0003407082939233818,
            "start_logit": 4.264132022857666,
            "end_logit": -3.8893816471099854,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan (S/V)",
            "probability": 0.0003033013302217721,
            "start_logit": 4.264132022857666,
            "end_logit": -4.00568151473999,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "artan",
            "probability": 0.00019612733634478583,
            "start_logit": -3.749995708465576,
            "end_logit": 3.572483539581299,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril/v",
            "probability": 0.00019275190835959667,
            "start_logit": 3.549659013748169,
            "end_logit": -3.7445313930511475,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril/valsartan (S/V) on the renin-angiotensin-aldosterone",
            "probability": 0.00016675966748444182,
            "start_logit": 3.549659013748169,
            "end_logit": -3.8893816471099854,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "an",
            "probability": 0.00016380630510249715,
            "start_logit": -3.930075168609619,
            "end_logit": 3.572483539581299,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "ril",
            "probability": 0.00015168433010704946,
            "start_logit": -3.0702247619628906,
            "end_logit": 2.6357500553131104,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sacubitril/valsartan (S/V)",
            "probability": 0.00014845082986663554,
            "start_logit": 3.549659013748169,
            "end_logit": -4.00568151473999,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "sa",
            "probability": 0.0001349462223595928,
            "start_logit": 3.549659013748169,
            "end_logit": -4.1010589599609375,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "bitril/valsartan",
            "probability": 0.00010559571327542937,
            "start_logit": -4.369142055511475,
            "end_logit": 3.572483539581299,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan (S/V) on the renin-angiotensin-aldosterone system",
            "probability": 0.00010050868581218824,
            "start_logit": 4.264132022857666,
            "end_logit": -5.110164165496826,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "effects of sacubitril/valsartan",
            "probability": 8.650779432189517e-05,
            "start_logit": -4.568525314331055,
            "end_logit": 3.572483539581299,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsartan (",
            "probability": 6.81578886593273e-05,
            "start_logit": 4.264132022857666,
            "end_logit": -5.498581409454346,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "vals",
            "probability": 6.685814760471736e-05,
            "start_logit": 4.264132022857666,
            "end_logit": -5.5178351402282715,
            "question_text": "Which two drugs are included in the Entresto pill?"
        },
        {
            "text": "valsart",
            "probability": 5.8512781295476135e-05,
            "start_logit": 4.264132022857666,
            "end_logit": -5.651163101196289,
            "question_text": "Which two drugs are included in the Entresto pill?"
        }
    ],
    "5c6585287c78d69471000004": [
        {
            "text": "Rydapt",
            "probability": 0.4915823839682555,
            "start_logit": -0.16880866885185242,
            "end_logit": -4.415761470794678,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "R",
            "probability": 0.22957861793751125,
            "start_logit": -0.16880866885185242,
            "end_logit": -5.177145481109619,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Rydap",
            "probability": 0.08332619470715963,
            "start_logit": -0.16880866885185242,
            "end_logit": -6.1906280517578125,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Midostaurin",
            "probability": 0.030265032242819557,
            "start_logit": -3.3148274421691895,
            "end_logit": -4.057379245758057,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Midostaurin (PKC412, Rydapt",
            "probability": 0.021149383786050562,
            "start_logit": -3.3148274421691895,
            "end_logit": -4.415761470794678,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "(PKC412, Rydapt",
            "probability": 0.01883946585186299,
            "start_logit": -3.4304842948913574,
            "end_logit": -4.415761470794678,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Midostaurin (PKC412,",
            "probability": 0.0151023050984774,
            "start_logit": -3.3148274421691895,
            "end_logit": -4.7525248527526855,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "(PKC412,",
            "probability": 0.013452844019731722,
            "start_logit": -3.4304842948913574,
            "end_logit": -4.7525248527526855,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Midostaurin (PKC412",
            "probability": 0.012688861702327118,
            "start_logit": -3.3148274421691895,
            "end_logit": -4.926647663116455,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "(PKC412",
            "probability": 0.01130299488430837,
            "start_logit": -3.4304842948913574,
            "end_logit": -4.926647663116455,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Midostaurin (",
            "probability": 0.010618560785769005,
            "start_logit": -3.3148274421691895,
            "end_logit": -5.104768753051758,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Midostaurin (PKC412, R",
            "probability": 0.00987717716944276,
            "start_logit": -3.3148274421691895,
            "end_logit": -5.177145481109619,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "PKC412, Rydapt",
            "probability": 0.00977346921935489,
            "start_logit": -4.086766719818115,
            "end_logit": -4.415761470794678,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "(",
            "probability": 0.009458810495054315,
            "start_logit": -3.4304842948913574,
            "end_logit": -5.104768753051758,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "(PKC412, R",
            "probability": 0.008798400174630638,
            "start_logit": -3.4304842948913574,
            "end_logit": -5.177145481109619,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "PKC412,",
            "probability": 0.006979017238252998,
            "start_logit": -4.086766719818115,
            "end_logit": -4.7525248527526855,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "PKC412",
            "probability": 0.00586372636341967,
            "start_logit": -4.086766719818115,
            "end_logit": -4.926647663116455,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "PKC412, R",
            "probability": 0.004564401876490345,
            "start_logit": -4.086766719818115,
            "end_logit": -5.177145481109619,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "Midostaurin (PKC412, Rydap",
            "probability": 0.0035849487873566605,
            "start_logit": -3.3148274421691895,
            "end_logit": -6.1906280517578125,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        },
        {
            "text": "(PKC412, Rydap",
            "probability": 0.003193403691725035,
            "start_logit": -3.4304842948913574,
            "end_logit": -6.1906280517578125,
            "question_text": "For which indications has midostaurin received FDA and EMA approval?"
        }
    ],
    "5c73ad087c78d69471000091": [
        {
            "text": "ivacaftor",
            "probability": 0.4342691211947175,
            "start_logit": 5.750826358795166,
            "end_logit": 5.375646114349365,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor and ivacaftor",
            "probability": 0.3044528165881882,
            "start_logit": 5.3956780433654785,
            "end_logit": 5.375646114349365,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor",
            "probability": 0.2586052760242124,
            "start_logit": 5.3956780433654785,
            "end_logit": 5.212432861328125,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "combination therapy of lumacaftor and ivacaftor",
            "probability": 0.0007605253120566607,
            "start_logit": -0.5965839624404907,
            "end_logit": 5.375646114349365,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "combination therapy of lumacaftor",
            "probability": 0.0006459978280110399,
            "start_logit": -0.5965839624404907,
            "end_logit": 5.212432861328125,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "i",
            "probability": 0.0001484334230310413,
            "start_logit": 5.750826358795166,
            "end_logit": -2.6056370735168457,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "The combination therapy of lumacaftor and ivacaftor",
            "probability": 0.00014519657753751434,
            "start_logit": -2.252504825592041,
            "end_logit": 5.375646114349365,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "The combination therapy of lumacaftor",
            "probability": 0.0001233314292593627,
            "start_logit": -2.252504825592041,
            "end_logit": 5.212432861328125,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor and i",
            "probability": 0.00010406213914841955,
            "start_logit": 5.3956780433654785,
            "end_logit": -2.6056370735168457,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "ivacaft",
            "probability": 9.914952427004419e-05,
            "start_logit": 5.750826358795166,
            "end_logit": -3.0091445446014404,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "therapy of lumacaftor and ivacaftor",
            "probability": 8.984591448095842e-05,
            "start_logit": -2.732497215270996,
            "end_logit": 5.375646114349365,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "therapy of lumacaftor",
            "probability": 7.63160209006175e-05,
            "start_logit": -2.732497215270996,
            "end_logit": 5.212432861328125,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "l",
            "probability": 7.1662924658873e-05,
            "start_logit": 5.3956780433654785,
            "end_logit": -2.978651762008667,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor and ivacaft",
            "probability": 6.95107030505605e-05,
            "start_logit": 5.3956780433654785,
            "end_logit": -3.0091445446014404,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "or and ivacaftor",
            "probability": 6.792385371678485e-05,
            "start_logit": -3.0122060775756836,
            "end_logit": 5.375646114349365,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "iva",
            "probability": 6.738517596687067e-05,
            "start_logit": 5.750826358795166,
            "end_logit": -3.39534854888916,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "or",
            "probability": 5.769520261268247e-05,
            "start_logit": -3.0122060775756836,
            "end_logit": 5.212432861328125,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "of lumacaftor and ivacaftor",
            "probability": 5.2325554979357376e-05,
            "start_logit": -3.27310848236084,
            "end_logit": 5.375646114349365,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaftor and iva",
            "probability": 4.7241688662928614e-05,
            "start_logit": 5.3956780433654785,
            "end_logit": -3.39534854888916,
            "question_text": "Which drugs are included in the Orkambi pill?"
        },
        {
            "text": "lumacaft",
            "probability": 4.618292053833733e-05,
            "start_logit": 5.3956780433654785,
            "end_logit": -3.418015241622925,
            "question_text": "Which drugs are included in the Orkambi pill?"
        }
    ],
    "5c6c46677c78d69471000035": [
        {
            "text": "PCR",
            "probability": 0.19689159035547832,
            "start_logit": -2.5675368309020996,
            "end_logit": -3.1658763885498047,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "nCounter Platform is a new and promising technology for measuring nucleic acid abundances. It has several advantages over PCR",
            "probability": 0.09971052730179121,
            "start_logit": -3.2479188442230225,
            "end_logit": -3.1658763885498047,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoString nCounter Platform is a new and promising technology for measuring nucleic acid abundances. It has several advantages over PCR",
            "probability": 0.08496976557062441,
            "start_logit": -3.4078946113586426,
            "end_logit": -3.1658763885498047,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "PCR-based techniques",
            "probability": 0.07986347260972748,
            "start_logit": -2.5675368309020996,
            "end_logit": -4.068211078643799,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "nCounter",
            "probability": 0.05938244374655821,
            "start_logit": -3.2479188442230225,
            "end_logit": -3.6841490268707275,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoString nCounter",
            "probability": 0.05060360686774947,
            "start_logit": -3.4078946113586426,
            "end_logit": -3.6841490268707275,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "PCR-based techniques, including avoidance of amplification",
            "probability": 0.047754602919091275,
            "start_logit": -2.5675368309020996,
            "end_logit": -4.582454204559326,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "PCR-based techniques, including avoidance of amplification, direct sequence interrogation and digital detection for absolute quantification",
            "probability": 0.04318401689489179,
            "start_logit": -2.5675368309020996,
            "end_logit": -4.683059215545654,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "nCounter Platform is a new and promising technology for measuring nucleic acid abundances. It has several advantages over PCR-based techniques",
            "probability": 0.04044473891287514,
            "start_logit": -3.2479188442230225,
            "end_logit": -4.068211078643799,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "PCR-based techniques, including avoidance of amplification, direct sequence interrogation",
            "probability": 0.036177521640402756,
            "start_logit": -2.5675368309020996,
            "end_logit": -4.860091686248779,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "PCR-based techniques, including avoidance of amplification, direct sequence interrogation and digital detection",
            "probability": 0.034299635766844215,
            "start_logit": -2.5675368309020996,
            "end_logit": -4.913394927978516,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "PCR-based techniques, including avoidance of amplification, direct sequence interrogation and digital detection for absolute quantification.",
            "probability": 0.034048020387746784,
            "start_logit": -2.5675368309020996,
            "end_logit": -4.92075777053833,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "nCounter Platform is a new and promising technology for measuring nucleic acid abundances",
            "probability": 0.03202546789135327,
            "start_logit": -3.2479188442230225,
            "end_logit": -4.301616191864014,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoString nCounter Platform is a new and promising technology for measuring nucleic acid abundances",
            "probability": 0.027290964882591313,
            "start_logit": -3.4078946113586426,
            "end_logit": -4.301616191864014,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "PCR-based techniques,",
            "probability": 0.0253252381186119,
            "start_logit": -2.5675368309020996,
            "end_logit": -5.216728210449219,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "nCounter Platform",
            "probability": 0.024130443161174252,
            "start_logit": -3.2479188442230225,
            "end_logit": -4.5846734046936035,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "PCR-based techniques, including avoidance of amplification, direct sequence",
            "probability": 0.023395863263879386,
            "start_logit": -2.5675368309020996,
            "end_logit": -5.295970439910889,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "nucleic acid abundances. It has several advantages over PCR",
            "probability": 0.021954550247476324,
            "start_logit": -4.761215686798096,
            "end_logit": -3.1658763885498047,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "NanoString nCounter Platform",
            "probability": 0.02056310556170753,
            "start_logit": -3.4078946113586426,
            "end_logit": -4.5846734046936035,
            "question_text": "List available R packages for processing NanoString data"
        },
        {
            "text": "nCounter Platform is a new and promising technology for measuring nucleic acid abundances.",
            "probability": 0.017984423899424812,
            "start_logit": -3.2479188442230225,
            "end_logit": -4.878641605377197,
            "question_text": "List available R packages for processing NanoString data"
        }
    ],
    "5c76e6d27c78d694710000ac": [
        {
            "text": "Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9",
            "probability": 0.10021047638999854,
            "start_logit": 4.993062496185303,
            "end_logit": 4.793314456939697,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab9",
            "probability": 0.08972902872122523,
            "start_logit": 4.882584095001221,
            "end_logit": 4.793314456939697,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9",
            "probability": 0.08656529539191152,
            "start_logit": 4.846688747406006,
            "end_logit": 4.793314456939697,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Cathepsin D, Rab9",
            "probability": 0.0848311638804139,
            "start_logit": 4.826452732086182,
            "end_logit": 4.793314456939697,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9, and V-ATPase",
            "probability": 0.08009780433646321,
            "start_logit": 4.993062496185303,
            "end_logit": 4.5692901611328125,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "V-ATPase",
            "probability": 0.07601573509562365,
            "start_logit": 4.940754413604736,
            "end_logit": 4.5692901611328125,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab9, and V-ATPase",
            "probability": 0.07172002813201767,
            "start_logit": 4.882584095001221,
            "end_logit": 4.5692901611328125,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9, and V-ATPase",
            "probability": 0.06919126963976277,
            "start_logit": 4.846688747406006,
            "end_logit": 4.5692901611328125,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Cathepsin D, Rab9, and V-ATPase",
            "probability": 0.0678051857540714,
            "start_logit": 4.826452732086182,
            "end_logit": 4.5692901611328125,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7",
            "probability": 0.06087046441779688,
            "start_logit": 4.846688747406006,
            "end_logit": 4.441163539886475,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Lysosomal Associated Membrane Protein 1, Cathepsin D",
            "probability": 0.05290331054303557,
            "start_logit": 4.993062496185303,
            "end_logit": 4.154507637023926,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein 1, Cathepsin D",
            "probability": 0.04569971992294575,
            "start_logit": 4.846688747406006,
            "end_logit": 4.154507637023926,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Cathepsin D",
            "probability": 0.044784233826280724,
            "start_logit": 4.826452732086182,
            "end_logit": 4.154507637023926,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Lysosomal Associated Membrane Protein 1",
            "probability": 0.03125691368442428,
            "start_logit": 4.993062496185303,
            "end_logit": 3.628282308578491,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein 1",
            "probability": 0.027000809332563123,
            "start_logit": 4.846688747406006,
            "end_logit": 3.628282308578491,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "ATPase",
            "probability": 0.005661431554102029,
            "start_logit": 2.3434908390045166,
            "end_logit": 4.5692901611328125,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Lysosomal Associated Membrane Protein",
            "probability": 0.0017259977157715251,
            "start_logit": 4.993062496185303,
            "end_logit": 0.7318469882011414,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab7, Lysosomal Associated Membrane Protein",
            "probability": 0.0014909768668302482,
            "start_logit": 4.846688747406006,
            "end_logit": 0.7318469882011414,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Lysosomal Associated Membrane Protein 1, Cathepsin D, Rab9,",
            "probability": 0.0012874050309082858,
            "start_logit": 4.993062496185303,
            "end_logit": 0.4386703073978424,
            "question_text": "List phagosomal markers."
        },
        {
            "text": "Rab9,",
            "probability": 0.0011527497638535186,
            "start_logit": 4.882584095001221,
            "end_logit": 0.4386703073978424,
            "question_text": "List phagosomal markers."
        }
    ],
    "5c0119f3133db5eb7800002b": [
        {
            "text": "Streptococcus pneumoniae",
            "probability": 0.5409655807903104,
            "start_logit": 3.258115291595459,
            "end_logit": 3.5566089153289795,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus, Streptococcus pneumoniae",
            "probability": 0.07173740021598135,
            "start_logit": 1.2377718687057495,
            "end_logit": 3.5566089153289795,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Klebsiella pneumoniae",
            "probability": 0.062048178885191735,
            "start_logit": 3.3681886196136475,
            "end_logit": 1.2810910940170288,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae, and Klebsiella pneumoniae",
            "probability": 0.05558080089892821,
            "start_logit": 3.258115291595459,
            "end_logit": 1.2810910940170288,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "S. pneumoniae",
            "probability": 0.05170275429630467,
            "start_logit": 2.3621129989624023,
            "end_logit": 2.104766607284546,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Klebsiella pneumonia",
            "probability": 0.047549897901054065,
            "start_logit": 3.3681886196136475,
            "end_logit": 1.0149595737457275,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae, and Klebsiella pneumonia",
            "probability": 0.04259369824363353,
            "start_logit": 3.258115291595459,
            "end_logit": 1.0149595737457275,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "S. aureus, S. pneumoniae",
            "probability": 0.028160297829475222,
            "start_logit": 1.7545150518417358,
            "end_logit": 2.104766607284546,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus",
            "probability": 0.01822044963561177,
            "start_logit": 1.2377718687057495,
            "end_logit": 2.1861412525177,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "S. aureus",
            "probability": 0.017370897394788753,
            "start_logit": 1.7545150518417358,
            "end_logit": 1.6216497421264648,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "S. pneumoniae, and K. pneumoniae",
            "probability": 0.01484901814790935,
            "start_logit": 2.3621129989624023,
            "end_logit": 0.8571892976760864,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "S. aureus, S. pneumoniae, and K. pneumoniae",
            "probability": 0.008087630518173307,
            "start_logit": 1.7545150518417358,
            "end_logit": 0.8571892976760864,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae",
            "probability": 0.007370565337236714,
            "start_logit": 1.2377718687057495,
            "end_logit": 1.2810910940170288,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Klebsiella",
            "probability": 0.007289720661854343,
            "start_logit": 3.3681886196136475,
            "end_logit": -0.8603548407554626,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumoniae, and Klebsiella",
            "probability": 0.006529901763354186,
            "start_logit": 3.258115291595459,
            "end_logit": -0.8603548407554626,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumonia",
            "probability": 0.005648346745311104,
            "start_logit": 1.2377718687057495,
            "end_logit": 1.0149595737457275,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus pneumonia",
            "probability": 0.004737593507818188,
            "start_logit": 3.258115291595459,
            "end_logit": -1.1812174320220947,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "Streptococcus",
            "probability": 0.0041800574200212375,
            "start_logit": 3.258115291595459,
            "end_logit": -1.3064217567443848,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "K. pneumoniae",
            "probability": 0.003139985800021886,
            "start_logit": 0.8083975315093994,
            "end_logit": 0.8571892976760864,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        },
        {
            "text": "pneumoniae",
            "probability": 0.0022372240070200273,
            "start_logit": -0.7781622409820557,
            "end_logit": 2.104766607284546,
            "question_text": "List bacterial families for which delafloxacin has been shown to be effective."
        }
    ],
    "5c7036127c78d69471000064": [
        {
            "text": "robotic cystectomy",
            "probability": 0.2805541475517423,
            "start_logit": 4.400209426879883,
            "end_logit": 4.661448955535889,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic cystectomy) study is to compare open radical cystectomy",
            "probability": 0.25642352944044067,
            "start_logit": 4.400209426879883,
            "end_logit": 4.571512699127197,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open radical cystectomy",
            "probability": 0.18374062758239854,
            "start_logit": 4.066904067993164,
            "end_logit": 4.571512699127197,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic cystectomy) study is to compare open radical cystectomy (ORC) vs robot-assisted",
            "probability": 0.03621595565192332,
            "start_logit": 4.400209426879883,
            "end_logit": 2.6141819953918457,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "radical cystectomy",
            "probability": 0.032832258440584475,
            "start_logit": 2.344790458679199,
            "end_logit": 4.571512699127197,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open radical cystectomy (ORC) vs robot-assisted",
            "probability": 0.02595059211025447,
            "start_logit": 4.066904067993164,
            "end_logit": 2.6141819953918457,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open vs robotic cystectomy",
            "probability": 0.02557989826796094,
            "start_logit": 2.005249500274658,
            "end_logit": 4.661448955535889,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open vs robotic cystectomy) study is to compare open radical cystectomy",
            "probability": 0.023379757005332586,
            "start_logit": 2.005249500274658,
            "end_logit": 4.571512699127197,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "cystectomy",
            "probability": 0.022727280472310936,
            "start_logit": 1.8870086669921875,
            "end_logit": 4.661448955535889,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "cystectomy) study is to compare open radical cystectomy",
            "probability": 0.02077249445124656,
            "start_logit": 1.8870086669921875,
            "end_logit": 4.571512699127197,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic",
            "probability": 0.01809056163686592,
            "start_logit": 4.400209426879883,
            "end_logit": 1.9200725555419922,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robot-assisted",
            "probability": 0.013638722189347495,
            "start_logit": 3.4236226081848145,
            "end_logit": 2.6141819953918457,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robot-assisted RC (RARC), pelvic lymph node dissection",
            "probability": 0.01186000463722809,
            "start_logit": 3.4236226081848145,
            "end_logit": 2.474440813064575,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic cystectomy) study is to compare open radical cystectomy (ORC) vs robot",
            "probability": 0.011513339439927495,
            "start_logit": 4.400209426879883,
            "end_logit": 1.4681885242462158,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open radical cystectomy (ORC) vs robot-assisted RC (RARC)",
            "probability": 0.010077176606640183,
            "start_logit": 4.066904067993164,
            "end_logit": 1.6682606935501099,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "open radical cystectomy (ORC) vs robot",
            "probability": 0.008249898981102736,
            "start_logit": 4.066904067993164,
            "end_logit": 1.4681885242462158,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robot-assisted RC (RARC)",
            "probability": 0.005296211030832204,
            "start_logit": 3.4236226081848145,
            "end_logit": 1.6682606935501099,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "radical cystectomy (ORC) vs robot-assisted",
            "probability": 0.004637061264352001,
            "start_logit": 2.344790458679199,
            "end_logit": 2.6141819953918457,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robot",
            "probability": 0.004335857918593667,
            "start_logit": 3.4236226081848145,
            "end_logit": 1.4681885242462158,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        },
        {
            "text": "robotic cystectomy) study is to compare open radical cystectomy (ORC)",
            "probability": 0.0041246253209156905,
            "start_logit": 4.400209426879883,
            "end_logit": 0.4416573941707611,
            "question_text": "Which two surgical methods were compared in the RAZOR trial?"
        }
    ],
    "5c5214207e3cb0e231000003": [
        {
            "text": "gene-specific bias",
            "probability": 0.3752263557811021,
            "start_logit": 0.7363939881324768,
            "end_logit": 0.25879761576652527,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "development of drugs against disease-associated genes. By explicitly identifying the reasons for gene-specific bias",
            "probability": 0.08906851767834492,
            "start_logit": -0.7017295360565186,
            "end_logit": 0.25879761576652527,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "gene-specific bias and performing a meta-analysis",
            "probability": 0.064882566437737,
            "start_logit": 0.7363939881324768,
            "end_logit": -1.4961528778076172,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "drugs against disease-associated genes. By explicitly identifying the reasons for gene-specific bias",
            "probability": 0.06466452579562798,
            "start_logit": -1.0219227075576782,
            "end_logit": 0.25879761576652527,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases",
            "probability": 0.0460759694709404,
            "start_logit": 0.7363939881324768,
            "end_logit": -1.8384402990341187,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "bias",
            "probability": 0.04233502309072655,
            "start_logit": -1.4455207586288452,
            "end_logit": 0.25879761576652527,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "reasons for gene-specific bias",
            "probability": 0.028227204184647952,
            "start_logit": -1.8508492708206177,
            "end_logit": 0.25879761576652527,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "disease-associated genes. By explicitly identifying the reasons for gene-specific bias",
            "probability": 0.027092872733738175,
            "start_logit": -1.8918647766113281,
            "end_logit": 0.25879761576652527,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "development of drugs against disease-associated genes",
            "probability": 0.026321185681640512,
            "start_logit": -0.7017295360565186,
            "end_logit": -0.9602341651916504,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "identifiable chemical, physical, and biological properties of genes",
            "probability": 0.0259637389348231,
            "start_logit": -1.5541954040527344,
            "end_logit": -0.1214415431022644,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "development of drugs",
            "probability": 0.02496822499719104,
            "start_logit": -0.7017295360565186,
            "end_logit": -1.0130043029785156,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases,",
            "probability": 0.024127813462849115,
            "start_logit": 0.7363939881324768,
            "end_logit": -2.4853665828704834,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "gene",
            "probability": 0.022885206456060406,
            "start_logit": 0.7363939881324768,
            "end_logit": -2.538241147994995,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "chemical, physical, and biological properties of genes",
            "probability": 0.021847467752590607,
            "start_logit": -1.7268112897872925,
            "end_logit": -0.1214415431022644,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "the development of drugs against disease-associated genes. By explicitly identifying the reasons for gene-specific bias",
            "probability": 0.02054761180389889,
            "start_logit": -2.1683907508850098,
            "end_logit": 0.25879761576652527,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "National Institutes of Health (NIH), and the development of drugs against disease-associated genes. By explicitly identifying the reasons for gene-specific bias",
            "probability": 0.02013413584592737,
            "start_logit": -2.188718795776367,
            "end_logit": 0.25879761576652527,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "gene-specific bias and performing a meta-analysis of existing computational and experimental knowledge bases, we describe gene-specific strategies",
            "probability": 0.01968305627868584,
            "start_logit": 0.7363939881324768,
            "end_logit": -2.6889736652374268,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "drugs against disease-associated genes",
            "probability": 0.019109411887021584,
            "start_logit": -1.0219227075576782,
            "end_logit": -0.9602341651916504,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "funding awarded by the National Institutes of Health (NIH), and the development of drugs against disease-associated genes",
            "probability": 0.018711961174412078,
            "start_logit": -1.0429407358169556,
            "end_logit": -0.9602341651916504,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        },
        {
            "text": "drugs",
            "probability": 0.018127150552034482,
            "start_logit": -1.0219227075576782,
            "end_logit": -1.0130043029785156,
            "question_text": "List potential reasons regarding why potentially important genes are ignored"
        }
    ],
    "5c7ab080d774d0424000000b": [
        {
            "text": "cyclic dinucleotide",
            "probability": 0.6624346973301031,
            "start_logit": 2.1090850830078125,
            "end_logit": 1.1263751983642578,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic dinucleotide (CDN)",
            "probability": 0.19187883245779896,
            "start_logit": 2.1090850830078125,
            "end_logit": -0.11268269270658493,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic dinucleotide (CDN",
            "probability": 0.06234094548415672,
            "start_logit": 2.1090850830078125,
            "end_logit": -1.2369283437728882,
            "question_text": "List STING agonists."
        },
        {
            "text": "c",
            "probability": 0.01763260803640761,
            "start_logit": 2.1090850830078125,
            "end_logit": -2.4997968673706055,
            "question_text": "List STING agonists."
        },
        {
            "text": "dinucleotide",
            "probability": 0.014846470277006743,
            "start_logit": -1.6890747547149658,
            "end_logit": 1.1263751983642578,
            "question_text": "List STING agonists."
        },
        {
            "text": "CDN)",
            "probability": 0.007519599950611491,
            "start_logit": -1.1302660703659058,
            "end_logit": -0.11268269270658493,
            "question_text": "List STING agonists."
        },
        {
            "text": "(CDN)",
            "probability": 0.007064444955462849,
            "start_logit": -1.1927045583724976,
            "end_logit": -0.11268269270658493,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic din",
            "probability": 0.0049089183322198185,
            "start_logit": 2.1090850830078125,
            "end_logit": -3.7784931659698486,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic",
            "probability": 0.004849621731330379,
            "start_logit": 2.1090850830078125,
            "end_logit": -3.7906460762023926,
            "question_text": "List STING agonists."
        },
        {
            "text": "dinucleotide (CDN)",
            "probability": 0.004300383712316172,
            "start_logit": -1.6890747547149658,
            "end_logit": -0.11268269270658493,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic dinucleotide (",
            "probability": 0.004255901862907634,
            "start_logit": 2.1090850830078125,
            "end_logit": -3.9212400913238525,
            "question_text": "List STING agonists."
        },
        {
            "text": "tide",
            "probability": 0.0033584692177461993,
            "start_logit": -3.175351619720459,
            "end_logit": 1.1263751983642578,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic dinucleotide (CDN) STING agonists",
            "probability": 0.0027030154161756725,
            "start_logit": 2.1090850830078125,
            "end_logit": -4.375178813934326,
            "question_text": "List STING agonists."
        },
        {
            "text": "CDN",
            "probability": 0.002443098931649169,
            "start_logit": -1.1302660703659058,
            "end_logit": -1.2369283437728882,
            "question_text": "List STING agonists."
        },
        {
            "text": "leotide",
            "probability": 0.0023947674824183643,
            "start_logit": -3.5135507583618164,
            "end_logit": 1.1263751983642578,
            "question_text": "List STING agonists."
        },
        {
            "text": "(CDN",
            "probability": 0.002295220229366343,
            "start_logit": -1.1927045583724976,
            "end_logit": -1.2369283437728882,
            "question_text": "List STING agonists."
        },
        {
            "text": "dinucleotide (CDN",
            "probability": 0.001397183749434272,
            "start_logit": -1.6890747547149658,
            "end_logit": -1.2369283437728882,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic dinucleotide (CDN) STING agonists administered by intratumoral (i.t.) injection",
            "probability": 0.001252807447243929,
            "start_logit": 2.1090850830078125,
            "end_logit": -5.14415979385376,
            "question_text": "List STING agonists."
        },
        {
            "text": "cyclic dinucleo",
            "probability": 0.0011502093517986776,
            "start_logit": 2.1090850830078125,
            "end_logit": -5.229602813720703,
            "question_text": "List STING agonists."
        },
        {
            "text": "tide (CDN)",
            "probability": 0.0009728040438459588,
            "start_logit": -3.175351619720459,
            "end_logit": -0.11268269270658493,
            "question_text": "List STING agonists."
        }
    ],
    "5c6dfdf27c78d69471000047": [
        {
            "text": "Nivolumab",
            "probability": 0.9721755565699738,
            "start_logit": 2.9532129764556885,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "immune-checkpoint inhibitor Nivolumab",
            "probability": 0.011255451100065705,
            "start_logit": -1.505470871925354,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "inhibitor Nivolumab",
            "probability": 0.0043704372616258265,
            "start_logit": -2.451460361480713,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "the immune-checkpoint inhibitor Nivolumab",
            "probability": 0.0021831835197114,
            "start_logit": -3.1455392837524414,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Nivolumab (Opdivo",
            "probability": 0.002176015896267879,
            "start_logit": 2.9532129764556885,
            "end_logit": -3.738647937774658,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "checkpoint inhibitor Nivolumab",
            "probability": 0.0019398618153525845,
            "start_logit": -3.263706684112549,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "immune-checkpoint inhibitor",
            "probability": 0.000942614281997598,
            "start_logit": -1.505470871925354,
            "end_logit": -0.11655783653259277,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "approval of the immune-checkpoint inhibitor Nivolumab",
            "probability": 0.0008635242724635958,
            "start_logit": -4.073056697845459,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Ni",
            "probability": 0.0008102648313605458,
            "start_logit": 2.9532129764556885,
            "end_logit": -4.726537704467773,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "lumab",
            "probability": 0.0006039246575785311,
            "start_logit": -4.430629253387451,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "Nivolumab (",
            "probability": 0.0005876517730103403,
            "start_logit": 2.9532129764556885,
            "end_logit": -5.047764301300049,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "ab",
            "probability": 0.0005240432316239785,
            "start_logit": -4.57250452041626,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "inhibitor",
            "probability": 0.0003660125697990841,
            "start_logit": -2.451460361480713,
            "end_logit": -0.11655783653259277,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "of the immune-checkpoint inhibitor Nivolumab",
            "probability": 0.0002023409371015546,
            "start_logit": -5.524124622344971,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "due to approval of the immune-checkpoint inhibitor Nivolumab",
            "probability": 0.00018825791512006558,
            "start_logit": -5.59626579284668,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "volumab",
            "probability": 0.00018802528958183822,
            "start_logit": -5.5975022315979,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "the immune-checkpoint inhibitor",
            "probability": 0.00018283584972349418,
            "start_logit": -3.1455392837524414,
            "end_logit": -0.11655783653259277,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "point inhibitor Nivolumab",
            "probability": 0.00016821912101703967,
            "start_logit": -5.708811283111572,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "checkpoint inhibitor",
            "probability": 0.00016245830007137246,
            "start_logit": -3.263706684112549,
            "end_logit": -0.11655783653259277,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        },
        {
            "text": "to approval of the immune-checkpoint inhibitor Nivolumab",
            "probability": 0.00010932080655378087,
            "start_logit": -6.139791965484619,
            "end_logit": 2.3633928298950195,
            "question_text": "List drugs that were tested in the CheckMate 214 trial."
        }
    ],
    "5c6e01af7c78d69471000048": [
        {
            "text": "cytomegalovirus",
            "probability": 0.6737425052812206,
            "start_logit": 4.684032917022705,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prophylaxis against human cytomegalovirus",
            "probability": 0.16307072781966284,
            "start_logit": 3.265368938446045,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "human cytomegalovirus",
            "probability": 0.10462673037835667,
            "start_logit": 2.8215839862823486,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus in immunocompromised transplant recipients",
            "probability": 0.024642774311964814,
            "start_logit": 4.684032917022705,
            "end_logit": 1.4403654336929321,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prophylaxis",
            "probability": 0.006482643951321262,
            "start_logit": 3.265368938446045,
            "end_logit": 1.5236741304397583,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prophylaxis against human cytomegalovirus in immunocompromised transplant recipients",
            "probability": 0.005964467301748256,
            "start_logit": 3.265368938446045,
            "end_logit": 1.4403654336929321,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovirus in immunocompromised transplant",
            "probability": 0.004282823813695723,
            "start_logit": 4.684032917022705,
            "end_logit": -0.30950573086738586,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "human cytomegalovirus in immunocompromised transplant recipients",
            "probability": 0.0038268223891209812,
            "start_logit": 2.8215839862823486,
            "end_logit": 1.4403654336929321,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "galovirus",
            "probability": 0.0025437739957077077,
            "start_logit": -0.895166277885437,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "omegalovirus",
            "probability": 0.0019039967118296207,
            "start_logit": -1.1848598718643188,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "ytomegalovirus",
            "probability": 0.0015097903988450013,
            "start_logit": -1.4168442487716675,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "axis against human cytomegalovirus",
            "probability": 0.001318680443226987,
            "start_logit": -1.5521835088729858,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "ovirus",
            "probability": 0.0010459461198690306,
            "start_logit": -1.7838932275772095,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "prophylaxis against human cytomegalovirus in immunocompromised transplant",
            "probability": 0.0010366025461481482,
            "start_logit": 3.265368938446045,
            "end_logit": -0.30950573086738586,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "against human cytomegalovirus",
            "probability": 0.0008694007209205382,
            "start_logit": -1.968766212463379,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "antiviral in clinical development for prophylaxis against human cytomegalovirus",
            "probability": 0.0007532725256012858,
            "start_logit": -2.1121432781219482,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "cytomegalovir",
            "probability": 0.0007335955474413984,
            "start_logit": 4.684032917022705,
            "end_logit": -2.073915719985962,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "human cytomegalovirus in immunocompromised transplant",
            "probability": 0.0006650876987885917,
            "start_logit": 2.8215839862823486,
            "end_logit": -0.30950573086738586,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "c",
            "probability": 0.0004960456218557637,
            "start_logit": 4.684032917022705,
            "end_logit": -2.465205669403076,
            "question_text": "List two indications of Letermovir?"
        },
        {
            "text": "for prophylaxis against human cytomegalovirus",
            "probability": 0.00048431242267460217,
            "start_logit": -2.553840160369873,
            "end_logit": 4.748729705810547,
            "question_text": "List two indications of Letermovir?"
        }
    ],
    "5c544c1707647bbc4b000003": [
        {
            "text": "AsCNAR",
            "probability": 0.8764048744174726,
            "start_logit": 2.3925516605377197,
            "end_logit": 2.5409739017486572,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\"",
            "probability": 0.07814979609924753,
            "start_logit": 2.3925516605377197,
            "end_logit": 0.12377317994832993,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "\"AsCNAR",
            "probability": 0.023751294565690535,
            "start_logit": -1.2156394720077515,
            "end_logit": 2.5409739017486572,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references)",
            "probability": 0.0054244232365181335,
            "start_logit": 2.3925516605377197,
            "end_logit": -2.54394268989563,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references),",
            "probability": 0.003847790850837758,
            "start_logit": 2.3925516605377197,
            "end_logit": -2.887355089187622,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references",
            "probability": 0.0027255450520482826,
            "start_logit": 2.3925516605377197,
            "end_logit": -3.2321858406066895,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "\"AsCNAR\"",
            "probability": 0.0021179238974858854,
            "start_logit": -1.2156394720077515,
            "end_logit": 0.12377317994832993,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references), was demonstrated by detecting the copy-number neutral LOH",
            "probability": 0.0013933333097988381,
            "start_logit": 2.3925516605377197,
            "end_logit": -3.9031553268432617,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis",
            "probability": 0.001239519879083432,
            "start_logit": 2.3925516605377197,
            "end_logit": -4.020130157470703,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (all",
            "probability": 0.0009901492696803124,
            "start_logit": 2.3925516605377197,
            "end_logit": -4.244753837585449,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "As",
            "probability": 0.0008585432460708167,
            "start_logit": 2.3925516605377197,
            "end_logit": -4.3873724937438965,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (",
            "probability": 0.0008141220074541911,
            "start_logit": 2.3925516605377197,
            "end_logit": -4.440499305725098,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "called \"AsCNAR",
            "probability": 0.0006276898129470054,
            "start_logit": -4.84898567199707,
            "end_logit": 2.5409739017486572,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "NAR",
            "probability": 0.0003520968691069621,
            "start_logit": -5.427125453948975,
            "end_logit": 2.5409739017486572,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "new algorithm, called \"AsCNAR",
            "probability": 0.00029392812210473685,
            "start_logit": -5.607696533203125,
            "end_logit": 2.5409739017486572,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references), was demonstrated",
            "probability": 0.0002926957994667457,
            "start_logit": 2.3925516605377197,
            "end_logit": -5.463475704193115,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "algorithm, called \"AsCNAR",
            "probability": 0.00024186343050976308,
            "start_logit": -5.802658557891846,
            "end_logit": 2.5409739017486572,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "AsCNAR\" (allele-specific copy-number analysis using anonymous references), was demonstrated by",
            "probability": 0.00022312548911068635,
            "start_logit": 2.3925516605377197,
            "end_logit": -5.734875202178955,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "\"AsCNAR\" (allele-specific copy-number analysis using anonymous references)",
            "probability": 0.0001470063413615241,
            "start_logit": -1.2156394720077515,
            "end_logit": -2.54394268989563,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        },
        {
            "text": "\"AsCNAR\" (allele-specific copy-number analysis using anonymous references),",
            "probability": 0.00010427830400436966,
            "start_logit": -1.2156394720077515,
            "end_logit": -2.887355089187622,
            "question_text": "List uniparental disomy (UPD) detection algorithms"
        }
    ],
    "5c6b7daa7c78d6947100002b": [
        {
            "text": "telangiectasias",
            "probability": 0.1438341431352043,
            "start_logit": 3.788182258605957,
            "end_logit": 4.466103553771973,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis",
            "probability": 0.11204522768733399,
            "start_logit": 3.788182258605957,
            "end_logit": 4.216345310211182,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis",
            "probability": 0.09715747021525727,
            "start_logit": 3.6456127166748047,
            "end_logit": 4.216345310211182,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis, monoclonal gammopathy",
            "probability": 0.08956128461975732,
            "start_logit": 3.6456127166748047,
            "end_logit": 4.13493537902832,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy",
            "probability": 0.08643486613387798,
            "start_logit": 3.6100807189941406,
            "end_logit": 4.13493537902832,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythrocytosis, monoclonal gammopathy, perinephric fluid collections",
            "probability": 0.06920154131312685,
            "start_logit": 3.6456127166748047,
            "end_logit": 3.87703537940979,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy, perinephric fluid collections",
            "probability": 0.06678584373876473,
            "start_logit": 3.6100807189941406,
            "end_logit": 3.87703537940979,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.05340069467688824,
            "start_logit": 3.6100807189941406,
            "end_logit": 3.6533679962158203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "perinephric fluid collections",
            "probability": 0.051447152523041044,
            "start_logit": 3.349144697189331,
            "end_logit": 3.87703537940979,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "perinephric fluid collections, and intrapulmonary shunting",
            "probability": 0.04113616793739154,
            "start_logit": 3.349144697189331,
            "end_logit": 3.6533679962158203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, elevated erythropoietin",
            "probability": 0.0318654275445311,
            "start_logit": 3.788182258605957,
            "end_logit": 2.9589643478393555,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin level and erythrocytosis",
            "probability": 0.03051741638788173,
            "start_logit": 2.487577199935913,
            "end_logit": 4.216345310211182,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "intrapulmonary shunting",
            "probability": 0.028873221756466002,
            "start_logit": 2.995171546936035,
            "end_logit": 3.6533679962158203,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin level and erythrocytosis, monoclonal gammopathy",
            "probability": 0.02813143455587333,
            "start_logit": 2.487577199935913,
            "end_logit": 4.13493537902832,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin level and erythrocytosis",
            "probability": 0.017895977797539556,
            "start_logit": 1.9538556337356567,
            "end_logit": 4.216345310211182,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "erythropoietin level and erythrocytosis, monoclonal gammopathy",
            "probability": 0.016496793890611223,
            "start_logit": 1.9538556337356567,
            "end_logit": 4.13493537902832,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, elevated erythropoietin level",
            "probability": 0.011622372465808979,
            "start_logit": 3.788182258605957,
            "end_logit": 1.9503746032714844,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "elevated erythropoietin",
            "probability": 0.008679089157353381,
            "start_logit": 2.487577199935913,
            "end_logit": 2.9589643478393555,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias, elevated erythropoietin level and erythrocytosis,",
            "probability": 0.007747173102289436,
            "start_logit": 3.788182258605957,
            "end_logit": 1.5447707176208496,
            "question_text": "List major features of TEMPI Syndrome."
        },
        {
            "text": "telangiectasias,",
            "probability": 0.007166701361001865,
            "start_logit": 3.788182258605957,
            "end_logit": 1.466888189315796,
            "question_text": "List major features of TEMPI Syndrome."
        }
    ],
    "5c561da707647bbc4b00000f": [
        {
            "text": "reference variants (RS) remains unknown.",
            "probability": 0.10689330639510958,
            "start_logit": -4.567841053009033,
            "end_logit": -4.433729648590088,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "reference variants",
            "probability": 0.09448246860308307,
            "start_logit": -4.567841053009033,
            "end_logit": -4.5571465492248535,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "dbSNP reference variants (RS) remains unknown.",
            "probability": 0.08235258594625106,
            "start_logit": -4.828662395477295,
            "end_logit": -4.433729648590088,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "reference variants (RS) remains unknown",
            "probability": 0.07506494877601216,
            "start_logit": -4.567841053009033,
            "end_logit": -4.787207126617432,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "dbSNP reference variants",
            "probability": 0.07279104631013027,
            "start_logit": -4.828662395477295,
            "end_logit": -4.5571465492248535,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "reference variants (RS)",
            "probability": 0.05795217293074463,
            "start_logit": -4.567841053009033,
            "end_logit": -5.045942783355713,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "dbSNP reference variants (RS) remains unknown",
            "probability": 0.057831428871492875,
            "start_logit": -4.828662395477295,
            "end_logit": -4.787207126617432,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "dbSNP",
            "probability": 0.050910079679072566,
            "start_logit": -4.828662395477295,
            "end_logit": -4.914678573608398,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "unknown.",
            "probability": 0.05026937969129833,
            "start_logit": -5.3222761154174805,
            "end_logit": -4.433729648590088,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "dbSNP reference variants (RS)",
            "probability": 0.044647428945742626,
            "start_logit": -4.828662395477295,
            "end_logit": -5.045942783355713,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "clinical relevance about most of the 154 million dbSNP reference variants (RS) remains unknown.",
            "probability": 0.036676341928057105,
            "start_logit": -5.637540340423584,
            "end_logit": -4.433729648590088,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "unknown",
            "probability": 0.035301260095569956,
            "start_logit": -5.3222761154174805,
            "end_logit": -4.787207126617432,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "154 million dbSNP reference variants (RS) remains unknown.",
            "probability": 0.032665535606764454,
            "start_logit": -5.75335168838501,
            "end_logit": -4.433729648590088,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "clinical relevance about most of the 154 million dbSNP reference variants",
            "probability": 0.032418038524179585,
            "start_logit": -5.637540340423584,
            "end_logit": -4.5571465492248535,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "variants (RS) remains unknown.",
            "probability": 0.03238863505429342,
            "start_logit": -5.76186466217041,
            "end_logit": -4.433729648590088,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "154 million dbSNP reference variants",
            "probability": 0.02887290651260288,
            "start_logit": -5.75335168838501,
            "end_logit": -4.5571465492248535,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "variants",
            "probability": 0.028628155474045635,
            "start_logit": -5.76186466217041,
            "end_logit": -4.5571465492248535,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "Despite significant efforts in expert curation, clinical relevance about most of the 154 million dbSNP reference variants (RS) remains unknown.",
            "probability": 0.027998595368373767,
            "start_logit": -5.907517910003662,
            "end_logit": -4.433729648590088,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "Despite significant efforts in expert curation",
            "probability": 0.02610002461049325,
            "start_logit": -5.907517910003662,
            "end_logit": -4.503947734832764,
            "question_text": "List the releases of tmVar"
        },
        {
            "text": "clinical relevance about most of the 154 million dbSNP reference variants (RS) remains unknown",
            "probability": 0.025755660676682644,
            "start_logit": -5.637540340423584,
            "end_logit": -4.787207126617432,
            "question_text": "List the releases of tmVar"
        }
    ],
    "5c57041807647bbc4b000015": [
        {
            "text": "adipogenesis",
            "probability": 0.5018091551831986,
            "start_logit": 2.163794755935669,
            "end_logit": 2.556304693222046,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenesis. shRNA-mediated STAMP2 knockdown in ASCs significantly suppresses adipogenesis",
            "probability": 0.24437477379490125,
            "start_logit": 1.4442778825759888,
            "end_logit": 2.556304693222046,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenesis and interferes with optimal expression of adipogenic",
            "probability": 0.05264413474507151,
            "start_logit": 2.163794755935669,
            "end_logit": 0.3016396462917328,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenic",
            "probability": 0.03563019749235866,
            "start_logit": 1.7734334468841553,
            "end_logit": 0.3016396462917328,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenic genes and adipocyte metabolic function. Furthermore, ASC-derived adipocyte-mediated stimulation of prostate tumor",
            "probability": 0.030569236578571954,
            "start_logit": 1.7734334468841553,
            "end_logit": 0.14844028651714325,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "metabolic",
            "probability": 0.023018467779718922,
            "start_logit": 1.3605891466140747,
            "end_logit": 0.27758726477622986,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenesis and interferes with optimal expression of adipogenic genes and adipocyte metabolic",
            "probability": 0.022660064454317154,
            "start_logit": 2.163794755935669,
            "end_logit": -0.5413110852241516,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenic genes and adipocyte metabolic",
            "probability": 0.015336610158123704,
            "start_logit": 1.7734334468841553,
            "end_logit": -0.5413110852241516,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "metabolic function. Furthermore, ASC-derived adipocyte-mediated stimulation of prostate tumor",
            "probability": 0.01445667283187379,
            "start_logit": 1.0245953798294067,
            "end_logit": 0.14844028651714325,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenesis and interferes with optimal expression of adipogenic genes and adipocyte metabolic function",
            "probability": 0.011417912658299027,
            "start_logit": 2.163794755935669,
            "end_logit": -1.226731777191162,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "metabolic function. Furthermore, ASC-derived adipocyte-mediated stimulation of prostate tumor growth",
            "probability": 0.009639329856246558,
            "start_logit": 1.0245953798294067,
            "end_logit": -0.2568642199039459,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenic genes and adipocyte metabolic function",
            "probability": 0.007727783635075939,
            "start_logit": 1.7734334468841553,
            "end_logit": -1.226731777191162,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "metabolic function",
            "probability": 0.006901326934462584,
            "start_logit": 1.3605891466140747,
            "end_logit": -0.9269958734512329,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenesis and interferes with optimal expression of adipogenic genes",
            "probability": 0.0067440131379214625,
            "start_logit": 2.163794755935669,
            "end_logit": -1.7532600164413452,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "prostate tumor",
            "probability": 0.005167094727973828,
            "start_logit": -0.0042501334100961685,
            "end_logit": 0.14844028651714325,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "adipogenic genes",
            "probability": 0.004564430988538546,
            "start_logit": 1.7734334468841553,
            "end_logit": -1.7532600164413452,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "prostate tumor growth",
            "probability": 0.003445283092496779,
            "start_logit": -0.0042501334100961685,
            "end_logit": -0.2568642199039459,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "esis. shRNA-mediated STAMP2 knockdown in ASCs significantly suppresses adipogenesis",
            "probability": 0.0015151726190989546,
            "start_logit": -3.6388957500457764,
            "end_logit": 2.556304693222046,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "metabolic function, as well as their ability to facilitate PCa growth",
            "probability": 0.0012478947860997726,
            "start_logit": 1.3605891466140747,
            "end_logit": -2.637251615524292,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        },
        {
            "text": "prostate cancer (PCa) and metabolic disease. STAMP2 has unique anti-inflammatory and pro-metabolic",
            "probability": 0.0011304445456510291,
            "start_logit": -0.9200036525726318,
            "end_logit": -0.4555058181285858,
            "question_text": "What 2 biological processes are regulated by STAMP2 in adipocytes?"
        }
    ],
    "5c56bbb107647bbc4b000011": [
        {
            "text": "E6V'",
            "probability": 0.3772812401589303,
            "start_logit": -0.28847774863243103,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V",
            "probability": 0.2551405174665124,
            "start_logit": -0.28847774863243103,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V'),",
            "probability": 0.07568203573108204,
            "start_logit": -0.28847774863243103,
            "end_logit": -3.940426826477051,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E6V'",
            "probability": 0.06809951694638625,
            "start_logit": -2.0004985332489014,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E6V",
            "probability": 0.04605303456276093,
            "start_logit": -2.0004985332489014,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E",
            "probability": 0.044952922638191346,
            "start_logit": -0.28847774863243103,
            "end_logit": -4.4613518714904785,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V'), leaving relevant mentions natural language",
            "probability": 0.034038619160167836,
            "start_logit": -0.28847774863243103,
            "end_logit": -4.739471912384033,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V')",
            "probability": 0.01708386012404264,
            "start_logit": -0.28847774863243103,
            "end_logit": -5.428833484649658,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "E6V'), leaving relevant mentions natural language (NL) largely untapped",
            "probability": 0.013943041340525349,
            "start_logit": -0.28847774863243103,
            "end_logit": -5.63198709487915,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E6V'),",
            "probability": 0.013660658220469003,
            "start_logit": -2.0004985332489014,
            "end_logit": -3.940426826477051,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "Existing methods primarily target standard (ST) mutation mentions (e.g. 'E6V'",
            "probability": 0.0091975717481104,
            "start_logit": -4.002529144287109,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E",
            "probability": 0.008114032692692424,
            "start_logit": -2.0004985332489014,
            "end_logit": -4.4613518714904785,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "Existing methods primarily target standard (ST) mutation mentions (e.g. 'E6V",
            "probability": 0.006219957330133146,
            "start_logit": -4.002529144287109,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "'E6V'), leaving relevant mentions natural language",
            "probability": 0.0061439935930897895,
            "start_logit": -2.0004985332489014,
            "end_logit": -4.739471912384033,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation mentions (e.g. 'E6V'",
            "probability": 0.005216929857455082,
            "start_logit": -4.569559574127197,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "mutation mentions (e.g. 'E6V'",
            "probability": 0.004733770527873394,
            "start_logit": -4.666746616363525,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods primarily target standard (ST) mutation mentions (e.g. 'E6V'",
            "probability": 0.00459894375478923,
            "start_logit": -4.695641994476318,
            "end_logit": -2.3339767456054688,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "standard (ST) mutation mentions (e.g. 'E6V",
            "probability": 0.003528005216630654,
            "start_logit": -4.569559574127197,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "mutation mentions (e.g. 'E6V",
            "probability": 0.0032012634965379295,
            "start_logit": -4.666746616363525,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        },
        {
            "text": "methods primarily target standard (ST) mutation mentions (e.g. 'E6V",
            "probability": 0.0031100854336198187,
            "start_logit": -4.695641994476318,
            "end_logit": -2.7251532077789307,
            "question_text": "Which methods have been developed for extracting sequence variants from the literature?"
        }
    ],
    "5c6f107c7c78d69471000051": [
        {
            "text": "FAK inhibitors PF-562271 or defactinib inhibited FAK",
            "probability": 0.325218110411856,
            "start_logit": 5.441032886505127,
            "end_logit": 5.282779693603516,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK",
            "probability": 0.3240802962705554,
            "start_logit": 5.437528133392334,
            "end_logit": 5.282779693603516,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "integrins with FAK inhibitors PF-562271 or defactinib inhibited FAK",
            "probability": 0.1728739738051491,
            "start_logit": 4.8090996742248535,
            "end_logit": 5.282779693603516,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "integrins with FAK",
            "probability": 0.11906982093985984,
            "start_logit": 4.8090996742248535,
            "end_logit": 4.909926891326904,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "integrins",
            "probability": 0.03640207245806147,
            "start_logit": 4.8090996742248535,
            "end_logit": 3.7248425483703613,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "integrin",
            "probability": 0.00950004482935719,
            "start_logit": 4.8090996742248535,
            "end_logit": 2.3815133571624756,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitors PF-562271 or defactinib inhibited FAK phosphorylation",
            "probability": 0.004791706737930138,
            "start_logit": 5.441032886505127,
            "end_logit": 1.0651702880859375,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK phosphorylation",
            "probability": 0.0047749423834466875,
            "start_logit": 5.437528133392334,
            "end_logit": 1.0651702880859375,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "pFAK-Y397 expression and cell survival, whereas targeting integrins with FAK",
            "probability": 0.0006632864689118921,
            "start_logit": -0.3811586797237396,
            "end_logit": 4.909926891326904,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitor",
            "probability": 0.0004418949141613915,
            "start_logit": 5.441032886505127,
            "end_logit": -1.3183995485305786,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitors",
            "probability": 0.000394935034419081,
            "start_logit": 5.441032886505127,
            "end_logit": -1.4307503700256348,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "integrins with FAK inhibitor",
            "probability": 0.00023489506694022067,
            "start_logit": 4.8090996742248535,
            "end_logit": -1.3183995485305786,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "AK inhibitors PF-562271 or defactinib inhibited FAK",
            "probability": 0.00023460430964776356,
            "start_logit": -1.7933181524276733,
            "end_logit": 5.282779693603516,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "targeting integrins with FAK inhibitors PF-562271 or defactinib inhibited FAK",
            "probability": 0.0002126275730401957,
            "start_logit": -1.8916763067245483,
            "end_logit": 5.282779693603516,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "integrins with FAK inhibitors",
            "probability": 0.00020993292381053973,
            "start_logit": 4.8090996742248535,
            "end_logit": -1.4307503700256348,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "pFAK-Y397 expression and cell survival, whereas targeting integrins",
            "probability": 0.00020278019998012483,
            "start_logit": -0.3811586797237396,
            "end_logit": 3.7248425483703613,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "AK",
            "probability": 0.00019140604377074284,
            "start_logit": -1.996821403503418,
            "end_logit": 5.282779693603516,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitors PF-562271 or defactinib inhibited",
            "probability": 0.000174699980092826,
            "start_logit": 5.441032886505127,
            "end_logit": -2.24640154838562,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK inhibitors PF-562271 or defactinib inhibited FAK p",
            "probability": 0.00016427218737260945,
            "start_logit": 5.441032886505127,
            "end_logit": -2.3079469203948975,
            "question_text": "Which molecules are targeted by defactinib?"
        },
        {
            "text": "FAK p",
            "probability": 0.0001636974616367695,
            "start_logit": 5.437528133392334,
            "end_logit": -2.3079469203948975,
            "question_text": "Which molecules are targeted by defactinib?"
        }
    ],
    "5c6ffa257c78d69471000056": [
        {
            "text": "NAGLU",
            "probability": 0.25583596089948046,
            "start_logit": 4.691812038421631,
            "end_logit": 3.9889185428619385,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH (coding for heparan N-sulfatase) - causing MPS IIIA, NAGLU",
            "probability": 0.16622236170151097,
            "start_logit": 4.260601997375488,
            "end_logit": 3.9889185428619385,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "heparan N-sulfatase) - causing MPS IIIA, NAGLU",
            "probability": 0.0835349165008878,
            "start_logit": 3.572540283203125,
            "end_logit": 3.9889185428619385,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH",
            "probability": 0.08246680303555551,
            "start_logit": 4.260601997375488,
            "end_logit": 3.2879879474639893,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH (coding for heparan N-sulfatase",
            "probability": 0.07457647777804001,
            "start_logit": 4.260601997375488,
            "end_logit": 3.1874172687530518,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIIA, NAGLU",
            "probability": 0.06636310047262278,
            "start_logit": 3.342416763305664,
            "end_logit": 3.9889185428619385,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "NAGLU (coding for alpha-N-acetylglucosaminidase",
            "probability": 0.04902526426617104,
            "start_logit": 4.691812038421631,
            "end_logit": 2.3367178440093994,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "HGSNAT",
            "probability": 0.041193429095758065,
            "start_logit": 3.7475123405456543,
            "end_logit": 3.1069605350494385,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "heparan N-sulfatase",
            "probability": 0.037478349966569256,
            "start_logit": 3.572540283203125,
            "end_logit": 3.1874172687530518,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIIB, HGSNAT",
            "probability": 0.0323189272739396,
            "start_logit": 3.5048866271972656,
            "end_logit": 3.1069605350494385,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "NAGLU (coding for alpha-N-acetylglucosaminidase)",
            "probability": 0.01691077619909964,
            "start_logit": 4.691812038421631,
            "end_logit": 1.2723331451416016,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH (coding for heparan N-sulfatase) - causing MPS IIIA",
            "probability": 0.016298459114198777,
            "start_logit": 4.260601997375488,
            "end_logit": 1.6666626930236816,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "NAGLU (coding for alpha-N-acetylglucosaminidase) - causing MPS IIIB",
            "probability": 0.01343102313792929,
            "start_logit": 4.691812038421631,
            "end_logit": 1.0419492721557617,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIIA, NAGLU (coding for alpha-N-acetylglucosaminidase",
            "probability": 0.012717010254360216,
            "start_logit": 3.342416763305664,
            "end_logit": 2.3367178440093994,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIID",
            "probability": 0.01166679400430346,
            "start_logit": 3.7082488536834717,
            "end_logit": 1.8846919536590576,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "alpha-N-acetylglucosaminidase) - causing MPS IIIB, HGSNAT",
            "probability": 0.00857449941822008,
            "start_logit": 2.1780261993408203,
            "end_logit": 3.1069605350494385,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "SGSH (coding for heparan N-sulfatase)",
            "probability": 0.008429787418821215,
            "start_logit": 4.260601997375488,
            "end_logit": 1.0073636770248413,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "GNS (coding for N-acetylglucosamine-6-sulfatase) - causing MPS IIID",
            "probability": 0.008258237364868642,
            "start_logit": 3.36271333694458,
            "end_logit": 1.8846919536590576,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "heparan N-sulfatase) - causing MPS IIIA",
            "probability": 0.008190777746513948,
            "start_logit": 3.572540283203125,
            "end_logit": 1.6666626930236816,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        },
        {
            "text": "MPS IIIA",
            "probability": 0.00650704435114927,
            "start_logit": 3.342416763305664,
            "end_logit": 1.6666626930236816,
            "question_text": "Please list the 4 genes involved in Sanfilippo syndrome, also known as mucopolysaccharidosis III (MPS-III)."
        }
    ],
    "5c580fe107647bbc4b00001b": [
        {
            "text": "gynecological cancer",
            "probability": 0.30605503707883697,
            "start_logit": 1.8505316972732544,
            "end_logit": 2.518650770187378,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers remains undefined and the clinical significance of uc.189 in gynecological cancer",
            "probability": 0.21269511473838665,
            "start_logit": 1.4866265058517456,
            "end_logit": 2.518650770187378,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological cancers",
            "probability": 0.12383152504170351,
            "start_logit": 1.8505316972732544,
            "end_logit": 1.6138077974319458,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancer",
            "probability": 0.12151853690278944,
            "start_logit": 0.9268335700035095,
            "end_logit": 2.518650770187378,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers remains undefined and the clinical significance of uc.189 in gynecological cancers",
            "probability": 0.08605759499455652,
            "start_logit": 1.4866265058517456,
            "end_logit": 1.6138077974319458,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers",
            "probability": 0.06284093490927357,
            "start_logit": 1.4866265058517456,
            "end_logit": 1.2993977069854736,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "human cancers remains undefined and the clinical significance of uc.189 in gynecological cancer",
            "probability": 0.014989206796873062,
            "start_logit": -1.165902853012085,
            "end_logit": 2.518650770187378,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological cancers remains unknown. This study was to identify the prognostic value of uc.189 expression in gynecological cancer",
            "probability": 0.014984855102243998,
            "start_logit": 1.8505316972732544,
            "end_logit": -0.49807414412498474,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "endometrial adenocarcinoma",
            "probability": 0.01254251122870516,
            "start_logit": 0.6685009002685547,
            "end_logit": 0.5060403943061829,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "endometrial adenocarcinomas (EACs), 29 ovarian cystoadenocarcinoma",
            "probability": 0.00999985507866298,
            "start_logit": 0.6685009002685547,
            "end_logit": 0.2794872224330902,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "human cancers remains undefined and the clinical significance of uc.189 in gynecological cancers",
            "probability": 0.006064714224403159,
            "start_logit": -1.165902853012085,
            "end_logit": 1.6138077974319458,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "human cancer",
            "probability": 0.006014419398309418,
            "start_logit": -1.165902853012085,
            "end_logit": 1.6054801940917969,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cancers remains unknown. This study was to identify the prognostic value of uc.189 expression in gynecological cancer",
            "probability": 0.005949706579264479,
            "start_logit": 0.9268335700035095,
            "end_logit": -0.49807414412498474,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "human cancers",
            "probability": 0.004428572653502244,
            "start_logit": -1.165902853012085,
            "end_logit": 1.2993977069854736,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cervical squamous cell carcinomas (CSCCs), 98 endometrial adenocarcinoma",
            "probability": 0.004136184510117786,
            "start_logit": -0.4408491253852844,
            "end_logit": 0.5060403943061829,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "squamous cell carcinomas (CSCCs), 98 endometrial adenocarcinoma",
            "probability": 0.003136442028534752,
            "start_logit": -0.7175338268280029,
            "end_logit": 0.5060403943061829,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "ovarian cystoadenocarcinoma",
            "probability": 0.0019074718660192138,
            "start_logit": -0.9882909655570984,
            "end_logit": 0.2794872224330902,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "gynecological cancers remains unknown. This study was to identify the prognostic value of uc.189 expression in gynecological cancers",
            "probability": 0.0010133885878221473,
            "start_logit": 1.8505316972732544,
            "end_logit": -3.191814422607422,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cervical squamous cell carcinoma",
            "probability": 0.0010118347740071248,
            "start_logit": -0.4408491253852844,
            "end_logit": -0.9019680619239807,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        },
        {
            "text": "cystoadenocarcinoma",
            "probability": 0.0008220935059876253,
            "start_logit": -1.8299708366394043,
            "end_logit": 0.2794872224330902,
            "question_text": "List clinical disorders or diseases where uc.189 is involved?"
        }
    ],
    "5c58282e07647bbc4b00001e": [
        {
            "text": "RNA sequencing (RNA-seq",
            "probability": 0.31253980397243936,
            "start_logit": 0.5395100712776184,
            "end_logit": -0.1359476000070572,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "RNA sequencing",
            "probability": 0.2515458996735551,
            "start_logit": 0.5395100712776184,
            "end_logit": -0.3530539572238922,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "RNA-seq",
            "probability": 0.2314051379509228,
            "start_logit": 0.238948255777359,
            "end_logit": -0.1359476000070572,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "RNA sequencing (RNA-seq)",
            "probability": 0.08733362615507237,
            "start_logit": 0.5395100712776184,
            "end_logit": -1.410943865776062,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "RNA-seq)",
            "probability": 0.06466200321144046,
            "start_logit": 0.238948255777359,
            "end_logit": -1.410943865776062,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "EMASE software (Expectation-Maximization",
            "probability": 0.007083974239261728,
            "start_logit": -1.1091355085372925,
            "end_logit": -2.2741987705230713,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "Expectation-Maximization",
            "probability": 0.0061465285336761225,
            "start_logit": -1.2510831356048584,
            "end_logit": -2.2741987705230713,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "R",
            "probability": 0.005492839093724707,
            "start_logit": 0.5395100712776184,
            "end_logit": -4.177234172821045,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "EMASE",
            "probability": 0.00522256695623433,
            "start_logit": -1.1091355085372925,
            "end_logit": -2.579044818878174,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "EMASE software",
            "probability": 0.003836779969656062,
            "start_logit": -1.1091355085372925,
            "end_logit": -2.8874003887176514,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "RNA",
            "probability": 0.003606103713653222,
            "start_logit": 0.5395100712776184,
            "end_logit": -4.59805154800415,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "EMASE software (Expectation-Maximization for Allele Specific Expression",
            "probability": 0.0035471269387182722,
            "start_logit": -1.1091355085372925,
            "end_logit": -2.965895891189575,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "RNA sequencing (R",
            "probability": 0.003149090328227638,
            "start_logit": 0.5395100712776184,
            "end_logit": -4.733565807342529,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "Expectation-Maximization for Allele Specific Expression",
            "probability": 0.003077723916691613,
            "start_logit": -1.2510831356048584,
            "end_logit": -2.965895891189575,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "sequencing (RNA-seq",
            "probability": 0.0028754335843919118,
            "start_logit": -4.149018287658691,
            "end_logit": -0.1359476000070572,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "(RNA-seq",
            "probability": 0.002704907473410928,
            "start_logit": -4.210154056549072,
            "end_logit": -0.1359476000070572,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "sequencing",
            "probability": 0.0023142765137243184,
            "start_logit": -4.149018287658691,
            "end_logit": -0.3530539572238922,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "Allele-specific expression (ASE) refers to the differential abundance of the allelic copies of a transcript. RNA sequencing",
            "probability": 0.0012352681474148868,
            "start_logit": -4.776827335357666,
            "end_logit": -0.3530539572238922,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "EMASE software (Expectation",
            "probability": 0.0011891359580930184,
            "start_logit": -1.1091355085372925,
            "end_logit": -4.058806896209717,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        },
        {
            "text": "Expectation",
            "probability": 0.001031773669690922,
            "start_logit": -1.2510831356048584,
            "end_logit": -4.058806896209717,
            "question_text": "Name the algorithms for counting multi-mapping reads"
        }
    ],
    "5c596ad686df2b9174000015": [
        {
            "text": "ITGA4",
            "probability": 0.21494757769101927,
            "start_logit": 4.957327365875244,
            "end_logit": 4.547606945037842,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8",
            "probability": 0.17420760959354473,
            "start_logit": 4.957327365875244,
            "end_logit": 4.337460517883301,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8",
            "probability": 0.15579573858262757,
            "start_logit": 4.845625400543213,
            "end_logit": 4.337460517883301,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM1",
            "probability": 0.07155961531432432,
            "start_logit": 4.957327365875244,
            "end_logit": 3.4477436542510986,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8) and at previously implicated loci (ITGAL",
            "probability": 0.06580347387208337,
            "start_logit": 4.957327365875244,
            "end_logit": 3.3638854026794434,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8) and at previously implicated loci (ITGAL and ICAM1",
            "probability": 0.06399653348436152,
            "start_logit": 4.845625400543213,
            "end_logit": 3.4477436542510986,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8) and at previously implicated loci (ITGAL",
            "probability": 0.0588487542945067,
            "start_logit": 4.845625400543213,
            "end_logit": 3.3638854026794434,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGAL and ICAM1",
            "probability": 0.036992373019548254,
            "start_logit": 4.297508239746094,
            "end_logit": 3.4477436542510986,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGAL",
            "probability": 0.034016765472619,
            "start_logit": 4.297508239746094,
            "end_logit": 3.3638854026794434,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ICAM1",
            "probability": 0.03162867274705413,
            "start_logit": 4.140860557556152,
            "end_logit": 3.4477436542510986,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8) and at previously implicated loci (ITGAL and ICAM",
            "probability": 0.0274126564480299,
            "start_logit": 4.957327365875244,
            "end_logit": 2.48821759223938,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB8) and at previously implicated loci (ITGAL and ICAM",
            "probability": 0.024515433440577442,
            "start_logit": 4.845625400543213,
            "end_logit": 2.48821759223938,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGAL and ICAM",
            "probability": 0.014170830968389222,
            "start_logit": 4.297508239746094,
            "end_logit": 2.48821759223938,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ICAM",
            "probability": 0.012116134723667325,
            "start_logit": 4.140860557556152,
            "end_logit": 2.48821759223938,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB",
            "probability": 0.004865122384049756,
            "start_logit": 4.957327365875244,
            "end_logit": 0.7593046426773071,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGB",
            "probability": 0.004350931264635136,
            "start_logit": 4.845625400543213,
            "end_logit": 0.7593046426773071,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA",
            "probability": 0.002496536767908781,
            "start_logit": 4.957327365875244,
            "end_logit": 0.09211724996566772,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "ITGA4 and ITGB8)",
            "probability": 0.0007885068296847062,
            "start_logit": 4.957327365875244,
            "end_logit": -1.060401439666748,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "PLCG2",
            "probability": 0.000745805680637434,
            "start_logit": 2.0371272563934326,
            "end_logit": 1.8041226863861084,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        },
        {
            "text": "(ITGA4",
            "probability": 0.0007409274207314978,
            "start_logit": -0.7129194140434265,
            "end_logit": 4.547606945037842,
            "question_text": "Which integrin genes are activated by the immune system in inflammatory bowel disease?"
        }
    ],
    "5c72a9147c78d6947100006e": [
        {
            "text": "trifluridine/tipiracil",
            "probability": 0.41782869611453693,
            "start_logit": 6.214666843414307,
            "end_logit": 6.018850326538086,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine",
            "probability": 0.2958230050121457,
            "start_logit": 6.214666843414307,
            "end_logit": 5.673540115356445,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiracil",
            "probability": 0.2803373328804282,
            "start_logit": 5.81558895111084,
            "end_logit": 6.018850326538086,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102",
            "probability": 0.0023967474400146734,
            "start_logit": 6.214666843414307,
            "end_logit": 0.8578913807868958,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiracil (TAS-102",
            "probability": 0.0016080699845889097,
            "start_logit": 5.81558895111084,
            "end_logit": 0.8578913807868958,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine/tipiraci",
            "probability": 0.0003604893591090055,
            "start_logit": 6.214666843414307,
            "end_logit": -1.0365140438079834,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiraci",
            "probability": 0.00024186616765233115,
            "start_logit": 5.81558895111084,
            "end_logit": -1.0365140438079834,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "triflurid",
            "probability": 0.00022758868949490112,
            "start_logit": 6.214666843414307,
            "end_logit": -1.4964364767074585,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "luridine/tipiracil",
            "probability": 0.00016717296376441925,
            "start_logit": -1.6091309785842896,
            "end_logit": 6.018850326538086,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "cil",
            "probability": 0.00013380374918465953,
            "start_logit": -1.831785798072815,
            "end_logit": 6.018850326538086,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "t",
            "probability": 0.00012986945645944084,
            "start_logit": 6.214666843414307,
            "end_logit": -2.0574467182159424,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "luridine",
            "probability": 0.00011835857363904133,
            "start_logit": -1.6091309785842896,
            "end_logit": 5.673540115356445,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "fluridine/tipiracil",
            "probability": 0.00010588408883671689,
            "start_logit": -2.065814971923828,
            "end_logit": 6.018850326538086,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102, Lonsurf\u00ae)",
            "probability": 0.00010260560664321147,
            "start_logit": 6.214666843414307,
            "end_logit": -2.293083906173706,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 9.147510432073783e-05,
            "start_logit": 6.214666843414307,
            "end_logit": -2.407909631729126,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "fluridine",
            "probability": 7.496600792125633e-05,
            "start_logit": -2.065814971923828,
            "end_logit": 5.673540115356445,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "ridine/tipiracil",
            "probability": 7.015524338399005e-05,
            "start_logit": -2.477449417114258,
            "end_logit": 6.018850326538086,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiracil (TAS-102, Lonsurf\u00ae)",
            "probability": 6.884204548998063e-05,
            "start_logit": 5.81558895111084,
            "end_logit": -2.293083906173706,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 6.137416364338216e-05,
            "start_logit": 5.81558895111084,
            "end_logit": -2.407909631729126,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        },
        {
            "text": "/tipiracil",
            "probability": 5.16973487426872e-05,
            "start_logit": -2.7827534675598145,
            "end_logit": 6.018850326538086,
            "question_text": "Which drugs are included in the Lonsurf pill?"
        }
    ],
    "5c72b6be7c78d69471000072": [
        {
            "text": "PI3K-\u03b4 and PI3K-\u03b3",
            "probability": 0.3875199849207311,
            "start_logit": 4.371785640716553,
            "end_logit": 3.5989151000976562,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b3",
            "probability": 0.30866027349852426,
            "start_logit": 4.144259452819824,
            "end_logit": 3.5989151000976562,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4",
            "probability": 0.28539739668026554,
            "start_logit": 4.371785640716553,
            "end_logit": 3.293030261993408,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K",
            "probability": 0.008956640260996063,
            "start_logit": 4.371785640716553,
            "end_logit": -0.16845713555812836,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4 and PI3K",
            "probability": 0.0059355043121348955,
            "start_logit": 4.371785640716553,
            "end_logit": -0.579900324344635,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "AKT",
            "probability": 0.0008317876544910842,
            "start_logit": 1.397663950920105,
            "end_logit": 0.42909127473831177,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "AKT at serine 473 only out to 12 hours, with mTORC2 dependent re-phosphorylation of pAKT",
            "probability": 0.0007159910444772905,
            "start_logit": 1.397663950920105,
            "end_logit": 0.27918174862861633,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "P",
            "probability": 0.0006103768483567046,
            "start_logit": 4.371785640716553,
            "end_logit": -2.8545310497283936,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "\u03b4 and PI3K-\u03b3",
            "probability": 0.00029315534910174065,
            "start_logit": -2.8150343894958496,
            "end_logit": 3.5989151000976562,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4 and P",
            "probability": 0.00022149296922443167,
            "start_logit": 4.371785640716553,
            "end_logit": -3.8682167530059814,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "\u03b4",
            "probability": 0.00021590053858421107,
            "start_logit": -2.8150343894958496,
            "end_logit": 3.293030261993408,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "\u03b3",
            "probability": 0.000213962516140171,
            "start_logit": -3.1299362182617188,
            "end_logit": 3.5989151000976562,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "K-\u03b4 and PI3K-\u03b3",
            "probability": 6.653611149380463e-05,
            "start_logit": -4.29799222946167,
            "end_logit": 3.5989151000976562,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4 and PI3K-\u03b3 in clinical development in hematologic malignancies (HM)",
            "probability": 6.502812900459256e-05,
            "start_logit": 4.371785640716553,
            "end_logit": -5.093787670135498,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "pAKT",
            "probability": 6.292451723140912e-05,
            "start_logit": -0.31137266755104065,
            "end_logit": -0.443513423204422,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "K-\u03b3",
            "probability": 6.147466556720518e-05,
            "start_logit": -4.377111911773682,
            "end_logit": 3.5989151000976562,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b3 in clinical development in hematologic malignancies (HM)",
            "probability": 5.179500636015092e-05,
            "start_logit": 4.144259452819824,
            "end_logit": -5.093787670135498,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "K-\u03b4",
            "probability": 4.9001945046638216e-05,
            "start_logit": -4.29799222946167,
            "end_logit": 3.293030261993408,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4 and PI3K-\u03b3 in clinical development in hematologic malignancies",
            "probability": 3.8861669867334006e-05,
            "start_logit": 4.371785640716553,
            "end_logit": -5.6085991859436035,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        },
        {
            "text": "PI3K-\u03b4 and PI3K-\u03b3 in clinical development",
            "probability": 3.1911362400877184e-05,
            "start_logit": 4.371785640716553,
            "end_logit": -5.80564546585083,
            "question_text": "Which enzymes are inhibited by Duvelisib?"
        }
    ],
    "5c78174b7c78d694710000b1": [
        {
            "text": "OMSSA",
            "probability": 0.5403500645639355,
            "start_logit": 4.1781182289123535,
            "end_logit": 3.6611759662628174,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Mascot, OMSSA",
            "probability": 0.18280651994321764,
            "start_logit": 3.094329357147217,
            "end_logit": 3.6611759662628174,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Mascot",
            "probability": 0.07038986176285593,
            "start_logit": 3.094329357147217,
            "end_logit": 2.706796884536743,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Comet, Mascot, OMSSA",
            "probability": 0.0626904302698658,
            "start_logit": 2.0241098403930664,
            "end_logit": 3.6611759662628174,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "OMSSA, and X!",
            "probability": 0.030083984481253028,
            "start_logit": 4.1781182289123535,
            "end_logit": 0.7729517221450806,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Comet, Mascot",
            "probability": 0.02413902262304694,
            "start_logit": 2.0241098403930664,
            "end_logit": 2.706796884536743,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "OMSSA, and X",
            "probability": 0.016153413763643692,
            "start_logit": 4.1781182289123535,
            "end_logit": 0.15109017491340637,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "OMSSA, and X!Tandem",
            "probability": 0.012081371007425526,
            "start_logit": 4.1781182289123535,
            "end_logit": -0.13937655091285706,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Comet",
            "probability": 0.011132323728828993,
            "start_logit": 2.0241098403930664,
            "end_logit": 1.9328200817108154,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Mascot, OMSSA, and X!",
            "probability": 0.010177751183358862,
            "start_logit": 3.094329357147217,
            "end_logit": 0.7729517221450806,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "X!",
            "probability": 0.007317620596164352,
            "start_logit": 2.7644104957580566,
            "end_logit": 0.7729517221450806,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "OMSSA,",
            "probability": 0.0058273242106743,
            "start_logit": 4.1781182289123535,
            "end_logit": -0.868483304977417,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Mascot, OMSSA, and X",
            "probability": 0.005464882025539533,
            "start_logit": 3.094329357147217,
            "end_logit": 0.15109017491340637,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Mascot, OMSSA, and X!Tandem",
            "probability": 0.004087264043898388,
            "start_logit": 3.094329357147217,
            "end_logit": -0.13937655091285706,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "X",
            "probability": 0.003929152181582313,
            "start_logit": 2.7644104957580566,
            "end_logit": 0.15109017491340637,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Comet, Mascot, OMSSA, and X!",
            "probability": 0.0034902890830293674,
            "start_logit": 2.0241098403930664,
            "end_logit": 0.7729517221450806,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "O",
            "probability": 0.0030945158430024686,
            "start_logit": 4.1781182289123535,
            "end_logit": -1.5014097690582275,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "X!Tandem",
            "probability": 0.0029386695558539146,
            "start_logit": 2.7644104957580566,
            "end_logit": -0.13937655091285706,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Mascot, OMSSA,",
            "probability": 0.0019714494906073634,
            "start_logit": 3.094329357147217,
            "end_logit": -0.868483304977417,
            "question_text": "List search engines used in proteomics."
        },
        {
            "text": "Comet, Mascot, OMSSA, and X",
            "probability": 0.0018740896422159577,
            "start_logit": 2.0241098403930664,
            "end_logit": 0.15109017491340637,
            "question_text": "List search engines used in proteomics."
        }
    ],
    "5c62a276e842deac6700000a": [
        {
            "text": "C1QTNF4",
            "probability": 0.2807790517326822,
            "start_logit": 0.47748371958732605,
            "end_logit": -0.30165988206863403,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD, and C1QTNF4",
            "probability": 0.2768434949377605,
            "start_logit": 0.4633679986000061,
            "end_logit": -0.30165988206863403,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "DNMT3A, PRKCD, and C1QTNF4",
            "probability": 0.18181176368012744,
            "start_logit": 0.04288753867149353,
            "end_logit": -0.30165988206863403,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "DNMT3A",
            "probability": 0.10296283854644746,
            "start_logit": 0.04288753867149353,
            "end_logit": -0.8702636361122131,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD",
            "probability": 0.0704183832794336,
            "start_logit": 0.4633679986000061,
            "end_logit": -1.6706578731536865,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "DNMT3A, PRKCD",
            "probability": 0.04624595012577537,
            "start_logit": 0.04288753867149353,
            "end_logit": -1.6706578731536865,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "DNMT3",
            "probability": 0.014111308280252224,
            "start_logit": 0.04288753867149353,
            "end_logit": -2.8576552867889404,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "C1QTNF4. We identify a burden of rare variants across PRKCD",
            "probability": 0.009115304996551967,
            "start_logit": 0.47748371958732605,
            "end_logit": -3.7292730808258057,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD, and C1QTNF4. We identify a burden of rare variants across PRKCD",
            "probability": 0.008987539765151736,
            "start_logit": 0.4633679986000061,
            "end_logit": -3.7292730808258057,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "C1QTNF4 on NF-\u03baB activation and apoptosis,",
            "probability": 0.003602164629369712,
            "start_logit": -0.22127902507781982,
            "end_logit": -3.958930253982544,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "14",
            "probability": 0.0013403279352907761,
            "start_logit": -2.8371362686157227,
            "end_logit": -2.331693649291992,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD associated with SLE risk (P\u2009=\u20090.0028), and across DNMT3A",
            "probability": 0.0010374155735622496,
            "start_logit": -2.3904597759246826,
            "end_logit": -3.0345518589019775,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "14 genes with missense de novo mutations (DNM),",
            "probability": 0.0010057896845735894,
            "start_logit": -2.8371362686157227,
            "end_logit": -2.618834972381592,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "identified 14",
            "probability": 0.00032894533670900153,
            "start_logit": -4.24191427230835,
            "end_logit": -2.331693649291992,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "14 genes with missense de novo mutations",
            "probability": 0.00029713335037640545,
            "start_logit": -2.8371362686157227,
            "end_logit": -3.838182210922241,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "we sequenced the exomes of 30 SLE parent-affected-offspring trios and identified 14",
            "probability": 0.00028235453747774136,
            "start_logit": -4.394642353057861,
            "end_logit": -2.331693649291992,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "identified 14 genes with missense de novo mutations (DNM),",
            "probability": 0.0002468424463440911,
            "start_logit": -4.24191427230835,
            "end_logit": -2.618834972381592,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "missense de novo mutations (DNM),",
            "probability": 0.00020246735191759043,
            "start_logit": -4.4400858879089355,
            "end_logit": -2.618834972381592,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "Using extreme-phenotype sampling, we sequenced the exomes of 30 SLE parent-affected-offspring trios and identified 14",
            "probability": 0.00019286038448618328,
            "start_logit": -4.775839328765869,
            "end_logit": -2.331693649291992,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        },
        {
            "text": "PRKCD associated with SLE risk (P\u2009=\u20090.0028),",
            "probability": 0.00018806342570993622,
            "start_logit": -2.3904597759246826,
            "end_logit": -4.742260456085205,
            "question_text": "De novo mutations in which novel genes are involved in systemic lupus erythematosus?"
        }
    ],
    "5c7034ae7c78d69471000063": [
        {
            "text": "dolutegravir",
            "probability": 0.1900902039291982,
            "start_logit": 5.864151477813721,
            "end_logit": 6.366611957550049,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir (DTG)/lamivudine (3TC)/abacavir",
            "probability": 0.175451626347046,
            "start_logit": 5.864151477813721,
            "end_logit": 6.2864766120910645,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "abacavir",
            "probability": 0.17274805712327526,
            "start_logit": 5.8486223220825195,
            "end_logit": 6.2864766120910645,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "lamivudine (3TC)/abacavir",
            "probability": 0.15681074158488228,
            "start_logit": 5.751827716827393,
            "end_logit": 6.2864766120910645,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir (DTG)/lamivudine",
            "probability": 0.14620662227157138,
            "start_logit": 5.864151477813721,
            "end_logit": 6.1041340827941895,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "lamivudine",
            "probability": 0.1306728774213604,
            "start_logit": 5.751827716827393,
            "end_logit": 6.1041340827941895,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "rilpivirine",
            "probability": 0.007505983819415707,
            "start_logit": 4.433462619781494,
            "end_logit": 4.565502643585205,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "rilpivirine (RPV)/emtricitabine",
            "probability": 0.005012046263600677,
            "start_logit": 4.433462619781494,
            "end_logit": 4.161646366119385,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "rilpivirine (RPV)/emtricitabine (FTC)/tenofovir",
            "probability": 0.003382861914042202,
            "start_logit": 4.433462619781494,
            "end_logit": 3.768524169921875,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "rilpivirine (RPV)/emtricitabine (FTC)/tenofovir alafenamide",
            "probability": 0.0023629643037513534,
            "start_logit": 4.433462619781494,
            "end_logit": 3.4097189903259277,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "tenofovir",
            "probability": 0.0019361246393328787,
            "start_logit": 3.8754289150238037,
            "end_logit": 3.768524169921875,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "tenofovir alafenamide",
            "probability": 0.0013524032392118448,
            "start_logit": 3.8754289150238037,
            "end_logit": 3.4097189903259277,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir (DTG)/lamivudine (3TC)/abacavir (ABC)",
            "probability": 0.0012337816042132625,
            "start_logit": 5.864151477813721,
            "end_logit": 1.3291971683502197,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "emtricitabine",
            "probability": 0.001226976306215461,
            "start_logit": 3.0261712074279785,
            "end_logit": 4.161646366119385,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "abacavir (ABC)",
            "probability": 0.0012147700165554337,
            "start_logit": 5.8486223220825195,
            "end_logit": 1.3291971683502197,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "lamivudine (3TC)/abacavir (ABC)",
            "probability": 0.0011026982897712238,
            "start_logit": 5.751827716827393,
            "end_logit": 1.3291971683502197,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "emtricitabine (FTC)/tenofovir",
            "probability": 0.0008281430771843255,
            "start_logit": 3.0261712074279785,
            "end_logit": 3.768524169921875,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "emtricitabine (FTC)/tenofovir alafenamide",
            "probability": 0.0005784665704687557,
            "start_logit": 3.0261712074279785,
            "end_logit": 3.4097189903259277,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "dolutegravir (DTG)/lamivudine (3TC)",
            "probability": 0.00014925441867332865,
            "start_logit": 5.864151477813721,
            "end_logit": -0.7829896807670593,
            "question_text": "List drugs included in the TRIUMEQ pill."
        },
        {
            "text": "lamivudine (3TC)",
            "probability": 0.00013339686023023986,
            "start_logit": 5.751827716827393,
            "end_logit": -0.7829896807670593,
            "question_text": "List drugs included in the TRIUMEQ pill."
        }
    ],
    "5c928958ecadf2e73f000017": [
        {
            "text": "single-reaction multiplexing",
            "probability": 0.22776363945792977,
            "start_logit": -0.5814327597618103,
            "end_logit": -1.3745355606079102,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing",
            "probability": 0.2149045194564464,
            "start_logit": -0.6395473480224609,
            "end_logit": -1.3745355606079102,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes",
            "probability": 0.09858872080479046,
            "start_logit": -0.5814327597618103,
            "end_logit": -2.2118871212005615,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing with orthogonal CRISPR enzymes",
            "probability": 0.09302258129877106,
            "start_logit": -0.6395473480224609,
            "end_logit": -2.2118871212005615,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes;",
            "probability": 0.04308966546549551,
            "start_logit": -0.5814327597618103,
            "end_logit": -3.0395607948303223,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar",
            "probability": 0.0425633242193443,
            "start_logit": -0.5814327597618103,
            "end_logit": -3.0518510341644287,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar;",
            "probability": 0.04130191287550354,
            "start_logit": -0.5814327597618103,
            "end_logit": -3.081935167312622,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing with orthogonal CRISPR enzymes;",
            "probability": 0.040656901481027616,
            "start_logit": -0.6395473480224609,
            "end_logit": -3.0395607948303223,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "(i) four-channel single-reaction multiplexing",
            "probability": 0.03890889199051478,
            "start_logit": -2.3485183715820312,
            "end_logit": -1.3745355606079102,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "lateral-flow readout",
            "probability": 0.02412288309296317,
            "start_logit": -2.3955178260803223,
            "end_logit": -1.8055980205535889,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "Cas13 with Csm6, an auxiliary CRISPR-associated enzyme; and (iv) lateral-flow readout",
            "probability": 0.019086952808586813,
            "start_logit": -2.629673719406128,
            "end_logit": -1.8055980205535889,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "(i) four-channel single-reaction multiplexing with orthogonal CRISPR enzymes",
            "probability": 0.016841923927832004,
            "start_logit": -2.3485183715820312,
            "end_logit": -2.2118871212005615,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four",
            "probability": 0.01631880267515744,
            "start_logit": -0.6395473480224609,
            "end_logit": -3.952411413192749,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement",
            "probability": 0.015389888472869675,
            "start_logit": -0.5814327597618103,
            "end_logit": -4.069133281707764,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement",
            "probability": 0.01452100341661981,
            "start_logit": -0.6395473480224609,
            "end_logit": -4.069133281707764,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "Csm6, an auxiliary CRISPR-associated enzyme; and (iv) lateral-flow readout",
            "probability": 0.013886513815280216,
            "start_logit": -2.947760581970215,
            "end_logit": -1.8055980205535889,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative",
            "probability": 0.01015502141444703,
            "start_logit": -0.5814327597618103,
            "end_logit": -4.484875679016113,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "quantitative measurement of input as low as 2 attomolar",
            "probability": 0.009792691598139861,
            "start_logit": -2.0507893562316895,
            "end_logit": -3.0518510341644287,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "four-channel single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative",
            "probability": 0.009581687412159416,
            "start_logit": -0.6395473480224609,
            "end_logit": -4.484875679016113,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        },
        {
            "text": "quantitative measurement of input as low as 2 attomolar;",
            "probability": 0.009502474316120953,
            "start_logit": -2.0507893562316895,
            "end_logit": -3.081935167312622,
            "question_text": "List the four advances integrated into the SHERLOCKv2 platform."
        }
    ],
    "5c63286ae842deac6700000e": [
        {
            "text": "Heterozygous mutations in",
            "probability": 0.27310587211040355,
            "start_logit": -1.7171614170074463,
            "end_logit": -2.9709360599517822,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "Heterozygous",
            "probability": 0.21344812885149317,
            "start_logit": -1.7171614170074463,
            "end_logit": -3.2174017429351807,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "Heterozygous mutations",
            "probability": 0.19956343407724297,
            "start_logit": -1.7171614170074463,
            "end_logit": -3.284663438796997,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "He",
            "probability": 0.09697878851543014,
            "start_logit": -1.7171614170074463,
            "end_logit": -4.006303310394287,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "in",
            "probability": 0.07186813829247451,
            "start_logit": -3.052187919616699,
            "end_logit": -2.9709360599517822,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "mutations in",
            "probability": 0.03899598332350923,
            "start_logit": -3.663562297821045,
            "end_logit": -2.9709360599517822,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "terozygous mutations in",
            "probability": 0.030866261344919214,
            "start_logit": -3.897357225418091,
            "end_logit": -2.9709360599517822,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "mutations",
            "probability": 0.028495075141088302,
            "start_logit": -3.663562297821045,
            "end_logit": -3.284663438796997,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "terozygous",
            "probability": 0.02412377909637486,
            "start_logit": -3.897357225418091,
            "end_logit": -3.2174017429351807,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        },
        {
            "text": "terozygous mutations",
            "probability": 0.022554539247064,
            "start_logit": -3.897357225418091,
            "end_logit": -3.284663438796997,
            "question_text": "List clinical symptoms of the MECOM-associated syndrome"
        }
    ],
    "5c72fb4a7c78d69471000082": [
        {
            "text": "autosomal recessive syndrome with variable phenotype",
            "probability": 0.2555194582423733,
            "start_logit": -2.00679612159729,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Allgrove or triple A syndrome (AS or AAA) is a rare autosomal recessive syndrome with variable phenotype",
            "probability": 0.09727619536188607,
            "start_logit": -2.9725403785705566,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "variable phenotype",
            "probability": 0.09413651382208772,
            "start_logit": -3.0053486824035645,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "rare autosomal recessive syndrome with variable phenotype",
            "probability": 0.07635132223603784,
            "start_logit": -3.214749336242676,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "a rare autosomal recessive syndrome with variable phenotype",
            "probability": 0.05698626551930215,
            "start_logit": -3.50728440284729,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "autosomal recessive",
            "probability": 0.05542002876382697,
            "start_logit": -2.00679612159729,
            "end_logit": -2.907655954360962,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "triple A syndrome (AS or AAA) is a rare autosomal recessive syndrome with variable phenotype",
            "probability": 0.04782194578148308,
            "start_logit": -3.682610034942627,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "syndrome with variable phenotype",
            "probability": 0.0460495813353267,
            "start_logit": -3.7203760147094727,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Allgrove",
            "probability": 0.045726725903945706,
            "start_logit": -2.9725403785705566,
            "end_logit": -2.134169816970825,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "autosomal recessive syndrome with variable phenotype due to mutations",
            "probability": 0.0321615651048691,
            "start_logit": -2.00679612159729,
            "end_logit": -3.451824903488159,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "is a rare autosomal recessive syndrome with variable phenotype",
            "probability": 0.030029773398046307,
            "start_logit": -4.147905349731445,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "autosomal recessive syndrome",
            "probability": 0.0256748606525089,
            "start_logit": -2.00679612159729,
            "end_logit": -3.6770846843719482,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "with variable phenotype",
            "probability": 0.024911219500189093,
            "start_logit": -4.334776401519775,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "Allgrove or triple A syndrome (AS or AAA) is a rare autosomal recessive",
            "probability": 0.021098391418307133,
            "start_logit": -2.9725403785705566,
            "end_logit": -2.907655954360962,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "autosomal recessive syndrome with variable phenotype due",
            "probability": 0.017783646347842276,
            "start_logit": -2.00679612159729,
            "end_logit": -4.044317722320557,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "phenotype",
            "probability": 0.01775945269566615,
            "start_logit": -4.6731767654418945,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "rare autosomal recessive",
            "probability": 0.016559961826718282,
            "start_logit": -3.214749336242676,
            "end_logit": -2.907655954360962,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "syndrome (AS or AAA) is a rare autosomal recessive syndrome with variable phenotype",
            "probability": 0.013368769311492662,
            "start_logit": -4.9571733474731445,
            "end_logit": -1.379298448562622,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "autosomal recessive syndrome with",
            "probability": 0.013004479437990936,
            "start_logit": -2.00679612159729,
            "end_logit": -4.357303142547607,
            "question_text": "List features of the Triple A syndrome."
        },
        {
            "text": "a rare autosomal recessive",
            "probability": 0.012359843340099406,
            "start_logit": -3.50728440284729,
            "end_logit": -2.907655954360962,
            "question_text": "List features of the Triple A syndrome."
        }
    ],
    "5c8d00980101eac870000006": [
        {
            "text": "BZD9L1",
            "probability": 0.953269967517986,
            "start_logit": 4.39091682434082,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "(BZD9L1",
            "probability": 0.016197389480480395,
            "start_logit": 0.3158687651157379,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "BZD9L1)",
            "probability": 0.01447920216346072,
            "start_logit": 4.39091682434082,
            "end_logit": -0.05926709249615669,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "novel sirtuin inhibitor (BZD9L1",
            "probability": 0.0028964964612048366,
            "start_logit": -1.4054794311523438,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "a novel sirtuin inhibitor (BZD9L1",
            "probability": 0.001984976373238379,
            "start_logit": -1.783374309539795,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "B",
            "probability": 0.0017457991347280778,
            "start_logit": 4.39091682434082,
            "end_logit": -2.1747679710388184,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "L1",
            "probability": 0.0011751248361167783,
            "start_logit": -2.3076069355010986,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "1",
            "probability": 0.0009345233279756726,
            "start_logit": -2.5367000102996826,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "BZD9L",
            "probability": 0.0009131633277046467,
            "start_logit": 4.39091682434082,
            "end_logit": -2.8228209018707275,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "This study aims to investigate the mode of action of a novel sirtuin inhibitor (BZD9L1",
            "probability": 0.0008355173757248076,
            "start_logit": -2.6486854553222656,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "study aims to investigate the mode of action of a novel sirtuin inhibitor (BZD9L1",
            "probability": 0.0007677726121307067,
            "start_logit": -2.733242988586426,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "D9L1",
            "probability": 0.0007615340818787329,
            "start_logit": -2.7414016723632812,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "investigate the mode of action of a novel sirtuin inhibitor (BZD9L1",
            "probability": 0.0006782335051512251,
            "start_logit": -2.8572449684143066,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "BZD9L1) and its associated molecular pathways in colorectal cancer (CRC) cells.",
            "probability": 0.0005800490373222905,
            "start_logit": 4.39091682434082,
            "end_logit": -3.276623010635376,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "BZD9L1) and its associated molecular pathways in colorectal cancer",
            "probability": 0.000571124970628737,
            "start_logit": 4.39091682434082,
            "end_logit": -3.2921276092529297,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "inhibitor (BZD9L1",
            "probability": 0.0004686818768181502,
            "start_logit": -3.2268123626708984,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "BZD9",
            "probability": 0.00044912486991369985,
            "start_logit": 4.39091682434082,
            "end_logit": -3.5324347019195557,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "to investigate the mode of action of a novel sirtuin inhibitor (BZD9L1",
            "probability": 0.0004461466220216175,
            "start_logit": -3.2760889530181885,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "of a novel sirtuin inhibitor (BZD9L1",
            "probability": 0.00042530064670331897,
            "start_logit": -3.3239402770996094,
            "end_logit": 4.127917766571045,
            "question_text": "List sirtuin inhibitors."
        },
        {
            "text": "BZD",
            "probability": 0.0004198717788116291,
            "start_logit": 4.39091682434082,
            "end_logit": -3.5997862815856934,
            "question_text": "List sirtuin inhibitors."
        }
    ],
    "5c8d0a980101eac870000008": [
        {
            "text": "prostate cancer",
            "probability": 0.2711580232160605,
            "start_logit": -3.8032779693603516,
            "end_logit": -3.564908266067505,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "cancer",
            "probability": 0.144677129896285,
            "start_logit": -4.4314751625061035,
            "end_logit": -3.564908266067505,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "high risk HPVs are associated with an increased risk of prostate cancer",
            "probability": 0.14417515336497763,
            "start_logit": -4.434950828552246,
            "end_logit": -3.564908266067505,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "human papilloma viruses",
            "probability": 0.06892736754212826,
            "start_logit": -3.996567964553833,
            "end_logit": -4.74126672744751,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "Although high risk HPVs are associated with an increased risk of prostate cancer",
            "probability": 0.056543726036686,
            "start_logit": -5.370965480804443,
            "end_logit": -3.564908266067505,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "increased risk of prostate cancer",
            "probability": 0.045729037990208665,
            "start_logit": -5.583246231079102,
            "end_logit": -3.564908266067505,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "high risk",
            "probability": 0.038395435616595655,
            "start_logit": -4.434950828552246,
            "end_logit": -4.887998580932617,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "HPVs are associated with an increased risk of prostate cancer",
            "probability": 0.032962309238962845,
            "start_logit": -5.910614967346191,
            "end_logit": -3.564908266067505,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "risk of prostate cancer",
            "probability": 0.03149372098116211,
            "start_logit": -5.956191539764404,
            "end_logit": -3.564908266067505,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "human papilloma",
            "probability": 0.023766859303524863,
            "start_logit": -3.996567964553833,
            "end_logit": -5.806027889251709,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "associated with an increased risk of prostate cancer",
            "probability": 0.022621189286982004,
            "start_logit": -6.287092685699463,
            "end_logit": -3.564908266067505,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "high risk HPVs",
            "probability": 0.019140662300374568,
            "start_logit": -4.434950828552246,
            "end_logit": -5.584122180938721,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "human papilloma viruses (HPVs) in prostate cancer",
            "probability": 0.01818858369387399,
            "start_logit": -3.996567964553833,
            "end_logit": -6.073525905609131,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "cancer it is not known if they have a causal role. The purpose of this study is to investigate the potential role of human papilloma",
            "probability": 0.015384875956332403,
            "start_logit": -4.4314751625061035,
            "end_logit": -5.806027889251709,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "Although high risk",
            "probability": 0.015058218714483264,
            "start_logit": -5.370965480804443,
            "end_logit": -4.887998580932617,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "papilloma viruses",
            "probability": 0.011688775137791098,
            "start_logit": -5.770992279052734,
            "end_logit": -4.74126672744751,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "high risk HPVs are associated with an increased risk",
            "probability": 0.01129424045208735,
            "start_logit": -4.434950828552246,
            "end_logit": -6.111644268035889,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "cancer in the same patients, and (ii) to determine if HPVs are biologically active.",
            "probability": 0.010405615107348044,
            "start_logit": -6.257739543914795,
            "end_logit": -4.370802879333496,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "human papilloma viruses (HPVs)",
            "probability": 0.009350990881766927,
            "start_logit": -3.996567964553833,
            "end_logit": -6.738837718963623,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        },
        {
            "text": "biologically active.",
            "probability": 0.009038085282368945,
            "start_logit": -6.398637771606445,
            "end_logit": -4.370802879333496,
            "question_text": "Which proteins are markers of HPV oncogenic activity?"
        }
    ],
    "5c73acf57c78d6947100008c": [
        {
            "text": "Car, Relax, Alone, Forget, Friends, Trouble",
            "probability": 0.07926404206961565,
            "start_logit": 3.71958327293396,
            "end_logit": 3.496227741241455,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax, Alone, Forget",
            "probability": 0.07127482071839256,
            "start_logit": 3.71958327293396,
            "end_logit": 3.389986276626587,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Forget, Friends, Trouble",
            "probability": 0.07054841606280253,
            "start_logit": 3.603097915649414,
            "end_logit": 3.496227741241455,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Trouble",
            "probability": 0.0634419449284055,
            "start_logit": 3.4969239234924316,
            "end_logit": 3.496227741241455,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Forget",
            "probability": 0.06343766448885564,
            "start_logit": 3.603097915649414,
            "end_logit": 3.389986276626587,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car",
            "probability": 0.05699878735142117,
            "start_logit": 3.71958327293396,
            "end_logit": 3.166473150253296,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax, Alone, Forget, Friends",
            "probability": 0.055099897282654985,
            "start_logit": 3.71958327293396,
            "end_logit": 3.1325910091400146,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax",
            "probability": 0.05371223839878166,
            "start_logit": 3.71958327293396,
            "end_logit": 3.107084035873413,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Friends, Trouble",
            "probability": 0.05275363324016992,
            "start_logit": 3.3124313354492188,
            "end_logit": 3.496227741241455,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Forget, Friends",
            "probability": 0.04904128501421093,
            "start_logit": 3.603097915649414,
            "end_logit": 3.1325910091400146,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Alcohol",
            "probability": 0.04650825659581412,
            "start_logit": 3.3459787368774414,
            "end_logit": 3.3366775512695312,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Relax, Alone, Forget, Friends, Trouble",
            "probability": 0.04491072995336736,
            "start_logit": 3.151475429534912,
            "end_logit": 3.496227741241455,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Relax, Alone, Forget",
            "probability": 0.0403840649830479,
            "start_logit": 3.151475429534912,
            "end_logit": 3.389986276626587,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Alcohol (AUD) and other substance use disorders (SUD) are common among adolescents. The CRAFFT (Car",
            "probability": 0.039229360430434054,
            "start_logit": 3.3459787368774414,
            "end_logit": 3.166473150253296,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Alone, Forget, Friends, Trouble",
            "probability": 0.03808075229279144,
            "start_logit": 2.9865076541900635,
            "end_logit": 3.496227741241455,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Alcohol (AUD) and other substance use disorders (SUD) are common among adolescents. The CRAFFT (Car, Relax",
            "probability": 0.036967396283013536,
            "start_logit": 3.3459787368774414,
            "end_logit": 3.107084035873413,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Friends",
            "probability": 0.036671354335769506,
            "start_logit": 3.3124313354492188,
            "end_logit": 3.1325910091400146,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Car, Relax, Alone",
            "probability": 0.03621344794716061,
            "start_logit": 3.71958327293396,
            "end_logit": 2.712873697280884,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Alone, Forget",
            "probability": 0.03424249787951027,
            "start_logit": 2.9865076541900635,
            "end_logit": 3.389986276626587,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        },
        {
            "text": "Relax, Alone, Forget, Friends",
            "probability": 0.031219409743780648,
            "start_logit": 3.151475429534912,
            "end_logit": 3.1325910091400146,
            "question_text": "Which features are evaluated with the CRAFFT screening test?"
        }
    ],
    "5c5f0f581a4c55d80b000012": [
        {
            "text": "circulating T-cell subsets",
            "probability": 0.43085711750328415,
            "start_logit": -0.5059024691581726,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "circulating",
            "probability": 0.2696344872177926,
            "start_logit": -0.5059024691581726,
            "end_logit": -0.9740215539932251,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "circulating T-cell subsets after microwave ablation",
            "probability": 0.049537539567667606,
            "start_logit": -0.5059024691581726,
            "end_logit": -2.668358087539673,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "T-cell subsets",
            "probability": 0.03945057818040901,
            "start_logit": -2.89663028717041,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "circulating T-cell subset",
            "probability": 0.035096192473550565,
            "start_logit": -0.5059024691581726,
            "end_logit": -3.012996196746826,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "subsets",
            "probability": 0.03170253649353673,
            "start_logit": -3.1152822971343994,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "changes of circulating T-cell subsets",
            "probability": 0.02586117068491697,
            "start_logit": -3.318936347961426,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "circulating T-cell",
            "probability": 0.0214183982652994,
            "start_logit": -0.5059024691581726,
            "end_logit": -3.50683856010437,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "circulating T",
            "probability": 0.01632877661886778,
            "start_logit": -0.5059024691581726,
            "end_logit": -3.7781598567962646,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "changes of circulating",
            "probability": 0.01618416689246464,
            "start_logit": -3.318936347961426,
            "end_logit": -0.9740215539932251,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "s",
            "probability": 0.015038270880652637,
            "start_logit": -3.8610806465148926,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "circulating T-cell subsets after microwave",
            "probability": 0.008623635411609468,
            "start_logit": -0.5059024691581726,
            "end_logit": -4.416582107543945,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "circulating T-cell subsets after microwave ablation (MWA)",
            "probability": 0.006364339435708152,
            "start_logit": -0.5059024691581726,
            "end_logit": -4.720378398895264,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "investigate the changes of circulating T-cell subsets",
            "probability": 0.005823018447516656,
            "start_logit": -4.8098602294921875,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "circulating T-cell subsets after",
            "probability": 0.005415776816815394,
            "start_logit": -0.5059024691581726,
            "end_logit": -4.881772518157959,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "microwave ablation",
            "probability": 0.005077871760889092,
            "start_logit": -2.783740997314453,
            "end_logit": -2.668358087539673,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "T-cell subsets after microwave ablation",
            "probability": 0.004535806647233766,
            "start_logit": -2.89663028717041,
            "end_logit": -2.668358087539673,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "to investigate the changes of circulating T-cell subsets",
            "probability": 0.00450607837630967,
            "start_logit": -5.066251754760742,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "cell subsets",
            "probability": 0.004305920143339216,
            "start_logit": -5.111688137054443,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        },
        {
            "text": "hepatocellular carcinoma (HCC). Our aim is to investigate the changes of circulating T-cell subsets",
            "probability": 0.004238318182136729,
            "start_logit": -5.127512454986572,
            "end_logit": -0.5053123235702515,
            "question_text": "List lymphocytes that are analyzed by a flow cytometer."
        }
    ],
    "5c73ad057c78d6947100008f": [
        {
            "text": "palonosetron",
            "probability": 0.3569909679257885,
            "start_logit": 6.605102062225342,
            "end_logit": 6.674813747406006,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "netupitant/palonosetron",
            "probability": 0.2730519841238532,
            "start_logit": 6.3370537757873535,
            "end_logit": 6.674813747406006,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "netupitant",
            "probability": 0.26829929870458286,
            "start_logit": 6.3370537757873535,
            "end_logit": 6.657254695892334,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "dulaglutide (Trulicity) for glycemic control in type-2 diabetes; netupitant/palonosetron",
            "probability": 0.0400120823376382,
            "start_logit": 4.4165730476379395,
            "end_logit": 6.674813747406006,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "dulaglutide (Trulicity) for glycemic control in type-2 diabetes; netupitant",
            "probability": 0.03931564044606608,
            "start_logit": 4.4165730476379395,
            "end_logit": 6.657254695892334,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "palonosetron (Akynzeo) for prevention of nausea and vomiting related to chemotherapy; and naloxegol",
            "probability": 0.014467947674457991,
            "start_logit": 6.605102062225342,
            "end_logit": 3.469038963317871,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "dulaglutide",
            "probability": 0.00596474271879111,
            "start_logit": 4.4165730476379395,
            "end_logit": 4.771498203277588,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "naloxegol",
            "probability": 0.0007226228602478221,
            "start_logit": 3.6082985401153564,
            "end_logit": 3.469038963317871,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "sofosbuvir (Harvoni) for hepatitis C virus genotype 1 infection; dulaglutide",
            "probability": 0.00046929561630259354,
            "start_logit": 1.8741847276687622,
            "end_logit": 4.771498203277588,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "Ledipasvir",
            "probability": 0.00010091043069571814,
            "start_logit": 2.0592002868652344,
            "end_logit": 3.049483060836792,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "palonose",
            "probability": 7.916470662152987e-05,
            "start_logit": 6.605102062225342,
            "end_logit": -1.739121437072754,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "Ledipasvir/sofosbuvir",
            "probability": 6.659939306836207e-05,
            "start_logit": 2.0592002868652344,
            "end_logit": 2.6339452266693115,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "p",
            "probability": 6.225563131572712e-05,
            "start_logit": 6.605102062225342,
            "end_logit": -1.979403018951416,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "nt/palonosetron",
            "probability": 6.193440169970554e-05,
            "start_logit": -2.054287910461426,
            "end_logit": 6.674813747406006,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "nt",
            "probability": 6.085638452706378e-05,
            "start_logit": -2.054287910461426,
            "end_logit": 6.657254695892334,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "netupitant/palonose",
            "probability": 6.055077623164133e-05,
            "start_logit": 6.3370537757873535,
            "end_logit": -1.739121437072754,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "palonosetron (Akynzeo) for prevention of nausea and vomiting related to chemotherapy",
            "probability": 5.6784182396771817e-05,
            "start_logit": 6.605102062225342,
            "end_logit": -2.071394205093384,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "sofosbuvir",
            "probability": 5.535017967004716e-05,
            "start_logit": 1.8741847276687622,
            "end_logit": 2.6339452266693115,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "tron",
            "probability": 5.059368356078177e-05,
            "start_logit": -2.2565369606018066,
            "end_logit": 6.674813747406006,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        },
        {
            "text": "dulaglutide (Trulicity)",
            "probability": 5.041782248448004e-05,
            "start_logit": 4.4165730476379395,
            "end_logit": -0.0017782652284950018,
            "question_text": "List two drugs that are included in the Akynzeo pill?"
        }
    ],
    "5c5f2dc21a4c55d80b000024": [
        {
            "text": "inulin",
            "probability": 0.15375222600642496,
            "start_logit": 4.4191718101501465,
            "end_logit": 4.58504581451416,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "polydextrose",
            "probability": 0.14843894618570894,
            "start_logit": 4.224991321563721,
            "end_logit": 4.744057655334473,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "inulin and other fructo-oligosaccharides, galactooligosaccharides",
            "probability": 0.13465023509328483,
            "start_logit": 4.4191718101501465,
            "end_logit": 4.452383995056152,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "galactooligosaccharides, and polydextrose",
            "probability": 0.12219282557537564,
            "start_logit": 4.0304179191589355,
            "end_logit": 4.744057655334473,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "fructo-oligosaccharides, galactooligosaccharides, and polydextrose",
            "probability": 0.10180261969291556,
            "start_logit": 3.847853422164917,
            "end_logit": 4.744057655334473,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "galactooligosaccharides",
            "probability": 0.09127954074129367,
            "start_logit": 4.0304179191589355,
            "end_logit": 4.452383995056152,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "inulin and other fructo-oligosaccharides",
            "probability": 0.08213774083560774,
            "start_logit": 4.4191718101501465,
            "end_logit": 3.9581010341644287,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "fructo-oligosaccharides, galactooligosaccharides",
            "probability": 0.07604780663736889,
            "start_logit": 3.847853422164917,
            "end_logit": 4.452383995056152,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "fructo-oligosaccharides",
            "probability": 0.046389781854960385,
            "start_logit": 3.847853422164917,
            "end_logit": 3.9581010341644287,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "short-chain fatty acids are produced. Saccharides such as inulin",
            "probability": 0.017166663719709062,
            "start_logit": 2.2267987728118896,
            "end_logit": 4.58504581451416,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "short-chain fatty acids are produced. Saccharides such as inulin and other fructo-oligosaccharides",
            "probability": 0.00917080039909517,
            "start_logit": 2.2267987728118896,
            "end_logit": 3.9581010341644287,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "short-chain fatty acids are produced. Saccharides",
            "probability": 0.003561462708479242,
            "start_logit": 2.2267987728118896,
            "end_logit": 3.0122478008270264,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "inulin and other fructo-oligosaccharide",
            "probability": 0.0025635227010847987,
            "start_logit": 4.4191718101501465,
            "end_logit": 0.49108579754829407,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "other fructo-oligosaccharides, galactooligosaccharides, and polydextrose",
            "probability": 0.002497720982068421,
            "start_logit": 0.140196293592453,
            "end_logit": 4.744057655334473,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "other fructo-oligosaccharides, galactooligosaccharides",
            "probability": 0.0018658282355739492,
            "start_logit": 0.140196293592453,
            "end_logit": 4.452383995056152,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "inulin and other fructo-oligosaccharides,",
            "probability": 0.001472083325115743,
            "start_logit": 4.4191718101501465,
            "end_logit": -0.06361794471740723,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "fructo-oligosaccharide",
            "probability": 0.0014478272432836233,
            "start_logit": 3.847853422164917,
            "end_logit": 0.49108579754829407,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "Saccharides such as inulin",
            "probability": 0.0013572369317246386,
            "start_logit": -0.3107196092605591,
            "end_logit": 4.58504581451416,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "other fructo-oligosaccharides",
            "probability": 0.0011381704306060681,
            "start_logit": 0.140196293592453,
            "end_logit": 3.9581010341644287,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        },
        {
            "text": "short-chain fatty acids",
            "probability": 0.0010669607003188002,
            "start_logit": 2.2267987728118896,
            "end_logit": 1.806890606880188,
            "question_text": "List some substances important for proper nervous system function that gut microbes produce."
        }
    ],
    "5c851a8175a4a5d219000005": [
        {
            "text": "toxin B",
            "probability": 0.33409226426697736,
            "start_logit": 3.929953098297119,
            "end_logit": 3.7019002437591553,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA) and toxin B",
            "probability": 0.2532886578098518,
            "start_logit": 3.6530656814575195,
            "end_logit": 3.7019002437591553,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin B (TcdB)",
            "probability": 0.10325413663585276,
            "start_logit": 3.929953098297119,
            "end_logit": 2.5276763439178467,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A",
            "probability": 0.08859947613719192,
            "start_logit": 3.6530656814575195,
            "end_logit": 2.651496410369873,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA) and toxin B (TcdB)",
            "probability": 0.07828107525683659,
            "start_logit": 3.6530656814575195,
            "end_logit": 2.5276763439178467,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin B (TcdB",
            "probability": 0.03932259910479519,
            "start_logit": 3.929953098297119,
            "end_logit": 1.5622824430465698,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA)",
            "probability": 0.030614199568012996,
            "start_logit": 3.6530656814575195,
            "end_logit": 1.5888344049453735,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA) and toxin B (TcdB",
            "probability": 0.02981202923300648,
            "start_logit": 3.6530656814575195,
            "end_logit": 1.5622824430465698,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "TcdB)",
            "probability": 0.01102495652343066,
            "start_logit": 1.6929212808609009,
            "end_logit": 2.5276763439178467,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin",
            "probability": 0.0052237646113808215,
            "start_logit": 3.929953098297119,
            "end_logit": -0.4562986195087433,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "TcdB",
            "probability": 0.004198669028124211,
            "start_logit": 1.6929212808609009,
            "end_logit": 1.5622824430465698,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA",
            "probability": 0.004100705294103272,
            "start_logit": 3.6530656814575195,
            "end_logit": -0.4214705526828766,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "B",
            "probability": 0.004006196790946515,
            "start_logit": -0.49362173676490784,
            "end_logit": 3.7019002437591553,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "toxin A (TcdA) and toxin",
            "probability": 0.003960344098461161,
            "start_logit": 3.6530656814575195,
            "end_logit": -0.4562986195087433,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "A (TcdA) and toxin B",
            "probability": 0.002943495801459822,
            "start_logit": -0.8018661737442017,
            "end_logit": 3.7019002437591553,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "(TcdA) and toxin B",
            "probability": 0.002885076599494523,
            "start_logit": -0.8219126462936401,
            "end_logit": 3.7019002437591553,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "B (TcdB)",
            "probability": 0.0012381501611541303,
            "start_logit": -0.49362173676490784,
            "end_logit": 2.5276763439178467,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "(TcdB)",
            "probability": 0.00111962380069497,
            "start_logit": -0.5942474603652954,
            "end_logit": 2.5276763439178467,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "A",
            "probability": 0.0010296244145963508,
            "start_logit": -0.8018661737442017,
            "end_logit": 2.651496410369873,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        },
        {
            "text": "TcdA) and toxin B",
            "probability": 0.0010049548636284682,
            "start_logit": -1.8765214681625366,
            "end_logit": 3.7019002437591553,
            "question_text": "List 3 enterotoxins produced by Clostridium difficile."
        }
    ],
    "5c7d520ed774d0424000000f": [
        {
            "text": "leptin",
            "probability": 0.43530503065076526,
            "start_logit": 4.639339447021484,
            "end_logit": 3.6941888332366943,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and leptin",
            "probability": 0.32157172081977753,
            "start_logit": 4.336513042449951,
            "end_logit": 3.6941888332366943,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin",
            "probability": 0.2405880012820722,
            "start_logit": 4.336513042449951,
            "end_logit": 3.4040541648864746,
            "question_text": "List adipokines."
        },
        {
            "text": "ad",
            "probability": 0.0004880296915698618,
            "start_logit": 4.336513042449951,
            "end_logit": -2.7964107990264893,
            "question_text": "List adipokines."
        },
        {
            "text": "le",
            "probability": 0.0003085091207074812,
            "start_logit": 4.639339447021484,
            "end_logit": -3.5578620433807373,
            "question_text": "List adipokines."
        },
        {
            "text": "(adiponectin and leptin",
            "probability": 0.00025242786157068367,
            "start_logit": -2.8133373260498047,
            "end_logit": 3.6941888332366943,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponect",
            "probability": 0.00025155658767139424,
            "start_logit": 4.336513042449951,
            "end_logit": -3.4591190814971924,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and le",
            "probability": 0.00022790411745572778,
            "start_logit": 4.336513042449951,
            "end_logit": -3.5578620433807373,
            "question_text": "List adipokines."
        },
        {
            "text": "(adiponectin",
            "probability": 0.00018885713746338625,
            "start_logit": -2.8133373260498047,
            "end_logit": 3.4040541648864746,
            "question_text": "List adipokines."
        },
        {
            "text": "lept",
            "probability": 0.00018057534649264204,
            "start_logit": 4.639339447021484,
            "end_logit": -4.093465328216553,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and lept",
            "probability": 0.00013339594266222244,
            "start_logit": 4.336513042449951,
            "end_logit": -4.093465328216553,
            "question_text": "List adipokines."
        },
        {
            "text": "leptin)",
            "probability": 0.00010658712040346583,
            "start_logit": 4.639339447021484,
            "end_logit": -4.620650768280029,
            "question_text": "List adipokines."
        },
        {
            "text": "onectin and leptin",
            "probability": 9.175619122653895e-05,
            "start_logit": -3.8253278732299805,
            "end_logit": 3.6941888332366943,
            "question_text": "List adipokines."
        },
        {
            "text": "adiponectin and leptin)",
            "probability": 7.8738818327293e-05,
            "start_logit": 4.336513042449951,
            "end_logit": -4.620650768280029,
            "question_text": "List adipokines."
        },
        {
            "text": "onectin",
            "probability": 6.864856958246223e-05,
            "start_logit": -3.8253278732299805,
            "end_logit": 3.4040541648864746,
            "question_text": "List adipokines."
        },
        {
            "text": "in",
            "probability": 4.3863042340159634e-05,
            "start_logit": -4.563390731811523,
            "end_logit": 3.6941888332366943,
            "question_text": "List adipokines."
        },
        {
            "text": "in and leptin",
            "probability": 3.7564358293554454e-05,
            "start_logit": -4.718407154083252,
            "end_logit": 3.6941888332366943,
            "question_text": "List adipokines."
        },
        {
            "text": "ptin",
            "probability": 3.0421052111613455e-05,
            "start_logit": -4.929327964782715,
            "end_logit": 3.6941888332366943,
            "question_text": "List adipokines."
        },
        {
            "text": "leptin) concentrations were determined at baseline in all participants.",
            "probability": 2.5750138169000722e-05,
            "start_logit": 4.639339447021484,
            "end_logit": -6.041173458099365,
            "question_text": "List adipokines."
        },
        {
            "text": "ctin and leptin",
            "probability": 2.0662151337659438e-05,
            "start_logit": -5.316159248352051,
            "end_logit": 3.6941888332366943,
            "question_text": "List adipokines."
        }
    ],
    "5c73ace67c78d69471000083": [
        {
            "text": "dystrophic thumbs",
            "probability": 0.24852570110633787,
            "start_logit": 4.186461925506592,
            "end_logit": 5.044119358062744,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onycho-osteodystrophy, dystrophic thumbs",
            "probability": 0.1816067584939221,
            "start_logit": 3.8727593421936035,
            "end_logit": 5.044119358062744,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "dystrophic thumbs, sensorineural deafness",
            "probability": 0.14083632501751625,
            "start_logit": 4.186461925506592,
            "end_logit": 4.476171493530273,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.12418258823784123,
            "start_logit": 4.060616493225098,
            "end_logit": 4.476171493530273,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onycho-osteodystrophy",
            "probability": 0.11354103645314298,
            "start_logit": 3.8727593421936035,
            "end_logit": 4.574440002441406,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onycho-osteodystrophy, dystrophic thumbs, sensorineural deafness",
            "probability": 0.1029142191361686,
            "start_logit": 3.8727593421936035,
            "end_logit": 4.476171493530273,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "dystrophic thumbs,",
            "probability": 0.012779145071720344,
            "start_logit": 4.186461925506592,
            "end_logit": 2.076387643814087,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onycho-osteodystrophy, dystrophic thumbs,",
            "probability": 0.009338185557741203,
            "start_logit": 3.8727593421936035,
            "end_logit": 2.076387643814087,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "osteodystrophy, dystrophic thumbs",
            "probability": 0.00885038422353031,
            "start_logit": 0.8513765335083008,
            "end_logit": 5.044119358062744,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onycho-osteodystrophy,",
            "probability": 0.008390018400981795,
            "start_logit": 3.8727593421936035,
            "end_logit": 1.9693183898925781,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "dystrophic thumbs, sensorineural deafness,",
            "probability": 0.007137715529349167,
            "start_logit": 4.186461925506592,
            "end_logit": 1.4939658641815186,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "sensorineural deafness,",
            "probability": 0.006293688708717517,
            "start_logit": 4.060616493225098,
            "end_logit": 1.4939658641815186,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "dystrophic thumbs, sensorineural deafness, and increased urinary levels of 2-oxoglutarate",
            "probability": 0.006229761297301688,
            "start_logit": 4.186461925506592,
            "end_logit": 1.3579111099243164,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "osteodystrophy",
            "probability": 0.005533284146921257,
            "start_logit": 0.8513765335083008,
            "end_logit": 4.574440002441406,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "sensorineural deafness, and increased urinary levels of 2-oxoglutarate",
            "probability": 0.005493099041789372,
            "start_logit": 4.060616493225098,
            "end_logit": 1.3579111099243164,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "onycho-osteodystrophy, dystrophic thumbs, sensorineural deafness,",
            "probability": 0.005215788043515853,
            "start_logit": 3.8727593421936035,
            "end_logit": 1.4939658641815186,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "osteodystrophy, dystrophic thumbs, sensorineural deafness",
            "probability": 0.005015399145787688,
            "start_logit": 0.8513765335083008,
            "end_logit": 4.476171493530273,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "deafness",
            "probability": 0.0036981694944622505,
            "start_logit": 0.5467014908790588,
            "end_logit": 4.476171493530273,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "thumbs",
            "probability": 0.002820430901363633,
            "start_logit": -0.292194664478302,
            "end_logit": 5.044119358062744,
            "question_text": "List features of the DOOR syndrome."
        },
        {
            "text": "thumbs, sensorineural deafness",
            "probability": 0.0015983019918891003,
            "start_logit": -0.292194664478302,
            "end_logit": 4.476171493530273,
            "question_text": "List features of the DOOR syndrome."
        }
    ],
    "5c6d6b377c78d69471000039": [
        {
            "text": "graphical",
            "probability": 0.22076918952993618,
            "start_logit": -0.1665535718202591,
            "end_logit": -0.44301432371139526,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "graphical pedigree editors",
            "probability": 0.1963422900281237,
            "start_logit": -0.1665535718202591,
            "end_logit": -0.5602725744247437,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical",
            "probability": 0.14407523570345168,
            "start_logit": -0.1665535718202591,
            "end_logit": -0.8697964549064636,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical pedigree editors",
            "probability": 0.1241342669341643,
            "start_logit": -0.1665535718202591,
            "end_logit": -1.018768310546875,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "standalone graphical",
            "probability": 0.03759154151090747,
            "start_logit": -1.9368922710418701,
            "end_logit": -0.44301432371139526,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "standalone graphical pedigree editors",
            "probability": 0.03343224370055502,
            "start_logit": -1.9368922710418701,
            "end_logit": -0.5602725744247437,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "graphical pedigree editors and drawing applications exist but there are no freely available lightweight",
            "probability": 0.028656482177828426,
            "start_logit": -0.1665535718202591,
            "end_logit": -2.4847524166107178,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "standalone graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical",
            "probability": 0.02453245498238183,
            "start_logit": -1.9368922710418701,
            "end_logit": -0.8697964549064636,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "standalone graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical pedigree editors",
            "probability": 0.02113700040443798,
            "start_logit": -1.9368922710418701,
            "end_logit": -1.018768310546875,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "graphical pedigree editors and drawing applications",
            "probability": 0.020390689433338473,
            "start_logit": -0.1665535718202591,
            "end_logit": -2.8250536918640137,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "Several standalone graphical",
            "probability": 0.018736358154062677,
            "start_logit": -2.6332054138183594,
            "end_logit": -0.44301432371139526,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "lightweight graphical",
            "probability": 0.017798227577580525,
            "start_logit": -2.2577903270721436,
            "end_logit": -0.8697964549064636,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigree editors",
            "probability": 0.017554473312538496,
            "start_logit": -2.581104278564453,
            "end_logit": -0.5602725744247437,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "Several standalone graphical pedigree editors",
            "probability": 0.016663282927244425,
            "start_logit": -2.6332054138183594,
            "end_logit": -0.5602725744247437,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "lightweight graphical pedigree editors",
            "probability": 0.015334834763816765,
            "start_logit": -2.2577903270721436,
            "end_logit": -1.018768310546875,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "there are no freely available lightweight graphical",
            "probability": 0.013306463673133453,
            "start_logit": -2.5486392974853516,
            "end_logit": -0.8697964549064636,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "pedigree editors and drawing applications exist but there are no freely available lightweight graphical",
            "probability": 0.012881406648520107,
            "start_logit": -2.581104278564453,
            "end_logit": -0.8697964549064636,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical pedigree",
            "probability": 0.012269411012566123,
            "start_logit": -0.1665535718202591,
            "end_logit": -3.3330228328704834,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "Several standalone graphical pedigree editors and drawing applications exist but there are no freely available lightweight graphical",
            "probability": 0.012227454487732428,
            "start_logit": -2.6332054138183594,
            "end_logit": -0.8697964549064636,
            "question_text": "Which web-based pedigree editors are available?"
        },
        {
            "text": "graphical pedigree editors and drawing applications exist but there are no",
            "probability": 0.012166693037680141,
            "start_logit": -0.1665535718202591,
            "end_logit": -3.3414299488067627,
            "question_text": "Which web-based pedigree editors are available?"
        }
    ],
    "5c6d783e7c78d6947100003a": [
        {
            "text": "ArachnoServer",
            "probability": 0.6855024112805886,
            "start_logit": 4.693759918212891,
            "end_logit": 5.066975116729736,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver",
            "probability": 0.16030722090865132,
            "start_logit": 4.693759918212891,
            "end_logit": 3.613915205001831,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver",
            "probability": 0.061751945879742746,
            "start_logit": 3.739793300628662,
            "end_logit": 3.613915205001831,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org)",
            "probability": 0.04699660746105625,
            "start_logit": 4.693759918212891,
            "end_logit": 2.3868985176086426,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver.org)",
            "probability": 0.018103563545153068,
            "start_logit": 3.739793300628662,
            "end_logit": 2.3868985176086426,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org",
            "probability": 0.009642548072587737,
            "start_logit": 4.693759918212891,
            "end_logit": 0.803008496761322,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (",
            "probability": 0.005242715258613152,
            "start_logit": 4.693759918212891,
            "end_logit": 0.1936626434326172,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver.org",
            "probability": 0.0037144060220503836,
            "start_logit": 3.739793300628662,
            "end_logit": 0.803008496761322,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org) is a manually curated database",
            "probability": 0.002408086654198905,
            "start_logit": 4.693759918212891,
            "end_logit": -0.5843443870544434,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org) is a manually",
            "probability": 0.001733483114110029,
            "start_logit": 4.693759918212891,
            "end_logit": -0.9130441546440125,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver.org) is a manually curated database",
            "probability": 0.0009276190797952783,
            "start_logit": 3.739793300628662,
            "end_logit": -0.5843443870544434,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org) is",
            "probability": 0.0008817006156487523,
            "start_logit": 4.693759918212891,
            "end_logit": -1.5890796184539795,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver.org) is a manually",
            "probability": 0.0006677550445900935,
            "start_logit": 3.739793300628662,
            "end_logit": -0.9130441546440125,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "A",
            "probability": 0.0004978076402211794,
            "start_logit": 4.693759918212891,
            "end_logit": -2.1607184410095215,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org) is a manually curated",
            "probability": 0.0003799896061915914,
            "start_logit": 4.693759918212891,
            "end_logit": -2.430788278579712,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver.org) is",
            "probability": 0.0003396399013785116,
            "start_logit": 3.739793300628662,
            "end_logit": -1.5890796184539795,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.a",
            "probability": 0.0003098308067088123,
            "start_logit": 4.693759918212891,
            "end_logit": -2.6349058151245117,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "www.arachnoserver",
            "probability": 0.00023687455205459145,
            "start_logit": -1.8235567808151245,
            "end_logit": 3.613915205001831,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "ArachnoServer (www.arachnoserver.org) is a",
            "probability": 0.00020941875734411676,
            "start_logit": 4.693759918212891,
            "end_logit": -3.0265963077545166,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        },
        {
            "text": "arachnoserver.org) is a manually curated",
            "probability": 0.00014637579931461194,
            "start_logit": 3.739793300628662,
            "end_logit": -2.430788278579712,
            "question_text": "Which curated databases exist for spider-venom toxins?"
        }
    ],
    "5c851c2675a4a5d219000006": [
        {
            "text": "bezlotoxumab",
            "probability": 0.2687422009237222,
            "start_logit": 6.606626987457275,
            "end_logit": 6.623544692993164,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab",
            "probability": 0.23267948524113957,
            "start_logit": 6.462536334991455,
            "end_logit": 6.623544692993164,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab",
            "probability": 0.2030850859572285,
            "start_logit": 6.606626987457275,
            "end_logit": 6.343417167663574,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab",
            "probability": 0.15578084318615026,
            "start_logit": 6.462536334991455,
            "end_logit": 6.222332954406738,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "Bezlotoxumab",
            "probability": 0.13821405670395778,
            "start_logit": 6.221805572509766,
            "end_logit": 6.343417167663574,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotox",
            "probability": 0.0003107207322350604,
            "start_logit": 6.606626987457275,
            "end_logit": -0.139068603515625,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotox",
            "probability": 0.0002690248862355803,
            "start_logit": 6.462536334991455,
            "end_logit": -0.139068603515625,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxuma",
            "probability": 0.000191893712117036,
            "start_logit": 6.606626987457275,
            "end_logit": -0.6210215091705322,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxuma",
            "probability": 0.00016614335226448643,
            "start_logit": 6.462536334991455,
            "end_logit": -0.6210215091705322,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "TcdB, respectively. Bezlotoxumab",
            "probability": 9.618323330393774e-05,
            "start_logit": -1.048498272895813,
            "end_logit": 6.343417167663574,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "antitoxin antibodies actoxumab and bezlotoxumab",
            "probability": 6.739652251613074e-05,
            "start_logit": -1.684287428855896,
            "end_logit": 6.623544692993164,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB",
            "probability": 5.562883224662827e-05,
            "start_logit": 6.606626987457275,
            "end_logit": -1.8592615127563477,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bez",
            "probability": 5.1417970837491446e-05,
            "start_logit": 6.606626987457275,
            "end_logit": -1.9379754066467285,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB",
            "probability": 4.8163957901740234e-05,
            "start_logit": 6.462536334991455,
            "end_logit": -1.8592615127563477,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "antitoxin antibodies actoxumab",
            "probability": 4.512253022434006e-05,
            "start_logit": -1.684287428855896,
            "end_logit": 6.222332954406738,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "actoxumab and bez",
            "probability": 4.451815511478669e-05,
            "start_logit": 6.462536334991455,
            "end_logit": -1.9379754066467285,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotox",
            "probability": 4.0786707066673486e-05,
            "start_logit": 6.606626987457275,
            "end_logit": -2.169606924057007,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "act",
            "probability": 3.9255337277804667e-05,
            "start_logit": 6.462536334991455,
            "end_logit": -2.0637850761413574,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxuma",
            "probability": 3.828883617260711e-05,
            "start_logit": 6.606626987457275,
            "end_logit": -2.232804775238037,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        },
        {
            "text": "antibodies actoxumab and bezlotoxumab",
            "probability": 3.378322228769002e-05,
            "start_logit": -2.3749165534973145,
            "end_logit": 6.623544692993164,
            "question_text": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection"
        }
    ],
    "5c8bfe25d558e5f23200000f": [
        {
            "text": "bone metabolism",
            "probability": 0.1820396287764393,
            "start_logit": 4.922332763671875,
            "end_logit": 6.187004566192627,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "immune-inflammatory response and bone metabolism",
            "probability": 0.16812031094625804,
            "start_logit": 4.842788219451904,
            "end_logit": 6.187004566192627,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "modulates the host immune-inflammatory response and bone metabolism",
            "probability": 0.1662964783839915,
            "start_logit": 4.831880569458008,
            "end_logit": 6.187004566192627,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "bone metabolism, and might be involved in dental implant osseointegration",
            "probability": 0.06141582219544371,
            "start_logit": 4.922332763671875,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "immune-inflammatory response",
            "probability": 0.05870510843400919,
            "start_logit": 4.842788219451904,
            "end_logit": 5.134851455688477,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "modulates the host immune-inflammatory response",
            "probability": 0.05806825326921258,
            "start_logit": 4.831880569458008,
            "end_logit": 5.134851455688477,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "immune-inflammatory response and bone metabolism, and might be involved in dental implant osseointegration",
            "probability": 0.05671977686352242,
            "start_logit": 4.842788219451904,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "modulates the host immune-inflammatory response and bone metabolism, and might be involved in dental implant osseointegration",
            "probability": 0.05610445932463652,
            "start_logit": 4.831880569458008,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "host immune-inflammatory response and bone metabolism",
            "probability": 0.05393334418434358,
            "start_logit": 3.705857276916504,
            "end_logit": 6.187004566192627,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "dental implant osseointegration",
            "probability": 0.0362092034148466,
            "start_logit": 4.393978595733643,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "host immune-inflammatory response",
            "probability": 0.018832720453168417,
            "start_logit": 3.705857276916504,
            "end_logit": 5.134851455688477,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "host immune-inflammatory response and bone metabolism, and might be involved in dental implant osseointegration",
            "probability": 0.018195821970715967,
            "start_logit": 3.705857276916504,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "inflammatory response and bone metabolism",
            "probability": 0.01373708846106886,
            "start_logit": 2.338207721710205,
            "end_logit": 6.187004566192627,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "osseointegration",
            "probability": 0.01356657881002028,
            "start_logit": 3.4122745990753174,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "the host immune-inflammatory response and bone metabolism",
            "probability": 0.012094599675532875,
            "start_logit": 2.210867404937744,
            "end_logit": 6.187004566192627,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "might be involved in dental implant osseointegration",
            "probability": 0.005865380423134718,
            "start_logit": 2.573732614517212,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "involved in dental implant osseointegration",
            "probability": 0.005645806062203258,
            "start_logit": 2.5355782508850098,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "ulates the host immune-inflammatory response and bone metabolism",
            "probability": 0.005018266178615518,
            "start_logit": 1.3311928510665894,
            "end_logit": 6.187004566192627,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "inflammatory response",
            "probability": 0.00479678667696738,
            "start_logit": 2.338207721710205,
            "end_logit": 5.134851455688477,
            "question_text": "List the functions of the protein lactotransferrin."
        },
        {
            "text": "inflammatory response and bone metabolism, and might be involved in dental implant osseointegration",
            "probability": 0.004634565495868996,
            "start_logit": 2.338207721710205,
            "end_logit": 5.100447654724121,
            "question_text": "List the functions of the protein lactotransferrin."
        }
    ],
    "5c900983ecadf2e73f000002": [
        {
            "text": "patisiran",
            "probability": 0.682091945177087,
            "start_logit": 5.868518352508545,
            "end_logit": 5.809826374053955,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1007, and patisiran",
            "probability": 0.08184648329846668,
            "start_logit": 3.748199224472046,
            "end_logit": 5.809826374053955,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1002, QPI-1007, and patisiran",
            "probability": 0.06329863256343046,
            "start_logit": 3.491217613220215,
            "end_logit": 5.809826374053955,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siG12D-LODER (phase 2), QPI-1002, QPI-1007, and patisiran",
            "probability": 0.05534009499800586,
            "start_logit": 3.356851577758789,
            "end_logit": 5.809826374053955,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL1001, siG12D-LODER (phase 2), QPI-1002, QPI-1007",
            "probability": 0.0333777612567534,
            "start_logit": 4.706339359283447,
            "end_logit": 3.954730749130249,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL1001",
            "probability": 0.03076244614865648,
            "start_logit": 4.706339359283447,
            "end_logit": 3.873135566711426,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1007",
            "probability": 0.012803898729260422,
            "start_logit": 3.748199224472046,
            "end_logit": 3.954730749130249,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1002, QPI-1007",
            "probability": 0.00990231037889948,
            "start_logit": 3.491217613220215,
            "end_logit": 3.954730749130249,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siG12D-LODER (phase 2), QPI-1002, QPI-1007",
            "probability": 0.008657292817801407,
            "start_logit": 3.356851577758789,
            "end_logit": 3.954730749130249,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL1001, siG12D-LODER (phase 2), QPI-1002",
            "probability": 0.005654989898266255,
            "start_logit": 4.706339359283447,
            "end_logit": 2.1793792247772217,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL040012, SYL1001",
            "probability": 0.005040098077448672,
            "start_logit": 2.897470235824585,
            "end_logit": 3.873135566711426,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL1001, siG12D-LODER",
            "probability": 0.002956423976261161,
            "start_logit": 4.706339359283447,
            "end_logit": 1.5308213233947754,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "QPI-1002",
            "probability": 0.0016776878692199156,
            "start_logit": 3.491217613220215,
            "end_logit": 2.1793792247772217,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siG12D-LODER (phase 2), QPI-1002",
            "probability": 0.0014667521603503107,
            "start_logit": 3.356851577758789,
            "end_logit": 2.1793792247772217,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "Atu027, SYL040012, SYL1001",
            "probability": 0.0013202824897287678,
            "start_logit": 1.5578904151916504,
            "end_logit": 3.873135566711426,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL040012, SYL1001, siG12D-LODER (phase 2), QPI-1002",
            "probability": 0.0009265096662505886,
            "start_logit": 2.897470235824585,
            "end_logit": 2.1793792247772217,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "SYL040012",
            "probability": 0.0008985338022904562,
            "start_logit": 2.897470235824585,
            "end_logit": 2.148719072341919,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "siG12D-LODER",
            "probability": 0.0007668167993406988,
            "start_logit": 3.356851577758789,
            "end_logit": 1.5308213233947754,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "1007, and patisiran",
            "probability": 0.0006896442266667264,
            "start_logit": -1.0282255411148071,
            "end_logit": 5.809826374053955,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        },
        {
            "text": "TKM-080301, Atu027, SYL040012, SYL1001",
            "probability": 0.0005213956658152707,
            "start_logit": 0.6287986040115356,
            "end_logit": 3.873135566711426,
            "question_text": "Name siRNA drugs that have entered phase 2-3 clinical trials (by 2019)."
        }
    ],
    "5c6b15467c78d69471000024": [
        {
            "text": "PlantAPA",
            "probability": 0.5664928207372855,
            "start_logit": -0.10264009237289429,
            "end_logit": 0.20748835802078247,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "PlantAPA (http://bmi.xmu.edu.cn/plantapa",
            "probability": 0.20599349715520515,
            "start_logit": -0.10264009237289429,
            "end_logit": -0.8041314482688904,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "plantapa",
            "probability": 0.11061787885692556,
            "start_logit": -0.7244029641151428,
            "end_logit": -0.8041314482688904,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "plantapa) to visualize and analyze genome-wide poly(A) sites in plants. PlantAPA",
            "probability": 0.08978394436015079,
            "start_logit": -0.7244029641151428,
            "end_logit": -1.012807011604309,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "web service called PlantAPA",
            "probability": 0.005141662488880961,
            "start_logit": -4.804728031158447,
            "end_logit": 0.20748835802078247,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "PlantAPA (http://bmi.xmu.edu.cn/plantapa)",
            "probability": 0.0046616124081675005,
            "start_logit": -0.10264009237289429,
            "end_logit": -4.592614650726318,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "open-access web service called PlantAPA",
            "probability": 0.002564326446807164,
            "start_logit": -5.50040864944458,
            "end_logit": 0.20748835802078247,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "Plant",
            "probability": 0.0025247995862125593,
            "start_logit": -0.10264009237289429,
            "end_logit": -5.205814361572266,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "plantapa)",
            "probability": 0.0025032716263664037,
            "start_logit": -0.7244029641151428,
            "end_logit": -4.592614650726318,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "We have created an open-access web service called PlantAPA",
            "probability": 0.0019855635054012383,
            "start_logit": -5.75620174407959,
            "end_logit": 0.20748835802078247,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "web service called PlantAPA (http://bmi.xmu.edu.cn/plantapa",
            "probability": 0.0018696601236673257,
            "start_logit": -4.804728031158447,
            "end_logit": -0.8041314482688904,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "APA",
            "probability": 0.001609037486175159,
            "start_logit": -5.966468334197998,
            "end_logit": 0.20748835802078247,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "plantapa) to visualize and analyze genome-wide poly(A) sites in plants.",
            "probability": 0.0009477216427063649,
            "start_logit": -0.7244029641151428,
            "end_logit": -5.563907623291016,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "open-access web service called PlantAPA (http://bmi.xmu.edu.cn/plantapa",
            "probability": 0.0009324647255686246,
            "start_logit": -5.50040864944458,
            "end_logit": -0.8041314482688904,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "visualize and analyze genome-wide poly(A) sites in plants. PlantAPA",
            "probability": 0.0006551947675438696,
            "start_logit": -5.644631862640381,
            "end_logit": -1.012807011604309,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "APA (http://bmi.xmu.edu.cn/plantapa",
            "probability": 0.0005850934852089742,
            "start_logit": -5.966468334197998,
            "end_logit": -0.8041314482688904,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "differential gene expression between conditions, making it more powerful for the study of APA-mediated gene expression regulation. More importantly, PlantAPA",
            "probability": 0.000493505516652023,
            "start_logit": -4.453540802001953,
            "end_logit": -2.4872965812683105,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "switching, and differential gene expression between conditions, making it more powerful for the study of APA-mediated gene expression regulation. More importantly, PlantAPA",
            "probability": 0.00024749206757750043,
            "start_logit": -5.143696308135986,
            "end_logit": -2.4872965812683105,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "PlantAPA offers a bioinformatics pipeline",
            "probability": 0.00020887447224831655,
            "start_logit": -2.4890453815460205,
            "end_logit": -5.3115925788879395,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        },
        {
            "text": "PlantAPA offers a bioinformatics pipeline that allows users to upload their own short reads or ESTs for poly(A) site extraction,",
            "probability": 0.00018157854124921198,
            "start_logit": -2.4890453815460205,
            "end_logit": -5.4516377449035645,
            "question_text": "Mention computational tools that have been developed for alternative polyadenylation (APA) sites analysis"
        }
    ],
    "5c6bda9d7c78d69471000031": [
        {
            "text": "Cistrome",
            "probability": 0.2537886940982484,
            "start_logit": 4.939469337463379,
            "end_logit": 3.9520528316497803,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome database",
            "probability": 0.20839190007699182,
            "start_logit": 4.939469337463379,
            "end_logit": 3.7549712657928467,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB",
            "probability": 0.11442976980210269,
            "start_logit": 4.292442321777344,
            "end_logit": 3.802539110183716,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome",
            "probability": 0.1033459061599838,
            "start_logit": 4.292442321777344,
            "end_logit": 3.7006595134735107,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser), available online at http://cistrome.org/db",
            "probability": 0.04509461833928538,
            "start_logit": 4.292442321777344,
            "end_logit": 2.871340751647949,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome Data Browser), available online at http://cistrome.org/db",
            "probability": 0.041500125387994,
            "start_logit": 4.209375858306885,
            "end_logit": 2.871340751647949,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser), available online at http://cistrome",
            "probability": 0.03949955647327986,
            "start_logit": 4.292442321777344,
            "end_logit": 2.7388672828674316,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome Data Browser), available online at http://cistrome",
            "probability": 0.036351046017905855,
            "start_logit": 4.209375858306885,
            "end_logit": 2.7388672828674316,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser",
            "probability": 0.03361996721367106,
            "start_logit": 4.292442321777344,
            "end_logit": 2.577697992324829,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome Data Browser",
            "probability": 0.030940118938585223,
            "start_logit": 4.209375858306885,
            "end_logit": 2.577697992324829,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "cistrome.org/db",
            "probability": 0.02273240818207242,
            "start_logit": 3.607470989227295,
            "end_logit": 2.871340751647949,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "cistrome",
            "probability": 0.01991191130625828,
            "start_logit": 3.607470989227295,
            "end_logit": 2.7388672828674316,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "the Cistrome",
            "probability": 0.009554995513986687,
            "start_logit": 1.6600314378738403,
            "end_logit": 3.9520528316497803,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "the Cistrome database",
            "probability": 0.007845832839251611,
            "start_logit": 1.6600314378738403,
            "end_logit": 3.7549712657928467,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser)",
            "probability": 0.007265929729865853,
            "start_logit": 4.292442321777344,
            "end_logit": 1.0457741022109985,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome Data Browser)",
            "probability": 0.006686762322303418,
            "start_logit": 4.209375858306885,
            "end_logit": 1.0457741022109985,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome database, a collection of ChIP-seq and chromatin accessibility data (DNase-seq",
            "probability": 0.00567196791455576,
            "start_logit": 4.939469337463379,
            "end_logit": 0.1510869562625885,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome database, a collection of ChIP-seq and chromatin accessibility data (DNase",
            "probability": 0.005115291959723871,
            "start_logit": 4.939469337463379,
            "end_logit": 0.04778530076146126,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome DB (Cistrome Data Browser),",
            "probability": 0.004297891366381086,
            "start_logit": 4.292442321777344,
            "end_logit": 0.5207023620605469,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        },
        {
            "text": "Cistrome Data Browser),",
            "probability": 0.003955306357552786,
            "start_logit": 4.209375858306885,
            "end_logit": 0.5207023620605469,
            "question_text": "Which curated data resources for ChIP-seq data are available?"
        }
    ],
    "5c73ad0f7c78d69471000096": [
        {
            "text": "ocular hypertension",
            "probability": 0.3662179258229171,
            "start_logit": 5.69894552230835,
            "end_logit": 5.604671955108643,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle glaucoma and ocular hypertension",
            "probability": 0.20229654056438673,
            "start_logit": 5.105451583862305,
            "end_logit": 5.604671955108643,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle glaucoma",
            "probability": 0.17447619007625145,
            "start_logit": 5.105451583862305,
            "end_logit": 5.456725597381592,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "glaucoma and ocular hypertension",
            "probability": 0.13449913187352394,
            "start_logit": 4.697274684906006,
            "end_logit": 5.604671955108643,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "glaucoma",
            "probability": 0.11600245872907922,
            "start_logit": 4.697274684906006,
            "end_logit": 5.456725597381592,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "hypertension",
            "probability": 0.002418199375284826,
            "start_logit": 0.6787401437759399,
            "end_logit": 5.604671955108643,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular hypertension.",
            "probability": 0.0011058669680389405,
            "start_logit": 5.69894552230835,
            "end_logit": -0.19792701303958893,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle glaucoma and ocular hypertension.",
            "probability": 0.0006108741440114002,
            "start_logit": 5.105451583862305,
            "end_logit": -0.19792701303958893,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "glaucoma and ocular hypertension.",
            "probability": 0.00040614655013027735,
            "start_logit": 4.697274684906006,
            "end_logit": -0.19792701303958893,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "laucoma and ocular hypertension",
            "probability": 0.0003305866599372937,
            "start_logit": -1.3111695051193237,
            "end_logit": 5.604671955108643,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "laucoma",
            "probability": 0.00028512351597794215,
            "start_logit": -1.3111695051193237,
            "end_logit": 5.456725597381592,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle",
            "probability": 0.00024520181282674386,
            "start_logit": 5.105451583862305,
            "end_logit": -1.11073637008667,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "open-angle g",
            "probability": 0.00018790913863746213,
            "start_logit": 5.105451583862305,
            "end_logit": -1.376859426498413,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "cular hypertension",
            "probability": 0.0001609631618466161,
            "start_logit": -2.030862808227539,
            "end_logit": 5.604671955108643,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular hypertens",
            "probability": 0.00015774688089141716,
            "start_logit": 5.69894552230835,
            "end_logit": -2.145320177078247,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "ocular h",
            "probability": 0.0001352854167024529,
            "start_logit": 5.69894552230835,
            "end_logit": -2.2989251613616943,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "a and ocular hypertension",
            "probability": 0.00012869901196496645,
            "start_logit": -2.2545619010925293,
            "end_logit": 5.604671955108643,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "g",
            "probability": 0.00012493350576994297,
            "start_logit": 4.697274684906006,
            "end_logit": -1.376859426498413,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "a",
            "probability": 0.00011099998651276153,
            "start_logit": -2.2545619010925293,
            "end_logit": 5.456725597381592,
            "question_text": "Which diseases are treated with netarsudil?"
        },
        {
            "text": "coma and ocular hypertension",
            "probability": 9.921680530872002e-05,
            "start_logit": -2.514730930328369,
            "end_logit": 5.604671955108643,
            "question_text": "Which diseases are treated with netarsudil?"
        }
    ],
    "5c6c497d7c78d69471000036": [
        {
            "text": "FlatNJ",
            "probability": 0.19809990276231895,
            "start_logit": 4.633411884307861,
            "end_logit": 4.01534366607666,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet, QNet and FlatNJ",
            "probability": 0.1199173316216926,
            "start_logit": 4.131443023681641,
            "end_logit": 4.01534366607666,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "QNet and FlatNJ",
            "probability": 0.11258773471284204,
            "start_logit": 4.068373203277588,
            "end_logit": 4.01534366607666,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition, NeighborNet, QNet and FlatNJ",
            "probability": 0.09132722656771276,
            "start_logit": 3.8590893745422363,
            "end_logit": 4.01534366607666,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet, QNet",
            "probability": 0.0803797064737677,
            "start_logit": 4.131443023681641,
            "end_logit": 3.615302801132202,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "QNet",
            "probability": 0.07546673150895562,
            "start_logit": 4.068373203277588,
            "end_logit": 3.615302801132202,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet",
            "probability": 0.06677382639909883,
            "start_logit": 4.131443023681641,
            "end_logit": 3.429852247238159,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition, NeighborNet, QNet",
            "probability": 0.061215969078885824,
            "start_logit": 3.8590893745422363,
            "end_logit": 3.615302801132202,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition, NeighborNet",
            "probability": 0.050853936540066105,
            "start_logit": 3.8590893745422363,
            "end_logit": 3.429852247238159,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree",
            "probability": 0.04449761092077353,
            "start_logit": 4.633411884307861,
            "end_logit": 2.522007703781128,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet, QNet and FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree",
            "probability": 0.026936079678755047,
            "start_logit": 4.131443023681641,
            "end_logit": 2.522007703781128,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "QNet and FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree",
            "probability": 0.025289690423090178,
            "start_logit": 4.068373203277588,
            "end_logit": 2.522007703781128,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition, NeighborNet, QNet and FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree",
            "probability": 0.02051411099963653,
            "start_logit": 3.8590893745422363,
            "end_logit": 2.522007703781128,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "split-decomposition",
            "probability": 0.012933412100996607,
            "start_logit": 3.8590893745422363,
            "end_logit": 2.06070876121521,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "SplitsTree",
            "probability": 0.009664016263677787,
            "start_logit": 3.1063857078552246,
            "end_logit": 2.522007703781128,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "decomposition, NeighborNet, QNet and FlatNJ",
            "probability": 0.0012465541075100369,
            "start_logit": -0.4349765479564667,
            "end_logit": 4.01534366607666,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "decomposition, NeighborNet, QNet",
            "probability": 0.0008355560610823404,
            "start_logit": -0.4349765479564667,
            "end_logit": 3.615302801132202,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "decomposition, NeighborNet",
            "probability": 0.0006941214121954451,
            "start_logit": -0.4349765479564667,
            "end_logit": 3.429852247238159,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "FlatNJ. Some of these approaches are implemented in the user-friendly SplitsTree software",
            "probability": 0.0004666305491458394,
            "start_logit": 4.633411884307861,
            "end_logit": -2.0356452465057373,
            "question_text": "Which tools have been developed for computing split-networks?"
        },
        {
            "text": "NeighborNet,",
            "probability": 0.0002998518177960956,
            "start_logit": 4.131443023681641,
            "end_logit": -1.9759258031845093,
            "question_text": "Which tools have been developed for computing split-networks?"
        }
    ],
    "5c88550075a4a5d219000008": [
        {
            "text": "Ac-hE18A-NH(2)",
            "probability": 0.2648467811575415,
            "start_logit": -1.8842747211456299,
            "end_logit": -4.378951549530029,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A",
            "probability": 0.2541281786062258,
            "start_logit": -1.8842747211456299,
            "end_logit": -4.42026424407959,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE",
            "probability": 0.14339269467660828,
            "start_logit": -1.8842747211456299,
            "end_logit": -4.992516040802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH",
            "probability": 0.06345662576077517,
            "start_logit": -1.8842747211456299,
            "end_logit": -5.807746410369873,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2).",
            "probability": 0.0570555584990064,
            "start_logit": -2.3217501640319824,
            "end_logit": -5.476602077484131,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2",
            "probability": 0.05426682148076869,
            "start_logit": -1.8842747211456299,
            "end_logit": -5.9641900062561035,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18A-NH(2)",
            "probability": 0.03303657958544299,
            "start_logit": -3.965810775756836,
            "end_logit": -4.378951549530029,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18A",
            "probability": 0.031699557611139136,
            "start_logit": -3.965810775756836,
            "end_logit": -4.42026424407959,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18A-NH(2). This peptide consists of residues 141-150,",
            "probability": 0.025179338476558434,
            "start_logit": -2.3217501640319824,
            "end_logit": -6.2946038246154785,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "Ac-hE18",
            "probability": 0.024558253269914,
            "start_logit": -2.3217501640319824,
            "end_logit": -6.319579601287842,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE",
            "probability": 0.01788658389182769,
            "start_logit": -3.965810775756836,
            "end_logit": -4.992516040802002,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18A-NH",
            "probability": 0.007915481766502962,
            "start_logit": -3.965810775756836,
            "end_logit": -5.807746410369873,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18A-NH(2",
            "probability": 0.006769159734027569,
            "start_logit": -3.965810775756836,
            "end_logit": -5.9641900062561035,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "NH(2)",
            "probability": 0.005125547619531906,
            "start_logit": -5.829188823699951,
            "end_logit": -4.378951549530029,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18A-NH(2).",
            "probability": 0.0032413199875772143,
            "start_logit": -5.189795017242432,
            "end_logit": -5.476602077484131,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "2)",
            "probability": 0.0021350553091425803,
            "start_logit": -6.7049336433410645,
            "end_logit": -4.378951549530029,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18A-NH(2). This peptide consists of residues 141-150,",
            "probability": 0.0014304354426652773,
            "start_logit": -5.189795017242432,
            "end_logit": -6.2946038246154785,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "hE18",
            "probability": 0.0013951516605545443,
            "start_logit": -5.189795017242432,
            "end_logit": -6.319579601287842,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "design and studies of a dual-domain apoE mimetic peptide, Ac-hE18A",
            "probability": 0.001252807085596869,
            "start_logit": -7.006145000457764,
            "end_logit": -4.610846042633057,
            "question_text": "List 3 apoE mimetics."
        },
        {
            "text": "NH",
            "probability": 0.001228068378592815,
            "start_logit": -5.829188823699951,
            "end_logit": -5.807746410369873,
            "question_text": "List 3 apoE mimetics."
        }
    ],
    "5ca60a77ecadf2e73f00004d": [
        {
            "text": "describe latent enhancers,",
            "probability": 0.10664297359194143,
            "start_logit": -4.2433366775512695,
            "end_logit": -2.3838164806365967,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Here, we describe latent enhancers,",
            "probability": 0.08250689688058109,
            "start_logit": -4.499941349029541,
            "end_logit": -2.3838164806365967,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "lack the histone marks characteristic of enhancers",
            "probability": 0.08040893411783495,
            "start_logit": -3.6387434005737305,
            "end_logit": -3.270771026611328,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "enhancers,",
            "probability": 0.07337909422939577,
            "start_logit": -4.617184162139893,
            "end_logit": -2.3838164806365967,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "lack the histone marks",
            "probability": 0.06782746104243215,
            "start_logit": -3.6387434005737305,
            "end_logit": -3.4409291744232178,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "lack the histone marks characteristic of enhancers but acquire these features in response to stimulation",
            "probability": 0.06745766426599074,
            "start_logit": -3.6387434005737305,
            "end_logit": -3.4463961124420166,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "we describe latent enhancers,",
            "probability": 0.06015805590681948,
            "start_logit": -4.815847873687744,
            "end_logit": -2.3838164806365967,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers",
            "probability": 0.0453712110329368,
            "start_logit": -4.210990905761719,
            "end_logit": -3.270771026611328,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "genome that in terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers",
            "probability": 0.04181436439651236,
            "start_logit": -4.292628765106201,
            "end_logit": -3.270771026611328,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "defined as regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers",
            "probability": 0.038917220280040556,
            "start_logit": -4.364431858062744,
            "end_logit": -3.270771026611328,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "terminally differentiated cells are unbound by TFs and lack the histone marks",
            "probability": 0.038272041316636585,
            "start_logit": -4.210990905761719,
            "end_logit": -3.4409291744232178,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "describe latent enhancers",
            "probability": 0.038156714142885545,
            "start_logit": -4.2433366775512695,
            "end_logit": -3.4116013050079346,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers but acquire these features in response to stimulation",
            "probability": 0.03806338132422039,
            "start_logit": -4.210990905761719,
            "end_logit": -3.4463961124420166,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "describe latent enhancers, defined as regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks",
            "probability": 0.037053909512864025,
            "start_logit": -4.2433366775512695,
            "end_logit": -3.4409291744232178,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "genome that in terminally differentiated cells are unbound by TFs and lack the histone marks",
            "probability": 0.03527172948172975,
            "start_logit": -4.292628765106201,
            "end_logit": -3.4409291744232178,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "defined as regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks",
            "probability": 0.032827897439306024,
            "start_logit": -4.364431858062744,
            "end_logit": -3.4409291744232178,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "stimulation",
            "probability": 0.03129248612590394,
            "start_logit": -4.40686559677124,
            "end_logit": -3.4463961124420166,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "Here, we describe latent enhancers",
            "probability": 0.029520857990467393,
            "start_logit": -4.499941349029541,
            "end_logit": -3.4116013050079346,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers",
            "probability": 0.028802164581947814,
            "start_logit": -4.6654181480407715,
            "end_logit": -3.270771026611328,
            "question_text": "Which enhancers are characterized as latent?"
        },
        {
            "text": "enhancers",
            "probability": 0.026254942339553198,
            "start_logit": -4.617184162139893,
            "end_logit": -3.4116013050079346,
            "question_text": "Which enhancers are characterized as latent?"
        }
    ],
    "5c8c095e0101eac870000002": [
        {
            "text": "neutrophils",
            "probability": 0.18540323668029157,
            "start_logit": 2.6724085807800293,
            "end_logit": 2.075119733810425,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "macrophages",
            "probability": 0.14747155368673395,
            "start_logit": 3.0744452476501465,
            "end_logit": 1.4441852569580078,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, macrophages",
            "probability": 0.12685390368076777,
            "start_logit": 2.361323833465576,
            "end_logit": 2.0067074298858643,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, monocytes, macrophages",
            "probability": 0.09865201262661387,
            "start_logit": 2.6724085807800293,
            "end_logit": 1.4441852569580078,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, monocytes",
            "probability": 0.07813802092438941,
            "start_logit": 2.6724085807800293,
            "end_logit": 1.2110633850097656,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophil",
            "probability": 0.061015273709290926,
            "start_logit": 2.6724085807800293,
            "end_logit": 0.9637108445167542,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "bone marrow",
            "probability": 0.05656793114443529,
            "start_logit": 2.812230348587036,
            "end_logit": 0.7482070922851562,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "monocytes, macrophages",
            "probability": 0.04512877231547226,
            "start_logit": 1.8903299570083618,
            "end_logit": 1.4441852569580078,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "monocytes",
            "probability": 0.035744561733625245,
            "start_logit": 1.8903299570083618,
            "end_logit": 1.2110633850097656,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "macrophage",
            "probability": 0.031551893370446144,
            "start_logit": 3.0744452476501465,
            "end_logit": -0.09781644493341446,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "macrophages and distinct subtypes of dendritic cells",
            "probability": 0.022455605291418552,
            "start_logit": 3.0744452476501465,
            "end_logit": -0.4379097819328308,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, monocytes, macrophage",
            "probability": 0.021106835219128987,
            "start_logit": 2.6724085807800293,
            "end_logit": -0.09781644493341446,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, monocytes, macrophages and distinct subtypes of dendritic cells",
            "probability": 0.015021816759678994,
            "start_logit": 2.6724085807800293,
            "end_logit": -0.4379097819328308,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, macrophages and distinct subtypes of dendritic cells",
            "probability": 0.012957941091970444,
            "start_logit": 2.361323833465576,
            "end_logit": -0.27461981773376465,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "macrophages and distinct subtypes of dendritic",
            "probability": 0.012371307866284771,
            "start_logit": 3.0744452476501465,
            "end_logit": -1.0340701341629028,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "bone marrow cells",
            "probability": 0.011912920720047479,
            "start_logit": 2.812230348587036,
            "end_logit": -0.8096115589141846,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "dendritic cells",
            "probability": 0.011324337987408407,
            "start_logit": 2.389859199523926,
            "end_logit": -0.4379097819328308,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "monocytes, macrophage",
            "probability": 0.009655409307354517,
            "start_logit": 1.8903299570083618,
            "end_logit": -0.09781644493341446,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, macrophage",
            "probability": 0.008390802578657552,
            "start_logit": 2.361323833465576,
            "end_logit": -0.7091924548149109,
            "question_text": "Which cells secrete lactotransferrin?"
        },
        {
            "text": "neutrophils, monocytes, macrophages and distinct subtypes of dendritic",
            "probability": 0.008275863305983741,
            "start_logit": 2.6724085807800293,
            "end_logit": -1.0340701341629028,
            "question_text": "Which cells secrete lactotransferrin?"
        }
    ],
    "5c9d18f1ecadf2e73f000033": [
        {
            "text": "MOP receptors",
            "probability": 0.4010420734600101,
            "start_logit": 1.6634629964828491,
            "end_logit": 0.5050198435783386,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "nociceptin/orphainin FQ, NOP. Morphine",
            "probability": 0.14691330322459376,
            "start_logit": 1.020165205001831,
            "end_logit": 0.14409393072128296,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "nociceptin",
            "probability": 0.125585373080153,
            "start_logit": 1.020165205001831,
            "end_logit": -0.012762917205691338,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Morphine is the current gold standard analgesic acting at MOP receptors",
            "probability": 0.10400110312199767,
            "start_logit": 0.3137981593608856,
            "end_logit": 0.5050198435783386,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Morphine",
            "probability": 0.0724919552163225,
            "start_logit": 0.3137981593608856,
            "end_logit": 0.14409393072128296,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "MOP",
            "probability": 0.034792249716649425,
            "start_logit": 1.6634629964828491,
            "end_logit": -1.9396518468856812,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "morphine",
            "probability": 0.02011218188237014,
            "start_logit": -0.016062872484326363,
            "end_logit": -0.8081949353218079,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "NOP. Morphine is the current gold standard analgesic acting at MOP receptors",
            "probability": 0.016760435702798508,
            "start_logit": -1.5115822553634644,
            "end_logit": 0.5050198435783386,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "NOP. Morphine",
            "probability": 0.01168253718374583,
            "start_logit": -1.5115822553634644,
            "end_logit": 0.14409393072128296,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "orphainin FQ, NOP. Morphine is the current gold standard analgesic acting at MOP receptors",
            "probability": 0.011554545724832667,
            "start_logit": -1.8835244178771973,
            "end_logit": 0.5050198435783386,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Morphine is the current gold standard analgesic acting at MOP",
            "probability": 0.00902257541062799,
            "start_logit": 0.3137981593608856,
            "end_logit": -1.9396518468856812,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "nociceptin/orphainin",
            "probability": 0.0088443143509399,
            "start_logit": 1.020165205001831,
            "end_logit": -2.6659739017486572,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "orphainin FQ, NOP. Morphine",
            "probability": 0.008053872373324411,
            "start_logit": -1.8835244178771973,
            "end_logit": 0.14409393072128296,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Opioid receptors",
            "probability": 0.0074875611048781775,
            "start_logit": -0.5659521818161011,
            "end_logit": -1.2463881969451904,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "nociceptin/orphainin FQ, NOP.",
            "probability": 0.006579202662873148,
            "start_logit": 1.020165205001831,
            "end_logit": -2.9618351459503174,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "nociceptin/orphainin FQ, NOP",
            "probability": 0.0059171122085597185,
            "start_logit": 1.020165205001831,
            "end_logit": -3.0679001808166504,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "M",
            "probability": 0.0041350338245914435,
            "start_logit": 1.6634629964828491,
            "end_logit": -4.06955099105835,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "nociceptin/orphainin FQ, NOP. Morphine is the current gold standard analgesic acting at M",
            "probability": 0.0021731934398502334,
            "start_logit": 1.020165205001831,
            "end_logit": -4.06955099105835,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "NOP. Morphine is the current gold standard analgesic acting at MOP",
            "probability": 0.0014540451062917204,
            "start_logit": -1.5115822553634644,
            "end_logit": -1.9396518468856812,
            "question_text": "List targets of classical analgesics."
        },
        {
            "text": "Opioid receptors are currently classified as mu (mu: mOP), delta",
            "probability": 0.0013973312045896461,
            "start_logit": -0.5659521818161011,
            "end_logit": -2.925067186355591,
            "question_text": "List targets of classical analgesics."
        }
    ],
    "5c961603ecadf2e73f000022": [
        {
            "text": "multiple sclerosis",
            "probability": 0.34864328175490517,
            "start_logit": 1.6406053304672241,
            "end_logit": 1.2255024909973145,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "treat MS patients in Sweden",
            "probability": 0.14050202756343674,
            "start_logit": 0.8714897036552429,
            "end_logit": 1.085790753364563,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "treat MS patients",
            "probability": 0.13813325847362254,
            "start_logit": 0.8714897036552429,
            "end_logit": 1.068787693977356,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "to treat MS patients in Sweden",
            "probability": 0.12331685839600838,
            "start_logit": 0.741024911403656,
            "end_logit": 1.085790753364563,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "to treat MS patients",
            "probability": 0.12123781962705131,
            "start_logit": 0.741024911403656,
            "end_logit": 1.068787693977356,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "MS patients in Sweden",
            "probability": 0.017477376539121934,
            "start_logit": -1.2128249406814575,
            "end_logit": 1.085790753364563,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "MS patients",
            "probability": 0.01718271979975051,
            "start_logit": -1.2128249406814575,
            "end_logit": 1.068787693977356,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "rituximab to treat MS patients in Sweden",
            "probability": 0.016794185439492994,
            "start_logit": -1.2526994943618774,
            "end_logit": 1.085790753364563,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "rituximab to treat MS patients",
            "probability": 0.016511046839662345,
            "start_logit": -1.2526994943618774,
            "end_logit": 1.068787693977356,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Off-label use of rituximab to treat MS patients in Sweden",
            "probability": 0.009879014331890432,
            "start_logit": -1.7833194732666016,
            "end_logit": 1.085790753364563,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Off-label use of rituximab to treat MS patients",
            "probability": 0.009712460836591953,
            "start_logit": -1.7833194732666016,
            "end_logit": 1.068787693977356,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "Sweden",
            "probability": 0.00885809907062725,
            "start_logit": -1.8924000263214111,
            "end_logit": 1.085790753364563,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "use of rituximab to treat MS patients in Sweden",
            "probability": 0.0054777354602461754,
            "start_logit": -2.3730404376983643,
            "end_logit": 1.085790753364563,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "use of rituximab to treat MS patients",
            "probability": 0.005385384547839934,
            "start_logit": -2.3730404376983643,
            "end_logit": 1.068787693977356,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "treat MS patients in Sweden is high,",
            "probability": 0.005328544895288889,
            "start_logit": 0.8714897036552429,
            "end_logit": -2.1863529682159424,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "to treat MS patients in Sweden is high,",
            "probability": 0.004676796681901494,
            "start_logit": 0.741024911403656,
            "end_logit": -2.1863529682159424,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "multiple sclerosis in Sweden",
            "probability": 0.00293210858889208,
            "start_logit": 1.6406053304672241,
            "end_logit": -3.5528249740600586,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "treat MS patients in Sweden is high",
            "probability": 0.0029053690051866064,
            "start_logit": 0.8714897036552429,
            "end_logit": -2.7928707599639893,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "to treat MS patients in Sweden is high",
            "probability": 0.0025500057501944904,
            "start_logit": 0.741024911403656,
            "end_logit": -2.7928707599639893,
            "question_text": "List off label uses for Rituximab."
        },
        {
            "text": "multiple",
            "probability": 0.0024959063982887236,
            "start_logit": 1.6406053304672241,
            "end_logit": -3.713894844055176,
            "question_text": "List off label uses for Rituximab."
        }
    ],
    "5c890ff475a4a5d219000010": [
        {
            "text": "bronchial asthma",
            "probability": 0.15025401935667573,
            "start_logit": 5.728762149810791,
            "end_logit": 6.278196334838867,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchitis and bronchial asthma",
            "probability": 0.14197316513119354,
            "start_logit": 5.672072887420654,
            "end_logit": 6.278196334838867,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchitis",
            "probability": 0.09061165679223356,
            "start_logit": 5.672072887420654,
            "end_logit": 5.829141139984131,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchial asthma; against the common cold and lung emphysema",
            "probability": 0.07858348959787663,
            "start_logit": 5.728762149810791,
            "end_logit": 5.630030632019043,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchitis and bronchial asthma; against the common cold and lung emphysema",
            "probability": 0.07425256770523177,
            "start_logit": 5.672072887420654,
            "end_logit": 5.630030632019043,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchial asthma; against the common cold",
            "probability": 0.07413599527404093,
            "start_logit": 5.728762149810791,
            "end_logit": 5.571770191192627,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "bronchitis and bronchial asthma; against the common cold",
            "probability": 0.07005018530799895,
            "start_logit": 5.672072887420654,
            "end_logit": 5.571770191192627,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "loosening agent in bronchitis and bronchial asthma",
            "probability": 0.05164243389629273,
            "start_logit": 4.660778522491455,
            "end_logit": 6.278196334838867,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "loosening agent in bronchitis",
            "probability": 0.03295979554870369,
            "start_logit": 4.660778522491455,
            "end_logit": 5.829141139984131,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "as a loosening agent in bronchitis and bronchial asthma",
            "probability": 0.02948666023535688,
            "start_logit": 4.100372791290283,
            "end_logit": 6.278196334838867,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "loosening agent in bronchitis and bronchial asthma; against the common cold and lung emphysema",
            "probability": 0.02700921202823081,
            "start_logit": 4.660778522491455,
            "end_logit": 5.630030632019043,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "asthma",
            "probability": 0.02696761917184512,
            "start_logit": 4.011071681976318,
            "end_logit": 6.278196334838867,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "loosening agent in bronchitis and bronchial asthma; against the common cold",
            "probability": 0.025480604456824648,
            "start_logit": 4.660778522491455,
            "end_logit": 5.571770191192627,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "lung emphysema",
            "probability": 0.02455223608559822,
            "start_logit": 4.565403461456299,
            "end_logit": 5.630030632019043,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "a loosening agent in bronchitis and bronchial asthma",
            "probability": 0.023178349859736783,
            "start_logit": 3.8596534729003906,
            "end_logit": 6.278196334838867,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "as a loosening agent in bronchitis",
            "probability": 0.018819296834908125,
            "start_logit": 4.100372791290283,
            "end_logit": 5.829141139984131,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "as a loosening agent in bronchitis and bronchial asthma; against the common cold and lung emphysema",
            "probability": 0.015421648404498004,
            "start_logit": 4.100372791290283,
            "end_logit": 5.630030632019043,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "against the common cold and lung emphysema",
            "probability": 0.015279077802471664,
            "start_logit": 4.091084957122803,
            "end_logit": 5.630030632019043,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "a loosening agent in bronchitis",
            "probability": 0.014793138411473889,
            "start_logit": 3.8596534729003906,
            "end_logit": 5.829141139984131,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        },
        {
            "text": "as a loosening agent in bronchitis and bronchial asthma; against the common cold",
            "probability": 0.01454884809880824,
            "start_logit": 4.100372791290283,
            "end_logit": 5.571770191192627,
            "question_text": "Name the uses of Sideritis scardica in traditional medicine."
        }
    ],
    "5c979ffcecadf2e73f000028": [
        {
            "text": "Toxocara cani and T. cati",
            "probability": 0.28074111997359324,
            "start_logit": 5.821109294891357,
            "end_logit": 5.7716288566589355,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara cani",
            "probability": 0.2151516325529352,
            "start_logit": 5.821109294891357,
            "end_logit": 5.5055389404296875,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. cati",
            "probability": 0.17158152932505188,
            "start_logit": 5.328734874725342,
            "end_logit": 5.7716288566589355,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworms Toxocara cani and T. cati",
            "probability": 0.12128744724572911,
            "start_logit": 4.981839656829834,
            "end_logit": 5.7716288566589355,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworms Toxocara cani",
            "probability": 0.09295108705682716,
            "start_logit": 4.981839656829834,
            "end_logit": 5.5055389404296875,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "dog and cat roundworms Toxocara cani and T. cati",
            "probability": 0.02872846979431076,
            "start_logit": 3.54156494140625,
            "end_logit": 5.7716288566589355,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "dog and cat roundworms Toxocara cani",
            "probability": 0.02201664358101526,
            "start_logit": 3.54156494140625,
            "end_logit": 5.5055389404296875,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "cat roundworms Toxocara cani and T. cati",
            "probability": 0.011829768549112342,
            "start_logit": 2.6542954444885254,
            "end_logit": 5.7716288566589355,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworm",
            "probability": 0.00996408908879224,
            "start_logit": 4.981839656829834,
            "end_logit": 3.2724530696868896,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "cat roundworms Toxocara cani",
            "probability": 0.009065982269730528,
            "start_logit": 2.6542954444885254,
            "end_logit": 5.5055389404296875,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworms",
            "probability": 0.007779713744420342,
            "start_logit": 4.981839656829834,
            "end_logit": 3.0249850749969482,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara",
            "probability": 0.0052605504733063335,
            "start_logit": 5.821109294891357,
            "end_logit": 1.7944315671920776,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "Toxocara cani and T. cati,",
            "probability": 0.004345367783194367,
            "start_logit": 5.821109294891357,
            "end_logit": 1.6033062934875488,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "cani and T. cati",
            "probability": 0.003925977063132572,
            "start_logit": 1.551291584968567,
            "end_logit": 5.7716288566589355,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "cati",
            "probability": 0.00319596928734811,
            "start_logit": 1.345566749572754,
            "end_logit": 5.7716288566589355,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "cani",
            "probability": 0.0030087518870687774,
            "start_logit": 1.551291584968567,
            "end_logit": 5.5055389404296875,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "T. cati,",
            "probability": 0.0026557735816913116,
            "start_logit": 5.328734874725342,
            "end_logit": 1.6033062934875488,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "dog and cat roundworm",
            "probability": 0.002360120844453416,
            "start_logit": 3.54156494140625,
            "end_logit": 3.2724530696868896,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworms Toxocara",
            "probability": 0.002272694281744875,
            "start_logit": 4.981839656829834,
            "end_logit": 1.7944315671920776,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        },
        {
            "text": "roundworms Toxocara cani and T. cati,",
            "probability": 0.0018773116165421416,
            "start_logit": 4.981839656829834,
            "end_logit": 1.6033062934875488,
            "question_text": "What are 2 organisms that can cause Human toxocariasis?"
        }
    ],
    "5c97f579ecadf2e73f00002a": [
        {
            "text": "central nervous system",
            "probability": 0.6088031003913609,
            "start_logit": 3.406078338623047,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "substantia nigra",
            "probability": 0.34440925991242954,
            "start_logit": 3.134702205657959,
            "end_logit": 3.358074903488159,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "central nervous system (CNS)",
            "probability": 0.017556967851079932,
            "start_logit": 3.406078338623047,
            "end_logit": 0.11031901091337204,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nervous system",
            "probability": 0.008269508720210577,
            "start_logit": -0.8928414583206177,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "central",
            "probability": 0.006765388479427906,
            "start_logit": 3.406078338623047,
            "end_logit": -0.8433122038841248,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "the central nervous system",
            "probability": 0.002680467362704638,
            "start_logit": -2.019425392150879,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "central nervous",
            "probability": 0.002480755880626664,
            "start_logit": 3.406078338623047,
            "end_logit": -1.8465685844421387,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nigra",
            "probability": 0.0019871272860451923,
            "start_logit": -2.0204384326934814,
            "end_logit": 3.358074903488159,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "system",
            "probability": 0.0018165896965960813,
            "start_logit": -2.4084556102752686,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "stantia nigra",
            "probability": 0.0009058886554803295,
            "start_logit": -2.805967330932617,
            "end_logit": 3.358074903488159,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "throughout the central nervous system",
            "probability": 0.0009003916305789217,
            "start_logit": -3.110342025756836,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "abundant throughout the central nervous system",
            "probability": 0.000780285915372645,
            "start_logit": -3.253511428833008,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "gra",
            "probability": 0.0007216783334814457,
            "start_logit": -3.033304214477539,
            "end_logit": 3.358074903488159,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "substantia nigra (SN)",
            "probability": 0.0005422237216809051,
            "start_logit": 3.134702205657959,
            "end_logit": -3.095832347869873,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "neuromodulator which is abundant throughout the central nervous system",
            "probability": 0.0004278561069679187,
            "start_logit": -3.8543848991394043,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "(SST) is a neuromodulator which is abundant throughout the central nervous system",
            "probability": 0.0002567694868613545,
            "start_logit": -4.364993095397949,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "nervous system (CNS)",
            "probability": 0.00023848022234385864,
            "start_logit": -0.8928414583206177,
            "end_logit": 0.11031901091337204,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "sub",
            "probability": 0.0001638918887931366,
            "start_logit": 3.134702205657959,
            "end_logit": -4.292304039001465,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "central nervous system (",
            "probability": 0.00014820885905614392,
            "start_logit": 3.406078338623047,
            "end_logit": -4.664264678955078,
            "question_text": "List places in the body where somatostatin is produced."
        },
        {
            "text": "Somatostatin (SST) is a neuromodulator which is abundant throughout the central nervous system",
            "probability": 0.00014515959890185886,
            "start_logit": -4.935338020324707,
            "end_logit": 3.656363010406494,
            "question_text": "List places in the body where somatostatin is produced."
        }
    ],
    "5c9f79c3ecadf2e73f00003d": [
        {
            "text": "antidietary antibodies",
            "probability": 0.3916060070893761,
            "start_logit": 2.177842140197754,
            "end_logit": 2.3787407875061035,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "TGF-\u03b22",
            "probability": 0.31464858752145985,
            "start_logit": 2.3386824131011963,
            "end_logit": 1.999100685119629,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "antidietary antibodies and TGF-\u03b22",
            "probability": 0.26790063531546976,
            "start_logit": 2.177842140197754,
            "end_logit": 1.999100685119629,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "antibodies",
            "probability": 0.009204429911404235,
            "start_logit": -1.572729229927063,
            "end_logit": 2.3787407875061035,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "antibodies and TGF-\u03b22",
            "probability": 0.006296820213023756,
            "start_logit": -1.572729229927063,
            "end_logit": 1.999100685119629,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "antidietary",
            "probability": 0.003033628691639242,
            "start_logit": 2.177842140197754,
            "end_logit": -2.4817559719085693,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "\u03b22",
            "probability": 0.0010382972179116205,
            "start_logit": -3.3751919269561768,
            "end_logit": 1.999100685119629,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "TGF-\u03b22)",
            "probability": 0.0009012633919118331,
            "start_logit": 2.3386824131011963,
            "end_logit": -3.856313467025757,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "anti",
            "probability": 0.0008782851665919543,
            "start_logit": 2.177842140197754,
            "end_logit": -3.721299409866333,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "antidietary antibodies and TGF-\u03b22)",
            "probability": 0.0007673609380601077,
            "start_logit": 2.177842140197754,
            "end_logit": -3.856313467025757,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "immunoregulatory components of colostrum (antidietary antibodies",
            "probability": 0.0005955848333836229,
            "start_logit": -4.3106255531311035,
            "end_logit": 2.3787407875061035,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "2",
            "probability": 0.0005715565702007948,
            "start_logit": -3.972165822982788,
            "end_logit": 1.999100685119629,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "T",
            "probability": 0.0004933466118450762,
            "start_logit": 2.3386824131011963,
            "end_logit": -4.458899021148682,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "antidietary antibodies and T",
            "probability": 0.0004200491468439094,
            "start_logit": 2.177842140197754,
            "end_logit": -4.458899021148682,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "immunoregulatory components of colostrum (antidietary antibodies and TGF-\u03b22",
            "probability": 0.00040744409523655494,
            "start_logit": -4.3106255531311035,
            "end_logit": 1.999100685119629,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "TGF-\u03b22) in the neonatal gut.",
            "probability": 0.0003619441966034028,
            "start_logit": 2.3386824131011963,
            "end_logit": -4.76862096786499,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "antidietary antibodies and TGF-\u03b22) in the neonatal gut.",
            "probability": 0.0003081694438313206,
            "start_logit": 2.177842140197754,
            "end_logit": -4.76862096786499,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "(antidietary antibodies",
            "probability": 0.00023684696256986987,
            "start_logit": -5.232755184173584,
            "end_logit": 2.3787407875061035,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "colostrum (antidietary antibodies",
            "probability": 0.0001677138817596893,
            "start_logit": -5.57790994644165,
            "end_logit": 2.3787407875061035,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        },
        {
            "text": "(antidietary antibodies and TGF-\u03b22",
            "probability": 0.00016202880087721924,
            "start_logit": -5.232755184173584,
            "end_logit": 1.999100685119629,
            "question_text": "What are the 3 types of immunoglobulin heavy chain containing antibodies found in human breast milk?"
        }
    ],
    "5c9fb583ecadf2e73f000042": [
        {
            "text": "Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.1118744563048462,
            "start_logit": 1.213346004486084,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "depression; 4) Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.09949555071638529,
            "start_logit": 1.0960816144943237,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "depression",
            "probability": 0.07382055267798149,
            "start_logit": 1.0960816144943237,
            "end_logit": 2.1570112705230713,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "3) How well do screening tools detect depression; 4) Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.07258823135655458,
            "start_logit": 0.7807714939117432,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "diagnosis, treatment, and improved outcomes",
            "probability": 0.07162200582825984,
            "start_logit": 0.7673710584640503,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "How well do screening tools detect depression; 4) Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.06824391117745233,
            "start_logit": 0.7190569043159485,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "depression screening; 2) What are the prevalence and predictors of screening; 3) How well do screening tools detect depression",
            "probability": 0.06009351773890764,
            "start_logit": 0.8903464078903198,
            "end_logit": 2.1570112705230713,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "3) How well do screening tools detect depression",
            "probability": 0.05385671337136071,
            "start_logit": 0.7807714939117432,
            "end_logit": 2.1570112705230713,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "How well do screening tools detect depression",
            "probability": 0.050633452488614304,
            "start_logit": 0.7190569043159485,
            "end_logit": 2.1570112705230713,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "screening tools detect depression; 4) Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.04353806477438705,
            "start_logit": 0.26960429549217224,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "depression screening; 2) What are the prevalence and predictors of screening",
            "probability": 0.03888163362477935,
            "start_logit": 0.8903464078903198,
            "end_logit": 1.7216312885284424,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "improved outcomes",
            "probability": 0.03646558867247139,
            "start_logit": 0.0923377275466919,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "screening tools detect depression",
            "probability": 0.03230299225476537,
            "start_logit": 0.26960429549217224,
            "end_logit": 2.1570112705230713,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "4) Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.03149999942301456,
            "start_logit": -0.054043784737586975,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "prevalence and predictors of screening; 3) How well do screening tools detect depression; 4) Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.030888997819660945,
            "start_logit": -0.07363124936819077,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "detect depression; 4) Does screening lead to diagnosis, treatment, and improved outcomes",
            "probability": 0.027032666028540497,
            "start_logit": -0.20698532462120056,
            "end_logit": 2.455487012863159,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "What are the prevalence and predictors of screening; 3) How well do screening tools detect depression",
            "probability": 0.02687630671284817,
            "start_logit": 0.08568953722715378,
            "end_logit": 2.1570112705230713,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "depression screening",
            "probability": 0.0244910212851448,
            "start_logit": 0.8903464078903198,
            "end_logit": 1.259415864944458,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "prevalence and predictors of screening; 3) How well do screening tools detect depression",
            "probability": 0.02291803878965632,
            "start_logit": -0.07363124936819077,
            "end_logit": 2.1570112705230713,
            "question_text": "What are 5 key questions in human performance modeling?"
        },
        {
            "text": "Does screening lead to diagnosis, treatment",
            "probability": 0.022876298954368924,
            "start_logit": 1.213346004486084,
            "end_logit": 0.8682110905647278,
            "question_text": "What are 5 key questions in human performance modeling?"
        }
    ],
    "5ca9f932ecadf2e73f000054": [
        {
            "text": "bacterial gene expression",
            "probability": 0.21194086065394555,
            "start_logit": 0.1920659840106964,
            "end_logit": -1.4536837339401245,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial",
            "probability": 0.2107461842778652,
            "start_logit": 0.1920659840106964,
            "end_logit": -1.459336519241333,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene",
            "probability": 0.08587548442494736,
            "start_logit": 0.1920659840106964,
            "end_logit": -2.3570926189422607,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "tumour",
            "probability": 0.08309887538940376,
            "start_logit": 0.5327944755554199,
            "end_logit": -2.7306883335113525,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "cells",
            "probability": 0.05998568422897405,
            "start_logit": -1.5039982795715332,
            "end_logit": -1.0198208093643188,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized in vivo using ultrasound",
            "probability": 0.04973960961420502,
            "start_logit": 0.1920659840106964,
            "end_logit": -2.9031894207000732,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized in vivo",
            "probability": 0.043385075659865796,
            "start_logit": 0.1920659840106964,
            "end_logit": -3.0398755073547363,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "engineered cells",
            "probability": 0.04267247947208917,
            "start_logit": -1.8445500135421753,
            "end_logit": -1.0198208093643188,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized in vivo using ultrasound,",
            "probability": 0.03599390411454461,
            "start_logit": 0.1920659840106964,
            "end_logit": -3.2266414165496826,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "gene expression",
            "probability": 0.033318968494682,
            "start_logit": -1.6581144332885742,
            "end_logit": -1.4536837339401245,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter genes, which are genetic constructs that allow bacterial gene expression",
            "probability": 0.02876196082996807,
            "start_logit": -1.8051875829696655,
            "end_logit": -1.4536837339401245,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter genes, which are genetic constructs that allow bacterial",
            "probability": 0.02859983430548719,
            "start_logit": -1.8051875829696655,
            "end_logit": -1.459336519241333,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "gene",
            "probability": 0.01350038190461179,
            "start_logit": -1.6581144332885742,
            "end_logit": -2.3570926189422607,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "tumour localization, and develop acoustically distinct reporters that enable multiplexed imaging of cellular populations",
            "probability": 0.012069602368072205,
            "start_logit": 0.5327944755554199,
            "end_logit": -4.660029411315918,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter genes, which are genetic constructs that allow bacterial gene",
            "probability": 0.011653945877467058,
            "start_logit": -1.8051875829696655,
            "end_logit": -2.3570926189422607,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "reporter",
            "probability": 0.010854656741480338,
            "start_logit": -1.8051875829696655,
            "end_logit": -2.428143262863159,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "cells in vivo in proof-of-concept models of gastrointestinal and tumour",
            "probability": 0.010839950324851261,
            "start_logit": -1.5039982795715332,
            "end_logit": -2.7306883335113525,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized",
            "probability": 0.009593887424426855,
            "start_logit": 0.1920659840106964,
            "end_logit": -4.548864841461182,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "bacterial gene expression to be visualized in vivo using ultrasound, a widely available inexpensive technique with deep tissue penetration and high spatial resolution",
            "probability": 0.008863896553978762,
            "start_logit": 0.1920659840106964,
            "end_logit": -4.628004550933838,
            "question_text": "What are acoustic reported genes used to detect?"
        },
        {
            "text": "expression",
            "probability": 0.008504757339133936,
            "start_logit": -3.023615598678589,
            "end_logit": -1.4536837339401245,
            "question_text": "What are acoustic reported genes used to detect?"
        }
    ],
    "5ca64b5becadf2e73f000051": [
        {
            "text": "moesin",
            "probability": 0.3452616132369187,
            "start_logit": 5.9855170249938965,
            "end_logit": 6.289514541625977,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin/radixin/moesin",
            "probability": 0.2299862506011465,
            "start_logit": 5.5792341232299805,
            "end_logit": 6.289514541625977,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin",
            "probability": 0.16618795000959877,
            "start_logit": 5.254333972930908,
            "end_logit": 6.289514541625977,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin/radixin",
            "probability": 0.11003025471071255,
            "start_logit": 5.5792341232299805,
            "end_logit": 5.552250385284424,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin",
            "probability": 0.079507807191132,
            "start_logit": 5.254333972930908,
            "end_logit": 5.552250385284424,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin",
            "probability": 0.06620594455060905,
            "start_logit": 5.5792341232299805,
            "end_logit": 5.044265270233154,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM) proteins",
            "probability": 0.0004901767260801129,
            "start_logit": 5.9855170249938965,
            "end_logit": -0.2677771747112274,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin/radixin/moesin (ERM) proteins",
            "probability": 0.0003265173510202894,
            "start_logit": 5.5792341232299805,
            "end_logit": -0.2677771747112274,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM)",
            "probability": 0.00027656072593945836,
            "start_logit": 5.9855170249938965,
            "end_logit": -0.8401127457618713,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin (ERM) proteins",
            "probability": 0.00023594127504053485,
            "start_logit": 5.254333972930908,
            "end_logit": -0.2677771747112274,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM) proteins are expressed in leukocytes and mediate cell shape changes and polarity",
            "probability": 0.0002016316295080398,
            "start_logit": 5.9855170249938965,
            "end_logit": -1.1561007499694824,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "/radixin/moesin",
            "probability": 0.00018541184047188975,
            "start_logit": -1.5439611673355103,
            "end_logit": 6.289514541625977,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "/moesin",
            "probability": 0.00018471241540395913,
            "start_logit": -1.5477405786514282,
            "end_logit": 6.289514541625977,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin/radixin/moesin (ERM)",
            "probability": 0.00018422309919145685,
            "start_logit": 5.5792341232299805,
            "end_logit": -0.8401127457618713,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "m",
            "probability": 0.00016856081478858914,
            "start_logit": 5.9855170249938965,
            "end_logit": -1.3352465629577637,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin (ERM)",
            "probability": 0.00013311951961918965,
            "start_logit": 5.254333972930908,
            "end_logit": -0.8401127457618713,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM) proteins are expressed in leukocytes and mediate cell shape changes",
            "probability": 0.00012501424723990748,
            "start_logit": 5.9855170249938965,
            "end_logit": -1.63411545753479,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "Ezrin/radixin/m",
            "probability": 0.00011228201544925354,
            "start_logit": 5.5792341232299805,
            "end_logit": -1.3352465629577637,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "moesin (ERM) proteins are expressed in leukocytes",
            "probability": 9.897483212664793e-05,
            "start_logit": 5.9855170249938965,
            "end_logit": -1.8676775693893433,
            "question_text": "List the ERM proteins."
        },
        {
            "text": "radixin/moesin (ERM) proteins are expressed in leukocytes and mediate cell shape changes and polarity",
            "probability": 9.70532080032956e-05,
            "start_logit": 5.254333972930908,
            "end_logit": -1.1561007499694824,
            "question_text": "List the ERM proteins."
        }
    ],
    "5c9007460101eac870000012": [
        {
            "text": "ATP/ADP",
            "probability": 0.2916017913808274,
            "start_logit": 3.1407861709594727,
            "end_logit": 0.7729660868644714,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ATP",
            "probability": 0.18390201077380747,
            "start_logit": 3.1407861709594727,
            "end_logit": 0.3119800090789795,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP- and ATP/ADP",
            "probability": 0.15330231788558402,
            "start_logit": 2.4978089332580566,
            "end_logit": 0.7729660868644714,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP",
            "probability": 0.12957533305181748,
            "start_logit": 2.3296594619750977,
            "end_logit": 0.7729660868644714,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP- and ATP",
            "probability": 0.09668186324214047,
            "start_logit": 2.4978089332580566,
            "end_logit": 0.3119800090789795,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ATP/ADP-Pi-actin filaments",
            "probability": 0.05205454220522438,
            "start_logit": 3.1407861709594727,
            "end_logit": -0.9501309990882874,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP- and ATP/ADP-Pi-actin filaments",
            "probability": 0.027366368151394496,
            "start_logit": 2.4978089332580566,
            "end_logit": -0.9501309990882874,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP-Pi-actin filaments",
            "probability": 0.02313080660843058,
            "start_logit": 2.3296594619750977,
            "end_logit": -0.9501309990882874,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ATP/ADP-Pi",
            "probability": 0.00989293549552288,
            "start_logit": 3.1407861709594727,
            "end_logit": -2.6106021404266357,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP- and ATP/ADP-Pi",
            "probability": 0.005200962363689862,
            "start_logit": 2.4978089332580566,
            "end_logit": -2.6106021404266357,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP-Pi",
            "probability": 0.004395996353871531,
            "start_logit": 2.3296594619750977,
            "end_logit": -2.6106021404266357,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin filaments",
            "probability": 0.004141601664911392,
            "start_logit": 0.6095767021179199,
            "end_logit": -0.9501309990882874,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "AT",
            "probability": 0.003749602901246708,
            "start_logit": 3.1407861709594727,
            "end_logit": -3.580773115158081,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "actin filaments. We mapped surface-exposed cofilin-2-specific residues required for ATP-actin",
            "probability": 0.0028843198842501377,
            "start_logit": 0.6095767021179199,
            "end_logit": -1.3119244575500488,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ATP-actin",
            "probability": 0.0028596563827886063,
            "start_logit": 0.600989043712616,
            "end_logit": -1.3119244575500488,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ATP/ADP-Pi-actin",
            "probability": 0.002746407338766826,
            "start_logit": 3.1407861709594727,
            "end_logit": -3.892129421234131,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP- and AT",
            "probability": 0.0019712595495029765,
            "start_logit": 2.4978089332580566,
            "end_logit": -3.580773115158081,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ATP/ADP-Pi-actin filaments.",
            "probability": 0.0017889834395277493,
            "start_logit": 3.1407861709594727,
            "end_logit": -4.320775508880615,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP- and ATP/ADP-Pi-actin",
            "probability": 0.0014438546790032346,
            "start_logit": 2.4978089332580566,
            "end_logit": -3.892129421234131,
            "question_text": "Name three binding partners of cofilin 2."
        },
        {
            "text": "ADP-Pi-actin filaments. We mapped surface-exposed cofilin-2-specific residues required for ATP",
            "probability": 0.00130938664769196,
            "start_logit": 2.3296594619750977,
            "end_logit": -3.82173752784729,
            "question_text": "Name three binding partners of cofilin 2."
        }
    ],
    "5c990afbecadf2e73f000030": [
        {
            "text": "UHRF1",
            "probability": 0.38845845275177726,
            "start_logit": 3.9591503143310547,
            "end_logit": 2.98529314994812,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 UBL-mediated interaction between UHRF1 and DNMT1, and the binding of DNMT1",
            "probability": 0.12954247094677934,
            "start_logit": 3.69462251663208,
            "end_logit": 2.1516435146331787,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 UBL-mediated interaction between UHRF1",
            "probability": 0.10158481633930495,
            "start_logit": 3.69462251663208,
            "end_logit": 1.9085288047790527,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 UBL-mediated interaction between UHRF1 and DNMT1",
            "probability": 0.09553886454220865,
            "start_logit": 3.69462251663208,
            "end_logit": 1.8471678495407104,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 and DNMT1, and the binding of DNMT1",
            "probability": 0.07536598974831092,
            "start_logit": 3.1529698371887207,
            "end_logit": 2.1516435146331787,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 and DNMT1",
            "probability": 0.05558316923421613,
            "start_logit": 3.1529698371887207,
            "end_logit": 1.8471678495407104,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "DNMT1",
            "probability": 0.05123191246564829,
            "start_logit": 2.7669763565063477,
            "end_logit": 2.1516435146331787,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "DNMT1, and the binding of DNMT1",
            "probability": 0.03648843922897343,
            "start_logit": 2.4276092052459717,
            "end_logit": 2.1516435146331787,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "DNMT1 to ubiquitinated histone H3 that is catalyzed by UHRF1",
            "probability": 0.02498189133482874,
            "start_logit": 2.7669763565063477,
            "end_logit": 1.4334321022033691,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 RING domain are critical for the proper subnuclear localization of DNMT1",
            "probability": 0.017241101967096252,
            "start_logit": 3.317656993865967,
            "end_logit": 0.5118964314460754,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 plays multiple roles in regulating DNMT1-mediated DNA methylation maintenance during DNA replication. The UHRF1",
            "probability": 0.005770630264249778,
            "start_logit": -0.2502546012401581,
            "end_logit": 2.98529314994812,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 UBL",
            "probability": 0.004532970471691359,
            "start_logit": 3.69462251663208,
            "end_logit": -1.2009878158569336,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF",
            "probability": 0.004365523867564471,
            "start_logit": 3.9591503143310547,
            "end_logit": -1.5031548738479614,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UBL-mediated interaction between UHRF1 and DNMT1, and the binding of DNMT1",
            "probability": 0.0028081589478790303,
            "start_logit": -0.13685718178749084,
            "end_logit": 2.1516435146331787,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UBL-mediated interaction between UHRF1",
            "probability": 0.002202106451165847,
            "start_logit": -0.13685718178749084,
            "end_logit": 1.9085288047790527,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UBL-mediated interaction between UHRF1 and DNMT1",
            "probability": 0.002071045236157555,
            "start_logit": -0.13685718178749084,
            "end_logit": 1.8471678495407104,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "UHRF1 N-terminal ubiquitin-like domain (UBL) also binds directly to DNMT1",
            "probability": 0.0008267515040191732,
            "start_logit": 1.3221503496170044,
            "end_logit": -0.530144214630127,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "DNMT1 to ubiquitinated histone H3 that is catalyzed by UHRF",
            "probability": 0.0006074116035936069,
            "start_logit": 2.7669763565063477,
            "end_logit": -2.2832677364349365,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "DNMT1 RFTS",
            "probability": 0.0005367627362318023,
            "start_logit": 1.22539222240448,
            "end_logit": -0.8653340935707092,
            "question_text": "List proteins with RING domain."
        },
        {
            "text": "DNMT1 to promote its localization onto replication foci. Here, we present the crystal structure of DNMT1",
            "probability": 0.0002615303583036462,
            "start_logit": -0.02077922411262989,
            "end_logit": -0.3381684422492981,
            "question_text": "List proteins with RING domain."
        }
    ],
    "5c9d170cecadf2e73f000032": [
        {
            "text": "obesity",
            "probability": 0.6576394259471791,
            "start_logit": 5.892611503601074,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight and obesity",
            "probability": 0.24836762803917656,
            "start_logit": 4.918864727020264,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "increased body weight",
            "probability": 0.06508618951045766,
            "start_logit": 4.918864727020264,
            "end_logit": 4.794250965118408,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "body weight and obesity",
            "probability": 0.020210668378658442,
            "start_logit": 2.410165309906006,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "body weight",
            "probability": 0.005296323851105449,
            "start_logit": 2.410165309906006,
            "end_logit": 4.794250965118408,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "weight and obesity",
            "probability": 0.0009256319578546958,
            "start_logit": -0.6733238697052002,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "besity",
            "probability": 0.00047009345344817537,
            "start_logit": -1.350869059562683,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "Human FAAH gene mutations are associated with increased body weight and obesity",
            "probability": 0.000417305987510495,
            "start_logit": -1.4699808359146118,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "associated with increased body weight and obesity",
            "probability": 0.0003030088779276948,
            "start_logit": -1.7900384664535522,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "weight",
            "probability": 0.00024256726813191506,
            "start_logit": -0.6733238697052002,
            "end_logit": 4.794250965118408,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "with increased body weight and obesity",
            "probability": 0.00017619922291053707,
            "start_logit": -2.3321852684020996,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "mutations are associated with increased body weight and obesity",
            "probability": 0.0001664922778418043,
            "start_logit": -2.3888516426086426,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "FAAH gene mutations are associated with increased body weight and obesity",
            "probability": 0.00013956286255105763,
            "start_logit": -2.5652854442596436,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "o",
            "probability": 0.00011997350945281023,
            "start_logit": 5.892611503601074,
            "end_logit": -2.4756925106048584,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "Human FAAH gene mutations are associated with increased body weight",
            "probability": 0.00010935747464912177,
            "start_logit": -1.4699808359146118,
            "end_logit": 4.794250965118408,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "obesity.",
            "probability": 7.978498624790899e-05,
            "start_logit": 5.892611503601074,
            "end_logit": -2.8836281299591064,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "associated with increased body weight",
            "probability": 7.940524861413198e-05,
            "start_logit": -1.7900384664535522,
            "end_logit": 4.794250965118408,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "gene mutations are associated with increased body weight and obesity",
            "probability": 7.77103846804688e-05,
            "start_logit": -3.1508116722106934,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "fatty acid ethanolamides (FAA). Human FAAH gene mutations are associated with increased body weight and obesity",
            "probability": 4.649672473322221e-05,
            "start_logit": -3.6644186973571777,
            "end_logit": 6.133448600769043,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        },
        {
            "text": "with increased body weight",
            "probability": 4.617403686820913e-05,
            "start_logit": -2.3321852684020996,
            "end_logit": 4.794250965118408,
            "question_text": "What conditions are associated with mutations in the gene FAAH?"
        }
    ],
    "5c961281ecadf2e73f000021": [
        {
            "text": "rheumatoid arthritis",
            "probability": 0.19988701953644003,
            "start_logit": 5.559441566467285,
            "end_logit": 5.464865207672119,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "rheumatoid arthritis, chronic lymphocytic leukemia",
            "probability": 0.15194179284918147,
            "start_logit": 5.559441566467285,
            "end_logit": 5.190610408782959,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "chronic lymphocytic leukemia",
            "probability": 0.11292114460556706,
            "start_logit": 5.262633800506592,
            "end_logit": 5.190610408782959,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "diffuse large B-cell non-Hodgkin's lymphoma, rheumatoid arthritis",
            "probability": 0.0762394403153556,
            "start_logit": 4.5955681800842285,
            "end_logit": 5.464865207672119,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "follicular and diffuse large B-cell non-Hodgkin's lymphoma",
            "probability": 0.0714698774383596,
            "start_logit": 4.928857803344727,
            "end_logit": 5.066972732543945,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis",
            "probability": 0.05532315982629282,
            "start_logit": 5.559441566467285,
            "end_logit": 4.180304527282715,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "diffuse large B-cell non-Hodgkin's lymphoma",
            "probability": 0.05121264340690733,
            "start_logit": 4.5955681800842285,
            "end_logit": 5.066972732543945,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "pemphigus vulgaris",
            "probability": 0.04915820517604186,
            "start_logit": 5.107801914215088,
            "end_logit": 4.513796329498291,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "chronic lymphocytic leukemia, granulomatosis with polyangiitis",
            "probability": 0.041115445682431036,
            "start_logit": 5.262633800506592,
            "end_logit": 4.180304527282715,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin's lymphoma, rheumatoid arthritis",
            "probability": 0.029125605992492042,
            "start_logit": 3.6333069801330566,
            "end_logit": 5.464865207672119,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "microscopic polyangiitis",
            "probability": 0.02438812880416534,
            "start_logit": 4.3486833572387695,
            "end_logit": 4.571967601776123,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "Chronic graft-versus-host disease and pemphigus vulgaris",
            "probability": 0.02365316411891136,
            "start_logit": 4.376255035400391,
            "end_logit": 4.513796329498291,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "Chronic graft-versus-host disease",
            "probability": 0.023175305909116442,
            "start_logit": 4.376255035400391,
            "end_logit": 4.493386745452881,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia",
            "probability": 0.022139490611151672,
            "start_logit": 3.6333069801330566,
            "end_logit": 5.190610408782959,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "granulomatosis with polyangiitis",
            "probability": 0.020047797122003625,
            "start_logit": 4.544369220733643,
            "end_logit": 4.180304527282715,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "non-Hodgkin's lymphoma",
            "probability": 0.019564667153034586,
            "start_logit": 3.6333069801330566,
            "end_logit": 5.066972732543945,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis",
            "probability": 0.011492604259630586,
            "start_logit": 5.559441566467285,
            "end_logit": 2.608816623687744,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "chronic lymphocytic leukemia, granulomatosis",
            "probability": 0.008541152524009409,
            "start_logit": 5.262633800506592,
            "end_logit": 2.608816623687744,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "rheumatoid arthritis, chronic lymphocytic leukemia,",
            "probability": 0.004438708265413655,
            "start_logit": 5.559441566467285,
            "end_logit": 1.6574763059616089,
            "question_text": "List 3 indications for rituximab."
        },
        {
            "text": "granulomatosis",
            "probability": 0.004164646403494985,
            "start_logit": 4.544369220733643,
            "end_logit": 2.608816623687744,
            "question_text": "List 3 indications for rituximab."
        }
    ]
}
